PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, ZJ; Zhao, H; He, L; Shi, YH; Qin, YY; Shi, YY; Li, ZQ; You, L; Zhao, JL; Liu, JY; Liang, XY; Zhao, XM; Zhao, JZ; Sun, YP; Zhang, B; Jiang, H; Zhao, DN; Bian, YH; Gao, XA; Geng, L; Li, YR; Zhu, DY; Sun, XQ; Xu, JE; Hao, CF; Ren, CE; Zhang, YJ; Chen, SL; Zhang, W; Yang, AJ; Yan, JH; Li, YA; Ma, JL; Zhao, YR				Chen, Zi-Jiang; Zhao, Han; He, Lin; Shi, Yuhua; Qin, Yingying; Shi, Yongyong; Li, Zhiqiang; You, Li; Zhao, Junli; Liu, Jiayin; Liang, Xiaoyan; Zhao, Xiaoming; Zhao, Junzhao; Sun, Yingpu; Zhang, Bo; Jiang, Hong; Zhao, Dongni; Bian, Yuehong; Gao, Xuan; Geng, Ling; Li, Yiran; Zhu, Dongyi; Sun, Xiuqin; Xu, Jin-e; Hao, Cuifang; Ren, Chun-e; Zhang, Yajie; Chen, Shiling; Zhang, Wei; Yang, Aijun; Yan, Junhao; Li, Yuan; Ma, Jinlong; Zhao, Yueran			Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3	NATURE GENETICS			English	Article							HORMONE RECEPTOR GENE; CHINESE WOMEN; POLYMORPHISMS; MUTATIONS; DISEASE; GLUCOSE; METAANALYSIS; PREVALENCE; PROMOTER; FAILURE	Polycystic ovary syndrome (PCOS) is a common metabolic disorder in women. To identify causative genes, we conducted a genome-wide association study (GWAS) of PCOS in Han Chinese. The discovery set included 744 PCOS cases and 895 controls; subsequent replications involved two independent cohorts (2,840 PCOS cases and 5,012 controls from northern Han Chinese; 498 cases and 780 controls from southern and central Han Chinese). We identified strong evidence of associations between PCOS and three loci: 2p16.3 (rs13405728; combined P-value by meta-analysis P-meta = 7.55 x 10(-21), odds ratio (OR) 0.71); 2p21 (rs13429458, P-meta = 1.73 x 10(-23), OR 0.67); and 9q33.3 (rs2479106, P-meta = 8.12 x 10(-19), OR 1.34). These findings provide new insight into the pathogenesis of PCOS. Follow-up studies of the candidate genes in these regions are recommended.	[Chen, Zi-Jiang; Zhao, Han; Shi, Yuhua; Qin, Yingying; You, Li; Bian, Yuehong; Gao, Xuan; Geng, Ling; Yan, Junhao; Li, Yuan; Ma, Jinlong; Zhao, Yueran] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Shandong, Peoples R China; [Chen, Zi-Jiang; Zhao, Han; Shi, Yuhua; Qin, Yingying; You, Li; Bian, Yuehong; Gao, Xuan; Geng, Ling; Yan, Junhao; Li, Yuan; Ma, Jinlong; Zhao, Yueran] Shandong Key Lab Reprod Med, Jinan, Shandong, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [He, Lin; Shi, Yongyong; Li, Zhiqiang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Ctr, Shanghai 200030, Peoples R China; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Zhao, Junli] Ningxia Med Univ, Affiliated Hosp, Ningxia, Peoples R China; [Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Liang, Xiaoyan] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Zhao, Xiaoming] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai 200030, Peoples R China; [Zhao, Junzhao] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Zhang, Bo] Maternal & Child Hlth Hosp Guangxi, Guangxi, Peoples R China; [Zhao, Dongni] China Med Univ, Shengjing Hosp, Liaoning, Peoples R China; [Li, Yiran] Qingdao Women & Children Med Healthcare Ctr, Qingdao, Shandong, Peoples R China; [Li, Yiran; Ren, Chun-e] Affiliated Hosp, Weifang Med Coll, Weifang, Shandong, Peoples R China; [Zhu, Dongyi] Linyi Peoples Hosp, Linyi, Shandong, Peoples R China; [Sun, Xiuqin] Shandong Jingning First Peoples Hosp, Jingning, Shandong, Peoples R China; [Xu, Jin-e] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China; [Zhang, Yajie] Jinan Hlth Inst Matern & Infant, Jinan, Shandong, Peoples R China; [Chen, Shiling] Nanfang Hosp, Nanfang, Guangdong, Peoples R China; [Zhang, Wei] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Yang, Aijun] Jining Med Coll, Affiliated Hosp, Jining, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Ningxia Medical University; Nanjing Medical University; Sun Yat Sen University; Shanghai Jiao Tong University; Wenzhou Medical University; Zhengzhou University; Weifang Medical University; Qingdao University; Southern Medical University - China; Fudan University; Jining Medical University	Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Shandong, Peoples R China.	zjchen59@yahoo.com; shiyongyong@gmail.com	Yan, Junhao/AAH-8310-2019; Li, Zhiqiang/AAI-4003-2021; liang, xiaoyan/GYJ-5006-2022; Li, Yuan/GXV-1310-2022; Shi, Yongyong/GSO-1627-2022; Chen, Zi-Jiang/GOE-6119-2022	Li, Zhiqiang/0000-0002-0174-9254; Shi, Yongyong/0000-0003-1710-1505; Chen, Zi-Jiang/0000-0001-6637-6631	National Basic Research Program of China (973 Program) [2006CB944004, 2010CB945000, 2007CB947403, 2007CB914703, 2007CB947300, 2010CB529600]; National 863 Project of China [2006AA02A407, 2009AA022701]; National Natural Science Foundation of China [30973170]; Shanghai Municipal Commission of Science and Technology [09DJ1400601]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National 863 Project of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology	We thank all participants involved in this study. We thank J. Simpson for revising this manuscript and X. Xu, X. Xing, T. Li, M. Guo, L. Cui, Q. Zheng, C. Li, J. Zhang, D. Wu, C. Zhang, X. Yan, W. He, Y. Cui, M. Xia, J. Li, P. Wang, H. Lv, S. Xu and L. Wang for subject recruitment. This study was supported by grants from the National Basic Research Program of China (973 Program-2006CB944004, 2010CB945000, 2007CB947403, 2007CB914703, 2007CB947300, 2010CB529600), the National 863 Project of China grants (2006AA02A407, 2009AA022701), the National Natural Science Foundation of China (30973170) and the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen Zi-jiang, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P582; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Drieschner N, 2006, THYROID, V16, P1091, DOI 10.1089/thy.2006.16.1091; Du J, 2010, MOL GENET METAB, V100, P292, DOI 10.1016/j.ymgme.2010.03.018; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Espinos-Gomez JJ, 2009, GYNECOL ENDOCRINOL, V25, P199, DOI 10.1080/09513590802585597; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Huang M, 2006, INT J MOL MED, V17, P599; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kulshreshtha B, 2008, GYNECOL ENDOCRINOL, V24, P637, DOI 10.1080/09513590802342858; Latronico AC, 2000, CLIN ENDOCRINOL, V53, P609, DOI 10.1046/j.1365-2265.2000.01135.x; Latronico AC, 1998, MOL ENDOCRINOL, V12, P442, DOI 10.1210/me.12.3.442; MANTEL N, 1959, J NATL CANCER I, V22, P719; Olszanecka-Glinianowicz M, 2007, EUR J OBSTET GYN R B, V133, P197, DOI 10.1016/j.ejogrb.2006.10.037; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Radziuk J, 2000, J CLIN ENDOCR METAB, V85, P4426, DOI 10.1210/jc.85.12.4426; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shi YH, 2008, FERTIL STERIL, V90, P1139, DOI 10.1016/j.fertnstert.2007.07.1375; Shi YH, 2007, NEUROENDOCRINOL LETT, V28, P807; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Toledo SPA, 1996, J CLIN ENDOCR METAB, V81, P3850, DOI 10.1210/jc.81.11.3850; Tong Y, 2001, HORM METAB RES, V33, P221, DOI 10.1055/s-2001-14941; Valkenburg O, 2009, HUM REPROD, V24, P2014, DOI 10.1093/humrep/dep113; Villuendas G, 2002, J CLIN ENDOCR METAB, V87, P1134, DOI 10.1210/jc.87.3.1134; Wang Y, 2006, FERTIL STERIL, V86, P223, DOI 10.1016/j.fertnstert.2005.12.037; Wild Sarah, 2000, Hum Fertil (Camb), V3, P101, DOI 10.1080/1464727002000198781; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yi P, 2009, PRENATAL DIAG, V29, P217, DOI 10.1002/pd.2072; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	39	473	511	3	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					55	U75		10.1038/ng.732	http://dx.doi.org/10.1038/ng.732			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21151128				2022-12-17	WOS:000285683500016
J	Katayama, H; Sasai, K; Kawai, H; Yuan, ZM; Bondaruk, J; Suzuki, F; Fujii, S; Arlinghaus, RB; Czerniak, BA; Sen, S				Katayama, H; Sasai, K; Kawai, H; Yuan, ZM; Bondaruk, J; Suzuki, F; Fujii, S; Arlinghaus, RB; Czerniak, BA; Sen, S			Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53	NATURE GENETICS			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; TUMOR AMPLIFIED KINASE; PROLYL ISOMERASE PIN1; CENTROSOME AMPLIFICATION; CELL-DIVISION; DNA-BINDING; PROTEIN; GENE; REGULATOR; REQUIRES	Aurora kinase A (also called STK15 and BTAK) is overexpressed in many human cancers. Ectopic overexpression of aurora kinase A in mammalian cells induces centrosome amplification, chromosome instability and oncogenic transformation, a phenotype characteristic of loss-of-function mutations of p53. Here we show that aurora kinase A phosphorylates p53 at Ser315, leading to its ubiquitination by Mdm2 and proteolysis. p53 is not degraded in the presence of inactive aurora kinase A or ubiquitination-defective Mdm2. Destabilization of p53 by aurora kinase A is abrogated in the presence of mutant Mdm2 that is unable to bind p53 and after repression of Mdm2 by RNA interference. Silencing of aurora kinase A results in less phosphorylation of p53 at Ser315, greater stability of p53 and cell-cycle arrest at G2-M. Cells depleted of aurora kinase A are more sensitive to cisplatin-induced apoptosis, and elevated expression of aurora kinase A abolishes this response. In a sample of bladder tumors with wildtype p53, elevated expression of aurora kinase A was correlated with low p53 concentration. We conclude that aurora kinase A is a key regulatory component of the p53 pathway and that overexpression of aurora kinase A leads to increased degradation of p53, causing downregulation of checkpoint-response pathways and facilitating oncogenic transformation of cells.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA; Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA; Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima 7348553, Japan; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Hiroshima University; University of Texas System; UTMD Anderson Cancer Center	Sen, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Div Pathol & Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ssen@mail.mdanderson.org	高, 雨莉/HGU-8187-2022	Kawai, Hidehiko/0000-0003-2213-7166				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; CHAN CSM, 1993, GENETICS, V135, P677; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giet R, 1999, J CELL SCI, V112, P3591; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Goepfert TM, 2000, CURR TOP DEV BIOL, V49, P331; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kiat LS, 2002, J BIOL CHEM, V277, P45558, DOI 10.1074/jbc.M206820200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu JX, 1996, MOL CELL BIOL, V16, P998; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Sen S, 1997, P NATL ACAD SCI USA, V94, P6164, DOI 10.1073/pnas.94.12.6164; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shaw P, 1996, ONCOGENE, V12, P921; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Shieh SY, 2000, GENE DEV, V14, P289; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Tanaka T, 1999, CANCER RES, V59, P2041; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	48	473	501	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					55	62		10.1038/ng1279	http://dx.doi.org/10.1038/ng1279			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702041	Bronze			2022-12-17	WOS:000187666800014
J	Hirotsune, S; Fleck, MW; Gambello, MJ; Bix, GJ; Chen, A; Clark, GD; Ledbetter, DH; McBain, CJ; Wynshaw-Boris, A				Hirotsune, S; Fleck, MW; Gambello, MJ; Bix, GJ; Chen, A; Clark, GD; Ledbetter, DH; McBain, CJ; Wynshaw-Boris, A			Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality	NATURE GENETICS			English	Article							PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; CYCLIN-DEPENDENT KINASE-5; CORTICAL DEVELOPMENT; ASPERGILLUS-NIDULANS; CELL-MIGRATION; REELER MICE; BRAIN; PROTEIN; SUBUNIT	Heterozygous mutation or deletion of the beta subunit of platelet-activating factor acetylhydrolase (PAFAH1B1, also known as LIS1) in humans is associated with type I lissencephaly, a severe developmental brain disorder thought to result from abnormal neuronal migration. To further understand the function of PAFAH1B1, we produced three different mutant alleles in mouse Pafah1b1. Homozygous null mice die early in embryogenesis soon after implantation. Mice with one inactive allele display cortical, hippocampal and olfactory bulb disorganization resulting from delayed neuronal migration by a cell-autonomous neuronal pathway.. Mice with further reduction of Pafah1b1 activity display more severe brain disorganization as well as cerebellar defects. Our results demonstrate an essential, dosage-sensitive neuronal-specific role for Pafah1b1 in neuronal migration throughout the brain, and an essential role in early embryonic development. The phenotypes observed are distinct from those of other mouse mutants with neuronal migration defects, suggesting that Pafah1b1 participates in a novel pathway for neuronal migration.	NICHHD, Genet Dis Res Branch, Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Baylor Coll Med, Cain Fdn Res Labs, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Cain Fdn Res Labs, Div Neurosci, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Chicago; Baylor College of Medicine; Baylor College of Medicine	Wynshaw-Boris, A (corresponding author), NICHHD, Genet Dis Res Branch, Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037146] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37146] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; ASOU H, 1992, NEUROSCI LETT, V144, P221, DOI 10.1016/0304-3940(92)90754-U; Barkovich AJ, 1996, NEUROPEDIATRICS, V27, P59, DOI 10.1055/s-2007-973750; Bix GJ, 1998, J NEUROSCI, V18, P307; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Clark GD, 1995, NEUROREPORT, V6, P2569, DOI 10.1097/00001756-199512150-00029; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; DOVER R, 1994, HISTOCHEMISTRY, V102, P383, DOI 10.1007/BF00268909; Garrett W.M., 1998, BIOCHEMICA, V1, P17; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Luna L.G., 1992, HISTOPATHOLOGICAL ME; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; NAGATA I, 1994, INT J DEV NEUROSCI, V12, P387, DOI 10.1016/0736-5748(94)90022-1; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; OSHIMA T, 1996, P NATL ACAD SCI USA, V93, P11173; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; REINER O, 1995, J NEUROSCI, V15, P3730; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RELD CB, 1996, PROGR BRAIN RES, P17; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; WILLINS DA, 1995, GENETICS, V141, P1287; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297	43	473	481	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					333	339		10.1038/1221	http://dx.doi.org/10.1038/1221			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697693				2022-12-17	WOS:000075107600015
J	Laporte, J; Hu, LJ; Kretz, C; Mandel, JL; Kioschis, P; Coy, JF; Klauck, SM; Poustka, A; Dahl, N				Laporte, J; Hu, LJ; Kretz, C; Mandel, JL; Kioschis, P; Coy, JF; Klauck, SM; Poustka, A; Dahl, N			A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast	NATURE GENETICS			English	Article							CENTRONUCLEAR MYOPATHY; MENTAL-RETARDATION; DNA; LINKAGE; XQ28; LOCALIZATION; SEQUENCES; HOMOLOGY; PROTEINS; RNA	X-linked recessive myotubular myopathy (MTM1) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. We have restricted the candidate region to 280 kb and characterized two candidate genes using positional cloning strategies. The presence of frameshift or missense mutations (of which two are new mutations) in seven patients proved that one of these genes is indeed implicated in MTM1. The protein encoded by the MTM1 gene is highly conserved in yeast, which is surprising for a muscle specific disease. The protein contains the consensus sequence for the active site of tyrosine phosphatases, a wide class of proteins involved in signal transduction. At least three other genes, one located within 100 kb distal from the MTM1 gene, encode proteins with very high sequence similarities and define, together with the MTM1 gene, a new family of putative tyrosine phosphatases in man.	UNIV STRASBOURG 1,CNRS,INSERM,INST GENET & BIOL MOL & CELLULAIRE,F-67404 ILLKIRCH GRAFFENS,FRANCE; DEUTSCH KREBSFORSCHUNGSZENTRUM,ABT MOL GENOMANAL,D-69120 HEIDELBERG,GERMANY; UNIV UPPSALA,CHILDRENS HOSP,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; German Cancer Research Center (DKFZ); Uppsala University			laporte, jocelyn/J-7008-2012; Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSSON B, 1995, DNA SEQUENCE, V5, P219, DOI 10.3109/10425179509030969; BERRY R, 1995, NAT GENET, V10, P415, DOI 10.1038/ng0895-415; BIANCALANA V, 1991, HUM GENET, V88, P228, DOI 10.1007/BF00206078; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DAHL N, 1994, J MED GENET, V31, P922, DOI 10.1136/jmg.31.12.922; DAHL N, 1995, AM J HUM GENET, V56, P1108; DARNFORS C, 1990, CLIN GENET, V37, P335; DONOGHUE MJ, 1994, TRENDS GENET, V10, P396, DOI 10.1016/0168-9525(94)90056-6; FARDEAU M, 1992, SKELETAL MUSCLE PATH; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; GEDEON A, 1991, J MED GENET, V28, P372, DOI 10.1136/jmg.28.6.372; GREGG RG, 1991, GENOMICS, V9, P701, DOI 10.1016/0888-7543(91)90363-J; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HECKMATT JZ, 1985, BRAIN, V108, P941, DOI 10.1093/brain/108.4.941; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; HU LJ, IN PRESS HUM GENET; JANSSEN EAM, 1994, NEUROMUSCULAR DISORD, V4, P455, DOI 10.1016/0960-8966(94)90084-1; KIOSCHIS P, IN PRESS GENOMICS; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LANFRANCHI G, IN PRESS GENOME RES; LEHESJOKI AE, 1990, J MED GENET, V27, P288, DOI 10.1136/jmg.27.5.288; LIECHTIGALLATI S, 1991, NEUROMUSCULAR DISORD, V4, P239; MAURO LJ, 1994, J BIOL CHEM, V269, P30659; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOUREY RJ, 1994, CURR OPIN GENET DEV, V4, P31, DOI 10.1016/0959-437X(94)90088-4; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; SAMSON F, 1995, AM J HUM GENET, V57, P120; SARNAT HB, 1990, CAN J NEUROL SCI, V17, P109, DOI 10.1017/S0317167100030304; SAWCHAK JA, 1991, NEUROLOGY, V41, P135, DOI 10.1212/WNL.41.1.135; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; STARR J, 1990, J MED GENET, V27, P281, DOI 10.1136/jmg.27.5.281; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; THOMAS NST, 1990, J MED GENET, V27, P284, DOI 10.1136/jmg.27.5.284; Tonks N K, 1993, Semin Cell Biol, V4, P373, DOI 10.1006/scel.1993.1044; TUGENDREICH S, 1994, HUM MOL GENET, V3, P1509, DOI 10.1093/hmg/3.suppl_1.1509; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLGRENPETTERSSON C, 1994, NEUROMUSCULAR DISORD, V4, P71, DOI 10.1016/0960-8966(94)90050-7; WALLGRENPETTERSSON C, 1995, J MED GENET, V32, P673, DOI 10.1136/jmg.32.9.673; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Xu Y, 1994, Genet Eng (N Y), V16, P241; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949	52	473	491	1	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					175	182		10.1038/ng0696-175	http://dx.doi.org/10.1038/ng0696-175			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640223				2022-12-17	WOS:A1996UN39500016
J	Smallwood, SA; Tomizawa, S; Krueger, F; Ruf, N; Carli, N; Segonds-Pichon, A; Sato, S; Hata, K; Andrews, SR; Kelsey, G				Smallwood, Sebastien A.; Tomizawa, Shin-ichi; Krueger, Felix; Ruf, Nico; Carli, Natasha; Segonds-Pichon, Anne; Sato, Shun; Hata, Kenichiro; Andrews, Simon R.; Kelsey, Gavin			Dynamic CpG island methylation landscape in oocytes and preimplantation embryos	NATURE GENETICS			English	Article							MATERNAL GENOMIC IMPRINTS; DNA METHYLATION; GERM-CELLS; HISTONE H3; DNMT3L; DOMAIN; ESTABLISHMENT; TRANSCRIPTION; GENES	Elucidating how and to what extent CpG islands (CGIs) are methylated in germ cells is essential to understand genomic imprinting and epigenetic reprogramming(1-3). Here we present, to our knowledge, the first integrated epigenomic analysis of mammalian oocytes, identifying over a thousand CGIs methylated in mature oocytes. We show that these CGIs depend on DNMT3A and DNMT3L(4,5) but are not distinct at the sequence level, including in CpG periodicity(6). They are preferentially located within active transcription units and are relatively depleted in H3K4me3, supporting a general transcription-dependent mechanism of methylation. Very few methylated CGIs are fully protected from post-fertilization reprogramming but, notably, the majority show incomplete demethylation in embryonic day (E) 3.5 blastocysts. Our study shows that CGI methylation in gametes is not entirely related to genomic imprinting but is a strong factor in determining methylation status in preimplantation embryos, suggesting a need to reassess mechanisms of post-fertilization demethylation.	[Smallwood, Sebastien A.; Tomizawa, Shin-ichi; Ruf, Nico; Carli, Natasha; Kelsey, Gavin] Babraham Inst, Epigenet Programme, Cambridge, England; [Krueger, Felix; Segonds-Pichon, Anne; Andrews, Simon R.] Babraham Inst, Bioinformat Grp, Cambridge, England; [Sato, Shun; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan; [Kelsey, Gavin] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; National Center for Child Health & Development - Japan; University of Cambridge	Kelsey, G (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	gavin.kelsey@babraham.ac.uk	Tomizawa, Shinichi/AAT-7149-2020; Smallwood, Sebastien/M-9783-2014; Krueger, Felix/J-3340-2019	Tomizawa, Shinichi/0000-0002-8291-6623; Krueger, Felix/0000-0002-5513-3324; Kelsey, Gavin/0000-0002-9762-5634	Medical Research Council [G0800013, G0801156]; Biotechnology and Biological Sciences Research Council; Babraham Institute; Centre for Trophoblast Research; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000L747, BBS/E/B/0000S222, BBS/E/B/0000M233] Funding Source: researchfish; Medical Research Council [G9723500] Funding Source: researchfish; BBSRC [BBS/E/B/0000L747, BBS/E/B/0000M233, BBS/E/B/0000S222] Funding Source: UKRI; MRC [G0801156, G9723500, G0800013] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre for Trophoblast Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Tabbada for technical assistance with Illumina sequencing, H. Mertani, P. Mollard, W. Dean and W. Reik for input and discussions and M. Branco and W. Reik for making available the DNMT3A conditional knockout line. This work was supported by grants G0800013 and G0801156 from the Medical Research Council to G. K. and by the Biotechnology and Biological Sciences Research Council. S. A. S. was supported by the Babraham Institute and the Centre for Trophoblast Research.	Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Bock C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r14; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Hata K, 2002, DEVELOPMENT, V129, P1983; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reinhart B, 2006, MOL CELL BIOL, V26, P8347, DOI 10.1128/MCB.00981-06; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Tartakover-Matalon S, 2007, HUM REPROD, V22, P1161, DOI 10.1093/humrep/del464; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	31	472	484	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					811	U126		10.1038/ng.864	http://dx.doi.org/10.1038/ng.864			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21706000	Green Accepted			2022-12-17	WOS:000293178300020
J	Noble, SM; French, S; Kohn, LA; Chen, V; Johnson, AD				Noble, Suzanne M.; French, Sarah; Kohn, Lisa A.; Chen, Victoria; Johnson, Alexander D.			Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity	NATURE GENETICS			English	Article							SIGNATURE-TAGGED MUTAGENESIS; SELECTABLE MARKER URA3; LARGE-SCALE; GENE IDENTIFICATION; FILAMENTOUS GROWTH; HYPHAL FORMATION; UNITED-STATES; VIRULENCE; MUTANTS; STRAINS	Candida albicans is the most common cause of serious fungal disease in humans. Creation of isogenic null mutants of this diploid organism, which requires sequential gene targeting, allows dissection of virulence mechanisms. Published analyses of such mutants show a near-perfect correlation between C. albicans pathogenicity and the ability to undergo a yeast-to-hypha morphological switch in vitro. However, most studies have used mutants constructed with a marker that is itself a virulence determinant and therefore complicates their interpretation. Using alternative markers, we created similar to 3,000 homozygous deletion strains affecting 674 genes, or roughly 11% of the C. albicans genome. Screening for infectivity in a mouse model and for morphological switching and cell proliferation in vitro, we identified 115 infectivity-attenuated mutants, of which nearly half demonstrated normal morphological switching and proliferation. Analysis of such mutants revealed that virulence requires the glycolipid glucosylceramide. To our knowledge, this is the first C. albicans small molecule that has been found to be required specifically for virulence.	[Noble, Suzanne M.; Kohn, Lisa A.; Chen, Victoria; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Noble, Suzanne M.; French, Sarah] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Noble, SM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	suzanne.noble@ucsf.edu		Noble, Suzanne/0000-0001-9855-8448	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [K08 AI062800, K08 AI062800-01, K08 AI062800-03, K08 AI062800-02] Funding Source: Medline; PHS HHS [R01 A149187] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI062800] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arbour M, 2009, FEMS YEAST RES, V9, P1070, DOI 10.1111/j.1567-1364.2009.00563.x; Arguelles JC, 1999, RES MICROBIOL, V150, P521, DOI 10.1016/S0923-2508(99)00105-9; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Badrane H, 2008, MICROBIOL-SGM, V154, P3296, DOI 10.1099/mic.0.2008/018002-0; Bastidas RJ, 2009, P NATL ACAD SCI USA, V106, P351, DOI 10.1073/pnas.0811994106; Bouchonville K, 2009, EUKARYOT CELL, V8, P1554, DOI 10.1128/EC.00209-09; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; Donovan M, 2001, INFECT IMMUN, V69, P2542, DOI 10.1128/IAI.69.4.2542-2548.2001; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Elson SL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000664; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Huh WK, 2001, INFECT IMMUN, V69, P3939, DOI 10.1128/IAI.69.6.3939-3946.2001; Jia N, 2002, ANTIMICROB AGENTS CH, V46, P947, DOI 10.1128/AAC.46.4.947-957.2002; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; KIRSCH DR, 1991, INFECT IMMUN, V59, P3297, DOI 10.1128/IAI.59.9.3297-3300.1991; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Mecsas J, 2002, CURR OPIN MICROBIOL, V5, P33, DOI 10.1016/S1369-5274(02)00282-5; Mio T, 2000, MICROBIOL-SGM, V146, P1753, DOI 10.1099/00221287-146-7-1753; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Pedreno Y, 2007, MICROBIOL-SGM, V153, P1372, DOI 10.1099/mic.0.2006/003921-0; Rieg G, 1999, INFECT IMMUN, V67, P3193, DOI 10.1128/IAI.67.7.3193-3198.1999; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Sharkey LL, 2005, MICROBIOL-SGM, V151, P1061, DOI 10.1099/mic.0.27487-0; Shea JE, 2000, CURR OPIN MICROBIOL, V3, P451, DOI 10.1016/S1369-5274(00)00120-X; Skrzypek MS, 2010, NUCLEIC ACIDS RES, V38, pD428, DOI 10.1093/nar/gkp836; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sundstrom P, 2002, INFECT IMMUN, V70, P3281, DOI 10.1128/IAI.70.6.3281-3283.2002; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wu W, 2007, MOL MICROBIOL, V64, P1587, DOI 10.1111/j.1365-2958.2007.05759.x; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998	51	472	488	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2010	42	7					590	U166		10.1038/ng.605	http://dx.doi.org/10.1038/ng.605			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20543849	Green Accepted			2022-12-17	WOS:000279242400011
J	Pilpel, Y; Sudarsanam, P; Church, GM				Pilpel, Y; Sudarsanam, P; Church, GM			Identifying regulatory networks by combinatorial analysis of promoter elements	NATURE GENETICS			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELL-CYCLE; COMPUTATIONAL ANALYSIS; EXCISION-REPAIR; GENOMIC SCALE; IDENTIFICATION; SEQUENCES; DATABASE	Several computational methods based on microarray data are currently used to study genome-wide transcriptional regulation. Few studies, however, address the combinatorial nature of transcription, a well-established phenomenon in eukaryotes. Here we describe a new approach using microarray data to uncover novel functional motif combinations in the promoters of Saccharomyces cerevisiae. In addition to identifying novel motif combinations that affect expression patterns during the cell cycle, sporulation and various stress responses, we observed regulatory cross-talk among several of these processes. We have also generated motif-association maps that provide a global view of transcription networks. The maps are highly connected, suggesting that a small number of transcription factors are responsible for a complex set of expression patterns in diverse conditions. This approach may be useful for modeling transcriptional regulatory networks in more complex eukaryotes.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969				Aach J, 2000, GENOME RES, V10, P431, DOI 10.1101/gr.10.4.431; ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; BULYK ML, 2001, P NATL ACAD SCI US, V12; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; KEI OV, 1995, NUCLEIC ACIDS RES, V23, P4097; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Leem SH, 1998, NUCLEIC ACIDS RES, V26, P3154, DOI 10.1093/nar/26.13.3154; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Quandt K, 1996, GENOMICS, V33, P301, DOI 10.1006/geno.1996.0197; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Umemura K, 1997, EUR J BIOCHEM, V243, P748, DOI 10.1111/j.1432-1033.1997.00748.x; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wagner A, 1999, BIOINFORMATICS, V15, P776, DOI 10.1093/bioinformatics/15.10.776; Wang J, 1999, J MOL BIOL, V286, P315, DOI 10.1006/jmbi.1998.2489; Werner T, 1999, MAMM GENOME, V10, P168, DOI 10.1007/s003359900963; Wolfsberg TG, 1999, GENOME RES, V9, P775; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	39	472	497	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					153	159		10.1038/ng724	http://dx.doi.org/10.1038/ng724			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11547334				2022-12-17	WOS:000171374100020
J	Ikeda, H; Yamaguchi, M; Sugai, S; Aze, Y; Narumiya, S; Kakizuka, A				Ikeda, H; Yamaguchi, M; Sugai, S; Aze, Y; Narumiya, S; Kakizuka, A			Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo	NATURE GENETICS			English	Article							ALZHEIMERS-DISEASE; TRANSGENE EXPRESSION; KININOGEN GENES; SEQUENCES; RECEPTOR; LOCALIZATION; APOPTOSIS; ALPHA; CDNA; ACID	Recently, we identified a novel gene, MJD1, which contains an expanded CAG triplet repeat in Machado-Joseph disease. Here we report the induction of apoptosis in cultured cells expressing a portion of the MJD1 gene that includes the expanded CAG repeats. Cell death occurs only when the CAG repeat is translated into polyglutamine residues, which apparently precipitate in large covalently modified forms. We also created ataxic transgenic mice by expressing the expanded polyglutamine stretch in Purkinje cells. Our results demonstrate the potential involvement of the expanded polyglutamine as the common aetiological agent for inherited neurodegenerative diseases with CAG expansions.	KYOTO UNIV, FAC MED, DEPT PHARMACOL, KYOTO 60601, JAPAN; ONO PHARMACEUT, FUKUI INST SAFETY RES, MIKUNI, FUKUI 913, JAPAN	Kyoto University; Ono Pharmaceutical Co Ltd				Ikeda, Hanako/0000-0001-9572-8659				Alzheimer A., 1907, Z GESAMTE NEUROL PSY, V18, P177; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; EADIE MJ, 1975, HDB CLIN NEUROLOGY, V20, P403; FLEID J, 1988, MOL CELL BIOL, V8, P2159; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GORDON JW, 1993, METHOD ENZYMOL, V225, P747; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAKIZUKA A, 1992, GENE DEV, V6, P578, DOI 10.1101/gad.6.4.578; KAKIZUKA A, 1988, J BIOL CHEM, V263, P3884; KAKIZUKA A, 1990, J BIOL CHEM, V265, P10102; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KAWAKAMI H, 1995, NAT GENET, V9, P344, DOI 10.1038/ng0495-344; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MAYEUX R, 1995, MERRITTS TXB NEUROLO; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; ROSL F, 1992, NUCLEIC ACIDS RES, V20, P5243, DOI 10.1093/nar/20.19.5243; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; SAITOU M, 1994, J BIOL CHEM, V269, P19101; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213; YAMAGUCHI M, 1992, J BIOL CHEM, V267, P22035; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	52	472	484	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					196	202		10.1038/ng0696-196	http://dx.doi.org/10.1038/ng0696-196			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640226				2022-12-17	WOS:A1996UN39500019
J	HO, C; CONNER, DA; POLLAK, MR; LADD, DJ; KIFOR, O; WARREN, HB; BROWN, EM; SEIDMAN, JG; SEIDMAN, CE				HO, C; CONNER, DA; POLLAK, MR; LADD, DJ; KIFOR, O; WARREN, HB; BROWN, EM; SEIDMAN, JG; SEIDMAN, CE			A MOUSE MODEL OF HUMAN FAMILIAL HYPOCALCIURIC HYPERCALCEMIA AND NEONATAL SEVERE HYPERPARATHYROIDISM	NATURE GENETICS			English	Article							PARATHYROID-HORMONE LEVELS; KINDREDS	Mice lacking the calcium-sensing receptor (Casr) were created to examine the receptor's role in calcium homeostasis and to elucidate the mechanism by which inherited human Casr gene defects cause diseases. Casr(+/-) mice, analogous to humans with familial hypocalciuric hypercalcemia, had benign and modest elevations of serum calcium, magnesium and parathyroid hormone levels as well as hypocalciuria. In contrast, Casr(-/-) mice, like humans with neonatal severe hyperparathyroidism, had markedly elevated serum calcium and parathyroid hormone levels, parathyroid hyperplasia, bone abnormalities, retarded growth and premature death. Our findings suggest that Casr mutations cause these human disorders by reducing the number of functional receptor molecules on the cell surface.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV RENAL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CTR ANIM RESOURCES & COMPARAT MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					NIDDK NIH HHS [DK02138, DK41415, DK46422] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K11DK002138, R01DK041415, R01DK046422] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLAIR JW, 1991, EUR J PEDIATR SURG, V1, P110, DOI 10.1055/s-2008-1042470; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BRENT GA, 1988, J CLIN ENDOCR METAB, V67, P944, DOI 10.1210/jcem-67-5-944; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; BROWN EM, 1995, AM J KIDNEY DIS, V25, P506, DOI 10.1016/0272-6386(95)90118-3; DUNN TB, 1949, J NATL CANCER I, V10, P725; ERICKSON PA, 1993, ANTIBODIES CELL BIOL, P283; HENDRICKSON BA, IN PRESS J EXP MED; HUMMEL KP, 1966, BIOL LABORATORY MOUS, P258; INGMAN F, 1966, MICROCHEM J, V10, P545, DOI 10.1016/0026-265X(66)90239-6; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; MARX SJ, 1982, NEW ENGL J MED, V306, P257, DOI 10.1056/NEJM198202043060502; MARX SJ, 1985, AM J MED, V78, P15, DOI 10.1016/0002-9343(85)90455-3; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MCMURTRY CT, 1992, AM J MED, V93, P247, DOI 10.1016/0002-9343(92)90229-5; POLLAK MR, 1994, J CLIN INVEST, V93, P1108, DOI 10.1172/JCI117062; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; POWELL BR, 1992, PEDIATRICS, V91, P144; RICCARDI D, 1994, P NATL ACAD SCI USA, V92, P131; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; SARKAR BCR, 1967, ANAL BIOCHEM, V20, P155, DOI 10.1016/0003-2697(67)90273-4; WARREN HB, 1989, ENDOCRINOLOGY, V125, P2683, DOI 10.1210/endo-125-5-2683	24	472	486	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					389	394		10.1038/ng1295-389	http://dx.doi.org/10.1038/ng1295-389			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493018				2022-12-17	WOS:A1995TH62900015
J	BARENDSE, W; ARMITAGE, SM; KOSSAREK, LM; SHALOM, A; KIRKPATRICK, BW; RYAN, AM; CLAYTON, D; LI, L; NEIBERGS, HL; ZHANG, N; GROSSE, WM; WEISS, J; CREIGHTON, P; MCCARTHY, F; RON, M; TEALE, AJ; FRIES, R; MCGRAW, RA; MOORE, SS; GEORGES, M; SOLLER, M; WOMACK, JE; HETZEL, DJS				BARENDSE, W; ARMITAGE, SM; KOSSAREK, LM; SHALOM, A; KIRKPATRICK, BW; RYAN, AM; CLAYTON, D; LI, L; NEIBERGS, HL; ZHANG, N; GROSSE, WM; WEISS, J; CREIGHTON, P; MCCARTHY, F; RON, M; TEALE, AJ; FRIES, R; MCGRAW, RA; MOORE, SS; GEORGES, M; SOLLER, M; WOMACK, JE; HETZEL, DJS			A GENETIC-LINKAGE MAP OF THE BOVINE GENOME	NATURE GENETICS			English	Article							DOPAMINE BETA-HYDROXYLASE; AMINO-ACID SEQUENCE; INSITU HYBRIDIZATION; PARATHYROID-HORMONE; NUCLEOTIDE-SEQUENCE; HUMAN CHROMOSOME-21; SYNTENIC GROUPS; COSMID CLONES; SHEEP; LOCI	A cattle genetic linkage map was constructed which marks about 90% of the expected length of the cattle genome. Over 200 DNA polymorphisms were genotyped in cattle families which comprise 295 individuals in full sibling pedigrees. One hundred and seventy-one loci were found linked to one-other locus. Twenty nine of the 30 chromosome pairs are represented by at least one of the 36 linkage groups. Less than a 50 cM difference was found in the male and female genetic maps. The conserved loci on this map show as many differences in gene order compared to humans as is found between humans and mice. The conservation is consistent with the patterns of karyotypic evolution found in the rodents, primates and artiodactyls. This map will be important for localizing quantitative trait loci and provides a basis for further mapping.	UNIV GEORGIA, DEPT PHYSIOL & PHARMACOL, ATHENS, GA 30602 USA; HEBREW UNIV JERUSALEM, DEPT GENET, IL-91904 JERUSALEM, ISRAEL; UNIV WISCONSIN, DEPT MEAT & ANIM SCI, MADISON, WI 53706 USA; TEXAS A&M UNIV, DEPT VET PATHOBIOL, COLL STN, TX 77843 USA; TEXAS A&M UNIV, CTR ANIM GENET, COLL STN, TX 77843 USA; TRINITY COLL DUBLIN, DEPT GENET, DUBLIN, IRELAND; AGR RES ORG, ANIM GENET & BREEDING UNIT, IL-50250 BET DAGAN, ISRAEL; INT LAB RES ANIM DIS, NAIROBI, KENYA; ETH ZUERICH, INST NUTZTIERWISSENSCH, CH-8092 ZURICH, SWITZERLAND; GENMARK INC, SALT LAKE CITY, UT 84108 USA	University System of Georgia; University of Georgia; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Trinity College Dublin; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Swiss Federal Institutes of Technology Domain; ETH Zurich	BARENDSE, W (corresponding author), UNIV QUEENSLAND, GEHRMANN LABS, CSIRO, DIV TROP ANIM PROD, BRISBANE, QLD 4072, AUSTRALIA.		Barendse, William J/D-8608-2011; Moore, Stephen S/F-5285-2013	Barendse, William J/0000-0002-5464-0658; Fries, Ruedi/0000-0002-4657-1787; Moore, Stephen/0000-0002-9758-166X				ANDERSSON L, 1991, IMMUNOGENETICS, V33, P188, DOI 10.1007/BF01719239; [Anonymous], 1992, Science, V258, P67; Avraham A., 1993, Animal Genetics, V24, P147; BARENDSE W, 1992, GENOMICS, V14, P38, DOI 10.1016/S0888-7543(05)80280-0; BARENDSE W, IN PRESS GENOMICS; BLANCHE H, 1991, GENOMICS, V9, P420, DOI 10.1016/0888-7543(91)90407-6; BROWN WM, 1990, NUCLEIC ACIDS RES, V18, P4614, DOI 10.1093/nar/18.15.4614; BROWN WM, 1989, NUCLEIC ACIDS RES, V17, P10495, DOI 10.1093/nar/17.24.10495; BROWN WM, 1989, NUCLEIC ACIDS RES, V17, P6397, DOI 10.1093/nar/17.15.6397; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; COLBERT EH, 1955, EVOLUTION VERTABRATE; COX DW, 1984, CYTOGENET CELL GENET, V37, P441; DEKKERS JCM, 1991, THEOR APPL GENET, V81, P212, DOI 10.1007/BF00215725; DIETZ AB, 1992, MAMM GENOME, V3, P106, DOI 10.1007/BF00431254; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRINKWATER RD, IN PRESS GENOMICS; ECHARD G, 1993, GENETIC MAPS; EGOZCUE J, 1969, COMPARATIVE MAMMALIA, P357; FAN YS, 1992, GENOMICS, V14, P542, DOI 10.1016/S0888-7543(05)80264-2; FRIES R, 1993, MAMM GENOME, V4, P405, DOI 10.1007/BF00296815; FRIES R, 1988, GENOMICS, V3, P302, DOI 10.1016/0888-7543(88)90120-6; FRIES R, 1989, J HERED, V80, P401, DOI 10.1093/oxfordjournals.jhered.a110883; GALLAGHER DS, 1992, J HERED, V83, P287, DOI 10.1093/oxfordjournals.jhered.a111215; GALLAGHER DS, 1992, J HERED, V83, P451, DOI 10.1093/oxfordjournals.jhered.a111251; GALLAGHER DS, IN PRESS MAMMAL GENO; GEORGES M, 1991, GENOMICS, V11, P24, DOI 10.1016/0888-7543(91)90098-Y; GEORGES M, 1992, Patent No. 13102; HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3; HAWKINS JW, 1987, HUM GENET, V76, P375, DOI 10.1007/BF00272448; HAY RE, 1987, BIOCHEM BIOPH RES CO, V148, P31, DOI 10.1016/0006-291X(87)91072-2; HAYES HC, 1993, MAMM GENOME, V4, P207, DOI 10.1007/BF00417564; HEDIGER R, 1990, GENOMICS, V8, P171, DOI 10.1016/0888-7543(90)90241-L; HEDIGER R, 1991, CYTOGENET CELL GENET, V57, P127, DOI 10.1159/000133131; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HILLARD AL, 1992, LOCUS MAP MOUSE COMP; IMANGHALI M, 1987, CYTOGENET CELL GENET, V46, P632; JAGIELLO GM, 1974, BIOL REPROD, V10, P354, DOI 10.1095/biolreprod10.3.354; JOHNSON SE, 1993, CYTOGENET CELL GENET, V62, P176, DOI 10.1159/000133466; JUNIEN C, 1991, CYTOGENET CELL GENET, V58, P459, DOI 10.1159/000133171; Kaukinen J., 1993, Animal Genetics, V24, P148, DOI 10.1111/j.1365-2052.1993.tb00274.x; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; KIELN J, 1993, ANNU REV IMMUNOL, V11, P269; KIM KE, 1988, DNA-J MOLEC CELL BIO, V7, P227, DOI 10.1089/dna.1988.7.227; KIRKPATRICK BW, 1992, ANIM GENET, V23, P543, DOI 10.1111/j.1365-2052.1992.tb00176.x; KORNBLIHTT AR, 1983, P NATL ACAD SCI-BIOL, V80, P3218, DOI 10.1073/pnas.80.11.3218; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KOSSAREK LM, IN PRESS J ANIM SCI; LEWIS EJ, 1990, J BIOL CHEM, V265, P1021; LOGUE DN, 1978, J REPROD FERTIL, V54, P159, DOI 10.1530/jrf.0.0540159; Medrano J. F., 1990, Animal Biotechnology, V1, P73, DOI 10.1080/10495399009525730; MOORE SS, 1992, ANIM GENET, V23, P463, DOI 10.1111/j.1365-2052.1992.tb02168.x; MOORE SS, IN PRESS MAMMAL GENO; NADIER CF, 1969, COMP MAMMALIAN CYTOG, P277; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OHNO S, 1969, COMP MAMMALIAN CYTOG, P18; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; QUMSIYEH MB, 1989, GENOMICS, V5, P160, DOI 10.1016/0888-7543(89)90103-1; RYAN AM, 1993, ANIM GENET, V24, P23, DOI 10.1111/j.1365-2052.1993.tb00914.x; RYAN AM, 1992, MAMM GENOME, V3, P575, DOI 10.1007/BF00350624; RYAN AM, IN PRESS MAMMAL GENO; SAIDIMEHTAR N, 1981, CYTOGENET CELL GENET, V30, P193, DOI 10.1159/000131610; SCHIMENTI JC, 1984, NUCLEIC ACIDS RES, V12, P1641, DOI 10.1093/nar/12.3.1641; SHALOM A, ANIM GENET, V24, P327; STEELE MR, 1991, GENOMICS, V10, P889, DOI 10.1016/0888-7543(91)90177-G; STEFFEN P, 1993, ANIM GENET, V24, P121, DOI 10.1111/j.1365-2052.1993.tb00252.x; Sun H. S., 1993, Animal Genetics, V24, P142, DOI 10.1111/j.1365-2052.1993.tb00263.x; Taylor KM, 1969, COMPARATIVE MAMMALIA, P346, DOI 10.1007/978-3-642-85943-4_21; TOLDO SS, IN PRESS MAMMAL GENO; VANRENS GLM, 1989, GENE, V78, P225, DOI 10.1016/0378-1119(89)90225-4; WANG NY, 1990, BIOCHEMISTRY-US, V29, P6466, DOI 10.1021/bi00479a019; WEAVER CA, 1984, GENE, V28, P319, DOI 10.1016/0378-1119(84)90149-5; WEIFFENBACH B, 1991, GENOMICS, V10, P173, DOI 10.1016/0888-7543(91)90498-4; White M.J.D., 1978, MODES SPECIATION; WOMACK JE, 1989, CYTOGENET CELL GENET, V51, P1109; WOMACK JE, 1991, CYTOGENET CELL GENET, V58, P2132; WOMACK JE, 1986, J HERED, V77, P2, DOI 10.1093/oxfordjournals.jhered.a110160; WOMACK JE, 1993, GENETIC MAPS; ZIEGLER A, 1991, CYTOGENET CELL GENET, V58, P295, DOI 10.1159/000133166; [No title captured]	81	472	489	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1994	6	3					227	235		10.1038/ng0394-227	http://dx.doi.org/10.1038/ng0394-227			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012383				2022-12-17	WOS:A1994MZ56200008
J	HASTBACKA, J; DELACHAPELLE, A; KAITILA, I; SISTONEN, P; WEAVER, A; LANDER, E				HASTBACKA, J; DELACHAPELLE, A; KAITILA, I; SISTONEN, P; WEAVER, A; LANDER, E			LINKAGE DISEQUILIBRIUM MAPPING IN ISOLATED FOUNDER POPULATIONS - DIASTROPHIC DYSPLASIA IN FINLAND	NATURE GENETICS			English	Article							FMS PROTO-ONCOGENE; C-FMS; RECEPTOR; GENE; POLYMORPHISM; ALLELES; MAP	Linkage disequilibrium mapping in isolated populations provides a powerful tool for fine structure localization of disease genes. Here, Luria and Delbruck's classical methods for analysing bacterial cultures are adapted to the study of human isolated founder populations in order to estimate (i) the recombination fraction between a disease locus and a marker; (ii) the expected degree of allelic homogeneity in a population; and (iii) the mutation rate of marker loci. Using these methods, we report striking linkage disequilibrium for diastrophic dysplasia (DTD) in Finland indicating that the DTD gene should lie within 0.06 centimorgans (or about 60 kilobases) of the CSF1R gene. Predictions about allelic homogeneity in Finland and mutation rates in simple sequence repeats are confirmed by independent observations.	UNIV HELSINKI, DEPT MED GENET, SF-00290 HELSINKI 29, FINLAND; FOLKHALSAN INST GENET, SF-00290 HELSINKI, FINLAND; UNIV HELSINKI, CENT HOSP, DEPT MED GENET, SF-00100 HELSINKI 10, FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV, BLOOD TRANSFUS SERV, HELSINKI, FINLAND; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, CTR GENOME RES, CAMBRIDGE, MA 02139 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)								BRODY LC, 1992, J BIOL CHEM, V267, P3302; CAVALLISFORZA LL, 1971, GNETICS HUMAN POPULA, P71; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DIETRICH W, 1992, GENETICS, V131, P423; GEDDEDAHL T, 1992, FINSKA LAKRESALLSKAP, V135, P199; GOODMAN RM, 1980, POPULATION STRUCTURE, P337; HAMPE A, 1989, ONCOGENE RES, V4, P9; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; HASTBACKA J, 1991, GENOMICS, V11, P968, DOI 10.1016/0888-7543(91)90021-6; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KAPLAN N, 1992, AM J HUM GENET, V51, P333; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIRK RL, 1980, POPULATION STRUCTURE, P13; KLEIN D, 1980, POPULATION STRUCTURE, P367; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; Luria SE, 1943, GENETICS, V28, P491; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MONONEN T, 1991, HUM GENET, V87, P266; Morton Newton E., 1980, POPULATION STRUCTURE, P43; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NORIO R, 1973, ANN CLIN RES, V5, P109; Norio R., 1981, BIOCULTURAL ASPECTS, P359; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P1160, DOI 10.1093/nar/19.5.1160-a; ROBERTS WM, 1988, CELL, V55, P655, DOI 10.1016/0092-8674(88)90224-3; SAHORTA S, 1991, GENETICS, V127, P257; Sambrook J., 1989, MOL CLONING LAB MANU; SHERR CJ, 1990, BLOOD, V75, P1; SIRUGO G, 1992, AM J HUM GENET, V50, P559; STEVENSON AC, 1967, MUTAT RES, V4, P339, DOI 10.1016/0027-5107(67)90029-2; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; VERBEEK JS, 1985, MOL CELL BIOL, V5, P422, DOI 10.1128/MCB.5.2.422; WALKER BA, 1972, MEDICINE, V51, P41, DOI 10.1097/00005792-197201000-00003; Weir BS, 1990, GENETIC DATA ANAL; XU DQ, 1985, P NATL ACAD SCI USA, V82, P2862, DOI 10.1073/pnas.82.9.2862	35	472	490	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					204	211		10.1038/ng1192-204	http://dx.doi.org/10.1038/ng1192-204			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345170				2022-12-17	WOS:A1992JW16500010
J	Wang, ZG; Ruggero, D; Ronchetti, S; Zhong, S; Gaboli, M; Rivi, R; Pandolfi, PP				Wang, ZG; Ruggero, D; Ronchetti, S; Zhong, S; Gaboli, M; Rivi, R; Pandolfi, PP			Pml is essential for multiple apoptotic pathways	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; FAS-MEDIATED APOPTOSIS; NECROSIS-FACTOR-ALPHA; RING FINGER DOMAIN; RETINOIC ACID; RAR-ALPHA; INTERFERON-GAMMA; DNA-DAMAGE; ICE-LIKE; CELLS	The PML gene of acute promyelocytic leukaemia (APL) encodes a cell growth and tumour suppressor, however, the mechanisms by which PML suppresses tumorigenesis are poorly understood. We show here that Pml is required for Fas- and caspase-dependent DNA-damage-induced apoptosis. We also found that Pml is essential for induction of programmed cell death by Fas, tumour necrosis factor a (TNF), ceramide and type I and II interferons (IFNs). As a result, Pml(-/-) mice and cells are protected from the lethal effects of ionizing radiation and anti-fas antibody. Pml is required for caspase 1 and caspase 3 activation upon exposure to these stimuli. The PML-RAR alpha fusion protein of APL renders haemopoietic progenitor cells resistant to Fas-, TNF- and IFN-induced apoptosis with a lack of caspase 3 activation, thus acting as a Pml dominant-negative product. These results demonstrate that Pml is a mediator of multiple apoptotic signals, and implicate inhibition of apoptosis in the pathogenesis of APL.	Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, Mem Sloan Kettering Canc Ctr,Dept Human Genet, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, Mem Sloan Kettering Canc Ctr,Mol Biol Program, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, Mem Sloan Kettering Canc Ctr,Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.		Ronchetti, Simona/L-2325-2013	Ronchetti, Simona/0000-0002-5639-4243	NCI NIH HHS [CA-08748, CA 71692] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA071692, P30CA008748, R01CA071692] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; HONG SH, 1997, P NATL ACAD SCI USA, V94, P9038; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kalantry S, 1997, J CELL PHYSIOL, V173, P288, DOI 10.1002/(SICI)1097-4652(199711)173:2<288::AID-JCP38>3.3.CO;2-Q; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LAVAU C, 1995, ONCOGENE, V11, P871; Lenardo M J, 1997, Semin Immunol, V9, P1, DOI 10.1006/smim.1996.0050; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; MACIEJEWSKI J, 1995, BLOOD, V85, P3183, DOI 10.1182/blood.V85.11.3183.bloodjournal85113183; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NasonBurchenal K, 1996, BLOOD, V88, P3926, DOI 10.1182/blood.V88.10.3926.bloodjournal88103926; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; Penninger JM, 1998, ADV IMMUNOL, V68, P51, DOI 10.1016/S0065-2776(08)60558-1; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; SELLERI C, 1995, J CELL PHYSIOL, V165, P538, DOI 10.1002/jcp.1041650312; Smyth MJ, 1996, BIOCHEM J, V316, P25, DOI 10.1042/bj3160025; Stadler M, 1995, ONCOGENE, V11, P2565; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Wang ZG, 1998, SCIENCE, V279, P1547; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7	41	471	491	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					266	272		10.1038/3073	http://dx.doi.org/10.1038/3073			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806545				2022-12-17	WOS:000076698100020
J	McGovern, DPB; Gardet, A; Torkvist, L; Goyette, P; Essers, J; Taylor, KD; Neale, BM; Ong, RTH; Lagace, C; Li, C; Green, T; Stevens, CR; Beauchamp, C; Fleshner, PR; Carlson, M; D'Amato, M; Halfvarson, J; Hibberd, ML; Lordal, M; Padyukov, L; Andriulli, A; Colombo, E; Latiano, A; Palmieri, O; Bernard, EJ; Deslandres, C; Hommes, DW; de Jong, DJ; Stokkers, PC; Weersma, RK; Sharma, Y; Silverberg, MS; Cho, JH; Wu, J; Roeder, K; Brant, SR; Schumm, LP; Duerr, RH; Dubinsky, MC; Glazer, NL; Haritunians, T; Ippoliti, A; Melmed, GY; Siscovick, DS; Vasiliauskas, EA; Targan, SR; Annese, V; Wijmenga, C; Pettersson, S; Rotter, JI; Xavier, RJ; Daly, MJ; Rioux, JD; Seielstad, M				McGovern, Dermot P. B.; Gardet, Agnes; Torkvist, Leif; Goyette, Philippe; Essers, Jonah; Taylor, Kent D.; Neale, Benjamin M.; Ong, Rick T. H.; Lagace, Caroline; Li, Chun; Green, Todd; Stevens, Christine R.; Beauchamp, Claudine; Fleshner, Phillip R.; Carlson, Marie; D'Amato, Mauro; Halfvarson, Jonas; Hibberd, Martin L.; Lordal, Mikael; Padyukov, Leonid; Andriulli, Angelo; Colombo, Elisabetta; Latiano, Anna; Palmieri, Orazio; Bernard, Edmond-Jean; Deslandres, Colette; Hommes, Daan W.; de Jong, Dirk J.; Stokkers, Pieter C.; Weersma, Rinse K.; Sharma, Yashoda; Silverberg, Mark S.; Cho, Judy H.; Wu, Jing; Roeder, Kathryn; Brant, Steven R.; Schumm, L. Phillip; Duerr, Richard H.; Dubinsky, Marla C.; Glazer, Nicole L.; Haritunians, Talin; Ippoliti, Andy; Melmed, Gil Y.; Siscovick, David S.; Vasiliauskas, Eric A.; Targan, Stephan R.; Annese, Vito; Wijmenga, Cisca; Pettersson, Sven; Rotter, Jerome I.; Xavier, Ramnik J.; Daly, Mark J.; Rioux, John D.; Seielstad, Mark		NIDDK IBD Genetics Consortium	Genome-wide association identifies multiple ulcerative colitis susceptibility loci	NATURE GENETICS			English	Article							GENETIC-VARIANTS; CROHNS-DISEASE; RISK; CONTRIBUTE; IMMUNITY	Ulcerative colitis is a chronic, relapsing inflammatory condition of the gastrointestinal tract with a complex genetic and environmental etiology. In an effort to identify genetic variation underlying ulcerative colitis risk, we present two distinct genome-wide association studies of ulcerative colitis and their joint analysis with a previously published scan(1), comprising, in aggregate, 2,693 individuals with ulcerative colitis and 6,791 control subjects. Fifty-nine SNPs from 14 independent loci attained an association significance of P < 10(-5). Seven of these loci exceeded genome-wide significance (P < 5 x 10(-8)). After testing an independent cohort of 2,009 cases of ulcerative colitis and 1,580 controls, we identified 13 loci that were significantly associated with ulcerative colitis (P < 5 x 10(-8)), including the immunoglobulin receptor gene FCGR2A, 5p15, 2p16 and ORMDL3 (orosomucoid1-like 3). We confirmed association with 14 previously identified ulcerative colitis susceptibility loci, and an analysis of acknowledged Crohn's disease loci showed that roughly half of the known Crohn's disease associations are shared with ulcerative colitis. These data implicate approximately 30 loci in ulcerative colitis, thereby providing insight into disease pathogenesis.	[McGovern, Dermot P. B.; Fleshner, Phillip R.; Dubinsky, Marla C.; Ippoliti, Andy; Melmed, Gil Y.; Vasiliauskas, Eric A.; Targan, Stephan R.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Gardet, Agnes; Li, Chun; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA; [Gardet, Agnes; Li, Chun; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastroenterol Unit, Boston, MA USA; [Torkvist, Leif] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Torkvist, Leif; Lordal, Mikael] Karolinska Univ Hosp, IBD Clin Res Grp, Stockholm, Sweden; [Goyette, Philippe; Lagace, Caroline; Beauchamp, Claudine; Rioux, John D.] Univ Montreal, Montreal, PQ, Canada; [Goyette, Philippe; Lagace, Caroline; Beauchamp, Claudine; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Essers, Jonah; Neale, Benjamin M.; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Taylor, Kent D.; Haritunians, Talin; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Ong, Rick T. H.; Seielstad, Mark] Genome Inst Singapore, Singapore, Singapore; [Green, Todd; Stevens, Christine R.; Xavier, Ramnik J.; Daly, Mark J.] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Carlson, Marie] Univ Uppsala Hosp, Dept Med Sci, Gastroenterol Res Grp, Uppsala, Sweden; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Halfvarson, Jonas] Orebro Univ Hosp, Dept Internal Med, Div Gastroenterol, Orebro, Sweden; [Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Lordal, Mikael] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [Padyukov, Leonid] Karolinska Univ Hosp Solna, Rheumatol Unit, Dept Med, Karolinska Inst, Stockholm, Sweden; [Andriulli, Angelo; Colombo, Elisabetta; Latiano, Anna; Palmieri, Orazio; Annese, Vito] Osped Casa Sollievo Sofferenza, Ist Ricovero & Cura Carattere Sci, San Giovanni Rotondo, Italy; [Bernard, Edmond-Jean] Univ Montreal, Ctr Hosp Univ, Montreal, PQ, Canada; [Deslandres, Colette] Hop St Justine, Dept Gastroenterol, Montreal, PQ H3T 1C5, Canada; [Hommes, Daan W.] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands; [de Jong, Dirk J.] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Stokkers, Pieter C.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [NIDDK IBD Genetics Consortium] Yale Univ, NIDDK, New Haven, CT USA; [Sharma, Yashoda; Cho, Judy H.] Yale Univ, Dept Med, Sect Digest Dis, New Haven, CT 06520 USA; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada; [Cho, Judy H.] Yale Univ, Dept Genet, New Haven, CT USA; [Wu, Jing] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Roeder, Kathryn; Brant, Steven R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Roeder, Kathryn; Brant, Steven R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Schumm, L. Phillip] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Glazer, Nicole L.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Glazer, Nicole L.; Siscovick, David S.] Univ Washington, Dept Gen Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Pettersson, Sven] Singapore Gen Hosp, Lab Inflammat Biol, Singapore 0316, Singapore; [Seielstad, Mark] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Universite de Montreal; Universite de Montreal; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cedars Sinai Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Orebro University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; IRCCS Casa Sollievo Della Sofferenza; Universite de Montreal; Universite de Montreal; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yale University; Yale University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Yale University; Carnegie Mellon University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Groningen; Karolinska Institutet; Singapore General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco	McGovern, DPB (corresponding author), Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.	mcgovernd@cshs.org; john.david.rioux@umontreal.ca; mark.seielstad@ucsf.edu	Andriulli, Angelo/B-5027-2017; Hibberd, Martin L/D-5050-2009; Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015; D'Amato, Mauro/F-2450-2010; Deslandres, Colette/AAO-5814-2021; Wijmenga, Cisca/AAE-7719-2019; Duerr, Richard H/B-4188-2009; de Jong, D.J./L-4417-2015; Halfvarson, Jonas/AAU-4687-2020; Seielstad, Mark/T-7841-2019; Palmieri, Orazio/J-7697-2012; Wijmenga, Cisca/D-2173-2009; Weersma, Rinse/ABE-3807-2021; Rotter, Jerome/AAY-6598-2021; Silverberg, Mark/B-4183-2008; Annese, Vito/AGW-4200-2022; Latiano, Anna/R-1965-2016; D'Amato, Mauro/B-5050-2019; Padyukov, Leonid/A-4890-2009	Andriulli, Angelo/0000-0001-8862-7083; Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; D'Amato, Mauro/0000-0003-2743-5197; Wijmenga, Cisca/0000-0002-5635-1614; Duerr, Richard H/0000-0001-6586-3905; Palmieri, Orazio/0000-0002-0019-7929; Annese, Vito/0000-0002-0082-892X; Latiano, Anna/0000-0003-3719-2061; D'Amato, Mauro/0000-0003-2743-5197; Glazer, Nicole/0000-0002-6397-609X; Padyukov, Leonid/0000-0003-2950-5670; Roeder, Kathryn/0000-0002-8869-6254; Melmed, Gil/0000-0002-2591-5165; Halfvarson, Jonas/0000-0003-0122-7234; Stevens, Christine/0000-0002-2621-2234; Schumm, Phil/0000-0002-3050-2429; Hibberd, Martin/0000-0001-8587-1849; Seielstad, Mark/0000-0001-5783-1401	US National Center for Research Resources (NCRR) [M01-RR00425]; US National Institutes of Health/NIDDK [P01-DK046763, DK83756, DK086502, DK043351, DK062431, DK062422, DK062420, DK062432, DK062423, DK062413, DK062429]; Diabetes Endocrinology Research Center [DK063491]; Cedars-Sinai Medical Center; US National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL087652]; US National Institute of Neurological Disorders and Stroke; Crohn's and Colitis Foundation of America; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation; US National Institute of Allergy and Infectious Diseases [AI065687, AI067152]; US National Institute of Diabetes and Digestive and Kidney Diseases [DK064869]; Swedish Society of Medicine; Bengt Ihre Foundation; Karolinska Institutet; Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Medical Research Council; Soderbergh Foundation; Swedish Cancer Foundation;  [DK76984];  [DK084554]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC015103, N01HC085082, N01HC085084, N01HC085080, N01HC085083, N01HC085085, N01HC035129, N01HC085081, N01HC045133, N01HC085079, N01HC075150, N01HC085086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152, P01AI065687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, U01DK062432, R01DK083756, U01DK062423, R03DK076984, P30DK063491, U01DK062431, P01DK046763, U01DK062429, P30DK040561, R01DK060049, U01DK062413, U01DK062420, R01DK064869, R21DK084554, RC1DK086502, U01DK062422] Funding Source: NIH RePORTER	US National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Endocrinology Research Center; Cedars-Sinai Medical Center; US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Crohn's and Colitis Foundation of America; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation(Burroughs Wellcome Fund); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Society of Medicine; Bengt Ihre Foundation; Karolinska Institutet(Karolinska Institutet); Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Soderbergh Foundation; Swedish Cancer Foundation; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by US National Center for Research Resources (NCRR) grant M01-RR00425 to the Cedars-Sinai General Research Center Genotyping core; US National Institutes of Health/NIDDK grant P01-DK046763; Diabetes Endocrinology Research Center grant DK063491; Cedars-Sinai Medical Center Inflammatory Bowel Disease Research Funds. Additional funding was provided by grants DK76984 (M. C. D.) and DK084554 (M. C. D. and D. P. B. M.). Cardiovascular Health Study research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150 and N01-HC-45133; grant numbers U01 HL080295 and R01 HL087652 from the US National Heart, Lung, and Blood Institute; and additional contribution from the US National Institute of Neurological Disorders and Stroke. A full list of principal Cardiovascular Health Study investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. A. G. is supported by the Crohn's and Colitis Foundation of America. R.J.X. and M.J.D. are supported by grants DK83756, DK086502 and DK043351 (NIDDK).; The NIDDK IBD Genetics Consortium is funded by the following grants: DK062431 (S. R. B.), DK062422 (J.H.C.), DK062420 (R. H. D.), DK062432 (J.D.R.), DK062423 (M. S. S.), DK062413 (D. P. B. M.) and DK062429 (J.H.C.). J.H.C. is also funded by Bohmfalk Funds for Medical Research, Burroughs Wellcome Medical Foundation and the Crohn's and Colitis Foundation of America. J.D.R. is also funded by grants from the US National Institute of Allergy and Infectious Diseases (AI065687; AI067152) and from the US National Institute of Diabetes and Digestive and Kidney Diseases (DK064869).; Activities in Sweden were supported by the Swedish Society of Medicine, the Bengt Ihre Foundation, the Karolinska Institutet, the Swedish National Program for IBD Genetics, the Swedish Organization for IBD, the Swedish Medical Research Council, the Soderbergh Foundation and the Swedish Cancer Foundation. Support for genotyping and genetic data analysis was provided by the Singapore National Cancer Centre, Singapore General Hospital and the Singapore Millennium Foundation (to S. P.) and the Agency for Science Technology and Research (A*STAR), Singapore (to M. L. H. and M. S.). Genotyping and DNA handling at the Genome Institute of Singapore were performed by W.Y. Meah, K. K. Heng, H. B. Toh, X. Lin, S. Rajaram, D. Tan and C. H. Wong. We are grateful to the funders and investigators of the Epidemiological Investigation of Rheumatoid Arthritis for providing genotype data from healthy Swedish individuals.	Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Wang Y, 2000, J BIOL CHEM, V275, P27013; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	27	470	491	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					332	U88		10.1038/ng.549	http://dx.doi.org/10.1038/ng.549			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20228799	Green Accepted			2022-12-17	WOS:000276150500013
J	Kolasinska-Zwierz, P; Down, T; Latorre, I; Liu, T; Liu, XS; Ahringer, J				Kolasinska-Zwierz, Paulina; Down, Thomas; Latorre, Isabel; Liu, Tao; Liu, X. Shirley; Ahringer, Julie			Differential chromatin marking of introns and expressed exons by H3K36me3	NATURE GENETICS			English	Article							TRANSCRIPTION ELONGATION; METHYLATION STATES; HISTONE H3; SET2; RNA; METHYLTRANSFERASE; INTERFERENCE; RECRUITMENT; PATTERNS; MAPS	Variation in patterns of methylations of histone tails reflects and modulates chromatin structure and function(1). To provide a framework for the analysis of chromatin function in Caenorhabditis elegans, we generated a genome-wide map of histone H3 tail methylations. We find that C. elegans genes show distributions of histone modifications that are similar to those of other organisms, with H3K4me3 near transcription start sites, H3K36me3 in the body of genes and H3K9me3 enriched on silent genes. We also observe a novel pattern: exons are preferentially marked with H3K36me3 relative to introns. H3K36me3 exon marking is dependent on transcription and is found at lower levels in alternatively spliced exons, supporting a splicing-related marking mechanism. We further show that the difference in H3K36me3 marking between exons and introns is evolutionarily conserved in human and mouse. We propose that H3K36me3 exon marking in chromatin provides a dynamic link between transcription and splicing.	[Kolasinska-Zwierz, Paulina; Down, Thomas; Latorre, Isabel; Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Kolasinska-Zwierz, Paulina; Down, Thomas; Latorre, Isabel; Ahringer, Julie] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Cambridge; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Ahringer, J (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ja219@cam.ac.uk	Liu, Tao/AAO-6310-2021; Liu, Tao/G-3585-2010	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0003-0446-9001; Ahringer, Julie/0000-0002-7074-4051; Latorre, Isabel/0000-0003-0638-1783	National Human Genome Research Institute [1-U01HG004270-01]; Wellcome Trust Senior Research Fellowship [054523]; Cambridge Newton Trust; Gates Foundation; Wellcome Trust Research Career Development Fellowship [083563]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust Senior Research Fellowship(Wellcome Trust); Cambridge Newton Trust(National Institute for Health Research (NIHR)); Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all the members of our modENCODE consortium for help and advice, and especially J. Lieb's laboratory for help with ChIP protocol development and S. Strome's laboratory for discussions about H3K36me3. We are very grateful to H. Holster for expert microarray processing at Roche. This work was supported by National Human Genome Research Institute modENCODE grant 1-U01HG004270-01, by a Wellcome Trust Senior Research Fellowship (054523) and Cambridge Newton Trust funding to J. A., by a Gates Foundation studentship to P. K.-Z. and by a Wellcome Trust Research Career Development Fellowship (083563) to T. D.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Bargmann C.I., 2006, CHEMOSENSATION C ELE, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blumenthal Thomas, 2005, WormBook, P1, DOI 10.1895/wormbook.1.5.1; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cui M., 2007, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.139.1; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187	30	470	482	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					376	381		10.1038/ng.322	http://dx.doi.org/10.1038/ng.322			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19182803	Green Accepted			2022-12-17	WOS:000263640200022
J	SHIBATA, D; PEINADO, MA; IONOV, Y; MALKHOSYAN, S; PERUCHO, M				SHIBATA, D; PEINADO, MA; IONOV, Y; MALKHOSYAN, S; PERUCHO, M			GENOMIC INSTABILITY IN REPEATED SEQUENCES IS AN EARLY SOMATIC EVENT IN COLORECTAL TUMORIGENESIS THAT PERSISTS AFTER TRANSFORMATION	NATURE GENETICS			English	Article							DNA-REPLICATION; GENE-MUTATIONS; CHAIN-REACTION; CANCER; IDENTIFICATION; MICROSATELLITES; POLYMORPHISMS; MUTAGENESIS; EVOLUTION; CARCINOMA	Genomic instability at simple repeated sequences (SRS) is a landmark for some sporadic and hereditary cancers of the colon. We have identified several human tumour cell lines with up to 1,000-fold increases in mutation rates for endogenous microsatellite sequences, relative to normal cells or tumour cells without the mutator phenotype and show that they are very early events in tumorigenesis. Our in vivo and in vitro results show that the genomic instability persists after transformation and that microsatellite mutations accumulate as consecutive somatic slippage events of a single or a few repeated units. This mechanism may account for the repeat expansions in triplet hereditary diseases and the same defect in replication fidelity in non-polyposis colon cancer could also contribute to the non-mendelian anticipation in these diseases.	CALIF INST BIOL RES,LA JOLLA,CA 92037; UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033	University of Southern California			Peinado, Miguel A./A-5591-2008	Peinado, Miguel A./0000-0002-4090-793X; Perucho, Manuel/0000-0002-2169-2662	NCI NIH HHS [CA38579, CA33021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033021, R01CA038579] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BRATTAIN MG, 1981, CANCER RES, V41, P1751; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; DEXTER DL, 1979, CANCER RES, V39, P1020; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEARON ER, 1992, FASEB J, V6, P2783, DOI 10.1096/fasebj.6.10.1321771; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; FOULDS L, 1954, CANCER RES, V14, P327; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; IONOV J, 1993, NATURE, V363, P658; KERN SE, 1993, J NATL CANCER I, V85, P1020, DOI 10.1093/jnci/85.13.1020; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; LEITH JT, 1986, MAMMALIAN TUMOUR CEL; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LOEB LA, 1974, CANCER RES, V34, P2311; LYNCH HT, 1988, J NATL CANCER I, V80, P278, DOI 10.1093/jnci/80.4.278; LYNCH HT, 1991, CANCER GENET CYTOGEN, V143, P160; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAUMOVA A, IN PRESS AM J HUM GE; NELSON RL, 1972, J THEOR BIOL, V37, P197, DOI 10.1016/0022-5193(72)90127-0; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; PARDUE ML, 1991, CELL, V66, P427, DOI 10.1016/0092-8674(81)90007-6; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; PEINADO MA, 1993, INT J ONCOL, V2, P123; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; SHIBATA D, 1993, J NATL CANCER I, V85, P1058, DOI 10.1093/jnci/85.13.1058; SHIBATA D, 1992, AM J PATHOL, V141, P1; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUGARBAKER P, 1985, CANCER PRINCIPLES PR, P814; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TORN BH, 1976, IN VITRO, V12, P180; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4035, DOI 10.1093/nar/18.13.4035; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213	57	470	478	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					273	281		10.1038/ng0394-273	http://dx.doi.org/10.1038/ng0394-273			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012390				2022-12-17	WOS:A1994MZ56200015
J	Riviere, JB; Mirzaa, GM; O'Roak, BJ; Beddaoui, M; Alcantara, D; Conway, RL; St-Onge, J; Schwartzentruber, JA; Gripp, KW; Nikkel, SM; Worthylake, T; Sullivan, CT; Ward, TR; Butler, HE; Kramer, NA; Albrecht, B; Armour, CM; Armstrong, L; Caluseriu, O; Cytrynbaum, C; Drolet, BA; Innes, AM; Lauzon, JL; Lin, AE; Mancini, GMS; Meschino, WS; Reggin, JD; Saggar, AK; Lerman-Sagie, T; Uyanik, G; Weksberg, R; Zirn, B; Beaulieu, CL; Majewski, J; Bulman, DE; O'Driscoll, M; Shendure, J; Graham, JM; Boycott, KM; Dobyns, WB				Riviere, Jean-Baptiste; Mirzaa, Ghayda M.; O'Roak, Brian J.; Beddaoui, Margaret; Alcantara, Diana; Conway, Robert L.; St-Onge, Judith; Schwartzentruber, Jeremy A.; Gripp, Karen W.; Nikkel, Sarah M.; Worthylake, Thea; Sullivan, Christopher T.; Ward, Thomas R.; Butler, Hailly E.; Kramer, Nancy A.; Albrecht, Beate; Armour, Christine M.; Armstrong, Linlea; Caluseriu, Oana; Cytrynbaum, Cheryl; Drolet, Beth A.; Innes, A. Micheil; Lauzon, Julie L.; Lin, Angela E.; Mancini, Grazia M. S.; Meschino, Wendy S.; Reggin, James D.; Saggar, Anand K.; Lerman-Sagie, Tally; Uyanik, Goekhan; Weksberg, Rosanna; Zirn, Birgit; Beaulieu, Chandree L.; Majewski, Jacek; Bulman, Dennis E.; O'Driscoll, Mark; Shendure, Jay; Graham, John M., Jr.; Boycott, Kym M.; Dobyns, William B.		Finding Rare Dis Genes FORGE Canad	De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes	NATURE GENETICS			English	Article							MACROCEPHALY-CAPILLARY MALFORMATION; KINASE-B-GAMMA; GLUCOSE-HOMEOSTASIS; ACTIVATING MUTATION; INSULIN-RESISTANCE; CORPUS-CALLOSUM; CUTIS MARMORATA; COWDEN-DISEASE; GENE-MUTATIONS; HIGH-FREQUENCY	Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features(1-5). We performed exome sequencing in 3 families with MCAP or MPPH, and our initial observations were confirmed in exomes from 7 individuals with MCAP and 174 control individuals, as well as in 40 additional subjects with megalencephaly, using a combination of Sanger sequencing, restriction enzyme assays and targeted deep sequencing. We identified de novo germline or postzygotic mutations in three core components of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. These include 2 mutations in AKT3, 1 recurrent mutation in PIK3R2 in 11 unrelated families with MPPH and 15 mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and 1 with MPPH. Our data highlight the central role of PI3K-AKT signaling in vascular, limb and brain development and emphasize the power of massively parallel sequencing in a challenging context of phenotypic and genetic heterogeneity combined with postzygotic mosaicism.	[Riviere, Jean-Baptiste; St-Onge, Judith; Sullivan, Christopher T.; Ward, Thomas R.; Butler, Hailly E.; Dobyns, William B.] Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA USA; [Mirzaa, Ghayda M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [O'Roak, Brian J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Beddaoui, Margaret; Worthylake, Thea; Beaulieu, Chandree L.; Boycott, Kym M.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Alcantara, Diana; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Conway, Robert L.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Schwartzentruber, Jeremy A.] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE USA; [Nikkel, Sarah M.; Boycott, Kym M.] Childrens Hosp Eastern Ontario, Div Genet, Ottawa, ON K1H 8L1, Canada; [Kramer, Nancy A.; Graham, John M., Jr.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Albrecht, Beate] Univ Hosp Essen, Dept Human Genet, Essen, Germany; [Armour, Christine M.] Queens Univ, Dept Paediat, Kingston, ON, Canada; [Armstrong, Linlea] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Caluseriu, Oana; Innes, A. Micheil; Lauzon, Julie L.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Cytrynbaum, Cheryl; Weksberg, Rosanna] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Drolet, Beth A.] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Drolet, Beth A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Lin, Angela E.] MassGen Hosp Children, Dept Med Genet, Boston, MA USA; [Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Meschino, Wendy S.] N York Gen Hosp, Dept Genet, Toronto, ON, Canada; [Reggin, James D.] Providence Sacred Heart Med Ctr, Spokane, WA USA; [Reggin, James D.] Childrens Hosp, Spokane, WA USA; [Saggar, Anand K.] Univ London, St Georges Hosp, Dept Clin Genet, London, England; [Lerman-Sagie, Tally] Wolfson Med Ctr, Pediat Neurol Unit, Holon, Israel; [Uyanik, Goekhan] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Zirn, Birgit] Univ Goettingen, Dept Neuropediat, Gottingen, Germany; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Bulman, Dennis E.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Chicago; University of Washington; University of Washington Seattle; University of Ottawa; Children's Hospital of Eastern Ontario; University of Sussex; Michigan State University; McGill University; Nemours Alfred I. duPont Hospital for Children; University of Ottawa; Children's Hospital of Eastern Ontario; Cedars Sinai Medical Center; University of Duisburg Essen; Queens University - Canada; University of British Columbia; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Medical College of Wisconsin; Medical College of Wisconsin; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; North York General Hospital; St Georges University London; University of London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dobyns, WB (corresponding author), Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA USA.	wbd@uw.edu	Caluseriu, Oana/AAK-9563-2020; Dobyns, William/AAI-2768-2020; Shendure, Jay/AAU-3684-2021; Lerman-Sagie, Tally/AAY-7598-2021; Dobyns, William Brian/ABC-6525-2021; Graham, John M./J-1429-2019; innes, allan micheil/A-9955-2017; Scherer, Stephen W./B-3785-2013	Dobyns, William/0000-0002-7681-2844; Lerman-Sagie, Tally/0000-0001-6641-6875; Scherer, Stephen W./0000-0002-8326-1999; Innes, Micheil/0000-0001-9881-5467; Shendure, Jay/0000-0002-1516-1865; Alcantara, Diana/0000-0003-3185-1548; Armstrong, Linlea/0000-0002-8191-6429; O'Driscoll, Mark/0000-0003-2765-316X; O'Roak, Brian/0000-0002-4141-0095; Schwartzentruber, Jeremy/0000-0002-6183-2092	US National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS) grant [NS058721]; National Institute of Child Health & Human Development (NICHD) grant [HD36657]; National Institute of General Medical Sciences (NIGMS) grant [5-T32-GM08243]; Government of Canada (to FORGE) through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec and Genome British Columbia; Banting Postdoctoral Fellowship from the CIHR; Clinical Investigatorship Award from the CIHR Institute of Genetics; Cancer Research UK (CR-UK); Medical Research Council (UK); Leukaemia Lymphoma Research (UK); Simons Foundation Autism Research Initiative (SFARI) [191889]; NIEHS Environmental Genome Project [HHSN273200800010C]; NHLBI GO Exome Sequencing Project and its ongoing studies [HL-102923, HL-102925, HL-102926, HL-103010]; Women's Health Institute (WHI) [HL-102924]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103010, RC2HL102926, UC2HL103010, UC2HL102924, RC2HL102923, UC2HL102926, UC2HL102923, RC2HL102925, RC2HL102924, UC2HL102925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046616, R01NS058721] Funding Source: NIH RePORTER	US National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS) grant; National Institute of Child Health & Human Development (NICHD) grant; National Institute of General Medical Sciences (NIGMS) grant; Government of Canada (to FORGE) through Genome Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec and Genome British Columbia; Banting Postdoctoral Fellowship from the CIHR; Clinical Investigatorship Award from the CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Cancer Research UK (CR-UK)(Cancer Research UK); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Lymphoma Research (UK); Simons Foundation Autism Research Initiative (SFARI); NIEHS Environmental Genome Project; NHLBI GO Exome Sequencing Project and its ongoing studies; Women's Health Institute (WHI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the US National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS) grant NS058721 (to W.B.D.), National Institute of Child Health & Human Development (NICHD) grant HD36657 and National Institute of General Medical Sciences (NIGMS) grant 5-T32-GM08243 (to J.M.G.), the Government of Canada (to FORGE) through Genome Canada, the Canadian Institutes of Health Research (CIHR) and the Ontario Genomics Institute (OGI-049). Additional funding was provided to FORGE by Genome Quebec and Genome British Columbia. J.-B.R. is supported by a Banting Postdoctoral Fellowship from the CIHR. K.M.B. is supported by a Clinical Investigatorship Award from the CIHR Institute of Genetics. The laboratory of M.O. is funded by Cancer Research UK (CR-UK), the Medical Research Council (UK) and Leukaemia Lymphoma Research (UK). M.O. is a Senior CR-UK Research Fellow. We would like to thank the Simons Foundation Autism Research Initiative (SFARI) for providing control exome data (grant 191889 to J.S.). We also thank the NIEHS Environmental Genome Project (contract HHSN273200800010C) and the NHLBI GO Exome Sequencing Project and its ongoing studies-Lung GO (HL-102923), Broad GO (HL-102925), Seattle GO (HL-102926), Heart GO (HL-103010) and the Women's Health Institute (WHI; HL-102924) Sequencing Projects-for providing exome variant calls for comparison.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ballif BC, 2012, HUM GENET, V131, P145, DOI 10.1007/s00439-011-1073-y; Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; BROWNSTEIN MJ, 1996, BIOTECHNIQUES, V20, P1008; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; ClaytonSmith J, 1997, CLIN DYSMORPHOL, V6, P291, DOI 10.1097/00019605-199710000-00001; Conway RL, 2007, AM J MED GENET A, V143A, P2981, DOI 10.1002/ajmg.a.32040; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gripp KW, 2009, AM J MED GENET A, V149A, P868, DOI 10.1002/ajmg.a.32732; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Mirzaa G, 2004, NEUROPEDIATRICS, V35, P353, DOI 10.1055/s-2004-830497; Mirzaa GM, 2012, AM J MED GENET A, V158A, P269, DOI 10.1002/ajmg.a.34402; Moore CA, 1997, AM J MED GENET, V70, P67, DOI 10.1002/(SICI)1096-8628(19970502)70:1<67::AID-AJMG13>3.3.CO;2-4; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Oduber CEU, 2011, EUR J MED GENET, V54, P262, DOI 10.1016/j.ejmg.2011.02.007; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Riviere J-B, 2012, NAT GENET, V44, pS1; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; SCARANO E, 1967, P NATL ACAD SCI USA, V57, P1394, DOI 10.1073/pnas.57.5.1394; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VOLINIA S, 1994, GENOMICS, V24, P472, DOI 10.1006/geno.1994.1655	55	469	482	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					934	+		10.1038/ng.2331	http://dx.doi.org/10.1038/ng.2331			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22729224	Green Accepted			2022-12-17	WOS:000306854700021
J	Argout, X; Salse, J; Aury, JM; Guiltinan, MJ; Droc, G; Gouzy, J; Allegre, M; Chaparro, C; Legavre, T; Maximova, SN; Abrouk, M; Murat, F; Fouet, O; Poulain, J; Ruiz, M; Roguet, Y; Rodier-Goud, M; Barbosa-Neto, JF; Sabot, F; Kudrna, D; Ammiraju, JSS; Schuster, SC; Carlson, JE; Sallet, E; Schiex, T; Dievart, A; Kramer, M; Gelley, L; Shi, Z; Berard, A; Viot, C; Boccara, M; Risterucci, AM; Guignon, V; Sabau, X; Axtell, MJ; Ma, ZR; Zhang, YF; Brown, S; Bourge, M; Golser, W; Song, XA; Clement, D; Rivallan, R; Tahi, M; Akaza, JM; Pitollat, B; Gramacho, K; D'Hont, A; Brunel, D; Infante, D; Kebe, I; Costet, P; Wing, R; McCombie, WR; Guiderdoni, E; Quetier, F; Panaud, O; Wincker, P; Bocs, S; Lanaud, C				Argout, Xavier; Salse, Jerome; Aury, Jean-Marc; Guiltinan, Mark J.; Droc, Gaetan; Gouzy, Jerome; Allegre, Mathilde; Chaparro, Cristian; Legavre, Thierry; Maximova, Siela N.; Abrouk, Michael; Murat, Florent; Fouet, Olivier; Poulain, Julie; Ruiz, Manuel; Roguet, Yolande; Rodier-Goud, Maguy; Barbosa-Neto, Jose Fernandes; Sabot, Francois; Kudrna, Dave; Ammiraju, Jetty Siva S.; Schuster, Stephan C.; Carlson, John E.; Sallet, Erika; Schiex, Thomas; Dievart, Anne; Kramer, Melissa; Gelley, Laura; Shi, Zi; Berard, Aurelie; Viot, Christopher; Boccara, Michel; Risterucci, Ange Marie; Guignon, Valentin; Sabau, Xavier; Axtell, Michael J.; Ma, Zhaorong; Zhang, Yufan; Brown, Spencer; Bourge, Mickael; Golser, Wolfgang; Song, Xiang; Clement, Didier; Rivallan, Ronan; Tahi, Mathias; Akaza, Joseph Moroh; Pitollat, Bertrand; Gramacho, Karina; D'Hont, Angelique; Brunel, Dominique; Infante, Diogenes; Kebe, Ismael; Costet, Pierre; Wing, Rod; McCombie, W. Richard; Guiderdoni, Emmanuel; Quetier, Francis; Panaud, Olivier; Wincker, Patrick; Bocs, Stephanie; Lanaud, Claire			The genome of Theobroma cacao	NATURE GENETICS			English	Article							COCOA; GENE; SEQUENCE; PLANTS; BIOSYNTHESIS; RESISTANCE; EVOLUTION; PATHOGEN; ORIGIN; MODEL	We sequenced and assembled the draft genome of Theobroma cacao, an economically important tropical-fruit tree crop that is the source of chocolate. This assembly corresponds to 76% of the estimated genome size and contains almost all previously described genes, with 82% of these genes anchored on the 10 T. cacao chromosomes. Analysis of this sequence information highlighted specific expansion of some gene families during evolution, for example, flavonoid-related genes. It also provides a major source of candidate genes for T. cacao improvement. Based on the inferred paleohistory of the T. cacao genome, we propose an evolutionary scenario whereby the ten T. cacao chromosomes were shaped from an ancestor through eleven chromosome fusions.	[Argout, Xavier; Droc, Gaetan; Allegre, Mathilde; Legavre, Thierry; Fouet, Olivier; Ruiz, Manuel; Roguet, Yolande; Rodier-Goud, Maguy; Dievart, Anne; Viot, Christopher; Boccara, Michel; Risterucci, Ange Marie; Guignon, Valentin; Sabau, Xavier; Clement, Didier; Rivallan, Ronan; Pitollat, Bertrand; D'Hont, Angelique; Guiderdoni, Emmanuel; Bocs, Stephanie; Lanaud, Claire] Ctr Cooperat Int Rech Agron Dev CIRAD, Biol Syst Dept, UMR DAP, F-34398 Montpellier, France; [Salse, Jerome; Abrouk, Michael; Murat, Florent] INRA, UMR 1095, Clermont Ferrand, France; [Aury, Jean-Marc; Poulain, Julie; Wincker, Patrick] CEA, IG, Evry, France; [Aury, Jean-Marc; Poulain, Julie; Wincker, Patrick] CNRS, UMR 8030, CP5706, Evry, France; [Aury, Jean-Marc; Poulain, Julie; Wincker, Patrick] Univ Evry, Evry, France; Penn State Univ, Dept Hort, University Pk, PA 16802 USA; [Guiltinan, Mark J.; Maximova, Siela N.; Carlson, John E.; Shi, Zi; Zhang, Yufan] Huck Inst Life Sci, University Pk, PA USA; [Shi, Zi; Zhang, Yufan] Penn State Univ, Plant Biol Grad Program, University Pk, PA 16802 USA; [Gouzy, Jerome; Sallet, Erika] CNRS, INRA, LIPM, Castanet Tolosan, France; [Chaparro, Cristian; Barbosa-Neto, Jose Fernandes; Sabot, Francois; Panaud, Olivier] UPVD, CNRS, IRD, UMR 5096,Lab Genome & Dev Plantes, Perpignan, France; Univ Arizona, Arizona Genom Inst, Tucson, AZ USA; [Kudrna, Dave; Ammiraju, Jetty Siva S.; Golser, Wolfgang; Song, Xiang; Wing, Rod] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Schuster, Stephan C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Carlson, John E.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Carlson, John E.] Chonnam Natl Univ, Dept Bioenergy Sci & Technol WCU, Kwangju, South Korea; [Schiex, Thomas] INRA, UR875, UBIA, F-31326 Castanet Tolosan, France; [Kramer, Melissa; Gelley, Laura; Zhang, Yufan; McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Berard, Aurelie; Brunel, Dominique] CP5724, Ctr Natl Genotypage, UR Etud Polymorphisme Genomes Vegetaux 1279, Inst Genom,INRA,CEA, Evry, France; [Axtell, Michael J.; Ma, Zhaorong] Penn State Univ, Bioinformat & Genom PhD Program, University Pk, PA 16802 USA; [Axtell, Michael J.; Ma, Zhaorong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Brown, Spencer; Bourge, Mickael; Kebe, Ismael] CNRS, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France; [Tahi, Mathias; Akaza, Joseph Moroh] CNRA, Divo, Cote Ivoire; [Gramacho, Karina] CEPLAC, Itabuna Bahia, Brazil; [Infante, Diogenes] IDEA, Ctr Nacl Biotecnol Agr, Caracas, Venezuela; [Costet, Pierre] Chocolaterie VALRHONA, Tain Lhermitage, France; [Quetier, Francis] Univ Evry Val Essonne, Dept Biol, Evry, France	CIRAD; INRAE; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); University of Arizona; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chonnam National University; INRAE; Cold Spring Harbor Laboratory; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Argout, X (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Biol Syst Dept, UMR DAP, TA A 96-03, F-34398 Montpellier, France.	xavier.argout@cirad.fr	DHONT, Angélique/AAL-8074-2021; Wing, Rod A/Z-2885-2019; GRAMACHO, KARINA PERES/J-3868-2014; Viot, Christopher/AAE-8789-2022; Abrouk, Michael/W-1972-2017; Gaetan, DROC/AAH-2616-2021; Sabot, Francois/B-7820-2010; BROWN, Spencer/B-6878-2014; GRAMACHO, KARINA PERES/AAO-8862-2020; Aury, Jean-Marc/N-1621-2019; song, xiang/A-2336-2012; Ruiz, Manuel/E-6171-2010; Gouzy, Jerome/AAH-4977-2020; Abrouk, Michael/F-8516-2014; Infante, Diogenes/M-5488-2019; Chaparro, Cristian/D-1427-2015; Quetier, Francis/J-7923-2017; Infante, Diogenes/A-8444-2015	Wing, Rod A/0000-0001-6633-6226; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Viot, Christopher/0000-0001-6321-4741; Abrouk, Michael/0000-0001-9082-1432; Gaetan, DROC/0000-0003-1849-1269; Sabot, Francois/0000-0002-8522-7583; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Aury, Jean-Marc/0000-0003-1718-3010; Gouzy, Jerome/0000-0001-5695-4557; Abrouk, Michael/0000-0001-9082-1432; Chaparro, Cristian/0000-0002-5162-349X; CLEMENT, Didier/0000-0002-7602-6472; Poulain, Julie/0000-0002-8744-3116; Quetier, Francis/0000-0003-4388-9287; Dievart, Anne/0000-0001-9460-4638; Ruiz, Manuel/0000-0001-8153-276X; Murat, Florent/0000-0003-2116-2511; Sallet, Erika/0000-0003-4637-473X; Lanaud, Claire/0000-0001-6411-7310; Infante, Diogenes/0000-0002-8312-2198	National Science Foundation [DBI0923128]; CIRAD; Agropolis foundation; Region Languedoc Roussillon; Agence Nationale de la Recherche (ANR); Valrhona and the Venezuelan Ministry of Science, Technology and Industry; Schatz Center for Tree Molecular Genetics in the School of Forest Resources	National Science Foundation(National Science Foundation (NSF)); CIRAD; Agropolis foundation; Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Valrhona and the Venezuelan Ministry of Science, Technology and Industry; Schatz Center for Tree Molecular Genetics in the School of Forest Resources	We would like to thank CIRAD, the Agropolis foundation, the Region Languedoc Roussillon, Agence Nationale de la Recherche (ANR), Valrhona and the Venezuelan Ministry of Science, Technology and Industry for their financial contribution to this project. We thank the Toulouse Midi-Pyrenees bioinformatic platform for providing us with computational resources. Activities at Pennsylvania State University were supported by a gift from the Hershey Corp. and through support from the Schatz Center for Tree Molecular Genetics in the School of Forest Resources. Acquisition of an Illumina sequencer by the Cold Spring Harbor Laboratory was supported by the National Science Foundation grant DBI0923128 to W. R. M. We would like to thank F. C. Baurens, Y. Jiao, O. Garsmeur and C. dePamphilis for helpful advice and assistance with bioinformatics. We would like to express our special appreciation to V. Mooleedhar, who collected the cacao accession in Belize and made it available to us for our analysis.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; ALLEGRE M, HIGH DENSIT IN PRESS; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Araujo IS, 2009, PLANT MOL BIOL REP, V27, P177, DOI 10.1007/s11105-008-0069-9; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; CHANLIAU S, 1996, 12 INT COC RES C SAL, P959; Coe Sophie D., 1996, TRUE HIST CHOCOLATE; DAVIE J. H., 1935, Genetica, V17, P487, DOI 10.1007/BF01508190; Degroeve S, 2005, BIOINFORMATICS, V21, P1332, DOI 10.1093/bioinformatics/bti166; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Foissac S, 2008, CURR BIOINFORM, V3, P87, DOI 10.2174/157489308784340702; FOUET O, STRUCTURAL IN PRESS; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; GRIFFITHS G, 1991, PLANTA, V184, P279, DOI [10.1007/BF01102429, 10.1007/BF00197958]; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Henderson JS, 2007, P NATL ACAD SCI USA, V104, P18937, DOI 10.1073/pnas.0708815104; *ICCO MARK COMM, 2007, 10 M EBRD OFF LOND M, V10, P16; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lanaud C, 2009, MOL BREEDING, V24, P361, DOI 10.1007/s11032-009-9297-4; LANAUD C, 2003, P 14 INT COC RES C, P13; Lehmann Przemyslaw, 2002, Journal of Applied Genetics, V43, P403; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu Y, 2005, J INTEGR PLANT BIOL, V47, P769, DOI 10.1111/j.1744-7909.2005.00111.x; LIU YS, 2010, TECTONIC EVOLUTION P, P1; MARIE D, 1993, BIOL CELL, V78, P41, DOI 10.1016/0248-4900(93)90113-S; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maximova SN, 2006, PLANTA, V224, P740, DOI 10.1007/s00425-005-0188-6; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mooleedhar V., 1995, Cocoa Growers' Bulletin, P26; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Pugh T, 2004, THEOR APPL GENET, V108, P1151, DOI 10.1007/s00122-003-1533-4; Rimbach G, 2009, INT J MOL SCI, V10, P4290, DOI 10.3390/ijms10104290; Salse J, 2009, BRIEF BIOINFORM, V10, P619, DOI 10.1093/bib/bbp037; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shi Z, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-248; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tarr D Ellen K, 2009, BMC Res Notes, V2, P197, DOI 10.1186/1756-0500-2-197; Tomas-Barberan FA, 2007, J AGR FOOD CHEM, V55, P3926, DOI 10.1021/jf070121j; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; ZIEGLEDER G, 1990, Z LEBENSM UNTERS FOR, V191, P306, DOI 10.1007/BF01202432	59	469	577	6	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					101	108		10.1038/ng.736	http://dx.doi.org/10.1038/ng.736			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21186351				2022-12-17	WOS:000286623800006
J	Marlhens, F; Bareil, C; Griffoin, JM; Zrenner, E; Amalric, P; Eliaou, C; Liu, SY; Harris, E; Redmond, TM; Arnaud, B; Claustres, M; Hamel, CP				Marlhens, F; Bareil, C; Griffoin, JM; Zrenner, E; Amalric, P; Eliaou, C; Liu, SY; Harris, E; Redmond, TM; Arnaud, B; Claustres, M; Hamel, CP			Mutations in RPE65 cause Leber's congenital amaurosis	NATURE GENETICS			English	Letter							RETINAL-PIGMENT EPITHELIUM; MICROSOMAL PROTEIN; GENE; DYSTROPHY		HOP ST CHARLES,LAB NEUROBIOL AUDIT PLAST SYNAPT,INSERM,U254,F-34295 MONTPELLIER 5,FRANCE; INST BIOL,BIOCHIM GENET LAB,MONTPELLIER,FRANCE; UNIV TUBINGEN,HOSP EYE,TUBINGEN,GERMANY; CABINET OPTHALMOL,ALBI,FRANCE; HOP GUI DE CHAULIAC,SERV OPTALMOL,MONTPELLIER,FRANCE; NEI,RETINAL CELL & MOL BIOL LAB,NIH,BETHESDA,MD 20892	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Eberhard Karls University of Tubingen; Universite de Montpellier; CHU de Montpellier; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)			BAREIL, Corinne/A-8387-2008	Redmond, T. Michael/0000-0002-1813-5291				CAMUZAT A, 1995, HUM MOL GENET, V4, P1447, DOI 10.1093/hmg/4.8.1447; Crouch R. K., 1997, Investigative Ophthalmology and Visual Science, V38, pS304; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HAMEL CP, 1994, GENOMICS, V20, P509, DOI 10.1006/geno.1994.1212; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Leber T., 1869, GRAEFES ARCH KLIN EX, V15, P13, DOI 10.1007/BF0272121318; LI TS, 1995, P NATL ACAD SCI USA, V92, P7700, DOI 10.1073/pnas.92.17.7700; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; REDMOND TM, 1995, INVEST OPHTH VIS SCI, V36, pS598; Sullivan LS, 1996, MOL MED TODAY, V2, P380, DOI 10.1016/S1357-4310(96)10037-X; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352	13	469	485	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					139	141		10.1038/ng1097-139	http://dx.doi.org/10.1038/ng1097-139			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326927				2022-12-17	WOS:A1997XZ55500013
J	Park, JH; Wacholder, S; Gail, MH; Peters, U; Jacobs, KB; Chanock, SJ; Chatterjee, N				Park, Ju-Hyun; Wacholder, Sholom; Gail, Mitchell H.; Peters, Ulrike; Jacobs, Kevin B.; Chanock, Stephen J.; Chatterjee, Nilanjan			Estimation of effect size distribution from genome-wide association studies and implications for future discoveries	NATURE GENETICS			English	Article							BREAST-CANCER; SUSCEPTIBILITY LOCI; GENETIC ASSOCIATION; RISK ALLELES; ODDS RATIOS; VARIANTS; POWER; IDENTIFICATION	We report a set of tools to estimate the number of susceptibility loci and the distribution of their effect sizes for a trait on the basis of discoveries from existing genome-wide association studies (GWASs). We propose statistical power calculations for future GWASs using estimated distributions of effect sizes. Using reported GWAS findings for height, Crohn's disease and breast, prostate and colorectal (BPC) cancers, we determine that each of these traits is likely to harbor additional loci within the spectrum of low-penetrance common variants. These loci, which can be identified from sufficiently powerful GWASs, together could explain at least 15-20% of the known heritability of these traits. However, for BPC cancers, which have modest familial aggregation, our analysis suggests that risk models based on common variants alone will have modest discriminatory power (63.5% area under curve), even with new discoveries.	[Park, Ju-Hyun; Wacholder, Sholom; Gail, Mitchell H.; Chanock, Stephen J.; Chatterjee, Nilanjan] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Jacobs, Kevin B.; Chanock, Stephen J.] NCI, Core Genotyping Facil, NIH, US Dept HHS, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chatterjee, N (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA.	chattern@mail.nih.gov		Jacobs, Kevin/0000-0002-4657-6473	National Cancer Institute; US National Institutes of Health; National Institutes of Health	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the intramural program of the National Cancer Institute, US National Institutes of Health. The research of N.C. and J.-H.P. was also partially funded by the Gene-Environment Initiative of the National Institutes of Health.	Ambrosius WT, 2004, AM J HUM GENET, V74, P683, DOI 10.1086/383282; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eberle MA, 2007, PLOS GENET, V3, P1827, DOI 10.1371/journal.pgen.0030170; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Gail MH, 2009, J NATL CANCER I, V101, P959, DOI 10.1093/jnci/djp130; Ghosh A, 2008, AM J HUM GENET, V82, P1064, DOI 10.1016/j.ajhg.2008.03.002; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Schork NJ, 2002, AM J HUM GENET, V70, P1480, DOI 10.1086/340788; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Xu JF, 2009, PROSTATE, V69, P1565, DOI 10.1002/pros.21002; Yu K, 2007, AM J HUM GENET, V81, P540, DOI 10.1086/520678; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437	36	468	479	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					570	U139		10.1038/ng.610	http://dx.doi.org/10.1038/ng.610			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20562874	Green Accepted			2022-12-17	WOS:000279242400008
J	Maller, J; George, S; Purcell, S; Fagerness, J; Altshuler, D; Daly, MJ; Seddon, JM				Maller, Julian; George, Sarah; Purcell, Shaun; Fagerness, Jes; Altshuler, David; Daly, Mark J.; Seddon, Johanna M.			Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; BODY-MASS INDEX; FAMILIAL AGGREGATION; EXTENDED FAMILIES; GENOMEWIDE-SCAN; MACULOPATHY; ASSOCIATION; SUSCEPTIBILITY; HAPLOTYPE; POLYMORPHISM	Age-related macular degeneration (AMD) is a common, late-onset disease with seemingly typical complexity: recurrence ratios for siblings of an affected individual are three- to sixfold higher than in the general population, and family-based analysis has resulted in only modestly significant evidence for linkage. In a case-control study drawn from a US-based population of European descent, we have identified a previously unrecognized common, noncoding variant in CFH, the gene encoding complement factor H, that substantially increases the influence of this locus on AMD, and we have strongly replicated the associations of four other previously reported common alleles in three genes ( P values ranging from 10(-6) to 10(-70)). Despite excellent power to detect epistasis, we observed purely additive accumulation of risk from alleles at these genes. We found no differences in association of these loci with major phenotypic categories of advanced AMD. Genotypes at these five common SNPs define a broad spectrum of interindividual disease risk and explain about half of the classical sibling risk of AMD in our study population.	Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Epidemiol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Seddon, JM (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Epidemiol Unit, 243 Charles St, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; johanna_seddon@meei.harvard.edu	Altshuler, David M/A-4476-2009; maller, julian B/A-9323-2009; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Maller, Julian/0000-0002-1565-9559	NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NEI NIH HHS [EY11309] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sham PC, 2004, BEHAV GENET, V34, P207, DOI 10.1023/B:BEGE.0000013734.39266.a3; Snow KK, 2002, AM J OPHTHALMOL, V134, P842, DOI 10.1016/S0002-9394(02)01755-5; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4	28	468	502	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1055	1059		10.1038/ng1873	http://dx.doi.org/10.1038/ng1873			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16936732				2022-12-17	WOS:000240112100024
J	ElGhouzzi, V; LeMerrer, M; PerrinSchmitt, F; Lajeunie, E; Benit, P; Renier, D; Bourgeois, P; BolcatoBellemin, AL; Munnich, A; Bonaventure, J				ElGhouzzi, V; LeMerrer, M; PerrinSchmitt, F; Lajeunie, E; Benit, P; Renier, D; Bourgeois, P; BolcatoBellemin, AL; Munnich, A; Bonaventure, J			Mutations of the TWIST gene in the Saethre-Chotzen syndrome	NATURE GENETICS			English	Article							SYNDROME LOCUS; PFEIFFER-SYNDROME; JACKSON-WEISS; DNA-BINDING; CRANIOSYNOSTOSIS; LOCALIZATION; DROSOPHILA; EMBRYOS; GROWTH; TRANSLOCATIONS	Saethre-Chotzen syndrome (acrocephalo-syndactyly type III, ACS III) is an autosomal dominant craniosynostosis with brachydactyly, soft tissue syndactyly and facial dysmorphism including ptosis, facial asymmetry and prominent ear crura. ACS III has been mapped to chromosome 7p21-22. Of interest, TWIST, the human counterpart of the murine Twist gene, has been localized on chromosome 7p21 as well, The Twist gene product is a transcription factor containing a basic helix-loop-helix (b-HLH) domain, required in head mesenchyme for cranial neural tube morphogenesis in mice, The co-localisation of ACS III and TWIST prompted us to screen ACS III patients for TWIST gene mutations especially as mice heterozygous for Twist null mutations displayed skull defects and duplication of hind leg digits. Here, we report 21-bp insertions and nonsense mutations of the TWIST gene (S127X, E130X) in seven ACS III probands and describe impairment of head mesenchyme induction by TWIST as a novel pathophysiological mechanism in human craniosynostoses.	INST NECKER,UNITE RECH HANDICAPS GENET ENFANT,INSERM U393,F-75743 PARIS 15,FRANCE; LGME,CNRS,INSERM U184,F-67085 STRASBOURG,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			EL GHOUZZI, Vincent/X-4364-2018	EL GHOUZZI, Vincent/0000-0001-5894-8978; Bourgeois, Patrice/0000-0001-6055-7108				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BOURGEOIS P, MAMM GENOME, V7, P915; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; INOUYE M, 1976, Congenital Anomalies, V16, P171; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LEWANDA AF, 1994, GENOMICS, V19, P115, DOI 10.1006/geno.1994.1020; LEWANDA AF, 1994, AM J HUM GENET, V55, P1195; Ma HW, 1996, HUM GENET, V98, P228, DOI 10.1007/s004390050197; Meyers GA, 1996, AM J HUM GENET, V58, P491; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, J MED GENET, V31, P393, DOI 10.1136/jmg.31.5.393; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; ROSE CSP, 1994, HUM MOL GENET, V3, P1405; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; STOETZEL C, 1995, MECH DEVELOP, V51, P251, DOI 10.1016/0925-4773(95)00369-X; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; TSUJI K, 1994, AM J MED GENET, V49, P98, DOI 10.1002/ajmg.1320490119; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	29	468	476	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					42	46						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988167				2022-12-17	WOS:A1997WA37300019
J	SHINOHARA, A; OGAWA, H; MATSUDA, Y; USHIO, N; IKEO, K; OGAWA, T				SHINOHARA, A; OGAWA, H; MATSUDA, Y; USHIO, N; IKEO, K; OGAWA, T			CLONING OF HUMAN, MOUSE AND FISSION YEAST RECOMBINATION GENES HOMOLOGOUS TO RAD51 AND RECA	NATURE GENETICS			English	Article							C-TERMINUS; DNA; PROTEIN; REMOVAL	Rad51, of Saccharomyces cerevisiae, is a homologue of recA of Escherichia coli and plays crucial roles in both mitotic and meiotic recombination and in repair of double-strand breaks of DNA. We have cloned genes from human, mouse and fission yeast that are homologous to rad51. The 339 amino acid proteins predicted for the two mammalian genes are almost identical and are highly homologous (83%) with the yeast proteins. The mouse gene is transcribed at a high level in thymus, spleen, testis and ovary and at a lower level in brain and other tissues. The rad51 homologues fail to complement the DNA repair defect of rad51 mutants of S. cerevisiae. The mouse gene is located in the F1 region of chromosome 2 and the human gene maps to chromosome 15.	NATL INST RADIOL SCI,DIV GENET,INAGE,CHIBA 263,JAPAN; NATL INST GENET,MISHIMA,SHIZUOKA 411,JAPAN	National Institutes for Quantum Science & Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	SHINOHARA, A (corresponding author), OSAKA UNIV,FAC SCI,DEPT BIOL,TOYONAKA,OSAKA 560,JAPAN.							BASILE G, 1992, MOL CELL BIOL, V12, P3235, DOI 10.1128/MCB.12.7.3235; BENEDICT RC, 1988, J BIOL CHEM, V263, P15513; BEZZUBOVA O, 1993, NUCLEIC ACIDS RES, V21, P1577, DOI 10.1093/nar/21.7.1577; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; CORMACK BP, 1991, CELL, V65, P341, DOI 10.1016/0092-8674(91)90167-W; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILL G, 1991, CELL, V65, P333, DOI 10.1016/0092-8674(91)90166-V; HORII T, 1980, P NATL ACAD SCI-BIOL, V77, P313, DOI 10.1073/pnas.77.1.313; JACHYMCZYK WJ, 1981, MOL GEN GENET, V182, P196, DOI 10.1007/BF00269658; KOBAYASHI T, 1993, MOL GEN GENET, V237, P225, DOI 10.1007/BF00282804; KOZAK M, 1987, NUCLEIC ACIDS RES, V16, P8126; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEWIN B, 1990, CELL, V61, P1161, DOI 10.1016/0092-8674(90)90675-5; LUTZKER SG, 1989, MOBILE DNA, P693; MASUKATA H, 1983, MOL GEN GENET, V189, P226, DOI 10.1007/BF00337809; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; Nei M., 1975, MOL POPULATION GENET; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; RESNICK M A, 1987, P157; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; SIRACUSA LD, 1992, MAMM GENOME, V3, pS20, DOI 10.1007/BF00648420; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; TATEISHI S, 1992, J MOL BIOL, V223, P115, DOI 10.1016/0022-2836(92)90720-5; TOMIZAWA JI, 1968, COLD SPRING HARB SYM, V33, P243, DOI 10.1101/SQB.1968.033.01.028; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; YU X, 1991, J STRUCT BIOL, V106, P243, DOI 10.1016/1047-8477(91)90074-7	29	467	499	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					239	243		10.1038/ng0793-239	http://dx.doi.org/10.1038/ng0793-239			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358431				2022-12-17	WOS:A1993LJ84200010
J	Mukherji, S; Ebert, MS; Zheng, GXY; Tsang, JS; Sharp, PA; van Oudenaarden, A				Mukherji, Shankar; Ebert, Margaret S.; Zheng, Grace X. Y.; Tsang, John S.; Sharp, Phillip A.; van Oudenaarden, Alexander			MicroRNAs can generate thresholds in target gene expression	NATURE GENETICS			English	Article							MAMMALIAN MICRORNAS; MESSENGER-RNAS; DIFFERENTIATION; IMPACT; ROBUSTNESS; SPONGES; LET-7	MicroRNAs (miRNAs) are short, highly conserved noncoding RNA molecules that repress gene expression in a sequence-dependent manner. We performed single-cell measurements using quantitative fluorescence microscopy and flow cytometry to monitor a target gene's protein expression in the presence and absence of regulation by miRNA. We find that although the average level of repression is modest, in agreement with previous population-based measurements, the repression among individual cells varies dramatically. In particular, we show that regulation by miRNAs establishes a threshold level of target mRNA below which protein production is highly repressed. Near this threshold, protein expression responds sensitively to target mRNA input, consistent with a mathematical model of molecular titration. These results show that miRNAs can act both as a switch and as a fine-tuner of gene expression.	[Mukherji, Shankar] MIT, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Ebert, Margaret S.; Sharp, Phillip A.; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zheng, Grace X. Y.] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Tsang, John S.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Ebert, Margaret S.; Zheng, Grace X. Y.; Sharp, Phillip A.; van Oudenaarden, Alexander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		US National Institutes of Health (NIH) [1DP1OD003936]; NIH-National Cancer Institute (NCI) Physical Sciences Oncology Center at the Massachusetts Institute of Technology [U54CA143874]; NIH [R01-CA133404, R01-GM34277]; NCI [PO1-CA42063, P30-CA14051]; Howard Hughes Medical Institute; Paul and Cleo Schimmel Scholarship; Natural Sciences and Engineering Research Council of Canada; NATIONAL CANCER INSTITUTE [R01CA133404, P30CA014051, P01CA042063, U54CA143874, DP1CA174420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Cancer Institute (NCI) Physical Sciences Oncology Center at the Massachusetts Institute of Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Paul and Cleo Schimmel Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Institutes of Health (NIH) Director's Pioneer Award to A.v.O. (1DP1OD003936) and the NIH-National Cancer Institute (NCI) Physical Sciences Oncology Center at the Massachusetts Institute of Technology (U54CA143874); and by US Public Health Service grants R01-CA133404, R01-GM34277 from the NIH, PO1-CA42063 from the NCI (to P. A. S.) and partially by Cancer Center Support (core) grant P30-CA14051 from the NCI. M. S. E. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship and a Paul and Cleo Schimmel Scholarship. G.X.Y.Z. and J.S.T. were partially supported by Natural Sciences and Engineering Research Council of Canada Post Graduate Scholarships. We thank G. Neuert for help with cloning the reporter genes, Koch Institute flow cytometry staff for training and cell sorting and D. Bartel for helpful discussions.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	28	466	497	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					854	U60		10.1038/ng.905	http://dx.doi.org/10.1038/ng.905			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21857679	Green Accepted, Green Submitted			2022-12-17	WOS:000294325800010
J	Ohgami, RS; Campagna, DR; Greer, EL; Antiochos, B; McDonald, A; Chen, J; Sharp, JJ; Fujiwara, Y; Barker, JE; Fleming, MD				Ohgami, RS; Campagna, DR; Greer, EL; Antiochos, B; McDonald, A; Chen, J; Sharp, JJ; Fujiwara, Y; Barker, JE; Fleming, MD			Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; PROSTATE-CANCER; SACCHAROMYCES-CEREVISIAE; FERRIC REDUCTASE; MEMBRANE ANTIGEN; APOPTOSIS; PROTEIN; INDUCTION; MUTATION; PRODUCT	The reduction of iron is an essential step in the transferrin (Tf) cycle, which is the dominant pathway for iron uptake by red blood cell precursors. A deficiency in iron acquisition by red blood cells leads to hypochromic, microcytic anemia. Using a positional cloning strategy, we identified a gene, six-transmembrane epithelial antigen of the prostate 3 (Steap3), responsible for the iron deficiency anemia in the mouse mutant nm1054. Steap3 is expressed highly in hematopoietic tissues, colocalizes with the Tf cycle endosome and facilitates Tf-bound iron uptake. Steap3 shares homology with F420H2:NADP(+) oxidoreductases found in archaea and bacteria, as well as with the yeast FRE family of metalloreductases. Overexpression of Steap3 stimulates the reduction of iron, and mice lacking Steap3 are deficient in erythroid ferrireductase activity. Taken together, these findings indicate that Steap3 is an endosomal ferrireductase required for efficient Tf-dependent iron uptake in erythroid cells.	Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Tosteson Med Educ Ctr, Med Scientist Training Program, Boston, MA 02115 USA; Millennium Pharmaceut Inc, Cambridge, MA 01239 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Childrens Hosp, Div Hematol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Jackson Laboratory; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Fleming, MD (corresponding author), Childrens Hosp, Dept Pathol, 300 Longwood Ave, Boston, MA 02115 USA.	mark.fleming@childrens.harvard.edu	Ohgami, R/AAE-1448-2019	Fleming, Mark/0000-0003-0948-4024; Greer, Eric/0000-0002-7501-7371	NHLBI NIH HHS [R01 HL074247-01, R01 HL074247] Funding Source: Medline; NIDDK NIH HHS [R01 DK027726, P30 DK049216] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, R01DK027726] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Dhungana S, 2004, BIOCHEMISTRY-US, V43, P205, DOI 10.1021/bi0353631; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Goldman G L, 1976, J Forensic Sci, V21, P625; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUNSHIN HS, 2005, BLOOD           0616, DOI DOI 10.1182/BLOOD-2004-02-0716; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; INMAN RS, 1994, BIOCHEMISTRY-US, V33, P11850, DOI 10.1021/bi00205a022; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lesuisse E, 1996, J BIOL CHEM, V271, P13578, DOI 10.1074/jbc.271.23.13578; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; OHGAMI RS, 2005, BLOOD           0630, DOI DOI 10.1185/BLOOD-2005-01-0379; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Ponka P, 1997, BLOOD, V89, P1; Porkka KP, 2002, LAB INVEST, V82, P1573, DOI 10.1097/01.LAB.0000038554.26102.C6; Porkka KP, 2003, INT J CANCER, V106, P729, DOI 10.1002/ijc.11278; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Steiner MS, 2000, CANCER RES, V60, P4419; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; Yang DM, 2001, CANCER RES, V61, P5857; Zhang XG, 2001, ONCOGENE, V20, P5982, DOI 10.1038/sj.onc.1204831	30	466	485	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1264	1269		10.1038/ng1658	http://dx.doi.org/10.1038/ng1658			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227996	Green Accepted			2022-12-17	WOS:000233045200028
J	GEISSLER, WM; DAVIS, DL; WU, L; BRADSHAW, KD; PATEL, S; MENDONCA, BB; ELLISTON, KO; WILSON, JD; RUSSELL, DW; ANDERSSON, S				GEISSLER, WM; DAVIS, DL; WU, L; BRADSHAW, KD; PATEL, S; MENDONCA, BB; ELLISTON, KO; WILSON, JD; RUSSELL, DW; ANDERSSON, S			MALE PSEUDOHERMAPHRODITISM CAUSED BY MUTATIONS OF TESTICULAR 17-BETA-HYDROXYSTEROID DEHYDROGENASE-3	NATURE GENETICS			English	Article							HUMAN-PLACENTA; DIFFERENTIATION; DEFICIENCY; SEQUENCE	Defects in the conversion of androstenedione to testosterone in the fetal testes by the enzyme 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) give rise to genetic males with female external genitalia. We have used expression cloning to isolate cDNAs encoding a microsomal 17 beta-HSD type 3 isozyme that shares 23% sequence identity with other 17 beta-HSD enzymes, uses NADPH as a cofactor, and is expressed predominantly in the testes. The 17 beta HSD3 gene on chromosome 9q22 contains 11 exons. Four substitution and two splice junction mutations were identified in the 17 beta HSD3 genes of five unrelated male pseudohermaphrodites. The substitution mutations severely compromised the activity of the 17 beta-HSD type 3 isozyme.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT OBSTET & GYNECOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT BIOCHEM,RAHWAY,NJ 07065; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT BIOL DATA,RAHWAY,NJ 07065; UNIV SAO PAULO,DEPT MED,SAO PAULO,SP,BRAZIL	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Merck & Company; Merck & Company; Universidade de Sao Paulo			Mendonca, Berenice B/J-6917-2015; Mendonca, Berenice B/C-2827-2012; Mendonca, Berenice/AAS-3742-2021	Mendonca, Berenice B/0000-0003-1762-1084; Mendonca, Berenice/0000-0003-1762-1084; Elliston, Keith/0000-0002-9110-9233; Russell, David/0000-0002-0277-403X				AKESODE FA, 1977, CLIN ENDOCRINOL, V7, P443, DOI 10.1111/j.1365-2265.1977.tb01336.x; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; ECKSTEIN B, 1989, J CLIN ENDOCR METAB, V68, P477, DOI 10.1210/jcem-68-2-477; GRIFFIN JE, IN PRESS METABOLIC B; Grumbach M. M., 1992, WILLIAMS TXB ENDOCRI, P853; INANO H, 1977, J STEROID BIOCHEM, V8, P787; INANO H, 1980, STEROID BIOCH, V13, P287; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; KOHN G, 1985, J PEDIATR ENDOCRINOL, V1, P30; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KROZOWSKI Z, 1992, MOL CELL ENDOCRINOL, V84, pC25, DOI 10.1016/0303-7207(92)90064-D; LEE MM, 1993, ENDOCR REV, V14, P152, DOI 10.1210/er.14.2.152; LIN SX, 1992, J BIOL CHEM, V267, P16182; LUU-THE V, 1990, Molecular Endocrinology, V4, P268; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; NEW MI, 1989, METABOLIC BASIS INHE, P1881; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; POUTANEN M, 1993, ENDOCRINOLOGY, V133, P2639, DOI 10.1210/en.133.6.2639; Sambrook J., 1989, MOL CLONING LAB MANU; THE VL, 1989, MOL ENDOCRINOL, V3, P1301, DOI 10.1210/mend-3-8-1301; THIGPEN AE, 1992, J CLIN INVEST, V90, P799, DOI 10.1172/JCI115954; TIGHPEN AE, 1993, J CLIN INVEST, V92, P903; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; WILSON JD, 1978, ANNU REV PHYSIOL, V40, P279, DOI 10.1146/annurev.ph.40.030178.001431; WU L, 1993, J BIOL CHEM, V268, P12964	27	466	499	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					34	39		10.1038/ng0594-34	http://dx.doi.org/10.1038/ng0594-34			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075637				2022-12-17	WOS:A1994NJ84200010
J	Stahl, EA; Breen, G; Forstner, AJ; McQuillin, A; Ripke, S; Trubetskoy, V; Mattheisen, M; Wang, YP; Coleman, JRI; Gaspar, HA; de Leeuw, CA; Steinberg, S; Pavlides, JMW; Trzaskowski, M; Byrne, EM; Pers, TH; Holmans, PA; Richards, AL; Abbott, L; Agerbo, E; Akil, H; Albani, D; Alliey-Rodriguez, N; Als, TD; Anjorin, A; Antilla, V; Awasthi, S; Badner, JA; Baekvad-Hansen, M; Barchas, JD; Bass, N; Bauer, M; Belliveau, R; Bergen, SE; Pedersen, CB; Boen, E; Boks, MP; Boocock, J; Budde, M; Bunney, W; Burmeister, M; Bybjerg-Grauholm, J; Byerley, W; Casas, M; Cerrato, F; Cervantes, P; Chambert, K; Charney, AW; Chen, D; Churchhouse, C; Clarke, TK; Coryell, W; Craig, DW; Cruceanu, C; Curtis, D; Czerski, PM; Dale, AM; de Jong, S; Degenhardt, F; Del-Favero, J; DePaulo, JR; Djurovic, S; Dobbyn, AL; Dumont, A; Elvsashagen, T; Escott-Price, V; Fan, CC; Fischer, SB; Flickinger, M; Foroud, TM; Forty, L; Frank, J; Fraser, C; Freimer, NB; Frisen, L; Gade, K; Gage, D; Garnham, J; Giambartolomei, C; Pedersen, MG; Goldstein, J; Gordon, SD; Gordon-Smith, K; Green, EK; Green, MJ; Greenwood, TA; Grove, J; Guan, WH; Guzman-Parra, J; Hamshere, ML; Hautzinger, M; Heilbronner, U; Herms, S; Hipolito, M; Hoffmann, P; Holland, D; Huckins, L; Jamain, S; Johnson, JS; Jureus, A; Kandaswamy, R; Karlsson, R; Kennedy, JL; Kittel-Schneider, S; Knowles, JA; Kogevinas, M; Koller, AC; Kupka, R; Lavebratt, C; Lawrence, J; Lawson, WB; Leber, M; Lee, PH; Levy, SE; Li, JZ; Liu, CY; Lucae, S; Maaser, A; MacIntyre, DJ; Mahon, PB; Maier, W; Martinsson, L; McCarroll, S; McGuffin, P; McInnis, MG; Mckay, JD; Medeiros, H; Medland, SE; Meng, F; Milani, L; Montgomery, GW; Morris, DW; Muhleisen, TW; Mullins, N; Nguyen, H; Nievergelt, CM; Adolfsson, AN; Nwulia, EA; O'Donovan, C; Loohuis, LMO; Ori, APS; Oruc, L; Osby, U; Perlis, RH; Perry, A; Andrea, P; Potash, JB; Purcell, SM; Regeer, EJ; Reif, A; Reinbold, CS; Rice, JP; Rivas, F; Rivera, M; Roussos, P; Ruderfer, DM; Ryu, E; Sanchez-Mora, C; Schatzberg, AF; Scheftner, WA; Schork, NJ; Weickert, CS; Shehktman, T; Shilling, PD; Sigurdsson, E; Slaney, C; Smeland, OB; Sobell, JL; Hansen, CS; Spijker, AT; St Clair, D; Steffens, M; Strauss, JS; Streit, F; Strohmaier, J; Szelinger, S; Thompson, RC; Thorgeirsson, TE; Treutlein, J; Vedder, H; Wang, WQ; Watson, SJ; Weickert, TW; Witt, SH; Xi, S; Xu, W; Young, AH; Zandi, P; Zhang, P; Zollner, S; Adolfsson, R; Agartz, I; Alda, M; Backlund, L; Baune, BT; Bellivier, F; Berrettini, WH; Biernacka, JM; Blackwood, DHR; Boehnke, M; Borglum, AD; Corvin, A; Craddock, N; Daly, MJ; Dannlowski, U; Esko, T; Etain, B; Frye, M; Fullerton, JM; Gershon, ES; Gill, M; Goes, F; Grigoroiu-Serbanescu, M; Hauser, J; Hougaard, DM; Hultman, CM; Jones, I; Jones, LA; Kahn, RS; Kirov, G; Landen, M; Leboyer, M; Lewis, CM; Li, QQS; Lissowska, J; Martin, NG; Mayoral, F; McElroy, SL; McIntosh, AM; McMahon, FJ; Melle, I; Metspalu, A; Mitchell, PB; Morken, G; Mors, O; Mortensen, PB; Muller-Myhsok, B; Myers, RM; Neale, BM; Nimgaonkar, V; Nordentoft, M; Nothen, MM; O'Donovan, MC; Oedegaard, KJ; Owen, MJ; Paciga, SA; Pato, C; Pato, MT; Posthuma, D; Ramos-Quiroga, JA; Ribases, M; Rietschel, M; Rouleau, GA; Schalling, M; Schofield, PR; Schulze, TG; Serretti, A; Smoller, JW; Stefansson, H; Stefansson, K; Stordal, E; Sullivan, PF; Turecki, G; Vaaler, AE; Vieta, E; Vincent, JB; Werge, T; Nurnberger, JI; Wray, NR; Di Florio, A; Edenberg, HJ; Cichon, S; Ophoff, RA; Scott, LJ; Andreassen, OA; Kelsoe, J; Sklar, P				Stahl, Eli A.; Breen, Gerome; Forstner, Andreas J.; McQuillin, Andrew; Ripke, Stephan; Trubetskoy, Vassily; Mattheisen, Manuel; Wang, Yunpeng; Coleman, Jonathan R. I.; Gaspar, Helena A.; de Leeuw, Christiaan A.; Steinberg, Stacy; Pavlides, Jennifer M. Whitehead; Trzaskowski, Maciej; Byrne, Enda M.; Pers, Tune H.; Holmans, Peter A.; Richards, Alexander L.; Abbott, Liam; Agerbo, Esben; Akil, Huda; Albani, Diego; Alliey-Rodriguez, Ney; Als, Thomas D.; Anjorin, Adebayo; Antilla, Verneri; Awasthi, Swapnil; Badner, Judith A.; Baekvad-Hansen, Marie; Barchas, Jack D.; Bass, Nicholas; Bauer, Michael; Belliveau, Richard; Bergen, Sarah E.; Pedersen, Carsten Bocker; Boen, Erlend; Boks, Marco P.; Boocock, James; Budde, Monika; Bunney, William; Burmeister, Margit; Bybjerg-Grauholm, Jonas; Byerley, William; Casas, Miquel; Cerrato, Felecia; Cervantes, Pablo; Chambert, Kimberly; Charney, Alexander W.; Chen, Danfeng; Churchhouse, Claire; Clarke, Toni-Kim; Coryell, William; Craig, David W.; Cruceanu, Cristiana; Curtis, David; Czerski, Piotr M.; Dale, Anders M.; de Jong, Simone; Degenhardt, Franziska; Del-Favero, Jurgen; DePaulo, J. Raymond; Djurovic, Srdjan; Dobbyn, Amanda L.; Dumont, Ashley; Elvsashagen, Torbjorn; Escott-Price, Valentina; Fan, Chun Chieh; Fischer, Sascha B.; Flickinger, Matthew; Foroud, Tatiana M.; Forty, Liz; Frank, Josef; Fraser, Christine; Freimer, Nelson B.; Frisen, Louise; Gade, Katrin; Gage, Diane; Garnham, Julie; Giambartolomei, Claudia; Pedersen, Marianne Giortz; Goldstein, Jaqueline; Gordon, Scott D.; Gordon-Smith, Katherine; Green, Elaine K.; Green, Melissa J.; Greenwood, Tiffany A.; Grove, Jakob; Guan, Weihua; Guzman-Parra, Jose; Hamshere, Marian L.; Hautzinger, Martin; Heilbronner, Urs; Herms, Stefan; Hipolito, Maria; Hoffmann, Per; Holland, Dominic; Huckins, Laura; Jamain, Stephane; Johnson, Jessica S.; Jureus, Anders; Kandaswamy, Radhika; Karlsson, Robert; Kennedy, James L.; Kittel-Schneider, Sarah; Knowles, James A.; Kogevinas, Manolis; Koller, Anna C.; Kupka, Ralph; Lavebratt, Catharina; Lawrence, Jacob; Lawson, William B.; Leber, Markus; Lee, Phil H.; Levy, Shawn E.; Li, Jun Z.; Liu, Chunyu; Lucae, Susanne; Maaser, Anna; MacIntyre, Donald J.; Mahon, Pamela B.; Maier, Wolfgang; Martinsson, Lina; McCarroll, Steve; McGuffin, Peter; McInnis, Melvin G.; Mckay, James D.; Medeiros, Helena; Medland, Sarah E.; Meng, Fan; Milani, Lili; Montgomery, Grant W.; Morris, Derek W.; Muhleisen, Thomas W.; Mullins, Niamh; Nguyen, Hoang; Nievergelt, Caroline M.; Adolfsson, Annelie Nordin; Nwulia, Evaristus A.; O'Donovan, Claire; Loohuis, Loes M. Olde; Ori, Anil P. S.; Oruc, Lilijana; Osby, Urban; Perlis, Roy H.; Perry, Amy; Andrea, Pfennig; Potash, James B.; Purcell, Shaun M.; Regeer, Eline J.; Reif, Andreas; Reinbold, Celine S.; Rice, John P.; Rivas, Fabio; Rivera, Margarita; Roussos, Panos; Ruderfer, Douglas M.; Ryu, Euijung; Sanchez-Mora, Cristina; Schatzberg, Alan F.; Scheftner, William A.; Schork, Nicholas J.; Weickert, Cynthia Shannon; Shehktman, Tatyana; Shilling, Paul D.; Sigurdsson, Engilbert; Slaney, Claire; Smeland, Olav B.; Sobell, Janet L.; Hansen, Christine Soholm; Spijker, Anne T.; St Clair, David; Steffens, Michael; Strauss, John S.; Streit, Fabian; Strohmaier, Jana; Szelinger, Szabolcs; Thompson, Robert C.; Thorgeirsson, Thorgeir E.; Treutlein, Jens; Vedder, Helmut; Wang, Weiqing; Watson, Stanley J.; Weickert, Thomas W.; Witt, Stephanie H.; Xi, Simon; Xu, Wei; Young, Allan H.; Zandi, Peter; Zhang, Peng; Zollner, Sebastian; Adolfsson, Rolf; Agartz, Ingrid; Alda, Martin; Backlund, Lena; Baune, Bernhard T.; Bellivier, Frank; Berrettini, Wade H.; Biernacka, Joanna M.; Blackwood, Douglas H. R.; Boehnke, Michael; Borglum, Anders D.; Corvin, Aiden; Craddock, Nicholas; Daly, Mark J.; Dannlowski, Udo; Esko, Tonu; Etain, Bruno; Frye, Mark; Fullerton, Janice M.; Gershon, Elliot S.; Gill, Michael; Goes, Fernando; Grigoroiu-Serbanescu, Maria; Hauser, Joanna; Hougaard, David M.; Hultman, Christina M.; Jones, Ian; Jones, Lisa A.; Kahn, Rene S.; Kirov, George; Landen, Mikael; Leboyer, Marion; Lewis, Cathryn M.; Li, Qingqin S.; Lissowska, Jolanta; Martin, Nicholas G.; Mayoral, Fermin; McElroy, Susan L.; McIntosh, Andrew M.; McMahon, Francis J.; Melle, Ingrid; Metspalu, Andres; Mitchell, Philip B.; Morken, Gunnar; Mors, Ole; Mortensen, Preben Bo; Muller-Myhsok, Bertram; Myers, Richard M.; Neale, Benjamin M.; Nimgaonkar, Vishwajit; Nordentoft, Merete; Noethen, Markus M.; O'Donovan, Michael C.; Oedegaard, Ketil J.; Owen, Michael J.; Paciga, Sara A.; Pato, Carlos; Pato, Michele T.; Posthuma, Danielle; Ramos-Quiroga, Josep Antoni; Ribases, Marta; Rietschel, Marcella; Rouleau, Guy A.; Schalling, Martin; Schofield, Peter R.; Schulze, Thomas G.; Serretti, Alessandro; Smoller, Jordan W.; Stefansson, Hreinn; Stefansson, Kari; Stordal, Eystein; Sullivan, Patrick F.; Turecki, Gustavo; Vaaler, Arne E.; Vieta, Eduard; Vincent, John B.; Werge, Thomas; Nurnberger, John I.; Wray, Naomi R.; Di Florio, Arianna; Edenberg, Howard J.; Cichon, Sven; Ophoff, Roel A.; Scott, Laura J.; Andreassen, Ole A.; Kelsoe, John; Sklar, Pamela		eQTLGen Consortium; BIOS Consortium; Bipolar Disorder Working Grp Psych	Genome-wide association study identifies 30 loci associated with bipolar disorder	NATURE GENETICS			English	Article							LD SCORE REGRESSION; SCHIZOPHRENIA; HERITABILITY; GWAS; RISK; METAANALYSIS; INDIVIDUALS; VARIANTS; GENES; POLYGENICITY	Bipolar disorder is a highly heritable psychiatric disorder. We performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 variants with P < 1 x 10(-4) in an additional 9,412 cases and 137,760 controls. Eight of the 19 variants that were genome-wide significant (P < 5 x 10(-8)) in the discovery GWAS were not genome-wide significant in the combined analysis, consistent with small effect sizes and limited power but also with genetic heterogeneity. In the combined analysis, 30 loci were genome-wide significant, including 20 newly identified loci. The significant loci contain genes encoding ion channels, neurotransmitter transporters and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including regulation of insulin secretion and endocannabinoid signaling. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder. These findings address key clinical questions and provide potential biological mechanisms for bipolar disorder.	[Stahl, Eli A.; Dobbyn, Amanda L.; Huckins, Laura; Johnson, Jessica S.; Nguyen, Hoang; Roussos, Panos; Wang, Weiqing; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Stahl, Eli A.; Charney, Alexander W.; Dobbyn, Amanda L.; Huckins, Laura; Johnson, Jessica S.; Nguyen, Hoang; Purcell, Shaun M.; Roussos, Panos; Wang, Weiqing; Kahn, Rene S.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Stahl, Eli A.; Pers, Tune H.; Esko, Tonu; Neale, Benjamin M.] Broad Inst, Med & Populat Genet, Cambridge, MA 02142 USA; [Breen, Gerome; Coleman, Jonathan R. I.; Gaspar, Helena A.; de Jong, Simone; Kandaswamy, Radhika; McGuffin, Peter; Mullins, Niamh; Rivera, Margarita; Lewis, Cathryn M.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, London, England; [Breen, Gerome; Coleman, Jonathan R. I.; Gaspar, Helena A.; de Jong, Simone; Lewis, Cathryn M.] Kings Coll London, NIHR BRC Mental Hlth, London, England; [Forstner, Andreas J.; Fischer, Sascha B.; Herms, Stefan; Hoffmann, Per; Muhleisen, Thomas W.; Reinbold, Celine S.; Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland; [Forstner, Andreas J.] Univ Basel, Dept Psychiat UPK, Basel, Switzerland; [Forstner, Andreas J.; Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Koller, Anna C.; Maaser, Anna; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany; [Forstner, Andreas J.; Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Koller, Anna C.; Maaser, Anna; Noethen, Markus M.; Cichon, Sven] Univ Hosp Bonn, Bonn, Germany; [Forstner, Andreas J.] Univ Marburg, Ctr Human Genet, Marburg, Germany; [Forstner, Andreas J.; Fischer, Sascha B.; Herms, Stefan; Hoffmann, Per; Reinbold, Celine S.; Cichon, Sven] Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland; [McQuillin, Andrew; Bass, Nicholas] UCL, Div Psychiat, London, England; [Ripke, Stephan; Abbott, Liam; Belliveau, Richard; Cerrato, Felecia; Chambert, Kimberly; Chen, Danfeng; Churchhouse, Claire; Dumont, Ashley; Gage, Diane; Goldstein, Jaqueline; Lee, Phil H.; McCarroll, Steve; Daly, Mark J.; Neale, Benjamin M.; Smoller, Jordan W.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Ripke, Stephan; Trubetskoy, Vassily; Awasthi, Swapnil] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Ripke, Stephan; Antilla, Verneri; Churchhouse, Claire; Lee, Phil H.; Daly, Mark J.; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Mattheisen, Manuel; Als, Thomas D.; Grove, Jakob; Borglum, Anders D.; Mortensen, Preben Bo] Aarhus Univ, Ctr Integrat Sequencing, iSEQ, Aarhus, Denmark; [Mattheisen, Manuel; Als, Thomas D.; Grove, Jakob; Borglum, Anders D.] Aarhus Univ, Dept Biomed Human Genet, Aarhus, Denmark; [Mattheisen, Manuel; Agartz, Ingrid] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Mattheisen, Manuel] Univ Hosp Wurzburg, Ctr Mental Hlth, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Mattheisen, Manuel; Agerbo, Esben; Als, Thomas D.; Baekvad-Hansen, Marie; Pedersen, Carsten Bocker; Bybjerg-Grauholm, Jonas; Pedersen, Marianne Giortz; Grove, Jakob; Hansen, Christine Soholm; Borglum, Anders D.; Hougaard, David M.; Mors, Ole; Mortensen, Preben Bo; Nordentoft, Merete; Werge, Thomas] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Wang, Yunpeng] Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, Copenhagen, Denmark; [Wang, Yunpeng] Univ Oslo, Inst Clin Med, Oslo, Norway; [de Leeuw, Christiaan A.; Posthuma, Danielle] Vrije Univ Amsterdam, Amsterdam Neurosci, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands; [Steinberg, Stacy; Thorgeirsson, Thorgeir E.; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet Amgen, Reykjavik, Iceland; [Pavlides, Jennifer M. Whitehead; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Trzaskowski, Maciej; Byrne, Enda M.; Montgomery, Grant W.; Wray, Naomi R.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Pers, Tune H.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Holmans, Peter A.; Richards, Alexander L.; Escott-Price, Valentina; Forty, Liz; Fraser, Christine; Hamshere, Marian L.; Craddock, Nicholas; Jones, Ian; Kirov, George; O'Donovan, Michael C.; Owen, Michael J.; Di Florio, Arianna] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Agerbo, Esben; Pedersen, Carsten Bocker; Pedersen, Marianne Giortz; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Agerbo, Esben; Pedersen, Carsten Bocker; Pedersen, Marianne Giortz; Mortensen, Preben Bo] Aarhus Univ, Ctr Integrated Register Based Res, Aarhus, Denmark; [Akil, Huda; Meng, Fan] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Albani, Diego] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Milan, Italy; [Alliey-Rodriguez, Ney; Gershon, Elliot S.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Anjorin, Adebayo] Berkshire Healthcare NHS Fdn Trust, Dept Psychiat, Bracknell, Berks, England; [Badner, Judith A.] Rush Univ, Med Ctr, Dept Psychiat, Chicago, IL 60612 USA; [Baekvad-Hansen, Marie; Bybjerg-Grauholm, Jonas; Hansen, Christine Soholm; Hougaard, David M.] Statens Serum Inst, Dept Congenital Disorders, Ctr Neonatal Screening, Copenhagen, Denmark; [Barchas, Jack D.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Bauer, Michael; Andrea, Pfennig] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Psychiat & Psychotherapy, Dresden, Germany; [Bergen, Sarah E.; Jureus, Anders; Karlsson, Robert; Hultman, Christina M.; Landen, Mikael; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Boen, Erlend; Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Boks, Marco P.; Kahn, Rene S.; Ophoff, Roel A.] UMC Utrecht Brain Ctr Rudolf Magnus, Psychiat, Utrecht, Netherlands; [Boocock, James; Ophoff, Roel A.] Univ Calif Los Angeles, Human Genet, Los Angeles, CA USA; [Budde, Monika; Gade, Katrin; Heilbronner, Urs; Schulze, Thomas G.] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Psychiat Phen & Genom, Munich, Germany; [Bunney, William] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Burmeister, Margit] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Burmeister, Margit] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Byerley, William] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Casas, Miquel; Sanchez-Mora, Cristina; Ramos-Quiroga, Josep Antoni; Ribases, Marta] Inst Salud Carlos III, Biomed Network Res Ctr Mental Hlth CIBERSAM, Madrid, Spain; [Casas, Miquel; Sanchez-Mora, Cristina; Ramos-Quiroga, Josep Antoni; Ribases, Marta] Hosp Univ Vall dHebron, Dept Psychiat, Barcelona, Spain; [Casas, Miquel; Ramos-Quiroga, Josep Antoni] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, Barcelona, Spain; [Casas, Miquel; Sanchez-Mora, Cristina; Ramos-Quiroga, Josep Antoni; Ribases, Marta] Univ Autonoma Barcelona, Vall dHebron Res Inst, Grp Psychiat Mental Hlth & Addict, Psychiat Genet Unit, Barcelona, Spain; [Cervantes, Pablo; Cruceanu, Cristiana] McGill Univ, Ctr Hlth, Mood Disorders Program, Dept Psychiat, Montreal, PQ, Canada; [Clarke, Toni-Kim; Blackwood, Douglas H. R.; McIntosh, Andrew M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Coryell, William] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Craig, David W.] USC, Translat Genom, Phoenix, AZ USA; [Cruceanu, Cristiana; Muller-Myhsok, Bertram] Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany; [Curtis, David] Queen Mary Univ London, Ctr Psychiat, London, England; [Curtis, David] UCL, UCL Genet Inst, London, England; [Czerski, Piotr M.; Hauser, Joanna] Poznan Univ Med Sci, Lab Psychiat Genet, Dept Psychiat, Poznan, Poland; [Dale, Anders M.; Holland, Dominic] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Dale, Anders M.; Greenwood, Tiffany A.; Nievergelt, Caroline M.; Shehktman, Tatyana; Shilling, Paul D.; Kelsoe, John] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Del-Favero, Jurgen] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Unit, Antwerp, Belgium; [DePaulo, J. Raymond; Mahon, Pamela B.; Potash, James B.; Goes, Fernando; Schulze, Thomas G.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Djurovic, Srdjan] Oslo Univ Hosp Ulleval, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Psychosis Res, NORMENT, Bergen, Norway; [Elvsashagen, Torbjorn] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Elvsashagen, Torbjorn] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Flickinger, Matthew; Boehnke, Michael; Scott, Laura J.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Flickinger, Matthew; Boehnke, Michael; Scott, Laura J.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Foroud, Tatiana M.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Frank, Josef; Streit, Fabian; Strohmaier, Jana; Treutlein, Jens; Witt, Stephanie H.; Rietschel, Marcella; Schulze, Thomas G.] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Freimer, Nelson B.; Loohuis, Loes M. Olde; Ori, Anil P. S.; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Frisen, Louise; Lavebratt, Catharina; Schalling, Martin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Frisen, Louise; Lavebratt, Catharina; Schalling, Martin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Frisen, Louise; Martinsson, Lina; Backlund, Lena] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Frisen, Louise; Martinsson, Lina; Backlund, Lena] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Frisen, Louise] Child & Adolescent Psychiat Res Ctr, Stockholm, Sweden; [Gade, Katrin; Schulze, Thomas G.] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany; [Garnham, Julie; O'Donovan, Claire; Slaney, Claire; Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Giambartolomei, Claudia] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Gordon, Scott D.; Medland, Sarah E.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet & Computat Biol, Brisbane, Qld, Australia; [Gordon-Smith, Katherine; Perry, Amy; Jones, Lisa A.] Univ Worcester, Dept Psychol Med, Worcester, England; [Green, Elaine K.] Univ Plymouth, Plymouth Univ Peninsula Sch Med, Sch Biomed Sci, Plymouth, Devon, England; [Green, Elaine K.] Univ Plymouth, Plymouth Univ Peninsula Sch Dent, Sch Biomed Sci, Plymouth, Devon, England; [Green, Melissa J.; Weickert, Cynthia Shannon; Weickert, Thomas W.; Mitchell, Philip B.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Green, Melissa J.; Weickert, Cynthia Shannon; Weickert, Thomas W.; Fullerton, Janice M.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Grove, Jakob] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Guan, Weihua] Univ Minnesota Syst, Biostat, Minneapolis, MN USA; [Guzman-Parra, Jose; Rivas, Fabio; Mayoral, Fermin] Univ Reg Hosp, Biomed Inst IBIMA, Mental Hlth Dept, Malaga, Spain; [Hautzinger, Martin] Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany; [Hipolito, Maria; Lawson, William B.; Nwulia, Evaristus A.] Howard Univ Hosp, Dept Psychiat & Behav Sci, Washington, DC USA; [Holland, Dominic] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, La Jolla, CA 92093 USA; [Jamain, Stephane] INSERM, U955, Psychiat Translat, Creteil, France; [Jamain, Stephane; Leboyer, Marion] Univ Paris Est, Fac Med, Creteil, France; [Kennedy, James L.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Kennedy, James L.] Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON, Canada; [Kennedy, James L.; Strauss, John S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Kennedy, James L.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kittel-Schneider, Sarah; Reif, Andreas] Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Knowles, James A.] Suny Downstate Med Ctr, Coll Med, Cell Biol, Brooklyn, NY 11203 USA; [Knowles, James A.; Medeiros, Helena; Pato, Carlos; Pato, Michele T.] Suny Downstate Med Ctr, Coll Med, Inst Genom Hlth, Brooklyn, NY 11203 USA; [Kogevinas, Manolis] ISGlobal, Barcelona, Spain; [Kupka, Ralph] Altrecht, Psychiat, Utrecht, Netherlands; [Kupka, Ralph] GGZ InGeest, Psychiat, Amsterdam, Netherlands; [Kupka, Ralph] Vrije Univ Amsterdam Med Ctr, Psychiat, Amsterdam, Netherlands; [Lawrence, Jacob] Rth East London NHS Fdn Trust, Ilford, England; [Leber, Markus] Univ Hosp Bonn, Dept Neurodegenerat Dis & Geropsychiat, Bonn, Germany; [Lee, Phil H.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Levy, Shawn E.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Liu, Chunyu] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Lucae, Susanne] Max Planck Inst Psychiat, Munich, Germany; [MacIntyre, Donald J.] NHS 24, Mental Hlth, Glasgow, Lanark, Scotland; [MacIntyre, Donald J.] Univ Edinburgh, Ctr Clin Brain Sci, Div Psychiat, Edinburgh, Midlothian, Scotland; [Mahon, Pamela B.; Purcell, Shaun M.] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [McCarroll, Steve; Esko, Tonu] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [McInnis, Melvin G.; Meng, Fan; Thompson, Robert C.; Watson, Stanley J.; Zollner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Mckay, James D.] Int Agcy Res Canc, Genet Canc Susceptibil Grp, Lyon, France; [Milani, Lili; Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Morris, Derek W.] Natl Univ Ireland, Neuroimaging & Cognit Genom NICOG Ctr, Discipline Biochem, Galway, Ireland; [Morris, Derek W.; Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Morris, Derek W.; Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Trinity Translat Med Inst, Dublin, Ireland; [Muhleisen, Thomas W.; Cichon, Sven] Forschungszentrum Julich, Inst Neurosci & Med INM 1, Julich, Germany; [Nievergelt, Caroline M.] Vet Affairs San Diego Healthcare Syst, Res Psychiat, San Diego, CA USA; [Adolfsson, Annelie Nordin; Adolfsson, Rolf] Umea Univ, Fac Med, Dept Clin Sci, Psychiat, Umea, Sweden; [Oruc, Lilijana] Univ Sarajevo, Ctr Clin, Psychiat Clin, Dept Clin Psychiat, Sarajevo, Bosnia & Herceg; [Osby, Urban] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Osby, Urban] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Perlis, Roy H.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Perlis, Roy H.] Massachusetts Gen Hosp, Div Clin Res, Boston, MA 02114 USA; [Regeer, Eline J.] Altrecht, Outpatient Clin Bipolar Disorder, Utrecht, Netherlands; [Rice, John P.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Rivera, Margarita] Univ Granada, Ctr Biomed Res, Inst Neurosci, Dept Biochem & Mol Biol 2, Granada, Spain; [Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Ruderfer, Douglas M.] Vanderbilt Univ, Med Ctr, Med, Psychiat,Biomed Informat, Nashville, TN USA; [Ryu, Euijung; Biernacka, Joanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Schatzberg, Alan F.] Stanford Univ, Sch Med, Psychiat & Behav Sci, Stanford, CA 94305 USA; [Scheftner, William A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Schork, Nicholas J.] Scripps Translat Sci Inst, La Jolla, CA USA; [Sigurdsson, Engilbert; Stefansson, Kari] Univ Iceland, Sch Hlth Sci, Dept Psychiat, Fac Med, Reykjavik, Iceland; [Smeland, Olav B.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Smeland, Olav B.; Andreassen, Ole A.] Univ Oslo, NORMENT, Oslo, Norway; [Sobell, Janet L.] Univ Southern Calif, Psychiat & Behav Sci, Los Angeles, CA USA; [Spijker, Anne T.] PsyQ, Mood Disorders, Rotterdam, Netherlands; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Steffens, Michael] Fed Inst Drugs & Med Devices BfArM, Res Div, Bonn, Germany; [Strauss, John S.; Vincent, John B.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Szelinger, Szabolcs] TGen, Neurogen, Phoenix, AZ USA; [Vedder, Helmut] Psychiat Zentrum Nordbaden, Dept Psychiat, Wiesloch, Germany; [Xi, Simon] Pfizer Global Res & Dev, Computat Sci Ctr Emphasis, Cambridge, MA USA; [Xu, Wei] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada; [Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Young, Allan H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Psychol Med, London, England; [Zandi, Peter] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Zhang, Peng] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Agartz, Ingrid] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT,Div Mental Hlth & Addict, Oslo, Norway; [Agartz, Ingrid] Univ Oslo, Diakonhjemmet Hosp, Oslo, Norway; [Alda, Martin] Natl Inst Mental Hlth, Klecany, Czech Republic; [Baune, Bernhard T.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Baune, Bernhard T.; Dannlowski, Udo] Univ Munster, Dept Psychiat, Munster, Germany; [Bellivier, Frank; Etain, Bruno; Leboyer, Marion] AP HP, Dept Psychiat & Addict Med, Paris, France; [Bellivier, Frank] FondaMental Fdn, Paris Bipolar Expert Ctr, Paris, France; [Bellivier, Frank] FondaMental Fdn, TRD Expert Ctr, Paris, France; [Bellivier, Frank; Etain, Bruno] INSERM, UMR S1144, Team Biomarkers Relapse & Therapeut Response Addi, Paris, France; [Bellivier, Frank; Etain, Bruno] Univ Paris Diderot, Dept Psychiat, Paris, France; [Berrettini, Wade H.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Esko, Tonu] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA; [Etain, Bruno] Inst Psychiat Psychol & Neurosci, Ctr Affect Disorders, London, England; [Frye, Mark] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Fullerton, Janice M.; Schofield, Peter R.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Gershon, Elliot S.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Clin Psychiat Hosp, Biometr Psychiat Genet Res Unit, Bucharest, Romania; [Landen, Mikael] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Leboyer, Marion] INSERM, Paris, France; [Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London, England; [Li, Qingqin S.] Janssen Res & Dev LLC, Neurosci Therapeut Area, Titusville, NJ USA; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr & Inst Oncol, Canc Epidemiol & Prevent, Warsaw, Poland; [Martin, Nicholas G.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [McElroy, Susan L.] Lindner Ctr HOPE, Res Inst, Mason, OH USA; [McIntosh, Andrew M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [McMahon, Francis J.; Schulze, Thomas G.] NIMH, Human Genet Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Melle, Ingrid] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Melle, Ingrid] Oslo Univ Hosp, Inst Clin Med, Oslo, Norway; [Melle, Ingrid] Univ Oslo, Oslo, Norway; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Morken, Gunnar] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Mental Hlth, Trondheim, Norway; [Morken, Gunnar] St Olavs Univ Hosp, Dept Psychiat, Trondheim, Norway; [Mors, Ole] Aarhus Univ Hosp, Psychosis Res Unit, Risskov, Denmark; [Muller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Muller-Myhsok, Bertram] Univ Liverpool, Liverpool, Merseyside, England; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Psychiat & Human Genet, Pittsburgh, PA USA; [Nordentoft, Merete] Univ Copenhagen, Mental Hlth Ctr Copenhagen, Mental Hlth Serv Capital Reg Denmark, Copenhagen, Denmark; [Oedegaard, Ketil J.] Haukeland Univ Sjukehus, Div Psychiat, Bergen, Norway; [Oedegaard, Ketil J.] Univ Bergen, Fac Med & Dent, Bergen, Norway; [Paciga, Sara A.] Pfizer Global Res & Dev, Human Genet & Computat Biomed, Groton, CT USA; [Pato, Carlos] Suny Downstate Med Ctr, Coll Med, Inst Genom Hlth, Brooklyn, NY 11203 USA; [Posthuma, Danielle] Vrije Univ Med Ctr, Amsterdam Neurosci, Dept Clin Genet, Amsterdam, Netherlands; [Rouleau, Guy A.] McGill Univ, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Rouleau, Guy A.] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada; [Serretti, Alessandro] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy; [Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Stordal, Eystein] Hosp Namsos, Dept Psychiat, Namsos, Norway; [Stordal, Eystein] Norwegian Univ Sci & Technol, Dept Mental Hlth, Trondheim, Norway; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Sullivan, Patrick F.; Di Florio, Arianna] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Vaaler, Arne E.] Univ Sykehuset Trondheim, Sankt Olavs Hosp, Dept Psychiat, Trondheim, Norway; [Vieta, Eduard] Univ Barcelona, Hosp Clin, Clin Inst Neurosci, IDIBAPS,CIBERSAM, Barcelona, Spain; [Werge, Thomas] Mental Hlth Serv Copenhagen, MHC Sct Hans, Inst Biol Psychiat, Roskilde, Denmark; [Breen, Gerome; Werge, Thomas] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Nurnberger, John I.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Edenberg, Howard J.] Indiana Univ Sch Med, Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Stahl, Eli A.; Forstner, Andreas J.; McQuillin, Andrew; Ripke, Stephan; Sklar, Pamela] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Fan, Chun Chieh] Univ Calif, Dept Cognit Sci, San Diego, CA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; King's College London; University of London; King's College London; University of Basel; University of Basel; University of Bonn; University of Bonn; Philipps University Marburg; University of Basel; University of London; University College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Massachusetts General Hospital; Aarhus University; Aarhus University; Karolinska Institutet; University of Wurzburg; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Oslo; Vrije Universiteit Amsterdam; University of Queensland; University of Queensland; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Cardiff University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Michigan System; University of Michigan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Chicago; Rush University; Statens Serum Institut; Cornell University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Karolinska Institutet; Diakonhjemmet Hospital; University of California System; University of California Los Angeles; University of Munich; University of California System; University of California Irvine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); McGill University; University of Edinburgh; University of Iowa; Max Planck Society; University of London; Queen Mary University London; University of London; University College London; Poznan University of Medical Sciences; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Flanders Institute for Biotechnology (VIB); University of Antwerp; Johns Hopkins University; University of Oslo; University of Bergen; University of Oslo; University of Oslo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University-Purdue University Indianapolis; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of California System; University of California Los Angeles; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Gottingen; Dalhousie University; University of California System; University of California Los Angeles; QIMR Berghofer Medical Research Institute; University of Worcester; University of Plymouth; University of Plymouth; University of New South Wales Sydney; Neuroscience Research Australia; Aarhus University; Eberhard Karls University of Tubingen; Howard University; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Goethe University Frankfurt; Goethe University Frankfurt Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; ISGlobal; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Bonn; Harvard University; Massachusetts General Hospital; HudsonAlpha Institute for Biotechnology; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Max Planck Society; University of Edinburgh; Harvard University; Brigham & Women's Hospital; University of Bonn; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; World Health Organization; International Agency for Research on Cancer (IARC); University of Tartu; Ollscoil na Gaillimhe-University of Galway; Trinity College Dublin; Trinity College Dublin; Helmholtz Association; Research Center Julich; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Umea University; University of Sarajevo; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); University of Granada; Icahn School of Medicine at Mount Sinai; Vanderbilt University; Mayo Clinic; Stanford University; Rush University; Scripps Research Institute; University of Iceland; University of Oslo; University of Oslo; University of Southern California; University of Aberdeen; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Translational Genomics Research Institute; Pfizer; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of London; King's College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Oslo; Diakonhjemmet Hospital; University of Oslo; National Institute of Mental Health - Czech Republic; University of Melbourne; University of Munster; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Harvard University; Boston Children's Hospital; Mayo Clinic; University of New South Wales Sydney; University of Chicago; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; King's College London; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Maria Sklodowska-Curie National Research Institute of Oncology; University of Queensland; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Oslo; University of Oslo; University of Oslo; University of Tartu; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Aarhus University; University of Munich; University of Liverpool; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Copenhagen; University of Bergen; Haukeland University Hospital; University of Bergen; Pfizer; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; McGill University; McGill University; University of Bologna; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Norwegian University of Science & Technology (NTNU); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; McGill University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Copenhagen; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Johns Hopkins University; University of California System; University of California San Diego	Stahl, EA (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Stahl, EA (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Stahl, EA (corresponding author), Broad Inst, Med & Populat Genet, Cambridge, MA 02142 USA.; Kelsoe, J (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.; Stahl, EA (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA.	eli.stahl@mssm.edu; jkelsoe@ucsd.edu	Jamain, Stéphane/P-3710-2017; Serretti, Alessandro/G-3955-2017; St Clair, David/AAN-2412-2021; blackwood, douglas/AIB-8874-2022; Gaspar, Héléna Alexandra/H-5104-2016; Mortensen, Preben B/D-2358-2015; Kupka, Ralph/HDM-4184-2022; Morris, Derek/AAW-8343-2021; Grigoroiu-Serbanescu, Maria/R-3689-2019; Wray, Naomi/C-8639-2015; Cruceanu, Cristiana/AAK-2885-2021; Rivera, Margarita/J-3017-2017; Guzman-Parra, Jose/X-4172-2019; Smeland, Olav Bjerkehagen/AAM-5284-2020; McIntosh, Andrew M/B-9379-2008; Weickert, Thomas/AFS-7669-2022; Kennedy, James Lowery/AAZ-6947-2020; Wang, Yunpeng/W-8871-2018; Hougaard, David/AAD-6368-2019; Nordentoft, Merete/AAH-3253-2019; Mattheisen, Manuel/S-3725-2019; Bergen, Sarah/I-8313-2012; Clarke, Toni/AAE-7069-2019; Weickert, Thomas/AAI-6324-2021; Mahon, Pamela Belmonte/O-9806-2018; Jones, Ian R/B-4925-2009; Bybjerg-Grauholm, Jonas/AAO-5447-2020; xu, wei/HHD-2891-2022; Medland, Sarah/AAT-7595-2020; Stefansson, Kari/AAE-7187-2019; Huckins, Laura/GPX-8325-2022; Landen, Mikael/AAD-7917-2020; Daly, Mark J/B-2453-2017; Ripke, Stephan/AAK-5486-2021; Leboyer, Marion/AAW-3648-2021; McQuillin, Andrew/C-1623-2008; ALBANI, DIEGO/I-5183-2018; Etain, Bruno/L-6647-2017; Breen, Gerome/Y-2706-2019; Lewis, Cathryn M/A-5225-2010; Heilbronner, Urs/GXF-9880-2022; Coleman, Jonathan/T-9412-2019; Morken, Gunnar/AAX-3373-2020; Montgomery, Grant W/B-7148-2008; Alda, Martin/F-5812-2010; Lissowska, Jolanta/AAH-3252-2020; Smeland, Olav/ADE-5677-2022; Ribasés, Marta/B-5309-2019; Vieta, Eduard/Y-2919-2019; Hoffmann, Per/A-5149-2010; Greenwood, Tiffany/F-6356-2012; Andreassen, Ole A./AAY-7531-2020	Jamain, Stéphane/0000-0002-4321-4100; Serretti, Alessandro/0000-0003-4363-3759; Gaspar, Héléna Alexandra/0000-0002-5540-2707; Mortensen, Preben B/0000-0002-5230-9865; Morris, Derek/0000-0002-3413-570X; Grigoroiu-Serbanescu, Maria/0000-0002-1304-6687; Wray, Naomi/0000-0001-7421-3357; Cruceanu, Cristiana/0000-0002-7799-5531; Rivera, Margarita/0000-0003-4717-1045; Guzman-Parra, Jose/0000-0002-1463-6435; Smeland, Olav Bjerkehagen/0000-0002-3761-5215; McIntosh, Andrew M/0000-0002-0198-4588; Weickert, Thomas/0000-0002-6408-718X; Kennedy, James Lowery/0000-0002-8733-3806; Wang, Yunpeng/0000-0001-9831-1090; Mattheisen, Manuel/0000-0002-8442-493X; Bergen, Sarah/0000-0002-5888-0034; Clarke, Toni/0000-0002-7745-6351; Mahon, Pamela Belmonte/0000-0002-3947-441X; Jones, Ian R/0000-0001-5821-5889; Bybjerg-Grauholm, Jonas/0000-0003-1705-4008; Medland, Sarah/0000-0003-1382-380X; Huckins, Laura/0000-0002-5369-6502; Daly, Mark J/0000-0002-0949-8752; Leboyer, Marion/0000-0001-5473-3697; McQuillin, Andrew/0000-0003-1567-2240; ALBANI, DIEGO/0000-0002-7050-6723; Etain, Bruno/0000-0002-5377-1488; Breen, Gerome/0000-0003-2053-1792; Lewis, Cathryn M/0000-0002-8249-8476; Coleman, Jonathan/0000-0002-6759-0944; Morken, Gunnar/0000-0003-1972-5901; Montgomery, Grant W/0000-0002-4140-8139; Alda, Martin/0000-0001-9544-3944; Lissowska, Jolanta/0000-0003-2695-5799; Ribasés, Marta/0000-0003-1039-1116; Vieta, Eduard/0000-0002-0548-0053; Hoffmann, Per/0000-0002-6573-983X; Greenwood, Tiffany/0000-0002-6080-6503; de Jong, Simone/0000-0002-8002-7195	US National Institute of Mental Health; Brain and Behavior Research Foundation; Stanley Medical Research Institute; University of Michigan; Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; Marriot Foundation; Mayo Clinic Center for Individualized Medicine; NIMH Intramural Research Program; Canadian Institutes of Health Research; UK Maudsley NHS Foundation Trust; NIHR; NRS; MRC; Wellcome Trust; European Research Council; German Ministry for Education and Research; German Research Foundation IZKF of Munster; Deutsche Forschungsgemeinschaft; ImmunoSensation; Dr Lisa-Oehler Foundation; University of Bonn; Swiss National Science Foundation; French Foundation FondaMental; French ANR; Spanish Ministerio de Economia; CIBERSAM; Industria y Competitividad; European Regional Development Fund (ERDF); Generalitat de Catalunya; EU Horizon 2020 Research and Innovation Programme; BBMRI-NL; South-East Norway Regional Health Authority; Swedish Research Council; Stockholm County Council; Soderstrom Foundation; Lundbeck Foundation; Aarhus University; Australia NHMRC; NSW Ministry of Health; MRC [MR/L023784/2, UKDRI-3003] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH101367, U01MH109514, U01MH109536] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation; Stanley Medical Research Institute; University of Michigan(University of Michigan System); Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; Marriot Foundation; Mayo Clinic Center for Individualized Medicine; NIMH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UK Maudsley NHS Foundation Trust; NIHR(National Institute for Health Research (NIHR)); NRS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation IZKF of Munster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ImmunoSensation; Dr Lisa-Oehler Foundation; University of Bonn; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); French Foundation FondaMental; French ANR(French National Research Agency (ANR)); Spanish Ministerio de Economia(Spanish Government); CIBERSAM; Industria y Competitividad; European Regional Development Fund (ERDF)(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); EU Horizon 2020 Research and Innovation Programme; BBMRI-NL; South-East Norway Regional Health Authority; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Soderstrom Foundation; Lundbeck Foundation(Lundbeckfonden); Aarhus University; Australia NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NSW Ministry of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This paper is dedicated to the memory of Psychiatric Genomics Consortium (PGC) founding member and Bipolar Disorder Working Group co-chair Pamela Sklar. We thank the participants who donated their time, experiences and DNA to this research, and the clinical and scientific teams that worked with them. We are deeply indebted to the investigators who comprise the PGC. Analyses were carried out on the NL Genetic Cluster Computer (http://www.geneticcluster.org), hosted by SURFsara, and the Mount Sinai high performance computing cluster (http://hpc.mssm.edu). PGC members have received major funding from the US National Institute of Mental Health. This work was funded in part by the Brain and Behavior Research Foundation, Stanley Medical Research Institute, University of Michigan, Pritzker Neuropsychiatric Disorders Research Fund L.L.C., Marriot Foundation and the Mayo Clinic Center for Individualized Medicine, the NIMH Intramural Research Program; Canadian Institutes of Health Research; the UK Maudsley NHS Foundation Trust, NIHR, NRS, MRC, Wellcome Trust; European Research Council; German Ministry for Education and Research, German Research Foundation IZKF of Munster, Deutsche Forschungsgemeinschaft, ImmunoSensation, the Dr Lisa-Oehler Foundation, University of Bonn; the Swiss National Science Foundation; French Foundation FondaMental and ANR; Spanish Ministerio de Economia, CIBERSAM, Industria y Competitividad, European Regional Development Fund (ERDF), Generalitat de Catalunya, EU Horizon 2020 Research and Innovation Programme; BBMRI-NL; South-East Norway Regional Health Authority and Mrs Throne-Holst; Swedish Research Council, Stockholm County Council, Soderstrom Foundation; Lundbeck Foundation, Aarhus University; Australia NHMRC, NSW Ministry of Health, Janette M. O'Neil and Betty C. Lynch. The views expressed are those of the authors and not necessarily those of their institutions or any funding or regulatory bodies. Additional acknowledgements, including funding sources, are presented in the Supplementary Note.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Allardyce J, 2018, JAMA PSYCHIAT, V75, P28, DOI 10.1001/jamapsychiatry.2017.3485; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Charney AW, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.242; Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157; Cichon S, 2011, AM J HUM GENET, V88, P372, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Desfosses J, 2010, PHARMACEUTICALS, V3, P3101, DOI 10.3390/ph3103101; Duncan L, 2017, AM J PSYCHIAT, V174, P850, DOI 10.1176/appi.ajp.2017.16121402; Edvardsen J, 2008, J AFFECT DISORDERS, V106, P229, DOI 10.1016/j.jad.2007.07.001; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Ferrari AJ, 2016, BIPOLAR DISORD, V18, P440, DOI 10.1111/bdi.12423; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gale CR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.56; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gaspar HA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12325-3; Goes FS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.106; Goes FS, 2015, AM J MED GENET B, V168, P649, DOI 10.1002/ajmg.b.32349; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142; Green EK, 2013, MOL PSYCHIATR, V18, P614, DOI 10.1038/mp.2012.48; Holland D., 2018, SNP HERITABILITY POL, DOI [10.1101/133132, DOI 10.1101/133132]; Hou LP, 2016, HUM MOL GENET, V25, P3383, DOI 10.1093/hmg/ddw181; Ikeda M, 2018, MOL PSYCHIATR, V23, P639, DOI 10.1038/mp.2016.259; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Lee SH, 2016, MOL METAB, V5, P589, DOI 10.1016/j.molmet.2016.06.011; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; MacCabe JH, 2010, BRIT J PSYCHIAT, V196, P109, DOI 10.1192/bjp.bp.108.060368; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McIntyre RS, 2012, BIPOLAR DISORD, V14, P697, DOI 10.1111/bdi.12006; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Olier I., 2010, ESANN 2010, P481; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Palmer C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006916; Pavlides JMW, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0338-4; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04558-1; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S., 2014, RICOPILI TOOL VISUAL; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ruderfer DM, 2018, CELL, V173, P1705, DOI 10.1016/j.cell.2018.05.046; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Serra Gino, 2007, Clin Pract Epidemiol Ment Health, V3, P25, DOI 10.1186/1745-0179-3-25; Simonsen C, 2011, SCHIZOPHRENIA BULL, V37, P73, DOI 10.1093/schbul/sbp034; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Vreeker A, 2016, PSYCHOL MED, V46, P807, DOI 10.1017/S0033291715002299; W.H. Organization, 1992, ICD 10 CLASS MENT BE; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3; Yang CP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03247-3; Zamberletti E, 2012, CURR PHARM DESIGN, V18, P4980, DOI 10.2174/138161212802884744; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	74	465	467	12	189	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2019	51	5					793	+		10.1038/s41588-019-0397-8	http://dx.doi.org/10.1038/s41588-019-0397-8			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW7AK		Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000466842000007
J	Pujana, MA; Han, JDJ; Starita, LM; Stevens, KN; Tewari, M; Ahn, JS; Rennert, G; Moreno, V; Kirchhoff, T; Gold, B; Assmann, V; ElShamy, WM; Rual, JF; Levine, D; Rozek, LS; Gelman, RS; Gunsalus, KC; Greenberg, RA; Sobhian, B; Bertin, N; Venkatesan, K; Ayivi-Guedehoussou, N; Sole, X; Hernandez, P; Lazaro, C; Nathanson, KL; Weber, BL; Cusick, ME; Hill, DE; Offit, K; Livingston, DM; Gruber, SB; Parvin, JD; Vidal, M				Pujana, Miguel Angel; Han, Jing-Dong J.; Starita, Lea M.; Stevens, Kristen N.; Tewari, Muneesh; Ahn, Jin Sook; Rennert, Gad; Moreno, Victor; Kirchhoff, Tomas; Gold, Bert; Assmann, Volker; ElShamy, Wael M.; Rual, Jean-Francois; Levine, Douglas; Rozek, Laura S.; Gelman, Rebecca S.; Gunsalus, Kristin C.; Greenberg, Roger A.; Sobhian, Bijan; Bertin, Nicolas; Venkatesan, Kavitha; Ayivi-Guedehoussou, Nono; Sole, Xavier; Hernandez, Pilar; Lazaro, Conxi; Nathanson, Katherine L.; Weber, Barbara L.; Cusick, Michael E.; Hill, David E.; Offit, Kenneth; Livingston, David M.; Gruber, Stephen B.; Parvin, Jeffrey D.; Vidal, Marc			Network modeling links breast cancer susceptibility and centrosome dysfunction	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; GENETIC INSTABILITY; ZYG-9 FORM; PROTEIN; BRCA1; AMPLIFICATION; MUTATIONS; COMPLEX; TAC-1	Many cancer-associated genes remain to be identified to clarify the underlying molecular mechanisms of cancer susceptibility and progression. Better understanding is also required of how mutations in cancer genes affect their products in the context of complex cellular networks. Here we have used a network modeling strategy to identify genes potentially associated with higher risk of breast cancer. Starting with four known genes encoding tumor suppressors of breast cancer, we combined gene expression profiling with functional genomic and proteomic ( or `omic') data from various species to generate a network containing 118 genes linked by 866 potential functional associations. This network shows higher connectivity than expected by chance, suggesting that its components function in biologically related pathways. One of the components of the network is HMMR, encoding a centrosome subunit, for which we demonstrate previously unknown functional associations with the breast cancer associated gene BRCA1. Two case-control studies of incident breast cancer indicate that the HMMR locus is associated with higher risk of breast cancer in humans. Our network modeling strategy should be useful for the discovery of additional cancer-associated genes.	Harvard Univ, Sch Med, CCSB, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Carmel Hosp, Dept Community Med & Epidemiol, CHS Natl Canc Control Ctr, IL-34362 Haifa, Israel; Technion, Bruce Rappaport Fac Med, IL-34362 Haifa, Israel; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; IDIBELL, Catalan Inst Oncol, Dept Epidemiol, Barcelona 08907, Spain; IDIBELL, Catalan Inst Oncol, Canc Registry, Barcelona 08907, Spain; IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona 08907, Spain; Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; Natl Canc Inst, Human Genet Sect, Lab Genome Divers, Frederick, MD 21702 USA; Univ Hamburg, Hosp Eppendorf, Inst Tumor Biol, Ctr Med Expt, D-20246 Hamburg, Germany; Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona 08907, Spain; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Michigan System; University of Michigan; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hamburg; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; New York University; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan	Pujana, MA (corresponding author), Harvard Univ, Sch Med, CCSB, Dept Genet, 44 Binney St, Boston, MA 02115 USA.		ElShamy, Wael/AAF-2867-2019; Bertin, Nicolas/O-9602-2019; Hill, David E/B-6617-2011; Purrington, Kristen/AAN-6494-2021; Moreno, Victor/A-1697-2010; Pujana, Miquel Angel/N-3127-2014; ElShamy, Wael M./L-1090-2018; GARCIA, CONXI LAZARO/Q-2410-2016; Parvin, Jeffrey D/C-8955-2009; Solé, Xavier/AAF-3015-2019; Bertin, Nicolas/C-3025-2008	Purrington, Kristen/0000-0002-5710-1692; Moreno, Victor/0000-0002-2818-5487; Pujana, Miquel Angel/0000-0003-3222-4044; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Solé, Xavier/0000-0002-2197-3325; Kirchhoff, Tomas/0000-0002-9055-2364; Rual, Jean-Francois/0000-0003-4465-8819; Sobhian, Bijan/0000-0001-7255-6006; Bertin, Nicolas/0000-0002-9835-9606; Rennert, Gad/0000-0002-8512-068X; Levine, Douglas/0000-0003-1038-8232; Nathanson, Katherine/0000-0002-6740-0901; jhangiry, parvin/0000-0003-1415-7212	NCI NIH HHS [CA90281, P30 CA046592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090281, P30CA046592] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bieche I, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-37; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; CLAUS EB, 1990, ANN HUM GENET, V54, P169, DOI 10.1111/j.1469-1809.1990.tb00373.x; Cunliffe HE, 2003, CANCER RES, V63, P7158; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HASHIMOTO H, 1976, B KOCHI FRUIT TREE E, V1, P1; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Khalil IG, 2005, CURR OPIN ONCOL, V17, P44, DOI 10.1097/01.cco.0000150951.38222.16; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.e02-07-0377; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Pihan GA, 2003, CANCER RES, V63, P1398; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9	50	465	486	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1338	1349		10.1038/ng.2007.2	http://dx.doi.org/10.1038/ng.2007.2			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17922014				2022-12-17	WOS:000250575900018
J	Robinson, DR; Wu, YM; Kalyana-Sundaram, S; Cao, XH; Lonigro, RJ; Sung, YS; Chen, CL; Zhang, L; Wang, R; Su, FY; Iyer, MK; Roychowdhury, S; Siddiqui, J; Pienta, KJ; Kunju, LP; Talpaz, M; Mosquera, JM; Singer, S; Schuetze, SM; Antonescu, CR; Chinnaiyan, AM				Robinson, Dan R.; Wu, Yi-Mi; Kalyana-Sundaram, Shanker; Cao, Xuhong; Lonigro, Robert J.; Sung, Yun-Shao; Chen, Chun-Liang; Zhang, Lei; Wang, Rui; Su, Fengyun; Iyer, Matthew K.; Roychowdhury, Sameek; Siddiqui, Javed; Pienta, Kenneth J.; Kunju, Lakshmi P.; Talpaz, Moshe; Mosquera, Juan Miguel; Singer, Samuel; Schuetze, Scott M.; Antonescu, Cristina R.; Chinnaiyan, Arul M.			Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing	NATURE GENETICS			English	Article							EXPRESSION; NAB2; TRANSCRIPTION; COREPRESSOR; SPECTRUM; CELLS; EGR-1	A 44-year old woman with recurrent solitary fibrous tumor (SFT)/hemangiopericytoma was enrolled in a clinical sequencing program including whole-exome and transcriptome sequencing. A gene fusion of the transcriptional repressor NAB2 with the transcriptional activator STAT6 was detected. Transcriptome sequencing of 27 additional SFTs identified the presence of a NAB2-STAT6 gene fusion in all tumors. Using RT-PCR and sequencing, we detected this fusion in all 51 SFTs, indicating high levels of recurrence. Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6. Overexpression of the NAB2-STAT6 gene fusion induced proliferation in cultured cells and activated the expression of EGR-responsive genes. These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.	[Robinson, Dan R.; Wu, Yi-Mi; Kalyana-Sundaram, Shanker; Cao, Xuhong; Lonigro, Robert J.; Wang, Rui; Su, Fengyun; Iyer, Matthew K.; Roychowdhury, Sameek; Siddiqui, Javed; Pienta, Kenneth J.; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan R.; Wu, Yi-Mi; Kalyana-Sundaram, Shanker; Wang, Rui; Su, Fengyun; Siddiqui, Javed; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Kalyana-Sundaram, Shanker] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Lonigro, Robert J.; Pienta, Kenneth J.; Talpaz, Moshe; Schuetze, Scott M.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI USA; [Sung, Yun-Shao; Chen, Chun-Liang; Zhang, Lei; Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Iyer, Matthew K.; Chinnaiyan, Arul M.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Roychowdhury, Sameek; Pienta, Kenneth J.; Talpaz, Moshe; Schuetze, Scott M.] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA; [Pienta, Kenneth J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Mosquera, Juan Miguel] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Bharathidasan University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; Memorial Sloan Kettering Cancer Center	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	antonesc@mskcc.org; arul@umich.edu	Zhang, Lei/GYQ-7446-2022; Pienta, Kenneth/E-7679-2015	Singer, Samuel/0000-0001-9713-8230; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Pienta, Kenneth/0000-0002-4138-2186; Talpaz, Moshe/0000-0003-3361-3981	National Cancer Institute (NCI) Early Detection Research Network [U01 CA111275]; National Functional Genomics Center [W81XWH-11-1-0520]; US Department of Defense; US National Institutes of Health through the University of Michigan's Cancer Center Support Grant [5 P30 CA46592, PO1 CA047179-15A2, P50 CA 140146-01]; Linn Fund; Cycle for Survival; Alan Rosenthal Research Fund for research in sarcoma; Weinstein Solitary Fibrous Tumor Research Fund; Doris Duke Charitable Foundation Clinical Scientist Award; Burroughs Wellcome Foundation Award in Clinical Translational Research; NATIONAL CANCER INSTITUTE [P30CA046592, P30CA008748, P50CA069568, P50CA140146, P01CA047179, U01CA111275] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Functional Genomics Center; US Department of Defense(United States Department of Defense); US National Institutes of Health through the University of Michigan's Cancer Center Support Grant; Linn Fund; Cycle for Survival; Alan Rosenthal Research Fund for research in sarcoma; Weinstein Solitary Fibrous Tumor Research Fund; Doris Duke Charitable Foundation Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Foundation Award in Clinical Translational Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank T. Barrette for hardware and database management, S. Birkeland, M. Pierce-Burlingame and K. Giles for assistance with sample and manuscript preparation and X. Jing for carrying out microarray experiments. We also thank the larger MI-ONCOSEQ team, including cancer geneticists S. Gruber and J. Innis; bioethicists J.S. Roberts and S.Y. Kim; genetic counselors J. Everett, J. Long and V. Raymond; and radiologists E. Higgins, E. Caoili and R. Dunnick. M. Quist performed initial SNV analysis. L. Sam, A. Balbin and P. Vats assisted with bioinformatics analysis. This project was supported in part by the National Cancer Institute (NCI) Early Detection Research Network (U01 CA111275), the National Functional Genomics Center (W81XWH-11-1-0520) and the US Department of Defense (A.M.C.). Additional infrastructure support was generously provided by the Prostate Cancer Foundation. The work was also supported in part by the US National Institutes of Health through the University of Michigan's Cancer Center Support Grant (5 P30 CA46592) and grants PO1 CA047179-15A2 (C.R.A. and S.S.) and P50 CA 140146-01 (C.R.A. and S.S.); the Linn Fund and Cycle for Survival (C.R.A.); the Alan Rosenthal Research Fund for research in sarcoma (C.R.A.); and the Weinstein Solitary Fibrous Tumor Research Fund (C.R.A.). A.M.C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award and a Burroughs Wellcome Foundation Award in Clinical Translational Research. A.M.C. is an American Cancer Society Research Professor and an A. Alfred Taubman Scholar.	Aparicio SAJR, 2010, J PATHOL, V220, P307, DOI 10.1002/path.2636; Gold JS, 2002, CANCER, V94, P1057, DOI 10.1002/cncr.10328; Hajdu M, 2010, J PATHOL, V221, P300, DOI 10.1002/path.2715; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mosquera JM, 2009, AM J SURG PATHOL, V33, P1314, DOI 10.1097/PAS.0b013e3181a6cd33; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Park MS, 2009, CURR OPIN ONCOL, V21, P327, DOI 10.1097/CCO.0b013e32832c9532; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Stacchiotti S, 2010, MOL CANCER THER, V9, P1286, DOI 10.1158/1535-7163.MCT-09-1205; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	18	464	500	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					180	185		10.1038/ng.2509	http://dx.doi.org/10.1038/ng.2509			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313952	Green Accepted			2022-12-17	WOS:000314333000013
J	Schwartz, YB; Kahn, TG; Nix, DA; Li, XY; Bourgon, R; Biggin, M; Pirrotta, V				Schwartz, Yuri B.; Kahn, Tatyana G.; Nix, David A.; Li, Xiao-Yong; Bourgon, Richard; Biggin, Mark; Pirrotta, Vincenzo			Genome-wide analysis of Polycomb targets in Drosophila melanogaster	NATURE GENETICS			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; BITHORAX COMPLEX; RESPONSE ELEMENT; BINDING-SITES; GENES; ZESTE; CHROMATIN; PROTEINS; ENHANCER	Polycomb group (PcG) complexes are multiprotein assemblages that bind to chromatin and establish chromatin states leading to epigenetic silencing(1,2). PcG proteins regulate homeotic genes in flies and vertebrates, but little is known about other PcG targets and the role of the PcG in development, differentiation and disease. Here, we determined the distribution of the PcG proteins PC, E(Z) and PSC and of trimethylation of histone H3 Lys27 (me3K27) in the D. melanogaster genome. At more than 200 PcG target genes, binding sites for the three PcG proteins colocalize to presumptive Polycomb response elements (PREs). In contrast, H3 me3K27 forms broad domains including the entire transcription unit and regulatory regions. PcG targets are highly enriched in genes encoding transcription factors, but they also include genes coding for receptors, signaling proteins, morphogens and regulators representing all major developmental pathways.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Transcript Network Project, Genom Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, 604 Allison Rd, Piscataway, NJ 08854 USA.	pirrotta@biology.rutgers.edu		Bourgon, Richard/0000-0002-5890-4374	NIGMS NIH HHS [GM704403] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barges S, 2000, DEVELOPMENT, V127, P779; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bloyer S, 2003, DEV BIOL, V261, P426, DOI 10.1016/S0012-1606(03)00314-2; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CHIANG A, 1995, DEVELOPMENT, V121, P1681; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; JONES RS, 1990, GENETICS, V126, P185; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PHILLIPS MD, 1990, GENETICS, V125, P91; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Shimell MJ, 2000, DEV BIOL, V218, P38, DOI 10.1006/dbio.1999.9576; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773	30	464	490	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					700	705		10.1038/ng1817	http://dx.doi.org/10.1038/ng1817			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16732288	Green Submitted			2022-12-17	WOS:000237954800026
J	Tokuhiro, S; Yamada, R; Chang, XT; Suzuki, A; Kochi, Y; Sawada, T; Suzuki, M; Nagasaki, M; Ohtsuki, M; Ono, M; Furukawa, H; Nagashima, M; Yoshino, S; Mabuchi, A; Sekine, A; Saito, S; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K				Tokuhiro, S; Yamada, R; Chang, XT; Suzuki, A; Kochi, Y; Sawada, T; Suzuki, M; Nagasaki, M; Ohtsuki, M; Ono, M; Furukawa, H; Nagashima, M; Yoshino, S; Mabuchi, A; Sekine, A; Saito, S; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K			An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis	NATURE GENETICS			English	Article							CYTOKINE GENE-CLUSTER; TRANSCRIPTIONAL REGULATION; LINKAGE DISEQUILIBRIUM; HUMAN GENOME; SUSCEPTIBILITY; IDENTIFICATION; EXPRESSION; PROMOTER; ASTHMA; DIFFERENTIATION	Rheumatoid arthritis is a common inflammatory disease with complex genetic components. We investigated the genetic contribution of the cytokine gene cluster in chromosome 5q31 to susceptibility to rheumatoid arthritis in the Japanese population by case-control linkage disequilibrium (LD) mapping using single nucleotide polymorphisms (SNPs). Here we report that there is significant association between rheumatoid arthritis and the organic cation transporter gene SLC22A4 (P=0.000034). We show that expression of SLC22A4 is specific to hematological and immunological tissues and that SLC22A4 is also highly expressed in the inflammatory joints of mice with collagen-induced arthritis. A SNP affects the transcriptional efficiency of SLC22A4 in vitro, owing to an allelic difference in affinity to Runt-related transcription factor 1 (RUNX1), a transcriptional regulator in the hematopoietic system. A SNP in RUNX1 is also strongly associated with rheumatoid arthritis (P=0.00035). Our data indicate that the regulation of SLC22A4 expression by RUNX1 is associated with susceptibility to rheumatoid arthritis, which may represent an example of an epistatic effect of two genes on this disorder.	RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Sankyo Co Ltd, Tokyo 140, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; Nippon Med Coll, Dept Joint Dis & Rheumatism, Tokyo 113, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping, Kanagawa, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Kanagawa, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Res Grp Personalized Med, Tokyo, Japan	RIKEN; Daiichi Sankyo Company Limited; University of Tokyo; Nippon Medical School; RIKEN; RIKEN; RIKEN; University of Tokyo; RIKEN	Yamada, R (corresponding author), RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis,Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.		Sawed, Tetsuji/GRX-6582-2022; Yamamoto, Kazuhiko/N-5096-2015; Suzuki, Akari/N-5389-2015; Tsunoda, Tatsuhiko/K-2061-2014; Peng, Bo/A-6920-2009	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Peng, Bo/0000-0001-8225-2284; Yamada, Ryo/0000-0002-1587-630X				Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beohar N, 1998, J BIOL CHEM, V273, P9168, DOI 10.1074/jbc.273.15.9168; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; DEIGHTON CM, 1989, CLIN GENET, V36, P178; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; GALSON DL, 1988, MOL CELL BIOL, V8, P381, DOI 10.1128/MCB.8.1.381; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kauppi P, 2001, GENOMICS, V77, P35, DOI 10.1006/geno.2001.6613; Lee JK, 2002, BIOCHEM BIOPH RES CO, V295, P771, DOI 10.1016/S0006-291X(02)00679-4; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Mansur AH, 1998, CLIN EXP ALLERGY, V28, P141; Miyazawa K, 1998, J BIOL CHEM, V273, P7620, DOI 10.1074/jbc.273.13.7620; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Nepom GT, 1998, ADV IMMUNOL, V68, P315, DOI 10.1016/S0065-2776(08)60563-5; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Saito S, 2002, J HUM GENET, V47, P576, DOI 10.1007/s100380200088; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; TAKAHASHI A, 1995, BLOOD, V86, P607, DOI 10.1182/blood.V86.2.607.bloodjournal862607; Uchida H, 1997, J IMMUNOL, V158, P2251; Wu X, 1998, J BIOL CHEM, V273, P32776, DOI 10.1074/jbc.273.49.32776; Yabuuchi H, 1999, J PHARMACOL EXP THER, V289, P768	42	464	492	2	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					341	348		10.1038/ng1267	http://dx.doi.org/10.1038/ng1267			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14608356				2022-12-17	WOS:000186791000015
J	Martinez-Botas, J; Anderson, JB; Tessier, D; Lapillonne, A; Chang, BHJ; Quast, MJ; Gorenstein, D; Chen, KH; Chan, L				Martinez-Botas, J; Anderson, JB; Tessier, D; Lapillonne, A; Chang, BHJ; Quast, MJ; Gorenstein, D; Chen, KH; Chan, L			Absence of perilipin results in leanness and reverses obesity in Lepr db db mice	NATURE GENETICS			English	Article							HORMONE-SENSITIVE LIPASE; NEUTRAL LIPID DROPLETS; ADIPOSE-TISSUE; ADIPOCYTES; RECEPTOR; PROTEINS; CELLS; GENE	Obesity is a disorder of energy balance(1). Hormone-sensitive lipase (HSL) mediates the hydrolysis of triacylglycerol(2). the major form of stored energy in the body. Perilipin (encoded by the gene Plin), an adipocyte protein, has been postulated to modulate HSL activity(3-5). We show here that targeted disruption of Plin results in healthy mice that have constitutively activated fat-cell HSL. Plin(-/-) mice consume more food than control mice, but have normal body weight. They are much leaner and more muscular than controls, have 62% smaller white adipocytes, show elevated basal lipolysis that is resistant to beta -adrenergic agonist stimulation, and are cold-sensitive except when fed. They are also resistant to diet-induced obesity. Breeding the Plin(-/-) alleles into Lepr(db/db) mice reverses the obesity by increasing the metabolic rate of the mice. Our results demonstrate a role for perilipin in mining in basal HSL activity and regulating lipolysis and energy balance; thus, agents that inactivate perilipin may prove useful as anti-obesity medications.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Radiol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77550 USA	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Chan, L (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Martinez-Botas, Javier/AAD-8733-2021	Martinez-Botas, Javier/0000-0002-5190-3619	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-51586] Funding Source: Medline; NIEHS NIH HHS [ES-06676] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Holm C, 1997, METHOD ENZYMOL, V286, P45; LONDOS C, 1995, BIOCHEM SOC T, V23, P611, DOI 10.1042/bst0230611; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; YEAMAN SJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P128, DOI 10.1016/0167-4889(90)90067-N	15	464	484	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					474	479		10.1038/82630	http://dx.doi.org/10.1038/82630			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101849				2022-12-17	WOS:000165671700024
J	Albertson, DG; Ylstra, B; Segraves, R; Collins, C; Dairkee, SH; Kowbel, D; Kuo, WL; Gray, JW; Pinkel, D				Albertson, DG; Ylstra, B; Segraves, R; Collins, C; Dairkee, SH; Kowbel, D; Kuo, WL; Gray, JW; Pinkel, D			Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene	NATURE GENETICS			English	Article							BREAST-CANCER; VITAMIN-D; HYBRIDIZATION; CLONING; SYSTEM; MAP		Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Canc, Canc Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Canc, Breast Oncol Program, San Francisco, CA 94143 USA; Calif Pacific Med Ctr, Geraldine Brush Canc Res Inst, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center	Albertson, DG (corresponding author), Univ Calif San Francisco, Canc Res Inst, Box 0808, San Francisco, CA 94143 USA.		Ylstra, Bauke/D-2906-2012; Dairkee, Shanaz Hashmi/D-6743-2012	Ylstra, Bauke/0000-0001-9479-3010; Dairkee, Shanaz/0000-0002-2073-9684	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA045919, R01CA080314] Funding Source: NIH RePORTER; NCI NIH HHS [CA80314, CA45919] Funding Source: Medline; NICHD NIH HHS [HD17665] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERTSON DG, 1993, GENETICS, V134, P211; ALBERTSON DG, 1995, CAENORHABDITIS ELEGA, P339; Alini M, 1996, DEV BIOL, V176, P124, DOI 10.1006/dbio.1996.9989; BRODEUR GM, 1998, GENETIC BASIS HUMAN, P161; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Courjal F, 1997, CANCER RES, V57, P4360; Geschwind DH, 1998, DEV GENET, V23, P215, DOI 10.1002/(SICI)1520-6408(1998)23:3<215::AID-DVG7>3.0.CO;2-X; John EM, 1999, CANCER EPIDEM BIOMAR, V8, P399; Kim UJ, 1996, P NATL ACAD SCI USA, V93, P6297, DOI 10.1073/pnas.93.13.6297; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Tanner MM, 1995, CLIN CANCER RES, V1, P1455; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719	15	464	480	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					144	146		10.1038/75985	http://dx.doi.org/10.1038/75985			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835626				2022-12-17	WOS:000087459200010
J	Achermann, JC; Ito, M; Ito, M; Hindmarsh, PC; Jameson, JL				Achermann, JC; Ito, M; Ito, M; Hindmarsh, PC; Jameson, JL			A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans	NATURE GENETICS			English	Letter							NUCLEAR RECEPTOR SF-1; FACTOR-I; EXPRESSION		Northwestern Univ, Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; UCL, London Ctr Pediat Endocrinol, Cobbold Labs, London W1N 8AA, England	Northwestern University; University of London; University College London	Achermann, JC (corresponding author), Northwestern Univ, Sch Med, Div Endocrinol Metab & Mol Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	ljameson@nwu.edu	Achermann, John/N-2906-2019; Hindmarsh, P C/C-4964-2008; Achermann, John/C-5476-2008	Achermann, John/0000-0001-8787-6272; Achermann, John/0000-0001-8787-6272; Jameson, James/0000-0001-9538-4059	NICHD NIH HHS [P01 HD21921, U54-HD-29164] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD029164] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; CLEMENS JW, 1994, ENDOCRINOLOGY, V134, P1499, DOI 10.1210/en.134.3.1499; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Giuili G, 1997, DEVELOPMENT, V124, P1799; Ito M, 1999, J BIOL CHEM, V274, P9029, DOI 10.1074/jbc.274.13.9029; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Wong M, 1996, J MOL ENDOCRINOL, V17, P139, DOI 10.1677/jme.0.0170139	15	464	479	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					125	126		10.1038/9629	http://dx.doi.org/10.1038/9629			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369247				2022-12-17	WOS:000080680900010
J	Overturf, K; AlDhalimy, M; Tanguay, R; Brantly, M; Ou, CN; Finegold, M; Grompe, M				Overturf, K; AlDhalimy, M; Tanguay, R; Brantly, M; Ou, CN; Finegold, M; Grompe, M			Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I	NATURE GENETICS			English	Article							TYROSINEMIA TYPE-I; LETHAL ALBINO MICE; FUMARYLACETOACETATE HYDROLASE; LIVER; EXPRESSION; DEFICIENT; ENZYME; TRANSPLANTATION; MOUSE; CELLS	Current strategies for hepatic gene therapy are either quantitatively inefficient or suffer from lack of permanent gene expression. We have utilized an animal model of hereditary tyrosinaemia type I (HT1), a recessive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whether in vivo selection of corrected hepatocytes could improve the efficiency of liver gene transfer. As few as 1,000 transplanted wild-type hepatocytes were able to repopulate mutant liver, demonstrating their strong competitive growth advantage. Mutant hepatocytes corrected in situ by retroviral gene transfer were also positively selected. In mutant animals treated by multiple retrovirus injections >90% of hepatocytes became FAH positive and liver function was restored to normal. Our results demonstrate that in vivo selection is a useful strategy for hepatic gene therapy and may lead to effective treatment of human HT1 by retroviral gene transfer.	OREGON HLTH SCI UNIV, DEPT MOLEC & MED GENET, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97201 USA; UNIV LAVAL, LAB GENET CELLULAIRE & DEV, ST FOY, PQ G1K 7P4, CANADA; NHLBI, NIH, PULM CRIT CARE MED BRANCH, BETHESDA, MD 20892 USA; TEXAS CHILDRENS HOSP, DEPT PATHOL, HOUSTON, TX 77030 USA	Oregon Health & Science University; Oregon Health & Science University; Laval University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baylor College of Medicine			Brantly, Mark/AAH-2922-2020	Grompe, Markus/0000-0002-6616-4345	NIDDK NIH HHS [DK-48252] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048252] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN MD, 1990, EUR J PEDIATR, V149, P637, DOI 10.1007/BF02034752; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Fausto N., 1994, LIVER BIOL PATHOBIOL; Fausto Nelson, 1994, P1501; GERBER MA, 1992, ROLE CELL TYPES HEPA, P209; GLUECKSOHNWAELSCH S, 1979, CELL, V16, P225, DOI 10.1016/0092-8674(79)90001-1; GRENIER A, 1985, METHOD ENZYMAT AN, P79; GROMPE M, 1992, BIOCHEM MED METAB B, V48, P26, DOI 10.1016/0885-4505(92)90044-Y; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; GROMPE M, 1992, HUM GENE THER, V3, P35, DOI 10.1089/hum.1992.3.1-35; GROSSMAN M, 1993, CURR OPIN GENET DEV, V3, P110, DOI 10.1016/S0959-437X(05)80350-8; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HIRSCHHORN R, 1994, AM J HUM GENET, V55, P59; HORWICH AL, 1991, CURR TOP MICROBIOL, V168, P185; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; KAY MA, 1993, SCIENCE, V262, P117, DOI 10.1126/science.8211118; KLEBIG ML, 1992, P NATL ACAD SCI USA, V89, P1363, DOI 10.1073/pnas.89.4.1363; KNOX WE, 1955, METHOD ENZYMOL, V2, P287, DOI 10.1016/S0076-6879(55)02202-7; KVITTINGEN EA, 1994, J CLIN INVEST, V94, P1657, DOI 10.1172/JCI117509; KVITTINGEN EA, 1993, J CLIN INVEST, V91, P1816, DOI 10.1172/JCI116393; LABELLE Y, 1993, BIOCHIM BIOPHYS ACTA, V1180, P250, DOI 10.1016/0925-4439(93)90046-4; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MCLACHLIN JR, 1993, VIROLOGY, V195, P1, DOI 10.1006/viro.1993.1340; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL GA, 1994, METABOLIC MOL BASIS, P1077; PARADIS K, 1990, AM J HUM GENET, V47, P338; PEETERS MJV, IN PRESS BIOTECHNIQU; PHANEUF D, 1991, AM J HUM GENET, V48, P525; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; RHIM JA, 1995, P NATL ACAD SCI USA, V92, P4942, DOI 10.1073/pnas.92.11.4942; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; RUPPERT S, 1990, CELL, V61, P895, DOI 10.1016/0092-8674(90)90200-X; RUSSO P, 1990, AM J HUM GENET, V47, P317; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SCRIVER CR, 1994, METABOLIC BASIS INHE; TANGUAY RM, 1990, AM J HUM GENET, V47, P308; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	51	464	483	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					266	273		10.1038/ng0396-266	http://dx.doi.org/10.1038/ng0396-266			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589717				2022-12-17	WOS:A1996TY18300015
J	PATIL, N; COX, DR; BHAT, D; FAHAM, M; MYERS, RM; PETERSON, AS				PATIL, N; COX, DR; BHAT, D; FAHAM, M; MYERS, RM; PETERSON, AS			A POTASSIUM CHANNEL MUTATION IN WEAVER MICE IMPLICATES MEMBRANE EXCITABILITY IN GRANULE CELL-DIFFERENTIATION	NATURE GENETICS			English	Article							CEREBELLAR CORTEX; MUTANT MICE; NEURONAL DIFFERENTIATION; MOUSE CHROMOSOME-16; K+ CHANNELS; GENE; SECONDARY; MIGRATION; DEFICIT; INVITRO	Early events in neuronal differentiation are generally considered to be regulated by factors independent of alterations in membrane permeability. Weaver mice harbour a mutation that blocks neuronal differentiation just after cessation of cell division, prior to cell migration and synaptogenesis. Cerebellar granule cells in homozygous weaver mice fail to differentiate, either because intrinsic cues are absent or because the granule cells are unable to respond to those cues. We now report that weaver mice have a missense mutation in a gene encoding a G-protein coupled inward rectifier potassium channel. The mutation alters the putative ion-permeable, pore-forming domain of the protein, suggesting that granule cell differentiation is regulated by changes in membrane permeability.	DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94305	Duke University; Duke University; University of California System; University of California San Francisco	PATIL, N (corresponding author), STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024610] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000206] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00206] Funding Source: Medline; NICHD NIH HHS [HD 24610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; DIETRICH W, 1992, GENETICS, V131, P423; EISENBERG B, 1989, NEUROSCI LETT, V96, P168, DOI 10.1016/0304-3940(89)90052-9; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; HARRISON SMW, 1994, DEV DYNAM, V200, P26, DOI 10.1002/aja.1002000104; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HATTEN ME, 1986, J NEUROSCI, V6, P2676; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hoshi T, 1993, Curr Opin Neurobiol, V3, P283, DOI 10.1016/0959-4388(93)90119-J; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LANE PW, 1964, MOUSE NEWS LETT, P30; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Lyon M., 1989, GENETIC VARIANTS STR; MJAATVEDT AE, 1993, GENOMICS, V17, P382, DOI 10.1006/geno.1993.1336; ORIETA M, 1989, P NATL ACAD SCI USA, V86, P2766; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PATIL N, 1994, HUM MOL GENET, V3, P1811, DOI 10.1093/hmg/3.10.1811; PETERSON A, 1994, HUM MOL GENET, V3, P1735, DOI 10.1093/hmg/3.10.1735; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; REEVES RH, 1993, MAMM GENOME, V4, pS223, DOI 10.1007/BF00360842; REEVES RH, 1989, GENOMICS, V5, P522, DOI 10.1016/0888-7543(89)90018-9; REZAI Z, 1972, DEV BIOL, V29, P17, DOI 10.1016/0012-1606(72)90039-5; ROFFLERTARLOV S, 1987, J NEUROSCI, V7, P2364; SCHMIDT MJ, 1982, J NEUROSCI, V2, P376; SMEYNE RJ, 1989, J NEUROSCI, V9, P1608; TAGLIALATELA M, 1994, BIOPHYS J, V66, P179, DOI 10.1016/S0006-3495(94)80755-6; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; TSAUR ML, 1995, DIABETES, V44, P592, DOI 10.2337/diabetes.44.5.592; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; 1992, CURRENT PROTOCOLS MO, V1	37	464	471	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					126	129		10.1038/ng1095-126	http://dx.doi.org/10.1038/ng1095-126			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550338				2022-12-17	WOS:A1995RX80600012
J	Hodges, E; Xuan, Z; Balija, V; Kramer, M; Molla, MN; Smith, SW; Middle, CM; Rodesch, MJ; Albert, TJ; Hannon, GJ; McCombie, WR				Hodges, Emily; Xuan, Zhenyu; Balija, Vivekanand; Kramer, Melissa; Molla, Michael N.; Smith, Steven W.; Middle, Christina M.; Rodesch, Matthew J.; Albert, Thomas J.; Hannon, Gregory J.; McCombie, W. Richard			Genome-wide in situ exon capture for selective resequencing	NATURE GENETICS			English	Article							HUMAN CANCER; SEQUENCES; PROTEINS	Increasingly powerful sequencing technologies are ushering in an era of personal genome sequences and raising the possibility of using such information to guide medical decisions. Genome resequencing also promises to accelerate the identification of disease-associated mutations. Roughly 98% of the human genome is composed of repeats and intergenic or non-proteincoding sequences. Thus, it is crucial to focus resequencing on high-value genomic regions. Protein-coding exons represent one such type of high-value target. We have developed a method of using flexible, high-density microarrays to capture any desired fraction of the human genome, in this case corresponding to more than 200,000 protein-coding exons. Depending on the precise protocol, up to 55-85% of the captured fragments are associated with targeted regions and up to 98% of intended exons can be recovered. This methodology provides an adaptable route toward rapid and efficient resequencing of any sizeable, non-repeat portion of the human genome.	Cold Spring Harbor Lab, Warson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY USA; NimbleGlen Syst Inc, Madison, WI 53711 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Roche Holding; Roche NimbleGen	McCombie, WR (corresponding author), Cold Spring Harbor Lab, Warson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	McCombie@cshl.edu	Hannon, Gregory/AAB-3568-2019	Xuan, Zhenyu/0000-0001-9344-8493; Hodges, Emily/0000-0001-6513-610X; McCombie, W. Richard/0000-0003-1899-0682				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Futreal PA, 2005, COLD SH Q B, V70, P43, DOI 10.1101/sqb.2005.70.015; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439	17	463	546	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1522	1527		10.1038/ng.2007.42	http://dx.doi.org/10.1038/ng.2007.42			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982454				2022-12-17	WOS:000251267400023
J	Okosun, J; Bodor, C; Wang, J; Araf, S; Yang, CY; Pan, CY; Boller, S; Cittaro, D; Bozek, M; Iqbal, S; Matthews, J; Wrench, D; Marzec, J; Tawana, K; Popov, N; O'Riain, C; O'Shea, D; Carlotti, E; Davies, A; Lawrie, CH; Matolcsy, A; Calaminici, M; Norton, A; Byers, RJ; Mein, C; Stupka, E; Lister, TA; Lenz, G; Montoto, S; Gribben, JG; Fan, YH; Grosschedl, R; Chelala, C; Fitzgibbon, J				Okosun, Jessica; Boedoer, Csaba; Wang, Jun; Araf, Shamzah; Yang, Cheng-Yuan; Pan, Chenyi; Boller, Soeren; Cittaro, Davide; Bozek, Monika; Iqbal, Sameena; Matthews, Janet; Wrench, David; Marzec, Jacek; Tawana, Kiran; Popov, Nikolay; O'Riain, Ciaran; O'Shea, Derville; Carlotti, Emanuela; Davies, Andrew; Lawrie, Charles H.; Matolcsy, Andras; Calaminici, Maria; Norton, Andrew; Byers, Richard J.; Mein, Charles; Stupka, Elia; Lister, T. Andrew; Lenz, Georg; Montoto, Silvia; Gribben, John G.; Fan, Yuhong; Grosschedl, Rudolf; Chelala, Claude; Fitzgibbon, Jude			Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma	NATURE GENETICS			English	Article							SOMATIC HYPERMUTATION; HODGKIN LYMPHOMA; GLOBULAR DOMAIN; READ ALIGNMENT; PAIRED-END; CELL; DNA; TRANSFORMATION; EXPRESSION; DISCOVERY	Follicular lymphoma is an incurable malignancy(1), with transformation to an aggressive subtype representing a critical event during disease progression. Here we performed whole-genome or whole-exome sequencing on 10 follicular lymphoma-transformed follicular lymphoma pairs followed by deep sequencing of 28 genes in an extension cohort, and we report the key events and evolutionary processes governing tumor initiation and transformation. Tumor evolution occurred through either a 'rich' or 'sparse' ancestral common progenitor clone (CPC). We identified recurrent mutations in linker histone, JAK-STAT signaling, NF-kappa B signaling and B cell developmental genes. Longitudinal analyses identified early driver mutations in chromatin regulator genes (CREBBP, EZH2 and KMT2D (MLL2)), whereas mutations in EBF1 and regulators of NF-.B signaling (MYD88 and TNFAIP3) were gained at transformation. Collectively, this study provides new insights into the genetic basis of follicular lymphoma and the clonal dynamics of transformation and suggests that personalizing therapies to target key genetic alterations in the CPC represents an attractive therapeutic strategy.	[Okosun, Jessica; Boedoer, Csaba; Araf, Shamzah; Iqbal, Sameena; Matthews, Janet; Wrench, David; Tawana, Kiran; Popov, Nikolay; O'Riain, Ciaran; O'Shea, Derville; Carlotti, Emanuela; Calaminici, Maria; Lister, T. Andrew; Montoto, Silvia; Gribben, John G.; Fitzgibbon, Jude] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England; [Boedoer, Csaba; Matolcsy, Andras] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Wang, Jun; Marzec, Jacek; Chelala, Claude] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Yang, Cheng-Yuan; Boller, Soeren; Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, Freiburg, Germany; [Pan, Chenyi; Fan, Yuhong] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Pan, Chenyi; Fan, Yuhong] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Cittaro, Davide; Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Bozek, Monika; Mein, Charles] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, London, England; [Davies, Andrew] Univ Southampton, Canc Sci Div, Southampton, Hants, England; [Lawrie, Charles H.] Biodonostia Res Inst, Dept Oncol, San Sebastian, Spain; [Norton, Andrew] Christie Natl Hlth Serv NHS Fdn Trust, Dept Histopathol, Manchester, Lancs, England; [Byers, Richard J.] Manchester Royal Infirm, Dept Histopathol, Manchester M13 9WL, Lancs, England; [Lenz, Georg] Charite, Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany	University of London; Queen Mary University London; Semmelweis University; University of London; Queen Mary University London; Max Planck Society; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; Queen Mary University London; University of Southampton; Christie NHS Foundation Trust; University of Manchester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Okosun, J (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England.	j.e.okosun@qmul.ac.uk; bodor.csaba1@med.semmelweis-univ.hu	Cittaro, Davide/K-2405-2018; Lenz, Georg/I-6844-2012; Montoto, Silvia/M-6812-2019; Bodor, Csaba/O-4524-2017	Cittaro, Davide/0000-0003-0384-3700; Montoto, Silvia/0000-0002-3006-9725; Pan, Chenyi/0000-0002-0089-7482; O'Shea, Derville/0000-0002-5244-5023; Okosun, Jessica/0000-0001-6021-5044; chelala, claude/0000-0002-2488-0669; Byers, Richard/0000-0003-0796-0365; Bodor, Csaba/0000-0002-0729-692X; Mein, Charles/0000-0003-0811-9658; Fitzgibbon, Jude/0000-0002-9069-1866; Stupka, Elia/0000-0003-3154-4011; Wang, Jun/0000-0003-2509-9599; Lawrie, Charles/0000-0002-8882-1131; Marzec, Jacek/0000-0001-6577-8866	Cancer Research UK through the Genomic Initiative and Programme grant [15968]; Leukemia and Lymphoma Research; Hungarian Scientific Research Fund [K-76204]; Georgia Cancer Coalition Distinguished Scholar Award; US National Institutes of Health [GM085261]; European Hematology Association (EHA) Partner fellowship [2009/1]; European Union and the State of Hungary; European Social Fund in the framework [TAMOP 4.2.4. A/1-11-1-2012-0001]; Kay Kendall Leukaemia Fund (KKLF) Junior Clinical Research Fellowship [KKL 557]; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085261] Funding Source: NIH RePORTER; Cancer Research UK [15968] Funding Source: researchfish; National Institute for Health Research [ACF-2011-19-002] Funding Source: researchfish	Cancer Research UK through the Genomic Initiative and Programme grant; Leukemia and Lymphoma Research; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Georgia Cancer Coalition Distinguished Scholar Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Hematology Association (EHA) Partner fellowship; European Union and the State of Hungary; European Social Fund in the framework; Kay Kendall Leukaemia Fund (KKLF) Junior Clinical Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We are indebted to the patients for donating tumor specimens as part of this study. We would like to thank T. Chaplin-Perkins and B. Young for performing the SNP 6.0 array experiments as part of the Affymetrix Array Core Facility and G. Clark at the London Research Institute for automated DNA sequencing. This study was predominantly funded by Cancer Research UK through the Genomic Initiative and Programme grant (15968) to J. F. and was also supported by Leukemia and Lymphoma Research (grant to J. F.) and Hungarian Scientific Research Fund (Orszogos Tudomonyos Kutatosi Alapprogramok, OTKA) grant K-76204 (to A. M.). Y. F. is a recipient of the Georgia Cancer Coalition Distinguished Scholar Award, and C. P. and Y. F. are, in part, supported by US National Institutes of Health grant GM085261 (to Y. F.). C. B. is a recipient of the European Hematology Association (EHA) Partner fellowship (2009/1) and was supported by the European Union and the State of Hungary, cofinanced by the European Social Fund in the framework of TAMOP 4.2.4. A/1-11-1-2012-0001 National Excellence Program. J. O. is a recipient of the Kay Kendall Leukaemia Fund (KKLF) Junior Clinical Research Fellowship (KKL 557).	Al-Tourah AJ, 2008, J CLIN ONCOL, V26, P5165, DOI 10.1200/JCO.2008.16.0283; Baus D, 2009, LEUKEMIA, V23, P1885, DOI 10.1038/leu.2009.103; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bodor C, 2011, LEUKEMIA, V25, P726, DOI 10.1038/leu.2010.311; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eide MB, 2010, BLOOD, V116, P1489, DOI 10.1182/blood-2010-03-272278; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2004, METHOD ENZYMOL, V377, P85; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Khodabakhshi AH, 2012, ONCOTARGET, V3, P1308; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Ladetto M, 2001, EXP HEMATOL, V29, P183, DOI 10.1016/S0301-472X(00)00651-2; Landau DA, 2013, GENOME MED, V5, DOI 10.1186/gm451; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Medrzycki M, 2012, JOVE-J VIS EXP, DOI 10.3791/3577; Montoto S, 2007, J CLIN ONCOL, V25, P2426, DOI 10.1200/JCO.2006.09.3260; Montoto S, 2011, J CLIN ONCOL, V29, P1827, DOI 10.1200/JCO.2010.32.7577; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mottok A, 2007, BLOOD, V110, P3387, DOI 10.1182/blood-2007-03-082511; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Ritz O, 2008, LEUKEMIA, V22, P2106, DOI 10.1038/leu.2008.85; Ritz O, 2009, BLOOD, V114, P1236, DOI 10.1182/blood-2009-03-209759; Ruminy P, 2008, BLOOD, V112, P1951, DOI 10.1182/blood-2007-11-124560; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Treiber N, 2010, GENE DEV, V24, P2270, DOI 10.1101/gad.1976610; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vyas P, 2012, J BIOL CHEM, V287, P11778, DOI 10.1074/jbc.M111.312819; Weigert O, 2012, CANCER DISCOV, V2, P47, DOI 10.1158/2159-8290.CD-11-0208; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691	57	462	473	4	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					176	+		10.1038/ng.2856	http://dx.doi.org/10.1038/ng.2856			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24362818	Green Accepted			2022-12-17	WOS:000331208300015
J	Stein, JL; Medland, SE; Vasquez, AA; Hibar, DP; Senstad, RE; Winkler, AM; Toro, R; Appel, K; Bartecek, R; Bergmann, O; Bernard, M; Brown, AA; Cannon, DM; Chakravarty, MM; Christoforou, A; Domin, M; Grimm, O; Hollinshead, M; Holmes, AJ; Homuth, G; Hottenga, JJ; Langan, C; Lopez, LM; Hansell, NK; Hwang, KS; Kim, S; Laje, G; Lee, PH; Liu, XM; Loth, E; Lourdusamy, A; Mattingsdal, M; Mohnke, S; Maniega, SM; Nho, K; Nugent, AC; O'Brien, C; Papmeyer, M; Putz, B; Ramasamy, A; Rasmussen, J; Rijpkema, M; Risacher, SL; Roddey, JC; Rose, EJ; Ryten, M; Shen, L; Sprooten, E; Strengman, E; Teumer, A; Trabzuni, D; Turner, J; van Eijk, K; van Erp, TGM; van Tol, MJ; Wittfeld, K; Wolf, C; Woudstra, S; Aleman, A; Alhusaini, S; Almasy, L; Binder, EB; Brohawn, DG; Cantor, RM; Carless, MA; Corvin, A; Czisch, M; Curran, JE; Davies, G; de Almeida, MAA; Delanty, N; Depondt, C; Duggirala, R; Dyer, TD; Erk, S; Fagerness, J; Fox, PT; Freimer, NB; Gill, M; Goring, HHH; Hagler, DJ; Hoehn, D; Holsboer, F; Hoogman, M; Hosten, N; Jahanshad, N; Johnson, MP; Kasperaviciute, D; Kent, JW; Kochunov, P; Lancaster, JL; Lawrie, SM; Liewald, DC; Mandl, R; Matarin, M; Mattheisen, M; Meisenzahl, E; Melle, I; Moses, EK; Muhleisen, TW; Nauck, M; Nothen, MM; Olvera, RL; Pandolfo, M; Pike, GB; Puls, R; Reinvang, I; Renteria, ME; Rietschel, M; Roffman, JL; Royle, NA; Rujescu, D; Savitz, J; Schnack, HG; Schnell, K; Seiferth, N; Smith, C; Steen, VM; Hernandez, MCV; Van den Heuvel, M; van der Wee, NJ; Van Haren, NEM; Veltman, JA; Volzke, H; Walker, R; Westlye, LT; Whelan, CD; Agartz, I; Boomsma, DI; Cavalleri, GL; Dale, AM; Djurovic, S; Drevets, WC; Hagoort, P; Hall, J; Heinz, A; Jack, CR; Foroud, TM; Le Hellard, S; Macciardi, F; Montgomery, GW; Poline, JB; Porteous, DJ; Sisodiya, SM; Starr, JM; Sussmann, J; Toga, AW; Veltman, DJ; Walter, H; Weiner, MW; Bis, JC; Ikram, MA; Smith, AV; Gudnason, V; Tzourio, C; Vernooij, MW; Launer, LJ; DeCarli, C; Seshadri, S; Andreassen, OA; Apostolova, LG; Bastin, ME; Blangero, J; Brunner, HG; Buckner, RL; Cichon, S; Coppola, G; de Zubicaray, GI; Deary, IJ; Donohoe, G; de Geus, EJC; Espeseth, T; Fernandez, G; Glahn, DC; Grabe, HJ; Hardy, J; Pol, HEH; Jenkinson, M; Kahn, RS; McDonald, C; McIntosh, AM; McMahon, FJ; McMahon, KL; Meyer-Lindenberg, A; Morris, DW; Muller-Myhsok, B; Nichols, TE; Ophoff, RA; Paus, T; Pausova, Z; Penninx, BW; Potkin, SG; Samann, PG; Saykin, AJ; Schumann, G; Smoller, JW; Wardlaw, JM; Weale, ME; Martin, NG; Franke, B; Wright, MJ; Thompson, PM				Stein, Jason L.; Medland, Sarah E.; Vasquez, Alejandro Arias; Hibar, Derrek P.; Senstad, Rudy E.; Winkler, Anderson M.; Toro, Roberto; Appel, Katja; Bartecek, Richard; Bergmann, Orjan; Bernard, Manon; Brown, Andrew A.; Cannon, Dara M.; Chakravarty, M. Mallar; Christoforou, Andrea; Domin, Martin; Grimm, Oliver; Hollinshead, Marisa; Holmes, Avram J.; Homuth, Georg; Hottenga, Jouke-Jan; Langan, Camilla; Lopez, Lorna M.; Hansell, Narelle K.; Hwang, Kristy S.; Kim, Sungeun; Laje, Gonzalo; Lee, Phil H.; Liu, Xinmin; Loth, Eva; Lourdusamy, Anbarasu; Mattingsdal, Morten; Mohnke, Sebastian; Maniega, Susana Munoz; Nho, Kwangsik; Nugent, Allison C.; O'Brien, Carol; Papmeyer, Martina; Putz, Benno; Ramasamy, Adaikalavan; Rasmussen, Jerod; Rijpkema, Mark; Risacher, Shannon L.; Roddey, J. Cooper; Rose, Emma J.; Ryten, Mina; Shen, Li; Sprooten, Emma; Strengman, Eric; Teumer, Alexander; Trabzuni, Daniah; Turner, Jessica; van Eijk, Kristel; van Erp, Theo G. M.; van Tol, Marie-Jose; Wittfeld, Katharina; Wolf, Christiane; Woudstra, Saskia; Aleman, Andre; Alhusaini, Saud; Almasy, Laura; Binder, Elisabeth B.; Brohawn, David G.; Cantor, Rita M.; Carless, Melanie A.; Corvin, Aiden; Czisch, Michael; Curran, Joanne E.; Davies, Gail; de Almeida, Marcio A. A.; Delanty, Norman; Depondt, Chantal; Duggirala, Ravi; Dyer, Thomas D.; Erk, Susanne; Fagerness, Jesen; Fox, Peter T.; Freimer, Nelson B.; Gill, Michael; Goering, Harald H. H.; Hagler, Donald J.; Hoehn, David; Holsboer, Florian; Hoogman, Martine; Hosten, Norbert; Jahanshad, Neda; Johnson, Matthew P.; Kasperaviciute, Dalia; Kent, Jack W., Jr.; Kochunov, Peter; Lancaster, Jack L.; Lawrie, Stephen M.; Liewald, David C.; Mandl, Rene; Matarin, Mar; Mattheisen, Manuel; Meisenzahl, Eva; Melle, Ingrid; Moses, Eric K.; Muehleisen, Thomas W.; Nauck, Matthias; Noethen, Markus M.; Olvera, Rene L.; Pandolfo, Massimo; Pike, G. Bruce; Puls, Ralf; Reinvang, Ivar; Renteria, Miguel E.; Rietschel, Marcella; Roffman, Joshua L.; Royle, Natalie A.; Rujescu, Dan; Savitz, Jonathan; Schnack, Hugo G.; Schnell, Knut; Seiferth, Nina; Smith, Colin; Steen, Vidar M.; Hernandez, Maria C. Valdes; Van den Heuvel, Martijn; van der Wee, Nic J.; Van Haren, Neeltje E. M.; Veltman, Joris A.; Voelzke, Henry; Walker, Robert; Westlye, Lars T.; Whelan, Christopher D.; Agartz, Ingrid; Boomsma, Dorret I.; Cavalleri, Gianpiero L.; Dale, Anders M.; Djurovic, Srdjan; Drevets, Wayne C.; Hagoort, Peter; Hall, Jeremy; Heinz, Andreas; Jack, Clifford R., Jr.; Foroud, Tatiana M.; Le Hellard, Stephanie; Macciardi, Fabio; Montgomery, Grant W.; Poline, Jean Baptiste; Porteous, David J.; Sisodiya, Sanjay M.; Starr, John M.; Sussmann, Jessika; Toga, Arthur W.; Veltman, Dick J.; Walter, Henrik; Weiner, Michael W.; Bis, Joshua C.; Ikram, M. Arfan; Smith, Albert V.; Gudnason, Vilmundur; Tzourio, Christophe; Vernooij, Meike W.; Launer, Lenore J.; DeCarli, Charles; Seshadri, Sudha; Andreassen, Ole A.; Apostolova, Liana G.; Bastin, Mark E.; Blangero, John; Brunner, Han G.; Buckner, Randy L.; Cichon, Sven; Coppola, Giovanni; de Zubicaray, Greig I.; Deary, Ian J.; Donohoe, Gary; de Geus, Eco J. C.; Espeseth, Thomas; Fernandez, Guillen; Glahn, David C.; Grabe, Hans J.; Hardy, John; Pol, Hilleke E. Hulshoff; Jenkinson, Mark; Kahn, Rene S.; McDonald, Colm; McIntosh, Andrew M.; McMahon, Francis J.; McMahon, Katie L.; Meyer-Lindenberg, Andreas; Morris, Derek W.; Mueller-Myhsok, Bertram; Nichols, Thomas E.; Ophoff, Roel A.; Paus, Tomas; Pausova, Zdenka; Penninx, Brenda W.; Potkin, Steven G.; Saemann, Philipp G.; Saykin, Andrew J.; Schumann, Gunter; Smoller, Jordan W.; Wardlaw, Joanna M.; Weale, Michael E.; Martin, Nicholas G.; Franke, Barbara; Wright, Margaret J.; Thompson, Paul M.		ADNI; EPIGEN Consortium; IMAGEN Consortium; Saguenay Youth Study Grp SYS; Cohorts Heart Aging Res Genomic Ep; Enhancing Neuro Imaging Genetics M	Identification of common variants associated with human hippocampal and intracranial volumes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TEMPORAL-LOBE EPILEPSY; AUTOMATED SEGMENTATION; GENOTYPE IMPUTATION; ALZHEIMERS-DISEASE; BRAIN VOLUME; HUMAN HEIGHT; FUNCTIONAL IMPLICATIONS; NA+/H+ EXCHANGER; UNIFIED APPROACH	Identifying genetic variants influencing human brain structures may reveal new biological mechanisms underlying cognition and neuropsychiatric illness. The volume of the hippocampus is a biomarker of incipient Alzheimer's disease(1,2) and is reduced in schizophrenia(3), major depression(4) and mesial temporal lobe epilepsy(5). Whereas many brain imaging phenotypes are highly heritable(6,7), identifying and replicating genetic influences has been difficult, as small effects and the high costs of magnetic resonance imaging (MRI) have led to underpowered studies. Here we report genome-wide association meta-analyses and replication for mean bilateral hippocampal, total brain and intracranial volumes from a large multinational consortium. The intergenic variant rs7294919 was associated with hippocampal volume (12q24.22; N = 21,151; P = 6.70 x 10(-16)) and the expression levels of the positional candidate gene TESC in brain tissue. Additionally, rs10784502, located within HMGA2, was associated with intracranial volume (12q14.3; N = 15,782; P = 1.12 x 10(-12)). We also identified a suggestive association with total brain volume at rs10494373 within DDR2 (1q23.3; N = 6,500; P = 5.81 x 10(-7)).	[Stein, Jason L.; Hibar, Derrek P.; Senstad, Rudy E.; Hwang, Kristy S.; Jahanshad, Neda; Toga, Arthur W.; Apostolova, Liana G.; Thompson, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, Lab Neuro Imaging, Los Angeles, CA 90095 USA; [Medland, Sarah E.; Hansell, Narelle K.; Renteria, Miguel E.; Montgomery, Grant W.; Martin, Nicholas G.; Wright, Margaret J.] Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia; [Medland, Sarah E.] Queensland Inst Med Res, Quantitat Genet Lab, Brisbane, Qld 4006, Australia; [Medland, Sarah E.] Broad Inst Harvard Univ & MIT, Cambridge, MA USA; [Vasquez, Alejandro Arias; Hoogman, Martine; Veltman, Joris A.; Brunner, Han G.; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Rijpkema, Mark; Hoogman, Martine; Hagoort, Peter; Fernandez, Guillen; Franke, Barbara] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Winkler, Anderson M.; Glahn, David C.] Hartford Hosp, Olin Neuropsychiat Res Ctr, Inst Living, Hartford, CT 06115 USA; [Winkler, Anderson M.; Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Toro, Roberto] Inst Pasteur, Lab Human Genet & Cognit Funct, Paris, France; [Toro, Roberto] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France; [Toro, Roberto] Univ Paris Diderot, Dept Neurosci, Paris, France; [Appel, Katja; Wittfeld, Katharina; Grabe, Hans J.] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Appel, Katja] Univ Heidelberg, Inst Psychol, Dept Clin Psychol & Psychotherapy, Heidelberg, Germany; [Bartecek, Richard; Mandl, Rene; Schnack, Hugo G.; Van den Heuvel, Martijn; Van Haren, Neeltje E. M.; Pol, Hilleke E. Hulshoff; Kahn, Rene S.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst, Utrecht, Netherlands; [Bergmann, Orjan; Brown, Andrew A.; Mattingsdal, Morten; Melle, Ingrid; Agartz, Ingrid; Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bernard, Manon; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Brown, Andrew A.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Cannon, Dara M.] Natl Univ Ireland Galway, Clin Neuroimaging Lab, Dept Anat, Galway, Ireland; [Langan, Camilla; McDonald, Colm] Natl Univ Ireland Galway, Clin Neuroimaging Lab, Dept Psychiat, Galway, Ireland; [Chakravarty, M. Mallar; Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dr Einar Martens Res Grp Biol Psychiat, Dept Clin Med, Bergen, Norway; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Domin, Martin; Hosten, Norbert; Puls, Ralf] Ernst Moritz Arndt Univ Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Grimm, Oliver; Rietschel, Marcella; Meyer-Lindenberg, Andreas] Univ Heidelberg, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany; [Hollinshead, Marisa; Holmes, Avram J.; Buckner, Randy L.] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Hollinshead, Marisa; Buckner, Randy L.] Howard Hughes Med Inst, Cambridge, MA USA; [Homuth, Georg; Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Hottenga, Jouke-Jan; Boomsma, Dorret I.; de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Lopez, Lorna M.; Maniega, Susana Munoz; Liewald, David C.; Royle, Natalie A.; Hernandez, Maria C. Valdes; Porteous, David J.; Starr, John M.; Bastin, Mark E.; Deary, Ian J.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Hwang, Kristy S.; Apostolova, Liana G.; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Kim, Sungeun; Nho, Kwangsik; Risacher, Shannon L.; Shen, Li; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Neuroimaging, Dept Radiol & Imaging Sci, Indianapolis, IN USA; [Kim, Sungeun; Shen, Li; Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Laje, Gonzalo; Liu, Xinmin; McMahon, Francis J.] NIMH, Mood & Anxiety Disorders Sect, Human Genet Branch,US Dept HHS, Intramural Res Program,US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Lee, Phil H.; Brohawn, David G.; Fagerness, Jesen; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Lee, Phil H.; Roffman, Joshua L.; Buckner, Randy L.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Liu, Xinmin] Columbia Univ, Med Ctr, Taub Inst Res Alzheimer Dis & Aging Brain, New York, NY USA; [Loth, Eva; Lourdusamy, Anbarasu; Schumann, Gunter] Kings Coll London, MRC, Social Genet & Dev Psychiat SGDP Ctr, Inst Psychiat, London WC2R 2LS, England; [Mattingsdal, Morten] Sorlandet Hosp, Res Unit, Kristiansand, Norway; [Mohnke, Sebastian; Erk, Susanne; Seiferth, Nina; Heinz, Andreas; Walter, Henrik] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Maniega, Susana Munoz; Royle, Natalie A.; Hernandez, Maria C. Valdes; Bastin, Mark E.; Wardlaw, Joanna M.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Nho, Kwangsik] Regenstrief Inst Hlth Care, Div Med Informat, Indianapolis, IN USA; [Nugent, Allison C.; Savitz, Jonathan; Drevets, Wayne C.] NIMH, Sect Neuroimaging Mood & Anxiety Disorders, Intramural Res Program, NIH,US Dept HHS, Bethesda, MD 20892 USA; [O'Brien, Carol; Rose, Emma J.; Corvin, Aiden; Gill, Michael; Donohoe, Gary; Morris, Derek W.] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Dept Psychiat, Inst Mol Med, Dublin, Ireland; [O'Brien, Carol; Rose, Emma J.; Corvin, Aiden; Gill, Michael; Donohoe, Gary; Morris, Derek W.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Papmeyer, Martina; Sprooten, Emma; Lawrie, Stephen M.; Hall, Jeremy; Sussmann, Jessika; McIntosh, Andrew M.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Putz, Benno; Wolf, Christiane; Binder, Elisabeth B.; Czisch, Michael; Hoehn, David; Holsboer, Florian; Mueller-Myhsok, Bertram; Saemann, Philipp G.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Ramasamy, Adaikalavan; Weale, Michael E.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Rasmussen, Jerod; van Erp, Theo G. M.; Macciardi, Fabio; Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Rijpkema, Mark; Hagoort, Peter; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Roddey, J. Cooper; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ryten, Mina; Trabzuni, Daniah; Hardy, John] UCL, Dept Mol Neurosci, London, England; [Ryten, Mina; Trabzuni, Daniah; Hardy, John] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Strengman, Eric; van Eijk, Kristel] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Utrecht, Netherlands; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Turner, Jessica] Mind Res Network, Albuquerque, NM USA; [van Tol, Marie-Jose; van der Wee, Nic J.; Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van Tol, Marie-Jose; van der Wee, Nic J.; Penninx, Brenda W.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Tol, Marie-Jose; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Behav & Cognit Neurosci Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands; [Woudstra, Saskia; Veltman, Dick J.; Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Alhusaini, Saud; Delanty, Norman; Whelan, Christopher D.; Cavalleri, Gianpiero L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Almasy, Laura; Carless, Melanie A.; Curran, Joanne E.; de Almeida, Marcio A. A.; Duggirala, Ravi; Dyer, Thomas D.; Johnson, Matthew P.; Kent, Jack W., Jr.; Moses, Eric K.; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Cantor, Rita M.; Freimer, Nelson B.; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland; [Depondt, Chantal; Pandolfo, Massimo] Univ Libre Brussels, Dept Neurol, Hop Erasme, Brussels, Belgium; [Buckner, Randy L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Fox, Peter T.; Kochunov, Peter; Lancaster, Jack L.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Hagler, Donald J.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Hoogman, Martine; Fernandez, Guillen] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, Nijmegen, Netherlands; [Hoogman, Martine; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Kasperaviciute, Dalia; Matarin, Mar; Sisodiya, Sanjay M.] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London, England; [Kochunov, Peter] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Mattheisen, Manuel; Muehleisen, Thomas W.; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Mattheisen, Manuel; Muehleisen, Thomas W.; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Mattheisen, Manuel] Univ Bonn, Inst Genom Math, Bonn, Germany; [Meisenzahl, Eva; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80804 Munich, Germany; [Melle, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders DZNE, Bonn, Germany; [Olvera, Rene L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Pike, G. Bruce] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Reinvang, Ivar; Westlye, Lars T.; Espeseth, Thomas] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway; [Reinvang, Ivar; Espeseth, Thomas] Ctr Adv Study, Oslo, Norway; [Renteria, Miguel E.; de Zubicaray, Greig I.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Savitz, Jonathan; Drevets, Wayne C.] Laureate Inst Brain Res, Tulsa, OK USA; [Schnell, Knut] Univ Heidelberg, Univ Heidelberg Hosp, Dept Gen Psychiat, Heidelberg, Germany; [Schnell, Knut; Walter, Henrik] Univ Bonn, Dept Psychiat, Div Med Psychol, Bonn, Germany; [Smith, Colin; Walker, Robert] Univ Edinburgh, Dept Pathol, MRC Sudden Death Tissue Bank Edinburgh, Edinburgh, Midlothian, Scotland; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Res & Dev, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Jack, Clifford R., Jr.] Mayo Clin & Mayo Fdn, Aging & Dementia Imaging Res Lab, Dept Radiol, Rochester, MN USA; [Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA; [Poline, Jean Baptiste] Commissariat Energie Atom, Inst Imagerie Biomed I2BM, Gif Sur Yvette, France; [Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Mol Med Ctr,Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Ikram, M. Arfan; Vernooij, Meike W.] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Vernooij, Meike W.] Univ Med Ctr, Erasmus Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Vernooij, Meike W.] Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Tzourio, Christophe] Univ Bordeaux, U708, Bordeaux, France; [Tzourio, Christophe] INSERM, U708, Bordeaux, France; [Launer, Lenore J.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Seshadri, Sudha] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Bastin, Mark E.] Univ Edinburgh, Div Hlth Sci Med Phys, Edinburgh, Midlothian, Scotland; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Espeseth, Thomas] Univ Bergen, Dept Biol & Med Psychol, Fac Psychol, Bergen, Norway; [Grabe, Hans J.] German Ctr Neurodegenerat Dis DZNE, Greifswald, Germany; [Jenkinson, Mark; Nichols, Thomas E.] Univ Oxford, FMRIB, Oxford, England; [McMahon, Katie L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Hartford Hospital; Yale University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Ernst Moritz Arndt Universitat Greifswald; Ruprecht Karls University Heidelberg; Utrecht University; Utrecht University Medical Center; University of Oslo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oslo; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Toronto; University Toronto Affiliates; Baycrest; University of Bergen; University of Bergen; Haukeland University Hospital; Ernst Moritz Arndt Universitat Greifswald; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Harvard University; Howard Hughes Medical Institute; Ernst Moritz Arndt Universitat Greifswald; Vrije Universiteit Amsterdam; University of Edinburgh; University of Edinburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Columbia University; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Edinburgh; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Trinity College Dublin; Trinity College Dublin; Royal Infirmary of Edinburgh; University of Edinburgh; Max Planck Society; University of London; King's College London; University of California System; University of California Irvine; Radboud University Nijmegen; University of California System; University of California San Diego; University of London; University College London; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; King Faisal Specialist Hospital & Research Center; Lovelace Respiratory Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Vrije Universiteit Amsterdam; Royal College of Surgeons - Ireland; Texas Biomedical Research Institute; University of California System; University of California Los Angeles; Universite Libre de Bruxelles; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; Radboud University Nijmegen; Max Planck Society; University of London; University College London; University System of Maryland; University of Maryland Baltimore; University of Bonn; University of Bonn; University of Bonn; University of Munich; University of Oslo; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Texas System; University of Texas Health San Antonio; McGill University; University of Oslo; University of Queensland; Laureate Institute for Brain Research, Inc.; Ruprecht Karls University Heidelberg; University of Bonn; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald; Diakonhjemmet Hospital; University of Oslo; Mayo Clinic; Indiana University System; Indiana University Bloomington; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Edinburgh; University of Edinburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; University of Iceland; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; University of California System; University of California Davis; University of California System; University of California Davis; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Edinburgh; Helmholtz Association; Research Center Julich; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Bergen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Oxford; University of Queensland; University of Warwick; University of Groningen	Thompson, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Lab Neuro Imaging, Los Angeles, CA 90095 USA.	thompson@loni.ucla.edu	Hsiung, Robin/AAT-1661-2021; Maniega, Susana Muñoz/I-8730-2014; Winkler, Anderson M/P-7773-2016; Preda, Adrian/K-8889-2013; Franke, Barbara/D-4836-2009; Savitz, Jonathan/C-3088-2009; Artiges, Eric/AAT-7219-2021; DeCarli, Charles/B-5541-2009; Lourdusamy, Anbarasu/P-6606-2014; Turner, Jessica A/N-2228-2017; Porteous, David/AAA-3446-2021; Heinz, Andreas/ABB-7736-2020; Trabzuni, Daniah/AAI-2037-2021; Almasy, Laura/V-3156-2019; Levey, Allan/F-2104-2011; van den Heuvel, Martijn/AFR-3213-2022; Vollstädt-Klein, Sabine/C-6744-2012; Lawrie, Stephen MacGregor/AAD-1607-2021; de Zubicaray, Greig I/B-1763-2008; Medland, Sarah/AAT-7595-2020; Gudnason, Vilmundur/K-6885-2015; Ramasamy, Adaikalavan/G-2632-2010; Cannon, Dara M/C-1323-2009; Walter, Henrik/O-2612-2013; Mattheisen, Manuel/S-3725-2019; Finsterbusch, Jürgen/M-2969-2016; Roffman, Joshua/G-8228-2012; McIntosh, Andrew M/B-9379-2008; Desrivières, Sylvane/ABC-4336-2021; Hulshoff Pol, Hilleke Evertje/B-4795-2014; lambert, jean-charles/F-8787-2013; Binder, Elisabeth B/K-8905-2014; Porteous, David J/C-7289-2013; Hardy, John/C-2451-2009; Thompson, Paul M/C-4194-2018; Rujescu, Dan/GRS-3875-2022; Breteler, Monique M.B./J-5058-2014; Nichols, Thomas E./N-9902-2017; Jahanshad, Neda/ABD-5944-2021; Shen, Li/AAB-6870-2021; Wardlaw, Joanna M/Y-3456-2019; Morris, Derek/AAW-8343-2021; Andreassen, Ole A./AAY-7531-2020; Weale, Michael E/F-2587-2010; Martin, Nicholas/R-9235-2019; Sprooten, Emma/N-3836-2017; Jack, Clifford R/F-2508-2010; Melle, Ingrid S/B-4858-2011; Wittfeld, Katharina/AFB-1549-2022; Boomsma, Dorret I/AAX-4470-2020; Brunner, Han/C-9928-2013; Cichon, Sven/B-9618-2014; van Haren, Neeltje/AAC-7656-2020; Poustka, Luise/D-9299-2017; Fox, Peter/B-4725-2010; Cavalleri, Gianpiero/A-6632-2010; Macciardi, Fabio/N-3768-2014; McMahon, Francis J/A-7290-2009; Trabzuni, Daniah M/C-4034-2012; Risacher, Shannon/AAI-2141-2019; Stacey, David/AFX-6013-2022; Romanczuk-Seiferth, Nina/AFN-0829-2022; Ryten, Mina/Q-8419-2016; Laje, Gonzalo/L-2654-2014; Blangero, John/ABA-7175-2021; Rijpkema, Mark/D-1974-2010; /ABD-6198-2020; Mandl, René C.W./AAU-7037-2020; Mattingsdal, Morten/Q-9367-2016; McDonald, Colm/C-1430-2009; Donohoe, Gary/J-6481-2013; Potkin, Steven G/A-2021-2013; Schumann, Gunter/H-1013-2013; Lopez, Lorna/AAR-4912-2020; Desrivieres, Sylvane/B-7399-2011; Wright, Margaret Jane/A-4560-2016; Matarin, Mar/F-1771-2016; Gudnason, Vilmundur/AAE-7126-2019; Hansell, Narelle K/A-4553-2016; Cavalieri, Margherita/G-8053-2012; Fernandez, Guillen/B-3771-2009; Müller-Myhsok, Bertram/A-3289-2013; Mattheisen, Manuel/B-4949-2012; Lourdusamy, Anbarasu/G-3387-2011; Jenkinson, Mark/AAC-8861-2019; McMahon, Katie L/C-6440-2009; Romanczuk-Seiferth, Nina/AFN-7029-2022; Tzourio, christophe/B-4015-2009; Hagoort, Peter/B-7417-2012; LICEND, CEMND/F-1296-2015; Hoogman, Martine/G-8958-2015; Pike, Bruce/K-5562-2014; Vasquez, Alejandro Arias/E-4762-2012; Teumer, Alexander/S-7438-2019; Deary, Ian J/C-6297-2009; Kochunov, Peter/GQH-9532-2022; de Geus, Eco J.C./M-9318-2015; Artiges, Eric/C-2815-2019; Ikram, M. Arfan/AAM-5225-2021; Lopez, Lorna M/F-7265-2010; Penninx, Brenda WJH/S-7627-2017; Wright, Margaret J/H-3308-2014; Montgomery, Grant W/B-7148-2008; Rose, Emma J/A-9960-2010; Veltman, Joris A/F-5128-2010; Dufouil, Carole/J-4968-2012; Smith, Albert Vernon/K-5150-2015; Pütz, Benno/P-2630-2016; Rentería, Miguel E./M-6671-2017; Cichon, Sven/H-8803-2013; Bartečků, Elis/E-1906-2012; Medland, Sarah E/C-7630-2013; Vernooij, Meike Willemijn/E-4061-2016; de Zubicaray, Greig/ABC-8955-2021; Turner, Jessica A/H-7282-2015; Hernandez, María/GYU-3543-2022; Tzourio, christophe/L-6344-2019; Smolka, Michael/B-4865-2011; Meyer-Lindenberg, Andreas/H-1076-2011; Moreno, Margarita/K-9869-2014; Saykin, Andrew/A-1318-2007	Hsiung, Robin/0000-0002-8017-0856; Maniega, Susana Muñoz/0000-0001-5185-6384; Winkler, Anderson M/0000-0002-4169-9781; Preda, Adrian/0000-0003-3373-2438; Franke, Barbara/0000-0003-4375-6572; Savitz, Jonathan/0000-0001-8143-182X; Artiges, Eric/0000-0003-4461-7646; Turner, Jessica A/0000-0003-0076-8434; Porteous, David/0000-0003-1249-6106; Heinz, Andreas/0000-0001-5405-9065; Trabzuni, Daniah/0000-0003-4826-9570; Levey, Allan/0000-0002-3153-502X; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Lawrie, Stephen MacGregor/0000-0002-2444-5675; de Zubicaray, Greig I/0000-0003-4506-0579; Medland, Sarah/0000-0003-1382-380X; Gudnason, Vilmundur/0000-0001-5696-0084; Ramasamy, Adaikalavan/0000-0002-7598-2892; Cannon, Dara M/0000-0001-7378-3411; Mattheisen, Manuel/0000-0002-8442-493X; Roffman, Joshua/0000-0003-4073-532X; McIntosh, Andrew M/0000-0002-0198-4588; Desrivières, Sylvane/0000-0002-9120-7060; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; lambert, jean-charles/0000-0003-0829-7817; Porteous, David J/0000-0003-1249-6106; Hardy, John/0000-0002-3122-0423; Thompson, Paul M/0000-0002-4720-8867; Breteler, Monique M.B./0000-0002-0626-9305; Nichols, Thomas E./0000-0002-4516-5103; Wardlaw, Joanna M/0000-0002-9812-6642; Morris, Derek/0000-0002-3413-570X; Weale, Michael E/0000-0003-4593-1186; Martin, Nicholas/0000-0003-4069-8020; Sprooten, Emma/0000-0002-1691-9105; Jack, Clifford R/0000-0001-7916-622X; Melle, Ingrid S/0000-0002-9783-548X; Wittfeld, Katharina/0000-0003-4383-5043; Cichon, Sven/0000-0002-9475-086X; van Haren, Neeltje/0000-0002-3090-7653; Fox, Peter/0000-0002-0465-2028; Macciardi, Fabio/0000-0003-0537-4266; McMahon, Francis J/0000-0002-9469-305X; Trabzuni, Daniah M/0000-0003-4826-9570; Stacey, David/0000-0002-9392-9235; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Laje, Gonzalo/0000-0003-2763-3329; Rijpkema, Mark/0000-0002-8495-4703; Mattingsdal, Morten/0000-0003-4440-0324; McDonald, Colm/0000-0003-1661-5192; Donohoe, Gary/0000-0003-3037-7426; Lopez, Lorna/0000-0002-0241-9783; Desrivieres, Sylvane/0000-0002-9120-7060; Wright, Margaret Jane/0000-0001-7133-4970; Matarin, Mar/0000-0002-4717-5735; Gudnason, Vilmundur/0000-0001-5696-0084; Hansell, Narelle K/0000-0002-8229-9741; Fernandez, Guillen/0000-0002-5522-0604; Mattheisen, Manuel/0000-0002-8442-493X; Jenkinson, Mark/0000-0001-6043-0166; McMahon, Katie L/0000-0002-6357-615X; Tzourio, christophe/0000-0002-6517-2984; Hoogman, Martine/0000-0002-1261-7628; Pike, Bruce/0000-0001-8924-683X; Vasquez, Alejandro Arias/0000-0002-4786-0169; Teumer, Alexander/0000-0002-8309-094X; Deary, Ian J/0000-0002-1733-263X; de Geus, Eco J.C./0000-0001-6022-2666; Artiges, Eric/0000-0003-4461-7646; Penninx, Brenda WJH/0000-0001-7779-9672; Montgomery, Grant W/0000-0002-4140-8139; Rose, Emma J/0000-0001-5365-4794; Veltman, Joris A/0000-0002-3218-8250; Smith, Albert Vernon/0000-0003-1942-5845; Pütz, Benno/0000-0002-2208-209X; Rentería, Miguel E./0000-0003-4626-7248; Cichon, Sven/0000-0002-9475-086X; Bartečků, Elis/0000-0001-9148-2145; Medland, Sarah E/0000-0003-1382-380X; de Zubicaray, Greig/0000-0003-4506-0579; Turner, Jessica A/0000-0003-0076-8434; Tzourio, christophe/0000-0002-6517-2984; Lourdusamy, Anbarasu/0000-0002-1978-6301; Flor, Herta/0000-0003-4809-5398; Walker, Robert/0000-0001-7383-7846; Walters, James/0000-0002-6980-4053; Djurovic, Srdjan/0000-0002-8140-8061; Ikram, Mohammad Arfan/0000-0003-0372-8585; Shen, Li/0000-0002-5443-0503; Hall, Jeremy/0000-0002-0403-3278; Curran, Joanne/0000-0002-6898-155X; Agartz, Ingrid/0000-0002-9839-5391; Chouraki, Vincent/0000-0002-4698-1794; Whelan, Christopher/0000-0003-0308-5583; Smolka, Michael/0000-0001-5398-5569; Gill, Michael/0000-0003-0206-5337; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Risacher, Shannon/0000-0002-3304-7943; Grimm, Oliver/0000-0002-0767-0301; Moreno, Margarita/0000-0001-7336-6167; Saykin, Andrew/0000-0002-1376-8532; O'Brien, Carol/0000-0002-0828-5376; Banaschewski, Tobias/0000-0003-4595-1144; Moses, Eric/0000-0001-7781-4465; van den Heuvel, Martijn/0000-0003-1570-1195; Bastin, Mark/0000-0002-0490-0845; Lemaitre, Herve/0000-0002-5952-076X; Nothen, Markus/0000-0002-8770-2464; Walter, Henrik/0000-0002-9403-6121; Becker, James/0000-0003-4425-4726; Nees, Frauke/0000-0002-7796-8234; Robbins, Trevor/0000-0003-0642-5977; Delaney, Norman/0000-0002-3953-9842; Carless, Melanie/0000-0001-8350-2302; Afonso de Almeida, Marcio Augusto/0000-0002-8114-3892; Vernooij, Meike/0000-0003-4658-2176; Van Duijn, Cornelia/0000-0002-2374-9204; MIRANDA, RUBEN/0000-0002-9445-7348; Nugent, Allison/0000-0003-2569-2480; Holmes, Avram/0000-0001-6583-803X; Toro, Roberto/0000-0002-6671-858X; Beiser, Alexa/0000-0001-8551-7778; Le Hellard, Stephanie/0000-0002-8085-051X; Andreassen, Ole A./0000-0002-4461-3568; Stein, Jason/0000-0003-4829-0513; Amouyel, Philippe/0000-0001-9088-234X; Kent, Jack/0000-0002-0758-7639; Cavalleri, Gianpiero/0000-0002-9802-0506; Westlye, Lars T./0000-0001-8644-956X; Seshadri, Sudha/0000-0001-6135-2622; Loth, Eva/0000-0001-9458-9167; Corvin, Aiden/0000-0001-6717-4089; Erk, Susanne/0000-0003-0961-3543	Eli Lilly Company; Wyeth; Bristol-Myers Squibb; AstraZeneca; GlaxoSmithKline; German Research Foundation; Federal Ministry of Education and Research Germany; Janssen-Cilag; Novartis; Lundbeck; SALUS-Institute for Trend-Research and Therapy Evaluation in Mental Health; Federal Ministry of Education and Research, Germany; BioRad Laboratories; Siemens AG; Zeitschrift fur Laboratoriumsmedizin; Bruker Daltronics; Abbott; Jurilab Kuopio; Roche Diagnostics; Instand; Becton Dickinson; Hofmann La Roche; Humboldt Foundation; Araclon; Medivation/Pfizer; Ipsen; TauRx Therapeutics; Bayer Healthcare; Biogen Idec; Exonhit Therapeutics; SA; Servier; Synarc; Pfizer; Janssen; Merck; Avid; DoD; VA; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Anonymous Foundation; BioClinica (ADNI 2); Cure Alzheimer's Fund; Eisai; Elan; Gene Network Sciences; Genentech; GE Healthcare; Innogenetics; Johnson Johnson; Medpace; Roche; Schering Plough; US NIH [U01 AG024904, U24 RR21992, MH0708143, MH083824, MH078111, MH59490, C06 RR13556, C06 RR017515, R01D0042157-01A, MH079799]; Foundation for the NIH; NIH [U01 AG024904, RC2 AG036535-01, P30 AG010129, K01 AG030514, EB006395, AG040060, EB008432, P41 RR013642, HD050735, AG036535, AG020098, EB008281]; NIA [R01 AG019771-09]; NCRAD [U24AG021886]; ADNI (NIH) [U01 AG024904]; NIA; National Institute of Biomedical Imaging and Bioengineering (NIBIB); Dana Foundation; Biobanking and Biomolecular Resources Research Infrastructure Netherlands (BBMRI-NL); Netherlands Organisation for Scientific Research (NWO) [93511010]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Health Foundation; Italian Ministry of University and Research [RBIN04SWHR]; European Commission [PL037286]; UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre; MRC [93558]; NIA at the University of California, Los Angeles [AG16570]; Age UK's Disconnected Mind programme; Research Into Ageing [251, 285]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1]; UK MRC [G1001401, 8200, G0901254]; Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); Scottish Funding Council through the SINAPSE Collaboration; AXA; German Federal Ministry of Education and Research (BMBF); Exzellenz-Stiftung of the Max Planck Society; BMBF in the framework of the National Genome Research Network (NGFN) [FKZ 01GS0481]; Research Council of Norway [154313/ V50, 177458/V50, 167153/V50, 163070/V50, 183782/V50]; Bergen Research Foundation; University of Bergen; Research Council of Norway (FUGE; Psykisk Helse), Helse Vest Regionalt Helseforetak (RHF); Dr Einar Martens Fund; NWO (MagW/ZonMW) [904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008, 911-09-032, SPI 56-464-14192, 10-000-1002]; Center for Medical Systems Biology (CMSB; NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure; VU University; EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam; European Science Foundation [EU/QLRT-2001-01254]; European Community [HEALTH-F4-2007-201413]; European Science Council (ERC) Genetics of Mental Illness [230374]; Rutgers University Cell; DNA Repository (NIMH) [U24 MH068457-06]; Genetic Association Information Network (a public-private partnership between the NIH and Pfizer, Affymetrix and Abbott Laboratories); National Institute of Mental Health (NIMH) from NIH; US Department of Health and Human Services [K99 MH085098, 1ZIA MH002810, 1ZIA MH002790]; US National Institute of Child Health and Human Development [R01 HD050735]; Australian National Health and Medical Research Council (NHMRC) [496682]; NHMRC [389891, 613667]; Australian Research Council (ARC) [FT0991634, FT110100548]; Achievement Rewards for College Scientists foundation; US NIMH [F31 MH087061, MH078075]; National Science Foundation (NSF) [DGE-0707424]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation; German Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; German Research Foundation (DFG) [GR 1912/5-1]; Federal Ministry of Education and Research [03ZIK012, 03IS2061A]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Simons Foundation; Howard Hughes Medical Institute; Oslo University Hospital-Ulleval; Eastern Norway Health Authority [2004-123]; Wellcome Trust [072894/z/03/z-Gill, 084730]; Science Foundation Ireland [08/IN.1/B1916_Corvin, 08/RFP/GEN1538]; University College London (UCL)/University College London Hospitals (UCLH) Comprehensive Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC) [114]; European Union Marie Curie Reintegration; UK NIHR [08-08-SCC]; Comprehensive Local Research Network (CLRN) [CEL1300]; The Big Lottery Fund; Wolfson Trust; Epilepsy Society; UK Department of Health's NIHR Biomedical Research Centres; Brainwave-the Irish Epilepsy Association; Fonds National de la Recherche Scientifique [FC 63574 / 3.4.620.06 F]; Fonds Erasme pour la Recherche Medicale at the Universite Libre de Bruxelles; MRC Sudden Death Brain and Tissue Bank; Sun Health Research Institute Brain Bank; Netherlands Organization for Health Research and Development ZonMw [917.46.370];  [NBIC/BioAssist/RK/2008.024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050735] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021992, C06RR017515, P41RR013642, C06RR013556, S10RR029392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006395, R01EB008432, R01EB008281, R01EB015611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457, R01MH078111, R01MH059490, R01MH078075, R01MH079799, F31MH087061, R01MH083824, ZIAMH002810, R01MH097268, R37MH059490, ZIAMH002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007270, P30AG013846, R56AG020098, U24AG021886, R01AG020098, P30AG019610, U19AG010483, RC2AG036535, P30AG010129, P50AG016570, R01AG040060, R01AG040770, K01AG030514, R01AG019771, U01AG024904] Funding Source: NIH RePORTER; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0901858, G0900908, G1001245, G0600429, G0701075, G1001401, G0700704, G0802462, G0901254] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0701075, G0700704, G0801418B, G0900908, G9817803B, G0901254, G1001245, G0802462, G1001401, G0600429, G0901858] Funding Source: researchfish; Chief Scientist Office [SCD/10] Funding Source: researchfish	Eli Lilly Company(Eli Lilly); Wyeth(Wyeth); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research Germany(Federal Ministry of Education & Research (BMBF)); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Lundbeck(Lundbeck Corporation); SALUS-Institute for Trend-Research and Therapy Evaluation in Mental Health; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); BioRad Laboratories; Siemens AG(Siemens AG); Zeitschrift fur Laboratoriumsmedizin; Bruker Daltronics; Abbott(Abbott Laboratories); Jurilab Kuopio; Roche Diagnostics; Instand; Becton Dickinson; Hofmann La Roche; Humboldt Foundation(Alexander von Humboldt Foundation); Araclon; Medivation/Pfizer(Pfizer); Ipsen(Ipsen); TauRx Therapeutics; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Biogen Idec(Biogen); Exonhit Therapeutics; SA; Servier(Servier); Synarc; Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Avid; DoD(United States Department of Defense); VA(US Department of Veterans Affairs); Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Anonymous Foundation; BioClinica (ADNI 2); Cure Alzheimer's Fund; Eisai(Eisai Co Ltd); Elan; Gene Network Sciences; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); Innogenetics; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medpace; Roche(Roche Holding); Schering Plough(Merck & CompanySchering Plough Corporation); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRAD; ADNI (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Dana Foundation; Biobanking and Biomolecular Resources Research Infrastructure Netherlands (BBMRI-NL); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Health Foundation; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA at the University of California, Los Angeles; Age UK's Disconnected Mind programme(General Electric); Research Into Ageing; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Scottish Funding Council through the SINAPSE Collaboration; AXA; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Exzellenz-Stiftung of the Max Planck Society; BMBF in the framework of the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Research Council of Norway(Research Council of Norway); Bergen Research Foundation; University of Bergen; Research Council of Norway (FUGE; Psykisk Helse), Helse Vest Regionalt Helseforetak (RHF)(Research Council of Norway); Dr Einar Martens Fund; NWO (MagW/ZonMW); Center for Medical Systems Biology (CMSB; NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure; VU University; EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam; European Science Foundation(European Science Foundation (ESF)European Commission); European Community(European Commission); European Science Council (ERC) Genetics of Mental Illness(European Research Council (ERC)); Rutgers University Cell; DNA Repository (NIMH); Genetic Association Information Network (a public-private partnership between the NIH and Pfizer, Affymetrix and Abbott Laboratories); National Institute of Mental Health (NIMH) from NIH; US Department of Health and Human Services; US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Achievement Rewards for College Scientists foundation(General Electric); US NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Simons Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Oslo University Hospital-Ulleval; Eastern Norway Health Authority; Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University College London (UCL)/University College London Hospitals (UCLH) Comprehensive Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC); European Union Marie Curie Reintegration(European Commission); UK NIHR(National Institute for Health Research (NIHR)); Comprehensive Local Research Network (CLRN); The Big Lottery Fund; Wolfson Trust; Epilepsy Society; UK Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Brainwave-the Irish Epilepsy Association; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme pour la Recherche Medicale at the Universite Libre de Bruxelles; MRC Sudden Death Brain and Tissue Bank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sun Health Research Institute Brain Bank; Netherlands Organization for Health Research and Development ZonMw(Netherlands Organization for Health Research and Development); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Some authors received commercial funding unrelated to the topic of this paper. N.J.v.d. W. received speaking fees from Eli Lilly & Company and Wyeth and served on advisory panels of Eli Lilly & Company, Pfizer, Wyeth and Servier. A. A. received an investigator-initiated unrestricted research grant from Bristol-Myers Squibb and speaker's fees from AstraZeneca, Bristol-Myers Squibb and GlaxoSmithKline. H.J.G. received external research support from the German Research Foundation, the Federal Ministry of Education and Research Germany, speaker's honoraria from Bristol-Myers Squibb, Eli Lilly & Company, Novartis, Eisai, Boehringer Ingelheim and Servier and travel funds from Janssen-Cilag, Eli Lilly & Company, Novartis, AstraZeneca, Lundbeck and the SALUS-Institute for Trend-Research and Therapy Evaluation in Mental Health. M.N. received research grants from the Federal Ministry of Education and Research, Germany, the German Research Foundation, BioRad Laboratories, Siemens AG, Zeitschrift fur Laboratoriumsmedizin, Bruker Daltronics, Abbott, Jurilab Kuopio, Roche Diagnostics, Instand and Becton Dickinson. H. V. received external research support via research grants from Hofmann La Roche, the Humboldt Foundation, the Federal Ministry of Education and Research (Germany) and the German Research Foundation. M. W. is on the following scientific advisory boards: Lilly, Araclon and Institut Catala de Neurociencies Aplicades, the Gulf War Veterans Illnesses Advisory Committee, VACO, Biogen Idec and Pfizer. M. W. received funding for consulting from Astra Zeneca, Araclon, Medivation/Pfizer, Ipsen, TauRx Therapeutics, Bayer Healthcare, Biogen Idec, Exonhit Therapeutics, SA, Servier, Synarc, Pfizer and Janssen; for travel from NeuroVigil, CHRU-Hopital Roger Salengro, Siemens, AstraZeneca, Geneva University Hospitals, Lilly, the University of California, San Diego-ADNI, Paris University, Institut Catala de Neurociencies Aplicades, the University of New Mexico School of Medicine, Ipsen, Clinical Trials on Alzheimer's Disease (CTAD), Pfizer, AD PD Meeting, Paul Sabatier University, Novartis and Tohoku University; and research support from: Merck, Avid, DoD, VA. M. W. received honoraria from PMDA/the Japanese Ministry of Health, Labour, and Welfare, Tohoku University, Neuro Vigil, Insitut Catala de Neurociencies Aplicades. M. W. owns stock options for Synarc, Elan. Organizations contributing to the Foundation for the US NIH and thus to the National Institute on Aging (NIA)-funded Alzheimer's Disease Neuroimaging Initiative included Abbott, the Alzheimer's Association, the Alzheimer's Drug Discovery Foundation, Anonymous Foundation, AstraZeneca, Bayer Healthcare, BioClinica (ADNI 2), Bristol-Myers Squibb, the Cure Alzheimer's Fund, Eisai, Elan, Gene Network Sciences, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson & Johnson, Eli Lilly & Company, Medpace, Merck, Novartis, Pfizer, Roche, Schering Plough, Synarc and Wyeth.; ADNI: The ADNI study was supported by the US NIH (U01 AG024904) and the Foundation for the NIH for genotype and phenotype data collection, the NIH (RC2 AG036535-01) for data analysis, the NIA (R01 AG019771-09) for additional data analysis and NCRAD (U24AG021886) for DNA used in part for the GWAS. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (see URLs). As such, the investigators within ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. The ADNI sample wishes to acknowledge the investigators who contributed to the design and implementation of ADNI (see URLs). Data collection and sharing for this project were funded by ADNI (NIH grant U01 AG024904). ADNI is funded by the NIA, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and through generous contributions from Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson & Johnson, Eli Lilly & Company, Medpace, Merck and Cocpany, Novartis AG, Pfizer, F. Hoffman-La Roche, Schering-Plough and Synarc, as well as from nonprofit partners at the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation, with participation from the US Food and Drug Administration (FDA). Private sector contributions to ADNI are facilitated by the Foundation for the NIH (see URLs). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants (P30 AG010129 and K01 AG030514) and by the Dana Foundation. ADNI was launched in 2003 by the NIA, the NIBIB, the FDA, private pharmaceutical companies and nonprofit organizations as a 5-year public-private partnership. The primary goal of ADNI has been to test whether serial MRI), positron emission tomography (PET), other biological markers and clinical and neuropsychological assessments can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease. Determination of sensitive and specific markers of very early Alzheimer's disease progression is intended to aid researchers and clinicians in developing new treatments and monitoring their effectiveness, as well as lessening the time and cost of clinical trials. The Principal Investigator of this initiative is M. W. Weiner. ADNI is the result of efforts of many coinvestigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the United States and Canada. The initial goal of ADNI was to recruit 800 adults ages 55 to 90 to participate in the research-approximately 200 cognitively normal older individuals to be followed for 3 years, 400 people with MCI to be followed for 3 years and 200 people with early Alzheimer's disease to be followed for 2 years. For up-to-date information, please visit the ADNI website (see URLs).; BIG: The BIG study wishes to acknowledge S. Kooijman for coordination of sample collection and A. Heister, M. Naber, R. Makkinje, M. Hakobjan and M. Steehouwer for genotyping. The BIG study was supported by a Biobanking and Biomolecular Resources Research Infrastructure Netherlands (BBMRI-NL) complementation grant for brain segmentation and the Netherlands Organisation for Scientific Research (NWO) Horizon Breakthrough grant (grant number 93511010 (to A. A. V.).; Bipolar Family Study: The Bipolar Family Study wishes to thank the Scottish Mental Health Research Network for research assistant support, the Brain Research Imaging Centre Edinburgh (see URLs), a center in the Scottish Funding Council Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration (see URLs), for image acquisition and the Wellcome Trust Clinical Research Facility for genotyping. Genotyping was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award (to A. M. M.), and data collection was supported by the Health Foundation Clinician Scientist Fellowship.; fBIRN: fBIRN wishes to acknowledge D. B. Keator for leading fBIRN neuroinformatics development, B. A. Mueller for image calibration and quality assurance and A. Belger, V. D. Calhoun, G. G. Brown, J. M. Ford, G. H. Glover, R. Kikinis, K. Lim, J. Laurriello, J. Bustillo, G. McCarthy, D. S. O'Leary, B. Rosen, A. W. T. and J. T. Voyvodic for their leadership contributions to fBIRN scanner and sequence calibration, tool development and data collection efforts. The fBIRN study was supported by the US NIH (U24 RR21992) for phenotypic data collection. Genotyping was performed with the support of the grant RBIN04SWHR to F. M. from the Italian Ministry of University and Research.; GOBS: The GOBS study was supported by the US NIH (MH0708143 and MH083824 to D. C. G., MH078111 and MH59490 to J. B., C06 RR13556 and C06 RR017515). P. K. was also supported by an NIH grant (EB006395).; IMAGEN: IMAGEN is funded by the European Commission Framework Programme 6 (FP-6) Integrated Project IMAGEN (PL037286), the European Commission Framework Programme 7 (FP-7) Project Alzheimer's Disease, Alcoholism, Memory, Schizophrenia (ADAMS), the FP-7 Innovative Medicine Initiative Project European Autism Interventions (AIMS), the UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre Mental Health program and the MRC programme grant Developmental Pathways into Adolescent Substance Abuse (93558).; ImaGene: ImaGene wishes to acknowledge J. Lee and J. Lane for processing the blood samples, The Easton Consortium for Alzheimer's Disease Drug Discovery and Biomarker Development and the Alzheimer's Disease Research Center (ADRC) funded by the NIA at the University of California, Los Angeles (AG16570).; LBC1936: We thank the participants in LBC1936. We thank C. Murray, A. J. Gow, S. E. Harris, M. Luciano, P. Redmond, E. Sandeman, I. Gerrish, J. Boyd-Ellison, N. Leslie, A. Howden and C. Scott for data collection and preparation. This project is funded by the Age UK's Disconnected Mind programme and also by Research Into Ageing (251 and 285). The entire genome association part of the study was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F019394/1). Analysis of brain images was funded by UK MRC grants (G1001401 and 8200). The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/ 84698). Imaging was performed at the Brain Research Imaging Centre, Edinburgh, a center in the SINAPSE Collaboration. Funding from BBSRC, the Engineering and Physical Sciences Research Council (EPSRC), the Economic and Social Research Council (ESRC) and the MRC and Scottish Funding Council through the SINAPSE Collaboration is gratefully acknowledged. L. M. L. is the beneficiary of a postdoctoral grant from the AXA Research Fund.; MooDS: This work was funded by the German Federal Ministry of Education and Research (BMBF) in the National Genome Research Network (NGFN-plus) through the MooDs grant Molecular Causes of Major Mood Disorders and Schizophrenia (coordinator M. M. N.). Additional funding for genotyping was provided by a NARSAD Distinguished Investigator award to A. M.-L.; MPIP: The MPIP Munich Morphometry Sample comprises images acquired as part of the Munich Antidepressant Response Signature Study and the Recurrent Unipolar Depression (RUD) Case-Control Study performed at the MPIP and control subjects acquired at the Department of Psychiatry at the Ludwig-Maximilians-University. We wish to acknowledge A. Olynyik and radiographers R. Schirmer, E. Schreiter and R. Borschke for image acquisition and data preparation. We thank D. P. Auer for local study management in the initial phase of the RUD study. We are grateful to GlaxoSmithKline for providing the genotypes of the RUD Case-Control Sample. We thank the staff of the Center of Applied Genotyping (CAGT) for generating the genotypes of the MARS cohort. The study is supported by a grant from the Exzellenz-Stiftung of the Max Planck Society. This work has also been funded by the BMBF in the framework of the National Genome Research Network (NGFN) (FKZ 01GS0481).; NCNG: We would like to thank the personnel involved in recruitment and data collection and, in particular, P. Due-Tonnessen for clinical assessment of the MRI images. The NCNG study was supported by Research Council of Norway grants (154313/ V50 and 177458/V50). The NCNG GWAS was financed by grants from the Bergen Research Foundation, the University of Bergen, the Research Council of Norway (FUGE; Psykisk Helse), Helse Vest Regionalt Helseforetak (RHF) and the Dr Einar Martens Fund.; NESDA-NTR: Funding was obtained from the NWO (MagW/ZonMW 904-61-090; 985-10-002; 904-61-193; 480-04-004; 400-05-717, Addiction-31160008; 911-09-032; SPI 56-464-14192 and Geestkracht Program, 10-000-1002), the Center for Medical Systems Biology (CMSB; NWO Genomics), NBIC/BioAssist/RK/2008.024, BBMRI-NL, Biobanking and Biomolecular Resources Research Infrastructure, the VU University, the EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, the European Science Foundation (EU/QLRT-2001-01254), the European Community's FP7 (HEALTH-F4-2007-201413), the European Science Council (ERC) Genetics of Mental Illness (230374), Rutgers University Cell and DNA Repository (cooperative agreement NIMH U24 MH068457-06), the US NIH (R01D0042157-01A) and the Genetic Association Information Network (a public-private partnership between the NIH and Pfizer, Affymetrix and Abbott Laboratories).; NIMH-IRP: This study was supported by funding from the Intramural Research Program of the National Institute of Mental Health (NIMH) from the NIH and the US Department of Health and Human Services (K99 MH085098 to G. L., 1ZIA MH002810 to F. J. M. and 1ZIA MH002790 to W. C. D.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.; QTIM: We are extremely grateful to the twins for their participation, the radiographers at the Centre for Advanced Imaging at the University of Queensland for image acquisition and the many research assistants and support staff at the Queensland Institute of Medical Research for twin recruitment and daily management, and we especially thank K. Johnson for MRI scanning and processing, A. Henders for DNA processing and preparation and S. Gordon for quality control and management of the genotypes. Phenotyping was funded by the US National Institute of Child Health and Human Development (R01 HD050735) and the Australian National Health and Medical Research Council (NHMRC) (project grant 496682). Genotyping was funded by the NHMRC (Medical Bioinformatics Genomics Proteomics Program, 389891). G. M. was supported by an NHMRC Fellowship (613667), and G.Z. was supported by Australian Research Council (ARC) Future Fellowship (FT0991634). S. E. M. is funded by an ARC Future Fellowship (FT110100548). J.L.S. was supported by the Achievement Rewards for College Scientists foundation and the US NIMH (F31 MH087061). D. P. H. is partially supported by a National Science Foundation (NSF) Graduate Research Fellowhip Program (GRFP) grant (DGE-0707424). P. T. was also supported by the NIH (grants U01 AG024904, AG040060, EB008432, P41 RR013642, HD050735, AG036535, AG020098 and EB008281).; SYS: The Saguenay Youth Study Group wishes to thank the following individuals for their contribution in acquiring and analyzing the data: N. Arbour, M.-E. Bouchard, A. Houde, A. Gauthier and H. Simard for the recruitment and assessment of participating families, M. Berube, S. Masson, S. Castonguay and M.-J. Morin for MRI acquisition and E. Ding and N. Qiu for MR data management. We thank J. Mathieu for the medical follow up of participants in whom we detected any medically relevant abnormalities. We are grateful to all families for participating in the study. The Saguenay Youth Study Group is supported by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Quebec and the Canadian Foundation for Innovation. For more information, please see the study website (see URLs).; SHIP: The Study of Health in Pomerania (SHIP) is supported by the German Federal Ministry of Education and Research (grants 01ZZ9603, 01ZZ0103 and 01ZZ0403) and the German Research Foundation (DFG; GR 1912/5-1). Genome-wide data and MRI scans were supported by the Federal Ministry of Education and Research (grant 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the Center of Knowledge Interchange program of the Siemens AG. We thank all staff members and participants of the SHIP study, as well as all of the genotyping staff for generating the SHIP SNP data set. The genetic data analysis workflow was created using the Software InforSense. Genetic data were stored using the database Cache (InterSystems).; SHIP-TREND: The authors from SHIP are grateful to M. Stanke for the opportunity to use his Server Cluster for SNP Imputation. This cohort is part of the Community Medicine Research net (CMR) of the University of Greifswald, which is funded by the German Federal Ministry of Education and Research and the German Ministry of Cultural Affairs, as well as by the Social Ministry of the Federal State of Mecklenburg-West Pomerania. CMR encompasses several research projects that share data from the population-based Study of Health in Pomerania (SHIP; see URLs). The work is also supported by the German Research Foundation (DFG; GR 1912/5-1) and the Greifswald Approach to Individualized Medicine (GANI_MED) network funded by the Federal Ministry of Education and Research (grant 03IS2061A). Genome-wide data and MRI scans were supported by the Federal Ministry of Education and Research (grant 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the Center of Knowledge Interchange program of the Siemens AG.; Superstruct: We thank the investigators and participants who contributed to the brain genomics data collection for Superstruct at Massachusetts General Hospital and Harvard University, with funding from the Simons Foundation, the Howard Hughes Medical Institute and the US NIH (grant MH079799).; TOP: We thank the study participants of TOP and the personnel involved in data collection and logistics, especially T. D. Bjella. This work was supported by the Oslo University Hospital-Ulleval, the Eastern Norway Health Authority (2004-123), the Research Council of Norway (167153/V50, 163070/V50 and 183782/V50), and by Eli Lilly & Company (who covered part of the genotyping costs).; TCD: We wish to express our sincere thanks to all participants and to clinical staff who facilitated patients' involvement. In particular, we acknowledge colleagues from the Trinity College Institute of Neuroscience A. Bodke, J. McGrath, F. Newell, H. Garavan, and J. O'Doherty for their support in sample collection. Collection and analysis of these samples were funded by the Wellcome Trust (072894/z/03/z-Gill) and the Science Foundation Ireland (08/IN.1/B1916_Corvin).; EPIGEN: Work from the London Cohort was supported by research grants from the Wellcome Trust (grant 084730 to S. M. S.), University College London (UCL)/University College London Hospitals (UCLH) Comprehensive Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC) (grant 114 to S. M. S.), the European Union Marie Curie Reintegration (to M. Matarin and S. M. S.), the UK NIHR (08-08-SCC), the Comprehensive Local Research Network (CLRN) Flexibility and Sustainability Funding (FSF) (grant CEL1300 to S. M. S.), The Big Lottery Fund, the Wolfson Trust and the Epilepsy Society. This work was undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. Work from the Royal College of Surgeons in Ireland was supported by research grants from the Science Foundation Ireland (Research Frontiers Programme award 08/RFP/GEN1538) and Brainwave-the Irish Epilepsy Association. The collection of Belgian subjects was supported by the Fonds National de la Recherche Scientifique (grant FC 63574 / 3.4.620.06 F) and the Fonds Erasme pour la Recherche Medicale at the Universite Libre de Bruxelles.; UCL Institute of Neurology Control Brain Tissue Collection: Funding was provided by the UK MRC (grant G0901254), the MRC Sudden Death Brain and Tissue Bank and the Sun Health Research Institute Brain Bank.; UMCU: The UMCU study was supported by the Netherlands Organization for Health Research and Development ZonMw (917.46.370 to H. E. H.) and the US NIMH (MH078075 to R.A.O.).	Allen AS, 2006, GENET EPIDEMIOL, V30, P248, DOI 10.1002/gepi.20141; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bao Y, 2009, GENE EXPR PATTERNS, V9, P273, DOI 10.1016/j.gep.2009.03.004; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dick DM, 2011, MOL PSYCHIATR, V16, P800, DOI 10.1038/mp.2010.73; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Fears SC, 2009, J NEUROSCI, V29, P2867, DOI 10.1523/JNEUROSCI.5153-08.2009; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Freitag CM, 2009, BIOL PSYCHIAT, V66, P316, DOI 10.1016/j.biopsych.2009.03.011; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Jackson DN, 1984, MAB MULTIDIMENSIONAL; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kasperaviciute D, 2010, BRAIN, V133, P2136, DOI 10.1093/brain/awq130; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Levay K, 2010, EXP CELL RES, V316, P1254, DOI 10.1016/j.yexcr.2010.01.007; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li MX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014480; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Morra JH, 2008, NEUROIMAGE, V43, P59, DOI 10.1016/j.neuroimage.2008.07.003; Pantel J, 2000, HIPPOCAMPUS, V10, P752, DOI 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rogers J, 2010, NEUROIMAGE, V53, P1103, DOI 10.1016/j.neuroimage.2010.02.020; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Stein JL, 2011, MOL PSYCHIATR, V16, P927, DOI 10.1038/mp.2011.32; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	68	462	469	2	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					552	+		10.1038/ng.2250	http://dx.doi.org/10.1038/ng.2250			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22504417	Green Published, Green Accepted			2022-12-17	WOS:000303416300016
J	Tomlinson, IPM; Webb, E; Carvajal-Carmona, L; Broderick, P; Howarth, K; Pittman, AM; Spain, S; Lubbe, S; Walther, A; Sullivan, K; Jaeger, E; Fielding, S; Rowan, A; Vijayakrishnan, J; Domingo, E; Chandler, I; Kemp, Z; Qureshi, M; Farrington, SM; Tenesa, A; Prendergast, JGD; Barnetson, RA; Penegar, S; Barclay, E; Wood, W; Martin, L; Gorman, M; Thomas, H; Peto, J; Bishop, DT; Gray, R; Maher, ER; Lucassen, A; Kerr, D; Evans, DGR; Schafmayer, C; Buch, S; Volzke, H; Hampe, J; Schreiber, S; John, U; Koessler, T; Pharoah, P; van Wezel, T; Morreau, H; Wijnen, JT; Hopper, JL; Southey, MC; Giles, GG; Severi, G; Castellvi-Bel, S; Ruiz-Ponte, C; Carracedo, A; Castells, A; Forsti, A; Hemminki, K; Vodicka, P; Naccarati, A; Lipton, L; Ho, JWC; Cheng, KK; Sham, PC; Luk, J; Agundez, JAG; Ladero, JM; de la Hoya, M; Caldes, T; Niittymaeki, I; Tuupanen, S; Karhu, A; Aaltonen, L; Cazier, JB; Campbell, H; Dunlop, MG; Houlston, RS				Tomlinson, Ian P. M.; Webb, Emily; Carvajal-Carmona, Luis; Broderick, Peter; Howarth, Kimberley; Pittman, Alan M.; Spain, Sarah; Lubbe, Steven; Walther, Axel; Sullivan, Kate; Jaeger, Emma; Fielding, Sarah; Rowan, Andrew; Vijayakrishnan, Jayaram; Domingo, Enric; Chandler, Ian; Kemp, Zoe; Qureshi, Mobshra; Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Penegar, Steven; Barclay, Ella; Wood, Wendy; Martin, Lynn; Gorman, Maggie; Thomas, Huw; Peto, Julian; Bishop, D. Timothy; Gray, Richard; Maher, Eamonn R.; Lucassen, Anneke; Kerr, David; Evans, D. Gareth R.; Schafmayer, Clemens; Buch, Stephan; Voelzke, Henry; Hampe, Jochen; Schreiber, Stefan; John, Ulrich; Koessler, Thibaud; Pharoah, Paul; van Wezel, Tom; Morreau, Hans; Wijnen, Juul T.; Hopper, John L.; Southey, Melissa C.; Giles, Graham G.; Severi, Gianluca; Castellvi-Bel, Sergi; Ruiz-Ponte, Clara; Carracedo, Angel; Castells, Antoni; Foersti, Asta; Hemminki, Kari; Vodicka, Pavel; Naccarati, Alessio; Lipton, Lara; Ho, Judy W. C.; Cheng, K. K.; Sham, Pak C.; Luk, J.; Agundez, Jose A. G.; Ladero, Jose M.; de la Hoya, Miguel; Caldes, Trinidad; Niittymaeki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri; Cazier, Jean-Baptiste; Campbell, Harry; Dunlop, Malcolm G.; Houlston, Richard S.		CORGI Consortium; EPICOLON Consortium	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3	NATURE GENETICS			English	Article							PROSTATE-CANCER; BREAST-CANCER; RISK; METAANALYSIS; VARIANT; EIF3S3; TUMORS; GENES; SCAN	To identify colorectal cancer (CRC) susceptibility alleles, we conducted a genome-wide association study. In phase 1, we genotyped 550,163 tagSNPs in 940 familial colorectal tumor cases (627 CRC, 313 high-risk adenoma) and 965 controls. In phase 2, we genotyped 42,708 selected SNPs in 2,873 CRC cases and 2,871 controls. In phase 3, we evaluated 11 SNPs showing association at P < 10(-4) in a joint analysis of phases 1 and 2 in 4,287 CRC cases and 3,743 controls. Two SNPs were taken forward to phase 4 genotyping ( 10,731 CRC cases and 10,961 controls from eight centers). In addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P=2.5 x 10(-13) overall; P=6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P=3.3 x 10(-18) overall; P=9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H. These data provide further evidence for the 'common-disease common-variant' model of CRC predisposition.	[Tomlinson, Ian P. M.; Carvajal-Carmona, Luis; Howarth, Kimberley; Spain, Sarah; Walther, Axel; Jaeger, Emma; Rowan, Andrew; Domingo, Enric; Kemp, Zoe; Barclay, Ella; Martin, Lynn; Gorman, Maggie] London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Pittman, Alan M.; Lubbe, Steven; Sullivan, Kate; Fielding, Sarah; Vijayakrishnan, Jayaram; Chandler, Ian; Qureshi, Mobshra; Penegar, Steven; Wood, Wendy; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Edinburgh, Colon Canc Genet Grp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Dunlop, Malcolm G.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Martin, Lynn; Evans, D. Gareth R.; Dunlop, Malcolm G.] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Martin, Lynn; Maher, Eamonn R.] Univ Birmingham, Sch Med, Dept Med & Mol Genet, Birmingham B15 2TG, W Midlands, England; [Martin, Lynn; Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Thomas, Huw] St Marks Hosp, Family Canc Clin, Harrow HA1 3UJ, Middx, England; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; [Peto, Julian] Inst Canc Res, Canc Res UK Epidemiol & Genet Unit, Sutton SM2 5NG, Surrey, England; [Bishop, D. Timothy] Univ Leeds, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Gray, Richard] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TA, W Midlands, England; [Lucassen, Anneke] Univ Southampton, Southampton SO16 5YA, Hants, England; [Lucassen, Anneke] Princess Anne Hosp, Wessex Clib Genet Serv, Southampton SO16 5YA, Hants, England; [Kerr, David] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schafmayer, Clemens; Schreiber, Stefan] Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; [Voelzke, Henry; John, Ulrich] Ernst Moritz Arndt Univ Greifswald, Univ Hosp, SHIP Biobank, D-17487 Greifswald, Germany; [Voelzke, Henry; John, Ulrich] Ernst Moritz Arndt Univ Greifswald, Univ Hosp, Dept Community Med, D-17487 Greifswald, Germany; [Buch, Stephan; Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Buch, Stephan; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wijnen, Juul T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2333 ZA Leiden, Netherlands; [Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3053, Australia; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Parkville, Vic 3052, Australia; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; [Castellvi-Bel, Sergi; Castells, Antoni] IDIBAPS, Dept Gastroenterol, Inst Malalties Digest & Metab, Hosp Clin,CIBER EHD, Barcelona, Catalonia, Spain; [Ruiz-Ponte, Clara; Carracedo, Angel] CeGen USC, CIBERER, Genom Med Grp, FPGMX,Spanish Natl Genotyping Ctr,Hosp Clin, Santiago De Compostela, Galicia, Spain; [Foersti, Asta; Hemminki, Kari] DKFZ, Div Mol Genet Epidemiol, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Foersti, Asta; Hemminki, Kari] Karolinska Inst, Ctr Family & Community Med, S-14183 Huddinge, Sweden; [Vodicka, Pavel; Naccarati, Alessio] Acad Sci Czech Republic, Inst Expt Med, Prague 14200, Czech Republic; [Lipton, Lara] Western Hosp, Dept Med Oncol & Clin Haematol, Footscray, Vic 3011, Australia; [Ho, Judy W. C.; Cheng, K. K.; Sham, Pak C.; Luk, J.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Sch Med, Badajoz, Spain; [Ladero, Jose M.] San Carlos Univ Hosp, Serv Gastroenterol, Madrid, Spain; [de la Hoya, Miguel; Caldes, Trinidad] Hosp San Carlos, Mol Oncol Lab, Madrid 28040, Spain; [Niittymaeki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki, Finland; [Cazier, Jean-Baptiste] London Res Inst, London WC2A 3PX, England; [Campbell, Harry] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Koessler, Thibaud; Pharoah, Paul] Univ Cambridge, Can Res United Kingdom Dept Oncol, Strangeways Res Lab, Cambridge CB1 8RN, England; [van Wezel, Tom; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands	University of London; Institute of Cancer Research - UK; University of Edinburgh; University of Edinburgh; University of Manchester; University of Birmingham; Birmingham Women's Hospital; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; University of Leeds; University of Birmingham; University of Southampton; Radcliffe Infirmary; University of Oxford; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Melbourne; University of Melbourne; Cancer Council Victoria; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Western Hospital; University of Hong Kong; Universidad de Extremadura; Hospital Clinico San Carlos; Hospital Clinico San Carlos; University of Helsinki; University of Edinburgh; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Tomlinson, IPM (corresponding author), London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England.	ian.tomlinson@cancer.org.uk; richard.houlston@icr.ac.uk	Luk, John/A-4085-2008; Agúndez, José A. G./A-5503-2008; Pittman, Alan M/D-6231-2012; Buch, Stephan/AAV-5028-2021; Cazier, Jean-Baptiste/GLR-2949-2022; Cazier, Jean-Baptiste/F-2369-2010; Kössler, Thibaud/AAZ-9734-2020; Sham, Pak Chung/C-4388-2009; Castells, Antoni/ABC-1002-2021; MAHER, EAMONN R/A-9507-2008; Vodicka, Pavel/H-3370-2014; Domingo, Enric/A-9099-2018; van Wezel, Tom/Z-3092-2019; Dunlop, Malcolm G/F-1973-2011; van Wezel, Tom/A-9599-2008; Ruiz-Ponte, Clara/I-3849-2015; Farrington, Susan M/Q-2710-2019; Farrington, Susan M/C-7319-2013; Severi, Gianluca/H-3774-2018; Pittman, Alan/AAP-2534-2020; Pharoah, Paul/V-6658-2019; van Wezel, Tom/AAL-5626-2021; Aaltonen, Lauri/A-5375-2010; Cheng, King Yip/C-4551-2009; Severi, Gianluca/Q-1824-2019; Carracedo, Angel/D-4257-2012; Campbell, Harry/E-2959-2010; Lubbe, Steven/L-8261-2013; Hampe, Jochen/A-2555-2010; Evans, D Gareth/AAB-4308-2022; Carvajal-Carmona, Luis G/B-3882-2010; de la Hoya, MIguel/Z-2911-2019; Spain, Sarah/G-1968-2010; Lucassen, Anneke/D-7764-2017	Luk, John/0000-0002-6323-7940; Agúndez, José A. G./0000-0001-6895-9160; Pittman, Alan M/0000-0002-8112-2987; Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Castells, Antoni/0000-0001-8431-2033; MAHER, EAMONN R/0000-0002-6226-6918; Domingo, Enric/0000-0003-4390-8767; van Wezel, Tom/0000-0001-5773-7730; Dunlop, Malcolm G/0000-0002-3033-5851; van Wezel, Tom/0000-0001-5773-7730; Ruiz-Ponte, Clara/0000-0002-2200-0162; Farrington, Susan M/0000-0001-5955-7389; Severi, Gianluca/0000-0001-7157-419X; Pittman, Alan/0000-0002-8112-2987; Pharoah, Paul/0000-0001-8494-732X; Aaltonen, Lauri/0000-0001-6839-4286; Severi, Gianluca/0000-0001-7157-419X; Carracedo, Angel/0000-0003-1085-8986; Campbell, Harry/0000-0002-6169-6262; Lubbe, Steven/0000-0002-7103-6671; Hampe, Jochen/0000-0002-2421-6127; Evans, D Gareth/0000-0002-8482-5784; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Kossler, Thibaud/0000-0001-9196-9076; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Bishop, Tim/0000-0002-8752-8785; Tenesa, Albert/0000-0003-4884-4475; Spain, Sarah/0000-0002-7591-8364; Penegar, Steven/0000-0002-3768-0236; Castellvi-Bel, Sergi/0000-0003-1217-5097; Giles, Graham/0000-0003-4946-9099; Lucassen, Anneke/0000-0003-3324-4338; de la Hoya, Miguel/0000-0002-8113-1410; John, Ulrich/0000-0003-0587-5298; Houlston, Richard/0000-0002-5268-0242; Gray, Richard/0000-0003-4440-574X; Southey, Melissa/0000-0002-6313-9005; Webb, Emily/0000-0002-4019-7456; Karhu, Auli/0000-0002-7927-0796; Wood, Wendy/0000-0001-9062-4455; Vodicka, Pavel/0000-0003-2376-1243; Prendergast, James/0000-0001-8916-018X; Broderick, Peter/0000-0002-8348-5829; Naccarati, Alessio/0000-0001-5774-0905	MRC [MC_U127527198, G0301096] Funding Source: UKRI; Cancer Research UK [C348/A3758, A8896, C48/A6361] Funding Source: Medline; Medical Research Council [G0000657-53203, MC_U127527198, G0301096] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Boland CR, 1998, CANCER RES, V58, P5248; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 2003, HUM GENET, V112, P434, DOI 10.1007/s00439-002-0902-4; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; PETITTI D, 1994, META ANAL DECISION A; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Shima H, 2005, PATHOBIOLOGY, V72, P220, DOI 10.1159/000086792; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; World Heath Organization, 1977, INT CLASS DIS 1975 R; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	22	462	472	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					623	630		10.1038/ng.111	http://dx.doi.org/10.1038/ng.111			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372905				2022-12-17	WOS:000255366700031
J	Gretarsdottir, S; Thorleifsson, G; Reynisdottir, ST; Manolescu, A; Jonsdottir, S; Jonsdottir, T; Gudmundsdottir, T; Bjarnadottir, SM; Einarsson, OB; Gudjonsdottir, HM; Hawkins, M; Gudmundsson, G; Gudmundsdottir, H; Andrason, H; Gudmundsdottir, AS; Sigurdardottir, M; Chou, TT; Nahmias, J; Goss, S; Sveinbjornsdottir, S; Valdimarsson, EM; Jakobsson, F; Agnarsson, U; Gudnason, V; Thorgeirsson, G; Fingerle, J; Gurney, M; Gudbjartsson, D; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR				Gretarsdottir, S; Thorleifsson, G; Reynisdottir, ST; Manolescu, A; Jonsdottir, S; Jonsdottir, T; Gudmundsdottir, T; Bjarnadottir, SM; Einarsson, OB; Gudjonsdottir, HM; Hawkins, M; Gudmundsson, G; Gudmundsdottir, H; Andrason, H; Gudmundsdottir, AS; Sigurdardottir, M; Chou, TT; Nahmias, J; Goss, S; Sveinbjornsdottir, S; Valdimarsson, EM; Jakobsson, F; Agnarsson, U; Gudnason, V; Thorgeirsson, G; Fingerle, J; Gurney, M; Gudbjartsson, D; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR			The gene encoding phosphodiesterase 4D confers risk of ischemic stroke	NATURE GENETICS			English	Article							SMOOTH-MUSCLE CELLS; DEPENDENT PROTEIN-KINASE; COORDINATED REGULATION; PDE4D ACTIVITY; IN-VIVO; CAMP; ACTIVATION; PROLIFERATION; MUTATIONS; PHOSPHORYLATION	We previously mapped susceptibility to stroke to chromosome 5q12. Here we finely mapped this locus and tested it for association with stroke. We found the strongest association in the gene encoding phosphodiesterase 4D (PDE4D), especially for carotid and cardiogenic stroke, the forms of stroke related to atherosclerosis. Notably, we found that haplotypes can be classified into three distinct groups: wild-type, at-risk and protective. We also observed a substantial disregulation of multiple PDE4D isoforms in affected individuals. We propose that PDE4D is involved in the pathogenesis of stroke, possibly through atherosclerosis, which is the primary pathological process underlying ischemic stroke.	deCODE Genet, IS-101 Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Reykjavik, Iceland; Iceland Heart Assoc Heart Prevent Clin, Reykjavik, Iceland; Hoffmann La Roche AG, Div Pharma, Preclin Res, Basel, Switzerland	Landspitali National University Hospital; Roche Holding	Gretarsdottir, S (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.		Manolescu, Andrei/G-4565-2014; Gudnason, Vilmundur/AAE-7126-2019; Stefansson, Kari/AAE-7187-2019; Gudnason, Vilmundur/K-6885-2015	Manolescu, Andrei/0000-0002-0713-4664; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Gudbjartsson, Daniel/0000-0002-5222-9857				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; ALBERTS MJ, 1999, GENETICS CEREBROVASC; Baillie G, 2001, MOL PHARMACOL, V60, P1100, DOI 10.1124/mol.60.5.1100; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; BRASS LM, 1995, BAILLIERE CLIN NEUR, V4, P221; Caplan LR., 2000, CAPLANS STROKE CLIN, V3rd ed., P34; Chen XN, 1997, P NATL ACAD SCI USA, V94, P10756, DOI 10.1073/pnas.94.20.10756; DEMPSTER AB, 1971, J MOL SPECTROSC, V39, P1, DOI 10.1016/0022-2852(71)90269-4; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Fukumoto S, 1999, CIRC RES, V85, P985; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Indolfi C, 2000, J AM COLL CARDIOL, V36, P288, DOI 10.1016/S0735-1097(00)00679-3; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Landells LJ, 2001, BRIT J PHARMACOL, V133, P722, DOI 10.1038/sj.bjp.0704120; Le Jeune IR, 2002, J BIOL CHEM, V277, P35980, DOI 10.1074/jbc.M204832200; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEWONTIN RC, 1964, GENETICS, V49, P49; Leys D, 2002, J NEUROL, V249, P507, DOI 10.1007/s004150200057; Liu HG, 2000, J BIOL CHEM, V275, P26615, DOI 10.1074/jbc.M001634200; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; OGAWA S, 1992, AM J PHYSIOL, V262, pC546, DOI 10.1152/ajpcell.1992.262.3.C546; Palmer D, 1998, CIRC RES, V82, P852; PALSDOTTIR A, 1988, LANCET, V2, P603; PAN XL, 1994, BIOCHEM PHARMACOL, V48, P827, DOI 10.1016/0006-2952(94)90062-0; RICE JA, 1995, MATH STAT DATA ANAL, P308; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Vicini E, 1997, MOL ENDOCRINOL, V11, P839, DOI 10.1210/me.11.7.839	42	462	511	1	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					131	138		10.1038/ng1245	http://dx.doi.org/10.1038/ng1245			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	14517540				2022-12-17	WOS:000185625300009
J	Hernandez, PA; Gorlin, RJ; Lukens, JN; Taniuchi, S; Bohinjec, J; Francois, F; Klotman, ME; Diaz, GA				Hernandez, PA; Gorlin, RJ; Lukens, JN; Taniuchi, S; Bohinjec, J; Francois, F; Klotman, ME; Diaz, GA			Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease	NATURE GENETICS			English	Article							SEVERE CONGENITAL NEUTROPENIA; LINKAGE ANALYSIS; MYELOKATHEXIS; LYMPHOPOIESIS; MYELOPOIESIS; DISORDER; MICE; INTERNALIZATION; HEMATOPOIESIS; APOPTOSIS	WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection(1). Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis(2). The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Minnesota, Sch Dent, Dept Oral Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Dent, Dept Genet, Minneapolis, MN 55455 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Kansai Med Univ, Dept Pediat, Osaka, Japan; Univ Med Ctr, Dept Haematol, Ljubljana, Slovenia; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University; Kansai Medical University; University Medical Centre Ljubljana; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Diaz, GA (corresponding author), Mt Sinai Sch Med, Dept Human Genet, 1 Gustave L Levy Pl, New York, NY 10029 USA.		Diaz, George/AAF-6199-2021; klotman, mary e/A-1921-2016					Aprikyan AAG, 2000, BLOOD, V95, P320, DOI 10.1182/blood.V95.1.320.001k23_320_327; Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; BOHINJEC J, 1981, BLUT, V42, P191, DOI 10.1007/BF01026389; Burger JA, 2000, BLOOD, V96, P2655; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Diaz GA, 1998, GENOMICS, V54, P13, DOI 10.1006/geno.1998.5530; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hord JD, 1997, J PEDIAT HEMATOL ONC, V19, P443, DOI 10.1097/00043426-199709000-00007; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MENTZER WC, 1977, BRIT J HAEMATOL, V36, P313, DOI 10.1111/j.1365-2141.1977.tb00654.x; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Onai N, 2000, BLOOD, V96, P2074; OREGAN S, 1977, AM J DIS CHILD, V131, P655, DOI 10.1001/archpedi.1977.02120190049011; Signoret N, 1998, J CELL SCI, V111, P2819; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taniuchi S, 1999, AM J HEMATOL, V62, P106, DOI 10.1002/(SICI)1096-8652(199910)62:2<106::AID-AJH8>3.3.CO;2-4; WETZLER M, 1990, AM J MED, V89, P663, DOI 10.1016/0002-9343(90)90187-I; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; ZUELZER WW, 1964, NEW ENGL J MED, V270, P699, DOI 10.1056/NEJM196404022701402	30	461	498	2	29	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					70	74		10.1038/ng1149	http://dx.doi.org/10.1038/ng1149			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692554				2022-12-17	WOS:000182667900019
J	Patterson, SD; Aebersold, RH				Patterson, SD; Aebersold, RH			Proteomics: the first decade and beyond	NATURE GENETICS			English	Review							2-DIMENSIONAL GEL-ELECTROPHORESIS; PROTEIN INTERACTION MAP; GENE-EXPRESSION PATTERNS; CODED AFFINITY TAGS; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; ELECTROSPRAY-IONIZATION; POLYACRYLAMIDE-GELS	Proteomics is the systematic study of the many and diverse properties of proteins in a parallel manner with the aim of providing detailed descriptions of the structure, function and control of biological systems in health and disease. Advances in methods and technologies have catalyzed an expansion of the scope of biological studies from the reductionist biochemical analysis of single proteins to proteome-wide measurements. Proteomics and other complementary analysis methods are essential components of the emerging 'systems biology' approach that seeks to comprehensively describe biological systems through integration of diverse types of data and, in the future, to ultimately allow computational simulations of complex biological systems.	Celera Genom Corp, Rockville, MD 20850 USA; Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Patterson, SD (corresponding author), Farmal Biomed LLC, 129 N Hill Ave,Suite 107, Pasadena, CA 91106 USA.	scottp@farmalbiomed.com						Adam BL, 2002, CANCER RES, V62, P3609; Adam GC, 2002, NAT BIOTECHNOL, V20, P805, DOI 10.1038/nbt714; Adam GC, 2001, CHEM BIOL, V8, P81, DOI 10.1016/S1074-5521(00)90060-7; ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Aebersold R, 2000, NAT BIOTECHNOL, V18, P359, DOI 10.1038/74325; AEBERSOLD R, 1998, PROTEINS ANAL DESIGN, P3; AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; ANDERSON NG, 1982, CLIN CHEM, V28, P739; Anderson NL, 2000, CURR OPIN BIOTECH, V11, P408, DOI 10.1016/S0958-1669(00)00118-X; ANDERSON NL, 1984, CLIN CHEM, V30, P2031; Appella E, 1995, EXS, V73, P105; Bangur CS, 2002, ONCOGENE, V21, P3814, DOI 10.1038/sj.onc.1205480; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BELEW M, 1990, J CHROMATOGR, V516, P333, DOI 10.1016/S0021-9673(01)89275-X; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bogyo M, 1998, CHEM BIOL, V5, P307, DOI 10.1016/S1074-5521(98)90169-7; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Brody EN, 1999, MOL DIAGN, V4, P381, DOI 10.1016/S1084-8592(99)80014-9; Bures EJ, 2001, PROTEOMICS, V1, P79, DOI 10.1002/1615-9861(200101)1:1<79::AID-PROT79>3.3.CO;2-#; Cagney G, 2002, NAT BIOTECHNOL, V20, P163, DOI 10.1038/nbt0202-163; Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; CHOO Y, 1995, CURR OPIN BIOTECH, V6, P431, DOI 10.1016/0958-1669(95)80073-5; Collings BA, 2002, J AM SOC MASS SPECTR, V13, P577, DOI 10.1016/S1044-0305(02)00361-6; Conrads TP, 2001, ANAL CHEM, V73, P2132, DOI 10.1021/ac001487x; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; Cravatt BF, 2000, CURR OPIN CHEM BIOL, V4, P663, DOI 10.1016/S1367-5931(00)00147-2; Davis MT, 2001, J CHROMATOGR B, V752, P281, DOI 10.1016/S0378-4347(00)00547-8; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; DELEENHEER AP, 1992, MASS SPECTROM REV, V11, P249, DOI 10.1002/mas.1280110402; Deshaies RJ, 2002, MOL CELL PROTEOMICS, V1, P3, DOI 10.1074/mcp.R100001-MCP200; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eklund M, 2002, PROTEINS, V48, P454, DOI 10.1002/prot.10169; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Futcher B, 1999, MOL CELL BIOL, V19, P7357; GARRELS JI, 1989, J BIOL CHEM, V264, P5283; GARRELS JI, 1989, J BIOL CHEM, V264, P5269; GARRELS JI, 1989, J BIOL CHEM, V264, P5299; Garrels JI, 1996, NUCLEIC ACIDS RES, V24, P46, DOI 10.1093/nar/24.1.46; Gauss C, 1999, ELECTROPHORESIS, V20, P575, DOI 10.1002/(SICI)1522-2683(19990301)20:3<575::AID-ELPS575>3.0.CO;2-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Goshe MB, 2001, ANAL CHEM, V73, P2578, DOI 10.1021/ac010081x; Gras R, 2001, CURR OPIN MOL THER, V3, P526; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greis KD, 1996, ANAL BIOCHEM, V234, P38, DOI 10.1006/abio.1996.0047; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; GUINA T, IN PRESS P NATL ACAD; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Gygi SP, 2002, J PROTEOME RES, V1, P47, DOI 10.1021/pr015509n; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HAAB BB, 2001, GENOME BIOL, V0002; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HAYES BK, 1995, ANAL BIOCHEM, V228, P115, DOI 10.1006/abio.1995.1322; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; Herbert B, 1999, ELECTROPHORESIS, V20, P660, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<660::AID-ELPS660>3.0.CO;2-Q; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holt LJ, 2000, CURR OPIN BIOTECH, V11, P445, DOI 10.1016/S0958-1669(00)00133-6; Houseman BT, 2002, TRENDS BIOTECHNOL, V20, P279, DOI 10.1016/S0167-7799(02)01984-4; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; JAMES P, 1993, BIOCHEM BIOPH RES CO, V195, P58, DOI 10.1006/bbrc.1993.2009; Jenkins RE, 2001, PROTEOMICS, V1, P13, DOI 10.1002/1615-9861(200101)1:1<13::AID-PROT13>3.3.CO;2-A; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; KLOSE J, 1975, HUMANGENETIK, V26, P231; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Krylov AS, 2001, NUCLEIC ACIDS RES, V29, P2654, DOI 10.1093/nar/29.12.2654; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; KUMAZAKI T, 1987, J BIOCHEM-TOKYO, V102, P1539, DOI 10.1093/oxfordjournals.jbchem.a122202; Lai R, 2002, CANCER, V95, P1071, DOI 10.1002/cncr.10772; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Link AJ, 1997, INT J MASS SPECTROM, V160, P303, DOI 10.1016/S0168-1176(96)04489-8; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MacBeath G, 2000, SCIENCE, V289, P1760; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; MANN M, 1994, MICROCHARACTERIZATIO, P223; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; Martin F, 1996, J MOL BIOL, V255, P86, DOI 10.1006/jmbi.1996.0008; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MCCONNELL SJ, 1995, J MOL BIOL, V250, P460, DOI 10.1006/jmbi.1995.0390; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Medzihradszky KF, 2000, ANAL CHEM, V72, P552, DOI 10.1021/ac990809y; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Mirgorodskaya OA, 2000, RAPID COMMUN MASS SP, V14, P1226, DOI 10.1002/1097-0231(20000730)14:14<1226::AID-RCM14>3.0.CO;2-V; Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225; Munchbach M, 2000, ANAL CHEM, V72, P4047, DOI 10.1021/ac000265w; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; NORD K, 1995, PROTEIN ENG, V8, P601, DOI 10.1093/protein/8.6.601; NUWAYSIR LM, 1993, J AM SOC MASS SPECTR, V4, P662, DOI 10.1016/1044-0305(93)85031-R; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Patterson SD, 2000, CELL DEATH DIFFER, V7, P137, DOI 10.1038/sj.cdd.4400640; PATTERSON SD, 1995, ELECTROPHORESIS, V16, P1791, DOI 10.1002/elps.11501601299; PATTERSON SD, 1998, PROTEOMICS INTEGRATI, P127; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.0.CO;2-R; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; RANISH JA, IN PRESS NAT GENET; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ritchie RF, 1999, J CLIN LAB ANAL, V13, P280, DOI 10.1002/(SICI)1098-2825(1999)13:6<280::AID-JCLA5>3.3.CO;2-L; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHEELE GA, 1975, J BIOL CHEM, V250, P5375; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Siebert R, 2001, CURR OPIN ONCOL, V13, P316, DOI 10.1097/00001622-200109000-00002; Simpson RJ, 2000, ELECTROPHORESIS, V21, P1707, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1707::AID-ELPS1707>3.3.CO;2-H; Smith RD, 2001, ELECTROPHORESIS, V22, P1652, DOI 10.1002/1522-2683(200105)22:9<1652::AID-ELPS1652>3.0.CO;2-E; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Spahr CS, 2000, ELECTROPHORESIS, V21, P1635, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1635::AID-ELPS1635>3.0.CO;2-1; Spahr CS, 2001, PROTEOMICS, V1, P93, DOI 10.1002/1615-9861(200101)1:1<93::AID-PROT93>3.0.CO;2-3; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; Tanaka K., 1987, P 2 JAP CHIN JT S MA, P185; TARROUX P, 1987, ELECTROPHORESIS, V8, P187, DOI 10.1002/elps.1150080404; TEMPST P, 1990, ELECTROPHORESIS, V11, P537, DOI 10.1002/elps.1150110704; Thornton Janet, 2001, Trends in Biochemical Sciences, V26, P88, DOI 10.1016/S0968-0004(00)01765-5; Tramontano Anna, 1994, Journal of Molecular Recognition, V7, P9, DOI 10.1002/jmr.300070103; Tsien RY, 1998, SCIENCE, V280, P1954, DOI 10.1126/science.280.5371.1954; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tucker CL, 2001, NAT BIOTECHNOL, V19, P1042, DOI 10.1038/nbt1101-1042; Tucker CL, 2001, TRENDS CELL BIOL, V11, P102, DOI 10.1016/S0962-8924(00)01902-4; Turecek F, 2002, J MASS SPECTROM, V37, P1, DOI 10.1002/jms.275; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Uttenweiler-Joseph S, 2001, PROTEOMICS, V1, P668, DOI 10.1002/1615-9861(200104)1:5<668::AID-PROT668>3.3.CO;2-J; van Berkum NL, 2001, CURR OPIN BIOTECH, V12, P48, DOI 10.1016/S0958-1669(00)00173-7; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDEKERCKHOVE J, 1985, EUR J BIOCHEM, V152, P9, DOI 10.1111/j.1432-1033.1985.tb09157.x; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walter G, 2000, CURR OPIN MICROBIOL, V3, P298, DOI 10.1016/S1369-5274(00)00093-X; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514; Yates JR, 1997, J PROTEIN CHEM, V16, P495; Zhang BL, 2000, METHOD ENZYMOL, V318, P399; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806; Zhou HH, 2001, TRENDS BIOTECHNOL, V19, pS34, DOI 10.1016/S0167-7799(01)01798-X; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777; Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	198	461	520	3	112	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			311	323		10.1038/ng1106	http://dx.doi.org/10.1038/ng1106			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610541				2022-12-17	WOS:000181390900012
J	Lewis, DL; Hagstrom, JE; Loomis, AG; Wolff, JA; Herweijer, H				Lewis, DL; Hagstrom, JE; Loomis, AG; Wolff, JA; Herweijer, H			Efficient delivery of siRNA for inhibition of gene expression in postnatal mice	NATURE GENETICS			English	Article							DOUBLE-STRANDED-RNA; DROSOPHILA CELLS; PLASMID DNA; INTERFERENCE	It has recently been shown that RNA interference can be induced in cultured mammalian cells by delivery of short interfering RNAs (siRNAs). Here we describe a method for efficient in vivo delivery of siRNAs to organs of postnatal mice and demonstrate effective and specific inhibition of transgene expression in a variety of organs.	Mirus Corp, Madison, WI 53719 USA; Univ Wisconsin, Waisman Ctr, Dept Pediat & Med Genet, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Lewis, DL (corresponding author), Mirus Corp, 505 S Rosa Rd, Madison, WI 53719 USA.							Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.3.CO;2-I; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	15	461	594	1	55	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					107	108		10.1038/ng944	http://dx.doi.org/10.1038/ng944			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12145662				2022-12-17	WOS:000177714900008
J	Behjati, S; Tarpey, PS; Presneau, N; Scheipl, S; Pillay, N; Van Loo, P; Wedge, DC; Cooke, SL; Gundem, G; Davies, H; Nik-Zainal, S; Martin, S; McLaren, S; Goodie, V; Robinson, B; Butler, A; Teague, JW; Halai, D; Khatri, B; Myklebost, O; Baumhoer, D; Jundt, G; Hamoudi, R; Tirabosco, R; Amary, MF; Futreal, PA; Stratton, MR; Campbell, PJ; Flanagan, AM				Behjati, Sam; Tarpey, Patrick S.; Presneau, Nadege; Scheipl, Susanne; Pillay, Nischalan; Van Loo, Peter; Wedge, David C.; Cooke, Susanna L.; Gundem, Gunes; Davies, Helen; Nik-Zainal, Serena; Martin, Sancha; McLaren, Stuart; Goodie, Victoria; Robinson, Ben; Butler, Adam; Teague, Jon W.; Halai, Dina; Khatri, Bhavisha; Myklebost, Ola; Baumhoer, Daniel; Jundt, Gernot; Hamoudi, Rifat; Tirabosco, Roberto; Amary, M. Fernanda; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.; Flanagan, Adrienne M.			Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone	NATURE GENETICS			English	Article							PEDIATRIC GLIOBLASTOMA; HISTONE H3.3; HUMAN REPLACEMENT; K27M MUTATION; EXPRESSION; BREAST; GENES; CANCERS; GLIOMAS	It is recognized that some mutated cancer genes contribute to the development of many cancer types, whereas others are cancer type specific. For genes that are mutated in multiple cancer classes, mutations are usually similar in the different affected cancer types. Here, however, we report exquisite tumor type specificity for different histone H3.3 driver alterations. In 73 of 77 cases of chondroblastoma (95%), we found p.Lys36Met alterations predominantly encoded in H3F3B, which is one of two genes for histone H3.3. In contrast, in 92% (49/53) of giant cell tumors of bone, we found histone H3.3 alterations exclusively in H3F3A, leading to p.Gly34Trp or, in one case, p.Gly34Leu alterations. The mutations were restricted to the stromal cell population and were not detected in osteoclasts or their precursors. In the context of previously reported H3F3A mutations encoding p.Lys27Met and p.Gly34Arg or p.Gly34Val alterations in childhood brain tumors, a remarkable picture of tumor type specificity for histone H3.3 driver alterations emerges, indicating that histone H3.3 residues, mutations and genes have distinct functions.	[Behjati, Sam; Tarpey, Patrick S.; Van Loo, Peter; Wedge, David C.; Cooke, Susanna L.; Gundem, Gunes; Davies, Helen; Nik-Zainal, Serena; Martin, Sancha; McLaren, Stuart; Goodie, Victoria; Robinson, Ben; Butler, Adam; Teague, Jon W.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge, England; [Presneau, Nadege; Scheipl, Susanne; Pillay, Nischalan; Hamoudi, Rifat; Flanagan, Adrienne M.] Univ Coll London Canc Inst, London, England; [Presneau, Nadege; Hamoudi, Rifat; Flanagan, Adrienne M.] Sarah Cannon Univ Coll London Adv Diagnost Mol Pr, London, England; [Scheipl, Susanne] Med Univ, Univ Klin Orthopadie & Orthopad Chirurg, Graz, Austria; [Pillay, Nischalan; Halai, Dina; Khatri, Bhavisha; Tirabosco, Roberto; Amary, M. Fernanda; Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp Natl Hlth Serv NHS Trus, Stanmore, Middx, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Louvain, Belgium; [Myklebost, Ola] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Tumour Biol, Oslo, Norway; [Baumhoer, Daniel; Jundt, Gernot] Univ Basel Hosp, Inst Pathol, Bone Tumour Reference Ctr, CH-4031 Basel, Switzerland; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of London; University College London; University of London; University College London; Medical University of Graz; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Oslo; University of Basel; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Flanagan, AM (corresponding author), Univ Coll London Canc Inst, London, England.	a.flanagan@ucl.ac.uk	Myklebost, Ola/E-9335-2010; Wedge, David/AAC-4977-2021; Nik-Zainal, Serena/ABD-4437-2020; Amary, Fernanda/AAI-7339-2020	Myklebost, Ola/0000-0002-2866-3223; Behjati, Sam/0000-0002-6600-7665; Wedge, David/0000-0002-7572-3196; Flanagan, Adrienne/0000-0002-2832-1303; Martin, Sancha/0000-0001-6213-5259; Van Loo, Peter/0000-0003-0292-1949; Pillay, Nischalan/0000-0003-0579-4105; Hamoudi, Rifat/0000-0002-1402-0868; Presneau, Nadege/0000-0002-2107-6691	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Skeletal Cancer Action Trust (SCAT), UK; Rosetrees Trust UK; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Centre; Norwegian Research Council [218241/H10]; Research Foundation-Flanders (FWO); Wellcome Trust; Rosetrees Trust [M23-F1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Skeletal Cancer Action Trust (SCAT), UK; Rosetrees Trust UK(Rosetrees Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Centre; Norwegian Research Council(Research Council of NorwayEuropean Commission); Research Foundation-Flanders (FWO)(FWO); Wellcome Trust(Wellcome TrustEuropean Commission); Rosetrees Trust(Rosetrees Trust)	We are grateful to the patients for participating in the research and to the clinicians and support staff involved in their care. This work was supported by funding from the Wellcome Trust (grant 077012/Z/05/Z), the Skeletal Cancer Action Trust (SCAT), UK, and the Rosetrees Trust UK. Material was obtained from the Royal National Orthopaedic Hospital Musculoskeletal Research Programme and Biobank, all of which was coordinated by D. Brooking and R. Grinnell, Biobank staff at the Royal National Orthopaedic Hospital. Support was provided to A. M. F. by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre and the Cancer Research UK University College London Experimental Cancer Centre. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant WT088340MA). O.M. is funded by the Norwegian Research Council (grant 218241/H10).; P.V.L. is a postdoctoral researcher of the Research Foundation-Flanders (FWO). S. B. is funded through the Wellcome Trust PhD Programme for Clinicians.	ALBIG W, 1995, GENOMICS, V30, P264, DOI 10.1006/geno.1995.9878; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fletcher C.D.M., 2013, PATHOLOGY GENETICS T, P427; Frank D, 2003, GENE, V312, P135, DOI 10.1016/S0378-1119(03)00609-7; Gessi M, 2013, J NEURO-ONCOL, V112, P67, DOI 10.1007/s11060-012-1040-z; Gielen GH, 2013, AM J CLIN PATHOL, V139, P345, DOI 10.1309/AJCPABOHBC33FVMO; HORTON MA, 1985, CANCER RES, V45, P5663; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; Lasky T, 1996, ENVIRON HEALTH PERSP, V104, P1324, DOI 10.2307/3432969; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LopezFernandez LA, 1997, INT J DEV BIOL, V41, P699; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tarpey PS, 2013, NAT GENET, V45, P923, DOI 10.1038/ng.2668; Taylor RM, 2012, LAB INVEST, V92, P600, DOI 10.1038/labinvest.2012.5; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wulling M, 2001, J CANCER RES CLIN, V127, P467, DOI 10.1007/s004320100234; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	27	460	471	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1479	U105		10.1038/ng.2814	http://dx.doi.org/10.1038/ng.2814			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24162739	Green Accepted			2022-12-17	WOS:000327715800015
J	Cho, YS; Chen, CH; Hu, C; Long, JR; Ong, RTH; Sim, XL; Takeuchi, F; Wu, Y; Go, MJ; Yamauchi, T; Chang, YC; Kwak, SH; Ma, RCW; Yamamoto, K; Adair, LS; Aung, T; Cai, QY; Chang, LC; Chen, YT; Gao, YT; Hu, FB; Kim, HL; Kim, S; Kim, YJ; Lee, JJM; Lee, NR; Li, Y; Liu, JJ; Lu, W; Nakamura, J; Nakashima, E; Ng, DPK; Tay, WT; Tsai, FJ; Wong, TY; Yokota, M; Zheng, W; Zhang, R; Wang, C; So, WY; Ohnaka, K; Ikegami, H; Hara, K; Cho, YM; Cho, NH; Chang, TJ; Bao, Y; Hedman, AK; Morris, AP; McCarthy, MI; Takayanagi, R; Park, KS; Jia, WP; Chuang, LM; Chan, JCN; Maeda, S; Kadowaki, T; Lee, JY; Wu, JY; Teo, YY; Tai, ES; Shu, XO; Mohlke, KL; Kato, N; Han, BG; Seielstad, M				Cho, Yoon Shin; Chen, Chien-Hsiun; Hu, Cheng; Long, Jirong; Ong, Rick Twee Hee; Sim, Xueling; Takeuchi, Fumihiko; Wu, Ying; Go, Min Jin; Yamauchi, Toshimasa; Chang, Yi-Cheng; Kwak, Soo Heon; Ma, Ronald C. W.; Yamamoto, Ken; Adair, Linda S.; Aung, Tin; Cai, Qiuyin; Chang, Li-Ching; Chen, Yuan-Tsong; Gao, Yutang; Hu, Frank B.; Kim, Hyung-Lae; Kim, Sangsoo; Kim, Young Jin; Lee, Jeannette Jen-Mai; Lee, Nanette R.; Li, Yun; Liu, Jian Jun; Lu, Wei; Nakamura, Jiro; Nakashima, Eitaro; Ng, Daniel Peng-Keat; Tay, Wan Ting; Tsai, Fuu-Jen; Wong, Tien Yin; Yokota, Mitsuhiro; Zheng, Wei; Zhang, Rong; Wang, Congrong; So, Wing Yee; Ohnaka, Keizo; Ikegami, Hiroshi; Hara, Kazuo; Cho, Young Min; Cho, Nam H.; Chang, Tien-Jyun; Bao, Yuqian; Hedman, Asa K.; Morris, Andrew P.; McCarthy, Mark I.; Takayanagi, Ryoichi; Park, Kyong Soo; Jia, Weiping; Chuang, Lee-Ming; Chan, Juliana C. N.; Maeda, Shiro; Kadowaki, Takashi; Lee, Jong-Young; Wu, Jer-Yuarn; Teo, Yik Ying; Tai, E. Shyong; Shu, Xiao Ou; Mohlke, Karen L.; Kato, Norihiro; Han, Bok-Ghee; Seielstad, Mark		DIAGRAM Consortium; MuTHER Consortium	Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; JAPANESE POPULATION; GENETIC-LOCI; VARIANTS; RISK; CHILDHOOD; MELLITUS; COMPLEX; KCNQ1	We conducted a three-stage genetic study to identify susceptibility loci for type 2 diabetes (T2D) in east Asian populations. We followed our stage 1 meta-analysis of eight T2D genome-wide association studies (6,952 cases with T2D and 11,865 controls) with a stage 2 in silico replication analysis (5,843 cases and 4,574 controls) and a stage 3 de novo replication analysis (12,284 cases and 13,172 controls). The combined analysis identified eight new T2D loci reaching genome-wide significance, which mapped in or near GLIS3, PEPD, FITM2-R3HDML-HNF4A, KCNK16, MAEA, GCC1-PAX4, PSMD6 and ZFAND3. GLIS3, which is involved in pancreatic beta cell development and insulin gene expression(1,2), is known for its association with fasting glucose levels(3,4). The evidence of an association with T2D for PEPD(5) and HNF4A(6,7) has been shown in previous studies. KCNK16 may regulate glucose-dependent insulin secretion in the pancreas. These findings, derived from an east Asian population, provide new perspectives on the etiology of T2D.	[Cho, Yoon Shin; Go, Min Jin; Kim, Hyung-Lae; Kim, Young Jin; Lee, Jong-Young] Natl Inst Hlth, Ctr Genome Sci, Gangoe Myeon, Yeonje Ri, South Korea; [Chen, Chien-Hsiun; Chang, Li-Ching; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Hu, Cheng; Wang, Congrong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200030, Peoples R China; [Long, Jirong; Shu, Xiao Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Ong, Rick Twee Hee] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Res Inst, Shinjuku Ku, Tokyo, Japan; [Wu, Ying; Li, Yun; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Yamauchi, Toshimasa; Hara, Kazuo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Chang, Yi-Cheng; Chang, Tien-Jyun; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Kwak, Soo Heon; Cho, Young Min; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Ma, Ronald C. W.; So, Wing Yee; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal,Higashi Ku, Fukuoka 812, Japan; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Aung, Tin; Tay, Wan Ting; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Gao, Yutang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA; [Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Kim, Sangsoo] Soongsil Univ, Sch Syst Biomed Sci, Seoul, South Korea; [Lee, Jeannette Jen-Mai; Ng, Daniel Peng-Keat; Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Lee, Nanette R.] Univ San Carlos, Off Populat Studies Fdn Inc, Cebu, Philippines; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Liu, Jian Jun; Teo, Yik Ying; Seielstad, Mark] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Lu, Wei] Shanghai Inst Prevent Med, Shanghai, Peoples R China; [Nakamura, Jiro; Nakashima, Eitaro] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Nakashima, Eitaro; Wong, Tien Yin] Chubu Rosai Hosp, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Ohnaka, Keizo] Kyushu Univ, Dept Geriatr Med, Grad Sch Med Sci, Higashi Ku, Fukuoka 812, Japan; [Ikegami, Hiroshi] Kinki Univ, Sch Med, Dept Endocrinol Metab & Diabet, Osaka 589, Japan; [Cho, Nam H.] Ajou Univ, Sch Med, Dept Prevent Med, Suwon 441749, South Korea; [Hedman, Asa K.; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Edocrinol & Metab, Churchill Hosp, Oxford, England; [Takayanagi, Ryoichi] Kyushu Univ, Dept Internal Med & Bioregulatory Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 812, Japan; [Park, Kyong Soo] Seoul Natl Univ, World Class Univ Program, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Maeda, Shiro] Natl Taiwan Univ, Sch Med, Grad Inst Clin Med, Taipei 10764, Taiwan; RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Seielstad, Mark] Blood Syst Res Inst, San Francisco, CA USA	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Academia Sinica - Taiwan; China Medical University Taiwan; Shanghai Jiao Tong University; Vanderbilt University; National University of Singapore; National University of Singapore; National Center for Global Health & Medicine - Japan; University of North Carolina; University of North Carolina Chapel Hill; University of Tokyo; National Taiwan University; National Taiwan University Hospital; Seoul National University (SNU); Chinese University of Hong Kong; Prince of Wales Hospital; Kyushu University; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore; Singapore National Eye Center; National University of Singapore; Shanghai Jiao Tong University; Harvard University; Harvard T.H. Chan School of Public Health; Ewha Womans University; Soongsil University; National University of Singapore; University of San Carlos; University of North Carolina; University of North Carolina Chapel Hill; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nagoya University; Centre for Eye Research Australia; University of Melbourne; Aichi Gakuin University; Kyushu University; Kindai University (Kinki University); Ajou University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Kyushu University; Seoul National University (SNU); Seoul National University (SNU); National Taiwan University; RIKEN; National University of Singapore; National University of Singapore; National University of Singapore; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute	Cho, YS (corresponding author), Natl Inst Hlth, Ctr Genome Sci, Osong Hlth Technol Adm Complex, Gangoe Myeon, Yeonje Ri, South Korea.	yooncho33@korea.kr; eshyong@pacific.net.sg; mark.seielstad@ucsf.edu	Nakamura, Jiro/L-3693-2019; Gao, Y./GWZ-3665-2022; Liu, Jianjun/AAK-4989-2020; Langenberg, Claudia/ABG-9067-2021; Park, Kyong Soo/C-2265-2008; Chuang, Lee-Ming/AAF-3324-2019; Meitinger, Thomas/O-1318-2015; Hide, Winston/R-3815-2019; Seielstad, Mark/T-7841-2019; Jia, Weiping/B-7483-2012; Roden, Michael/AAD-3843-2019; Chen, Chien Hsiun/Q-3826-2018; Benediktsson, Rafn/R-2457-2018; Rudan, Igor/I-1467-2012; Chang, Yi-cheng/O-1334-2018; Ma, Ronald/C-2788-2009; zhang, weihua/GXV-1334-2022; FROGUEL, Philippe/O-6799-2017; Hu, Cheng/C-3346-2008; Tsai, Fuu-Jen/J-4140-2015; Wong, Tien Yin/AAC-9724-2020; Gao, Yu/HGE-1937-2022; Elliott, Amanda/G-5120-2012; Ikegami, Hiroshi/AGP-9878-2022; Hide, Winston Hide/C-7217-2009; Lu, Wei/AAE-2921-2022; Cho, Young Min/J-5669-2012; Zondervan, Krina T/M-1143-2013; Lee, Jong-Young/M-6319-2013; Kwak, Soo Heon/H-1463-2011; Sim, Xueling/AAZ-6652-2020; Hide, Winston A/V-2727-2017; Tai, E Shyong/J-9831-2013; Walters, G. Bragi/L-4215-2013; Wu, Jer-Yuarn/S-7010-2018; Kim, Young-jin/GSD-3168-2022; Zheng, Wei/O-3351-2013; Boehm, Bernhard Otto/F-8750-2015; gao, yi/HCI-8298-2022; Chan, Juliana/B-7918-2016; Aulchenko, Yurii/M-8270-2013; McCarthy, Mark/M-3763-2015	Liu, Jianjun/0000-0002-3255-3019; Langenberg, Claudia/0000-0002-5017-7344; Park, Kyong Soo/0000-0003-3597-342X; Hide, Winston/0000-0002-8621-3271; Benediktsson, Rafn/0000-0002-2954-9801; Rudan, Igor/0000-0001-6993-6884; Chang, Yi-cheng/0000-0002-8077-5011; Ma, Ronald/0000-0002-1227-803X; FROGUEL, Philippe/0000-0003-2972-0784; Hu, Cheng/0000-0003-4314-2386; Wong, Tien Yin/0000-0002-8448-1264; Hide, Winston Hide/0000-0002-8621-3271; Lu, Wei/0000-0002-4150-8674; Zondervan, Krina T/0000-0002-0275-9905; Lee, Jong-Young/0000-0002-0092-9958; Kwak, Soo Heon/0000-0003-1230-0919; Sim, Xueling/0000-0002-1233-7642; Hide, Winston A/0000-0002-8621-3271; Walters, G. Bragi/0000-0002-5415-6487; Zheng, Wei/0000-0003-1226-070X; Chan, Juliana/0000-0003-1325-1194; bennett, amanda/0000-0003-2140-8710; Dina, Christian/0000-0002-7722-7348; Tai, E Shyong/0000-0003-2929-8966; Meitinger, Thomas/0000-0002-8838-8403; CHUANG, LEE-MING/0000-0003-0978-2662; Jorgensen, Torben/0000-0001-9453-2830; Hattersley, Andrew/0000-0001-5620-473X; Lindgren, Cecilia/0000-0002-4903-9374; Hammond, Christopher/0000-0002-3227-2620; CHANG, TIEN-JYUN/0000-0001-9437-5847; Aulchenko, Yurii/0000-0002-7899-1575; Bergman, Richard/0000-0003-1539-4471; Van Duijn, Cornelia/0000-0002-2374-9204; Long, Jirong/0000-0002-7433-9766; Zeggini, Eleftheria/0000-0003-4238-659X; Seielstad, Mark/0000-0001-5783-1401; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Gloyn, Anna/0000-0003-1205-1844; McCarthy, Mark/0000-0002-4393-0510; Weedon, Michael/0000-0002-6174-6135	Ministry of Education, Culture, Sports, Science and Technology Japan; National Institute of Biomedical Innovation Organization (NIBIO); Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency; National Center for Global Health and Medicine (NCGM); US National Institutes of Health [DK078150, TW05596, HL085144, TW008288, RR20649, ES10126, DK56350, R01CA124558, R01CA64277, R01CA70867, R01CA90899, R01CA100374, R01CA118229, R01CA92585, UL1 RR024975, DK58845, HG004399]; Hong Kong Government Research Grants Council [CUHK 1/04C, CUHK4724/07M]; Government of the Hong Kong Special Administrative Region [ITS/487/09FP]; Korea Centers for Disease Control and Prevention [4845-301, 4851-302, 4851-307]; Korea National Institute of Health, the Republic of Korea [2011-N73005-00]; National Science Council of Taiwan [NSC99-3112-B-002-019]; National Genotyping Center of National Research Program for Genomic Medicine, Taiwan [NSC98-3112-B-001-037]; Department of Defense [BC050791]; Vanderbilt Ingram; Allen Foundation; National 973 Program [2011CB504001]; National Natural Science Foundation of China [30800617]; Shanghai Rising-Star Program, China [09QA1404400]; National 863 Program [2006AA02A409]; Shanghai Municipality for Basic Research, China [08dj1400601]; Ministry of Health Welfare [00-PJ3-PG6-GN07-001]; Ministry of Education, Science and Technology (MEST); National Research Foundation (NRF), Korea [R31-2008-000-10103-0]; Biomedical Research Council of Singapore [BMRC05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore [NMRC/1174/2008]; National Medical Research Council [NMRC/CSA/008/2009, NMRC0796/2003, NMRC/STaR/0003/2008]; Biomedical Research Council (BMRC) [09/1/35/19/616]; Singapore National Research Foundation [NRF-RF-2010-05]; Grants-in-Aid for Scientific Research [23390247, 21390209, 24591347] Funding Source: KAKEN; MRC [G0900339] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R01TW008288, R01TW005596] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA090899, R01CA100374, R01CA070867, R01CA064277, R01CA124558, R01CA092585, R01CA148667, R01CA118229] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020649, UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, P30DK056350, R01DK078150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; Medical Research Council [MC_U106179471, G0600717B, G0900339] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation Organization (NIBIO)(National Institute of Biomedical Innovation); Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency(Core Research for Evolutional Science and Technology (CREST)); National Center for Global Health and Medicine (NCGM); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Government Research Grants Council(Hong Kong Research Grants Council); Government of the Hong Kong Special Administrative Region; Korea Centers for Disease Control and Prevention; Korea National Institute of Health, the Republic of Korea; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Genotyping Center of National Research Program for Genomic Medicine, Taiwan(Ministry of Science and Technology, Taiwan); Department of Defense(United States Department of Defense); Vanderbilt Ingram; Allen Foundation; National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program, China; National 863 Program(National High Technology Research and Development Program of China); Shanghai Municipality for Basic Research, China; Ministry of Health Welfare; Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation (NRF), Korea(National Research Foundation of Korea); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation(National Research Foundation, Singapore); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the participants and the staff of the BioBank Japan project. The project was supported by a grant from the Leading Project of Ministry of Education, Culture, Sports, Science and Technology Japan.; The Japan Cardiometabolic Genome Epidemiology (CAGE) Network Studies were supported by grants for the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation Organization (NIBIO); the Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency; the Grant of National Center for Global Health and Medicine (NCGM).; We thank the Office of Population Studies Foundation research and data collection teams for the Cebu Longitudinal Health and Nutrition Survey. This work was supported by US National Institutes of Health grants DK078150, TW05596, HL085144 and TW008288 and pilot funds from grants RR20649, ES10126, and DK56350.; We acknowledge support from the Hong Kong Government Research Grants Council Central Allocation Scheme (CUHK 1/04C), Research Grants Council Earmarked Research Grant (CUHK4724/07M) and the Innovation and Technology Fund of the Government of the Hong Kong Special Administrative Region (ITS/487/09FP). We acknowledge the Chinese University of Hong Kong Information Technology Services Center for support of computing resources. We would also like to thank the dedicated medical and nursing staff at the Prince of Wales Hospital Diabetes and Endocrine Centre.; This work was supported by grants from Korea Centers for Disease Control and Prevention (4845-301, 4851-302, 4851-307) and an intramural grant from the Korea National Institute of Health (2011-N73005-00), the Republic of Korea. The work by the National Taiwan University Hospital was supported in part by the grant (NSC99-3112-B-002-019) from the National Science Council of Taiwan. We would also like to acknowledge the National Genotyping Center of National Research Program for Genomic Medicine (NSC98-3112-B-001-037), Taiwan. The work by the Shanghai Diabetes Genetic Study was supported in part by the US National Institutes of Health grants R01CA124558, R01CA64277, R01CA70867, R01CA90899, R01CA100374, R01CA118229, R01CA92585, UL1 RR024975, DK58845 and HG004399, the Department of Defense Idea Award BC050791, Vanderbilt Ingram professorship funds and the Allen Foundation Fund. We thank the dedicated investigators and staff members from research teams at Vanderbilt University, Shanghai Cancer Institute and the Shanghai Institute of Preventive Medicine, and especially, the study participants for their contributions in the studies.; The work of the Shanghai Diabetes Study was supported by grants from the National 973 Program (2011CB504001), the Project of National Natural Science Foundation of China (30800617) and the Shanghai Rising-Star Program (09QA1404400), China.; The work of the Shanghai Jiao Tong University Diabetes Study was supported by grants from the National 863 Program (2006AA02A409) and the major program of the Shanghai Municipality for Basic Research (08dj1400601), China.; The work of the Seoul National University Hospital was supported by grants from the Korea Health 21 R&D Project, Ministry of Health & Welfare (00-PJ3-PG6-GN07-001) and the World Class University project of the Ministry of Education, Science and Technology (MEST) and National Research Foundation (NRF) (R31-2008-000-10103-0), Korea. The Singapore Prospective Study Program (SP2) was funded through grants from the Biomedical Research Council of Singapore (BMRC05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC/1174/2008). E. S. T. also receives additional support from the National Medical Research Council through a clinicians scientist award (NMRC/CSA/008/2009). The Singapore Malay Eye Study (SiMES) was funded by the National Medical Research Council (NMRC0796/2003 and NMRC/STaR/0003/2008) and Biomedical Research Council (BMRC, 09/1/35/19/616). Y.Y.T. acknowledges support from the Singapore National Research Foundation, NRF-RF-2010-05. The Genome Institute of Singapore carried out all the genotyping for the samples from Singapore also provided funding for the genotyping of the samples from SP2.	Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Jo W, 2011, TOHOKU J EXP MED, V223, P113, DOI 10.1620/tjem.223.113; Johansson S, 2007, DIABETES, V56, P3112, DOI 10.2337/db07-0513; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Luke MR, 2005, BIOCHEM J, V388, P835, DOI 10.1042/BJ20041810; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nakajima H, 1996, RES COMMUN MOL PATH, V94, P327; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; Stommel M, 2010, OBESITY, V18, P1821, DOI 10.1038/oby.2009.472; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tkac I, 2005, DIABETES RES CLIN PR, V68, pS2, DOI 10.1016/j.diabres.2005.03.002; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	36	460	483	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2012	44	1					67	U97		10.1038/ng.1019	http://dx.doi.org/10.1038/ng.1019			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158537	Green Submitted, Green Accepted			2022-12-17	WOS:000298664000016
J	Otto, EA; Schermer, B; Obara, T; O'Toole, JF; Hiller, KS; Mueller, AM; Ruf, RG; Hoefele, J; Beekmann, F; Landau, D; Foreman, JW; Goodship, JA; Strachan, T; Kispert, A; Wolf, MT; Gagnadoux, MF; Nivet, H; Antignac, C; Walz, G; Drummond, IA; Benzing, T; Hildebrandt, F				Otto, EA; Schermer, B; Obara, T; O'Toole, JF; Hiller, KS; Mueller, AM; Ruf, RG; Hoefele, J; Beekmann, F; Landau, D; Foreman, JW; Goodship, JA; Strachan, T; Kispert, A; Wolf, MT; Gagnadoux, MF; Nivet, H; Antignac, C; Walz, G; Drummond, IA; Benzing, T; Hildebrandt, F			Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; ADOLESCENT NEPHRONOPHTHISIS; CANDIDATE GENE; SITUS-INVERSUS; PROTEIN; INTERACTS; NEPHROCYSTIN; IDENTIFICATION; PROGRESSION; PATHWAY	Nephronophthisis (NPHP), an autosomal recessive cystic kidney disease, leads to chronic renal failure in children. The genes mutated in NPHP1 and NPHP4 have been identified, and a gene locus associated with infantile nephronophthisis (NPHP2) was mapped. The kidney phenotype of NPHP2 combines clinical features of NPHP and polycystic kidney disease (PKD). Here, we identify inversin (INVS) as the gene mutated in NPHP2 with and without situs inversus. We show molecular interaction of inversin with nephrocystin, the product of the gene mutated in NPHP1 and interaction of nephrocystin with beta-tubulin, a main component of primary cilia. We show that nephrocystin, inversin and beta-tubulin colocalize to primary cilia of renal tubular cells. Furthermore, we produce a PKD-like renal cystic phenotype and randomization of heart looping by knockdown of invs expression in zebrafish. The interaction and colocalization in cilia of inversin, nephrocystin and beta-tubulin connect pathogenetic aspects of NPHP to PKD, to primary cilia function and to left-right axis determination.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Hosp Freiburg, Div Renal, Freiburg, Germany; Univ Hosp Freiburg, Clin Res Ctr, Freiburg, Germany; Massachusetts Gen Hosp, Renal Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; Soroka Med Ctr, Dept Pediat, IL-84101 Beer Sheva, Israel; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Hannover Med Sch, Inst Mol Biol, Hannover, Germany; Univ Paris 05, Necker Hosp, Dept Pediat Nephrol, Paris, France; Univ Paris 05, Necker Hosp, INSERM, U574, Paris, France; CHU Tours, Chambray Les Tours, France; Inst Reg Sante, Chambray Les Tours, France; Univ Paris 05, Necker Hosp, Dept Genet, Paris, France; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Freiburg; University of Freiburg; Harvard University; Massachusetts General Hospital; Harvard University; Ben Gurion University; Soroka Medical Center; Duke University; Newcastle University - UK; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, 8220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Hoefele, Julia/AAB-6448-2020; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; ANTIGNAC, Corinne/H-8945-2017	Hoefele, Julia/0000-0002-7917-7129; Schermer, Bernhard/0000-0002-5194-9000; Otto, Edgar/0000-0002-2387-9973; ANTIGNAC, Corinne/0000-0002-9934-4940	NIDDK NIH HHS [R21 DK069604, R01 DK078209] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069604, R01DK078209] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Calvet JP, 2003, NAT GENET, V33, P113, DOI 10.1038/ng1078; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Drummond IA, 1998, DEVELOPMENT, V125, P4655; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; GAGNADOUX MF, 1989, PEDIATR NEPHROL, V3, P50, DOI 10.1007/BF00859626; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; HIDLEBRANDT F, 1999, PEDIAT NEPHROLOGY; Hildebrandt F, 2000, J AM SOC NEPHROL, V11, P1753, DOI 10.1681/ASN.V1191753; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Kuida S, 2000, GENOME RES, V10, P49; McQuinn TC, 2001, ANAT RECORD, V263, P62, DOI 10.1002/ar.1077; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Omran H, 2001, J AM SOC NEPHROL, V12, P107, DOI 10.1681/ASN.V121107; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto E, 2000, J AM SOC NEPHROL, V11, P270, DOI 10.1681/ASN.V112270; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SMITH CH, 1945, AM J DIS CHILD, V69, P369; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; WOO DDL, 1994, NATURE, V368, P750, DOI 10.1038/368750a0; Woo DDL, 1997, KIDNEY INT, V51, P1613, DOI 10.1038/ki.1997.222; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004	49	460	479	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					413	420		10.1038/ng1217	http://dx.doi.org/10.1038/ng1217			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12872123	Green Accepted			2022-12-17	WOS:000184470500019
J	Abdelhak, S; Kalatzis, V; Heilig, R; Compain, S; Samson, D; Vincent, C; Weil, D; Cruaud, C; Sahly, I; Leibovici, M; BitnerGlindzicz, M; Francis, M; Lacombe, D; Vigneron, J; Charachon, R; Boven, K; Bedbeder, P; VanRegemorter, N; Weissenbach, J; Petit, C				Abdelhak, S; Kalatzis, V; Heilig, R; Compain, S; Samson, D; Vincent, C; Weil, D; Cruaud, C; Sahly, I; Leibovici, M; BitnerGlindzicz, M; Francis, M; Lacombe, D; Vigneron, J; Charachon, R; Boven, K; Bedbeder, P; VanRegemorter, N; Weissenbach, J; Petit, C			A human homologue of the Drosophila eyes absent gene underlies Branchio-Oto-Renal (BOR) syndrome and identifies a novel gene family	NATURE GENETICS			English	Article							KIDNEY DEVELOPMENT; VARIABLE EXPRESSIVITY; APPLE MACINTOSH; HEARING-LOSS; PAX6 GENE; PROTEIN; DYSPLASIA; MUTATIONS; DEFECTS; SYSTEM	A candidate gene for Branchio-Oto-Renal (BOR) syndrome was identified at chromosome 8q13.3 by positional cloning and shown to underlie the disease. This gene is a human homologue of the Drosophila eyes absent gene (eya), and was therefore called EYA1. A highly conserved 271-amino acid C-terminal region was also found in the products of two other human genes (EYA2 and EYA3), demonstrating the existence of a novel gene family. The expression pattern of the murine EYA1 orthologue, Eya1, suggests a role in the development of all components of the inner ear, from the emergence of the otic placode. In the developing kidney, the expression pattern is indicative of a role for Eya1 in the metanephric cells surrounding the 'just-divided' ureteric branches.	INST PASTEUR, URA CNRS 1968, UNITE GENET MOL HUMAINE, F-75724 PARIS 15, FRANCE; GENET HUMAN RES CTR, F-91000 EVRY, FRANCE; UNIV LONDON, INST CHILD HLTH, LONDON WC1N 1EH, ENGLAND; UNIV WALES HOSP, WELSH HEARING INST, CARDIFF CF4 4XW, S GLAM, WALES; CHRU, GRP HOSP PELLEGRIN ENFANTS, CLIN PEDIAT & GENET MED, F-33076 BORDEAUX, FRANCE; SERV NEONATAL GENET, F-54042 NANCY, FRANCE; HOP NORD ALBERT MICHALLON, CTR HOSP UNIV, OTORHINOLARYNGOL CLIN, F-38043 GRENOBLE 09, FRANCE; UNIV ANTWERP HOSP, B-2650 EDEGEM, BELGIUM; CTR HOSP INTERCOMMUNAL, SERV OTORHINOLARYNGOL & CHIRURG CERVICO FACIALE, F-94010 CRETEIL, FRANCE; FREE UNIV BRUSSELS, HOP ERASME, CTR GENET, B-1070 BRUSSELS, BELGIUM	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Cardiff University; CHU Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Antwerp; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Libre de Bruxelles; Vrije Universiteit Brussel			Kalatzis, Vasiliki/F-6170-2019; Leibovici, Michel/ABB-6745-2020; Vincent, Christophe/F-6261-2016; Bitner-Glindzicz, Maria/A-4231-2009; Abdelhak, Sonia/L-2831-2013	Kalatzis, Vasiliki/0000-0002-9626-8807; Vincent, Christophe/0000-0003-3201-7213; Petit, Christine/0000-0002-9069-002X; Abdelhak, Sonia/0000-0001-8466-5525; Cruaud, Corinne/0000-0002-4752-7278; Lacombe, Didier/0000-0002-8956-2207; Steinbach, Delphine/0000-0001-7144-7908				Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; BRYDEN MM, 1972, J MORPHOL, V138, P187, DOI 10.1002/jmor.1051380205; CHEN A, 1995, AM J MED GENET, V58, P365, DOI 10.1002/ajmg.1320580413; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CLAPP WL, 1994, RENAL PATHOLOGY CLIN, P3; COREY DP, 1994, P NATL ACAD SCI USA, V91, P433, DOI 10.1073/pnas.91.2.433; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dressler G R, 1995, Curr Opin Nephrol Hypertens, V4, P253, DOI 10.1097/00041552-199505000-00010; FRASER FC, 1983, AM J MED GENET, V14, P473, DOI 10.1002/ajmg.1320140311; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; FUCHS R, 1994, COMPUT APPL BIOSCI, V10, P171; FUCHS R, 1991, COMPUT APPL BIOSCI, V7, P105; GIMSING S, 1986, ANN OTO RHINOL LARYN, V95, P421, DOI 10.1177/000348948609500419; GREENBERG CR, 1988, PRENATAL DIAG, V8, P103, DOI 10.1002/pd.1970080204; Gu JZ, 1996, GENOMICS, V31, P201, DOI 10.1006/geno.1996.0032; HAAN EA, 1989, AM J MED GENET, V32, P490, DOI 10.1002/ajmg.1320320412; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; HEIMLER A, 1986, AM J MED GENET, V25, P15, DOI 10.1002/ajmg.1320250104; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HURST HC, 1995, PROTEIN PROFILE, V2, P105; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kalatzis V, 1996, GENOMICS, V34, P422, DOI 10.1006/geno.1996.0307; KONIG R, 1994, EUR J PEDIATR, V153, P446, DOI 10.1007/s004310050171; KOSEKI C, 1992, J CELL BIOL, V119, P1327, DOI 10.1083/jcb.119.5.1327; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MELNICK M, 1976, CLIN GENET, V9, P25; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; MIRZAYANS F, 1995, AM J HUM GENET, V57, P539; NI L, 1994, AM J MED GENET, V51, P176, DOI 10.1002/ajmg.1320510222; PATTERSON LT, 1994, CURR OPIN GENET DEV, V4, P696, DOI 10.1016/0959-437X(94)90136-Q; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SPENCE SE, 1992, GENOMICS, V12, P403, DOI 10.1016/0888-7543(92)90392-6; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; SULK KK, 1995, HEREDITARY HEARING L, P22; Torres M, 1995, DEVELOPMENT, V121, P4057; VANDEWATER TR, 1992, DEV AUDITORY VESTIBU, V2, P1; VINCENT C, 1994, HUM MOL GENET, V3, P1859, DOI 10.1093/hmg/3.10.1859; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	58	460	496	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1997	15	2					157	164		10.1038/ng0297-157	http://dx.doi.org/10.1038/ng0297-157			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020840				2022-12-17	WOS:A1997WF08700014
J	OBRIEN, SJ; WOMACK, JE; LYONS, LA; MOORE, KJ; JENKINS, NA; COPELAND, NG				OBRIEN, SJ; WOMACK, JE; LYONS, LA; MOORE, KJ; JENKINS, NA; COPELAND, NG			ANCHORED REFERENCE LOCI FOR COMPARATIVE GENOME MAPPING IN MAMMALS	NATURE GENETICS			English	Review							GENETIC-LINKAGE MAP; MOUSE X-CHROMOSOME; INTERSPECIFIC BACKCROSS MICE; SOMATIC-CELL HYBRIDIZATION; DOMESTIC CAT; BINDING-PROTEIN; GROWTH-FACTOR; SYNTENIC CONSERVATION; THYROGLOBULIN GENE; BETA-SUBUNIT	Recent advances in gene mapping technologies have led to increased emphasis in developing representative genetic maps for several species, particularly domestic plants and animals. These maps are being compiled with two distinct goals: to provide a resource for genetic analysis, and to help dissect the evolution of genome organization by comparing linkage relationships of homologous genes. We propose here a list of 321 reference anchor loci suitable for comparative gene mapping in mammals and other vertebrate classes. We selected cloned mouse and human functional genes spaced an average of 5-10 centiMorgans throughout their respective genomes. We also attempted to include loci that are evolutionarily conserved and represented in comparative gene maps in other mammalian orders, particularly cattle and the domestic cat. We believe that the map may provide the basis for a unified approach to comparative analysis of mammalian species genomes.	TEXAS A&M UNIV SYST, DEPT VET PATHOBIOL, COLL STN, TX 77843 USA; TEXAS A&M UNIV SYST, CTR ANIM GENET, INST BIOSCI & TECHNOL, COLL STN, TX 77843 USA; NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MAMMALIAN GENET LAB, FREDERICK, MD 21702 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	OBRIEN, SJ (corresponding author), NCI, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21702 USA.		OBRIEN, STEPHEN/ABD-1346-2020	Lyons, Leslie/0000-0002-1628-7726; OBRIEN, STEPHEN/0000-0001-7857-0757	OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADKISON LR, 1988, CYTOGENET CELL GENET, V47, P62, DOI 10.1159/000132507; ADKISON LR, 1988, CYTOGENET CELL GENET, V47, P155, DOI 10.1159/000132536; AMAR L C, 1988, Genomics, V2, P220, DOI 10.1016/0888-7543(88)90006-7; ANDERSSON L, 1988, J HERED, V79, P1; AVNER P, 1987, P NATL ACAD SCI USA, V84, P1629, DOI 10.1073/pnas.84.6.1629; BACH I, 1990, GENOMICS, V8, P155, DOI 10.1016/0888-7543(90)90238-P; BAHARY N, 1991, GENOMICS, V11, P33, DOI 10.1016/0888-7543(91)90099-Z; BARANOV V S, 1988, Byulleten' Eksperimental'noi Biologii i Meditsiny, V105, P587; BARANOV VS, 1987, CHROMOSOMA, V96, P60, DOI 10.1007/BF00285885; BARNARD PJ, 1990, CYTOGENET CELL GENET, V53, P91, DOI 10.1159/000132902; Barton D E, 1988, Oncogene Res, V3, P323; BEEVER JE, IN PRESS ANIMAL GENE; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BERMAN EJ, 1986, CYTOGENET CELL GENET, V41, P114, DOI 10.1159/000132213; BLATT C, 1988, P NATL ACAD SCI USA, V85, P7642, DOI 10.1073/pnas.85.20.7642; BONNER T, 1984, SCIENCE, V223, P71, DOI 10.1126/science.6691137; BOUQUET Y, 1986, ANIM GENET, V17, P175; BRANNAN CI, 1992, GENOMICS, V13, P1075, DOI 10.1016/0888-7543(92)90021-J; BRESSAN A, 1991, GENE, V103, P201, DOI 10.1016/0378-1119(91)90274-F; BROCKDORFF N, 1987, NATURE, V328, P166, DOI 10.1038/328166a0; BROWNELL E, 1986, AM J HUM GENET, V39, P194; BUCHBERG AM, 1988, ONCOGENE RES, V2, P149; BUCHBERG AM, 1989, GENETICS, V122, P153; BUCKWALTER MS, 1991, GENOMICS, V10, P515, DOI 10.1016/0888-7543(91)90430-M; CACCIA N, 1984, CELL, V37, P1091, DOI 10.1016/0092-8674(84)90443-4; CECI JD, 1990, GENOMICS, V6, P673, DOI 10.1016/0888-7543(90)90503-M; CECI JD, 1989, GENOMICS, V5, P699, DOI 10.1016/0888-7543(89)90111-0; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHENG SV, 1989, GENOMICS, V4, P419, DOI 10.1016/0888-7543(89)90349-2; COPELAND NG, 1991, GENOMICS, V9, P44, DOI 10.1016/0888-7543(91)90219-5; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; COPELAND NG, 1992, GENOMICS, V13, P1356, DOI 10.1016/0888-7543(92)90069-5; COX RD, 1991, GENOMICS, V10, P375, DOI 10.1016/0888-7543(91)90322-6; CZOSNEK H, 1982, EMBO J, V1, P1299, DOI 10.1002/j.1460-2075.1982.tb01314.x; DAIN AR, 1984, BIOCHEM GENET, V22, P429, DOI 10.1007/BF00484514; DANCIGER M, 1990, GENOMICS, V8, P727, DOI 10.1016/0888-7543(90)90262-S; DANCIGER M, 1990, GENOMICS, V6, P428, DOI 10.1016/0888-7543(90)90472-7; DANCIGER M, 1992, GENOMICS, V12, P688, DOI 10.1016/0888-7543(92)90295-4; DAVISSON MT, 1991, CYTOGENET CELL GENET, V58, P1152, DOI 10.1159/000133726; DEAN M, 1987, Genomics, V1, P167, DOI 10.1016/0888-7543(87)90009-7; DELAPEYRIERE O, 1990, ONCOGENE, V5, P823; DERRY JMJ, 1991, GENOMICS, V10, P593, DOI 10.1016/0888-7543(91)90441-G; DICKINSON ME, 1990, GENOMICS, V6, P505, DOI 10.1016/0888-7543(90)90480-I; DIETRICH W, 1992, GENETICS, V131, P423; DIETZ AB, 1989, J HERED, V80, P410, DOI 10.1093/oxfordjournals.jhered.a110887; DIETZ AB, 1992, MAMM GENOME, V3, P106, DOI 10.1007/BF00431254; DIETZ AB, 1992, THESIS TEXAS AM U CO; DUNCAN R, 1988, MOL CELL BIOL, V8, P2705, DOI 10.1128/MCB.8.7.2705; ECHARD G, 1984, CYTOGENET CELL GENET, V37, P458; ELDUGUE C, 1992, 23 P INT C AN GEN; EPPIG JT, 1992, MAMM GENOME, V3, P300, DOI 10.1007/BF00349940; FARR CJ, 1992, SCIENCE, V258, P49, DOI 10.1126/science.1439767; FLETCHER C, 1991, GENOMICS, V9, P647, DOI 10.1016/0888-7543(91)90358-L; FOREMAN ME, 1989, BIOCHEM GENET, V27, P541, DOI 10.1007/BF02396151; FORSTER M, 1980, NATURWISSENSCHAFTEN, V67, P48, DOI 10.1007/BF00424513; FRANCKE U, 1981, CYTOGENET CELL GENET, V31, P58, DOI 10.1159/000131626; FRIES R, 1989, J HERED, V80, P401, DOI 10.1093/oxfordjournals.jhered.a110883; GARTNER J, IN PRESS GENOMICS; Gilbert DA, 1988, GENOMICS, V2, P329, DOI 10.1016/0888-7543(88)90022-5; GLASER T, 1989, GENOMICS, V5, P510, DOI 10.1016/0888-7543(89)90017-7; GOLD DP, 1987, P NATL ACAD SCI USA, V84, P1664, DOI 10.1073/pnas.84.6.1664; GONZALEZ FJ, 1987, DNA-J MOLEC CELL BIO, V6, P149, DOI 10.1089/dna.1987.6.149; GUNAWARDANA A, 1992, ANIM GENET, V23, P161, DOI 10.1111/j.1365-2052.1992.tb00035.x; GUYER M, 1992, SCIENCE, V258, P67; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; HALLERMAN EM, 1988, ANIM GENET, V19, P123; HEDIGER R, 1990, GENOMICS, V8, P171, DOI 10.1016/0888-7543(90)90241-L; HEUERTZ S, 1981, CYTOGENET CELL GENET, V30, P137, DOI 10.1159/000131601; HEUERTZ S, 1978, ANN GENET-PARIS, V21, P197; HOGAN A, 1991, DEVELOPMENT, V113, P363; HOLCOMBE RF, 1991, GENET RES, V58, P41, DOI 10.1017/S0016672300029591; HOWARD TA, 1991, GENOMICS, V10, P207, DOI 10.1016/0888-7543(91)90502-6; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P579, DOI 10.1007/BF01534919; JOSEPH DR, 1990, P NATL ACAD SCI USA, V87, P733, DOI 10.1073/pnas.87.2.733; JUSTICE MJ, 1992, GENOMICS, V13, P1281, DOI 10.1016/0888-7543(92)90047-V; JUSTICE MJ, 1990, GENOMICS, V6, P341, DOI 10.1016/0888-7543(90)90575-F; JUSTICE MJ, 1990, GENETICS, V125, P855; KEER JT, 1990, GENOMICS, V7, P566, DOI 10.1016/0888-7543(90)90200-E; KILLARY AM, 1986, SOMAT CELL MOLEC GEN, V12, P641, DOI 10.1007/BF01671950; KINGSLEY DM, 1989, GENETICS, V123, P165; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LANGER JA, 1992, MAMM GENOME, V3, P237, DOI 10.1007/BF00355725; LARSEN B, 1970, AARSBERETN I STERILI, V13, P165; LAW SW, 1985, BIOCHEM BIOPH RES CO, V131, P1003, DOI 10.1016/0006-291X(85)91339-7; LI L, 1992, IMMUNOGENETICS, V36, P224, DOI 10.1007/BF00215052; LIVINGSTON R, 1989, THESIS TEXAS AM U CO; LOGINOVA UA, 1990, 9TH P EUR C AN GEN, V11; LOVETT M, 1987, BIOCHEM BIOPH RES CO, V144, P1069, DOI 10.1016/S0006-291X(87)80073-6; MALO D, 1991, GENOMICS, V10, P666, DOI 10.1016/0888-7543(91)90450-S; MANCOLL RE, 1992, MAMM GENOME, V2, P201, DOI 10.1007/BF00302878; MASUDA R, 1991, GENOMICS, V11, P1007, DOI 10.1016/0888-7543(91)90026-B; MATSUDA Y, 1991, MAMM GENOME, V1, P71, DOI 10.1007/BF02443781; MATTEI MG, 1990, ONCOGENE, V5, P151; MCALPINE PJ, 1991, CYTOGENET CELL GENET, V58, P5, DOI 10.1159/000133160; MCBRIDE OW, 1990, CYTOGENET CELL GENET, V53, P108, DOI 10.1159/000132906; McKusick V.A., 1983, MENDELIAN INHERITANC; MONTEAGUDO LV, 1992, 23 P INT C AN GEN; MOORE KJ, 1992, GENOMICS, V12, P388, DOI 10.1016/0888-7543(92)90389-A; MOSELEY WS, 1989, GENOMICS, V5, P899, DOI 10.1016/0888-7543(89)90132-8; MULLINS LJ, 1988, GENOMICS, V3, P187, DOI 10.1016/0888-7543(88)90078-X; NADEAU JH, 1992, MAMM GENOME, V3, P480, DOI 10.1007/BF00778825; NAN Z, 1992, GENOMICS, V14, P131, DOI 10.1016/S0888-7543(05)80295-2; NAN Z, 1992, GENOMICS, V14, P126, DOI 10.1016/S0888-7543(05)80294-0; O'Brien S.J., 1991, Current Opinion in Genetics & Development, V1, P105, DOI 10.1016/0959-437X(91)80050-V; OBRIEN SJ, 1986, J HERED, V77, P374, DOI 10.1093/oxfordjournals.jhered.a110264; OBRIEN SJ, 1988, ANNU REV GENET, V22, P323, DOI 10.1146/annurev.ge.22.120188.001543; OBRIEN SJ, 1982, SCIENCE, V216, P257, DOI 10.1126/science.7063884; OBRIEN SJ, 1991, CYTOGENET CELL GENET, V58, P1124, DOI 10.1159/000133725; OBRIEN SJ, 1990, GENETIC MAPS, V5, P1114; ODONNELL JJ, 1988, AM J HUM GENET, V43, P922; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAKEY RJ, 1991, GENOMICS, V10, P338; PRITCHARD MA, 1991, GENOMICS, V10, P801, DOI 10.1016/0888-7543(91)90466-R; REEVES RH, 1987, CYTOGENET CELL GENET, V44, P76, DOI 10.1159/000132347; REGNIER DC, 1989, J VIROL, V63, P3678, DOI 10.1128/JVI.63.9.3678-3682.1989; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; SAUNDERS AM, 1990, GENOMICS, V8, P525, DOI 10.1016/0888-7543(90)90040-2; SCHERER G, 1989, GENOMICS, V5, P275, DOI 10.1016/0888-7543(89)90058-X; SCHUCHMAN EH, 1989, GENOMICS, V4, P442, DOI 10.1016/0888-7543(89)90354-6; SCHURR E, 1990, GENOMICS, V8, P477, DOI 10.1016/0888-7543(90)90034-R; SEIGEL LJ, 1984, SCIENCE, V223, P175, DOI 10.1126/science.6318318; SELDIN MF, 1991, GENOMICS, V9, P678, DOI 10.1016/0888-7543(91)90361-H; SHIMIZU N, 1981, CYTOGENET CELL GENET, V29, P26, DOI 10.1159/000131548; SIRACUSA LD, 1991, GENETICS, V127, P169; SIRACUSA LD, 1991, GENETICS, V128, P813; SIRACUSA LD, 1990, GENOMICS, V6, P491, DOI 10.1016/0888-7543(90)90479-E; SIRACUSA LD, 1991, GENOMICS, V10, P313, DOI 10.1016/0888-7543(91)90314-5; SKOW L C, 1987, Genomics, V1, P283, DOI 10.1016/0888-7543(87)90057-7; SKOW LC, 1988, DNA-J MOLEC CELL BIO, V7, P143, DOI 10.1089/dna.1988.7.143; STUBBS L, 1990, GENOMICS, V7, P284, DOI 10.1016/0888-7543(90)90553-7; SUNDARESAN S, 1989, SOMAT CELL MOLEC GEN, V15, P465, DOI 10.1007/BF01534897; SUNDARESAN S, 1989, SOMAT CELL MOLEC GEN, V15, P471, DOI 10.1007/BF01534898; SUNDARESAN S, 1989, SOMAT CELL MOLEC GEN, V15, P367, DOI 10.1007/BF01534975; TAYLOR BA, 1987, P NATL ACAD SCI USA, V84, P1986, DOI 10.1073/pnas.84.7.1986; THREADGILL DS, 1991, CYTOGENET CELL GENET, V57, P123, DOI 10.1159/000133130; THREADGILL DS, 1991, GENOMICS, V11, P1143, DOI 10.1016/0888-7543(91)90042-D; THREADGILL DS, 1991, P NATL ACAD SCI USA, V88, P154, DOI 10.1073/pnas.88.1.154; THREADGILL DW, 1990, GENOMICS, V8, P22, DOI 10.1016/0888-7543(90)90221-F; THREADGILL DW, 1990, GENOMICS, V8, P29, DOI 10.1016/0888-7543(90)90222-G; THREADGILL DW, 1991, ANIM GENET, V22, P117, DOI 10.1111/j.1365-2052.1991.tb00653.x; THREADGILL DW, 1990, CYTOGENET CELL GENET, V53, P32, DOI 10.1159/000132890; TOBINJANZEN TC, 1992, IMMUNOGENETICS, V36, P157, DOI 10.1007/BF00661092; Trowsdale J, 1992, CURR OPIN GENET DEV, V2, P492, DOI 10.1016/S0959-437X(05)80163-7; UMENO M, 1988, J BIOL CHEM, V263, P4956; WANG L-M, 1988, Genomics, V3, P172, DOI 10.1016/0888-7543(88)90150-4; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; WHITE PC, 1984, NATURE, V312, P465, DOI 10.1038/312465a0; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; WOMACK JE, 1989, CYTOGENET CELL GENET, V51, P1109; WOMACK JE, 1991, CYTOGENET CELL GENET, V58, P2132; WOMACK JE, 1986, J HERED, V77, P2, DOI 10.1093/oxfordjournals.jhered.a110160; WOMACK JE, 1990, GENETIC MAPS, V5; YUHKI N, 1988, IMMUNOGENETICS, V27, P414, DOI 10.1007/BF00364427; 1988, MAPPING SEQUENCHING	154	460	471	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1993	3	2					103	+		10.1038/ng0293-103	http://dx.doi.org/10.1038/ng0293-103			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499943				2022-12-17	WOS:A1993KL01000005
J	Evangelou, E; Warren, HR; Mosen-Ansorena, D; Mifsu, B; Pazoki, R; Gao, H; Ntritsos, G; Dimou, N; Cabrer, CP; Karaman, I; Ng, FL; Evangelou, M; Witkowska, K; Tzanis, E; Hellwege, JN; Giri, A; Edwards, DRV; Sun, YV; Cho, K; Gaziano, JM; Wilson, PWF; Tsao, PS; Kovesdy, CP; Esko, T; Magi, R; Milani, L; Almgren, P; Boutin, T; Debette, S; Ding, J; Giulianini, F; Holliday, EG; Jackson, AU; Li-Gao, R; Lin, WY; Luan, JA; Mangino, M; Oldmeadow, C; Prins, BP; Qian, Y; Sargurupremraj, M; Shah, N; Surendran, P; Theriault, S; Verweij, N; Willems, SM; Zhao, JH; Amouyel, P; Connell, J; de Mutsert, R; Doney, ASF; Farrall, M; Menni, C; Morris, AD; Noordam, R; Pare, G; Poulter, NR; Shields, DC; Stanton, A; Thom, S; Abecasis, G; Amin, N; Arking, DE; Ayers, KL; Barbieri, CM; Batini, C; Bis, JC; Blake, T; Bochud, M; Boehnke, M; Boerwinkle, E; Boomsma, DI; Bottinger, EP; Braund, PS; Brumat, M; Campbell, A; Campbell, H; Chakravarti, A; Chambers, JC; Chauhan, G; Ciullo, M; Cocca, M; Collins, F; Cordell, HJ; Davies, G; de Borst, MH; de Geus, EJ; Deary, IJ; Deelen, J; Del Greco, MF; Demirkale, CY; Dorr, M; Ehret, GB; Elosua, R; Enroth, S; Erzurumluoglu, AM; Ferreira, T; Franberg, M; Franco, OH; Gandin, I; Gasparini, P; Giedraitis, V; Gieger, C; Girotto, G; Goel, A; Gow, AJ; Gudnason, V; Guo, XQ; Gyllensten, U; Hamsten, A; Harris, TB; Harris, SE; Hartman, CA; Havulinna, AS; Hicks, AA; Hofer, E; Hofman, A; Hottenga, JJ; Huffman, JE; Hwang, SJ; Ingelsson, E; James, A; Jansen, R; Jarvelin, MR; Joehanes, R; Johansson, A; Johnson, AD; Joshi, PK; Jousilahti, P; Jukema, JW; Jula, A; Kahonen, M; Kathiresan, S; Keavney, BD; Khaw, KT; Knekt, P; Knight, J; Kolcic, I; Kooner, JS; Koskinen, S; Kristiansson, K; Kutalik, Z; Laan, M; Larson, M; Launer, LJ; Lehne, B; Lehtimaki, T; Liewald, DCM; Lin, L; Lind, L; Lindgren, CM; Liu, YM; Loos, RJF; Lopez, LM; Lu, YC; Lyytikainen, LP; Mahajan, A; Mamasoula, C; Marrugat, J; Marten, J; Milaneschi, Y; Morgan, A; Morris, AP; Morrison, AC; Munson, PJ; Nalls, MA; Nandakumar, P; Nelson, CP; Niiranen, T; Nolte, IM; Nutile, T; Oldehinkel, AJ; Oostra, BA; O'Reilly, PF; Org, E; Padmanabhan, S; Palmas, W; Palotie, A; Pattie, A; Penninx, BWJH; Perola, M; Peters, A; Polasek, O; Pramstaller, PP; Nguyen, QT; Raitakari, OT; Ren, M; Rettig, R; Rice, K; Ridker, PM; Ried, JS; Riese, H; Ripatti, S; Robino, A; Rose, LM; Rotter, JI; Rudan, I; Ruggiero, D; Saba, Y; Sala, CF; Salomaa, V; Samani, NJ; Sarin, AP; Schmidt, R; Schmidt, H; Shrine, N; Siscovick, D; Smith, AV; Snieder, H; Sober, S; Sorice, R; Starr, JM; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sundstrom, J; Swertz, MA; Taylor, KD; Teumer, A; Tobin, MD; Tomaszewski, M; Toniolo, D; Traglia, M; Trompet, S; Tuomilehto, J; Tzourio, C; Uitterlinden, AG; Vaez, A; van der Most, PJ; van Duijn, CM; Vergnaud, AC; Verwoert, GC; Vitart, V; Volker, U; Vollenweider, P; Vuckovic, D; Watkins, H; Wild, SH; Willemsen, G; Wilson, JF; Wright, AF; Yao, J; Zemunik, T; Zhang, WH; Attia, JR; Butterworth, AS; Chasman, D; Conen, D; Cucca, F; Danesh, J; Hayward, C; Howson, JMM; Laakso, M; Lakatta, EG; Langenberg, C; Melander, O; Mook-Kanamori, DO; Palmer, CNA; Risch, L; Scott, RA; Scott, RJ; Sever, P; Spector, TD; van der Harst, P; Wareham, NJ; Zeggini, E; Levy, D; Munroe, PB; Newton-Cheh, C; Brown, MJ; Metspalu, A; Hung, AM; O'Donnell, C; Edwards, TL; Psaty, BM; Tzoulaki, I; Barnes, MR; Wain, LV; Elliott, P; Caulfield, MJ				Evangelou, Evangelos; Warren, Helen R.; Mosen-Ansorena, David; Mifsu, Borbala; Pazoki, Raha; Gao, He; Ntritsos, Georgios; Dimou, Niki; Cabrer, Claudia P.; Karaman, Ibrahim; Ng, FuLiang; Evangelou, Marina; Witkowska, Katarzyna; Tzanis, Evan; Hellwege, Jacklyn N.; Giri, Ayush; Edwards, Digna R. Velez; Sun, Yan, V; Cho, Kelly; Gaziano, J. Michael; Wilson, Peter W. F.; Tsao, Philip S.; Kovesdy, Csaba P.; Esko, Tonu; Magi, Reedik; Milani, Lili; Almgren, Peter; Boutin, Thibaud; Debette, Stephanie; Ding, Jun; Giulianini, Franco; Holliday, Elizabeth G.; Jackson, Anne U.; Li-Gao, Ruifang; Lin, Wei-Yu; Luan, Jian'an; Mangino, Massimo; Oldmeadow, Christopher; Prins, Bram Peter; Qian, Yong; Sargurupremraj, Muralidharan; Shah, Nabi; Surendran, Praveen; Theriault, Sebastien; Verweij, Niek; Willems, Sara M.; Zhao, Jing-Hua; Amouyel, Philippe; Connell, John; de Mutsert, Renee; Doney, Alex S. F.; Farrall, Martin; Menni, Cristina; Morris, Andrew D.; Noordam, Raymond; Pare, Guillaume; Poulter, Neil R.; Shields, Denis C.; Stanton, Alice; Thom, Simon; Abecasis, Goncalo; Amin, Najaf; Arking, Dan E.; Ayers, Kristin L.; Barbieri, Caterina M.; Batini, Chiara; Bis, Joshua C.; Blake, Tineka; Bochud, Murielle; Boehnke, Michael; Boerwinkle, Eric; Boomsma, Dorret, I; Bottinger, Erwin P.; Braund, Peter S.; Brumat, Marco; Campbell, Archie; Campbell, Harry; Chakravarti, Aravinda; Chambers, John C.; Chauhan, Ganesh; Ciullo, Marina; Cocca, Massimiliano; Collins, Francis; Cordell, Heather J.; Davies, Gail; de Borst, Martin H.; de Geus, Eco J.; Deary, Ian J.; Deelen, Joris; Del Greco, Fabiola M.; Demirkale, Cumhur Yusuf; Doerr, Marcus; Ehret, Georg B.; Elosua, Roberto; Enroth, Stefan; Erzurumluoglu, A. Mesut; Ferreira, Teresa; Franberg, Mattias; Franco, Oscar H.; Gandin, Ilaria; Gasparini, Paolo; Giedraitis, Vilmantas; Gieger, Christian; Girotto, Giorgia; Goel, Anuj; Gow, Alan J.; Gudnason, Vilmundur; Guo, Xiuqing; Gyllensten, Ulf; Hamsten, Anders; Harris, Tamara B.; Harris, Sarah E.; Hartman, Catharina A.; Havulinna, Aki S.; Hicks, Andrew A.; Hofer, Edith; Hofman, Albert; Hottenga, Jouke-Jan; Huffman, Jennifer E.; Hwang, Shih-Jen; Ingelsson, Erik; James, Alan; Jansen, Rick; Jarvelin, Marjo-Riitta; Joehanes, Roby; Johansson, Asa; Johnson, Andrew D.; Joshi, Peter K.; Jousilahti, Pekka; Jukema, J. Wouter; Jula, Antti; Kahonen, Mika; Kathiresan, Sekar; Keavney, Bernard D.; Khaw, Kay-Tee; Knekt, Paul; Knight, Joanne; Kolcic, Ivana; Kooner, Jaspal S.; Koskinen, Seppo; Kristiansson, Kati; Kutalik, Zoltan; Laan, Maris; Larson, Marty; Launer, Lenore J.; Lehne, Benjamin; Lehtimaki, Terho; Liewald, David C. M.; Lin, Li; Lind, Lars; Lindgren, Cecilia M.; Liu, YongMei; Loos, Ruth J. F.; Lopez, Lorna M.; Lu, Yingchang; Lyytikainen, Leo-Pekka; Mahajan, Anubha; Mamasoula, Chrysovalanto; Marrugat, Jaume; Marten, Jonathan; Milaneschi, Yuri; Morgan, Anna; Morris, Andrew P.; Morrison, Alanna C.; Munson, Peter J.; Nalls, Mike A.; Nandakumar, Priyanka; Nelson, Christopher P.; Niiranen, Teemu; Nolte, Ilja M.; Nutile, Teresa; Oldehinkel, Albertine J.; Oostra, Ben A.; O'Reilly, Paul F.; Org, Elin; Padmanabhan, Sandosh; Palmas, Walter; Palotie, Aarno; Pattie, Alison; Penninx, Brenda W. J. H.; Perola, Markus; Peters, Annette; Polasek, Ozren; Pramstaller, Peter P.; Nguyen, Quang Tri; Raitakari, Olli T.; Ren, Meixia; Rettig, Rainer; Rice, Kenneth; Ridker, Paul M.; Ried, Janina S.; Riese, Harriette; Ripatti, Samuli; Robino, Antonietta; Rose, Lynda M.; Rotter, Jerome, I; Rudan, Igor; Ruggiero, Daniela; Saba, Yasaman; Sala, Cinzia F.; Salomaa, Veikko; Samani, Nilesh J.; Sarin, Antti-Pekka; Schmidt, Reinhold; Schmidt, Helena; Shrine, Nick; Siscovick, David; Smith, Albert, V; Snieder, Harold; Sober, Siim; Sorice, Rossella; Starr, John M.; Stott, David J.; Strachan, David P.; Strawbridge, Rona J.; Sundstrom, Johan; Swertz, Morris A.; Taylor, Kent D.; Teumer, Alexander; Tobin, Martin D.; Tomaszewski, Maciej; Toniolo, Daniela; Traglia, Michela; Trompet, Stella; Tuomilehto, Jaakko; Tzourio, Christophe; Uitterlinden, Andre G.; Vaez, Ahmad; van der Most, Peter J.; van Duijn, Cornelia M.; Vergnaud, Anne-Claire; Verwoert, Germaine C.; Vitart, Veronique; Voelker, Uwe; Vollenweider, Peter; Vuckovic, Dragana; Watkins, Hugh; Wild, Sarah H.; Willemsen, Gonneke; Wilson, James F.; Wright, Alan F.; Yao, Jie; Zemunik, Tatijana; Zhang, Weihua; Attia, John R.; Butterworth, Adam S.; Chasman, Daniell; Conen, David; Cucca, Francesco; Danesh, John; Hayward, Caroline; Howson, Joanna M. M.; Laakso, Markku; Lakatta, Edward G.; Langenberg, Claudia; Melander, Olle; Mook-Kanamori, Dennis O.; Palmer, Colin N. A.; Risch, Lorenz; Scott, Robert A.; Scott, Rodney J.; Sever, Peter; Spector, Tim D.; van der Harst, Pim; Wareham, Nicholas J.; Zeggini, Eleftheria; Levy, Daniel; Munroe, Patricia B.; Newton-Cheh, Christopher; Brown, Morris J.; Metspalu, Andres; Hung, Adriana M.; O'Donnell, Christopherj; Edwards, Todd L.; Psaty, Bruce M.; Tzoulaki, Ioanna; Barnes, Michael R.; Wain, Louise, V; Elliott, Paul; Caulfield, Mark J.		Million Vet Program	Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR RISK; GLOBAL BURDEN; HYPERTENSION; DISEASE; VARIANTS; METAANALYSIS; COMMON; HEALTH; RARE	High blood pressure is a highly heritable and modifiable risk factor for cardiovascular disease. We report the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry. We identify 535 novel blood pressure loci that not only offer new biological insights into blood pressure regulation but also highlight shared genetic architecture between blood pressure and lifestyle exposures. Our findings identify new biological pathways for blood pressure regulation with potential for improved cardiovascular disease prevention in the future.	[Evangelou, Evangelos; Mosen-Ansorena, David; Pazoki, Raha; Gao, He; Karaman, Ibrahim; Evangelou, Marina; Chambers, John C.; Jarvelin, Marjo-Riitta; Lehne, Benjamin; Vergnaud, Anne-Claire; Zhang, Weihua; Tzoulaki, Ioanna; Elliott, Paul] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Evangelou, Evangelos; Ntritsos, Georgios; Dimou, Niki; Tzoulaki, Ioanna] Univ Ioannina, Dept Hyg & Epidemiol, Med Sch, Ioannina, Greece; [Warren, Helen R.; Mifsu, Borbala; Cabrer, Claudia P.; Ng, FuLiang; Witkowska, Katarzyna; Tzanis, Evan; Munroe, Patricia B.; Brown, Morris J.; Barnes, Michael R.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Warren, Helen R.; Cabrer, Claudia P.; Munroe, Patricia B.; Brown, Morris J.; Barnes, Michael R.; Caulfield, Mark J.] Queen Mary Univ London, Barts Cardiovasc Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Gao, He; Chambers, John C.; Jarvelin, Marjo-Riitta; Kooner, Jaspal S.; Tzoulaki, Ioanna; Elliott, Paul] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Evangelou, Marina] Imperial Coll London, Dept Math, London, England; [Hellwege, Jacklyn N.; Edwards, Todd L.] Vanderbilt Univ, Div Epidemiol, Inst Med & Publ Hlth, Vanderbilt Genet Inst,Med Ctr,Dept Med, Tennessee Valley Healthcare Syst 626, Nashville, TN USA; [Giri, Ayush; Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Vanderbilt Genet Inst, Dept Obstet & Gynecol,Med Ctr,Tennessee Valley Hl, Nashville, TN USA; [Sun, Yan, V] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Sun, Yan, V] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA; [Cho, Kelly; Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Cho, Kelly; Gaziano, J. Michael] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA USA; [Wilson, Peter W. F.] Atlanta VAMC, Atlanta, GA USA; [Wilson, Peter W. F.] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA; [Tsao, Philip S.] Stanford Univ, Div Cardiovasc Med, VA Palo Alto Hlth Care Syst, Sch Med, Stanford, CA USA; [Kovesdy, Csaba P.] Memphis VA Med Ctr, Nephrol Sect, Memphis, TN USA; [Kovesdy, Csaba P.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Esko, Tonu; Magi, Reedik; Milani, Lili; Org, Elin; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Esko, Tonu; Verweij, Niek; Kathiresan, Sekar] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Almgren, Peter; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Boutin, Thibaud; Huffman, Jennifer E.; Marten, Jonathan; Vitart, Veronique; Wilson, James F.; Wright, Alan F.; Hayward, Caroline] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Debette, Stephanie] Bordeaux Univ Hosp, Dept Neurol, Bordeaux, France; [Debette, Stephanie; Sargurupremraj, Muralidharan; Tzourio, Christophe] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, CHU Bordeaux, Inserm, Bordeaux, France; [Ding, Jun; Qian, Yong] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA; [Giulianini, Franco; Ridker, Paul M.; Rose, Lynda M.; Chasman, Daniell] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Holliday, Elizabeth G.; Oldmeadow, Christopher; Attia, John R.; Scott, Rodney J.] Univ Newcastle, Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Holliday, Elizabeth G.; Oldmeadow, Christopher; Attia, John R.; Scott, Rodney J.] Univ Newcastle, Fac Hlth, New Lambton Hts, NSW, Australia; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Li-Gao, Ruifang; de Mutsert, Renee; Mook-Kanamori, Dennis O.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Lin, Wei-Yu; Surendran, Praveen; Butterworth, Adam S.; Danesh, John; Howson, Joanna M. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Luan, Jian'an; Willems, Sara M.; Zhao, Jing-Hua; Loos, Ruth J. F.; Langenberg, Claudia; Scott, Robert A.; Wareham, Nicholas J.] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Cambridge, England; [Mangino, Massimo; Menni, Cristina; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London, England; [Prins, Bram Peter; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Hinxton, England; [Shah, Nabi; Doney, Alex S. F.; Palmer, Colin N. A.] Univ Dundee, Sch Med, Div Mol & Clin Med, Dundee, Scotland; [Shah, Nabi] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan; [Theriault, Sebastien; Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Theriault, Sebastien] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Verweij, Niek; Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Verweij, Niek; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Amouyel, Philippe] Univ Lille, Epidemiol & Publ Hlth Dept, RID AGE Risk Factors & Mol Determinants Aging Rel, Inst Pasteur Lille,Ctr Hosp Univ Lille,Inserm,UMR, Lille, France; [Connell, John] Univ Dundee, Ninewells Hosp & Med Sch, Dundee, Scotland; [Farrall, Martin; Goel, Anuj; Lindgren, Cecilia M.; Mahajan, Anubha; Morris, Andrew P.; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Farrall, Martin; Goel, Anuj; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Morris, Andrew D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Noordam, Raymond] Leiden Univ, Dept Internal Med, Sect Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Poulter, Neil R.] Imperial Clin Trials Unit, London, England; [Shields, Denis C.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Stanton, Alice] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin, Ireland; [Thom, Simon] Imperial Coll London, Int Ctr Circulatory Hlth, London, England; [Abecasis, Goncalo] SPH II, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI USA; [Amin, Najaf; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Genet Epidemiol Unit, Dept Epidemiol, Rotterdam, Netherlands; [Arking, Dan E.; Chakravarti, Aravinda; Ehret, Georg B.; Nandakumar, Priyanka] Johns Hopkins Univ, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Ayers, Kristin L.; Cordell, Heather J.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Ayers, Kristin L.] Sema4, Stamford, CT USA; [Barbieri, Caterina M.; Sala, Cinzia F.; Toniolo, Daniela; Traglia, Michela] Ist Sci San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Batini, Chiara; Blake, Tineka; Erzurumluoglu, A. Mesut; Shrine, Nick; Tobin, Martin D.; Wain, Louise, V] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Bochud, Murielle; Kutalik, Zoltan] Univ Hosp Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Boomsma, Dorret, I; de Geus, Eco J.; Hottenga, Jouke-Jan; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, EMGO Inst, Med Ctr, Amsterdam, Netherlands; [Bottinger, Erwin P.; Loos, Ruth J. F.; Lu, Yingchang] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Braund, Peter S.; Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Braund, Peter S.; Nelson, Christopher P.; Samani, Nilesh J.; Wain, Louise, V] Glenfield Hosp, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Brumat, Marco; Gandin, Ilaria; Gasparini, Paolo; Girotto, Giorgia; Morgan, Anna; Vuckovic, Dragana] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Campbell, Archie; Harris, Sarah E.] Univ Edinburgh, Ctr Genom & Expt Med, Inst Genet & Mol Med, Med Genet Sect, Edinburgh, Midlothian, Scotland; [Campbell, Archie; Padmanabhan, Sandosh] Univ Edinburgh, Ctr Genom & Expt Med, Generat Scotland, Edinburgh, Midlothian, Scotland; [Campbell, Harry; Joshi, Peter K.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Chambers, John C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Chambers, John C.; Kooner, Jaspal S.; Zhang, Weihua] Ealing Gen Hosp, Dept Cardiol, Southall, Middx, England; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Chauhan, Ganesh] Indian Inst Sci, Ctr Brain Res, Bangalore, Karnataka, India; [Ciullo, Marina; Nutile, Teresa; Ruggiero, Daniela; Sorice, Rossella] CNR, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Ciullo, Marina; Ruggiero, Daniela] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Cocca, Massimiliano; Gasparini, Paolo; Girotto, Giorgia; Robino, Antonietta] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Collins, Francis] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Davies, Gail; Deary, Ian J.; Gow, Alan J.; Harris, Sarah E.; Liewald, David C. M.; Lopez, Lorna M.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Gail; Deary, Ian J.; Liewald, David C. M.; Pattie, Alison] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [de Borst, Martin H.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Deelen, Joris] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Del Greco, Fabiola M.; Hicks, Andrew A.; Pramstaller, Peter P.] Eurac Res, Inst Biomed, Bolzano, Italy; [Del Greco, Fabiola M.; Hicks, Andrew A.; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Demirkale, Cumhur Yusuf; Munson, Peter J.; Nguyen, Quang Tri] NIH, Ctr Informat Technol, Math & Stat Comp Lab, Off Intramural Res, Bethesda, MD USA; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Doerr, Marcus; Teumer, Alexander; Voelker, Uwe] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Ehret, Georg B.; Lin, Li] Geneva Univ Hosp, Dept Med, Cardiol, Geneva, Switzerland; [Elosua, Roberto; Marrugat, Jaume] IMIM, CIBERCV & Cardiovasc Epidemiol & Genet, Barcelona, Spain; [Elosua, Roberto] Univ Vic Cent Catalunya, Fac Med, Vic, Spain; [Enroth, Stefan; Gyllensten, Ulf; Johansson, Asa] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Ferreira, Teresa] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Ferreira, Teresa; Lindgren, Cecilia M.] Univ Oxford, Li Ka Shing Ctr Hlth Hlth Informat & Discovery, Big Data Inst, Oxford, England; [Franberg, Mattias; Hamsten, Anders; Strawbridge, Rona J.] Karolinska Inst, Dept Med Solna, Cardiovasc Med Unit, Stockholm, Sweden; [Franberg, Mattias; Hamsten, Anders; Strawbridge, Rona J.] Karolinska Univ Jukhuset, Ctr Mol Med, L8 03, Solna, Sweden; [Franberg, Mattias] Stockholm Univ, Dept Numer Anal & Comp Sci, Stockholm, Sweden; [Franco, Oscar H.; Hofman, Albert; Uitterlinden, Andre G.; Verwoert, Germaine C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Giedraitis, Vilmantas] Dept Publ Hlth & Caring Sci, Geriatr, Uppsala, Sweden; [Gieger, Christian] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Gieger, Christian; Peters, Annette; Ried, Janina S.] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Gieger, Christian; Peters, Annette] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Gow, Alan J.] Heriot Watt Univ, Sch Social Sci, Dept Psychol, Edinburgh, Midlothian, Scotland; [Gudnason, Vilmundur; Smith, Albert, V] Univ Iceland, Fac Med, Reykjavik, Iceland; [Gudnason, Vilmundur; Smith, Albert, V] Iceland Heart Assoc, Kopavogur, Iceland; [Guo, Xiuqing; Rotter, Jerome, I; Taylor, Kent D.; Yao, Jie] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Dept Pediat, LABioMed, Torrance, CA USA; [Harris, Tamara B.; Launer, Lenore J.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Havulinna, Aki S.; Jousilahti, Pekka; Jula, Antti; Knekt, Paul; Koskinen, Seppo; Kristiansson, Kati; Niiranen, Teemu; Perola, Markus; Salomaa, Veikko] Natl Inst Hlth & Welf THL, Dept Publ Hlth Solut, Helsinki, Finland; [Havulinna, Aki S.; Palotie, Aarno; Perola, Markus; Ripatti, Samuli; Sarin, Antti-Pekka] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Huffman, Jennifer E.; Hwang, Shih-Jen; Joehanes, Roby; Johnson, Andrew D.; Larson, Marty; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA USA; [Huffman, Jennifer E.; Hwang, Shih-Jen] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA USA; [James, Alan] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep, Hosp Ave, Nedlands, WA, Australia; [James, Alan] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Jansen, Rick] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam Neurosci, Amsterdam, Netherlands; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Joehanes, Roby] Harvard Med Sch, Hebrew SeniorLife, Boston, MA USA; [Johnson, Andrew D.; Levy, Daniel] NHLBI, Populat Sci Branch, Bldg 10, Bethesda, MD 20892 USA; [Jukema, J. Wouter; Trompet, Stella] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Fac Med & Life Sci, Finnish Cardiovasc Res Ctr Tampere, Dept Clin Physiol, Tampere, Finland; [Kathiresan, Sekar] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA; [Keavney, Bernard D.; Tomaszewski, Maciej] Univ Manchester, Fac Biol, Div Cardiovasc Sci, Manchester, Lancs, England; [Keavney, Bernard D.; Tomaszewski, Maciej] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Med, Manchester, Lancs, England; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Knight, Joanne] Data Sci Inst, Lancaster, England; [Knight, Joanne] Lancaster Med Sch, Lancaster, England; [Kolcic, Ivana; Polasek, Ozren] Univ Split, Fac Med, Dept Publ Hlth, Split, Croatia; [Kooner, Jaspal S.; Sever, Peter] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Laan, Maris; Sober, Siim] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia; [Lehtimaki, Terho; Lyytikainen, Leo-Pekka] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho; Lyytikainen, Leo-Pekka] Univ Tampere, Fac Med & Life Sci, Finnish Cardiovasc Res Ctr Tampere, Dept Clin Chem, Tampere, Finland; [Lind, Lars; Sundstrom, Johan] Uppsala Univ, Cardiovasc Epidemiol, Dept Med Sci, Uppsala, Sweden; [Lindgren, Cecilia M.; Newton-Cheh, Christopher] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Liu, YongMei] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth Dev Inst, New York, NY 10029 USA; [Lopez, Lorna M.] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Psychiat, Dublin, Ireland; [Lopez, Lorna M.] Univ Coll Dublin, Ctr Proteome Res, UCD Conway Inst, Dublin, Ireland; [Mamasoula, Chrysovalanto] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam Publ Hlth & Amsterdam Neurosci, GGZ InGeest, Amsterdam, Netherlands; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Nalls, Mike A.] Glen Echo, Data Tecn Int, Glen Echo, MD USA; [Nalls, Mike A.] NIA, Lab Neurogenet, Bethesda, MD 20892 USA; [Niiranen, Teemu] Univ Turku, Dept Med, Turku Univ Hosp, Turku, Finland; [Nolte, Ilja M.; Snieder, Harold; Vaez, Ahmad; van der Most, Peter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Oldehinkel, Albertine J.; Riese, Harriette] Univ Groningen, Univ Med Ctr Groningen, ICPF, Groningen, Netherlands; [O'Reilly, Paul F.] Kings Coll London, SGDP Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Padmanabhan, Sandosh] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Coll Med, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Palmas, Walter] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Palotie, Aarno] Massachusetts Gen Hosp, Analyt & Translat Genet Unit Dept, Dept Med, Dept Neurol, Boston, MA 02114 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res & Program Med & Populat, Cambridge, MA USA; [Perola, Markus] Univ Tartu, Tartu, Estonia; [Peters, Annette] German Ctr Cardiovasc Dis Res DZHK, Partner Site Munich, Neuherberg, Germany; [Polasek, Ozren] Psychiat Hosp Sveti Ivan, Zagreb, Croatia; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Ren, Meixia] Fujian Med Univ, Fujian Prov Hosp, Dept Geriatr Med, Fujian Key Lab Geriatr, Fuzhou, Fujian, Peoples R China; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Karlsburg, Germany; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Ridker, Paul M.; Chasman, Daniell] Harvard Med Sch, Boston, MA USA; [Ripatti, Samuli] Univ Helsinki, Fac Med, Publ Hlth, Helsinki, Finland; [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, Graz, Austria; [Siscovick, David] New York Acad Med, New York, NY USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Stott, David J.] Univ Glasgow, Fac Med, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Strachan, David P.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Trompet, Stella] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Tuomilehto, Jaakko] Dasman Diabet Inst, Kuwait, Kuwait; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Saudi Diabet Res Grp, Jeddah, Saudi Arabia; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Vaez, Ahmad] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran; [Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Vollenweider, Peter] CHU Vaudois, Dept Internal Med, Univ Hosp, Lausanne, Switzerland; [Vuckovic, Dragana] Sidra Med & Res Ctr, Expt Genet Div, Doha, Qatar; [Wild, Sarah H.] Univ Edinburgh, Ctr Populat Hlth Sci, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Zemunik, Tatijana] Univ Split, Fac Med, Dept Biol, Split, Croatia; [Butterworth, Adam S.; Danesh, John] Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Res Unit Do, Cambridge, England; [Conen, David] Univ Hosp, Div Cardiol, Basel, Switzerland; [Conen, David] McMaster Univ, Dept Med, Div Cardiol, Hamilton, ON, Canada; [Cucca, Francesco] CNR, Inst Genet & Biomed Res, Natl Res Council, Cagliari, Italy; [Cucca, Francesco] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Lakatta, Edward G.] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA; [Mook-Kanamori, Dennis O.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Risch, Lorenz] Lab Med Zentrum Dr Risch, Schaan, Liechtenstein; [Risch, Lorenz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Risch, Lorenz] Univ Bern, Bern Univ Hosp, Univ Inst Clin Chem, Inselspital, Bern, Switzerland; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Hung, Adriana M.] Tennessee Valley Healthcare Syst Nashville VA, Nashville, TN USA; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA USA; [O'Donnell, Christopherj] Harvard Med Sch, Brigham & Womens Hosp, Sect Cardiol, VA Boston Healthcare, Boston, MA USA; [O'Donnell, Christopherj] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA USA; [Elliott, Paul] Imperial Coll Healthcare NHS Trust, Imperial Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Elliott, Paul] Imperial Coll London, London, England; [Elliott, Paul] Imperial Coll London, UK Dementia Res Inst UK DRI, London, England; [Elliott, Paul] Hlth Data Res UK London Substant Site, London, England	Imperial College London; University of Ioannina; University of London; Queen Mary University London; University of London; Queen Mary University London; Imperial College London; Imperial College London; Vanderbilt University; Vanderbilt University; Emory University; Rollins School Public Health; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tartu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; University of Edinburgh; CHU Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Brigham & Women's Hospital; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge; University of Cambridge; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Wellcome Trust Sanger Institute; University of Dundee; COMSATS University Islamabad (CUI); McMaster University; Laval University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; University of Dundee; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University College Dublin; Royal College of Surgeons - Ireland; Imperial College London; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Newcastle University - UK; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Leicester; University of Washington; University of Washington Seattle; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Vrije Universiteit Amsterdam; Icahn School of Medicine at Mount Sinai; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Trieste; University of Edinburgh; University of Edinburgh; University of Edinburgh; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Indian Institute of Science (IISC) - Bangalore; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Neuromed; IRCCS Burlo Garofolo; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Edinburgh; University of Edinburgh; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; European Academy of Bozen-Bolzano; University of Lubeck; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Greifswald Medical School; German Centre for Cardiovascular Research; University of Geneva; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Karolinska Institutet; Stockholm University; Erasmus University Rotterdam; Erasmus MC; Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heriot Watt University; University of Iceland; Icelandic Heart Association; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Groningen; Finland National Institute for Health & Welfare; University of Helsinki; Medical University of Graz; Medical University of Graz; Harvard University; Harvard T.H. Chan School of Public Health; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Uppsala University; Stanford University; University of Western Australia; University of Western Australia; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Oulu; University of Oulu; University of Oulu; Harvard University; Harvard Medical School; Hebrew SeniorLife; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tampere University; Tampere University Hospital; Tampere University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; University of Manchester; University of Cambridge; University of Split; Imperial College London; Swiss Institute of Bioinformatics; University of Tartu; Tampere University; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wake Forest University; Icahn School of Medicine at Mount Sinai; Royal College of Surgeons - Ireland; University College Dublin; Newcastle University - UK; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Liverpool; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Turku; University of Groningen; University of Groningen; University of London; King's College London; University of Glasgow; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tartu; German Centre for Cardiovascular Research; Krankenhaus Bozen; University of Lubeck; University of Turku; University of Turku; Fujian Medical University; Fujian Provincial Hospital; Greifswald Medical School; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of Helsinki; Medical University of Graz; New York Academy of Medicine; University of Edinburgh; University of Glasgow; St Georges University London; University of Groningen; Greifswald Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Finland National Institute for Health & Welfare; University of Helsinki; King Abdulaziz University; Erasmus University Rotterdam; Erasmus MC; Isfahan University Medical Science; Greifswald Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Sidra Medical & Research Center; University of Edinburgh; University of Split; University of Cambridge; McMaster University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bern; University Hospital of Bern; Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; Imperial College London; Imperial College London; Imperial College London	Elliott, P (corresponding author), Imperial Coll London, Dept Epidemiol & Biostat, London, England.; Caulfield, MJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.; Caulfield, MJ (corresponding author), Queen Mary Univ London, Barts Cardiovasc Biomed Res Ctr, Natl Inst Hlth Res, London, England.; Elliott, P (corresponding author), Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England.; Elliott, P (corresponding author), Imperial Coll Healthcare NHS Trust, Imperial Biomed Res Ctr, Natl Inst Hlth Res, London, England.	p.elliott@imperial.ac.uk; m.j.caulfield@qmul.ac.uk	Polasek, Ozren/B-6002-2011; CHAUHAN, GANESH/AAI-5110-2021; Vaez, Ahmad/B-4336-2018; Erzurumluoglu, A Mesut/E-4445-2018; Mangino, Massimo/F-5134-2011; de Geus, Eco J.C./M-9318-2015; Hwang, Shih-Jen/HGU-5826-2022; Verweij, Niek/ABC-6249-2021; Langenberg, Claudia/ABG-9067-2021; Havulinna, Aki/AAM-4769-2021; Sargurupremraj, Muralidharan/AHA-7680-2022; Kolcic, Ivana/E-2713-2017; Loos, Ruth/GON-5877-2022; Gasparini, Paolo/B-6173-2014; Wilson, James F/A-5704-2009; Franco, Óscar H/ABE-2305-2020; Mägi, Reedik/AAJ-9679-2021; Toniolo, Daniela/AAE-2969-2019; Lin, Wei-Yu/F-4505-2010; Palmer, Colin NA/C-7053-2008; Risch, Lorenz/D-4629-2011; EHRET, Georg B/A-9532-2009; Colaus, PsyColaus/K-6607-2013; Gudnason, Vilmundur/AAE-7126-2019; Campbell, Archie/AAZ-1757-2021; Rudan, Igor/I-1467-2012; Lehtimäki, Terho/AAD-1094-2022; Teumer, Alexander/S-7438-2019; Johansson, Åsa/AAG-6799-2021; Sundström, Johan/A-6286-2009; Shah, Nabi/AAG-7378-2021; Attia, John R/F-5376-2013; Loos, Ruth J F/Q-2862-2016; Strawbridge, Rona/H-5422-2012; Traglia, Michela/AAX-5816-2020; Levy, Daniel/ABB-2752-2021; Rotter, Jerome/AAY-6598-2021; Stanton, Alice V/F-4697-2012; Sundstrom, Johan/R-2139-2019; Milani, Lili/N-1097-2019; Schmidt, Reinhold/E-1137-2014; zhang, weihua/GXV-1334-2022; Gandin, Ilaria/B-2634-2017; ruggiero, daniela/K-5638-2016; Tzourio, christophe/B-4015-2009; Deelen, Joris/H-3201-2019; Peters, Annette/A-6117-2011; Lopez, Lorna/AAR-4912-2020; Debette, Stephanie/T-4946-2019; Jukema, J. Wouter/ABD-6503-2021; Li-Gao, Ruifang/B-7172-2018; Evangelou, Evangelos/C-3033-2013; Smith, Albert Vernon/AHC-3838-2022; Tzoulaki, Ioanna/ABE-6269-2020; Boomsma, Dorret I/AAX-4470-2020; Johnson, Andrew D/G-6520-2013; Johansson, Åsa/G-5270-2011; Laan, Maris/A-4100-2011; Sala, Cinzia Felicita/AAN-1900-2020; Hicks, Andrew Anthony/E-9518-2017; Enroth, Stefan/C-7396-2009; Lakatta, Edward G/AAL-1447-2020; Campbell, Harry/E-2959-2010; Raitakari, Olli/AAQ-7389-2021; Levy, Daniel/ABF-6873-2021; Ciullo, Marina/AAE-3041-2020; Riese, Harriëtte/E-7234-2012; Dörr, Marcus/F-1919-2010; Khaw, Kay-Tee/AAZ-3209-2021; Gow, Alan J/A-6070-2009; Org, Elin/AAJ-9631-2021; Tzourio, christophe/L-6344-2019; Penninx, Brenda WJH/S-7627-2017; Robino, Antonietta/K-9398-2016; Girotto, Giorgia/I-9452-2018; Niiranen, Teemu/R-1507-2017; Doney, Alexander/P-7437-2017; Scott, Rodney/B-2827-2013	Polasek, Ozren/0000-0002-5765-1862; Vaez, Ahmad/0000-0001-9048-3795; Erzurumluoglu, A Mesut/0000-0003-1322-8138; Mangino, Massimo/0000-0002-2167-7470; de Geus, Eco J.C./0000-0001-6022-2666; Verweij, Niek/0000-0002-4303-7685; Langenberg, Claudia/0000-0002-5017-7344; Kolcic, Ivana/0000-0001-7918-6052; Wilson, James F/0000-0001-5751-9178; Franco, Óscar H/0000-0002-4606-4929; Toniolo, Daniela/0000-0001-9545-6032; Lin, Wei-Yu/0000-0002-9267-7988; Palmer, Colin NA/0000-0002-6415-6560; Risch, Lorenz/0000-0003-2692-6699; EHRET, Georg B/0000-0002-5730-0675; Gudnason, Vilmundur/0000-0001-5696-0084; Rudan, Igor/0000-0001-6993-6884; Lehtimäki, Terho/0000-0002-2555-4427; Teumer, Alexander/0000-0002-8309-094X; Johansson, Åsa/0000-0002-2915-4498; Sundström, Johan/0000-0003-2247-8454; Shah, Nabi/0000-0003-2764-3615; Attia, John R/0000-0001-9800-1308; Loos, Ruth J F/0000-0002-8532-5087; Strawbridge, Rona/0000-0001-8506-3585; Sundstrom, Johan/0000-0003-2247-8454; Milani, Lili/0000-0002-5323-3102; Gandin, Ilaria/0000-0003-3196-2491; ruggiero, daniela/0000-0003-3898-7827; Tzourio, christophe/0000-0002-6517-2984; Deelen, Joris/0000-0003-4483-3701; Peters, Annette/0000-0001-6645-0985; Lopez, Lorna/0000-0002-0241-9783; Debette, Stephanie/0000-0001-8675-7968; Jukema, J. Wouter/0000-0002-3246-8359; Li-Gao, Ruifang/0000-0003-0650-1351; Evangelou, Evangelos/0000-0002-5488-2999; Smith, Albert Vernon/0000-0003-1942-5845; Tzoulaki, Ioanna/0000-0002-4275-9328; Johnson, Andrew D/0000-0001-6369-5178; Johansson, Åsa/0000-0002-2915-4498; Laan, Maris/0000-0002-8519-243X; Hicks, Andrew Anthony/0000-0001-6320-0411; Enroth, Stefan/0000-0002-5056-9137; Campbell, Harry/0000-0002-6169-6262; Levy, Daniel/0000-0003-1843-8724; Ciullo, Marina/0000-0002-9621-9984; Riese, Harriëtte/0000-0003-3661-3151; Dörr, Marcus/0000-0001-7471-475X; Gow, Alan J/0000-0002-3320-4531; Tzourio, christophe/0000-0002-6517-2984; Chauhan, Ganesh/0000-0002-8564-5021; Shrine, Nick/0000-0003-3641-4371; Marrugat, Jaume/0000-0003-3320-554X; Lindgren, Cecilia/0000-0002-4903-9374; CUCCA, Francesco/0000-0002-7414-1995; Karaman, Ibrahim/0000-0001-9341-8155; Ayers, Kristin/0000-0002-4984-5229; Gasparini, Paolo/0000-0002-0859-0856; Mifsud, Borbala/0000-0003-3429-3094; Vuckovic, Dragana/0000-0001-9343-6142; Evangelou, Marina/0000-0003-0789-8944; Penninx, Brenda WJH/0000-0001-7779-9672; Lakatta, Edward/0000-0002-4772-0035; Sargurupremraj, Muralidharan/0000-0003-1684-3750; Keavney, Bernard/0000-0001-9573-0812; Robino, Antonietta/0000-0003-2152-2353; Girotto, Giorgia/0000-0003-4507-6589; Amouyel, Philippe/0000-0001-9088-234X; Joshi, Peter/0000-0002-6361-5059; Knight, Joanne/0000-0002-7148-1660; Boutin, Thibaud/0000-0003-4754-1675; Palotie, Aarno/0000-0002-2527-5874; Melander, Olle/0000-0002-2581-484X; Pazoki, Raha/0000-0002-5142-2348; Noordam, Raymond/0000-0001-7801-809X; Zemunik, Tatijana/0000-0001-8120-2891; Goel, Anuj/0000-0003-2307-4021; Tomaszewski, Maciej/0000-0001-8215-6567; Jansen, Rick/0000-0002-3333-6737; Niiranen, Teemu/0000-0002-7394-7487; Stanton, Alice/0000-0002-4961-165X; Van Duijn, Cornelia/0000-0002-2374-9204; Elliott, Paul/0000-0002-7511-5684; Padmanabhan, Sandosh/0000-0003-3869-5808; Org, Elin/0000-0001-8688-9717; Shields, Denis/0000-0003-4015-2474; Prins, Bram/0000-0001-5774-034X; Pramstaller, Peter P/0000-0002-9831-8302; Amin, Najaf/0000-0002-8944-1771; Dimou, Niki/0000-0003-1678-9328; Saba, Yasaman/0000-0002-3549-2493; ELOSUA, ROBERTO/0000-0001-8235-0095; Theriault, Sebastien/0000-0003-1893-8307; De Borst, Martin/0000-0002-4127-8733; Kahonen, Mika/0000-0002-4510-7341; Doney, Alexander/0000-0002-6210-5620; Morris, Andrew/0000-0002-6805-6014; Willemsen, Gonneke/0000-0003-3755-0236; Oldmeadow, Christopher/0000-0001-6104-1322; Cordell, Heather/0000-0002-1879-5572; Tobin, Martin/0000-0002-3596-7874; NUTILE, TERESA/0000-0001-7062-8352; Wain, Louise/0000-0003-4951-1867; Scott, Rodney/0000-0001-7724-3404; Nelson, Christopher/0000-0001-8025-2897	National Institute for Health Research (NIHR); Medical Research Council [MR/L01632X.1, MR/L01632X/1, MR/L016311/1]; MRC eMedLab Medical Bioinformatics Career Development Fellowship [MR/L016311/1]; NIHR Imperial College Health Care NHS Trust; Imperial College London Biomedical Research Centre; Canadian Institutes of Health Research; Universite Laval (Quebec City, Canada); Canada Research Chair in Genetic and Molecular Epidemiology; CISCO Professorship in Integrated Health Biosystems; EU PhenoMeNal project (Horizon 2020) [654241]; NIH-NIDDK [U01DK102163]; European Research Council (ERC); EU Joint Programme Neurodegenerative Disease Research (JPND); Agence Nationale de la Recherche (ANR); core MRC grant; NIH [R01-DK062370, CRR00070 CR00.01, R01DK110113, U01HG007417, R01DK101855, R01DK107786]; Tripartite Immunometabolism Consortium (TrIC); Novo Nordisk Foundation [NNF15CC0018486]; Marie Sklodowska-Curie GF grant [661395]; ICIN-NHI; MRC AimHy [MR/M016560/1]; Data Tecnica International; National Institute on Aging, NIH; Italian Ministry of Health [RF2010, RC2008]; Royal Netherlands Academy of Science Professor Award [PAH/6635]; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research Investigator (STaR) Award [NMRC/STaR/0028/2017]; National Institutes for Health Research (NIHR); NIHR Biomedical Research Centre, Oxford; China Scholarship Council [2011632047]; Medical Research Council UK [G1000143, MC_UU_12015/1, MC_PC_13048, MC_U106179471]; Cancer Research UK [C864/A14136]; EU FP6 programme [LSHM_CT_2006_037197]; Swiss National Foundation SPUM project [FN 33CM30-124087]; Geneva University; Fondation pour Recherches Medicales, Geneve; Li Ka Shing Foundation; WT-SSI/John Fell funds; Widenlife; Dutch Science Organization (ZonMW-VENI Grant) [916.14.023]; National Institute for Health Research ( NIHR) BioResource Clinical Research Facility; Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Wellcome Trust core award [090532/Z/09/Z]; BHF Centre of Research Excellence [RE/13/1/30181]; European Union Seventh Framework Programme FP7/2007-2013 [HEALTH-F2-2013-601456]; Wellcome Trust Institutional strategic support fund; Forschungs-und Forder-Stiftung INOVA, Liechtenstein; British Heart Foundation [PG/17/35/33001, RG/13/13/30194, SP/13/2/30111]; NIHR Senior Investigator Award; Biomedical Research Centre Award; Marie Sklodowska-Curie GF [661395]; Wellcome Trust [WT098051]; Vanderbilt Molecular and Genetic Epidemiology of Cancer (MAGEC) training program [T32CA160056]; VA grant [1I01CX000982, I01BX003360]; NHLBI, NIH [R21HL121429]; VA Boston Healthcare, Section of Cardiology; Department of Medicine, Brigham; Women's Hospital, Harvard Medical School; UK Medical Research Council [MR/L003120/1]; UK National Institute for Health Research Cambridge Biomedical Research Centre; NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards [HPRU-2012-10141]; Medical Research Council (MRC); Public Health England (PHE) Centre for Environment and Health [(MR/L01341X/]; MRC; Alzheimer's Society; Alzheimer's Research UK; Medical Research Council; MRC eMedLab award; NIHR Biomedical Research Centre at Barts; BBSRC [BB/F019394/1] Funding Source: UKRI; ESRC [ES/S008349/1] Funding Source: UKRI; MRC [MC_UU_00007/10, MR/N01104X/2, MC_PC_U127561128, MR/R023484/1, MR/L003120/1, UKDRI-5001, MR/L01341X/1, MR/M004422/1, MR/K007017/1, G1001799, MR/N01104X/1, MR/S003746/1, MR/N003284/1, MR/N015746/1, MR/L01632X/1, MC_UU_12015/1, G0601966] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043483] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA160056] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL121429, ZIAHL006170, R01HL105756, ZIAHL006001, U01HL130114] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007417, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062370, U01DK102163, R01DK062370, R01DK101855, R01DK107786, P30DK020572, R01DK110113, R01DK075787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007380, ZIAAG000693] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023680] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003360, I01CX000982] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC eMedLab Medical Bioinformatics Career Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Imperial College Health Care NHS Trust; Imperial College London Biomedical Research Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Universite Laval (Quebec City, Canada); Canada Research Chair in Genetic and Molecular Epidemiology; CISCO Professorship in Integrated Health Biosystems; EU PhenoMeNal project (Horizon 2020); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Research Council (ERC)(European Research Council (ERC)European Commission); EU Joint Programme Neurodegenerative Disease Research (JPND); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); core MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tripartite Immunometabolism Consortium (TrIC); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Marie Sklodowska-Curie GF grant; ICIN-NHI; MRC AimHy(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Data Tecnica International; National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Italian Ministry of Health(Ministry of Health, Italy); Royal Netherlands Academy of Science Professor Award; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research Investigator (STaR) Award(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes for Health Research (NIHR); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); China Scholarship Council(China Scholarship Council); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); EU FP6 programme(European Commission); Swiss National Foundation SPUM project; Geneva University; Fondation pour Recherches Medicales, Geneve; Li Ka Shing Foundation; WT-SSI/John Fell funds; Widenlife; Dutch Science Organization (ZonMW-VENI Grant); National Institute for Health Research ( NIHR) BioResource Clinical Research Facility(National Institute for Health Research (NIHR)); Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Wellcome Trust core award(Wellcome Trust); BHF Centre of Research Excellence; European Union Seventh Framework Programme FP7/2007-2013; Wellcome Trust Institutional strategic support fund(Wellcome Trust); Forschungs-und Forder-Stiftung INOVA, Liechtenstein; British Heart Foundation(British Heart Foundation); NIHR Senior Investigator Award; Biomedical Research Centre Award; Marie Sklodowska-Curie GF; Wellcome Trust(Wellcome Trust); Vanderbilt Molecular and Genetic Epidemiology of Cancer (MAGEC) training program; VA grant; NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Boston Healthcare, Section of Cardiology(US Department of Veterans Affairs); Department of Medicine, Brigham; Women's Hospital, Harvard Medical School; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England (PHE) Centre for Environment and Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC eMedLab award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre at Barts; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	H.R.W. was funded by the National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Centre at Barts and The London School of Medicine and Dentistry. D.M.-A. is supported by the Medical Research Council (grant number MR/L01632X.1). B.M. holds an MRC eMedLab Medical Bioinformatics Career Development Fellowship, funded from award MR/L016311/1. H.G. was funded by the NIHR Imperial College Health Care NHS Trust and Imperial College London Biomedical Research Centre. C.P.C. was funded by the National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Center at Barts and The London School of Medicine and Dentistry. S. Theriault was supported by Canadian Institutes of Health Research; Universite Laval (Quebec City, Canada). G.P. was supported by Canada Research Chair in Genetic and Molecular Epidemiology and CISCO Professorship in Integrated Health Biosystems. I. Karaman was supported by the EU PhenoMeNal project (Horizon 2020, 654241). C.P.K. is supported by grant U01DK102163 from the NIH-NIDDK and by resources from the Memphis VA Medical Center. S.D. was supported for this work by grants from the European Research Council (ERC), the EU Joint Programme Neurodegenerative Disease Research (JPND) and the Agence Nationale de la Recherche (ANR). T. Boutin, J. Marten, V.V., A.F.W. and C.H. were supported by a core MRC grant to the MRCHGU QTL in Health and Disease research programme. M. Boehnke is supported by NIH grant R01-DK062370. H.W. and A. Goel acknowledge support of the Tripartite Immunometabolism Consortium (TrIC), Novo Nordisk Foundation (grant NNF15CC0018486). N.V. was supported by a Marie Sklodowska-Curie GF grant (661395) and ICIN-NHI. C. Menni is funded by the MRC AimHy (MR/M016560/1) project grant. M.A.N.'s participation is supported by a consulting contract between Data Tecnica International and the National Institute on Aging, NIH. M. Brumat, M. Cocca, I.G., P.G., G.G., A. Morgan, A.R., D.V., C.M.B., C.F.S., M. Traglia and D.T. were supported by Italian Ministry of Health grant RF2010 to P.G. and RC2008 to P.G.D.I.B. is supported by the Royal Netherlands Academy of Science Professor Award (PAH/6635). J.C.C. is supported by the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research Investigator (STaR) Award (NMRC/STaR/0028/2017). C.P.C., P.B.M. and M.R.B. were funded by the National Institutes for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Centre at Barts.T.F. is supported by the NIHR Biomedical Research Centre, Oxford. M.R. is the recipient of an award from China Scholarship Council (No. 2011632047). C.L. was supported by the Medical Research Council UK (G1000143, MC_UU_12015/1, MC_PC_13048 and MC_U106179471), Cancer Research UK (C864/A14136) and EU FP6 programme (LSHM_CT_2006_037197). G.B.E. is supported by the Swiss National Foundation SPUM project FN 33CM30-124087, Geneva University, and the Fondation pour Recherches Medicales, Geneve. C.M.L. is supported by the Li Ka Shing Foundation; WT-SSI/John Fell funds; the NIHR Biomedical Research Centre, Oxford; Widenlife; and NIH (CRR00070 CR00.01). R.J.F.L. is supported by the NIH (R01DK110113, U01HG007417, R01DK101855 and R01DK107786). D.O.M.-K. is supported by the Dutch Science Organization (ZonMW-VENI Grant 916.14.023). M.M.; r was supported by the National Institute for Health Research ( NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. H.W. and M.F. acknowledge the support of the Wellcome Trust core award (090532/Z/09/Z) and the BHF Centre of Research Excellence (RE/13/1/30181). A. Goel and H.W. acknowledge the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no. HEALTH-F2-2013-601456 (CVGenes@Target) and A. Goel the Wellcome Trust Institutional strategic support fund. L.R. was supported by Forschungs-und Forder-Stiftung INOVA, Liechtenstein. M. Tomaszewski is supported by British Heart Foundation (PG/17/35/33001). P. Sever is recipient of an NIHR Senior Investigator Award and is supported by the Biomedical Research Centre Award to Imperial College Healthcare NHS Trust. P.v.d.H. was supported by the ICIN-NHI and Marie Sklodowska-Curie GF (call: H2020-MSCA-IF-2014, Project ID: 661395). N.J.W. was supported by the Medical Research Council UK (G1000143, MC_UU_12015/1, MC_PC_13048 and MC_U106179471), Cancer Research UK (C864/A14136) and EU FP6 programme (LSHM_CT_2006_037197). E.Z. was supported by the Wellcome Trust (WT098051). J.N.H. was supported by the Vanderbilt Molecular and Genetic Epidemiology of Cancer (MAGEC) training program, funded by T32CA160056 (PI: X.-O. Shu) and by VA grant 1I01CX000982. A. Giri was supported by VA grant 1I01CX000982. T.L.E. and D.R.V.E. were supported by grant R21HL121429 from NHLBI, NIH. A.M.H. was supported by VA Award #I01BX003360. C.J.O. was supported by VA Boston Healthcare, Section of Cardiology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. The MRC/BHF Cardiovascular Epidemiology Unit is supported by the UK Medical Research Council (MR/L003120/1), British Heart Foundation (RG/13/13/30194) and UK National Institute for Health Research Cambridge Biomedical Research Centre. J. Danesh is a British Heart Foundation Professor and NIHR Senior Investigator. L.V.W. holds a GlaxoSmithKline/British Lung Foundation Chair in Respiratory Research. P.E. acknowledges support from the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London, the NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (HPRU-2012-10141), and the Medical Research Council (MRC) and Public Health England (PHE) Centre for Environment and Health (MR/L01341X/1). P.E. is a UK Dementia Research Institute (DRI) professor at Imperial College London, funded by the MRC, Alzheimer's Society and Alzheimer's Research UK. He is also associate director of Health Data Research-UK London, funded by a consortium led by the Medical Research Council. M.J.C. was funded by the National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Center at Barts and The London School of Medicine and Dentistry. M.J.C. is a National Institute for Health Research (NIHR) senior investigator, and this work is funded by the MRC eMedLab award to M.J.C. and M.R.B. and by the NIHR Biomedical Research Centre at Barts.r This research has been conducted using the UK Biobank Resource under application numbers 236 and 10035. This research was supported by the British Heart Foundation (grant SP/13/2/30111). Large-scale comprehensive genotyping of UK Biobank for cardiometabolic traits and diseases: UK CardioMetabolic Consortium (UKCMC).; r Computing: This work was enabled using the computing resources of (i) the UK Medical Bioinformatics aggregation, integration, visualisation and analysis of large, complex data (UK Med-Bio), which is supported by the Medical Research Council (grant number MR/L01632X/1), and (ii) the MRC eMedLab Medical Bioinformatics Infrastructure, supported by the Medical Research Council (grant number MR/L016311/1). The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the US Department of Health and Human Services. C.P.K. is an employee of the US Department of Veterans Affairs. Opinions expressed in this paper are those of the authors and do not necessarily represent the opinion of the Department of Veterans Affairs or the United States Government.	Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Cabrera CP, 2015, WIRES SYST BIOL MED, V7, P73, DOI 10.1002/wsbm.1290; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Canela-Xandri Oriol, 2018, Nat Genet, V50, P1593, DOI 10.1038/s41588-018-0248-z; Conrad KP, 2010, HYPERTENSION, V56, P2, DOI 10.1161/HYPERTENSIONAHA.109.133926; Douma S, 2008, LANCET, V371, P1921, DOI 10.1016/S0140-6736(08)60834-X; Drelon C, 2015, MOL CELL ENDOCRINOL, V408, P156, DOI 10.1016/j.mce.2014.12.014; Dunham I, 2015, F1000RESEARCH, V4, P18, DOI DOI 10.12688/f1000research.6032.1; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; El Wakil A, 2011, MOL CELL ENDOCRINOL, V332, P32, DOI 10.1016/j.mce.2010.11.014; Elliott P, 2014, ENVIRON RES, V134, P280, DOI 10.1016/j.envres.2014.07.025; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; Feng WG, 2017, J AM SOC NEPHROL, V28, P1362, DOI 10.1681/ASN.2016080927; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Miyamoto Y, 2017, LIFE SCI, V177, P20, DOI 10.1016/j.lfs.2017.04.005; Munafo MR, 2018, INT J EPIDEMIOL, V47, P226, DOI 10.1093/ije/dyx206; Munoz M, 2016, NAT GENET, V48, P980, DOI 10.1038/ng.3618; Nakao E, 2017, AM J HYPERTENS, V30, P808, DOI 10.1093/ajh/hpx053; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Oliveira-Paula GH, 2015, EUR J CLIN PHARMACOL, V71, P949, DOI 10.1007/s00228-015-1872-5; Pawlak JB, 2017, PEPTIDES, V88, P1, DOI 10.1016/j.peptides.2016.12.002; Pazoki R, 2018, CIRCULATION, V137, P653, DOI 10.1161/CIRCULATIONAHA.117.030898; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pinero J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav028; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Pulit SL, 2017, GENET EPIDEMIOL, V41, P145, DOI 10.1002/gepi.22032; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Sofat R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002146; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sun HJ, 2016, NEUROPHARMACOLOGY, V103, P247, DOI 10.1016/j.neuropharm.2015.12.023; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Teo AED, 2015, NEW ENGL J MED, V373, P1429, DOI 10.1056/NEJMoa1504869; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Tzoulaki I, 2016, CIRCULATION, V133, P2314, DOI 10.1161/CIRCULATIONAHA.115.008718; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wain LV, 2017, HYPERTENSION, V70, pE4, DOI 10.1161/HYPERTENSIONAHA.117.09438; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang RH, 1999, ARTERIOSCL THROM VAS, V19, P2762, DOI 10.1161/01.ATV.19.11.2762; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	68	459	463	7	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2018	50	10					1412	+		10.1038/s41588-018-0205-x	http://dx.doi.org/10.1038/s41588-018-0205-x			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV4DF	30224653	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000446047000013
J	Gunderson, KL; Steemers, FJ; Lee, G; Mendoza, LG; Chee, MS				Gunderson, KL; Steemers, FJ; Lee, G; Mendoza, LG; Chee, MS			A genome-wide scalable SNP genotyping assay using microarray technology	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LARGE-SCALE IDENTIFICATION; MUTATION DETECTION; PRIMER EXTENSION; DNA ARRAYS; HYBRIDIZATION; AMPLIFICATION; PROBES	Oligonucleotide probe arrays have enabled massively parallel analysis of gene expression levels from a single cDNA sample. Application of microarray technology to analyzing genomic DNA has been stymied by the sequence complexity of the entire human genome. A robust, single base - resolution direct genomic assay would extend the reach of microarray technology. We developed an array-based whole-genome genotyping assay that does not require PCR and enables effectively unlimited multiplexing. The assay achieves a high signal-to-noise ratio by combining specific hybridization of picomolar concentrations of whole genome - amplified DNA to arrayed probes with allele-specific primer extension and signal amplification. As proof of principle, we genotyped several hundred previously characterized SNPs. The conversion rate, call rate and accuracy were comparable to those of high-performance PCR-based genotyping assays.	Illumina Inc, San Diego, CA 92121 USA; Ambion Inc, Austin, TX 78744 USA; Prognosys Biosci Inc, San Diego, CA 92121 USA	Illumina	Gunderson, KL (corresponding author), Illumina Inc, 9885 Town Ctr Dr, San Diego, CA 92121 USA.	kgunderson@illumina.com			NCI NIH HHS [R43 CA103406] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R43CA103406] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOBROW MN, 1989, J IMMUNOL METHODS, V125, P979; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Chen Y, 2004, J AM CHEM SOC, V126, P3016, DOI 10.1021/ja039355j; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; DI X, 2005, BIOINFORMATICS   JAN; Erdogan F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e36; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Gunderson KL, 1998, GENOME RES, V8, P1142, DOI 10.1101/gr.8.11.1142; Hacker GW, 1998, EUR J HISTOCHEM, V42, P111; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Lucito R, 1998, P NATL ACAD SCI USA, V95, P4487, DOI 10.1073/pnas.95.8.4487; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Pastinen T, 2000, GENOME RES, V10, P1031, DOI 10.1101/gr.10.7.1031; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rao KVN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng066; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; Simpson CL, 2004, BIOTECHNIQUES, V37, P996, DOI 10.2144/04376BIN03; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Storhoff JJ, 2002, P SOC PHOTO-OPT INS, V4937, P1, DOI 10.1117/12.476069; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang G, 2004, GENOME RES, V14, P2357, DOI 10.1101/gr.2813404; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; WU DY, 1989, DNA-J MOLEC CELL BIO, V8, P135, DOI 10.1089/dna.1.1989.8.135	35	459	542	1	67	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2005	37	5					549	554		10.1038/ng1547	http://dx.doi.org/10.1038/ng1547			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15838508				2022-12-17	WOS:000228862300027
J	Evgrafov, OV; Mersiyanova, I; Irobi, J; Van Den Bosch, L; Dierick, I; Leung, CL; Schagina, O; Verpoorten, N; Van Impe, K; Fedotov, V; Dadali, E; Auer-Grumbach, M; Windpassinger, C; Wagner, K; Mitrovic, Z; Hilton-Jones, D; Talbot, K; Martin, JJ; Vasserman, N; Tverskaya, S; Polyakov, A; Liem, RKH; Gettemans, J; Robberecht, W; De Jonghe, P; Timmerman, V				Evgrafov, OV; Mersiyanova, I; Irobi, J; Van Den Bosch, L; Dierick, I; Leung, CL; Schagina, O; Verpoorten, N; Van Impe, K; Fedotov, V; Dadali, E; Auer-Grumbach, M; Windpassinger, C; Wagner, K; Mitrovic, Z; Hilton-Jones, D; Talbot, K; Martin, JJ; Vasserman, N; Tverskaya, S; Polyakov, A; Liem, RKH; Gettemans, J; Robberecht, W; De Jonghe, P; Timmerman, V			Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy	NATURE GENETICS			English	Article							ALPHA-B-CRYSTALLIN; SPINAL MUSCULAR-ATROPHY; MISSENSE MUTATION; UP-REGULATION; HSP27; PROTEIN; TYPE-2; MAPS; GENE; MYOPATHY	Charcot-Marie-Tooth disease (CMT) is the most common inherited neuromuscular disease and is characterized by considerable clinical and genetic heterogeneity(1). We previously reported a Russian family with autosomal dominant axonal CMT and assigned the locus underlying the disease (CMT2F; OMIM 606595) to chromosome 7q11-q21 (ref. 2). Here we report a missense mutation in the gene encoding 27-kDa small heat-shock protein 131 (HSPB1, also called HSP27) that segregates in the family with CMT2F Screening for mutations in HSPB1 in 301 individuals with CMT and 115 individuals with distal hereditary motor neuropathies (distal HMNs) confirmed the previously observed mutation and identified four additional missense mutations. We observed the additional HSPB1 mutations in four families with distal HMN and in one individual with CMT neuropathy. Four mutations are located in the Hsp20-alpha-crystallin domain, and one mutation is in the C-terminal part of the HSP27 protein. Neuronal cells transfected with mutated HSPB1 were less viable than cells expressing the wild-type protein. Cotransfection of neurofilament light chain (NEFL) and mutant HSPB1 resulted in altered neurofilament assembly in cells devoid of cytoplasmic intermediate filaments.	New York State Psychiat Inst & Hosp, Res Fdn Mental Hyg, Dept Psychiat, Unit 28, New York, NY 10032 USA; Russian Acad Med Sci, Med Genet Res Ctr, DNA Diagnost Lab, Moscow, Russia; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Katholieke Univ Leuven, Dept Expt Neurol, Neurobiol Lab, Louvain, Belgium; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; State Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; Ctr Diagnost, Genet Counseling Dept, Voronezh, Russia; Med Univ Graz, Inst Med Biol & Human Genet, Graz, Austria; Univ Zagreb, Sch Med, Clin Hosp Ctr, Dept Neurol,Ctr Neuromuscular Dis, Zagreb 41001, Croatia; Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 2JD, England; Univ Antwerp, Born Bunge Fdn, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium	New York State Psychiatry Institute; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Flanders Institute for Biotechnology (VIB); University of Antwerp; KU Leuven; Columbia University; Flanders Institute for Biotechnology (VIB); Ghent University; Medical University of Graz; University of Zagreb; Radcliffe Infirmary; University of Oxford; University of Antwerp; University of Antwerp	Evgrafov, OV (corresponding author), New York State Psychiat Inst & Hosp, Res Fdn Mental Hyg, Dept Psychiat, Unit 28, 1051 Riverside Dr, New York, NY 10032 USA.	Evgrafo@pi.cpmc.columbia.edu	Shchagina, Olga/W-4835-2018; Talbot, Kevin/F-7361-2011; Van Den Bosch, Ludo/B-7258-2012; Timmerman, Vincent/O-7283-2019	Shchagina, Olga/0000-0003-4905-1303; Timmerman, Vincent/0000-0002-2162-0933; Van Den Bosch, Ludo/0000-0003-0104-4067; Talbot, Kevin/0000-0001-5490-1697				Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Batulan Z, 2003, J NEUROSCI, V23, P5789; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; CARPER SW, 1990, NUCLEIC ACIDS RES, V18, P6457, DOI 10.1093/nar/18.21.6457; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; HARDING AE, 1980, J NEUROL SCI, V45, P337, DOI 10.1016/0022-510X(80)90177-X; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; IROBI J, 2004, NAT GENET; Ismailov SM, 2001, EUR J HUM GENET, V9, P646, DOI 10.1038/sj.ejhg.5200686; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Nelis E, 2004, J MED GENET, V41, P193, DOI 10.1136/jmg.2003.012633; Perez-Olle R, 2002, J CELL SCI, V115, P4937, DOI 10.1242/jcs.00148; Perng MD, 1999, J CELL SCI, V112, P2099; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tang BS, 2004, HUM GENET, V114, P527, DOI 10.1007/s00439-004-1102-1; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vleminckx V, 2002, J NEUROPATH EXP NEUR, V61, P968, DOI 10.1093/jnen/61.11.968; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	30	459	490	1	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2004	36	6					602	606		10.1038/ng1354	http://dx.doi.org/10.1038/ng1354			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15122254	Bronze			2022-12-17	WOS:000221763700017
J	POLLAK, MR; BROWN, EM; ESTEP, HL; MCLAINE, PN; KIFOR, O; PARK, J; HEBERT, SC; SEIDMAN, CE; SEIDMAN, JG				POLLAK, MR; BROWN, EM; ESTEP, HL; MCLAINE, PN; KIFOR, O; PARK, J; HEBERT, SC; SEIDMAN, CE; SEIDMAN, JG			AUTOSOMAL-DOMINANT HYPOCALCEMIA CAUSED BY A CA2+-SENSING RECEPTOR GENE MUTATION	NATURE GENETICS			English	Article							PRIMARY HYPERPARATHYROIDISM; HYPERCALCEMIA; EXPRESSION; CLONING	Defects in the human Ca2+-sensing receptor gene have recently been shown to cause familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. We now demonstrate that a missense mutation (Glu128Ala) in this gene causes familial hypocalcaemia in affected members of one family. Xenopus oocytes expressing the mutant receptor exhibit a larger increase in inositol 1,4,5-triphosphate in response to Ca2+ than oocytes expressing the wild-type receptor. We conclude that this extracellular domain mutation increases the receptor's activity at low Ca2+ concentrations, causing hypocalcaemia in patients heterozygous for such a mutation.	EASTERN VIRGINIA MED SCH,DEPT INTERNAL MED,NORFOLK,VA 23505; CHILDRENS HOSP EASTERN ONTARIO,DEPT PEDIAT,OTTAWA K1H 8L1,ON,CANADA; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115	Eastern Virginia Medical School; University of Ottawa; Children's Hospital of Eastern Ontario; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	POLLAK, MR (corresponding author), CHILDRENS HOSP,HOWARD HUGHES MED INST,DEPT MED,75 FRANCIS ST,BOSTON,MA 02115, USA.		Centeno, Patricia Pacios/O-8368-2016		NIDDK NIH HHS [DK46422, DK44588, DK02138] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044588, R01DK046422, K11DK002138] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel F.M., 1989, SHORT PROTOCOLS MOL; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HUNTER AGW, 1981, J MED GENET, V18, P431, DOI 10.1136/jmg.18.6.431; KHOSLA S, 1993, J CLIN ENDOCR METAB, V76, P715, DOI 10.1210/jc.76.3.715; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEFKOWITZ RJ, 1993, NATURE, V365, P603, DOI 10.1038/365603a0; MARX SJ, 1986, J CLIN ENDOCR METAB, V62, P445, DOI 10.1210/jcem-62-2-445; Ott J., 1991, ANAL HUMAN GENETIC L; PARKER I, 1994, CELL CALCIUM, V15, P276, DOI 10.1016/0143-4160(94)90067-1; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; POLLAK MR, 1994, J CLIN INVEST, V93, P1108, DOI 10.1172/JCI117062; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; SHANE E, 1993, PRIMER METABOLIC BON; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SHERWOOD LM, 1993, PRIMER METABOLIC BON; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	21	459	474	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					303	307		10.1038/ng1194-303	http://dx.doi.org/10.1038/ng1194-303			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874174				2022-12-17	WOS:A1994PP76500023
J	DJABALI, M; SELLERI, L; PARRY, P; BOWER, M; YOUNG, BD; EVANS, GA				DJABALI, M; SELLERI, L; PARRY, P; BOWER, M; YOUNG, BD; EVANS, GA			A TRITHORAX-LIKE GENE IS INTERRUPTED BY CHROMOSOME 11Q23 TRANSLOCATIONS IN ACUTE LEUKEMIAS	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; YEAST ARTIFICIAL-CHROMOSOME; ACUTE MONOCYTIC LEUKEMIA; HOMEOBOX GENE; CELL-LINE; BREAKPOINT; PROTEIN; IDENTIFICATION; HYBRIDIZATION; REARRANGEMENT	Some acute lymphocytic leukaemias, particularly those in young children, are associated with a t(4;11)(q21;q23) reciprocal translocation. We have cloned the translocation breakpoint on chromosome 11q23 and isolated corresponding RNA transcripts from this region. The translocation occurs within a cluster of Alu repetitive elements located within an intron of a gene that gives rise to 11.5 (kb) transcript spanning the translocation breakpoint. The 11.5 kb transcript encodes a protein that is highly homologous to the Drosophila trithorax gene, a developmental regulator. An analysis of a series of leukaemic patients carrying t(4;11) and t(9;11) translocations indicate that the majority of breakpoints in infant leukaemias lie within a 5 kb region.	SALK INST BIOL STUDIES,MOLEC GENET LAB,LA JOLLA,CA 92037; ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND	Salk Institute; Cancer Research UK; University of London; Queen Mary University London				Bower, Mark/0000-0002-4077-6351				ABE R, 1983, CANCER GENET CYTOGEN, V9, P139, DOI 10.1016/0165-4608(83)90034-1; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ARTHUR DC, 1982, BLOOD, V59, P96; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERGER R, 1982, LEUKEMIA RES, V6, P17, DOI 10.1016/0145-2126(82)90039-X; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; CHEN CS, 1991, BLOOD, V78, P2498; CHUU WM, 1990, AM J HEMATOL, V34, P246, DOI 10.1002/ajh.2830340403; CIMINO G, 1992, CANCER RES, V52, P3811; CIMINO G, 1991, CANCER RES, V51, P6712; DERRE J, 1990, GENE CHROMOSOME CANC, V2, P341, DOI 10.1002/gcc.2870020413; DJABALI M, 1990, NUCLEIC ACIDS RES, V20, P6789; EVANS GA, 1988, IMMUNOGENETICS, V28, P365, DOI 10.1007/BF00364236; EVANS GA, 1989, P NATL ACAD SCI USA, V86, P5030, DOI 10.1073/pnas.86.13.5030; FEDER M, 1985, CANCER GENET CYTOGEN, V15, P143, DOI 10.1016/0165-4608(85)90142-6; GIBBONS B, 1990, BRIT J HAEMATOL, V74, P264, DOI 10.1111/j.1365-2141.1990.tb02581.x; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HAGEMEIJER A, 1987, LEUKEMIA, V1, P24; HAGEMEIJER A, 1982, CANCER GENET CYTOGEN, V5, P95, DOI 10.1016/0165-4608(82)90001-2; HATANO M, 1991, SCIENCE, V78, P2996; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KAMPS MP, 1991, GENE DEV, V5, P353; KEARNEY L, IN PRESS BLOOD; KONSUWAN K, 1988, EMBO J, V7, P2131; LICHTER P, 1990, SCIENCE, V85, P9664; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; PUI CH, 1987, BLOOD, V69, P1289; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; SAIT SNJ, 1987, CANCER GENET CYTOGEN, V24, P181; SELLERI L, 1991, P NATL ACAD SCI USA, V88, P887, DOI 10.1073/pnas.88.3.887; SHEN WF, 1991, NUCLEIC ACIDS RES, V19, P539, DOI 10.1093/nar/19.3.539; STEPHEN F, 1990, J MOL BIOL, V215, P403, DOI DOI 10.1006/JMBI.1990.9999; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; VANDERFELTZ MJM, 1989, NUCLEIC ACIDS RES, V17, P1, DOI 10.1093/nar/17.1.1; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	37	459	477	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					113	118		10.1038/ng1092-113	http://dx.doi.org/10.1038/ng1092-113			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303259				2022-12-17	WOS:A1992JR08400009
J	Maitra, A; Arking, DE; Shivapurkar, N; Ikeda, M; Stastny, V; Kassauei, K; Sui, GP; Cutler, DJ; Liu, Y; Brimble, SN; Noaksson, K; Hyllner, J; Schulz, TC; Zeng, XM; Freed, WJ; Crook, J; Abraham, S; Colman, A; Sartipy, P; Matsui, SI; Carpenter, M; Gazdar, AF; Rao, M; Chakravarti, A				Maitra, A; Arking, DE; Shivapurkar, N; Ikeda, M; Stastny, V; Kassauei, K; Sui, GP; Cutler, DJ; Liu, Y; Brimble, SN; Noaksson, K; Hyllner, J; Schulz, TC; Zeng, XM; Freed, WJ; Crook, J; Abraham, S; Colman, A; Sartipy, P; Matsui, SI; Carpenter, M; Gazdar, AF; Rao, M; Chakravarti, A			Genomic alterations in cultured human embryonic stem cells	NATURE GENETICS			English	Article							EPIGENETIC INACTIVATION; METHYLATION; CANCER; GENE; AMPLIFICATION; TUMORIGENESIS; MUTATIONS; PHENOTYPE; FREQUENT; TUMORS	Cultured human embryonic stem cell (hESC) lines are an invaluable resource because they provide a uniform and stable genetic system for functional analyses and therapeutic applications. Nevertheless, these dividing cells, like other cells, probably undergo spontaneous mutation at a rate of 10(-9) per nucleotide. Because each mutant has only a few progeny, the overall biological properties of the cell culture are not altered unless a mutation provides a survival or growth advantage. Clonal evolution that leads to emergence of a dominant mutant genotype may potentially affect cellular phenotype as well. We assessed the genomic fidelity of paired early- and late-passage hESC lines in the course of tissue culture. Relative to early-passage lines, eight of nine late-passage hESC lines had one or more genomic alterations commonly observed in human cancers, including aberrations in copy number (45%), mitochondrial DNA sequence (22%) and gene promoter methylation (90%), although the latter was essentially restricted to 2 of 14 promoters examined. The observation that hESC lines maintained in vitro develop genetic and epigenetic alterations implies that periodic monitoring of these lines will be required before they are used in in vivo applications and that some late-passage hESC lines may be unusable for therapeutic purposes.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21205 USA; Univ Texas, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; NIA, Neurosci Lab, Baltimore, MD 21224 USA; BresaGen Inc, Athens, GA USA; Cellartis AB, Gothenburg, Sweden; NIDA, Cellular Neurobiol Branch, Baltimore, MD USA; ES Cell Int, Singapore, Singapore; SUNY Buffalo, Roswell Pk Canc Inst, Buffalo, NY 14260 USA; Robarts Res Inst, London, ON N6A 5C1, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Takara Bio Inc.; Cellartis; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Western University (University of Western Ontario)	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 733 N Broadway Res Bldg, Baltimore, MD 21205 USA.	raomah@grc.nia.nih.gov; aravinda@jhmi.edu	Crook, Jeremy Micah/AAH-8441-2020	Crook, Jeremy Micah/0000-0002-6415-1639; Constable, Sandii/0000-0002-3809-4976	NATIONAL INSTITUTE ON AGING [Z01AG000688, ZIAAG000688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000472, Z01DA000472] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Buzzard JJ, 2004, NAT BIOTECHNOL, V22, P381, DOI 10.1038/nbt0404-381; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Huang Jing, 2004, Human Genomics, V1, P287; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Reddy J, 2005, ONCOGENE, V24, P732, DOI 10.1038/sj.onc.1208032; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Sait SNJ, 2002, GENE CHROMOSOME CANC, V34, P42, DOI 10.1002/gcc.10038; Shivapurkar N, 2004, INT J CANCER, V109, P786, DOI 10.1002/ijc.20041; Toyooka KO, 2002, AM J PATHOL, V161, P629, DOI 10.1016/S0002-9440(10)64218-6; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598	26	458	501	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1099	1103		10.1038/ng1631	http://dx.doi.org/10.1038/ng1631			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142235				2022-12-17	WOS:000232185600021
J	Gayther, SA; Batley, SJ; Linger, L; Bannister, A; Thorpe, K; Chin, SF; Daigo, Y; Russell, P; Wilson, A; Sowter, HM; Delhanty, JDA; Ponder, BAJ; Kouzarides, T; Caldas, C				Gayther, SA; Batley, SJ; Linger, L; Bannister, A; Thorpe, K; Chin, SF; Daigo, Y; Russell, P; Wilson, A; Sowter, HM; Delhanty, JDA; Ponder, BAJ; Kouzarides, T; Caldas, C			Mutations truncating the EP300 acetylase in human cancers	NATURE GENETICS			English	Article							E1A-ASSOCIATED PROTEIN P300; COACTIVATORS P300; CBP; GENE; P53; BINDING; FAMILY	The EP300 protein is a histone acetyltransferase(1.2) that regulates transcription via chromatin remodelling(3) and is important in the processes of cell proliferation(4) and differentiation(5). EP300 acetylation of TP53 in response to DNA damage regulates its DNA-binding and transcription functions(6-9). A role for EP300 in cancer has been implied by the fact that it is targeted by viral oncoproteins, it is fused to MLL in leukaemia and two missense sequence alterations in EP300 were identified in epithelial malignancies(10-13). Nevertheless, direct demonstration of the role of EP300 in tumorigenesis by inactivating mutations in human cancers has been lacking. Here we describe EP300 mutations, which predict a truncated protein, in 6 (3%) of 193 epithelial cancers analysed. Of these six mutations, two were in primary tumours (a colorectal cancer and a breast cancer) and four were in cancer cell lines (colorectal, breast and pancreatic). In addition, we identified a somatic in-frame insertion in a primary breast cancer and missense alterations in a primary colorectal cancer and two cell lines (breast and pancreatic). Inactivation of the second allele was demonstrated in five of six cases with truncating mutations and in two other cases. Our data show that EP300 is mutated in epithelial cancers and provide the first evidence that it behaves as a classical tumour-suppressor gene.	Univ Cambridge, Dept Oncol, Cambridge, England; Univ Cambridge, Dept Pathol, Cambridge, England; Univ Cambridge, Strangeways Res Labs, Cambridge, England; Univ Cambridge, Canbridge Inst Med Res, Wellcome Trust Ctr Study Mol Mechanisms Dis, Cambridge, England; Univ Cambridge, Wellcome CRC Inst, Cambridge, England; Derby City Gen Hosp, Oncol Res Lab, Derby, England; Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge, England; UCL, London Sch Med, Dept Obstet & Gynaecol, London, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Nottingham; University of Cambridge; University of London; University College London	Caldas, C (corresponding author), Univ Cambridge, Dept Oncol, Cambridge, England.	cc234@cam.ac.uk	Thorpe, Karen/N-1159-2017; Caldas, Carlos/U-7250-2019; Caldas, Carlos/A-7543-2008	Thorpe, Karen/0000-0001-8927-4064; Caldas, Carlos/0000-0003-3547-1489; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436; chin, suet-feung/0000-0001-5697-1082; Daigo, Yataro/0000-0002-0915-3025				ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; CALDAS C, 1994, NAT GENET, V8, P410, DOI 10.1038/ng1294-410c; Foster KA, 1996, CANCER RES, V56, P3622; Gayther SA, 1997, ONCOGENE, V15, P2119, DOI 10.1038/sj.onc.1201591; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Muraoka M, 1996, ONCOGENE, V12, P1565; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	18	458	492	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2000	24	3					300	303		10.1038/73536	http://dx.doi.org/10.1038/73536			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700188				2022-12-17	WOS:000085590600025
J	Koob, MD; Moseley, ML; Schut, LJ; Benzow, KA; Bird, TD; Day, JW; Ranum, LPW				Koob, MD; Moseley, ML; Schut, LJ; Benzow, KA; Bird, TD; Day, JW; Ranum, LPW			An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)	NATURE GENETICS			English	Article							MACHADO-JOSEPH DISEASE; RNA-BINDING-PROTEIN; MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; CLINICAL-FEATURES; MICE; TRANSCRIPTS; FAMILIES; MYOPATHY; LENGTH	Myotonic dystrophy (DM) is the only disease reported to be caused by a CTG expansion. We now report that a non-coding CTC expansion causes a novel form of spinocerebellar ataxia (SCA8). This expansion, located on chromosome 13q21, was isolated directly from the genomic DNA of an ataxia patient by RAPID cloning. SCA8 patients have expansions similar in size (107-127 CTG repeats) to those found among adult-onset DM patients. SCA8 is the first example of a dominant SCA not caused by a CAG expansion translated as a polyglutamine tract.	Univ Minnesota, Dept Neurol & Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Cell Biol & Dev, Minneapolis, MN 55455 USA; Dept Vet Affairs Med Ctr, Seattle, WA 98108 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Koob, MD (corresponding author), Univ Minnesota, Dept Neurol & Genet, Box 295 UMHC,420 Delaware St SE, Minneapolis, MN 55455 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS033718, R01NS036282] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS33718, R01 NS36282] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brice A, 1998, J NEUROL, V245, P505, DOI 10.1007/s004150050234; Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Groenen P, 1998, BIOESSAYS, V20, P901, DOI 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOFFMANRADVANYI H, 1993, HUM MOL GENET, V2, P1263; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; Klockgether T, 1998, TRENDS NEUROSCI, V21, P413, DOI 10.1016/S0166-2236(98)01315-0; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACIEL P, 1995, AM J HUM GENET, V57, P54; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; NELLEN W, 1993, TRENDS BIOCHEM SCI, V18, P419, DOI 10.1016/0968-0004(93)90137-C; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; SCHANK SC, 1993, BIOMASS BIOENERG, V4, P1, DOI 10.1016/0961-9534(93)90021-U; SUBRAMONY SH, 1991, HDB CLIN NEUROLOGY, P271; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zoghbi HY, 1991, CURR NEUROL, V11, P121	29	458	483	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					379	384		10.1038/7710	http://dx.doi.org/10.1038/7710			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192387				2022-12-17	WOS:000079439700018
J	Kalachikov, S; Evgrafov, O; Ross, B; Winawer, M; Barker-Cummings, C; Boneschi, FM; Choi, C; Morozov, P; Das, K; Teplitskaya, E; Yu, A; Cayanis, E; Penchaszadeh, G; Kottmann, AH; Pedley, TA; Hauser, WA; Ottman, R; Gilliam, TC				Kalachikov, S; Evgrafov, O; Ross, B; Winawer, M; Barker-Cummings, C; Boneschi, FM; Choi, C; Morozov, P; Das, K; Teplitskaya, E; Yu, A; Cayanis, E; Penchaszadeh, G; Kottmann, AH; Pedley, TA; Hauser, WA; Ottman, R; Gilliam, TC			Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; MEMBRANE-PROTEINS; CHROMOSOME 10Q; GENE; MAP; IDENTIFICATION; DROSOPHILA; SEQUENCES; HELICES; SLIT	The epilepsies are a common, clinically heterogeneous group of disorders defined by recurrent unprovoked seizures(1). Here we describe identification of the causative gene in autosomal-dominant partial epilepsy with auditory features (ADPEAF, MIM 600512), a rare form of idiopathic lateral temporal lobe epilepsy characterized by partial seizures with auditory disturbances(2,3). We constructed a complete, 4.2-Mb physical map across the genetically implicated disease-gene region, identified 28 putative genes (Fig. 1) and resequenced all or part of 21 genes before identifying presumptive mutations in one copy of the leucine-rich, glioma-inactivated 1 gene (LGI1) in each of five families with ADPEAF. Previous studies have indicated that loss of both copies of LGI1 promotes glial tumor progression. We show that the expression pattern of mouse Lgi1 is predominantly neuronal and is consistent with the anatomic regions involved in temporal lobe epilepsy. Discovery of LGI1 as a cause of ADPEAF suggests new avenues for research on pathogenic mechanisms of idiopathic epilepsies.	Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Epidemiol Brain Disorders, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Med Genet, New York, NY 10032 USA; PsychoGenics Inc, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute	Ottman, R (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, 630 W 168 St,P&S Box 16, New York, NY 10032 USA.		Kottmann, Andreas/Y-1180-2019; Hauser, W Allen/AAB-5277-2020; Ottman, Ruth/O-2371-2013; Boneschi, Filippo Martinelli/H-8592-2012	Kottmann, Andreas/0000-0002-5435-7502; Ottman, Ruth/0000-0001-7074-242X; martinelli boneschi, filippo/0000-0002-9955-1368	NINDS NIH HHS [R01 NS020656-13, R01 NS036319, R01 NS036319-08, R01 NS020656] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020656, R01NS036319] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; GRAY IC, 1995, GENOMICS, V28, P328, DOI 10.1006/geno.1995.1149; Gray IC, 1997, GENOMICS, V43, P85, DOI 10.1006/geno.1997.4809; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Juretic D, 1998, COMPUT CHEM, V22, P279, DOI 10.1016/S0097-8485(97)00070-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Mautner VF, 2000, NEUROGENETICS, V3, P31, DOI 10.1007/s100480000091; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; Michelucci R, 2000, EPILEPSIA, V41, P967, DOI 10.1111/j.1528-1157.2000.tb00280.x; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Nobile C, 1998, MAMM GENOME, V9, P835, DOI 10.1007/s003359900877; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Poza JJ, 1999, ANN NEUROL, V45, P182, DOI 10.1002/1531-8249(199902)45:2<182::AID-ANA8>3.0.CO;2-G; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Somerville RPT, 2000, MAMM GENOME, V11, P622, DOI 10.1007/s0033500101280; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Winawer MR, 2000, NEUROLOGY, V54, P2173, DOI 10.1212/WNL.54.11.2173; WINAWER MR, 2002, EPILEPSIA, V43, P55; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477	30	457	476	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					335	341		10.1038/ng832	http://dx.doi.org/10.1038/ng832			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11810107	Green Accepted			2022-12-17	WOS:000174157600022
J	Kawaguchi, TK; Skaletsky, H; Brown, LG; Minx, PJ; Cordum, HS; Waterston, RH; Wilson, RK; Silber, S; Oates, R; Rozen, S; Page, DC				Kawaguchi, TK; Skaletsky, H; Brown, LG; Minx, PJ; Cordum, HS; Waterston, RH; Wilson, RK; Silber, S; Oates, R; Rozen, S; Page, DC			The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men	NATURE GENETICS			English	Article							INTRACYTOPLASMIC SPERM INJECTION; DAZ GENE-CLUSTER; INTRACHROMOSOMAL RECOMBINATION; AZOOSPERMIC MEN; MICRODELETIONS; SEQUENCE; INTERVAL; GENOME; FAMILY; LOCUS	Deletions of the AZFc (azoospermia factor c) region of the Y chromosome are the most common known cause of spermatogenic failure. We determined the complete nucleotide sequence of AZFc by identifying and distinguishing between near-identical amplicons (massive repeat units) using an iterative mapping-sequencing process. A complex of three palindromes, the largest spanning 3 Mb with 99.97% identity between its arms, encompasses the AZFc region. The palindromes are constructed from six distinct families of amplicons, with unit lengths of 115-678 kb, and may have resulted from tandem duplication and inversion during primate evolution. The palindromic complex contains 11 families of transcription units, all expressed in testis. Deletions of AZFc that cause infertility are remarkably uniform, spanning a 3.5-Mb segment and bounded by 229-kb direct repeats that probably served as substrates for homologous recombination.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO 63107 USA; Boston Univ, Sch Med, Dept Urol, Boston, MA 02228 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Saint Luke's Hospital - Missouri; Boston University	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Oates, Robert/0000-0003-2330-6697; Rozen, Steven G./0000-0002-4288-0056				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chai NN, 1998, GENOMICS, V49, P283, DOI 10.1006/geno.1998.5255; Delbridge ML, 1999, NAT GENET, V22, P223, DOI 10.1038/10279; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; Girardi SK, 1997, HUM REPROD, V12, P1635, DOI 10.1093/humrep/12.8.1635; Glaser B, 1998, CHROMOSOME RES, V6, P481, DOI 10.1023/A:1009256613348; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kleiman SE, 1999, HUM REPROD, V14, P33, DOI 10.1093/humrep/14.1.33; KOBAYASHI K, 1994, HUM MOL GENET, V3, P1965, DOI 10.1093/hmg/3.11.1965; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEWIN B, 1995, CELL, V80, P1, DOI 10.1016/0092-8674(95)90442-5; LIU L, 1987, NUCLEIC ACIDS RES, V15, P9461, DOI 10.1093/nar/15.22.9461; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Mulhall JP, 1997, HUM REPROD, V12, P503; Nakahori Y, 1996, HORM RES, V46, P20, DOI 10.1159/000185175; Ohno S., 1967, SEX CHROMOSOMES SEX; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Page DC, 1999, HUM REPROD, V14, P1722, DOI 10.1093/humrep/14.7.1722; Pearson W R, 2000, Methods Mol Biol, V132, P185; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Sargent CA, 1999, J MED GENET, V36, P670; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Silber SJ, 1998, HUM REPROD, V13, P3332, DOI 10.1093/humrep/13.12.3332; Simoni M, 1997, FERTIL STERIL, V67, P542, DOI 10.1016/S0015-0282(97)80083-0; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Vogel T, 1999, HUM REPROD, V14, P3023, DOI 10.1093/humrep/14.12.3023; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Yen PH, 1998, GENOMICS, V54, P5, DOI 10.1006/geno.1998.5526	49	457	497	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					279	286		10.1038/ng757	http://dx.doi.org/10.1038/ng757			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687796				2022-12-17	WOS:000171911000013
J	WATKINS, H; CONNER, D; THIERFELDER, L; JARCHO, JA; MACRAE, C; MCKENNA, WJ; MARON, BJ; SEIDMAN, JG; SEIDMAN, CE				WATKINS, H; CONNER, D; THIERFELDER, L; JARCHO, JA; MACRAE, C; MCKENNA, WJ; MARON, BJ; SEIDMAN, JG; SEIDMAN, CE			MUTATIONS IN THE CARDIAC MYOSIN BINDING PROTEIN-C GENE ON CHROMOSOME-11 CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY	NATURE GENETICS			English	Note							MYBP-C; CLINICAL MANIFESTATIONS; PATHO-PHYSIOLOGY; MUSCLE; IMMUNOGLOBULIN-C2; INTERRELATIONS; EXPRESSION; SEQUENCE; THERAPY; DOMAIN		BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,BOSTON,MA 02115; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115; FRANZ VOLHARD KLIN,BERLIN,GERMANY; MAX DELBRUCK CTR MOLEC MED,BERLIN,GERMANY; MINNEAPOLIS HEART INST FDN,MINNEAPOLIS,MN 55407	Harvard University; Brigham & Women's Hospital; St Georges University London; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Franz-Volhard Clinical Research Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Minneapolis Heart Institute Foundation	WATKINS, H (corresponding author), BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115, USA.		McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460; Watkins, Hugh/0000-0002-5287-9016	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; FURST DO, 1992, J CELL SCI, V102, P769; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GEISTERFERLOWRA.AA, 1990, CELL, V62, P999; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACRAE CA, IN PRESS J CLIN INVE; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MCKENNA WJ, 1995, METABOLIC MOL BASES, P4253; MOOS C, 1980, BIOCHIM BIOPHYS ACTA, V632, P141, DOI 10.1016/0304-4165(80)90071-9; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SCHLENDER KK, 1991, J BIOL CHEM, V266, P2811; SCHULTHEISS T, 1990, J CELL BIOL, V110, P1159, DOI 10.1083/jcb.110.4.1159; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; VAUGHAN KT, 1992, SYM SOC EXP BIOL, V46, P167; VAUGHAN KT, 1993, J BIOL CHEM, V268, P3670; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1994, CURRENT PROTOCOLS HU; WEBER FE, 1993, EUR J BIOCHEM, V216, P661, DOI 10.1111/j.1432-1033.1993.tb18186.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	24	457	466	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					434	437		10.1038/ng1295-434	http://dx.doi.org/10.1038/ng1295-434			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493025				2022-12-17	WOS:A1995TH62900022
J	Gao, YB; Chen, ZL; Li, JG; Hu, XD; Shi, XJ; Sun, ZM; Zhang, F; Zhao, ZR; Li, ZT; Liu, ZY; Zhao, YD; Sun, J; Zhou, CC; Yao, R; Wang, SY; Wang, P; Sun, N; Zhang, BH; Dong, JS; Yu, Y; Luo, M; Feng, XL; Shi, SS; Zhou, F; Tan, FW; Qiu, B; Li, N; Shao, K; Zhang, LJ; Zhang, LJ; Xue, Q; Gao, SG; He, J				Gao, Yi-Bo; Chen, Zhao-Li; Li, Jia-Gen; Hu, Xue-Da; Shi, Xue-Jiao; Sun, Zeng-Miao; Zhang, Fan; Zhao, Zi-Ran; Li, Zi-Tong; Liu, Zi-Yuan; Zhao, Yu-Da; Sun, Jian; Zhou, Cheng-Cheng; Yao, Ran; Wang, Su-Ya; Wang, Pan; Sun, Nan; Zhang, Bai-Hua; Dong, Jing-Si; Yu, Yue; Luo, Mei; Feng, Xiao-Li; Shi, Su-Sheng; Zhou, Fang; Tan, Feng-Wei; Qiu, Bin; Li, Ning; Shao, Kang; Zhang, Li-Jian; Zhang, Lan-Jun; Xue, Qi; Gao, Shu-Geng; He, Jie			Genetic landscape of esophageal squamous cell carcinoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RECURRENT SOMATIC MUTATIONS; SUSCEPTIBILITY LOCI; CANCER GENOME; LUNG-CANCER; GASTRIC ADENOCARCINOMA; FREQUENT MUTATION; LIM PROTEIN; EXOME; FAMILY	Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers'. We performed exome sequencing on 113 tumor-normal pairs, yielding a mean of 82 non-silent mutations per tumor, and 8 cell lines. The mutational profile of ESCC closely resembles those of squamous cell carcinomas of other tissues but differs from that of esophageal adenocarcinoma. Genes involved in cell cycle and apoptosis regulation were mutated in 99% of cases by somatic alterations of TP53 (93%), CCND1 (33%), CDKN2A (20%), NFE2L2 (10%) and RB1 (9%). Histone modifier genes were frequently mutated, including KMT2D (also called MLL2; 19%), KMT2C (MLL3; 6%), KDM6A (7%), EP300 (10%) and CREBBP (6%). EP300 mutations were associated with poor survival. The Hippo and Notch pathways were dysregulated by mutations in FAT1, FAT2, FAT3 or FAT4 (27%) or AJUBA (1UB; 7%) and NOTCH1, NOTCH2 or NOTCH3 (22%) or FBXW7 (5%), respectively. These results define the mutational landscape of ESCC and highlight mutations in epigenetic modulators with prognostic and potentially therapeutic implications.	[Gao, Yi-Bo; Chen, Zhao-Li; Li, Jia-Gen; Hu, Xue-Da; Shi, Xue-Jiao; Sun, Zeng-Miao; Zhang, Fan; Liu, Zi-Yuan; Zhao, Yu-Da; Sun, Jian; Zhou, Cheng-Cheng; Yao, Ran; Wang, Su-Ya; Sun, Nan; Zhang, Bai-Hua; Dong, Jing-Si; Yu, Yue; Luo, Mei; Zhou, Fang; Tan, Feng-Wei; Qiu, Bin; Li, Ning; Shao, Kang; Xue, Qi; Gao, Shu-Geng; He, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China; [Zhao, Zi-Ran; Li, Zi-Tong; Wang, Pan] Peking Union Med Coll, Dept Clin Med, Beijing 100021, Peoples R China; [Zhao, Zi-Ran; Li, Zi-Tong; Wang, Pan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Feng, Xiao-Li; Shi, Su-Sheng] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Zhang, Li-Jian] Peking Univ, Canc Hosp, Dept Thorac Surg, Beijing 100871, Peoples R China; [Zhang, Lan-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking University; Sun Yat Sen University	He, J (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China.	prof.hejie@263.net	Gao, Yi-Bo/AAP-4866-2020	Gao, Yi-Bo/0000-0002-0501-9814	National High-Tech Research and Development Program of China [2012AA02A503]; National Natural Science Foundation of China [81172336, 81372219, 81301851, U1302223]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT13006]; Beijing Municipal Natural Science Foundation [7141011]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	We thank M.-H. Xiong and all the staff and assistants in the Lab and Tumor Bank of the Department of Thoracic Surgery for their support in collecting and processing samples. This work was supported by the National High-Tech Research and Development Program of China (2012AA02A503), the National Natural Science Foundation of China (81172336, 81372219, 81301851 and U1302223), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT13006) and the Beijing Municipal Natural Science Foundation (7141011).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen SB, 2013, J THORAC ONCOL, V8, P495, DOI 10.1097/JTO.0b013e3182829e2c; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Goodman RH, 2000, GENE DEV, V14, P1553; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hu N, 2002, CLIN CANCER RES, V8, P1121; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim Y, 2014, J CLIN ONCOL, V32, P121, DOI 10.1200/JCO.2013.50.8556; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li Y, 2011, ANN THORAC SURG, V91, P1531, DOI 10.1016/j.athoracsur.2010.12.012; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Maesawa C, 1998, GENE CHROMOSOME CANC, V21, P276, DOI 10.1002/(SICI)1098-2264(199803)21:3<276::AID-GCC15>3.3.CO;2-H; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Morgan MA, 2013, MOL CELL BIOL, V33, P1698, DOI 10.1128/MCB.00203-13; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Okines A, 2011, NAT REV CLIN ONCOL, V8, P492, DOI 10.1038/nrclinonc.2011.45; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; STONER GD, 1991, CANCER RES, V51, P365; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042281; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055834; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	79	456	478	5	96	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1097	1102		10.1038/ng.3076	http://dx.doi.org/10.1038/ng.3076			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25151357				2022-12-17	WOS:000342554100012
J	Amundadottir, L; Kraft, P; Stolzenberg-Solomon, RZ; Fuchs, CS; Petersen, GM; Arslan, AA; Bueno-De-Mesquita, HB; Gross, M; Helzlsouer, K; Jacobs, EJ; LaCroix, A; Zheng, W; Albanes, D; Bamlet, W; Berg, CD; Berrino, F; Bingham, S; Buring, JE; Bracci, PM; Canzian, F; Clavel-Chapelon, F; Clipp, S; Cotterchio, M; de Andrade, M; Duell, EJ; Fox, JW; Gallinger, S; Gaziano, JM; Giovannucci, EL; Goggins, M; Gonzalez, CA; Hallmans, G; Hankinson, SE; Hassan, M; Holly, EA; Hunter, DJ; Hutchinson, A; Jackson, R; Jacobs, KB; Jenab, M; Kaaks, R; Klein, AP; Kooperberg, C; Kurtz, RC; Li, DH; Lynch, SM; Mandelson, M; McWilliams, RR; Mendelsohn, JB; Michaud, DS; Olson, SH; Overvad, K; Patel, AV; Peeters, PHM; Rajkovic, A; Riboli, E; Risch, HA; Shu, XO; Thomas, G; Tobias, GS; Trichopoulos, D; Van Den Eeden, SK; Virtamo, J; Wactawski-Wende, J; Wolpin, BM; Yu, H; Yu, K; Zeleniuch-Jacquotte, A; Chanock, SJ; Hartge, P; Hoover, RN				Amundadottir, Laufey; Kraft, Peter; Stolzenberg-Solomon, Rachael Z.; Fuchs, Charles S.; Petersen, Gloria M.; Arslan, Alan A.; Bueno-de-Mesquita, H. Bas; Gross, Myron; Helzlsouer, Kathy; Jacobs, Eric J.; LaCroix, Andrea; Zheng, Wei; Albanes, Demetrius; Bamlet, William; Berg, Christine D.; Berrino, Franco; Bingham, Sheila; Buring, Julie E.; Bracci, Paige M.; Canzian, Federico; Clavel-Chapelon, Francoise; Clipp, Sandra; Cotterchio, Michelle; de Andrade, Mariza; Duell, Eric J.; Fox, John W., Jr.; Gallinger, Steven; Gaziano, J. Michael; Giovannucci, Edward L.; Goggins, Michael; Gonzalez, Carlos A.; Hallmans, Goran; Hankinson, Susan E.; Hassan, Manal; Holly, Elizabeth A.; Hunter, David J.; Hutchinson, Amy; Jackson, Rebecca; Jacobs, Kevin B.; Jenab, Mazda; Kaaks, Rudolf; Klein, Alison P.; Kooperberg, Charles; Kurtz, Robert C.; Li, Donghui; Lynch, Shannon M.; Mandelson, Margaret; McWilliams, Robert R.; Mendelsohn, Julie B.; Michaud, Dominique S.; Olson, Sara H.; Overvad, Kim; Patel, Alpa V.; Peeters, Petra H. M.; Rajkovic, Aleksandar; Riboli, Elio; Risch, Harvey A.; Shu, Xiao-Ou; Thomas, Gilles; Tobias, Geoffrey S.; Trichopoulos, Dimitrios; Van Den Eeden, Stephen K.; Virtamo, Jarmo; Wactawski-Wende, Jean; Wolpin, Brian M.; Yu, Herbert; Yu, Kai; Zeleniuch-Jacquotte, Anne; Chanock, Stephen J.; Hartge, Patricia; Hoover, Robert N.			Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer	NATURE GENETICS			English	Article							BASE-LINE CHARACTERISTICS; WOMENS HEALTH; BLOOD-GROUP; RISK; DESIGN; GENES; POLYMORPHISMS; RATIONALE; MORTALITY; ALLERGIES	We conducted a two-stage genome-wide association study of pancreatic cancer, a cancer with one of the lowest survival rates worldwide. We genotyped 558,542 SNPs in 1,896 individuals with pancreatic cancer and 1,939 controls drawn from 12 prospective cohorts plus one hospital-based case-control study. We conducted a combined analysis of these groups plus an additional 2,457 affected individuals and 2,654 controls from eight case-control studies, adjusting for study, sex, ancestry and five principal components. We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28). This SNP maps to the first intron of the ABO blood group gene. Our results are consistent with earlier epidemiologic evidence suggesting that people with blood group O may have a lower risk of pancreatic cancer than those with groups A or B.	[Amundadottir, Laufey; Chanock, Stephen J.] Natl Canc Inst, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlt & Human Serv, Bethesda, MD 20892 USA; [Amundadottir, Laufey; Stolzenberg-Solomon, Rachael Z.; Albanes, Demetrius; Hutchinson, Amy; Mendelsohn, Julie B.; Thomas, Gilles; Tobias, Geoffrey S.; Yu, Kai; Chanock, Stephen J.; Hartge, Patricia; Hoover, Robert N.] Natl Canc Inst, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Kraft, Peter; Giovannucci, Edward L.; Hankinson, Susan E.; Hunter, David J.; Michaud, Dominique S.; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Fuchs, Charles S.; Wolpin, Brian M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fuchs, Charles S.; Giovannucci, Edward L.; Hankinson, Susan E.; Hunter, David J.; Wolpin, Brian M.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Petersen, Gloria M.; Bamlet, William; de Andrade, Mariza] Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Arslan, Alan A.] NYU, Dept Obstet & Gynecol, Sch Med, New York, NY 10016 USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Inst Canc, New York, NY USA; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Gross, Myron] Univ Minnesota, Sch Med, Dept Lab Med Pathol, Minneapolis, MN 55455 USA; [Helzlsouer, Kathy] St Johns Mercy Med Ctr, Prevent & Res Ctr, Baltimore, MD USA; [Jacobs, Eric J.; Patel, Alpa V.] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [LaCroix, Andrea; Kooperberg, Charles; Mandelson, Margaret] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Berg, Christine D.] Natl Canc Inst, Canc Prevent Div, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Berrino, Franco] Ist Nazl Tumori, Etiol Epidemiol & Prevent Unit, Fdn IRCCS, I-20133 Milan, Italy; [Bingham, Sheila] Univ Cambridge, MRC, Dunn Human Nutr Unit, Cambridge, England; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Bracci, Paige M.; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Canzian, Federico; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, DKFZ, D-6900 Heidelberg, Germany; [Clavel-Chapelon, Francoise] INSERM, Villejuif, France; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, Villejuif, France; [Clipp, Sandra] Johns Hopkins Bloomberg Sch Publ Hlth, George W Comstock Ctr Publ Hlth Res & Prevent, Hagerstown, MD USA; [Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Duell, Eric J.; Jenab, Mazda] Int Agcy Res Canc, F-69372 Lyon, France; [Fox, John W., Jr.] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Sol Goldman Pancreat Res Ctr, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Res Ctr, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Sol Goldman Pancreat Res Ctr, Baltimore, MD 21205 USA; [Gonzalez, Carlos A.] ICO, Unit Nutr Environm & Canc, Canc Epidemiol Res Programme, Barcelona, Spain; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hassan, Manal; Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Hutchinson, Amy; Jacobs, Kevin B.] SAIC Frederick Inc, Core Genotyping Facil, Adv Technol Program, NCI, Frederick, MD USA; [Jackson, Rebecca] Ohio State Univ, Dept Internal Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Jackson, Rebecca] Ohio State Univ, Ctr Clin & Translat Sci, Columbus, OH 43210 USA; [Jacobs, Kevin B.] Bioinformed LLC, Gaithersburg, MD USA; [Klein, Alison P.] Johns Hopkins Med Inst, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Sol Goldman Pancreat Res Ctr, Baltimore, MD 21205 USA; [Lynch, Shannon M.] Natl Canc Inst, Epidemiol & Genet Res Program, Div Canc Control & Populat Sci, NIH,Dept Hlth & Human Serv, Bethesda, MD USA; [Kurtz, Robert C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Mandelson, Margaret] Grp Hlth Ctr Hlth Studies, Seattle, WA USA; [McWilliams, Robert R.] Mayo Clin, Dept Oncol, Coll Med, Rochester, MN USA; [Michaud, Dominique S.; Peeters, Petra H. M.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London, England; [Olson, Sara H.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rajkovic, Aleksandar] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Risch, Harvey A.; Yu, Herbert] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Trichopoulos, Dimitrios] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens, Greece; [Van Den Eeden, Stephen K.] No Calif Reg, Div Res, Kaiser Permanente, Oakland, CA USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Mayo Clinic; New York University; New York University; New York University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Mercy Medical Center - Maryland; American Cancer Society; Fred Hutchinson Cancer Center; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fondazione IRCCS Istituto Nazionale Tumori Milan; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; World Health Organization; International Agency for Research on Cancer (IARC); Michigan State University; Michigan State University College of Human Medicine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Umea University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Mayo Clinic; Imperial College London; Memorial Sloan Kettering Cancer Center; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Utrecht University; Utrecht University Medical Center; Baylor College of Medicine; Yale University; Athens Medical School; National & Kapodistrian University of Athens; Kaiser Permanente; Finland National Institute for Health & Welfare; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chanock, SJ (corresponding author), Natl Canc Inst, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlt & Human Serv, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Wactawski-Wende, Jean/AGH-5457-2022; zhang, weihua/GXV-1334-2022; Gallinger, Steven/E-4575-2013; Berrino, Franco/AAC-2364-2020; Canzian, Federico/I-2804-2014; Clavel-Chapelon, Francoise/G-6733-2014; Zheng, Wei/O-3351-2013; Stolzenberg-Solomon, Rachael/Y-9280-2018; González, Carlos A A/O-4651-2014; Amundadottir, Laufey T/L-7656-2016; Albanes, Demetrius/B-9749-2015; Tobias, Geoffrey S/M-4135-2016; Michaud, Dominique S/I-5231-2014; Hassan, Moustapha/H-9260-2015	Wactawski-Wende, Jean/0000-0003-3096-9595; Berrino, Franco/0000-0002-4858-1866; Zheng, Wei/0000-0003-1226-070X; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; González, Carlos A A/0000-0003-2822-9715; Amundadottir, Laufey T/0000-0003-1859-8971; Tobias, Geoffrey S/0000-0002-2878-8253; Arslan, Alan/0000-0002-7775-8085; Bamlet, William/0000-0003-2903-1284; Jenab, Mazda/0000-0002-0573-1852; Hassan, Moustapha/0000-0003-1927-5859; Overvad, Kim/0000-0001-6429-7921; Riboli, Elio/0000-0001-6795-6080; Jacobs, Kevin/0000-0002-4657-6473; Olson, Sara/0000-0003-0182-2754; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Canzian, Federico/0000-0002-4261-4583; Cotterchio, Michelle/0000-0003-2862-7895; Duell, Eric J/0000-0001-5256-0163	NATIONAL CANCER INSTITUTE [R01CA097193, P50CA102701, R01CA082729, P50CA062924, ZIACP010193, R01CA124908] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 CP010193-01] Funding Source: Medline; NCI NIH HHS [P50 CA062924-150011, P50 CA102701, R01 CA097193, P50 CA062924-160011, P50 CA062924-140011, R01 CA082729, P50 CA102701-08, P50 CA062924, R01 CA124908] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Anderson KE, 2006, CANC EPIDEMIOLOGY PR; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970.abs; Duell EJ, 2008, CANCER EPIDEM BIOMAR, V17, P1470, DOI 10.1158/1055-9965.EPI-07-2797; Eppel A, 2007, INT J CANCER, V121, P2241, DOI 10.1002/ijc.22884; FERLAY J, 2004, 5 IARC; FOSTER GS, 1972, NEW ENGL J MED, V286, P1353; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gallicchio L, 2008, AM J EPIDEMIOL, V167, P807, DOI 10.1093/aje/kwm378; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; ITZKOWITZ SH, 1987, JNCI-J NATL CANCER I, V79, P425; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Klein AP, 2004, CANCER RES, V64, P2634, DOI 10.1158/0008-5472.CAN-03-3823; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; MARCUS DM, 1969, NEW ENGL J MED, V280, P994, DOI 10.1056/NEJM196905012801806; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Olson SH, 2007, CANCER DETECT PREV, V31, P345, DOI 10.1016/j.cdp.2007.10.002; Pare G, 2008, PLOS GENET, V4; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Risch HA, 2003, JNCI-J NATL CANCER I, V95, P948, DOI 10.1093/jnci/95.13.948; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wolpin BM, 2007, CANCER RES, V67, P7923, DOI 10.1158/0008-5472.CAN-07-0373; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; Xu WH, 2007, PREV MED, V45, P313, DOI 10.1016/j.ypmed.2007.05.015; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zeleniuch-Jacquotte A, 2005, INT J CANCER, V114, P323, DOI 10.1002/ijc.20694; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	44	455	464	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					986	U47		10.1038/ng.429	http://dx.doi.org/10.1038/ng.429			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19648918	Green Accepted			2022-12-17	WOS:000269382100009
J	Mizuguchi, T; Collod-Beroud, G; Akiyama, T; Abifadel, M; Harada, N; Morisaki, T; Allard, D; Varret, M; Claustres, M; Morisaki, H; Ihara, M; Kinoshita, A; Yoshiura, K; Junien, C; Kajii, T; Jondeau, G; Ohta, T; Kishino, T; Furukawa, Y; Nakamura, Y; Niikawa, N; Boileau, C; Matsumoto, N				Mizuguchi, T; Collod-Beroud, G; Akiyama, T; Abifadel, M; Harada, N; Morisaki, T; Allard, D; Varret, M; Claustres, M; Morisaki, H; Ihara, M; Kinoshita, A; Yoshiura, K; Junien, C; Kajii, T; Jondeau, G; Ohta, T; Kishino, T; Furukawa, Y; Nakamura, Y; Niikawa, N; Boileau, C; Matsumoto, N			Heterozygous TGFBR2 mutations in Marfan syndrome	NATURE GENETICS			English	Article							II RECEPTOR GENE; BETA ACTIVATION; MICROSATELLITE INSTABILITY; COLON-CANCER; INACTIVATION; LOCUS	Marfan syndrome is an extracellular matrix disorder with cardinal manifestations in the eye, skeleton and cardiovascular systems associated with defects in the gene encoding fibrillin (FBN1) at 15q21.1 (ref. 1). A second type of the disorder ( Marfan syndrome type 2; OMIM 154705) is associated with a second locus, MFS2, at 3p25-p24.2 in a large French family (family MS1)(2). Identification of a 3p24.1 chromosomal breakpoint disrupting the gene encoding TGF-beta receptor 2 (TGFBR2) in a Japanese individual with Marfan syndrome led us to consider TGFBR2 as the gene underlying association with Marfan syndrome at the MSF2 locus. The mutation 1524G --> A in TGFBR2 ( causing the synonymous amino acid substitution Q508Q) resulted in abnormal splicing and segregated with MFS2 in family MS1. We identified three other missense mutations in four unrelated probands, which led to loss of function of TGF-beta signaling activity on extracellular matrix formation. These results show that heterozygous mutations in TGFBR2, a putative tumor-suppressor gene implicated in several malignancies, are also associated with inherited connective-tissue disorders.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan; Inst Univ Rech Clin, Genet Mol Lab, Montpellier, France; Univ Paris 05, INSERM, U383, Hop Necker Enfants Malad, Paris, France; Natl Okayama Med Ctr, Div Pediat Surg, Okayama, Japan; Kyushu Med Sci Nagasaki Lab, Nagasaki, Japan; Natl Cardiovasc Ctr, Res Inst, Dept Biosci, Suita, Osaka 565, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Biophys, Nagasaki 852, Japan; Hop Ambroise Pare, Lab Biochim Hormonol & Genet Mol, Boulogne, France; Hop Ambroise Pare, Serv Cardiol, Boulogne, France; Nagasaki Univ, Ctr Frontier Life Sci, Div Funct Gen, Nagasaki 852, Japan; Hlth Sci Univ Hokkaido, Ishikari, Hokkaido 06102, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan	Nagasaki University; Japan Science & Technology Agency (JST); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Cerebral & Cardiovascular Center - Japan; Nagasaki University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Nagasaki University; Health Sciences University of Hokkaido; University of Tokyo; Yokohama City University	Boileau, C (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan.	boileau@necker.fr; naomat@yokohama-cu.ac.jp	VARRET, Mathilde/C-2279-2016; COLLOD-BEROUD, Gwenaëlle/A-8342-2008; Abifadel, Marianne/ABH-5370-2020; boileau, catherine/M-4482-2017	VARRET, Mathilde/0000-0001-9261-1551; COLLOD-BEROUD, Gwenaëlle/0000-0003-4098-6161; boileau, catherine/0000-0002-0371-7539; ALLARD, Delphine/0000-0001-7534-8982; ABIFADEL, Marianne/0000-0001-7645-8323				Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; BOILEAU C, 1993, AM J HUM GENET, V53, P46; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; COLLOD G, 1994, NAT GENET, V8, P264, DOI 10.1038/ng1194-264; Collod-Beroud G, 2002, EUR J HUM GENET, V10, P673, DOI 10.1038/sj.ejhg.5200876; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; Grady WM, 1999, CANCER RES, V59, P320; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Kissin EY, 2002, ARTHRITIS RHEUM, V46, P3000, DOI 10.1002/art.10621; Lu SL, 1999, BIOCHEM BIOPH RES CO, V259, P385, DOI 10.1006/bbrc.1999.0788; Lu SL, 1998, NAT GENET, V19, P17, DOI 10.1038/ng0598-17; Lucke CD, 2001, CANCER RES, V61, P482; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Matsukawa R, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<71::AID-HUMU9>3.0.CO;2-0; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; PARSONS R, 1995, CANCER RES, V55, P5548; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Tanaka S, 2000, BRIT J CANCER, V82, P1557	22	455	482	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					855	860		10.1038/ng1392	http://dx.doi.org/10.1038/ng1392			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15235604	Green Accepted			2022-12-17	WOS:000222974000018
J	Karkkainen, MJ; Ferrell, RE; Lawrence, EC; Kimak, MA; Levinson, KL; McTigue, MA; Alitalo, K; Finegold, DN				Karkkainen, MJ; Ferrell, RE; Lawrence, EC; Kimak, MA; Levinson, KL; McTigue, MA; Alitalo, K; Finegold, DN			Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; CRYSTAL-STRUCTURE; LYMPHATIC ENDOTHELIUM; FLT4; LYMPHEDEMA; ANGIOGENESIS; PROTEIN; LIGAND; DOMAIN	Primary lymphoedema is a rare, autosomal dominant disorder that leads to a disabling and disfiguring swelling of the extremities and, when untreated, tends to worsen with time. Here we link primary human lymphoedema to the FLT4 locus, encoding vascular endothelial growth factor receptor-3 (VEGFR-3). in several families. All disease-associated alleles analysed had missense mutations and encoded proteins with an inactive tyrosine kinase, preventing downstream gene activation, Our study establishes that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGFR-3 signal transduction are a cause of primary lymphoedema.	Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA USA; Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, Mol Canc Biol Lab, Helsinki, Finland; Agouron Pharmaceut Inc, San Diego, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ludwig Institute for Cancer Research; University of Helsinki; Pfizer	Ferrell, RE (corresponding author), Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA.	rferrell@helex.hgen.pitt.edu	Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; Finegold, David/0000-0001-9901-2578	NICHD NIH HHS [HD35174] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD035174] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Barber JCK, 1996, AM J MED GENET, V62, P84, DOI 10.1002/(SICI)1096-8628(19960301)62:1<84::AID-AJMG17>3.3.CO;2-C; Bardelli A, 1997, BBA-REV CANCER, V1333, pM41, DOI 10.1016/S0304-419X(97)00026-7; BESMER P, 1993, DEVELOPMENT, P125; Brunger A.T., 1992, X PLOR VERSION 3 1 M; Burke D, 1998, TRENDS BIOCHEM SCI, V23, P59, DOI 10.1016/S0968-0004(97)01170-5; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Evans AL, 1999, AM J HUM GENET, V64, P547, DOI 10.1086/302248; FELDER S, 1992, J CELL BIOL, V117, P203, DOI 10.1083/jcb.117.1.203; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; GALLAND F, 1993, ONCOGENE, V8, P1233; Groen SE, 1998, AM J MED GENET, V80, P448, DOI 10.1002/(SICI)1096-8628(19981228)80:5<448::AID-AJMG3>3.0.CO;2-Q; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hardie G., 1995, PROTEIN KINASE FACTS; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Jussila L, 1998, CANCER RES, V58, P1599; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; Kukk E, 1996, DEVELOPMENT, V122, P3829; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; LEU JJ, 1995, VASCULAR PATHOLOGY, P489; Mangion J, 1999, AM J HUM GENET, V65, P427, DOI 10.1086/302500; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; Meige H., 1898, PRESSE MED, V6, P341; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Milroy WF., 1892, N Y MED J, V56, P505; Mowat D, 1999, AM J MED GENET, V83, P361, DOI 10.1002/(SICI)1096-8628(19990423)83:5<361::AID-AJMG3>3.0.CO;2-W; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; PAJUSOLA K, 1992, CANCER RES, V52, P5738; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; PAJUSOLA K, 1993, ONCOGENE, V8, P2931; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robertson K, 1997, GUT, V41, P436, DOI 10.1136/gut.41.4.436; SCHINZEL A, 1983, CATALOG UNBALANCED C; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; SPRITZ RA, 1994, J INVEST DERMATOL, V103, P1375; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Veikkola T, 2000, CANCER RES, V60, P203; Witte MH, 1998, LYMPHOLOGY, V31, P145; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	46	455	485	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2000	25	2					153	159		10.1038/75997	http://dx.doi.org/10.1038/75997			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835628				2022-12-17	WOS:000087459200012
J	Greene, CS; Krishnan, A; Wong, AK; Ricciotti, E; Zelaya, RA; Himmelstein, DS; Zhang, R; Hartmann, BM; Zaslavsky, E; Sealfon, SC; Chasman, DI; FitzGerald, GA; Dolinski, K; Grosser, T; Troyanskaya, OG				Greene, Casey S.; Krishnan, Arjun; Wong, Aaron K.; Ricciotti, Emanuela; Zelaya, Rene A.; Himmelstein, Daniel S.; Zhang, Ran; Hartmann, Boris M.; Zaslavsky, Elena; Sealfon, Stuart C.; Chasman, Daniel I.; FitzGerald, Garret A.; Dolinski, Kara; Grosser, Tilo; Troyanskaya, Olga G.			Understanding multicellular function and disease with human tissue-specific networks	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ENHANCER-BINDING; GENE-FUNCTION; EXPRESSION; LEF-1; GENOME; CELLS; PREDICTION; RESOURCE; AIRWAY	Tissue and cell-type identity lie at the core of human physiology and disease. Understanding the genetic underpinnings of complex tissues and individual cell lineages is crucial for developing improved diagnostics and therapeutics. We present genome-wide functional interaction networks for 144 human tissues and cell types developed using a data-driven Bayesian methodology that integrates thousands of diverse experiments spanning tissue and disease states. Tissue-specific networks predict lineage-specific responses to perturbation, identify the changing functional roles of genes across tissues and illuminate relationships among diseases. We introduce NetWAS, which combines genes with nominally significant genome-wide association study (GWAS) P values and tissue-specific networks to identify disease-gene associations more accurately than GWAS alone. Our webserver, GIANT, provides an interface to human tissue networks through multi-gene queries, network visualization, analysis tools including NetWAS and downloadable networks. GIANT enables systematic exploration of the landscape of interacting genes that shape specialized cellular functions across more than a hundred human tissues and cell types.	[Greene, Casey S.; Zelaya, Rene A.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA; [Greene, Casey S.] Dartmouth Hitchcock Norris Cotton Canc Ctr, Lebanon, NH USA; [Greene, Casey S.] Dartmouth Coll, Inst Quantitat Biomed Sci, Hanover, NH 03755 USA; [Krishnan, Arjun; Dolinski, Kara; Troyanskaya, Olga G.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wong, Aaron K.; Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Ricciotti, Emanuela; FitzGerald, Garret A.; Grosser, Tilo] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Ricciotti, Emanuela; FitzGerald, Garret A.; Grosser, Tilo] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Himmelstein, Daniel S.] Univ Calif San Francisco, Biol & Med Informat, San Francisco, CA 94143 USA; [Zhang, Ran] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Hartmann, Boris M.; Zaslavsky, Elena; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Chasman, Daniel I.] Harvard Univ, Sch Med, Boston, MA USA; [Troyanskaya, Olga G.] Simons Fdn, Simons Ctr Data Anal, New York, NY USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Princeton University; Princeton University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; Princeton University; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Troyanskaya, OG (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ogt@genomics.princeton.edu	Ricciotti, Emanuela/AAH-2729-2019; Grosser, Tilo/A-1057-2007; Hartmann, Boris M./A-6121-2010; Greene, Casey/L-2057-2015; Himmelstein, Daniel S/J-8986-2013; Dolinski, Kara/GPP-4026-2022	Grosser, Tilo/0000-0001-8569-8396; Hartmann, Boris M./0000-0002-5649-6776; Greene, Casey/0000-0001-8713-9213; Himmelstein, Daniel S/0000-0002-3012-7446; Zhang, Ran/0000-0002-7630-1251; Wong, Aaron/0000-0002-7294-0646; Troyanskaya, Olga/0000-0002-5676-5737; SEALFON, Stuart/0000-0001-5791-1217; Zaslavsky, Elena/0000-0002-4828-7771; Zelaya, Rene/0000-0003-1037-309X; Dolinski, Kara/0000-0002-7010-0264; Krishnan, Arjun/0000-0002-7980-4110	US National Institutes of Health (NIH) [R01 GM071966, R01 HG005998, U54 HL117798]; US NIH [T32 CA009528, P20 GM 103534, T32 HG003284, P50 GM071508, HHSN272201000054C]; NATIONAL CANCER INSTITUTE [T32CA009528] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005998, T32HG003284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM071966, P20GM103534] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011194] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was primarily supported by US National Institutes of Health (NIH) grants R01 GM071966 and R01 HG005998 to O.G.T. and U54 HL117798 to G.A.F. C.S.G. was supported in part by US NIH grants T32 CA009528 and P20 GM 103534. A.K.W. was supported in part by US NIH grant T32 HG003284. This work was supported in part by US NIH grant P50 GM071508 and by US NIH contract HHSN272201000054C. O.G.T. is a senior fellow of the Genetic Networks program of the Canadian Institute for Advanced Research (CIFAR).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cohen MM, 2013, J CRANIOFAC SURG, V24, P130, DOI 10.1097/SCS.0b013e3182636b7e; D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Driskell RR, 2004, AM J PHYSIOL-LUNG C, V287, pL752, DOI 10.1152/ajplung.00026.2004; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; Duan DS, 1999, DEVELOPMENT, V126, P4441; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erdfelder F, 2010, HEMATOL REP, V2, P24, DOI 10.4081/hr.2010.e3; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hibbs MA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000322; Ho JE, 2011, J HYPERTENS, V29, P62, DOI 10.1097/HJH.0b013e3283406927; Hoeppner LH, 2009, J CELL PHYSIOL, V221, P480, DOI 10.1002/jcp.21879; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Hwang S, 2011, NAT PROTOC, V6, P1429, DOI 10.1038/nprot.2011.372; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kofler S, 2005, CLIN SCI, V108, P205, DOI 10.1042/CS20040174; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Myers CL, 2007, BIOINFORMATICS, V23, P2322, DOI 10.1093/bioinformatics/btm332; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; OLDHAM PD, 1960, LANCET, V1, P1085; Pandey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088889; Park CY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002957; Park SK, 2011, MOL CELLS, V32, P67, DOI 10.1007/s10059-011-1031-5; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qin C, 2014, NUCLEIC ACIDS RES, V42, pD1118, DOI 10.1093/nar/gkt1129; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Thorn Caroline F, 2013, Methods Mol Biol, V1015, P311, DOI 10.1007/978-1-62703-435-7_20; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Wang X, 2009, ZEBRAFISH, V6, P49, DOI 10.1089/zeb.2008.0570; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	64	454	462	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					569	576		10.1038/ng.3259	http://dx.doi.org/10.1038/ng.3259			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915600	Green Submitted, Green Accepted			2022-12-17	WOS:000355386500005
J	Francioli, LC; Menelaou, A; Pulit, SL; Van Dijk, F; Palamara, PF; Elbers, CC; Neerincx, PBT; Ye, K; Guryev, V; Kloosterman, WP; Deelen, P; Abdellaoui, A; Van Leeuwen, EM; Van Oven, M; Vermaat, M; Li, M; Laros, JFJ; Karssen, LC; Kanterakis, A; Amin, N; Hottenga, JJ; Lameijer, EW; Kattenberg, M; Dijkstra, M; Byelas, H; Van Settenl, J; Van Schaik, BDC; Bot, J; Nijman, IJ; Renkens, I; Marscha, T; Schonhuth, A; Hehir-Kwa, JY; Handsaker, RE; Polak, P; Sohail, M; Vuzman, D; Hormozdiari, F; Van Enckevort, D; Mei, H; Koval, V; Moed, MTH; Van der Velde, KJ; Rivadeneira, F; Estrada, K; Medina-Gomez, C; Isaacs, A; McCarroll, SA; Beekrnan, M; De Craen, AJM; Suchiman, HED; Hofman, A; Oostra, B; Uitterlinden, AG; Willemsen, G; Plattee, M; Veldink, JH; Van den Berg, LH; Pitts, SJ; Potluri, S; Sundar, P; Cox, DR; Sunyaev, SR; Den Dunnen, JT; Stoneking, M; De Knijff, P; Kayser, M; Li, QB; Li, YR; Du, YP; Chen, R; Cao, H; Li, N; Cao, S; Wang, J; Bovenberg, JA; Peer, I; Slagboom, PE; Van Duijn, CM; Boomsma, DI; Van Ommen, GJB; De Bakker, PIW; Swertz, MA; Wijmenga, C				Francioli, Laurent C.; Menelaou, Andronild; Pulit, Sara L.; Van Dijk, Freerk; Palamara, Pier Francesco; Elbers, Clara C.; Neerincx, Pieter B. T.; Ye, Kai; Guryev, Victor; Kloosterman, Wigard P.; Deelen, Patrick; Abdellaoui, Abdel; Van Leeuwen, Elisabeth M.; Van Oven, Mannis; Vermaat, Martijn; Li, Mingkun; Laros, Jeroen F. J.; Karssen, Lennart C.; Kanterakis, Alexandros; Amin, Najaf; Hottenga, Jouke Jan; Lameijer, Eric-Wubbo; Kattenberg, Mathijs; Dijkstra, Martijn; Byelas, Heorhiy; Van Settenl, Jessica; Van Schaik, Barbera D. C.; Bot, Jan; Nijman, Isaac J.; Renkens, Ivo; Marscha, Tobias; Schonhuth, Alexander; Hehir-Kwa, Jayne Y.; Handsaker, Robert E.; Polak, Paz; Sohail, Mashaal; Vuzman, Dana; Hormozdiari, Fereydoun; Van Enckevort, David; Mei, Hailiang; Koval, Vyacheslav; Moed, Ma-Tthijs H.; Van der Velde, K. Joeri; Rivadeneira, Fernando; Estrada, Karol; Medina-Gomez, Carolina; Isaacs, Aaron; McCarroll, Steven A.; Beekrnan, Marian; De Craen, Anton J. M.; Suchiman, H. Eka D.; Hofman, Albert; Oostra, Ben; Uitterlinden, Andre G.; Willemsen, Gonneke; Plattee, Mathieu; Veldink, Jan H.; Van den Berg, Leonard H.; Pitts, Steven J.; Potluri, Shobha; Sundar, Purnima; Cox, David R.; Sunyaev, Shamil R.; Den Dunnen, Johan T.; Stoneking, Mark; De Knijff, Peter; Kayser, Manfred; Li, Qibin; Li, Yingrui; Du, Yuanping; Chen, Ruoyan; Cao, Hongzhi; Li, Ning; Cao, Sujie; Wang, Jun; Bovenberg, Jasper A.; Peer, Itsik; Slagboom, P. Eline; Van Duijn, Cornelia M.; Boomsma, Dorret I.; Van Ommen, Gert-Jan B.; De Bakker, Paul I. W.; Swertz, Morris A.; Wijmenga, Cisca		Genome Netherlands Consortium; LifeLines Cohort Study	Whole-genome sequence variation, population structure and demographic history of the Dutch population	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; GENETIC-VARIATION; HUMAN-DISEASE; HAPLOTYPE MAP; VARIANTS; RARE; COMMON; IMPACT; EXOMES; EVOLUTION	Whole-genome sequencing enables complete characterization of genetic variation, but geographic clustering of rare alleles demands many diverse populations be studied. Here we describe the Genome of the Netherlands (GoNL) Project, in which we sequenced the whole genomes of 250 Dutch parent-offspring families and constructed a haplotype map of 20.4 million single-nucleotide variants and 1.2 million insertions and deletions. The intermediate coverage (similar to 13x) and trio design enabled extensive characterization of structural variation, including midsize events (30-500 bp) previously poorly catalogued and de novo mutations. We demonstrate that the quality of the haplotypes boosts imputation accuracy in independent samples, especially for lower frequency alleles. Population genetic analyses demonstrate fine-scale structure across the country and support multiple ancient migrations, consistent with historical changes in sea level and flooding. The GoNL Project illustrates how single-population whole-genome sequencing can provide detailed characterization of genetic variation and may guide the design of future population studies.	[Francioli, Laurent C.; Menelaou, Andronild; Pulit, Sara L.; Elbers, Clara C.; Kloosterman, Wigard P.; Van Settenl, Jessica; Nijman, Isaac J.; Renkens, Ivo; De Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Van Dijk, Freerk; Neerincx, Pieter B. T.; Deelen, Patrick; Kanterakis, Alexandros; Dijkstra, Martijn; Byelas, Heorhiy; Moed, Ma-Tthijs H.; Plattee, Mathieu; Swertz, Morris A.; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Van Dijk, Freerk; Neerincx, Pieter B. T.; Deelen, Patrick; Kanterakis, Alexandros; Dijkstra, Martijn; Byelas, Heorhiy; Moed, Ma-Tthijs H.; Swertz, Morris A.; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Palamara, Pier Francesco; Peer, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Ye, Kai] Washington Univ, Genome Inst, St Louis, MO USA; [Ye, Kai; Lameijer, Eric-Wubbo; Koval, Vyacheslav; McCarroll, Steven A.; Beekrnan, Marian; De Craen, Anton J. M.; Suchiman, H. Eka D.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands; [Guryev, Victor] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Abdellaoui, Abdel; Hottenga, Jouke Jan; Kattenberg, Mathijs; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Van Leeuwen, Elisabeth M.; Karssen, Lennart C.; Amin, Najaf; Van der Velde, K. Joeri; Medina-Gomez, Carolina; Hofman, Albert; Uitterlinden, Andre G.; Van Duijn, Cornelia M.] Erasmus MC Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Van Oven, Mannis; Kayser, Manfred] Erasmus MC Univ, Med Ctr, Dept Forens Mol Biol, Rotterdam, Netherlands; [Vermaat, Martijn; Laros, Jeroen F. J.; Sunyaev, Shamil R.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden Genome Technol Ctr, Leiden, Netherlands; [Vermaat, Martijn; Laros, Jeroen F. J.; Hormozdiari, Fereydoun; Van Enckevort, David] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Li, Mingkun; Den Dunnen, Johan T.; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Van Schaik, Barbera D. C.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, Amsterdam, Netherlands; [Bot, Jan] SURFsara, Amsterdam, Netherlands; [Marscha, Tobias; Schonhuth, Alexander] Life Sci Grp, Ctr Wiskunde & lnformat, Amsterdam, Netherlands; [Hehir-Kwa, Jayne Y.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Handsaker, Robert E.; Polak, Paz; Sohail, Mashaal; Rivadeneira, Fernando; Isaacs, Aaron; Cox, David R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Ctr Neurosci, Nijmegen, Netherlands; [Handsaker, Robert E.; Isaacs, Aaron] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Sohail, Mashaal; Cox, David R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Vuzman, Dana] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA USA; [Mei, Hailiang; Van der Velde, K. Joeri; Rivadeneira, Fernando; Estrada, Karol; Uitterlinden, Andre G.] Erasmus MC Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, Fernando] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Oostra, Ben] Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands; [Van den Berg, Leonard H.; Pitts, Steven J.; Potluri, Shobha; Sundar, Purnima] Rinat Pfizer Inc, San Francisco, CA USA; [Sunyaev, Shamil R.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [De Knijff, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Forens Lab DNA Res, Leiden, Netherlands; [Li, Qibin; Li, Yingrui; Du, Yuanping; Chen, Ruoyan; Cao, Hongzhi; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Ning; Cao, Sujie] BGI Europe, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Bovenberg, Jasper A.] Legal Pathways Inst Hlth & Bio Law, Aerdenhout, Netherlands; [Peer, Itsik] Columbia Univ, Dept Syst Biol, New York, NY USA; [Van Ommen, Gert-Jan B.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [De Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Columbia University; Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Pfizer; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Beijing Genomics Institute (BGI); University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Columbia University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	De Bakker, PIW (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands.	pdebakker@umcutrecht.nl; c.wijmenga@umcg.nl	Li, Yingrui/K-1064-2015; Boomsma, Dorret I/AAX-4470-2020; Polak, Paz/AAH-9380-2020; Suchiman, H. Eka D./F-5024-2017; Beekman, Marian/L-3004-2019; Ye, Kai/GSD-9856-2022; Hehir, g. J.Y./L-4358-2015; Kanterakis, Alexandros/ABC-1705-2021; van Leeuwen, Elisabeth/G-3382-2017; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Medina-Gomez, Carolina/I-1725-2019; dunnen, johan den/ABH-4228-2020; Slagboom, P. Eline/R-4790-2016; Rivadeneira, Fernando/O-5385-2015; de Knijff, Peter/Y-2519-2018; de Bakker, Paul IW/B-8730-2009; Ye, Kai/B-3640-2012; Deelen, Patrick/B-3566-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Suchiman, H. Eka D./0000-0002-7168-5516; Beekman, Marian/0000-0003-0585-6206; Ye, Kai/0000-0002-2851-6741; Kanterakis, Alexandros/0000-0003-4276-0115; Wijmenga, Cisca/0000-0002-5635-1614; Medina-Gomez, Carolina/0000-0001-7999-5538; dunnen, johan den/0000-0002-6304-1710; Slagboom, P. Eline/0000-0002-2875-4723; Rivadeneira, Fernando/0000-0001-9435-9441; de Knijff, Peter/0000-0002-0899-771X; de Bakker, Paul IW/0000-0001-7735-7858; Deelen, Patrick/0000-0002-5654-3966; Van Duijn, Cornelia/0000-0002-2374-9204; Guryev, Victor/0000-0002-5810-6022; Veldink, Jan/0000-0001-5572-9657; Pulit, Sara/0000-0002-2502-3669; van der Velde, Joeri/0000-0002-0934-8375; van Enckevort, Esther/0000-0002-2440-3993; van Oven, Mannis/0000-0003-0026-7998; Karssen, Lennart C./0000-0002-1959-342X; Hehir-Kwa, Jayne/0000-0003-0837-304X; Amin, Najaf/0000-0002-8944-1771; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Willemsen, Gonneke/0000-0003-3755-0236; Palamara, Pier Francesco/0000-0002-7999-1972; van Schaik, Barbera/0000-0002-5568-8127; Laros, Jeroen F.J./0000-0002-8715-7371; Marschall, Tobias/0000-0002-9376-1030	BBMRI-NL - Netherlands Organization for Scientific Research (NWO) [184.021.007]; eBioGrid; CTMM/TraIT; Ubbo Emmius Fund; Netherlands Bioinformatics Center (NBIC); BU-BioSHARE; Samenwerkingsverband Noord Nederland; European Fund for Regional Development; Dutch Ministry of Economic Affairs, Pieken in de Delta; provinces-of Groningen and Drenthe; Netherlands Organization for Scientific Research (NWO); Center for Medical Systems Biology-2; European Research Council [ERC 230374]; VIDI awards (NWO) [016.138.318, 016.126.354]	BBMRI-NL - Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); eBioGrid; CTMM/TraIT; Ubbo Emmius Fund; Netherlands Bioinformatics Center (NBIC); BU-BioSHARE; Samenwerkingsverband Noord Nederland; European Fund for Regional Development(European Commission); Dutch Ministry of Economic Affairs, Pieken in de Delta; provinces-of Groningen and Drenthe; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center for Medical Systems Biology-2; European Research Council(European Research Council (ERC)European Commission); VIDI awards (NWO)	We wish to dedicate this work to the memory of David R. Cox, an enthusiastic supporter of human genetic research in the Netherlands for many years. The GoNL Project is funded by the BBMRI-NL, a research infrastructure financed by the Netherlands Organization for Scientific Research (NWO project 184.021.007). We acknowledge additional financial support from eBioGrid, CTMM/TraIT, the Ubbo Emmius Fund, the Netherlands Bioinformatics Center (NBIC) and BU-BioSHARE. We thank the individual participants of the biobanks; M. Depristo, E. Banks, R. Poplin and G. del Angel from the Broad Institute for expert advice on setting up our alignment and calling pipeline; K. Garimella for the initial implementation of PhaseByTransmission; G. Strikwerda, W Albers, R. Teeninga, H. Gankema and H. Wind of the Groningen Center for Information Technology (see URLs) for support of the compute cluster and Target storage; E. Valentyn and R. Williams of Target (see URLs) for hosting project data on IBM GPFS storage; T. Visser and I. Nooren of BiG Grid (see URLs) and SURFsara for providing backup storage, additional computing capacity and expert advice; the team from MOLGENIS (see URLs) for software development support; H. Lauvenberg for handling data access requests; K. Zych for design of the GoNL logo; L. Franke, H.-J. Westra and J. Gutierrez-Achury for useful discussions; and S. Raychaudhuri and B. Neale for their critical reading of the manuscript. Target is supported by Samenwerkingsverband Noord Nederland, the European Fund for Regional Development, the Dutch Ministry of Economic Affairs, Pieken in de Delta and the provinces-of Groningen and Drenthe. Target operates under the auspices of Sensor Universe. BiG Grid and the Life Science Grid are financially supported by the Netherlands Organization for Scientific Research (NWO). A.A. is funded by the Center for Medical Systems Biology-2, and D.I.B. is funded by the European Research Council (ERC 230374). A.S. and P.I.W.d.B. are recipients of VIDI awards (NWO projects 016.138.318 and 016.126.354, respectively).	Abdellaoui A, 2013, EUR J HUM GENET, V21, P1277, DOI 10.1038/ejhg.2013.48; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Boomsma DI, 2014, EUR J HUM GENET, V22, P221, DOI 10.1038/ejhg.2013.118; Brandsma M., 2012, Norsk Epidemiologi, V21, P143; Cassa CA, 2013, HUM MUTAT, V34, P1216, DOI 10.1002/humu.22375; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lao Oscar, 2013, Investig Genet, V4, P9, DOI 10.1186/2041-2223-4-9; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menelaou A, 2013, BIOINFORMATICS, V29, P84, DOI 10.1093/bioinformatics/bts632; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Zheng HX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00745	46	454	459	4	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					818	825		10.1038/ng.3021	http://dx.doi.org/10.1038/ng.3021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24974849	Green Submitted			2022-12-17	WOS:000339704400009
J	Mansouri, A; Chowdhury, K; Gruss, P				Mansouri, A; Chowdhury, K; Gruss, P			Follicular cells of the thyroid gland require Pax8 gene function	NATURE GENETICS			English	Article							DEVELOPING EXCRETORY SYSTEM; MOUSE; DIFFERENTIATION; EXPRESSION; MIDBRAIN; LUNG	The thyroid gland develops from two distinct embryonic lineages: follicular cells (which produce thyroxine) and parafollicular C-cells (which produce calcitonin) are of endodermal and neural crest origin, respectively, Little is known about the molecular mechanisms governing the generation of these different cell types, Mice lacking the transcription factor Ttf1 lack both cell types and thus are unable to develop a thyroid gland. By analysis of Pax8(-/-) mice, we demonstrate that Pax8 is required for the formation of the follicular cells in the thyroid. We present evidence that Pax8 is necessary for providing cues for the differentiation of competent endoderm primordia into thyroxin-producing follicular cells.	MPI Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Max Planck Society	Gruss, P (corresponding author), MPI Biophys Chem, Dept Mol Cell Biol, Am Fassberg, D-37077 Gottingen, Germany.	pgruss@gwdg.de						ASANO M, 1992, MECH DEVELOP, V39, P29, DOI 10.1016/0925-4773(92)90023-D; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; FONTAINE J, 1979, GEN COMP ENDOCR, V37, P81, DOI 10.1016/0016-6480(79)90049-2; HILFER SR, 1968, EPITHELIAL MESENCHYM, P177; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Nagy A., 1993, Gene targeting: a practical approach., P147; PEARSE AGE, 1967, NATURE, V214, P929, DOI 10.1038/214929a0; PLACHOV D, 1990, DEVELOPMENT, V110, P643; POHL V, 1990, J CELL BIOL, V111, P663, DOI 10.1083/jcb.111.2.663; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TORRES M, 1994, CELL BIOL LAB HDB, P112; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WILKINSON DG, 1992, IN SITU HYBRIDISATIO	20	454	473	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					87	90		10.1038/ng0598-87	http://dx.doi.org/10.1038/ng0598-87			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590297				2022-12-17	WOS:000073346700025
J	OKUBO, K; HORI, N; MATOBA, R; NIIYAMA, T; FUKUSHIMA, A; KOJIMA, Y; MATSUBARA, K				OKUBO, K; HORI, N; MATOBA, R; NIIYAMA, T; FUKUSHIMA, A; KOJIMA, Y; MATSUBARA, K			LARGE-SCALE CDNA SEQUENCING FOR ANALYSIS OF QUANTITATIVE AND QUALITATIVE ASPECTS OF GENE-EXPRESSION	NATURE GENETICS			English	Article							CONSTRUCTION; LIBRARY; CLONING	Large scale sequencing of cDNAs provides a complementary approach to structural analysis of the human genome by generating expressed sequence tags (ESTs). We have initiated the large-scale sequencing of a 3'-directed cDNA library from the human liver cell line HepG2, that is a non-biased representation of the mRNA population. 982 random cDNA clones were sequenced yielding more than 270 kilobases. A significant portion of the identified genes encoded secretable proteins and components for protein-synthesis. The abundance of cDNA species varied from 2.2% to less than 0.004%. Fifty two percent of the mRNA were abundant species consisting of 173 genes and the rest were non-abundant, consisting of about 6,600 genes.	OSAKA UNIV,INST MOLEC & CELLULAR BIOL,1-3 YAMADA OKA,SUITA,OSAKA 565,JAPAN	Osaka University								ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ALBERTS B, 1983, MOL BIOL CELL, P33; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; DARLINGTON GJ, 1987, METHOD ENZYMOL, V151, P38; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JAISWAL AK, 1988, J BIOL CHEM, V263, P13572; KO MSH, 1990, NUCLEIC ACIDS RES, V18, P5705, DOI 10.1093/nar/18.19.5705; KOLLER M, 1990, BIOCHIM BIOPHYS ACTA, V1087, P180, DOI 10.1016/0167-4781(90)90203-E; LEWIN B, 1980, GENE EXPRESSION, V2, P719; NAKAYAMA K, 1989, TRENDS GENET, V5, P325; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; Okubo K, 1991, DNA Seq, V2, P137, DOI 10.3109/10425179109039684; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41	19	454	498	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					173	179		10.1038/ng1192-173	http://dx.doi.org/10.1038/ng1192-173			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345164				2022-12-17	WOS:A1992JW16500004
J	Howe, JR; Bair, JL; Sayed, MG; Anderson, ME; Mitros, FA; Petersen, GM; Velculescu, VE; Traverso, G; Vogelstein, B				Howe, JR; Bair, JL; Sayed, MG; Anderson, ME; Mitros, FA; Petersen, GM; Velculescu, VE; Traverso, G; Vogelstein, B			Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis	NATURE GENETICS			English	Letter							COWDEN-DISEASE; SIGNALING PATHWAYS; SMAD PROTEINS; CANCER; CELLS; PTEN; SMAD4/DPC4; CARCINOMA; KINASE; BREAST	Juvenile polyposis (JP; OMIM 174900) is an autosomal dominant gastrointestinal hamartomatous polyposis syndrome in which patients are at risk for developing gastrointestinal cancers(1,2). Previous studies have demonstrated a locus for JP mapping to 18q21.1 (ref. 3) and germline mutations in the homolog of the gene for mothers against decapentaplegic. Drosophila. (MADH4. also known as SMAD4) in several JP families(4). However, mutations in MADH4 are only present in a subset of JP cases'. and although mutations in the gene for phosphatase and tensin homolog (PTEN) have been described in a few families(6,7), undefined genetic heterogeneity remains. Using a genome-wide screen in four JP kindreds without germline mutations in MADH4 or PTEN, we identified linkage with markers from chromosome 10q22-23 (maximum lod score of 4.74, theta =0.00). We found no recombinants using markers developed from the vicinity of the gene for bone morphogenetic protein receptor 1A (BMPR1A), a serine-threonine kinase type I receptor involved in bone morphogenetic protein (BMP) signaling(8). Genomic sequencing of BMPR1A in each of these JP kindreds disclosed germline nonsense mutations in all affected kindred members but not in normal control individuals. These findings indicate involvement of an additional gene in the transforming growth factor-beta (TGF-beta) superfamily in the genesis of JP, and document an unanticipated function for BMP in colonic epithelial growth control.	Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Mayo Clin & Mayo Fdn, Clin Epidemiol Sect, Rochester, MN 55905 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Oncol Ctr, Baltimore, MD USA	University of Iowa; University of Iowa; Mayo Clinic; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Howe, JR (corresponding author), Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA.		Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Howe, James/0000-0001-5312-5972	NATIONAL CANCER INSTITUTE [R37CA043460, R01CA043460, P50CA062924] Funding Source: NIH RePORTER; NCI NIH HHS [CA62924, CA43460] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dai JL, 1999, P NATL ACAD SCI USA, V96, P1427, DOI 10.1073/pnas.96.4.1427; Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Fink SP, 2001, CANCER RES, V61, P256; GENTRY WC, 1974, ARCH DERMATOL, V109, P521, DOI 10.1001/archderm.109.4.521; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henningfeld KA, 2000, J BIOL CHEM, V275, P21827, DOI 10.1074/jbc.M000978200; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Houlston R, 1998, HUM MOL GENET, V7, P1907, DOI 10.1093/hmg/7.12.1907; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 1998, ANN SURG ONCOL, V5, P751, DOI 10.1007/BF02303487; Howe JR, 1998, AM J HUM GENET, V62, P1129, DOI 10.1086/301840; IWASAKI S, 1995, J BIOL CHEM, V270, P5476, DOI 10.1074/jbc.270.10.5476; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; JARVINEN H, 1984, GUT, V25, P792, DOI 10.1136/gut.25.7.792; Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; Raida M, 1999, INT J CANCER, V83, P38, DOI 10.1002/(SICI)1097-0215(19990924)83:1<38::AID-IJC8>3.3.CO;2-2; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; TENDIJKE P, 1993, ONCOGENE, V8, P2879; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; Woodford-Richens K, 2000, CANCER RES, V60, P2477	30	453	483	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					184	187		10.1038/88919	http://dx.doi.org/10.1038/88919			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381269				2022-12-17	WOS:000169011800024
J	OUAHCHI, K; ARITA, M; KAYDEN, H; HENTATI, F; BENHAMIDA, M; SOKOL, R; ARAI, H; INOUE, K; MANDEL, JL; KOENIG, M				OUAHCHI, K; ARITA, M; KAYDEN, H; HENTATI, F; BENHAMIDA, M; SOKOL, R; ARAI, H; INOUE, K; MANDEL, JL; KOENIG, M			ATAXIA WITH ISOLATED VITAMIN-E-DEFICIENCY IS CAUSED BY MUTATIONS IN THE ALPHA-TOCOPHEROL TRANSFER PROTEIN	NATURE GENETICS			English	Article							RAT-LIVER; FRIEDREICH ATAXIA; BINDING-PROTEIN; ABSORPTION; GENE	Ataxia with isolated vitamin E deficiency (AVED) is an autosomal recessive neurodegenerative disease which maps to chromosome 8q13. AVED patients have an impaired ability to incorporate a-tocopherol into lipoproteins secreted by the liver, a function putatively attributable to the a-tocopherol transfer protein (alpha-TTP). Here we report the identification of three frame-shift mutations in the alpha TTP gene. A 744delA mutation accounts for 68% of the mutant alleles in the 17 families analysed and appears to have spread in North Africa and Italy. This mutation correlates with a severe phenotype but alters only the C-terminal tenth of the protein. Two other mutations were found in single families. The finding of alpha TTP gene mutations in AVED patients substantiates the therapeutic role of vitamin E as a protective agent against neurological damage in this disease.	UNIV TOKYO, FAC PHARMACEUT SCI, DEPT HLTH CHEM, BUNKYO KU, TOKYO 113, JAPAN; NYU, MED CTR, DEPT MED, NEW YORK, NY 10016 USA; INST NATL NEUROL, TUNIS 1007, TUNISIA; UNIV COLORADO, SCH MED, PEDIAT GASTROENTEROL & NUTR SECT, DENVER, CO 80218 USA; CHU STRASBOURG, F-67000 STRASBOURG, FRANCE; FAC MED STRASBOURG, STRASBOURG, FRANCE	University of Tokyo; New York University; Universite de Tunis-El-Manar; Institut National de Neurologie; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	OUAHCHI, K (corresponding author), UNIV STRASBOURG 1, INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM, 1 RUE LAURENT FRIES, BP 163, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE.			Arita, Makoto/0000-0001-9902-0463	NCRR NIH HHS [RR00069] Funding Source: Medline; NIADDK NIH HHS [AM34914] Funding Source: Medline; NIDDK NIH HHS [DK38446] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034914] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038446, R01DK038446] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMIEL J, IN PRESS J INHER MET; ARITA M, IN PRESS BIOCH J; BEHRENS WA, 1982, NUTR RES, V2, P611, DOI 10.1016/S0271-5317(82)80073-0; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BENHAMIDA M, 1993, NEUROLOGY, V43, P2179, DOI 10.1212/WNL.43.11.2179; BURCK U, 1981, NEUROPEDIATRICS, V12, P267, DOI 10.1055/s-2008-1059657; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; DOERFLINGER N, IN PRESS AM J HUM GE; DUCLOS F, 1994, HUM MOL GENET, V3, P909, DOI 10.1093/hmg/3.6.909; HARDING AE, 1985, NEW ENGL J MED, V313, P32, DOI 10.1056/NEJM198507043130107; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; KAYDEN HJ, 1993, NEUROLOGY, V43, P2167, DOI 10.1212/WNL.43.11.2167; KAYDEN HJ, 1993, J LIPID RES, V34, P343; KOHLSCHUTTER A, 1988, J INHERIT METAB DIS, V11, P149, DOI 10.1007/BF01804221; KRENDEL DA, 1987, NEUROLOGY, V37, P538, DOI 10.1212/WNL.37.3.538; LAPLANTE P, 1984, CAN J NEUROL SCI, V11, P561, DOI 10.1017/S0317167100035046; MOWRI H, 1981, EUR J BIOCHEM, V117, P537; MULLER DPR, 1983, LANCET, V1, P225; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SATO Y, 1993, J BIOL CHEM, V268, P17705; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; SCHUBERT D, 1992, P NATL ACAD SCI USA, V89, P8264, DOI 10.1073/pnas.89.17.8264; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SOKOL RJ, 1988, J LAB CLIN MED, V111, P548; STUMPF DA, 1987, NEUROLOGY, V37, P68, DOI 10.1212/WNL.37.1.68; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; TRABER MG, 1994, P NATL ACAD SCI USA, V91, P10005, DOI 10.1073/pnas.91.21.10005; TRABER MG, 1993, J LIPID RES, V34, P201; TRABERT W, 1989, FORTSCHR NEUROL PSYC, V57, P495, DOI 10.1055/s-2007-1001146; YOKOTA T, 1987, ANN NEUROL, V22, P84, DOI 10.1002/ana.410220119	32	453	467	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1995	9	2					141	145		10.1038/ng0295-141	http://dx.doi.org/10.1038/ng0295-141			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719340				2022-12-17	WOS:A1995QE67200014
J	JORDAN, T; HANSON, I; ZALETAYEV, D; HODGSON, S; PROSSER, J; SEAWRIGHT, A; HASTIE, N; VANHEYNINGEN, V				JORDAN, T; HANSON, I; ZALETAYEV, D; HODGSON, S; PROSSER, J; SEAWRIGHT, A; HASTIE, N; VANHEYNINGEN, V			THE HUMAN PAX6 GENE IS MUTATED IN 2 PATIENTS WITH ANIRIDIA	NATURE GENETICS			English	Article								Aniridia is an inherited ocular disorder of variable expressivity characterized by iris hypoplasia. A candidate aniridia gene, AN, which is the human homologue of the mouse Pax-6 gene, has recently been isolated by positional cloning from the WAGR region of 11p13. Here we describe mutations in this gene in two cases of sporadic aniridia, one detected at the DNA level and one at the RNA level, both of which are predicted to affect protein function. Mutations in Pax-6 have been described previously in Small eye, the proposed mouse model for aniridia. We present new phenotypic evidence for the validity of this mouse model.	WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; ACAD MED SCI, INST MED GENET, MOSCOW 115478, USSR; GUYS HOSP, DIV MED & MOLEC GENET, LONDON SE1 9RT, ENGLAND	University of Edinburgh; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Guy's & St Thomas' NHS Foundation Trust			Zaletaev, Dmitri V/E-5331-2010; van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022	Zaletaev, Dmitri V/0000-0002-9323-2673; van Heyningen, Veronica/0000-0003-0359-0141; Hanson, Isabel/0000-0002-1878-0530	Medical Research Council [MC_U127527199] Funding Source: Medline; MRC [MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAVIS LM, 1989, SOMAT CELL MOLEC GEN, V15, P605, DOI 10.1007/BF01534921; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FERRELL RE, 1980, P NATL ACAD SCI-BIOL, V77, P1580, DOI 10.1073/pnas.77.3.1580; FRANKE U, 1978, AM J HUM GENET, V30, pA81; GESSLER M, 1989, SCIENCE, V244, P1575, DOI 10.1126/science.2544995; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; Green MC., 1989, GENETIC VARIANTS STR, P12; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HITTNER HM, 1982, AM J OPHTHALMOL, V93, P57, DOI 10.1016/0002-9394(82)90700-0; HODGSON SV, 1980, J MED GENET, V17, P478, DOI 10.1136/jmg.17.6.478; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; KEEN J, 1991, TRENDS GENET, V7, P5; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; LYONS LA, IN PRESS GENOMICS; MANNENS M, 1989, CYTOGENET CELL GENET, V52, P32, DOI 10.1159/000132834; MAUMENEE IH, 1977, AM J OPHTHALMOL, V83, P718, DOI 10.1016/0002-9394(77)90139-8; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; NEVIN NC, 1990, AM J MED GENET, V35, P468, DOI 10.1002/ajmg.1320350404; PUSCHEL AW, 1992, DEVELOPMENT, V114, P643; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; SHAW MW, 1960, AM J HUM GENET, V12, P389; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THEILER K, 1978, ANAT EMBRYOL, V155, P81, DOI 10.1007/BF00315732; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; VANDERMEERDEJONG R, 1990, GENOMICS, V7, P270, DOI 10.1016/0888-7543(90)90550-E; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warwick R, 1973, GRAYS ANATOMY; WENGER RH, 1991, TRENDS GENET, V7, P178, DOI 10.1016/0168-9525(91)90430-X; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	37	453	471	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1992	1	5					328	332		10.1038/ng0892-328	http://dx.doi.org/10.1038/ng0892-328			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1302030				2022-12-17	WOS:A1992JJ12100008
J	Carvill, GL; Heavin, SB; Yendle, SC; McMahon, JM; O'Roak, BJ; Cook, J; Khan, A; Dorschner, MO; Weaver, M; Calvert, S; Malone, S; Wallace, G; Stanley, T; Bye, AME; Bleasel, A; Howell, KB; Kivity, S; Mackay, MT; Rodriguez-Casero, V; Webster, R; Korczyn, A; Afawi, Z; Zelnick, N; Lerman-Sagie, T; Lev, D; Moller, RS; Gill, D; Andrade, DM; Freeman, JL; Sadleir, LG; Shendure, J; Berkovic, SF; Scheffer, IE; Mefford, HC				Carvill, Gemma L.; Heavin, Sinead B.; Yendle, Simone C.; McMahon, Jacinta M.; O'Roak, Brian J.; Cook, Joseph; Khan, Adiba; Dorschner, Michael O.; Weaver, Molly; Calvert, Sophie; Malone, Stephen; Wallace, Geoffrey; Stanley, Thorsten; Bye, Ann M. E.; Bleasel, Andrew; Howell, Katherine B.; Kivity, Sara; Mackay, Mark T.; Rodriguez-Casero, Victoria; Webster, Richard; Korczyn, Amos; Afawi, Zaid; Zelnick, Nathanel; Lerman-Sagie, Tally; Lev, Dorit; Moller, Rikke S.; Gill, Deepak; Andrade, Danielle M.; Freeman, Jeremy L.; Sadleir, Lynette G.; Shendure, Jay; Berkovic, Samuel F.; Scheffer, Ingrid E.; Mefford, Heather C.			Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1	NATURE GENETICS			English	Article							AUTISM SPECTRUM DISORDERS; INTELLECTUAL DISABILITY; SODIUM-CHANNEL; MENTAL-RETARDATION; GENE SCN2A; MICRODELETION; SEIZURES; EPILEPSIES; PHENOTYPE; DELETIONS	Epileptic encephalopathies are a devastating group of epilepsies with poor prognosis, of which the majority are of unknown etiology. We perform targeted massively parallel resequencing of 19 known and 46 candidate genes for epileptic encephalopathy in 500 affected individuals (cases) to identify new genes involved and to investigate the phenotypic spectrum associated with mutations in known genes. Overall, we identified pathogenic mutations in 10% of our cohort. Six of the 46 candidate genes had 1 or more pathogenic variants, collectively accounting for 3% of our cohort. We show that de novo CHD2 and SYNGAP1 mutations are new causes of epileptic encephalopathies, accounting for 1.2% and 1% of cases, respectively. We also expand the phenotypic spectra explained by SCN1A, SCN2A and SCN8A mutations. To our knowledge, this is the largest cohort of cases with epileptic encephalopathies to undergo targeted resequencing. Implementation of this rapid and efficient method will change diagnosis and understanding of the molecular etiologies of these disorders.	[Carvill, Gemma L.; Cook, Joseph; Khan, Adiba; Mefford, Heather C.] Univ Washington, Div Med Genet, Dept Pediat, Seattle, WA 98195 USA; [Heavin, Sinead B.; Yendle, Simone C.; McMahon, Jacinta M.; Berkovic, Samuel F.; Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Dept Med, Epilepsy Res Ctr, Melbourne, Vic, Australia; [O'Roak, Brian J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Dorschner, Michael O.; Weaver, Molly] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Dorschner, Michael O.; Weaver, Molly] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Calvert, Sophie; Malone, Stephen; Wallace, Geoffrey] Royal Childrens Hosp, Neurosci Childrens Hlth Queensland, Brisbane, Qld, Australia; [Calvert, Sophie; Malone, Stephen; Wallace, Geoffrey] Univ Queensland, Mater Childrens Hosp, Neurosci Childrens Hlth Queensland, Brisbane, Qld 4101, Australia; [Stanley, Thorsten; Sadleir, Lynette G.] Univ Otago, Sch Med & Hlth Sci, Dept Paediat, Wellington, New Zealand; [Bye, Ann M. E.] Univ New S Wales, Dept Paediat Neurol, Sydney Childrens Hosp, Sydney, NSW, Australia; [Bleasel, Andrew] Univ Sydney, Westmead Hosp, Dept Neurol, Sydney, NSW 2006, Australia; [Howell, Katherine B.; Mackay, Mark T.; Freeman, Jeremy L.; Scheffer, Ingrid E.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Kivity, Sara] Schneider Childrens Med Ctr Israel, Epilepsy Unit, Petah Tiqwa, Israel; [Mackay, Mark T.; Freeman, Jeremy L.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Mackay, Mark T.; Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Rodriguez-Casero, Victoria] Monash Med Ctr, Melbourne, Vic, Australia; [Webster, Richard; Gill, Deepak] Childrens Hosp Westmead, TY Nelson Dept Neurol, Sydney, NSW, Australia; [Korczyn, Amos] Tel Aviv Univ, Dept Neurol, IL-69978 Tel Aviv, Israel; [Afawi, Zaid] Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel; [Zelnick, Nathanel] Technion Israel Inst Technol, Fac Med, Carmel Med Ctr, Dept Pediat, Haifa, Israel; [Lerman-Sagie, Tally; Lev, Dorit] Wolfson Med Ctr, Metab Neurogenet Serv, Holon, Israel; [Lerman-Sagie, Tally; Moller, Rikke S.] Danish Epilepsy Ctr, Dianalund, Denmark; [Andrade, Danielle M.] Univ Toronto, Toronto Western Hosp, Dept Med, Div Neurol,Krembil Neurosci Program, Toronto, ON M5T 2S8, Canada; [Scheffer, Ingrid E.] Florey Inst, Melbourne, Vic, Australia	University of Washington; University of Washington Seattle; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Royal Children's Hospital Brisbane; University of Queensland; University of Otago; University of New South Wales Sydney; University of Sydney; University of Sydney; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; University of Sydney; Tel Aviv University; Tel Aviv University; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Florey Institute of Neuroscience & Mental Health	Mefford, HC (corresponding author), Univ Washington, Div Med Genet, Dept Pediat, Seattle, WA 98195 USA.	scheffer@unimelb.edu.au; hmefford@uw.edu	Shendure, Jay/AAU-3684-2021; Korczyn, Amos D/C-3461-2017; jiang, yu/HGU-0029-2022; Lerman-Sagie, Tally/AAY-7598-2021; Bleasel, Andrew/W-6205-2019; Stanley, Thorsten/ABB-3880-2020; Afawi, Zaid/AAE-7848-2022; Scheffer, Ingrid E/G-1668-2013; Wallace, Geoff/H-1252-2013	Korczyn, Amos D/0000-0003-0125-2579; Lerman-Sagie, Tally/0000-0001-6641-6875; Bleasel, Andrew/0000-0002-1843-3619; Scheffer, Ingrid E/0000-0002-2311-2174; Wallace, Geoff/0000-0001-9306-3542; McMahon, Jacinta/0000-0001-8891-0049; Berkovic, Samuel/0000-0003-4580-841X; Shendure, Jay/0000-0002-1516-1865; Mackay, Mark/0000-0002-3787-1112; Moller, Rikke S./0000-0002-9664-1448; Andrade, Danielle/0000-0003-0953-2698; Gill, Deepak/0000-0002-6219-9479; Sadleir, Lynette/0000-0002-5355-7115; Freeman, Jeremy/0000-0002-4184-3683; O'Roak, Brian/0000-0002-4141-0095	US National Institutes of Health (NIH; National Institute of Neurological Disorders and Stroke (NINDS)) [1R01NS069605]; Burroughs Wellcome Fund Career Award for Medical Scientists; National Health and Medical Research Council of Australia [628952, 1006110]; Health Research Council of New Zealand; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605] Funding Source: NIH RePORTER	US National Institutes of Health (NIH; National Institute of Neurological Disorders and Stroke (NINDS))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals with epileptic encephalopathies and their families for participating in our research. H. C. M. is supported by a grant from the US National Institutes of Health (NIH; National Institute of Neurological Disorders and Stroke (NINDS) 1R01NS069605) and is a recipient of a Burroughs Wellcome Fund Career Award for Medical Scientists. This work was supported by the National Health and Medical Research Council of Australia (program grant 628952 to S. F. B. and I. E. S., practitioner fellowship 1006110 to I. E. S.) and a Health Research Council of New Zealand project grant to L.G.S.	Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Camprubi C, 2009, AM J MED GENET A, V149A, P343, DOI 10.1002/ajmg.a.32659; Capelli LP, 2012, EUR J MED GENET, V55, P132, DOI 10.1016/j.ejmg.2011.10.004; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dhamija R, 2011, PEDIATR NEUROL, V45, P60, DOI 10.1016/j.pediatrneurol.2011.02.002; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hamdan FF, 2010, M S-MED SCI, V26, P133, DOI 10.1051/medsci/2010262133; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Hoppman-Chaney N, 2013, CLIN GENET, V83, P345, DOI 10.1111/j.1399-0004.2012.01925.x; Kamien BA, 2012, J CLIN NEUROSCI, V19, P934, DOI 10.1016/j.jocn.2012.01.017; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Marco E.J., 2009, BMJ CASE REP, V2009, P1999; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Ogiwara I, 2009, NEUROLOGY, V73, P1046, DOI 10.1212/WNL.0b013e3181b9cebc; Oliva M, 2012, EPILEPSIA, V53, P1849, DOI 10.1111/j.1528-1167.2012.03631.x; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012; Thierry G, 2012, AM J MED GENET A, V158A, P1633, DOI 10.1002/ajmg.a.35423; Tsai MH, 2013, EPILEPSIA, V54, P280, DOI 10.1111/epi.12065; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	37	452	481	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2013	45	7					825	U158		10.1038/ng.2646	http://dx.doi.org/10.1038/ng.2646			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23708187	Green Accepted			2022-12-17	WOS:000321005200021
J	Poetter, K; Jiang, H; Hassanzadeh, S; Master, SR; Chang, A; Dalakas, MC; Rayment, I; Sellers, JR; Fananapazir, L; Epstein, ND				Poetter, K; Jiang, H; Hassanzadeh, S; Master, SR; Chang, A; Dalakas, MC; Rayment, I; Sellers, JR; Fananapazir, L; Epstein, ND			Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle	NATURE GENETICS			English	Article							HYPERTROPHIC CARDIOMYOPATHY; BETA-MYOSIN; HEAVY-CHAIN; STRETCH ACTIVATION; GENE; EXPRESSION; PHOSPHORYLATION; SEQUENCE; LOCATION; ACTIN	The muscle myosins are hexomeric proteins consisting of two heavy chains and two pairs of light chains, the latter called essential (ELC) and regulatory (RLC). The light chains stabilize the long alpha helical neck of the myosin head. Their function in striated muscle, however, is only partially understood. We report here the identification of distinct missense mutations in a skeletal/ventricular ELC and RLC, each of which are associated with a rare variant of cardiac hypertrophy as well as abnormal skeletal muscle. We show that myosin containing the mutant ELC has abnormal function, map the mutant residues on the three-dimensional structure of myosin and suggest that the mutations disrupt the stretch activation response of the cardiac papillary muscles.	NHLBI,INHERITED CARDIAC DIS SECT,NIH,BETHESDA,MD 20892; NHLBI,MOLEC CARDIOL LAB,NIH,BETHESDA,MD 20892; NINCDS,NEUROMUSCULAR DIS SECT,NIH,BETHESDA,MD 20892; UNIV WISCONSIN,INST ENZYME RES,MADISON,WI 53705; UNIV WISCONSIN,DEPT BIOCHEM,MADISON,WI 53705	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison			rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Master, Stephen/0000-0002-6808-631X				BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DU Y, 1993, L01652 GENB; EDEN D, 1994, BIOPHYS J, V68, pS372; EISENBERG E, 1974, J BIOL CHEM, V249, P4742; EISENBERG E, 1980, ANNU REV PHYSIOL, V42, P293, DOI 10.1146/annurev.ph.42.030180.001453; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; FANANAPAZIR L, 1994, CIRCULATION, V89, P22, DOI 10.1161/01.CIR.89.1.22; FANANAPAZIR L, 1993, P NATL ACAD SCI USA, V90, P3993, DOI 10.1073/pnas.90.9.3993; FISHER AJ, 1995, BIOPHYS J, V68, pS19; FODOR WL, 1989, J BIOL CHEM, V264, P2143; Hill T.L., 1977, FREE ENERGY TRANSDUC; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MACERA MJ, 1992, GENOMICS, V13, P829, DOI 10.1016/0888-7543(92)90161-K; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; MARON BJ, 1979, AM J CARDIOL, V43, P1242, DOI 10.1016/0002-9149(79)90160-7; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; MORANO I, 1986, BASIC RES CARDIOL, V81, pS17; PAVLAKIS SG, 1988, ADV CONT NEUROLOGY, P95; PERRYMAN MB, 1992, J CLIN INVEST, V90, P271, DOI 10.1172/JCI115848; PERSECHINI A, 1985, J BIOL CHEM, V260, P7951; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Steiger G.J., 1977, P221; STEIGER GJ, 1971, PFLUG ARCH EUR J PHY, V330, P347, DOI 10.1007/BF00588586; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; TRAYER IP, 1987, EUR J BIOCHEM, V164, P259, DOI 10.1111/j.1432-1033.1987.tb11019.x; UMEMOTO S, 1990, J BIOL CHEM, V265, P14864; VANBUREN P, 1994, P NATL ACAD SCI USA, V91, P12403, DOI 10.1073/pnas.91.26.12403; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0	45	452	472	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					63	69		10.1038/ng0596-63	http://dx.doi.org/10.1038/ng0596-63			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673105				2022-12-17	WOS:A1996UH43000017
J	YANG, YP; NUNES, FA; BERENCSI, K; GONCZOL, E; ENGELHARDT, JF; WILSON, JM				YANG, YP; NUNES, FA; BERENCSI, K; GONCZOL, E; ENGELHARDT, JF; WILSON, JM			INACTIVATION OF E2A IN RECOMBINANT ADENOVIRUSES IMPROVES THE PROSPECT FOR GENE-THERAPY IN CYSTIC-FIBROSIS	NATURE GENETICS			English	Article							TYPE-5; PATHOGENESIS; PNEUMONIA; INVIVO; TRANSCRIPTION; TRANSLATION; EPITHELIUM; TRANSPORT; INFECTION	Although first generation recombinant adenoviruses, deleted of sequences spanning E1a and E1b, have been useful for in vivo applications of gene therapy, expression of the recombinant gene has been transient and often associated with the development of inflammation. We show that with first generation adenovirus-mediated gene transfer to the mouse lung, viral proteins are expressed leading to destructive cellular immune responses and repopulation of the lung with nontransgene containing cells. Second generation E1 deleted viruses further crippled by a temperature sensitive mutation in the E2a gene were associated with substantially longer recombinant gene expression and less inflammation. Stable expression of human CF transmembrane conductance regulator has been achieved in lungs of CF mice instilled with a second generation virus.	UNIV PENN,MED CTR,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MOLEC & CELLULAR ENGN,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Engelhardt, John/0000-0003-2389-9277	NIDDK NIH HHS [R01 DK047967] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047967] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BABBISS LE, 1984, J VIROL, V50, P202; BABISS LE, 1985, MOL CELL BIOL, V5, P2552, DOI 10.1128/MCB.5.10.2552; BERENCSI K, IN PRESS J GEN VIROL; BROUGH DE, 1993, VIROLOGY, V196, P269, DOI 10.1006/viro.1993.1475; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; DUNCAN SJ, 1978, J GEN VIROL, V40, P45, DOI 10.1099/0022-1317-40-1-45; ENGELHARDT JF, 1993, HUM GENE THER, V4, P759, DOI 10.1089/hum.1993.4.6-759; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; ENGELHARDT JF, IN PRESS P NATN ACAD; ENSINGER MJ, 1972, J VIROL, V10, P328, DOI 10.1128/JVI.10.3.328-339.1972; GAYNOR RB, 1983, CELL, V33, P683, DOI 10.1016/0092-8674(83)90011-9; GINSBERG HS, 1990, P NATL ACAD SCI USA, V87, P6191, DOI 10.1073/pnas.87.16.6191; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; HORWITZ MS, 1990, VIROLOGY, P01679; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LOGAN J, 1984, P NATL ACAD SCI-BIOL, V81, P3655, DOI 10.1073/pnas.81.12.3655; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MULLBACHER A, 1989, IMMUNOL CELL BIOL, V67, P31, DOI 10.1038/icb.1989.4; NEVINS JR, 1981, CELL, V26, P213, DOI 10.1016/0092-8674(81)90304-4; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; SNOUWAERT JN, 1992, SCIENCE, V257, P1803; SPERGEL JM, 1992, J VIROL, V66, P1021, DOI 10.1128/JVI.66.2.1021-1030.1992; WILSON JM, 1993, NATURE, V365, P691, DOI 10.1038/365691a0; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K; ZABNER J, 1994, NAT GENET, V6, P75, DOI 10.1038/ng0194-75	31	452	477	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					362	369		10.1038/ng0794-362	http://dx.doi.org/10.1038/ng0794-362			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7522742				2022-12-17	WOS:A1994NU30600009
J	Hancock, DB; Eijgelsheim, M; Wilk, JB; Gharib, SA; Loehr, LR; Marciante, KD; Franceschini, N; van Durme, YMTA; Chen, TH; Barr, RG; Schabath, MB; Couper, DJ; Brusselle, GG; Psaty, BM; van Duijn, CM; Rotter, JI; Uitterlinden, AG; Hofman, A; Punjabi, NM; Rivadeneira, F; Morrison, AC; Enright, PL; North, KE; Heckbert, SR; Lumley, T; Stricker, BHC; O'Connor, GT; London, SJ				Hancock, Dana B.; Eijgelsheim, Mark; Wilk, Jemma B.; Gharib, Sina A.; Loehr, Laura R.; Marciante, Kristin D.; Franceschini, Nora; van Durme, Yannick M. T. A.; Chen, Ting-hsu; Barr, R. Graham; Schabath, Matthew B.; Couper, David J.; Brusselle, Guy G.; Psaty, Bruce M.; van Duijn, Cornelia M.; Rotter, Jerome I.; Uitterlinden, Andre G.; Hofman, Albert; Punjabi, Naresh M.; Rivadeneira, Fernando; Morrison, Alanna C.; Enright, Paul L.; North, Kari E.; Heckbert, Susan R.; Lumley, Thomas; Stricker, Bruno H. C.; O'Connor, George T.; London, Stephanie J.			Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function	NATURE GENETICS			English	Article							LUNG-FUNCTION DECLINE; SEROTONINERGIC RECEPTORS; REFERENCE VALUES; ADAM33 GENE; IDENTIFICATION; HEART; POPULATION; HEDGEHOG; DESIGN; RAGE	Spirometric measures of lung function are heritable traits that reflect respiratory health and predict morbidity and mortality. We meta-analyzed genome-wide association studies for two clinically important lung-function measures: forced expiratory volume in the first second (FEV1) and its ratio to forced vital capacity (FEV1/FVC), an indicator of airflow obstruction. This meta-analysis included 20,890 participants of European ancestry from four CHARGE Consortium studies: Atherosclerosis Risk in Communities, Cardiovascular Health Study, Framingham Heart Study and Rotterdam Study. We identified eight loci associated with FEV1/FVC (HHIP, GPR126, ADAM19, AGER-PPT2, FAM13A, PTCH1, PID1 and HTR4) and one locus associated with FEV1 (INTS12-GSTCD-NPNT) at or near genome-wide significance (P < 5 x 10(-8)) in the CHARGE Consortium dataset. Our findings may offer insights into pulmonary function and pathogenesis of chronic lung disease.	[Hancock, Dana B.; Loehr, Laura R.; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Eijgelsheim, Mark; Brusselle, Guy G.; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Hofman, Albert; Rivadeneira, Fernando; Stricker, Bruno H. C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Wilk, Jemma B.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Gharib, Sina A.; Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Loehr, Laura R.; Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [van Durme, Yannick M. T. A.; Brusselle, Guy G.] Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium; [van Durme, Yannick M. T. A.; Brusselle, Guy G.] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Chen, Ting-hsu; O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Chen, Ting-hsu; O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, Div Gen Med, New York, NY USA; [Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care, New York, NY USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Couper, David J.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Rivadeneira, Fernando; Stricker, Bruno H. C.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Punjabi, Naresh M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Punjabi, Naresh M.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol & Dis Control, Ctr Human Genet, Houston, TX USA; [Enright, Paul L.] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Stricker, Bruno H. C.] Netherlands Genom Initiat, Rotterdam, Netherlands; [Stricker, Bruno H. C.] Inspectorate Hlth Care, The Hague, Netherlands; [London, Stephanie J.] NIEHS, Lab Resp Biol, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Erasmus University Rotterdam; Erasmus MC; Boston University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Ghent University; Ghent University; Ghent University Hospital; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University; Columbia University; Columbia University; H Lee Moffitt Cancer Center & Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; University of Arizona; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	London, SJ (corresponding author), NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA.	london2@niehs.nih.gov	Rivadeneira, Fernando/O-5385-2015; Schabath, Matthew B./J-3763-2016; Hancock, Dana/D-8577-2012; Rotter, Jerome/AAY-6598-2021; Punjabi, Naresh/EMH-1007-2022; London, Stephanie/C-3734-2019	Rivadeneira, Fernando/0000-0001-9435-9441; Schabath, Matthew B./0000-0003-3241-3216; O'Connor, George/0000-0002-6476-3926; Couper, David/0000-0002-4313-9235; Van Duijn, Cornelia/0000-0002-2374-9204; GHARIB, SINA A./0000-0002-2480-4367; Hancock, Dana/0000-0003-2240-3604; Morrison, Alanna/0000-0001-6381-4296; Loehr, Laura/0000-0002-9054-1825; London, Stephanie/0000-0003-4911-5290	MRC [G0000934] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC055015, N01HC055021, N01HC055222, N01HC055019, N01HC055018, N01HC085079, N01HC095159, N01HC055016, N01HC055022, N01HC015103, N01HC075150, N01HC025195, N01HC055020, N01HC045133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R01HL059367, R42HL055018, R01HL064278, R01HL087652, R01HL086694, RC1HL100543, R41HL055019, R01HL077612, R01HL087641, U01HL080295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES043012, ZIAES043012] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES043012, ZIA ES043012-11] Funding Source: Medline; Medical Research Council [G0000934] Funding Source: Medline; NCRR NIH HHS [M01-RR00425, M01 RR000425] Funding Source: Medline; NHGRI NIH HHS [U01HG004402, U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [U01 HL080295, N01HC55015, N01HC25195, N01HC75150, N01HC55019, N01HC55016, N01-HC-55020, R01HL59367, N01-HC-75150, N01-HC-55015, N01HC55020, R01HL086694, N01HC55222, N01HC55022, R01 HL087652, N01HC85079, N01-HC-55018, N01HC55021, R01 HL087641, N01HC85086, N01-HC-55016, N01-HC-55021, R01HL087641, R01 HL086694, R01 HL077612, N01 HC-55222, N01-HC-55019, N01HC55018, N01-HC-85079 THROUGH N01-HC-85086, RC1 HL100543, R01 HL059367, N01-HC-55022, N01-HC-25195, N02-HL-6-4278] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491, DK063491] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abecasis GR, 2001, GENET EPIDEMIOL, V21, pS341, DOI 10.1002/gepi.2001.21.s1.s341; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bayer H, 2007, AM J RESP CELL MOL, V36, P85, DOI 10.1165/rcmb.2006-0151OC; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; CARDOSO WV, 1995, AM J PHYSIOL-LUNG C, V269, pL429, DOI 10.1152/ajplung.1995.269.4.L429; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen MH, 2007, CELL, V130, P386, DOI 10.1016/j.cell.2007.07.017; CRAPO RO, 1994, NEW ENGL J MED, V331, P25, DOI 10.1056/NEJM199407073310107; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; DeMeo DL, 2003, SEMIN RESP CRIT CARE, V24, P151, DOI 10.1055/s-2003-39014; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Dupont LJ, 1999, EUR RESPIR J, V14, P642, DOI 10.1034/j.1399-3003.1999.14c26.x; Eisner MD, 2007, ANN EPIDEMIOL, V17, P364, DOI 10.1016/j.annepidem.2006.10.008; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; ENRIGHT PL, 1993, AM REV RESPIR DIS, V147, P125, DOI 10.1164/ajrccm/147.1.125; ENRIGHT PL, 1994, CHEST, V106, P827, DOI 10.1378/chest.106.3.827; Estrada K, 2009, BIOINFORMATICS, V25, P2750, DOI 10.1093/bioinformatics/btp497; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Givelber RJ, 1998, AM J RESP CRIT CARE, V157, P1445, DOI 10.1164/ajrccm.157.5.9704021; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hole DJ, 1996, BRIT MED J, V313, P711; Huang JTJ, 2005, INT J MOL MED, V15, P719; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Jongepier H, 2004, CLIN EXP ALLERGY, V34, P757, DOI 10.1111/j.1365-2222.2004.1938.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lechin F, 1996, ANN ALLERG ASTHMA IM, V77, P245, DOI 10.1016/S1081-1206(10)63263-2; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; *NAT HEART BLOOD I, 1989, QUAL ASS QUAL CONTR; PAUWELS RA, 2001, AM J RESP CRIT CARE, V163, P1276; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; TEAM RDC, 2007, LANGUAGE ENV STAT CO; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; WEY E, 1994, EUR J BIOCHEM, V220, P753, DOI 10.1111/j.1432-1033.1994.tb18676.x; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	76	451	465	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					45	U61		10.1038/ng.500	http://dx.doi.org/10.1038/ng.500			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20010835	Green Accepted			2022-12-17	WOS:000273055100015
J	Sharp, AJ; Hansen, S; Selzer, RR; Cheng, Z; Regan, R; Hurst, JA; Stewart, H; Price, SM; Blair, E; Hennekam, RC; Fitzpatrick, CA; Segraves, R; Richmond, TA; Guiver, C; Albertson, DG; Pinkel, D; Eis, PS; Schwartz, S; Knight, SJL; Eichler, EE				Sharp, Andrew J.; Hansen, Sierra; Selzer, Rebecca R.; Cheng, Ze; Regan, Regina; Hurst, Jane A.; Stewart, Helen; Price, Sue M.; Blair, Edward; Hennekam, Raoul C.; Fitzpatrick, Carrie A.; Segraves, Rick; Richmond, Todd A.; Guiver, Cheryl; Albertson, Donna G.; Pinkel, Daniel; Eis, Peggy S.; Schwartz, Stuart; Knight, Samantha J. L.; Eichler, Evan E.			Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; MENTAL-RETARDATION; SOTOS-SYNDROME; REARRANGEMENTS; RECOMBINATION; BREAKPOINTS; MICRODELETION; POLYMORPHISM; MOSAICISM; INVERSION	Genomic disorders are characterized by the presence of flanking segmental duplications that predispose these regions to recurrent rearrangement. Based on the duplication architecture of the genome, we investigated 130 regions that we hypothesized as candidates for previously undescribed genomic disorders(1). We tested 290 individuals with mental retardation by BAC array comparative genomic hybridization and identified 16 pathogenic rearrangements, including de novo microdeletions of 17q21.31 found in four individuals. Using oligonucleotide arrays, we refined the breakpoints of this microdeletion, defining a 478-kb critical region containing six genes that were deleted in all four individuals. We mapped the breakpoints of this deletion and of four other pathogenic rearrangements in 1q21.1, 15q13, 15q24 and 17q12 to flanking segmental duplications, suggesting that these are also sites of recurrent rearrangement. In common with the 17q21.31 deletion, these breakpoint regions are sites of copy number polymorphism in controls, indicating that these may be inherently unstable genomic regions.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford Genet Knowledge Pk, Oxford OX3 7BN, England; Churchill Hosp, Oxford Radcliffe Hosp NHS Trust, Dept Clin Genet, Oxford OX3 7LJ, England; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1E 6BT, England; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Roche Holding; Roche NimbleGen; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Chicago; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Sharp, Andrew/A-5783-2008	Knight, Samantha/0000-0002-6047-3462; Eis, Peggy/0000-0002-3075-8707	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NICHD NIH HHS [HD043569] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Juyal RC, 1996, AM J MED GENET, V66, P193, DOI 10.1002/(SICI)1096-8628(19961211)66:2<193::AID-AJMG13>3.3.CO;2-9; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; Liehr T, 1996, HUM GENET, V98, P22, DOI 10.1007/s004390050154; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Zhou Y, 2005, P NATL ACAD SCI USA, V102, P4051, DOI 10.1073/pnas.0407957102	28	451	465	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1038	1042		10.1038/ng1862	http://dx.doi.org/10.1038/ng1862			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16906162				2022-12-17	WOS:000240112100021
J	Allen, E; Xie, ZX; Gustafson, AM; Sung, GH; Spatafora, JW; Carrington, JC				Allen, E; Xie, ZX; Gustafson, AM; Sung, GH; Spatafora, JW; Carrington, JC			Evolution of microRNA genes by inverted duplication of target gene sequences in Arabidopsis thaliana	NATURE GENETICS			English	Article							TRANS-ACTING SIRNAS; PLANT DEVELOPMENT; RNA-INTERFERENCE; MIRNA; PROTEIN; DICER; ACCUMULATION; BIOGENESIS; EXPRESSION; GENOMICS	MicroRNAs (miRNAs) in plants and animals function as post-transcriptional regulators of target genes, many of which are involved in multicellular development. miRNAs guide effector complexes to target mRNAs through base-pair complementarity, facilitating site-specific cleavage or translational repression. Biogenesis of miRNAs involves nucleolytic processing of a precursor transcript with extensive foldback structure. Here, we provide evidence that genes encoding miRNAs in plants originated by inverted duplication of target gene sequences. Several recently evolved genes encoding miRNAs in Arabidopsis thaliana and other small RNA-generating loci possess the hallmarks of inverted duplication events that formed the arms on each side of their respective foldback precursors. We propose a model for miRNA evolution that suggests a mechanism for de novo generation of new miRNA genes with unique target specificities.	Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Carrington, JC (corresponding author), Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	Carrington, James C/A-4656-2012	Carrington, James C/0000-0003-3572-129X; Allen, Edwards/0000-0002-8318-6319; Xie, Zhixin/0000-0002-6191-5170				Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Finnegan EJ, 2003, J CELL SCI, V116, P4689, DOI 10.1242/jcs.00838; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Herbert A, 2004, NAT GENET, V36, P19, DOI 10.1038/ng1275; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LIN JT, 1988, STATISTICIAN, V37, P413, DOI 10.2307/2348766; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Poethig RS, 2001, GENOME RES, V11, P313, DOI 10.1101/gr.180001; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SCHANK RC, 1991, J LEARN SCI, V1, P7; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1	50	451	504	2	58	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2004	36	12					1282	1290		10.1038/ng1478	http://dx.doi.org/10.1038/ng1478			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15565108				2022-12-17	WOS:000225354100015
J	Sehnert, AJ; Huq, A; Weinstein, BM; Walker, C; Fishman, M; Stainier, DYR				Sehnert, AJ; Huq, A; Weinstein, BM; Walker, C; Fishman, M; Stainier, DYR			Cardiac troponin T is essential in sarcomere assembly and cardiac contractility	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SUDDEN-DEATH; CARDIOVASCULAR-SYSTEM; MUTATIONS; ZEBRAFISH; TROPOMYOSIN; DISEASE; CHAIN; GENES	Mutations of the gene (TNNT2) encoding the thin-filament contractile protein cardiac troponin T are responsible for 15% of all cases of familial hypertrophic cardiomyopathy, the leading cause of sudden death in young athletes(1,2). Mutant proteins are thought to act through a dominant-negative mode that impairs function of heart muscle(3). TNNT2 mutations can also lead to dilated cardiomyopathy, a leading cause of heart failure(4). Despite the importance of cardiac troponin T in human disease, its loss-of-function phenotype has not been described. We show that the zebrafish silent heart (sih) mutation affects the gene tnnt2. We characterize two mutated alleles of sih that severely reduce tnnt2 expression: one affects mRNA splicing, and the other affects gene transcription. Tnnt2, together with alpha-tropomyosin (Tpma) and cardiac troponins C and I (Tnni3), forms a calcium-sensitive regulatory complex within sarcomeres(5). Unexpectedly, in addition to loss of Tnnt2 expression in sih mutant hearts, we observed a significant reduction in Tpma and Tnni3, and consequently, severe sarcomere defects. This interdependence of thin-filament protein expression led us to postulate that some mutations in tnnt2 may trigger misregulation of thin-filament protein expression, resulting in sarcomere loss and myocyte disarray, the life-threatening hallmarks of TNNT2 mutations in mice and humans(6,7).	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Oregon; Harvard University; Massachusetts General Hospital	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, 513 Parnassus Ave,Box 0448, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026				Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Amemiya CT, 1999, METHOD CELL BIOL, V60, P235; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BURGGREN WW, 1991, ANNU REV PHYSIOL, V53, P107, DOI 10.1146/annurev.physiol.53.1.107; Chen JN, 1996, DEVELOPMENT, V123, P293; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; MALOUF NN, 1992, J BIOL CHEM, V267, P9269; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; OHARA O, 1989, P NATL ACAD SCI USA, V86, P5673, DOI 10.1073/pnas.86.15.5673; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Westerfield M, 1995, ZEBRAFISH BOOK; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	25	451	460	0	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					106	110		10.1038/ng875	http://dx.doi.org/10.1038/ng875			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967535				2022-12-17	WOS:000175362500024
J	Saada, A; Shaag, A; Mandel, H; Nevo, Y; Eriksson, S; Elpeleg, O				Saada, A; Shaag, A; Mandel, H; Nevo, Y; Eriksson, S; Elpeleg, O			Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; MTDNA DEPLETION; CLONING; EXPRESSION; CDNA; DISEASE; LIVER; GENE	The mitochondrial deoxyribonucleotide (dNTP) pool is separated from the cytosolic pool because the mitochondria inner membrane is impermeable to charged molecules. The mitochondrial pool is maintained by either import of cytosolic dNTPs through dedicated transporters(1,2) or by salvaging deoxynucleasides within the mitochondria; apparently, enzymes of the de novo dNTP synthesis pathway are not present in the mitochondria. In non-replicating cells, where cytosolic dNTP synthesis is downregulated, mtDNA synthesis depends solely on the mitochondrial salvage pathway enzymes, the deoxyribonucleosides kinases. Two of the four human deoxyribonucleoside kinases, deoxyguanosine kinase (dGK) and thymidine kinase-2 (TK2), are expressed in mitochondria(3-6). Human dGK efficiently phosphorylates deoxyguanosine and deoxyadenosine, whereas TK2 phosphorylates deoxythymidine, deoxycytidine and deoxyuridine. Here we identify two mutations in TK2, histidine 90 to asparagine and isoleucine 181 to asparagine, in four individuals who developed devastating myopathy and depletion of muscular mitochondrial DNA in infancy. In these individuals, the activity of TK2 in muscle mitochondria is reduced to 14-45% of the mean value in healthy control individuals. Mutations in TK2 represent a new etiology for mitochondrial DNA depletion, underscoring the importance of the mitochondrial dNTP pool in the pathogenesis of mitochondrial depletion.	Hebrew Univ Jerusalem, Fac Med, Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel; Rambam Med Ctr, Dept Pediat, IL-31096 Haifa, Israel; Tel Aviv Sourasky Med Ctr, Pediat Neurol Unit, IL-65211 Tel Aviv, Israel; Swedish Univ Agr Sci, Dept Vet Med Chem, SE-75123 Uppsala, Sweden	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Swedish University of Agricultural Sciences	Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.		Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656				BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0; BODNAR AG, 1993, AM J HUM GENET, V53, P663; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; DOOIJEWAARD G, 1976, BIOCHIM BIOPHYS ACTA, V440, P1, DOI 10.1016/0005-2728(76)90109-2; Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; HOPPEL C, 1969, ARCH BIOCHEM BIOPHYS, V135, P173, DOI 10.1016/0003-9861(69)90528-1; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; MARIOTTI C, 1995, J NEUROL, V242, P547, DOI 10.1007/BF00868806; MORAES CT, 1991, AM J HUM GENET, V48, P492; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Spelbrink JN, 1998, HUM GENET, V102, P327, DOI 10.1007/s004390050700; Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935; TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209; Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783; Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0	28	451	462	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					342	344		10.1038/ng751	http://dx.doi.org/10.1038/ng751			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687801				2022-12-17	WOS:000171911000024
J	JEFFREYS, AJ; TAMAKI, K; MACLEOD, A; MONCKTON, DG; NEIL, DL; ARMOUR, JAL				JEFFREYS, AJ; TAMAKI, K; MACLEOD, A; MONCKTON, DG; NEIL, DL; ARMOUR, JAL			COMPLEX GENE CONVERSION EVENTS IN GERMLINE MUTATION AT HUMAN MINISATELLITES	NATURE GENETICS			English	Article							RECOMBINATION INITIATION SITE; HYPERVARIABLE MINISATELLITES; VNTR LOCI; HUMAN DNA; SEQUENCE; TANDEM; ALLELES	Mutation at the human minisatellites MS32, MS205 and MS31A has been investigated by characterizing mutant alleles in pedigrees and in the case of MS32 by direct analysis of mutant molecules in single sperm. Most mutations at all three loci are polar, involving the preferential gain of a few repeat units at one end of the tandem repeat array. Incoming repeats can be derived from the same allele or the homologous chromosome, though they are frequently rearranged during mutation. Lack of exchange of flanking markers suggests the involvement of complex conversion-like events in the generation of mutant alleles. At MS32, high frequency mutation processes in sperm appear to be largely germline specific and to occur at a constant rate irrespective of allele size. Together with mutational polarity, this implies that germline instability is controlled by elements outside the tandem repeat array.			JEFFREYS, AJ (corresponding author), UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,ENGLAND.		; Monckton, Darren/B-4943-2013	Armour, John/0000-0002-8558-8506; Monckton, Darren/0000-0002-8298-8264; Neil, David/0000-0002-9994-9536	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMOUR JAL, 1993, HUM MOL GENET, V2, P1137, DOI 10.1093/hmg/2.8.1137; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; Armour JAL, 1992, CURR OPIN GENET DEV, V2, P850, DOI 10.1016/S0959-437X(05)80106-6; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; GRAY IC, 1991, P ROY SOC B-BIOL SCI, V243, P241, DOI 10.1098/rspb.1991.0038; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HARDING RM, 1992, GENETICS, V132, P847; HENKE J, 1993, INT J LEGAL MED, V105, P217, DOI 10.1007/BF01642797; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1991, AM J HUM GENET, V48, P824; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; MASSEY R, 1993, EMBO J, V12, P1459; MONCKTON DG, 1991, GENOMICS, V11, P465, DOI 10.1016/0888-7543(91)90158-B; MONCKTON DG, 1993, HUM MOL GENET, V2, P513, DOI 10.1093/hmg/2.5.513; NEIL DL, 1993, HUM MOL GENET, V2, P1129; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RACK KA, 1993, AM J HUM GENET, V52, P987; ROYLE NJ, 1992, NUCLEIC ACIDS RES, V20, P1164, DOI 10.1093/nar/20.5.1164; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SCHULTES NP, 1991, MOL CELL BIOL, V11, P322, DOI 10.1128/MCB.11.1.322; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; TAMAKI K, 1993, HUM MOL GENET, V2, P1629, DOI 10.1093/hmg/2.10.1629; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; 1993, CELL, V72, P971	30	451	462	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					136	145		10.1038/ng0294-136	http://dx.doi.org/10.1038/ng0294-136			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162067				2022-12-17	WOS:A1994MU76300007
J	Petersen, GM; Amundadottir, L; Fuchs, CS; Kraft, P; Stolzenberg-Solomon, RZ; Jacobs, KB; Arslan, AA; Bueno-de-Mesquita, HB; Gallinger, S; Gross, M; Helzlsouer, K; Holly, EA; Jacobs, EJ; Klein, AP; LaCroix, A; Li, DH; Mandelson, MT; Olson, SH; Risch, HA; Zheng, W; Albanes, D; Bamlet, WR; Berg, CD; Boutron-Ruault, MC; Buring, JE; Bracci, PM; Canzian, F; Clipp, S; Cotterchio, M; de Andrade, M; Duell, EJ; Gaziano, JM; Giovannucci, EL; Goggins, M; Hallmans, G; Hankinson, SE; Hassan, M; Howard, B; Hunter, DJ; Hutchinson, A; Jenab, M; Kaaks, R; Kooperberg, C; Krogh, V; Kurtz, RC; Lynch, SM; McWilliams, RR; Mendelsohn, JB; Michaud, DS; Parikh, H; Patel, AV; Peeters, PHM; Rajkovic, A; Riboli, E; Rodriguez, L; Seminara, D; Shu, XO; Thomas, G; Tjonneland, A; Tobias, GS; Trichopoulos, D; Van Den Eeden, SK; Virtamo, J; Wactawski-Wende, J; Wang, ZM; Wolpin, BM; Yu, H; Yu, K; Zeleniuch-Jacquotte, A; Fraumeni, JF; Hoover, RN; Hartge, P; Chanock, SJ				Petersen, Gloria M.; Amundadottir, Laufey; Fuchs, Charles S.; Kraft, Peter; Stolzenberg-Solomon, Rachael Z.; Jacobs, Kevin B.; Arslan, Alan A.; Bueno-de-Mesquita, H. Bas; Gallinger, Steven; Gross, Myron; Helzlsouer, Kathy; Holly, Elizabeth A.; Jacobs, Eric J.; Klein, Alison P.; LaCroix, Andrea; Li, Donghui; Mandelson, Margaret T.; Olson, Sara H.; Risch, Harvey A.; Zheng, Wei; Albanes, Demetrius; Bamlet, William R.; Berg, Christine D.; Boutron-Ruault, Marie-Christine; Buring, Julie E.; Bracci, Paige M.; Canzian, Federico; Clipp, Sandra; Cotterchio, Michelle; de Andrade, Mariza; Duell, Eric J.; Gaziano, J. Michael; Giovannucci, Edward L.; Goggins, Michael; Hallmans, Goran; Hankinson, Susan E.; Hassan, Manal; Howard, Barbara; Hunter, David J.; Hutchinson, Amy; Jenab, Mazda; Kaaks, Rudolf; Kooperberg, Charles; Krogh, Vittorio; Kurtz, Robert C.; Lynch, Shannon M.; McWilliams, Robert R.; Mendelsohn, Julie B.; Michaud, Dominique S.; Parikh, Hemang; Patel, Alpa V.; Peeters, Petra H. M.; Rajkovic, Aleksandar; Riboli, Elio; Rodriguez, Laudina; Seminara, Daniela; Shu, Xiao-Ou; Thomas, Gilles; Tjonneland, Anne; Tobias, Geoffrey S.; Trichopoulos, Dimitrios; Van Den Eeden, Stephen K.; Virtamo, Jarmo; Wactawski-Wende, Jean; Wang, Zhaoming; Wolpin, Brian M.; Yu, Herbert; Yu, Kai; Zeleniuch-Jacquotte, Anne; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Hartge, Patricia; Chanock, Stephen J.			A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33	NATURE GENETICS			English	Article							BASE-LINE CHARACTERISTICS; RECOMBINATION HOTSPOTS; WOMENS HEALTH; BREAST-CANCER; RISK; GENE; VARIANTS; TELOMERASE; CELLS; LUNG	We conducted a genome-wide association study of pancreatic cancer in 3,851 affected individuals (cases) and 3,934 unaffected controls drawn from 12 prospective cohort studies and 8 case-control studies. Based on a logistic regression model for genotype trend effect that was adjusted for study, age, sex, self-described ancestry and five principal components, we identified eight SNPs that map to three loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Two correlated SNPs, rs9543325 (P = 3.27 x 10(-11), per-allele odds ratio (OR) 1.26, 95% CI 1.18-1.35) and rs9564966 (P = 5.86 x 10(-8), per-allele OR 1.21, 95% CI 1.13-1.30), map to a nongenic region on chromosome 13q22.1. Five SNPs on 1q32.1 map to NR5A2, and the strongest signal was at rs3790844 (P = 2.45 x 10(-10), per-allele OR 0.77, 95% CI 0.71-0.84). A single SNP, rs401681 (P = 3.66 x 10(-7), per-allele OR 1.19, 95% CI 1.11-1.27), maps to the CLPTM1L-TERT locus on 5p15.33, which is associated with multiple cancers. Our study has identified common susceptibility loci for pancreatic cancer that warrant follow-up studies.	[Amundadottir, Laufey; Parikh, Hemang; Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Petersen, Gloria M.; Bamlet, William R.; de Andrade, Mariza; McWilliams, Robert R.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Fuchs, Charles S.; Wolpin, Brian M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fuchs, Charles S.; Giovannucci, Edward L.; Hankinson, Susan E.; Hunter, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Giovannucci, Edward L.; Hankinson, Susan E.; Hunter, David J.; Michaud, Dominique S.; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Jacobs, Kevin B.; Hutchinson, Amy; Wang, Zhaoming] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD USA; [Arslan, Alan A.] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Inst Canc, New York, NY USA; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gross, Myron] Univ Minnesota, Dept Lab Med & Pathol, Sch Med, Minneapolis, MN 55455 USA; [Helzlsouer, Kathy] Mercy Med Ctr, Prevent & Res Ctr, Baltimore, MD USA; [Holly, Elizabeth A.; Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jacobs, Eric J.; Patel, Alpa V.] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA; [Klein, Alison P.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Res Ctr, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [LaCroix, Andrea; Mandelson, Margaret T.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Li, Donghui; Hassan, Manal] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Mandelson, Margaret T.] Grp Hlth Ctr Hlth Studies, Seattle, WA USA; [Olson, Sara H.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Risch, Harvey A.; Yu, Herbert] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Boutron-Ruault, Marie-Christine] Univ Paris Sud, INSERM, Inst Gustave Roussy, Villejuif, France; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Dept Aging, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Canzian, Federico] German Canc Res Ctr, Heidelberg, Germany; [Clipp, Sandra] George W Comstock Ctr Publ Hlth Res & Prevent, Johns Hopkins Bloomberg Sch Publ Hlth, Hagerstown, MD USA; [Cotterchio, Michelle] Univ Toronto, Canc Care Ontario & Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Duell, Eric J.] Catalan Inst Oncol, Barcelona, Spain; [Gaziano, J. Michael] Brigham & Womens Hosp, Phys Hlth Study, Div Aging, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Phys Hlth Study, Div Cardiovasc Dis, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Phys Hlth Study, Div Prevent Med, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Howard, Barbara] Georgetown Univ, MedStar Res Inst, Hyattsville, MD USA; [Krogh, Vittorio] Fdn IRCCS, Ist Nazl Tumoridi Milano, Nutr Epidemiol Unit, Milan, Italy; [Kurtz, Robert C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Lynch, Shannon M.; Seminara, Daniela] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Michaud, Dominique S.; Peeters, Petra H. M.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London, England; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rajkovic, Aleksandar] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Biol, Pittsburgh, PA USA; [Rodriguez, Laudina] Hlth & Hlth Care Serv Council, Publ Hlth & Participat Directorate, Asturias, Spain; [Thomas, Gilles] Ctr Leon Berard, INSERM, F-69373 Lyon, France; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Van Den Eeden, Stephen K.] Kaiser Permanente, Div Res, Oakland, CA USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; New York University; New York University; New York University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Minnesota System; University of Minnesota Twin Cities; Mercy Medical Center - Maryland; University of California System; University of California San Francisco; American Cancer Society; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cancer Care Ontario; University of Toronto; Catalan Institute of Oncology; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Umea University; Georgetown University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; Utrecht University; Utrecht University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Danish Cancer Society; Academy of Athens; Kaiser Permanente; Finland National Institute for Health & Welfare; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chanock, SJ (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Wang, Zhaoming/R-5527-2018; Canzian, Federico/I-2804-2014; Albanes, Demetrius/B-9749-2015; Zheng, Wei/O-3351-2013; Amundadottir, Laufey T/L-7656-2016; Stolzenberg-Solomon, Rachael/Y-9280-2018; Tobias, Geoffrey S/M-4135-2016; Boutron-Ruault, Marie-Christine/H-3936-2014; zhang, weihua/GXV-1334-2022; Krogh, Vittorio/K-2628-2016; Gallinger, Steven/E-4575-2013; Parikh, Hemang/AAY-7174-2021; Michaud, Dominique S/I-5231-2014; Krogh, Vittorio/AAA-9171-2019; Wactawski-Wende, Jean/AGH-5457-2022	Wang, Zhaoming/0000-0001-7556-3869; Zheng, Wei/0000-0003-1226-070X; Amundadottir, Laufey T/0000-0003-1859-8971; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Tobias, Geoffrey S/0000-0002-2878-8253; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; Wactawski-Wende, Jean/0000-0003-3096-9595; Jenab, Mazda/0000-0002-0573-1852; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Canzian, Federico/0000-0002-4261-4583; Arslan, Alan/0000-0002-7775-8085; Duell, Eric J/0000-0001-5256-0163; Riboli, Elio/0000-0001-6795-6080; Tjonneland, Anne/0000-0003-4385-2097; Olson, Sara/0000-0003-0182-2754; Jacobs, Kevin/0000-0002-4657-6473; Bamlet, William/0000-0003-2903-1284	NATIONAL CANCER INSTITUTE [R01CA097193, R01CA082729, R37CA070867, P50CA062924, K07CA140790, ZIACP010193, R01CA124908, P50CA102701] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA CP010193-03] Funding Source: Medline; NCI NIH HHS [R01 CA082729, P50 CA062924, P50 CA062924-150011, R01 CA097193, K07 CA140790, P50 CA102701, R01 CA124908, R37 CA070867, P50 CA062924-130011, P50 CA062924-140011, P50 CA062924-160011] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Anderson KE, 2006, CANC EPIDEMIOLOGY PR, P721; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970.abs; Chen CS, 2001, GENE CHROMOSOME CANC, V31, P333, DOI 10.1002/gcc.1152; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Duell EJ, 2008, CANCER EPIDEM BIOMAR, V17, P1470, DOI 10.1158/1055-9965.EPI-07-2797; Eppel A, 2007, INT J CANCER, V121, P2241, DOI 10.1002/ijc.22884; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Ferlay J, 2004, IARC CANC BASE; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gallicchio L, 2008, AM J EPIDEMIOL, V167, P807, DOI 10.1093/aje/kwm378; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lee YK, 2008, FRONT BIOSCI, V13, P5950, DOI 10.2741/3128; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Li N, 2003, GENETICS, V165, P2213; Li Y, 2007, AM J HUM GENET, V80, P705, DOI 10.1086/513205; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Olson SH, 2007, CANCER DETECT PREV, V31, P345, DOI 10.1016/j.cdp.2007.10.002; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Risch HA, 2003, JNCI-J NATL CANCER I, V95, P948, DOI 10.1093/jnci/95.13.948; Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi C, 2009, ARCH PATHOL LAB MED, V133, P365, DOI 10.1043/1543-2165-133.3.365; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wolpin BM, 2007, CANCER RES, V67, P7923, DOI 10.1158/0008-5472.CAN-07-0373; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Yu ZX, 2007, GENET EPIDEMIOL, V31, P553, DOI 10.1002/gepi.20228; Zeleniuch-Jacquotte A, 2005, INT J CANCER, V114, P323, DOI 10.1002/ijc.20694; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	63	450	455	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					224	U29		10.1038/ng.522	http://dx.doi.org/10.1038/ng.522			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101243	Green Accepted			2022-12-17	WOS:000274912400010
J	Wang, YF; Broderick, P; Webb, E; Wu, XF; Vijayakrishnan, J; Matakidou, A; Qureshi, M; Dong, Q; Gu, XJ; Chen, WV; Spitz, MR; Eisen, T; Amos, CI; Houlston, RS				Wang, Yufei; Broderick, Peter; Webb, Emily; Wu, Xifeng; Vijayakrishnan, Jayaram; Matakidou, Athena; Qureshi, Mobshra; Dong, Qiong; Gu, Xiangjun; Chen, Wei Vivien; Spitz, Margaret R.; Eisen, Timothy; Amos, Christopher I.; Houlston, Richard S.			Common 5p15.33 and 6p21.33 variants influence lung cancer risk	NATURE GENETICS			English	Article							MICROSATELLITE INSTABILITY; SUSCEPTIBILITY LOCUS	We conducted a genome-wide association (GWA) study of lung cancer comparing 511,919 SNP genotypes in 1,952 cases and 1,438 controls. The most significant association was attained at 15q25.1 (rs8042374; P = 7.75 x 10(-12)), confirming recent observations. Pooling data with two other GWA studies (5,095 cases, 5,200 controls) and with replication in an additional 2,484 cases and 3,036 controls, we identified two newly associated risk loci mapping to 6p21.33 (rs3117582, BAT3-MSH5; P-combined 4.97 x 10(-10)) and 5p15.33 (rs401681, CLPTM1L; P-combined 7.90 x 10(-9)).	[Wang, Yufei; Broderick, Peter; Webb, Emily; Vijayakrishnan, Jayaram; Matakidou, Athena; Qureshi, Mobshra; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Wu, Xifeng; Dong, Qiong; Gu, Xiangjun; Chen, Wei Vivien; Spitz, Margaret R.; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Eisen, Timothy] Univ Cambridge, Dept Oncol, Cambridge CB2 2RE, England	University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; University of Cambridge	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.houlston@icr.ac.uk	Wang, Weili/D-1546-2011	Broderick, Peter/0000-0002-8348-5829; Webb, Emily/0000-0002-4019-7456; Houlston, Richard/0000-0002-5268-0242; Vijayakrishnan, Jayaram/0000-0002-8284-2249	Cancer Research UK [A1298/A8780]; HEAL; Sanofi-Aventis; US NIH [P50CA70907, R01CA121197, R01CA133996]; MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA121197, P50CA070907, R01CA133996] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); HEAL; Sanofi-Aventis(Sanofi-Aventis); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Cancer Research UK (A1298/A8780) provided principal funding for this study. Additional funding was provided by HEAL and Sanofi-Aventis and US NIH Grants P50CA70907, R01CA121197 and R01CA133996. We would like to thank all individuals who participated in this study. We are grateful to colleagues at UK Clinical Genetics Centres and the UK National Cancer Research Network.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Hirose T, 2002, MOL CARCINOGEN, V33, P172, DOI 10.1002/mc.10035; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Li XJ, 2004, INT J CANCER, V112, P451, DOI 10.1002/ijc.20436; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wang YC, 2006, ANN NY ACAD SCI, V1075, P179, DOI 10.1196/annals.1368.024; Xu LH, 2001, INT J CANCER, V91, P200, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1031>3.0.CO;2-0; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250	11	450	459	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1407	1409		10.1038/ng.273	http://dx.doi.org/10.1038/ng.273			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978787	Green Accepted			2022-12-17	WOS:000261215900015
J	Marin, MC; Jost, CA; Brooks, LA; Irwin, MS; O'Nions, J; Tidy, JA; James, N; McGregor, JM; Harwood, CA; Yulug, IG; Vousden, KH; Allday, MJ; Gusterson, B; Ikawa, S; Hinds, PW; Crook, T; Kaelin, WG				Marin, MC; Jost, CA; Brooks, LA; Irwin, MS; O'Nions, J; Tidy, JA; James, N; McGregor, JM; Harwood, CA; Yulug, IG; Vousden, KH; Allday, MJ; Gusterson, B; Ikawa, S; Hinds, PW; Crook, T; Kaelin, WG			A common polymorphism acts as an intragenic modifier of mutant p53 behaviour	NATURE GENETICS			English	Article							HUMAN LUNG-CANCER; CERVICAL-CANCER; CELL-LINES; WILD-TYPE; GENE; MUTATIONS; P73; SUPPRESSION; GROWTH; RISK	The p73 protein, a homologue of the tumour-suppressor protein p53, can activate p53-responsive promoters and induce apoptosis in p53-deficient cells. Here we report that some tumour-derived p53 mutants can bind to and inactivate p73. The binding of such mutants is influenced by whether TP53 (encoding p53) codon 72, by virtue of a common polymorphism in the human population, encodes Arg or Pro. The ability of mutant p53 to bind p73, neutralize p73-induced apoptosis and transform cells in cooperation with EJ-Ras was enhanced when codon 72 encoded Arg. We found that the Arg-containing allele was preferentially mutated and retained in squamous cell tumours arising in Arg/Pro germline heterozygotes. Thus, inactivation of p53 family members may contribute to the biological properties of a subset of p53 mutants, and a polymorphic residue within p53 affects mutant behaviour.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; London Sch Hyg & Trop Med, London WC1, England; Inst Canc Res, Sect Cell Biol & Expt Pathol, London SW3 6JB, England; Univ Sheffield, No Gen Hosp, Dept Gynecol Oncol, Sheffield S5 7AU, S Yorkshire, England; Univ Birmingham, CRC, Inst Canc Studies, Birmingham, W Midlands, England; Ctr Cutaneous Res, London, England; NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA; St Marys Hosp, Imperial Coll Sci Technol & Med, Ludwig Inst Canc Res, London, England; Tohoku Univ, Inst Dev Aging & Canc, Dept Cell Biol, Sendai, Miyagi 980, Japan; Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of London; London School of Hygiene & Tropical Medicine; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Northern General Hospital; University of Sheffield; University of Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Imperial College London; Ludwig Institute for Cancer Research; Tohoku University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Marin, Maria C/G-1040-2010; 井川, 俊太郎/L-5911-2015; Marín Vieira, María del Carmen/B-8108-2015; gusterson, barry a/D-3752-2009	Marin, Maria C/0000-0002-7149-287X; Marín Vieira, María del Carmen/0000-0002-7149-287X; Harwood, Catherine/0000-0002-1375-0965; Yulug, Isik/0000-0002-7577-2502				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; BIRGANDER R, 1995, CARCINOGENESIS, V16, P2233, DOI 10.1093/carcin/16.9.2233; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; BRACHMAN DG, 1992, CANCER RES, V52, P4832; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Davison TS, 1999, J BIOL CHEM, V274, P18709, DOI 10.1074/jbc.274.26.18709; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gong JG, 1999, NATURE, V399, P806; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; Helland A, 1998, NATURE, V396, P530, DOI 10.1038/25034; Hildesheim A, 1998, NATURE, V396, P531, DOI 10.1038/25040; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; JIN XM, 1995, CARCINOGENESIS, V16, P2205, DOI 10.1093/carcin/16.9.2205; JONES M, 1992, GENE CHROMOSOME CANC, V1, P89; Josefsson AM, 1998, NATURE, V396, P531, DOI 10.1038/25037; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; KAWAJIRI K, 1993, CARCINOGENESIS, V14, P1085, DOI 10.1093/carcin/14.6.1085; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lanham S, 1998, LANCET, V352, P1631, DOI 10.1016/S0140-6736(05)61083-5; Levine AJ, 1995, ANN NY ACAD SCI, V768, P111, DOI 10.1111/j.1749-6632.1995.tb12115.x; Li RZ, 1998, ONCOGENE, V16, P3269, DOI 10.1038/sj.onc.1201867; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mateu MG, 1999, P NATL ACAD SCI USA, V96, P3595, DOI 10.1073/pnas.96.7.3595; MCGREGOR J, 1997, ONCOGENE, V14, P1737; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Minaguchi T, 1998, CANCER RES, V58, P4585; Murata M, 1996, CARCINOGENESIS, V17, P261, DOI 10.1093/carcin/17.2.261; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; ORFY K, 1994, EMBO J, V13, P3496; Rosenthal AN, 1998, LANCET, V352, P871, DOI 10.1016/S0140-6736(98)07357-7; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; SHAULSKY G, 1991, CANCER RES, V51, P5232; Storey A, 1998, NATURE, V396, P532, DOI 10.1038/25043; UNGER T, 1993, MOL CELL BIOL, V13, P5186, DOI 10.1128/MCB.13.9.5186; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; WESTON A, 1994, CARCINOGENESIS, V15, P583, DOI 10.1093/carcin/15.4.583; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; ZHANG W, 1992, GENE, V117, P271, DOI 10.1016/0378-1119(92)90738-B	49	450	460	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					47	54		10.1038/75586	http://dx.doi.org/10.1038/75586			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802655				2022-12-17	WOS:000086884000015
J	Lee, JH; Huynh, M; Silhavy, JL; Kim, S; Dixon-Salazar, T; Heiberg, A; Scott, E; Bafna, V; Hill, KJ; Collazo, A; Funari, V; Russ, C; Gabriel, SB; Mathern, GW; Gleeson, JG				Lee, Jeong Ho; My Huynh; Silhavy, Jennifer L.; Kim, Sangwoo; Dixon-Salazar, Tracy; Heiberg, Andrew; Scott, Eric; Bafna, Vineet; Hill, Kiley J.; Collazo, Adrienne; Funari, Vincent; Russ, Carsten; Gabriel, Stacey B.; Mathern, Gary W.; Gleeson, Joseph G.			De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly	NATURE GENETICS			English	Article							TUBEROUS SCLEROSIS COMPLEX; KINASE-B-GAMMA; HUMAN CANCER; CELL-GROWTH; MITOTIC RECOMBINATION; CORTICAL DYSPLASIAS; PROTEUS SYNDROME; AKT3 MUTATION; GENE; CLASSIFICATION	De novo somatic mutations in focal areas are well documented in diseases such as neoplasia but are rarely reported in malformation of the developing brain. Hemimegalencephaly (HME) is characterized by overgrowth of either one of the two cerebral hemispheres. The molecular etiology of HME remains a mystery. The intractable epilepsy that is associated with HME can be relieved by the surgical treatment hemispherectomy, allowing sampling of diseased tissue. Exome sequencing and mass spectrometry analysis in paired brain-blood samples from individuals with HME (n = 20 cases) identified de novo somatic mutations in 30% of affected individuals in the PIK3CA, AKT3 and MTOR genes. A recurrent PIK3CA c.1633G > A mutation was found in four separate cases. Identified mutations were present in 8-40% of sequenced alleles in various brain regions and were associated with increased neuronal S6 protein phosphorylation in the brains of affected individuals, indicating aberrant activation of mammalian target of rapamycin (mTOR) signaling. Thus HME is probably a genetically mosaic disease caused by gain of function in phosphatidylinositol 3-kinase (PI3K)-AKT3-mTOR signaling.	[Lee, Jeong Ho; Silhavy, Jennifer L.; Dixon-Salazar, Tracy; Heiberg, Andrew; Scott, Eric; Hill, Kiley J.; Collazo, Adrienne; Gleeson, Joseph G.] Univ Calif San Diego, Rady Childrens Hosp, Inst Genom Med, La Jolla, CA 92093 USA; [Lee, Jeong Ho; Silhavy, Jennifer L.; Dixon-Salazar, Tracy; Heiberg, Andrew; Scott, Eric; Hill, Kiley J.; Collazo, Adrienne; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [My Huynh; Mathern, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA 90095 USA; [My Huynh; Mathern, Gary W.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Mattel Childrens Hosp, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Kim, Sangwoo; Bafna, Vineet] Univ Calif San Diego, Sch Engn, Dept Comp Sci, La Jolla, CA 92093 USA; [Funari, Vincent] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Russ, Carsten; Gabriel, Stacey B.] Broad Inst MIT & Harvard, Cambridge, MA USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Rady Childrens Hosp, Inst Genom Med, La Jolla, CA 92093 USA.	gmathern@ucla.edu; jogleeson@ucsd.edu	Bafna, Vineet/AAY-8111-2020; Lee, Jeong Ho/G-7361-2012; Mathern, Gary W./J-2483-2016	Bafna, Vineet/0000-0002-5810-6241; Kim, Sangwoo/0000-0001-5356-0827	US National Institute of Neurological Disorders and Stroke [P30NS047101]; Genomics Core at Cedars-Sinai Medical Center; Broad Institute; US National Human Genome Research Institute [U54HG003067]; Daland Fellowship from the American Philosophical Society; US National Institutes of Health [R01 NS038992, R01 NS048453, R01 NS052455, R01 NS041537, P01 HD070494]; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455, R01NS083823, R01NS038992, P30NS047101, R01NS041537] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Genomics Core at Cedars-Sinai Medical Center; Broad Institute; US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Daland Fellowship from the American Philosophical Society; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Meerloo at the UCSD Neurosciences Core for microscopy services (supported by the US National Institute of Neurological Disorders and Stroke; P30NS047101), the Genomics Core at Cedars-Sinai Medical Center, the Broad Institute (supported by the US National Human Genome Research Institute; U54HG003067 to E. Lander) for sequencing support and analysis, D. Neelam (Sequenom) for technical support and W.B. Dobyns and M.L. Warman for sharing unpublished results. This work was supported by grants from the Daland Fellowship from the American Philosophical Society (to J.H.L.), the US National Institutes of Health (R01 NS038992 to G.W.M. and R01 NS048453, R01 NS052455, R01 NS041537 and P01 HD070494), the Simons Foundation Autism Research Initiative and the Howard Hughes Medical Institute (to J.G.G.).	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Auriemma A, 2000, Eur J Ultrasound, V12, P61, DOI 10.1016/S0929-8266(00)00099-9; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Boer K, 2007, NEUROPATH APPL NEURO, V33, P455, DOI 10.1111/j.1365-2990.2006.00818.x; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Chapman K, 2008, SEMIN PEDIATR NEUROL, V15, P190, DOI 10.1016/j.spen.2008.10.010; Choate KA, 2010, SCIENCE, V330, P94, DOI 10.1126/science.1192280; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Di Rocco C, 2006, CHILD NERV SYST, V22, P852, DOI 10.1007/s00381-006-0149-9; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; GRIFFITHS PD, 1994, NEUROPEDIATRICS, V25, P140, DOI 10.1055/s-2008-1073012; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Hemb M, 2010, NEUROLOGY, V74, P1768, DOI 10.1212/WNL.0b013e3181e0f17a; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jonas R, 2004, NEUROLOGY, V62, P1712, DOI 10.1212/01.WNL.0000127109.14569.C3; Jongmans MCJ, 2012, AM J HUM GENET, V90, P426, DOI 10.1016/j.ajhg.2012.01.004; Jonkman MF, 2009, NEW ENGL J MED, V360, P1680, DOI 10.1056/NEJMc0809896; Jozwiak J, 2005, HISTOL HISTOPATHOL, V20, P1321, DOI 10.14670/HH-20.1321; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Merks JHM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e111; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Salamon N, 2006, BRAIN, V129, P352, DOI 10.1093/brain/awh681; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Sharma Suvasini, 2009, Dermatol Online J, V15, P12; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yu J, 2005, BRAIN PATHOL, V15, P179	42	449	461	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					941	+		10.1038/ng.2329	http://dx.doi.org/10.1038/ng.2329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22729223	Green Accepted			2022-12-17	WOS:000306854700022
J	van de Laar, IMBH; Oldenburg, RA; Pals, G; Roos-Hesselink, JW; de Graaf, BM; Verhagen, JMA; Hoedemaekers, YM; Willemsen, R; Severijnen, LA; Venselaar, H; Vriend, G; Pattynama, PM; Collee, M; Majoor-Krakauer, D; Poldermans, D; Frohn-Mulder, IME; Micha, D; Timmermans, J; Hilhorst-Hofstee, Y; Bierma-Zeinstra, SM; Willems, PJ; Kros, JM; Oei, EHG; Oostra, BA; Wessels, MW; Bertoli-Avella, AM				van de laar, Ingrid M. B. H.; Oldenburg, Rogier A.; Pals, Gerard; Roos-Hesselink, Jolien W.; de Graaf, Bianca M.; Verhagen, Judith M. A.; Hoedemaekers, Yvonne M.; Willemsen, Rob; Severijnen, Lies-Anne; Venselaar, Hanka; Vriend, Gert; Pattynama, Peter M.; Collee, Margriet; Majoor-Krakauer, Danielle; Poldermans, Don; Frohn-Mulder, Ingrid M. E.; Micha, Dimitra; Timmermans, Janneke; Hilhorst-Hofstee, Yvonne; Bierma-Zeinstra, Sita M.; Willems, Patrick J.; Kros, Johan M.; Oei, Edwin H. G.; Oostra, Ben A.; Wessels, Marja W.; Bertoli-Avella, Aida M.			Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; MARFAN-SYNDROME; RECEPTOR; INDIVIDUALS; ACTIVATION; DESIGN; DISC	Thoracic aortic aneurysms and dissections are a main feature of connective tissue disorders, such as Marfan syndrome and Loeys-Dietz syndrome. We delineated a new syndrome presenting with aneurysms, dissections and tortuosity throughout the arterial tree in association with mild craniofacial features and skeletal and cutaneous anomalies. In contrast with other aneurysm syndromes, most of these affected individuals presented with early-onset osteoarthritis. We mapped the genetic locus to chromosome 15q22.2-24.2 and show that the disease is caused by mutations in SMAD3. This gene encodes a member of the TGF-beta pathway that is essential for TGF-beta signal transmission(1-3). SMAD3 mutations lead to increased aortic expression of several key players in the TGF-beta pathway, including SMAD3. Molecular diagnosis will allow early and reliable identification of cases and relatives at risk for major cardiovascular complications. Our findings endorse the TGF-beta pathway as the primary pharmacological target for the development of new treatments for aortic aneurysms and osteoarthritis.	[van de laar, Ingrid M. B. H.; Oldenburg, Rogier A.; de Graaf, Bianca M.; Verhagen, Judith M. A.; Hoedemaekers, Yvonne M.; Willemsen, Rob; Severijnen, Lies-Anne; Collee, Margriet; Majoor-Krakauer, Danielle; Oostra, Ben A.; Wessels, Marja W.; Bertoli-Avella, Aida M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Pals, Gerard; Micha, Dimitra] Vrije Univ Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Roos-Hesselink, Jolien W.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Venselaar, Hanka; Vriend, Gert] Radboud Univ Nijmegen, Med Ctr, NCMLS, Nijmegen, Netherlands; [Venselaar, Hanka; Vriend, Gert] CMBI, Nijmegen, Netherlands; [Pattynama, Peter M.; Oei, Edwin H. G.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Poldermans, Don] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [Frohn-Mulder, Ingrid M. E.] Erasmus MC, Dept Pediat Cardiol, Rotterdam, Netherlands; [Timmermans, Janneke] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Hilhorst-Hofstee, Yvonne] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Bierma-Zeinstra, Sita M.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Willems, Patrick J.] GENDIA Network, Antwerp, Belgium; [Kros, Johan M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bertoli-Avella, AM (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	a.bertoliavella@erasmusmc.nl	Majoor-Krakauer, Danielle/AAC-3939-2020; Bierma-Zeinstra, Sita/AAF-2122-2019; Vriend, G./H-8112-2014; Micha, Dimitra/U-4979-2019; Venselaar, Hanka/D-2009-2016; Vriend, Gert/D-6730-2011; Timmermans, J./L-4693-2015; Hilhorst-Hofstee, Yvonne/AAC-5120-2022; Oei, Edwin HG/E-8174-2013; Bertoli-Avella, Aida/AAW-2751-2020	Micha, Dimitra/0000-0001-7890-4411; Venselaar, Hanka/0000-0001-9824-6559; Hilhorst-Hofstee, Yvonne/0000-0003-0951-6524; Bertoli-Avella, Aida/0000-0001-9544-1877; Verhagen, Judith/0000-0002-0340-3433; Pals, Gerard/0000-0003-4091-7115	Erasmus Medical Center, The Netherlands; Center for Biomedical Genetics (CBG), The Netherlands	Erasmus Medical Center, The Netherlands(Netherlands Government); Center for Biomedical Genetics (CBG), The Netherlands(Netherlands Government)	This work was partially funded by an Erasmus Fellowship (Erasmus Medical Center, The Netherlands) to A.M.B.-A. and a grant from the Center for Biomedical Genetics (CBG), The Netherlands to B.A.O.	Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lacro RV, 2007, AM HEART J, V154, P624, DOI 10.1016/j.ahj.2007.06.024; LANE NE, 1993, J RHEUMATOL, V20, P1911; Li CG, 2009, SPINE, V34, P1363, DOI 10.1097/BRS.0b013e3181a3c7c7; LILIENFELD DE, 1987, ARTERIOSCLEROSIS, V7, P637, DOI 10.1161/01.ATV.7.6.637; Lin Fay Y, 2008, J Cardiovasc Comput Tomogr, V2, P298, DOI 10.1016/j.jcct.2008.08.002; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Maleszewski JJ, 2009, AM J SURG PATHOL, V33, P194, DOI 10.1097/PAS.0b013e31817f3661; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Prokova V, 2007, BIOCHEMISTRY-US, V46, P13775, DOI 10.1021/bi701540u; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; SILVERMAN DI, 1995, AM J CARDIOL, V75, P157, DOI 10.1016/S0002-9149(00)80066-1; van de Laar I, 2009, EUR HEART J, V30, P2485, DOI 10.1093/eurheartj/ehp271; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang XW, 2006, CIRCULATION, V114, pI200, DOI 10.1161/CIRCULATIONAHA.105.000240; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	28	449	454	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					121	U65		10.1038/ng.744	http://dx.doi.org/10.1038/ng.744			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217753				2022-12-17	WOS:000286623800009
J	McKay, JD; Hung, RJ; Gaborieau, V; Boffetta, P; Chabrier, A; Byrnes, G; Zaridze, D; Mukeria, A; Szeszenia-Dabrowska, N; Lissowska, J; Rudnai, P; Fabianova, E; Mates, D; Bencko, V; Foretova, L; Janout, V; McLaughlin, J; Shepherd, F; Montpetit, A; Narod, S; Krokan, HE; Skorpen, F; Elvestad, MB; Vatten, L; Njolstad, I; Axelsson, T; Chen, C; Goodman, G; Barnett, M; Loomis, MM; Lubinski, J; Matyjasik, J; Lener, M; Oszutowska, D; Field, J; Liloglou, T; Xinarianos, G; Cassidy, A; Zelenika, D; Boland, A; Delepine, M; Foglio, M; Lechner, D; Matsuda, F; Blanche, H; Gut, I; Heath, S; Lathrop, M; Brennan, P				McKay, James D.; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Chabrier, Amelie; Byrnes, Graham; Zaridze, David; Mukeria, Anush; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Rudnai, Peter; Fabianova, Eleonora; Mates, Dana; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; McLaughlin, John; Shepherd, Frances; Montpetit, Alexandre; Narod, Steven; Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Vatten, Lars; Njolstad, Inger; Axelsson, Tomas; Chen, Chu; Goodman, Gary; Barnett, Matt; Loomis, Melissa M.; Lubinski, Jan; Matyjasik, Joanna; Lener, Marcin; Oszutowska, Dorota; Field, John; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian; Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Blanche, Helene; Gut, Ivo; Heath, Simon; Lathrop, Mark; Brennan, Paul		EPIC Study	Lung cancer susceptibility locus at 5p15.33	NATURE GENETICS			English	Article							HUMAN TELOMERASE; GENES; RNA	We carried out a genome-wide association study of lung cancer (3,259 cases and 4,159 controls), followed by replication in 2,899 cases and 5,573 controls. Two uncorrelated disease markers at 5p15.33, rs402710 and rs2736100 were detected by the genome-wide data (P - 2 x 10(-7) and P = 4 x 10(-6)) and replicated by the independent study series (P = 7 x 10(-5) and P = 0.016). The susceptibility region contains two genes, TERT and CLPTM1L, suggesting that one or both may have a role in lung cancer etiology.	[McKay, James D.; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Chabrier, Amelie; Byrnes, Graham; Brennan, Paul] Int Agcy Res Canc, F-69008 Lyon, France; [Hung, Rayjean J.; McLaughlin, John] Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Zaridze, David; Mukeria, Anush] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow 115478, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, PL-90950 Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, PL-02781 Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, PL-02781 Warsaw, Poland; [Rudnai, Peter] Natl Inst Environm Hlth, H-1097 Budapest, Hungary; [Fabianova, Eleonora] Specialized Inst Hyg & Epidemiol, Banska Bystrica 97556, Slovakia; [Mates, Dana] Inst Publ Hlth, Bucharest 050463, Romania; [Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague 12800 2, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno 65653, Czech Republic; [Janout, Vladimir] Palacky Univ, Olomouc 77515, Czech Republic; [McLaughlin, John] Canc Care Ontario, Toronto, ON M5G 2L7, Canada; [Shepherd, Frances] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Montpetit, Alexandre] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Narod, Steven] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Vatten, Lars] Norwegian Univ Sci & Technol, N-7489 Trondheim, Norway; [Njolstad, Inger] Univ Tromso, Inst Community Med, N-9037 Tromso, Norway; [Axelsson, Tomas] Uppsala Univ, Acad Hosp, Dept Med Sci, SNP Technol Platform, Uppsala 75185, Sweden; [Chen, Chu; Goodman, Gary; Barnett, Matt; Loomis, Melissa M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Lubinski, Jan; Matyjasik, Joanna; Lener, Marcin; Oszutowska, Dorota] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [Field, John; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Liverpool L3 9TA, Merseyside, England; [Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Gut, Ivo; Heath, Simon; Lathrop, Mark] CEA, Inst Genom, Ctr Natl Genotypage, F-91000 Evry, France; [Blanche, Helene; Lathrop, Mark] Fdn Jean Dausset CEPH, F-75010 Paris, France	World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Russian Academy of Medical Sciences; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Charles University Prague; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Uppsala University; Fred Hutchinson Cancer Center; Pomeranian Medical University; University of Liverpool; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH	Brennan, P (corresponding author), Int Agcy Res Canc, F-69008 Lyon, France.	brennan@iarc.fr	Lissowska, Jolanta/AAH-3252-2020; Gut, Ivo/ABF-3188-2020; Clavel-Chapelon, Francoise/G-6733-2014; Narod, Steven A/AAA-6112-2022; Szeszenia-Dabrowska, Neonila/F-7190-2010; Foglio, mary A./B-9149-2012; Zaridze, David/K-5605-2013; Bencko, Vladimir/H-8598-2017; Njolstad, Inger/X-3784-2019; Hung, Rayjean J/A-7439-2013; Panico, Salvatore/K-6506-2016; McLaughlin, John R/E-4577-2013; Trubicka, Joanna/R-1215-2018; Field, John K./AAD-5674-2020; Xinarianos, George/B-7534-2012; Vatten, Lars/AFK-2073-2022; Krogh, Vittorio/K-2628-2016; Vatten, Lars/AAF-9380-2022; Heath, Simon C/J-4138-2012; Boffetta, Paolo/AAI-7767-2021; Linseisen, Jakob/B-5353-2014; Oszutowska-Mazurek, Dorota/D-2000-2017; Janout, Vladimir/M-5133-2014; Matsuda, Fumihiko/B-9893-2009	Lissowska, Jolanta/0000-0003-2695-5799; Gut, Ivo/0000-0001-7219-632X; Foglio, mary A./0000-0001-7715-4452; Bencko, Vladimir/0000-0003-1935-2228; Panico, Salvatore/0000-0002-5498-8312; Trubicka, Joanna/0000-0002-9848-3674; Field, John K./0000-0003-3951-6365; Krogh, Vittorio/0000-0003-0122-8624; Heath, Simon C/0000-0002-9550-0897; Boffetta, Paolo/0000-0002-3811-2791; Linseisen, Jakob/0000-0002-9386-382X; Oszutowska-Mazurek, Dorota/0000-0001-6403-4160; tumino, rosario/0000-0003-2666-414X; Byrnes, Graham/0000-0003-3893-7539; Foretova, Lenka/0000-0003-0494-2620; mates, dana/0000-0002-6219-9807; PALLI, Domenico/0000-0002-5558-2437; Skorpen, Frank/0000-0001-7093-8000; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; Navarro, Carmen/0000-0001-8896-7483; Riboli, Elio/0000-0001-6795-6080; Hung, Rayjean/0000-0002-4486-7496; Larranaga, Nerea/0000-0002-9993-9880; Xinarianos, George/0000-0001-9185-5554	Institut National du Cancer, France; European Community [LSHG-CT-2005-512113, MTKD-CT-2004-510114]; Norwegian Cancer Association; Research Council of Norway; Ontario Institute of Cancer Research; US National Cancer Institute [R01 CA092039]; NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER	Institut National du Cancer, France(Institut National du Cancer (INCA) France); European Community(European Commission); Norwegian Cancer Association; Research Council of Norway(Research Council of Norway); Ontario Institute of Cancer Research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P. Brennan and M. Lathrop designed the study. J.D.M., R.J.H., V.G., M.B.E., A. B. and H. Blanche coordinated the preparation and inclusion of all biological samples. J.D.M., S.H. and V.G. undertook the statistical analysis. Bioinformatics analysis was undertaken by F.M., M.F. and S.H. D. Z., D.L. and I.G. coordinated the genotyping of the central Europe samples. A.M. and R.J.H. coordinated the genotyping of the Toronto samples. J.D.M., D.Z., M.D., A.C., T.A. and H.E.K. coordinated the genotyping of the other studies. All other coauthors coordinated the initial recruitment and management of the studies. M. Lathrop obtained financial support for genotyping of the central Europe study; P. Brennan, R.J.H. and H.E.K. obtained financial support for genotyping of the other studies. P. Brennan and J.D.M. drafted the manuscript with substantial contributions from R.J.H. and M. Lathrop. All authors contributed to the final paper. The authors thank all of the participants who took part in this research and the funders and support and technical staff who made this study possible. Support for the central Europe, HUNT2/Tromso and CARET genome-wide studies and follow- up genotyping was provided by Institut National du Cancer, France. Support for the HUNT2/Tromso genome-wide study was also provided by the European Community (Integrated Project DNA repair, grant no. LSHG-CT-2005-512113), the Norwegian Cancer Association and the Functional Genomics Programme of Research Council of Norway. Funding for the Toronto genome-wide study was provided by the Ontario Institute of Cancer Research. Funding for the Szczecin/Poland replication study was provided by European Community program "Marie- Curie Host Fellowships for the Transfer of Knowledge,'' grant no. MTKD-CT-2004-510114. Additional funding for study coordination, genotyping of replication studies and statistical analysis was provided by the US National Cancer Institute (R01 CA092039).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; Lantuejoul S, 2007, INT J CANCER, V120, P1835, DOI 10.1002/ijc.22473; Mavrogiannou E, 2007, CLIN CHEM, V53, P53, DOI 10.1373/clinchem.2006.073015; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wu TC, 2003, LUNG CANCER-J IASLC, V41, P163, DOI 10.1016/S0169-5002(03)00195-8; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250	15	449	469	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1404	1406		10.1038/ng.254	http://dx.doi.org/10.1038/ng.254			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978790	Green Accepted			2022-12-17	WOS:000261215900014
J	Hornstein, E; Shomron, N				Hornstein, Eran; Shomron, Noam			Canalization of development by microRNAs	NATURE GENETICS			English	Article								Animal development is an extremely robust process resulting in stereotyped outcomes. Canalization is a design principle wherein developmental pathways are stabilized to increase phenotypic reproducibility. Recent revelations into microRNA (miRNA) function suggest that miRNAs act as key players in canalizing genetic programs. We suggest that miRNA interactions with the network of protein-coding genes evolved to buffer stochastic perturbations and thereby confer robustness to developmental genetic programs.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; MIT, Dept Biol, Cambridge, MA 02139 USA	Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Hornstein, E (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	eran.hornstein@weizmann.ac.il	HORNSTEIN, ERAN/K-1340-2012	HORNSTEIN, ERAN/0000-0002-5534-1924				Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brennecke J, 2005, GENE DEV, V19, P2261, DOI 10.1101/gad.1363905; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.3.CO;2-A; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Gibson G, 1996, SCIENCE, V271, P200, DOI 10.1126/science.271.5246.200; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Keller EF, 2002, ANN NY ACAD SCI, V981, P189; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nijhout HF, 2002, BIOESSAYS, V24, P553, DOI 10.1002/bies.10093; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RENDEL JM, 1965, GENETICS, V52, P1137; RENDEL JM, 1969, P NATL ACAD SCI USA, V64, P578, DOI 10.1073/pnas.64.2.578; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 2003, CURR BIOL, V13, pR958, DOI 10.1016/j.cub.2003.11.042; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	67	449	460	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38			6			S20	S24		10.1038/ng1803	http://dx.doi.org/10.1038/ng1803			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736020				2022-12-17	WOS:000202983200005
J	Scott, DA; Wang, R; Kreman, TM; Sheffield, VC; Karniski, LP				Scott, DA; Wang, R; Kreman, TM; Sheffield, VC; Karniski, LP			The Pendred syndrome gene encodes a chloride-iodide transport protein	NATURE GENETICS			English	Article							SULFATE TRANSPORTER; EXCHANGE; CLONING; MUTATIONS; VESICLES; GOITER; MAPS	Pendred syndrome is the most common form of syndromic deafness and characterized by congenital sensorineural hearing loss and goitre(1-3). This disorder was mapped to chromosome 7 and the gene causing Pendred syndrome (PDS) was subsequently identified by positional cloning(4-6). PDS encodes a putative transmembrane protein designated pendrin. Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate-anion transporter(7) (encoded by Sat-1; 29% amino acid sequence identity), the human diastrophic dysplasia sulfate transporter(8) (encoded by DTD; 32%) and the human sulfate transporter 'downregulated in adenoma'(9,10) (encoded by DRA; 45%), On the basis of this homology and the presence of a slightly modified sulfate-transporter signature sequence comprising its putative second transmembrane domain(6-9), pendrin has been proposed to function as a sulfate transporter. We were unable to detect evidence of sulfate transport following the expression of pendrin in Xenopus laevis oocytes by microinjection of PDS cRNA or in Sf9 cells following infection with PDS-recombinant baculovirus. The rates of transport for iodide and chloride were significantly increased following the expression of pendrin in both cell systems. Our results demonstrate that pendrin functions as a transporter of chloride and iodide, but not sulfate, and may provide insight into thyroid physiology and the pathophysiology of Pendred syndrome.	Dept Vet Affairs Med Ctr, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Dept Vet Affairs Med Ctr, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Dept Vet Affairs Med Ctr, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Karniski, LP (corresponding author), Dept Vet Affairs Med Ctr, Howard Hughes Med Inst, 200 Hawkins Dr, Iowa City, IA 52242 USA.			Sheffield, Val/0000-0002-6282-0835	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047881, R55DK047881] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00457] Funding Source: Medline; NIDDK NIH HHS [DK-47881] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMOWICZ MJ, 1992, J CLIN INVEST, V90, P1200, DOI 10.1172/JCI115981; ARONSON PS, 1989, ANNU REV PHYSIOL, V51, P419; BISSIG M, 1994, J BIOL CHEM, V269, P3017; BROWN CDA, 1989, AM J PHYSIOL, V257, pG661, DOI 10.1152/ajpgi.1989.257.4.G661; CARRASCO N, 1993, BIOCHIM BIOPHYS ACTA, V1154, P65, DOI 10.1016/0304-4157(93)90017-I; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; GORLIN JR, 1995, HEREDITARY HEARING L, P337; HAGEN GA, 1971, NEW ENGL J MED, V285, P1394, DOI 10.1056/NEJM197112162852502; HALLIGAN RD, 1991, AM J PHYSIOL, V260, pC347, DOI 10.1152/ajpcell.1991.260.2.C347; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; JOHNSEN T, 1986, ACTA OTO-LARYNGOL, V102, P239, DOI 10.3109/00016488609108673; KARNISKI LP, 1987, AM J PHYSIOL, V253, pF513, DOI 10.1152/ajprenal.1987.253.3.F513; Karniski LP, 1998, AM J PHYSIOL-RENAL, V275, pF79, DOI 10.1152/ajprenal.1998.275.1.F79; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Reardon W, 1996, J MED GENET, V33, P1037, DOI 10.1136/jmg.33.12.1037; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; TROTTER WR, 1960, BRIT MED BULL, V16, P92, DOI 10.1093/oxfordjournals.bmb.a069828	24	449	547	2	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					440	443		10.1038/7783	http://dx.doi.org/10.1038/7783			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192399				2022-12-17	WOS:000079439700030
J	Daccord, N; Celton, JM; Linsmith, G; Becker, C; Choisne, N; Schijlen, E; van de Geest, H; Bianco, L; Micheletti, D; Velasco, R; Di Pierro, EA; Gouzy, J; Rees, DJG; Guerif, P; Muranty, H; Durel, CE; Laurens, F; Lespinasse, Y; Gaillard, S; Aubourg, S; Quesneville, H; Weigel, D; van de Weg, E; Troggio, M; Bucher, E				Daccord, Nicolas; Celton, Jean-Marc; Linsmith, Gareth; Becker, Claude; Choisne, Nathalie; Schijlen, Elio; van de Geest, Henri; Bianco, Luca; Micheletti, Diego; Velasco, Riccardo; Di Pierro, Erica Adele; Gouzy, Jerome; Rees, D. Jasper G.; Guerif, Philippe; Muranty, Helene; Durel, Charles-Eric; Laurens, Francois; Lespinasse, Yves; Gaillard, Sylvain; Aubourg, Sebastien; Quesneville, Hadi; Weigel, Detlef; van de Weg, Eric; Troggio, Michela; Bucher, Etienne			High-quality de novo assembly of the apple genome and methylome dynamics of early fruit development	NATURE GENETICS			English	Article							DIRECTED DNA METHYLATION; TRANSPOSABLE ELEMENTS; EPIGENETIC MUTATION; RNA; ANNOTATION; EPIGENOME; REVEALS; BRETSCHNEIDERI; TRANSCRIPTION; COMPLETENESS	Using the latest sequencing and optical mapping technologies, we have produced a high-quality de novo assembly of the apple (Malus domestica Borkh.) genome. Repeat sequences, which represented over half of the assembly, provided an unprecedented opportunity to investigate the uncharacterized regions of a tree genome; we identified a new hyper-repetitive retrotransposon sequence that was over-represented in heterochromatic regions and estimated that a major burst of different transposable elements (TEs) occurred 21 million years ago. Notably, the timing of this TE burst coincided with the uplift of the Tian Shan mountains, which is thought to be the center of the location where the apple originated, suggesting that TEs and associated processes may have contributed to the diversification of the apple ancestor and possibly to its divergence from pear. Finally, genome-wide DNA methylation data suggest that epigenetic marks may contribute to agronomically relevant aspects, such as apple fruit development.	[Daccord, Nicolas; Celton, Jean-Marc; Guerif, Philippe; Muranty, Helene; Durel, Charles-Eric; Laurens, Francois; Lespinasse, Yves; Gaillard, Sylvain; Aubourg, Sebastien; Bucher, Etienne] Univ Bretagne Loire, AGROCAMPUS Ouest, Univ Angers, IRHS,INRA,QUASAV SFR4207, Angers, France; [Linsmith, Gareth; Bianco, Luca; Micheletti, Diego; Velasco, Riccardo; Troggio, Michela] Fdn E Mach San Michele AllAdige, Res & Innovat Ctr, Dept Genom & Biol Fruit Crops, San Michele All Adige, Italy; [Becker, Claude; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Choisne, Nathalie; Quesneville, Hadi] Univ Paris Saclay, Res Unit Genom Info, URGI UR1164, INRA, Versailles, France; [Schijlen, Elio; van de Geest, Henri] Wageningen UR Biosci, Wageningen, Netherlands; [Di Pierro, Erica Adele] Univ Milan, Dept Biosci, Milan, Italy; [Gouzy, Jerome] Univ Toulouse, INRA, CNRS, LIPM, Castanet Tolosan, France; [Rees, D. Jasper G.] Agr Res Council, Biotechnol Platform, Pretoria, South Africa; [van de Weg, Eric] Wageningen UR Plant Breeding, Wageningen, Netherlands; [Becker, Claude] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Vienna Bioctr VBC, Vienna, Austria	INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers; Fondazione Edmund Mach; Max Planck Society; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research; University of Milan; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Agricultural Research Council of South Africa; Wageningen University & Research; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Bucher, E (corresponding author), Univ Bretagne Loire, AGROCAMPUS Ouest, Univ Angers, IRHS,INRA,QUASAV SFR4207, Angers, France.	etienne.bucher@inra.fr	Becker, Claude/H-9011-2019; Van de Weg, Eric W/G-3225-2011; Weigel, Detlef/AAR-3312-2021; Muranty, Helene/AAE-5877-2019; Di Pierro, Erica A/AAI-8868-2020; Weigel, Detlef/GSJ-0799-2022; Gaillard, Sylvain/F-8087-2011; Rees, David Jasper Gilbert/AAZ-8073-2020; Weigel, Detlef/C-1418-2008; Quesneville, Hadi/AAG-1048-2020; Gouzy, Jerome/AAH-4977-2020; Bucher, Etienne/E-7681-2013	Becker, Claude/0000-0003-3406-4670; Van de Weg, Eric W/0000-0002-9443-5974; Weigel, Detlef/0000-0002-2114-7963; Rees, David Jasper Gilbert/0000-0003-3321-1325; Weigel, Detlef/0000-0002-2114-7963; Quesneville, Hadi/0000-0003-3001-4908; Gouzy, Jerome/0000-0001-5695-4557; Gaillard, Sylvain/0000-0002-1802-169X; Micheletti, Diego/0000-0001-9175-9853; Velasco, Riccardo/0000-0002-8760-5031; Di Pierro, Erica Adele/0000-0002-3394-3190; CHOISNE, Nathalie/0000-0001-6024-1664; MURANTY, Helene/0000-0003-3956-3807; Bucher, Etienne/0000-0002-3114-3763; Bianco, Luca/0000-0002-0196-8422	EPICENTER ConnecTalent grant of the Pays de la Loire; Provincia autonoma di Trento; EU [265582]; Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 1101]	EPICENTER ConnecTalent grant of the Pays de la Loire; Provincia autonoma di Trento(Autonomous Province of Trento); EU(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Mirouze and C. Vitte for their support with the TE analysis, and T. Giraud and A. Cornille for their insights on apple evolution. We are very grateful to the Horticulture Experimental Unit of the Institut National de la Recherche Agronomique (Pays de la Loire) for taking care of the apple trees used in this study. We thank the IMAC and ANAN platforms from the Structure Federative de Recherche 'Qualite et Sante du Vegetal' (SFR QUASAV) for their technical support. This research was funded by the EPICENTER ConnecTalent grant of the Pays de la Loire (E.B.) and supported by the Provincia autonoma di Trento (G.L., L.B., D.M., R.V. and M.T.), the EU seventh Framework Programme by the FruitBreedomics project no. 265582: "Integrated approach for increasing breeding efficiency in fruit tree crops (http://www.fruitbreedomics.com/)" (F.L., L.B., D.M., R.V. and M. T.), the Max Planck Society (C.B. and D.W.) and the Deutsche Forschungsgemeinschaft (SFB 1101; C.B. and D.W.).	Ansorge W. J., 2016, NEXT GENERAT SEQUENC, V1, P1, DOI DOI 10.4172/2469-9853.S1-005; Badouin H, 2015, GENETICS, V200, P1275, DOI 10.1534/genetics.115.177709; Balukhovsky A. N., 1997, HIST GEOTECTONICS ME; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Belyayev A, 2014, J EVOLUTION BIOL, V27, P2573, DOI 10.1111/jeb.12513; Bianco L, 2016, PLANT J, V86, P62, DOI 10.1111/tpj.13145; Bianco L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110377; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Celton JM, 2014, NEW PHYTOL, V203, P287, DOI 10.1111/nph.12787; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; de la Chaux N, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-2; Di Pierro EA, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.57; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Sharkawy I, 2015, J EXP BOT, V66, P7359, DOI 10.1093/jxb/erv433; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falginella L, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0507-4; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Foissac S, 2008, CURR BIOINFORM, V3, P87, DOI 10.2174/157489308784340702; Gallusci P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00807; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gueguen L, 2013, MOL BIOL EVOL, V30, P1745, DOI 10.1093/molbev/mst097; Guo M, 2011, PLANT SCI, V181, P1, DOI 10.1016/j.plantsci.2011.03.010; Hagmann J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004920; He GM, 2011, ANNU REV PLANT BIOL, V62, P411, DOI 10.1146/annurev-arplant-042110-103806; Hoede C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091929; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jukes TH., 1969, MAMMALIAN PROTEIN ME, P21, DOI [10.1016/B978-1-4832-3211-9.50009-7, DOI 10.1093/BIOINFORMATICS/BTM404]; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kawakatsu T, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.58, 10.1038/NPLANTS.2016.58]; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047864; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lassois L, 2016, PLANT MOL BIOL REP, V34, P827, DOI 10.1007/s11105-015-0966-7; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lespinasse Y, 1998, ACTA HORTIC, P49, DOI 10.17660/ActaHortic.1998.484.4; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li XW, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0139-0; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu RE, 2015, P NATL ACAD SCI USA, V112, P10804, DOI 10.1073/pnas.1503362112; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma JX, 2006, P NATL ACAD SCI USA, V103, P383, DOI 10.1073/pnas.0509810102; Mahesh HB, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2523-7; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Matzke MA, 2015, ANNU REV PLANT BIOL, V66, P243, DOI 10.1146/annurev-arplant-043014-114633; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Redwan RM, 2016, DNA RES, V23, P427, DOI 10.1093/dnares/dsw026; Roudier F, 2009, TRENDS GENET, V25, P511, DOI 10.1016/j.tig.2009.09.013; Sahlin K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-281; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Shin J-H, 2006, J STAT SOFTW, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Telias A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-93; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Veeckman E, 2016, PLANT CELL, V28, P1759, DOI 10.1105/tpc.16.00349; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Ye CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31900; Yin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17644; Zapata L, 2016, P NATL ACAD SCI USA, V113, pE4052, DOI 10.1073/pnas.1607532113; Zhang GH, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0104-3; Zhang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06780	79	448	486	24	193	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1099	+		10.1038/ng.3886	http://dx.doi.org/10.1038/ng.3886			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28581499	Green Published, hybrid			2022-12-17	WOS:000404253300019
J	Meynard, D; Kautz, L; Darnaud, V; Canonne-Hergaux, F; Coppin, H; Roth, MP				Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Canonne-Hergaux, Francois; Coppin, Helene; Roth, Marie-Paule			Lack of the bone morphogenetic protein BMP6 induces massive iron overload	NATURE GENETICS			English	Article							HEPCIDIN; EXPRESSION; HEMOCHROMATOSIS; FERROPORTIN; HEMOJUVELIN; MEMBRANE; MODEL; MICE; TFR2; HFE	Expression of hepcidin, a key regulator of intestinal iron absorption, can be induced in vitro by several bone morphogenetic proteins (BMPs), including BMP2, BMP4 and BMP9 (refs. 1,2). However, in contrast to BMP6, expression of other BMPs is not regulated at the mRNA level by iron in vivo(3), and their relevance to iron homeostasis is unclear. We show here that targeted disruption of Bmp6 in mice causes a rapid and massive accumulation of iron in the liver, the acinar cells of the exocrine pancreas, the heart and the renal convoluted tubules. Despite their severe iron overload, the livers of Bmp6-deficient mice have low levels of phosphorylated Smad1, Smad5 and Smad8, and these Smads are not significantly translocated to the nucleus. In addition, hepcidin synthesis is markedly reduced. This indicates that Bmp6 is critical for iron homeostasis and that it is functionally nonredundant with other members of the Bmp subfamily. Notably, Bmp6-deficient mice retain their capacity to induce hepcidin in response to inflammation. The iron burden in Bmp6 mutant mice is significantly greater than that in mice deficient in the gene associated with classical hemochromatosis (Hfe), suggesting that mutations in BMP6 might cause iron overload in humans with severe juvenile hemochromatosis for which the genetic basis has not yet been characterized.	[Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Coppin, Helene; Roth, Marie-Paule] INSERM, U563, F-31300 Toulouse, France; [Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Coppin, Helene; Roth, Marie-Paule] Univ Toulouse, UPS, Ctr Physiopathol Toulouse Purpan, F-31300 Toulouse, France; [Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Coppin, Helene; Roth, Marie-Paule] Inst Biomed, F-31300 Toulouse, France; [Canonne-Hergaux, Francois] CNRS, UPR 2301, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Roth, MP (corresponding author), INSERM, U563, F-31300 Toulouse, France.	marie.paule.roth@inserm.fr	Canonne-Hergaux, Francois/L-5363-2016; Coppin, Hélène/G-4326-2013; meynard, delphine/B-4236-2014; CANONNE-HERGAUX, François/AAC-2073-2020; Roth, Marie-Paule/Q-2866-2018	Canonne-Hergaux, Francois/0000-0002-0621-2157; Coppin, Hélène/0000-0001-7911-6353; meynard, delphine/0000-0002-9927-5535; CANONNE-HERGAUX, François/0000-0002-0621-2157; Roth, Marie-Paule/0000-0001-9691-4234; Kautz, Leon/0000-0002-2320-0457	Agence Nationale pour la Recherche (ANR); European Commission [LSHM-CT-2006-037296]; Fondation pour la Recherche Medicale	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The authors thank E. Robertson (Dunn School of Pathology, University of Oxford) for kindly providing the Bmp6-deficient mice, C. Rouanet for excellent technical assistance, J. Seumois and M. Calise (Service de Zootechnie, IFR30, Toulouse) for their help with the mouse breeding, and S. Allart (Cellular Imaging platform, IFR30), F. Capilla and T. Al Saati (Experimental Histopathology platform, IFR30) for skilled advice. This work was supported in part by grants from the Agence Nationale pour la Recherche (ANR, programme IRONGENES), the European Commission (LSHM-CT-2006-037296: EUROIRON1) and the Fondation pour la Recherche Medicale (to L. K.).	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Canonne-Hergaux F, 2001, BLOOD, V97, P1138, DOI 10.1182/blood.V97.4.1138; Cox TM, 2002, BLOOD CELL MOL DIS, V29, P411, DOI 10.1006/bcmd.2002.0580; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pipemo A, 2007, BLOOD, V110, P4096, DOI 10.1182/blood-2007-06-096503; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.0.CO;2-8; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	26	448	474	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					478	481		10.1038/ng.320	http://dx.doi.org/10.1038/ng.320			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19252488				2022-12-17	WOS:000264659000024
J	Lettre, G; Jackson, AU; Gieger, C; Schumacher, FR; Berndt, SI; Sanna, S; Eyheramendy, S; Voight, BF; Butler, JL; Guiducci, C; Illig, T; Hackett, R; Heid, IM; Jacobs, KB; Lyssenko, V; Uda, M; Boehnke, M; Chanock, SJ; Groop, LC; Hu, FB; Isomaa, B; Kraft, P; Peltonen, L; Salomaa, V; Schlessinger, D; Hunter, DJ; Hayes, RB; Abecasis, GR; Wichmann, HE; Mohlke, KL; Hirschhorn, JN				Lettre, Guillaume; Jackson, Anne U.; Gieger, Christian; Schumacher, Fredrick R.; Berndt, Sonja I.; Sanna, Serena; Eyheramendy, Susana; Voight, Benjamin F.; Butler, Johannah L.; Guiducci, Candace; Illig, Thomas; Hackett, Rachel; Heid, Iris M.; Jacobs, Kevin B.; Lyssenko, Valeriya; Uda, Manuela; Boehnke, Michael; Chanock, Stephen J.; Groop, Leif C.; Hu, Frank B.; Isomaa, Bo; Kraft, Peter; Peltonen, Leena; Salomaa, Veikko; Schlessinger, David; Hunter, David J.; Hayes, Richard B.; Abecasis, Goncalo R.; Wichmann, H-Erich; Mohlke, Karen L.; Hirschhorn, Joel N.		Diabet Genetics Initiative; FUSION; KORA; Prostate Lung Colorectal Ovarian C; Nurses' Hlth Study; SardiNIA	Identification of ten loci associated with height highlights new biological pathways in human growth	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; FTO GENE; PROLIFERATION; LINKAGE; ADULT; LET-7; HMGA2; RISK; DIFFERENTIATION	Height is a classic polygenic trait, reflecting the combined influence of multiple as-yet- undiscovered genetic factors. We carried out a meta-analysis of genome-wide association study data of height from 15,821 individuals at 2.2 million SNPs, and followed up the strongest findings in 410,000 subjects. Ten newly identified and two previously reported loci were strongly associated with variation in height (P values from 4 x 10(-7) to 8 x 10(-22)). Together, these 12 loci account for similar to 2% of the population variation in height. Individuals with <= 8 height-increasing alleles and >= 16 height-increasing alleles differ in height by similar to 3.5 cm. The newly identified loci, along with several additional loci with strongly suggestive associations, encompass both strong biological candidates and unexpected genes, and highlight several pathways (let-7 targets, chromatin remodeling proteins and Hedgehog signaling) as important regulators of human stature. These results expand the picture of the biological regulation of human height and of the genetic architecture of this classical complex trait.	[Lettre, Guillaume; Voight, Benjamin F.; Guiducci, Candace; Hackett, Rachel; Peltonen, Leena; Hunter, David J.; Hirschhorn, Joel N.] MIT, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02142 USA; [Lettre, Guillaume; Butler, Johannah L.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet & Endocrinol, Boston, MA 02115 USA; [Lettre, Guillaume; Butler, Johannah L.; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Jackson, Anne U.; Sanna, Serena; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Gieger, Christian; Eyheramendy, Susana; Illig, Thomas; Heid, Iris M.; Wichmann, H-Erich] GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; [Gieger, Christian; Eyheramendy, Susana; Heid, Iris M.; Wichmann, H-Erich] Univ Munich, Dept Epidemiol, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Schumacher, Fredrick R.; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Schumacher, Fredrick R.; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Schumacher, Fredrick R.; Hu, Frank B.; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Dept Epidemiol, Boston, MA 02115 USA; [Berndt, Sonja I.; Hayes, Richard B.] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Bethesda, MD 20892 USA; [Sanna, Serena; Uda, Manuela] Cittadella Univ Monserrato, INN, Consiglio Nazl Ric, I-09042 Cagliari, Italy; [Voight, Benjamin F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; [Lyssenko, Valeriya; Groop, Leif C.] Lund Univ, Dept Clin Sci Diabetes & Endocrinol, Malmo Univ Hosp, S-20502 Malmo, Sweden; [Chanock, Stephen J.] NCI, NIH, DHHS, Lab Translat Genom,Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Groop, Leif C.] Univ Helsinki, Dept Med, Helsinki Univ Cent Hosp, Helsinki, Finland; [Groop, Leif C.] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Isomaa, Bo] Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; [Isomaa, Bo] Folkhalsan Res Ctr, Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Peltonen, Leena] Univ Helsinki, Dept Mol Med, Natl Publ Hlth Inst, FI-00014 Helsinki, Finland; [Peltonen, Leena] Univ Helsinki, Dept Mol Med, Dept Med Genet, FI-00014 Helsinki, Finland; [Salomaa, Veikko] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FI-00300 Helsinki, Finland; [Schlessinger, David] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health; Folkhalsan Research Center; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School	Hirschhorn, JN (corresponding author), MIT, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02142 USA.	joelh@broad.mit.edu	Berndt, Sonja I/J-8423-2016; Wichmann, Heinz Erich/AAA-5695-2022; Abecasis, Goncalo R/B-7840-2010; Uda, Manuela/AAC-2645-2019; Schumacher, Fredrick/R-6043-2019; sanna, serena/H-3009-2019; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; Piras, Maria Grazia/P-2061-2018; Lai, Sandra/AAY-4176-2020; Voight, Benjamin/F-1775-2011; Dei, Mariano/AAY-3870-2020	Uda, Manuela/0000-0002-4890-6456; Schumacher, Fredrick/0000-0002-3073-7463; sanna, serena/0000-0002-3768-1749; Piras, Maria Grazia/0000-0001-9004-0900; Voight, Benjamin/0000-0002-6205-9994; Gieger, Christian/0000-0001-6986-9554; Hayes, Richard/0000-0002-0918-661X; Abecasis, Goncalo/0000-0003-1509-1825; Jacobs, Kevin/0000-0002-4657-6473; Eyheramendy, Susana/0000-0003-4723-9660; Dei, Mariano/0000-0002-7404-508X	NATIONAL CANCER INSTITUTE [P01CA087969, Z01CP010152, R01CA049449, U01CA098233, U01CA049449] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193, R01DK075787, R01DK062370, U01DK062370, R56DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [5U01CA098233, CA49449, U01 CA098233, P01 CA087969, R01 CA049449, U01 CA049449, 5P01CA087969] Funding Source: Medline; NHGRI NIH HHS [HG02651, R01 HG002651] Funding Source: Medline; NHLBI NIH HHS [U01 HL084729, HL084729] Funding Source: Medline; NIDDK NIH HHS [R01 DK062370, R56 DK062370, U01 DK062370, DK72193, R01 DK072193, R01 DK075787, DK62370, 5 R01 DK 075787] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Asp J, 2006, GENE CHROMOSOME CANC, V45, P820, DOI 10.1002/gcc.20346; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mathias RA, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S36; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	40	448	463	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					584	591		10.1038/ng.125	http://dx.doi.org/10.1038/ng.125			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391950	Green Submitted, Green Accepted			2022-12-17	WOS:000255366700026
J	Reid, S; Schindler, D; Hanenberg, H; Barker, K; Hanks, S; Kalb, R; Neveling, K; Kelly, P; Seal, S; Freund, M; Wurm, M; Batish, SD; Lach, FP; Yetgin, S; Neitzel, H; Ariffin, H; Tischkowitz, M; Mathew, CG; D Auerbach, A; Rahman, N				Reid, Sarah; Schindler, Detlev; Hanenberg, Helmut; Barker, Karen; Hanks, Sandra; Kalb, Reinhard; Neveling, Kornelia; Kelly, Patrick; Seal, Sheila; Freund, Marcel; Wurm, Melanie; Batish, Sat Dev; Lach, Francis P.; Yetgin, Sevgi; Neitzel, Heidemarie; Ariffin, Hany; Tischkowitz, Marc; Mathew, Christopher G.; D Auerbach, Arleen; Rahman, Nazneen			Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer	NATURE GENETICS			English	Article							SHARED GENETIC SUSCEPTIBILITY; COMPLEMENTATION GROUPS; BREAST-CANCER; BRCA2; TUMORS	PALB2 was recently identified as a nuclear binding partner of BRCA2. Biallelic BRCA2 mutations cause Fanconi anemia subtype FA- D1 and predispose to childhood malignancies. We identified pathogenic mutations in PALB2 ( also known as FANCN) in seven families affected with Fanconi anemia and cancer in early childhood, demonstrating that biallelic PALB2 mutations cause a new subtype of Fanconi anemia, FA-N, and, similar to biallelic BRCA2 mutations, confer a high risk of childhood cancer.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany; Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Rockefeller Univ, Lab Human Genet & Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Hacettepe Univ, Div Pediat Hematol, Ihsan Dooramacy Children Hosp, TR-06100 Ankara, Turkey; Charite Univ Med Berlin, Dept Human Genet, D-13353 Berlin, Germany; Univ Malaya, Med Ctr, Paediat Haematol Oncol Unit, Kuala Lumpur, Malaysia; Sir Mortimer B Davis Jewish Hosp, Canc Prevent Ctr, Montreal, PQ H3T 1E2, Canada; McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England	University of London; Institute of Cancer Research - UK; University of Wurzburg; Heinrich Heine University Dusseldorf; Indiana University System; Indiana University-Purdue University Indianapolis; Rockefeller University; Cornell University; Hacettepe University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universiti Malaya; McGill University; McGill University; McGill University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Tischkowitz, Marc/O-4452-2018; Rahman, Nazneen/B-8890-2012; Mathew, Christopher G/G-3434-2015; ARIFFIN, HANY/B-8590-2010; Kalb, Reinhard/AAR-3249-2021; Rahman, Nazneen/D-2802-2013	Tischkowitz, Marc/0000-0002-7880-0628; Mathew, Christopher G/0000-0003-4178-1838; ARIFFIN, HANY/0000-0002-4607-8837; Kalb, Reinhard/0000-0003-3906-6907; Rahman, Nazneen/0000-0003-4376-0440; Lach, Francis/0000-0003-3708-7122; Auerbach, Arleen/0000-0002-6911-8379	NCI NIH HHS [R01CA82678] Funding Source: Medline; NHLBI NIH HHS [R37HL32987] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [2003:592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082678] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; DECHADAREVIAN JP, 1985, ARCH PATHOL LAB MED, V109, P367; Godthelp BC, 2006, MUTAT RES-FUND MOL M, V594, P39, DOI 10.1016/j.mrfmmm.2005.07.008; Hirsch B, 2004, BLOOD, V103, P2554, DOI 10.1182/blood-2003-06-1970; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Offit K, 2003, JNCI-J NATL CANCER I, V95, P1548, DOI 10.1093/jnci/djg072; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	15	448	459	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					162	164		10.1038/ng1947	http://dx.doi.org/10.1038/ng1947			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200671				2022-12-17	WOS:000244063900012
J	Letts, VA; Felix, R; Biddlecome, GH; Arikkath, J; Mahaffey, CL; Valenzuela, A; Bartlett, FS; Mori, Y; Campbell, KP; Frankel, WN				Letts, VA; Felix, R; Biddlecome, GH; Arikkath, J; Mahaffey, CL; Valenzuela, A; Bartlett, FS; Mori, Y; Campbell, KP; Frankel, WN			The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit	NATURE GENETICS			English	Article							CALCIUM-CHANNEL; SKELETAL-MUSCLE; CA2+ CHANNELS; MUTANT MOUSE; BETA-SUBUNIT; MICE; BRAIN; EXPRESSION; EPILEPSY; SEIZURES	Stargazer mice have spike-wave seizures characteristic of absence epilepsy, with accompanying defects in the cerebellum and inner ear. We describe here a novel gene, Cacng2, whose expression is disrupted in two stargazer alleles. It encodes a 36-kD protein (stargazin) with structural similarity to the gamma-subunit of skeletal muscle voltage-gated calcium (Ca2+) channels. Stargazin is brain-specific and, like other neuronal Ca2+-channel subunits, is enriched in synaptic plasma membranes. In vitro, stargazin increases steady-state inactivation of alpha(1) class A Ca2+ channels. The anticipated effect in stargazer mutants, inappropriate Ca2+ entry, may contribute to their more pronounced seizure phenotype compared with other mouse absence models with Ca2+-channel defects. The discovery that the stargazer gene encodes a gamma-subunit completes the identification of the major subunit types for neuronal Ca2+ channels, namely alpha(1) alpha(2)delta,beta and gamma, providing a new opportunity to understand how these channels function in the mammalian brain and how they may be targeted in the treatment of neuroexcitability disorders.	Jackson Lab, Bar Harbor, ME 04609 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA; Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan	Jackson Laboratory; Howard Hughes Medical Institute; University of Iowa; University of Iowa; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Frankel, WN (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	val@jax.org; wnf@jax.org	Felix, Ricardo/A-6989-2008	Felix, Ricardo/0000-0002-5383-7176; Campbell, Kevin/0000-0003-2066-5889	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032801, R01NS032801] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32801] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COX GA, 1997, CELL, V91, P1; De Waard M, 1996, Ion Channels, V4, P41; DiPasquale E, 1997, J NEUROPHYSIOL, V77, P621, DOI 10.1152/jn.1997.77.2.621; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Eberst R, 1997, PFLUG ARCH EUR J PHY, V433, P633, DOI 10.1007/s004240050324; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; KINGSTON RE, 1997, CURRENT PROTOCOLS MO; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert RC, 1997, J NEUROSCI, V17, P6621; Lerche H, 1996, PFLUG ARCH EUR J PHY, V431, P461, DOI 10.1007/s004240050021; Letts VA, 1997, GENOMICS, V43, P62, DOI 10.1006/geno.1997.4780; LEVEQUE C, 1994, J BIOL CHEM, V271, P13804; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Ludwig A, 1997, J NEUROSCI, V17, P1339; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Noebels J L, 1986, Adv Neurol, V44, P97; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Nooney JM, 1997, TRENDS PHARMACOL SCI, V18, P363, DOI 10.1016/S0165-6147(97)01110-3; Ottman R, 1997, AM J HUM GENET, V60, P667; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; QIAO X, 1998, IN PRESS J NEUROSCI; Qiao XO, 1996, J NEUROSCI, V16, P640; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Scott VES, 1998, J NEUROSCI, V18, P641; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; SWEET HO, 1991, MOUSE GENOME, V89, P552; TAYLOR BA, 1993, GENOMICS, V16, P380, DOI 10.1006/geno.1993.1201; VARADI G, 1995, TRENDS PHARMACOL SCI, V16, P43, DOI 10.1016/S0165-6147(00)88977-4; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; WEI XY, 1991, J BIOL CHEM, V266, P21943; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Wissenbach U, 1998, BIOL CHEM, V379, P45, DOI 10.1515/bchm.1998.379.1.45; WITCHER DR, 1994, METHOD ENZYMOL, V238, P335; [No title captured]	59	448	469	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1998	19	4					340	347		10.1038/1228	http://dx.doi.org/10.1038/1228			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697694				2022-12-17	WOS:000075107600016
J	Indo, Y; Tsuruta, M; Hayashida, Y; Karim, MA; Ohta, K; Kawano, T; Mitsubuchi, H; Tonoki, H; Awaya, Y; Matsuda, I				Indo, Y; Tsuruta, M; Hayashida, Y; Karim, MA; Ohta, K; Kawano, T; Mitsubuchi, H; Tonoki, H; Awaya, Y; Matsuda, I			Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis	NATURE GENETICS			English	Letter							NERVE GROWTH-FACTOR; SYSTEM; LOCALIZATION; ONCOGENE; CLONING		HOKKAIDO UNIV,SCH MED,DEPT PEDIAT,SAPPORO,HOKKAIDO 060,JAPAN; SEIBO INT CATHOLIC HOSP,DEPT PEDIAT,HSAN IV ASSOC TOMORROW,TOKYO 161,JAPAN	Hokkaido University	Indo, Y (corresponding author), KUMAMOTO UNIV,SCH MED,DEPT PEDIAT,HONJO 1-1-1,KUMAMOTO 860,JAPAN.							BROWN JW, 1966, ARCH NEUROL-CHICAGO, V15, P294, DOI 10.1001/archneur.1966.00470150072012; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DYCK PJ, 1984, PERIPHERAL NEUROPATH, P1557; GABELLA G, 1976, STRUCTURE AUTONOMIC, P153; GRECO A, 1993, GENOMICS, V18, P397, DOI 10.1006/geno.1993.1482; INDO Y, 1987, J CLIN INVEST, V80, P63, DOI 10.1172/JCI113064; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KRAWCZAK M, 1992, HUM GENET, V90, P41; LANGER J, 1981, ACTA NEUROPATHOL, V54, P199, DOI 10.1007/BF00687742; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MCKUSICK VA, 1994, MENDELIAN INHERITANC, P2073; MOUNTCASTLE VB, 1974, MED PHYSL, P1319; MURAGAKI Y, 1995, J COMP NEUROL, V356, P387, DOI 10.1002/cne.903560306; NAKAGAWARA A, 1995, GENOMICS, V25, P538, DOI 10.1016/0888-7543(95)80055-Q; RAFEL E, 1980, MUSCLE NERVE, V3, P216, DOI 10.1002/mus.880030305; ROSEMBERG S, 1994, PEDIATR NEUROL, V11, P50, DOI 10.1016/0887-8994(94)90091-4; Sambrook J, 1989, MOL CLONING LAB MANU; SCRIBANU N, 1978, PEDIATR RES, V12, P556, DOI 10.1203/00006450-197804001-01159; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SWANSON AG, 1965, ARCH NEUROL-CHICAGO, V12, P12, DOI 10.1001/archneur.1965.00460250016002; SWANSON AG, 1963, ARCH NEUROL-CHICAGO, V8, P299, DOI 10.1001/archneur.1963.00460030083008; VEGA JA, 1994, ANAT REC, V240, P579, DOI 10.1002/ar.1092400415; WAKE MH, 1979, HYMANS COMP VERTEBRA, P139	29	448	470	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					485	488		10.1038/ng0896-485	http://dx.doi.org/10.1038/ng0896-485			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696348				2022-12-17	WOS:A1996VB62000034
J	RUTTLEDGE, MH; SARRAZIN, J; RANGARATNAM, S; PHELAN, CM; TWIST, E; MEREL, P; DELATTRE, O; THOMAS, G; NORDENSKJOLD, M; COLLINS, VP; DUMANSKI, JP; ROULEAU, GA				RUTTLEDGE, MH; SARRAZIN, J; RANGARATNAM, S; PHELAN, CM; TWIST, E; MEREL, P; DELATTRE, O; THOMAS, G; NORDENSKJOLD, M; COLLINS, VP; DUMANSKI, JP; ROULEAU, GA			EVIDENCE FOR THE COMPLETE INACTIVATION OF THE NF2 GENE IN THE MAJORITY OF SPORADIC MENINGIOMAS	NATURE GENETICS			English	Article							TUMOR SUPPRESSOR GENES; POINT MUTATIONS; PLASMID DNA; NEUROFIBROMATOSIS; CHROMOSOME-22; POLYMORPHISMS; ONCOGENESIS; SEQUENCE	Meningiomas are common central nervous system tumours which present usually in the 4th and 5th decades of life. Loss of constitutional heterozygosity on chromosome 22 in 60% of sporadic meningiomas has implied the involvement of a tumour suppressor gene. The neurofibromatosis type 2 gene (NF2), a prime candidate for involvement in meningioma, was screened for point mutations. After examining eight of the 16 known NF2 exons in 151 meningiomas, 24 inactivating mutations were characterized. Significantly, these aberrations were exclusively detected in tumours which lost the other chromosome 22 allele. These results provide strong evidence that the suppressor gene on chromosome 22, frequently inactivated in meningioma, is the NF2 gene, and suggest that another gene is involved in the development of 40% of meningiomas.	MONTREAL GEN HOSP,RES INST,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,MONTREAL GEN HOSP,DIV MED GENET,MONTREAL H3G 1A4,PQ,CANADA; KAROLINSKA HOSP,LUDWIG INST CANC RES,S-10401 STOCKHOLM,SWEDEN; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN; INST CURIE,INSERM,CJF 9201,GENET TUMEURS LAB,F-75231 PARIS,FRANCE; SAHLGRENS UNIV HOSP,DEPT PATHOL,S-41345 GOTHENBURG,SWEDEN	McGill University; McGill University; Karolinska Institutet; Karolinska University Hospital; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sahlgrenska University Hospital	RUTTLEDGE, MH (corresponding author), MCGILL UNIV,CTR RES NEUROSCI,1650 CEDAR AVE,MONTREAL H3G 1A4,PQ,CANADA.			delattre, olivier/0000-0002-8730-2276; Nordenskjold, Magnus/0000-0002-4974-425X				ALSAADI A, 1987, CANCER GENET CYTOGEN, V26, P127, DOI 10.1016/0165-4608(87)90140-3; BERGERHEIM U, 1989, CANCER RES, V49, P1390; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; CASALONE R, 1987, CANCER GENET CYTOGEN, V27, P145, DOI 10.1016/0165-4608(87)90269-X; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; DUMANSKI JP, 1990, CANCER RES, V50, P5863; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; EVANS DGR, 1992, J MED GENET, V29, P847, DOI 10.1136/jmg.29.12.847; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HULTMAN T, 1991, BIOTECHNIQUES, V10, P84; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; KEPES J, 1982, MENINGIOMAS BIOL PAT; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PULST SM, 1993, NEUROLOGY, V43, P2096, DOI 10.1212/WNL.43.10.2096; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; RUTTLEDGE MH, IN PRESS GENES CHROM; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871, DOI 10.1093/nar/20.4.871; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; VANHEYNINGEN V, 1992, TRENDS GENET, V8, P16, DOI 10.1016/0168-9525(92)90019-Z; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WERTELECKI W, 1988, NEW ENGL J MED, V319, P278, DOI 10.1056/NEJM198808043190505	33	448	452	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					180	184		10.1038/ng0294-180	http://dx.doi.org/10.1038/ng0294-180			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162072				2022-12-17	WOS:A1994MU76300014
J	Yang, J; Bakshi, A; Zhu, Z; Hemani, G; Vinkhuyzen, AAE; Lee, SH; Robinson, MR; Perry, JRB; Nolte, IM; van Vliet-Ostaptchouk, JV; Snieder, H; Esko, T; Milani, L; Magi, R; Metspalu, A; Hamsten, A; Magnusson, PKE; Pedersen, NL; Ingelsson, E; Soranzo, N; Keller, MC; Wray, NR; Goddard, ME; Visscher, PM				Yang, Jian; Bakshi, Andrew; Zhu, Zhihong; Hemani, Gibran; Vinkhuyzen, Anna A. E.; Lee, Sang Hong; Robinson, Matthew R.; Perry, John R. B.; Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold; Esko, Tonu; Milani, Lili; Maegi, Reedik; Metspalu, Andres; Hamsten, Anders; Magnusson, Patrik K. E.; Pedersen, Nancy L.; Ingelsson, Erik; Soranzo, Nicole; Keller, Matthew C.; Wray, Naomi R.; Goddard, Michael E.; Visscher, Peter M.		LifeLines Cohort Study	Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE-IMPUTATION; COMPLEX DISEASES; COMMON SNPS; ARCHITECTURE; PROPORTION; TRAIT; LOCI	We propose a method (GREML-LDMS) to estimate heritability for human complex traits in unrelated individuals using whole-genome sequencing data. We demonstrate using simulations based on whole-genome sequencing data that similar to 97% and similar to 68% of variation at common and rare variants, respectively, can be captured by imputation. Using the GREML-LDMS method, we estimate from 44,126 unrelated individuals that all similar to 17 million imputed variants explain 56% (standard error (s.e.) = 2.3%) of variance for height and 27% (s.e. = 2.5%) of variance for body mass index (BMI), and we find evidence that height- and BMI-associated variants have been under natural selection. Considering the imperfect tagging of imputation and potential overestimation of heritability from previous family-based studies, heritability is likely to be 60-70% for height and 30-40% for BMI. Therefore, the missing heritability is small for both traits. For further discovery of genes associated with complex traits, a study design with SNP arrays followed by imputation is more cost-effective than whole-genome sequencing at current prices.	[Yang, Jian; Bakshi, Andrew; Zhu, Zhihong; Hemani, Gibran; Vinkhuyzen, Anna A. E.; Lee, Sang Hong; Robinson, Matthew R.; Wray, Naomi R.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Hemani, Gibran] Univ Bristol, Sch Social & Community Med, IEU, MRC, Bristol, Avon, England; [Lee, Sang Hong] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Perry, John R. B.] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Esko, Tonu; Milani, Lili; Maegi, Reedik; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA USA; [Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Cardiovasc Genet & Genom Grp, Stockholm, Sweden; [Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Soranzo, Nicole] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, England; [Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge, England; [Keller, Matthew C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Goddard, Michael E.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Jobs Transport & Resources, Dept Econ Dev, Biosci Res Div, Bundoora, Vic, Australia	University of Queensland; University of Queensland; University of Bristol; University of New England; University of Cambridge; University of Groningen; University of Groningen; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Tartu; Karolinska Institutet; Karolinska Institutet; Uppsala University; Stanford University; Wellcome Trust Sanger Institute; University of Cambridge; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Melbourne	Yang, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	Jian.yang@uq.edu.au	Milani, Lili/N-1097-2019; Mägi, Reedik/AAJ-9679-2021; Zhu, Zhihong/F-8720-2015; Visscher, Peter/ABB-6151-2020; Yang, Jian/A-5852-2010; Wray, Naomi/C-8639-2015; Lee, Sang Hong/A-2569-2011; Magnusson, Patrik KE/C-4458-2017; Vinkhuyzen, Anna/N-8691-2013	Milani, Lili/0000-0002-5323-3102; Zhu, Zhihong/0000-0002-6783-3037; Visscher, Peter/0000-0002-2143-8760; Yang, Jian/0000-0003-2001-2474; Wray, Naomi/0000-0001-7421-3357; Lee, Sang Hong/0000-0001-9701-2718; Magnusson, Patrik KE/0000-0002-7315-7899; Magi, Reedik/0000-0002-2964-6011; Vinkhuyzen, Anna/0000-0003-3352-0603; Goddard, Michael/0000-0001-9917-7946; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Robinson, Matthew/0000-0001-8982-8813; Hemani, Gibran/0000-0003-0920-1055; Soranzo, Nicole/0000-0003-1095-3852; Bakshi, Andrew/0000-0001-5650-7036	Australian National Health and Medical Research Council [1052684, 1078037, 1050218]; Australian Research Council [130102666]; US National Institutes of Health [R01MH100141]; Sylvia and Charles Viertel Charitable Foundation; University of Queensland Foundation; Medical Research Council [MC_U106179472, MC_UU_12015/2, MC_PC_15018] Funding Source: researchfish; MRC [MC_UU_12015/2, MC_U106179472] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100141] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sylvia and Charles Viertel Charitable Foundation; University of Queensland Foundation(University of Queensland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Australian National Health and Medical Research Council (grants 1052684, 1078037 and 1050218), the Australian Research Council (grant 130102666), the US National Institutes of Health (R01MH100141), the Sylvia and Charles Viertel Charitable Foundation and the University of Queensland Foundation. This study makes use of data from the database of Genotypes and Phenotypes (dbGaP) available under accessions phs000090, phs000091 and phs000428 and the EGCUT, LifeLines, TwinGene and UK10K studies (see the Supplementary Note for the full set of acknowledgments for these data).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lynch M, 1998, GENETICS ANAL QUANTI; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; UK10K Consortium, NATURE IN PRESS; Uricchio L.H., 2015, BIORXIV, DOI [10.1101/015917, DOI 10.1101/015917]; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2014, NAT GENET, V46, P1356, DOI 10.1038/ng.3139; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	39	447	452	5	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1114	+		10.1038/ng.3390	http://dx.doi.org/10.1038/ng.3390			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26323059	Green Accepted, Green Submitted			2022-12-17	WOS:000361969900006
J	Berman, BP; Weisenberger, DJ; Aman, JF; Hinoue, T; Ramjan, Z; Liu, YP; Noushmehr, H; Lange, CPE; van Dijk, CM; Tollenaar, RAEM; Van den Berg, D; Laird, PW				Berman, Benjamin P.; Weisenberger, Daniel J.; Aman, Joseph F.; Hinoue, Toshinori; Ramjan, Zachary; Liu, Yaping; Noushmehr, Houtan; Lange, Christopher P. E.; van Dijk, Cornelis M.; Tollenaar, Rob A. E. M.; Van den Berg, David; Laird, Peter W.			Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains	NATURE GENETICS			English	Article							BODY-SPECIFIC METHYLATION; TUMOR-SUPPRESSOR; GENE; GENOME; CHROMATIN; PLURIPOTENT; EXPRESSION; BINDING	Extensive changes in DNA methylation are common in cancer and may contribute to oncogenesis through transcriptional silencing of tumor-suppressor genes(1). Genome-scale studies have yielded important insights into these changes(2-5) but have focused on CpG islands or gene promoters. We used whole-genome bisulfite sequencing (bisulfite-seq) to comprehensively profile a primary human colorectal tumor and adjacent normal colon tissue at single-basepair resolution. Regions of focal hypermethylation in the tumor were located primarily at CpG islands and were concentrated within regions of long-range (>100 kb) hypomethylation. These hypomethylated domains covered nearly half of the genome and coincided with late replication and attachment to the nuclear lamina in human cell lines. We confirmed the confluence of hypermethylation and hypomethylation within these domains in 25 diverse colorectal tumors and matched adjacent tissue. We propose that widespread DNA methylation changes in cancer are linked to silencing programs orchestrated by the three-dimensional organization of chromatin within the nucleus.	[Berman, Benjamin P.; Weisenberger, Daniel J.; Aman, Joseph F.; Hinoue, Toshinori; Ramjan, Zachary; Liu, Yaping; Noushmehr, Houtan; Van den Berg, David; Laird, Peter W.] Univ So Calif, Keck Sch Med, Univ So Calif Epigenome Ctr, Los Angeles, CA 90033 USA; [Lange, Christopher P. E.] Groene Hart Hosp, Dept Surg, Gouda, Netherlands; [Lange, Christopher P. E.; Tollenaar, Rob A. E. M.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [van Dijk, Cornelis M.] Groene Hart Hosp, Dept Pathol, Gouda, Netherlands	University of Southern California; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Laird, PW (corresponding author), Univ So Calif, Keck Sch Med, Univ So Calif Epigenome Ctr, Los Angeles, CA 90033 USA.	plaird@usc.edu	Berman, Benjamin P/D-5942-2014; N, Houtan/C-9692-2013; Weisenberger, Daniel/AAA-8314-2020; Van Den Berg, David J/G-8598-2017; BERMAN, BENJAMIN/AAT-3720-2021; Laird, Peter W/G-8683-2012; Liu, Yaping/A-8601-2018	Berman, Benjamin P/0000-0002-2099-9005; N, Houtan/0000-0003-4051-8114; Weisenberger, Daniel/0000-0001-8303-2603; Van Den Berg, David J/0000-0002-5404-5218; BERMAN, BENJAMIN/0000-0002-2099-9005; Laird, Peter W/0000-0001-9117-3641; Liu, Yaping/0000-0003-4165-7693	NCI NIH HHS [P30 CA014089, R01 CA118699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA118699] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79; Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83	39	447	462	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					40	U62		10.1038/ng.969	http://dx.doi.org/10.1038/ng.969			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22120008	Green Accepted			2022-12-17	WOS:000298664000011
J	Sandilands, A; Terron-Kwiatkowski, A; Hull, PR; O'Regan, GM; Clayton, TH; Watson, RM; Carrick, T; Evans, AT; Liao, HH; Zhao, YW; Campbell, LE; Schmuth, M; Gruber, R; Janecke, AR; Elias, PM; van Steensel, MAM; Nagtzaam, I; van Geel, M; Steijlen, PM; Munro, CS; Bradley, DG; Palmer, CNA; Smith, FJD; McLean, WHI; Irvine, AD				Sandilands, Aileen; Terron-Kwiatkowski, Ana; Hull, Peter R.; O'Regan, Grainne M.; Clayton, Timothy H.; Watson, Rosemarie M.; Carrick, Thomas; Evans, Alan T.; Liao, Haihui; Zhao, Yiwei; Campbell, Linda E.; Schmuth, Matthias; Gruber, Robert; Janecke, Andreas R.; Elias, Peter M.; van Steensel, Maurice A. M.; Nagtzaam, Ivo; van Geel, Michel; Steijlen, Peter M.; Munro, Colin S.; Bradley, Daniel G.; Palmer, Colin N. A.; Smith, Frances J. D.; McLean, W. H. Irwin; Irvine, Alan D.			Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema	NATURE GENETICS			English	Article							OF-FUNCTION MUTATIONS; PREDISPOSE; DERMATITIS; POLYMORPHISMS; PROFILAGGRIN; BARRIER; COMPLEX	We recently reported two common filaggrin (FLG) null mutations that cause ichthyosis vulgaris(1) and predispose to eczema and secondary allergic diseases(2). We show here that these common European mutations are ancestral variants carried on conserved haplotypes. To facilitate comprehensive analysis of other populations, we report a strategy for full sequencing of this large, highly repetitive gene, and we describe 15 variants, including seven that are prevalent. All the variants are either nonsense or frameshift mutations that, in representative cases, resulted in loss of filaggrin production in the epidermis. In an Irish case-control study, the five most common European mutations showed a strong association with moderate-to-severe childhood eczema (chi(2) test: P = 2.12 x 10(-51); Fisher's exact test: heterozygote odds ratio (OR) = 7.44 (95% confidence interval (c. i.) = 4.9 - 11.3), and homozygote OR 151 (95% c. i. = 20 - 1,136)). We found three additional rare null mutations in this case series, suggesting that the genetic architecture of filaggrin-related atopic dermatitis consists of both prevalent and rare risk alleles.	Univ Dundee, Ninewells Hosp & Med Sch, Epithelial Genet Grp, Human Genet Unit,Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; Tayside Univ Hosp NHS Trust, Ninewells Hosp & Med Sch, Dept Genet, Dundee DD1 9SY, Scotland; Tayside Univ Hosp NHS Trust, Ninewells Hosp & Med Sch, Dept Pathol, Dundee DD1 9SY, Scotland; Innsbruck Med Univ, Dept Dermatol, Innsbruck, Austria; Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; Vet Affairs Med Ctr, Dermatol & Metab Med Serv, San Francisco, CA 94121 USA; Univ Hosp Maastricht, Dept Dermatol, Maastricht, Netherlands; So Gen Hosp, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Ctr Biomed Res, Dundee DD1 9SY, Scotland; Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland	University of Dundee; Our Ladys Children Hospital Crumlin; University of Dundee; University of Dundee; Medical University of Innsbruck; Medical University of Innsbruck; US Department of Veterans Affairs; Veterans Health Administration (VHA); Maastricht University; Maastricht University Medical Centre (MUMC); University of Glasgow; Trinity College Dublin; University of Dundee; Trinity College Dublin	McLean, WHI (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Epithelial Genet Grp, Human Genet Unit,Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	w.h.i.mclean@dundee.ac.uk; irvinea@tcd.ie	van Steensel, Maurice A.M./V-3852-2019; Palmer, Colin NA/C-7053-2008; Irvine, Alan D/A-3982-2008; Bradley, Daniel G/A-3240-2012; Janecke, Andreas/AAA-5227-2019; Steijlen, Peter/X-2729-2019; McLean, William HI/C-6352-2009	Palmer, Colin NA/0000-0002-6415-6560; Irvine, Alan D/0000-0002-9048-2044; McLean, William Henry Irwin/0000-0001-5539-5757; van Steensel, Maurice/0000-0002-7507-2442; Hull, Peter/0000-0002-3896-9373; Bradley, Daniel G/0000-0001-7335-7092; Schmuth, Matthias/0000-0002-4064-1334; Janecke, Andreas/0000-0001-7155-0315	MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Gruber R, 2007, EUR J HUM GENET, V15, P179, DOI 10.1038/sj.ejhg.5201742; Irvine AD, 2007, J INVEST DERMATOL, V127, P504, DOI 10.1038/sj.jid.5700695; Irvine AD, 2006, J INVEST DERMATOL, V126, P1200, DOI 10.1038/sj.jid.5700365; JUDGE MR, 2004, ROOKS TXB DERMATOLOG, V1; Katagiri C, 2003, J DERMATOL SCI, V31, P29, DOI 10.1016/S0923-1811(02)00137-8; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Morar N, 2007, J INVEST DERMATOL, V127, P1667, DOI 10.1038/sj.jid.5700739; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Ruether A, 2006, BRIT J DERMATOL, V155, P1093, DOI 10.1111/j.1365-2133.2006.07500.x; Sandilands A, 2006, J INVEST DERMATOL, V126, P1770, DOI 10.1038/sj.jid.5700459; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stemmler S, 2007, J INVEST DERMATOL, V127, P722, DOI 10.1038/sj.jid.5700579; Takahashi M, 1996, ARCH BIOCHEM BIOPHYS, V329, P123, DOI 10.1006/abbi.1996.0199; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Weidinger S, 2007, J INVEST DERMATOL, V127, P724, DOI 10.1038/sj.jid.5700630	24	447	469	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					650	654		10.1038/ng2020	http://dx.doi.org/10.1038/ng2020			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417636				2022-12-17	WOS:000245971300021
J	Ross, AJ; May-Simera, H; Eichers, ER; Kai, M; Hill, J; Jagger, DJ; Leitch, CC; Chapple, JP; Munro, PM; Fisher, S; Tan, PL; Phillips, HM; Leroux, MR; Henderson, DJ; Murdoch, JN; Copp, AJ; Eliot, MM; Lupski, JR; Kemp, DT; Dollfus, H; Tada, M; Katsanis, N; Forge, A; Beales, PL				Ross, AJ; May-Simera, H; Eichers, ER; Kai, M; Hill, J; Jagger, DJ; Leitch, CC; Chapple, JP; Munro, PM; Fisher, S; Tan, PL; Phillips, HM; Leroux, MR; Henderson, DJ; Murdoch, JN; Copp, AJ; Eliot, MM; Lupski, JR; Kemp, DT; Dollfus, H; Tada, M; Katsanis, N; Forge, A; Beales, PL			Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; EAR HAIR-CELLS; GENE; ZEBRAFISH; MOUSE; MICE; MOVEMENTS; IDENTIFICATION; GASTRULATION; STRABISMUS	The evolutionarily conserved planar cell polarity (PCP) pathway (or noncanonical Wnt pathway) drives several important cellular processes, including epithelial cell polarization, cell migration and mitotic spindle orientation(1). In vertebrates, PCP genes have a vital role in polarized convergent extension movements during gastrulation and neurulation(2). Here we show that mice with mutations in genes involved in Bardet-Biedl syndrome (BBS), a disorder associated with ciliary dysfunction(3,4), share phenotypes with PCP mutants including open eyelids, neural tube defects and disrupted cochlear stereociliary bundles. Furthermore, we identify genetic interactions between BBS genes and a PCP gene in both mouse (Ltap, also called Vangl2) and zebrafish (vangl2). In zebrafish, the augmented phenotype results from enhanced defective convergent extension movements. We also show that Vangl2 localizes to the basal body and axoneme of ciliated cells, a pattern reminiscent of that of the BBS proteins. These data suggest that cilia are intrinsically involved in PCP processes.	UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Ear Inst, Ctr Auditory Res, London WC1E 6BT, England; Johns Hopkins Univ, Wilmer Eye Inst, Inst Med Genet, Baltimore, MD 21287 USA; UCL, Inst Ophthalmol, London EC1V 9EL, England; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; MRC Mammalian Genet Unit, Harwell, Berks, England; UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England; Hop Univ Strasbourg, Serv ORL, Strasbourg, France; Hop Univ Strasbourg, Serv Genet Med, Strasbourg, France; Univ Strasbourg 1, Fac Med, Med Genet Lab, Strasbourg, France	University of London; University College London; Baylor College of Medicine; University of London; University College London; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Newcastle University - UK; Simon Fraser University; MRC Harwell; University of London; University College London; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Beales, PL (corresponding author), UCL, Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.	p.beales@ucl.ac.uk	Tada, Masazumi/A-1431-2009; Beales, Philip L/C-7367-2009	Forge, Andrew/0000-0002-0995-0219; Chapple, Paul/0000-0003-1876-1505; May-Simera, Helen/0000-0002-9477-4036; Johnson, Colin/0000-0002-2979-8234; Henderson, Deborah/0000-0002-2705-5998; Phillips, Helen Margaret/0000-0003-4513-9148; Copp, Andrew/0000-0002-2544-9117; Dollfus, Helene/0000-0002-2249-895X; Katsanis, Nicholas/0000-0002-2480-0171; Jagger, Daniel/0000-0003-2796-5526	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; Bingham S, 2002, DEV BIOL, V242, P149, DOI 10.1006/dbio.2001.0532; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KEMP DT, 1986, HEARING RES, V22, P95, DOI 10.1016/0378-5955(86)90087-0; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Morrell CH, 1996, J ACOUST SOC AM, V100, P1949, DOI 10.1121/1.417906; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	30	447	455	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2005	37	10					1135	1140		10.1038/ng1644	http://dx.doi.org/10.1038/ng1644			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16170314				2022-12-17	WOS:000232185600028
J	Hanks, S; Coleman, K; Reid, S; Plaja, A; Firth, H; FitzPatrick, D; Kidd, A; Mehes, K; Nash, R; Robin, N; Shannon, N; Tolmie, J; Swansbury, J; Irrthum, A; Douglas, J; Rahman, N				Hanks, S; Coleman, K; Reid, S; Plaja, A; Firth, H; FitzPatrick, D; Kidd, A; Mehes, K; Nash, R; Robin, N; Shannon, N; Tolmie, J; Swansbury, J; Irrthum, A; Douglas, J; Rahman, N			Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B	NATURE GENETICS			English	Article							MOSAIC VARIEGATED ANEUPLOIDY; MITOTIC CHECKPOINT GENES; BUBR1	Mosaic variegated aneuploidy is a rare recessive condition characterized by growth retardation, microcephaly, childhood cancer and constitutional mosaicism for chromosomal gains and losses. In five families with mosaic variegated aneuploidy, including two with embryonal rhabdomyosarcoma, we identified truncating and missense mutations of BUB1B, which encodes BUBR1, a key protein in the mitotic spindle checkpoint. These data are the first to relate germline mutations in a spindle checkpoint gene with a human disorder and strongly support a causal link between aneuploidy and cancer development.	Inst Canc Res, Sect Canc Genet, Surrey, England; Hosp Materno Infantil Vall dHebron, Unitat Genet, Barcelona, Spain; Addenbrookes Hosp, Dept Med Genet, Cambridge, England; Wellington Hosp, Cent Reg Genet Serv, Wellington, New Zealand; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Univ Pecs, Dept Med Genet & Child Dev, Pecs, Hungary; Case Western Reserve Univ, Dept Human Genet, Cleveland, OH 44106 USA; Birmingham Womens Hosp, W Midland Reg Genet Serv, Birmingham, W Midlands, England; Inst Med Genet, Glasgow, Lanark, Scotland; Inst Canc Res, Sect Haematooncol, Surrey, England	University of London; Institute of Cancer Research - UK; Hospital Universitari Vall d'Hebron; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; University of Pecs; Case Western Reserve University; Birmingham Women's Hospital; University of Glasgow; University of London; Institute of Cancer Research - UK	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Surrey, England.	nazneen.rahman@icr.ac.uk	FitzPatrick, David R/C-7301-2013; Rahman, Nazneen/B-8890-2012; FitzPatrick, David R/B-8311-2008; Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440; FitzPatrick, David R./0000-0003-4861-969X				Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Jacquemont S, 2002, AM J MED GENET, V109, P17, DOI 10.1002/ajmg.10281; Kajii T, 2001, AM J MED GENET, V104, P57, DOI 10.1002/ajmg.1580; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Limwongse C, 1999, AM J MED GENET, V82, P20, DOI 10.1002/(SICI)1096-8628(19990101)82:1<20::AID-AJMG4>3.0.CO;2-5; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Plaja A, 2001, AM J MED GENET, V98, P216, DOI 10.1002/1096-8628(20010122)98:3<216::AID-AJMG1091>3.0.CO;2-0; Shichiri M, 2002, CANCER RES, V62, P13; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; TOLMIE JL, 1988, HUM GENET, V80, P197, DOI 10.1007/BF00702872	15	447	461	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1159	1161		10.1038/ng1449	http://dx.doi.org/10.1038/ng1449			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15475955	Bronze			2022-12-17	WOS:000224832800017
J	Papadopoulou, LC; Sue, CM; Davidson, MM; Tanji, K; Nishino, I; Sadlock, JE; Krishna, S; Walker, W; Selby, J; Glerum, DM; Van Coster, R; Lyon, G; Scalais, E; Lebel, R; Kaplan, P; Shanske, S; De Vivo, DC; Bonilla, E; Hirano, M; DiMauro, S; Schon, EA				Papadopoulou, LC; Sue, CM; Davidson, MM; Tanji, K; Nishino, I; Sadlock, JE; Krishna, S; Walker, W; Selby, J; Glerum, DM; Van Coster, R; Lyon, G; Scalais, E; Lebel, R; Kaplan, P; Shanske, S; De Vivo, DC; Bonilla, E; Hirano, M; DiMauro, S; Schon, EA			Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene	NATURE GENETICS			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL COPPER RECRUITMENT; SACCHAROMYCES-CEREVISIAE; SUBUNIT-II; FUNCTIONAL COMPLEMENTATION; MOLECULAR ANALYSIS; LEIGHS SYNDROME; NUCLEAR; PROTEIN; ACCUMULATION		Columbia Univ, Dept Neurol, New York, NY 10027 USA; Aristotle Univ Thessaloniki, Dept Pharmaceut Sci, Thessaloniki, Macedonia, Greece; Columbia Univ, Dept Pediat, New York, NY USA; Columbia Univ, Dept Pathol, New York, NY USA; Columbia Univ, Dept Genet & Dev, New York, NY USA; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; State Univ Ghent Hosp, Kinderklin C Hoopt, Ghent, Belgium; Clin St Vincent, Liege, Belgium; Genet Serv Inc, Glen Ellyn, IL USA; Childrens Hosp Philadelphia, Div Metab, Philadelphia, PA 19104 USA	Columbia University; Aristotle University of Thessaloniki; Columbia University; Columbia University; Columbia University; University of Alberta; Ghent University; Ghent University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Schon, EA (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10027 USA.		Nishino, Ichizo/G-2676-2010; Glerum, Moira/AHD-3271-2022	Nishino, Ichizo/0000-0001-9452-112X; Hirano, Michio/0000-0002-7070-7402	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028828, P01NS011766, P50NS011766, R01NS032527] Funding Source: NIH RePORTER; NINDS NIH HHS [NS11766, NS28828, NS32527] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams PL, 1997, ANN NEUROL, V41, P268, DOI 10.1002/ana.410410219; Amaravadi R, 1997, HUM GENET, V99, P329, DOI 10.1007/s004390050367; BONNEFOY N, 1994, P NATL ACAD SCI USA, V91, P11978, DOI 10.1073/pnas.91.25.11978; BUCHWALD P, 1991, MOL GEN GENET, V229, P413, DOI 10.1007/BF00267464; DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209; DIMAURO S, 1980, NEUROLOGY, V30, P795, DOI 10.1212/WNL.30.8.795; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; DIMAURO S, 1994, MITOCHONDRIAL DISORD, P91; GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895; KRUMMECK G, 1990, CURR GENET, V18, P13, DOI 10.1007/BF00321109; LOMBES A, 1991, NEUROLOGY, V41, P491, DOI 10.1212/WNL.41.4.491; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; MERANTE F, 1993, AM J HUM GENET, V53, P481; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Paret C, 1999, FEBS LETT, V447, P65, DOI 10.1016/S0014-5793(99)00266-5; PEL HJ, 1992, CURR GENET, V21, P139, DOI 10.1007/BF00318473; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; PREISS T, 1993, J BIOL CHEM, V268, P10659; Rentzsch A, 1999, CURR GENET, V35, P103, DOI 10.1007/s002940050438; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SCHULZE M, 1988, MOL GEN GENET, V211, P492, DOI 10.1007/BF00425706; SCHULZE M, 1989, MOL GEN GENET, V216, P37, DOI 10.1007/BF00332228; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; TAANMAN JW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P155, DOI 10.1016/0925-4439(92)90095-5; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	29	447	450	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1999	23	3					333	337						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	257QC	10545952				2022-12-17	WOS:000083792200024
J	Kottgen, A; Glazer, NL; Dehghan, A; Hwang, SJ; Katz, R; Li, M; Yang, Q; Gudnason, V; Launer, LJ; Harris, TB; Smith, AV; Arking, DE; Astor, BC; Boerwinkle, E; Ehret, GB; Ruczinski, I; Scharpf, RB; Chen, YDI; de Boer, IH; Haritunians, T; Lumley, T; Sarnak, M; Siscovick, D; Benjamin, EJ; Levy, D; Upadhyay, A; Aulchenko, YS; Hofman, A; Rivadeneira, F; Uitterlinden, AG; van Duijn, CM; Chasman, DI; Pare, G; Ridker, PM; Kao, WHL; Witteman, JC; Coresh, J; Shlipak, MG; Fox, CS				Koettgen, Anna; Glazer, Nicole L.; Dehghan, Abbas; Hwang, Shih-Jen; Katz, Ronit; Li, Man; Yang, Qiong; Gudnason, Vilmundur; Launer, Lenore J.; Harris, Tamara B.; Smith, Albert V.; Arking, Dan E.; Astor, Brad C.; Boerwinkle, Eric; Ehret, Georg B.; Ruczinski, Ingo; Scharpf, Robert B.; Chen, Yii-Der Ida; de Boer, Ian H.; Haritunians, Talin; Lumley, Thomas; Sarnak, Mark; Siscovick, David; Benjamin, Emelia J.; Levy, Daniel; Upadhyay, Ashish; Aulchenko, Yurii S.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Chasman, Daniel I.; Pare, Guillaume; Ridker, Paul M.; Kao, W. H. Linda; Witteman, Jacqueline C.; Coresh, Josef; Shlipak, Michael G.; Fox, Caroline S.			Multiple loci associated with indices of renal function and chronic kidney disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SERUM CREATININE; CARDIOVASCULAR-DISEASE; POOLED ANALYSIS; RISK-FACTOR; HEART; GFR; STANNIOCALCIN-1; EPIDEMIOLOGY; HERITABILITY	Chronic kidney disease (CKD) has a heritable component and is an important global public health problem because of its high prevalence and morbidity(1). We conducted genome-wide association studies (GWAS) to identify susceptibility loci for glomerular filtration rate, estimated by serum creatinine (eGFRcrea) and cystatin C (eGFRcys), and CKD (eGFRcrea < 60ml/min/1.73 m(2)) in European-ancestry participants of four population-based cohorts (ARIC, CHS, FHS, RS; n = 19,877; 2,388 CKD cases), and tested for replication in 21,466 participants (1,932 CKD cases). We identified significant SNP associations (P < 5 x 10(-8)) with CKD at the UMOD locus, with eGFRcrea at UMOD, SHROOM3 and GATM-SPATA5L1, and with eGFRcys at CST and STC1. UMOD encodes the most common protein in human urine, Tamm-Horsfall protein(2), and rare mutations in UMOD cause mendelian forms of kidney disease(3). Our findings provide new insights into CKD pathogenesis and underscore the importance of common genetic variants influencing renal function and disease.	[Hwang, Shih-Jen; Levy, Daniel; Fox, Caroline S.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Hwang, Shih-Jen; Levy, Daniel; Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Koettgen, Anna; Li, Man; Astor, Brad C.; Kao, W. H. Linda; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Glazer, Nicole L.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, DC USA; [Siscovick, David] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Dehghan, Abbas; Aulchenko, Yurii S.; Hofman, Albert; van Duijn, Cornelia M.; Witteman, Jacqueline C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Katz, Ronit; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Yang, Qiong] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Gudnason, Vilmundur; Smith, Albert V.] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Arking, Dan E.; Ehret, Georg B.] Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX USA; [Ehret, Georg B.] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Ruczinski, Ingo; Scharpf, Robert B.; Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Chen, Yii-Der Ida; Haritunians, Talin] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Sarnak, Mark] Tufts Univ New England Med Ctr, Boston, MA USA; [Siscovick, David] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Upadhyay, Ashish] Boston Med Ctr, Renal Sect, Boston, MA USA; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Chasman, Daniel I.; Pare, Guillaume; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Shlipak, Michael G.] Univ Calif San Francisco, San Francisco VA Med Ctr, Gen Internal Med Div, San Francisco, CA 94143 USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Boston University; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Geneva; Johns Hopkins University; Cedars Sinai Medical Center; University of Washington; University of Washington Seattle; Tufts Medical Center; University of Washington; University of Washington Seattle; Boston University; Boston University; Boston Medical Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fox, CS (corresponding author), Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA.	j.witteman@erasmusmc.nl; coresh@jhu.edu; michael.shlipak@ucsf.edu; foxca@nhlbi.nih.gov	Gudnason, Vilmundur/AAE-7126-2019; Launer, Lenore J/A-8218-2010; Li, Man/AAX-3400-2020; Pare, Guillaume/T-9631-2018; Kottgen, Anna/D-2920-2012; Hwang, Shih-Jen/HGU-5826-2022; Smith, Albert Vernon/K-5150-2015; Yang, Qiong/G-5438-2014; Levy, Daniel/ABF-6873-2021; Gudnason, Vilmundur/K-6885-2015; Levy, Daniel/ABB-2752-2021; EHRET, Georg B/A-9532-2009; Aulchenko, Yurii/M-8270-2013; Rivadeneira, Fernando/O-5385-2015; de Boer, Ian/GYJ-3282-2022; Katz, Ronit/ABA-1880-2021; Dehghan, Abbas/ABE-7377-2020; Dehghan, Abbas/B-9896-2008; Benjamin, Emelia/E-7103-2011	Gudnason, Vilmundur/0000-0001-5696-0084; Li, Man/0000-0002-3839-0281; Pare, Guillaume/0000-0002-6795-4760; Smith, Albert Vernon/0000-0003-1942-5845; Levy, Daniel/0000-0003-1843-8724; Gudnason, Vilmundur/0000-0001-5696-0084; EHRET, Georg B/0000-0002-5730-0675; Aulchenko, Yurii/0000-0002-7899-1575; Rivadeneira, Fernando/0000-0001-9435-9441; Upadhyay, Ashish/0000-0002-0536-5776; Ballantyne, Christie/0000-0002-6432-1730; Van Duijn, Cornelia/0000-0002-2374-9204; Glazer, Nicole/0000-0002-6397-609X; Dehghan, Abbas/0000-0001-6403-016X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Johnson, Andrew/0000-0001-6369-5178; Benjamin, Emelia/0000-0003-4076-2336	Intramural NIH HHS Funding Source: Medline; NCATS NIH HHS [UL1 TR000423] Funding Source: Medline; NCI NIH HHS [R01 CA047988, CA 047988] Funding Source: Medline; NCRR NIH HHS [KL2 RR025015, M01 RR000069, UL1 RR025005, UL1RR025005, M01RR00069, UL1 RR025005-01, KL2 RR025015-03] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402-01, U01HG004402, U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [R01HL59367, U01 HL080295, HL 043851, N01-HC-55022, N01-HC-85081, R01 HL043851, R01 HL059367, N01 HC015103, N01-HC-55016, N01 HC055018, N01 HC025195, R01 HL086694, U01 HL080295-01, N02 HL64278, R01 HL087652-01, R01 HL087652, N01HC55022, R01 HL086694-01A1, N01HC55222, N01-HC-55021, N01-HC-85086, N01HC55015, N01HC85086, N01-HC-85085, N01HC55018, N01 HC055016, R01 HL059367-02, N01 HC085086, N01 HC055022, N01-HC-25195, N02-HL-6-4278, N01HC55020, N01 HC045133, R01HL087641, N01 HC075150, N01-HC-85084, R01HL086694, N01 HC035129, N01 HC085079, N01HC85079, R01 HL087641, N01HC55021, N01-HC-55018, N01 HC055020, N01-HC-85079, R01 HL087641-01, N01HC25195, N01HC75150, N01HC55019, N01 HC055021, N01-HC-85082, N01 HC055019, N01-HC-55019, N01-HC-55015, N01 HC055222, N01-HC-55222, N01-HC-85083, N01-HC-75150, N01-HC-55020, N01-HC-85080, N01HC55016, N01 HC055015, R01 HL043851-09] Funding Source: Medline; NIA NIH HHS [R01 AG027002-01, N01AG12100, N01 AG012100, R01 AG027002] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491-019004, R01 DK076770, P30 DK063491-05, K01 DK067207-01A1, P30 DK063491, DK063491, K01DK067207, K01 DK067207] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, N01HC55021, ZIAHL006001] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Benetti E, 2009, AM J KIDNEY DIS, V53, P327, DOI 10.1053/j.ajkd.2008.08.020; Bochud M, 2005, KIDNEY INT, V67, P61, DOI 10.1111/j.1523-1755.2005.00055.x; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Freedman BI, 2000, CURR OPIN NEPHROL HY, V9, P273, DOI 10.1097/00041552-200005000-00011; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hsu CC, 2005, JAMA-J AM MED ASSOC, V293, P2892, DOI 10.1001/jama.293.23.2892; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Hwang SJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S10; Langefeld CD, 2004, AM J KIDNEY DIS, V43, P796, DOI 10.1053/j.ajkd.2003.12.043; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; *NIH, 2008, US REN DAT SYST USRD; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Yoshiko Y, 2004, PEPTIDES, V25, P1663, DOI 10.1016/j.peptides.2004.04.015; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	30	446	462	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					712	717		10.1038/ng.377	http://dx.doi.org/10.1038/ng.377			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19430482	Green Submitted, Green Accepted			2022-12-17	WOS:000266411700021
J	Houlston, RS; Webb, E; Broderick, P; Pittman, AM; Di Bernardo, MC; Lubbe, S; Chandler, I; Vijayakrishnan, J; Sullivan, K; Penegar, S; Carvajal-Carmona, L; Howarth, K; Jaeger, E; Spain, SL; Walther, A; Barclay, E; Martin, L; Gorman, M; Domingo, E; Teixeira, AS; Kerr, D; Cazier, JB; Niittymaki, I; Tuupanen, S; Karhu, A; Aaltonen, LA; Tomlinson, IPM; Farrington, SM; Tenesa, A; Prendergast, JGD; Barnetson, RA; Cetnarskyj, R; Porteous, ME; Pharoah, PDP; Koessler, T; Hampe, J; Buch, S; Schafmayer, C; Tepel, J; Schreiber, S; Volzke, H; Chang-Claude, J; Hoffmeister, M; Brenner, H; Zanke, BW; Montpetit, A; Hudson, TJ; Gallinger, S; Campbell, H; Dunlop, MG				Houlston, Richard S.; Webb, Emily; Broderick, Peter; Pittman, Alan M.; Di Bernardo, Maria Chiara; Lubbe, Steven; Chandler, Ian; Vijayakrishnan, Jayaram; Sullivan, Kate; Penegar, Steven; Carvajal-Carmona, Luis; Howarth, Kimberley; Jaeger, Emma; Spain, Sarah L.; Walther, Axel; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Domingo, Enric; Teixeira, Ana S.; Kerr, David; Cazier, Jean-Baptiste; Niittymaki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri A.; Tomlinson, Ian P. M.; Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Cetnarskyj, Roseanne; Porteous, Mary E.; Pharoah, Paul D. P.; Koessler, Thibaud; Hampe, Jochen; Buch, Stephan; Schafmayer, Clemens; Tepel, Jurgen; Schreiber, Stefan; Voelzke, Henry; Chang-Claude, Jenny; Hoffmeister, Michael; Brenner, Hermann; Zanke, Brent W.; Montpetit, Alexandre; Hudson, Thomas J.; Gallinger, Steven; Campbell, Harry; Dunlop, Malcolm G.		COGENT Study; Colorectal Canc Assoc Study Consor; CoRGI Consortium; Int Colorectal Canc Genetic Assoc	Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer	NATURE GENETICS			English	Article							FAMILIAL GASTRIC-CANCER; CADHERIN GENE CDH1; GERMLINE MUTATIONS; JUVENILE POLYPOSIS; PROSTATE-CANCER; BREAST-CANCER; BETA-CATENIN; SAMPLE-SIZE; RISK; 8Q24	Genome-wide association (GWA) studies have identified multiple loci at which common variants modestly influence the risk of developing colorectal cancer (CRC). To enhance power to identify additional loci with similar effect sizes, we conducted a meta-analysis of two GWA studies, comprising 13,315 individuals genotyped for 38,710 common tagging SNPs. We undertook replication testing in up to eight independent case-control series comprising 27,418 subjects. We identified four previously unreported CRC risk loci at 14q22.2 (rs4444235, BMP4; P = 8.1 x 10(-10)), 16q22.1 (rs9929218, CDH1; P = 1.2 x 10(-8)), 19q13.1 (rs10411210, RHPN2; P = 4.6 x 10(-9)) and 20p12.3 (rs961253; P = 2.0 x 10(-10)). These findings underscore the value of large sample series for discovery and follow-up of genetic variants contributing to the etiology of CRC.	[Houlston, Richard S.; Webb, Emily; Broderick, Peter; Pittman, Alan M.; Di Bernardo, Maria Chiara; Lubbe, Steven; Chandler, Ian; Vijayakrishnan, Jayaram; Sullivan, Kate; Penegar, Steven] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Carvajal-Carmona, Luis; Howarth, Kimberley; Jaeger, Emma; Spain, Sarah L.; Walther, Axel; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Domingo, Enric; Teixeira, Ana S.; Cazier, Jean-Baptiste; Tomlinson, Ian P. M.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Kerr, David] Univ Oxford, Dept Clin Pharmacol, Oxford OX2 6HA, England; [Niittymaki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki, Finland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Campbell, Harry; Dunlop, Malcolm G.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Campbell, Harry; Dunlop, Malcolm G.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cetnarskyj, Roseanne; Porteous, Mary E.] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Pharoah, Paul D. P.; Koessler, Thibaud] Univ Cambridge, Dept Oncol, Strangeways Res Lab, Canc Res UK Labs, Cambridge, England; [Hampe, Jochen; Buch, Stephan] Univ Hosp, Dept Gen Internal Med, D-24105 Kiel, Germany; [Schafmayer, Clemens; Tepel, Jurgen; Schreiber, Stefan] Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; [Schafmayer, Clemens; Tepel, Jurgen] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Voelzke, Henry] Univ Hosp Greifswald, Inst Epidemiol & Sozialmed, D-17487 Greifswald, Germany; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Hoffmeister, Michael; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Zanke, Brent W.] Ottawa Hlth Res Inst, Div Epidemiol, Ottawa, ON K1H 8L6, Canada; [Montpetit, Alexandre; Hudson, Thomas J.] McGill Univ, Montreal, PQ H3G 1A4, Canada; [Montpetit, Alexandre; Hudson, Thomas J.] Genome Quebec Innovat Ctr, Montreal, PQ H3G 1A4, Canada; [Hudson, Thomas J.; Gallinger, Steven] Canc Care Ontario, Toronto, ON M5G 1L7, Canada; [Hudson, Thomas J.; Gallinger, Steven] Ontario Inst Canc Res, Toronto, ON M5G 2L7, Canada	University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Helsinki; University of Edinburgh; University of Edinburgh; University of Edinburgh; Cancer Research UK; University of Cambridge; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Ottawa; Ottawa Hospital Research Institute; McGill University; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.houlston@icr.ac.uk; iant@well.ox.ac.uk; malcolm.dunlop@hgu.mrc.ac.uk	Aaltonen, Lauri/A-5375-2010; Campbell, Harry/E-2959-2010; Domingo, Enric/A-9099-2018; Cazier, Jean-Baptiste/GLR-2949-2022; Hoffmeister, Michael/AAB-2321-2022; Pittman, Alan M/D-6231-2012; Farrington, Susan M/C-7319-2013; Hoffmeister, Michael/T-7187-2019; Cazier, Jean-Baptiste/F-2369-2010; Pharoah, Paul/V-6658-2019; Pittman, Alan/AAP-2534-2020; Dunlop, Malcolm G/F-1973-2011; van Wezel, Tom/Z-3092-2019; Lubbe, Steven/L-8261-2013; Evans, D Gareth/AAB-4308-2022; Brenner, Hermann/ABE-6383-2020; Kössler, Thibaud/AAZ-9734-2020; Carvajal-Carmona, Luis G/B-3882-2010; Brenner, Hermann/B-4627-2017; Gallinger, Steven/E-4575-2013; Hoffmeister, Michael/B-5745-2012; Hampe, Jochen/A-2555-2010; Farrington, Susan M/Q-2710-2019; Buch, Stephan/AAV-5028-2021; van Wezel, Tom/A-9599-2008; Spain, Sarah/G-1968-2010	Aaltonen, Lauri/0000-0001-6839-4286; Campbell, Harry/0000-0002-6169-6262; Domingo, Enric/0000-0003-4390-8767; Cazier, Jean-Baptiste/0000-0001-7581-9051; Hoffmeister, Michael/0000-0002-8307-3197; Pittman, Alan M/0000-0002-8112-2987; Hoffmeister, Michael/0000-0002-8307-3197; Cazier, Jean-Baptiste/0000-0001-7581-9051; Pharoah, Paul/0000-0001-8494-732X; Pittman, Alan/0000-0002-8112-2987; Dunlop, Malcolm G/0000-0002-3033-5851; van Wezel, Tom/0000-0001-5773-7730; Lubbe, Steven/0000-0002-7103-6671; Evans, D Gareth/0000-0002-8482-5784; Brenner, Hermann/0000-0002-6129-1572; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Hampe, Jochen/0000-0002-2421-6127; Farrington, Susan M/0000-0001-5955-7389; van Wezel, Tom/0000-0001-5773-7730; Penegar, Steven/0000-0002-3768-0236; Karhu, Auli/0000-0002-7927-0796; Broderick, Peter/0000-0002-8348-5829; Webb, Emily/0000-0002-4019-7456; Spain, Sarah/0000-0002-7591-8364; Prendergast, James/0000-0001-8916-018X; Kossler, Thibaud/0000-0001-9196-9076; Tenesa, Albert/0000-0003-4884-4475; Houlston, Richard/0000-0002-5268-0242	Cancer Research UK [A6360, C348/A3758, A8896, C48/A6361]; Bobby Moore Cancer Research UK [C1298/A8362]; European Union [CPRB LSHC-CT-2004-503465]; St George's Hospital Medical School; CORE; Bobby Moore Fund; Medical Research Council [G000065753203]; Scottish Executive Chief Scientist's Office [K/OPR/2/2/D333, CZB/4/449]; MRC; Academy of Finland; Finnish Cancer Society; Sigrid Juselius Foundation; European Commission [9LSHG-CT-2004-512142]; German National Genome Research Network (NGFN) [BmBF 01GR0468]; National Genotyping Platform; MediGrid and Services@MediGrid [01AK803G, 01IG07015B]; Federal Ministry of Education and Research [ZZ9603]; German Research Council (Deutsche Forschungsgemeinschaft), [BR 1704/6-1, BR 1704/6-3, CH 117/1-1]; German Federal Ministry for Education and Research [01 KH 0404]; Genome Canada through the Ontario Genomics Institute; Genome Quebec; Ministere du Developement Economique et Regional et de la Recherche du Quebec; Ontario Institute for Cancer Research; National Cancer Institute of Canada (NCIC); National Cancer Institute, National Institutes of Health [RFA CA-95-011]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA076783]; Medical Research Council [MC_U127527198, G0000934, G0301096] Funding Source: researchfish; Chief Scientist Office [CZB/4/449] Funding Source: researchfish; MRC [G0000934, MC_U127527198, G0301096] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [K22CA095011, U01CA074783, U24CA074783] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Bobby Moore Cancer Research UK(Cancer Research UK); European Union(European Commission); St George's Hospital Medical School; CORE(Luxembourg National Research Fund); Bobby Moore Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Executive Chief Scientist's Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); German National Genome Research Network (NGFN); National Genotyping Platform; MediGrid and Services@MediGrid; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Council (Deutsche Forschungsgemeinschaft),(German Research Foundation (DFG)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Genome Quebec; Ministere du Developement Economique et Regional et de la Recherche du Quebec; Ontario Institute for Cancer Research; National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ontario Registry for Studies of Familial Colorectal Cancer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Cancer Research UK provided principal funding for this study (A6360). We would like to thank all individuals that participated in this study.; Institute of Cancer Research: Work was supported by the Bobby Moore Cancer Research UK (C1298/A8362). Additional funding was provided by the European Union (CPRB LSHC-CT-2004-503465) and CORE. I. C. was in receipt of a clinical training fellowship from St George's Hospital Medical School. S. L. was supported by a PhD studentship from Cancer Research UK. We are grateful to colleagues at the UK National Cancer Research Network.; Oxford: Work was supported by CORE and the Bobby Moore Fund. We are grateful to colleagues at UK Clinical Genetics Centres and the UK National Cancer Research Network.; Edinburgh: The work was supported by Cancer Research UK grant numbers C348/A3758 and A8896, C48/A6361 and the Bobby Moore Fund, which supports the work of the Colon Cancer Genetics Group through Cancer Research UK. Additional funding was provided by the Medical Research Council (G000065753203), Scottish Executive Chief Scientist's Office (K/OPR/2/2/D333, CZB/4/449), center grant from CORE as part of the Digestive Cancer Campaign. J.P. was funded by an MRC PhD studentship. We gratefully acknowledge the work of the COGS and SOCCS administrative teams; R. Cetnarskyj and the research nurse teams, all who recruited to the studies; the Wellcome Trust Clinical Research Facility for sample preparation; and all clinicians and pathologists throughout Scotland at collaborating centers. The study used the biological and data resource of Generation Scotland.; Finland: This work was supported by grants from Academy of Finland (Finnish Centre of Excellence Program 2006-2011), the Finnish Cancer Society, the Sigrid Juselius Foundation and the European Commission (9LSHG-CT-2004-512142).; Cambridge: We thank the SEARCH study team and all the participants in the study. P. D. P. P. is a Cancer Research UK Senior Clinical Research Fellow. T. K. is funded by the Foundation Dr Henri Dubois-Ferriere Dinu Lipatti.; Kiel: The study was supported by the German National Genome Research Network (NGFN) through the PopGen biobank (BmBF 01GR0468) and the National Genotyping Platform. Further support was obtained through the MediGrid and Services@MediGrid projects (01AK803G and 01IG07015B). SHIP is part of the Community Medicine Research net (CMR) of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grant number. ZZ9603), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania.; Heidelberg: We wish to thank all participants and the staff of the participating clinics for their contribution to the data collection, B. Kaspereit, K. Smit and U. Eilber in the Division of Cancer Epidemiology, and U. Handte-Daub, S. Toth and B. Collins in the Division of Clinical Epidemiology and Aging Research, German Cancer Research Center for their excellent technical assistance. This study was supported by the German Research Council (Deutsche Forschungsgemeinschaft), grant numbers BR 1704/6-1, BR 1704/6-3 and CH 117/1-1, and by the German Federal Ministry for Education and Research, grant number 01 KH 0404.; Canada: We gratefully acknowledge the contribution of A. Belisle, V. Catudal and R. Frechette. Cancer Care Ontario, as the host organization to the ARCTIC Genome Project, acknowledges that this project was funded by Genome Canada through the Ontario Genomics Institute, by Genome Quebec, the Ministere du Developement Economique et Regional et de la Recherche du Quebec and the Ontario Institute for Cancer Research (B.W.Z., T.J.H. and S.G.). Additional funding was provided by the National Cancer Institute of Canada (NCIC) through the Cancer Risk Assessment (CaRE) Program Project Grant. The work was supported through collaboration and cooperative agreements with the Colon Cancer Family Registry and PIs, supported by the National Cancer Institute, National Institutes of Health under RFA CA-95-011, including the Ontario Registry for Studies of Familial Colorectal Cancer (S.G.) (U01 CA076783). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating institutions or investigators in the Colon CFR, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government or the Colon CFR. This study made use of genotyping data on the 1958 Birth Cohort. Genotyping data on controls was generated and generously supplied to us by Panagiotis Deloukas of the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk.	Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Behrens J, 2005, BIOCHEM SOC T, V33, P672, DOI 10.1042/BST0330672; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Boland CR, 1998, CANCER RES, V58, P5248; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Chang YWE, 2006, CANCER RES, V66, P11700, DOI 10.1158/0008-5472.CAN-06-1818; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Eisen T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-244; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Kim JS, 2002, CANCER RES, V62, P2744; Li LC, 2000, CANCER RES, V60, P873; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LUBIN JH, 1990, AM J EPIDEMIOL, V131, P552, DOI 10.1093/oxfordjournals.aje.a115530; Peck JW, 2002, J BIOL CHEM, V277, P43924, DOI 10.1074/jbc.M203569200; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Petitti D, 1994, METAANALYSIS DECISIO; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Salahshor S, 2001, INT J MOL MED, V8, P439; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wheeler JMD, 2001, GUT, V48, P367, DOI 10.1136/gut.48.3.367; World Heath Organization, 1977, INT CLASS DIS 1975 R; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	44	446	454	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1426	1435		10.1038/ng.262	http://dx.doi.org/10.1038/ng.262			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19011631	Green Accepted			2022-12-17	WOS:000261215900019
J	Franke, A; Balschun, T; Karlsen, TH; Sventoraityte, J; Nikolaus, S; Mayr, G; Domingues, FS; Albrecht, M; Nothnagel, M; Ellinghaus, D; Sina, C; Onnie, CM; Weersma, RK; Stokkers, PCF; Wijmenga, C; Gazouli, M; Strachan, D; McArdle, WL; Vermeire, S; Rutgeerts, P; Rosenstiel, P; Krawczak, M; Vatn, MH; Mathew, CG; Schreiber, S				Franke, Andre; Balschun, Tobias; Karlsen, Tom H.; Sventoraityte, Jurgita; Nikolaus, Susanna; Mayr, Gabriele; Domingues, Francisco S.; Albrecht, Mario; Nothnagel, Michael; Ellinghaus, David; Sina, Christian; Onnie, Clive M.; Weersma, Rinse K.; Stokkers, Pieter C. F.; Wijmenga, Cisca; Gazouli, Maria; Strachan, David; McArdle, Wendy L.; Vermeire, Severine; Rutgeerts, Paul; Rosenstiel, Philip; Krawczak, Michael; Vatn, Morten H.; Mathew, Christopher G.; Schreiber, Stefan		IBSEN Study Grp	Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CYTOKINE GENE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; IL-10 GENE; TNF-ALPHA; INTERLEUKIN-10; METAANALYSIS; PHENOTYPE; IBD	Inflammatory bowel disease (IBD) typically manifests as either ulcerative colitis (UC) or Crohn's disease (CD). Systematic identification of susceptibility genes for IBD has thus far focused mainly on CD, and little is known about the genetic architecture of UC. Here we report a genome-wide association study with 440,794 SNPs genotyped in 1,167 individuals with UC and 777 healthy controls. Twenty of the most significantly associated SNPs were tested for replication in three independent European case-control panels comprising a total of 1,855 individuals with UC and 3,091 controls. Among the four consistently replicated markers, SNP rs3024505 immediately flanking the IL10 (interleukin 10) gene on chromosome 1q32.1 showed the most significant association in the combined verification samples (P = 1.35 x 10(-12); OR = 1.46 (1.31-1.62)). The other markers were located in ARPC2 and in the HLA-BTNL2 region. Association between rs3024505 and CD (1,848 cases, 1,804 controls) was weak (P = 0.013; OR = 1.17 (1.01-1.34)). IL10 is an immunosuppressive cytokine that has long been proposed to influence IBD pathophysiology. Our findings strongly suggest that defective IL10 function is central to the pathogenesis of the UC subtype of IBD.	[Franke, Andre; Balschun, Tobias; Sventoraityte, Jurgita; Ellinghaus, David; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Karlsen, Tom H.; Vatn, Morten H.] Rikshosp Univ Hosp, Dept Med, N-0027 Oslo, Norway; [Nikolaus, Susanna; Sina, Christian] Univ Kiel, Poppgen Biobank, D-24105 Kiel, Germany; [Nikolaus, Susanna; Sina, Christian; Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Mayr, Gabriele; Domingues, Francisco S.; Albrecht, Mario] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Nothnagel, Michael; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany; [Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Weersma, Rinse K.] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [Weersma, Rinse K.; Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Stokkers, Pieter C. F.] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Gazouli, Maria] Univ Athens, Sch Med, Dept Biol, GR-11527 Athens, Greece; [Strachan, David] St Georgess Univ, Div Community Hlth Sci, London SW17 0RE, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, ALSPAC, Bristol BS8 1TQ, Avon, England; [Vermeire, Severine; Rutgeerts, Paul] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium; [Vatn, Morten H.] Akershus Univ Hosp, Fac Med, N-1474 Oslo, Norway	University of Kiel; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; University of Kiel; University of London; King's College London; University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Athens Medical School; National & Kapodistrian University of Athens; St Georges University London; University of Bristol; KU Leuven; University Hospital Leuven; University of Oslo	Schreiber, S (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Nothnagel, Michael/H-6887-2012; Nothnagel, Michael/L-7187-2019; Gazouli, Maria/W-6245-2019; Gazouli, Maria/I-2572-2018; Rosenstiel, Philip/A-5137-2009; Ellinghaus, David/ABC-3610-2020; Wijmenga, Cisca/D-2173-2009; Balschun, Tobias/B-2356-2010; Nothnagel, Michael/A-7759-2011; Wijmenga, Cisca/AAE-7719-2019; Weersma, Rinse/ABE-3807-2021; Nothnagel, Michael/G-6545-2014; Mathew, Christopher G/G-3434-2015; Albrecht, Mario/B-6694-2008; Ellinghaus, David/G-4467-2012; Franke, Andre/B-2151-2010; Sina, Christian/D-5348-2014; Krawczak, Michael/A-8964-2010	Nothnagel, Michael/0000-0001-8305-7114; Gazouli, Maria/0000-0002-3295-6811; Gazouli, Maria/0000-0002-3295-6811; Rosenstiel, Philip/0000-0002-9692-8828; Ellinghaus, David/0000-0002-4332-6110; Wijmenga, Cisca/0000-0002-5635-1614; Mathew, Christopher G/0000-0003-4178-1838; Albrecht, Mario/0000-0002-3103-9624; Franke, Andre/0000-0003-1530-5811; Krawczak, Michael/0000-0003-2603-1502; Domingues, Francisco/0000-0003-4567-4562; Vermeire, Severine/0000-0001-9942-3019	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); popgen biobank; DFG; British Birth Cohort collection; UK MRC [G0000934]; Wellcome Trust [068545/Z/02]; CORE (UK); Medical Research Council [G0000934, MC_qA137934] Funding Source: researchfish; MRC [G0000934, MC_qA137934] Funding Source: UKRI	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); popgen biobank; DFG(German Research Foundation (DFG)); British Birth Cohort collection; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); CORE (UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank all individuals with IBD, families and physicians for their cooperation. We gratefully acknowledge the cooperation of the German Crohn and Colitis Foundation (Deutsche Morbus Crohn und Colitis Vereinigung e. V.), the BMBF competence network "IBD'' and of the contributing gastroenterologists. Finally, we wish to thank T. Wesse, T. Henke, A. Dietsch, R. Vogler, C.v.d. Lancken and M. Friskovec for expert technical help. We thank T. Wienker and M. Steffens (IMBIE, University of Bonn) for performing the quality control of the GWAS datasets. We thank B. A. Lie and the Norwegian Bone Marrow Donor Registry at Rikshospitalet University Hospital, Oslo, for contributing the healthy Norwegian control population. This study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the popgen biobank and the SFB617 "Molecular Mechanisms of Epithelial Defense.'' The project received infrastructure support through the DFG excellence cluster "Inflammation at Interfaces.'' We acknowledge use of DNA from the 1958 British Birth Cohort collection (R. Jones, S. Ring, W. McArdle and M. Pembrey), funded by the UK MRC (grant G0000934) and The Wellcome Trust (grant 068545/Z/02). C. G. M. and C.M.O. were supported by The Wellcome Trust and CORE (UK).	Aithal GP, 2001, DIGEST DIS SCI, V46, P1520, DOI 10.1023/A:1010604307776; Balding J, 2004, MEDIAT INFLAMM, V13, P181, DOI 10.1080/09511920410001713529; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cantor MJ, 2005, AM J GASTROENTEROL, V100, P1134, DOI 10.1111/j.1572-0241.2005.40979.x; Castro-Santos P, 2006, AM J GASTROENTEROL, V101, P1039, DOI 10.1111/j.1572-0241.2006.00501.x; Celik Y, 2006, SCAND J GASTROENTERO, V41, P559, DOI 10.1080/00365520500349523; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fernandez L, 2005, INFLAMM BOWEL DIS, V11, P739, DOI 10.1097/01.MIB.0000173457.64868.20; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Kim Tae Ho, 2003, Korean J Gastroenterol, V42, P377; Klein W, 2000, ELECTROPHORESIS, V21, P3578, DOI 10.1002/1522-2683(200011)21:17<3578::AID-ELPS3578>3.3.CO;2-Q; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875; Parkes M, 1998, CLIN EXP IMMUNOL, V113, P28, DOI 10.1046/j.1365-2249.1998.00625.x; Schreiber S, 1998, GASTROENTEROLOGY, V114, pA1080; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Tagore A, 1999, TISSUE ANTIGENS, V54, P386, DOI 10.1034/j.1399-0039.1999.540408.x; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; van der Linde K, 2005, DIGEST LIVER DIS, V37, P330, DOI 10.1016/j.dld.2004.12.009; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; WEBB MC, 1993, TRANSPLANTATION, V56, P1585	30	446	461	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1319	1323		10.1038/ng.221	http://dx.doi.org/10.1038/ng.221			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836448				2022-12-17	WOS:000260501500024
J	Chuck, G; Cigan, AM; Saeteurn, K; Hake, S				Chuck, George; Cigan, A. Mark; Saeteurn, Koy; Hake, Sarah			The heterochronic maize mutant Corngrass1 results from overexpression of a tandem microRNA	NATURE GENETICS			English	Article							PHASE-CHANGE; GLOSSY15; MUTATIONS; SHOOT; MORPHOGENESIS; EXPRESSION; IDENTITY; PROTEIN; GENE	Retention of juvenile traits in the adult reproductive phase characterizes a process known as neoteny, and speculation exists over whether it has contributed to the evolution of new species. The dominant Corngrass1 (Cg1) mutant of maize is a neotenic mutation that results in phenotypes that may be present in the grass-like ancestors of maize. We cloned Cg1 and found that it encodes two tandem miR156 genes that are overexpressed in the meristem and lateral organs. Furthermore, a target of Cg1 is teosinte glume architecture1 (tga1) 1, a gene known to have had a role in the domestication of maize from teosinte. Cg1 mutant plants overexpressing miR156 have lower levels of mir172, a microRNA that targets genes controlling juvenile development(2). By altering the relative levels of both microRNAs, it is possible to either prolong or shorten juvenile development in maize, thus providing a mechanism for how species-level heterochronic changes can occur in nature.	Plant Gene Express Ctr, Albany, CA 94710 USA; Pioneer HiBred Int Inc, Johnston, IA 50131 USA	DuPont	Chuck, G (corresponding author), Plant Gene Express Ctr, 800 Buchanan St, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu						Allsopp A., 1965, DIFFERENTIATION DEV, P1236; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Cigan AM, 2001, SEX PLANT REPROD, V14, P135, DOI 10.1007/s004970100099; DOEBLEY J, 1991, GENETICS, V129, P285; EVANS MMS, 1994, DEVELOPMENT, V120, P1971; GALINAT WC, 1954, AM J BOT, V41, P803, DOI 10.2307/2438545; GALINAT WC, 1954, AM NAT, V88, P101, DOI 10.1086/281815; Goldschmidt R.B., 1940, MAT BASIS EVOLUTION, P436; GOLIBER TE, 1990, AM J BOT, V77, P399, DOI 10.2307/2444726; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson D., 1991, MOL PLANT PATHOLOGY, P163; KELLOGG EA, 2000, P 2 INT C COMP BIOL, V2; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; POETHIG RS, 1988, GENETICS, V119, P959; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; SINGLETON WR, 1951, AM NAT, V85, P81, DOI 10.1086/281656; Steeves TA, 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; TAKHTAJAN A, 1976, NEOTENY ORIGIN FLOW, P207; Unger E, 2002, TRANSGENIC RES, V11, P455, DOI 10.1023/A:1020350208095; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; WESSLER SR, 1985, P NATL ACAD SCI USA, V82, P4177, DOI 10.1073/pnas.82.12.4177; WHALEY W. GORDON, 1950, BULL TORREY BOT CLUB, V77, P274, DOI 10.2307/2481899	30	446	490	4	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					544	549		10.1038/ng2001	http://dx.doi.org/10.1038/ng2001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369828				2022-12-17	WOS:000245271200027
J	Meetei, AR; de Winter, JP; Medhurst, AL; Wallisch, M; Waisfisz, Q; van de Vrugt, HJ; Oostra, AB; Yan, ZJ; Ling, C; Bishop, CE; Hoatlin, ME; Joenje, H; Wang, WD				Meetei, AR; de Winter, JP; Medhurst, AL; Wallisch, M; Waisfisz, Q; van de Vrugt, HJ; Oostra, AB; Yan, ZJ; Ling, C; Bishop, CE; Hoatlin, ME; Joenje, H; Wang, WD			A novel ubiquitin ligase is deficient in Fanconi anemia	NATURE GENETICS			English	Article							TARGETED DISRUPTION; NUCLEAR-COMPLEX; REDUCED FERTILITY; GROUP-C; PROTEINS; GENE; FANCG/XRCC9; PATHWAY; MICE; HYPERSENSITIVITY	Fanconi anemia is a recessively inherited disease characterized by congenital defects, bone marrow failure and cancer susceptibility(1,2). Cells from individuals with Fanconi anemia are highly sensitive to DNA-crosslinking drugs, such as mitomycin C (MMC). Fanconi anemia proteins function in a DNA damage response pathway involving breast cancer susceptibility gene products, BRCA1 and BRCA2 (refs. 1,2). A key step in this pathway is monoubiquitination of FANCD2, resulting in the redistribution of FANCD2 to nuclear foci containing BRCA1 (ref. 3). The underlying mechanism is unclear because the five Fanconi anemia proteins known to be required for this ubiquitination have no recognizable ubiquitin ligase motifs. Here we report a new component of a Fanconi anemia protein complex, called PHF9, which possesses E3 ubiquitin ligase activity in vitro and is essential for FANCD2 monoubiquitination in vivo. Because PHF9 is defective in a cell line derived from an individual with Fanconi anemia, we conclude that PHF9 ( also called FANCL) represents a novel Fanconi anemia complementation group (FA-L). Our data suggest that PHF9 has a crucial role in the Fanconi anemia pathway as the likely catalytic subunit required for monoubiquitination of FANCD2.	NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Free Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Oregon Hlth & Sci Univ, Div Mol Med, Portland, OR 97239 USA; Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vrije Universiteit Amsterdam; Oregon Health & Science University; Baylor College of Medicine	Wang, WD (corresponding author), NIA, Genet Lab, NIH, 333 Cassell Dr,TRIAD Ctr Room 3000, Baltimore, MD 21224 USA.		Wang, Weidong/AAV-2446-2021; 高, 雨莉/HGU-8187-2022	Waisfisz, Quinten/0000-0002-7384-9182; Wang, Weidong/0000-0002-0658-7928; Wallisch, Michael/0000-0002-7133-795X	NATIONAL INSTITUTE ON AGING [Z01AG000688, ZIAAG000688] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; BRUNN D, 2003, DNA REPAIR; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Taniguchi T, 2002, BLOOD, V100, P2457, DOI 10.1182/blood-2002-03-0860; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Whitney MA, 1996, BLOOD, V88, P49; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435	30	446	464	0	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					165	170		10.1038/ng1241	http://dx.doi.org/10.1038/ng1241			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973351				2022-12-17	WOS:000185625300013
J	Akman, L; Yamashita, A; Watanabe, H; Oshima, K; Shiba, T; Hattori, M; Aksoy, S				Akman, L; Yamashita, A; Watanabe, H; Oshima, K; Shiba, T; Hattori, M; Aksoy, S			Genome sequence of the endocellular obligate symbiont of tsetse flies, Wigglesworthia glossinidia	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; ENDOSYMBIONT; EVOLUTION; IDENTIFICATION; EXPRESSION; MORSITANS; SECRETION; BUCHNERA; PATHWAY; MIDGUT	Many insects that rely on a single food source throughout their developmental cycle harbor beneficial microbes that provide nutrients absent from their restricted diet. Tsetse flies, the vectors of African trypanosomes, feed exclusively on blood and rely on one such intracellular microbe for nutritional provisioning and fecundity. As a result of co-evolution with hosts over millions of years, these mutualists have lost the ability to survive outside the sheltered environment of their host insect cells. We present the complete annotated genome of Wigglesworthia glossinidia brevipalpis, which is composed of one chromosome of 697,724 base pairs (bp) and one small plasmid, called pWig1, of 5,200 bp. Genes involved in the biosynthesis of vitamin metabolites, apparently essential for host nutrition and fecundity, have been retained. Unexpectedly, this obligate's genome bears hallmarks of both parasitic and free-living microbes, and the gene encoding the important regulatory protein DnaA is absent.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Vector Biol, New Haven, CT 06510 USA; Kitasato Univ, Sch Sci, Kanagawa 2288555, Japan; RIKEN, Human Genome Res Grp, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; Hitachi Instruments Serv Co Ltd, Tokyo, Japan	Yale University; Kitasato University; RIKEN; Hitachi Limited	Hattori, M (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Vector Biol, 60 Coll St,606 LEPH, New Haven, CT 06510 USA.	hattori@genome.ls.kitasato_u.ac.jp; serap.aksoy@yale.edu	Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Aksoy, Serap/K-2244-2019	Hattori, Masahira/0000-0001-9467-0344; Aksoy, Serap/0000-0001-9941-143X				Akman L, 2001, P NATL ACAD SCI USA, V98, P7546, DOI 10.1073/pnas.131057498; Aksoy S., 1995, Insect Molecular Biology, V4, P23, DOI 10.1111/j.1365-2583.1995.tb00004.x; Aksoy S, 2000, PARASITOL TODAY, V16, P114, DOI 10.1016/S0169-4758(99)01606-3; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ASAI T, 1994, J BACTERIOL, V176, P7113, DOI 10.1128/JB.176.22.7113-7114.1994; Charles H, 1999, J MOL EVOL, V48, P142, DOI 10.1007/PL00006452; Chen XA, 1999, J MOL EVOL, V48, P49, DOI 10.1007/PL00006444; Cheng Q, 1999, INSECT MOL BIOL, V8, P125, DOI 10.1046/j.1365-2583.1999.810125.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Douglas A.E., 1990, P319; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; HILL P, 1973, T ROY SOC TROP MED H, V67, P727, DOI 10.1016/0035-9203(73)90051-5; KAWAGISHI I, 1992, J GEN MICROBIOL, V138, P1051, DOI 10.1099/00221287-138-6-1051; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MA WC, 1974, NATURE, V247, P301, DOI 10.1038/247301a0; MOLOO SK, 1971, PARASITOLOGY, V63, P507, DOI 10.1017/S0031182000080021; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; NOGGE G, 1976, EXPERIENTIA, V32, P995, DOI 10.1007/BF01933932; NOGGE G, 1981, PARASITOLOGY, V82, P101; Ochman H, 1994, EXS, V69, P479; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	30	446	763	1	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					402	407		10.1038/ng986	http://dx.doi.org/10.1038/ng986			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12219091				2022-12-17	WOS:000179034800016
J	Peterfy, M; Phan, J; Xu, P; Reue, K				Peterfy, M; Phan, J; Xu, P; Reue, K			Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; SERUM LEPTIN LEVELS; MUTANT MOUSE; INSULIN-RESISTANCE; DIABETES-MELLITUS; ADIPOSE-TISSUE; MICE; REVEALS; GENOME; MAP	Mice carrying mutations in the fatty liver dystrophy (fld) gene have features of human lipodystrophy(1), a genetically heterogeneous group of disorders characterized by loss of body fat, fatty liver hypertriglyceridemia and insulin resistance(2-4). Through positional cloning, we have isolated the gene responsible and characterized two independent mutant alleles, fld and fld(2J). The gene (Lpin1) encodes a novel nuclear protein which we have named lipin. Consistent with the observed reduction of adipose tissue mass in fld and fld(2J) mice, wild-type Lpin1 mRNA is expressed at high levels in adipose tissue and is induced during differentiation of 3T3-L1 pre-adipocytes. Our results indicate that lipin is required for normal adipose tissue development, and provide a candidate gene for human lipodystrophy. Lipin defines a novel family of nuclear proteins containing at least three members in mammalian species, and homologs in distantly related organisms from human to yeast.	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Reue, K (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	Reuek@ucla.edu		Phan, Jack/0000-0001-5977-6004	NHLBI NIH HHS [HL24841] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DORFLER H, 1993, CLIN INVESTIGATOR, V71, P264; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hegele RA, 2000, J CLIN ENDOCR METAB, V85, P3089, DOI 10.1210/jc.85.9.3089; Klingenspor M, 1999, J BIOL CHEM, V274, P23078, DOI 10.1074/jbc.274.33.23078; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; OKANO H, 1991, J NEUROCHEM, V56, P560, DOI 10.1111/j.1471-4159.1991.tb08186.x; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Peterfy M, 1999, GENOMICS, V62, P436, DOI 10.1006/geno.1999.6023; Rehnmark S, 1998, J LIPID RES, V39, P2209; Reue K, 2000, J LIPID RES, V41, P1067; Rotimi CN, 1999, DIABETES, V48, P643, DOI 10.2337/diabetes.48.3.643; Rowe LB, 1996, MAMM GENOME, V7, P555, DOI 10.1007/s003359900166; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; SENIOR B, 1964, PEDIATRICS, V33, P593; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	26	446	469	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					121	124		10.1038/83685	http://dx.doi.org/10.1038/83685			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138012				2022-12-17	WOS:000166187900029
J	GeorgesLabouesse, E; Messaddeq, N; Yehia, G; Cadalbert, L; Dierich, A; LeMeur, M				GeorgesLabouesse, E; Messaddeq, N; Yehia, G; Cadalbert, L; Dierich, A; LeMeur, M			Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice	NATURE GENETICS			English	Letter							BASEMENT-MEMBRANE ADHESION; MONOCLONAL-ANTIBODY; CELL-ADHESION; HEMIDESMOSOMES; SUBUNIT; PROTEIN; DISRUPTION; COMPONENT; COMPLEX; KALININ				GeorgesLabouesse, E (corresponding author), ULP, INSERM,CNRS,INST GENET & BIOL MOL & CELLULAIRE, BP 163, CU STRASBOURG, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE.			Cadalbert, Laurence/0000-0003-1333-2146				ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLLO G, 1995, CELL ADHES COMMUN, V3, P101, DOI 10.3109/15419069509081280; DAMSKY C, 1993, FASEB J, V7, P1320, DOI 10.1096/fasebj.7.14.8224605; DECURTIS I, 1993, DEVELOPMENT, V118, P377; DELWEL GO, 1996, ADHESION RECEPTORS T, P9; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HEMLER ME, 1989, J BIOL CHEM, V264, P6529; HIERCK BP, 1993, CELL ADHES COMMUN, V1, P33, DOI 10.3109/15419069309095680; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; KENNEL SJ, 1986, CANCER RES, V46, P707; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARK M, 1993, DEVELOPMENT, V119, P319; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SIMONASSMANN P, 1994, DEV DYNAM, V201, P71, DOI 10.1002/aja.1002010108; SONNENBERG A, 1990, J CELL SCI, V96, P207; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; SPINARDI L, 1993, MOL BIOL CELL, V4, P871, DOI 10.1091/mbc.4.9.871; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; THORSTEINSDOTTIR S, 1995, DEV DYNAM, V204, P240, DOI 10.1002/aja.1002040304; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229	35	446	454	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					370	373		10.1038/ng0796-370	http://dx.doi.org/10.1038/ng0796-370			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673141				2022-12-17	WOS:A1996UU28300030
J	Liu, Y; Easton, J; Shao, Y; Maciaszek, J; Wang, ZM; Wilkinson, MR; McCastlain, K; Edmonson, M; Pounds, SB; Shi, L; Zhou, X; Ma, XT; Sioson, E; Li, YJ; Rusch, M; Gupta, P; Pei, DQ; Cheng, C; Smith, MA; Auvil, JG; Gerhard, DS; Relling, MV; Winick, NJ; Carroll, AJ; Heerema, NA; Raetz, E; Devidas, M; Willman, CL; Harvey, RC; Carroll, WL; Dunsmore, KP; Winter, SS; Wood, BL; Sorrentino, BP; Downing, JR; Loh, ML; Hunger, SP; Zhang, JH; Mullighan, CG				Liu, Yu; Easton, John; Shao, Ying; Maciaszek, Jamie; Wang, Zhaoming; Wilkinson, Mark R.; McCastlain, Kelly; Edmonson, Michael; Pounds, Stanley B.; Shi, Lei; Zhou, Xin; Ma, Xiaotu; Sioson, Edgar; Li, Yongjin; Rusch, Michael; Gupta, Pankaj; Pei, Deqing; Cheng, Cheng; Smith, Malcolm A.; Auvil, Jaime Guidry; Gerhard, Daniela S.; Relling, Mary V.; Winick, Naomi J.; Carroll, Andrew J.; Heerema, Nyla A.; Raetz, Elizabeth; Devidas, Meenakshi; Willman, Cheryl L.; Harvey, Richard C.; Carroll, William L.; Dunsmore, Kimberly P.; Winter, Stuart S.; Wood, Brent L.; Sorrentino, Brian P.; Downing, James R.; Loh, Mignon L.; Hunger, Stephen P.; Zhang, Jinghui; Mullighan, Charles G.			The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia	NATURE GENETICS			English	Article							BINDING PROTEINS ZFP36L1; UBIQUITIN LIGASE HUWE1; OF-FUNCTION MUTATIONS; CELL LEUKEMIA; CHROMOSOMAL TRANSLOCATION; TUMOR-SUPPRESSOR; SOMATIC MUTATIONS; CANCER GENOMES; HOMEOBOX GENE; MYC	Genetic alterations that activate NOTCH1 signaling and T cell transcription factors, coupled with inactivation of the INK4/ARF tumor suppressors, are hallmarks of T-lineage acute lymphoblastic leukemia (T-ALL), but detailed genome-wide sequencing of large T-ALL cohorts has not been carried out. Using integrated genomic analysis of 264 T-ALL cases, we identified 106 putative driver genes, half of which had not previously been described in childhood T-ALL (for example, CCND3, CTCF, MYB, SMARCA4, ZFP36L2 and MYCN). We describe new mechanisms of coding and noncoding alteration and identify ten recurrently altered pathways, with associations between mutated genes and pathways, and stage or subtype of T-ALL. For example, NRAS/FLT3 mutations were associated with immature T-ALL, JAK3/STAT5B mutations in HOXA1 deregulated ALL, PTPN2 mutations in TLX1 deregulated T-ALL, and PIK3R1/PTEN mutations in TAL1 deregulated ALL, which suggests that different signaling pathways have distinct roles according to maturational stage. This genomic landscape provides a logical framework for the development of faithful genetic models and new therapeutic approaches.	[Liu, Yu; Easton, John; Shao, Ying; Wang, Zhaoming; Edmonson, Michael; Zhou, Xin; Ma, Xiaotu; Sioson, Edgar; Li, Yongjin; Rusch, Michael; Gupta, Pankaj; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale, Memphis, TN USA; [Shao, Ying; Wilkinson, Mark R.; McCastlain, Kelly; Downing, James R.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Maciaszek, Jamie; Sorrentino, Brian P.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale, Memphis, TN USA; [Pounds, Stanley B.; Shi, Lei; Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Smith, Malcolm A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD USA; [Auvil, Jaime Guidry; Gerhard, Daniela S.] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Winick, Naomi J.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Heerema, Nyla A.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Raetz, Elizabeth] Univ Utah, Dept Pediat, Huntsman Canc Inst, Salt Lake City, UT USA; [Raetz, Elizabeth] Univ Utah, Primary Childrens Hosp, Salt Lake City, UT USA; [Devidas, Meenakshi] Univ Florida, Coll Med, Dept Biostat, Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Willman, Cheryl L.; Harvey, Richard C.] Univ New Mexico, Canc Res & Treatment Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Carroll, William L.] NYU, Med Ctr, Perlmutter Canc Ctr, Dept Pediat, New York, NY 10016 USA; [Dunsmore, Kimberly P.] Univ Virginia, Ctr Hlth Sci, Charlottesville, VA USA; [Winter, Stuart S.] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA; [Wood, Brent L.] Seattle Canc Care Alliance, Seattle, WA USA; [Loh, Mignon L.] Univ Calif San Francisco, Benioff Childrens Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Hunger, Stephen P.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Univ Penn, Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida; University of New Mexico; New York University; University of Virginia; University of New Mexico; Seattle Cancer Care Alliance; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Zhang, JH (corresponding author), St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale, Memphis, TN USA.; Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Hunger, SP (corresponding author), Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.; Hunger, SP (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA.; Hunger, SP (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	hungers@email.chop.edu; jinghui.zhang@stjude.org; charles.mullighan@stjude.org	Mullighan, Charles/H-3253-2011; Cheng, Cheng/N-8075-2018; Wang, Zhaoming/R-5527-2018; Devidas, Meenakshi/H-1170-2019; Zhang, Jing/GWZ-7332-2022; Rusch, Michael/AAG-1998-2019; Downing, James R./N-8102-2018; Relling, Mary/N-5032-2018; McCastlain, Kelly/O-3366-2018; Pounds, Stanley B/N-2480-2018	Mullighan, Charles/0000-0002-1871-1850; Wang, Zhaoming/0000-0001-7556-3869; Devidas, Meenakshi/0000-0002-1099-3478; Rusch, Michael/0000-0002-5363-1848; McCastlain, Kelly/0000-0001-7868-3049; Pounds, Stanley B/0000-0002-9167-2114; Harvey, Richard/0000-0002-4904-9767; Loh, Mignon/0000-0003-4099-4700; Dunsmore, Kimberly/0000-0002-6631-5174; Liu, Yu/0000-0001-8928-2558; Smith, Malcolm/0000-0001-9880-9876; Easton, John/0000-0003-4503-6608	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; St. Baldrick's Foundation; National Cancer Institute [P30 CA021765, U01 CA157937, U10 CA98543, U10 CA98413, U24 CA114766, R35 CA197695, HHSN261200800001E]; NATIONAL CANCER INSTITUTE [U01CA157937, P30CA016058, R35CA197695, U10CA098543, U24CA114766, U10CA098413, P30CA021765, RC2CA148529, U10CA180899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115279] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); St. Baldrick's Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Genome Sequencing Facility, Hartwell Center for Bioinformatics and Biotechnology, and flow cytometry and cell sorting core facility of St. Jude Children's Research Hospital. MSCV-IRES-YFP retroviral vector was provided by G. Grosveld. (St. Jude Children's Research Hospital, Memphis, Tennessee, USA) OP9-DL1 stromal cells were a gift from J.C. Zuniga-Pflucker (University of Toronto, Toronto, Ontario, Canada). This work was supported in part by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, St. Baldrick's Foundation (Scholar Award to C.G.M.), the National Cancer Institute (grants P30 CA021765 (St. Jude Cancer Center Support Grant), U01 CA157937 (to C.L.W. and S.P.H.), U10 CA98543 (to the Children's Oncology Group (COG); Chair's grant and supplement to support the COG ALL TARGET project), U10 CA98413 (to the COG Statistical Center) and U24 CA114766 (to COG; Specimen Banking), Outstanding Investigator Award R35 CA197695 (to C.G.M.), and Contract No. HHSN261200800001E (to C.G.M.)). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Atak ZK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003997; Bains T, 2012, LEUKEMIA, V26, P2144, DOI 10.1038/leu.2012.74; Balgobind BV, 2008, BLOOD, V111, P4322, DOI 10.1182/blood-2007-06-095075; Bandapalli OR, 2014, HAEMATOLOGICA, V99, pE188, DOI 10.3324/haematol.2014.104992; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; ERIKSON J, 1986, SCIENCE, V232, P884, DOI 10.1126/science.3486470; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Galloway A, 2016, SCIENCE, V352, P453, DOI 10.1126/science.aad5978; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HEBERT J, 1994, BLOOD, V84, P4038, DOI 10.1182/blood.V84.12.4038.bloodjournal84124038; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Inukai T, 2012, BRIT J HAEMATOL, V156, P358, DOI 10.1111/j.1365-2141.2011.08955.x; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Kontro M, 2014, LEUKEMIA, V28, P1738, DOI 10.1038/leu.2014.89; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mansour MR, 2007, CLIN CANCER RES, V13, P6964, DOI 10.1158/1078-0432.CCR-07-1474; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nagel S, 2003, CANCER RES, V63, P5329; Navarro JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7094; Neumann M, 2013, ONCOTARGET, V4, P954, DOI 10.18632/oncotarget.1106; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; R Development Core Team, 2009, R LANG ENV STAT COMP; Remke M, 2009, BLOOD, V114, P1053, DOI 10.1182/blood-2008-10-186536; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Treanor LM, 2014, J EXP MED, V211, P701, DOI 10.1084/jem.20122727; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; Van Limbergen H, 2001, GENE CHROMOSOME CANC, V30, P274, DOI 10.1002/1098-2264(2000)9999:9999<1::AID-GCC1089>3.3.CO;2-T; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vicente C, 2015, HAEMATOLOGICA, V100, P1301, DOI 10.3324/haematol.2015.130179; Wang JJ, 2000, P NATL ACAD SCI USA, V97, P3497, DOI 10.1073/pnas.97.7.3497; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Winter SS, 2015, PEDIATR BLOOD CANCER, V62, P1176, DOI 10.1002/pbc.25470; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111; Ye M, 2015, ONCOTARGET, V6, P34718, DOI 10.18632/oncotarget.5303; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhou X, 2016, NAT GENET, V48, P4, DOI 10.1038/ng.3466	79	445	454	12	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2017	49	8					1211	+		10.1038/ng.3909	http://dx.doi.org/10.1038/ng.3909			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FB8OI	28671688	Green Accepted			2022-12-17	WOS:000406397900011
J	Gudbjartsson, DF; Helgason, H; Gudjonsson, SA; Zink, F; Oddson, A; Gylfason, A; Besenbacher, S; Magnusson, G; Halldorsson, BV; Hjartarson, E; Sigurdsson, GT; Stacey, SN; Frigge, ML; Holm, H; Saemundsdottir, J; Helgadottir, HT; Johannsdottir, H; Sigfusson, G; Thorgeirsson, G; Sverrisson, JT; Gretarsdottir, S; Walters, GB; Rafnar, T; Thjodleifsson, B; Bjornsson, ES; Olafsson, S; Thorarinsdottir, H; Steingrimsdottir, T; Gudmundsdottir, TS; Theodors, A; Jonasson, JG; Sigurdsson, A; Bjornsdottir, G; Jonsson, JJ; Thorarensen, O; Ludvigsson, P; Gudbjartsson, H; Eyjolfsson, GI; Sigurdardottir, O; Olafsson, I; Arnar, DO; Magnusson, OT; Kong, A; Masson, G; Thorsteinsdottir, U; Helgason, A; Sulem, P; Stefansson, K				Gudbjartsson, Daniel F.; Helgason, Hannes; Gudjonsson, Sigurjon A.; Zink, Florian; Oddson, Asmundur; Gylfason, Arnaldur; Besenbacher, Soren; Magnusson, Gisli; Halldorsson, Bjarni V.; Hjartarson, Eirikur; Sigurdsson, Gunnar Th; Stacey, Simon N.; Frigge, Michael L.; Holm, Hilma; Saemundsdottir, Jona; Helgadottir, Hafdis Th; Johannsdottir, Hrefna; Sigfusson, Gunnlaugur; Thorgeirsson, Gudmundur; Sverrisson, Jon Th; Gretarsdottir, Solveig; Walters, G. Bragi; Rafnar, Thorunn; Thjodleifsson, Bjarni; Bjornsson, Einar S.; Olafsson, Sigurdur; Thorarinsdottir, Hildur; Steingrimsdottir, Thora; Gudmundsdottir, Thora S.; Theodors, Asgeir; Jonasson, Jon G.; Sigurdsson, Asgeir; Bjornsdottir, Gyda; Jonsson, Jon J.; Thorarensen, Olafur; Ludvigsson, Petur; Gudbjartsson, Hakon; Eyjolfsson, Gudmundur I.; Sigurdardottir, Olof; Olafsson, Isleifur; Arnar, David O.; Magnusson, Olafur Th; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Helgason, Agnar; Sulem, Patrick; Stefansson, Kari			Large-scale whole-genome sequencing of the Icelandic population	NATURE GENETICS			English	Article							VAN-LAERE-SYNDROME; GENETIC-VARIATION; LOW-FREQUENCY; HIGH-RISK; INTRAHEPATIC CHOLESTASIS; ATRIAL-FIBRILLATION; FUNCTIONAL IMPACT; PONTOBULBAR PALSY; WIDE ASSOCIATION; CODING VARIANTS	Here we describe the insights gained from sequencing the whole genomes of 2,636 Icelanders to a median depth of 20x. We found 20 million SNPs and 1.5 million insertions-deletions (indels). We describe the density and frequency spectra of sequence variants in relation to their functional annotation, gene position, pathway and conservation score. We demonstrate an excess of homozygosity and rare protein-coding variants in Iceland. We imputed these variants into 104,220 individuals down to a minor allele frequency of 0.1% and found a recessive frameshift mutation in MYL4 that causes early-onset atrial fibrillation, several mutations in ABCB4 that increase risk of liver diseases and an intronic variant in GNAS associating with increased thyroid-stimulating hormone levels when maternally inherited. These data provide a study design that can be used to determine how variation in the sequence of the human genome gives rise to human diversity.	[Gudbjartsson, Daniel F.; Helgason, Hannes; Gudjonsson, Sigurjon A.; Zink, Florian; Oddson, Asmundur; Gylfason, Arnaldur; Magnusson, Gisli; Halldorsson, Bjarni V.; Hjartarson, Eirikur; Sigurdsson, Gunnar Th; Stacey, Simon N.; Frigge, Michael L.; Holm, Hilma; Saemundsdottir, Jona; Helgadottir, Hafdis Th; Johannsdottir, Hrefna; Gretarsdottir, Solveig; Walters, G. Bragi; Rafnar, Thorunn; Sigurdsson, Asgeir; Bjornsdottir, Gyda; Gudbjartsson, Hakon; Magnusson, Olafur Th; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Helgason, Agnar; Sulem, Patrick; Stefansson, Kari] Amgen Inc, DeCODE Genet, Reykjavik, Iceland; [Gudbjartsson, Daniel F.; Helgason, Hannes; Gudbjartsson, Hakon; Kong, Augustine] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Besenbacher, Soren] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Halldorsson, Bjarni V.] Reykjavik Univ, Inst Biomed & Neural Engn, Reykjavik, Iceland; [Holm, Hilma] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Sigfusson, Gunnlaugur] Landspitali Univ Hosp, Childrens Hosp, Reykjavik, Iceland; [Thorgeirsson, Gudmundur; Thjodleifsson, Bjarni; Arnar, David O.] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Thorgeirsson, Gudmundur; Bjornsson, Einar S.; Olafsson, Sigurdur; Steingrimsdottir, Thora; Jonasson, Jon G.; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Sverrisson, Jon Th] Akureyri Hosp, Dept Internal Med, Akureyri, Iceland; [Bjornsson, Einar S.; Olafsson, Sigurdur; Thorarinsdottir, Hildur; Theodors, Asgeir] Landspitali Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Reykjavik, Iceland; [Steingrimsdottir, Thora; Gudmundsdottir, Thora S.] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Jonasson, Jon G.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Jonasson, Jon G.] Iceland Canc Registry, Reykjavik, Iceland; [Jonsson, Jon J.] Univ Iceland, Dept Biochem & Mol Biol, Fac Med, Reykjavik, Iceland; [Jonsson, Jon J.] Landspitali Univ Hosp, Dept Genet & Mol Med, Reykjavik, Iceland; [Thorarensen, Olafur; Ludvigsson, Petur] Landspitali Univ Hosp, Childrens Hosp Reykjavik, Sect Child Neurol, Dept Pediat, Reykjavik, Iceland; [Eyjolfsson, Gudmundur I.] Iceland Med Ctr Laeknasetrid, Lab Mjodd RAM, Reykjavik, Iceland; [Sigurdardottir, Olof] Akureyri Hosp, Dept Clin Biochem, Akureyri, Iceland; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland	University of Iceland; Aarhus University; Reykjavik University; Mayo Clinic; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland	Gudbjartsson, DF (corresponding author), Amgen Inc, DeCODE Genet, Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019	Helgason, Agnar/0000-0002-8545-3767; Oddsson, Asmundur/0000-0002-4606-5163; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Jonasson, Jon G./0000-0002-2635-5032; Halldorsson, Bjarni/0000-0003-0756-0767; Kong, Augustine/0000-0001-8193-5438; Helgadottir, Hafdis/0000-0003-4352-152X; Besenbacher, Soren/0000-0003-1455-1738; Bjornsdottir, Gyda/0000-0002-8100-0306	Villum Fonden [00007278] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z; Chan WM, 2011, HUM MOL GENET, V20, P1738, DOI 10.1093/hmg/ddr049; Chen FC, 2007, GENOME RES, V17, P16, DOI 10.1101/gr.5429606; Ciccolella M, 2013, J MED GENET, V50, P104, DOI 10.1136/jmedgenet-2012-101204; COHENHAGUENAUER O, 1989, HUM GENET, V81, P278, DOI 10.1007/BF00279004; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; da Silva FP, 2011, J NEUROL SCI, V300, P155, DOI 10.1016/j.jns.2010.10.010; Dakhil FO, 2010, AMYOTROPH LATERAL SC, V11, P397, DOI 10.3109/17482960903440775; Davit-Spraul A, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-1; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006; Gudbjartsson DF, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.11; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Haack TB, 2012, J INHERIT METAB DIS, V35, P943, DOI 10.1007/s10545-012-9513-y; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Johnson JO, 2012, BRAIN, V135, P2875, DOI 10.1093/brain/aws161; Johnson JO, 2010, AM J HUM GENET, V87, P567, DOI 10.1016/j.ajhg.2010.05.021; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lombaert A, 1976, Acta Neurol Belg, V76, P309; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mayr E., 1942, SYSTEMATICS ORIGIN S; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Nicolaou M, 2012, J PATHOL, V226, P300, DOI 10.1002/path.3019; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rotowski J., 1953, EDIN MED J, V60, P281; Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; STROHMAN RC, 1983, SCIENCE, V221, P955, DOI 10.1126/science.6879193; Stubbs Andrew, 2012, J Clin Bioinforma, V2, P19, DOI 10.1186/2043-9113-2-19; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; van Bogaert L., 1929, J NEUROL PSYCHIAT, V6, P380; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Zavolan M, 2006, CURR OPIN STRUC BIOL, V16, P362, DOI 10.1016/j.sbi.2006.05.002	79	445	451	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					435	U20		10.1038/ng.3247	http://dx.doi.org/10.1038/ng.3247			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25807286				2022-12-17	WOS:000353635800004
J	Toprak, E; Veres, A; Michel, JB; Chait, R; Hartl, DL; Kishony, R				Toprak, Erdal; Veres, Adrian; Michel, Jean-Baptiste; Chait, Remy; Hartl, Daniel L.; Kishony, Roy			Evolutionary paths to antibiotic resistance under dynamically sustained drug selection	NATURE GENETICS			English	Article							RIBOSOMAL-RNA GENE; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; CONTINUOUS-CULTURE; TETRACYCLINE RESISTANCE; PARALLEL EVOLUTION; MUTATIONS; EPIDEMIOLOGY; ARCHITECTURE; BACTERIA	Antibiotic resistance can evolve through the sequential accumulation of multiple mutations(1). To study such gradual evolution, we developed a selection device, the 'morbidostat', that continuously monitors bacterial growth and dynamically regulates drug concentrations, such that the evolving population is constantly challenged(2-5). We analyzed the evolution of resistance in Escherichia coli under selection with single drugs, including chloramphenicol, doxycycline and trimethoprim. Over a period of similar to 20 days, resistance levels increased dramatically, with parallel populations showing similar phenotypic trajectories. Whole-genome sequencing of the evolved strains identified mutations both specific to resistance to a particular drug and shared in resistance to multiple drugs. Chloramphenicol and doxycycline resistance evolved smoothly through diverse combinations of mutations in genes involved in translation, transcription and transport(3). In contrast, trimethoprim resistance evolved in a stepwise manner(1,6), through mutations restricted to the gene encoding the enzyme dihydrofolate reductase (DHFR)(7,8). Sequencing of DHFR over the time course of the experiment showed that parallel populations evolved similar mutations and acquired them in a similar order(9).	[Toprak, Erdal; Michel, Jean-Baptiste; Chait, Remy; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Veres, Adrian] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Michel, Jean-Baptiste] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA.	roy_kishony@hms.harvard.edu	Toprak, Erdal/P-6340-2014; Michel, Jean-Baptiste/AAH-9336-2020	Chait, Remy/0000-0003-0876-3187; Veres, Adrian/0000-0002-3849-3475	US National Institutes of Health [GM081617, GM079536]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases [AI057159]; Foundational Questions in Evolutionary Biology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617, R01GM079536] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundational Questions in Evolutionary Biology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Baym, S. Bershtein, T. Bollenbach, M. Ernebjerg, Y. Gerardin, J. Horn, A. Kocabas, C. Kocabas, D. Landgraf, R. Milo, B. Okumus, A. Palmer, J. M. Pedraza, M. Shuman, I. Wapinski, R. Ward, P. Yeh and all members of the Kishony laboratory for technical help and discussions. This work was supported in part by grants from the US National Institutes of Health (GM081617 to R. K. and GM079536 to D. L. H.) and The New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (AI057159 to R. K.). J.-B.M. is supported by a Foundational Questions in Evolutionary Biology Fellowship.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Asako H, 1997, APPL ENVIRON MICROB, V63, P1428, DOI 10.1128/AEM.63.4.1428-1433.1997; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Bull AT, 2010, J IND MICROBIOL BIOT, V37, P993, DOI 10.1007/s10295-010-0816-4; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Crandall KA, 1999, MOL BIOL EVOL, V16, P372, DOI 10.1093/oxfordjournals.molbev.a026118; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; DEMEREC M, 1945, P NATL ACAD SCI USA, V31, P16, DOI 10.1073/pnas.31.1.16; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; ETTAYEBI M, 1985, J BACTERIOL, V162, P551, DOI 10.1128/JB.162.2.551-557.1985; FLENSBURG J, 1987, EUR J BIOCHEM, V162, P473, DOI 10.1111/j.1432-1033.1987.tb10664.x; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Gerrits MM, 2003, ANTIMICROB AGENTS CH, V47, P2984, DOI 10.1128/AAC.47.9.2984-2986.2003; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; HUOVINEN P, 1987, ANTIMICROB AGENTS CH, V31, P1451, DOI 10.1128/AAC.31.10.1451; Lane PG, 1999, BIOTECHNOL PROGR, V15, P1115, DOI 10.1021/bp990084j; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MANKIN AS, 1992, P NATL ACAD SCI USA, V89, P6535, DOI 10.1073/pnas.89.14.6535; MATTHEWS DA, 1977, SCIENCE, V197, P452, DOI 10.1126/science.17920; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Ohmae E, 2001, J BIOCHEM-TOKYO, V130, P439, DOI 10.1093/oxfordjournals.jbchem.a003004; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Paalme T, 1997, ANTON LEEUW INT J G, V71, P217, DOI 10.1023/A:1000198404007; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Ross JI, 1998, ANTIMICROB AGENTS CH, V42, P1702, DOI 10.1128/AAC.42.7.1702; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; SMITH DR, 1982, MOL GEN GENET, V187, P72, DOI 10.1007/BF00384386; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Watson M, 2007, FEBS J, V274, P2661, DOI 10.1111/j.1742-4658.2007.05801.x; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Yee YC, 1996, J ANTIMICROB CHEMOTH, V38, P133, DOI 10.1093/jac/38.1.133; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	48	445	467	1	201	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					101	U140		10.1038/ng.1034	http://dx.doi.org/10.1038/ng.1034			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22179135	Green Accepted			2022-12-17	WOS:000298664000022
J	Ge, H; Liu, ZH; Church, GM; Vidal, M				Ge, H; Liu, ZH; Church, GM; Vidal, M			Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae	NATURE GENETICS			English	Article							EXPRESSION; GENOMES; YEAST	Genomic and proteomic approaches can provide hypotheses concerning function for the large number of genes predicted from genome sequences(1-5). Because of the artificial nature of the assays, however, the information from these high-throughput approaches should be considered with caution. Although it is possible that more meaningful hypotheses could be formulated by integrating the data from various functional genomic and proteomic projects(6), it has yet to be seen to what extent the data can be correlated and how such integration can be achieved. We developed a 'transcriptome-interactome correlation mapping' strategy to compare the interactions between proteins encoded by genes that belong to common expression-profiling clusters with those between proteins encoded by genes that belong to different clusters. Using this strategy with currently available data sets for Saccharomyces cerevisiae, we provide the first global evidence that genes with similar expression profiles are more likely to encode interacting proteins. We show how this correlation between transcriptome and interactome data can be used to improve the quality of hypotheses based on the information from both approaches. The strategy described here may help to integrate other functional genomic and proteomic data, both in yeast and in higher organisms.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER; NHGRI NIH HHS [1 RO1 HG01715-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hartigan J.A., 1975, CLUSTERING ALGORITHM; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Kumar A, 2001, NAT REV GENET, V2, P302, DOI 10.1038/35066084; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Padilla PA, 1998, J BACTERIOL, V180, P5718, DOI 10.1128/JB.180.21.5718-5726.1998; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Sternberg PW, 2001, CELL, V105, P173, DOI 10.1016/S0092-8674(01)00308-7; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107	18	445	468	2	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					482	486		10.1038/ng776	http://dx.doi.org/10.1038/ng776			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694880				2022-12-17	WOS:000172507500027
J	GAYTHER, SA; WARREN, W; MAZOYER, S; RUSSELL, PA; HARRINGTON, PA; CHIANO, M; SEAL, S; HAMOUDI, R; VANRENSBURG, EJ; DUNNING, AM; LOVE, R; EVANS, G; EASTON, D; CLAYTON, D; STRATTON, MR; PONDER, BAJ				GAYTHER, SA; WARREN, W; MAZOYER, S; RUSSELL, PA; HARRINGTON, PA; CHIANO, M; SEAL, S; HAMOUDI, R; VANRENSBURG, EJ; DUNNING, AM; LOVE, R; EVANS, G; EASTON, D; CLAYTON, D; STRATTON, MR; PONDER, BAJ			GERMLINE MUTATIONS OF THE BRCA1 GENE IN BREAST AND OVARIAN-CANCER FAMILIES PROVIDE EVIDENCE FOR A GENOTYPE-PHENOTYPE CORRELATION	NATURE GENETICS			English	Article								Mutations in the BRCA1 gene, discovered in 1994, are associated with an 80-90% lifetime risk of breast cancer. We have analysed 60 families with a history of breast and/or ovarian cancer for germline mutations in BRCA1. Twenty-two different mutations were detected in 32 families (53%), of which 14 are previously unreported. We observed a significant correlation between the location of the mutation in the gene and the ratio of breast to ovarian cancer incidence within each family. Our data suggest a transition in risk such that mutations in the 3' third of the gene are associated with a lower proportion of ovarian cancer. Haplotype analysis supports previous data which suggest some BRCA1 mutation carriers have common ancestors; however, we have found at least two examples where recurrent mutations appear to have arisen independently.	INST CANC RES,HADDOW LABS,MOLEC CARCINOGENESIS SECT,SUTTON SM2 5NG,SURREY,ENGLAND; INST PUBL HLTH,MRC,BIOSTAT UNIT,CAMBRIDGE CB2 2SR,ENGLAND; UNIV PRETORIA,DEPT HUMAN GENET,PRETORIA 0001,SOUTH AFRICA; CANC PREVENT PROGRAMME,MADISON,WI 53706; ST MARYS HOSP,REG GENET SERV,MANCHESTER M13 0JH,LANCS,ENGLAND; INST PUBL HLTH,DEPT COMMUNITY MED,CAMBRIDGE CB2 2SR,ENGLAND	University of London; Institute of Cancer Research - UK; MRC Biostatistics Unit; University of Cambridge; University of Pretoria; University of Manchester; University of Cambridge	GAYTHER, SA (corresponding author), ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,BOX 238,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.		van Rensburg, Elizabeth J./B-9104-2011; Mazoyer, Sylvie/N-7559-2017; Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; van Rensburg, Elizabeth/0000-0003-2077-230X; Dunning, Alison Margaret/0000-0001-6651-7166; Mazoyer, Sylvie/0000-0002-2135-0160; Hamoudi, Rifat/0000-0002-1402-0868				BEAUDET AL, 1989, HUM MUT, V2, P245; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P718; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; NEUHAUSEN SL, 1995, HUM MOL GENET, V3, P1919; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; STEICHENGERSDOR.E, 1994, AM J HUM GENET, V55, P870; STREUWING JP, 1995, NAT GENET, V11, P198; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; TONIN P, 1995, AM J HUM GENET, V57, P189; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	21	445	455	1	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					428	433		10.1038/ng1295-428	http://dx.doi.org/10.1038/ng1295-428			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493024				2022-12-17	WOS:A1995TH62900021
J	KURATA, N; NAGAMURA, Y; YAMAMOTO, K; HARUSHIMA, Y; SUE, N; WU, J; ANTONIO, BA; SHOMURA, A; SHIMIZU, T; LIN, SY; INOUE, T; FUKUDA, A; SHIMANO, T; KUBOKI, Y; TOYAMA, T; MIYAMOTO, Y; KIRIHARA, T; HAYASAKA, K; MIYAO, A; MONNA, L; ZHONG, HS; TAMURA, Y; WANG, ZX; MOMMA, T; UMEHARA, Y; YANO, M; SASAKI, T; MINOBE, Y				KURATA, N; NAGAMURA, Y; YAMAMOTO, K; HARUSHIMA, Y; SUE, N; WU, J; ANTONIO, BA; SHOMURA, A; SHIMIZU, T; LIN, SY; INOUE, T; FUKUDA, A; SHIMANO, T; KUBOKI, Y; TOYAMA, T; MIYAMOTO, Y; KIRIHARA, T; HAYASAKA, K; MIYAO, A; MONNA, L; ZHONG, HS; TAMURA, Y; WANG, ZX; MOMMA, T; UMEHARA, Y; YANO, M; SASAKI, T; MINOBE, Y			A 300 KILOBASE INTERVAL GENETIC-MAP OF RICE INCLUDING 883 EXPRESSED SEQUENCES	NATURE GENETICS			English	Article							LINKAGE MAPS; GENOMES; DNA	We have constructed a high resolution rice genetic map containing 1,383 DNA markers at an average interval of 300 kilobases (kb). The markers, distributed along 1,575 cM on 12 linkage groups, comprise 883 cDNAs, 265 genomic DNAs, 147 randomly amplified polymorphic DNAs (RAPD) and 88 other DNAs. cDNAs were derived from rice root and callus, analysed by single-run sequencing and searched for similarities with known proteins. Nearly 260 rice genes are newly identified and mapped, and genomic DNA and cloned RAPD fragments were also sequenced to generate STSs. Our map is the first significant gene expression map in plants. It is also the densest genetic map available in plants and the first to be backed up comprehensively by clone sequence data.	AICHI KEN AGR RES CTR, NAGAKUTE, AICHI 48011, JAPAN; WAKAYAMA AGR EXPT STN, WAKAYAMA 64004, JAPAN; IBARAKI AGR CTR, INST PLANT BIOTECHNOL, IWAMA, IBARAKI 31902, JAPAN; MIYAGI PREFECTURAL FURUKAWA AGR EXPT STN, FURUKAWA, MIYAGI, JAPAN		KURATA, N (corresponding author), NATL INST AGROBIOL RESOURCES, INST SOC TECHNOINNOVAT AGR FORESTRY & FISHERIES, TSUKUBA, IBARAKI 305, JAPAN.		Miyao, Akio/V-7306-2019; Ding, Cheng-Qiang/B-6287-2011	Miyao, Akio/0000-0002-2822-2866; 				AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Ashikawa I, 1994, DNA Res, V1, P67, DOI 10.1093/dnares/1.2.67; BURR B, 1993, GENETIC MAPS; DEVOS KM, 1992, OUTLOOK AGR, V22, P93; INOUE T, IN PRESS THEOR APPL; Kinoshita T., 1990, RICE GENET NEWSLETT, V7, P16; KURATA N, 1994, BIO-TECHNOL, V12, P276, DOI 10.1038/nbt0394-276; KURATA N, 1993, RICE GENET NEWS, V9, P130; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MACKILL DJ, 1993, THEOR APPL GENET, V85, P536, DOI 10.1007/BF00220910; MOCHIZUKI K, 1992, JPN J GENET, V67, P155, DOI 10.1266/jjg.67.155; MOHAN M, 1994, THEOR APPL GENET, V87, P782, DOI 10.1007/BF00221129; Monna L, 1994, DNA Res, V1, P139, DOI 10.1093/dnares/1.3.139; MOORE G, 1993, BIO-TECHNOL, V11, P584, DOI 10.1038/nbt0593-584; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; RONALD PC, 1991, RICE GENET NEWSL, V8, P142; SAITO A, 1991, JPN J BREED, V41, P665; SASAKI T, 1994, PLANT J, V6, P615, DOI 10.1046/j.1365-313X.1994.6040615.x; STEPHENS JC, 1992, GENETIC MAPS; TANKSLEY SD, 1992, GENETICS, V132, P1141; TANKSLEY SD, 1993, GENETIC MAPS; UMEDA M, 1991, JPN J GENET, V66, P569, DOI 10.1266/jjg.66.569; UMEHARA Y, IN PRESS PLANT BREED; Xiao J., 1992, RICE GENET NEWSL, V9, P124; 1993, PLANT MOL BIOL REPOR, V11, P291	26	445	499	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					365	372		10.1038/ng1294-365	http://dx.doi.org/10.1038/ng1294-365			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894488				2022-12-17	WOS:A1994PV68200018
J	Smith, JJ; Kuraku, S; Holt, C; Sauka-Spengler, T; Jiang, N; Campbell, MS; Yandell, MD; Manousaki, T; Meyer, A; Bloom, OE; Morgan, JR; Buxbaum, JD; Sachidanandam, R; Sims, C; Garruss, AS; Cook, M; Krumlauf, R; Wiedemann, LM; Sower, SA; Decatur, WA; Hall, JA; Amemiya, CT; Saha, NR; Buckley, KM; Rast, JP; Das, S; Hirano, M; McCurley, N; Guo, P; Rohner, N; Tabin, CJ; Piccinelli, P; Elgar, G; Ruffier, M; Aken, BL; Searle, SMJ; Muffato, M; Pignatelli, M; Herrero, J; Jones, M; Brown, CT; Chung-Davidson, YW; Nanlohy, KG; Libants, SV; Yeh, CY; McCauley, DW; Langeland, JA; Pancer, Z; Fritzsch, B; de Jong, PJ; Zhu, BL; Fulton, LL; Theising, B; Flicek, P; Bronner, ME; Warren, WC; Clifton, SW; Wilson, RK; Li, WM				Smith, Jeramiah J.; Kuraku, Shigehiro; Holt, Carson; Sauka-Spengler, Tatjana; Jiang, Ning; Campbell, Michael S.; Yandell, Mark D.; Manousaki, Tereza; Meyer, Axel; Bloom, Ona E.; Morgan, Jennifer R.; Buxbaum, Joseph D.; Sachidanandam, Ravi; Sims, Carrie; Garruss, Alexander S.; Cook, Malcolm; Krumlauf, Robb; Wiedemann, Leanne M.; Sower, Stacia A.; Decatur, Wayne A.; Hall, Jeffrey A.; Amemiya, Chris T.; Saha, Nil R.; Buckley, Katherine M.; Rast, Jonathan P.; Das, Sabyasachi; Hirano, Masayuki; McCurley, Nathanael; Guo, Peng; Rohner, Nicolas; Tabin, Clifford J.; Piccinelli, Paul; Elgar, Greg; Ruffier, Magali; Aken, Bronwen L.; Searle, Stephen M. J.; Muffato, Matthieu; Pignatelli, Miguel; Herrero, Javier; Jones, Matthew; Brown, C. Titus; Chung-Davidson, Yu-Wen; Nanlohy, Kaben G.; Libants, Scot V.; Yeh, Chu-Yin; McCauley, David W.; Langeland, James A.; Pancer, Zeev; Fritzsch, Bernd; de Jong, Pieter J.; Zhu, Baoli; Fulton, Lucinda L.; Theising, Brenda; Flicek, Paul; Bronner, Marianne E.; Warren, Wesley C.; Clifton, Sandra W.; Wilson, Richard K.; Li, Weiming			Sequencing of the sea lamprey (Petromyzon marinus) genome provides insights into vertebrate evolution	NATURE GENETICS			English	Article							LIMB; SHH; PERSPECTIVES; EXPRESSION; HAGFISH; FAMILY; MYELIN; FIN	Lampreys are representatives of an ancient vertebrate lineage that diverged from our own similar to 500 million years ago. By virtue of this deeply shared ancestry, the sea lamprey (P. marinus) genome is uniquely poised to provide insight into the ancestry of vertebrate genomes and the underlying principles of vertebrate biology. Here, we present the first lamprey whole-genome sequence and assembly. We note challenges faced owing to its high content of repetitive elements and GC bases, as well as the absence of broad-scale sequence information from closely related species. Analyses of the assembly indicate that two whole-genome duplications likely occurred before the divergence of ancestral lamprey and gnathostome lineages. Moreover, the results help define key evolutionary events within vertebrate lineages, including the origin of myelin-associated proteins and the development of appendages. The lamprey genome provides an important resource for reconstructing vertebrate origins and the evolutionary events that have shaped the genomes of extant organisms.	[Smith, Jeramiah J.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Smith, Jeramiah J.; Amemiya, Chris T.; Saha, Nil R.] Virginia Mason, Benaroya Res Inst, Seattle, WA USA; [Kuraku, Shigehiro] RIKEN, Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo, Japan; [Kuraku, Shigehiro; Manousaki, Tereza; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany; [Holt, Carson; Campbell, Michael S.; Yandell, Mark D.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Sauka-Spengler, Tatjana; Jones, Matthew; Bronner, Marianne E.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Bloom, Ona E.] Feinstein Inst Med Res, Manhasset, NY USA; [Bloom, Ona E.] Hofstra North Shore Long Isl Jewish LIJ, Sch Med, Hempstead, NY USA; [Morgan, Jennifer R.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Buxbaum, Joseph D.; Sachidanandam, Ravi] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Sims, Carrie; Garruss, Alexander S.; Cook, Malcolm; Krumlauf, Robb; Wiedemann, Leanne M.] Stowers Inst Med Res, Kansas City, MO USA; [Krumlauf, Robb] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA; [Wiedemann, Leanne M.] Univ Kansas, Sch Med, Dept Pathol & Lab Med, Kansas City, KS USA; [Sower, Stacia A.; Decatur, Wayne A.; Hall, Jeffrey A.] Univ New Hampshire, Ctr Mol & Comparat Endocrinol, Durham, NH 03824 USA; [Amemiya, Chris T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Buckley, Katherine M.; Rast, Jonathan P.] Univ Toronto, Dept Immunol, Sunnybrook Res Inst, Toronto, ON, Canada; [Buckley, Katherine M.; Rast, Jonathan P.] Univ Toronto, Dept Med Biophys, Sunnybrook Res Inst, Toronto, ON, Canada; [Das, Sabyasachi; Hirano, Masayuki; McCurley, Nathanael; Guo, Peng] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Das, Sabyasachi; Hirano, Masayuki; McCurley, Nathanael; Guo, Peng] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Rohner, Nicolas; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Piccinelli, Paul; Elgar, Greg] Natl Inst Med Res, MRC, London NW7 1AA, England; [Ruffier, Magali; Aken, Bronwen L.; Searle, Stephen M. J.] Wellcome Trust Sanger Inst, Cambridge, England; [Muffato, Matthieu; Pignatelli, Miguel; Herrero, Javier; Flicek, Paul] European Bioinformat Inst, Cambridge, England; [Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Brown, C. Titus] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Chung-Davidson, Yu-Wen; Nanlohy, Kaben G.; Libants, Scot V.; Yeh, Chu-Yin; Li, Weiming] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [McCauley, David W.] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; [Langeland, James A.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49007 USA; [Pancer, Zeev] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [de Jong, Pieter J.; Zhu, Baoli] Childrens Hosp Oakland, Oakland, CA USA; [Fulton, Lucinda L.; Theising, Brenda; Warren, Wesley C.; Clifton, Sandra W.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	University of Kentucky; Benaroya Research Institute; Virginia Mason Medical Center; RIKEN; University of Konstanz; Utah System of Higher Education; University of Utah; California Institute of Technology; Michigan State University; Northwell Health; Hofstra University; Marine Biological Laboratory - Woods Hole; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University System Of New Hampshire; University of New Hampshire; University of Washington; University of Washington Seattle; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Emory University; Emory University; Harvard University; Harvard Medical School; MRC National Institute for Medical Research; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Michigan State University; Michigan State University; Michigan State University; University of Oklahoma System; University of Oklahoma - Norman; Kalamazoo College; University System of Maryland; University of Maryland Baltimore; University of Iowa; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Washington University (WUSTL)	Li, WM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	jjsmit3@uky.edu; liweim@msu.edu	Chung-Davidson, Yu-Wen/L-6161-2019; sachidanandam, ravi/Q-6916-2019; Herrero, Javier/H-6971-2019; Li, Weiming/D-9615-2013; Buxbaum, Joseph D/G-6001-2010; Meyer, Axel/C-9826-2009; Krumlauf, Robb/AAH-5012-2019; Buckley, Katherine Michele/AAY-8151-2021; Kuraku, Shigehiro/B-2801-2009; Jiang, Ning/G-6546-2012; Wilson, Richard K./AAF-4139-2019	Chung-Davidson, Yu-Wen/0000-0001-5784-2653; sachidanandam, ravi/0000-0001-9844-4459; Herrero, Javier/0000-0001-7313-717X; Li, Weiming/0000-0001-5437-1518; Meyer, Axel/0000-0002-0888-8193; Krumlauf, Robb/0000-0001-9102-7927; Buckley, Katherine Michele/0000-0002-6585-8943; Kuraku, Shigehiro/0000-0003-1464-8388; Wilson, Richard K./0000-0002-1992-1358; Cook, Malcolm/0000-0002-2825-9183; Rohner, Nicolas/0000-0003-3248-2772; Nanlohy, Kaben/0000-0003-3752-7968; Fritzsch, Bernd/0000-0002-4882-8398; Brown, C. Titus/0000-0001-6001-2677; Smith, Jeramiah/0000-0001-5333-5531; Muffato, Matthieu/0000-0002-7860-3560; Bronner, Marianne/0000-0003-4274-1862; Das, Sabyasachi/0000-0002-9116-9623; Ruffier, Magali/0000-0002-8386-1580; Buxbaum, Joseph/0000-0001-8898-8313; Aken, Bronwen/0000-0002-3032-4095; Flicek, Paul/0000-0002-3897-7955; Wiedemann, Leanne/0000-0002-0964-4676; Decatur, Wayne/0000-0002-6961-7514; BLOOM, ONA/0000-0002-8340-2392; Elgar, Greg/0000-0001-7323-1596; Sauka-Spengler, Tatjana/0000-0001-9289-0263	National Human Genome Research Institute [U54HG003079]; US National Institutes of Health [F32GM087919, T32HG00035, DE017911, R03NS078519, R01HG004694, GM079492, GM090049, RR014085, R37HD032443]; National Science Foundation [MCB-0719558, IOS-0849569]; New Hampshire Agricultural Experiment Station [2471]; Charles Evans Research Award; Wellcome Trust [WT095908, WT098051]; Canadian Institutes of Health Research [MOP74667]; Natural Sciences and Engineering Research Council of Canada [312221];  [R24GM83982]; MRC [MC_U117597141] Funding Source: UKRI; Medical Research Council [MC_U117597141] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR014085] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004694, U54HG003079, T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM079492, R24GM095471, R24GM083982, R01GM100151, R01GM090049, T32GM007464, F32GM087919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078165, R01NS086907, R03NS078519] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); New Hampshire Agricultural Experiment Station; Charles Evans Research Award; Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Genome Institute, Washington University School of Medicine, Production Sequencing group for all sample procurement and genome sequencing work, the Michigan State University Genomic Core for transcriptome sequencing and the US Geological Survey, Lake Huron Biological Station for providing lamprey samples for sequencing. We thank F. Antonacci and E.E. Eichler (University of Washington) for performing FISH and providing access to computational facilities, respectively. We thank M. Robinson for bioinformatic analysis of immune system related genes and conversion of GFF files for BAC end mapping. A portion of this research was conducted at the Marine Biological Laboratory (Woods Hole, Massachusetts). We acknowledge the support of the Stowers Institute for Medical Research (SIMR) and technical support from the SIMR Molecular Biology Core, particularly K. Staehling, A. Perera and K. Delventhal for BAC screening and sequencing. We acknowledge the Center for High-Performance Computing at the University of Utah for the allocation of computational resources toward gene annotation. We recognize all the important work that could not be cited owing to space limitations. The lamprey genome project was funded by the National Human Genome Research Institute (U54HG003079 (R.K.W.)). Additional support was provided by grants from the US National Institutes of Health (R24GM83982 (W.L.)) and the Great Lakes Fisheries commission (W.L.). Partial funding was provided by several additional sources, including grants from the US National Institutes of Health (F32GM087919 and T32HG00035 (J.J.S.); DE017911 (M.E.B.); R03NS078519 (O.E.B.); R01HG004694 (M.D.Y.); GM079492, GM090049 and RR014085 (C.T.A.); and R37HD032443 (C.J.T.)), the National Science Foundation (MCB-0719558 (C.T.A.); IOS-0849569 (S.A.S.); IBN-0208138 (L. Holland); and IOS-1126998 (M.D.Y.)), the New Hampshire Agricultural Experiment Station (Scientific Contribution Number 2471 (S.A.S.)), the Charles Evans Research Award (O.E.B., J.D.B. and J.R.M.), the Wellcome Trust (WT095908 (P.F.) and WT098051), the Canadian Institutes of Health Research (MOP74667 (J.P.R.)) and the Natural Sciences and Engineering Research Council of Canada (312221 (J.P.R.)).	BULLOCK TH, 1984, NEUROSCI LETT, V48, P145, DOI 10.1016/0304-3940(84)90010-7; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Gould RM, 2005, BIOL BULL-US, V209, P49, DOI 10.2307/3593141; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Nikitina N., 2009, EMERGING MODEL ORGAN, V1, P405; Nikitina N, 2008, P NATL ACAD SCI USA, V105, P20083, DOI 10.1073/pnas.0806009105; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Saha NR, 2010, SEMIN IMMUNOL, V22, P25, DOI 10.1016/j.smim.2009.12.002; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Smith JJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-219; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Woolfe A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-100	27	444	460	0	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					415	421		10.1038/ng.2568	http://dx.doi.org/10.1038/ng.2568			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435085	Green Accepted, hybrid, Green Published			2022-12-17	WOS:000316840600012
J	Girirajan, S; Rosenfeld, JA; Cooper, GM; Antonacci, F; Siswara, P; Itsara, A; Vives, L; Walsh, T; McCarthy, SE; Baker, C; Mefford, HC; Kidd, JM; Browning, SR; Browning, BL; Dickel, DE; Levy, DL; Ballif, BC; Platky, K; Farber, DM; Gowans, GC; Wetherbee, JJ; Asamoah, A; Weaver, DD; Mark, PR; Dickerson, J; Garg, BP; Ellingwood, SA; Smith, R; Banks, VC; Smith, W; McDonald, MT; Hoo, JJ; French, BN; Hudson, C; Johnson, JP; Ozmore, JR; Moeschler, JB; Surti, U; Escobar, LF; El-Khechen, D; Gorski, JL; Kussmann, J; Salbert, B; Lacassie, Y; Biser, A; McDonald-McGinn, DM; Zackai, EH; Deardorff, MA; Shaikh, TH; Haan, E; Friend, KL; Fichera, M; Romano, C; Gecz, J; DeLisi, LE; Sebat, J; King, MC; Shaffer, LG; Eichler, EE				Girirajan, Santhosh; Rosenfeld, Jill A.; Cooper, Gregory M.; Antonacci, Francesca; Siswara, Priscillia; Itsara, Andy; Vives, Laura; Walsh, Tom; McCarthy, Shane E.; Baker, Carl; Mefford, Heather C.; Kidd, Jeffrey M.; Browning, Sharon R.; Browning, Brian L.; Dickel, Diane E.; Levy, Deborah L.; Ballif, Blake C.; Platky, Kathryn; Farber, Darren M.; Gowans, Gordon C.; Wetherbee, Jessica J.; Asamoah, Alexander; Weaver, David D.; Mark, Paul R.; Dickerson, Jennifer; Garg, Bhuwan P.; Ellingwood, Sara A.; Smith, Rosemarie; Banks, Valerie C.; Smith, Wendy; McDonald, Marie T.; Hoo, Joe J.; French, Beatrice N.; Hudson, Cindy; Johnson, John P.; Ozmore, Jillian R.; Moeschler, John B.; Surti, Urvashi; Escobar, Luis F.; El-Khechen, Dima; Gorski, Jerome L.; Kussmann, Jennifer; Salbert, Bonnie; Lacassie, Yves; Biser, Alisha; McDonald-McGinn, Donna M.; Zackai, Elaine H.; Deardorff, Matthew A.; Shaikh, Tamim H.; Haan, Eric; Friend, Kathryn L.; Fichera, Marco; Romano, Corrado; Gecz, Jozef; DeLisi, Lynn E.; Sebat, Jonathan; King, Mary-Claire; Shaffer, Lisa G.; Eichler, Evan E.			A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATIONS; COMORBID SCHIZOPHRENIA; CHROMOSOMAL IMBALANCE; LEARNING-DISABILITY; MENTAL-RETARDATION; DELETION SYNDROME; INCREASE RISK; COSTA-RICA; ARRAY CGH	We report the identification of a recurrent, 520-kb 16p12.1 microdeletion associated with childhood developmental delay. The microdeletion was detected in 20 of 11,873 cases compared with 2 of 8,540 controls (P = 0.0009, OR = 7.2) and replicated in a second series of 22 of 9,254 cases compared with 6 of 6,299 controls (P = 0.028, OR = 2.5). Most deletions were inherited, with carrier parents likely to manifest neuropsychiatric phenotypes compared to non-carrier parents (P = 0.037, OR = 6). Probands were more likely to carry an additional large copy-number variant when compared to matched controls (10 of 42 cases, P = 5.7 x 10(-5), OR = 6.6). The clinical features of individuals with two mutations were distinct from and/or more severe than those of individuals carrying only the co-occurring mutation. Our data support a two-hit model in which the 16p12.1 microdeletion both predisposes to neuropsychiatric phenotypes as a single event and exacerbates neurodevelopmental phenotypes in association with other large deletions or duplications. Analysis of other microdeletions with variable expressivity indicates that this two-hit model might be more generally applicable to neuropsychiatric disease.	[Girirajan, Santhosh; Cooper, Gregory M.; Antonacci, Francesca; Siswara, Priscillia; Itsara, Andy; Vives, Laura; Baker, Carl; Mefford, Heather C.; Kidd, Jeffrey M.; Dickel, Diane E.; King, Mary-Claire; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] Signature Genom Labs, Spokane, WA USA; [Walsh, Tom; King, Mary-Claire] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [McCarthy, Shane E.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Browning, Sharon R.; Browning, Brian L.] Univ Auckland, Dept Stat, Fac Sci, Auckland 1, New Zealand; [Levy, Deborah L.] McLean Hosp, Psychol Res Lab, Belmont, MA 02178 USA; [Levy, Deborah L.; DeLisi, Lynn E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Platky, Kathryn; Gowans, Gordon C.; Wetherbee, Jessica J.; Asamoah, Alexander] Univ Louisville, Dept Pediat, Weisskopf Child Evaluat Ctr, Louisville, KY 40292 USA; [Farber, Darren M.] Univ Louisville, Sch Med, Dept Neurol, Div Child Neurol, Louisville, KY 40292 USA; [Weaver, David D.; Mark, Paul R.] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Dickerson, Jennifer; Garg, Bhuwan P.] Indiana Univ, Sch Med, Dept Neurol, Div Pediat Neurol, Indianapolis, IN 46202 USA; [Ellingwood, Sara A.; Smith, Rosemarie; Banks, Valerie C.; Smith, Wendy] Maine Med Ctr, Div Genet, Portland, ME 04102 USA; [McDonald, Marie T.] Duke Univ, Med Ctr, Div Med Genet, Durham, NC USA; [Hoo, Joe J.; French, Beatrice N.] Univ Toledo, Coll Med, Dept Pediat, Toledo, OH 43606 USA; [Hoo, Joe J.; French, Beatrice N.] NW Ohio Reg Genet Ctr, Toledo, OH USA; [Hudson, Cindy; Johnson, John P.] Shodair Childrens Hosp, Helena, MT USA; [Ozmore, Jillian R.; Moeschler, John B.] Dartmouth Hitchcock Med Ctr, Div Clin Genet, Lebanon, NH 03766 USA; [Surti, Urvashi] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA; [Escobar, Luis F.; El-Khechen, Dima] St Vincent Childrens Hosp, Med Genet & Neurodev Ctr, Indianapolis, IN USA; [Gorski, Jerome L.; Kussmann, Jennifer] Univ Missouri, Div Med Genet, Columbia, MO USA; [Salbert, Bonnie] Geisinger Med Ctr, Danville, PA 17822 USA; [Lacassie, Yves] Louisiana State Univ, Hlth Sci Ctr, Div Genet, Dept Pediat, New Orleans, LA USA; [Lacassie, Yves] Childrens Hosp, New Orleans, LA USA; [Biser, Alisha; McDonald-McGinn, Donna M.; Zackai, Elaine H.; Deardorff, Matthew A.; Shaikh, Tamim H.] Univ Penn, Dept Pediat & Genet, Philadelphia, PA 19104 USA; [Biser, Alisha; McDonald-McGinn, Donna M.; Zackai, Elaine H.; Deardorff, Matthew A.; Shaikh, Tamim H.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Haan, Eric] S Australian Pathol Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA, Australia; [Haan, Eric; Gecz, Jozef] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Fichera, Marco; Romano, Corrado] Oasi Inst Res & Care Mental Retardat & Brain Ag, Troina, Italy; [DeLisi, Lynn E.] VA Boston Healthcare Syst, Brockton, MA USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cold Spring Harbor Laboratory; University of Auckland; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; University of Louisville; University of Louisville; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Maine Medical Center; Duke University; University System of Ohio; University of Toledo; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Missouri System; University of Missouri Columbia; Geisinger Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Adelaide; IRCCS Oasi Maria SS; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Cooper, Gregory/D-6914-2011; Mark, Paul/AAK-2153-2020; Browning, Brian L/A-1178-2010; Romano, Corrado/B-9695-2008; Antonacci, Francesca/F-5457-2013; McDonald-McGinn, Donna/L-8643-2019; Fichera, Marco/K-9220-2016; Browning, Sharon/B-1530-2008; Gecz, Jozef/X-3469-2019	Cooper, Gregory/0000-0001-5509-9923; Browning, Brian L/0000-0001-6454-6633; Romano, Corrado/0000-0003-1049-0683; Antonacci, Francesca/0000-0002-5833-6186; Fichera, Marco/0000-0002-8225-6880; Browning, Sharon/0000-0001-7251-9715; Gecz, Jozef/0000-0002-7884-6861; Sebat, Jonathan/0000-0002-9087-526X; McDonald-McGinn, Donna/0000-0003-4077-250X; Mark, Paul R./0000-0002-1020-888X; Walsh, Tom/0000-0002-8875-0310; Dickel, Diane/0000-0001-5497-6824; King, Mary-Claire/0000-0001-9426-1743; Kidd, Jeffrey/0000-0002-9631-1465	National Institute on Aging, National Heart, Lung, and Blood Institute, National Institutes of Health; Department of Health and Human Services; NIH [HD065285]; Simons Foundation [SFARI 137578]; NARSAD Award; Merck, Jane Coffin Childs Memorial Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institute on Aging, National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH National Institute on Aging (NIA)); Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NARSAD Award(NARSAD); Merck, Jane Coffin Childs Memorial Fund(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the subjects and their families for participating in this study. We thank M. Whyte for providing cardiological evaluation (for case SG07). We thank A. Singleton, L. Ferrucci and R. Krauss for sharing the control CNV data generated with support from the Intramural Research Program of the National Institute on Aging, National Heart, Lung, and Blood Institute (PARC project), and the National Institutes of Health, Department of Health and Human Services. For the schizophrenia study, genotyping of samples was also provided through the genetic association information network (GAIN). Samples and associated phenotype data for the genome-wide association of schizophrenia study were provided by the Molecular Genetics of Schizophrenia Collaboration (principal investigator: P. V. Gejman, Evanston Northwestern Healthcare (ENH) and Northwestern University, Evanston, Illinois, USA). We also thank J. Smith for SNP genotyping; T. Louie for bioinformatics support; C. Campbell, L. Perez-Jurado, G. Kirov, M. K. Rudd and C. Lese-Martin for useful discussions; and T. Brown, P. Sudmant and J. Kitzman for critical review of the manuscript. This work was supported by NIH grant HD065285 (E. E. E.), a grant from the Simons Foundation (SFARI 137578 to E. E. E.) and a NARSAD Award (M.-C. K.). G. M. C. is supported by a Merck, Jane Coffin Childs Memorial Fund post-doctoral fellowship. E. E. E. is an investigator of the Howard Hughes Medical Institute.	Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; DeLisi LE, 2001, PSYCHIATR GENET, V11, P145, DOI 10.1097/00041444-200109000-00006; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Eichler EE, 2001, J HERED, V92, P462, DOI 10.1093/jhered/92.6.462; Feenstra I, 2006, EUR J MED GENET, V49, P279, DOI 10.1016/j.ejmg.2005.10.131; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LINDGREN V, 1992, AM J HUM GENET, V50, P988; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Mao X, 2003, GENE CHROMOSOME CANC, V37, P176, DOI 10.1002/gcc.10184; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Moorhead TWJ, 2004, NEUROIMAGE, V22, P188, DOI 10.1016/j.neuroimage.2003.12.012; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Sanderson TL, 1999, LANCET, V354, P1867, DOI 10.1016/S0140-6736(99)01049-1; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; TURNER TH, 1989, PSYCHOL MED, V19, P301, DOI 10.1017/S0033291700012344; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	46	444	454	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					203	U24		10.1038/ng.534	http://dx.doi.org/10.1038/ng.534			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20154674	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000274912400007
J	Wu, LZ; Aster, JC; Blacklow, SC; Lake, R; Artavanis-Tsakonas, S; Griffin, JD				Wu, LZ; Aster, JC; Blacklow, SC; Lake, R; Artavanis-Tsakonas, S; Griffin, JD			MAML1, a human homologue of Drosophila Mastermind, is a transcriptional co-activator for NOTCH receptors	NATURE GENETICS			English	Article							NEUROGENIC LOCUS MASTERMIND; CREB BINDING-PROTEIN; SIGNAL-TRANSDUCTION; PATHWAY; LOCALIZATION; MELANOGASTER; REGULATOR; COMPLEX; DOMAIN; DELTEX	Notch receptors are involved in cell-fate determination in organisms as diverse as flies, frogs and humans'. In Drosophila melanogaster, loss-of-function mutations of Notch produce a 'neurogenic' phenotype in which cells destined to become epidermis switch fate and differentiate to neural cells. Upon ligand activation, the intracellular domain of Notch (ICN) translocates to the nucleus', and interacts directly with the DNA-binding protein Suppressor of hairless (Su(H)) in flies, or recombination signal binding protein J kappa (RBP-J kappa) in mammals(3), to activate gene transcription(4). But the precise mechanisms of Notch-induced gene expression are not completely understood. The gene mastermind has been identified in multiple genetic screens for modifiers of Notch mutations in Drosophila(5-8). Here we clone MAML1, a human homologue of the Drosophila gene Mastermind, and show that it encodes a protein of 130 kD localizing to nuclear bodies. MAML1 binds to the ankyrin repeat domain of all four mammalian NOTCH receptors, forms a DNA-binding complex with ICN and RBP-J kappa and amplifies NOTCH-induced transcription of HES1. These studies provide a molecular mechanism to explain the genetic links between mastermind and Notch in Drosophila and indicate that MAML1 functions as a transcriptional co-activator for NOTCH signalling.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Griffin, JD (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.	james_griffin@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [T32CA009362, R01CA082308] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061001] Funding Source: NIH RePORTER; NCI NIH HHS [CA82308, CA09362] Funding Source: Medline; NHLBI NIH HHS [HL61001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ASTER J, 1994, COLD SPRING HARB SYM, V59, P125, DOI 10.1101/SQB.1994.059.01.016; Aster JC, 1997, J BIOL CHEM, V272, P11336; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Go MJ, 1998, GENETICS, V150, P211; HAWLEY RG, 1994, GENE THER, V1, P136; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; PETTIT GR, 1996, J CHEM SOC P1, V8, P859; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Rebay Ilaria, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1097; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; YEDVOBNICK B, 1988, GENETICS, V118, P483; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	28	444	477	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					484	489		10.1038/82644	http://dx.doi.org/10.1038/82644			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101851				2022-12-17	WOS:000165671700026
J	Cossette, P; Liu, LD; Brisebois, K; Dong, HH; Lortie, A; Vanasse, M; Saint-Hilaire, JM; Carmant, L; Verner, A; Lu, WY; Wang, YT; Rouleau, GA				Cossette, P; Liu, LD; Brisebois, K; Dong, HH; Lortie, A; Vanasse, M; Saint-Hilaire, JM; Carmant, L; Verner, A; Lu, WY; Wang, YT; Rouleau, GA			Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy	NATURE GENETICS			English	Article							NEURONAL SODIUM-CHANNEL; FEBRILE SEIZURES PLUS; GENERALIZED EPILEPSY; GABA(A) RECEPTORS; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; CHROMOSOME-6; CHILDHOOD; GENE; GAMMA-2-SUBUNIT	Although many genes that predispose for epilepsy in humans have been determined, those that underlie the classical syndromes of idiopathic generalized epilepsy (IGE) have yet to be identified. We report that an Ala322Asp mutation in GABRA1, encoding the alpha1 subunit of the gamma-aminobutyric acid receptor subtype A (GABA(A)), is found in affected individuals of a large French Canadian family with juvenile myoclonic epilepsy. Compared with wildtype receptors, GABA(A) receptors that contain the mutant subunit show a lesser amplitude of GABA-activated currents in vitro, indicating that seizures may result from loss of function of this inhibitory ligand-gated channel. Our results confirm that mutation of GABRA1 predisposes towards a common idiopathic generalized epilepsy syndrome in humans.	McGill Univ, Ctr Hlth, Inst Res, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Vancouver Hosp, Res Ctr, Dept Med & Brain, Vancouver, BC, Canada; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; Univ Toronto, Dept Physiol, Toronto, ON, Canada; Hop St Justine, Neurol Serv, Montreal, PQ, Canada; Univ Montreal, Ctr Hosp, Hop Notre Dame, Serv Neurol, Montreal, PQ, Canada; McGill Univ, Montreal Gen Hosp, Montreal Genome Ctr, Montreal, PQ, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Universite de Montreal; Universite de Montreal; McGill University	Rouleau, GA (corresponding author), McGill Univ, Ctr Hlth, Inst Res, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.		Lu, Wei-Yang/K-4404-2013; Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Liu, Lidong/0000-0002-7026-690X				ANNEGERS JF, 1982, NEUROLOGY, V32, P174, DOI 10.1212/WNL.32.2.174; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; BERKOVIC SF, 1987, NEUROLOGY, V37, P993, DOI 10.1212/WNL.37.6.993; DOOSE H, 1973, NEUROPADIATRIE, V4, P162, DOI 10.1055/s-0028-1091737; EEGOLOFSSON O, 1971, NEUROPADIATRIE, V2, P375, DOI 10.1055/s-0028-1091791; Elmslie FV, 1996, AM J HUM GENET, V59, P653; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; GENTON P, 1994, IDIOPATHIC GEN EPILE, pCH22; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; JANZ D, 1997, EPILEPSY COMPREHENSI, V3, pCH228; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lu WY, 1998, J PHYSIOL-LONDON, V512, P29, DOI 10.1111/j.1469-7793.1998.029bf.x; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; PANAYIOTOPOULOS CP, 1989, ANN NEUROL, V25, P440, DOI 10.1002/ana.410250504; Picard F, 2000, BRAIN, V123, P1247, DOI 10.1093/brain/123.6.1247; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; Wolfe B. E., 1992, J PSYCHOTHERAPY INTE, V2, P29; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs	30	443	466	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					184	189		10.1038/ng885	http://dx.doi.org/10.1038/ng885			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	11992121				2022-12-17	WOS:000175903500016
J	Withers, DJ; Burks, DJ; Towery, HH; Altamuro, SL; Flint, CL; White, ME				Withers, DJ; Burks, DJ; Towery, HH; Altamuro, SL; Flint, CL; White, ME			Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling	NATURE GENETICS			English	Article							FACTOR-I RECEPTOR; ENDOCRINE PANCREAS; GROWTH-FACTORS; MICE; GENE; SUBSTRATE-2; EXPRESSION; APOPTOSIS; PHOSPHORYLATION; RAT	Insulin receptor substrates (Irs proteins) mediate the pleiotropic effects of insulin and Igf-l (insulin-like growth factor-1), including regulation of glucose homeostasis and cell growth and survival. We intercrossed mice heterozygous for two null alleles (Irs1(+/-) and Irs2(+/-)) and investigated growth and glucose metabolism in mice with viable genotypes. Our experiments revealed that Irs-1 and Irs-2 are critical for embryonic and post-natal growth, with Irs-l having the predominant role. By contrast, both Irs-l and Irs-2 function in peripheral carbohydrate metabolism, but Irs-2 has the major role in beta-cell development and compensation for peripheral insulin resistance. To establish a role for the Igf-l receptor in beta-cells, we intercrossed mice heterozygous for null alleles of Igf1r and Irs2. Our results reveal that Igf-l receptors promote beta-cell development and survival through the Irs-2 signalling pathway. Thus, Irs-2 integrates the effects of insulin in peripheral target tissues with Igf-l in pancreatic beta-cells to maintain glucose homeostasis.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	White, ME (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	morris.white@joslin.harvard.edu	Withers, Dominic J/D-7671-2014	Withers, Dominic J/0000-0002-8009-7521	NIDDK NIH HHS [DK43808] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043808] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BASERGA R, 1994, CELL, V79, P927, DOI 10.1016/0092-8674(94)90023-X; Bernal D, 1998, DIABETES, V47, P976, DOI 10.2337/diabetes.47.6.976; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; GUZ Y, 1995, DEVELOPMENT, V121, P11; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LeRoith D, 1997, ENDOCRINE, V7, P103, DOI 10.1007/BF02778074; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; SawkaVerhelle D, 1997, J BIOL CHEM, V272, P16414, DOI 10.1074/jbc.272.26.16414; SCAGLIA L, 1995, ENDOCRINOLOGY, V136, P5461, DOI 10.1210/en.136.12.5461; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Sharma S, 1997, MOL CELL BIOL, V17, P2598, DOI 10.1128/MCB.17.5.2598; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1992, J BIOL CHEM, V267, P22662; SWENNE I, 1992, DIABETOLOGIA, V35, P193, DOI 10.1007/BF00400917; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Vaisse C, 1997, DIABETES, V46, P1364, DOI 10.2337/diabetes.46.8.1364; Valentinis, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105; Velloso LA, 1995, FEBS LETT, V377, P353, DOI 10.1016/0014-5793(95)01370-9; WHITEHEAD M, 1994, I C S S, V8, P1; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074; Yenush L, 1998, MOL CELL BIOL, V18, P6784, DOI 10.1128/MCB.18.11.6784	36	443	465	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1999	23	1					32	40		10.1038/12631	http://dx.doi.org/10.1038/12631			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471495				2022-12-17	WOS:000082337300012
J	Munier, FL; Korvatska, E; Djemai, A; LePaslier, D; Zografos, L; Pescia, G; Schorderet, DF				Munier, FL; Korvatska, E; Djemai, A; LePaslier, D; Zografos, L; Pescia, G; Schorderet, DF			Kerato-epithelin mutations in four 5q31-linked corneal dystrophies	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; SEQUENCE-ANALYSIS; REIS-BUCKLERS; FASCICLIN-I; PROTEIN; BETA-IG-H3; CHROMOSOME-5Q; DEPOSITS; CLONING; CDNA	Granular dystrophy Groenouw type I (CDGG1), Reis-Bucklers (CDL1), lattice type I (CDL1) and Avellino (ACD) are four 5q31-linked human autosomal dominant corneal dystrophies. Clinically, they show progressive opacification of the cornea leading to severe visual handicap. The nature of the deposits remains unknown in spite of amyloid aetiology ascribed to the last two. We generated a YAC contig of the linked region and, following cDNA selection, recovered the beta ig-h3 gene. In six affected families we identified missense mutations. All detected mutations occurred at the CpG dinucleotide of two arginine codons: R555W in one CDGG1, R555Q in one CDRB, R124C in two CDL1 and R124H in two ACD families. This suggests, as the last two diseases are characterized by amyloid deposits, that R124 mutated kerato-epithelin (the product of beta ig-h3) forms amyloidogenic intermediates that precipitate in the cornea. Our data establish a common molecular origin for the 5q31-linked corneal dystrophies.	CHU VAUDOIS, MOL GENET UNIT, CH-1011 LAUSANNE, SWITZERLAND; HOP JULES GONIN, DEPT OPHTHALMOL, CH-1004 LAUSANNE, SWITZERLAND; CTR ETUD POLYMORPHISME HUMAIN, FDN JEAN DAUSSET, F-75010 PARIS, FRANCE; CHU VAUDOIS, DIV MED GENET, CH-1011 LAUSANNE, SWITZERLAND	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Foundation Jean Dausset-CEPH; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)				Le Paslier, Denis/0000-0003-4335-9956				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BLAKE DJ, 1995, TRENDS BIOCHEM SCI, V20, P133, DOI 10.1016/S0968-0004(00)88986-0; BUCHI ER, 1994, CORNEA, V13, P190; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Eiberg Hans, 1994, European Journal of Human Genetics, V2, P132; ESCRIBANO J, 1994, J CELL PHYSIOL, V160, P511, DOI 10.1002/jcp.1041600314; FOLBERG R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1080, DOI 10.1001/archopht.1994.01090200086027; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; GALLO G, 1988, MODERN PATHOL, V1, P453; GREGORY CY, 1995, J MED GENET, V32, P224, DOI 10.1136/jmg.32.3.224; KLINTWOR.GK, 1967, AM J PATHOL, V50, P371; Korvatska E, 1996, EUR J HUM GENET, V4, P214; KUCHLE M, 1995, CORNEA, V14, P333; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANNIS MJ, 1981, ARCH OPHTHALMOL-CHIC, V99, P1217, DOI 10.1001/archopht.1981.03930020091008; MOLLER HU, 1989, ACTA OPHTHALMOL, V67, P669; MOLLER HU, 1989, ACTA OPHTHALMOL, V67, P678; ROSENWASSER GOD, 1993, ARCH OPHTHALMOL-CHIC, V111, P1546, DOI 10.1001/archopht.1993.01090110112035; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Small KW, 1996, AM J OPHTHALMOL, V121, P384, DOI 10.1016/S0002-9394(14)70434-9; STOCK EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P354, DOI 10.1001/archopht.1991.01080030056038; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	27	443	475	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					247	251		10.1038/ng0397-247	http://dx.doi.org/10.1038/ng0397-247			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054935				2022-12-17	WOS:A1997WK38600012
J	Hacia, JG; Brody, LC; Chee, MS; Fodor, SPA; Collins, FS				Hacia, JG; Brody, LC; Chee, MS; Fodor, SPA; Collins, FS			Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis	NATURE GENETICS			English	Article							OVARIAN-CANCER FAMILIES; BREAST-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; 185DELAG; LINKAGE	The ability to scan a large gene rapidly and accurately for all possible heterozygous mutations in large numbers of patient samples will be critical for the future of medicine. We have designed high-density arrays consisting of over 96,600 oligonucleotides 20-nucleotides (nt) in length to screen for a wide range of heterozygous mutations in the 3.45-kilobases (kb) exon 11 of the hereditary breast and ovarian cancer gene BRCA1. Reference and test samples were co-hybridized to these arrays and differences in hybridization patterns quantitated by two-colour analysis. Fourteen of fifteen patient samples with known mutations were accurately diagnosed, and no false positive mutations were identified in 20 control samples. Eight single nucleotide polymorphisms were also readily detected. DNA chip-based assays may provide a valuable new technology for high-throughput cost-efficient detection of genetic alterations.	NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; AFFYMETRIX,SANTA CLARA,CA 95051	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix								CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.3.CO;2-D; Durocher F, 1996, HUM MOL GENET, V5, P835, DOI 10.1093/hmg/5.6.835; EASTON DF, 1993, AM J HUM GENET, V52, P678; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HOULDSWORTH J, 1994, AM J PATHOL, V145, P1253; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; ROWELL S, 1994, AM J HUM GENET, V55, P861; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TONIN P, 1995, AM J HUM GENET, V57, P189; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913	29	443	597	1	50	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					441	447		10.1038/ng1296-441	http://dx.doi.org/10.1038/ng1296-441			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944024				2022-12-17	WOS:A1996VV73000020
J	JAFFE, HA; DANEL, C; LONGENECKER, G; METZGER, M; SETOGUCHI, Y; ROSENFELD, MA; GANT, TW; THORGEIRSSON, SS; STRATFORDPERRICAUDET, LD; PERRICAUDET, M; PAVIRANI, A; LECOCQ, JP; CRYSTAL, RG				JAFFE, HA; DANEL, C; LONGENECKER, G; METZGER, M; SETOGUCHI, Y; ROSENFELD, MA; GANT, TW; THORGEIRSSON, SS; STRATFORDPERRICAUDET, LD; PERRICAUDET, M; PAVIRANI, A; LECOCQ, JP; CRYSTAL, RG			ADENOVIRUS-MEDIATED INVIVO GENE-TRANSFER AND EXPRESSION IN NORMAL RAT-LIVER	NATURE GENETICS			English	Article							ADULT-RAT; HUMAN ALPHA-1-ANTITRYPSIN; INSITU HYBRIDIZATION; DEFICIENT RABBITS; NUCLEAR-PROTEIN; THERAPY; TRANSPLANTATION; HEPATOCYTES; CELLS; DNA	Replication deficient, recombinant adenovirus (Ad) vectors do not require target cell replication for transfer and expression of exogenous genes and thus may be useful for in vivo gene therapy in hepatocytes. In vitro, primary cultures of rat hepatocytes infected with a recombinant Ad containing a human alpha-1-antitrypsin cDNA (Ad-alpha-1AT) synthesized and secreted human alpha-1AT for 4 weeks. In rats, in vivo intraportal administration of a recombinant Ad containing the E coli lacZ gene, was followed by expression of beta-galactosidase in hepatocytes 3 days after infection. Intraportal infusion of Ad-alpha-1AT produced detectable serum levels of human alpha-1AT for 4 weeks. Thus, targeted gene expression has been achieved in the liver, albeit at low levels, suggesting that adenovirus vectors may be a useful means for in vivo gene therapy in liver disorders.	NHLBI,PULM BRANCH,BETHESDA,MD 20892; INST GUSTAVE ROUSSY,CNRS,UA 1301,F-94805 VILLEJUIF,FRANCE; NCI,EXPTL CARCINOGENESIS LAB,BETHESDA,MD 20892; TRANSGENE SA,F-67082 STRASBOURG,FRANCE	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Transgene SA			Setoguchi, Yasuhiro/AAE-1448-2021	Setoguchi, Yasuhiro/0000-0002-0892-6364; Gant, Timothy/0000-0001-9057-4937				ALLAN FD, 1960, ESSENTIALS HUMAN EMB, P93; AM PH, 1990, NEW ENGL J MED, V322, P1652; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; BERNAUDIN JF, 1988, J IMMUNOL, V140, P3822; Brues AM, 1937, J EXP MED, V65, P15, DOI 10.1084/jem.65.1.15; BRUSILOW SW, 1989, METABOLIC BASIS INHE, P399; CASOLARO MA, 1987, J APPL PHYSIOL, V63, P2015, DOI 10.1152/jappl.1987.63.5.2015; CHANOCK RM, 1966, J AMER MED ASSOC, V195, P445, DOI 10.1001/jama.195.6.445; CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351; CURIEL DT, 1989, J BIOL CHEM, V264, P10477; DANNENBERG AM, 1981, METHODS STUDYING MON, P375; DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FRENCH T, 1989, CLIN CHEM LABORATORY, P213; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GARVER RI, 1987, SCIENCE, V237, P762, DOI 10.1126/science.3497452; GILARDI P, 1990, FEBS LETT, V267, P60, DOI 10.1016/0014-5793(90)80287-S; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRIFFITHS PD, 1990, BRIT MED BULL, V46, P512, DOI 10.1093/oxfordjournals.bmb.a072413; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; HATZOGLOU M, 1990, J BIOL CHEM, V265, P17285; HORWICH AL, 1991, CURR T MICR, V168, P186; HORWITZ MS, 1990, VIROLOGY, P01679; INAGAKI M, 1991, CELL STRUCT FUNCT, V16, P283, DOI 10.1247/csf.16.283; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; JONES SN, 1990, J BIOL CHEM, V265, P14684; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALEKO M, 1991, HUM GENE THER, V2, P27, DOI 10.1089/hum.1991.2.1-27; KANEDA Y, 1989, SCIENCE, V243, P375, DOI 10.1126/science.2911748; KANEDA Y, 1989, J BIOL CHEM, V264, P12126; KATO K, 1991, J BIOL CHEM, V266, P3361; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; LEDLEY FD, 1990, J INHERIT METAB DIS, V13, P597, DOI 10.1007/BF01799515; LONBERGHOLM K, 1969, J VIROL, V4, P323, DOI 10.1128/JVI.4.4.323-338.1969; MILLER AD, 1990, BLOOD, V76, P271; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; PASTAN I, 1986, CONCEPTS VIRAL PATHO, V2, P141; PEARSON B, 1963, LAB INVEST, V12, P1249; PHILIPSON L, 1968, J VIROL, V2, P1064, DOI 10.1128/JVI.2.10.1064-1075.1968; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; SHIMADA T, 1991, FEBS LETT, V279, P198, DOI 10.1016/0014-5793(91)80148-V; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P7128, DOI 10.1073/pnas.80.23.7128; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Strauss SE, 1984, ADENOVIRUSES, P451; VEHAR GA, 1989, METABOLIC BASIS INHE, P2107; WILSON JM, 1990, P NATL ACAD SCI USA, V87, P8437, DOI 10.1073/pnas.87.21.8437; WILSON JM, 1992, J BIOL CHEM, V267, P963; WILSON JM, 1990, MOL BIOL MED, V7, P223; WU CH, 1989, J BIOL CHEM, V264, P16985; WU GY, 1991, J BIOL CHEM, V266, P14338; YAMAMOTO T, 1980, CELL, V22, P787, DOI 10.1016/0092-8674(80)90555-3	59	443	505	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					372	378		10.1038/ng0892-372	http://dx.doi.org/10.1038/ng0892-372			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1302034				2022-12-17	WOS:A1992JJ12100017
J	Parma, P; Radi, O; Vidal, V; Chaboissier, MC; Dellambra, E; Valentini, S; Guerra, L; Schedl, A; Camerino, G				Parma, Pietro; Radi, Orietta; Vidal, Valerie; Chaboissier, Marie Christine; Dellambra, Elena; Valentini, Stella; Guerra, Liliana; Schedl, Andreas; Camerino, Giovanna			R-spondin1 is essential in sex determination, skin differentiation and malignancy	NATURE GENETICS			English	Article							SQUAMOUS-CELL CARCINOMA; PALMOPLANTAR KERATODERMA; HURIEZ-SYNDROME; R-SPONDIN; SOX9; MICE; ASSOCIATION; ACTIVATION; PROTEINS; REVERSAL	R-spondins are a recently characterized small family of growth factors. Here we show that human R-spondin1 (RSPO1) is the gene disrupted in a recessive syndrome characterized by XX sex reversal, palmoplantar hyperkeratosis and predisposition to squamous cell carcinoma of the skin. Our data show, for the first time, that disruption of a single gene can lead to complete female-to-male sex reversal in the absence of the testis-determining gene, SRY.	Univ Pavia, Dipartimento Patol Umana & Ereditaria, Sez Biol Gen & Genet Med, I-27100 Pavia, Italy; Fac Sci, Ctr Biochim, INSERM, U636, F-06108 Nice, France; IRCCS, Ist Dermopat Immacolata, Lab Ingn Tessuti & Fisiopatol Cutanea, I-00167 Rome, Italy	University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Camerino, G (corresponding author), Univ Pavia, Dipartimento Patol Umana & Ereditaria, Sez Biol Gen & Genet Med, Via Forianini 14, I-27100 Pavia, Italy.	camerino@unipv.it	Vidal, Valerie/M-1477-2018; CHABOISSIER, Marie-Christine/AAZ-5905-2021; Guerra, Liliana/G-8849-2016; CHABOISSIER, Marie-Christine/F-6166-2019; Schedl, Andreas/F-8823-2015; Schedl, Andreas/GOP-3427-2022; Dellambra, Elena/A-4005-2014; vidal, valerie/S-2597-2019	CHABOISSIER, Marie-Christine/0000-0003-0934-8217; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Schedl, Andreas/0000-0001-9380-7396; Dellambra, Elena/0000-0002-4329-3312; Parma, Pietro/0000-0003-1544-6673; Guerra, Liliana/0000-0001-6274-6607	Telethon [GGP06252] Funding Source: Medline	Telethon(Fondazione Telethon)		Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Christiano AM, 1997, TRENDS GENET, V13, P227, DOI 10.1016/S0168-9525(97)01104-9; Guerra L, 2003, ARCH DERMATOL, V139, P1303, DOI 10.1001/archderm.139.10.1303; HOGAN B, 1996, MANIPULATING MOUSE E; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Micali G, 2005, J AM ACAD DERMATOL, V53, pS234, DOI 10.1016/j.jaad.2005.02.033; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Radi O, 2005, AM J MED GENET A, V138A, P241, DOI 10.1002/ajmg.a.30935; Riggio E, 2005, PLAST RECONSTR SURG, V116, P689, DOI 10.1097/01.prs.0000175966.01538.73; Ross AJ, 2005, TRENDS ENDOCRIN MET, V16, P19, DOI 10.1016/j.tem.2004.11.004; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Vernole P, 2000, CLIN GENET, V57, P61, DOI 10.1034/j.1399-0004.2000.570109.x; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Yao HHC, 2005, MOL CELL ENDOCRINOL, V230, P87, DOI 10.1016/j.mce.2004.11.003; [No title captured]	26	442	470	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2006	38	11					1304	1309		10.1038/ng1907	http://dx.doi.org/10.1038/ng1907			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041600				2022-12-17	WOS:000241592700019
J	CHUNG, MY; RANUM, LPW; DUVICK, LA; SERVADIO, A; ZOGHBI, HY; ORR, HT				CHUNG, MY; RANUM, LPW; DUVICK, LA; SERVADIO, A; ZOGHBI, HY; ORR, HT			EVIDENCE FOR A MECHANISM PREDISPOSING TO INTERGENERATIONAL CAG REPEAT INSTABILITY IN SPINOCEREBELLAR ATAXIA TYPE-I	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; TRINUCLEOTIDE REPEAT; FRAGILE-X; HEREDITARY ATAXIA; LINKAGE; HLA; GENE; MUTATIONS; KINDREDS; FAMILY	Spinocerebellar ataxia type I (SCAI) is an autosomal dominant neurodegenerative disease caused by the expansion of a CAG trinucleotide repeat on chromosome 6p. Normal alleles range from 19-36 repeats while SCA1 alleles contain 43-81 repeats. We now show that in 63% of paternal transmissions, an increase in repeat number is observed, whereas 69% of maternal transmissions showed no change or a decrease in repeat number. Sequence analysis of the repeat from 126 chromosomes reveals an interrupted repeat configuration in 98% of the unexpanded alleles but a contiguous repeat (CAG)n configuration in 30 expanded alleles from seven SCA1 families. This indicates that the repeat instability in SCA1 is more complex than a simple variation in repeat number and that the loss of an interruption predisposes the SCA1 (CAG)n to expansion.	UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; UNIV MINNESOTA, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities				Zoghbi, Huda/0000-0002-0700-3349; Chung, Ming-yi/0000-0003-2198-6860; Orr, Harry/0000-0001-6118-741X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R01NS027699, R37NS022920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, IN PRESS MAPPING CLO; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WHITTINGTON JE, 1980, CYTOGENET CELL GENET, V28, P145, DOI 10.1159/000131524; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	26	442	455	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					254	258		10.1038/ng1193-254	http://dx.doi.org/10.1038/ng1193-254			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275090				2022-12-17	WOS:A1993MF12200015
J	Graham, RR; Cotsapas, C; Davies, L; Hackett, R; Lessard, CJ; Leon, JM; Burtt, NP; Guiducci, C; Parkin, M; Gates, C; Plenge, RM; Behrens, TW; Wither, JE; Rioux, JD; Fortin, PR; Graham, DC; Wong, AK; Vyse, TJ; Daly, MJ; Altshuler, D; Moser, KL; Gaffney, PM				Graham, Robert R.; Cotsapas, Chris; Davies, Leela; Hackett, Rachel; Lessard, Christopher J.; Leon, Joanlise M.; Burtt, Noel P.; Guiducci, Candace; Parkin, Melissa; Gates, Casey; Plenge, Robert M.; Behrens, Timothy W.; Wither, Joan E.; Rioux, John D.; Fortin, Paul R.; Graham, Deborah Cunninghame; Wong, Andrew K.; Vyse, Timothy J.; Daly, Mark J.; Altshuler, David; Moser, Kathy L.; Gaffney, Patrick M.			Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							RHEUMATOID-ARTHRITIS; UNITED-STATES; A20; ITGAM; RISK	Systemic lupus erythematosus (SLE) is an autoimmune disease influenced by genetic and environmental factors. We carried out a genome-wide association scan and replication study and found an association between SLE and a variant in TNFAIP3 (rs5029939, meta-analysis P = 2.89 x 10-(12), OR = 2.29). We also found evidence of two independent signals near TNFAIP3 associated with SLE, including one previously associated with rheumatoid arthritis ( RA). These results establish that variants near TNFAIP3 contribute to differential risk of SLE and RA.	[Lessard, Christopher J.; Moser, Kathy L.; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthritis & Immunol Res Program, Oklahoma City, OK 73104 USA; [Graham, Robert R.; Cotsapas, Chris; Davies, Leela; Hackett, Rachel; Burtt, Noel P.; Guiducci, Candace; Parkin, Melissa; Gates, Casey; Plenge, Robert M.; Daly, Mark J.; Altshuler, David] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Cotsapas, Chris; Daly, Mark J.] Harvard Univ, Sch Med, Mass Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cotsapas, Chris; Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Lessard, Christopher J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Leon, Joanlise M.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Wither, Joan E.] Arthritis Ctr Excellence, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Toronto Western Hosp, Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Wither, Joan E.; Fortin, Paul R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rioux, John D.] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Fortin, Paul R.] Univ Hlth Network, Univ Toronto Lupus Clin, Ctr Prognosis Studies Rheumat Dis, Toronto Western Hosp, Toronto, ON, Canada; [Graham, Deborah Cunninghame; Wong, Andrew K.; Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Mol Genet & Rheumatol Sect, London, England	Oklahoma Medical Research Foundation; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; Genentech; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Imperial College London	Gaffney, PM (corresponding author), Oklahoma Med Res Fdn, Arthritis & Immunol Res Program, Oklahoma City, OK 73104 USA.	gaffneyp@lupus.omrf.org	Rioux, John D/A-9599-2015; Daly, Mark J/B-2453-2017; Altshuler, David M/A-4476-2009; Wong, Andrew/M-8899-2016; Wong, Andrew/AAE-6995-2019	Rioux, John D/0000-0001-7560-8326; Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Wong, Andrew/0000-0003-2079-4779; Wong, Andrew/0000-0003-2079-4779; Gaffney, Patrick/0000-0002-1580-869X; Fortin, Paul R./0000-0002-7278-2596; Wither, Joan/0000-0001-5961-9228; Cotsapas, Chris/0000-0002-7772-5910; Lessard, Christopher J./0000-0003-2440-3843	US National Institutes of Health [AI063274, AR052125, AR043247]; NIH NSRA award [5F32AR50927-RRG]; Lupus Foundation of Minnesota; Arthritis Foundation; Wellcome Trust [076113]; ENH/Northwestern University [MH059571]; Emory University School of Medicine [MH59587]; Louisiana State University Health Sciences Center, New Orleans, Louisiana [MH067257]; University of California-Irvine [MH60870]; Washington University, St. Louis [U01, MH060879]; University of Iowa, Iowa [MH59566]; University of Colorado [MH059565]; University of Pennsylvania [MH061675]; University of Queensland [MH059588]; Mt. Sinai School of Medicine [MH59586]; Massachusetts General Hospital [63420]; Canadian Institute of Health Research [CIHR 62840]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063274, R56AI063274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR050927, P30AR053483, R01AR056768, K08AR002105, R01AR043274, R01AR052125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061675, R01MH060870, R01MH059587, R01MH059565, R01MH059588, R01MH060879, R01MH059566, R01MH067257, R01MH059586, R01MH063420, R01MH059571] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NSRA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Foundation of Minnesota; Arthritis Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); ENH/Northwestern University; Emory University School of Medicine; Louisiana State University Health Sciences Center, New Orleans, Louisiana; University of California-Irvine(University of California System); Washington University, St. Louis; University of Iowa, Iowa; University of Colorado; University of Pennsylvania; University of Queensland(University of Queensland); Mt. Sinai School of Medicine; Massachusetts General Hospital(General Electric); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work was obtained from the US National Institutes of Health (grants AI063274 (P. M. G.), AR052125 (P. M. G.) and AR043247 (K. L. M.)), NIH NSRA award (5F32AR50927-RRG), Lupus Foundation of Minnesota (P. M. G., K. L. M.) and the Arthritis Foundation (K. L. M.).; This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. Permission for use of these data was obtained from the oversight committees of the respective cohorts. Control subjects from the National Institute of Mental Health Schizophrenia Genetics Initiative (NIMH-GI), data and biomaterials are being collected by the "Molecular Genetics of Schizophrenia II'' (MGS-2) collaboration. The investigators and co-investigators are as follows: ENH/Northwestern University, MH059571, P. V. Gejman (Collaboration Coordinator; PI), A. R. Sanders; Emory University School of Medicine, MH59587, F. Amin (PI); Louisiana State University Health Sciences Center, New Orleans, Louisiana, MH067257, N. Buccola (PI); University of California-Irvine, MH60870, W. Byerley (PI); Washington University, St. Louis, U01, MH060879, C. R. Cloninger (PI); University of Iowa, Iowa, MH59566, R. Crowe (PI), D. Black; University of Colorado, MH059565, R. Freedman (PI); University of Pennsylvania, MH061675, D. Levinson (PI); University of Queensland, MH059588, B. Mowry (PI); Mt. Sinai School of Medicine, MH59586, J. Silverman (PI). The samples were collected by V. L. Nimgaonkar's group at the University of Pittsburgh, as part of a multi-institutional collaborative research project with J. Smoller and P. Sklar (Massachusetts General Hospital) (grant MH 63420). We thank T. Hudson for helpful discussions, T. McKenzie for coordinating the GenES study, J.O. Claudio for ensuring ethics approval of DNA sample sharing, J. Su for assistance with management of the GenES database and all the CaNIOS investigators that have contributed to GenES. GenES is funded by the Canadian Institute of Health Research (CIHR# 62840).; We thank S. Gabriel and the entire Affymetrix genotyping team at the Broad Institute of Harvard and MIT. We thank F. Kuruvilla, J. Korn and S. McCarroll for assistance with the Birdseed genotype-calling algorithm.; We would also like to acknowledge the research assistants and coordinators that recruited the individuals in the study. Most importantly, we thank the individuals who have participated in and contributed to these studies.	Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; KASLOW RA, 1978, ARTHRITIS RHEUM-US, V21, P473, DOI 10.1002/art.1780210412; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	12	441	452	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1059	1061		10.1038/ng.200	http://dx.doi.org/10.1038/ng.200			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165918	Green Accepted			2022-12-17	WOS:000258761200016
J	Yang, XZ; Smith, SL; Tian, XC; Lewin, HA; Renard, JP; Wakayama, T				Yang, Xiangzhong; Smith, Sadie L.; Tian, X. Cindy; Lewin, Harris A.; Renard, Jean-Paul; Wakayama, Teruhiko			Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; ADULT SOMATIC-CELLS; STEM-CELLS; GENE-EXPRESSION; MITOCHONDRIAL-DNA; IMPRINTED GENES; PREIMPLANTATION EMBRYOS; MAMMALIAN DEVELOPMENT; METHYLATION PATTERNS; ABERRANT	Therapeutic cloning, whereby somatic cell nuclear transfer (SCNT) is used to generate patient-specific embryonic stem cells (ESCs) from blastocysts cloned by nuclear transfer (ntESCs), holds great promise for the treatment of many human diseases. ntESCs have been derived in mice and cattle, but thus far there are no credible reports of human ntESCs. Here we review the recent literature on nuclear reprogramming by SCNT, including studies of gene expression, DNA methylation, chromatin remodeling, genomic imprinting and X chromosome inactivation. Reprogramming of genes expressed in the inner cell mass, from which ntESCs are derived, seems to be highly efficient. Defects in the extraembryonic lineage are probably the major cause of the low success rate of reproductive cloning but are not expected to affect the derivation of ntESCs. We remain optimistic that human therapeutic cloning is achievable and that the derivation of patient-specific ntESC lines will have great potential for regenerative medicine.	Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; INRA, Unite Mixte Rech Biol Dev & Reprod, F-78532 Jouy En Josas, France; RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	University of Connecticut; University of Connecticut; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; INRAE; UDICE-French Research Universities; Universite Paris Saclay; RIKEN	Yang, XZ (corresponding author), Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA.	xiangzhong.yang@uconn.edu	Pillay, Nischalan/F-9536-2012; LEWIN, HARRIS/HGC-6543-2022	LEWIN, HARRIS/0000-0002-1043-7287; Marjani, Sadie/0000-0003-1241-8538				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; BRAMBRINK T, 2006, P NATL ACAD SCI; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chavatte-Palmer P, 2002, BIOL REPROD, V66, P1596, DOI 10.1095/biolreprod66.6.1596; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; Cibelli JB, 1998, NAT BIOTECHNOL, V16, P642, DOI 10.1038/nbt0798-642; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; CIBELLI JB, 2002, PRINCIPLES CLONING; Constant F, 2006, BIOL REPROD, V75, P122, DOI 10.1095/biolreprod.106.051581; Daniels R, 2000, BIOL REPROD, V63, P1034, DOI 10.1095/biolreprod63.4.1034; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Eakin GS, 2003, DEV DYNAM, V228, P751, DOI 10.1002/dvdy.10363; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Enright BP, 2005, BIOL REPROD, V72, P944, DOI 10.1095/biolreprod.104.033225; Evans MJ, 1999, NAT GENET, V23, P90, DOI 10.1038/12696; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Han YM, 2003, THERIOGENOLOGY, V59, P33, DOI 10.1016/S0093-691X(02)01271-2; Hashizume Kazuyoshi, 2002, Cloning and Stem Cells, V4, P197, DOI 10.1089/15362300260339485; Hemberger M, 2002, CYTOGENET GENOME RES, V99, P210, DOI 10.1159/000071595; Hill JR, 2002, BIOL REPROD, V67, P55, DOI 10.1095/biolreprod67.1.55; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Illmensee K, 2006, FERTIL STERIL, V85, P1248, DOI 10.1016/j.fertnstert.2005.10.026; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Iwasaki S, 2000, BIOL REPROD, V62, P470, DOI 10.1095/biolreprod62.2.470; Jouneau A, 2006, DEVELOPMENT, V133, P1597, DOI 10.1242/dev.02317; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kennedy Donald, 2006, Science, V311, P335; Kim HR, 2005, PROTEOMICS, V5, P4264, DOI 10.1002/pmic.200401297; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Koo DB, 2002, BIOL REPROD, V67, P487, DOI 10.1095/biolreprod67.2.487; Kruip TAM, 1997, THERIOGENOLOGY, V47, P43, DOI 10.1016/S0093-691X(96)00338-X; Latham KE, 1999, CURR TOP DEV BIOL, V43, P1; Lee JB, 2006, NATURE, V440, pE2, DOI 10.1038/nature04686; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Monk M, 2001, MOL CELL ENDOCRINOL, V183, pS35, DOI 10.1016/S0303-7207(01)00575-5; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1990, DEVELOPMENT, V110, P815; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pfister-Genskow M, 2005, BIOL REPROD, V72, P546, DOI 10.1095/biolreprod.104.031799; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Scott LA, 2006, CYTOGENET GENOME RES, V112, P261, DOI 10.1159/000089880; Senda S, 2004, BIOCHEM BIOPH RES CO, V321, P38, DOI 10.1016/j.bbrc.2004.06.096; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Somers J, 2006, REPRODUCTION, V131, P1073, DOI 10.1530/rep.1.00967; Steinborn R, 2000, NAT GENET, V25, P255, DOI 10.1038/77000; Suemizu H, 2003, DEV BIOL, V253, P36, DOI 10.1006/dbio.2002.0870; Suteevun T, 2006, J ANIM SCI, V84, P2065, DOI 10.2527/jas.2005-695; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Thorvaldsen JL, 2006, DEV BIOL, V298, P344, DOI 10.1016/j.ydbio.2006.07.011; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; Wakayama S, 2005, J REPROD DEVELOP, V51, P765, DOI 10.1262/jrd.17061; Wakayama S, 2005, BIOL REPROD, V72, P932, DOI 10.1095/biolreprod.104.035105; Wakayama S, 2005, P NATL ACAD SCI USA, V102, P29, DOI 10.1073/pnas.0408548102; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Winger QA, 2000, MOL REPROD DEV, V56, P458, DOI 10.1002/1098-2795(200008)56:4&lt;458::AID-MRD3&gt;3.0.CO;2-L; Wrenzycki C, 2001, BIOL REPROD, V65, P309, DOI 10.1095/biolreprod65.1.309; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yang L, 2005, MOL REPROD DEV, V71, P431, DOI 10.1002/mrd.20311; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/ror.0.0030155; Zhu J, 2002, BIOL REPROD, V66, P635, DOI 10.1095/biolreprod66.3.635; Zuccotti M, 2000, J ENDOCRINOL INVEST, V23, P623, DOI 10.1007/BF03343786	93	441	489	4	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					295	302		10.1038/ng1973	http://dx.doi.org/10.1038/ng1973			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17325680				2022-12-17	WOS:000244480000010
J	Humphries, MM; Rancourt, D; Farrar, GJ; Kenna, P; Hazel, M; Bush, RA; Sieving, PA; Sheils, DM; McNally, N; Creighton, P; Erven, A; Boros, A; Gulya, K; Capecchi, MR; Humphries, P				Humphries, MM; Rancourt, D; Farrar, GJ; Kenna, P; Hazel, M; Bush, RA; Sieving, PA; Sheils, DM; McNally, N; Creighton, P; Erven, A; Boros, A; Gulya, K; Capecchi, MR; Humphries, P			Retinopathy induced in mice by targeted disruption of the rhodopsin gene	NATURE GENETICS			English	Article							SCOTOPIC THRESHOLD RESPONSE; RETINITIS-PIGMENTOSA; B-WAVE; ELECTRORETINOGRAM; ROD; MUTATIONS; SUBUNIT; LIGHT; CELLS; CAT	Retinitis pigmentosa (RP) represents the most common mendelian degenerative retinopathy of man, involving death of rod photoreceptors, cone cell degeneration, retinal vessel attenuation and pigmentary deposits(1,2). The patient experiences night blindness, usually followed by progressive loss of visual field. Genetic linkage between an autosomal dominant RP locus and rhodopsin(3), the photoreactive pigment of the rod cells, led to the identification of mutations within the rhodopsin gene in both dominant and recessive forms of Rp(3-7). To better understand the functional and structural role of rhodopsin in the normal retina and in the pathogenesis of retinal disease, we generated mice carrying a targeted disruption of the rhodopsin gene. Rho(-/-) mice do not elaborate rod outer segments, losing their photoreceptors over 3 months. There is no rod ERG response in 8-week-old animals. Rho(+/-) animals retain the majority of their photoreceptors although the inner and outer segments of these cells display some structural disorganization, the outer segments becoming shorter in older mice. These animals should provide a useful genetic background on which to express other mutant opsin transgenes, as well as a model to assess the therapeutic potential of re-introducing functional rhodopsin genes into degenerating retinal tissues.	UNIV DUBLIN TRINITY COLL,DEPT GENET,WELLCOME OCULAR GENET UNIT,DUBLIN 2,IRELAND; ROYAL VICTORIAN EYE & EAR HOSP,RES FDN,DUBLIN 2,IRELAND; UNIV UTAH,MED CTR,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV MICHIGAN,KELLOGG EYE CTR,ANN ARBOR,MI 48109; ATTILA JOZSEF UNIV,DEPT ZOOL & CELL BIOL,H-6722 SZEGED,HUNGARY	Trinity College Dublin; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; Szeged University			Bateson, Jane Farrar/AAO-6147-2020; Gulya, Karoly/M-7629-2018; Farrar, G Jane/B-9832-2011	Gulya, Karoly/0000-0001-6864-4150; 				Aguilar M., 1954, OPT ACTA, V1, P59, DOI [10.1080/713818657, DOI 10.1080/713818657]; BROWN KT, 1968, VISION RES, V8, P633, DOI 10.1016/0042-6989(68)90041-2; BUSH RA, 1995, INVEST OPHTH VIS SCI, V36, P2054; BUSH RA, 1992, CLIN VISION SCI, V7, P393; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DENG CX, 1993, MOL CELL BIOL, V13, P2134, DOI 10.1128/MCB.13.4.2134; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; GREEN DG, 1994, VISUAL NEUROSCI, V11, P919, DOI 10.1017/S0952523800003874; Heckenlively JR, 1988, RETINITIS PIGMENTOSA, P125; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Sambrook J., 1989, MOL CLONING; SIEVING PA, 1986, J NEUROPHYSIOL, V56, P1049, DOI 10.1152/jn.1986.56.4.1049; SIEVING PA, 1988, INVEST OPHTH VIS SCI, V29, P1608; SIEVING PA, 1991, CLIN VISION SCI, V6, P171; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; STEINBERG RH, 1991, PROGR RETINAL RES, V10; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0	27	441	452	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					216	219		10.1038/ng0297-216	http://dx.doi.org/10.1038/ng0297-216			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020854				2022-12-17	WOS:A1997WF08700028
J	JACOB, HJ; BROWN, DM; BUNKER, RK; DALY, MJ; DZAU, VJ; GOODMAN, A; KOIKE, G; KREN, V; KURTZ, T; LERNMARK, A; LEVAN, G; MAO, YP; PETTERSSON, A; PRAVENEC, M; SIMON, JS; SZPIRER, C; SZPIRER, J; TROLLIET, MR; WINER, ES; LANDER, ES				JACOB, HJ; BROWN, DM; BUNKER, RK; DALY, MJ; DZAU, VJ; GOODMAN, A; KOIKE, G; KREN, V; KURTZ, T; LERNMARK, A; LEVAN, G; MAO, YP; PETTERSSON, A; PRAVENEC, M; SIMON, JS; SZPIRER, C; SZPIRER, J; TROLLIET, MR; WINER, ES; LANDER, ES			A GENETIC-LINKAGE MAP OF THE LABORATORY RAT, RATTUS-NORVEGICUS	NATURE GENETICS			English	Article								We report the construction of the first complete genetic linkage map of the laboratory rat. By testing 1171 simple sequence length polymorphisms (SSLPs), we have identified 432 markers that show polymorphisms between the SHR and BN rat strains and mapped them in a single (SHR x BN) F-2 intercross. The loci define 21 large linkage groups corresponding to the 21 rat chromosomes, together with a pair of nearby markers on chromosome 9 that are not linked to the rest of the map. Because 99.5% of the markers fall into one of the 21 large linkage groups, the maps appear to cover the vast majority of the rat genome. The availability of the map should facilitate whole genome scans for genes underlying qualitative and quantitative traits relevant to mammalian physiology and pathobiology.	MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA USA; STANFORD UNIV, CARDIOVASC RES CTR, PALO ALTO, CA USA; UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA; GOTHENBURG UNIV, GOTHENBURG, SWEDEN; KAROLINSKA INST, DEPT MOLEC MED, STOCKHOLM, SWEDEN; FREE UNIV BRUSSELS, BRUSSELS, BELGIUM; CHARLES UNIV, DEPT BIOL, PRAGUE, CZECH REPUBLIC; ACAD SCI CZECH REPUBL, INST PHYSIOL, PRAGUE, CZECH REPUBLIC; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; University of California System; University of California San Francisco; University of Gothenburg; Karolinska Institutet; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Massachusetts Institute of Technology (MIT)	JACOB, HJ (corresponding author), MASSACHUSETTS GEN HOSP, CARDIOVASC RES CTR, BOSTON, MA USA.		Lernmark, Åke/F-8140-2015; Daly, Mark J/B-2453-2017; Pravenec, Michal/B-1666-2012	Lernmark, Åke/0000-0003-1735-0499; Daly, Mark J/0000-0002-0949-8752; Pravenec, Michal/0000-0001-9197-5871; Brown, Donna/0000-0002-8805-7225				BARGOU RCEF, 1991, GENE, V99, P197, DOI 10.1016/0378-1119(91)90127-W; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; CHING GY, 1991, J BIOL CHEM, V266, P19459; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; COX JL, 1992, GENE, V110, P175, DOI 10.1016/0378-1119(92)90645-6; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P389; DAMBROSIO E, 1986, MOL CELL BIOL, V6, P411, DOI 10.1128/MCB.6.2.411; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; DAS AT, 1993, EUR J BIOCHEM, V211, P795, DOI 10.1111/j.1432-1033.1993.tb17611.x; DEUCHARS KL, 1992, BIOCHIM BIOPHYS ACTA, V1130, P157, DOI 10.1016/0167-4781(92)90523-3; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; GILGOMEZ G, 1993, EUR J BIOCHEM, V213, P773, DOI 10.1111/j.1432-1033.1993.tb17819.x; GOLDMUNTZ EA, 1993, GENOMICS, V16, P761, DOI 10.1006/geno.1993.1261; GREENHOUSE DD, 1990, GENETIC MONITORING I; HOFKER MH, 1986, AM J HUM GENET, V39, P438; HOLLOWAY MP, 1993, THESIS SUNY STONY BR; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KURAMOTO T, 1994, GENOMICS, V19, P358, DOI 10.1006/geno.1994.1069; KURTZ TW, 1991, GENETIC APPROACHES C, P38; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEESMILLER JP, 1990, J MOL BIOL, V213, P399, DOI 10.1016/S0022-2836(05)80202-5; LEVAN G, 1990, LOCUS MAPS COMPLEX G; LEVAN G, 1992, LOCUS MAPS COMPLEX G; LEVIN MS, 1987, J BIOL CHEM, V262, P7118; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; Lindsey J. R., 1979, The laboratory rat. Volume I. Biology and diseases., P1; MATSUYAMA M, 1990, NEPHRON, V54, P334, DOI 10.1159/000185890; MOTOJIMA K, 1990, FEBS LETT, V264, P156, DOI 10.1016/0014-5793(90)80789-L; OZER J, 1993, GENE, V133, P187, DOI 10.1016/0378-1119(93)90637-I; PETTERSSON S, 1990, NATURE, V344, P165, DOI 10.1038/344165a0; PRAVENEC M, 1989, J HYPERTENS, V7, P217; RICHTER G, 1990, Cytokine, V2, P221, DOI 10.1016/1043-4666(90)90020-T; Robinson R., 1965, GENETICS NORWAY RAT; Sambrook J., 1989, MOL CLONING LAB MANU; SERIKAWA T, 1992, GENETICS, V131, P701; SHIER P, 1992, MOL ENDOCRINOL, V6, P723, DOI 10.1210/me.6.5.723; SPRENGEL R, 1989, J BIOL CHEM, V264, P20415; SZPIRER J, 1984, CYTOGENET CELL GENET, V38, P142, DOI 10.1159/000132047; TAY A, IN PRESS GENOMICS; WATANABE N, 1988, EUR J BIOCHEM, V174, P125, DOI 10.1111/j.1432-1033.1988.tb14071.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; YAMADA J, 1994, MAMM GENOME, V5, P63, DOI 10.1007/BF00292332; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; ZHA H, 1993, CYTOGENET CELL GENET, V63, P117, DOI 10.1159/000133514; 1993, ILAR NEWS, V34, pS1	49	441	449	0	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1995	9	1					63	69		10.1038/ng0195-63	http://dx.doi.org/10.1038/ng0195-63			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704027				2022-12-17	WOS:A1995PZ91300016
J	Savage, JE; Jansen, PR; Stringer, S; Watanabe, K; Bryois, J; de Leeuw, CA; Nagel, M; Awasthi, S; Barr, PB; Coleman, JRI; Grasby, KL; Hammerschlag, AR; Kaminski, JA; Karlsson, R; Krapohl, E; Lam, M; Nygaard, M; Reynolds, CA; Trampush, JW; Young, H; Zabaneh, D; Hagg, S; Hansell, NK; Karlsson, IK; Linnarsson, S; Montgomery, GW; Munoz-Manchado, AB; Quinlan, EB; Schumann, G; Skene, NG; Webb, BT; White, T; Arking, DE; Avramopoulos, D; Bilder, RM; Bitsios, P; Burdick, KE; Cannon, TD; Chiba-Falek, O; Christoforou, A; Cirulli, ET; Congdon, E; Corvin, A; Davies, G; Deary, IJ; DeRosse, P; Dickinson, D; Djurovic, S; Donohoe, G; Conley, ED; Eriksson, JG; Espeseth, T; Freimer, NA; Giakoumaki, S; Giegling, I; Gill, M; Glahn, DC; Hariri, AR; Hatzimanolis, A; Keller, MC; Knowles, E; Koltai, D; Konte, B; Lahti, J; Le Hellard, S; Lencz, T; Liewald, DC; London, E; Lundervold, AJ; Malhotra, AK; Melle, I; Morris, D; Need, AC; Ollier, W; Palotie, A; Payton, A; Pendleton, N; Poldrack, RA; Raikkonen, K; Reinvang, I; Roussos, P; Rujescu, D; Sabb, FW; Scult, MA; Smeland, OB; Smyrnis, N; Starr, JM; Steen, VM; Stefanis, NC; Straub, RE; Sundet, K; Tiemeier, H; Voineskos, AN; Weinberger, DR; Widen, E; Yu, J; Abecasis, G; Andreassen, OA; Breen, G; Christiansen, L; Debrabant, B; Dick, DM; Heinz, A; Hjerling-Leffler, J; Ikram, MA; Kendler, KS; Martin, NG; Medland, SE; Pedersen, NL; Plomin, R; Polderman, TJC; Ripke, S; van der Sluis, S; Sullivan, PF; Vrieze, SI; Wright, MJ; Posthuma, D				Savage, Jeanne E.; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; Bryois, Julien; de Leeuw, Christiaan A.; Nagel, Mats; Awasthi, Swapnil; Barr, Peter B.; Coleman, Jonathan R. I.; Grasby, Katrina L.; Hammerschlag, Anke R.; Kaminski, Jakob A.; Karlsson, Robert; Krapohl, Eva; Lam, Max; Nygaard, Marianne; Reynolds, Chandra A.; Trampush, Joey W.; Young, Hannah; Zabaneh, Delilah; Hagg, Sara; Hansell, Narelle K.; Karlsson, Ida K.; Linnarsson, Sten; Montgomery, Grant W.; Munoz-Manchado, Ana B.; Quinlan, Erin B.; Schumann, Gunter; Skene, Nathan G.; Webb, Bradley T.; White, Tonya; Arking, Dan E.; Avramopoulos, Dimitrios; Bilder, Robert M.; Bitsios, Panos; Burdick, Katherine E.; Cannon, Tyrone D.; Chiba-Falek, Ornit; Christoforou, Andrea; Cirulli, Elizabeth T.; Congdon, Eliza; Corvin, Aiden; Davies, Gail; Deary, Ian J.; DeRosse, Pamela; Dickinson, Dwight; Djurovic, Srdjan; Donohoe, Gary; Conley, Emily Drabant; Eriksson, Johan G.; Espeseth, Thomas; Freimer, Nelson A.; Giakoumaki, Stella; Giegling, Ina; Gill, Michael; Glahn, David C.; Hariri, Ahmad R.; Hatzimanolis, Alex; Keller, Matthew C.; Knowles, Emma; Koltai, Deborah; Konte, Bettina; Lahti, Jari; Le Hellard, Stephanie; Lencz, Todd; Liewald, David C.; London, Edythe; Lundervold, Astri J.; Malhotra, Anil K.; Melle, Ingrid; Morris, Derek; Need, Anna C.; Ollier, William; Palotie, Aarno; Payton, Antony; Pendleton, Neil; Poldrack, Russell A.; Raikkonen, Katri; Reinvang, Ivar; Roussos, Panos; Rujescu, Dan; Sabb, Fred W.; Scult, Matthew A.; Smeland, Olav B.; Smyrnis, Nikolaos; Starr, John M.; Steen, Vidar M.; Stefanis, Nikos C.; Straub, Richard E.; Sundet, Kjetil; Tiemeier, Henning; Voineskos, Aristotle N.; Weinberger, Daniel R.; Widen, Elisabeth; Yu, Jin; Abecasis, Goncalo; Andreassen, Ole A.; Breen, Gerome; Christiansen, Lene; Debrabant, Birgit; Dick, Danielle M.; Heinz, Andreas; Hjerling-Leffler, Jens; Ikram, M. Arfan; Kendler, Kenneth S.; Martin, Nicholas G.; Medland, Sarah E.; Pedersen, Nancy L.; Plomin, Robert; Polderman, Tinca J. C.; Ripke, Stephan; van der Sluis, Sophie; Sullivan, Patrick F.; Vrieze, Scott I.; Wright, Margaret J.; Posthuma, Danielle			Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence	NATURE GENETICS			English	Article							GENERAL COGNITIVE FUNCTION; EDUCATIONAL-ATTAINMENT; TEST BATTERIES; GWAS; TRAITS; RISK; LOCI; HERITABILITY; ANNOTATION; CONSORTIUM	Intelligence is highly heritable(1) and a major determinant of human health and well-being(2). Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in intelligence3-7, but much about its genetic underpinnings remains to be discovered. Here, we present a large-scale genetic association study of intelligence (n = 269,867), identifying 205 associated genomic loci (190 new) and 1,016 genes (939 new) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis. We find enrichment of genetic effects in conserved and coding regions and associations with 146 nonsynonymous exonic variants. Associated genes are strongly expressed in the brain, specifically in striatal medium spiny neurons and hippocampal pyramidal neurons. Gene set analyses implicate pathways related to nervous system development and synaptic structure. We confirm previous strong genetic correlations with multiple health-related outcomes, and Mendelian randomization analysis results suggest protective effects of intelligence for Alzheimer's disease and ADHD and bidirectional causation with pleiotropic effects for schizophrenia. These results are a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.	[Savage, Jeanne E.; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; de Leeuw, Christiaan A.; Hammerschlag, Anke R.; Polderman, Tinca J. C.; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands; [Jansen, Philip R.; White, Tonya; Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Bryois, Julien; Karlsson, Robert; Hagg, Sara; Karlsson, Ida K.; Pedersen, Nancy L.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Nagel, Mats; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Awasthi, Swapnil; Kaminski, Jakob A.; Malhotra, Anil K.; Heinz, Andreas; Ripke, Stephan] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany; [Barr, Peter B.; Dick, Danielle M.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Coleman, Jonathan R. I.; Krapohl, Eva; Zabaneh, Delilah; Breen, Gerome; Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Coleman, Jonathan R. I.; Breen, Gerome] South London & Maudsley NHS Trust, NIHR Biomed Res Ctr Mental Hlth, London, England; [Grasby, Katrina L.; Montgomery, Grant W.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Kaminski, Jakob A.] Berlin Inst Hlth, Berlin, Germany; [Lam, Max] Inst Mental Hlth, Singapore, Singapore; [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Twin Registry, Odense, Denmark; [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Aging Res Ctr, Dept Publ Hlth, Odense, Denmark; [Nygaard, Marianne; Christiansen, Lene; Debrabant, Birgit] Univ Southern Denmark, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark; [Reynolds, Chandra A.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Trampush, Joey W.] BrainWorkup LLC, Los Angeles, CA USA; [Trampush, Joey W.] Univ Southern Calif, Keck Sch Med, Dep Psychiat & Behav Sci, Los Angeles, CA USA; [Young, Hannah; Vrieze, Scott I.] Univ Minnesota, Dept Psychol, St Paul, MN 55108 USA; [Hansell, Narelle K.; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Linnarsson, Sten; Munoz-Manchado, Ana B.; Skene, Nathan G.; Hjerling-Leffler, Jens] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Stockholm, Sweden; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Quinlan, Erin B.; Schumann, Gunter] Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, Ctr Populat Neurosci & Precis Med PONS, London, England; [Skene, Nathan G.] UCL, Inst Neurol, Queen Sq, London, England; [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Arking, Dan E.; Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Bilder, Robert M.; Congdon, Eliza; Freimer, Nelson A.; London, Edythe] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Bitsios, Panos] Univ Crete, Dept Psychiat & Behav Sci, Fac Med, Iraklion, Greece; [Burdick, Katherine E.; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Burdick, Katherine E.; Roussos, Panos] James J Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN 2, Bronx, NY USA; [Burdick, Katherine E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA; [Cannon, Tyrone D.] Yale Univ, Dept Psychol, New Haven, CT USA; [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Neurol, Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC USA; [Christoforou, Andrea; Le Hellard, Stephanie; Steen, Vidar M.] Haukeland Hosp, Dr Einar Martens Res Grp Biol Psychiat, Ctr Med Genet & Mol Med, Bergen, Norway; [Cirulli, Elizabeth T.] Human Longev Inc, Durham, NC USA; [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [Davies, Gail; Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Gail; Deary, Ian J.; Liewald, David C.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.; Yu, Jin] Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA; [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.] Hofstra Northwell Sch Med, Dept Psychiat, Hempstead, NY USA; [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA; [Dickinson, Dwight] NIMH, Clin & Translat Neurosci Branch, Intramural Res Program, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Djurovic, Srdjan] Univ Bergen, Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan; Le Hellard, Stephanie; Melle, Ingrid; Steen, Vidar M.] Univ Bergen, KG Jebsen Ctr Psychosis Res, NORMENT, Bergen, Norway; [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Neuroimaging Cognit & Genom NICOG, Sch Psychol, Galway, Ireland; [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Discipline Biochem, Galway, Ireland; [Conley, Emily Drabant] 23andMe Inc, Mountain View, CA USA; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland; [Espeseth, Thomas; Reinvang, Ivar; Sundet, Kjetil] Univ Oslo, Dept Psychol, Oslo, Norway; [Espeseth, Thomas; Melle, Ingrid; Sundet, Kjetil; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Giakoumaki, Stella] Univ Crete, Dept Psychol, Rethimnon, Greece; [Giegling, Ina; Konte, Bettina; Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat, Halle, Germany; [Glahn, David C.; Knowles, Emma] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Hariri, Ahmad R.; Scult, Matthew A.] Duke Univ, Dept Psychol & Neurosci, Lab NeuroGenet, Durham, NC USA; [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Athens, Eginit Hosp, Dept Psychiat, Sch Med, Athens, Greece; [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Mental Hlth Res Inst, Athens, Greece; [Hatzimanolis, Alex; Stefanis, Nikos C.] Theodor Theohari Cozzika Fdn, Neurobiol Res Inst, Athens, Greece; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Koltai, Deborah] Duke Univ, Med Ctr, Div Med Psychol, Psychiat & Behav Sci, Durham, NC USA; [Koltai, Deborah] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Lahti, Jari] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland; [London, Edythe] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [London, Edythe] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Astri J.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway; [Need, Anna C.] Imperial Coll London, Dept Med, Div Brain Sci, London, England; [Ollier, William] Univ Manchester, Inst Populat Hlth, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Palotie, Aarno] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Payton, Antony] Univ Manchester, Ctr Epidemiol, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England; [Pendleton, Neil] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci,Salford Royal NHS Fdn Trust, Div Neurosci & Expt Psychol,Manchester Acad Hlth, Manchester, Lancs, England; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA; [Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Roussos, Panos] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA; [Sabb, Fred W.] Univ Oregon, Robert & Beverly Lewis Ctr Neuroimaging, Eugene, OR 97403 USA; [Smeland, Olav B.; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Smeland, Olav B.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Straub, Richard E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Univ Med Campus, Baltimore, MD USA; [Tiemeier, Henning; Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Voineskos, Aristotle N.] Univ Toronto, Campbell Family Mental Hlth Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Dick, Danielle M.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Dick, Danielle M.] Virginia Commonwealth Univ, Coll Behav & Emot Hlth Inst, Richmond, VA USA; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Virginia Commonwealth University; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; QIMR Berghofer Medical Research Institute; Berlin Institute of Health; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; University of California System; University of California Riverside; University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; University of Queensland; Karolinska Institutet; University of Queensland; University of London; King's College London; University of London; University College London; Virginia Commonwealth University; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; University of Crete; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Duke University; Duke University; University of Bergen; Haukeland University Hospital; Trinity College Dublin; Trinity College Dublin; University of Edinburgh; University of Edinburgh; Northwell Health; Northwell Health; Northwell Health; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Bergen; University of Oslo; University of Bergen; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oslo; University of Oslo; University of Crete; Martin Luther University Halle Wittenberg; Yale University; Duke University; Athens Medical School; National & Kapodistrian University of Athens; University of Colorado System; University of Colorado Boulder; Duke University; Duke University; University of Helsinki; University of Helsinki; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Bergen; University of Bergen; Imperial College London; University of Manchester; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester; Stanford University; University of Helsinki; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oregon; University of Oslo; University of Oslo; University of Edinburgh; Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Oslo; Virginia Commonwealth University; Virginia Commonwealth University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Queensland	Posthuma, D (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands.; Posthuma, D (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	d.posthuma@vu.nl	Medland, Sarah/AAT-7595-2020; Ripke, Stephan/AAK-5486-2021; Grasby, Katrina/M-7536-2016; Heinz, Andreas/ABB-7736-2020; Reynolds, Chandra/AAH-2886-2020; Smeland, Olav Bjerkehagen/AAM-5284-2020; Morris, Derek/AAW-8343-2021; Lahti, Jari/P-2283-2019; Bilder, Robert M/A-8894-2008; Lahti, Jari/P-7987-2018; Ikram, M. Arfan/AAM-5225-2021; Voineskos, Aristotle/J-5014-2013; Lencz, Todd/J-3418-2014; DeRosse, Pamela/X-1412-2019; Rujescu, Dan/GRS-3875-2022; Lam, Max/AAM-4946-2021; Andreassen, Ole A./AAY-7531-2020; Breen, Gerome D/A-5540-2010; Tiemeier, Henning/H-6534-2019; Webb, Bradley T/B-1459-2009; Hansell, Narelle K/A-4553-2016; Barr, Peter/AAJ-9096-2020; Pendleton, Neil/F-2333-2015; Karlsson, Ida K/S-6064-2019; Linnarsson, Sten/HCH-3909-2022; Coleman, Jonathan/T-9412-2019; Deary, Ian J/C-6297-2009; Kendler, Kenneth/AAF-2876-2019; Smyrnis, Nikolaos/AAA-3783-2020; Giegling, Ina/ABA-3677-2021; Smeland, Olav/ADE-5677-2022; White, Tonya/AAU-2226-2021; Manchado, Ana Munoz/AAB-6399-2019; Donohoe, Gary/J-6481-2013; DeRosse, Pamela/H-1083-2012; Knowles, Emma/P-3821-2018; Knowles, Emma/V-2567-2019; Grasby, Katrina/AAU-9349-2021; Hatzimanolis, Alex/GOG-7992-2022; Wright, Margaret Jane/A-4560-2016; Kaminski, Jakob/W-1349-2019; Konte, Bettina/AAT-1142-2021; Yu, Jin/E-3732-2013; Hjerling Leffler, Jens/E-3775-2012	Medland, Sarah/0000-0003-1382-380X; Grasby, Katrina/0000-0001-8539-0228; Heinz, Andreas/0000-0001-5405-9065; Smeland, Olav Bjerkehagen/0000-0002-3761-5215; Morris, Derek/0000-0002-3413-570X; Lahti, Jari/0000-0002-4310-5297; Bilder, Robert M/0000-0001-5085-7852; Lahti, Jari/0000-0002-4310-5297; Lencz, Todd/0000-0001-8586-338X; Breen, Gerome D/0000-0003-2053-1792; Tiemeier, Henning/0000-0002-4395-1397; Webb, Bradley T/0000-0002-0576-5366; Hansell, Narelle K/0000-0002-8229-9741; Barr, Peter/0000-0001-9321-657X; Pendleton, Neil/0000-0003-0794-2386; Karlsson, Ida K/0000-0003-3605-7829; Coleman, Jonathan/0000-0002-6759-0944; Deary, Ian J/0000-0002-1733-263X; White, Tonya/0000-0003-0271-1896; Donohoe, Gary/0000-0003-3037-7426; DeRosse, Pamela/0000-0003-0823-8163; Knowles, Emma/0000-0003-0642-267X; Wright, Margaret Jane/0000-0001-7133-4970; Kaminski, Jakob/0000-0001-8155-3683; Konte, Bettina/0000-0001-5287-308X; Awasthi, Swapnil/0000-0002-9692-8123; Plomin, Robert/0000-0002-0756-3629; Walters, James/0000-0002-6980-4053; Posthuma, Danielle/0000-0001-7582-2365; Voineskos, Aristotle/0000-0003-0156-0395; Jansen, Philip/0000-0003-1550-2444; Skene, Nathan/0000-0002-6807-3180; Schumann, Gunter/0000-0003-4905-5523; Yu, Jin/0000-0002-2990-6602; Hagg, Sara/0000-0002-2452-1500; de Leeuw, Christiaan/0000-0003-1076-9828; Payton, Antony/0000-0003-0335-152X; Young, Hannah/0000-0002-4248-9612; Giakoumaki, Stella/0000-0002-4166-8125; Debrabant, Birgit/0000-0002-1964-3204; Cirulli Rogers, Liz/0000-0001-7808-2809; Nygaard, Marianne/0000-0003-0703-2665; Poldrack, Russell/0000-0001-6755-0259; Koltai, Deborah/0000-0002-4254-9902; Munoz Manchado, Ana/0000-0002-1121-6072; ripke, stephan/0000-0003-3622-835X; Savage, Jeanne/0000-0002-2034-8341; Palotie, Aarno/0000-0002-2527-5874; Raikkonen, Katri/0000-0003-3124-3470; Ikram, Mohammad Arfan/0000-0003-0372-8585; Watanabe, Kyoko/0000-0002-3303-8860; Pedersen, Nancy/0000-0001-8057-3543; Djurovic, Srdjan/0000-0002-8140-8061; Trampush, Joey/0000-0003-0830-508X; Hjerling Leffler, Jens/0000-0002-4539-1776; Polderman, Tinca/0000-0001-5564-301X; Zabaneh, Delilah/0000-0003-4740-3862; van der Sluis, Sophie/0000-0001-9958-7216	Netherlands Organization for Scientific Research [433-09-228, VIDI 452-12-014, VICI 453-13-005, 645-000-003]; Sophia Foundation for Scientific Research (SSWO) [S14-27]; Netherlands Scientific Organization (NWO) [480-05-003]; Vrije Universiteit, Amsterdam, The Netherlands; Dutch Brain Foundation; Swedish Research Council [20143863]; Wellcome Trust [108726/Z/15/Z]; Swedish Brain Foundation; Dutch National Computing and Networking Services, SurfSARA; Swiss National Science Foundation; UK Biobank resource [16406]; BBSRC [BB/F022441/1, BB/F019394/1] Funding Source: UKRI; MRC [G0600237, G0901461, G19/2, G0100594] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002717, K01MH098126, R01MH085018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K02AA018755, R37AA011408, P50AA022537, R01AA023974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018164] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Sophia Foundation for Scientific Research (SSWO); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Vrije Universiteit, Amsterdam, The Netherlands(Netherlands Government); Dutch Brain Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Brain Foundation; Dutch National Computing and Networking Services, SurfSARA; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UK Biobank resource; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Netherlands Organization for Scientific Research through the following grants: NWO Brain and Cognition 433-09-228 (D.P.), NWO MagW VIDI 452-12-014 (S.v.d.S.), NWO VICI 453-13-005 (D.P.), and 645-000-003 (D.P.). P.R.J. was funded by the Sophia Foundation for Scientific Research (SSWO, grant S14-27 to P.R.J.). The analyses were carried out on the Genetic Cluster Computer, which is financed by the Netherlands Scientific Organization (NWO: 480-05-003 to D.P.), Vrije Universiteit, Amsterdam, The Netherlands, and the Dutch Brain Foundation, and is hosted by the Dutch National Computing and Networking Services, SurfSARA. J.H.-L. was funded by the Swedish Research Council (Vetenskapsradet, award 20143863), StratNeuro, the Wellcome Trust (108726/Z/15/Z), and the Swedish Brain Foundation (Hjarnfonden). N.G.S. was supported by the Wellcome Trust (108726/Z/15/Z). J.B. was funded by the Swiss National Science Foundation. This research has been conducted using the UK Biobank resource under application 16406. We thank the numerous participants, researchers, and staff from many studies who collected and contributed to the data. Additional acknowledgements can be found in the Supplementary Information.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Coleman JRI, 2019, MOL PSYCHIATR, V24, P182, DOI 10.1038/s41380-018-0040-6; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Hill WD, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.246; Jensen A. R., 1998, G FACTOR SCI MENTAL; Johnson W, 2004, INTELLIGENCE, V32, P95, DOI 10.1016/S0160-2896(03)00062-X; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Johnson W, 2009, INTELLIGENCE, V37, P466, DOI 10.1016/j.intell.2009.05.006; Kendler KS, 2015, AM J PSYCHIAT, V172, P259, DOI 10.1176/appi.ajp.2014.14040516; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Le Hellard S, 2017, SCHIZOPHRENIA BULL, V43, P654, DOI 10.1093/schbul/sbw085; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Peloso GM, 2016, EUR J HUM GENET, V24, P924, DOI 10.1038/ejhg.2015.197; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Plomin R, 2018, NAT REV GENET, V19, P148, DOI 10.1038/nrg.2017.104; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Richards M, 2011, INT J EPIDEMIOL, V40, P516, DOI 10.1093/ije/dyq166; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Trampush JW, 2017, MOL PSYCHIATR, V22, P336, DOI 10.1038/mp.2016.244; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wraw C, 2015, INTELLIGENCE, V53, P23, DOI 10.1016/j.intell.2015.08.001; Zabaneh D, 2018, MOL PSYCHIATR, V23, P1226, DOI 10.1038/mp.2017.121; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	53	440	444	15	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					912	+		10.1038/s41588-018-0152-6	http://dx.doi.org/10.1038/s41588-018-0152-6			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	29942086	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000437224400005
J	Hansel-Hertsch, R; Beraldi, D; Lensing, SV; Marsico, G; Zyner, K; Parry, A; Di Antonio, M; Pike, J; Kimura, H; Narita, M; Tannahill, D; Balasubramanian, S				Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Di Antonio, Marco; Pike, Jeremy; Kimura, Hiroshi; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar			G-quadruplex structures mark human regulatory chromatin	NATURE GENETICS			English	Article							SMALL-MOLECULE; HUMAN GENOME; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; FORMING SEQUENCES; BINDING; TARGETS; MOTIFS; CELLS; TRANSCRIPTION	G-quadruplex (G4) structural motifs have been linked to transcription(1,2), replication(3) and genome instability(4,5) and are implicated in cancer and other diseases(6-8). However, it is crucial to demonstrate the bona fide formation of G4 structures within an endogenous chromatin context(9,10). Herein we address this through the development of G4 ChIP-seq, an antibody-based G4 chromatin immunoprecipitation and high-throughput sequencing approach. We find similar to 10,000 G4 structures in human chromatin, predominantly in regulatory, nucleosome-depleted regions. G4 structures are enriched in the promoters and 5' UTRs of highly transcribed genes, particularly in genes related to cancer and in somatic copy number amplifications, such as MYC. Strikingly, de novo and enhanced G4 formation are associated with increased transcriptional activity, as shown by HDAC inhibitor-induced chromatin relaxation and observed in immortalized as compared to normal cellular states. Our findings show that regulatory, nucleosome-depleted chromatin and elevated transcription shape the endogenous human G4 DNA landscape.	[Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Pike, Jeremy; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar] Li Ka Shing Ctr, Cambridge Inst, Canc Res UK, Cambridge, England; [Di Antonio, Marco; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge, England; [Kimura, Hiroshi] Tokyo Inst Technol, Inst Innovat Res, Cell Biol Unit, Yokohama, Kanagawa, Japan; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Tokyo Institute of Technology; University of Cambridge	Balasubramanian, S (corresponding author), Li Ka Shing Ctr, Cambridge Inst, Canc Res UK, Cambridge, England.; Balasubramanian, S (corresponding author), Univ Cambridge, Dept Chem, Cambridge, England.; Balasubramanian, S (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge, England.	sb10031@cam.ac.uk	Pike, Jeremy/B-3995-2017; Kimura, Hiroshi/B-9524-2015; Balasubramanian, Shankar/C-1671-2009	Pike, Jeremy/0000-0003-4163-0335; Kimura, Hiroshi/0000-0003-0854-083X; Zyner, Katherine/0000-0002-4997-0150; Parry, Aled/0000-0001-5192-3727; Balasubramanian, Shankar/0000-0002-0281-5815; Tannahill, David/0000-0002-3811-6864; Narita, Masashi/0000-0001-7764-577X; Di Antonio, Marco/0000-0002-7321-1867; Beraldi, Dario/0000-0003-1504-5212; Haensel-Hertsch, Robert/0000-0002-2835-4471	European Molecular Biology Organization; EMBO Long-Term Fellowship; University of Cambridge; Cancer Research UK [C14303/A17197]; Wellcome Trust [099232/z/12/z]; Cancer Research UK [18618, 15890, 19836] Funding Source: researchfish	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	The authors would like to thank the staff at the Genomic and Light Microscopy and Biorepository core facilities at Cancer Research UK Cambridge Institute. We are grateful to the European Molecular Biology Organization for funding R.H.-H. with the EMBO Long-Term Fellowship. We acknowledge support from University of Cambridge and Cancer Research UK program. The Balasubramanian and Narita laboratories are supported by core funding from Cancer Research UK (C14303/A17197). S.B. is a Senior Investigator of the Wellcome Trust (grant no. 099232/z/12/z).	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Foulk MS, 2015, GENOME RES, V25, P725, DOI 10.1101/gr.183848.114; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/nchembio.1475, 10.1038/NCHEMBIO.1475]; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hoffmann RF, 2016, NUCLEIC ACIDS RES, V44, P152, DOI 10.1093/nar/gkv900; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Raiber EA, 2012, NUCLEIC ACIDS RES, V40, P1499, DOI 10.1093/nar/gkr882; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2014, NAT REV GENET, V15, P783, DOI 10.1038/nrg3796; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sabouri N, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0101-5; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Zhao M, 2016, NUCLEIC ACIDS RES, V44, pD1023, DOI 10.1093/nar/gkv1268	43	440	448	16	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1267	1272		10.1038/ng.3662	http://dx.doi.org/10.1038/ng.3662			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27618450	Green Submitted			2022-12-17	WOS:000384391600023
J	Austin, CP; Battey, JF; Bradley, A; Bucan, M; Capecchi, M; Collins, FS; Dove, WF; Duyk, G; Dymecki, S; Eppig, JT; Grieder, FB; Heintz, N; Hicks, G; Insel, TR; Joyner, A; Koller, BH; Lloyd, KCK; Magnuson, T; Moore, MW; Nagy, A; Pollock, JD; Roses, AD; Sands, AT; Seed, B; Skarnes, WC; Snoddy, J; Soriano, P; Stewart, DJ; Stewart, F; Stillman, B; Varmus, H; Varticovski, L; Verma, IM; Vogt, TF; von Melchner, H; Witkowski, J; Woychik, RP; Wurst, W; Yancopoulos, GD; Young, SG; Zambrowicz, B				Austin, CP; Battey, JF; Bradley, A; Bucan, M; Capecchi, M; Collins, FS; Dove, WF; Duyk, G; Dymecki, S; Eppig, JT; Grieder, FB; Heintz, N; Hicks, G; Insel, TR; Joyner, A; Koller, BH; Lloyd, KCK; Magnuson, T; Moore, MW; Nagy, A; Pollock, JD; Roses, AD; Sands, AT; Seed, B; Skarnes, WC; Snoddy, J; Soriano, P; Stewart, DJ; Stewart, F; Stillman, B; Varmus, H; Varticovski, L; Verma, IM; Vogt, TF; von Melchner, H; Witkowski, J; Woychik, RP; Wurst, W; Yancopoulos, GD; Young, SG; Zambrowicz, B		Comprehensive Knockout Mouse Proje	The knockout mouse project	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GENE-TRAP MUTAGENESIS; GENOME; MICE; SEQUENCE; IDENTIFICATION; DEFICIENCY; PHENOTYPE; INSIGHTS; RESOURCE	Mouse knockout technology provides a powerful means of elucidating gene function in vivo, and a publicly available genome-wide collection of mouse knockouts would be significantly enabling for biomedical discovery. To date, published knockouts exist for only about 10% of mouse genes. Furthermore, many of these are limited in utility because they have not been made or phenotyped in standardized ways, and many are not freely available to researchers. It is time to harness new technologies and efficiencies of production to mount a high-throughput international effort to produce and phenotype knockouts for all mouse genes, and place these resources into the public domain.	NHGRI, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 85112 USA; Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; TPG Ventures, San Francisco, CA 94104 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA; NIH, Natl Ctr Res Resources, Bethesda, MD 20817 USA; Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA; Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; NIMH, Bethesda, MD 20892 USA; Skirball Inst Biomol Med, New York, NY 10016 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; Deltagen, Redwood City, CA 94063 USA; Univ Toronto, Samuel Lumenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Natl Inst Drug Abuse, Bethesda, MD 20892 USA; GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; Lexicon Genet, The Woodlands, TX 77381 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Oak Ridge Natl Lab, Univ Tennessee ORNL Grad Sch Genome Sci & Technol, Oak Ridge, TN 37831 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Cold Spring Harbor Lab, Banbury Ctr, Cold Spring Harbor, NY 11724 USA; Univ Technol, Bioz, MPI CBG, D-1307 Dresden, Germany; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, NIH, Bethesda, MD 20892 USA; Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA; Merck Res Labs, West Point, PA 19486 USA; Goethe Univ Frankfurt, Sch Med, Lab Mol Hematol, D-60590 Frankfurt, Germany; Jackson Lab, Bar Harbor, ME 04609 USA; Max Planck Inst Psychiat, GSF Res Ctr, Inst Dev Genet, D-85764 Munich, Germany; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Univ Calif San Francisco, Gladstone Fdn Cardiovasc Dis, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Wellcome Trust Sanger Institute; University of Pennsylvania; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Jackson Laboratory; National Institutes of Health (NIH) - USA; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); GlaxoSmithKline; Lexicon Pharmaceuticals; Harvard University; Massachusetts General Hospital; United States Department of Energy (DOE); Oak Ridge National Laboratory; Fred Hutchinson Cancer Center; Cold Spring Harbor Laboratory; Max Planck Society; Technische Universitat Dresden; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Salk Institute; Merck & Company; Goethe University Frankfurt; Jackson Laboratory; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Regeneron; University of California System; University of California San Francisco; The J David Gladstone Institutes	Austin, CP (corresponding author), NHGRI, NIH, Bldg 31,Room 4B09,31 Ctr Dr, Bethesda, MD 20892 USA.	austinc@mail.nih.gov	Stewart, A. Francis/E-7789-2010; Soriano, Philippe M/E-5797-2015; Woychik, Richard P/C-8345-2019; Pollock, Jonathan D/B-1554-2009; Nagy, Andras/G-6465-2013; Witkowski, Jan/FHJ-8549-2022	Soriano, Philippe M/0000-0002-0427-926X; Woychik, Richard P/0000-0001-8196-1732; Nagy, Andras/0000-0003-4311-0413; Young, Stephen/0000-0001-7270-3176; Hicks, Geoffrey/0000-0003-4688-2312; Varticovski, Lyuba/0000-0002-5105-9008; Stillman, Bruce/0000-0002-9453-4091; Bradley, Allan/0000-0002-2349-8839; Witkowski, Jan/0000-0002-8159-2874; Wurst, Wolfgang/0000-0003-4422-7410	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003004] Funding Source: NIH RePORTER; Wellcome Trust [077188] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Clark J., 2000, PATENT POOLS SOLUTIO; D'Orleans-Juste P, 2003, CURR OPIN PHARMACOL, V3, P181, DOI 10.1016/S1471-4892(03)00017-1; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Goldstein JL, 2001, NAT MED, V7, P1079, DOI 10.1038/nm1001-1079; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Horton WA, 2003, LANCET, V362, P560, DOI 10.1016/S0140-6736(03)14119-0; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	25	440	480	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2004	36	9					921	924		10.1038/ng0904-921	http://dx.doi.org/10.1038/ng0904-921			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15340423	Green Accepted			2022-12-17	WOS:000223658100005
J	Schott, JJ; Alshinawi, C; Kyndt, F; Probst, V; Hoorntje, TM; Hulsbeek, M; Wilde, AAM; Escande, D; Mannens, MMAM; Le Marec, H				Schott, JJ; Alshinawi, C; Kyndt, F; Probst, V; Hoorntje, TM; Hulsbeek, M; Wilde, AAM; Escande, D; Mannens, MMAM; Le Marec, H			Cardiac conduction defects associate with mutations in SCN5A	NATURE GENETICS			English	Letter							DILATED CARDIOMYOPATHY; DISEASE; GENE; MAPS; EXCITABILITY; TISSUE; SODIUM; BLOCK		Hop Hotel Dieu, Lab Physiolpathol & Pharmacol Cellulaires & Mol, INSERM, Nantes, France; Hop G&R Laennec, Nantes, France; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Univ Utrecht Hosp, Dept Pediat Cardiol, Utrecht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Le Marec, H (corresponding author), Hop Hotel Dieu, Lab Physiolpathol & Pharmacol Cellulaires & Mol, INSERM, CJF96-01, Nantes, France.		KYNDT, Florence/D-6370-2015; Le Marec, Hervé/D-2718-2015; probst, vincent/D-4996-2015; Schott, jean-Jacques/F-8842-2013	KYNDT, Florence/0000-0001-6651-1696; Le Marec, Hervé/0000-0002-8288-8693; probst, vincent/0000-0002-5492-8619; Schott, jean-Jacques/0000-0002-9578-9475; Bezzina, Connie/0000-0002-0633-3514				Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BRINK PA, 1995, CIRCULATION, V91, P1633, DOI 10.1161/01.CIR.91.6.1633; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; DEMEEUS A, 1995, CIRC RES, V77, P735, DOI 10.1161/01.RES.77.4.735; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KRAWCZAK M, 1992, HUM GENET, V90, P41; KULBERTUS HE, 1975, CARDIAC ARRHYTHMIAS, P16; LENEGRE J, 1964, PROG CARDIOVASC DIS, V6, P317; LEV M, 1970, CIRCULATION, V42, P409, DOI 10.1161/01.CIR.42.3.409; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Rohr S, 1998, CIRC RES, V83, P781, DOI 10.1161/01.RES.83.8.781; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shaw RM, 1997, CIRC RES, V81, P727; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236	16	440	468	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					20	21		10.1038/12618	http://dx.doi.org/10.1038/12618			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471492				2022-12-17	WOS:000082337300010
J	Bollag, G; Clapp, DW; Shih, S; Adler, F; Zhang, YY; Thompson, P; Lange, BJ; Freedman, MH; McCormick, F; Jacks, T; Shannon, K				Bollag, G; Clapp, DW; Shih, S; Adler, F; Zhang, YY; Thompson, P; Lange, BJ; Freedman, MH; McCormick, F; Jacks, T; Shannon, K			Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; COLONY-STIMULATING FACTOR; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; TYPE-1 NEUROFIBROMATOSIS; SARCOMA-VIRUSES; GM-CSF; GENE; MUTATIONS; TRANSFORMATION; ONCOGENES	Individuals with neurofibromatosis type 1 (NF1) are predisposed to certain cancers including juvenile chronic myelogenous leukaemia (JCML). The NF1 tumour-suppressor gene encodes a protein (neurofibromin) that accelerates GTP hydrolysis on Pas proteins. Here we show that primary leukaemic cells from children with NF1 show a selective decrease in NF1-like GTPase activating protein (GAP) activity for Pas but retain normal cellular GAP activity. Leukaemic cells also show an elevated percentage of Pas in the GTP-bound conformation. JCML cells are hypersensitive to granulocyte-macrophage colony stimulating factor (GM-CSF), and we observed a similar pattern of aberrant growth in haematopoietic cells from Nf1(-/-) mouse embryos. These data define a specific role for neurofibromin in negatively regulating GM-CSF signaling through Pas in haematopoietic cells and they suggest that hypersensitivity to GM-CSF may be a primary event in the development of JCML.	INDIANA UNIV,JAMES WHITCOMB RILEY HOSP CHILDREN,MED CTR,HERMAN B WELLS RES CTR,INDIANAPOLIS,IN 46202; MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; CHILDRENS HOSP PHILADELPHIA,DIV HEMATOL ONCOL,PHILADELPHIA,PA 19104; HOSP SICK CHILDREN,DIV HEMATOL ONCOL,TORONTO,ON M5G 1X8,CANADA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bollag, G (corresponding author), ONYX PHARMACEUT,3031 RES DR,RICHMOND,CA 94806, USA.				NCRR NIH HHS [3M01 RR01271-13S1] Funding Source: Medline; NHLBI NIH HHS [HLO-2721] Funding Source: Medline; NIDDK NIH HHS [DK 07636] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007636] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; BADER JL, 1978, J PEDIATR-US, V92, P925, DOI 10.1016/S0022-3476(78)80362-X; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EMANUEL PD, 1991, BLOOD, V77, P925; FREEDMAN MH, 1992, BRIT J HAEMATOL, V80, P40, DOI 10.1111/j.1365-2141.1992.tb06398.x; GADNER H, 1992, HEMATOL ONCOL CLIN N, V6, P655, DOI 10.1016/S0889-8588(18)30334-4; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; JOHNSON MR, 1994, MOL CELL BIOL, V14, P641, DOI 10.1128/MCB.14.1.641; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KALRA R, 1994, BLOOD, V84, P3435; KANEKO Y, 1989, LEUKEMIA, V3, P36; LANFRANCONE L, 1995, ONCOGENE, V10, P907; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MIYAUCHI J, 1994, BLOOD, V83, P2248; MUI ALF, 1994, P SOC EXP BIOL MED, V206, P284; NEUBAUER A, 1991, BLOOD, V77, P594; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PIERCE JH, 1985, MOL CELL BIOL, V5, P667, DOI 10.1128/MCB.5.4.667; RICCARDI VM, 1986, NEUROFIBROMATOSIS; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; SHANNON KM, 1992, BLOOD, V79, P1311; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	44	440	451	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					144	148		10.1038/ng0296-144	http://dx.doi.org/10.1038/ng0296-144			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563751				2022-12-17	WOS:A1996TU07900013
J	Eyre, S; Bowes, J; Diogo, D; Lee, A; Barton, A; Martin, P; Zhernakova, A; Stahl, E; Viatte, S; McAllister, K; Amos, CI; Padyukov, L; Toes, REM; Huizinga, TWJ; Wijmenga, C; Trynka, G; Franke, L; Westra, HJ; Alfredsson, L; Hu, XL; Sandor, C; de Bakker, PIW; Davila, S; Khor, CC; Heng, KK; Andrews, R; Edkins, S; Hunt, SE; Langford, C; Symmons, D; Concannon, P; Onengut-Gumuscu, S; Rich, SS; Deloukas, P; Gonzalez-Gay, MA; Rodriguez-Rodriguez, L; Arlsetig, L; Martin, J; Rantapaa-Dahlqvist, S; Plenge, RM; Raychaudhuri, S; Klareskog, L; Gregersen, PK; Worthington, J				Eyre, Steve; Bowes, John; Diogo, Dorothee; Lee, Annette; Barton, Anne; Martin, Paul; Zhernakova, Alexandra; Stahl, Eli; Viatte, Sebastien; McAllister, Kate; Amos, Christopher I.; Padyukov, Leonid; Toes, Rene E. M.; Huizinga, Tom W. J.; Wijmenga, Cisca; Trynka, Gosia; Franke, Lude; Westra, Harm-Jan; Alfredsson, Lars; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Davila, Sonia; Khor, Chiea Chuen; Heng, Khai Koon; Andrews, Robert; Edkins, Sarah; Hunt, Sarah E.; Langford, Cordelia; Symmons, Deborah; Concannon, Pat; Onengut-Gumuscu, Suna; Rich, Stephen S.; Deloukas, Panos; Gonzalez-Gay, Miguel A.; Rodriguez-Rodriguez, Luis; Arlsetig, Lisbeth; Martin, Javier; Rantapaa-Dahlqvist, Solbritt; Plenge, Robert M.; Raychaudhuri, Soumya; Klareskog, Lars; Gregersen, Peter K.; Worthington, Jane		Biol Rheumatoid Arthrit Genetics G; Wellcome Trust Case Control Consor	High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis	NATURE GENETICS			English	Article							RISK LOCI; METAANALYSIS; ASSOCIATION; EXPRESSION	Using the Immunochip custom SNP array, which was designed for dense genotyping of 186 loci identified through genome-wide association studies (GWAS), we analyzed 11,475 individuals with rheumatoid arthritis (cases) of European ancestry and 15,870 controls for 129,464 markers. We combined these data in a meta-analysis with GWAS data from additional independent cases (n = 2,363) and controls (n = 17,872). We identified 14 new susceptibility loci, 9 of which were associated with rheumatoid arthritis overall and five of which were specifically associated with disease that was positive for anticitrullinated peptide antibodies, bringing the number of confirmed rheumatoid arthritis risk loci in individuals of European ancestry to 46. We refined the peak of association to a single gene for 19 loci, identified secondary independent effects at 6 loci and identified association to low-frequency variants at 4 loci. Bioinformatic analyses generated strong hypotheses for the causal SNP at seven loci. This study illustrates the advantages of dense SNP mapping analysis to inform subsequent functional investigations.	[Eyre, Steve; Bowes, John; Barton, Anne; Martin, Paul; Viatte, Sebastien; McAllister, Kate; Symmons, Deborah; Raychaudhuri, Soumya; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Diogo, Dorothee; Stahl, Eli; Trynka, Gosia; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Plenge, Robert M.; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Diogo, Dorothee; Stahl, Eli; Trynka, Gosia; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Plenge, Robert M.; Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Lee, Annette; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Zhernakova, Alexandra; Wijmenga, Cisca; Trynka, Gosia; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Zhernakova, Alexandra; Wijmenga, Cisca; Trynka, Gosia; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ, Hosp Solna, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Dept Environm Med, Stockholm, Sweden; [Hu, Xinli] Harvard Massachusetts Inst Technol Div Hlth Sci &, Boston, MA USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Davila, Sonia; Khor, Chiea Chuen; Heng, Khai Koon] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Andrews, Robert; Edkins, Sarah; Hunt, Sarah E.; Langford, Cordelia; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Concannon, Pat; Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Gonzalez-Gay, Miguel A.] Hosp Marques de Valdecilla, Inst Fdn Invest Marques de Valdecilla, Dept Rheumatol, Santander, Spain; [Arlsetig, Lisbeth; Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Arlsetig, Lisbeth; Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Rheumatol, Umea, Sweden; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Eyre, Steve; Bowes, John; Barton, Anne; Martin, Paul; Viatte, Sebastien; McAllister, Kate; Symmons, Deborah; Raychaudhuri, Soumya; Worthington, Jane] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester Musculoskeletal Biomed Res Unit, Natl Inst Hlth Res, Manchester, Lancs, England; [Diogo, Dorothee; Stahl, Eli; Trynka, Gosia; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Plenge, Robert M.; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Zhernakova, Alexandra; Toes, Rene E. M.; Huizinga, Tom W. J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands	University of Manchester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northwell Health; University of Groningen; University of Groningen; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Wellcome Trust Sanger Institute; University of Virginia; Hospital Universitario Marques de Valdecilla (HUMV); Umea University; Umea University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Manchester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Worthington, J (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England.	jane.worthington@manchester.ac.uk	Wijmenga, Cisca/AAE-7719-2019; Worthington, Jane/M-9770-2014; O'Donovan, Michael C/P-7005-2018; Deloukas, Panos/B-2922-2013; Raza, Karim/AAN-3089-2021; eyre, stephen/K-3776-2017; Wijmenga, Cisca/D-2173-2009; González-Gay, Miguel A./B-2306-2008; Brown, Matthew A/E-5749-2010; Viatte, Sebastien/B-4253-2015; Martin, Javier/B-8141-2008; Breen, Gerome D/A-5540-2010; Bowes, John/B-3472-2015; de Bakker, Paul IW/B-8730-2009; Franke, Lude/P-7036-2016; Alfredsson, Lars/AAC-9007-2019; Breen, Gerome/Y-2706-2019; Rodriguez-Rodriguez, Luis/H-5880-2013; Timpson, Nicholas John/O-7548-2015; Collier, David A/D-1649-2011; Attrill, Lauren/V-1688-2018; Newhouse, Stephen J/C-9330-2011; Barton, Anne/N-2053-2014; Martín, Javier/AAV-5209-2021; Zhernakova, Alexandra/ABA-9372-2020; Dominiczak, Anna F/P-9390-2017; Martín, María/HDL-9512-2022; McCarthy, Mark/M-3763-2015; Yuldasheva, Nadira Yusupovna/GXM-9013-2022; Padyukov, Leonid/A-4890-2009; Ng, Wan-Fai/R-8083-2016; Prescott, Natalie/F-6490-2011; dobson, richard/C-9269-2011	Wijmenga, Cisca/0000-0002-5635-1614; Worthington, Jane/0000-0003-0544-042X; O'Donovan, Michael C/0000-0001-7073-2379; Deloukas, Panos/0000-0001-9251-070X; Raza, Karim/0000-0003-1570-1232; eyre, stephen/0000-0002-1251-6974; González-Gay, Miguel A./0000-0002-7924-7406; Brown, Matthew A/0000-0003-0538-8211; Viatte, Sebastien/0000-0001-6471-3358; Martin, Javier/0000-0002-2202-0622; Breen, Gerome D/0000-0003-2053-1792; Bowes, John/0000-0003-4659-031X; de Bakker, Paul IW/0000-0001-7735-7858; Franke, Lude/0000-0002-5159-8802; Alfredsson, Lars/0000-0003-1688-6697; Breen, Gerome/0000-0003-2053-1792; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Timpson, Nicholas John/0000-0002-7141-9189; Collier, David A/0000-0003-4087-1559; Newhouse, Stephen J/0000-0002-1843-9842; Barton, Anne/0000-0003-3316-2527; Dominiczak, Anna F/0000-0003-4913-3608; Lango Allen, Hana/0000-0002-7803-8688; Bruce, Ian/0000-0003-3047-500X; Caulfield, Mark/0000-0001-9295-3594; Zeggini, Eleftheria/0000-0003-4238-659X; McCarthy, Mark/0000-0002-4393-0510; Young-Min, Steven/0000-0001-8270-6207; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Birrell, Fraser/0000-0002-6163-6155; Padyukov, Leonid/0000-0003-2950-5670; Duffus, Kate/0000-0002-8925-1863; Tobin, Martin/0000-0002-3596-7874; Weedon, Michael/0000-0002-6174-6135; Concannon, Patrick/0000-0002-5801-1859; Bukhari, Marwan/0000-0003-4311-5222; Symmons, Deborah/0000-0002-8625-1200; Martin, Paul/0000-0002-1016-6851; Ng, Wan-Fai/0000-0002-5539-388X; Zhernakova, Alexandra/0000-0002-4574-0841; Wallace, Chris/0000-0001-9755-1703; Packham, Jon/0000-0001-5531-1680; Grozeva, Detelina/0000-0003-3239-8415; Dunger, Professor David/0000-0002-2566-9304; Hattersley, Andrew/0000-0001-5620-473X; Jones, Lisa/0000-0002-5122-8334; Rich, Stephen/0000-0003-3872-7793; Hunt, Sarah/0000-0002-8350-1235; Morgan, Ann/0000-0003-1109-624X; Hyrich, Kimme/0000-0001-8242-9262; Conaghan, Philip/0000-0002-3478-5665; Munroe, Patricia/0000-0002-4176-2947; Hall, Alistair/0000-0003-0306-7887; Khor, Chiea Chuen/0000-0002-1128-4729; Lindgren, Cecilia/0000-0002-4903-9374; Young, Allan/0000-0003-2291-6952; Klareskog, Lars/0000-0001-9601-6186; MacGregor, Alex/0000-0003-2163-2325; DIOGO, DOROTHEE/0000-0003-2913-5913; Newport, Melanie/0000-0002-8946-7525; Bishop, Tim/0000-0002-8752-8785; Prescott, Natalie/0000-0002-5901-7371; Raychaudhuri, Soumya/0000-0002-1901-8265; Cooper, Cyrus/0000-0003-3510-0709; Ouwehand, Willem/0000-0002-7744-1790; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Forbes, Alastair/0000-0001-7416-9843; Parkes, Miles/0000-0002-6467-0631; Trynka, Gosia/0000-0002-6955-9529; Isaacs, John/0000-0002-6103-7056; dobson, richard/0000-0003-4224-9245; Iles, Mark/0000-0002-2603-6509; Toes, Rene/0000-0002-9618-6414; Dennison, Elaine/0000-0002-3048-4961; Lees, Charlie/0000-0002-0732-8215	Arthritis Research UK [17552]; Manchester Biomedical Research Centre; Arthritis Foundation; Uppsala University; Uppsala University Hospital; Science for Life Laboratory-Uppsala; Swedish Research Council [80576801, 70374401]; Redes Tematicas de Investigacion Cooperative en Salud (RETICS) Program, Instituto de Salud Carlos III, Spain [RD08/0075]; Wellcome Trust [076113/C/04/Z, 068545/Z/02]; US National Institutes for Health research program [RP-PG-0310-1002]; UK Medical Research Council [G0000934]; US National Institutes of Health [K08AR055688, 1R01AR062886-01, RO1-AR-4-4422, NO1-AR-2-2263, NO1-AR1-2256, RO1 AI068759, RC2AR059092-01, R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; Eileen Ludwig Greenland Center for Rheumatoid Arthritis; family of Robert S. Boas; Burroughs Wellcome Fund; MRC [G0600329, G0400491, MC_U147585819, G0800759, G0000934, G0800675, MC_U147585827] Funding Source: UKRI; Medical Research Council [G0800675, G0000934, G0400491, MC_UP_A620_1014, G0800759, MC_U147585827, MC_U147585819, U1475000001, G0600329, MC_U147585824] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10299, NF-SI-0611-10219, NF-SI-0508-10335, NF-SI-0508-10082] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; Chief Scientist Office [ETM/75, ETM/137, CZB/4/540] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688, R01AR057108, N01AR022263, R01AR056768, R01AR062886, RC2AR059092, R01AR059648, R01AR044422, N01AR012256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	Arthritis Research UK(Versus Arthritis); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Arthritis Foundation; Uppsala University; Uppsala University Hospital; Science for Life Laboratory-Uppsala; Swedish Research Council(Swedish Research CouncilEuropean Commission); Redes Tematicas de Investigacion Cooperative en Salud (RETICS) Program, Instituto de Salud Carlos III, Spain; Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes for Health research program; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eileen Ludwig Greenland Center for Rheumatoid Arthritis; family of Robert S. Boas; Burroughs Wellcome Fund(Burroughs Wellcome Fund); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); Chief Scientist Office; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank). Barrett and C. Wallace for the SNP selection. We thank the Wellcome Trust Sanger Institute Genotyping Facility, and, in particular, E. Gray, S. Bumpstead, D. Simpkin and H. Blackburn. Genotyping of the UK Rheumatoid Arthritis Genetics samples was supported by the Arthritis Research UK grant reference number 17552 and the Manchester Biomedical Research Centre. This work was made possible by funds from the Arthritis Foundation (S.R., principal investigator) and the US National Institutes Health (K08AR055688 to S.R. and 1R01AR062886-01 to P.I.W.d.B). P. Gilbert prepared the UK samples. Genotyping of the Swedish Umea samples was performed by the SNP&SEQ Technology Platform in Uppsala, which is supported by Uppsala University, Uppsala University Hospital, Science for Life Laboratory-Uppsala and the Swedish Research Council (contracts 80576801 and 70374401). This work was partially supported by the Redes Tematicas de Investigacion Cooperative en Salud (RETICS) Program, RD08/0075 (RIER), from the Instituto de Salud Carlos III, Spain. We acknowledge use of DNA from the UK Blood Services collection of Common Controls (UKBS-CC collection), which is funded by Wellcome Trust grant 076113/C/04/Z and by the US National Institutes for Health research program grant to the National Health Service Blood and Transplant (RP-PG-0310-1002). We acknowledge the use of DNA from the British 1958 Birth Cohort collection, which is funded by the UK Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. The North American Rheumatoid Arthritis Consortium and analysis of other US patient and control collections at the Feinstein Institute were supported by the US National Institutes of Health RO1-AR-4-4422, NO1-AR-2-2263; NO1-AR1-2256, RO1 AI068759 and RC2AR059092-01, with additional support from the Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the family of Robert S. Boas. R.M.P. is supported by grants from the US National Institutes of Health (R01-AR057108, R01-AR056768, U01-GM092691 and R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stevens L, 2006, EUR J IMMUNOL, V36, P3305, DOI 10.1002/eji.200636400; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	17	439	462	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1336	1340		10.1038/ng.2462	http://dx.doi.org/10.1038/ng.2462			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143596	Green Accepted, Green Submitted			2022-12-17	WOS:000311713200012
J	Studer, A; Zhao, Q; Ross-Ibarra, J; Doebley, J				Studer, Anthony; Zhao, Qiong; Ross-Ibarra, Jeffrey; Doebley, John			Identification of a functional transposon insertion in the maize domestication gene tb1	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; ELEMENT INSERTIONS; EVOLUTION; RETROTRANSPOSON; POLYMORPHISM; EXPRESSION; PLANT; COALESCENT; DIVERSITY; HAPLOTYPE	Genetic diversity created by transposable elements is an important source of functional variation upon which selection acts during evolution(1-6). Transposable elements are associated with adaptation to temperate climates in Drosophila(7), a SINE element is associated with the domestication of small dog breeds from the gray wolf(8) and there is evidence that transposable elements were targets of selection during human evolution(9). Although the list of examples of transposable elements associated with host gene function continues to grow, proof that transposable elements are causative and not just correlated with functional variation is limited. Here we show that a transposable element (Hopscotch) inserted in a regulatory region of the maize domestication gene, teosinte branched1 (tb1), acts as an enhancer of gene expression and partially explains the increased apical dominance in maize compared to its progenitor, teosinte. Molecular dating indicates that the Hopscotch insertion predates maize domestication by at least 10,000 years, indicating that selection acted on standing variation rather than new mutation.	[Studer, Anthony; Zhao, Qiong; Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Doebley, J (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jdoebley@wisc.edu	Ross-Ibarra, Jeffrey/D-7782-2011; Studer, Anthony/V-2570-2019	Ross-Ibarra, Jeffrey/0000-0003-1656-4954; 	US Department of Agriculture [MSN101593]; US National Science Foundation [DBI0820619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	US Department of Agriculture(United States Department of Agriculture (USDA)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Doebley laboratory for technical assistance, especially H. Wang. We also thank A.J. Eckert, K. Thornton, G. Coop and R.A. Cartwright for helpful discussion and J. Holland for statistical advice. This work is supported by US Department of Agriculture Hatch grant MSN101593 and US National Science Foundation grant DBI0820619.	Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Clark RM, 2005, MOL BIOL EVOL, V22, P2304, DOI 10.1093/molbev/msi228; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Gonzalez J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000905; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; HUDSON RR, 1987, GENETICS, V116, P153; MACKAY TFC, 1992, GENETICS, V130, P315; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Pi WH, 2010, P NATL ACAD SCI USA, V107, P12992, DOI 10.1073/pnas.1004139107; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; TORKAMANZEHI A, 1992, GENETICS, V131, P73; WHITE SE, 1994, P NATL ACAD SCI USA, V91, P11792, DOI 10.1073/pnas.91.25.11792; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; ZHAO Q, 2006, THESIS U WISCONSIN M; Zhao Q, 2011, GENET RES, V93, P65, DOI 10.1017/S0016672310000509	33	439	457	3	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1160	U164		10.1038/ng.942	http://dx.doi.org/10.1038/ng.942			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21946354	Green Accepted			2022-12-17	WOS:000296584000024
J	Tarpey, PS; Smith, R; Pleasance, E; Whibley, A; Edkins, S; Hardy, C; O'Meara, S; Latimer, C; Dicks, E; Menzies, A; Stephens, P; Blow, M; Greenman, C; Xue, YL; Tyler-Smith, C; Thompson, D; Gray, K; Andrews, J; Barthorpe, S; Buck, G; Cole, J; Dunmore, R; Jones, D; Maddison, M; Mironenko, T; Turner, R; Turrell, K; Varian, J; West, S; Widaa, S; Wray, P; Teague, J; Butler, A; Jenkinson, A; Jia, MM; Richardson, D; Shepherd, R; Wooster, R; Tejada, MI; Martinez, F; Carvill, G; Goliath, R; de Brouwer, APM; van Bokhoven, H; Van Esch, H; Chelly, J; Raynaud, M; Ropers, HH; Abidi, FE; Srivastava, AK; Cox, J; Luo, Y; Mallya, U; Moon, J; Parnau, J; Mohammed, S; Tolmie, JL; Shoubridge, C; Corbett, M; Gardner, A; Haan, E; Rujirabanjerd, S; Shaw, M; Vandeleur, L; Fullston, T; Easton, DF; Boyle, J; Partington, M; Hackett, A; Field, M; Skinner, C; Stevenson, RE; Bobrow, M; Turner, G; Schwartz, CE; Gecz, J; Raymond, FL; Futreal, PA; Stratton, MR				Tarpey, Patrick S.; Smith, Raffaella; Pleasance, Erin; Whibley, Annabel; Edkins, Sarah; Hardy, Claire; O'Meara, Sarah; Latimer, Calli; Dicks, Ed; Menzies, Andrew; Stephens, Phil; Blow, Matt; Greenman, Chris; Xue, Yali; Tyler-Smith, Chris; Thompson, Deborah; Gray, Kristian; Andrews, Jenny; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Dunmore, Rebecca; Jones, David; Maddison, Mark; Mironenko, Tatiana; Turner, Rachel; Turrell, Kelly; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, Jon; Butler, Adam; Jenkinson, Andrew; Jia, Mingming; Richardson, David; Shepherd, Rebecca; Wooster, Richard; Tejada, M. Isabel; Martinez, Francisco; Carvill, Gemma; Goliath, Rene; de Brouwer, Arjan P. M.; van Bokhoven, Hans; Van Esch, Hilde; Chelly, Jamel; Raynaud, Martine; Ropers, Hans-Hilger; Abidi, Fatima E.; Srivastava, Anand K.; Cox, James; Luo, Ying; Mallya, Uma; Moon, Jenny; Parnau, Josef; Mohammed, Shehla; Tolmie, John L.; Shoubridge, Cheryl; Corbett, Mark; Gardner, Alison; Haan, Eric; Rujirabanjerd, Sinitdhorn; Shaw, Marie; Vandeleur, Lucianne; Fullston, Tod; Easton, Douglas F.; Boyle, Jackie; Partington, Michael; Hackett, Anna; Field, Michael; Skinner, Cindy; Stevenson, Roger E.; Bobrow, Martin; Turner, Gillian; Schwartz, Charles E.; Gecz, Jozef; Raymond, F. Lucy; Futreal, P. Andrew; Stratton, Michael R.			A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation	NATURE GENETICS			English	Article							HUMAN GENOME; PROTEIN EVOLUTION; CANCER GENOMES; DNA-SEQUENCE; MUTATIONS; SELECTION; GENETICS; DISEASE; GENES; CONSERVATION	Large-scale systematic resequencing has been proposed as the key future strategy for the discovery of rare, disease-causing sequence variants across the spectrum of human complex disease. We have sequenced the coding exons of the X chromosome in 208 families with X-linked mental retardation (XLMR), the largest direct screen for constitutional disease-causing mutations thus far reported. The screen has discovered nine genes implicated in XLMR, including SYP, ZNF711 and CASK reported here, confirming the power of this strategy. The study has, however, also highlighted issues confronting whole-genome sequencing screens, including the observation that loss of function of 1% or more of X-chromosome genes is compatible with apparently normal existence.	[Tarpey, Patrick S.; Smith, Raffaella; Pleasance, Erin; Edkins, Sarah; Hardy, Claire; O'Meara, Sarah; Latimer, Calli; Dicks, Ed; Menzies, Andrew; Stephens, Phil; Blow, Matt; Greenman, Chris; Xue, Yali; Tyler-Smith, Chris; Gray, Kristian; Andrews, Jenny; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Dunmore, Rebecca; Jones, David; Maddison, Mark; Mironenko, Tatiana; Turner, Rachel; Turrell, Kelly; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, Jon; Butler, Adam; Jenkinson, Andrew; Jia, Mingming; Richardson, David; Shepherd, Rebecca; Wooster, Richard; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge, England; [Whibley, Annabel; Cox, James; Luo, Ying; Mallya, Uma; Moon, Jenny; Parnau, Josef; Bobrow, Martin; Raymond, F. Lucy] Cambridge Inst Med Res, Cambridge, England; [Thompson, Deborah; Easton, Douglas F.] Strangeways Res Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 4RN, England; [Tejada, M. Isabel] Hosp Cruces, Mol Genet Lab, Bizkaia, Spain; [Martinez, Francisco] Hosp Univ La Fe, Unidad Genet & Diagnost Prenatal, Valencia, Spain; [Carvill, Gemma; Goliath, Rene] Univ S Africa, Fac Hlth Sci, Human Genet Res Unit, MRC, ZA-0001 Pretoria, South Africa; [de Brouwer, Arjan P. M.; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Van Esch, Hilde] Katholieke Univ Leuven Hosp, Ctr Human Genet, Leuven, Belgium; [Chelly, Jamel] Univ Paris 05, Inst Cochin, INSERM, CNRS,Unite 567,UMR 8104, Paris, France; [Raynaud, Martine] Ctr Hosp Reg Univ Tours, INSERM, U930, Serv Genet, Tours, France; [Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Abidi, Fatima E.; Srivastava, Anand K.; Skinner, Cindy; Stevenson, Roger E.; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Mohammed, Shehla] Guys Hosp, London SE1 9RT, England; [Tolmie, John L.] Yorkhill Hosp, Inst Med Genet, Glasgow, Lanark, Scotland; [Shoubridge, Cheryl; Corbett, Mark; Gardner, Alison; Haan, Eric; Rujirabanjerd, Sinitdhorn; Shaw, Marie; Vandeleur, Lucianne; Fullston, Tod; Gecz, Jozef] Womens & Childrens Hosp, Adelaide, SA, Australia; [Boyle, Jackie; Partington, Michael; Hackett, Anna; Field, Michael; Turner, Gillian] GOLD Serv, Waratah, NSW, Australia; [Gecz, Jozef] Univ Adelaide, Adelaide, SA, Australia; [Stratton, Michael R.] Inst Canc Res, Surrey, England	Wellcome Trust Sanger Institute; University of Cambridge; Cancer Research UK; University of Cambridge; Hospital Universitario Cruces; Hospital Universitari i Politecnic La Fe; University of South Africa; Radboud University Nijmegen; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Greenwood Genetic Center; Guy's & St Thomas' NHS Foundation Trust; University of Glasgow; Womens & Childrens Hospital Australia; University of Adelaide; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Bokhoven, J.H.L.M. van van/H-8015-2014; TEJADA, Maria-Isabel/O-5051-2019; Blow, Matthew/G-6369-2012; Gecz, Jozef/X-3469-2019; Van+Esch, Hilde/AAU-5688-2020; Chelly, Jamel/J-7528-2015; Whibley, Annabel/G-2836-2011; Cox, James/R-1910-2016; M Isabel, Tejada/E-2394-2012; van Bokhoven, Hans/D-8764-2012; Corbett, Mark/A-8063-2010; Whibley, Annabel/P-2509-2017; de Brouwer, Arjan PM/P-5949-2015; Raynaud, Martine/R-9811-2019; Shoubridge, Cheryl/A-1571-2016; Martinez, Francisco/A-2543-2009	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; TEJADA, Maria-Isabel/0000-0002-7334-1864; Blow, Matthew/0000-0002-8844-9149; Gecz, Jozef/0000-0002-7884-6861; Chelly, Jamel/0000-0002-0939-8719; Corbett, Mark/0000-0001-9298-3072; Whibley, Annabel/0000-0003-1878-7705; Raynaud, Martine/0000-0002-6888-6480; Shoubridge, Cheryl/0000-0002-0157-3084; Martinez, Francisco/0000-0002-0589-2584; Gray, Kristian/0000-0002-7035-7107; Van Esch, Hilde/0000-0002-9604-5726; Buck, Gemma/0000-0001-5289-1050; Jenkinson, Andrew/0000-0002-0703-6984; Richardson, David/0000-0003-0247-9118	European Community's Seventh Framework Programme-the GEN2PHEN Project; New South Wales Department of Health; Australian NHMRC; SMILE foundation; WCH Foundation; D. Harwood, EU (EURO-MRX) [QLG3-CT-2002-01810]; US National Institutes of Health [HD26202]; South Carolina Department of Disabilities and Special Needs (SCDDSN); Action Medical Research; Wellcome Trust; Cancer Research UK [10118, 11022] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme-the GEN2PHEN Project(European Commission); New South Wales Department of Health; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); SMILE foundation; WCH Foundation; D. Harwood, EU (EURO-MRX); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs (SCDDSN); Action Medical Research; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to express our gratitude to the many families with members with mental retardation or learning disability who agreed to participate in these studies performed by the IGOLD consortium. We would also like to thank many clinicians and researchers, including J. T. den Dunnen, L. Holloway, M. May, B. Kerr, J. Erikson, R. Smith, E. Fraser, P. Hodgins, I. Wilkinson, A. J. Gardener, D. Amor, D. Anderson, M. Edwards, V. J. Ajith, A. Barnicoat, P. Beales, K. Becker, A. Brady, C. Brewer, J. Christodoulou, J. Clayton- Smith, T. Cole, A. Collins, J. Cook, J. Craig, S. Davies, H. Dawkins, M. Delatycki, D. Donnai, M. Edwards, F. Essop, D. Fitzpatrick, F. Flinter, B. Franco, A. Fryer, T. Homfray, S. Garcia, C. Gardiner, R. Gardner, C. Garrett, R. Gibbons, A. Green, P. Guilbert, D. Halliday, B. Hamel, P. Harper, E. Hobson, S. Holder, E. Holinski- Feder, H. Hughes, J. Hurst, F. Kavalier, B. Kerr, U. Kini, T. Kleefstra, F. Kooy, K. Lachlan, W. Lam, M. Lees, S. Lindsay, C. Longman, S. Lynch, S. Mansour, C. Mercel, J. McGaughran, V. Murday, J. Nelson, G. Neri, R. Newbury-Ecob, C. Owens, M. Patton, M. Porteous, S. Price, A. Proctor, O. Quarrell, N. Rahman, W. Reardon, E. Rosser, F. Stewart, H. Stewart, S. Tompkins, D. Trump, B. de Vries, T. Webb, D. Wellesley, D. Williams, L. Wilson, R. Winter, N. Wood, and J. Yates, who referred families for research, and N. Rahman for comments on the manuscript. The work was supported by the European Community's Seventh Framework Programme-the GEN2PHEN Project, the New South Wales Department of Health, the Australian NHMRC, the SMILE foundation, the WCH Foundation, D. Harwood, EU grant QLG3-CT-2002-01810 (EURO-MRX), US National Institutes of Health (HD26202) to C. E. S., the South Carolina Department of Disabilities and Special Needs (SCDDSN), Action Medical Research and the Wellcome Trust.	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; BAIRD PA, 1985, AM J MENT DEF, V89, P323; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LAXOVA R, 1977, AM J MED GENET, V1, P75, DOI 10.1002/ajmg.1320010109; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; McCandless SE, 2004, AM J HUM GENET, V74, P121, DOI 10.1086/381053; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Osada N, 2007, MOL BIOL EVOL, V24, P1622, DOI 10.1093/molbev/msm080; Polder JJ, 2002, J INTELL DISABIL RES, V46, P168, DOI 10.1046/j.1365-2788.2002.00384.x; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sakharkar Meena Kishore, 2004, Front Biosci, V9, P3262, DOI 10.2741/1478; SCHREPPERS-TIJDINK G A J, 1988, Journal de Genetique Humaine, V36, P425; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; W.H. Organization, 1992, ICD 10 CLASS MENT BE; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013	42	439	458	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					535	543		10.1038/ng.367	http://dx.doi.org/10.1038/ng.367			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377476	Green Accepted			2022-12-17	WOS:000265575600014
J	Plenge, RM; Cotsapas, C; Davies, L; Price, AL; Bakker, PIW; Maller, J; Pe'er, I; Burtt, NP; Blumenstiel, B; DeFelice, M; Parkin, M; Barry, R; Winslow, W; Healy, C; Graham, RR; Neale, BM; Izmailova, E; Roubenoff, R; Parker, AN; Glass, R; Karlson, EW; Maher, N; Hafler, DA; Lee, DM; Seldin, MF; Remmers, EF; Lee, AT; Padyukov, L; Alfredsson, L; Coblyn, J; Weinblatt, ME; Gabriel, SB; Purcell, S; Klareskog, L; Gregersen, PK; Shadick, NA; Daly, MJ; Altshuler, D				Plenge, Robert M.; Cotsapas, Chris; Davies, Leela; Price, Alkes L.; Bakker, Paul I. Wde; Maller, Julian; Pe'er, Itsik; Burtt, Noel P.; Blumenstiel, Brendan; DeFelice, Matt; Parkin, Melissa; Barry, Rachel; Winslow, Wendy; Healy, Claire; Graham, Robert R.; Neale, Benjamin M.; Izmailova, Elena; Roubenoff, Ronenn; Parker, Alexander N.; Glass, Roberta; Karlson, Elizabeth W.; Maher, Nancy; Hafler, David A.; Lee, David M.; Seldin, Michael F.; Remmers, Elaine F.; Lee, Annette T.; Padyukov, Leonid; Alfredsson, Lars; Coblyn, Jonathan; Weinblatt, Michael E.; Gabriel, Stacey B.; Purcell, Shaun; Klareskog, Lars; Gregersen, Peter K.; Shadick, Nancy A.; Daly, Mark J.; Altshuler, David			Two independent alleles at 6q23 associated with risk of rheumatoid arthritis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION-STRUCTURE; STRATIFICATION; VARIANT	To identify susceptibility alleles associated with rheumatoid arthritis, we genotyped 397 individuals with rheumatoid arthritis for 116,204 SNPs and carried out an association analysis in comparison to publicly available genotype data for 1,211 related individuals from the Framingham Heart Study(1). After evaluating and adjusting for technical and population biases, we identified a SNP at 6q23 ( rs10499194, similar to 150 kb from TNFAIP3 and OLIG3) that was reproducibly associated with rheumatoid arthritis both in the genome-wide association ( GWA) scan and in 5,541 additional case-control samples (P = 10(-3), GWA scan; P < 10(-6), replication; P = 10(-9), combined). In a concurrent study, the Wellcome Trust Case Control Consortium ( WTCCC) has reported strong association of rheumatoid arthritis susceptibility to a different SNP located 3.8 kb from rs10499194 ( rs6920220; P = 5 x 10(-6) in WTCCC)(2). We show that these two SNP associations are statistically independent, are each reproducible in the comparison of our data and WTCCC data, and define risk and protective haplotypes for rheumatoid arthritis at 6q23.	MIT, Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Harvard Med Sch, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Harvard Med Sch, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02115 USA; Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; Coll London, London SE5 8AF, England; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Harvard Med Sch, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; NIAMSD, NIH, Genet Genom Branch, Bethesda, MD 20892 USA; N Shore Long Island Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; Karilinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University; University of London; University College London; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwell Health; Karolinska Institutet; Karolinska Institutet	Plenge, RM (corresponding author), MIT, Broad Inst Harvard, Program Med & Populat Genet, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	rplenge@partners.org	Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009; maller, julian B/A-9323-2009; Alfredsson, Lars/AAC-9007-2019; Daly, Mark J/B-2453-2017; Padyukov, Leonid/A-4890-2009	Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Alfredsson, Lars/0000-0003-1688-6697; Daly, Mark J/0000-0002-0949-8752; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186; Maller, Julian/0000-0002-1565-9559; Roubenoff, Ronenn/0000-0002-3959-3179; Healy, Claire M/0000-0001-7940-4611; Remmers, Elaine F/0000-0002-9522-1249; Cotsapas, Chris/0000-0002-7772-5910; Izmailova, Elena/0000-0002-7150-1748	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, Z01AR041139, N01AR022263] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI055314-02, K08 AI055314, K08 AI055314-03, AI55314-3, K08 AI055314-01A1, K08 AI055314-04, K08 AI055314-05] Funding Source: Medline; NIAMS NIH HHS [R01-AR44422, N01-AR-2-2263, R01 AR044422] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Irigoyen P, 2005, ARTHRITIS RHEUM-US, V52, P3813, DOI 10.1002/art.21419; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	28	439	456	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1477	1482		10.1038/ng.2007.27	http://dx.doi.org/10.1038/ng.2007.27			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982456	Green Accepted			2022-12-17	WOS:000251267400015
J	Segre, D; DeLuna, A; Church, GM; Kishony, R				Segre, D; DeLuna, A; Church, GM; Kishony, R			Modular epistasis in yeast metabolism	NATURE GENETICS			English	Article							DELETERIOUS MUTATIONS; NETWORK; ORGANIZATION; PRINCIPLES; EVOLUTION; STRAINS; BIOLOGY; FLUX	Epistatic interactions, manifested in the effects of mutations on the phenotypes caused by other mutations, may help uncover the functional organization of complex biological networks(1-3). Here, we studied system-level epistatic interactions by computing growth phenotypes of all single and double knockouts of 890 metabolic genes in Saccharomyces cerevisiae, using the framework of flux balance analysis(4). A new scale for epistasis identified a distinctive trimodal distribution of these epistatic effects, allowing gene pairs to be classified as buffering, aggravating or noninteracting(2,5). We found that the ensuing epistatic interaction network(6) could be organized hierarchically into function-enriched modules that interact with each other 'monochromatically' (i.e., with purely aggravating or purely buffering epistatic links). This property extends the concept of epistasis from single genes to functional units and provides a new definition of biological modularity, which emphasizes interactions between, rather than within, functional modules. Our approach can be used to infer functional gene modules from purely phenotypic epistasis measurements.	Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kishony, R (corresponding author), Harvard Univ, Bauer Ctr Genom Res, 7 Divin Ave, Cambridge, MA 02138 USA.	rkishony@cgr.harvard.edu	Segrè, Daniel/A-1993-2009; DeLuna, Alexander/H-9986-2016	Segrè, Daniel/0000-0003-4859-1914; DeLuna, Alexander/0000-0002-9236-2804; church, george/0000-0001-6232-9969				Almaas E, 2004, NATURE, V427, P839, DOI 10.1038/nature02289; Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Burch CL, 2003, J EVOLUTION BIOL, V16, P1223, DOI 10.1046/j.1420-9101.2003.00632.x; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 1999, J MOL EVOL, V49, P703, DOI 10.1007/PL00000082; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kaufman A, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P332; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Remold SK, 2004, NAT GENET, V36, P423, DOI 10.1038/ng1324; Salthe S. N., 1985, EVOLVING HIERARCHICA; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wloch DM, 2001, J EVOLUTION BIOL, V14, P310, DOI 10.1046/j.1420-9101.2001.00267.x; You LC, 2002, GENETICS, V160, P1273	30	439	452	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					77	83		10.1038/ng1489	http://dx.doi.org/10.1038/ng1489			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15592468				2022-12-17	WOS:000225997500024
J	Lefebvre, L; Viville, S; Barton, SC; Ishino, F; Keverne, EB; Surani, MA				Lefebvre, L; Viville, S; Barton, SC; Ishino, F; Keverne, EB; Surani, MA			Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest	NATURE GENETICS			English	Article							SILVER-RUSSELL-SYNDROME; EMBRYONIC STEM-CELLS; UNIPARENTAL DISOMY; DIAGNOSTIC-CRITERIA; ANGELMAN-SYNDROME; HUMAN PEG1/MEST; MICE LACKING; CHROMOSOME-7; MOUSE; EXPRESSION	Mest (also known as Peg1), an imprinted gene expressed only from the paternal allele during development, was disrupted by gene targeting in embryonic stem (ES) cells. The targeted mutation is imprinted and reversibly silenced by passage through the female germ line. Paternal transmission activates the targeted allele and causes embryonic growth retardation associated with reduced postnatal survival rates in mutant progeny. More significantly. Mest-deficient females show abnormal maternal behaviour and impaired placentophagia, a distinctive mammalian behaviour. Our results provide evidence for the involvement of an imprinted gene in the control of adult behaviour.	Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England; Tokyo Inst Technol, Ctr Gene Res, Midori Ku, Yokohama, Kanagawa 226, Japan; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England	University of Cambridge; Tokyo Institute of Technology; University of Cambridge	Surani, MA (corresponding author), Wellcome CRC Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.	as10021@mole.bio.cam.ac.uk	Lefebvre, Louis/O-9309-2016	Lefebvre, Louis/0000-0001-5664-9480; Viville, Stephane/0000-0002-5088-3003	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ainscough J. F. X., 1996, Epigenetic mechanisms of gene regulation., P173; ALLEN ND, 1995, P NATL ACAD SCI USA, V92, P10782, DOI 10.1073/pnas.92.23.10782; BEECHEY CV, 1989, MOUSE NEWS LETT, V84, P82; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; CATTANACH BM, 1990, DEVELOPMENT, P63; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DICKINSON C, 1988, PHYSIOL BEHAV, V43, P313, DOI 10.1016/0031-9384(88)90193-X; Eggermann T, 1997, HUM GENET, V100, P415, DOI 10.1007/s004390050526; FRANZ JR, 1986, PHYSIOL BEHAV, V38, P629, DOI 10.1016/0031-9384(86)90256-8; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FUNDELE RH, 1994, DEV GENET, V15, P515, DOI 10.1002/dvg.1020150610; HAIG D, 1991, CELL, V64, P1045; HOGLUND P, 1994, AM J HUM GENET, V55, P747; HOLM VA, 1993, PEDIATRICS, V91, P398; John RM, 1996, CURR OPIN CELL BIOL, V8, P348, DOI 10.1016/S0955-0674(96)80008-1; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; KRISTAL MB, 1991, NEUROSCI BIOBEHAV R, V15, P425, DOI 10.1016/S0149-7634(05)80035-1; LANGLOIS S, 1995, J MED GENET, V32, P871, DOI 10.1136/jmg.32.11.871; LATHE R, 1987, GENE, V57, P193, DOI 10.1016/0378-1119(87)90122-3; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; Lefebvre L, 1997, HUM MOL GENET, V6, P1907, DOI 10.1093/hmg/6.11.1907; Miyoshi N, 1998, P NATL ACAD SCI USA, V95, P1102, DOI 10.1073/pnas.95.3.1102; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishita Y, 1996, GENOMICS, V36, P539, DOI 10.1006/geno.1996.0502; NUMAN M, 1994, ACTA PAEDIATR, V83, P19, DOI 10.1111/j.1651-2227.1994.tb13261.x; PATTON MA, 1988, J MED GENET, V25, P557, DOI 10.1136/jmg.25.8.557; Preece MA, 1997, J MED GENET, V34, P6, DOI 10.1136/jmg.34.1.6; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; SADO T, 1993, DEV GROWTH DIFFER, V35, P551; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Thomas SA, 1997, CELL, V91, P583, DOI 10.1016/S0092-8674(00)80446-8; VOSS R, 1989, AM J HUM GENET, V45, P373; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224	42	439	449	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					163	169		10.1038/2464	http://dx.doi.org/10.1038/2464			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771709				2022-12-17	WOS:000076231300018
J	Stark, KL; Xu, B; Bagchi, A; Lai, WS; Liu, H; Hsu, R; Wan, X; Pavlidis, P; Mills, AA; Karayiorgou, M; Gogos, JA				Stark, Kimberly L.; Xu, Bin; Bagchi, Anindya; Lai, Wen-Sung; Liu, Hui; Hsu, Ruby; Wan, Xiang; Pavlidis, Paul; Mills, Alea A.; Karayiorgou, Maria; Gogos, Joseph A.			Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model	NATURE GENETICS			English	Article							22Q11 DELETION SYNDROME; CARDIO-FACIAL SYNDROME; PREPULSE INHIBITION; GENETIC-VARIATION; SYNDROME REGION; MICE; SCHIZOPHRENIA; MEMORY; DISORDER; SYSTEM	Individuals with 22q11.2 microdeletions show behavioral and cognitive deficits and are at high risk of developing schizophrenia. We analyzed an engineered mouse strain carrying a chromosomal deficiency spanning a segment syntenic to the human 22q11.2 locus. We uncovered a previously unknown alteration in the biogenesis of microRNAs (miRNAs) and identified a subset of brain miRNAs affected by the microdeletion. We provide evidence that the abnormal miRNA biogenesis emerges because of haploinsufficiency of the Dgcr8 gene, which encodes an RNA-binding moiety of the 'microprocessor' complex and contributes to the behavioral and neuronal deficits associated with the 22q11.2 microdeletion.	[Xu, Bin; Lai, Wen-Sung; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, New York, NY 10032 USA; [Stark, Kimberly L.; Liu, Hui; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA; [Bagchi, Anindya; Mills, Alea A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hsu, Ruby; Gogos, Joseph A.] Columbia Univ, Dept Neurosci, Coll Phys & Surg, New York, NY 10032 USA; [Wan, Xiang; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada; [Wan, Xiang; Pavlidis, Paul] Univ British Columbia, Bioinformat Ctr, Vancouver, BC V6T 1Z4, Canada	Columbia University; Columbia University; Cold Spring Harbor Laboratory; Columbia University; University of British Columbia; University of British Columbia	Gogos, JA (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	jag90@columbia.edu	Pavlidis, Paul/H-8406-2013	Pavlidis, Paul/0000-0002-0426-5028; Lai, Wen-Sung/0000-0001-6918-5531	NIMH NIH HHS [MH077235, MH067068] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068, R01MH077235] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gothelf D, 2004, AM J MED GENET B, V126B, P99, DOI 10.1002/ajmg.b.20124; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gothelf D, 2004, AM J MED GENET B, V126B, P116, DOI 10.1002/ajmg.b.20144; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jurata LW, 2006, SCHIZOPHR RES, V88, P251, DOI 10.1016/j.schres.2006.07.017; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Long JM, 2006, NEUROGENETICS, V7, P247, DOI 10.1007/s10048-006-0054-0; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Meechan DW, 2006, MOL CELL NEUROSCI, V33, P412, DOI 10.1016/j.mcn.2006.09.001; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Paylor R, 2001, HUM MOL GENET, V10, P2645, DOI 10.1093/hmg/10.23.2645; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Schratt GM, 2006, NATURE, V441, P902, DOI 10.1038/nature04909; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sivagnanasundaram S, 2007, BRAIN RES, V1139, P48, DOI 10.1016/j.brainres.2007.01.014; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	50	438	456	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					751	760		10.1038/ng.138	http://dx.doi.org/10.1038/ng.138			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469815	Green Submitted			2022-12-17	WOS:000256212000017
J	Haigis, KM; Kendall, KR; Wang, YF; Cheung, A; Haigis, MC; Glickman, JN; Niwa-Kawakita, M; Sweet-Cordero, A; Sebolt-Leopold, J; Shannon, KM; Settleman, J; Giovannini, M; Jacks, T				Haigis, Kevin M.; Kendall, Krystle R.; Wang, Yufang; Cheung, Ann; Haigis, Marcia C.; Glickman, Jonathan N.; Niwa-Kawakita, Michiko; Sweet-Cordero, Alejandro; Sebolt-Leopold, Judith; Shannon, Kevin M.; Settleman, Jeffrey; Giovannini, Marco; Jacks, Tyler			Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon	NATURE GENETICS			English	Article							INTESTINAL EPITHELIUM; PROTEIN-KINASE; STEM-CELL; IN-VIVO; H-RAS; CANCER; GROWTH; MOUSE; MICE; IDENTIFICATION	Kras is commonly mutated in colon cancers, but mutations in Nras are rare. We have used genetically engineered mice to determine whether and how these related oncogenes regulate homeostasis and tumorigenesis in the colon. Expression of K-Ras(G12D) in the colonic epithelium stimulated hyperproliferation in a Mek-dependent manner. N-Ras(G12D) did not alter the growth properties of the epithelium, but was able to confer resistance to apoptosis. In the context of an Apc-mutant colonic tumor, activation of K-Ras led to defects in terminal differentiation and expansion of putative stem cells within the tumor epithelium. This K-Ras tumor phenotype was associated with attenuated signaling through the MAPK pathway, and human colon cancer cells expressing mutant K-Ras were hypersensitive to inhibition of Raf, but not Mek. These studies demonstrate clear phenotypic differences between mutant Kras and Nras, and suggest that the oncogenic phenotype of mutant K-Ras might be mediated by noncanonical signaling through Ras effector pathways.	[Haigis, Kevin M.; Cheung, Ann; Jacks, Tyler] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Haigis, Kevin M.; Cheung, Ann; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Haigis, Kevin M.; Kendall, Krystle R.; Wang, Yufang; Settleman, Jeffrey] Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; [Haigis, Kevin M.; Kendall, Krystle R.; Wang, Yufang; Settleman, Jeffrey] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs, Boston, MA 02115 USA; [Glickman, Jonathan N.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Niwa-Kawakita, Michiko; Giovannini, Marco] Ctr Etude Polymorphisme Humain, Fdn Jean Dausset, INSERM, U674, Paris, France; [Niwa-Kawakita, Michiko; Giovannini, Marco] Inst Univ Hematol, Paris, France; [Sweet-Cordero, Alejandro] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Sweet-Cordero, Alejandro] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Sebolt-Leopold, Judith] JS Leopold Consulting, Ann Arbor, MI 48105 USA; [Shannon, Kevin M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Stanford University; Stanford University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	tjacks@mit.edu		Kawakita, Michiko/0000-0002-9450-583X	NATIONAL CANCER INSTITUTE [R01CA072614, U01CA084221, U54CA112967, R37CA072614, P30CA014051, U01CA084306, P50CA127003, K01CA118425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088827] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [U01 CA084221-07, P30 CA014051-33, R01 CA072614-05S1, R01 CA072614-06, U01-CA84306, R01 CA072614-04, U54 CA112967, P30 CA014051-34, P30-CA14051, U01 CA084306-02, U01 CA084221-01, U01 CA084306, R01 CA072614-08, P30 CA014051, U01-CA84221, U01 CA084221-06, U54 CA112967-040002, R01 CA072614-07, U01 CA084221-02, U01 CA084221, K01 CA118425, R01 CA072614-09, U01 CA084306-01, R01-CA72614, U01 CA084221-09, U01 CA084221-03, P50-CA127003, U01 CA084221-04, K01-CA118425, U54 CA112967-030002, P50 CA127003, U54 CA112967-020002, P30 CA014051-35, R01 CA072614-05, U01 CA084306-05, U01 CA084221-05, U01 CA084306-04, R01 CA072614-03, R01 CA072614-04S1, K01 CA118425-01A1, U54-CA112967, U01 CA084221-08, R01 CA072614, U01 CA084306-03, K01 CA118425-02, R01 CA072614-10, P30 CA014051-36, R37 CA072614, U54 CA112967-010002] Funding Source: Medline; NIGMS NIH HHS [R01 GM088827] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Holt KH, 1996, MOL CELL BIOL, V16, P577; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janssen KP, 2002, GASTROENTEROLOGY, V123, P492, DOI 10.1053/gast.2002.34786; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Keller JW, 2007, ONCOGENE, V26, P3051, DOI 10.1038/sj.onc.1210103; Keller JW, 2007, J CELL PHYSIOL, V210, P740, DOI 10.1002/jcp.20898; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wolfman JC, 2002, MOL CELL BIOL, V22, P1589, DOI 10.1128/MCB.22.5.1589-1606.2002; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997	36	438	444	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					600	608		10.1038/ng.115	http://dx.doi.org/10.1038/ng.115			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372904	Green Accepted			2022-12-17	WOS:000255366700028
J	Henderson, IR; Zhang, XY; Lu, C; Johnson, L; Meyers, BC; Green, PJ; Jacobsen, SE				Henderson, Ian R.; Zhang, Xiaoyu; Lu, Cheng; Johnson, Lianna; Meyers, Blake C.; Green, Pamela J.; Jacobsen, Steven E.			Dissecting Arabidopsis thaliana DICER function in small RNA processing, gene silencing and DNA methylation patterning	NATURE GENETICS			English	Article							TRANS-ACTING SIRNAS; INTERFERING RNA; DE-NOVO; BIOGENESIS; GENOME; METHYLTRANSFERASE; DICER-LIKE-4; MAINTENANCE; COMPONENT	Small RNAs have several important biological functions(1). MicroRNAs (miRNAs) and trans-acting small interfering RNAs (tasiRNAs) regulate mRNA stability and translation, and siRNAs cause post-transcriptional gene silencing of transposons, viruses and transgenes and are important in both the establishment and maintenance of cytosine DNA methylation(2). Here, we study the role of the four Arabidopsis thaliana DICER-LIKE genes (DCL1-DCL4) in these processes. Sequencing of small RNAs from a dcl2 dcl3 dcl4 triple mutant showed markedly reduced tasiRNA and siRNA production and indicated that DCL1, in addition to its role as the major enzyme for processing miRNAs, has a previously unknown role in the production of small RNAs from endogenous inverted repeats. DCL2, DCL3 and DCL4 showed functional redundancy in siRNA and tasiRNA production and in the establishment and maintenance of DNA methylation. Our studies also suggest that asymmetric DNA methylation can be maintained by pathways that do not require siRNAs.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Delaware Biotechnol Inst, Newark, DE 19714 USA; Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19714 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Delaware; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Zhang, xiaoyu/GXA-3206-2022; Henderson, Ian/A-2174-2012; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Henderson, Ian/0000-0001-5066-1489	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60398] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; SCHANK RC, 1991, J LEARN SCI, V1, P7; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	29	438	456	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					721	725		10.1038/ng1804	http://dx.doi.org/10.1038/ng1804			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16699516				2022-12-17	WOS:000237954800030
J	Bouatia-Naji, N; Bonnefond, A; Cavalcanti-Proenca, C; Sparso, T; Holmkvist, J; Marchand, M; Delplanque, J; Lobbens, S; Rocheleau, G; Durand, E; De Graeve, F; Chevre, JC; Borch-Johnsen, K; Hartikainen, AL; Ruokonen, A; Tichet, J; Marre, M; Weill, J; Heude, B; Tauber, M; Lemaire, K; Schuit, F; Elliott, P; Jorgensen, T; Charpentier, G; Hadjadj, S; Cauchi, S; Vaxillaire, M; Sladek, R; Visvikis-Siest, S; Balkau, B; Levy-Marchal, C; Pattou, F; Meyre, D; Blakemore, AIF; Jarvelin, MR; Walley, AJ; Hansen, T; Dina, C; Pedersen, O; Froguel, P				Bouatia-Naji, Nabila; Bonnefond, Amelie; Cavalcanti-Proenca, Christine; Sparso, Thomas; Holmkvist, Johan; Marchand, Marion; Delplanque, Jerome; Lobbens, Stephane; Rocheleau, Ghislain; Durand, Emmanuelle; De Graeve, Franck; Chevre, Jean-Claude; Borch-Johnsen, Knut; Hartikainen, Anna-Liisa; Ruokonen, Aimo; Tichet, Jean; Marre, Michel; Weill, Jacques; Heude, Barbara; Tauber, Maithe; Lemaire, Katleen; Schuit, Frans; Elliott, Paul; Jorgensen, Torben; Charpentier, Guillaume; Hadjadj, Samy; Cauchi, Stephane; Vaxillaire, Martine; Sladek, Robert; Visvikis-Siest, Sophie; Balkau, Beverley; Levy-Marchal, Claire; Pattou, Francois; Meyre, David; Blakemore, Alexandra I. F.; Jarvelin, Marjo-Riita; Walley, Andrew J.; Hansen, Torben; Dina, Christian; Pedersen, Oluf; Froguel, Philippe			A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; GENE; MELATONIN; POLYMORPHISM; COHORT	In genome-wide association (GWA) data from 2,151 nondiabetic French subjects, we identified rs1387153, near MTNR1B (which encodes the melatonin receptor 2 (MT2)), as a modulator of fasting plasma glucose (FPG; P = 1.3 x 10(-7)). In European populations, the rs1387153 T allele is associated with increased FPG (beta = 0.06 mmol/l, P = 7.6 x 10(-29), N = 16,094), type 2 diabetes (T2D) risk (odds ratio (OR) = 1.15, 95% CI = 1.08-1.22, P = 6.3 x 10(-5), cases N = 6,332) and risk of developing hyperglycemia or diabetes over a 9-year period (hazard ratio (HR) = 1.20, 95% CI = 1.06-1.36, P = 0.005, incident cases N = 515). RT-PCR analyses confirm the presence of MT2 transcripts in neural tissues and show MT2 expression in human pancreatic islets and beta cells. Our data suggest a possible link between circadian rhythm regulation and glucose homeostasis through the melatonin signaling pathway.	[Bouatia-Naji, Nabila; Bonnefond, Amelie; Cavalcanti-Proenca, Christine; Marchand, Marion; Delplanque, Jerome; Lobbens, Stephane; Durand, Emmanuelle; De Graeve, Franck; Chevre, Jean-Claude; Cauchi, Stephane; Vaxillaire, Martine; Meyre, David; Dina, Christian; Froguel, Philippe] CNRS, Inst Biol, UMR 8090, F-59019 Lille, France; [Bouatia-Naji, Nabila; Bonnefond, Amelie; Cavalcanti-Proenca, Christine; Marchand, Marion; Delplanque, Jerome; Lobbens, Stephane; Durand, Emmanuelle; De Graeve, Franck; Chevre, Jean-Claude; Cauchi, Stephane; Vaxillaire, Martine; Meyre, David; Dina, Christian; Froguel, Philippe] Univ Lille 2, Inst Pasteur, F-59019 Lille, France; [Sparso, Thomas; Holmkvist, Johan; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rocheleau, Ghislain; Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Rocheleau, Ghislain; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Rocheleau, Ghislain] Prognomix, Montreal, PQ H1Y 3L1, Canada; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus C, Denmark; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Clin Sci Obstet & Gynecol, FIN-90014 Oulu, Finland; [Ruokonen, Aimo] Univ Oulu, Dept Clin Sci Clin Chem, FIN-90014 Oulu, Finland; [Tichet, Jean] Inst Inter Reg Sante IRSA, F-37521 La Riche, France; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, F-75018 Paris, France; [Marre, Michel] Univ Paris 07, INSERM, U695, F-75870 Paris, France; [Weill, Jacques] Jeanne Flandre Hosp, Pediatr Endocrine Unit, F-59800 Lille, France; [Heude, Barbara; Balkau, Beverley] INSERM, U780, F-94807 Villejuif, France; [Heude, Barbara; Balkau, Beverley] Univ Paris Sud, F-91405 Orsay, France; [Tauber, Maithe] Childrens Hosp, CHU, INSERM, U563, F-31059 Toulouse, France; [Lemaire, Katleen; Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium; [Elliott, Paul; Jarvelin, Marjo-Riita] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Jorgensen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, F-91108 Essonnes, France; [Hadjadj, Samy] Univ Poitiers, INSERM, UFR Med Pharm, Ctr Hosp Univ Poitiers,U927,CIC 0802, F-86034 Poitiers, France; [Visvikis-Siest, Sophie] INSERM, Cardiovasc Genet team, CIC 9501, F-54000 Nancy, France; [Levy-Marchal, Claire] Hop Robert Debre, INSERM, U690, F-75019 Paris, France; [Levy-Marchal, Claire] Paris Diderot Univ, F-75005 Paris, France; [Pattou, Francois] Univ Lille Nord France, CHRU Lille, INSERM, U859, F-59045 Lille, France; [Blakemore, Alexandra I. F.; Walley, Andrew J.; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England; [Jarvelin, Marjo-Riita] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riita] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, DK-5230 Odense, Denmark	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Steno Diabetes Center; McGill University; Aarhus University; University of Oulu; University of Oulu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; Imperial College London; University of Copenhagen; University of Copenhagen; Centre Hospitalier Sud Francilien; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Imperial College London; University of Oulu; University of Oulu; University of Southern Denmark	Froguel, P (corresponding author), CNRS, Inst Biol, UMR 8090, F-59019 Lille, France.	p.froguel@imperial.ac.uk	Chèvre, Jean-Claude/C-3943-2015; Bonnefond, Amélie/O-2784-2017; Walley, Andrew J/D-2573-2009; Dina, Christian R/D-3535-2015; Visvikis-Siest, Sophie/H-2324-2014; Heude, Barbara/G-3095-2016; Pedersen, Oluf/Z-1731-2019; Bouatia-Naji, Nabila/AGF-1400-2022; Sladek, Robert/R-2391-2019; Jansen, Heiko T./A-5770-2008; BOUATIA-NAJI, NABILA/D-5863-2013; Meyre, David/D-7315-2011; Pattou, Francois/O-6151-2017; Blakemore, Alexandra I F/D-2253-2009; Heude, Barbara/GLU-9626-2022; TAUBER, Maithe/K-7386-2014; Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; FROGUEL, Philippe/O-6799-2017	Chèvre, Jean-Claude/0000-0002-5329-5231; Bonnefond, Amélie/0000-0001-9976-3005; Walley, Andrew J/0000-0001-7707-7549; Dina, Christian R/0000-0002-7722-7348; Visvikis-Siest, Sophie/0000-0001-8104-8425; Heude, Barbara/0000-0002-1565-1629; Pedersen, Oluf/0000-0002-3321-3972; Bouatia-Naji, Nabila/0000-0001-5424-2134; Sladek, Robert/0000-0002-2730-1204; Jansen, Heiko T./0000-0003-0178-396X; Meyre, David/0000-0003-4850-7444; Pattou, Francois/0000-0001-8388-3766; Blakemore, Alexandra I F/0000-0003-0661-564X; Heude, Barbara/0000-0002-1565-1629; FROGUEL, Philippe/0000-0003-2972-0784; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Marre, Michel/0000-0002-3071-1837; Elliott, Paul/0000-0002-7511-5684	Medical Research Council [G0600331] Funding Source: Medline; MRC [G0600331] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Boden G, 1996, AM J PHYSIOL-ENDOC M, V271, pE246, DOI 10.1152/ajpendo.1996.271.2.E246; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hadjadj S, 2008, DIABETES CARE, V31, P1847, DOI 10.2337/dc07-2079; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jaquet D, 2004, HORM RES, V62, P92, DOI 10.1159/000079709; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Peschke E, 2006, J PINEAL RES, V40, P135, DOI 10.1111/j.1600-079X.2005.00287.x; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Van Cauter E, 1998, THERAPIE, V53, P467; Visvikis-Siest S, 2008, CLIN CHEM LAB MED, V46, P733, DOI 10.1515/CCLM.2008.178; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	28	437	447	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					89	94		10.1038/ng.277	http://dx.doi.org/10.1038/ng.277			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19060909	Green Published			2022-12-17	WOS:000262085300021
J	Marsh, DJ; Hollopeter, G; Huszar, D; Laufer, R; Yagaloff, KA; Fisher, SL; Burn, P; Palmiter, RD				Marsh, DJ; Hollopeter, G; Huszar, D; Laufer, R; Yagaloff, KA; Fisher, SL; Burn, P; Palmiter, RD			Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides	NATURE GENETICS			English	Article							MOLECULAR-CLONING; LEPTIN DEFICIENCY; OBESITY; GENE; IDENTIFICATION; NEUROPEPTIDE; ANTAGONIST; PROTEIN	Mutations reducing the functional activity of leptin(1,2), the leptin receptor(3,4), alpha-melanocyte stimulating hormone(5) (alpha-MSH) and the melanocortin-4 receptor(6) (Mc4r) all lead to obesity in mammals. Moreover, mutant mice that ectopically express either agouti(7) (Aula mice) or agouti-related protein(8) (Agrp), antagonists of melanocortin signalling(8,9), become obese. These data suggest that alpha-MSH signalling transduced by Mc4r tonically inhibits feeding; however, it is not known to what extent this pathway mediates leptin signalling. We show here that Mc4r-deficient (Mc4r(-/-)) mice do not respond to the anorectic actions of MTII, an MSH-like agonist, suggesting that alpha-MSH inhibits feeding primarily by activating Mc4r. Obese Mc4(-/-) mice do not respond significantly to the inhibitory effects of leptin on feeding, whereas non-obese Mc4r(-/-) mice do. These data demonstrate that melanocortin signalling transduced by Mc4r is not an exclusive target of leptin action and that factors resulting from obesity contribute to leptin resistance. Leptin resistance of obese Mc4r(-/-) mice does not prevent their response to the anorectic actions of ciliary neurotrophic factor (CNTF), corticotropin releasing factor (CRF), or urocortin; or the orexigenic actions of neuropeptide Y (NPY) or peptide YY (PYY), indicating that these neuromodulators act independently or downstream of Mdr signalling.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Ist Ric Biol Mol P Angeletti, IRBM, I-00040 Rome, Italy; Hoffmann La Roche, Dept Metab Dis, Nutley, NJ 07110 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Merck & Company; Roche Holding	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	palmiter@u.washington.edu	Laufer, Ralph/H-9336-2013					Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Costa A, 1997, NEUROREPORT, V8, P1131, DOI 10.1097/00001756-199703240-00014; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; HOLLOPETER G, IN PRESS REGUL PEPT; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MANNE J, 1995, P NATL ACAD SCI USA, V92, P4721, DOI 10.1073/pnas.92.11.4721; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	437	458	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					119	122		10.1038/5070	http://dx.doi.org/10.1038/5070			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	9916804				2022-12-17	WOS:000077960700022
J	Minetti, C; Sotgia, F; Bruno, C; Scartezzini, P; Broda, P; Bado, M; Masetti, E; Mazzocco, M; Egeo, A; Donati, MA; Volonte, D; Galbiati, F; Cordone, G; Bricarelli, FD; Lisanti, MP; Zara, F				Minetti, C; Sotgia, F; Bruno, C; Scartezzini, P; Broda, P; Bado, M; Masetti, E; Mazzocco, M; Egeo, A; Donati, MA; Volonte, D; Galbiati, F; Cordone, G; Bricarelli, FD; Lisanti, MP; Zara, F			Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy	NATURE GENETICS			English	Article							HETEROTRIMERIC G-PROTEINS; EXPRESSION; IDENTIFICATION; SEQUENCE; ISOFORMS; CELLS	Limb-girdle muscular dystrophy (LGMD) is a clinically and genetically heterogeneous group of myopathies. including autosomal dominant and recessive forms(1-3). To date, two autosomal dominant forms have been recognized(2,3): LGMD1A, linked to chromosome 5q, and LGMD1B, associated with cardiac defects and linked to chromosome 1q11-21. Here we describe eight patients from two different families with a new form of autosomal dominant LGMD, which we propose to call LGMD1C, associated with a severe deficiency of caveolin-3 in muscle fibres. Caveolin-3 (or M-caveolin) is the muscle-specific form of the caveolin protein family, which also includes caveolin-1 and -2 (refs 4-9). Caveolins are the principal protein components of caveolae (50-100 nm invaginations found in most cell types) which represent appendages or sub-compartments of plasma membranes(10,11). We localized the human caveolin-3 gene (CAV3) to chromosome 3p25 and identified two mutations in the gene: a missense mutation in the membrane-spanning region and a micro-deletion in the scaffolding domain. These mutations may interfere with caveolin-3 oligomerization and disrupt caveolae formation at the muscle cell plasma membrane.	Univ Genoa, Ist Giannina Gaslini, Serv Malattie Neuromuscolari, I-16147 Genoa, Italy; EO Osped Galliera, Lab Genet Umana, Genoa, Italy; Columbia Univ, Dept Neurol, New York, NY USA; EO Osped Galliera, Div Neonatol, Genoa, Italy; Univ Florence, Dipartimento Pediat, Florence, Italy; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	University of Genoa; IRCCS Istituto Giannina Gaslini; Ente Ospedaliero Ospedali Galliera; Columbia University; Ente Ospedaliero Ospedali Galliera; University of Florence; Yeshiva University; Albert Einstein College of Medicine	Minetti, C (corresponding author), Univ Genoa, Ist Giannina Gaslini, Serv Malattie Neuromuscolari, Largo Gaslini 5, I-16147 Genoa, Italy.	minettic@unige.it	Bruno, Claudio/A-3148-2015; Lisanti, Michael/B-6131-2018; Minetti, Carlo/K-4666-2018; Galbiati, Ferruccio/AAF-3527-2020; Mazzocco, Michela/AFT-6759-2022; Zara, Federico/U-3477-2017; Lisanti, Michael P/C-6866-2013	Bruno, Claudio/0000-0002-3426-2901; Lisanti, Michael/0000-0003-2034-1382; Minetti, Carlo/0000-0002-0640-1804; Zara, Federico/0000-0001-9744-5222; MARIA ALICE, DONATI/0000-0003-4769-5025; Broda, Paolo/0000-0002-4178-1128; Sotgia, Federica/0000-0003-2826-4529	NIGMS NIH HHS [GM-50443] Funding Source: Medline; Telethon [641] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bushby K, 1996, NEUROMUSCULAR DISORD, V6, P439, DOI 10.1016/S0960-8966(96)00392-6; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; MINETTI C, 1994, NEUROLOGY, V44, P1149, DOI 10.1212/WNL.44.6.1149; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; OKAMOTO T, IN PRESS J BIOL CHEM; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Scartezzini P, 1997, HUM GENET, V99, P387, DOI 10.1007/s004390050377; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; SIMIONESCU N, 1975, J CELL BIOL, V64, P586, DOI 10.1083/jcb.64.3.586; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; SPEER MC, 1992, AM J HUM GENET, V50, P1211; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	30	437	448	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					365	368		10.1038/ng0498-365	http://dx.doi.org/10.1038/ng0498-365			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537420				2022-12-17	WOS:000072755500020
J	Borgel, J; Guibert, S; Li, YF; Chiba, H; Schubeler, D; Sasaki, H; Forne, T; Weber, M				Borgel, Julie; Guibert, Sylvain; Li, Yufeng; Chiba, Hatsune; Schuebeler, Dirk; Sasaki, Hiroyuki; Forne, Thierry; Weber, Michael			Targets and dynamics of promoter DNA methylation during early mouse development	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; MAMMALIAN DEVELOPMENT; PREIMPLANTATION DEVELOPMENT; METHYLTRANSFERASES DNMT3A; PATERNAL GENOME; GERM-CELL; PLURIPOTENT; DEMETHYLATION; POLYCOMB	DNA methylation is extensively reprogrammed during the early phases of mammalian development, yet genomic targets of this process are largely unknown. We optimized methylated DNA immunoprecipitation for low numbers of cells and profiled DNA methylation during early development of the mouse embryonic lineage in vivo. We observed a major epigenetic switch during implantation at the transition from the blastocyst to the postimplantation epiblast. During this period, DNA methylation is primarily targeted to repress the germline expression program. DNA methylation in the epiblast is also targeted to promoters of lineage-specific genes such as hematopoietic genes, which are subsequently demethylated during terminal differentiation. De novo methylation during early embryogenesis is catalyzed by Dnmt3b, and absence of DNA methylation leads to ectopic gene activation in the embryo. Finally, we identify nonimprinted genes that inherit promoter DNA methylation from parental gametes, suggesting that escape of post-fertilization DNA methylation reprogramming is prevalent in the mouse genome.	[Borgel, Julie; Guibert, Sylvain; Forne, Thierry; Weber, Michael] Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Mol Genet,UMR 5535, Montpellier, France; [Li, Yufeng; Chiba, Hatsune; Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, Fukuoka 812, Japan; [Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Kyushu University; Friedrich Miescher Institute for Biomedical Research	Weber, M (corresponding author), Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Mol Genet,UMR 5535, Montpellier, France.	michael.weber@igmm.cnrs.fr	Weber, Michael/P-1914-2016; Forne, Thierry/D-3718-2013	Weber, Michael/0000-0003-3484-5821; Forne, Thierry/0000-0002-9179-1551	Epigenome NoE [LSHG-CT-2006-037415]; Novartis Research Foundation; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-07-BLAN-0052-02]; Association pour la Recherche sur le Cancer (ARC) [4868]; European Chemical Industry Council (CEFIC) [LRI-EMSG49-CNRS-08]	Epigenome NoE; Novartis Research Foundation; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); European Chemical Industry Council (CEFIC)	We thank R. Vicente for assistance with the flow cytometry, T. Gostan for help with R programming, and E. Posfai and R. Hirasawa for advice on embryo dissection. This research was supported by the Epigenome NoE (LSHG-CT-2006-037415), Novartis Research Foundation, Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR-07-BLAN-0052-02), Association pour la Recherche sur le Cancer (ARC contract 4868) and European Chemical Industry Council (CEFIC) Long Research Initiative (LRI-EMSG49-CNRS-08).	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; BHULANI N, 2009, NATURE, V463, P1042; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lei H, 1996, DEVELOPMENT, V122, P3195; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Skinner MK, 2009, EPIGENOMICS-UK, V1, P111, DOI 10.2217/EPI.09.11; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Waterland RA, 2009, HUM MOL GENET, V18, P3026, DOI 10.1093/hmg/ddp241; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	50	436	448	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2010	42	12					1093	U90		10.1038/ng.708	http://dx.doi.org/10.1038/ng.708			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21057502				2022-12-17	WOS:000284578800012
J	Tonkin, ET; Wang, TJ; Lisgo, S; Bamshad, MJ; Strachan, T				Tonkin, ET; Wang, TJ; Lisgo, S; Bamshad, MJ; Strachan, T			NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome	NATURE GENETICS			English	Article							BRACHMANN-DELANGE-SYNDROME; DUP(3Q) SYNDROME; EXPRESSION; DROSOPHILA; GENES; BRAIN; DELINEATION; ACTIVATION; PRIMORDIA; DISEASE	Cornelia de Lange syndrome (CdLS) is a multiple malformation disorder characterized by dysmorphic facial features, mental retardation, growth delay and limb reduction defects(1,2). We indentified and characterized a new gene, NIPBL, that is mutated in individuals with CdLS and determined its structure and the structures of mouse, rat and zebrafish homologs. We named its protein product delangin. Vertebrate delangins have substantial homology to orthologs in flies, worms, plants and fungi, including Scc2-type sister chromatid cohesion proteins, and D. melanogaster Nipped-B. We propose that perturbed delangin function may inappropriately activate DLX genes, thereby contributing to the proximodistal limb patterning defects in CdLS. Genome analyses typically identify individual delangin or Nipped-B-like orthologs in diploid animal and plant genomes. The evolution of an ancestral sister chromatid cohesion protein to acquire an additional role in developmental gene regulation suggests that there are parallels between CdLS and Roberts syndrome.	Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Newcastle University - UK; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Strachan, T (corresponding author), Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	tom.strachan@ncl.ac.uk	Tonkin, Emma T/L-8370-2016	Tonkin, Emma/0000-0001-5759-0927; Lisgo, Steven/0000-0001-5186-3971	Medical Research Council [G9826762, G9900837] Funding Source: Medline; MRC [G9900837, G9826762] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allanson JE, 1997, J MED GENET, V34, P645, DOI 10.1136/jmg.34.8.645; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; IRELAND M, 1991, J MED GENET, V28, P639, DOI 10.1136/jmg.28.9.639; IRELAND M, 1993, AM J MED GENET, V47, P959, DOI 10.1002/ajmg.1320470705; Iulianella A, 2003, GENE EXPR PATTERNS, V3, P571, DOI 10.1016/S1567-133X(03)00123-6; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; KRAJEWSKAWALASEK M, 1995, CLIN GENET, V47, P324; Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813; Luzzani S, 2003, AM J MED GENET A, V119A, P283, DOI 10.1002/ajmg.a.20191; Mehta AV, 1997, AM J MED GENET, V71, P434, DOI 10.1002/(SICI)1096-8628(19970905)71:4<434::AID-AJMG12>3.0.CO;2-H; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rooney DE, 2001, HUMAN CYTOGENETICS C; Russell KL, 2001, AM J MED GENET, V104, P267, DOI 10.1002/ajmg.10066; SATALOFF RT, 1990, ARCH OTOLARYNGOL, V116, P1044; Seitz LC, 1996, GENETICS, V142, P1105; STEINBACH P, 1981, AM J MED GENET, V10, P159, DOI 10.1002/ajmg.1320100210; TONKIN ET, IN PRESS HUM GENET; VANALLEN MI, 1993, AM J MED GENET, V47, P947, DOI 10.1002/ajmg.1320470704; Vuilleumier N, 2002, ACTA NEUROPATHOL, V104, P327, DOI 10.1007/s00401-002-0562-4; WILSON GN, 1985, AM J MED GENET, V22, P117, DOI 10.1002/ajmg.1320220113; WILSON WG, 1983, J MED GENET, V20, P469, DOI 10.1136/jmg.20.6.469; Yamaguchi K, 1999, CLIN NEUROPATHOL, V18, P99	30	436	460	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					636	641		10.1038/ng1363	http://dx.doi.org/10.1038/ng1363			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15146185	Bronze			2022-12-17	WOS:000221763700023
J	Cheung, VG; Conlin, LK; Weber, TM; Arcaro, M; Jen, KY; Morley, M; Spielman, RS				Cheung, VG; Conlin, LK; Weber, TM; Arcaro, M; Jen, KY; Morley, M; Spielman, RS			Natural variation in human gene expression assessed in lymphoblastoid cells	NATURE GENETICS			English	Article							LOCUS; MAP	The sequencing of the human genome has resulted in greater attention to genetic variation among individuals, and variation at the DNA sequence level is now being extensively studied. At the same time, it has become possible to study variation at the level of gene expression by various methods. At present, it is largely unknown how widespread this variation in transcript levels is over the entire genome and to what extent individual differences in expression level are genetically determined. In the present study, we used lymphoblastoid cells to examine variation in gene expression and identified genes whose transcript levels differed greatly among unrelated individuals. We also found evidence for familial aggregation of expression phenotype by comparing variation among unrelated individuals, among siblings within families and between monozygotic twins. These observations suggest that there is a genetic contribution to polymorphic variation in the level of gene expression.	Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020; Jen, Kuang-Yu/AAM-5429-2020; Jen, Kuang-Yu/AAM-5722-2020	Jen, Kuang-Yu/0000-0003-2815-5912; Morley, Michael/0000-0002-0958-7376	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM081930-08, R01 GM081930] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Watts JA, 2002, AM J HUM GENET, V71, P791, DOI 10.1086/342974; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	13	436	578	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					422	425		10.1038/ng1094	http://dx.doi.org/10.1038/ng1094			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12567189				2022-12-17	WOS:000181312700023
J	Tavtigian, SV; Simard, J; Teng, DHF; Abtin, V; Baumgard, M; Beck, A; Camp, NJ; Carillo, AR; Chen, Y; Dayananth, P; Desrochers, M; Dumont, M; Farnham, JM; Frank, D; Frye, C; Ghaffari, S; Gupte, JS; Hu, R; Iliev, D; Janecki, T; Kort, EN; Laity, KE; Leavitt, A; Leblanc, G; McArthur-Morrison, J; Pederson, A; Penn, B; Peterson, KT; Reid, JE; Richards, S; Schroeder, M; Smith, R; Snyder, SC; Swedlund, B; Swensen, J; Thomas, A; Tranchant, M; Woodland, AM; Labrie, F; Skolnick, MH; Neuhausen, S; Rommens, J; Cannon-Albright, LA				Tavtigian, SV; Simard, J; Teng, DHF; Abtin, V; Baumgard, M; Beck, A; Camp, NJ; Carillo, AR; Chen, Y; Dayananth, P; Desrochers, M; Dumont, M; Farnham, JM; Frank, D; Frye, C; Ghaffari, S; Gupte, JS; Hu, R; Iliev, D; Janecki, T; Kort, EN; Laity, KE; Leavitt, A; Leblanc, G; McArthur-Morrison, J; Pederson, A; Penn, B; Peterson, KT; Reid, JE; Richards, S; Schroeder, M; Smith, R; Snyder, SC; Swedlund, B; Swensen, J; Thomas, A; Tranchant, M; Woodland, AM; Labrie, F; Skolnick, MH; Neuhausen, S; Rommens, J; Cannon-Albright, LA			A candidate prostate cancer susceptibility gene at chromosome 17p	NATURE GENETICS			English	Article							POLYADENYLATION SPECIFICITY FACTOR; ANDROGEN RECEPTOR GENE; LINKAGE ANALYSIS; BETA-LACTAMASE; PROTEIN; LOCUS; RISK; SUBSTITUTION; INHERITANCE; SIMILARITY	It is difficult to identify genes that predispose to prostate cancer due to late age at diagnosis, presence of phenocopies within high-risk pedigrees and genetic complexity. A genome-wide scan of large, high-risk pedigrees from Utah has provided evidence for linkage to a locus on chromosome 17p. We carried out positional cloning and mutation screening within the refined interval, identifying a gene, ELAC2, harboring mutations (including a frameshift and a nonconservative missense change) that segregate with prostate cancer in two pedigrees. In addition, two common missense variants in the gene are associated with the occurrence of prostate cancer. ELAC2 is a member of an uncharacterized gene family predicted to encode a metal-dependent hydrolase domain that is conserved among eukaryotes, archaebacteria and eubacteria. The gene product bears amino acid sequence similarity to two better understood protein families, namely the PSO2 (SNM1) DNA interstrand crosslink repair proteins and the 73-kD subunit of mRNA 3' end cleavage and polyadenylation specificity factor (CPSF73).	Myriad Genet Inc, Salt Lake City, UT 84108 USA; Univ Laval, Med Ctr, Oncol & Mol Endocrinol Res Ctr, CHUL, Quebec City, PQ, Canada; Univ Utah, Sch Med, Dept Med Informat, Genet Epidemiol Grp, Salt Lake City, UT USA; LDS Hosp, Intermt Hlth Care, Salt Lake City, UT USA; Univ Toronto, Hosp Sick Children, Program Genet & Genomic Biol, Toronto, ON M5G 1X8, Canada	Myriad Genetics, Inc; Laval University; Utah System of Higher Education; University of Utah; Intermountain Healthcare; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Tavtigian, SV (corresponding author), Myriad Genet Inc, Salt Lake City, UT 84108 USA.	seant@myriad.com		Farnham, James/0000-0002-8213-949X; Durocher, Francine/0000-0001-8012-4641; Thomas, Alun/0000-0001-5650-7044; Smith, Richard/0000-0003-1201-6731; Simard, Jacques/0000-0001-6906-3390; albright, lisa/0000-0003-2602-3668	NCI NIH HHS [N01-PC-67000, CA62154, CA64477] Funding Source: Medline; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067000] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA064477, R01CA062154] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BARBEYRON T, 1995, MICROBIOL-UK, V141, P2897, DOI 10.1099/13500872-141-11-2897; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P47, DOI 10.1107/S090744499700927X; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chanfreau G, 1996, SCIENCE, V274, P1511, DOI 10.1126/science.274.5292.1511; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; GLOVANNUCCI E, 1997, P NATL ACAD SCI USA, V94, P3320; HAASE E, 1989, MOL GEN GENET, V218, P64, DOI 10.1007/BF00330566; Jaffe JM, 2000, CANCER RES, V60, P1626; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; JORDE LB, 1981, SCI HUMAINES, V56, P105; Jorde LB, 1981, INFORMATION SCI HUMA, V56, P105; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Makridakis N, 1997, CANCER RES, V57, P1020; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; Melino S, 1998, TRENDS BIOCHEM SCI, V23, P381, DOI 10.1016/S0968-0004(98)01264-X; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Neuhausen SL, 1999, HUM MOL GENET, V8, P2437, DOI 10.1093/hmg/8.13.2437; Nevill-Manning CG, 1998, P NATL ACAD SCI USA, V95, P5865, DOI 10.1073/pnas.95.11.5865; NIEGEMANN E, 1994, MUTAT RES-DNA REPAIR, V315, P275, DOI 10.1016/0921-8777(94)90038-8; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; OTT J, 1986, GENET EPIDEMIOL, P251; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Skolnick M, 1980, BANBURY REPORT, P285; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1997, CANCER RES, V57, P1194; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807	52	436	466	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					172	180		10.1038/84808	http://dx.doi.org/10.1038/84808			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175785				2022-12-17	WOS:000166839200018
J	Thomas, G; Jacobs, KB; Kraft, P; Yeager, M; Wacholder, S; Cox, DG; Hankinson, SE; Hutchinson, A; Wang, Z; Yu, K; Chatterjee, N; Garcia-Closas, M; Gonzalez-Bosquet, J; Prokunina-Olsson, L; Orr, N; Willett, WC; Colditz, GA; Ziegler, RG; Berg, CD; Buys, SS; McCarty, CA; Feigelson, HS; Calle, EE; Thun, MJ; Diver, R; Prentice, R; Jackson, R; Kooperberg, C; Chlebowski, R; Lissowska, J; Peplonska, B; Brinton, LA; Sigurdson, A; Doody, M; Bhatti, P; Alexander, BH; Buring, J; Lee, IM; Vatten, LJ; Hveem, K; Kumle, M; Hayes, RB; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, RN; Chanock, SJ; Hunter, DJ				Thomas, Gilles; Jacobs, Kevin B.; Kraft, Peter; Yeager, Meredith; Wacholder, Sholom; Cox, David G.; Hankinson, Susan E.; Hutchinson, Amy; Wang, Zhaoming; Yu, Kai; Chatterjee, Nilanjan; Garcia-Closas, Montserrat; Gonzalez-Bosquet, Jesus; Prokunina-Olsson, Ludmila; Orr, Nick; Willett, Walter C.; Colditz, Graham A.; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S.; McCarty, Catherine A.; Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, Ryan; Prentice, Ross; Jackson, Rebecca; Kooperberg, Charles; Chlebowski, Rowan; Lissowska, Jolanta; Peplonska, Beata; Brinton, Louise A.; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Alexander, Bruce H.; Buring, Julie; Lee, I-Min; Vatten, Lars J.; Hveem, Kristian; Kumle, Merethe; Hayes, Richard B.; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.			A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)	NATURE GENETICS			English	Article							SUSCEPTIBILITY GENE; CONFER SUSCEPTIBILITY; COMMON VARIANTS; MUTATIONS; BRCA2; LOCI	We conducted a three-stage genome-wide association study (GWAS) of breast cancer in 9,770 cases and 10,799 controls in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. In stage 1, we genotyped 528,173 SNPs in 1,145 cases of invasive breast cancer and 1,142 controls. In stage 2, we analyzed 24,909 top SNPs in 4,547 cases and 4,434 controls. In stage 3, we investigated 21 loci in 4,078 cases and 5,223 controls. Two new loci achieved genome-wide significance. A pericentromeric SNP on chromosome 1p11.2 (rs11249433; P = 6.74 x 10(-10) adjusted genotype test, 2 degrees of freedom) resides in a large linkage disequilibrium block neighboring NOTCH2 and FCGR1B; this signal was stronger for estrogen-receptor-positive tumors. A second SNP on chromosome 14q24.1 (rs999737; P = 1.74 x 10(-7)) localizes to RAD51L1, a gene in the homologous recombination DNA repair pathway. We also confirmed associations with loci on chromosomes 2q35, 5p12, 5q11.2, 8q24, 10q26 and 16q12.1.	[Thomas, Gilles; Jacobs, Kevin B.; Yeager, Meredith; Wacholder, Sholom; Hutchinson, Amy; Wang, Zhaoming; Yu, Kai; Chatterjee, Nilanjan; Garcia-Closas, Montserrat; Gonzalez-Bosquet, Jesus; Prokunina-Olsson, Ludmila; Ziegler, Regina G.; Brinton, Louise A.; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Hayes, Richard B.; Tucker, Margaret; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD USA; [Jacobs, Kevin B.; Hutchinson, Amy; Wang, Zhaoming] NCI, SAIC Frederick Inc, Core Genotyping Facil, Adv Technol Program, Frederick, MD 21701 USA; [Kraft, Peter; Cox, David G.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Cox, David G.; Hankinson, Susan E.; Willett, Walter C.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Cox, David G.; Hankinson, Susan E.; Willett, Walter C.; Buring, Julie; Lee, I-Min; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Willett, Walter C.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Colditz, Graham A.] Washington Univ, Sch Med, St Louis, MO USA; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Buys, Saundra S.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, Ryan] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Prentice, Ross; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Jackson, Rebecca] Ohio State Univ, Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Chlebowski, Rowan] Harbor Univ Calif Los Angeles, Med Ctr, Torrance, CA USA; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Peplonska, Beata] Nofer Inst Occupat Med, Lodz, Poland; [Alexander, Bruce H.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Buring, Julie; Lee, I-Min] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Vatten, Lars J.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Kumle, Merethe] Univ Tromso, Inst Community Med, Tromso, Norway; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Hunter, David J.] Broad Inst Harvard & MIT, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; American Cancer Society; Fred Hutchinson Cancer Center; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hunter, DJ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.	dhunter@hsph.harvard.edu	Wang, Zhaoming/R-5527-2018; Garcia-Closas, Montserrat/AAZ-6930-2021; Hveem, Kristian/AFV-4683-2022; Vatten, Lars/AFK-2073-2022; Cox, David G/A-2023-2009; Prokunina-Olsson, Ludmila/V-7960-2019; Vatten, Lars/AAF-9380-2022; Colditz, Graham/A-3963-2009; Garcia-Closas, Montserrat/F-3871-2015; Cox, David/ABA-7454-2020; Diver, Ryan/AAG-3469-2019; Lee, I-Min/ABD-5409-2021; Peplonska, Beata/F-6004-2010; Peplonska, Beata/AAO-1265-2020; Yeager, Meredith/AAA-5322-2020; Lissowska, Jolanta/AAH-3252-2020; Prokunina-Olsson, Ludmila/A-8240-2019; Brinton, Louise A/G-7486-2015; Tucker, Margaret A/B-4297-2015	Wang, Zhaoming/0000-0001-7556-3869; Garcia-Closas, Montserrat/0000-0003-1033-2650; Cox, David G/0000-0002-2152-9259; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Colditz, Graham/0000-0002-7307-0291; Garcia-Closas, Montserrat/0000-0003-1033-2650; Diver, Ryan/0000-0002-5418-9000; Peplonska, Beata/0000-0003-3915-2872; Lissowska, Jolanta/0000-0003-2695-5799; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Brinton, Louise A/0000-0003-3853-8562; Jacobs, Kevin/0000-0002-4657-6473; McCarty, Catherine/0000-0003-1089-0142; Cox, David/0000-0003-2047-4687; Bhatti, Parveen/0000-0003-1709-1781; Hayes, Richard/0000-0002-0918-661X; Gonzalez Bosquet, Jesus/0000-0002-2079-4528	US National Institutes of Health [CA65725, CA87969, CA49449, CA67262, CA50385, 5UO1CA098233]; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; National Cancer Institute; NIH; DHHS;  [UO1 CA098710]; NATIONAL CANCER INSTITUTE [R01CA067262, P01CA087969, U01CA067262, U01CA098233, U01CA098710, R01CA049449, U01CA049449, R01CA050385, R01CA065725] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Nurses' Health Studies are supported by US National Institutes of Health grants CA65725, CA87969, CA49449, CA67262, CA50385 and 5UO1CA098233. We thank B. Egan, L. Egan, H. Judge Ellis, H. Ranu and P. Soule for assistance, and the participants in the Nurses' Health Studies. The WHI program is supported by contracts from the National Heart, Lung and Blood Institute, NIH. We thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. A full listing of WHI investigators can be found at http://www.whi.org. The ACS study is supported by UO1 CA098710. We thank C. Lichtman for data management and the participants on the CPS-II. The US Radiologic Technologists Study (USRT) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS. The PLCO study is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. We thank P. Prorok, Division of Cancer Prevention, National Cancer Institute, the Screening Center investigators and staff of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), and T. Sheehy and staff at SAIC- Frederick. We acknowledge the study participants for their contributions to making this study possible. We thank the radiologic technologists who participated in the study; J. Reid of the American Registry of Radiologic Technologists for continued support of the study; D. Kampa and A. Iwan of the University of Minnesota for study coordination and data collection; B. Kopp and staff at SAIC- Frederick for biospecimen processing; and L. Bowen of Information Management Systems for data management.	Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COLDITZ GA, 2006, CANC EPIDEMIOLOGY PR, P995; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Falush D, 2003, GENETICS, V164, P1567; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Pepe MS, 2008, JNCI-J NATL CANCER I, V100, P978, DOI 10.1093/jnci/djn215; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	27	435	450	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					579	584		10.1038/ng.353	http://dx.doi.org/10.1038/ng.353			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19330030	Green Accepted			2022-12-17	WOS:000265575600019
J	Hiroi, Y; Kudoh, S; Monzen, K; Ikeda, Y; Yazaki, Y; Nagai, R; Komuro, I				Hiroi, Y; Kudoh, S; Monzen, K; Ikeda, Y; Yazaki, Y; Nagai, R; Komuro, I			Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation	NATURE GENETICS			English	Letter							HOLT-ORAM-SYNDROME; T-BOX GENES; TRANSCRIPTION FACTORS CSX/NKX-2.5; CONGENITAL HEART-DISEASE; MUTATIONS; LIMB; TINMAN; EXPRESSION; GATA-4; CELLS	The cardiac homeobox protein Nkx2-5 is essential in cardiac development, and mutations in Csx (which encodes Nkx2-5) cause various congenital heart diseases(1-5). Using the yeast two-hybrid system with Nkx2-5 as the 'bait', we isolated the T-box-containing transcription factor Tbx5; mutations in TBX5 cause heart and limb malformations in Holt-Gram syndrome(6-8) (HOS). Co-transfection of Nkx2-5 and Tbx5 into COS-7 cells showed that they also associate with each other in mammalian cells. Glutathione S-transferase (GST) 'pull-down' assays indicated that the N-terminal domain and N-terminal part of the T-box of Tbx5 and the homeodomain of Nkx2-5 were necessary for their interaction. Tbx5 and Nkx2-5 directly bound to the promoter of the gene for cardiac-specific natriuretic peptide precursor type A (Nppa) in tandem, and both transcription factors showed synergistic activation. Deletion analysis showed that both the N-terminal domain and T-box of Tbx5 were important for this transactivation. A G80R mutation of Tbx5, which causes substantial cardiac defects with minor skeletal abnormalities in HOS, did not activate Nppa or show synergistic activation, whereas R237Q, which causes upper-limb malformations without cardiac abnormalities(8). activated the Nppa promoter to a similar extent to that of wildtype Tbx5. P19CL6 cell lines(9,10) overexpressing wildtype Tbx5 started to beat earlier and expressed cardiac-specific genes more abundantly than did parental P19CL6 cells, whereas cell lines expressing the G80R mutant did not differentiate into beating cardiomyocytes. These results indicate that two different types of cardiac transcription factors synergistically induce cardiac development.	Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; Kanazawa Med Univ, Dept Cardiovasc Med, Kanazawa, Ishikawa, Japan; Int Med Ctr Japan, Tokyo, Japan	Chiba University; University of Tokyo; Kanazawa Medical University; National Center for Global Health & Medicine - Japan	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan.		Pillay, Nischalan/F-9536-2012					AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; BODMER R, 1993, DEVELOPMENT, V118, P719; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Horb ME, 1999, DEVELOPMENT, V126, P1739; Hosoda T, 1999, JPN CIRC J, V63, P425, DOI 10.1253/jcj.63.425; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Li QY, 1997, NAT GENET, V15, P21; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shiojima I, 1999, J BIOL CHEM, V274, P8231, DOI 10.1074/jbc.274.12.8231; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tanaka M, 1998, DEV GENET, V22, P239, DOI 10.1002/(SICI)1520-6408(1998)22:3<239::AID-DVG6>3.3.CO;2-G; Tanaka M, 1999, DEVELOPMENT, V126, P1269	29	435	449	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					276	280		10.1038/90123	http://dx.doi.org/10.1038/90123			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431700				2022-12-17	WOS:000169656400022
J	Leister, D; Ballvora, A; Salamini, F; Gebhardt, C				Leister, D; Ballvora, A; Salamini, F; Gebhardt, C			A PCR-based approach for isolating pathogen resistance genes from potato with potential for wide application in plants	NATURE GENETICS			English	Article							F SP LYCOPERSICI; NEMATODE GLOBODERA-ROSTOCHIENSIS; RACE-SPECIFIC RESISTANCE; DISEASE RESISTANCE; PHYTOPHTHORA-INFESTANS; CONFERRING RESISTANCE; CLADOSPORIUM-FULVUM; SOLANUM-TUBEROSUM; VIRUS-RESISTANCE; LINKAGE MAPS	Plant genes for pathogen resistance can be used to engineer disease resistant crops. Oligonucleotides were designed from sequence motifs conserved between resistance genes of tobacco and Arabidopsis thaliana and used as PCR primers in potato DNA. Amplification products were obtained that were homologous to known resistance genes and linked without recombination with the nematode resistance locus Gro1 and the Phytophthora infestans resistance locus R7 of potato. Map positions of PCR-derived potato gene fragments were also correlated with resistance loci of the related tomato and tobacco genomes. Our results indicate that plant resistance genes that are effective against nematodes, fungi,viruses and bacteria may be isolated based on common sequence motifs and PCR methodology.	MAX PLANCK INST ZUCHTUNGSFORSCH, D-50829 COLOGNE, GERMANY	Max Planck Society			Gebhardt, Chris/HGD-6090-2022; Leister, Dario/D-5587-2009	Leister, Dario/0000-0003-1897-8421				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALINTKURTI PJ, 1994, THEOR APPL GENET, V88, P691, DOI 10.1007/BF01253972; BALLVORA A, 1995, MOL GEN GENET, V249, P82, DOI 10.1007/BF00290239; BARONE A, 1990, MOL GEN GENET, V224, P177, DOI 10.1007/BF00271550; BEHARE J, 1991, MOL PLANT MICROBE IN, V4, P489, DOI 10.1094/MPMI-4-489; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BONIERBALE MW, 1988, GENETICS, V120, P1095; BOURNIVAL BL, 1989, THEOR APPL GENET, V78, P489, DOI 10.1007/BF00290832; CHUNWONGSE J, 1994, THEOR APPL GENET, V89, P76, DOI 10.1007/BF00226986; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; ELKHARBOTLY A, 1994, MOL GEN GENET, V242, P749, DOI 10.1007/BF00283432; ELKHARBOTLY A, IN PRESS THEOR APPL; ELLIS JG, 1995, P NATL ACAD SCI USA, V92, P4185, DOI 10.1073/pnas.92.10.4185; Ganal MW, 1995, MOL PLANT MICROBE IN, V8, P886, DOI 10.1094/MPMI-8-0886; GEBHARDT C, 1995, GENET RES, V65, P1, DOI 10.1017/S001667230003295X; GEBHARDT C, 1993, THEOR APPL GENET, V85, P541, DOI 10.1007/BF00220911; GEBHARDT C, 1991, THEOR APPL GENET, V83, P49, DOI 10.1007/BF00229225; GEBHARDT C, 1989, THEOR APPL GENET, V78, P65, DOI 10.1007/BF00299755; GEBHARDT C, 1994, DNA BASED MARKERS PL; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HAMALAINEN JH, IN PRESS THEOR APPL; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; JONES DA, 1992, TOMATO GENET COOP RE, V42, P19; KALOSHIAN I, 1995, P NATL ACAD SCI USA, V92, P622, DOI 10.1073/pnas.92.2.622; KREIKE CM, 1993, THEOR APPL GENET, V87, P464, DOI 10.1007/BF00215092; LAWRENCE GJ, 1995, PLANT CELL, V7, P1195, DOI 10.1105/tpc.7.8.1195; LEONARDSSCHIPPERS C, 1992, MOL GEN GENET, V233, P278, DOI 10.1007/BF00587589; LEONARDSSCHIPPERS C, 1994, GENETICS, V137, P67; LEVESQUE H, 1990, THEOR APPL GENET, V80, P602, DOI 10.1007/BF00224218; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; MESSEGUER R, 1991, THEOR APPL GENET, V82, P529, DOI 10.1007/BF00226787; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; RITTER E, 1990, GENETICS, V125, P645; RITTER E, 1991, MOL GEN GENET, V227, P81, DOI 10.1007/BF00260710; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SARFATTI M, 1991, THEOR APPL GENET, V82, P22, DOI 10.1007/BF00231273; SARFATTI M, 1989, THEOR APPL GENET, V78, P755, DOI 10.1007/BF00262574; SEGAL G, 1992, MOL GEN GENET, V231, P179, DOI 10.1007/BF00279789; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; STEVENS MR, 1995, THEOR APPL GENET, V90, P451, DOI 10.1007/BF00221989; TANKSLEY SD, 1992, GENETICS, V132, P1141; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; VANBERKEL J, 1994, PLANT PHYSIOL, V104, P445, DOI 10.1104/pp.104.2.445; VANDERBEEK JG, 1994, THEOR APPL GENET, V89, P467, DOI 10.1007/BF00225382; VANDERBIEZEN EA, 1995, MOL GEN GENET, V247, P453, DOI 10.1007/BF00293147; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; YAGHOOBI J, 1995, THEOR APPL GENET, V91, P457, DOI 10.1007/BF00222973; YOUNG ND, 1988, GENETICS, V120, P579; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889; ZAMIR D, 1995, TOMATO GENET COOP RE, V43, P51	56	435	513	1	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1996	14	4					421	429		10.1038/ng1296-421	http://dx.doi.org/10.1038/ng1296-421			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944022				2022-12-17	WOS:A1996VV73000018
J	Jagadeesh, KA; Wenger, AM; Berger, MJ; Guturu, H; Stenson, PD; Cooper, DN; Bernstein, JA; Bejerano, G				Jagadeesh, Karthik A.; Wenger, Aaron M.; Berger, Mark J.; Guturu, Harendra; Stenson, Peter D.; Cooper, David N.; Bernstein, Jonathan A.; Bejerano, Gill			M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity	NATURE GENETICS			English	Article							MENDELIAN DISORDERS; MUTATIONS; STANDARDS; IDENTIFICATION; PREDICTION; GENOMICS; ELEMENTS	Variant pathogenicity classifiers such as SIFT, PolyPhen-2, CADD, and MetaLR assist in interpretation of the hundreds of rare, missense variants in the typical patient genome by deprioritizing some variants as likely benign. These widely used methods misclassify 26 to 38% of known pathogenic mutations, which could lead to missed diagnoses if the classifiers are trusted as definitive in a clinical setting. We developed M-CAP, a clinical pathogenicity classifier that outperforms existing methods at all thresholds and correctly dismisses 60% of rare, missense variants of uncertain significance in a typical genome at 95% sensitivity.	[Jagadeesh, Karthik A.; Berger, Mark J.; Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Wenger, Aaron M.; Guturu, Harendra; Bernstein, Jonathan A.; Bejerano, Gill] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Stenson, Peter D.; Cooper, David N.] Cardiff Univ, Dept Med Genet, Heath Pk, Cardiff, S Glam, Wales; [Bejerano, Gill] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Cardiff University; Stanford University	Bejerano, G (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Bejerano, G (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Bejerano, G (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	bejerano@stanford.edu	Cooper, David N/H-4384-2011	Cooper, David N/0000-0002-8943-8484	Qiagen; Cardiff University; Stanford Pediatrics Department; DARPA; Packard Foundation Fellowship; Microsoft Faculty Fellowship	Qiagen; Cardiff University; Stanford Pediatrics Department; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Packard Foundation Fellowship; Microsoft Faculty Fellowship(Microsoft)	We thank the members of the Bejerano laboartory, particularly J. Notwell, S. Chinchali, and J. Birgmeier, for technical advice and helpful discussions. P.D.S. and D.N.C. receive financial support from Qiagen through a license agreement with Cardiff University. We thank the PolyPhen-2, CADD, Eigen, FATHMM, MutationTaster, and MetaLR teams for making their training and testing data readily available. This work was funded in part by the Stanford Pediatrics Department, DARPA, a Packard Foundation Fellowship, and a Microsoft Faculty Fellowship to G.B.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brownstein CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r53; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Fusi N., 2015, SILICO PREDICTIVE MO; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; HASTIE T, 2003, ELEMENTS STAT LEARNI; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Iglesias A, 2014, GENET MED, V16, P922, DOI 10.1038/gim.2014.58; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ogutu J.O., 2011, BIOMED CENTRAL, V5, pS11, DOI [DOI 10.1186/1753-6561-5-S3-S11, 10.1186/1753-6561-5-S3-S11]; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	34	434	439	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1581	1586		10.1038/ng.3703	http://dx.doi.org/10.1038/ng.3703			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27776117				2022-12-17	WOS:000389011100021
J	Parviz, F; Matullo, C; Garrison, WD; Savatski, L; Adamson, JW; Ning, G; Kaestner, KH; Rossi, JM; Zaret, KS; Duncan, SA				Parviz, F; Matullo, C; Garrison, WD; Savatski, L; Adamson, JW; Ning, G; Kaestner, KH; Rossi, JM; Zaret, KS; Duncan, SA			Hepatocyte nuclear factor 4 alpha controls the development of a hepatic epithelium and liver morphogenesis	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR HNF-4; RAT-LIVER; GENE-TRANSCRIPTION; VISCERAL ENDODERM; EXPRESSION; DIFFERENTIATION; CELLS; FETAL; EMBRYOGENESIS; GASTRULATION	Although advances have been made in understanding cell differentiation, only rudimentary knowledge exists concerning how differentiated cells form tissues and organs. We studied liver organogenesis because the cell and tissue architecture of this organ is well defined. Approximately 60% of the adult liver consists of hepatocytes that are arranged as single-cell anastomosing plates extending from the portal region of the liver lobule toward the central vein(1). The basal surface of the hepatocytes is separated from adjacent sinusoidal endothelial cells by the space of Disse, where the exchange of substances between serum and hepatocytes takes place. The hepatocytes apical surface forms bile canaliculi that transport bile to the hepatic ducts. Proper liver architecture is crucial for hepatic function(2) and is commonly disrupted in disease states, including cirrhosis and hepatitis(3). Here we report that hepatocyte nuclear factor 4alpha (Hnf4alpha) is essential for morphological and functional differentiation of hepatocytes(4), accumulation of hepatic glycogen stores and generation of a hepatic epithelium. We show that Hnf4alpha is a dominant regulator of the epithelial phenotype because its ectopic expression in fibroblasts induces a mesenchymal-to-epithelial transition. Most importantly, the morphogenetic parameters controlled by Hnf4alpha in hepatocytes are essential for normal liver architecture, including the organization of the sinusoidal endothelium.	Med Coll Wisconsin, Dept Anat Cell Biol & Neurobiol, Milwaukee, WI 53226 USA; Fox Chase Canc Ctr, Program Cell & Dev Biol, Philadelphia, PA 19111 USA; Blood Ctr SE, Blood Res Inst, Milwaukee, WI 53226 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Medical College of Wisconsin; Fox Chase Cancer Center; Versiti Blood Center of Wisconsin; University of Pennsylvania	Duncan, SA (corresponding author), Med Coll Wisconsin, Dept Anat Cell Biol & Neurobiol, Milwaukee, WI 53226 USA.			Duncan, Stephen/0000-0002-2507-7827; Matullo, Christine/0000-0003-1598-7007				BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Boustead JN, 2003, BIOCHEM J, V369, P17, DOI 10.1042/BJ20021382; CASCIO S, 1991, DEVELOPMENT, V113, P217; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Daniels E, 1996, DEV DYNAM, V206, P272, DOI 10.1002/(SICI)1097-0177(199607)206:3<272::AID-AJA5>3.3.CO;2-U; DEWOLFPEETERS C, 1974, EXP MOL PATHOL, V21, P339, DOI 10.1016/0014-4800(74)90100-2; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Duncan SA, 1997, DEVELOPMENT, V124, P279; Enzan H, 1997, MICROSC RES TECHNIQ, V39, P336, DOI 10.1002/(SICI)1097-0029(19971115)39:4<336::AID-JEMT4>3.0.CO;2-F; FERACCI H, 1987, DEV BIOL, V123, P73, DOI 10.1016/0012-1606(87)90429-5; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Li JX, 2000, GENE DEV, V14, P464; MEDLOCK ES, 1983, ANAT REC, V207, P31, DOI 10.1002/ar.1092070105; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Parviz F, 2002, GENESIS, V32, P130, DOI 10.1002/gene.10058; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; SHERLOCK S, 1909, DIS LIVER BILIARY SY, P371; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Spath GF, 1997, MOL CELL BIOL, V17, P1913; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; VASSY J, 1988, CELL DIFFER DEV, V24, P9, DOI 10.1016/0045-6039(88)90082-6; WOOD RL, 1965, ANAT RECORD, V151, P507, DOI 10.1002/ar.1091510403	26	433	458	0	24	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					292	296		10.1038/ng1175	http://dx.doi.org/10.1038/ng1175			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808453				2022-12-17	WOS:000183815300016
J	THOMAS, GR; FORBES, JR; ROBERTS, EA; WALSHE, JM; COX, DW				THOMAS, GR; FORBES, JR; ROBERTS, EA; WALSHE, JM; COX, DW			THE WILSON-DISEASE GENE - SPECTRUM OF MUTATIONS AND THEIR CONSEQUENCES	NATURE GENETICS			English	Article							COPPER-TRANSPORTING ATPASE; MENKES DISEASE; CANDIDATE GENE; DNA MARKERS; ENCODES	We have previously reported the cloning of a gene that encodes a copper transporting P-type ATPase (ATP7B) which is defective in Wilson disease. We have now identified in 58 WND patients, 20 new mutations as well as three of five previously published mutations: 11 small insertions and deletions, seven missense, two nonsense and three splice site mutations, Two of the mutations are relatively frequent, representing 38% of the mutations in patients of European origin. Our findings suggest a wider spectrum of age of onset than is considered typical of Wilson disease: mutations that completely disrupt the gene can produce liver disease in early childhood when Wilson disease may not typically considered in the differential diagnosis. The mutations identified provide an explanation for at least part of the wide phenotypic variation observed in Wilson disease.	HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO,ON M5S 1A1,CANADA; MIDDLESEX HOSP,LONDON,ENGLAND	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of London; University College London								BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; BYTH BC, 1994, NUCLEIC ACIDS RES, V22, P1766, DOI 10.1093/nar/22.9.1766; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; COX DW, 1972, AM J HUM GENET, V24, P646; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DAS S, 1994, AM J HUM GENET, V55, P883; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; HOUWEN RHJ, 1993, J HEPATOL, V17, P269, DOI 10.1016/S0168-8278(05)80204-1; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; MACLENNAN DH, 1992, ACTA PHYSIOL SCAND, V146, P141; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; RAD MR, 1994, YEAST, V10, P1217, DOI 10.1002/yea.320100910; TANNER MS, 1981, ARCH DIS CHILD, V56, P4, DOI 10.1136/adc.56.1.4; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; THOMAS GR, 1994, AM J HUM GENET, V54, P71; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541	21	433	469	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					210	217		10.1038/ng0295-210	http://dx.doi.org/10.1038/ng0295-210			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7626145				2022-12-17	WOS:A1995QE67200025
J	Horike, S; Cai, ST; Miyano, M; Cheng, JF; Kohwi-Shigematsu, T				Horike, S; Cai, ST; Miyano, M; Cheng, JF; Kohwi-Shigematsu, T			Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome	NATURE GENETICS			English	Article							CPG-BINDING PROTEIN; DNA METHYLATION; MONOCHROMOSOMAL HYBRIDS; HISTONE METHYLATION; IN-VIVO; MECP2; GENE; BRAIN; IDENTIFICATION; EXPRESSION	Mutations in MECP2 are associated with Rett syndrome, an X-linked neurodevelopmental disorder. To identify genes targeted by Mecp2, we sequenced 100 in vivo Mecp2-binding sites in mouse brain. Several sequences mapped to an imprinted gene cluster on chromosome 6, including Dlx5 and Dlx6, whose transcription was roughly two times greater in brains of Mecp2-null mice compared with those of wild-type mice. The maternally expressed gene DLX5 showed a loss of imprinting in lymphoblastoid cells from individuals with Rett syndrome. Because Dlx5 regulates production of enzymes that synthesize gamma-aminobutyric acid (GABA), loss of imprinting of Dlx5 may alter GABAergic neuron activity in individuals with Rett syndrome. In mouse brain, Dlx5 imprinting was relaxed, yet Mecp2-mediated silent-chromatin structure existed at the Dlx5-Dlx6 locus in brains of wild-type, but not Mecp2-null, mice. Mecp2 targeted histone deacetylase 1 to a sharply defined, similar to1-kb region at the Dlx5-Dlx6 locus and promoted repressive histone methylation at Lys9 at this site. Chromatin immunoprecipitation-combined loop assays showed that Mecp2 mediated the silent chromatin-derived 11-kb chromatin loop at the Dlx5-Dlx6 locus. This loop was absent in chromatin of brains of Mecp2-null mice, and Dlx5-Dlx6 interacted with far distant sequences, forming distinct active chromatin-associated loops. These results show that formation of a silent-chromatin loop is a new mechanism underlying gene regulation by Mecp2.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd,Mail Stop 84-171, Berkeley, CA 94720 USA.	terumiks@lbl.gov	MIYANO, MASARU/I-1353-2015; Horike, Shin-ichi/C-4319-2015	Horike, Shin-ichi/0000-0002-4256-9129; Cheng, Jan-Fang/0000-0001-7315-7613				Alvarez JD, 2000, GENE DEV, V14, P521; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Budden SS, 2001, BRAIN DEV-JPN, V23, pS133, DOI 10.1016/S0387-7604(01)00338-2; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hoshiya H, 2003, J HUM GENET, V48, P208, DOI 10.1007/s10038-003-0006-6; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kimura MI, 2004, J HUM GENET, V49, P273, DOI 10.1007/s10038-004-0139-2; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Lalande M, 1999, Adv Neurol, V79, P421; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okita C, 2003, GENOMICS, V81, P556, DOI 10.1016/S0888-7543(03)00052-1; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Palferman S, 2001, AM J HUM GENET, V69, P570; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Weitzel JM, 1997, MOL CELL BIOL, V17, P5656, DOI 10.1128/MCB.17.9.5656; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	432	459	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					31	40		10.1038/ng1491	http://dx.doi.org/10.1038/ng1491			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15608638				2022-12-17	WOS:000225997500018
J	Falkenberg, M; Gaspari, M; Rantanen, A; Trifunovic, A; Larsson, NG; Gustafsson, CM				Falkenberg, M; Gaspari, M; Rantanen, A; Trifunovic, A; Larsson, NG; Gustafsson, CM			Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA	NATURE GENETICS			English	Article							HMG-BOX PROTEIN; RNA-POLYMERASE; FACTOR-A; CRYSTAL-STRUCTURE; FACTOR-I; DNA; SEQUENCE; MOUSE; ORGANIZATION; PURIFICATION	Characterization of the basic transcription machinery of mammalian mitochondrial DNA (mtDNA)(1,2) is of fundamental biological interest and may also lead to therapeutic interventions for human diseases associated with mitochondrial dysfunction(3-6). Here we report that mitochondrial transcription factors B1 (TFB1M) and B2 (TFB2M) are necessary for basal transcription of mammalian mitochondrial DNA (mtDNA). Human TFB1M and TFB2M are expressed ubiquitously and can each support promoter-specific mtDNA transcription in a pure recombinant in vitro system containing mitochondrial RNA polymerase (POLRMT)(7) and mitochondrial transcription factor A(8,9). Both TFB1M and TFB2M interact directly with POLRMT, but TFB2M is at least one order of magnitude more active in promoting transcription than TFB1M. Both factors are highly homologous to bacterial rRNA dimethyltransferases, which suggests that an RNA-modifying enzyme has been recruited during evolution to function as a mitochondrial transcription factor. The presence of two proteins that interact with mammalian POLRMT may allow flexible regulation of mtDNA gene expression in response to the complex physiological demands of mammalian metabolism.	Huddinge Hosp, Karolinska Inst, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden; Huddinge Hosp, Karolinska Inst, Novum, Dept Biosci, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Larsson, NG (corresponding author), Huddinge Hosp, Karolinska Inst, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden.		Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Gustafsson, Claes/0000-0003-3531-8468				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANTOSHECHKIN I, 1995, MOL CELL BIOL, V15, P7032; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bogenhagen DF, 1996, J BIOL CHEM, V271, P12036; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; Fernandez-Silva P, 1996, Methods Enzymol, V264, P129, DOI 10.1016/S0076-6879(96)64014-2; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6; Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; SANYAL A, 1995, J BIOL CHEM, V270, P11970, DOI 10.1074/jbc.270.20.11970; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yano M, 1997, J BIOL CHEM, V272, P8459, DOI 10.1074/jbc.272.13.8459	30	432	464	0	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					289	294		10.1038/ng909	http://dx.doi.org/10.1038/ng909			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068295				2022-12-17	WOS:000176494100018
J	Max, M; Shanker, YG; Huang, LQ; Rong, M; Liu, Z; Campagne, F; Weinstein, H; Damak, S; Margolskee, RF				Max, M; Shanker, YG; Huang, LQ; Rong, M; Liu, Z; Campagne, F; Weinstein, H; Damak, S; Margolskee, RF			Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac	NATURE GENETICS			English	Article							SACCHARIN PREFERENCE; BITTER; MICE; SUBSTANCES; RESPONSES; GUSTDUCIN; GENETICS; SUCROSE; CELLS	The ability to taste the sweetness of carbohydrate-rich foodstuffs has a critical role in the nutritional status of humans. Although several components of bitter transduction pathways have been identified(1-6), the receptors and other sweet transduction elements remain unknown. The Sac locus in mouse, mapped to the distal end of chromosome 4 (refs. 7-9), is the major determinant of differences between sweet-sensitive and -insensitive strains of mice in their responsiveness to saccharin, sucrose and other sweeteners(10-13). To identify the human Sac locus, we searched for candidate genes within a region of approximately one million base pairs of the sequenced human genome syntenous to the region of Sac in mouse. From this search, we identified a likely candidate: T1R3, a previously unknown G protein-coupled receptor (GPCR) and the only GPCR in this region. Mouse Tas1r3 (encoding T1r3) maps to within 20,000 bp of the marker closest to Sac (ref. 9) and, like human TA5IR3, is expressed selectively in taste receptor cells. By comparing the sequence of Tas1r3 from several independently derived strains of mice, we identified a specific polymorphism that assorts between taster and non-taster strains. According to models of its structure. T1r3 from non-tasters is predicted to have an extra amino-terminal glycosylation site that, if used, would interfere with dimerization.	NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA; NYU, Mt Sinai Sch Med, Dept Phys & Biophys, New York, NY USA; NYU, Mt Sinai Sch Med, Inst Computat Biomed, New York, NY USA	Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University	Margolskee, RF (corresponding author), NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, 550 1st Ave, New York, NY 10012 USA.	Bob@inka.mssm.edu	WEINSTEIN, HAREL/O-8245-2019; Campagne, Fabien/F-5158-2010	WEINSTEIN, HAREL/0000-0003-3473-9818; Huang, Liquan/0000-0003-3400-0685; Margolskee, Robert/0000-0002-9572-2887; Campagne, Fabien/0000-0001-6237-3564	NIDCD NIH HHS [DC00310, DC03155] Funding Source: Medline; NIMH NIH HHS [MH57241] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH057241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Blizard DA, 1999, CHEM SENSES, V24, P373, DOI 10.1093/chemse/24.4.373; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; HIJI Y, 1975, NATURE, V256, P427, DOI 10.1038/256427a0; HOGAN B, 1994, MANIPULATING MOUSE E; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Nakashima K, 1998, CELL PHYSIOL BIOCHEM, V8, P224, DOI 10.1159/000016285; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Rossler P, 1998, EUR J CELL BIOL, V77, P253; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	25	432	468	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					58	63		10.1038/ng0501-58	http://dx.doi.org/10.1038/ng0501-58			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326277				2022-12-17	WOS:000168413300017
J	Levy, JE; Jin, O; Fujiwara, Y; Kuo, F; Andrews, NC				Levy, JE; Jin, O; Fujiwara, Y; Kuo, F; Andrews, NC			Transferrin receptor is necessary for development of erythrocytes and the nervous system	NATURE GENETICS			English	Article							IRON UPTAKE; MOUSE; CELLS; MICE; ATRANSFERRINEMIA; HEMOCHROMATOSIS; PRECURSORS; LACKING; DEFECT; GENE	Plasma iron circulates bound to transferrin (Trf), which solubilizes the ferric ion and attenuates its reactivity. Diferric Trf interacts with cell-surface Trf receptor (Trfr) to undergo receptor-mediated endocytosis into specialized endosomes. Endosomal acidification leads to iron release, and iron is transported out of the endosome through the activity of divalent metal transporter 1 (DMT1, formerly Nramp2), a transmembrane iron transporter that functions only at low pH (ref. 1). Trf and Trfr then return to the cell surface for reuse, completing a highly efficient cycle. Although the Trf cycle is assumed to be the general mechanism for cellular iron uptake, this has not been validated experimentally. Mice with hypotransferrinaemia (hpx) have little or no plasma Trf (refs 2,3). They have severe anaemia, indicating that the Trf cycle is essential for iron uptake by erythroid cells'. Other hpx tissues, however, are generally normal, and there is a paradoxical increase in intestinal iron absorption and iron storage(3,4). To test the hypothesis that the Trf cycle has unique importance for erythropoiesis, we disrupted the Trfr gene in mice. This results in elimination of the Trf cycle, but leaves other Trf functions intact. Mice lacking Trfr have a more severe phenotype than hpx mice, affecting both erythropoiesis and neurologic development. Furthermore, haploinsufficiency for Trfr results in impaired erythroid development and abnormal iron homeostasis.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Andrews, NC (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.			Andrews, Nancy/0000-0003-0243-4462	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051057, R29HL051057] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL51057, HL03503] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON GJ, 1990, GASTROENTEROLOGY, V98, P576, DOI 10.1016/0016-5085(90)90276-7; ANDREWS NC, 1997, HEMATOLOGY INFANCY C, P423; BERNSTEIN SE, 1987, J LAB CLIN MED, V110, P690; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; DICKINSON TK, 1994, BRAIN RES, V635, P169, DOI 10.1016/0006-8993(94)91436-2; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gelvan D, 1996, BLOOD, V88, P3200, DOI 10.1182/blood.V88.8.3200.bloodjournal8883200; HUGGENVIK JI, 1989, BLOOD, V74, P482; INMAN RS, 1993, J BIOL CHEM, V268, P8521; JOINER CH, 1995, BLOOD, V86, P4307, DOI 10.1182/blood.V86.11.4307.bloodjournal86114307; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; STURROCK A, 1990, J BIOL CHEM, V265, P3139; TORRENCE JD, 1980, METHODS HAEMATOLOGY, P104; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	21	432	444	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					396	399		10.1038/7727	http://dx.doi.org/10.1038/7727			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192390				2022-12-17	WOS:000079439700021
J	Helbig, I; Mefford, HC; Sharp, AJ; Guipponi, M; Fichera, M; Franke, A; Muhle, H; de Kovel, C; Baker, C; von Spiczak, S; Kron, KL; Steinich, I; Kleefuss-Lie, AA; Leu, C; Gaus, V; Schmitz, B; Klein, KM; Reif, PS; Rosenow, F; Weber, Y; Lerche, H; Zimprich, F; Urak, L; Fuchs, K; Feucht, M; Genton, P; Thomas, P; Visscher, F; de Haan, GJ; Moller, RS; Hjalgrim, H; Luciano, D; Wittig, M; Nothnagel, M; Elger, CE; Nurnberg, P; Romano, C; Malafosse, A; Koeleman, BPC; Lindhout, D; Stephani, U; Schreiber, S; Eichler, EE; Sander, T				Helbig, Ingo; Mefford, Heather C.; Sharp, Andrew J.; Guipponi, Michel; Fichera, Marco; Franke, Andre; Muhle, Hiltrud; de Kovel, Carolien; Baker, Carl; von Spiczak, Sarah; Kron, Katherine L.; Steinich, Ines; Kleefuss-Lie, Ailing A.; Leu, Costin; Gaus, Verena; Schmitz, Bettina; Klein, Karl M.; Reif, Philipp S.; Rosenow, Felix; Weber, Yvonne; Lerche, Holger; Zimprich, Fritz; Urak, Lydia; Fuchs, Karoline; Feucht, Martha; Genton, Pierre; Thomas, Pierre; Visscher, Frank; de Haan, Gerrit-Jan; Moller, Rikke S.; Hjalgrim, Helle; Luciano, Daniela; Wittig, Michael; Nothnagel, Michael; Elger, Christian E.; Nuernberg, Peter; Romano, Corrado; Malafosse, Alain; Koeleman, Bobby P. C.; Lindhout, Dick; Stephani, Ulrich; Schreiber, Stefan; Eichler, Evan E.; Sander, Thomas			15q13.3 microdeletions increase risk of idiopathic generalized epilepsy	NATURE GENETICS			English	Article							SCHIZOPHRENIA; SEIZURES	We identified 15q13.3 microdeletions encompassing the CHRNA7 gene in 12 of 1,223 individuals with idiopathic generalized epilepsy (IGE), which were not detected in 3,699 controls (joint P = 5.32 x 10(-8)). Most deletion carriers showed common IGE syndromes without other features previously associated with 15q13.3 microdeletions, such as intellectual disability, autism or schizophrenia. Our results indicate that 15q13.3 microdeletions constitute the most prevalent risk factor for common epilepsies identified to date.	[Mefford, Heather C.; Baker, Carl; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sharp, Andrew J.; Guipponi, Michel; Malafosse, Alain] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Sharp, Andrew J.; Guipponi, Michel; Malafosse, Alain] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Fichera, Marco; Luciano, Daniela; Romano, Corrado] IRCCS Associaz Oasi Maria Santissima, I-94018 Troina, Italy; [Genton, Pierre] Ctr St Paul Hop Henri Gastaut, F-13258 Marseille 09, France; [Thomas, Pierre] Hop Louis Pasteur, Unite Fonctionnelle EEG Epileptol, Serv Neurol, F-06002 Nice 01, France; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany	University of Washington; University of Washington Seattle; University of Geneva; University of Geneva; CHU Nice; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Bonn		sandert@uni-koeln.de	Nothnagel, Michael/A-7759-2011; Sander-Effron, Samuel/AAX-2231-2020; Franke, Andre/B-2151-2010; de Kovel, Carolien/AAI-3531-2021; Nothnagel, Michael/L-7187-2019; Zimprich, Fritz/O-1406-2019; Muhle, Hiltrud/F-5715-2010; Resource Center, NINDS Human Genetics/AGF-2474-2022; Helbig, Ingo/G-8467-2018; Lindhout, Dick/AAH-5765-2019; Nothnagel, Michael/G-6545-2014; Helbig, Ingo/A-5544-2009; Romano, Corrado/B-9695-2008; Nothnagel, Michael/H-6887-2012; Helbig, Katherine/B-7454-2012; Fichera, Marco/K-9220-2016; Stephani, Ulrich/D-1004-2010; Zimprich, Fritz/W-1738-2017	Franke, Andre/0000-0003-1530-5811; de Kovel, Carolien/0000-0002-7818-1396; Nothnagel, Michael/0000-0001-8305-7114; Zimprich, Fritz/0000-0002-6998-5480; Helbig, Ingo/0000-0001-8486-0558; Romano, Corrado/0000-0003-1049-0683; Helbig, Katherine/0000-0001-8249-0549; Fichera, Marco/0000-0002-8225-6880; Zimprich, Fritz/0000-0002-6998-5480; Feucht, Martha/0000-0001-7691-8158; de Haan, Gerrit-Jan/0000-0003-2373-9863; Klein, Karl Martin/0000-0002-6654-1665; Leu, Costin/0000-0003-0598-3301; Lindhout, Dick/0000-0001-9580-624X; Moller, Rikke S./0000-0002-9664-1448	German Research Foundation [SA434/4-1]; German Federal Ministry of Education and Research (National Genome Research Network [NGFN-2]; European Community; EPICURE [LSHM-CT-2006-037315, 219250]; PopGen biobank; University of Kiel; Danish National Research Foundation; NIH [HD043569]; National Epilepsy Funds (NEF) [04-08]; Netherlands Organization for Scientific Research (NOW) [917.66.315]; German Research Foundation/German Federal Ministry of Education and Research (DFG/BMBF); Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (National Genome Research Network(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); EPICURE; PopGen biobank; University of Kiel; Danish National Research Foundation(Danmarks Grundforskningsfond); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Epilepsy Funds (NEF); Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO)); German Research Foundation/German Federal Ministry of Education and Research (DFG/BMBF)(German Research Foundation (DFG)Federal Ministry of Education & Research (BMBF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank all the subjects and their families for participating in this study. We are also grateful to H. Bode for referral of subjects and A. Ackerhans and K. Moldenhauer for database management. This study used samples from the NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds), as well as clinical data. NINDS Repository sample numbers corresponding to the samples used are available upon request. This study was supported by grants from the German Research Foundation (SA434/4-1, T. S., P. N.), the German Federal Ministry of Education and Research (National Genome Research Network, NGFN-2: NeuroNet, NGFNplus: EMINet), the European Community (FP6 Integrated Project EPICURE, LSHM-CT-2006-037315; grant agreement 219250, A.J.S.), the PopGen biobank, the University of Kiel (I. H.), the Danish National Research Foundation (R. S. M.), in part by grants from the NIH (HD043569, E. E. E.), the National Epilepsy Funds (NEF, grant no. 04-08, B. P. C. K., D. Lindhout), the Netherlands Organization for Scientific Research (NOW, grant no. 917.66.315, B.P.C.K., C.d.K.) and the German Research Foundation/German Federal Ministry of Education and Research (DFG/BMBF) excellence cluster "Inflammation at Interfaces'' (A. F., M. W., S. S.). E. E. E. is an investigator of the Howard Hughes Medical Institute.	Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; Ottman R, 2005, EPILEPSIA, V46, P7, DOI 10.1111/j.1528-1167.2005.00350.x; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239	13	431	459	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2009	41	2					160	162		10.1038/ng.292	http://dx.doi.org/10.1038/ng.292			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19136953	Green Submitted, Green Accepted			2022-12-17	WOS:000263091300013
J	Sharp, AJ; Mefford, HC; Li, K; Baker, C; Skinner, C; Stevenson, RE; Schroer, RJ; Novara, F; De Gregori, M; Ciccone, R; Broomer, A; Casuga, I; Wang, Y; Xiao, C; Barbacioru, C; Gimelli, G; Bernardina, BD; Torniero, C; Giorda, R; Regan, R; Murday, V; Mansour, S; Fichera, M; Castiglia, L; Failla, P; Ventura, M; Jiang, ZS; Cooper, GM; Knight, SJL; Romano, C; Zuffardi, O; Chen, CF; Schwartz, CE; Eichler, EE				Sharp, Andrew J.; Mefford, Heather C.; Li, Kelly; Baker, Carl; Skinner, Cindy; Stevenson, Roger E.; Schroer, Richard J.; Novara, Francesca; De Gregori, Manuela; Ciccone, Roberto; Broomer, Adam; Casuga, Iris; Wang, Yu; Xiao, Chunlin; Barbacioru, Catalin; Gimelli, Giorgio; Bernardina, Bernardo Dalla; Torniero, Claudia; Giorda, Roberto; Regan, Regina; Murday, Victoria; Mansour, Sahar; Fichera, Marco; Castiglia, Lucia; Failla, Pinella; Ventura, Mario; Jiang, Zhaoshi; Cooper, Gregory M.; Knight, Samantha J. L.; Romano, Corrado; Zuffardi, Orsetta; Chen, Caifu; Schwartz, Charles E.; Eichler, Evan E.			A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; ARRAY-CGH; MOLECULAR CHARACTERIZATION; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; ANGELMAN-SYNDROME; REARRANGEMENTS; ARCHITECTURE; POLYMORPHISM; 15Q11-Q13	We report a recurrent microdeletion syndrome causing mental retardation, epilepsy and variable facial and digital dysmorphisms. We describe nine affected individuals, including six probands: two with de novo deletions, two who inherited the deletion from an affected parent and two with unknown inheritance. The proximal breakpoint of the largest deletion is contiguous with breakpoint 3 (BP3) of the Prader-Willi and Angelman syndrome region, extending 3.95 Mb distally to BP5. A smaller 1.5-Mb deletion has a proximal breakpoint within the larger deletion (BP4) and shares the same distal BP5. This recurrent 1.5-Mb deletion contains six genes, including a candidate gene for epilepsy (CHRNA7) that is probably responsible for the observed seizure phenotype. The BP4-BP5 region undergoes frequent inversion, suggesting a possible link between this inversion polymorphism and recurrent deletion. The frequency of these microdeletions in mental retardation cases is similar to 0.3% (6/2,082 tested), a prevalence comparable to that of Williams, Angelman and Prader-Willi syndromes.	[Sharp, Andrew J.; Mefford, Heather C.; Baker, Carl; Jiang, Zhaoshi; Cooper, Gregory M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Li, Kelly; Broomer, Adam; Casuga, Iris; Wang, Yu; Xiao, Chunlin; Barbacioru, Catalin; Chen, Caifu] Appl Biosyst Inc, Assays Arrays R&D, Foster City, CA 94404 USA; [Skinner, Cindy; Stevenson, Roger E.; Schroer, Richard J.; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA; [Novara, Francesca; De Gregori, Manuela; Ciccone, Roberto; Zuffardi, Orsetta] Univ Pavia, I-27100 Pavia, Italy; [Gimelli, Giorgio] Ist Giannina Gaslini, I-16147 Genoa, Italy; [Bernardina, Bernardo Dalla; Torniero, Claudia] Univ Verona, Policlin GB Rossi, Servizio Neuropsichiatr Infantile, I-37134 Verona, Italy; [Giorda, Roberto] IRCCS E Medea, I-23842 Bosisio Parini, Italy; [Regan, Regina; Knight, Samantha J. L.] Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford Natl Inst Hlth Res NIHR Biomed Res Ctr, Oxford OX3 7BN, England; [Murday, Victoria] Duncan Guthrie Inst Med Genet, Dept Med Genet, Glasgow G3 8SJ, Lanark, Scotland; [Mansour, Sahar] St George Hosp, SW Reg Genet Serv, London SW17 0RE, England; [Fichera, Marco; Castiglia, Lucia; Failla, Pinella; Romano, Corrado] IRCCS, Assoc Oasi Maria Santissima, I-94018 Troina, Italy; [Ventura, Mario] Univ Bari, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Zuffardi, Orsetta] Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Thermo Fisher Scientific; Applied Biosystems; Greenwood Genetic Center; University of Pavia; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Eugenio Medea; University of Oxford; Wellcome Centre for Human Genetics; St Georges University London; IRCCS Oasi Maria SS; Universita degli Studi di Bari Aldo Moro; IRCCS Fondazione San Matteo; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Fichera, Marco/K-9220-2016; Castiglia, Lucia/D-8563-2017; Giorda, Roberto/Q-6010-2019; Cooper, Gregory/D-6914-2011; De Gregori, Manuela/J-1039-2014; Giorda, Roberto/J-1052-2014; Romano, Corrado/B-9695-2008; Ventura, Mario/E-6420-2011; Failla, Pinella/AAE-9963-2019	Fichera, Marco/0000-0002-8225-6880; Castiglia, Lucia/0000-0002-3261-8847; Giorda, Roberto/0000-0001-8175-9606; Cooper, Gregory/0000-0001-5509-9923; De Gregori, Manuela/0000-0002-3507-497X; Giorda, Roberto/0000-0001-8175-9606; Romano, Corrado/0000-0003-1049-0683; Ventura, Mario/0000-0001-7762-8777; Failla, Pinella/0000-0003-3969-7266; Knight, Samantha/0000-0002-6047-3462; Novara, Francesca/0000-0003-1216-0231; zuffardi, orsetta/0000-0002-1466-4559	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [U01 HL069757] Funding Source: Medline; NICHD NIH HHS [HD043569, R01 HD043569] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Erdogan F, 2007, AM J MED GENET A, V143A, P172, DOI 10.1002/ajmg.a.31541; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; LARSON SA, 2001, AM J MENT RETARD, V106, P231; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Sahoo T, 2005, AM J MED GENET A, V139A, P106, DOI 10.1002/ajmg.a.31000; Sahoo T, 2007, EUR J HUM GENET, V15, P943, DOI 10.1038/sj.ejhg.5201859; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stevenson RE, 2003, AM J MED GENET A, V123A, P29, DOI 10.1002/ajmg.a.20492; STEVENSON RE, 1996, P GREENW GEN CTR; Wang NJ, 2004, AM J HUM GENET, V75, P267, DOI 10.1086/422854; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	30	431	439	2	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					322	328		10.1038/ng.93	http://dx.doi.org/10.1038/ng.93			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278044	Green Accepted			2022-12-17	WOS:000253548400023
J	Torres, MA; Jones, JDG; Dangl, JL				Torres, MA; Jones, JDG; Dangl, JL			Pathogen-induced, NADPH oxidase-derived reactive oxygen intermediates suppress spread of cell death in Arabidopsis thaliana	NATURE GENETICS			English	Article							DISEASE RESISTANCE; SALICYLIC-ACID; NITRIC-OXIDE; HYPERSENSITIVE RESPONSE; OXIDATIVE STRESS; PLANT; TOBACCO; GENE; LSD1; LOCALIZATION	Plant immune responses are usually accompanied by the production of extracellular superoxide at and surrounding infection sites(1-3). Extracellular reactive oxygen intermediates (ROIs) in plants were proposed to drive programmed cell death correlated with disease resistance (the hypersensitive response). ROIs derived from this oxidative burst are generated by plasma membrane NADPH oxidases, anchored by gp91(phox) proteins related to those responsible for the respiratory oxidative burst activated in mammalian neutrophils during infection(4,5). Mutation of Arabidopsis thaliana respiratory burst oxidase (Atrboh) genes eliminated pathogen-induced ROI production but had only a modest effect on the hypersensitive response(4). We show that Atrboh function can be activated by exogenous ROIs. Unexpectedly, the subsequent oxidative burst can suppress cell death in cells surrounding sites of NADPH oxidase activation. This cell death requires salicylic acid, a plant immune system activator(6). Thus, ROIs generated by Atrboh proteins can antagonize salicylic acid-dependent pro-death signals. These results have implications for understanding how salicylic acid activates defense signaling in cells spatially removed from infection sites without causing cell death.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ N Carolina, Dept Microbiol & Immunol, Curriculum Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, CB 3280,Coker Hall,Room 108, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Jones, Jonathan DG/J-5129-2012; Lacruz, Miguel Angel Torres/H-6969-2015	Jones, Jonathan DG/0000-0002-4953-261X; Lacruz, Miguel Angel Torres/0000-0002-0435-1786				Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; AUH CK, 1995, PLANT PHYSIOL, V107, P1241, DOI 10.1104/pp.107.4.1241; Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Dorey S, 1997, MOL PLANT MICROBE IN, V10, P646, DOI 10.1094/MPMI.1997.10.5.646; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108	30	431	445	5	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1130	1134		10.1038/ng1639	http://dx.doi.org/10.1038/ng1639			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16170317				2022-12-17	WOS:000232185600027
J	Saigoh, K; Wang, YL; Suh, TG; Yamanishi, T; Sakai, Y; Kiyosawa, H; Harada, T; Ichihara, N; Wakana, S; Kikuchi, T; Wada, K				Saigoh, K; Wang, YL; Suh, TG; Yamanishi, T; Sakai, Y; Kiyosawa, H; Harada, T; Ichihara, N; Wakana, S; Kikuchi, T; Wada, K			Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice	NATURE GENETICS			English	Article							AXONAL DYSTROPHY GAD; PGP 9.5; MUTANT MOUSE; NEURODEGENERATIVE DISEASES; DEUBIQUITINATING ENZYMES; SENSORY NEURONS; NERVE-TERMINALS; DEGENERATION; PROTEIN; AXONOPATHY	The gracile axonal dystrophy (gad) mouse is an autosomal recessive mutant that shows sensory ataxia at an early stage, followed by motor ataxia at a later stage(1). Pathologically, the mutant is characterized by 'dying-back' type axonal degeneration and formation of spheroid bodies in nerve terminals(2-5) Recent pathological observations have associated brain ageing and neurodegenerative diseases with progressive accumulation of ubiquitinated protein conjugates(6,7). In gad mice, accumulation of amyloid beta-protein and ubiquitin-positive deposits occur retrogradely along the sensory and motor nervous systems(8,9). We previously reported that the gad mutation was transmitted by a gene on chromosome 5 (refs 10,11). Here we find that the gad mutation is caused by an in-frame deletion including exons 7 and 8 of Uchl1, encoding the ubiquitin carboxy-terminal hydrolase (UCH) isozyme (Uch-ll) selectively expressed in the nervous system and testis(12-15). The gad allele encodes a truncated Uch-ll lacking a segment of 42 amino acids containing a catalytic residue(16). As Uch-ll is thought to stimulate protein degradation by generating free monomeric ubiquitin(16-18), the gad mutation appears to affect protein turnover. Our data suggest that altered function of the ubiquitin system directly causes neurodegeneration, The gad mouse provides a useful model for investigating human neurodegenerative disorders.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Anim Models Human Dis, Tokyo 1878502, Japan; Kinki Univ, Sch Med, Dept Neurol, Osaka 5898511, Japan; Cent Inst Expt Anim, Dept Genet, Kawasaki, Kanagawa 216, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Kindai University (Kinki University)	Wada, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan.		Saigoh, Kazumasa/AAG-2956-2020; saigoh, Kazumasa/AFK-6417-2022; saigoh, Kazumasa/AAG-4678-2022	Saigoh, Kazumasa/0000-0002-0905-5935; 				Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Arnold J, 1998, PROG BRAIN RES, V117, P23; BIZZI A, 1991, BRAIN RES, V548, P292, DOI 10.1016/0006-8993(91)91135-N; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; DAY INM, 1987, FEBS LETT, V210, P157, DOI 10.1016/0014-5793(87)81327-3; DAY INM, 1990, BIOCHEM J, V268, P521, DOI 10.1042/bj2680521; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Harada T, 1998, J NEUROSCI, V18, P3336; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; ICHIHARA N, 1995, BRAIN RES, V695, P173, DOI 10.1016/0006-8993(95)00729-A; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; KAJIMOTO Y, 1992, J BIOCHEM-TOKYO, V112, P28, DOI 10.1093/oxfordjournals.jbchem.a123860; KIKUCHI T, 1990, ACTA NEUROPATHOL, V80, P145, DOI 10.1007/BF00308917; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024; MIURA H, 1993, NEUROPATH APPL NEURO, V19, P41, DOI 10.1111/j.1365-2990.1993.tb00403.x; MUKOYAMA M, 1989, ACTA NEUROPATHOL, V79, P294, DOI 10.1007/BF00294664; ODA K, 1992, NEUROPATH APPL NEURO, V18, P265, DOI 10.1111/j.1365-2990.1992.tb00789.x; Ophoff RA, 1998, TRENDS PHARMACOL SCI, V19, P121, DOI 10.1016/S0165-6147(98)01182-1; SUH JG, 1995, GENOMICS, V27, P549, DOI 10.1006/geno.1995.1091; Wakana S, 1997, MAMM GENOME, V8, P698, DOI 10.1007/s003359900542; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; WILKINSON KD, 1992, BIOCHEM SOC T, V20, P631, DOI 10.1042/bst0200631; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; WU J, 1996, ALZHEIMERS RES, V2, P163; YAMAZAKI K, 1988, P SOC EXP BIOL MED, V187, P209; YAMAZAKI K, 1987, JPN J GENET, V62, P479, DOI 10.1266/jjg.62.479	30	431	441	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					47	51		10.1038/12647	http://dx.doi.org/10.1038/12647			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471497				2022-12-17	WOS:000082337300014
J	Kimura, A; Harada, H; Park, JE; Nishi, H; Satoh, M; Takahashi, M; Hiroi, S; Sasaoka, T; Ohbuchi, N; Nakamura, T; Koyanagi, T; Hwang, TH; Choo, TA; Chung, KS; Hasegawa, A; Nagai, R; Okazaki, O; Nakamura, H; Matsuzaki, M; Sakamoto, T; Toshima, H; Koga, Y; Imaizumi, T; Sasazuki, T				Kimura, A; Harada, H; Park, JE; Nishi, H; Satoh, M; Takahashi, M; Hiroi, S; Sasaoka, T; Ohbuchi, N; Nakamura, T; Koyanagi, T; Hwang, TH; Choo, TA; Chung, KS; Hasegawa, A; Nagai, R; Okazaki, O; Nakamura, H; Matsuzaki, M; Sakamoto, T; Toshima, H; Koga, Y; Imaizumi, T; Sasazuki, T			Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy	NATURE GENETICS			English	Article							HEAVY-CHAIN GENE; PROTEIN-C GENE; SKELETAL-MUSCLE; BIOLOGICAL-ACTIVITY; MISSENSE MUTATION; ALPHA-TROPOMYOSIN; MOLECULAR-BASIS; SEQUENCE; LOCUS; MAPS	Hypertrophic cardiomyopathy (HCM), the most common cause of sudden death in the young, is an autosomal dominant disease characterized by ventricular hypertrophy accompanied by myofibrillar disarrays(1). Linkage studies and candidate-gene approaches have demonstrated that about half of the patients have mutations in one of six disease genes: cardiac beta-myosin heavy chain (c beta MHC)(2,3), cardiac troponin T (cTnT)(4,5), alpha-tropomyosin (alpha TM)(5,6), cardiac myosin binding protein C (cMBP-C)(7-9), ventricular myosin essential light chain (vMLC1)(10) and ventricular myosin regulatory light chain (vMLC2)(10) genes. Other disease genes remain unknown. Because all the known disease genes encode major contractile elements in cardiac muscle(11), we have systematically characterized the cardiac sarcomere genes, including cardiac troponin I (cTnI), cardiac actin (cACT) and cardiac troponin C (cTnC)(12) in 184 unrelated patients with HCM and found mutations in the cTnI gene in several patients(13).	KURUME UNIV,SCH MED,DEPT INTERNAL MED 3,KURUME,FUKUOKA 830,JAPAN; SAMSUNG MED CTR,DIV CARDIOL,SEOUL 135230,SOUTH KOREA; KURUME UNIV,INST CARDIOVASC RES,KURUME,FUKUOKA 830,JAPAN; GUNMA UNIV,SCH MED,DEPT INTERNAL MED 2,MAEBASHI,GUMMA 371,JAPAN; INT MED CTR,DEPT CARDIOL,TOKYO 162,JAPAN; YAMAGUCHI UNIV,SCH MED,DEPT INTERNAL MED 2,YAMAGUCHI 755,JAPAN; HANZOMON HOSP,TOKYO 102,JAPAN; KURUME UNIV,KURUME MED CTR,DEPT CARDIOL,KURUME,FUKUOKA 835,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,DEPT GENET,FUKUOKA 812,JAPAN	Kurume University; Sungkyunkwan University (SKKU); Samsung Medical Center; Kurume University; Gunma University; Yamaguchi University; Kurume University; Kyushu University	Kimura, A (corresponding author), TOKYO MED & DENT UNIV,MED RES INST,DEPT TISSUE PSYCHOL,DIV ADULT DIS,TOKYO 101,JAPAN.		nishi, Hiroaki/X-7736-2019; Kimura, Akinori/I-5989-2018	nishi, Hiroaki/0000-0002-6331-2947; Kimura, Akinori/0000-0002-4933-2132				BEALL CJ, 1991, J CELL BIOL, V114, P941, DOI 10.1083/jcb.114.5.941; Bermingham N, 1995, GENOMICS, V30, P620, DOI 10.1006/geno.1995.1288; Bhavsar PK, 1996, GENOMICS, V35, P11, DOI 10.1006/geno.1996.0317; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; FODOR WL, 1989, J BIOL CHEM, V264, P2143; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P5901, DOI 10.1073/pnas.79.19.5901; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; Ko YL, 1996, HUM GENET, V97, P457; LIEW CC, 1990, NUCLEIC ACIDS RES, V18, P3647, DOI 10.1093/nar/18.12.3647; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; MACRAE CA, 1995, J CLIN INVEST, V96, P1216, DOI 10.1172/JCI118154; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; NISHI H, 1995, CIRCULATION, V91, P2911, DOI 10.1161/01.CIR.91.12.2911; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; SCHREIER T, 1990, J BIOL CHEM, V265, P21247; SCHWARTZ K, 1995, CIRCULATION, V91, P532, DOI 10.1161/01.CIR.91.2.532; SOLARO RJ, 1995, ADV EXP MED BIOL, V382, P109; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; TAO T, 1989, BIOCHEMISTRY-US, V28, P5902, DOI 10.1021/bi00440a029; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434	29	431	450	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					379	382		10.1038/ng0897-379	http://dx.doi.org/10.1038/ng0897-379			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241277				2022-12-17	WOS:A1997XM90900022
J	Canna, SW; de Jesus, AA; Gounil, S; Brooks, SR; Marrero, B; Liu, Y; DiMattia, MA; Zaal, KJM; Sanchez, GAM; Kim, H; Chapelle, D; Plass, N; Huang, Y; Villarinol, AV; Biancotto, A; Fleisher, TA; Duncan, JA; O'Shea, JJ; Benseler, S; Grom, A; Deng, ZM; Laxer, RM; Goldbach-Mansky, R				Canna, Scott W.; de Jesus, Adriana A.; Gounil, Sushanth; Brooks, Stephen R.; Marrero, Bernadette; Liu, Yin; DiMattia, Michael A.; Zaal, Kristien J. M.; Sanchez, Gina A. Montealegre; Kim, Hanna; Chapelle, Dawn; Plass, Nicole; Huang, Yan; Villarinol, Alejandro V.; Biancotto, Angelique; Fleisher, Thomas A.; Duncan, Joseph A.; O'Shea, John J.; Benseler, Susanne; Grom, Alexei; Deng, Zuoming; Laxer, Ronald M.; Goldbach-Mansky, Raphaela			An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome	NATURE GENETICS			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; CYTOKINE PROFILES; BLAU-SYNDROME; DISEASE; INTERLEUKIN-18; MECHANISM; REVEALS; HETEROGENEITY; PATHOGENESIS; DEFICIENCY	Inflammasomes are innate immune sensors that respond to pathogen- and damage-associated signals with caspase-1 activation, interleukin (11)-1 beta and IL-18 secretion, and macrophage pyroptosis. The discovery that dominant gain-of-function mutations in NLRP3 cause the cryopyrin-associated periodic syndromes (CAPS) and trigger spontaneous inflammasome activation and IL-1 beta oversecretion led to successful treatment with IL-1-blocking agents(1). Herein we report a de novo missense mutation (c.1009A>T, encoding p.Thr337Ser) affecting the nucleotide-binding domain of the inflammasome component NLRC4 that causes early-onset recurrent fever flares and macrophage activation syndrome (MAS). Functional analyses demonstrated spontaneous inflammasome formation and production of the inflammasome-dependent cytokines IL-1 beta and IL-18, with the latter exceeding the levels seen in CAPS. The NLRC4 mutation caused constitutive caspase-1 cleavage in cells transduced with mutant NLRC4 and increased production of IL-18 in both patient-derived and mutant NLRC4 transduced macrophages. Thus, we describe a new monoallelic inflammasome defect that expands the monogenic autoinflammatory disease spectrum to include MAS and suggests new targets for therapy.	[Canna, Scott W.; Gounil, Sushanth; Villarinol, Alejandro V.; O'Shea, John J.] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Mol Immunol & Inflammat Branch, US Natl Inst Hlth NIH, Bethesda, MD USA; [de Jesus, Adriana A.; Marrero, Bernadette; Liu, Yin; Kim, Hanna; Chapelle, Dawn; Plass, Nicole; Huang, Yan; Goldbach-Mansky, Raphaela] NIAMS, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Brooks, Stephen R.; Deng, Zuoming] NIAMS, Biodata Min & Discovery Sect, Off Sci & Technol, NIH, Bethesda, MD USA; [DiMattia, Michael A.] NIAMS, Lab Struct Biol, NIH, Bethesda, MD USA; [Zaal, Kristien J. M.] NIAMS, Light Imaging Sect, Off Sci & Technol, NIH, Bethesda, MD USA; [Sanchez, Gina A. Montealegre; Chapelle, Dawn; Plass, Nicole] NIAMS, Office Clin Director, NIH, Bethesda, MD USA; [Biancotto, Angelique] NHLBI, Ctr Human Immunol, NIH, Bethesda, MD USA; [Fleisher, Thomas A.] NIH, Dept Lab, Ctr Clin, Bethesda, MD 20892 USA; [Duncan, Joseph A.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Benseler, Susanne] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Benseler, Susanne] Univ Calgary, Calgary, AB, Canada; [Grom, Alexei] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Grom, Alexei] Univ Cincinnati, Cincinnati, OH USA; [Laxer, Ronald M.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Alberta Childrens Hospital; University of Calgary; University of Calgary; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Canna, SW (corresponding author), NIAMS, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD 20892 USA.	scott.canna@nih.gov; goldbacr@mail.nih.gov	biancotto, angelique/C-4632-2011; Villarino, Alejandro/AAE-3517-2020; Goldbach-Mansky, Raphaela/N-5917-2017	biancotto, angelique/0000-0003-2271-009X; Villarino, Alejandro/0000-0001-8068-2176; Benseler, Susanne Maria/0000-0001-5756-3638; Kim, Hanna/0000-0002-0595-6533	Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health; Arthritis National Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, ZIAAR041138, ZIDAR041180, ZIAAR041202, ZIEAR041176, R01AR059049, ZIHAR041173] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health; Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CLINICAL CENTER	The authors are grateful to O. Navarro and G. Somers for assistance with data acquisition and to H. Convery and the patient and her family for assistance with research coordination. This research was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health. S.W.C. was also supported by the Arthritis National Research Foundation.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Canna SW, 2012, CURR OPIN RHEUMATOL, V24, P113, DOI 10.1097/BOR.0b013e32834dd37e; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horneff G, 2013, CLIN EXP RHEUMATOL, V31, pS99; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Ichida H, 2014, ARTHRIT CARE RES, V66, P642, DOI 10.1002/acr.22194; Kessel C, 2013, CLIN IMMUNOL, V147, P229, DOI 10.1016/j.clim.2012.11.008; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Martin TM, 2009, ARTHRITIS RHEUM, V60, P611, DOI 10.1002/art.24222; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; Megremis SD, 2004, RADIOLOGY, V231, P129, DOI 10.1148/radiol.2311020963; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Sanchez GAM, 2013, RHEUM DIS CLIN N AM, V39, P701, DOI 10.1016/j.rdc.2013.08.001; Schmid JP, 2010, IMMUNOL REV, V235, P10, DOI 10.1111/j.0105-2896.2010.00890.x; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shimizu M, 2013, CYTOKINE, V61, P345, DOI 10.1016/j.cyto.2012.11.025; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; Sibley CH, 2012, ARTHRITIS RHEUM-US, V64, P2375, DOI 10.1002/art.34409; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Terrell CE, 2013, BLOOD, V121, P5184, DOI 10.1182/blood-2013-04-495309; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Wada T, 2014, CYTOKINE, V65, P74, DOI 10.1016/j.cyto.2013.09.007; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Wittkowski H, 2008, ARTHRITIS RHEUM-US, V58, P3924, DOI 10.1002/art.24137; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	38	430	455	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1140	1146		10.1038/ng.3089	http://dx.doi.org/10.1038/ng.3089			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25217959	Green Accepted, Green Submitted			2022-12-17	WOS:000342554100020
J	Ripperger, JRA; Schibler, U				Ripperger, JRA; Schibler, U			Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions	NATURE GENETICS			English	Article							HISTONE H3; GENE-EXPRESSION; LYSINE 9; CLOCK; CELLS; METHYLATION; PACEMAKER; DEMETHYLATION; ACETYLATION; MECHANISMS	Mammalian circadian rhythms are based on transcriptional and post-translational feedback loops. Essentially, the activity of the transcription factors BMAL1 (also known as MOP3) and CLOCK is rhythmically counterbalanced by Period (PER) and Cryptochrome (CRY) proteins to govern time of day - dependent gene expression(1). Here we show that circadian regulation of the mouse albumin D element-binding protein (Dbp) gene involves rhythmic binding of BMAL1 and CLOCK and marked daily chromatin transitions. Thus, the Dbp transcription cycle is paralleled by binding of BMAL1 and CLOCK to multiple extra- and intragenic E boxes, acetylation of Lys9 of histone H3, trimethylation of Lys4 of histone H3 and a reduction of histone density. In contrast, the antiphasic daily repression cycle is accompanied by dimethylation of Lys9 of histone H3, the binding of heterochromatin protein 1 alpha and an increase in histone density. The rhythmic conversion of transcriptionally permissive chromatin to facultative heterochromatin relies on the presence of functional BMAL1-CLOCK binding sites.	Univ Fribourg, Dept Med, Biochem Sect, CH-1700 Fribourg, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva 4, Switzerland	University of Fribourg; University of Geneva; University of Geneva	Schibler, U (corresponding author), Univ Fribourg, Dept Med, Biochem Sect, CH-1700 Fribourg, Switzerland.	Ueli.Schibler@molbio.unige.ch						Akashi M, 2000, GENE DEV, V14, P645; Albrecht U, 2004, FRONT BIOSCI-LANDMRK, V9, P48, DOI 10.2741/1196; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Kimura H, 2005, DNA REPAIR, V4, P939, DOI 10.1016/j.dnarep.2005.04.012; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Wirth Dagmar, 2004, Methods Mol Biol, V267, P467; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Yin L, 1998, HEPATOLOGY, V27, P73, DOI 10.1002/hep.510270113; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	30	430	443	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					369	374		10.1038/ng1738	http://dx.doi.org/10.1038/ng1738			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16474407	Green Submitted			2022-12-17	WOS:000235589600021
J	OCONNELL, JR; WEEKS, DE				OCONNELL, JR; WEEKS, DE			THE VITESSE ALGORITHM FOR RAPID EXACT MULTILOCUS LINKAGE ANALYSIS VIA GENOTYPE SET-RECODING AND FUZZY INHERITANCE	NATURE GENETICS			English	Article							LOD SCORES; LIKELIHOOD CALCULATIONS; PEDIGREES; HUMANS; MAP; CONSTRUCTION; COMPUTATIONS; ELIMINATION; LOCUS	As genetic marker maps have improved, multipoint linkage analysis has become a crucial part of all disease mapping studies. Paradoxically, multipoint rod scores become increasingly difficult to compute, particularly as the numbers of markers, marker alleles and untyped people increase. We have solved this problem by using a novel set-recoding scheme to recode each person's genotype and 'fuzzy inheritance' to infer transmission probabilities. Our approach is implemented in a memory-efficient computer program, VITESSE, for extremely rapid computation of exact multipoint likelihoods. VITESSE enables fast and precise multipoint mapping of disease loci with highly polymorphic markers.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Wellcome Centre for Human Genetics			Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000932] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00932] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAMSHAD M, 1994, AM J HUM GENET, V55, P1153; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS D, 1993, HUM HERED, V43, P173, DOI 10.1159/000154174; DEMENAIS F, 1994, GENET EPIDEMIOL, V11, P291; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FOROUD T, 1991, AM J HUM GENET, V49, P1263; GUO SW, 1992, AM J HUM GENET, V51, P1111; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; IRWIN M, 1994, P NATL ACAD SCI USA, V91, P11684, DOI 10.1073/pnas.91.24.11684; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KONG A, 1993, GENET EPIDEMIOL, V10, P483, DOI 10.1002/gepi.1370100626; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LANGE K, 1989, ANN HUM GENET, V53, P67, DOI 10.1111/j.1469-1809.1989.tb01122.x; LANGE K, 1987, AM J HUM GENET, V40, P250; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; MAMELKA PM, 1988, PEDIGREE DRAW APPLE; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; McNeill D., 1993, FUZZY LOGIC; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1993, GENET EPIDEMIOL, V10, P361, DOI 10.1002/gepi.1370100605; ROTHSCHILD CB, 1993, AM J HUM GENET, V52, P110; SOBEL E, 1995, GENETIC MAPPING DNA; THOMAS DC, 1992, HUM HERED, V42, P63, DOI 10.1159/000154046; Thomas J.M., 1984, 8TH P INT C CAT BERL, V1, P31; WEEKS DE, 1993, HUM HERED, V43, P86, DOI 10.1159/000154123; WEEKS DE, 1994, GENETICS, V136, P1217; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEISSENBACH J, 1993, GENE, V135, P275, DOI 10.1016/0378-1119(93)90077-G; WORTHINGTON J, 1994, BRIT J RHEUMATOL, V33, P970	48	430	436	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					402	408		10.1038/ng1295-402	http://dx.doi.org/10.1038/ng1295-402			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493020				2022-12-17	WOS:A1995TH62900017
J	Garcia-Gonzalo, FR; Corbit, KC; Sirerol-Piquer, MS; Ramaswami, G; Otto, EA; Noriega, TR; Seol, AD; Robinson, JF; Bennett, CL; Josifova, DJ; Garcia-Verdugo, JM; Katsanis, N; Hildebrandt, F; Reiter, JF				Garcia-Gonzalo, Francesc R.; Corbit, Kevin C.; Salome Sirerol-Piquer, Maria; Ramaswami, Gokul; Otto, Edgar A.; Noriega, Thomas R.; Seol, Allen D.; Robinson, Jon F.; Bennett, Christopher L.; Josifova, Dragana J.; Manuel Garcia-Verdugo, Jose; Katsanis, Nicholas; Hildebrandt, Friedhelm; Reiter, Jeremy F.			A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; MULTIPOINT LINKAGE ANALYSIS; PRIMARY CILIUM; SYNDROME PROTEINS; DIFFUSION BARRIER; JOUBERT-SYNDROME; KIDNEY-DISEASE; MOUSE MODEL; BASAL BODY; CILIOPATHIES	Mutations affecting ciliary components cause ciliopathies. As described here, we investigated Tectonic1 (Tctn1), a regulator of mouse Hedgehog signaling, and found that it is essential for ciliogenesis in some, but not all, tissues. Cell types that do not require Tctn1 for ciliogenesis require it to localize select membrane-associated proteins to the cilium, including Arl13b, AC3, Smoothened and Pkd2. Tctn1 forms a complex with multiple ciliopathy proteins associated with Meckel and Joubert syndromes, including Mks1, Tmem216, Tmem67, Cep290, B9d1, Tctn2 and Cc2d2a. Components of this complex co-localize at the transition zone, a region between the basal body and ciliary axoneme. Like Tctn1, loss of Tctn2, Tmem67 or Cc2d2a causes tissue-specific defects in ciliogenesis and ciliary membrane composition. Consistent with a shared function for complex components, we identified a mutation in TCTN1 that causes Joubert syndrome. Thus, a transition zone complex of Meckel and Joubert syndrome proteins regulates ciliary assembly and trafficking, suggesting that transition zone dysfunction is the cause of these ciliopathies.	[Garcia-Gonzalo, Francesc R.; Corbit, Kevin C.; Noriega, Thomas R.; Seol, Allen D.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Garcia-Gonzalo, Francesc R.; Corbit, Kevin C.; Seol, Allen D.; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Salome Sirerol-Piquer, Maria; Manuel Garcia-Verdugo, Jose] Univ Valencia, Lab Morfol Celular, Unidad Mixta Ctr Invest Principe Felipe, Ctr Invest Biomed Red CIBERNED, Valencia, Spain; [Ramaswami, Gokul; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ramaswami, Gokul; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Robinson, Jon F.; Bennett, Christopher L.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC USA; [Robinson, Jon F.; Bennett, Christopher L.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Josifova, Dragana J.] Guys Hosp, Dept Clin Genet, London SE1 9RT, England; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Dept Comparat Neurobiol, Valencia, Spain; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; Prince Felipe Research Center; University of Valencia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University; Duke University; Guy's & St Thomas' NHS Foundation Trust; University of Valencia; Howard Hughes Medical Institute	Reiter, JF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	jeremy.reiter@ucsf.edu	García-Verdugo, José Manuel/L-8421-2017; Sirerol, Salome/K-6141-2012; Garcia-Gonzalo, Francesc/W-2639-2017; Katsanis, Nicholas/E-1837-2012	García-Verdugo, José Manuel/0000-0001-9872-6499; Sirerol, Salome/0000-0002-9678-4502; Garcia-Gonzalo, Francesc/0000-0002-9152-2191; Katsanis, Nicholas/0000-0002-2480-0171; Bennett, Christopher/0000-0002-8467-6192; Otto, Edgar/0000-0002-2387-9973	National Science Foundation; National Institute for General Medical Sciences-Initiative for Maximizing Student Diversity [R25-GM56847]; US National Institutes of Health [HD04260, DK072301, DK075972, DK1069274, DK1068306, RC4-K090917, AR054396]; March of Dimes; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, R01DK075972, R01DK068306, RC4DK090917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute for General Medical Sciences-Initiative for Maximizing Student Diversity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Institute for Regeneration Medicine and Nikon Imaging Centers at University of California San Francisco. The Servei Central de Suport a la Investigacio Experimental and M. Soriano-Navarro assisted with electron microscopy. Members of the Reiter lab provided valuable discussions. K. Anderson, D. Beier, J. Gleeson, C. Johnson, H. Khanna, R. Molday, K. Mykytyn, G. Pazour, S. Scales, J. Sillibourne and S. Somlo provided antibodies or plasmids. T.R.N. is supported by a National Science Foundation predoctoral grant and an National Institute for General Medical Sciences-Initiative for Maximizing Student Diversity grant (R25-GM56847). N.K. is a Distinguished George W. Brumley Professor. F. H. is an investigator of the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist and a Frederick G. L. Huetwell Professor. This work was funded by grants from the US National Institutes of Health to N.K. (HD04260, DK072301, DK075972), F.H. (DK1069274, DK1068306, RC4-K090917) and to J. F. Reiter (AR054396), and from the March of Dimes, the Burroughs Wellcome Fund, the Packard Foundation and the Sandler Family Supporting Foundation to J.F. Reiter.	Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cook SA, 2009, J AM SOC NEPHROL, V20, P753, DOI 10.1681/ASN.2008040412; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; Holopainen JM, 2010, BIOCHEMISTRY-US, V49, P7439, DOI 10.1021/bi1005249; Hopp K, 2011, HUM MOL GENET, V20, P2524, DOI 10.1093/hmg/ddr151; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nagy A., 2002, MANIPULATING MOUSE E; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Reiter JF, 2006, GENE DEV, V20, P22, DOI 10.1101/gad.1363606; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Shaheen R, 2011, HUM MUTAT, V32, P573, DOI 10.1002/humu.21507; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Won J, 2011, HUM MOL GENET, V20, P482, DOI 10.1093/hmg/ddq494	49	429	447	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					776	U88		10.1038/ng.891	http://dx.doi.org/10.1038/ng.891			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21725307	Green Accepted, Green Submitted			2022-12-17	WOS:000293178300014
J	Zheng, W; Long, JR; Gao, YT; Li, C; Zheng, Y; Xiang, YB; Wen, WQ; Levy, S; Deming, SL; Haines, JL; Gu, K; Fair, AM; Cai, QY; Lu, W; Shu, XO				Zheng, Wei; Long, Jirong; Gao, Yu-Tang; Li, Chun; Zheng, Ying; Xiang, Yong-Bin; Wen, Wanqing; Levy, Shawn; Deming, Sandra L.; Haines, Jonathan L.; Gu, Kai; Fair, Alecia Malin; Cai, Qiuyin; Lu, Wei; Shu, Xiao-Ou			Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1	NATURE GENETICS			English	Article							RECEPTOR-ALPHA GENE; RISK; CHROMOSOME; VARIANTS; ALLELES; BRCA2	We carried out a genome-wide association study among Chinese women to identify risk variants for breast cancer. After analyzing 607,728 SNPs in 1,505 cases and 1,522 controls, we selected 29 SNPs for a fast-track replication in an independent set of 1,554 cases and 1,576 controls. We further investigated four replicated loci in a third set of samples comprising 3,472 cases and 900 controls. SNP rs2046210 at 6q25.1, located upstream of the gene encoding estrogen receptor alpha (ESR1), showed strong and consistent association with breast cancer across all three stages. Adjusted odds ratio (95% CI) were 1.36 (1.24-1.49) and 1.59 (1.40-1.82), respectively, for genotypes A/G and A/A versus G/G (P for trend 2.0 x 10(-15)) in the pooled analysis of samples from all three stages. We also found a similar, albeit weaker, association in an independent study comprising 1,591 cases and 1,466 controls of European ancestry (P-trend = 0.01). These results strongly implicate 6q25.1 as a susceptibility locus for breast cancer.	[Zheng, Wei; Long, Jirong; Wen, Wanqing; Deming, Sandra L.; Cai, Qiuyin; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37232 USA; [Gao, Yu-Tang; Xiang, Yong-Bin] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China; [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Li, Chun; Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37232 USA; [Zheng, Ying; Gu, Kai; Lu, Wei] Shanghai Inst Prevent Med, Shanghai Ctr Dis Prevent & Control, Shanghai 200336, Peoples R China; [Levy, Shawn] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Fair, Alecia Malin] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA	Vanderbilt University; Shanghai Jiao Tong University; Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention; Vanderbilt University; Meharry Medical College	Zheng, W (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37232 USA.	wei.zheng@vanderbilt.edu	Zheng, Wei/O-3351-2013; Li, Chun/R-1095-2019; Haines, Jonathan/C-3374-2012; Li, Chun/B-8388-2012; Lu, Wei/AAE-2921-2022; zhang, weihua/GXV-1334-2022; Gao, Yu/HGE-1937-2022	Zheng, Wei/0000-0003-1226-070X; Li, Chun/0000-0002-8819-2443; Haines, Jonathan/0000-0002-4351-4728; Lu, Wei/0000-0002-4150-8674; Levy, Shawn/0000-0002-1369-5740; Long, Jirong/0000-0002-7433-9766	US National Institutes of Health [R01CA124558, R01CA64277, R01CA70867, R01CA90899, R01CA100374]; Ingram professorship funds [R01 CA118229, R01CA92585]; Department of Defense (DOD) Idea Award [BC011118, R01CA122756, BC050791]; Vanderbilt-Ingram Cancer Center [P30 CA68485]; NATIONAL CANCER INSTITUTE [R01CA124558, Z01BC011118, R01CA100374, R01CA070867, R01CA092585, R01CA122756, R01CA090899, R01CA064277, P30CA068485, R01CA118229] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ingram professorship funds; Department of Defense (DOD) Idea Award(United States Department of Defense); Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by US National Institutes of Health grants R01CA124558, R01CA64277, R01CA70867, R01CA90899 and R01CA100374, as well as Ingram professorship funds and research award funds to W. Z., R01 CA118229, R01CA92585 and Department of Defense (DOD) Idea Award BC011118 to X.-O. S., and R01CA122756 and DOD Idea Award BC050791 to Q. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The authors wish to thank study participants and research staff for their contributions and commitment to this project, R. Courtney and Q. Wang for DNA preparation, and B. Venuti for clerical support in the preparation of this manuscript. Sample preparation and stage 1 genotyping were conducted at the Survey and Biospecimen and Microarray Shared Resources that are supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA68485). Stage 2 and 3 genotyping was carried out at the Proactive Genomics.	Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cai QY, 2003, CANCER RES, V63, P5727; Cai QY, 2003, CANCER EPIDEM BIOMAR, V12, P853; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frank B, 2008, J NATL CANCER I, V100, P437, DOI 10.1093/jnci/djn037; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Houlston RS, 2004, ONCOGENE, V23, P6471, DOI 10.1038/sj.onc.1207951; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitrunen K, 2003, MUTAT RES-REV MUTAT, V544, P9, DOI 10.1016/S1383-5742(03)00016-4; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Zheng SL, 2003, CANCER RES, V63, P7624	27	429	444	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					324	328		10.1038/ng.318	http://dx.doi.org/10.1038/ng.318			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19219042	Green Accepted			2022-12-17	WOS:000263640200013
J	Brunetti-Pierri, N; Berg, JS; Scaglia, F; Belmont, J; Bacino, CA; Sahoo, T; Lalani, SR; Graham, B; Lee, B; Shinawi, M; Shen, J; Kang, SHL; Pursley, A; Lotze, T; Kennedy, G; Lansky-Shafer, S; Weaver, C; Roeder, ER; Grebe, TA; Arnold, GL; Hutchison, T; Reimschisel, T; Amato, S; Geragthy, MT; Innis, JW; Obersztyn, E; Nowakowska, B; Rosengren, SS; Bader, PI; Grange, DK; Naqvi, S; Garnica, AD; Bernes, SM; Fong, CT; Summers, A; Walters, WD; Lupski, JR; Stankiewicz, P; Cheung, SW; Patel, A				Brunetti-Pierri, Nicola; Berg, Jonathan S.; Scaglia, Fernando; Belmont, John; Bacino, Carlos A.; Sahoo, Trilochan; Lalani, Seema R.; Graham, Brett; Lee, Brendan; Shinawi, Marwan; Shen, Joseph; Kang, Sung-Hae L.; Pursley, Amber; Lotze, Timothy; Kennedy, Gail; Lansky-Shafer, Susan; Weaver, Christine; Roeder, Elizabeth R.; Grebe, Theresa A.; Arnold, Georgianne L.; Hutchison, Terry; Reimschisel, Tyler; Amato, Stephen; Geragthy, Michael T.; Innis, Jeffrey W.; Obersztyn, Ewa; Nowakowska, Beata; Rosengren, Sally S.; Bader, Patricia I.; Grange, Dorothy K.; Naqvi, Sayed; Garnica, Adolfo D.; Bernes, Saunder M.; Fong, Chin-To; Summers, Anne; Walters, W. David; Lupski, James R.; Stankiewicz, Pawel; Cheung, Sau Wai; Patel, Ankita			Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; CHROMOSOME 1Q21.1; HUMAN GENOME; BRAIN SIZE; LONG ARM; SCHIZOPHRENIA; HYDIN; ASPM; GENE; MICRODELETION	Chromosome region 1q21.1 contains extensive and complex low-copy repeats, and copy number variants (CNVs) in this region have recently been reported in association with congenital heart defects(1), developmental delay(2,3), schizophrenia and related psychoses(4,5). We describe 21 probands with the 1q21.1 microdeletion and 15 probands with the 1q21.1 microduplication. These CNVs were inherited in most of the cases in which parental studies were available. Consistent and statistically significant features of microcephaly and macrocephaly were found in individuals with microdeletion and microduplication, respectively. Notably, a paralog of the HYDIN gene located on 16q22.2 and implicated in autosomal recessive hydrocephalus(6) was inserted into the 1q21.1 region during the evolution of Homo sapiens(7); we found this locus to be deleted or duplicated in the individuals we studied, making it a probable candidate for the head size abnormalities observed. We propose that recurrent reciprocal microdeletions and microduplications within 1q21.1 represent previously unknown genomic disorders characterized by abnormal head size along with a spectrum of developmental delay, neuropsychiatric abnormalities, dysmorphic features and congenital anomalies. These phenotypes are subject to incomplete penetrance and variable expressivity.	[Brunetti-Pierri, Nicola; Berg, Jonathan S.; Scaglia, Fernando; Belmont, John; Bacino, Carlos A.; Sahoo, Trilochan; Lalani, Seema R.; Graham, Brett; Lee, Brendan; Shinawi, Marwan; Shen, Joseph; Kang, Sung-Hae L.; Pursley, Amber; Lupski, James R.; Stankiewicz, Pawel; Cheung, Sau Wai; Patel, Ankita] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Lotze, Timothy] Texas Childrens Hosp, Dept Pediat, Neurol Sect, Houston, TX 77030 USA; [Kennedy, Gail; Lansky-Shafer, Susan; Weaver, Christine] Carle Clin Assoc, Urbana, IL 61821 USA; [Kennedy, Gail; Lansky-Shafer, Susan; Weaver, Christine] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Roeder, Elizabeth R.] Univ Texas Hlth Sci Ctr San Antonio, Div Genet & Metab Disorders, Dept Pediat, San Antonio, TX 78207 USA; [Grebe, Theresa A.] St Josephs Hosp, CHC Phoenix Genet Program, Phoenix, AZ 85013 USA; [Arnold, Georgianne L.; Fong, Chin-To] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hutchison, Terry] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Reimschisel, Tyler; Grange, Dorothy K.] Washington Univ, Sch Med, Div Genet & Genom Med, St Louis, MO 63110 USA; [Amato, Stephen] Eastern Maine Med Ctr, Dept Med Genet, Bangor, ME 04401 USA; [Geragthy, Michael T.] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Innis, Jeffrey W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Innis, Jeffrey W.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Obersztyn, Ewa; Nowakowska, Beata] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Rosengren, Sally S.] Univ Connecticut, Sch Med, Div Human Genet, Farmington, CT 06030 USA; [Bader, Patricia I.] Parkview Hosp, Dept Cytogenet, Ft Wayne, IN 46805 USA; [Naqvi, Sayed] Miami Childrens Hosp, Dept Neurol, Miami, FL 33155 USA; [Garnica, Adolfo D.] Oklahoma State Univ, Dept Pediat, Tulsa, OK 74127 USA; [Bernes, Saunder M.] Phoenix Childrens Hosp, Dept Neurol, Phoenix, AZ 85016 USA; [Summers, Anne] N York Gen Hosp, Toronto, ON P1B 4E7, Canada; [Walters, W. David] Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72202 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Health San Antonio; St. Joseph's Hospital and Medical Center; University of Rochester; University of California System; University of California San Francisco; Washington University (WUSTL); Eastern Maine Medical Center; University of Ottawa; Children's Hospital of Eastern Ontario; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Connecticut; Phoenix Children's Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; Arkansas Children's Hospital	Patel, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	ankitap@bcm.edu	Graham, Brett/R-8685-2018; Stankiewicz, Paweł/AAP-7906-2021; Patel, Ankita/D-3247-2013; Belmont, John W/AAI-2494-2019; Lalani, Seema/AAI-5090-2020; Shen, Joseph/AAY-5083-2020; Brunetti-Pierri, Nicola/K-8465-2016; Belmont, John/AAH-6084-2021	Graham, Brett/0000-0001-8451-8154; Stankiewicz, Paweł/0000-0002-6456-7490; Belmont, John W/0000-0001-7409-3578; Shen, Joseph/0000-0002-5604-7639; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Berg, Jonathan/0000-0003-2360-2664; Obersztyn, Ewa/0000-0002-3044-9517; shinawi, Marwan/0000-0003-1329-4100	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091771] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL091771-01, R01 HL091771-02, R01 HL091771] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; CALLEN DF, 1993, J MED GENET, V30, P828, DOI 10.1136/jmg.30.10.828; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Doggett NA, 2006, GENOMICS, V88, P762, DOI 10.1016/j.ygeno.2006.07.012; FUJIWARA M, 1992, AM J MED GENET, V43, P561, DOI 10.1002/ajmg.1320430311; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Kelly BD, 2005, ACTA PSYCHIAT SCAND, V111, P202, DOI 10.1111/j.1600-0447.2004.00473.x; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; MCNEIL TF, 1993, BRIT J PSYCHIAT, V162, P517, DOI 10.1192/bjp.162.4.517; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; NATT E, 1989, CYTOGENET CELL GENET, V50, P145, DOI 10.1159/000132745; Ponting CP, 2006, BIOINFORMATICS, V22, P1031, DOI 10.1093/bioinformatics/btl022; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Ward KE, 1996, SCHIZOPHR RES, V22, P197, DOI 10.1016/S0920-9964(96)00076-X; WILSON DI, 1992, LANCET, V340, P573, DOI 10.1016/0140-6736(92)92107-Q; Zankl A, 2003, AM J MED GENET A, V121A, P146, DOI 10.1002/ajmg.a.20185	25	429	441	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1466	1471		10.1038/ng.279	http://dx.doi.org/10.1038/ng.279			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19029900	Green Accepted			2022-12-17	WOS:000261215900024
J	Cox, A; Dunning, AM; Garcia-Closas, M; Balasubramanian, S; Reed, MWR; Pooley, KA; Scollen, S; Baynes, C; Ponder, BAJ; Chanock, S; Lissowska, J; Brinton, L; Peplonska, B; Southey, MC; Hopper, JL; McCredie, MRE; Giles, GG; Fletcher, O; Johnson, N; Silva, ID; Gibson, L; Bojesen, SE; Nordestgaard, BG; Axelsson, CK; Torres, D; Hamann, U; Justenhoven, C; Brauch, H; Chang-Claude, J; Kropp, S; Risch, A; Wang-Gohrke, S; Schurmann, P; Bogdanova, N; Dork, T; Fagerholm, R; Aaltonen, K; Blomqvist, C; Nevanlinna, H; Seal, S; Renwick, A; Stratton, MR; Rahman, N; Sangrajrang, S; Hughes, D; Odefrey, F; Brennan, P; Spurdle, AB; Chenevix-Trench, G; Beesley, J; Mannermaa, A; Hartikainen, J; Kataja, V; Kosma, VM; Couch, FJ; Olson, JE; Goode, EL; Broeks, A; Schmidt, MK; Hogervorst, FBL; Van't Veer, LJ; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Wedren, S; Hall, P; Low, YL; Liu, JJ; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Sigurdson, AJ; Stredrick, DL; Alexander, BH; Struewing, JP; Pharoah, PDP; Easton, DF				Cox, Angela; Dunning, Alison M.; Garcia-Closas, Montserrat; Balasubramanian, Sabapathy; Reed, Malcolm W. R.; Pooley, Karen A.; Scollen, Serena; Baynes, Caroline; Ponder, Bruce A. J.; Chanock, Stephen; Lissowska, Jolanta; Brinton, Louise; Peplonska, Beata; Southey, Melissa C.; Hopper, John L.; McCredie, Margaret R. E.; Giles, Graham G.; Fletcher, Olivia; Johnson, Nichola; dos Santos Silva, Isabel; Gibson, Lorna; Bojesen, Stig E.; Nordestgaard, Borge G.; Axelsson, Christen K.; Torres, Diana; Hamann, Ute; Justenhoven, Christina; Brauch, Hiltrud; Chang-Claude, Jenny; Kropp, Silke; Risch, Angela; Wang-Gohrke, Shan; Schuermann, Peter; Bogdanova, Natalia; Doerk, Thilo; Fagerholm, Rainer; Aaltonen, Kirsimari; Blomqvist, Carl; Nevanlinna, Heli; Seal, Sheila; Renwick, Anthony; Stratton, Michael R.; Rahman, Nazneen; Sangrajrang, Suleeporn; Hughes, David; Odefrey, Fabrice; Brennan, Paul; Spurdle, Amanda B.; Chenevix-Trench, Georgia; Beesley, Jonathan; Mannermaa, Arto; Hartikainen, Jaana; Kataja, Vesa; Kosma, Veli-Matti; Couch, Fergus J.; Olson, Janet E.; Goode, Ellen L.; Broeks, Annegien; Schmidt, Marjanka K.; Hogervorst, Frans B. L.; Van't Veer, Laura J.; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Wedren, Sara; Hall, Per; Low, Yen-Ling; Liu, Jianjun; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Sigurdson, Alice J.; Stredrick, Denise L.; Alexander, Bruce H.; Struewing, Jeffery P.; Pharoah, Paul D. P.; Easton, Douglas F.		Kathleen Cunningham Fdn Consortium; Breast Canc Assoc Consortium	A common coding variant in CASP8 is associated with breast cancer risk	NATURE GENETICS			English	Article							TRANSFORMING-GROWTH-FACTOR-BETA-1 GENE; ATAXIA-TELANGIECTASIA; REDUCED RISK; TGF-BETA; SUSCEPTIBILITY; POLYMORPHISMS; WOMEN; IGFBP3; REGION; LOCUS	The Breast Cancer Association Consortium (BCAC) has been established to conduct combined case-control analyses with augmented statistical power to try to confirm putative genetic associations with breast cancer. We genotyped nine SNPs for which there was some prior evidence of an association with breast cancer: CASP8 D302H (rs1045485), IGFBP3-202 C -> A (rs2854744), SOD2 V16A (rs1799725), TGFB1 L10P (rs1982073), ATM S49C (rs1800054), ADH1B 3' UTR A -> G (rs1042026), CDKN1A S31R (rs1801270), ICAM5 V301I (rs1056538) and NUMA1 A794G (rs3750913). We included data from 9-15 studies, comprising 11,391-18,290 cases and 14,753-22,670 controls. We found evidence of an association with breast cancer for CASP8 D302H (with odds ratios (OR) of 0.89 (95% confidence interval (c.i.): 0.85-0.94) and 0.74 (95% c.i.: 0.62-0.87) for heterozygotes and rare homozygotes, respectively, compared with common homozygotes; P(trend) = 1.1 x 10(-7)) and weaker evidence for TGFB1 L10P (OR = 1.07 (95% c.i.: 1.02-1.13) and 1.16 (95% c.i.: 1.08-1.25), respectively; P(trend) = 2.8 x 10(-5)). These results demonstrate that common breast cancer susceptibility alleles with small effects on risk can be identified, given sufficiently powerful studies.	Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England; Univ Cambridge, Dept Oncol, Cambridge CB2 1TN, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; NCI, Core Genotyping Facil, Ctr Adv Technol, Bethesda, MD 20892 USA; Ctr Canc, PL-02781 Warsaw, Poland; M Sklodowska Curie Inst Oncol, PL-02781 Warsaw, Poland; Nofer Inst Occupat Med, PL-90950 Lodz, Poland; Univ Melbourne, Melbourne, Vic 3010, Australia; Univ Otago, Dunedin, New Zealand; Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3053, Australia; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; Univ Tubingen, D-72074 Tubingen, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Ulm, D-89069 Ulm, Germany; Hannover Med Sch, Dept Gynecol & Obstet, D-30625 Hannover, Germany; Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00290 Helsinki, Finland; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Natl Canc Inst, Bangkok 10400, Thailand; Int Agcy Res Canc, F-69372 Lyon, France; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FI-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Oncol, FI-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pathol, FI-70211 Kuopio, Finland; Mayo Clin Coll Med, Rochester, MN 55905 USA; Netherlands Canc Inst, Dept Expt Therapy, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Epidemiol & Mol Pathol, NL-1066 CX Amsterdam, Netherlands; Seoul Natl Univ, Coll Med, Seoul 151742, South Korea; Univ Ulsan, Coll Med, Dept Surg, Ulsan 680749, South Korea; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Genome Inst Singapore, Singapore 138672, Singapore; CNIO, Spanish Natl Canc Res Ctr, E-28049 Madrid, Spain; NCI, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA	University of Sheffield; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; University of Melbourne; University of Otago; Cancer Council Victoria; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Hannover Medical School; Hannover Medical School; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of London; Institute of Cancer Research - UK; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); QIMR Berghofer Medical Research Institute; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Mayo Clinic; Netherlands Cancer Institute; Netherlands Cancer Institute; Seoul National University (SNU); University of Ulsan; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Cox, A (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England.	a.cox@shef.ac.uk	Noh, Dong-Young/G-5531-2011; Bogdanova, Natalia V./Y-2205-2019; Peplonska, Beata/AAO-1265-2020; Reed, Malcolm Walter/AAG-9219-2020; Garcia-Closas, Montserrat/F-3871-2015; Hartikainen, Jaana M/E-6256-2015; Yoo, Keun-Young/J-5548-2012; Lissowska, Jolanta/AAH-3252-2020; Dörk, Thilo/J-8620-2012; Ribas-Despuig, Gloria/M-6190-2017; Garcia-Closas, Montserrat/AAZ-6930-2021; Liu, Jianjun/AAK-4989-2020; Kang, Dae Hee/E-8631-2012; Rahman, Nazneen/B-8890-2012; Pharoah, Paul/V-6658-2019; Peplonska, Beata/F-6004-2010; Struewing, Jeffery P/I-7502-2013; balasubramanian, saba prakash/H-2830-2019; Spurdle, Amanda B/A-4978-2011; Gonzalez-Neira, Anna/C-5791-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Brinton, Louise A/G-7486-2015; Chenevix-Trench, Georgia/AAV-2014-2020; Risch, Angela/H-2669-2013; Schmidt, Marjanka K/G-9058-2011; Ribas, Gloria/K-3379-2013; Rahman, Nazneen/D-2802-2013	Peplonska, Beata/0000-0003-3915-2872; Reed, Malcolm Walter/0000-0001-7442-2132; Garcia-Closas, Montserrat/0000-0003-1033-2650; Hartikainen, Jaana M/0000-0001-8267-1905; Lissowska, Jolanta/0000-0003-2695-5799; Dörk, Thilo/0000-0002-9458-0282; Garcia-Closas, Montserrat/0000-0003-1033-2650; Liu, Jianjun/0000-0002-3255-3019; Pharoah, Paul/0000-0001-8494-732X; Struewing, Jeffery P/0000-0002-4848-3334; balasubramanian, saba prakash/0000-0001-5953-2843; Spurdle, Amanda B/0000-0003-1337-7897; Gonzalez-Neira, Anna/0000-0002-5421-2020; Brinton, Louise A/0000-0003-3853-8562; Chenevix-Trench, Georgia/0000-0002-1878-2587; Risch, Angela/0000-0002-8026-5505; Schmidt, Marjanka K/0000-0002-2228-429X; Southey, Melissa/0000-0002-6313-9005; Fletcher, Olivia/0000-0001-9387-7116; Beesley, Jonathan/0000-0003-1942-325X; Brauch, Hiltrud/0000-0001-7531-2736; Ribas, Gloria/0000-0001-6883-4130; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Rahman, Nazneen/0000-0003-4376-0440; Kang, Daehee/0000-0003-4031-5878; Giles, Graham/0000-0003-4946-9099; Kataja, Vesa/0000-0003-4846-4843; Nevanlinna, Heli/0000-0002-0916-2976; Bowcock, Anne/0000-0001-8691-9090; Scollen, Serena/0000-0002-9311-1337; Blomqvist, Carl/0000-0003-3041-1938; Hughes, David John/0000-0003-1668-8770; Cox, Angela/0000-0002-5138-1099; Dunning, Alison Margaret/0000-0001-6651-7166; dos Santos Silva, Isabel/0000-0002-6596-8798	NATIONAL CANCER INSTITUTE [Z01SC010083, P01CA082267, R01CA095003, Z01CP010126] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA82267, CA-95-003] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [2004NOV49, BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now		Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Buchholz TA, 2004, CANCER, V100, P1345, DOI 10.1002/cncr.20133; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dunning AM, 2003, CANCER RES, V63, P2610; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Feigelson HS, 2006, CANCER EPIDEM BIOMAR, V15, P1236, DOI 10.1158/1055-9965.EPI-06-0163; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Frank B, 2005, J NATL CANCER I, V97, P1012, DOI 10.1093/jnci/dji178; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kammerer S, 2005, P NATL ACAD SCI USA, V102, P2004, DOI 10.1073/pnas.0409806102; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Krippl P, 2003, CANCER LETT, V201, P181, DOI 10.1016/S0304-3835(03)00468-3; Le Marchand L, 2004, CANCER EPIDEM BIOMAR, V13, P412; MacPherson G, 2004, JNCI-J NATL CANCER I, V96, P1866, DOI 10.1093/jnci/dji001; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rohrbacher M, 2005, CANCER EPIDEM BIOMAR, V14, P289; Schernhammer ES, 2003, INT J CANCER, V107, P60, DOI 10.1002/ijc.11358; Shin AS, 2005, CANCER EPIDEM BIOMAR, V14, P1567, DOI 10.1158/1055-9965.EPI-05-0078; Stredrick DL, 2006, HUM MUTAT, V27, P538, DOI 10.1002/humu.20323; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Ziv E, 2001, JAMA-J AM MED ASSOC, V285, P2859, DOI 10.1001/jama.285.22.2859	30	429	445	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					352	358		10.1038/ng1981	http://dx.doi.org/10.1038/ng1981			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293864				2022-12-17	WOS:000244480000017
J	Garcia-Cao, M; O'Sullivan, R; Peters, AHFM; Jenuwein, T; Blasco, MA				Garcia-Cao, M; O'Sullivan, R; Peters, AHFM; Jenuwein, T; Blasco, MA			Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases	NATURE GENETICS			English	Article							CHROMOSOMAL INSTABILITY; H3; HETEROCHROMATIN; METHYLATION; FUSIONS; REPEATS; MICE	Telomeres are capping structures at the ends of eukaryotic chromosomes composed of TTAGGG repeats bound to an array of specialized proteins(1-3). Telomeres are heterochromatic regions. Yeast and flies with defects in activities that modify the state of chromatin also have abnormal telomere function(4-6), but the putative role of chromatin-modifying activities in regulating telomeres in mammals is unknown. Here we report on telomere length and function in mice null with respect to both the histone methyltransferases (HMTases) Suv39h1 and Suv39h2 (called SUV39DN mice). Suv39h1 and Suv39h2 govern methylation of histone H3 Lys9 (H3-Lys9) in heterochromatic regions(7). We show that primary cells derived from SUV39DN mice have abnormally long telomeres relative to wild-type controls. Using chromatin immunoprecipitation (ChIP) analysis, we found that telomeres were enriched in di- and trimethylated H3-Lys9 but that telomeres of SUV39DN cells had less dimethylated and trimethylated H3-Lys9 but more monomethylated H3-Lys9. Concomitant with the decrease in H3-Lys9 methylation, telomeres in SUV39DN cells had reduced binding of the chromobox proteins Cbx1, Cbx3 and Cbx5, homologs of Drosophila melanogaster heterochromatin protein 1 (HP1). These findings indicate substantial changes in the state of telomeric heterochromatin in SUV39DN cells, which are associated with abnormal telomere elongation. Taken together, the results indicate epigenetic regulation of telomere length in mammals by Suv39h1 and Suv39h2.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Spanish Natl Canc Ctr CNIO, Mol Oncol Program, E-28029 Madrid, Spain	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Oncol Program, E-28029 Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Peters, Antoine/0000-0002-0311-1887				Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Dubrana K, 2001, CURR OPIN CELL BIOL, V13, P281, DOI 10.1016/S0955-0674(00)00210-6; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; McIlrath J, 2001, CANCER RES, V61, P912; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; PEREZBURGOS L, IN PRESS METHODS ENZ; PETERS AH, IN PRESS MOL CELL; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0	29	429	453	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					94	99		10.1038/ng1278	http://dx.doi.org/10.1038/ng1278			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702045	Bronze			2022-12-17	WOS:000187666800020
J	ANDRADE, MA; BORK, P				ANDRADE, MA; BORK, P			HEAT REPEATS IN THE HUNTINGTONS-DISEASE PROTEIN	NATURE GENETICS			English	Note							SACCHAROMYCES-CEREVISIAE		MAX DELBRUCK CTR MOLEC MED,D-13122 BERLIN,GERMANY	Helmholtz Association; Max Delbruck Center for Molecular Medicine	ANDRADE, MA (corresponding author), EUROPEAN MOLEC BIOL LAB,MEYERHOFSTR 1,D-69012 HEIDELBERG,GERMANY.		Andrade, Miguel A/B-6565-2008; Bork, Peer/F-1813-2013	Andrade, Miguel A/0000-0001-6650-1711; Bork, Peer/0000-0002-2627-833X				ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; [Anonymous], 1995, CELL, V81, P289; BORK B, IN PRESS METH ENZYM; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; CHOW TYK, 1992, J CELL SCI, V101, P709; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HARTWIG JH, 1994, PROTEIN PROFILE, V1, P711; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; Herman Paul K., 1992, Trends in Cell Biology, V2, P363, DOI 10.1016/0962-8924(92)90048-R; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARTON MJ, 1993, MOL CELL BIOL, V13; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; PFUHL M, 1994, EMBO J, V13, P1782, DOI 10.1002/j.1460-2075.1994.tb06446.x; QIN SL, 1990, J BIOL CHEM, V265, P1903; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; TROSSLER Y, 1995, NAT GENET, V10, P104; 1993, CELL, V72, P971	28	429	451	0	36	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					115	116		10.1038/ng1095-115	http://dx.doi.org/10.1038/ng1095-115			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550332				2022-12-17	WOS:A1995RX80600006
J	WARD, K; HATA, A; JEUNEMAITRE, X; HELIN, C; NELSON, L; NAMIKAWA, C; FARRINGTON, PF; OGASAWARA, M; SUZUMORI, K; TOMODA, S; BERREBI, S; SASAKI, M; CORVOL, P; LIFTON, RP; LALOUEL, JM				WARD, K; HATA, A; JEUNEMAITRE, X; HELIN, C; NELSON, L; NAMIKAWA, C; FARRINGTON, PF; OGASAWARA, M; SUZUMORI, K; TOMODA, S; BERREBI, S; SASAKI, M; CORVOL, P; LIFTON, RP; LALOUEL, JM			A MOLECULAR VARIANT OF ANGIOTENSINOGEN ASSOCIATED WITH PREECLAMPSIA	NATURE GENETICS			English	Article							PREGNANCY; GENE; SUSCEPTIBILITY; ECLAMPSIA; WOMEN	Pregnancy-induced hypertension (PIH) is a heterogeneous disorder which complicates 5-7% of all pregnancies and remains a leading cause of maternal, fetal and neonatal morbidity and mortality. Severe preeclampsia is the most distinctive and life-threatening form; a multi-system disorder more common in first pregnancies, it is characterized by high blood pressure and proteinuria. In a series of Caucasian women with pregnancy-induced hypertension, we have observed a significant association of preeclampsia with a molecular variant of angiotensinogen, T235, found previously to be associated with essential hypertension. This finding is corroborated in a sample ascertained in Japan. Together, these observations support a new pathophysiological interpretation of preeclampsia and of its relation to some forms of essential hypertension.	NAGOYA CITY UNIV,SCH MED,DEPT BIOCHEM,MIZUHO KU,NAGOYA,AICHI 467,JAPAN; UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,ECCLES INST HUMAN GENET,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; HOP BROUSSAIS,DEPT HYPERTENS,F-75674 PARIS 14,FRANCE; NAGOYA CITY UNIV,SCH MED,DEPT OBSTET & GYNECOL,MIZUHO KU,NAGOYA,AICHI 467,JAPAN; OSAKA CITY UNIV,SCH MED,DEPT OBSTET & GYNECOL,OSAKA 545,JAPAN; BRIGHAM & WOMENS HOSP,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Nagoya City University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Nagoya City University; Osaka Metropolitan University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	WARD, K (corresponding author), UNIV UTAH,SCH MED,DEPT OBSTET & GYNECOL,SALT LAKE CITY,UT 84132, USA.		JEUNEMAITRE, Xavier/AAQ-4853-2021	JEUNEMAITRE, Xavier/0000-0001-5925-381X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR 00064] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		August PA, 1990, HYPERTENSION PATHOPH, P1761; CHESLEY LC, 1976, AM J OBSTET GYNECOL, V124, P446, DOI 10.1016/0002-9378(76)90168-X; CHESLEY LC, 1988, HDB HYPERTENSION, V10, P38; COOPER DW, 1988, BRIT J OBSTET GYNAEC, V95, P644, DOI 10.1111/j.1471-0528.1988.tb06524.x; FISCHER KA, 1981, MEDICINE, V60, P267; GAILLARD I, 1989, DNA-J MOLEC CELL BIO, V8, P87, DOI 10.1089/dna.1.1989.8.87; GAILLARDSANCHEZ I, 1990, HUM GENET, V84, P341; GANT NF, 1987, AM J KIDNEY DIS, V9, P303, DOI 10.1016/S0272-6386(87)80126-9; JACOBSON C, UTAH DEMOGRAPHIC PER, P165; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; LARAGH JH, 1971, AM J OBSTET GYNECOL, V109, P210, DOI 10.1016/0002-9378(71)90869-6; LISTON WA, 1991, BRIT J OBSTET GYNAEC, V98, P1079, DOI 10.1111/j.1471-0528.1991.tb15358.x; LYNCH KR, 1991, HYPERTENSION, V17, P263, DOI 10.1161/01.HYP.17.3.263; MUSEY VC, 1987, J CLIN ENDOCR METAB, V64, P111, DOI 10.1210/jcem-64-1-111; PLOUIN PF, 1989, PRESSE MED, V18, P917; SCHWARTZ ML, 1983, AM J OBSTET GYNECOL, V146, P756, DOI 10.1016/0002-9378(83)91072-4; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P501, DOI 10.1016/0002-9378(86)90266-8; TAYLOR DJ, 1988, HDB HYPERTENSION, V10, P223; TEWKSBURY DA, 1982, HYPERTENSION, V4, P729, DOI 10.1161/01.HYP.4.5.729; TEWKSBURY DA, 1990, HYPERTENSION PATHOPH, P1197; Wallenburg HCS., 1988, HDB HYPERTENSION, P66; WANG DY, 1988, EUR J CANCER CLIN ON, V24, P1225, DOI 10.1016/0277-5379(88)90132-0; 1986, TECHNICAL B AM COLLE, V91	23	429	445	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					59	61		10.1038/ng0593-59	http://dx.doi.org/10.1038/ng0593-59			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513325				2022-12-17	WOS:A1993LA33700014
J	Fujimoto, A; Furuta, M; Totoki, Y; Tsunoda, T; Kato, M; Shiraishi, Y; Tanaka, H; Taniguchi, H; Kawakami, Y; Ueno, M; Gotoh, K; Ariizumi, S; Wardell, CP; Hayami, S; Nakamura, T; Aikata, H; Arihiro, K; Boroevich, KA; Abe, T; Nakano, K; Maejima, K; Sasaki-Oku, A; Ohsawa, A; Shibuya, T; Nakamura, H; Hama, N; Hosoda, F; Arai, Y; Ohashi, S; Urushidate, T; Nagae, G; Yamamoto, S; Ueda, H; Tatsuno, K; Ojima, H; Hiraoka, N; Okusaka, T; Kubo, M; Marubashi, S; Yamada, T; Hirano, S; Yamamoto, M; Ohdan, H; Shimada, K; Ishikawa, O; Yamaue, H; Chayama, K; Miyano, S; Aburatani, H; Shibata, T; Nakagawa, H				Fujimoto, Akihiro; Furuta, Mayuko; Totoki, Yasushi; Tsunoda, Tatsuhiko; Kato, Mamoru; Shiraishi, Yuichi; Tanaka, Hiroko; Taniguchi, Hiroaki; Kawakami, Yoshiiku; Ueno, Masaki; Gotoh, Kunihito; Ariizumi, Shun-ichi; Wardell, Christopher P.; Hayami, Shinya; Nakamura, Toru; Aikata, Hiroshi; Arihiro, Koji; Boroevich, Keith A.; Abe, Tetsuo; Nakano, Kaoru; Maejima, Kazuhiro; Sasaki-Oku, Aya; Ohsawa, Ayako; Shibuya, Tetsuo; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Arai, Yasuhito; Ohashi, Shoko; Urushidate, Tomoko; Nagae, Genta; Yamamoto, Shogo; Ueda, Hiroki; Tatsuno, Kenji; Ojima, Hidenori; Hiraoka, Nobuyoshi; Okusaka, Takuji; Kubo, Michiaki; Marubashi, Shigeru; Yamada, Terumasa; Hirano, Satoshi; Yamamoto, Masakazu; Ohdan, Hideki; Shimada, Kazuaki; Ishikawa, Osamu; Yamaue, Hiroki; Chayama, Kazuki; Miyano, Satoru; Aburatani, Hiroyuki; Shibata, Tatsuhiro; Nakagawa, Hidewaki			Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; HEPATOCELLULAR-CARCINOMA; SOMATIC MUTATIONS; RECURRENT MUTATIONS; COLORECTAL-CANCER; BREAST-CANCER; EXPRESSION; DNA; SIGNATURES; INTEGRATION	Liver cancer, which is most often associated with virus infection, is prevalent worldwide, and its underlying etiology and genomic structure are heterogeneous. Here we provide a whole-genome landscape of somatic alterations in 300 liver cancers from Japanese individuals. Our comprehensive analysis identified point mutations, structural variations (STVs), and virus integrations, in noncoding and coding regions. We discovered mutational signatures related to liver carcinogenesis and recurrently mutated coding and noncoding regions, such as long intergenic noncoding RNA genes (NEAT1 and MALAT1), promoters, CTCF-binding sites, and regulatory regions. STV analysis found a significant association with replication timing and identified known (CDKN2A, CCND1, APC, and TERT) and new (ASH1L, NCOR1, and MACROD2) cancer-related genes that were recurrently affected by STVs, leading to altered expression. These results emphasize the value of whole-genome sequencing analysis in discovering cancer driver mutations and understanding comprehensive molecular profiles of liver cancer, especially with regard to STVs and noncoding mutations.	[Fujimoto, Akihiro; Furuta, Mayuko; Taniguchi, Hiroaki; Wardell, Christopher P.; Nakano, Kaoru; Maejima, Kazuhiro; Sasaki-Oku, Aya; Ohsawa, Ayako; Nakagawa, Hidewaki] RIKEN Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan; [Totoki, Yasushi; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Arai, Yasuhito; Ohashi, Shoko; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan; [Tsunoda, Tatsuhiko; Boroevich, Keith A.; Abe, Tetsuo] RIKEN Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan; [Tsunoda, Tatsuhiko; Kato, Mamoru] JST, CREST, Tokyo, Japan; [Kato, Mamoru] Natl Canc Ctr, Res Inst, Dept Bioinformat, Chuo Ku, Tokyo 104, Japan; [Shiraishi, Yuichi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Lab DNA Informat Anal, Ctr Human Genome, Tokyo, Japan; [Kawakami, Yoshiiku; Aikata, Hiroshi; Chayama, Kazuki] Hiroshima Univ, Sch Med, Dept Med & Mol Sci, Hiroshima, Japan; [Ueno, Masaki; Hayami, Shinya; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Gotoh, Kunihito; Marubashi, Shigeru; Yamada, Terumasa; Ishikawa, Osamu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Ariizumi, Shun-ichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan; [Nakamura, Toru; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan; [Arihiro, Koji] Hiroshima Univ, Sch Med, Dept Anat Pathol, Hiroshima, Japan; [Shibuya, Tetsuo; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Urushidate, Tomoko; Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Nagae, Genta; Yamamoto, Shogo; Ueda, Hiroki; Tatsuno, Kenji; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Ojima, Hidenori] Keio Univ, Sch Med, Dept Pathol, Shinjyuku Ku, Tokyo 160, Japan; [Hiraoka, Nobuyoshi] Natl Canc Ctr, Div Pathol & Clin Labs, Chuo Ku, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Chuo Ku, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Ohdan, Hideki] Hiroshima Univ, Sch Med, Dept Surg Gastroenterol, Hiroshima, Japan; [Shimada, Kazuaki] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Chuo Ku, Tokyo, Japan; [Chayama, Kazuki] RIKEN Ctr Integrat Med Sci, Lab Digest Dis, Hiroshima, Japan	RIKEN; National Cancer Center - Japan; RIKEN; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); National Cancer Center - Japan; University of Tokyo; Hiroshima University; Wakayama Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University; Hokkaido University; Hiroshima University; University of Tokyo; University of Tokyo; University of Tokyo; Keio University; National Cancer Center - Japan; National Cancer Center - Japan; RIKEN; Hiroshima University; National Cancer Center - Japan; RIKEN	Shibata, T; Nakagawa, H (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan.; Shibata, T (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan.; Shibata, T (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan.	tashibat@ncc.go.jp; hidewaki@ims.u-tokyo.ac.jp	Shibata, Tatsuhiro/ABA-8234-2020; Ohdan, Hideki/G-4719-2019; Nagae, Genta/H-6579-2019; Tatsuno, Kenji/B-1765-2008; Nagae, Genta/AAN-1167-2021; Hayami, Shinya/Y-3354-2019; Shibata, Tatsuhiro/AAO-1278-2021; Tsunoda, Tatsuhiko/K-2061-2014; Wardell, Christopher/B-5053-2018	Ohdan, Hideki/0000-0002-9066-1288; Nagae, Genta/0000-0002-2929-7990; Hayami, Shinya/0000-0001-8392-2382; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Wardell, Christopher/0000-0002-9416-7818; Miyano, Satoru/0000-0002-1753-6616; Boroevich, Keith/0000-0001-7095-7332; Chayama, Kazuaki/0000-0002-5530-5341; Arai, Yasuhito/0000-0001-6306-9409; Taniguchi, Hiroaki/0000-0001-7270-390X	RIKEN President's Fund; JSPS [25134717, 25670375, 23114001, 15H04814]; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development; CREST from the Japan Science and Technology Agency; National Cancer Center Research and Development Funds [26-A-5]; National Cancer Center Biobank - National Cancer Center Research and Development Fund, Japan	RIKEN President's Fund; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); National Cancer Center Research and Development Funds; National Cancer Center Biobank - National Cancer Center Research and Development Fund, Japan	The supercomputing resource 'SHIROKANE' was provided by the Human Genome Center at The University of Tokyo. This work was supported in part by RIKEN President's Fund 2011, a Grant-in-Aid for the RIKEN CGM and IMS, a Grant-in-Aid for Scientific Research on Innovative Areas from JSPS grants (25134717, 25670375, 23114001, and 15H04814), the Princess Takamatsu Cancer Research Fund, the Takeda Science Foundation, the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, CREST from the Japan Science and Technology Agency, and National Cancer Center Research and Development Funds (26-A-5); the National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fujimoto A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7120; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo T, 2015, TUMOR BIOL, V36, P7649, DOI 10.1007/s13277-015-3463-6; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Jhunjhunwala S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0436-9; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kawaguchi T, 2015, P NATL ACAD SCI USA, V112, P4304, DOI 10.1073/pnas.1423819112; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Ni SB, 2013, CANCER SCI, V104, P817, DOI 10.1111/cas.12157; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Pitkanen E, 2014, ONCOTARGET, V5, P853, DOI 10.18632/oncotarget.1781; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shiraishi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114263; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Wong CM, 2007, HEPATOLOGY, V45, P1129, DOI 10.1002/hep.21578; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Xu C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-118; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120	63	428	438	7	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					500	+		10.1038/ng.3547	http://dx.doi.org/10.1038/ng.3547			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27064257				2022-12-17	WOS:000374834100008
J	DeNicola, GM; Chen, PH; Mullarky, E; Sudderth, JA; Hu, ZP; Wu, D; Tang, H; Xie, Y; Asara, JM; Huffman, KE; Wistuba, II; Minna, JD; DeBerardinis, RJ; Cantley, LC				DeNicola, Gina M.; Chen, Pei-Hsuan; Mullarky, Edouard; Sudderth, Jessica A.; Hu, Zeping; Wu, David; Tang, Hao; Xie, Yang; Asara, John M.; Huffman, Kenneth E.; Wistuba, Ignacio I.; Minna, John D.; DeBerardinis, Ralph J.; Cantley, Lewis C.			NRF2 regulates serine biosynthesis in non-small cell lung cancer	NATURE GENETICS			English	Article							GENE-EXPRESSION; KEAP1 MUTATIONS; GROWTH; ACTIVATION; CARCINOMA; GLUTAMINE; PATHWAY; GLUCOSE; PROTEIN; IMPAIR	Tumors have high energetic and anabolic needs for rapid cell growth and proliferation(1), and the serine biosynthetic pathway was recently identified as an important source of metabolic intermediates for these processes(2,3). We integrated metabolic tracing and transcriptional profiling of a large panel of non-small cell lung cancer (NSCLC) cell lines to characterize the activity and regulation of the serine/glycine biosynthetic pathway in NSCLC. Here we show that the activity of this pathway is highly heterogeneous and is regulated by NRF2, a transcription factor frequently deregulated in NSCLC. We found that NRF2 controls the expression of the key serine/glycine biosynthesis enzyme genes PHGDH, PSAT1 and SHMT2 via ATF4 to support glutathione and nucleotide production. Moreover, we show that expression of these genes confers poor prognosis in human NSCLC. Thus, a substantial fraction of human NSCLCs activates an NRF2-dependent transcriptional program that regulates serine and glycine metabolism and is linked to clinical aggressiveness.	[DeNicola, Gina M.; Mullarky, Edouard; Wu, David; Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Chen, Pei-Hsuan; Sudderth, Jessica A.; Hu, Zeping; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Tang, Hao; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA; [Huffman, Kenneth E.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Cantley, LC (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	lcantley@med.cornell.edu	Hu, Zeping/F-6205-2010; Cantley, Lewis C/D-1800-2014	Hu, Zeping/0000-0003-4146-7750; Cantley, Lewis C/0000-0002-1298-7653; Wu, David/0000-0003-4513-2739; DeNicola, Gina/0000-0001-6611-6696	US National Institutes of Health [P01 CA117969, R01 GM041890, R01 CA157996-01, 5R01 CA152301, P50 CA70907, 5P30 CA006516, 5 P01 CA120964]; Cancer Prevention Research Institute of Texas (CPRIT) [RP110708, RP120732, RP130272]; Welch Foundation [I-1733]; PanCAN/AACR Pathway to Leadership grant; NATIONAL CANCER INSTITUTE [R01CA152301, P50CA070907, P01CA117969, R01CA157996, P30CA006516, U01CA176284, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); Welch Foundation(The Welch Foundation); PanCAN/AACR Pathway to Leadership grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Poulogiannis for bioinformatics advice and H. Abbasi, C. Klimko and M. Yuan for technical support with mass spectrometry experiments. This work was supported by US National Institutes of Health grants P01 CA117969 and R01 GM041890 (L.C.C.), R01 CA157996-01 (R.J.D.), 5R01 CA152301 (Y.X.) and P50 CA70907 (J.D.M., I.I.W., Y.X. and K.E.H.) and by Cancer Prevention Research Institute of Texas (CPRIT) funding to J.D.M., Y.X., I.I.W. and K.E.H. (RP110708 and RP120732) and R.J.D. (RP130272). P.-H.C. was supported by a grant from the Welch Foundation to R.J.D. (I-1733). The mass spectrometry work was partially supported by US National Institutes of Health grants 5P30 CA006516 and 5 P01 CA120964 (J.M.A.). G.M.D. was the Malcolm A.S. Moore Hope Funds for Cancer Research Fellow and is supported by the PanCAN/AACR Pathway to Leadership grant.	Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Radle B, 2013, JOVE-J VIS EXP, DOI 10.3791/50195; Seng S, 2009, ONCOGENE, V28, P378, DOI 10.1038/onc.2008.396; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589	31	428	443	6	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1475	+		10.1038/ng.3421	http://dx.doi.org/10.1038/ng.3421			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26482881	Green Submitted, Green Accepted			2022-12-17	WOS:000365813200021
J	Tufarelli, C; Stanley, JAS; Garrick, D; Sharpe, JA; Ayyub, H; Wood, WG; Higgs, DR				Tufarelli, C; Stanley, JAS; Garrick, D; Sharpe, JA; Ayyub, H; Wood, WG; Higgs, DR			Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; HUMAN TELOMERIC REGION; ALPHA-GLOBIN; MOUSE EMBRYOS; CPG ISLAND; EXPRESSION; LOCUS; CELLS; MICE; DIFFERENTIATION	Nearly all human genetic disorders result from a limited repertoire of mutations in an associated gene or its regulatory elements. We recently described an individual with an inherited form of anemia (alpha-thalassemia) who has a deletion that results in a truncated, widely expressed gene (LUC7L) becoming juxtaposed to a structurally normal alpha-globin gene (HBA2). Although it retains all of its local and remote cis-regulatory elements, expression of HBA2 is silenced and its CpG island becomes completely methylated early during development. Here we show that in the affected individual, in a transgenic model and in differentiating embryonic stem cells, transcription of antisense RNA mediates silencing and methylation of the associated CpG island. These findings identify a new mechanism underlying human genetic disease.	Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med,John Radcliffe Hosp, Oxford OX3 9DS, England	University of Oxford	Higgs, DR (corresponding author), Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med,John Radcliffe Hosp, Oxford OX3 9DS, England.		GARRICK, David/O-5734-2019; Garrick, David/F-1728-2017; Tufarelli, Cristina/AAD-3265-2019	GARRICK, David/0000-0001-7422-7986; Garrick, David/0000-0001-7422-7986; Tufarelli, Cristina/0000-0002-1053-4618				Barbour VM, 2000, BLOOD, V96, P800, DOI 10.1182/blood.V96.3.800.015k11a_800_807; Baylin Stephen B., 2000, P293; Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cooper D. N., 1993, HUMAN GENE MUTATION; Daniels R, 1997, HUM REPROD, V12, P2251, DOI 10.1093/humrep/12.10.2251; Ehrlich Melanie, 2000, P273; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; FEI YJ, 1988, BRIT J HAEMATOL, V68, P249, DOI 10.1111/j.1365-2141.1988.tb06197.x; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Higgs DR, 1998, SEMIN HEMATOL, V35, P93; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; KULOZIK AE, 1988, BLOOD, V71, P467; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; MARTIN GR, 1978, NATURE, V271, P829; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; ROMBEL I, 1995, P NATL ACAD SCI USA, V92, P6454, DOI 10.1073/pnas.92.14.6454; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; SHARPE JA, 1993, P NATL ACAD SCI USA, V90, P11262, DOI 10.1073/pnas.90.23.11262; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; SPIVAK JL, 1973, BLOOD, V42, P257, DOI 10.1182/blood.V42.2.257.257; Tufarelli C, 2001, GENOMICS, V71, P307, DOI 10.1006/geno.2000.6394; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	43	428	455	1	28	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					157	165		10.1038/ng1157	http://dx.doi.org/10.1038/ng1157			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730694				2022-12-17	WOS:000183200500021
J	Guelzim, N; Bottani, S; Bourgine, P; Kepes, F				Guelzim, N; Bottani, S; Bourgine, P; Kepes, F			Topological and causal structure of the yeast transcriptional regulatory network	NATURE GENETICS			English	Article							SMALL-WORLD; BINDING	Interpretation of high-throughput biological data requires a knowledge of the design principles underlying the networks that sustain cellular functions. Of particular importance is the genetic network, a set of genes that interact through directed transcriptional regulation. Genes that exert a regulatory role encode dedicated transcription factors (hereafter referred to as regulating proteins) that can bind to specific DNA control regions of regulated genes to activate or inhibit their transcription. Regulated genes may themselves act in a regulatory manner, in which case they participate in a causal pathway. Looping pathways form feedback circuits. Because a gene can have several connections, circuits and pathways may crosslink and thus represent connected components. We have created a graph of 909 genetically or biochemically established interactions among 491 yeast genes. The number of regulating proteins per regulated gene has a narrow distribution with an exponential decay. The number of regulated genes per regulating protein has a broader distribution with a decay resembling a power law. Assuming in computer-generated graphs that gene connections fulfill these distributions but are otherwise random, the local clustering of connections and the number of short feedback circuits are largely underestimated. This deviation from randomness probably reflects functional constraints that include biosynthetic cost, response delay and differentiative and homeostatic regulation.	ATelier Genom Cognit, CNRS, ESA 8071, Genopole, F-91000 Evry, France; Ecole Polytech, Ctr Rech Epistemol Appl, F-75230 Paris, France; Univ Paris 07, UFR Phys, Grp Modelisat Phys Interfaces Biol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Kepes, F (corresponding author), ATelier Genom Cognit, CNRS, ESA 8071, Genopole, 523 Terrasses Agora, F-91000 Evry, France.	Francois.Kepes@genopole.cnrs.fr						Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; RAINE DJ, 2000, INTERJOURNAL COMPLEX; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Svetlov VV, 1995, YEAST, V11, P1439, DOI 10.1002/yea.320111502; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Thomas R., 1990, BIOL FEEDBACK; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442	23	428	441	2	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					60	63		10.1038/ng873	http://dx.doi.org/10.1038/ng873			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967534	Bronze			2022-12-17	WOS:000175362500015
J	Calogero, S; Grassi, F; Aguzzi, A; Voigtlander, T; Ferrier, P; Ferrari, S; Bianchi, ME				Calogero, S; Grassi, F; Aguzzi, A; Voigtlander, T; Ferrier, P; Ferrari, S; Bianchi, ME			The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice	NATURE GENETICS			English	Article							MOBILITY GROUP-1 PROTEIN; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; GLUCOCORTICOID RECEPTOR; ACTIVATION; INTERACTS; COMPLEX	High mobility group 1 (HMG1) protein is an abundant component of all mammalian nuclei, and related proteins exist in all eukaryotes(1,2). HMG1 binds linear DNA with moderate affinity and no sequence specificity(3), but bends the double helix significantly on binding through the minor groove(4). It binds with high affinity to DNA that is already sharply bent, such as linker DNA at the entry and exit of nucleosomes(5-7); thus, it is considered a structural protein of chromatin, HMG1 is also recruited to DNA by interactions with proteins required,for basal and regulated transcriptions(8-13) and V(D)J recombination(14,15). Here we generate mice harbouring deleted Hmg1. Hmg1(-/-) pups are born alive, hut die within 24 hours due to hypoglycaemia, Hmg1-deficient mice survive for several days if given glucose parenterally, then waste away with pleiotropic defects (but no alteration in the immune repertoire). Cell lines lacking Hmg1 grow normally, but the activation of gene expression by the glucocorticoid receptor (GR, encoded by the gene Grl1) is impaired. Thus, Hmg1 is not essential for the overall organization of chromatin in the cell nucleus, but is critical for proper transcriptional control by specific transcription factors.	San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy; Univ Milan, Dipartimento Biol & Genet Sci Med, I-20132 Milan, Italy; Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; CNRS Marseille Luminy, Ctr Immunol, INSERM, F-13288 Marseille, France; Univ Milan, Dipartimento Genet & Biol Microrganismi, I-20133 Milan, Italy	University of Milan; University of Zurich; University Zurich Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Milan	Bianchi, ME (corresponding author), San Raffaele Sci Inst, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.		Bianchi, Marco Emilio/K-3417-2018; Aguzzi, Adriano/A-3351-2008	Bianchi, Marco Emilio/0000-0002-5329-6445; GRASSI, FABIO/0000-0003-3348-1712; Aguzzi, Adriano/0000-0002-0344-6708				Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; FERRARI S, 1994, J BIOL CHEM, V269, P28803; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; NODA C, 1985, BIOCHEM BIOPH RES CO, V132, P232, DOI 10.1016/0006-291X(85)91012-5; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; REUE K, 1988, J BIOL CHEM, V263, P6857; RUPPERT S, 1990, CELL, V61, P895, DOI 10.1016/0092-8674(90)90200-X; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; SWAT W, 1991, J IMMUNOL METHODS, V137, P79, DOI 10.1016/0022-1759(91)90396-W; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; YOOWARREN H, 1981, J BIOL CHEM, V256, P224; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	26	428	454	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1999	22	3					276	280		10.1038/10338	http://dx.doi.org/10.1038/10338			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	210VT	10391216				2022-12-17	WOS:000081125900021
J	Shoemaker, DD; Lashkari, DA; Morris, D; Mittmann, M; Davis, RW				Shoemaker, DD; Lashkari, DA; Morris, D; Mittmann, M; Davis, RW			Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSFORMATION; DISRUPTION; SEQUENCE; ARRAYS; GENES; PCR	A quantitative and highly parallel method for analysing deletion mutants has been developed to aid in determining the biological function of thousands of newly identified open reading frames (ORFs) in Saccharomyces cerevisiae. This approach uses a PCR targeting strategy to generate large numbers of deletion strains. Each deletion strain is labelled with a unique 20-base tag sequence that can be detected by hybridization to a high-density oligonucleotide array. The tags serve as unique identifiers (molecular bar codes) that allow analysis of large numbers of deletion strains simultaneously through selective growth conditions. Hybridization experiments show that the arrays are specific, sensitive and quantitative. A pilot study with 11 known yeast genes suggests that the method can be extended to include all of the ORFs in the yeast genome, allowing whole genome analysis with a single selective growth condition and a single hybridization.	STANFORD UNIV, BECKMAN CTR, DEPT BIOCHEM, MED CTR, STANFORD, CA 94305 USA; AFFYMETRIX, SANTA CLARA, CA 95051 USA	Stanford University; Affymetrix								BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; JIMENEZ A, 1980, NATURE, V287, P869, DOI 10.1038/287869a0; LASHKARI DA, 1995, P NATL ACAD SCI USA, V92, P7912, DOI 10.1073/pnas.92.17.7912; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; LOCKHART D, IN PRESS NATURE BIOT; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sherman F., 1986, METHODS YEAST GENETI; SMITH V, 1995, P NATL ACAD SCI USA, V92, P6479, DOI 10.1073/pnas.92.14.6479; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310	17	428	705	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1996	14	4					450	456		10.1038/ng1296-450	http://dx.doi.org/10.1038/ng1296-450			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944025				2022-12-17	WOS:A1996VV73000021
J	Thorlacius, S; Olafsdottir, G; Tryggvadottir, L; Neuhausen, S; Jonasson, JG; Tavtigian, SV; Tulinius, H; Ogmundsdottir, HM; Eyfjord, JE				Thorlacius, S; Olafsdottir, G; Tryggvadottir, L; Neuhausen, S; Jonasson, JG; Tavtigian, SV; Tulinius, H; Ogmundsdottir, HM; Eyfjord, JE			A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes	NATURE GENETICS			English	Letter									ICELAND CANC SOC,MOL & CELL BIOL RES LAB,IS-125 REYKJAVIK,ICELAND; UNIV UTAH,SCH MED,DEPT MED INFORMAT,SALT LAKE CITY,UT; ICELAND CANC SOC,CANC REGISTRY,IS-125 REYKJAVIK,ICELAND; UNIV ICELAND,DEPT PATHOL,IS-121 REYKJAVIK,ICELAND	Utah System of Higher Education; University of Utah; University of Iceland			Ögmundsdóttir, Helga M/L-6970-2015	Tryggvadottir, Laufey/0000-0001-8067-9030; Jonasson, Jon G./0000-0002-2635-5032				BARDARDOTTIR RB, 1995, ACTA ONCOL, V34, P657; Jonasson JG, 1996, INT J CANCER, V65, P446, DOI 10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X; LATHROP GM, 1984, AM J HUM GENET, V36, P460; PARKIN DM, 1992, CANC INCIDENCE 5 CON, V6, P618; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; THORLACIUS S, 1993, CANCER RES, V53, P1637; THORLACIUS S, 1995, LANCET, V346, P544, DOI 10.1016/S0140-6736(95)91383-1; TONIN P, 1995, J MED GENET, V32, P982, DOI 10.1136/jmg.32.12.982; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153	12	428	434	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					117	119		10.1038/ng0596-117	http://dx.doi.org/10.1038/ng0596-117			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673089				2022-12-17	WOS:A1996UH43000029
J	LIM, LE; DUCLOS, F; BROUX, O; BOURG, N; SUNADA, Y; ALLAMAND, V; MEYER, J; RICHARD, IZ; MOOMAW, C; SLAUGHTER, C; TOME, FMS; FARDEAU, M; JACKSON, CE; BECKMANN, JS; CAMPBELL, KP				LIM, LE; DUCLOS, F; BROUX, O; BOURG, N; SUNADA, Y; ALLAMAND, V; MEYER, J; RICHARD, IZ; MOOMAW, C; SLAUGHTER, C; TOME, FMS; FARDEAU, M; JACKSON, CE; BECKMANN, JS; CAMPBELL, KP			BETA-SARCOGLYCAN - CHARACTERIZATION AND ROLE IN LIMB-GIRDLE MUSCULAR-DYSTROPHY LINKED TO 4Q12	NATURE GENETICS			English	Article							GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE; BINDING DOMAIN; LINKAGE; DEFICIENCY; SARCOLEMMA; PROTEINS; MAPS; PURIFICATION; LAMININ	beta-sarcoglycan, a 43 kDa dystrophin-associated glycoprotein, is an integral component of the dystrophin-glycoprotein complex. We have cloned human beta-sarcoglycan cDNA and mapped the beta-sarcoglycan gene to chromosome 4q12. Pericentromeric markers and an intragenic polymorphic CA repeat cosegregated perfectly with autosomal recessive limb-girdle muscular dystrophy in several Amish families. A Thr-to-Arg missense mutation was identified within the beta-sarcoglycan gene that leads to a dramatically reduced expression of beta-sarcoglycan in the sarcolemma and a concomitant loss of adhalin and 35 DAG, which may represent a disruption of a functional subcomplex within the dystrophin-glycoprotein complex. Thus, the beta-sarcoglycan gene is the fifth locus identified (LGMD2E) that is involved in autosomal recessive limb-girdle muscular dystrophy.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; CTR ETUD POLYMORPHISME HUMAIN,FDN JEAN DAUSSET,F-75010 PARIS,FRANCE; GENETHON SA,F-91000 EVRY,FRANCE; UNIV TEXAS,HOWARD HUGHES MED INST,BIOPOLYMER FACIL,DALLAS,TX 75235; INSERM,U153,F-75005 PARIS,FRANCE; HENRY FORD HOSP,DIV CLIN & MOLEC GENET,DETROIT,MI 48202	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Foundation Jean Dausset-CEPH; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); Henry Ford Health System; Henry Ford Hospital			Allamand, Valerie/M-4333-2017; Allamand, Valérie/AAH-6272-2021; Beckmann, Jacques S/A-9772-2008; Richard, isabelle/J-8298-2013	Allamand, Valérie/0000-0001-8997-9742; Beckmann, Jacques S/0000-0002-9741-1900; Campbell, Kevin/0000-0003-2066-5889				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; ALLAMAND V, 1995, HUM MOL GENET, V4, P459, DOI 10.1093/hmg/4.3.459; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FARDEAU M, IN PRESS BRAIN; FOUGEROUSSE F, 1994, HUM MOL GENET, V3, P285, DOI 10.1093/hmg/3.2.285; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JACKSON CE, 1961, PEDIATRICS, V28, P77; JACKSON CE, 1968, PEDIATRICS, V41, P495; JORGENSEN AO, 1990, J CELL BIOL, V110, P1173, DOI 10.1083/jcb.110.4.1173; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MILLS KA, 1992, GENOMICS, V14, P209, DOI 10.1016/S0888-7543(05)80208-3; MIZUNO Y, 1995, AM J PATHOL, V146, P530; MIZUNO Y, 1994, BIOCHEM BIOPH RES CO, V203, P979, DOI 10.1006/bbrc.1994.2278; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; RICHARD I, 1995, CELL, V87, P27; ROBERDS SL, 1995, FEBS LETT, V364, P245, DOI 10.1016/0014-5793(95)00395-P; ROBERDS SL, 1993, J BIOL CHEM, V268, P11496; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH DB, 1987, CURRENT PROTOCOLS MO; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; SPEER MC, 1992, AM J HUM GENET, V50, P1211; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALTON JN, 1954, BRAIN, V77, P169, DOI 10.1093/brain/77.2.169; YANG B, 1994, J BIOL CHEM, V269, P6040; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	59	428	436	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					257	265		10.1038/ng1195-257	http://dx.doi.org/10.1038/ng1195-257			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581448				2022-12-17	WOS:A1995TC63900013
J	WOOSTER, R; CLETONJANSEN, AM; COLLINS, N; MANGION, J; CORNELIS, RS; COOPER, CS; GUSTERSON, BA; PONDER, BAJ; VONDEIMLING, A; WIESTLER, OD; CORNELISSE, CJ; DEVILEE, P; STRATTON, MR				WOOSTER, R; CLETONJANSEN, AM; COLLINS, N; MANGION, J; CORNELIS, RS; COOPER, CS; GUSTERSON, BA; PONDER, BAJ; VONDEIMLING, A; WIESTLER, OD; CORNELISSE, CJ; DEVILEE, P; STRATTON, MR			INSTABILITY OF SHORT TANDEM REPEATS (MICROSATELLITES) IN HUMAN CANCERS	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; HUMAN-DISEASE; VWF GENE; POLYMORPHISM; MUTATIONS; REGION	The allele sizes of polymorphic microsatellite repeats in DNA from human cancers were compared to normal DNA from the same patients. In 16 out of 196 paired samples (8%), we found evidence of an extra allele of a different size in the tumour which was not present in the normal DNA. Sequence analysis confirmed that the extra allele originates from the appropriate locus and that the size change is attributable to alteration in the number of repeat units. This form of instability was more common in tri- and tetranucleotide repeats than in dinucleotide repeats. In any single tumour sample only one repeat in the set examined was abnormal, the remainder showing identical patterns in normal and tumour DNA or evidence of allele loss. The pattern of instability in diverse types of cancer differs from that reported in colorectal neoplasms.	INST CANC RES,HADDOW LABS,MOLEC CARCINOGENESIS SECT,SUTTON SM2 5NG,SURREY,ENGLAND; INST CANC RES,HADDOW LABS,CELL BIOL & EXPTL PATHOL SECT,SUTTON SM2 5NG,SURREY,ENGLAND; LEIDEN UNIV,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT PATHOL,2333 AL LEIDEN,NETHERLANDS; UNIV CAMBRIDGE,DEPT PATHOL,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE CB2 1QP,CAMBS,ENGLAND; UNIV KINIKEN BONN,INST NEUROPATHOL,D-53105 BONN,GERMANY	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Cambridge; University of Bonn			gusterson, barry a/D-3752-2009; von Deimling, Andreas/F-7774-2013; DEVILEE, PETER/ABR-2140-2022	von Deimling, Andreas/0000-0002-5863-540X; 				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DEVILEE P, 1991, CANCER RES, V51, P1020; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; GRODEN J, 1993, AM J HUM GENET, V52, P263; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEGO N, 1993, ONCOGENE, V8, P209; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHTANI MM, 1993, HUM MOL GENET, V2, P431, DOI 10.1093/hmg/2.4.431; MIWA S, 1994, NAT GENET, V6, P3, DOI 10.1038/ng0194-3; OUDET C, 1993, AM J HUM GENET, V52, P297; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; VANAMSTEL HKP, 1990, NUCLEIC ACIDS RES, V18, P4957, DOI 10.1093/nar/18.16.4957-a; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOOSTER R, 1992, NAT GENET, V2, P132; 1993, CELL, V72, P971	23	428	437	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					152	156		10.1038/ng0294-152	http://dx.doi.org/10.1038/ng0294-152			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162069				2022-12-17	WOS:A1994MU76300009
J	Holmfeldt, L; Wei, L; Diaz-Flores, E; Walsh, M; Zhang, JH; Ding, L; Payne-Turner, D; Churchman, M; Andersson, A; Chen, SC; McCastlain, K; Becksfort, J; Ma, J; Wu, G; Patel, SN; Heatley, SL; Phillips, LA; Song, GC; Easton, J; Parker, M; Chen, X; Rusch, M; Boggs, K; Vadodaria, B; Hedlund, E; Drenberg, C; Baker, S; Pei, DQ; Cheng, C; Huether, R; Lu, C; Fulton, RS; Fulton, LL; Tabib, Y; Dooling, DJ; Ochoa, K; Minden, M; Lewis, ID; To, LB; Marlton, P; Roberts, AW; Raca, G; Stock, W; Neale, G; Drexler, HG; Dickins, RA; Ellison, DW; Shurtleff, SA; Pui, CH; Ribeiro, RC; Devidas, M; Carroll, AJ; Heerema, NA; Wood, B; Borowitz, MJ; Gastier-Foster, JM; Raimondi, SC; Mardis, ER; Wilson, RK; Downing, JR; Hunger, SP; Loh, ML; Mullighan, CG				Holmfeldt, Linda; Wei, Lei; Diaz-Flores, Ernesto; Walsh, Michael; Zhang, Jinghui; Ding, Li; Payne-Turner, Debbie; Churchman, Michelle; Andersson, Anna; Chen, Shann-Ching; McCastlain, Kelly; Becksfort, Jared; Ma, Jing; Wu, Gang; Patel, Samir N.; Heatley, Susan L.; Phillips, Letha A.; Song, Guangchun; Easton, John; Parker, Matthew; Chen, Xiang; Rusch, Michael; Boggs, Kristy; Vadodaria, Bhavin; Hedlund, Erin; Drenberg, Christina; Baker, Sharyn; Pei, Deqing; Cheng, Cheng; Huether, Robert; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Tabib, Yashodhan; Dooling, David J.; Ochoa, Kerri; Minden, Mark; Lewis, Ian D.; To, L. Bik; Marlton, Paula; Roberts, Andrew W.; Raca, Gordana; Stock, Wendy; Neale, Geoffrey; Drexler, Hans G.; Dickins, Ross A.; Ellison, David W.; Shurtleff, Sheila A.; Pui, Ching-Hon; Ribeiro, Raul C.; Devidas, Meenakshi; Carroll, Andrew J.; Heerema, Nyla A.; Wood, Brent; Borowitz, Michael J.; Gastier-Foster, Julie M.; Raimondi, Susana C.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Hunger, Stephen P.; Loh, Mignon L.; Mullighan, Charles G.			The genomic landscape of hypodiploid acute lymphoblastic leukemia	NATURE GENETICS			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; NEUROFIBROMATOSIS TYPE-1 GENE; REGULATORY T-CELLS; TRANSMEMBRANE ADAPTER; HEMATOLOGIC MALIGNANCIES; P53 MUTATIONS; HUMAN CANCERS; MUTANT P53; IKAROS; CHILDHOOD	The genetic basis of hypodiploid acute lymphoblastic leukemia (ALL), a subtype of ALL characterized by aneuploidy and poor outcome, is unknown. Genomic profiling of 124 hypodiploid ALL cases, including whole-genome and exome sequencing of 40 cases, identified two subtypes that differ in the severity of aneuploidy, transcriptional profiles and submicroscopic genetic alterations. Near-haploid ALL with 24-31 chromosomes harbor alterations targeting receptor tyrosine kinase signaling and Ras signaling (71%) and the lymphoid transcription factor gene IKZF3 (encoding AIOLOS; 13%). In contrast, low-hypodiploid ALL with 32-39 chromosomes are characterized by alterations in TP53 (91.2%) that are commonly present in nontumor cells, IKZF2 (encoding HELIOS; 53%) and RB1 (41%). Both near-haploid and low-hypodiploid leukemic cells show activation of Ras-signaling and phosphoinositide 3-kinase (PI3K)-signaling pathways and are sensitive to PI3K inhibitors, indicating that these drugs should be explored as a new therapeutic strategy for this aggressive form of leukemia.	[Holmfeldt, Linda; Wei, Lei; Payne-Turner, Debbie; Churchman, Michelle; Andersson, Anna; Chen, Shann-Ching; McCastlain, Kelly; Ma, Jing; Patel, Samir N.; Heatley, Susan L.; Phillips, Letha A.; Song, Guangchun; Ellison, David W.; Shurtleff, Sheila A.; Raimondi, Susana C.; Downing, James R.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Diaz-Flores, Ernesto; Loh, Mignon L.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Walsh, Michael; Pui, Ching-Hon; Ribeiro, Raul C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Zhang, Jinghui; Becksfort, Jared; Wu, Gang; Parker, Matthew; Chen, Xiang; Rusch, Michael; Hedlund, Erin; Huether, Robert; Mardis, Elaine R.; Wilson, Richard K.] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Tabib, Yashodhan; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Andersson, Anna] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Easton, John; Boggs, Kristy; Vadodaria, Bhavin] St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Drenberg, Christina; Baker, Sharyn] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Minden, Mark] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5S 1A1, Canada; [Lewis, Ian D.; To, L. Bik] Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia; [Marlton, Paula] Princess Alexandra Hosp, Oncol Haematol Unit, Woolloongabba, Qld 4102, Australia; [Roberts, Andrew W.] Royal Melbourne Hosp, Dept Clin Haematol & Bone Marrow Transplant, Melbourne, Vic, Australia; [Raca, Gordana; Stock, Wendy] Univ Chicago Med, Sect Hematol Oncol, Chicago, IL USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Drexler, Hans G.] Deutsch Sammlung Mikroorganismen & Zellkulturen, Dept Human & Anim Cell Cultures, Braunschweig, Germany; [Dickins, Ross A.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Med Div, Parkville, Vic 3050, Australia; [Devidas, Meenakshi] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA; [Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Heerema, Nyla A.] Ohio State Univ, Ctr Comprehens Canc, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Wood, Brent] Seattle Childrens Hosp, Dept Lab Med, Seattle, WA USA; [Borowitz, Michael J.] Johns Hopkins Univ Hosp, Div Hematol Pathol, Baltimore, MD 21287 USA; [Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp Colorado, Sect Pediat Hematol Oncol Bone Marrow Transplanta, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA	St Jude Children's Research Hospital; University of California System; University of California San Francisco; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); Lund University; Skane University Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Institute Medical & Veterinary Science Australia; Royal Melbourne Hospital; St Jude Children's Research Hospital; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Royal Melbourne Hospital; Walter & Eliza Hall Institute; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Seattle Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Siteman Cancer Center; Washington University (WUSTL); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Mardis, Elaine/W-2202-2019; Wu, Gang/M-8012-2014; Wilson, Richard K./AAF-4139-2019; Ellison, David/N-4806-2018; Rusch, Michael/AAG-1998-2019; Raimondi, Susana C/N-8166-2018; Marlton, Paula/F-3026-2011; Mullighan, Charles/H-3253-2011; Downing, James R./N-8102-2018; Huether, Robert/E-9638-2012; Pui, Ching-Hon/N-8076-2018; Dickins, Ross A/K-2852-2012; Zhang, Jing/GWZ-7332-2022; Roberts, Andrew W/C-6736-2012; Heatley, Susan/AGP-2179-2022; McCastlain, Kelly/O-3366-2018; Chen, Xiang/N-2524-2018; Devidas, Meenakshi/H-1170-2019; Cheng, Cheng/N-8075-2018	Wu, Gang/0000-0002-1678-5864; Wilson, Richard K./0000-0002-1992-1358; Rusch, Michael/0000-0002-5363-1848; Mullighan, Charles/0000-0002-1871-1850; Huether, Robert/0000-0001-7077-7470; Pui, Ching-Hon/0000-0003-0303-5658; Dickins, Ross A/0000-0003-4112-5304; Roberts, Andrew W/0000-0002-7341-5720; McCastlain, Kelly/0000-0001-7868-3049; Chen, Xiang/0000-0002-2499-8261; Devidas, Meenakshi/0000-0002-1099-3478; Heatley, Susan/0000-0001-7497-6477; Parker, Matthew/0000-0003-2999-3870; Holmfeldt, Linda/0000-0003-4140-3423; Easton, John/0000-0003-4503-6608; Hagstrom-Andersson, Anna/0000-0002-2904-1311; Baker, Sharyn/0000-0003-3062-3252; Guttke, Christina/0000-0001-7759-8213; Loh, Mignon/0000-0003-4099-4700	The Henry Schueler 419 Foundation; Partnership for Cures; St. Baldrick's Foundation; US National Cancer Institute (NCI) [RC4CA156329]; US National Institutes of Health (NIH) [CA21765, U01 GM92666]; American Association for Cancer Research (AACR) Gertrude B. Elion Cancer Research Award; American Lebanese and Syrian Associated Charities (ALSAC) of SJCRH; NCI [CA98543, CA98413, CA114766, 5R25CA023944]; Swedish Research Council; Frank A. Campini Foundation; Team Connor Foundation; NATIONAL CANCER INSTITUTE [U24CA114766, U24CA196173, R25CA023944, P30CA021765, RC4CA156329, U10CA098543, U10CA098413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	The Henry Schueler 419 Foundation; Partnership for Cures; St. Baldrick's Foundation; US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research (AACR) Gertrude B. Elion Cancer Research Award; American Lebanese and Syrian Associated Charities (ALSAC) of SJCRH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Frank A. Campini Foundation; Team Connor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Morris, E. Walker and A. Merriman for performing SNP and gene expression microarrays and G. Zambetti and P. Brindle for insightful discussions of TP53 and CREBBP mutational data, respectively. We also thank H. Mulder, R. Collins, M. Barbato, E. Stonerock, E. Pinto and M. Ellis for technical assistance, the Tissue Resources Core facility and the Flow Cytometry and Cell Sorting Core facility of the St. Jude Children's Research Hospital (SJCRH). This work was supported by The Henry Schueler 41&9 Foundation in conjunction with Partnership for Cures, the St. Baldrick's Foundation, US National Cancer Institute (NCI) grant RC4CA156329, US National Institutes of Health (NIH) grants CA21765 and U01 GM92666, the American Association for Cancer Research (AACR) Gertrude B. Elion Cancer Research Award and the American Lebanese and Syrian Associated Charities (ALSAC) of SJCRH. Support was also provided by NCI grants to the Children's Oncology Group, including CA98543, CA98413 and CA114766. L.H. was supported by the Swedish Research Council. S.P.H. is the Ergen Family Chair in Pediatric Cancer. M.L.L. is a Clinical Scholar in the Leukemia Lymphoma Society and supported by the Frank A. Campini Foundation. C.G.M. is a Pew Scholar in the Biomedical Sciences and a St. Baldrick's Scholar. M.L.L. and E.D.-F. were supported by the Team Connor Foundation, and S.N.P. was supported by 5R25CA023944 from NCI. This paper is dedicated to Henry 'Hank' Schueler who died from complications of hypodiploid ALL and whose Foundation is dedicated to finding a cure for hypodiploid ALL in his memory and to James B. Nachman who was instrumental in the genesis of this project and who recently passed away.	[Anonymous], BLOOD; Balgobind BV, 2008, BLOOD, V111, P4322, DOI 10.1182/blood-2007-06-095075; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; De Filippi P, 2009, BRIT J HAEMATOL, V147, P706, DOI 10.1111/j.1365-2141.2009.07894.x; Deshpande A, 2006, CURR MOL MED, V6, P809; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Goodman RH, 2000, GENE DEV, V14, P1553; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Harrison CJ, 2004, BRIT J HAEMATOL, V125, P552, DOI 10.1111/j.1365-2141.2004.04948.x; Heerema NA, 1999, BLOOD, V94, P4036; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; IMAMURA J, 1994, BLOOD, V84, P2412, DOI 10.1182/blood.V84.8.2412.bloodjournal8482412; Kalland ME, 2012, EXP CELL RES, V318, P1611, DOI 10.1016/j.yexcr.2012.05.014; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Klopfenstein KJ, 1999, J PEDIAT HEMATOL ONC, V21, P158, DOI 10.1097/00043426-199903000-00014; KOHNO S, 1980, J NATL CANCER I, V64, P485; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Messiaen L, 2011, HUM MUTAT, V32, P213, DOI 10.1002/humu.21418; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nachman JB, 2007, BLOOD, V110, P1112, DOI 10.1182/blood-2006-07-038299; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Raimondi SC, 2003, CANCER-AM CANCER SOC, V98, P2715, DOI 10.1002/cncr.11841; Raimondi SC, 2012, CHILDHOOD LEUKEMIAS, 3RD EDITION, P135; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Romero F, 1999, EMBO J, V18, P3419, DOI 10.1093/emboj/18.12.3419; ROVINSKI B, 1988, ONCOGENE, V2, P445; Side LE, 1998, BLOOD, V92, P267, DOI 10.1182/blood.V92.1.267.413a31_267_272; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; STILLER CA, 1994, BRIT J CANCER, V70, P969, DOI 10.1038/bjc.1994.431; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	68	427	431	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					242	252		10.1038/ng.2532	http://dx.doi.org/10.1038/ng.2532			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23334668	Green Accepted			2022-12-17	WOS:000315664800007
J	McCarroll, SA; Altshuler, DM				McCarroll, Steven A.; Altshuler, David M.			Copy-number variation and association studies of human disease	NATURE GENETICS			English	Article							HUMAN GENOME; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIANTS; GENETIC ASSOCIATION; LARGE-SCALE; POLYMORPHISM; SUSCEPTIBILITY; NUCLEOTIDE; MAP	The central goal of human genetics is to understand the inherited basis of human variation in phenotypes, elucidating human physiology, evolution and disease. Rare mutations have been found underlying two thousand mendelian diseases; more recently, it has become possible to assess systematically the contribution of common SNPs to complex disease. The known role of copy-number alterations in sporadic genomic disorders, combined with emerging information about inherited copy-number variation, indicate the importance of systematically assessing copy-number variants (CNVs), including common copy-number polymorphisms (CNPs), in disease. Here we discuss evidence that CNVs affect phenotypes, directions for basic knowledge to support clinical study of CNVs, the challenge of genotyping CNPs in clinical cohorts, the use of SNPs as markers for CNPs and statistical challenges in testing CNVs for association with disease. Critical needs are high-resolution maps of common CNPs and techniques that accurately determine the allelic state of affected individuals.	[McCarroll, Steven A.; Altshuler, David M.] Harvard Univ, MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [McCarroll, Steven A.; Altshuler, David M.] Harvard Univ, Cambridge, MA 02138 USA; [McCarroll, Steven A.; Altshuler, David M.] Harvard Univ, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Altshuler, David M.] Harvard Univ, Dept Genet & Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	McCarroll, SA (corresponding author), Harvard Univ, MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA.	smccarro@broad.mit.edu	Pillay, Nischalan/F-9536-2012; McCarroll, Steven A/A-8433-2009; Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; McCarroll, Steven/0000-0002-6954-8184				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lieberfarb ME, 2003, CANCER RES, V63, P4781; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	42	427	477	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S37	S42		10.1038/ng2080	http://dx.doi.org/10.1038/ng2080			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597780				2022-12-17	WOS:000253974400007
J	Chakravarti, A				Chakravarti, A			Population genetics - making sense out of sequence	NATURE GENETICS			English	Review							LINKAGE DISEQUILIBRIUM; HUMAN GENOME; DNA; EVOLUTION; IDENTIFICATION; DIVERSITY; VARIANTS; CLUSTER; GLOBIN	The complete human genome nucleotide sequence and technologies for assessing sequence Variation on a genome-scale will prompt comprehensive studies of comparative genomic diversity inhuman populations across the globe. These studies, besides rejuvenating population genetics and our interest in how genetic Variation is created and maintained, will provide the intellectual basis for understanding the genetic basis for complex diseases-and traits.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Chakravarti, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	axc39@po.cwru.edu						Angrist M, 1998, GENOMICS, V48, P354, DOI 10.1006/geno.1997.5191; AnsariLari MA, 1997, NAT GENET, V16, P221, DOI 10.1038/ng0797-221; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; *COMM HUM GEN DIV, 1997, EV HUM GEN DIV; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Fisher R., 1930, GENETICAL THEORY NAT; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Haldane J. B., 1990, CAUSES EVOLUTION; HALUSHKA M, 1998, GENOME MAPPING SEQUE; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HUDSON RR, 1993, P NATL ACAD SCI USA, V90, P7425, DOI 10.1073/pnas.90.16.7425; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JORDE LB, 1995, AM J HUM GENET, V56, P11; Juengst ET, 1998, KENNEDY INST ETHIC J, V8, P183, DOI 10.1353/ken.1998.0010; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1983, NEURTRAL THEORY MOL; KIMURA M, 1995, COLD SPRING HARB SYM, V20, P33; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LI WH, 1991, GENETICS, V129, P513; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; McKusick V.A., 1998, MENDELIAN INHERITANC; NEI M, 1972, SCIENCE, V177, P434, DOI 10.1126/science.177.4047.434; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M., 1975, MOL POPULATION GENET; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Provine W.B., 1971, ORIGINS THEORETICAL; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WRIGHT S, 1997, EVOLUTION GENETICS P, V2; Wright S., 1977, EVOLUTION GENETICS P, V3	51	427	446	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1999	21			S			56	60		10.1038/4482	http://dx.doi.org/10.1038/4482			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156NU	9915503				2022-12-17	WOS:000078008200014
J	Eeles, RA; Al Olama, AA; Benlloch, S; Saunders, EJ; Leongamornlert, DA; Tymrakiewicz, M; Ghoussaini, M; Luccarini, C; Dennis, J; Jugurnauth-Little, S; Dadaev, T; Neal, DE; Hamdy, FC; Donovan, JL; Muir, K; Giles, GG; Severi, G; Wiklund, F; Gronberg, H; Haiman, CA; Schumacher, F; Henderson, BE; Le Marchand, L; Lindstrom, S; Kraft, P; Hunter, DJ; Gapstur, S; Chanock, SJ; Berndt, SI; Albanes, D; Andriole, G; Schleutker, J; Weischer, M; Canzian, F; Riboli, E; Key, TJ; Travis, RC; Campa, D; Ingles, SA; John, EM; Hayes, RB; Pharoah, PDP; Pashayan, N; Khaw, KT; Stanford, JL; Ostrander, EA; Signorello, LB; Thibodeau, SN; Schaid, D; Maier, C; Vogel, W; Kibel, AS; Cybulski, C; Lubhiski, J; Cannon-Albright, L; Brenner, H; Park, JY; Kaneva, R; Batra, J; Spurdle, AB; Clements, JA; Teixeira, MR; Dicks, E; Lee, A; Dunning, AM; Baynes, C; Conroy, D; Maranian, MJ; Ahmed, S; Govindasami, K; Guy, M; Wilkinson, RA; Sawyer, EJ; Morgan, A; Dearnaley, DP; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Van As, NJ; Woodhouse, CJ; Thompson, A; Dudderidge, T; Ogden, C; Cooper, CS; Lophatananon, A; Cox, A; Southey, MC; Hopper, JL; English, DR; Aly, M; Adolfsson, J; Xu, JF; Zheng, SL; Yeager, M; Kaaks, R; Diver, WR; Gaudet, MM; Stern, MC; Corral, R; Joshi, AD; Shahabi, A; Wahlfors, T; Tammela, TLJ; Auvinen, A; Virtamo, J; Klarskov, P; Nordestgaard, BG; Roder, MA; Nielsen, SF; Bojesen, SE; Siddiq, A; FitzGerald, LM; Kolb, S; Kwon, EM; Karyadi, DM; Blot, WJ; Zheng, W; Cai, QY; McDonnell, SK; Rinckleb, AE; Drake, B; Colditz, G; Wokolorczyk, D; Stephenson, RA; Teerlink, C; Muller, H; Rothenbacher, D; Sellers, TA; Lin, HY; Slavov, C; Mitev, V; Lose, F; Srinivasan, S; Maia, S; Paulo, P; Lange, E; Cooney, KA; Antoniou, AC; Vincent, D; Bacot, F; Tessier, DC; Kote-Jarai, Z; Easton, DF				Eeles, Rosalind A.; Al Olama, Ali Amin; Benlloch, Sara; Saunders, Edward J.; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Ghoussaini, Maya; Luccarini, Craig; Dennis, Joe; Jugurnauth-Little, Sarah; Dadaev, Tokhir; Neal, David E.; Hamdy, Freddie C.; Donovan, Jenny L.; Muir, Ken; Giles, Graham G.; Severi, Gianluca; Wiklund, Fredrik; Gronberg, Henrik; Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Le Marchand, Loic; Lindstrom, Sara; Kraft, Peter; Hunter, David J.; Gapstur, Susan; Chanock, Stephen J.; Berndt, Sonja I.; Albanes, Demetrius; Andriole, Gerald; Schleutker, Johanna; Weischer, Maren; Canzian, Federico; Riboli, Elio; Key, Tim J.; Travis, Ruth C.; Campa, Daniele; Ingles, Sue A.; John, Esther M.; Hayes, Richard B.; Pharoah, Paul D. P.; Pashayan, Nora; Khaw, Kay-Tee; Stanford, Janet L.; Ostrander, Elaine A.; Signorello, Lisa B.; Thibodeau, Stephen N.; Schaid, Dan; Maier, Christiane; Vogel, Walther; Kibel, Adam S.; Cybulski, Cezary; Lubhiski, Jan; Cannon-Albright, Lisa; Brenner, Hermann; Park, Jong Y.; Kaneva, Radka; Batra, Jyotsna; Spurdle, Amanda B.; Clements, Judith A.; Teixeira, Manuel R.; Dicks, Ed; Lee, Andrew; Dunning, Alison M.; Baynes, Caroline; Conroy, Don; Maranian, Melanie J.; Ahmed, Shahana; Govindasami, Koveela; Guy, Michelle; Wilkinson, Rosemary A.; Sawyer, Emma J.; Morgan, Angela; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas J.; Woodhouse, Christopher J.; Thompson, Alan; Dudderidge, Tim; Ogden, Chris; Cooper, Colin S.; Lophatananon, Artitaya; Cox, Angela; Southey, Melissa C.; Hopper, John L.; English, Dallas R.; Aly, Markus; Adolfsson, Jan; Xu, Jiangfeng; Zheng, Siqun L.; Yeager, Meredith; Kaaks, Rudolf; Diver, W. Ryan; Gaudet, Mia M.; Stern, Mariana C.; Corral, Roman; Joshi, Amit D.; Shahabi, Ahva; Wahlfors, Tiina; Tammela, Teuvo L. J.; Auvinen, Anssi; Virtamo, Jarmo; Klarskov, Peter; Nordestgaard, Borge G.; Roder, M. Andreas; Nielsen, Sune F.; Bojesen, Stig E.; Siddiq, Afshan; FitzGerald, Liesel M.; Kolb, Suzanne; Kwon, Erika M.; Karyadi, Danielle M.; Blot, William J.; Zheng, Wei; Cai, Qiuyin; McDonnell, Shannon K.; Rinckleb, Antje E.; Drake, Bettina; Colditz, Graham; Wokolorczyk, Dominika; Stephenson, Robert A.; Teerlink, Craig; Muller, Heiko; Rothenbacher, Dietrich; Sellers, Thomas A.; Lin, Hui-Yi; Slavov, Chavdar; Mitev, Vanio; Lose, Felicity; Srinivasan, Srilakshmi; Maia, Sofia; Paulo, Paula; Lange, Ethan; Cooney, Kathleen A.; Antoniou, Antonis C.; Vincent, Daniel; Bacot, Francois; Tessier, Daniel C.; Kote-Jarai, Zsofia; Easton, Douglas F.		COGS-Canc Res UK GWAS-ELLIPSE Part; Australian Prostate Canc; UK Genetic Prostate Canc Study; UK ProtecT Prostate Testing Canc; PRACTICAL Prostate Canc Assoc Grp	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; HOXB13; PREDISPOSITION; MUTATIONS; MEN	Prostate cancer is the most frequently diagnosed cancer in males in developed countries. To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a custom II lumina array (iCOGS) in blood DNA from 25,074 prostate cancer cases and 24,272 controls from the international PRACTICAL Consortium. Twenty-three new prostate cancer susceptibility loci were identified at genomewide significance (P < 5 x 10(-8)). More than 70 prostate cancer susceptibility loci, explaining similar to 30% of the familial risk for this disease, have now been identified. On the basis of combined risks conferred by the new and previously known risk loci, the top 1% of the risk distribution has a 4.7-fold higher risk than the average of the population being profiled. These results will facilitate population risk stratification for clinical studies.	[Eeles, Rosalind A.; Saunders, Edward J.; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Jugurnauth-Little, Sarah; Dadaev, Tokhir; Govindasami, Koveela; Guy, Michelle; Wilkinson, Rosemary A.; Sawyer, Emma J.; Morgan, Angela; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin S.; Kote-Jarai, Zsofia] Inst Canc Res, Sutton, Surrey, England; [Eeles, Rosalind A.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas J.; Woodhouse, Christopher J.; Thompson, Alan; Dudderidge, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv NHS Fdn, London, England; [Eeles, Rosalind A.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas J.; Woodhouse, Christopher J.; Thompson, Alan; Dudderidge, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv NHS Fdn, Sutton, Surrey, England; [Al Olama, Ali Amin; Benlloch, Sara; Ghoussaini, Maya; Luccarini, Craig; Dennis, Joe; Pharoah, Paul D. P.; Pashayan, Nora; Dicks, Ed; Lee, Andrew; Dunning, Alison M.; Baynes, Caroline; Conroy, Don; Maranian, Melanie J.; Ahmed, Shahana; Antoniou, Antonis C.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Neal, David E.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Hamdy, Freddie C.] Univ Oxford, John Radcliffe Hosp, Fac Med Sci, Oxford OX3 9DU, England; [Donovan, Jenny L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Muir, Ken; Lophatananon, Artitaya] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Muir, Ken] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Giles, Graham G.; Severi, Gianluca; English, Dallas R.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Giles, Graham G.; Severi, Gianluca; Hopper, John L.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Wiklund, Fredrik; Gronberg, Henrik; Aly, Markus] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Ingles, Sue A.; Stern, Mariana C.; Corral, Roman; Joshi, Amit D.; Shahabi, Ahva] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Lindstrom, Sara; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Gapstur, Susan; Diver, W. Ryan; Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Chanock, Stephen J.; Berndt, Sonja I.; Yeager, Meredith] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Albanes, Demetrius] NCI, Nutr Epidemiol Branch, US NIH, Bethesda, MD 20892 USA; [Andriole, Gerald; Drake, Bettina; Colditz, Graham] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Schleutker, Johanna; Wahlfors, Tiina] Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland; [Schleutker, Johanna; Wahlfors, Tiina] FimLab Labs, Tampere, Finland; [Schleutker, Johanna] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Weischer, Maren; Nordestgaard, Borge G.; Nielsen, Sune F.; Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Canzian, Federico; Campa, Daniele] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Key, Tim J.; Travis, Ruth C.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [John, Esther M.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Hayes, Richard B.] NYU, Dept Environm Med, Langone Med Ctr, Div Epidemiol, New York, NY 10016 USA; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Stanford, Janet L.; FitzGerald, Liesel M.; Kolb, Suzanne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Ostrander, Elaine A.; Kwon, Erika M.; Karyadi, Danielle M.] NHGRI, US NIH, Bethesda, MD 20892 USA; [Signorello, Lisa B.; Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Signorello, Lisa B.; Blot, William J.; Zheng, Wei; Cai, Qiuyin] Vanderbilt Univ, Sch Med, Dept Med,Div Epidemiol, Vanderbilt Epidemiol Ctr,Vanderbilt Ingram Canc C, Nashville, TN 37212 USA; [Thibodeau, Stephen N.; McDonnell, Shannon K.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Schaid, Dan] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Maier, Christiane; Rinckleb, Antje E.] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Maier, Christiane; Vogel, Walther; Rinckleb, Antje E.] Univ Hosp Ulm, Inst Human Genet, Ulm, Germany; [Kibel, Adam S.] Brigham & Womens Hosp, Div Urol Surg, Dana Farber Canc Inst, Boston, MA 02115 USA; [Cybulski, Cezary; Lubhiski, Jan; Wokolorczyk, Dominika] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Cannon-Albright, Lisa; Teerlink, Craig] Univ Utah, Sch Med, Dept Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa; Stephenson, Robert A.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Brenner, Hermann; Muller, Heiko; Rothenbacher, Dietrich] DKFZ, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Park, Jong Y.; Sellers, Thomas A.; Lin, Hui-Yi] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA; [Kaneva, Radka; Mitev, Vanio] Med Univ Sofia, Mol Med Ctr, Dept Med Chem & Biochem, Sofia, Bulgaria; [Batra, Jyotsna; Clements, Judith A.; Srinivasan, Srilakshmi] Queensland Univ Technol, Australian Prostate Canc Res Ctr, Queensland Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Batra, Jyotsna; Clements, Judith A.; Srinivasan, Srilakshmi] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Spurdle, Amanda B.; Lose, Felicity] Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia; [Teixeira, Manuel R.; Maia, Sofia; Paulo, Paula] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal; [Teixeira, Manuel R.; Maia, Sofia; Paulo, Paula] Univ Porto, Abel Salazar Biomed Sci Inst ICBAS, P-4100 Oporto, Portugal; [Cooper, Colin S.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cox, Angela] Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Sheffield, S Yorkshire, England; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Aly, Markus] Karolinska Inst, Danderyd Hosp, Div Urol, Dept Clin Sci, Stockholm, Sweden; [Adolfsson, Jan] Karolinska Inst, Reg Canc Ctr, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Xu, Jiangfeng] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Zheng, Siqun L.] Wake Forest Univ Hlth Sci, Ctr Canc Genom, Genom Genotyping Lab, Winston Salem, NC USA; [Yeager, Meredith] NCI, Core Genotyping Facil, SAIC Frederick, US NIH, Gaithersburg, MD USA; [Kaaks, Rudolf] DKFZ, Div Canc Epidemiol, Heidelberg, Germany; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Dept Epidemiol, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Klarskov, Peter] Copenhagen Univ Hosp, Herlev Hosp, Dept Urol, Herlev, Denmark; [Roder, M. Andreas] Copenhagen Univ Hosp, Rigshosp, Dept Urol, Copenhagen, Denmark; [Siddiq, Afshan] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Stephenson, Robert A.] Huntsman Canc Inst, Salt Lake City, UT USA; [Slavov, Chavdar] Med Univ Sofia, Alexandrovska Univ Hosp, Dept Urol, Sofia, Bulgaria; [Lange, Ethan] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Cooney, Kathleen A.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI USA; [Vincent, Daniel; Bacot, Francois; Tessier, Daniel C.] McGill Univ, Montreal, PQ, Canada; [Vincent, Daniel; Bacot, Francois; Tessier, Daniel C.] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Oxford; University of Oxford; University of Bristol; University of Warwick; University of Manchester; Cancer Council Victoria; University of Melbourne; Karolinska Institutet; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Harvard T.H. Chan School of Public Health; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Tampere University; University of Turku; University of Copenhagen; Herlev & Gentofte Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; University of Oxford; Cancer Prevention Institute of California; Stanford Cancer Institute; Stanford University; Stanford University; New York University; NYU Langone Medical Center; University of Cambridge; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Vanderbilt University; Mayo Clinic; Mayo Clinic; Ulm University; Ulm University; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Pomeranian Medical University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Helmholtz Association; German Cancer Research Center (DKFZ); H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Medical University Sofia; Queensland University of Technology (QUT); Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Portuguese Institute of Oncology; Universidade do Porto; University of East Anglia; University of Sheffield; University of Melbourne; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Helmholtz Association; German Cancer Research Center (DKFZ); Tampere University; Tampere University Hospital; Tampere University; Tampere University; Finland National Institute for Health & Welfare; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Imperial College London; Huntsman Cancer Institute; Medical University Sofia; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; McGill University	Eeles, RA (corresponding author), Inst Canc Res, Sutton, Surrey, England.	rosalind.eeles@icr.ac.uk	Albanes, Demetrius/B-9749-2015; Srilakshmi, Srinivasan/AAR-5334-2021; Kaneva, Radka P/V-6535-2017; Pharoah, Paul/V-6658-2019; Kaneva, Radka/AAT-5322-2021; Batra, Jyotsna/B-4130-2011; Campa, Daniele/K-1617-2016; Kaneva, Radka P/AGS-5076-2022; Severi, Gianluca/H-3774-2018; Nordestgaard, Borge Gronne/ABF-1310-2020; Brenner, Hermann/ABE-6383-2020; Severi, Gianluca/Q-1824-2019; Dudderidge, Tim/AAO-1430-2020; Auvinen, Anssi/AAD-9311-2020; Zheng, Wei/O-3351-2013; Paulo, Paula/F-1441-2016; Teixeira, Manuel António Rodrigues/E-4885-2011; Colditz, Graham/A-3963-2009; Røder, M. Andreas/H-7701-2019; Diver, Ryan/AAG-3469-2019; Spurdle, Amanda B/A-4978-2011; Canzian, Federico/I-2804-2014; Berndt, Sonja I/J-8423-2016; Brenner, Hermann/B-4627-2017; zhang, weihua/GXV-1334-2022; Schumacher, Fredrick/R-6043-2019; Dearnaley, David P/J-2318-2014; Auvinen, Anssi/AAL-2111-2020; Drake, Bettina/O-2072-2019; Teixeira, Manuel AC/AAZ-7251-2020; English, Dallas/AAH-5005-2019; Yeager, Meredith/AAA-5322-2020; Khaw, Kay-Tee/AAZ-3209-2021; Wahlfors, Tiina/U-7635-2018	Kaneva, Radka P/0000-0002-1437-1393; Pharoah, Paul/0000-0001-8494-732X; Campa, Daniele/0000-0003-3220-9944; Kaneva, Radka P/0000-0002-1437-1393; Severi, Gianluca/0000-0001-7157-419X; Brenner, Hermann/0000-0002-6129-1572; Severi, Gianluca/0000-0001-7157-419X; Zheng, Wei/0000-0003-1226-070X; Paulo, Paula/0000-0001-8387-2127; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Colditz, Graham/0000-0002-7307-0291; Røder, M. Andreas/0000-0002-0019-5333; Diver, Ryan/0000-0002-5418-9000; Spurdle, Amanda B/0000-0003-1337-7897; Brenner, Hermann/0000-0002-6129-1572; Schumacher, Fredrick/0000-0002-3073-7463; Dearnaley, David P/0000-0002-3954-2806; Auvinen, Anssi/0000-0003-1125-4818; Drake, Bettina/0000-0001-9340-5848; Teixeira, Manuel AC/0000-0002-1959-0624; English, Dallas/0000-0001-7828-8188; Ostrander, Elaine/0000-0001-6075-9738; Cox, Angela/0000-0002-5138-1099; Wahlfors, Tiina/0000-0002-3910-796X; Lin, Hui-Yi/0000-0002-3307-5549; Mitev, Vanyo/0000-0001-7528-590X; Southey, Melissa/0000-0002-6313-9005; Neal, David/0000-0002-6033-5086; Dadaev, Tokhir/0000-0002-8268-0438; Rothenbacher, Dietrich/0000-0002-3563-2791; Riboli, Elio/0000-0001-6795-6080; Hayes, Richard/0000-0002-0918-661X; Aly, Markus/0000-0002-7602-9198; Dennis, Joe/0000-0003-4591-1214; Canzian, Federico/0000-0002-4261-4583; Schleutker, Johanna/0000-0002-1863-0305; Clements, Judith/0000-0001-6026-1964; McDonnell, Shannon/0000-0001-6201-369X; Adolfsson, Jan/0000-0003-2992-1869; huddart, robert/0000-0003-3604-1990; albright, lisa/0000-0003-2602-3668; Pashayan, Nora/0000-0003-0843-2468; Lubinski, Jan/0000-0003-2931-3003; Saunders, Ed/0000-0003-4343-3570; Giles, Graham/0000-0003-4946-9099; Dunning, Alison Margaret/0000-0001-6651-7166; batra, Jyotsna/0000-0003-4646-6247; Bojesen, Stig/0000-0002-4061-4133; Lose, Felicity/0000-0001-8337-3547; Eeles, Rosalind/0000-0002-3698-6241; Cooney, Kathleen/0000-0003-3831-6943; Hamdy, Freddie/0000-0003-2627-2154; FitzGerald, Liesel/0000-0002-6882-2698; Siddiq, Afshan/0000-0002-9110-1434; van As, Nicholas/0000-0001-6829-8788; Teerlink, Craig/0000-0002-1992-2326; Dudderidge, Tim/0000-0001-6373-3613; Nordestgaard, Borge/0000-0002-1954-7220; Karyadi, Danielle/0000-0003-4164-5625; Leongamornlert, Daniel/0000-0002-3486-3168	Cancer Research UK [11174, 10124, 13065, 10588, 11022, 14136, 10118] Funding Source: Medline; Intramural NIH HHS [ZIA CP010195-06, Z99 CA999999] Funding Source: Medline; Medical Research Council [G0401527, G1000143, G0900871] Funding Source: Medline; NCATS NIH HHS [TL1 TR000132] Funding Source: Medline; NCI NIH HHS [P30 CA076292, P30 CA042014, R01 CA092579, R01 CA092447] Funding Source: Medline; NIGMS NIH HHS [T32 GM007814] Funding Source: Medline; Prostate Cancer UK [G2011/36] Funding Source: Medline; MRC [G0900871] Funding Source: UKRI; Cancer Research UK [15007, 16565, 16561] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA082664, R01CA092447, R01CA056678, ZIACP010201, R01CA092579, P30CA042014, P30CA076292] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000132] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Prostate Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akamatsu S, 2012, NAT GENET, V44, P426, DOI 10.1038/ng.1104; Al Olama AA, 2013, HUM MOL GENET, V22, P408, DOI 10.1093/hmg/dds425; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Callen DF, 2010, ONCOL REP, V23, P1045, DOI 10.3892/or_00000731; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards S, 2005, BRIT J CANCER, V92, P376, DOI 10.1038/sj.bjc.6602261; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Koutros S, 2010, CANCER RES, V70, P2389, DOI 10.1158/0008-5472.CAN-09-3575; MacInnis RJ, 2011, GENET EPIDEMIOL, V35, P549, DOI 10.1002/gepi.20605; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Sun T, 2010, CLIN CANCER RES, V16, P5244, DOI 10.1158/1078-0432.CCR-10-1261; Szarvas T, 2011, INT J CANCER, V128, P1486, DOI 10.1002/ijc.25454; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424	29	426	431	0	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					385	391		10.1038/ng.2560	http://dx.doi.org/10.1038/ng.2560			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23535732	Green Accepted, Green Submitted			2022-12-17	WOS:000316840600008
J	Repapi, E; Sayers, I; Wain, LV; Burton, PR; Johnson, T; Obeidat, M; Zhao, JH; Ramasamy, A; Zhai, GJ; Vitart, V; Huffman, JE; Igl, W; Albrecht, E; Deloukas, P; Henderson, J; Granell, R; McArdle, WL; Rudnicka, AR; Barroso, I; Loos, RJF; Wareham, NJ; Mustelin, L; Rantanen, T; Surakka, I; Imboden, M; Wichmann, HE; Grkovic, I; Jankovic, S; Zgaga, L; Hartikainen, AL; Peltonen, L; Gyllensten, U; Johansson, A; Zaboli, G; Campbell, H; Wild, SH; Wilson, JF; Glaser, S; Homuth, G; Volzke, H; Mangino, M; Soranzo, N; Spector, TD; Polasek, O; Rudan, I; Wright, AF; Heliovaara, M; Ripatti, S; Pouta, A; Naluai, AT; Olin, AC; Toren, K; Cooper, MN; James, AL; Palmer, LJ; Hingorani, AD; Wannamethee, SG; Whincup, PH; Smith, GD; Ebrahim, S; McKeever, TM; Pavord, ID; MacLeod, AK; Morris, AD; Porteous, DJ; Cooper, C; Dennison, E; Shaheen, S; Karrasch, S; Schnabel, E; Schulz, H; Grallert, H; Bouatia-Naji, N; Delplanque, J; Froguel, P; Blakey, JD; Britton, JR; Morris, RW; Holloway, JW; Lawlor, DA; Hui, J; Nyberg, F; Jarvelin, MR; Jackson, C; Kahonen, M; Kaprio, J; Probst-Hensch, NM; Koch, B; Hayward, C; Evans, DM; Elliott, P; Strachan, DP; Hall, IP; Tobin, MD				Repapi, Emmanouela; Sayers, Ian; Wain, Louise V.; Burton, Paul R.; Johnson, Toby; Obeidat, Ma'en; Zhao, Jing Hua; Ramasamy, Adaikalavan; Zhai, Guangju; Vitart, Veronique; Huffman, Jennifer E.; Igl, Wilmar; Albrecht, Eva; Deloukas, Panos; Henderson, John; Granell, Raquel; McArdle, Wendy L.; Rudnicka, Alicja R.; Barroso, Ines; Loos, Ruth J. F.; Wareham, Nicholas J.; Mustelin, Linda; Rantanen, Taina; Surakka, Ida; Imboden, Medea; Wichmann, H. Erich; Grkovic, Ivica; Jankovic, Stipan; Zgaga, Lina; Hartikainen, Anna-Liisa; Peltonen, Leena; Gyllensten, Ulf; Johansson, Asa; Zaboli, Ghazal; Campbell, Harry; Wild, Sarah H.; Wilson, James F.; Glaeser, Sven; Homuth, Georg; Voelzke, Henry; Mangino, Massimo; Soranzo, Nicole; Spector, Tim D.; Polasek, Ozren; Rudan, Igor; Wright, Alan F.; Heliovaara, Markku; Ripatti, Samuli; Pouta, Anneli; Naluai, Asa Torinsson; Olin, Anna-Carin; Toren, Kjell; Cooper, Matthew N.; James, Alan L.; Palmer, Lyle J.; Hingorani, Aroon D.; Wannamethee, S. Goya; Whincup, Peter H.; Smith, George Davey; Ebrahim, Shah; McKeever, Tricia M.; Pavord, Ian D.; MacLeod, Andrew K.; Morris, Andrew D.; Porteous, David J.; Cooper, Cyrus; Dennison, Elaine; Shaheen, Seif; Karrasch, Stefan; Schnabel, Eva; Schulz, Holger; Grallert, Harald; Bouatia-Naji, Nabila; Delplanque, Jerome; Froguel, Philippe; Blakey, John D.; Britton, John R.; Morris, Richard W.; Holloway, John W.; Lawlor, Debbie A.; Hui, Jennie; Nyberg, Fredrik; Jarvelin, Marjo-Riitta; Jackson, Cathy; Kahonen, Mika; Kaprio, Jaakko; Probst-Hensch, Nicole M.; Koch, Beate; Hayward, Caroline; Evans, David M.; Elliott, Paul; Strachan, David P.; Hall, Ian P.; Tobin, Martin D.		Wellcome Trust Case Control Consor; NSHD Resp Study Team	Genome-wide association study identifies five loci associated with lung function	NATURE GENETICS			English	Article							ADVANCED GLYCATION ENDPRODUCTS; IDIOPATHIC PULMONARY-FIBROSIS; IN-VITRO; RECEPTOR; HEIGHT; HEALTH; POPULATION; MORTALITY; VARIANTS; CANCER	Pulmonary function measures are heritable traits that predict morbidity and mortality and define chronic obstructive pulmonary disease (COPD). We tested genome-wide association with forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) in the SpiroMeta consortium (n = 20,288 individuals of European ancestry). We conducted a meta-analysis of top signals with data from direct genotyping (n <= 32,184 additional individuals) and in silico summary association data from the CHARGE Consortium (n = 21,209) and the Health 2000 survey (n < 883). We confirmed the reported locus at 4q31 and identified associations with FEV1 or FEV1/FVC and common variants at five additional loci: 2q35 in TNS1 (P = 1.11 x 10(-12)), 4q24 in GSTCD (2.18 x 10(-23)), 5q33 in HTR4 (P = 4.29 x 10(-9)), 6p21 in AGER (P = 3.07 x 10(-15)) and 15q23 in THSD4 (P = 7.24 x 10(-15)). mRNA analyses showed expression of TNS1, GSTCD, AGER, HTR4 and THSD4 in human lung tissue. These associations offer mechanistic insight into pulmonary function regulation and indicate potential targets for interventions to alleviate respiratory disease.	[Repapi, Emmanouela; Wain, Louise V.; Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Repapi, Emmanouela; Wain, Louise V.; Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Sayers, Ian; Obeidat, Ma'en; Blakey, John D.; Hall, Ian P.] Univ Nottingham Hosp, Nottingham Resp Biomed Res Unit, Div Therapeut & Mol Med, Nottingham NG7 2UH, England; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Ramasamy, Adaikalavan; Shaheen, Seif] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Ramasamy, Adaikalavan; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Zhai, Guangju; Mangino, Massimo; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Vitart, Veronique; Huffman, Jennifer E.; Wright, Alan F.; Hayward, Caroline] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Igl, Wilmar; Gyllensten, Ulf; Johansson, Asa; Zaboli, Ghazal] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Albrecht, Eva; Wichmann, H. Erich; Schnabel, Eva; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Deloukas, Panos; Barroso, Ines; Peltonen, Leena; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Henderson, John] Univ Bristol, Dept Community Based Med, Bristol, Avon, England; [McArdle, Wendy L.] Univ Bristol, Avon Longitudinal Study Parents & Children Lab, Dept Social Med, Bristol, Avon, England; [Rudnicka, Alicja R.; Whincup, Peter H.; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London, England; [Mustelin, Linda; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Rantanen, Taina] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Rantanen, Taina] Univ Jyvaskyla, Finnish Ctr Interdisciplinary Gerontol, Jyvaskyla, Finland; [Surakka, Ida; Peltonen, Leena; Ripatti, Samuli; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Surakka, Ida; Peltonen, Leena; Heliovaara, Markku; Ripatti, Samuli] Natl Inst Hlth & Welf, Helsinki, Finland; [Imboden, Medea; Probst-Hensch, Nicole M.] Univ Zurich, Inst Social & Prevent Med, Dept Chron Dis Epidemiol NICER, CH-8006 Zurich, Switzerland; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Grkovic, Ivica; Jankovic, Stipan; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Zgaga, Lina; Polasek, Ozren] Univ Zagreb, Fac Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Campbell, Harry; Wild, Sarah H.; Wilson, James F.; Rudan, Igor] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Glaeser, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med Cardiol Intens Care Pulm Med &, Greifswald, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, SHIP Clin Edidemiol Res, Greifswald, Germany; [Polasek, Ozren; Rudan, Igor] Gen Info, Zagreb, Croatia; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Naluai, Asa Torinsson] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden; [Cooper, Matthew N.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol, W Australian Sleep Disorders Res Inst, Perth, WA, Australia; [Olin, Anna-Carin; Toren, Kjell; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [James, Alan L.; Palmer, Lyle J.; Hui, Jennie] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Perth, WA, Australia; [Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Wannamethee, S. Goya; Morris, Richard W.] UCL, Dept Primary Care & Populat Hlth, London, England; [Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommunicable Dis Epidemiol Unit, London WC1, England; [McKeever, Tricia M.] Univ Nottingham, Sch Community Hlth Sci, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [McKeever, Tricia M.] Univ Nottingham, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Pavord, Ian D.] Univ Hosp Leicester Natl Hlth Serv Trust, Glenfield Hosp, Inst Lung Hlth, Leicester, Leics, England; [MacLeod, Andrew K.; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Mol Med,Med Genet Sect, Edinburgh, Midlothian, Scotland; [Morris, Andrew D.] Univ Dundee, Biomed Res Inst, Ninewells Hosp, Dundee, Scotland; [Cooper, Cyrus; Dennison, Elaine] Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Cooper, Cyrus] Univ Oxford, NIHR, Musculoskeletal Biomed Res Unit, Oxford, England; [Karrasch, Stefan; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Neuherberg, Germany; [Bouatia-Naji, Nabila; Delplanque, Jerome; Froguel, Philippe] Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London, England; [NSHD Resp Study Team] MRC Natl Survey Hlth & Dev, MRC Unit Lifelong Hlth & Ageing, London, England; [Holloway, John W.] Univ Southampton, Southampton Gen Hosp, Sch Med, Infect Inflammat & Immun Div, Southampton, Hants, England; [Holloway, John W.] Univ Southampton, Southampton Gen Hosp, Sch Med, Div Human Genet, Southampton, Hants, England; [Hui, Jennie] PathW lab Med WA, Nedlands, WA, Australia; [Nyberg, Fredrik] AstraZeneca Res & Dev, Molndal, Sweden; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jackson, Cathy] Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Probst-Hensch, Nicole M.] Univ Basel, Inst Social & Prevent Med, Swiss Trop Inst, Basel, Switzerland; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC, HPA, Ctr Environm & Hlth, London, England	University of Leicester; University of Leicester; University of Nottingham; University of London; Queen Mary University London; University of Cambridge; Imperial College London; Imperial College London; University of London; King's College London; University of Edinburgh; Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wellcome Trust Sanger Institute; University of Bristol; University of Bristol; St Georges University London; University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; Finland National Institute for Health & Welfare; University of Zurich; University of Munich; University of Munich; University of Split; University of Zagreb; University of Oulu; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Finland National Institute for Health & Welfare; University of Gothenburg; University of Western Australia; University of Western Australia; University of Gothenburg; University of Western Australia; University of London; University College London; University of London; University College London; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; University of Nottingham; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Edinburgh; University of Dundee; University of Southampton; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Imperial College London; University of Southampton; University of Southampton; University of Western Australia; AstraZeneca; University of Oulu; University of Oulu; University of St Andrews; Tampere University; Tampere University; Tampere University Hospital; University of Basel; Swiss Tropical & Public Health Institute; Health Protection Agency; Imperial College London	Tobin, MD (corresponding author), Univ Leicester, Dept Hlth Sci, Adrian Bldg, Leicester, Leics, England.	ian.hall@nottingham.ac.uk; mt47@leicester.ac.uk	Davey Smith, George/A-7407-2013; Wilson, James F/A-5704-2009; Burton, Paul R/H-7527-2016; Hayward, Caroline/M-8818-2016; Palmer, Lyle John/K-3196-2014; Olin, Anna-Carin/ABH-2627-2021; Schulz, Holger/J-5643-2015; Loos, Ruth J F/Q-2862-2016; Naluai, Åsa Torinsson/P-3269-2015; Cooper, Matthew N/J-4420-2014; Loos, Ruth/GON-5877-2022; Kaprio, Jaakko/A-1820-2008; Holloway, John W/B-5424-2009; FROGUEL, Philippe/O-6799-2017; Naluai, Åsa Torinsson/AAB-2166-2021; Grallert, Harald/B-3424-2013; Mangino, Massimo/F-5134-2011; Pinheiro, Maísa/E-7424-2012; Granell, Raquel/AAB-5256-2022; Palmer, Lyle John/N-1948-2019; Wichmann, Heinz Erich/AAA-5695-2022; Ramasamy, Adaikalavan/G-2632-2010; Porteous, David J/C-7289-2013; Rantanen, Taina/O-6579-2016; Deloukas, Panos/B-2922-2013; Spector, Tim D/F-6533-2012; Porteous, David/AAA-3446-2021; Evans, David M/H-6325-2013; Zgaga, Lina/Q-9415-2018; Bouatia-Naji, Nabila/AGF-1400-2022; Polasek, Ozren/B-6002-2011; Rudan, Igor/I-1467-2012; Granell, Raquel/AAY-4846-2020; Janković, Stipan/E-3315-2017; Ripatti, Samuli/H-9446-2014; Hui, Jennie/A-9543-2013; Grković, Ivica/D-8728-2017; Johansson, Åsa/G-5270-2011; jackson, cathy/H-4869-2013; Johansson, Åsa/AAG-6799-2021; BOUATIA-NAJI, NABILA/D-5863-2013; Campbell, Harry/E-2959-2010; Karrasch, Stefan/GQI-2691-2022; MacLeod, Andrew/Q-8655-2016	Davey Smith, George/0000-0002-1407-8314; Wilson, James F/0000-0001-5751-9178; Hayward, Caroline/0000-0002-9405-9550; Palmer, Lyle John/0000-0002-1628-3055; Schulz, Holger/0000-0002-1157-200X; Loos, Ruth J F/0000-0002-8532-5087; Naluai, Åsa Torinsson/0000-0002-0504-6492; Cooper, Matthew N/0000-0003-1139-3682; Kaprio, Jaakko/0000-0002-3716-2455; Holloway, John W/0000-0001-9998-0464; FROGUEL, Philippe/0000-0003-2972-0784; Naluai, Åsa Torinsson/0000-0002-0504-6492; Mangino, Massimo/0000-0002-2167-7470; Granell, Raquel/0000-0002-4890-4012; Palmer, Lyle John/0000-0002-1628-3055; Ramasamy, Adaikalavan/0000-0002-7598-2892; Porteous, David J/0000-0003-1249-6106; Rantanen, Taina/0000-0002-1604-1945; Deloukas, Panos/0000-0001-9251-070X; Porteous, David/0000-0003-1249-6106; Evans, David M/0000-0003-0663-4621; Zgaga, Lina/0000-0003-4089-9703; Bouatia-Naji, Nabila/0000-0001-5424-2134; Polasek, Ozren/0000-0002-5765-1862; Rudan, Igor/0000-0001-6993-6884; Ripatti, Samuli/0000-0002-0504-1202; Hui, Jennie/0000-0002-1653-2496; Grković, Ivica/0000-0001-9010-2091; Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498; Campbell, Harry/0000-0002-6169-6262; Wain, Louise/0000-0003-4951-1867; Barroso, Ines/0000-0001-5800-4520; Elliott, Paul/0000-0002-7511-5684; /0000-0001-8085-0731; Lawlor, Debbie A/0000-0002-6793-2262; MacLeod, Andrew/0000-0003-3298-5193; Surakka, Ida/0000-0002-6669-5541; s, hema/0000-0002-3440-9475; Cooper, Cyrus/0000-0003-3510-0709; Dennison, Elaine/0000-0002-3048-4961; Wannamethee, Sasiwarang/0000-0001-9484-9977; Hingorani, Aroon/0000-0001-8365-0081; Whincup, Peter/0000-0002-5589-4107; McKeever, Tricia/0000-0003-0914-0416; Nyberg, Fredrik/0000-0003-0892-5668; Rudnicka, Alicja R/0000-0003-0369-8574; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Morris, Richard/0000-0001-7240-4563; Pavord, Ian/0000-0002-4288-5973; Hall, Ian/0000-0001-9933-3216; Johnson, Toby/0000-0002-5998-3270; Sayers, Ian/0000-0001-5601-5410; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Soranzo, Nicole/0000-0003-1095-3852; Kahonen, Mika/0000-0002-4510-7341; Tobin, Martin/0000-0002-3596-7874	Academy of Finland [104781, 120315, 1114194]; Center of Excellence in Complex Disease Genetics; Arthritis Research Campaign; Asthma UK; AstraZeneca; Biocenter Oulu, University of Oulu; Biocentrum Helsinki; Biotechnology and Biological Sciences Research Council; British Heart Foundation [PG/06/154/22043, PG/97012, FS05/125]; British Lung Foundation; Cancer Research United Kingdom; Chief Scientists Office, part of the Scottish Government Health Directorate [CZD/16/6]; Department of Health Air Pollution PRP [0020029]; ENGAGE [HEALTH-F4-2007-201413]; European Commission [FP-5/QLG1-CT-2000-01643, FP-7/2007-2013, FP-6 LSHB-CT-2006-018996, FP-6 LSHG-CT-2006-01947, HEALTH-F2-2008-201865-GEFOS, QLG2-CT-2002-01254]; Finnish Ministry of Education; German Federal Ministry of Education and Research (BMBF) [01ZZ96030, 01ZZ0701, 01GI0883]; German Asthma and COPD Network (COSYCONET) [01GI0883]; German Ministry for Education, Research and Cultural Affairs; German National Genome Research Network; Healthway, Western Australia; HEFCE Science Research Investment Fund; Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; International Osteoporosis Foundation; Juvenile Diabetes Research Foundation International; Leicester Biomedical Research Unit in Cardiovascular Science (NIHR); Medical Research Council UK [G0500539, G0501942, G0000943, G990146]; Medical Research Fund of the Tampere University Hospital; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; MRC Human Genetics Unit; Munich Center of Health Sciences, as part of LMUinnovativ; National Human Genome Research Institute; National Institute for Health Research comprehensive Biomedical Research Centre; St. Thomas' NHS Foundation Trust; National Institute for Health; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/013/25942] Funding Source: researchfish; Medical Research Council [U1475000001, G0600717B, G9815508, G0000934, G9900991B, MC_UP_A620_1014, MC_U127561128, MC_U123092721, G0401540, G0902125, MC_U123092720, G0801056B, G0801056, MC_U106179471, G0600705, G0800582, G0600331, G0501942, MC_U106188470] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/2, CZB/4/710] Funding Source: researchfish; MRC [G0000934, MC_U127561128, MC_U123092720, G0600331, MC_U106188470, G0501942, G0902125, G0600705, G0801056, MC_U123092721, G0401540, G0800582] Funding Source: UKRI	Academy of Finland(Academy of Finland); Center of Excellence in Complex Disease Genetics(Academy of Finland); Arthritis Research Campaign(Versus Arthritis); Asthma UK; AstraZeneca(AstraZeneca); Biocenter Oulu, University of Oulu; Biocentrum Helsinki; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); British Lung Foundation; Cancer Research United Kingdom(Cancer Research UK); Chief Scientists Office, part of the Scottish Government Health Directorate; Department of Health Air Pollution PRP; ENGAGE; European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Ministry of Education; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Asthma and COPD Network (COSYCONET); German Ministry for Education, Research and Cultural Affairs; German National Genome Research Network; Healthway, Western Australia; HEFCE Science Research Investment Fund; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health, Neuherberg, Germany; International Osteoporosis Foundation; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Leicester Biomedical Research Unit in Cardiovascular Science (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Fund of the Tampere University Hospital; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Munich Center of Health Sciences, as part of LMUinnovativ; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St. Thomas' NHS Foundation Trust; National Institute for Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the many colleagues who contributed to collection and phenotypic characterization of the clinical sampling, genotyping and analysis of the GWAS data. We especially thank those who kindly agreed to participate in the studies. Major funding for this work is from the following sources (in alphabetical order): Academy of Finland (including project grants 104781, 120315 and 1114194) and Center of Excellence in Complex Disease Genetics; Arthritis Research Campaign; Asthma UK; AstraZeneca; Biocenter Oulu, University of Oulu; Biocentrum Helsinki; Biotechnology and Biological Sciences Research Council project grant; British Heart Foundation (including project grants PG/06/154/22043 and PG/97012 and Senior Research Fellowship FS05/125); British Lung Foundation; Cancer Research United Kingdom; Chief Scientists Office, part of the Scottish Government Health Directorate (including grant CZD/16/6); Department of Health Air Pollution PRP (ref. no. 0020029); ENGAGE project (HEALTH-F4-2007-201413); European Commission (EURO-BLCS, FP-5/QLG1-CT-2000-01643, FP-7/2007-2013, FP-6 LSHB-CT-2006-018996 (GABRIEL), FP-6 LSHG-CT-2006-01947 (EUROSPAN), HEALTH-F2-2008-201865-GEFOS and FP-5 GenomEUtwin project QLG2-CT-2002-01254); Finnish Ministry of Education; German Federal Ministry of Education and Research (BMBF, including grants 01ZZ96030, 01ZZ0701 and 01GI0883 and German Asthma and COPD Network (COSYCONET) grant 01GI0883); German Ministry for Education, Research and Cultural Affairs; German National Genome Research Network (NGFN-2 and NGFN-plus); Healthway, Western Australia; HEFCE Science Research Investment Fund; Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; International Osteoporosis Foundation; Juvenile Diabetes Research Foundation International; Leicester Biomedical Research Unit in Cardiovascular Science (NIHR); Medical Research Council UK (including grants G0500539, G0501942, G0000943 and G990146); Medical Research Fund of the Tampere University Hospital; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; MRC Human Genetics Unit; Munich Center of Health Sciences, as part of LMUinnovativ; National Human Genome Research Institute; National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute (grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01)); Oulu University Hospital; PHOEBE (FP6, LSHG-CT-2006-518418); Public Population Project in Genomics (Genome Canada and Genome Quebec), Republic of Croatia Ministry of Science, Education and Sports (research grant 108-1080315-0302); Royal Society; Siemens Health Care Sector; Swedish Heart and Lung Foundation (grant 20050561); Swedish Medical Research Council (project no.K2007-66X-20270-01-3); Swedish Research Council for Working Life and Social Research (FAS, grants 2001-0263 and 2003-0139); the Great Wine Estates of the Margaret River region of Western Australia; UBS Wealth Foundation (grant BA29s8Q7-DZZ); UK Department of Health Policy Research Programme; University of Nottingham; University of Bristol; US National Institutes of Health (U01 DK062418); US National Institutes of Health-National Institute of Mntal Health (5R01MH63706: 02);; Wellcome Trust including grants 068545/Z/02, 076113/B/04/Z, 079895, 077016/Z/05/Z, 075883 and 086160/Z/08/A); and Zentren fur Innovationskompetenz (BMBF grant 03ZIK012).	Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bayer H, 2007, AM J RESP CELL MOL, V36, P85, DOI 10.1165/rcmb.2006-0151OC; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupont LJ, 1999, EUR RESPIR J, V14, P642, DOI 10.1034/j.1399-3003.1999.14c26.x; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HUBERT HB, 1982, AM REV RESPIR DIS, V125, P409; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; LEWITTER FI, 1984, AM J EPIDEMIOL, V120, P518, DOI 10.1093/oxfordjournals.aje.a113912; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Manzke T, 2003, SCIENCE, V301, P226, DOI 10.1126/science.1084674; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCCLEARN GE, 1994, J GERONTOL, V49, pM264, DOI 10.1093/geronj/49.6.M264; Miller LAD, 2004, DEV DYNAM, V231, P57, DOI 10.1002/dvdy.20105; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myint PK, 2005, EUR RESPIR J, V26, P494, DOI 10.1183/09031936.05.00023605; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Sayers I, 2006, EUR J PHARMACOL, V531, P9, DOI 10.1016/j.ejphar.2005.11.026; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; STRACHAN DP, 1992, J EPIDEMIOL COMMUN H, V46, P66, DOI 10.1136/jech.46.1.66; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Wadsworth SJ, 2006, J CLIN IMMUNOL, V26, P376, DOI 10.1007/s10875-006-9029-z; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; WEIGT C, 1992, J MOL BIOL, V227, P593, DOI 10.1016/0022-2836(92)90915-7; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	42	426	436	0	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					36	U51		10.1038/ng.501	http://dx.doi.org/10.1038/ng.501			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20010834	Green Accepted, Bronze			2022-12-17	WOS:000273055100014
J	Golling, G; Amsterdam, A; Sun, ZX; Antonelli, M; Maldonado, E; Chen, WB; Burgess, S; Haldi, M; Artzt, K; Farrington, S; Lin, SY; Nissen, RM; Hopkins, N				Golling, G; Amsterdam, A; Sun, ZX; Antonelli, M; Maldonado, E; Chen, WB; Burgess, S; Haldi, M; Artzt, K; Farrington, S; Lin, SY; Nissen, RM; Hopkins, N			Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development	NATURE GENETICS			English	Article							MUTATIONS; SPECIFICATION; MELANOSOMES; PESCADILLO; HINDBRAIN; ORGANIZER; MUTANTS; SEARCH; SCREEN; EMBRYO	To rapidly identify genes required for early vertebrate development, we are carrying out a large-scale, insertional mutagenesis screen in zebrafish, using mouse retroviral vectors as the mutagen. We will obtain mutations in 450 to 500 different genes-roughly 20% of the genes that can be mutated to produce a visible embryonic phenotype in this species-and will clone the majority of the mutated alleles. So far, we have isolated more than 500 insertional mutants. Here we describe the first 75 insertional mutants for which the disrupted genes have been identified. In agreement with chemical mutagenesis screens, approximately one-third of the mutants have developmental defects that affect primarily one or a small number of organs, body shape or swimming behavior; the rest of the mutants show more widespread or pleiotropic abnormalities. Many of the genes we identified have not been previously assigned a biological role in vivo. Roughly 20% of the mutants result from lesions in genes for which the biochemical and cellular function of the proteins they encode cannot be deduced with confidence, if at all, from their predicted amino-acid sequences. All of the genes have either orthologs or clearly related genes in human. These results provide an unbiased view of the genetic construction kit for a vertebrate embryo, reveal the diversity of genes required for vertebrate development and suggest that hundreds of genes of unknown biochemical function essential for vertebrate development have yet to be identified.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Texas, Inst Cellular & Mol Biol, Dept Microbiol, Austin, TX USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin	Hopkins, N (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Maldonado, Ernesto/I-1032-2016; Maldonado, Ernesto/ABG-9116-2020; Chen, Wenbiao/ABG-1276-2020	Maldonado, Ernesto/0000-0002-9627-967X; Chen, Wenbiao/0000-0002-0750-8275; Burgess, Shawn/0000-0003-1147-0596; Nissen, Robert/0000-0002-0591-1167	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000183, ZIAHG000183] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Becker TS, 1998, DEVELOPMENT, V125, P4369; Belting HG, 2001, DEVELOPMENT, V128, P4165; Bhatnagar V, 1998, MOL CELL BIOCHEM, V189, P99, DOI 10.1023/A:1006876411202; Burgess S, 2002, DEVELOPMENT, V129, P905; Charpentier AH, 2000, CANCER RES, V60, P5977; Chen WB, 2001, DEVELOPMENT, V128, P2385; DIMENT S, 1995, J BIOL CHEM, V270, P4213, DOI 10.1074/jbc.270.9.4213; Driever W, 1996, DEVELOPMENT, V123, P37; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; Haffter P, 1996, DEVELOPMENT, V123, P1; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144; Jordan S, 2000, PIGM CELL RES, V13, P70, DOI 10.1034/j.1600-0749.2000.130204.x; Kane DA, 1996, DEVELOPMENT, V123, P57; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Pearson H, 2001, NATURE, V413, P244, DOI 10.1038/35095116; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Schilling TF, 1996, DEVELOPMENT, V123, P329; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670	30	426	466	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					135	140		10.1038/ng896	http://dx.doi.org/10.1038/ng896			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12006978				2022-12-17	WOS:000175903500008
J	van der Vlag, J; Otte, AP				van der Vlag, J; Otte, AP			Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation	NATURE GENETICS			English	Article							EXTRA SEX COMBS; GROUP GENE; COMPLEXES; DROSOPHILA; REGULATOR; IDENTIFICATION; EXPRESSION; HOMOLOGS; PRODUCT; CLONING	Polycomb-group (PcG) proteins form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations(1-3) Components of PcG complexes and their mutual interactions have been identified and analysed through extensive genetic and biochemical analyses. Molecular mechanisms underlying PcG-mediated repression of gene activity, however, have remained largely unknown. Previously we reported the existence of two distinct human PcG protein complexes(4). The EED/EZH protein complex contains the embryonic ectoderm development(4-8) (EED) and enhancer of zeste 2 (EZH2; refs 9,10) PcG proteins. The HPC/HPH PcG complex contains the human polycomb 2 (HPC2; ref. 11), human polyhomeotic(12) (HPH), BMI1 (ref. 13) and RING1 (refs 14,15) proteins. Here we show that EED (refs 4-8) interacts, both in vitro and in vivo, with histone deacetylase (HDAC) proteins(16,17). This interaction is highly specific because the HDAC proteins do not interact with other vertebrate PcG proteins. We further find that histone deacetylation activity co-immunoprecipitates with the EED protein. Finally, the histone deacetylase inhibitor trichostatin A (ref. 17) relieves transcriptional repression mediated by EED, but not by HPC2, a human homologue of polycomb(11). Our data indicate that PcG-mediated repression of gene activity involves histone deacetylation. This mechanistic link between two distinct, global gene repression systems is accomplished through the interaction of HDAC proteins with a particular PcG protein, EED.	Univ Amsterdam, Bioctr, EC Slater Inst Biochem Res, Amsterdam, Netherlands	University of Amsterdam	Otte, AP (corresponding author), Univ Amsterdam, Bioctr, EC Slater Inst Biochem Res, Kruislaan 403, Amsterdam, Netherlands.		Van der Vlag, Johan/E-4636-2010	Van der Vlag, Johan/0000-0001-7843-5918				Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; Gunster MJ, 1997, MOL CELL BIOL, V17, P2326, DOI 10.1128/MCB.17.4.2326; GUTJAHR T, 1995, EMBO J, V14, P4296, DOI 10.1002/j.1460-2075.1995.tb00104.x; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Monahan SJ, 1998, VIROLOGY, V241, P122, DOI 10.1006/viro.1997.8953; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Strouboulis J, 1999, MOL CELL BIOL, V19, P3958; STRUHL G, 1982, CELL, V31, P285, DOI 10.1016/0092-8674(82)90428-7; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001	29	426	437	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					474	478		10.1038/70602	http://dx.doi.org/10.1038/70602			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581039				2022-12-17	WOS:000084023900028
J	Blouin, JL; Dombroski, BA; Nath, SK; Lasseter, VK; Wolyniec, PS; Nestadt, G; Thornquist, M; Ullrich, G; McGrath, J; Kasch, L; Lamacz, M; Thomas, MG; Gehrig, C; Radhakrishna, U; Snyder, SE; Balk, KG; Neufeld, K; Swartz, KL; DeMarchi, N; Papadimitriou, GN; Dikeos, DG; Stefanis, CN; Chakravarti, A; Childs, B; Housman, DE; Kazazian, HH; Antonarakis, SE; Pulver, AE				Blouin, JL; Dombroski, BA; Nath, SK; Lasseter, VK; Wolyniec, PS; Nestadt, G; Thornquist, M; Ullrich, G; McGrath, J; Kasch, L; Lamacz, M; Thomas, MG; Gehrig, C; Radhakrishna, U; Snyder, SE; Balk, KG; Neufeld, K; Swartz, KL; DeMarchi, N; Papadimitriou, GN; Dikeos, DG; Stefanis, CN; Chakravarti, A; Childs, B; Housman, DE; Kazazian, HH; Antonarakis, SE; Pulver, AE			Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; VULNERABILITY LOCUS; GENETIC-LINKAGE; SUGGESTIVE EVIDENCE; POTENTIAL LINKAGE; FAMILIAL RISK; HUMAN GENOME; HETEROGENEITY; IDENTIFY; SUPPORT	Schizophrenia is a common disorder characterized by psychotic symptoms; diagnostic criteria have been established(1). Family, twin and adoption studies suggest that both genetic and environmental factors influence susceptibility (heritability is approximately 71%; ref. 2), however, little is known about the aetiology of schizophrenia. Clinical and family studies suggest aetiological heterogeneity(3-6). Previously, we reported that regions on chromosomes 22, 3 and 8 may be associated with susceptibility to schizophrenia(7-8), and collaborations provided some support for regions on chromosomes 8 and 22 (refs 9-13). We present here a genome-wide scan for schizophrenia susceptibility loci (SSL) using 452 microsatellite markers on 54 multiplex pedigrees. Non-parametric linkage (NPL) analysis provided significant evidence for an SSL on chromosome 13q32 (NPL score=4.18; P=0.00002), and suggestive evidence for another SSL on chromosome 8p21-22 (NPL=3.64; P=0.0001). Parametric linkage analysis provided additional support for these SSL. Linkage evidence at chromosome 8 is weaker than that at chromosome 13, so it is more probable that chromosome 8 may be a false positive linkage. Additional putative SSL were noted on chromosomes 14q13 (NPL=2.57: P=0.005), 7q11 (NPL=2.50, P=0.007) and 22q11 (NPL=2.42, P=0.009). Verification of suggestive SSL on chromosomes 13q and 8p was attempted in a follow-up sample of 54 multiplex pedigrees. This analysis confirmed the SSL in 13q14-q33 (NPL=2.36, P=0.007) and supported the SSL in 8p22-p21 (NPL=1.95, P=0.023).	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21231 USA; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Univ Geneva, Hop Cantonal, CH-1211 Geneva, Switzerland; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Naples 2, Inst Psichiatria, I-80138 Naples, Italy; Univ Athens, Eginit Hosp, Mental Hlth Res Inst, GR-11528 Athens, Greece; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Johns Hopkins University; University of Geneva; University of Geneva; University of Pennsylvania; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Universita della Campania Vanvitelli; National & Kapodistrian University of Athens; Massachusetts Institute of Technology (MIT)	Pulver, AE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21231 USA.	aepulver@welchlink.welch.jhu.edu	Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Neufeld, Karin/0000-0002-2395-1883; Swartz, Karen/0000-0003-0420-5823	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045588] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00722] Funding Source: Medline; NIMH NIH HHS [R01 MH-45588] Funding Source: Medline; PHS HHS [1 R01 35712] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; ANTONARAKIS SE, IN PRESS AM J MED GE; BUETOW KH, 1991, AM J HUM GENET, V49, P985; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LASHER L, 1991, AM J HUM GENET, V49, P369; LASSETER VK, 1995, AM J MED GENET, V60, P172, DOI 10.1002/ajmg.1320600217; Levinson DF, 1996, AM J MED GENET, V67, P580; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Lin MW, 1997, HUM GENET, V99, P417, DOI 10.1007/s004390050382; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MELTON B, 1994, GENET EPIDEMIOL, V11, P311, DOI 10.1002/gepi.1370110402; PULVER AE, 1989, GENET EPIDEMIOL, V6, P671, DOI 10.1002/gepi.1370060604; PULVER AE, 1991, GENET EPIDEMIOL, V8, P339, DOI 10.1002/gepi.1370080506; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; Pulver AE, 1996, COLD SPRING HARB SYM, V61, P797; PULVER AE, 1992, BRIT J PSYCHIAT, V160, P65, DOI 10.1192/bjp.160.1.65; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; RAO DC, 1981, HUM HERED, V31, P325, DOI 10.1159/000153233; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; TSUANG MT, 1995, SCHIZOPHR RES, V17, P161, DOI 10.1016/0920-9964(95)00057-S; Wildenauer DB, 1996, COLD SPRING HARB SYM, V61, P845	30	426	452	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					70	73		10.1038/1734	http://dx.doi.org/10.1038/1734			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731535				2022-12-17	WOS:000075671400023
J	Wen, B; Wu, H; Shinkai, Y; Irizarry, RA; Feinberg, AP				Wen, Bo; Wu, Hao; Shinkai, Yoichi; Irizarry, Rafael A.; Feinberg, Andrew P.			Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells	NATURE GENETICS			English	Article							NUCLEAR-ORGANIZATION; GENOME; CHROMOSOMES; PLASTICITY; MOUSE	Higher eukaryotes must adapt a totipotent genome to specialized cell types with stable but limited functions. One potential mechanism for lineage restriction is changes in chromatin, and differentiation-related chromatin changes have been observed for individual genes(1,2). We have taken a genome-wide view of histone H3 lysine 9 dimethylation (H3K9Me2) and find that differentiated tissues show surprisingly large K9-modified regions (up to 4.9 Mb). These regions are highly conserved between human and mouse and are differentiation specific, covering only similar to 4% of the genome in undifferentiated mouse embryonic stem (ES) cells, compared to 31% in differentiated ES cells, similar to 46% in liver and similar to 10% in brain. These modifications require histone methyltransferase G9a and are inversely related to expression of genes within the regions. We term these regions large organized chromatin K9 modifications (LOCKs). LOCKs are substantially lost in cancer cell lines, and they may provide a cell type-heritable mechanism for phenotypic plasticity in development and disease.	[Wen, Bo; Wu, Hao; Irizarry, Rafael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Wen, Bo; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wu, Hao; Irizarry, Rafael A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 606, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kyoto University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Wen, Bo/P-5332-2019; Wu, Hao/H-3899-2017; Feinberg, Andrew/AAY-7666-2020; Shinkai, Yoichi/N-3909-2014	Wen, Bo/0000-0003-0394-7366; Wu, Hao/0000-0003-1269-7354; Shinkai, Yoichi/0000-0002-6051-2484; Feinberg, Andrew/0000-0002-8364-1991	US National Institutes of Health [P50HG003233]; NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR021967] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Taverna, K. Reddy, R. Ohlsson and C. Sapienza for helpful discussions, and S. Taverna and W. Timp for assistance with illustration. This work was supported by US National Institutes of Health grant P50HG003233 to A. P. F.	Anderson DJ, 2008, CURR OPIN CELL BIOL, V20, P386, DOI 10.1016/j.ceb.2008.03.016; Atkinson SP, 2008, STEM CELLS, V26, P1174, DOI 10.1634/stemcells.2007-0497; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HEINZ E, 1928, JB WISS BOT, V69, P762; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Ward CM, 2003, J CELL SCI, V116, P4533, DOI 10.1242/jcs.00767; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	24	425	436	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					246	250		10.1038/ng.297	http://dx.doi.org/10.1038/ng.297			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19151716	Green Accepted			2022-12-17	WOS:000263091300028
J	Cai, ST; Lee, CC; Kohwi-Shigematsu, T				Cai, Shutao; Lee, Charles C.; Kohwi-Shigematsu, Terumi			SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes	NATURE GENETICS			English	Article							GLOBIN LOCUS REQUIRES; MAR-BINDING PROTEIN; HISTONE ACETYLATION; IN-VIVO; DIFFERENTIATION; CELLS; IDENTIFICATION; CONFORMATION; ORGANIZATION; SUFFICIENT	SATB1 (special AT-rich sequence binding protein 1) organizes cell type-specific nuclear architecture by anchoring specialized DNA sequences and recruiting chromatin remodeling factors to control gene transcription. We studied the role of SATB1 in regulating the coordinated expression of Il5, Il4 and Il13, located in the 200-kb T-helper 2 (T(H)2) cytokine locus on mouse chromosome 11. We show that on T(H)2 cell activation, SATB1 expression is rapidly induced to form a unique transcriptionally active chromatin structure at the cytokine locus. In this structure, chromatin is folded into numerous small loops, all anchored to SATB1 at their base. In addition, histone H3 is acetylated at Lys9 and Lys14, and the T(H)2-specific factors GATA3, STAT6 and c-Maf, the chromatin-remodeling enzyme Brg1 and RNA polymerase II are all bound across the 200-kb region. Before activation, the TH2 cytokine locus is already associated with GATA3 and STAT6, showing some looping, but these are insufficient to induce cytokine gene expression. Using RNA interference, we show that on cell activation, SATB1 is required not only for compacting chromatin into dense loops at the 200-kb cytokine locus but also for inducing Il4, Il5, Il13 and c-Maf expression. Thus, SATB1 is a necessary determinant for the hitherto unidentified higher-order, transcriptionally active chromatin structure that forms on TH2 cell activation.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	terumiks@lbl.gov						Alvarez JD, 2000, GENE DEV, V14, P521; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Glimcher LH, 2000, GENE DEV, V14, P1693; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee CC, 2003, PHOTOCH PHOTOBIO SCI, V2, P145, DOI 10.1039/b207598a; Lee CD, 2002, MRS INTERNET J N S R, V7; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	50	425	447	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1278	1288		10.1038/ng1913	http://dx.doi.org/10.1038/ng1913			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17057718	Green Submitted			2022-12-17	WOS:000241592700016
J	Rutsch, F; Ruf, N; Vaingankar, S; Toliat, MR; Suk, A; Hohne, W; Schauer, G; Lehmann, M; Roscioli, T; Schnabel, D; Epplen, JT; Knisely, A; Superti-Furga, A; McGill, J; Filippone, M; Sinaiko, AR; Vallance, H; Hinrichs, B; Smith, W; Ferre, M; Terkeltaub, R; Nurnberg, P				Rutsch, F; Ruf, N; Vaingankar, S; Toliat, MR; Suk, A; Hohne, W; Schauer, G; Lehmann, M; Roscioli, T; Schnabel, D; Epplen, JT; Knisely, A; Superti-Furga, A; McGill, J; Filippone, M; Sinaiko, AR; Vallance, H; Hinrichs, B; Smith, W; Ferre, M; Terkeltaub, R; Nurnberg, P			Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification	NATURE GENETICS			English	Article							NONSENSE; PC-1	Idiopathic infantile arterial calcification (IIAC; OMIM 208000) is characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. We analyzed affected individuals from 11 unrelated kindreds and found that IIAC was associated with mutations that inactivated ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). This cell surface enzyme generates inorganic pyrophosphate (PPi), a solute that regulates cell differentiation and serves as an essential physiologic inhibitor of calcification.	Univ Calif San Diego, Vet Affairs Med Ctr, Dept Med, La Jolla, CA 92161 USA; Humboldt Univ, Charite Univ Hosp, Inst Med Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; Humboldt Univ, Charite Univ Hosp, Inst Biochem, Berlin, Germany; Childrens Hosp & Clin, Dept Pathol, Minneapolis, MN USA; Royal Prince Alfred Hosp, Dept Clin & Mol Genet, Sydney, NSW, Australia; Humboldt Univ, Charite Univ Hosp, Dept Pediat, Berlin, Germany; Ruhr Univ Bochum, Dept Human Genet, D-4630 Bochum, Germany; Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; Univ Childrens Hosp, Div Metab & Mol Dis, Zurich, Switzerland; Royal Childrens Hosp, Dept Metab Med, Brisbane, Qld, Australia; Univ Padua, Sch Med, Dept Pediat, Padua, Italy; Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Biochem Dis Lab, Vancouver, BC, Canada; Eppendorf Univ Hosp, Dept Neonatol, Hamburg, Germany; Barbara Bush Childrens Hosp, Maine Med Ctr, Div Genet, Portland, OR USA; Prenatal Diagnost Ctr, Roanoke, VA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Children's Hospitals & Clinics of Minnesota; University of Sydney; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University Children's Hospital Zurich; Royal Children's Hospital Brisbane; University of Padua; University of Minnesota System; University of Minnesota Twin Cities; BC Women's Hospital & Health Centre; University of Hamburg; University Medical Center Hamburg-Eppendorf	Terkeltaub, R (corresponding author), Univ Calif San Diego, Vet Affairs Med Ctr, Dept Med, 3350 La Jolla Village Dr, La Jolla, CA 92161 USA.	rterkeltaub@ucsd.edu	superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531; Schnabel, Dirk/0000-0002-7944-7790; Epplen, Joerg T./0000-0002-6087-3327; Vallance, Hilary/0000-0003-1734-1445				Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; MAQUAT LE, 2000, TRANSLATIONAL CONTRO; MENTEN ML, 1948, AM J CLIN PATHOL, V18, P805; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rutsch F, 2003, CURR OPIN RHEUMATOL, V15, P302, DOI 10.1097/00002281-200305000-00019; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Saxena A, 2003, PEDIATR CARDIOL, V24, P80, DOI 10.1007/s00246-001-0067-2; VERA J, 1990, PEDIATR RADIOL, V20, P585, DOI 10.1007/BF02129060; Wax JR, 2001, AM J OBSTET GYNECOL, V185, P1267, DOI 10.1067/mob.2001.117186	15	425	446	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					379	381		10.1038/ng1221	http://dx.doi.org/10.1038/ng1221			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12881724				2022-12-17	WOS:000184470500015
J	Steinmetz, LM; Scharfe, C; Deutschbauer, AM; Mokranjac, D; Herman, ZS; Jones, T; Chu, AM; Giaever, G; Prokisch, H; Oefner, PJ; Davis, RW				Steinmetz, LM; Scharfe, C; Deutschbauer, AM; Mokranjac, D; Herman, ZS; Jones, T; Chu, AM; Giaever, G; Prokisch, H; Oefner, PJ; Davis, RW			Systematic screen for human disease genes in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; LOCUS HETEROGENEITY; OPTIC ATROPHY; MITOCHONDRIAL; CHROMOSOME; EXPRESSION; SEQUENCES; DATABASE; DELETION; LINKAGE	High similarity between yeast and human mitochondria allows functional genomic study of Saccharomyces cerevisiae to be used to identify human genes involved in disease(1). So far, 102 heritable disorders have been attributed to defects in a quarter of the known nuclear-encoded mitochondrial proteins in humans(2). Many mitochondrial diseases remain unexplained, however, in part because only 40-60% of the presumed 700-1,000 proteins involved in mitochondrial function and biogenesis have been identified(3). Here we apply a systematic functional screen using the pre-existing whole-genome pool of yeast deletion mutants(4-6) to identify mitochondrial proteins. Three million measurements of strain fitness identified 466 genes whose deletions impaired mitochondrial respiration, of which 265 were new. Our approach gave higher selection than other systematic approaches, including fivefold greater selection than gene expression analysis. To apply these advantages to human disorders involving mitochondria, human orthologs were identified and linked to heritable diseases using genomic map positions.	Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Univ Munich, Inst Physiol Chem, D-8000 Munich, Germany	Stanford University; Stanford University; Stanford University; University of Munich	Steinmetz, LM (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	larsms@stanford.edu; curts@stanford.edu	Prokisch, Holger/N-8964-2013	Steinmetz, Lars/0000-0002-3962-2865; Mokranjac, Dejana/0000-0002-4005-6979; Prokisch, Holger/0000-0003-2379-6286				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884; Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Christodoulou K, 2001, NEUROGENETICS, V3, P127, DOI 10.1007/s100480100112; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DiMauro S, 1998, NAT GENET, V19, P214, DOI 10.1038/883; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Grivell LA, 1999, FEBS LETT, V452, P57, DOI 10.1016/S0014-5793(99)00532-3; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; McMullan TFW, 2000, AM J HUM GENET, V66, P1455, DOI 10.1086/302860; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; PRIEST JM, 1995, GENOMICS, V29, P409, DOI 10.1006/geno.1995.9987; Scharfe C, 2000, NUCLEIC ACIDS RES, V28, P155, DOI 10.1093/nar/28.1.155; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627	29	425	434	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					400	404		10.1038/ng929	http://dx.doi.org/10.1038/ng929			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134146				2022-12-17	WOS:000177147100016
J	Hollander, MC; Sheikh, MS; Bulavin, DV; Lundgren, K; Augeri-Henmueller, L; Shehee, R; Molinaro, TA; Kim, KE; Tolosa, E; Ashwell, JD; Rosenberg, MP; Zhan, QM; Fernandez-Salguero, PM; Morgan, WF; Deng, CX; Fornace, AJ				Hollander, MC; Sheikh, MS; Bulavin, DV; Lundgren, K; Augeri-Henmueller, L; Shehee, R; Molinaro, TA; Kim, KE; Tolosa, E; Ashwell, JD; Rosenberg, MP; Zhan, QM; Fernandez-Salguero, PM; Morgan, WF; Deng, CX; Fornace, AJ			Genomic instability in Gadd45a-deficient mice	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; P53-DEFICIENT MICE; P53; GADD45; DEFICIENT; PROTEIN; P21	Gadd45a-null mice generated by gene targeting exhibited several of the phenotypes characteristic of p53-deficient mice, including genomic instability, increased radiation carcinogenesis and a low frequency of exencephaly. Genomic instability was exemplified by aneuploidy, chromosome aberrations, gene amplification and centrosome amplification, and was accompanied by abnormalities in mitosis, cytokinesis and growth control. Unequal segregation of chromosomes due to multiple spindle poles during mitosis occurred in several Gadd45a(-/-) cell lineages and may contribute to the aneuploidy. Our results indicate that Gadd45a is one component of the p53 pathway that contributes to the maintenance of genomic stability.	NCI, Gene Response Sect, DBS, Bethesda, MD 20892 USA; Glaxo Wellcome Res & Dev Inc, Res Triangle Pk, NC 27709 USA; NCI, Lab Immune Cell Biol, DBS, Bethesda, MD 20892 USA; NCI, Lab Metab, DBS, Bethesda, MD 20892 USA; Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; NIDDKD, Genet Dev & Dis Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fornace, AJ (corresponding author), NCI, Gene Response Sect, DBS, Bethesda, MD 20892 USA.		deng, chuxia/N-6713-2016; Tolosa, Eva/S-3454-2016; Fernandez-Salguero, Pedro M./J-8437-2014; Fornace, Albert/A-7407-2008	Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Fornace, Albert/0000-0001-9695-085X	DIVISION OF BASIC SCIENCES - NCI [Z01BC007184] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; BOUFFLER SD, 1995, CANCER RES, V55, P3883; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carrier F, 1999, MOL CELL BIOL, V19, P1673; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Kamien R, 1997, MUSIC THEOR SPECTRUM, V19, P1, DOI 10.1525/mts.1997.19.1.02a00010; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KEARSEY JM, 1995, ONCOGENE, V11, P1675; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; NELSONREES WA, 1980, CYTOGENET CELL GENET, V27, P216, DOI 10.1159/000131490; Pockwinse SM, 1997, P NATL ACAD SCI USA, V94, P3022, DOI 10.1073/pnas.94.7.3022; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takeshi K, 1998, JPN QUART, V45, P4; WANG X, IN PRESS J BIOL CHEM; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhan QM, 1998, MOL CELL BIOL, V18, P2768, DOI 10.1128/MCB.18.5.2768; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5	30	425	440	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					176	184		10.1038/13802	http://dx.doi.org/10.1038/13802			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508513				2022-12-17	WOS:000082827500016
J	Seielstad, MT; Minch, E; Cavalli-Sforza, LL				Seielstad, MT; Minch, E; Cavalli-Sforza, LL			Genetic evidence for a higher female migration rate in humans	NATURE GENETICS			English	Article							DNA; HAPLOTYPES; TRANSITION; LINEAGES; MARKERS; NUCLEAR	Mitochondrial DNA and the Y chromosome have been used extensively in the study of modern human origins and other phylogenetic questions, but not in the context of their sex-specific modes of transmission, mtDNA is transmitted exclusively by females, whereas the Y chromosome is passed only among males. As a result, differences in the reproductive output or migration rate of males and females will influence the geographic patterns and relative level of genetic diversity on the Y chromosome, autosomes and mtDNA (ref. 1). We have found that Y chromosome variants tend to be more localized geographically than those of mtDNA and the autosomes(2-5). The fraction of variation within human populations for Y chromosome single nucleotide polymorphisms (SNPs) is 35.5%, versus 80-85% for the autosomes and mtDNA (refs 6-8). A higher female than male migration rate (via patrilocality, the tendency for a wife to move into her husband's natal household) explains most of this discrepancy, because diverse Y chromosomes would enter a population at a lower rate than mtDNA or the autosomes. Polygyny may also contribute, but the reduction of variation within populations that we measure for the Y chromosome, relative to the autosomes and mitochondrial DNA, is of such magnitude that differences in the effective population sizes of the sexes alone are insufficient to produce the observation.	Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Harvard University; Harvard T.H. Chan School of Public Health; Stanford University	Seielstad, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Program Populat Genet, 665 Huntington Ave, Boston, MA 02115 USA.	mark@ppg.harvard.edu	Seielstad, Mark/T-7841-2019	Seielstad, Mark/0000-0001-5783-1401	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BURTON GJ, 1987, PLACENTA, V8, P37, DOI 10.1016/0143-4004(87)90038-5; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; DORJAHN DR, 1959, CONTINUITY CHANGE AF, P87; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; EXCOFFIER L, 1992, GENETICS, V131, P479; FELDMAN MW, IN PRESS MICROSATELL; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HEWLETT B, 1982, MAN, V17, P418, DOI 10.2307/2801706; Hrdlicka A, 1931, AM J PHYS ANTHROPOL, V16, P81, DOI 10.1002/ajpa.1330160118; ISAAC BL, 1980, ETHNOLOGY, V19, P297, DOI 10.2307/3773334; Keane B, 1997, MOL ECOL, V6, P267, DOI 10.1046/j.1365-294X.1997.00178.x; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Richards M, 1996, AM J HUM GENET, V59, P185; Salem AH, 1996, AM J HUM GENET, V59, P741; SCHNEIDER S, 1997, ARLEQUIN VER 1 1; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 1996, AM J HUM GENET, V59, P964; SLATKIN M, 1995, GENETICS, V139, P457; THOMAS JMC, 1963, NGBAKA LOBAYE; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WHITE DR, 1988, CURR ANTHROPOL, V29, P529, DOI 10.1086/203674; WIJSMAN EM, 1984, ANNU REV ECOL SYST, V15, P279	30	425	437	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					278	280		10.1038/3088	http://dx.doi.org/10.1038/3088			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	133QW	9806547				2022-12-17	WOS:000076698100022
J	Jenuth, JP; Peterson, AC; Fu, K; Shoubridge, EA				Jenuth, JP; Peterson, AC; Fu, K; Shoubridge, EA			Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; RED FIBERS MERRF; MOUSE EMBRYOS; D-LOOP; MUTATION; CELLS; EVOLUTION; TRANSCRIPTS; SEQUENCES; EPILEPSY	Mitochondrial DNA (mtDNA) is maternally inherited in mammals. Despite the high genome copy number in mature oocytes (10(5)) and the relatively small number of cell divisions in the female germline, mtDNA sequence variants segregate rapidly between generations. To investigate the molecular basis for this apparent paradox we created lines of heteroplasmic mice carrying two mtDNA genotypes. We show that the pattern of segregation can be explained by random genetic drift ocurring in early oogenesis, and that the effective number of segregating units for mtDNA is similar to 200 in mice. These results provide the basis for estimating recurrence risks for mitochondrial disease due to pathogenic mtDNA mutations and for predicting the rate of fixation of neutral mtDNA mutations in maternal lineages.	MONTREAL NEUROL HOSP & INST, MONTREAL, PQ H3A 2B4, CANADA; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ H3A 1B1, CANADA; MCGILL UNIV, MOL ONCOL GRP, MONTREAL, PQ H3A 1A1, CANADA	McGill University; McGill University; McGill University								ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; BIRKY CW, 1983, GENETICS, V103, P513; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; BOULET L, 1992, AM J HUM GENET, V51, P1187; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Ghosh SS, 1996, AM J HUM GENET, V58, P325; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GONDOS B, 1987, INT J GYNECOL PATHOL, V6, P114, DOI 10.1097/00004347-198706000-00003; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; HAUSWIRTH WW, 1984, CELL, V37, P1001, DOI 10.1016/0092-8674(84)90434-3; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOWELL N, 1992, HUM GENET, V90, P117; HOWELL N, 1994, AM J HUM GENET, V55, P203; HOWELL N, 1991, AM J HUM GENET, V49, P939; KOEHLER CM, 1991, GENETICS, V129, P247; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Larsson N G, 1995, Muscle Nerve Suppl, V3, pS102; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; MANGIA F, 1975, DEV BIOL, V45, P211, DOI 10.1016/0012-1606(75)90061-5; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X; NOGAWA T, 1988, J MORPHOL, V195, P225, DOI 10.1002/jmor.1051950208; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; REIS RJS, 1983, J BIOL CHEM, V258, P9078; SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; ZHU DP, 1992, AM J MED GENET, V42, P173, DOI 10.1002/ajmg.1320420208	38	425	439	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1996	14	2					146	151		10.1038/ng1096-146	http://dx.doi.org/10.1038/ng1096-146			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841183				2022-12-17	WOS:A1996VL44600017
J	Turner, JMA; Mahadevaiah, SK; Fernandez-Capetillo, O; Nussenzweig, A; Xu, XL; Deng, CX; Burgoyne, PS				Turner, JMA; Mahadevaiah, SK; Fernandez-Capetillo, O; Nussenzweig, A; Xu, XL; Deng, CX; Burgoyne, PS			Silencing of unsynapsed meiotic chromosomes in the mouse	NATURE GENETICS			English	Article							X-CHROMOSOME; SYNAPTONEMAL COMPLEXES; MICE; BRCA1; MEIOSIS; PROTEIN; CELLS; SPERMATOGENESIS; ASSOCIATION; MUTATION	In Neurospora, DNA unpaired in meiosis both is silenced and induces silencing of all DNA homologous to it. This process, called meiotic silencing by unpaired DNA, is thought to protect the host genome from invasion by transposable elements. We now show that silencing of unpaired (unsynapsed) chromosome regions also takes place in the mouse during both male and female meiosis. The tumor suppressor protein BRCA1 is implicated in this silencing, mirroring its role in the meiotic silencing of the X and Y chromosomes in normal male meiosis. These findings impact on the interpretation of the relationship between synaptic errors and sterility in mammals and extend our understanding of the biology of Brca1.	Natl Inst Med Res, MRC, Div Stem Cell Res & Dev Genet, London NW7 1AA, England; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Turner, JMA (corresponding author), Natl Inst Med Res, MRC, Div Stem Cell Res & Dev Genet, Mill Hill, London NW7 1AA, England.	jturner@nimr.mrc.ac.uk	Fernandez-Capetillo, Oscar/H-3508-2015; deng, chuxia/N-6713-2016	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; 	Medical Research Council [MC_U117588498, MC_U117532009] Funding Source: Medline; MRC [MC_U117532009] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001, ZIADK056001] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON LK, 1988, CHROMOSOMA, V96, P295, DOI 10.1007/BF00286917; Ashley T, 2000, Results Probl Cell Differ, V28, P131; BAARENDS WM, IN PRESS MOL CELL BI; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Boer P. de, 1989, Fertility and chromosome pairing: recent studies in plants and animals., P37; Burgoyne P S, 1984, Symp Soc Exp Biol, V38, P349; Burgoyne P. S., 1993, Chromosomes today: volume 11., P243; BURGOYNE PS, 1985, J REPROD FERTIL, V75, P633, DOI 10.1530/jrf.0.0750633; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; BURGOYNE PS, 1981, J REPROD FERTIL, V61, P207, DOI 10.1530/jrf.0.0610207; Fernandez-Capetillo O, 2003, J CELL BIOL, V163, P15, DOI 10.1083/jcb.200305124; FORD CE, 1964, CYTOGENETICS, V3, P295, DOI 10.1159/000129819; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; LYON MF, 1973, GENET RES, V21, P185, DOI 10.1017/S0016672300013355; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MAHADEVAIAH SK, 1993, J REPROD FERTIL, V97, P151, DOI 10.1530/jrf.0.0970151; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; Moens PB, 1999, CHROMOSOMA, V108, P95, DOI 10.1007/s004120050356; Moens PB, 2002, J CELL SCI, V115, P1611; MOORE GPM, 1971, EXP CELL RES, V68, P462, DOI 10.1016/0014-4827(71)90176-5; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Peters AHFM, 1997, CHROMOSOME RES, V5, P313, DOI 10.1023/B:CHRO.0000038762.60086.ef; Plug AW, 1998, J CELL SCI, V111, P413; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; SPEED RM, 1986, CHROMOSOMA, V94, P115, DOI 10.1007/BF00286989; Turner JMA, 2000, CHROMOSOMA, V109, P426, DOI 10.1007/s004120000097; TURNER JMA, IN PRESS CURR BIOL; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	39	424	442	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					41	47		10.1038/ng1484	http://dx.doi.org/10.1038/ng1484			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15580272				2022-12-17	WOS:000225997500019
J	Malecki, MT; Jhala, US; Antonellis, A; Fields, L; Doria, A; Orban, T; Saad, M; Warram, JH; Montminy, M; Krolewski, AS				Malecki, MT; Jhala, US; Antonellis, A; Fields, L; Doria, A; Orban, T; Saad, M; Warram, JH; Montminy, M; Krolewski, AS			Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus	NATURE GENETICS			English	Article							MOLECULAR-CLONING; CRYSTAL-STRUCTURE; GENE; YOUNG; P300; DIFFERENTIATION; RECOGNITION; BINDING; REGION; DIMER		Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Med, Div Endocrinol, Los Angeles, CA USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Krolewski, AS (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA.		Doria, Alessandro/H-9157-2018	Doria, Alessandro/0000-0002-3830-4304	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK047475] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-36836, DK-47475] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHRISTIE MR, 1990, J EXP MED, V172, P789, DOI 10.1084/jem.172.3.789; Doria A, 1999, DIABETES CARE, V22, P253, DOI 10.2337/diacare.22.2.253; Dupont S, 1999, DIABETOLOGIA, V42, P480, DOI 10.1007/s001250051182; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Furuta H, 1998, DIABETES, V47, P1356, DOI 10.2337/diabetes.47.8.1356; GRUBIN CE, 1994, DIABETOLOGIA, V37, P344, DOI 10.1007/s001250050115; HARRIS M, 1979, DIABETES, V28, P1039; HARRIS MI, 1985, DIABETES CARE, V8, P562, DOI 10.2337/diacare.8.6.562; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Mutoh H, 1998, GENE DEV, V12, P820, DOI 10.1101/gad.12.6.820; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; Sharma A, 1999, MOL CELL BIOL, V19, P704; Tamimi R, 1996, GENOMICS, V34, P418, DOI 10.1006/geno.1996.0306; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yokoyama M, 1996, MOL BRAIN RES, V42, P135, DOI 10.1016/S0169-328X(96)00154-4; Yoon YS, 1998, NEUROSCI LETT, V251, P17, DOI 10.1016/S0304-3940(98)00490-X	25	424	465	1	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1999	23	3					323	328		10.1038/15500	http://dx.doi.org/10.1038/15500			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	257QC	10545951				2022-12-17	WOS:000083792200022
J	PETRUKHIN, K; FISCHER, SG; PIRASTU, M; TANZI, RE; CHERNOV, I; DEVOTO, M; BRZUSTOWICZ, LM; CAYANIS, E; VITALE, E; RUSSO, JJ; MATSEOANE, D; BOUKHGALTER, B; WASCO, W; FIGUS, AL; LOUDIANOS, J; CAO, A; STERNLIEB, I; EVGRAFOV, O; PARANO, E; PAVONE, L; WARBURTON, D; OTT, J; PENCHASZADEH, GK; SCHEINBERG, IH; GILLIAM, TC				PETRUKHIN, K; FISCHER, SG; PIRASTU, M; TANZI, RE; CHERNOV, I; DEVOTO, M; BRZUSTOWICZ, LM; CAYANIS, E; VITALE, E; RUSSO, JJ; MATSEOANE, D; BOUKHGALTER, B; WASCO, W; FIGUS, AL; LOUDIANOS, J; CAO, A; STERNLIEB, I; EVGRAFOV, O; PARANO, E; PAVONE, L; WARBURTON, D; OTT, J; PENCHASZADEH, GK; SCHEINBERG, IH; GILLIAM, TC			MAPPING, CLONING AND GENETIC-CHARACTERIZATION OF THE REGION CONTAINING THE WILSON DISEASE GENE	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; HUMAN GENOME; ESTERASE-D; LINKAGE; LOCUS	Wilson disease (WD) is an autosomal recessive disorder of copper transport which maps to chromosome 13q14.3. In pursuit of the WD gene, we developed yeast artificial chromosome and cosmid contigs, and microsatellite markers which span the WD gene region. Linkage disequilibrium and haplotype analysis of 115 WD families confined the disease locus to a single marker interval. A candidate cDNA clone was mapped to this interval which, as shown in the accompanying paper, is very likely the WD gene. Our haplotype and mutation analyses predict that approximately half of all WD mutations will be rare in the American and Russian populations.	COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT MED,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032; NATL CTR STUDY WILSONS DIS,NEW YORK,NY; ST LUKES ROOSEVELT HOSP,NEW YORK,NY; IST RIC TALASSEMIE & ANEMIE MEDITERRANNEE,CAGLIARI,ITALY; HARVARD UNIV,SCH MED,DEPT NEUROSCI,BOSTON,MA; MOSCOW MED GENET RES CTR,MOSCOW,RUSSIA; UNIV CATANIA,PEDIAT CLIN,CATANIA,ITALY	Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Mount Sinai St. Luke's; Mount Sinai West; Harvard University; Harvard Medical School; Research Centre for Medical Genetics; University of Catania			Devoto, Marcella/AAP-7595-2021; Tanzi, Rudolph/AAE-9622-2019; vitale, emilia/A-5282-2011	Tanzi, Rudolph/0000-0002-7032-1454; Chernov, Igor/0000-0002-8879-1964; Vitale, Emilia/0000-0003-4651-3875; Petrukhin, Konstantin/0000-0002-5545-6924; DEVOTO, MARCELLA/0000-0002-4431-5114; PARANO, ENRICO/0000-0002-0713-7339	NHGRI NIH HHS [HG00462, 5-P20-HG00424] Funding Source: Medline; NINDS NIH HHS [NS28877] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000462, P20HG000424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028877] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BONNETAMIR B, 1986, GENET EPIDEMIOL, V3, P201, DOI 10.1002/gepi.1370030307; BOWCOCK AM, 1991, GENOMICS, V11, P517, DOI 10.1016/0888-7543(91)90058-M; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; FISCHER SG, IN PRESS ASSEMBLY OR; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; FUJIMURA FK, 1991, CLIN BIOCHEM, V24, P353, DOI 10.1016/0009-9120(91)80010-Z; HOUWEN RHJ, 1990, HUM GENET, V85, P560, DOI 10.1007/BF00194238; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; OLSEN AS, 1993, BIOTECHNIQUES, V14, P116; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; PIRASTU M, 1993, AM J HUM GENET, V53, P844; Scheinberg IH, 1984, MAJOR PROBLEMS INTER, VXXIII; STEWART EA, 1993, AM J HUM GENET, V53, P864; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; WARBURTON D, 1993, GENOMICS, V16, P355, DOI 10.1006/geno.1993.1197; WEBER JL, 1993, GENET, V2, P1123	24	424	436	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					338	343		10.1038/ng1293-338	http://dx.doi.org/10.1038/ng1293-338			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298640				2022-12-17	WOS:A1993ML14500008
J	Gitler, AD; Chesi, A; Geddie, ML; Strathearn, KE; Hamamichi, S; Hill, KJ; Caldwell, KA; Caldwell, GA; Cooper, AA; Rochet, JC; Lindquist, S				Gitler, Aaron D.; Chesi, Alessandra; Geddie, Melissa L.; Strathearn, Katherine E.; Hamamichi, Shusei; Hill, Kathryn J.; Caldwell, Kim A.; Caldwell, Guy A.; Cooper, Antony A.; Rochet, Jean-Christophe; Lindquist, Susan			alpha-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity	NATURE GENETICS			English	Article							FAMILIAL PARKINSONS-DISEASE; P-TYPE ATPASE; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; CELLULAR-MODEL; LEWY BODIES; AGGREGATION; CELLS; DJ-1	Parkinson's disease (PD), dementia with Lewy bodies and multiple system atrophy, collectively referred to as synucleinopathies, are associated with a diverse group of genetic and environmental susceptibilities. The best studied of these is PD. alpha-Synuclein (alpha-syn) has a key role in the pathogenesis of both familial and sporadic PD, but evidence linking it to other predisposition factors is limited. Here we report a strong genetic interaction between alpha-syn and the yeast ortholog of the PD-linked gene ATP13A2 (also known as PARK9). Dopaminergic neuron loss caused by alpha-syn overexpression in animal and neuronal PD models is rescued by coexpression of PARK9. Further, knockdown of the ATP13A2 ortholog in Caenorhabditis elegans enhances alpha-syn misfolding. These data provide a direct functional connection between alpha-syn and another PD susceptibility locus. Manganese exposure is an environmental risk factor linked to PD and PD-like syndromes. We discovered that yeast PARK9 helps to protect cells from manganese toxicity, revealing a connection between PD genetics (alpha-syn and PARK9) and an environmental risk factor (PARK9 and manganese). Finally, we show that additional genes from our yeast screen, with diverse functions, are potent modifiers of alpha-syn-induced neuron loss in animals, establishing a diverse, highly conserved interaction network for alpha-syn.	[Gitler, Aaron D.; Geddie, Melissa L.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gitler, Aaron D.; Geddie, Melissa L.; Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Gitler, Aaron D.; Chesi, Alessandra] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Strathearn, Katherine E.; Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Hamamichi, Shusei; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Hill, Kathryn J.; Cooper, Antony A.] Garvan Inst Med Res, Sydney, NSW 2010, Australia	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Pennsylvania; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alabama System; University of Alabama Tuscaloosa; Garvan Institute of Medical Research	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Lindquist_admin@wi.mit.edu	Chesi, Alessandra/AAT-8248-2020; Chesi, Alessandra/N-7693-2017	Rochet, Jean-Christophe/0000-0002-6484-1541; Cooper, Antony/0000-0002-6027-2353; Caldwell, Kim/0000-0003-1580-6122; Caldwell, Guy/0000-0002-8283-9090; Gitler, Aaron/0000-0001-8603-1526; Chesi, Alessandra/0000-0002-0954-7446	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049221, P50NS038372] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [1-DP2-OD004417-01, DP2 OD004417] Funding Source: Medline; NINDS NIH HHS [NS038372, P50 NS038372-100005, R01 NS049221, NS049221, P50 NS038372] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; BRENNER S, 1974, GENETICS, V77, P71; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gitler AD, 2008, NEUROSIGNALS, V16, P52, DOI 10.1159/000109759; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lees AJ, 2007, NEUROLOGY, V68, P1553, DOI 10.1212/01.wnl.0000265228.66664.f4; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Liu F, 2008, J NEUROCHEM, V105, P2435, DOI 10.1111/j.1471-4159.2008.05333.x; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Meulener MC, 2005, J NEUROCHEM, V93, P1524, DOI 10.1111/j.1471-4159.2005.03145.x; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Sharma N, 2001, AM J PATHOL, V159, P339, DOI 10.1016/S0002-9440(10)61700-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soper JH, 2008, MOL BIOL CELL, V19, P1093, DOI 10.1091/mbc.E07-08-0827; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; YEGERLOTEM E, NAT GENET IN PRESS; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	48	423	442	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					308	315		10.1038/ng.300	http://dx.doi.org/10.1038/ng.300			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19182805	Green Accepted			2022-12-17	WOS:000263640200011
J	Verstrepen, KJ; Jansen, A; Lewitter, F; Fink, GR				Verstrepen, KJ; Jansen, A; Lewitter, F; Fink, GR			Intragenic tandem repeats generate functional variability	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMARY-GLAND; YEAST; DNA; GENES; RECOMBINATION; REPLICATION; MUTATIONS; PROTEINS; FREQUENCIES	Tandemly repeated DNA sequences are highly dynamic components of genomes(1). Most repeats are in intergenic regions, but some are in coding sequences or pseudogenes(2). In humans, expansion of intragenic triplet repeats is associated with various diseases, including Huntington chorea and fragile X syndrome(3,4). The persistence of intragenic repeats in genomes suggests that there is a compensating benefit. Here we show that in the genome of Saccharomyces cerevisiae, most genes containing intragenic repeats encode cell- wall proteins. The repeats trigger frequent recombination events in the gene or between the gene and a pseudogene, causing expansion and contraction in the gene size. This size variation creates quantitative alterations in phenotypes ( e. g., adhesion, flocculation or biofilm formation). We propose that variation in intragenic repeat number provides the functional diversity of cell surface antigens that, in fungi and other pathogens, allows rapid adaptation to the environment and elusion of the host immune system.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Katholieke Univ Leuven, Fac Appl Biosci & Engn, Dept Microbial & Mol Syst, Ctr Malting & Brewing Sci, B-3001 Leuven, Belgium	Massachusetts Institute of Technology (MIT); Whitehead Institute; KU Leuven	Fink, GR (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	GFink@wi.mit.edu	Verstrepen, Kevin/AAA-4343-2021; Jansen, An/T-9228-2018	Jansen, An/0000-0003-2412-0456; Verstrepen, Kevin/0000-0002-3077-6219	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035010] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boceta C, 2000, PARASITE IMMUNOL, V22, P55, DOI 10.1046/j.1365-3024.2000.00269.x; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Davis AP, 2001, GENETICS, V159, P515; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Hartl DL, 2000, NAT REV GENET, V1, P145, DOI 10.1038/35038580; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Keim P, 1999, J APPL MICROBIOL, V87, P215, DOI 10.1046/j.1365-2672.1999.00873.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu HP, 1996, GENETICS, V144, P967; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Marinangeli P, 2004, FEMS YEAST RES, V4, P427, DOI 10.1016/S1567-1356(03)00172-7; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; PAYS E, 1994, ANNU REV MICROBIOL, V48, P25, DOI 10.1146/annurev.mi.48.100194.000325; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031; Sakihama N, 2004, PARASITOL INT, V53, P59, DOI 10.1016/j.parint.2003.11.002; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; SHERMAN F, 1991, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587	30	423	456	1	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					986	990		10.1038/ng1618	http://dx.doi.org/10.1038/ng1618			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16086015	Green Accepted, Green Published			2022-12-17	WOS:000231591900025
J	Kang, YK; Koo, DB; Park, JS; Choi, YH; Chung, AS; Lee, KK; Han, YM				Kang, YK; Koo, DB; Park, JS; Choi, YH; Chung, AS; Lee, KK; Han, YM			Aberrant methylation of donor genome in cloned bovine embryos	NATURE GENETICS			English	Letter							DNA METHYLTRANSFERASE; FETAL FIBROBLASTS; NUCLEAR TRANSFER; PATERNAL GENOME; GERM-CELLS; IN-VITRO; MOUSE; CALVES; DEMETHYLATION; CULTURE	Despite recent successes in cloning various animal species, the use of somatic cells as the source of donor nuclei has raised many practically relevant questions such as increased abortion rates, high birth weight and perinatal death(1-3). These anomalies may be caused by incomplete epigenetic reprogramming of donor DNA. Genome-wide demethylation occurs during early development, 'erasing' gamete-specific methylation patterns inherited from the parents(4-8). This process may be a prerequisite for the formation of pluripotent stem cells that are important for the later development(9), Here, we provide evidence that cloned bovine embryos may have impaired epigenetic reprogramming capabilities. We found highly aberrant methylation patterns in various genomic regions of cloned embryos. Cloned blastocysts closely resembled donor cells in their overall genomic methylation status, which was very different from that of normal blastocysts produced in vitro or in vivo. We found demethylation of the Bov-B long interspersed nuclear element sequence in normal embryos, hut not in cloned embryos, in which the donor-type methylation was simply maintained during preimplantation development. There were also significant variations in the degree of methylation among individual cloned blastocysts. Our findings indicate that the developmental anomalies of cloned embryos could be due to incomplete epigenetic reprogramming of donor genomic DNA.	KRIBB, Anim Dev Biotechnol Lab, Taejon 305600, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST)	Han, YM (corresponding author), KRIBB, Anim Dev Biotechnol Lab, POB 115, Taejon 305600, South Korea.		Han, Yong-Mahn/C-1652-2011					Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Gonzalgo ML, 1997, CANCER RES, V57, P594; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mertineit C, 1998, DEVELOPMENT, V125, P889; MONK M, 1987, DEVELOPMENT, V99, P371; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; RELK W, 1997, GENOMIC INPRINTING; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Shiga K, 1999, THERIOGENOLOGY, V52, P527, DOI 10.1016/S0093-691X(99)00149-1; Thompson JG, 1998, THERIOGENOLOGY, V49, P1239, DOI 10.1016/S0093-691X(98)00071-5; TSUNODA Y, 1986, J EXP ZOOL, V240, P119, DOI 10.1002/jez.1402400115; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zakhartchenko V, 1999, MOL REPROD DEV, V54, P264, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;264::AID-MRD7&gt;3.0.CO;2-Y; Zakhartchenko V, 1999, J REPROD FERTIL, V115, P325, DOI 10.1530/jrf.0.1150325	24	423	466	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					173	177		10.1038/88903	http://dx.doi.org/10.1038/88903			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381267				2022-12-17	WOS:000169011800022
J	Ellinor, PT; Lunetta, KL; Albert, CM; Glazer, NL; Ritchie, MD; Smith, AV; Arking, DE; Muller-Nurasyid, M; Krijthe, BP; Lubitz, SA; Bis, JC; Chung, MK; Doerr, M; Ozaki, K; Roberts, JD; Smith, JG; Pfeufer, A; Sinner, MF; Lohman, K; Ding, JZ; Smith, NL; Smith, JD; Rienstra, M; Rice, KM; Van Wagoner, DR; Magnani, JW; Wakili, R; Clauss, S; Rotter, JI; Steinbeck, G; Launer, LJ; Davies, RW; Borkovich, M; Harris, TB; Lin, HH; Volker, U; Volzke, H; Milan, DJ; Hofman, A; Boerwinkle, E; Chen, LY; Soliman, EZ; Voight, BF; Li, G; Chakravarti, A; Kubo, M; Tedrow, UB; Rose, LM; Ridker, PM; Conen, D; Tsunoda, T; Furukawa, T; Sotoodehnia, N; Xu, SY; Kamatani, N; Levy, D; Nakamura, Y; Parvez, B; Mahida, S; Furie, KL; Rosand, J; Muhammad, R; Psaty, BM; Meitinger, T; Perz, S; Wichmann, HE; Witteman, JCM; Kao, WHL; Kathiresan, S; Roden, DM; Uitterlinden, AG; Rivadeneira, F; McKnight, B; Sjogren, M; Newman, AB; Liu, YM; Gollob, MH; Melander, O; Tanaka, T; Stricker, BHC; Felix, SB; Alonso, A; Darbar, D; Barnard, J; Chasman, DI; Heckbert, SR; Benjamin, EJ; Gudnason, V; Kaab, S				Ellinor, Patrick T.; Lunetta, Kathryn L.; Albert, Christine M.; Glazer, Nicole L.; Ritchie, Marylyn D.; Smith, Albert V.; Arking, Dan E.; Mueller-Nurasyid, Martina; Krijthe, Bouwe P.; Lubitz, Steven A.; Bis, Joshua C.; Chung, Mina K.; Doerr, Marcus; Ozaki, Kouichi; Roberts, Jason D.; Smith, J. Gustav; Pfeufer, Arne; Sinner, Moritz F.; Lohman, Kurt; Ding, Jingzhong; Smith, Nicholas L.; Smith, Jonathan D.; Rienstra, Michiel; Rice, Kenneth M.; Van Wagoner, David R.; Magnani, Jared W.; Wakili, Reza; Clauss, Sebastian; Rotter, Jerome I.; Steinbeck, Gerhard; Launer, Lenore J.; Davies, Robert W.; Borkovich, Matthew; Harris, Tamara B.; Lin, Honghuang; Voelker, Uwe; Voelzke, Henry; Milan, David J.; Hofman, Albert; Boerwinkle, Eric; Chen, Lin Y.; Soliman, Elsayed Z.; Voight, Benjamin F.; Li, Guo; Chakravarti, Aravinda; Kubo, Michiaki; Tedrow, Usha B.; Rose, Lynda M.; Ridker, Paul M.; Conen, David; Tsunoda, Tatsuhiko; Furukawa, Tetsushi; Sotoodehnia, Nona; Xu, Siyan; Kamatani, Naoyuki; Levy, Daniel; Nakamura, Yusuke; Parvez, Babar; Mahida, Saagar; Furie, Karen L.; Rosand, Jonathan; Muhammad, Raafia; Psaty, Bruce M.; Meitinger, Thomas; Perz, Siegfried; Wichmann, H-Erich; Witteman, Jacqueline C. M.; Kao, W. H. Linda; Kathiresan, Sekar; Roden, Dan M.; Uitterlinden, Andre G.; Rivadeneira, Fernando; McKnight, Barbara; Sjogren, Marketa; Newman, Anne B.; Liu, Yongmei; Gollob, Michael H.; Melander, Olle; Tanaka, Toshihiro; Stricker, Bruno H. Ch; Felix, Stephan B.; Alonso, Alvaro; Darbar, Dawood; Barnard, John; Chasman, Daniel I.; Heckbert, Susan R.; Benjamin, Emelia J.; Gudnason, Vilmundur; Kaeaeb, Stefan			Meta-analysis identifies six new susceptibility loci for atrial fibrillation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; REPLICATION; CAVEOLIN-1; MUTATIONS; PATIENT; ZFHX3; HEART; RISK; PRX1	Atrial fibrillation is a highly prevalent arrhythmia and a major risk factor for stroke, heart failure and death(1). We conducted a genome-wide association study (GWAS) in individuals of European ancestry, including 6,707 with and 52,426 without atrial fibrillation. Six new atrial fibrillation susceptibility loci were identified and replicated in an additional sample of individuals of European ancestry, including 5,381 subjects with and 10,030 subjects without atrial fibrillation (P < 5 x 10(-8)). Four of the loci identified in Europeans were further replicated in silico in a GWAS of Japanese individuals, including 843 individuals with and 3,350 individuals without atrial fibrillation. The identified loci implicate candidate genes that encode transcription factors related to cardiopulmonary development, cardiac-expressed ion channels and cell signaling molecules.	[Ellinor, Patrick T.; Lubitz, Steven A.; Sinner, Moritz F.; Rienstra, Michiel; Milan, David J.; Mahida, Saagar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Ellinor, Patrick T.; Milan, David J.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Ellinor, Patrick T.; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Ellinor, Patrick T.; Albert, Christine M.; Tedrow, Usha B.; Ridker, Paul M.; Furie, Karen L.; Rosand, Jonathan; Chasman, Daniel I.] Harvard Univ, Sch Med, Boston, MA USA; [Lunetta, Kathryn L.; Xu, Siyan] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Lunetta, Kathryn L.; Sinner, Moritz F.; Magnani, Jared W.; Levy, Daniel; Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Lunetta, Kathryn L.; Sinner, Moritz F.; Magnani, Jared W.; Levy, Daniel; Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [Albert, Christine M.; Lubitz, Steven A.; Tedrow, Usha B.; Rose, Lynda M.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Albert, Christine M.; Tedrow, Usha B.; Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Glazer, Nicole L.; Bis, Joshua C.; Smith, Nicholas L.; Li, Guo; Sotoodehnia, Nona; Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Ritchie, Marylyn D.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Mueller-Nurasyid, Martina; Sinner, Moritz F.; Wakili, Reza; Clauss, Sebastian; Steinbeck, Gerhard; Kaeaeb, Stefan] Univ Munich, Dept Med 1, Univ Hosp Grosshadern, Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina; Stricker, Bruno H. Ch] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Krijthe, Bouwe P.; Hofman, Albert; Witteman, Jacqueline C. M.; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chung, Mina K.; Smith, Jonathan D.; Van Wagoner, David R.] Cleveland Clin, Dept Cardiovasc Med, Inst Heart & Vasc, Cleveland, OH 44106 USA; [Chung, Mina K.; Van Wagoner, David R.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Doerr, Marcus; Felix, Stephan B.] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, Greifswald, Germany; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN Ctr Genom Med, Lab Cardiovasc Dis, Kanagawa, Japan; [Roberts, Jason D.; Borkovich, Matthew; Gollob, Michael H.] Univ Ottawa, Inst Heart, Arrhythmia Res Lab, Ottawa, ON, Canada; [Smith, J. Gustav] Lund Univ, Dept Cardiol, Lund, Sweden; [Smith, J. Gustav; Voight, Benjamin F.; Kathiresan, Sekar] Broad Inst Harvard & MIT, Cambridge, MA USA; [Pfeufer, Arne; Meitinger, Thomas] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Lohman, Kurt] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Ding, Jingzhong] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Smith, Nicholas L.] Dept Vet Affairs Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Smith, Nicholas L.; Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Smith, Nicholas L.; Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Jonathan D.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Rienstra, Michiel] Univ Groningen, Dept Cardiol, Univ Med Ctr Groningen, Groningen, Netherlands; [Rice, Kenneth M.; McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Magnani, Jared W.; Lin, Honghuang; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, US NIH, Bethesda, MD 20892 USA; [Davies, Robert W.] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Cardiac Arrhythmia Ctr,Cardiovasc Div, Minneapolis, MN 55455 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Kubo, Michiaki] RIKEN Ctr Genom Med, Lab Genotyping Dev, Kanagawa, Japan; [Conen, David] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland; [Tsunoda, Tatsuhiko] RIKEN Ctr Genom Med, Lab Med Informat, Kanagawa, Japan; [Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Tokyo, Japan; [Sotoodehnia, Nona] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Xu, Siyan; Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Kamatani, Naoyuki] RIKEN Ctr Genom Med, Lab Stat Anal, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Parvez, Babar; Muhammad, Raafia; Roden, Dan M.; Darbar, Dawood] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Furie, Karen L.; Rosand, Jonathan] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Perz, Siegfried] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Neuherberg, Germany; [Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Kao, W. H. Linda] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Kao, W. H. Linda] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Uitterlinden, Andre G.; Rivadeneira, Fernando; Stricker, Bruno H. Ch] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Sjogren, Marketa; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA USA; [Liu, Yongmei] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Stricker, Bruno H. Ch] Inspectorate Hlth Care, The Hague, Netherlands; [Stricker, Bruno H. Ch] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Barnard, John] Cleveland Clin, Dept Quantitat Hlth Sci, Lerner Res Inst, Cleveland, OH 44106 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Prevent Med Sect, Boston, MA 02118 USA; [Kaeaeb, Stefan] Munich Heart Alliance, Munich, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Icelandic Heart Association; University of Iceland; Johns Hopkins University; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Ernst Moritz Arndt Universitat Greifswald; RIKEN; University of Ottawa; University of Ottawa Heart Institute; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Group Health Cooperative; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; University of Groningen; University of Washington; University of Washington Seattle; Boston University; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Ottawa; University of Ottawa Heart Institute; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; RIKEN; University of Basel; RIKEN; Tokyo Medical & Dental University (TMDU); University of Washington; University of Washington Seattle; Boston University; RIKEN; University of Tokyo; Vanderbilt University; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Vanderbilt University; Erasmus University Rotterdam; Erasmus MC; Lund University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Erasmus University Rotterdam; Erasmus MC; University of Minnesota System; University of Minnesota Twin Cities; Cleveland Clinic Foundation; Boston University; Munich Heart Alliance	Ellinor, PT (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.	pellinor@partners.org; skaab@med.uni-muenchen.de	Gudnason, Vilmundur/AAE-7126-2019; Tanaka, Toshihiro/J-9310-2014; Soliman, Elsayed Z/AAD-7135-2020; Roden, Dan/ABD-5412-2021; Rivadeneira, Fernando/O-5385-2015; Newman, Anne B./C-6408-2013; Tsunoda, Tatsuhiko/K-2061-2014; Meitinger, Thomas/O-1318-2015; Van Wagoner, David R/C-6783-2008; Müller-Nurasyid, Martina/I-8735-2018; furukawa, tetsushi/ABD-3178-2020; Levy, Daniel/ABB-2752-2021; Kaab, Stefan/H-3915-2012; Lin, Honghuang/A-3269-2019; Levy, Daniel/ABF-6873-2021; Sinner, Moritz/AAW-5043-2020; Ritchie, Marylyn/C-1114-2012; Wichmann, Heinz Erich/AAA-5695-2022; Tedrow, Usha/AFV-2528-2022; Rotter, Jerome/AAY-6598-2021; Kubo, Michiaki/N-7947-2015; Pfeufer, Arne/B-6634-2013; Li, Guo/E-5613-2012; Gudnason, Vilmundur/K-6885-2015; Alonso, Alvaro/A-4917-2010; Rice, Kenneth M/A-4150-2013; Darbar, Dawood/C-9079-2015; Wakili, Reza/F-1619-2014; Clauss, Sebastian/HDL-7189-2022; Smith, Albert Vernon/K-5150-2015; Benjamin, Emelia/E-7103-2011; Smith, Jonathan D./H-9723-2013	Gudnason, Vilmundur/0000-0001-5696-0084; Tanaka, Toshihiro/0000-0001-6201-9784; Soliman, Elsayed Z/0000-0001-5632-8150; Rivadeneira, Fernando/0000-0001-9435-9441; Newman, Anne B./0000-0002-0106-1150; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Van Wagoner, David R/0000-0001-8250-9828; Müller-Nurasyid, Martina/0000-0003-3793-5910; Lin, Honghuang/0000-0003-3043-3942; Levy, Daniel/0000-0003-1843-8724; Gudnason, Vilmundur/0000-0001-5696-0084; Alonso, Alvaro/0000-0002-2225-8323; Rice, Kenneth M/0000-0001-5779-4495; Darbar, Dawood/0000-0002-4103-5977; Clauss, Sebastian/0000-0002-5675-6128; Smith, Albert Vernon/0000-0003-1942-5845; Lunetta, Kathryn/0000-0002-9268-810X; Benjamin, Emelia/0000-0003-4076-2336; Rienstra, Michiel/0000-0002-2581-070X; Meitinger, Thomas/0000-0002-8838-8403; Ellinor, Patrick/0000-0002-2067-0533; Volker, Uwe/0000-0002-5689-3448; Chen, Lin/0000-0002-0700-814X; Ozaki, Kouichi/0000-0003-0028-1570; Glazer, Nicole/0000-0002-6397-609X; Albert, Christine/0000-0002-2081-1121; Gollob, Michael/0000-0003-0242-5208; Melander, Olle/0000-0002-2581-484X; Dorr, Marcus/0000-0001-7471-475X; Voight, Benjamin/0000-0002-6205-9994; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Smith, Jonathan D./0000-0002-0415-386X	NCATS NIH HHS [UL1 TR000124] Funding Source: Medline; NHLBI NIH HHS [U19 HL065962, U19 HL065962-12, R01 HL092217-04, R21 HL106092, L30 HL097675, R01 HL104156, K24 HL105780, R01 HL092217, R01 HL090620, R01 HL105756] Funding Source: Medline; NIDA NIH HHS [R21 DA027021] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090620, R01HL092217, ZIAHL006001, R01HL105756, R01HL104156, R21HL106092, K24HL105780, U19HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007270, ZIAAG007380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027021] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arola AM, 2007, MOL GENET METAB, V90, P435, DOI 10.1016/j.ymgme.2006.12.008; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Beqqali A, 2010, J CELL SCI, V123, P1141, DOI 10.1242/jcs.063859; Bergwerff M, 2000, VIRCHOWS ARCH, V436, P12, DOI 10.1007/PL00008193; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Ihida-Stansbury K, 2004, CIRC RES, V94, P1507, DOI 10.1161/01.RES.0000130656.72424.20; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Lin JJ, 2008, BIOCHEM CELL BIOL, V86, P405, DOI [10.1139/O08-118, 10.1139/o08-118]; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Matsuura T, 2002, MOL GENET METAB, V76, P207, DOI 10.1016/S1096-7192(02)00038-0; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Sinner MF, 2008, EUR HEART J, V29, P907, DOI 10.1093/eurheartj/ehm619; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	30	422	435	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					670	U88		10.1038/ng.2261	http://dx.doi.org/10.1038/ng.2261			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22544366	Green Accepted			2022-12-17	WOS:000304551100013
J	Gharavi, AG; Kiryluk, K; Choi, M; Li, YF; Hou, P; Xie, JY; Sanna-Cherchi, S; Men, CJ; Julian, BA; Wyatt, RJ; Novak, J; He, JC; Wang, HY; Lv, JC; Zhu, L; Wang, WM; Wang, ZH; Yasuno, K; Gunel, M; Mane, S; Umlauf, S; Tikhonova, I; Beerman, I; Savoldi, S; Magistroni, R; Ghiggeri, GM; Bodria, M; Lugani, F; Ravani, P; Ponticelli, C; Allegri, L; Boscutti, G; Frasca, G; Amore, A; Peruzzi, L; Coppo, R; Izzi, C; Viola, BF; Prati, E; Salvadori, M; Mignani, R; Gesualdo, L; Bertinetto, F; Mesiano, P; Amoroso, A; Scolari, F; Chen, N; Zhang, H; Lifton, RP				Gharavi, Ali G.; Kiryluk, Krzysztof; Choi, Murim; Li, Yifu; Hou, Ping; Xie, Jingyuan; Sanna-Cherchi, Simone; Men, Clara J.; Julian, Bruce A.; Wyatt, Robert J.; Novak, Jan; He, John C.; Wang, Haiyan; Lv, Jicheng; Zhu, Li; Wang, Weiming; Wang, Zhaohui; Yasuno, Kasuhito; Gunel, Murat; Mane, Shrikant; Umlauf, Sheila; Tikhonova, Irina; Beerman, Isabel; Savoldi, Silvana; Magistroni, Riccardo; Ghiggeri, Gian Marco; Bodria, Monica; Lugani, Francesca; Ravani, Pietro; Ponticelli, Claudio; Allegri, Landino; Boscutti, Giuliano; Frasca, Giovanni; Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna; Izzi, Claudia; Viola, Battista Fabio; Prati, Elisabetta; Salvadori, Maurizio; Mignani, Renzo; Gesualdo, Loreto; Bertinetto, Francesca; Mesiano, Paola; Amoroso, Antonio; Scolari, Francesco; Chen, Nan; Zhang, Hong; Lifton, Richard P.			Genome-wide association study identifies susceptibility loci for IgA nephropathy	NATURE GENETICS			English	Article							GALACTOSE-DEFICIENT IGA1; HLA-DR; RISK; VARIANTS; CFH; HAPLOTYPE; LINKAGE; GLOMERULONEPHRITIS; IMMUNOPROTEASOME; REPLICATION	We carried out a genome-wide association study of IgA nephropathy, a major cause of kidney failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with targeted follow up in Chinese and European cohorts comprising 1,950 cases and 1,920 controls. We identified three independent loci in the major histocompatibility complex, as well as a common deletion of CFHR1 and CFHR3 at chromosome 1q32 and a locus at chromosome 22q12 that each surpassed genome-wide significance (P values for association between 1.59 x 10(-26) and 4.84 x 10(-9) and minor allele odds ratios of 0.63-0.80). These five loci explain 4-7% of the disease variance and up to a tenfold variation in interindividual risk. Many of the alleles that protect against IgA nephropathy impart increased risk for other autoimmune or infectious diseases, and IgA nephropathy risk allele frequencies closely parallel the variation in disease prevalence among Asian, European and African populations, suggesting complex selective pressures.	[Gharavi, Ali G.; Kiryluk, Krzysztof; Li, Yifu; Hou, Ping; Xie, Jingyuan; Sanna-Cherchi, Simone; Lugani, Francesca] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10027 USA; [Choi, Murim; Men, Clara J.; Yasuno, Kasuhito; Gunel, Murat; Mane, Shrikant; Umlauf, Sheila; Tikhonova, Irina; Beerman, Isabel; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Hou, Ping; Wang, Haiyan; Lv, Jicheng; Zhu, Li; Zhang, Hong] Peking Univ, Renal Div, Hosp 1, Inst Nephrol,Key Lab Renal Dis,Minist Hlth China, Beijing 100871, Peoples R China; [Xie, Jingyuan; Wang, Weiming; Wang, Zhaohui; Chen, Nan] Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Wyatt, Robert J.] Bonheur Childrens Hosp, Childrens Fdn, Res Ctr, Memphis, TN USA; [Wyatt, Robert J.] Univ Tennessee, Ctr Hlth Sci, Div Pediat Nephrol, Memphis, TN 38163 USA; [He, John C.] Mt Sinai Sch Med, Dept Med, York, NY USA; [Mane, Shrikant; Umlauf, Sheila; Tikhonova, Irina] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06510 USA; [Savoldi, Silvana] Cirie Hosp, Nephrol & Dialysis Unit, Turin, Italy; [Magistroni, Riccardo] Univ Policlin Modena, Div Nefrol Dialisi & Trapianto, Azienda Osped, Modena, Italy; [Ghiggeri, Gian Marco; Bodria, Monica; Lugani, Francesca] Uremia Ist Giannina Gaslini, Lab Pathophysiol, Genoa, Italy; [Ravani, Pietro] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Ponticelli, Claudio] Ist Sci Humanitas, Div Nefrol & Dialisi, Milan, Italy; [Allegri, Landino] Univ Parma, Nephrol Sect, Dept Clin Med Nephrol & Hlth Sci, I-43100 Parma, Italy; [Boscutti, Giuliano] Osped Gorizia, Dept Nephrol, Gorizia, Italy; [Frasca, Giovanni] Osped Riuniti, Nephrol & Dialysis Unit, Ancona, Italy; [Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna] Regina Margherita Univ Hosp, Turin, Italy; [Izzi, Claudia; Scolari, Francesco] Univ Brescia, Montichiari, Italy; [Izzi, Claudia; Scolari, Francesco] Montichiari Hosp, Div Nephrol 2, Montichiari, Italy; [Viola, Battista Fabio] Spedali Civil Brescia, Div Nephrol, I-25125 Brescia, Italy; [Prati, Elisabetta] Osped Desenzano, Dialysis Ctr, Desenzano Del Garda, Italy; [Salvadori, Maurizio] Careggi Univ Hosp, Renal Unit, Florence, Italy; [Mignani, Renzo] Osped Infermi, Div Nephrol, Rimini, Italy; [Gesualdo, Loreto] Univ Foggia, Dept Biomed Sci, Foggia, Italy; [Bertinetto, Francesca; Mesiano, Paola; Amoroso, Antonio] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	Columbia University; Howard Hughes Medical Institute; Yale University; Peking University; Shanghai Jiao Tong University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center; Icahn School of Medicine at Mount Sinai; Yale University; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Calgary; University of Parma; A.O.U. Citta della Salute e della Scienza di Torino; Ospedale Infantile Regina Margherita; University of Turin; University of Brescia; Hospital Spedali Civili Brescia; University of Florence; Azienda Ospedaliero Universitaria Careggi; Hospital of Rimini; University of Foggia; University of Turin	Gharavi, AG (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10027 USA.	ag2239@columbia.edu; richard.lifton@yale.edu	Yasuno, Katsuhito/E-1960-2012; Ravani, Pietro/J-3050-2015; Gesualdo, Loreto/K-7751-2016; scolari, francesco/AAC-5957-2022; Izzi, Claudia/AAB-7004-2022; Xie, Jingyuan/AAX-2708-2021; xie, jing/GRY-1689-2022; Beerman, Isabel/AAN-4216-2020; Izzi, Claudia/GZG-8769-2022; PERUZZI, LICIA/I-1873-2012; bodria, monica/K-2115-2016; Beerman, Isabel/Y-2555-2019; amoroso, antonio/AAL-1475-2020; Choi, Murim/AAP-9120-2021; Ghiggeri, Gian Marco/N-4712-2015; AMOROSO, ANTONIO/AAN-3884-2020; Boscutti, Giuliano/AAH-8559-2021; Magistroni, Riccardo/AAL-8753-2020; Lugani, Francesca/J-7183-2016	Yasuno, Katsuhito/0000-0002-3606-532X; Ravani, Pietro/0000-0001-6973-8570; Gesualdo, Loreto/0000-0002-4861-0911; bodria, monica/0000-0001-9690-9945; amoroso, antonio/0000-0002-9437-9407; Ghiggeri, Gian Marco/0000-0003-3659-9062; Magistroni, Riccardo/0000-0002-3319-0248; Izzi, Claudia/0000-0001-6253-3185; Beerman, Isabel/0000-0002-7758-8231; Peruzzi, Licia/0000-0002-5704-3867; Scolari, Francesco/0000-0003-0233-9705; Wyatt, Robert/0000-0001-6077-0259; LI, YIFU/0000-0002-7077-7689; Lugani, Francesca/0000-0002-4189-8561	Center for Glomerular Diseases at Columbia University; Yale Center; Yale Center for Human Genetics and Genomics;  [RC1DK087445];  [R01DK082753];  [KL2 RR24157]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082753, K23DK090207, RC1DK087445, P30DK079310] Funding Source: NIH RePORTER	Center for Glomerular Diseases at Columbia University; Yale Center; Yale Center for Human Genetics and Genomics; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to all study participants for their contribution to this work. We also thank the staff of the Yale West Campus Center for Genome Analysis for their excellent support. We also appreciate the assistance of C.V. Barker and S.Y. Woodford with sample collection. This study was supported by RC1DK087445 (A.G.G., R.P.L.), R01DK082753 (A.G.G., J.N., B.A.J. and R.J.W.) and KL2 RR24157 (K.K.), the Center for Glomerular Diseases at Columbia University, the Yale Center Translational Science Award and the Yale Center for Human Genetics and Genomics. R.P.L. is an investigator of the Howard Hughes Medical Institute.	Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Begley GS, 2005, MOL IMMUNOL, V42, P137, DOI 10.1016/j.molimm.2004.07.005; Bisceglia L, 2006, AM J HUM GENET, V79, P1130, DOI 10.1086/510135; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Coppo R, 2009, KIDNEY INT, V75, P536, DOI 10.1038/ki.2008.579; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DAMICO G, 1987, Q J MED, V64, P709; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Esashi E, 2009, EUR J IMMUNOL, V39, P1664, DOI 10.1002/eji.200839149; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Gesualdo L, 2004, KIDNEY INT, V66, P890, DOI 10.1111/j.1523-1755.2004.00831.x; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; Lin XJ, 2009, NEPHROL DIAL TRANSPL, V24, P3372, DOI 10.1093/ndt/gfp294; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Paterson AD, 2007, J AM SOC NEPHROL, V18, P2408, DOI 10.1681/ASN.2007020241; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki K, 2003, KIDNEY INT, V63, P2286, DOI 10.1046/j.1523-1755.63.6s.2.x; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tsukamoto Y, 2009, CLIN EXP NEPHROL, V13, P249, DOI 10.1007/s10157-009-0156-8; VARIS J, 1993, J CLIN PATHOL, V46, P607, DOI 10.1136/jcp.46.7.607; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Zhou XD, 2009, ARTHRITIS RHEUM-US, V60, P3807, DOI 10.1002/art.24982; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	50	422	450	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					321	U68		10.1038/ng.787	http://dx.doi.org/10.1038/ng.787			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21399633	Green Published, Green Accepted, Green Submitted			2022-12-17	WOS:000288903700011
J	Martinson, JJ; Chapman, NH; Rees, DC; Liu, YT; Clegg, JB				Martinson, JJ; Chapman, NH; Rees, DC; Liu, YT; Clegg, JB			Global distribution of the CCR5 gene 32-basepair deletion	NATURE GENETICS			English	Article							DISEASES; HIV	A mutant allele of the beta-chemokine receptor gene CCR5 bearing a 32-basepair (bp) deletion (denoted Delta ccr5) which prevents cell invasion by the primary transmitting strain of HIV-1 has recently been characterized(1-3). Homozygotes for the mutation are resistant to infection, even after repeated high-risk exposures(1,4), but this resistance appears not to be total, as isolated cases of HIV-positive deletion homozygotes are now emerging(5), The consequence of the heterozygous state is not clear, but it may delay the progression to AIDS in infected individuals(2,3,6,7). A gene frequency of approximately 10% was found for Delta ccr5 in populations of European descent, but no mutant alleles were reported in indigenous non-European populations, As the total number of non-European samples surveyed was small in comparison with the Europeans the global distribution of this mutation is far from clear. We have devised a rapid PCR assay for Delta ccr5 and used it to screen 3,342 individuals from a globally-distributed range of populations. We find that Delta ccr5 is not confined to people of European descent but is found at frequencies of 2-5% throughout Europe, the Middle East and the Indian subcontinent (Fig. 1). Isolated occurrences are seen elsewhere throughout the world, but these most likely represent recent European gene flow into the indigenous populations, The inter-population differences in Delta ccr5 frequency may influence the pattern of HIV transmission and so will need to be incorporated into future predictions of HIV levels.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Martinson, JJ (corresponding author), JOHN RADCLIFFE HOSP,INST MOL MED,MRC,MOL HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND.		; Rees, David/B-6789-2011	Martinson, Jeremy/0000-0003-4673-7238; Rees, David/0000-0003-3647-1050	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; [Anonymous], 1984, AM NAT; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COX DW, 1995, METABOLIC MOL BASES, P4125; Cox MJ, 1996, BRIT J HAEMATOL, V92, P1022, DOI 10.1046/j.1365-2141.1996.4961037.x; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEGRUTTOLA V, 1989, J CLIN EPIDEMIOL, V42, P849, DOI 10.1016/0895-4356(89)90098-X; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Fauci AS, 1996, NAT MED, V2, P966, DOI 10.1038/nm0996-966; FLINT J, 1993, HUM GENET, V91, P91; Hill CM, 1996, NATURE, V382, P668, DOI 10.1038/382668a0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0	32	422	442	0	40	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					100	103		10.1038/ng0597-100	http://dx.doi.org/10.1038/ng0597-100			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140404				2022-12-17	WOS:A1997WX02400031
J	Lee, SH; DeCandia, TR; Ripke, S; Yang, J; Sullivan, PF; Goddard, ME; Keller, MC; Visscher, PM; Wray, NR				Lee, S. Hong; DeCandia, Teresa R.; Ripke, Stephan; Yang, Jian; Sullivan, Patrick F.; Goddard, Michael E.; Keller, Matthew C.; Visscher, Peter M.; Wray, Naomi R.		Schizophrenia Psychiat Genome-Wide; Int Schizophrenia Consortium ISC; Mol Genetics Schizophrenia	Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs	NATURE GENETICS			English	Article							VARIANTS; DISEASE; TRAIT	Schizophrenia is a complex disorder caused by both genetic and environmental factors. Using 9,087 affected individuals, 12,171 controls and 915,354 imputed SNPs from the Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (PGC-SCZ), we estimate that 23% (s.e. = 1%) of variation in liability to schizophrenia is captured by SNPs. We show that a substantial proportion of this variation must be the result of common causal variants, that the variance explained by each chromosome is linearly related to its length (r = 0.89, P = 2.6 x 10(-8)), that the genetic basis of schizophrenia is the same in males and females, and that a disproportionate proportion of variation is attributable to a set of 2,725 genes expressed in the central nervous system (CNS; P = 7.6 x 10(-8)). These results are consistent with a polygenic genetic architecture and imply more individual SNP associations will be detected for this disease as sample size increases.	[Lee, S. Hong; Visscher, Peter M.; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lee, S. Hong; Yang, Jian; Visscher, Peter M.; Wray, Naomi R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [DeCandia, Teresa R.; Keller, Matthew C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [DeCandia, Teresa R.; Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] MIT, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Ripke, Stephan] Harvard Univ, Cambridge, MA 02138 USA; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Goddard, Michael E.] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Melbourne, Vic, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of Melbourne	Wray, NR (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	naomi.wray@uq.edu.au	Hartmann, Annette/AAS-6331-2021; Visscher, Peter/ABB-6151-2020; Ripke, Stephan/AAK-5486-2021; van Os, Jim/C-2113-2014; Hansen, Thomas Folkmann/O-5965-2014; Yang, Jian/A-5852-2010; Lee, Sang Hong/A-2569-2011; Wray, Naomi/C-8639-2015; Andreassen, Ole A./AAY-7531-2020; Konte, Bettina/AAT-1142-2021; Mowry, Bryan/G-5046-2010	Visscher, Peter/0000-0002-2143-8760; Hansen, Thomas Folkmann/0000-0001-6703-7762; Yang, Jian/0000-0003-2001-2474; Lee, Sang Hong/0000-0001-9701-2718; Wray, Naomi/0000-0001-7421-3357; Konte, Bettina/0000-0001-5287-308X; ripke, stephan/0000-0003-3622-835X; Mowry, Bryan/0000-0002-4115-5645; Goddard, Michael/0000-0001-9917-7946; KELLER, MATTHEW/0000-0002-6075-9882	Australian National Health and Medical Research Council [389892, 442915, 496688, 613672, 613601]; Australian Research Council [DP0770096, DP1093502, FT0991360]; US National Institute of Mental Health [MH085812]; Netherlands Scientific Organization (NWO) [480-05-003]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059586, R01MH052618, P50MH066392, R01MH061884, R01MH077139, R01MH059565, R01MH059587, R01MH059588, R01MH059566, K01MH085812, P30MH074543, N01MH090001, U01MH046289, U01MH046318, U01MH079470, U01MH079469, R01MH078075, R01MH060870, R01MH061675, R01MH067257, R01MH059571, K23MH001760, R01MH080403, R01MH085542, R01MH060879, U01MH085520, R01MH071681, R01MH058693, R01MH079800, R01MH074027, R01MH081800, U01MH046276, R01MH084098, R01MH085548] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. D. Gordon for technical assistance. We acknowledge funding from the Australian National Health and Medical Research Council (389892, 442915, 496688, 613672 and 613601), the Australian Research Council (DP0770096, DP1093502 and FT0991360) and the US National Institute of Mental Health (MH085812). This research utilized the Cluster Computer, which is funded by the Netherlands Scientific Organization (NWO; 480-05-003). Acknowledgments for PGC-SCZ are listed in the Supplementary Note.	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Gilmour AR., 2006, ASREML USER GUIDE RE; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; McClellan J, 2010, JAMA-J AM MED ASSOC, V303, P2523, DOI 10.1001/jama.2010.869; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456	27	421	424	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					247	U35		10.1038/ng.1108	http://dx.doi.org/10.1038/ng.1108			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22344220	Green Accepted, Green Submitted			2022-12-17	WOS:000300843600006
J	Brest, P; Lapaquette, P; Souidi, M; Lebrigand, K; Cesaro, A; Vouret-Craviari, V; Mari, B; Barbry, P; Mosnier, JF; Hebuterne, X; Harel-Bellan, A; Mograbi, B; Darfeuille-Michaud, A; Hofman, P				Brest, Patrick; Lapaquette, Pierre; Souidi, Mouloud; Lebrigand, Kevin; Cesaro, Annabelle; Vouret-Craviari, Valerie; Mari, Bernard; Barbry, Pascal; Mosnier, Jean-Francois; Hebuterne, Xavier; Harel-Bellan, Annick; Mograbi, Baharia; Darfeuille-Michaud, Arlette; Hofman, Paul			A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; AUTOPHAGY; EXPRESSION; COLI	Susceptibility to Crohn's disease, a complex inflammatory disease, is influenced by common variants at many loci. The common exonic synonymous SNP (c.313C>T) in IRGM, found in strong linkage disequilibrium with a deletion polymorphism, has been classified as non-causative because of the absence of an alteration in the IRGM protein sequence or splice sites. Here we show that a family of microRNAs (miRNAs), miR-196, is overexpressed in the inflammatory intestinal epithelia of individuals with Crohn's disease and downregulates the IRGM protective variant (c.313C) but not the risk-associated allele (c.313T). Subsequent loss of tight regulation of IRGM expression compromises control of intracellular replication of Crohn's disease-associated adherent invasive Escherichia coli by autophagy. These results suggest that the association of IRGM with Crohn's disease arises from a miRNA-based alteration in IRGM regulation that affects the efficacy of autophagy, thereby implicating a synonymous polymorphism as a likely causal variant.	[Brest, Patrick; Cesaro, Annabelle; Vouret-Craviari, Valerie; Hebuterne, Xavier; Mograbi, Baharia; Hofman, Paul] Fac Med Nice, INSERM, ERI 21, EA4319, F-06034 Nice, France; [Brest, Patrick; Lebrigand, Kevin; Cesaro, Annabelle; Vouret-Craviari, Valerie; Mari, Bernard; Barbry, Pascal; Hebuterne, Xavier; Mograbi, Baharia; Hofman, Paul] Univ Nice Sophia Antipolis, Nice, France; [Lapaquette, Pierre; Darfeuille-Michaud, Arlette] Univ Auvergne, Clermont Univ, Jeune Equipe JE 2526, Clermont Ferrand, France; [Lapaquette, Pierre; Darfeuille-Michaud, Arlette] INRA, USC 2018, Clermont Ferrand, France; [Souidi, Mouloud; Harel-Bellan, Annick] Univ Paris 11, FRE 3239, Villejuif, France; [Souidi, Mouloud; Harel-Bellan, Annick] CNRS, Villejuif, France; [Lebrigand, Kevin; Mari, Bernard; Barbry, Pascal] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; [Mosnier, Jean-Francois] Univ Nantes, EA4273, Nantes, France; [Hebuterne, Xavier] Hop Archet, Ctr Hosp Univ Nice, Serv Gastroenterol, Nice, France; [Hofman, Paul] Hop Louis Pasteur, Ctr Hosp Univ Nice, Ctr Ressource Biol, INSERM, F-06002 Nice, France; [Hofman, Paul] Hop Louis Pasteur, Ctr Hosp Univ Nice, Lab Pathol Clin & Expt, F-06002 Nice, France	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Nantes Universite; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Hofman, P (corresponding author), Fac Med Nice, INSERM, ERI 21, EA4319, U210, F-06034 Nice, France.	arlette.darfeuille-michaud@u-clermont1.fr; hofman@unice.fr	brest, patrick/B-7311-2012; Cesaro, Annabelle/AAX-3177-2020; Lapaquette, Pierre/AAF-5537-2020; Mograbi, Baharia/Q-7953-2019; Mograbi, Baharia/N-5531-2018; Hofman, Paul/P-7654-2018; Mari, Bernard P/GVS-3100-2022; SOUIDI, Mouloud/ABI-1444-2020; Harel-Bellan, Annick/M-9795-2015; Mari, Bernard P/F-8960-2013; Mari, Bernard P/D-7445-2015; Barbry, Pascal/O-5021-2016; Mari, Bernard/Q-5832-2019	brest, patrick/0000-0002-1252-4747; Hofman, Paul/0000-0003-0431-9353; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Barbry, Pascal/0000-0001-9632-6483; Mari, Bernard/0000-0002-0422-9182; Harel-Bellan, Annick/0000-0002-2339-153X; Lapaquette, Pierre/0000-0002-2680-351X; Mograbi, Baharia/0000-0002-1025-3429	Ministere de la Recherche et de la Technologie [JE2526]; INRA [USC 2018]; Association F. Aupetit; Institut National du Cancer [07/3D1616/Pdoc-110-32/NG-NC, PL0079, INFLACOL]; European Community [MICROENVIMET, FP7-HEALTH-F2-2008-201279]; Association pour la Recherche sur le Cancer (ARC), Villejuif, France; Integrated Project SIROCCO [LSHG-CT-2006-037900]; French clinical research projects [PHRC-2010]; Infectiopole Sud PACA	Ministere de la Recherche et de la Technologie; INRA; Association F. Aupetit; Institut National du Cancer(Institut National du Cancer (INCA) France); European Community(European Commission); Association pour la Recherche sur le Cancer (ARC), Villejuif, France(Fondation ARC pour la Recherche sur le Cancer); Integrated Project SIROCCO; French clinical research projects; Infectiopole Sud PACA	This work was supported by grants from the Ministere de la Recherche et de la Technologie (JE2526, A. D.-M.), by INRA (USC 2018, A. D.-M.) by the Association F. Aupetit (A. D.-M. and V. V.-C.), by the Institut National du Cancer (07/3D1616/Pdoc-110-32/NG-NC (P. Brest), PL0079 (P. Barbry) and INFLACOL (P. H.)), the European Community (P. Barbry and B. Mari; MICROENVIMET, FP7-HEALTH-F2-2008-201279), Association pour la Recherche sur le Cancer (ARC), Villejuif, France (V. V.-C.), Integrated Project SIROCCO LSHG-CT-2006-037900 (A.H.-B.), French clinical research projects funding program 'MUTCROHN' (PHRC-2010) (X. H.) and the Infectiopole Sud PACA (P. H.). The confocal microscope was the property of the Universite d'Auvergne. The authors would like to thank E. Selva, V. Gavric-Tanga, K. Havet, O. Bordone, G. Cane, M. Ohanna and A. Chargui for their excellent technical assistance.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; Cesaro A, 2009, AM J PHYSIOL-GASTR L, V296, pG1332, DOI 10.1152/ajpgi.90641.2008; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	24	421	440	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					242	U24		10.1038/ng.762	http://dx.doi.org/10.1038/ng.762			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21278745				2022-12-17	WOS:000287693800015
J	Rudolph, KL; Millard, M; Bosenberg, MW; DePinho, RA				Rudolph, KL; Millard, M; Bosenberg, MW; DePinho, RA			Telomere dysfunction and evolution of intestinal carcinoma in mice and humans	NATURE GENETICS			English	Letter							COMPARATIVE GENOMIC HYBRIDIZATION; COLORECTAL-CANCER; CHROMOSOMAL GAINS; DEFICIENT MICE; MOUSE; NEOPLASIA; TUMORIGENESIS; PROGRESSION; MUTATION; CELLS	Telomerase activation is a common feature of advanced human cancers' and facilitates the malignant transformation of cultured human cells(2) and in mice(3,4). These experimental observations are in accord with the presence of robust telomerase activity in more advanced stages of human colorectal carcinogenesis(5-7). However, the occurrence of colon carcinomas in telomerase RNA (Terc)-null, p53-mutant mice(8) has revealed complex interactions between telomere dynamics, checkpoint responses and carcinogenesis9. We therefore sought to determine whether telomere dysfunction exerts differential effects on cancer initiation versus progression of mouse and human intestinal neoplasia. In successive generations of Apc(Min) Terc(-/-) mice(10,11). progressive telomere dysfunction led to an increase in initiated lesions (microscopic adenomas), yet a significant decline in the multiplicity and size of macroscopic adenomas. That telomere dysfunction also contributes to human colorectal carcinogenesis is supported by the appearance of anaphase bridges (a correlate of telomere dysfunction) at the adenomaearly carcinoma transition, a transition recognized for marked chromosomal instability(12-15). Together. these data are consistent with a model in which telomere dysfunction promotes the chromosomal instability that drives early carcinogenesis, while telomerase activation restores genomic stability to a level permissive for tumor progression. We propose that early and transient telomere dysfunction is a major mechanism underlying chromosomal instability of human cancer.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30623 Hannover, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Hannover Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.			Rudolph, Karl Lenhard/0000-0002-4839-2862; DePinho, Ronald/0000-0002-5625-577X				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; CHADENEAU C, 1995, CANCER RES, V55, P2533; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hanahan D, 2000, NATURE, V406, P573, DOI 10.1038/35020662; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Luongo C, 1996, GENE CHROMOSOME CANC, V17, P194, DOI 10.1002/1098-2264(199611)17:3<194::AID-GCC2870170302>3.0.CO;2-E; McClintock B, 1941, GENETICS, V26, P234; Meijer GA, 1998, J CLIN PATHOL, V51, P901, DOI 10.1136/jcp.51.12.901; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tang RP, 1998, CANCER RES, V58, P4052; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; YOUNG J, 1993, HUM MUTAT, V2, P351, DOI 10.1002/humu.1380020505	31	421	441	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					155	159		10.1038/88871	http://dx.doi.org/10.1038/88871			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381263				2022-12-17	WOS:000169011800018
J	van den Boogaard, MJH; Dorland, M; Beemer, FA; van Amstel, HKP				van den Boogaard, MJH; Dorland, M; Beemer, FA; van Amstel, HKP			MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans	NATURE GENETICS			English	Article							PALATE; LIP; PREVALENCE		Univ Utrecht, Med Ctr, Dept Med Genet, Utrecht, Netherlands	Utrecht University	van den Boogaard, MJH (corresponding author), Univ Utrecht, Med Ctr, Dept Med Genet, Utrecht, Netherlands.							Christensen K, 1996, AM J HUM GENET, V58, P182; Croen LA, 1998, AM J MED GENET, V79, P42, DOI 10.1002/(SICI)1096-8628(19980827)79:1<42::AID-AJMG11>3.0.CO;2-M; FITZPATRICK D, 1993, J CRAN GENET DEV BIO, V13, P230; FRASER FC, 1970, AM J HUM GENET, V22, P336; HEWITT JE, 1991, GENOMICS, V11, P670, DOI 10.1016/0888-7543(91)90074-O; Hu GZ, 1998, MOL CELL BIOL, V18, P6044, DOI 10.1128/MCB.18.10.6044; Lidral AC, 1998, AM J HUM GENET, V63, P557, DOI 10.1086/301956; Murray JC, 1997, CLEFT PALATE-CRAN J, V34, P7, DOI 10.1597/1545-1569(1997)034<0007:CAESOC>2.3.CO;2; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schutte BC, 1999, HUM MOL GENET, V8, P1853, DOI 10.1093/hmg/8.10.1853; Tolarova MM, 1998, AM J MED GENET, V75, P126; VANDERAS AP, 1987, CLEFT PALATE J, V24, P216; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224	15	421	430	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					342	343		10.1038/74155	http://dx.doi.org/10.1038/74155			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742093				2022-12-17	WOS:000086192800009
J	Hattersley, AT; Beards, F; Ballantyne, E; Appleton, M; Harvey, R; Ellard, S				Hattersley, AT; Beards, F; Ballantyne, E; Appleton, M; Harvey, R; Ellard, S			Mutations in the glucokinase gene of the fetus result in reduced birth weight	NATURE GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; FETAL GROWTH; INSULIN; HYPERGLYCEMIA; CHILDREN; LINKAGE; DEFECT; YOUNG; SIZE	Low birth weight and fetal thinness have been associated with non-insulin dependent diabetes mellitus (NIDDM) and insulin resistance in childhood and adulthood(1-6). It has been proposed that this association results from fetal programming in response to the intrauterine environment(7,8). An alternative explanation is that the same genetic influences alter both intrauterine growth and adult glucose tolerance. Fetal insulin secretion in response to maternal glycaemia plays a key role in fetal growth, and adult insulin secretion is a primary determinant of glucose tolerance. We hypothesized that a defect in the sensing of glucose by the pancreas, caused by a heterozygous mutation in the glucokinase gene(9), could reduce fetal growth and birth weight in addition to causing hyperglycaemia after birth. In 58 offspring, where one parent has a glucokinase mutation, the inheritance of a glucokinase mutation by the fetus resulted in a mean reduction of birth weight of 533 g (P=0.002). In 19 of 21 sibpairs discordant for the presence of a glucokinase mutation, the child with the mutation had a lower birth weight, with a mean difference of 521 g (P=0.0002). Maternal hyperglycaemia due to a glucokinase mutation resulted in a mean increase in birth weight of 601 g (P=0.001). The effects of maternal and fetal glucokinase mutations on birth weight were additive. We propose that these changes in birth weight reflect changes in fetal insulin secretion which are influenced directly by the fetal genotype and indirectly, through maternal hyperglycaemia, by the maternal genotype. This observation suggests that variation in fetal growth could be used in the assessment of the role of genes which modify either insulin secretion or insulin action.	Univ Exeter, Postgrad Med Sch, Dept Vasc Med & Diabet Res, Exeter EX2 5AX, Devon, England; Dr Grays Hosp, Elgin IV30 1SN, Moray, Scotland	University of Exeter	Hattersley, AT (corresponding author), Univ Exeter, Postgrad Med Sch, Dept Vasc Med & Diabet Res, Barrack Rd, Exeter EX2 5AX, Devon, England.			Ellard, Sian/0000-0002-7620-5526; Hattersley, Andrew/0000-0001-5620-473X				Barker D J, 1992, Paediatr Perinat Epidemiol, V6, P35, DOI 10.1111/j.1365-3016.1992.tb00741.x; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; BEARDS FE, 1998, DIABETIC MED; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; DONOHUE WL, 1954, J PEDIATR-US, V45, P505, DOI 10.1016/S0022-3476(54)80113-2; ELSAS LJ, 1985, AM J HUM GENET, V37, P73; Frayling TM, 1997, DIABETES, V46, P720, DOI 10.2337/diabetes.46.4.720; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALES CN, 1994, DIABETOLOGIA, V37, pS162, DOI 10.1007/BF00400840; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; LAW CM, 1995, DIABETIC MED, V12, P24, DOI 10.1111/j.1464-5491.1995.tb02057.x; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; PEDERSON J, 1977, PREGNANT DIABETIC HE; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; RANDLE PJ, 1993, DIABETOLOGIA, V36, P269, DOI 10.1007/BF00400227; STOFFEL M, 1992, NAT GENET, V2, P153, DOI 10.1038/ng1092-153; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; TANNER JM, 1970, ARCH DIS CHILD, V45, P566, DOI 10.1136/adc.45.242.566; VELHO G, 1992, LANCET, V340, P444, DOI 10.1016/0140-6736(92)91768-4; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; WRIGHT NM, 1993, AM J DIS CHILD, V147, P607; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x	27	421	429	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					268	270		10.1038/953	http://dx.doi.org/10.1038/953			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662401				2022-12-17	WOS:000074565900024
J	Burmeister, M; Novak, T; Liang, MY; Basu, S; Ploder, L; Hawes, NL; Vidgen, D; Hoover, F; Goldman, D; Kalnins, VI; Roderick, TH; Taylor, BA; Hankin, MH; McInnes, RR				Burmeister, M; Novak, T; Liang, MY; Basu, S; Ploder, L; Hawes, NL; Vidgen, D; Hoover, F; Goldman, D; Kalnins, VI; Roderick, TH; Taylor, BA; Hankin, MH; McInnes, RR			Ocular retardation mouse caused by Chx10 homeobox null allele: Impaired retinal progenitor proliferation and bipolar cell differentiation	NATURE GENETICS			English	Article							RAT RETINA; MAMMALIAN RETINA; PROTEIN; LOCUS; GENE; MICE; EYE; EXPRESSION; ANTIBODIES; DISRUPTION	Ocular retardation (or) is a murine eye mutation causing microphthalmia, a thin hypocellular retina and optic nerve aplasia. Here we show that mice carrying the or(j) allele have a premature stop codon in the homeobox of the Chx10 gene, a gene expressed at high levels in uncommitted retinal progenitor cells and mature bipolar cells. No CHX10 protein was detectable in the retinal neuroepithelium of or(j) homozygotes. The loss of CHX10 leads both to reduced proliferation of retinal progenitors and to a specific absence of differentiated bipolar cells. Other major retinal cell types were present and correctly positioned in the mutant retina, although rod outer segments were short and retinal lamination was incomplete. These results indicate that Chx10 is an essential component in the network of genes required for the development of the mammalian eye, with profound effects on retinal progenitor proliferation and bipolar cell specification or differentiation.	HOSP SICK CHILDREN, DEPT PEDIAT, TORONTO, ON M5G 1X8, CANADA; HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT PSYCHIAT, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON M5S 1A8, CANADA; MED COLL OHIO, DEPT ANAT & NEUROBIOL, TOLEDO, OH 43614 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA; UNIV TORONTO, DEPT ANAT & CELL BIOL, TORONTO, ON M5S 1A8, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; Jackson Laboratory; University of Toronto			Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434	NCI NIH HHS [CA33093] Funding Source: Medline; NIGMS NIH HHS [GM18684] Funding Source: Medline; NINDS NIH HHS [NS26777] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026777, R55NS026777] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; BARNSTABLE CJ, 1983, COLD SPRING HARB SYM, V48, P863, DOI 10.1101/SQB.1983.048.01.089; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CONDIE BG, 1994, NATURE, V371, P537, DOI 10.1038/371537a0; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; Dickson Barry, 1993, P1327; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; DRAGER UC, 1984, J NEUROSCI, V4, P2025; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; ERICKSON PA, 1987, EXP EYE RES, V44, P37, DOI 10.1016/S0014-4835(87)80023-4; FRANZ T, 1991, ANAT EMBRYOL, V184, P355, DOI 10.1007/BF00957897; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HANKIN MH, 1994, J NEUROBIOL, V25, P472, DOI 10.1002/neu.480250503; HAWES NL, 1980, MOUSE NEWS LETT, V63, P20; HAWES NL, 1990, MOUSE GENOME, V87, P93; Hentsch B, 1996, GENE DEV, V10, P70, DOI 10.1101/gad.10.1.70; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOOVER F, 1992, EXP EYE RES, V54, P561, DOI 10.1016/0014-4835(92)90135-F; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Humason GL., 1979, ANIMAL TISSUE TECHNI; IKEDA H, 1985, J VIROL, V55, P768, DOI 10.1128/JVI.55.3.768-777.1985; INOUE A, 1992, J BIOL CHEM, V267, P10613; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; KODAMA R, 1994, CURR OPIN GENET DEV, V4, P703, DOI 10.1016/0959-437X(94)90137-R; KONYUKHOV BV, 1975, DEV BIOL, V45, P1, DOI 10.1016/0012-1606(75)90235-3; KONYUKHOV BV, 1966, FOLIA BIOL-PRAGUE, V12, P116; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LINSER P, 1981, P NATL ACAD SCI-BIOL, V78, P7190, DOI 10.1073/pnas.78.11.7190; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; REH TA, 1993, J NEUROBIOL, V24, P949, DOI 10.1002/neu.480240708; ROBB RM, 1978, INVEST OPHTH VIS SCI, V17, P468; SHAW G, 1984, EUR J CELL BIOL, V33, P95; Sidman RL, 1961, STRUCTURE EYE, P487; SILVER J, 1979, DEV BIOL, V68, P175, DOI 10.1016/0012-1606(79)90252-5; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P1565, DOI 10.1177/39.11.1918930; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; SVENDSEN PC, 1995, DEVELOPMENT, V121, P1253; TAYLOR BA, 1992, CYTOGENET CELL GENET, V60, P250, DOI 10.1159/000133351; TAYLOR BA, 1975, NATURE, V256, P644, DOI 10.1038/256644a0; TAYLOR RG, 1993, GENOMICS, V16, P231, DOI 10.1006/geno.1993.1164; THEILER K, 1976, ANAT EMBRYOL, V150, P85; TRUSLOVE GM, 1962, J EMBRYOL EXP MORPH, V10, P652; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Wolff Tanya, 1993, P1277; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	58	421	426	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					376	384		10.1038/ng0496-376	http://dx.doi.org/10.1038/ng0496-376			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630490				2022-12-17	WOS:A1996UC55300015
J	Accili, D; Drago, J; Lee, EJ; Johnson, MD; Cool, MH; Salvatore, P; Asico, LD; Jose, PA; Taylor, SI; Westphal, H				Accili, D; Drago, J; Lee, EJ; Johnson, MD; Cool, MH; Salvatore, P; Asico, LD; Jose, PA; Taylor, SI; Westphal, H			Early neonatal death in mice homozygous for a null allele of the insulin receptor gene	NATURE GENETICS			English	Letter							GROWTH FACTOR-I; SUBSTRATE PHOSPHORYLATION; TYROSINE KINASE; BETA-SUBUNIT; AUTOPHOSPHORYLATION; MUTATION; LEPRECHAUNISM; EXPRESSION; BINDING; IGF-1		NICHHD, MAMMALIAN GENES & DEV LAB, BETHESDA, MD 20892 USA; GEORGETOWN UNIV, MED CTR, DEPT PEDIAT, WASHINGTON, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Accili, D (corresponding author), NIDDKD, DIABET BRANCH, BETHESDA, MD 20892 USA.			SALVATORE, Paola/0000-0002-7294-9253				ACCILI D, 1995, DIABETES METAB REV, V11, P47, DOI 10.1002/dmr.5610110105; ACCILI D, 1991, P NATL ACAD SCI USA, V88, P4708, DOI 10.1073/pnas.88.11.4708; ACCILI D, 1991, J BIOL CHEM, V266, P434; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; CARO JF, 1988, J CLIN INVEST, V81, P976, DOI 10.1172/JCI113451; CHIN JE, 1991, J BIOL CHEM, V266, P15587; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; FLORESRIVEROS JR, 1989, J BIOL CHEM, V264, P21557; FRATTALI AL, 1992, J BIOL CHEM, V267, P19521; GAROFALO RS, 1989, MOL CELL BIOL, V9, P2806, DOI 10.1128/MCB.9.7.2806; HEDO JA, 1981, BIOCHEMISTRY-US, V20, P3385, DOI 10.1021/bi00515a013; HONE J, 1995, HUM MUTAT, V6, P17, DOI 10.1002/humu.1380060105; JOSPE N, 1993, 75TH ANN M END SOC, P453; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; KROOK A, 1993, LANCET, V342, P277, DOI 10.1016/0140-6736(93)91820-C; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MAEGAWA H, 1988, J BIOL CHEM, V263, P12629; MORGAN DO, 1986, BIOCHEMISTRY-US, V25, P5560, DOI 10.1021/bi00367a032; MOSES AC, 1991, INSULIN LIKE GROWTH, P245; SCHULTZ GA, 1992, REPROD FERT DEVELOP, V4, P361, DOI 10.1071/RD9920361; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; TOBE K, 1995, J BIOL CHEM, V270, P5698, DOI 10.1074/jbc.270.11.5698; WADA J, 1993, P NATL ACAD SCI USA, V90, P10360, DOI 10.1073/pnas.90.21.10360; WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71	29	421	436	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1996	12	1					106	109		10.1038/ng0196-106	http://dx.doi.org/10.1038/ng0196-106			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528241				2022-12-17	WOS:A1996TM55500027
J	STEINGRIMSSON, E; MOORE, KJ; LAMOREUX, ML; FERREDAMARE, AR; BURLEY, SK; ZIMRING, DCS; SKOW, LC; HODGKINSON, CA; ARNHEITER, H; COPELAND, NG; JENKINS, NA				STEINGRIMSSON, E; MOORE, KJ; LAMOREUX, ML; FERREDAMARE, AR; BURLEY, SK; ZIMRING, DCS; SKOW, LC; HODGKINSON, CA; ARNHEITER, H; COPELAND, NG; JENKINS, NA			MOLECULAR-BASIS OF MOUSE MICROPHTHALMIA (MI) MUTATIONS HELPS EXPLAIN THEIR DEVELOPMENTAL AND PHENOTYPIC CONSEQUENCES	NATURE GENETICS			English	Article							LOOP-HELIX PROTEIN; DNA-BINDING; INSERTIONAL MUTATION; ZIPPER PROTEIN; TRANSCRIPTION; CELLS; LOCUS; GENE; MYC; MAX	Mutations in the mouse microphthalmia (mi) gene affect the development of a number of cell types including melanocytes, osteoclasts and mast cells. Recently, mutations in the human mi gene (MITF) were found in patients with Waardenburg Syndrome type 2 (WS2), a dominantly inherited syndrome associated with hearing loss and pigmentary disturbances. We have characterized the molecular defects associated with eight murine mi mutations, which vary in both their mode of inheritance and in the cell types they affect. These molecular data, combined with the extensive body of genetic data accumulated for murine mi, shed light on the phenotypic and developmental consequences of mi mutations and offer a mouse model for WS2.	NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702; TEXAS A&M UNIV,COLL VET MED,DEPT VET PATHOBIOL,COLLEGE STN,TX 77843; ROCKEFELLER UNIV,HOWARD HUGHES MED INST,MOLEC BIOPHYS LABS,NEW YORK,NY 10021; TEXAS A&M UNIV,COLL VET MED,DEPT VET ANAT & PUBL HLTH,COLLEGE STN,TX 77843; NINCDS,VIRAL & MOLEC PATHOGENESIS LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Texas A&M University System; Texas A&M University College Station; Howard Hughes Medical Institute; Rockefeller University; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)				Steingrimsson, Eirikur/0000-0001-5826-7486; Arnheiter, Heinz/0000-0003-2537-1134; Burley, Stephen K./0000-0002-2487-9713; Skow, Loren/0000-0001-8998-359X; Hodgkinson, Colin/0000-0002-5365-8119	NCI NIH HHS [N01-CO-4600, N01-CM-37536] Funding Source: Medline; DIVISION OF CANCER TREATMENT [N01CM037536] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER TREATMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Treatment & Diagnosis)		AROLAN RV, 1994, EMBO J, V13, P360; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOUSSET K, 1993, ONCOGENE, V8, P3211; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DEOL MS, 1970, PROC R SOC SER B-BIO, V175, P201, DOI 10.1098/rspb.1970.0019; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; FISHER DE, 1991, GENE DEV, V5, P2342, DOI 10.1101/gad.5.12a.2342; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; GREEN MC, 1988, GENETIC VARIANTS STR, P236; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROBMAN AB, 1947, J HERED, V38, P381, DOI 10.1093/oxfordjournals.jhered.a105681; GRUNEBERG H, 1948, J GENET, V49, P1, DOI 10.1007/BF02986377; GRUNEBERG H, 1952, GENETICS MOUSE; HEMESATH TJ, IN PRESS MICROPHTHAL; Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOLLANDER WF, 1968, GENETICS, V60, P189; HOLLANDER WF, 1964, MOUSE NEWS LETT, V30, P29; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KONYUKHOV B V, 1968, Genetica (Dordrecht), V4, P65; KRAKOWSKY JM, 1993, TRANSGENIC RES, V2, P14, DOI 10.1007/BF01977676; KRETZNER L, 1993, NEGATIVE REGULATION, P75; LAMOREUX ML, 1992, J HERED, V83, P435, DOI 10.1093/oxfordjournals.jhered.a111247; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; LERNER AB, 1986, MOUSE NEWS LETT, V74, P125; MARKERT CL, 1956, GENETICS, V41, P429; MARKS SC, 1981, AM J ANAT, V161, P1, DOI 10.1002/aja.1001610102; MILLER DOROTHEA STARBUCK, 1963, RADIATION RES, V19, P184; MINER G, 1968, MOUSE NEWS LETT, V38, P25; PACKER SO, 1967, J EXP ZOOL, V165, P21, DOI 10.1002/jez.1401650103; RAZ E, 1991, GENETICS, V129, P191; ROMAN C, 1991, SCIENCE, V254, P94, DOI 10.1126/science.1840705; SILVERS WK, 1979, MODEL MAMMALIAN GENE, P268; SOUTHARD JL, 1974, MOUSE NEWS LETT, V51, P23; STECHSCHULTE DJ, 1987, J CELL PHYSIOL, V132, P565, DOI 10.1002/jcp.1041320321; STELZNER KF, 1966, MOUSE NEWS LETT, V34, P41; STELZNER KF, 1964, MOUSE NEWS LETT, V31, P40; STEVENS J, 1982, PROC R SOC SER B-BIO, V215, P405, DOI 10.1098/rspb.1982.0050; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; TACHIBANA M, 1992, MOL CELL NEUROSCI, V3, P433, DOI 10.1016/1044-7431(92)90055-7; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; THESINGH CW, 1985, BONE, V6, P43, DOI 10.1016/8756-3282(85)90406-5; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WOLFE HG, 1964, GENET RES, V5, P432, DOI 10.1017/S001667230003487X; WOLFE HG, 1962, MOUSE NEWS LETT, V26, P35; WOOD BC, 1969, MOUSE NEWS LETT, V40, P32; ZHAO GQ, 1993, MOL CELL BIOL, V13, P4505, DOI 10.1128/MCB.13.8.4505; ZIMRING DCS, 1992, THESIS TEXAS A M U	57	421	435	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					256	263		10.1038/ng1194-256	http://dx.doi.org/10.1038/ng1194-256			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874168				2022-12-17	WOS:A1994PP76500015
J	STEENMAN, MJC; RAINIER, S; DOBRY, CJ; GRUNDY, P; HORON, IL; FEINBERG, AP				STEENMAN, MJC; RAINIER, S; DOBRY, CJ; GRUNDY, P; HORON, IL; FEINBERG, AP			LOSS OF IMPRINTING OF IGF2 IS LINKED TO REDUCED EXPRESSION AND ABNORMAL METHYLATION OF H19 IN WILMS-TUMOR	NATURE GENETICS			English	Article							GROWTH-FACTOR-II; SICKLE-CELL-ANEMIA; CALCITONIN GENE; GLOBIN GENES; INSULIN GENE; CHROMOSOME-11; DNA; CANCER; POLYMORPHISMS; RELAXATION	The insulin-like growth factor-II (IGF2) and H19 genes are imprinted in mouse and human, with expression of the paternal IGF2 and maternal H19 alleles. IGF2 undergoes loss of imprinting (LOI) in most Wilms' tumours (WT). We now show that: (i) LOI of IGF2 is associated with a 80-fold down regulation of H19 expression; (ii) these changes are associated with alterations in parental-origin-specific, tissue-independent sites of DNA methylation in the H19 promoter; and (iii) loss of heterozygosity is also associated with loss of H19 expression. Thus, imprinting of a large domain of the maternal chromosome results in a reversal to a paternal epigenotype. These data also suggest an epigenetic mechanism for inactivation of H19 as a tumour suppressor gene.	UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; CROSS CANC INST,MOLEC ONCOL PROGRAM,EDMONTON T6G 1Z2,AB,CANADA; MARYLAND CTR HLTH STAT,BALTIMORE,MD 21201; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alberta; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Steenman, Marja/D-3618-2015; Steenman, Marja/S-8433-2019; Feinberg, Andrew/AAY-7666-2020	Steenman, Marja/0000-0003-4547-4448; Steenman, Marja/0000-0003-4547-4448; Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [CA54358, CA65145] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA065145, R01CA054358] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTOLOMEI M, 1994, NAT GENET, V6, P4; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BAYLIN SB, 1987, BLOOD, V70, P412; Beckers J. M., 1990, ESO Messenger, P1; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; CATTANACH BM, 1990, DEVELOPMENT, P63; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FEINBERG AP, 1993, NAT GENET, V4, P110, DOI 10.1038/ng0693-110; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOCHBERG A, 1993, MED HYPOTHESES, V41, P355, DOI 10.1016/0306-9877(93)90083-3; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; LAMBERT S, 1991, INT J CANCER, V48, P826, DOI 10.1002/ijc.2910480607; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P648; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NELKIN BD, 1984, BIOCHEM BIOPH RES CO, V123, P648, DOI 10.1016/0006-291X(84)90278-X; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; PHILLIPS JA, 1980, P NATL ACAD SCI-BIOL, V77, P2853, DOI 10.1073/pnas.77.5.2853; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RAINIER S, 1994, HUM MOL GENET, V3, P386, DOI 10.1093/hmg/3.2.386; REDEKER E, 1993, HUM MOL GENET, V2, P823, DOI 10.1093/hmg/2.6.823; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SHAPIRO ET, 1990, J CLIN INVEST, V85, P1672, DOI 10.1172/JCI114619; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; TATOF KD, 1991, CELL, V65, P201; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WILKINS RJ, 1988, LANCET, V1, P329; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; XIANG K, 1988, NUCLEIC ACIDS RES, V16, P3599, DOI 10.1093/nar/16.8.3599; YEE D, 1988, CANCER RES, V48, P6691; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	54	421	438	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					433	439		10.1038/ng0794-433	http://dx.doi.org/10.1038/ng0794-433			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920665				2022-12-17	WOS:A1994NU30600021
J	Assie, G; Letouze, E; Fassnacht, M; Jouinot, A; Luscap, W; Barreau, O; Omeiri, H; Rodriguez, S; Perlemoine, K; Rene-Corail, F; Elarouci, N; Sbiera, S; Kroiss, M; Allolio, B; Waldmann, J; Quinkler, M; Mannelli, M; Mantero, F; Papathomas, T; De Krijger, R; Tabarin, A; Kerlan, V; Baudin, E; Tissier, F; Dousset, B; Groussin, L; Amar, L; Clauser, E; Bertagna, X; Ragazzon, B; Beuschlein, F; Libe, R; de Reynies, A; Bertherat, J				Assie, Guillaume; Letouze, Eric; Fassnacht, Martin; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Elarouci, Nabila; Sbiera, Silviu; Kroiss, Matthias; Allolio, Bruno; Waldmann, Jens; Quinkler, Marcus; Mannelli, Massimo; Mantero, Franco; Papathomas, Thomas; De Krijger, Ronald; Tabarin, Antoine; Kerlan, Veronique; Baudin, Eric; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Amar, Laurence; Clauser, Eric; Bertagna, Xavier; Ragazzon, Bruno; Beuschlein, Felix; Libe, Rossella; de Reynies, Aurelien; Bertherat, Jerome			Integrated genomic characterization of adrenocortical carcinoma	NATURE GENETICS			English	Article							LONG NONCODING RNAS; COPY-NUMBER CHANGES; HUMAN CANCER; MOLECULAR CLASSIFICATION; TUMOR-SUPPRESSOR; MUTATIONS; GENE; EXPRESSION; MANAGEMENT; MICRORNA	Adrenocortical carcinomas (ACCs) are aggressive cancers originating in the cortex of the adrenal gland(1). Despite overall poor prognosis, ACC outcome is heterogeneous(2,3). We performed exome sequencing and SNP array analysis of 45 ACCs and identified recurrent alterations in known driver genes(4,5) (CTNNB1, TP53, CDKN2A, RB1 and MEN1) and in genes not previously reported in ACC (ZNRF3, DAXX, TERT and MED12), which we validated in an independent cohort of 77 ACCs. ZNRF3, encoding a cell surface E3 ubiquitin ligase(6), was the most frequently altered gene (21%) and is a potential new tumor suppressor gene related to the beta-catenin pathway. Our integrated genomic analyses further identified two distinct molecular subgroups with opposite outcome. The C1A group of ACCs with poor outcome displayed numerous mutations and DNA methylation alterations, whereas the C1B group of ACCs with good prognosis displayed specific deregulation of two microRNA clusters. Thus, aggressive and indolent ACCs correspond to two distinct molecular entities driven by different oncogenic alterations.	[Assie, Guillaume; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Libe, Rossella; Bertherat, Jerome] INSERM, Inst Cochin, U1016, Paris, France; [Assie, Guillaume; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Libe, Rossella; Bertherat, Jerome] CNRS, UMR 8104, Paris, France; [Assie, Guillaume; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Libe, Rossella; Bertherat, Jerome] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Assie, Guillaume; Barreau, Olivia; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Libe, Rossella; Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, Ctr Rare Adrenal Dis, F-75674 Paris, France; [Letouze, Eric; Elarouci, Nabila; de Reynies, Aurelien] Ligue Natl Canc, Programme Cartes Identite Tumeurs CIT, Paris, France; [Fassnacht, Martin; Sbiera, Silviu; Beuschlein, Felix] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Sbiera, Silviu; Allolio, Bruno] Univ Hosp Wurzburg, Dept Internal Med 1, Endocrine & Diabet Unit, Wurzburg, Germany; [Fassnacht, Martin; Kroiss, Matthias] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Waldmann, Jens] Univ Hosp Giessen & Marburg, Marburg, Germany; [Quinkler, Marcus] Charite, Charite Campus Mitte, Dept Clin Epidemiol, D-13353 Berlin, Germany; [Mannelli, Massimo] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Mantero, Franco] Univ Padua, Dept Med, Endocrinol Unit, Padua, Italy; [Papathomas, Thomas; De Krijger, Ronald] Erasmus MC Univ Med Ctr, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Tabarin, Antoine] Univ Hosp Bordeaux, Dept Endocrinol Diabet & Metab Dis, Bordeaux, France; [Tabarin, Antoine; Kerlan, Veronique; Baudin, Eric; Bertagna, Xavier; Libe, Rossella; Bertherat, Jerome] Rare Adrenal Canc Network COMETE, Paris, France; [Kerlan, Veronique] Univ Hosp Brest, Dept Endocrinol Diabet & Metab Dis, Brest, France; [Baudin, Eric] Univ Paris 11, Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France; [Tissier, Frederique] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Pathol, Paris, France; [Dousset, Bertrand] Hop Cochin, AP HP, Dept Digest & Endocrine Surg, F-75674 Paris, France; [Amar, Laurence] Hop Europeen Georges Pompidou, AP HP, Hypertens Unit, Paris, France; [Clauser, Eric] Hop Cochin, AP HP, Oncogenet Lab, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; University of Wurzburg; University of Wurzburg; University Hospital of Giessen & Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Florence; University of Padua; Erasmus University Rotterdam; Erasmus MC; CHU Bordeaux; CHU Brest; Universite de Bretagne Occidentale; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Bertherat, J (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.	jerome.bertherat@cch.aphp.fr	Amar, Laurence/P-5278-2017; Sbiera, Silviu/E-8128-2019; Ragazzon, Bruno/E-6541-2017; Fassnacht, Martin/N-9614-2019; de Reyniès, Aurélien/Q-8640-2017; KERLAN, Veronique/AAF-3901-2020; jouinot, anne/AAA-9297-2022; Kroiss, Matthias/B-4785-2014; Kroiss, Matthias/AAF-1624-2019; Letouzé, Eric/AAP-9924-2020; de Krijger, Ronald/J-2564-2019	Amar, Laurence/0000-0003-3942-4276; Sbiera, Silviu/0000-0002-6271-5533; Ragazzon, Bruno/0000-0001-9476-4973; Fassnacht, Martin/0000-0001-6170-6398; de Reyniès, Aurélien/0000-0002-1328-5290; jouinot, anne/0000-0002-7922-2065; Kroiss, Matthias/0000-0002-7628-3161; Kroiss, Matthias/0000-0002-7628-3161; Letouzé, Eric/0000-0002-6369-2839; Quinkler, Marcus/0000-0003-4028-1671; RONDOF, Windy/0000-0002-8160-4900; Mannelli, Massimo/0000-0002-8001-9857; Rodriguez, Stephanie/0000-0003-4520-144X; Groussin, Lionel/0000-0003-1476-475X; Dousset, Bertrand/0000-0003-2526-7345; libe, rossella/0000-0003-2881-6362; BERTHERAT, Jerome/0000-0003-2551-3008; Assie, Guillaume/0000-0001-9590-0906; kerlan, veronique/0000-0001-8105-6628	Programme Hospitaller de Recherche Clinique [AOM95201]; Seventh Framework Programme [259735]; Institut National du Cancer Recherche Translationelle [2009-RT-02]; Institut National du Cancer; INSEAM; Conny-Maeva Charitable Foundation	Programme Hospitaller de Recherche Clinique; Seventh Framework Programme(European Commission); Institut National du Cancer Recherche Translationelle(Institut National du Cancer (INCA) France); Institut National du Cancer(Institut National du Cancer (INCA) France); INSEAM; Conny-Maeva Charitable Foundation	We thank E Letourneur, R. Pelletier and S. Jacques from the Genomic platform of the Cochin Institute and P. Nietscke from the Paris Descartes University Bioinformatics platform for their technical support, J. Metal and J. Godet from the Ligue Nationale Contre le Cancer for organization of the Cartes d'Identite des Tumeurs (CIT) program, P.F. Plouin for organization of the COMETE network, the tumor bank of Cochin Hospital (B. Terris and M. Sibony) for help in sample collection, the Oncogenetic Department of Cochin Hospital (V Duchossoy), A. Steel for management of the ENSAT database, the members of our laboratories and the COMETE and ENSAT networks for support and discussions, and all the staffs of the clinical and pathology departments who were involved in patient care. This study is part of the CIT Program from La Ligue Nationale Contre le Cancer. It was supported by funding from the Programme Hospitaller de Recherche Clinique to the COMETE network (grant AOM95201), the Seventh Framework Programme (FP7/2007-2013) under grant agreement 259735, Institut National du Cancer Recherche Translationelle 2009-RT-02, the Institut National du Cancer (to the Rare Adrenal Cancer Network COMETE), INSEAM (G.A. receives a Contrat d'Interface) and the Conny-Maeva Charitable Foundation (to the laboratory of J.B.).	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barreau O, 2013, J CLIN ENDOCR METAB, V98, pE174, DOI 10.1210/jc.2012-2993; Barreau O, 2012, J CLIN ENDOCR METAB, V97, pE301, DOI 10.1210/jc.2011-1588; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Cheunsuchon P, 2011, AM J PATHOL, V179, P2120, DOI 10.1016/j.ajpath.2011.07.002; De Martino MC, 2013, J CLIN ENDOCR METAB, V98, P4080, DOI 10.1210/jc.2013-2165; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Fassnacht M, 2012, NEW ENGL J MED, V366, P2189, DOI 10.1056/NEJMoa1200966; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Fonseca AL, 2012, GENE CHROMOSOME CANC, V51, P949, DOI 10.1002/gcc.21978; GICQUEL C, 1994, J CLIN ENDOCR METAB, V78, P1444, DOI 10.1210/jc.78.6.1444; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Icard P, 2001, WORLD J SURG, V25, P891, DOI 10.1007/s00268-001-0047-y; Kebebew E, 2006, WORLD J SURG, V30, P872, DOI 10.1007/s00268-005-0329-x; Kerkhofs TMA, 2013, EUR J CANCER, V49, P2579, DOI 10.1016/j.ejca.2013.02.034; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Laurell C, 2009, EUR J ENDOCRINOL, V161, P141, DOI 10.1530/EJE-09-0068; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; LUTON JP, 1990, NEW ENGL J MED, V322, P1195, DOI 10.1056/NEJM199004263221705; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724; Rechache NS, 2012, J CLIN ENDOCR METAB, V97, pE1004, DOI 10.1210/jc.2011-3298; Ronchi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073959; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Schteingart DE, 2005, ENDOCR-RELAT CANCER, V12, P667, DOI 10.1677/erc.1.01029; Soon PSH, 2009, MINERVA ENDOCRINOL, V34, P137; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Stephan EA, 2008, MOL CANCER THER, V7, P425, DOI 10.1158/1535-7163.MCT-07-0267; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Tombol Z, 2009, ENDOCR-RELAT CANCER, V16, P895, DOI 10.1677/ERC-09-0096; Wandoloski M, 2009, SURG CLIN N AM, V89, P1255, DOI 10.1016/j.suc.2009.06.019; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	53	420	424	7	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					607	612		10.1038/ng.2953	http://dx.doi.org/10.1038/ng.2953			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747642				2022-12-17	WOS:000336870700018
J	Beaty, TH; Murray, JC; Marazita, ML; Munger, RG; Ruczinski, I; Hetmanski, JB; Liang, KY; Wu, T; Murray, T; Fallin, MD; Redett, RA; Raymond, G; Schwender, H; Jin, SC; Cooper, ME; Dunnwald, M; Mansilla, MA; Leslie, E; Bullard, S; Lidral, AC; Moreno, LM; Menezes, R; Vieira, AR; Petrin, A; Wilcox, AJ; Lie, RT; Jabs, EW; Wu-Chou, YH; Chen, PK; Wang, H; Ye, XQ; Huang, SZ; Yeow, V; Chong, SS; Jee, SH; Shi, B; Christensen, K; Melbye, M; Doheny, KF; Pugh, EW; Ling, H; Castilla, EE; Czeizel, AE; Ma, L; Field, LL; Brody, L; Pangilinan, F; Mills, JL; Molloy, AM; Kirke, PN; Scott, JM; Arcos-Burgos, M; Scott, AF				Beaty, Terri H.; Murray, Jeffrey C.; Marazita, Mary L.; Munger, Ronald G.; Ruczinski, Ingo; Hetmanski, Jacqueline B.; Liang, Kung Yee; Wu, Tao; Murray, Tanda; Fallin, M. Daniele; Redett, Richard A.; Raymond, Gerald; Schwender, Holger; Jin, Sheng-Chih; Cooper, Margaret E.; Dunnwald, Martine; Mansilla, Maria A.; Leslie, Elizabeth; Bullard, Stephen; Lidral, Andrew C.; Moreno, Lina M.; Menezes, Renato; Vieira, Alexandre R.; Petrin, Aline; Wilcox, Allen J.; Lie, Rolv T.; Jabs, Ethylin W.; Wu-Chou, Yah Huei; Chen, Philip K.; Wang, Hong; Ye, Xiaoqian; Huang, Shangzhi; Yeow, Vincent; Chong, Samuel S.; Jee, Sun Ha; Shi, Bing; Christensen, Kaare; Melbye, Mads; Doheny, Kimberly F.; Pugh, Elizabeth W.; Ling, Hua; Castilla, Eduardo E.; Czeizel, Andrew E.; Ma, Lian; Field, L. Leigh; Brody, Lawrence; Pangilinan, Faith; Mills, James L.; Molloy, Anne M.; Kirke, Peadar N.; Scott, James M.; Arcos-Burgos, Mauricio; Scott, Alan F.			A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4	NATURE GENETICS			English	Article							INTERFERON-REGULATORY-FACTOR-6 IRF6; UNIFIED APPROACH; RELATIVES; COHORT; MARKER; TESTS	Case-parent trios were used in a genome-wide association study of cleft lip with and without cleft palate. SNPs near two genes not previously associated with cleft lip with and without cleft palate (MAFB, most significant SNP rs13041247, with odds ratio (OR) per minor allele = 0.704, 95% CI 0.635-0.778, P = 1.44 x 10(-11); and ABCA4, most significant SNP rs560426, with OR = 1.432, 95% CI 1.292-1.587, P = 5.01 x 10(-12)) and two previously identified regions (at chromosome 8q24 and IRF6) attained genome-wide significance. Stratifying trios into European and Asian ancestry groups revealed differences in statistical significance, although estimated effect sizes remained similar. Replication studies from several populations showed confirming evidence, with families of European ancestry giving stronger evidence for markers in 8q24, whereas Asian families showed stronger evidence for association with MAFB and ABCA4. Expression studies support a role for MAFB in palatal development.	[Beaty, Terri H.; Ruczinski, Ingo; Hetmanski, Jacqueline B.; Liang, Kung Yee; Wu, Tao; Murray, Tanda; Fallin, M. Daniele; Schwender, Holger; Jin, Sheng-Chih] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD 21218 USA; [Murray, Jeffrey C.; Dunnwald, Martine; Mansilla, Maria A.; Leslie, Elizabeth; Petrin, Aline] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Marazita, Mary L.; Cooper, Margaret E.; Menezes, Renato; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Pittsburgh, PA USA; [Munger, Ronald G.] Utah State Univ, Logan, UT 84322 USA; [Wu, Tao] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Redett, Richard A.; Raymond, Gerald; Jabs, Ethylin W.; Wang, Hong; Scott, Alan F.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Bullard, Stephen; Lidral, Andrew C.; Moreno, Lina M.] Univ Iowa, Dept Orthodont, Iowa City, IA USA; [Wilcox, Allen J.] NIEHS, NIH, Durham, NC USA; [Lie, Rolv T.] Univ Bergen, Bergen, Norway; [Jabs, Ethylin W.; Ye, Xiaoqian] Mt Sinai Sch Med, New York, NY USA; [Wu-Chou, Yah Huei; Chen, Philip K.] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Ye, Xiaoqian] Wuhan Univ, Wuhan 430072, Peoples R China; [Huang, Shangzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yeow, Vincent] KK Womens & Childrens Hosp, Singapore, Singapore; [Chong, Samuel S.] Natl Univ Singapore, Singapore 117548, Singapore; [Jee, Sun Ha] Yonsei Univ, Seoul 120749, South Korea; [Shi, Bing] Sichuan Univ, W China Sch Stomatol, Chengdu 610064, Peoples R China; [Christensen, Kaare] Univ So Denmark, Odense, Denmark; [Melbye, Mads] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Doheny, Kimberly F.; Pugh, Elizabeth W.; Ling, Hua] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; [Castilla, Eduardo E.] Fundacao Oswaldo Cruz FIOCRUZ, Dept Genet, Rio De Janeiro, Brazil; [Czeizel, Andrew E.] Fdn Community Control Hereditary Dis, Budapest, Hungary; [Ma, Lian] Beijing Univ, Sch Stomatol, Beijing 100871, Peoples R China; [Field, L. Leigh] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Brody, Lawrence; Pangilinan, Faith] NHGRI, NIH, Bethesda, MD 20892 USA; [Mills, James L.] NICHHD, NIH, Bethesda, MD 20892 USA; [Molloy, Anne M.; Scott, James M.] Trinity Coll Dublin, Dublin, Ireland; [Kirke, Peadar N.] Hlth Res Board, Dublin, Ireland; [Arcos-Burgos, Mauricio] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Johns Hopkins University; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; Utah State University; Peking University; Johns Hopkins University; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; Icahn School of Medicine at Mount Sinai; Chang Gung Memorial Hospital; Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; KK Women's & Children's Hospital; National University of Singapore; Yonsei University; Sichuan University; University of Southern Denmark; Statens Serum Institut; Johns Hopkins University; Fundacao Oswaldo Cruz; Peking University; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Trinity College Dublin; Health Research Board - Ireland; University of Miami	Beaty, TH (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD 21218 USA.	tbeaty@jhsph.edu	Christensen, Kaare/C-2360-2009; Vargas Alfonso, Alba Lucia/E-1581-2015; Inagemp, Inct/J-9451-2013; Leslie, Elizabeth/AAP-8941-2021; Wilcox, Allen J/C-7723-2019; Liang, Kung-Yee/F-8299-2011; Petrin, Aline/I-1880-2019; Chong, Samuel S./D-8098-2015; Arcos-Burgos, Mauricio/H-1326-2017	Christensen, Kaare/0000-0002-5429-5292; Vargas Alfonso, Alba Lucia/0000-0001-7984-0560; Leslie, Elizabeth/0000-0002-5735-1712; Wilcox, Allen J/0000-0002-3376-1311; Petrin, Aline/0000-0003-2239-8120; Chong, Samuel S./0000-0002-1872-5937; Mills, James/0000-0003-4496-332X; Molloy, Anne/0000-0002-1688-9049; Jee, Sun Ha/0000-0001-9519-3068; melbye, mads/0000-0001-8264-6785; Jabs, Ethylin/0000-0001-8983-5466; Jin, Sheng Chih/0000-0002-5777-7262; Arcos-Burgos, Mauricio/0000-0002-8529-0574	National Institute for Dental and Craniofacial Research [U01-DE-018993]; International Consortium to Identify Genes and Interactions Controlling Oral Clefts [2007 2009]; National Human Genome Research Institute (NHGRI); US National Institutes of Health (NIH) [HHSN268200782096C]; March of Dimes Basil O'Connor award [FY 98-0718]; Research Grant [6-FY01-61]; NIH [R03-AR-055313, P50-DE-16215, K99-DE-018441]; Canadian Institutes of Health Research [MT-11263]; NIH National Institute of Environmental Health Sciences;  [R01-DE-014581];  [R37-DE08559];  [R01-DE09886];  [R01-DE012472];  [R01-DE014677];  [R01-DE016148];  [P50-DE016215];  [R21-DE016930];  [R01-HD390661];  [R01-DE016877];  [JK02-AEO15291]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014581, R01DE016148, R00DE018413, R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012472, R01DE009886, R21DE016930, R21DE016877, P50DE016215, K99DE018413, U01DE018993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); International Consortium to Identify Genes and Interactions Controlling Oral Clefts; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor award(March of Dimes); Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; ; ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We sincerely thank all of the families at each recruitment site for participating in this study, and we gratefully acknowledge the invaluable assistance of clinical, field and laboratory staff who contributed to making this work possible. We are particularly grateful to K. Durda and J. L'Heureux of the University of Iowa for assistance with samples and phenotype data; L. Henkle for technical assistance; J. Resick, C. Brandon and K. Bardi of the University of Pittsburgh for assistance with recruitment; W. Carricato, K. Deeley and J. Ruff of the University of Pittsburgh for sample handling; P. Patel and M. Rose of Johns Hopkins for assistance with data analysis; F. Cheah of the National University of Singapore for sample processing and management; M. Feldkamp and J. Carey of the Utah Birth Defects Network for assistance with recruitment and case review; and D. Pearce of the Utah State University for sample collection and processing. Funding to support data collection, genotyping and analysis came from several sources, some to individual investigators and some to the consortium itself. The consortium for GWAS genotyping and analysis was supported by the National Institute for Dental and Craniofacial Research through U01-DE-018993; the International Consortium to Identify Genes and Interactions Controlling Oral Clefts, 2007 2009. This project was part of the Gene, Environment Association Studies Consortium (GENEVA) funded by the National Human Genome Research Institute (NHGRI) to enhance communication and collaboration among investigators conducting genome-wide studies for a variety of complex diseases. Our group benefited greatly from the work and efforts of the entire consortium, especially the work by the Coordinating Center (directed by B. Weir and C. Laurie of the University of Washington) in data cleaning and preparation of these case-parent trios for submission to the Database for Genotypes and Phenotypes (dbGaP). We also acknowledge the leadership of T. Manolio of NHGRI and E. Harris of National Institute of Dental and Craniofacial Research. Genotyping services were provided by the Center for Inherited Disease Research (CIDR), funded through a federal contract from the US National Institutes of Health (NIH) to Johns Hopkins University (contract number HHSN268200782096C). Funding for individual investigators and the replication studies include: R01-DE-014581 (T. H. B.); R37-DE08559 (J. C. M. and M. L. M.), R01-DE09886 (M. L. M., L. M. and L. L. F.), R01-DE012472 (M. L. M.), R01-DE014677 (A. C. L. and M. L. M.), R01-DE016148 (M. L. M.), P50-DE016215 (J. C. M. and M. L. M.), R21-DE016930 (M. L. M., E. E. C. and A. E. C.), R01-HD390661 and R01-DE016877 (R. G. M.). JK02-AEO15291 (A. C. L.), March of Dimes Basil O'Connor award #FY 98-0718 and Research Grant #6-FY01-61 (A. C. L.); NIH R03-AR-055313 and NIH P50-DE-16215 (project #3) (M. D.), K99-DE-018441 (R. M.); and the Canadian Institutes of Health Research MT-11263 (L. L. F.). The Smile Train Foundation supported data collection in Chengdu (E.W.J. and B. S.). This research was supported in part by the Intramural Research Program of the NIH National Institute of Environmental Health Sciences (A.J.W.).	Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; CORNELIS MC, 2010, GENET EPIDEMIOL, DOI DOI 10.1002/GEPI.20492; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Grosen D, 2010, J MED GENET, V47, P162, DOI 10.1136/jmg.2009.069385; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Laird NM, 2008, ADV GENET, V60, P219, DOI 10.1016/S0065-2660(07)00410-5; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; MITCHELL LE, 2002, CLEFT LIP PALATE, P214; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Vieira AR, 2007, AM J MED GENET A, V143A, P2075, DOI 10.1002/ajmg.a.31884; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	22	420	453	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2010	42	6					525	U76		10.1038/ng.580	http://dx.doi.org/10.1038/ng.580			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20436469	Green Accepted, Green Submitted			2022-12-17	WOS:000278081500019
J	Yi, R; O'Carroll, D; Pasolli, HA; Zhang, ZH; Dietrich, FS; Tarakhovsky, A; Fuchs, E				Yi, R; O'Carroll, D; Pasolli, HA; Zhang, ZH; Dietrich, FS; Tarakhovsky, A; Fuchs, E			Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; HAIR FOLLICLE; ENZYME DICER; ABSENCE; BIOGENESIS; INTEGRIN; TARGETS; NICHE	During embryogenesis, multipotent progenitors within the single-layered surface epithelium differentiate to form the epidermis and its appendages. Here, we show that microRNAs (miRNAs) have an essential role in orchestrating these events. We cloned more than 100 miRNAs from skin and show that epidermis and hair follicles differentially express discrete miRNA families. To explore the functional significance of this finding, we conditionally targeted Dicer1 gene ablation in embryonic skin progenitors. Within the first week after loss of miRNA expression, cell fate specification and differentiation were not markedly impaired, and in the interfollicular epidermis, apoptosis was not markedly increased. Notably, however, developing hair germs evaginate rather than invaginate, thereby perturbing the epidermal organization. Here we characterize miRNAs in skin, the existence of which was hitherto unappreciated, and demonstrate their differential expression and importance in the morphogenesis of epithelial tissues within this vital organ.	Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Duke University	Fuchs, E (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	tarakho@rockfeller.edu; fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	O'Carroll, Donal/0000-0002-8626-2217; Pasolli, Hilda Amalia/0000-0003-3899-3530; YI, RUI/0000-0002-6934-7091	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR050452] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	29	420	469	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2006	38	3					356	362		10.1038/ng1744	http://dx.doi.org/10.1038/ng1744			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462742				2022-12-17	WOS:000235589600019
J	Clayton, DG; Walker, NM; Smyth, DJ; Pask, R; Cooper, JD; Maier, LM; Smink, LJ; Lam, AC; Ovington, NR; Stevens, HE; Nutland, S; Howson, JMM; Faham, M; Moorhead, M; Jones, HB; Falkowski, M; Hardenbol, P; Willis, TD; Todd, JA				Clayton, DG; Walker, NM; Smyth, DJ; Pask, R; Cooper, JD; Maier, LM; Smink, LJ; Lam, AC; Ovington, NR; Stevens, HE; Nutland, S; Howson, JMM; Faham, M; Moorhead, M; Jones, HB; Falkowski, M; Hardenbol, P; Willis, TD; Todd, JA			Population structure, differential bias and genomic control in a large-scale, case-control association study	NATURE GENETICS			English	Article								The main problems in drawing causal inferences from epidemiological case-control studies are confounding by unmeasured extraneous factors, selection bias and differential misclassification of exposure(1). In genetics the first of these, in the form of population structure, has dominated recent debate(2-4). Population structure explained part of the significant +11.2% inflation of test statistics we observed in an analysis of 6,322 nonsynonymous SNPs in 816 cases of type 1 diabetes and 877 population-based controls from Great Britain. The remainder of the inflation resulted from differential bias in genotype scoring between case and control DNA samples, which originated from two laboratories, causing false-positive associations. To avoid excluding SNPs and losing valuable information, we extended the genomic control method(2-5) by applying a variable downweighting to each SNP.	Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England; ParAllele BioSci, San Francisco, CA 94080 USA	University of Cambridge	Clayton, DG (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.	david.clayton@cimr.cam.ac.uk; john.todd@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Howson, Joanna/0000-0001-7618-0050; Walker, Neil/0000-0001-9796-7688; smyth, deborah/0000-0002-6330-2669	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MOORHEAD M, IN PRESS EUR J HUM G; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	16	420	432	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1243	1246		10.1038/ng1653	http://dx.doi.org/10.1038/ng1653			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16228001				2022-12-17	WOS:000233045200024
J	Lander, ES				Lander, ES			Array of hope	NATURE GENETICS			English	Article									MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.							Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Bowtell DDL, 1999, NAT GENET, V21, P25, DOI 10.1038/4455; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194	18	420	472	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21			S			3	4		10.1038/4427	http://dx.doi.org/10.1038/4427			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156NU	9915492				2022-12-17	WOS:000078008200003
J	Town, M; Jean, G; Cherqui, S; Attard, M; Forestier, L; Whitmore, SA; Callen, DF; Gribouval, O; Broyer, M; Bates, GP; van't Hoff, W; Antignac, C				Town, M; Jean, G; Cherqui, S; Attard, M; Forestier, L; Whitmore, SA; Callen, DF; Gribouval, O; Broyer, M; Bates, GP; van't Hoff, W; Antignac, C			A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis	NATURE GENETICS			English	Article							YAC CLONES; TRANSPORT; VECTOR; MAP	Nephropathic cystinosis, an autosomal recessive disorder resulting from defective lysosomal transport of cystine, is the most common inherited cause of renal Fanconi syndrome. The cystinosis gene has been mapped to chromosome 17p13. We found that the locus D17S829 was homozygously deleted in 23 out of 70 patients, and identified a novel gene, CTNS, which mapped to the deletion interval. CTNS encodes an integral membrane protein, cystinosin, with features of a lysosomal membrane protein. Eleven different mutations, all predicted to cause loss of function of the protein, were found to segregate with the disorder.	INSERM U43, F-75015 Paris, France; Guys Hosp, UMDS, Div Med & Mol Genet, London SE1 9RT, England; Univ Paris 05, Hop Necker Enfants Malad, Serv Nephrol Pediat, F-75015 Paris, France; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA, Australia; UCL, Sch Med, Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Womens & Childrens Hospital Australia; University of London; University College London; UCL Medical School	Antignac, C (corresponding author), INSERM U43, Tour Lavoisier,149 Rue Sevres, F-75015 Paris, France.	m.town@umds.ac.uk; antignac@necker.fr	ANTIGNAC, Corinne/H-8945-2017; Callen, David F/G-1975-2012; Bates, Gillian P/E-1146-2012; Gribouval, Olivier/A-7689-2015	ANTIGNAC, Corinne/0000-0002-9934-4940; Bates, Gillian P/0000-0002-4041-6305; Gribouval, Olivier/0000-0003-0238-8224; Cherqui, Stephanie/0000-0003-1240-5219				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P189, DOI 10.1093/nar/24.1.189; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Collo G, 1996, J NEUROSCI, V16, P2495; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GAHL WA, 1983, BIOCHEM J, V216, P393, DOI 10.1042/bj2160393; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; HARDWICK KG, 1990, NUCLEIC ACIDS RES, V18, P2177, DOI 10.1093/nar/18.8.2177; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jean G, 1996, AM J HUM GENET, V58, P535; KLEIN P, 1985, BIOCHIM BIOPHYS ACTA, V815, P468, DOI 10.1016/0005-2736(85)90375-X; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LEHRACH H., 1990, GENOME ANAL, P39; McDowell G, 1996, BIOCHEM MOL MED, V58, P135, DOI 10.1006/bmme.1996.0041; MCDOWELL GA, 1995, NAT GENET, V10, P246, DOI 10.1038/ng0695-246; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Peters U, 1997, EUR J HUM GENET, V5, P9, DOI 10.1159/000484725; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Song I, 1996, ARCH BIOCHEM BIOPHYS, V334, P67, DOI 10.1006/abbi.1996.0430; Stoffel W., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671	28	420	430	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					319	324		10.1038/ng0498-319	http://dx.doi.org/10.1038/ng0498-319			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537412				2022-12-17	WOS:000072755500012
J	Berndt, SI; Gustafsson, S; Magi, R; Ganna, A; Wheeler, E; Feitosa, MF; Justice, AE; Monda, KL; Croteau-Chonka, DC; Day, FR; Esko, T; Fall, T; Ferreira, T; Gentilini, D; Jackson, AU; Luan, JA; Randall, JC; Vedantam, S; Willer, CJ; Winkler, TW; Wood, AR; Workalemahu, T; Hu, YJ; Lee, SH; Liang, LM; Lin, DY; Min, JL; Neale, BM; Thorleifsson, G; Yang, J; Albrecht, E; Amin, N; Bragg-Gresham, JL; Cadby, G; den Heijer, M; Eklund, N; Fischer, K; Goel, A; Hottenga, JJ; Huffman, JE; Jarick, I; Johansson, A; Johnson, T; Kanoni, S; Kleber, ME; Konig, IR; Kristiansson, K; Kutalik, Z; Lamina, C; Lecoeur, C; Li, G; Mangino, M; McArdle, WL; Medina-Gomez, C; Muller-Nurasyid, M; Ngwa, JS; Nolte, IM; Lavinia, P; Pechlivanis, S; Perola, M; Peters, MJ; Preuss, M; Rose, LM; Shi, JX; Shungin, D; Smith, AV; Strawbridge, RJ; Surakka, I; Teumer, A; Trip, MD; Tyrer, J; Van Vliet-Ostaptchouk, JV; Vandenput, L; Waite, LL; Zhao, JH; Absher, D; Asselbergs, FW; Atalay, M; Attwood, AP; Balmforth, AJ; Basart, H; Beilby, J; Bonnycastle, LL; Brambilla, P; Bruinenberg, M; Campbell, H; Chasman, DI; Chines, PS; Collins, FS; Connell, JM; Cookson, WO; de Faire, U; de Vegt, F; Dei, M; Dimitriou, M; Edkins, S; Estrada, K; Evans, DM; Farrall, M; Ferrario, MM; Ferrieres, J; Franke, L; Frau, F; Gejman, PV; Grallert, H; Gronberg, H; Gudnason, V; Hall, AS; Hall, P; Hartikainen, AL; Hayward, C; Heard-Costa, NL; Heath, AC; Hebebrand, J; Homuth, G; Hu, FB; Hunt, SE; Hypponen, E; Iribarren, C; Jacobs, KB; Jansson, JO; Jula, A; Kahonen, M; Kathiresan, S; Kee, F; Khaw, KT; Kivimaki, M; Koenig, W; Kraja, AT; Kumari, M; Kuulasmaa, K; Kuusisto, J; Laitinen, JH; Lakka, TA; Langenberg, C; Launer, LJ; Lind, L; Lindstrom, J; Liu, JJ; Liuzzi, A; Lokki, ML; Lorentzon, M; Madden, PA; Magnusson, PK; Manunta, P; Marek, D; Marz, W; Leach, IM; McKnight, B; Medland, SE; Mihailov, E; Milani, L; Montgomery, GW; Mooser, V; Muhleisen, TW; Munroe, PB; Musk, AW; Narisu, N; Navis, G; Nicholson, G; Nohr, EA; Ong, KK; Oostra, BA; Palmer, CNA; Palotie, A; Peden, JF; Pedersen, N; Peters, A; Polasek, O; Pouta, A; Pramstaller, PP; Prokopenko, I; Putter, C; Radhakrishnan, A; Raitakari, O; Rendon, A; Rivadeneira, F; Rudan, I; Saaristo, TE; Sambrook, JG; Sanders, AR; Sanna, S; Saramies, J; Schipf, S; Schreiber, S; Schunkert, H; Shin, SY; Signorini, S; Sinisalo, J; Skrobek, B; Soranzo, N; Stancakova, A; Stark, K; Stephens, JC; Stirrups, K; Stolk, RP; Stumvoll, M; Swift, AJ; Theodoraki, EV; Thorand, B; Tregouet, DA; Tremoli, E; Van der Klauw, MM; van Meurs, JBJ; Vermeulen, SH; Viikari, J; Virtamo, J; Vitart, V; Waeber, G; Wang, ZM; Widen, E; Wild, SH; Willemsen, G; Winkelmann, BR; Witteman, JCM; Wolffenbuttel, BHR; Wong, A; Wright, AF; Zillikens, MC; Amouyel, P; Boehm, BO; Boerwinkle, E; Boomsma, DI; Caulfield, MJ; Chanock, SJ; Cupples, LA; Cusi, D; Dedoussis, GV; Erdmann, J; Eriksson, JG; Franks, PW; Froguel, P; Gieger, C; Gyllensten, U; Hamsten, A; Harris, TB; Hengstenberg, C; Hicks, AA; Hingorani, A; Hinney, A; Hofman, A; Hovingh, KG; Hveem, K; Illig, T; Jarvelin, MR; Jockel, KH; Keinanen-Kiukaanniemi, SM; Kiemeney, LA; Kuh, D; Laakso, M; Lehtimaki, T; Levinson, DF; Martin, NG; Metspalu, A; Morris, AD; Nieminen, MS; Njolstad, I; Ohlsson, C; Oldehinkel, AJ; Ouwehand, WH; Palmer, LJ; Penninx, B; Power, C; Province, MA; Psaty, BM; Qi, L; Rauramaa, R; Ridker, PM; Ripatti, S; Salomaa, V; Samani, NJ; Snieder, H; Sorensen, TIA; Spector, TD; Stefansson, K; Tonjes, A; Tuomilehto, J; Uitterlinden, AG; Uusitupa, M; van der Harst, P; Vollenweider, P; Wallaschofski, H; Wareham, NJ; Watkins, H; Wichmann, HE; Wilson, JF; Abecasis, GR; Assimes, TL; Barroso, I; Boehnke, M; Borecki, IB; Deloukas, P; Fox, CS; Frayling, T; Groop, LC; Haritunian, T; Heid, IM; Hunter, D; Kaplan, RC; Karpe, F; Moffatt, MF; Mohlke, KL; O'Connell, JR; Pawitan, Y; Schadt, EE; Schlessinger, D; Steinthorsdottir, V; Strachan, DP; Thorsteinsdottir, U; van Duijn, CM; Visscher, PM; Di Blasio, AM; Hirschhorn, JN; Lindgren, CM; Morris, AP; Meyre, D; Scherag, A; McCarthy, MI; Speliotes, EK; North, KE; Loos, RJF; Ingelsson, E				Berndt, Sonja I.; Gustafsson, Stefan; Maegi, Reedik; Ganna, Andrea; Wheeler, Eleanor; Feitosa, Mary F.; Justice, Anne E.; Monda, Keri L.; Croteau-Chonka, Damien C.; Day, Felix R.; Esko, Tonu; Fall, Tove; Ferreira, Teresa; Gentilini, Davide; Jackson, Anne U.; Luan, Jian'an; Randall, Joshua C.; Vedantam, Sailaja; Willer, Cristen J.; Winkler, Thomas W.; Wood, Andrew R.; Workalemahu, Tsegaselassie; Hu, Yi-Juan; Lee, Sang Hong; Liang, Liming; Lin, Dan-Yu; Min, Josine L.; Neale, Benjamin M.; Thorleifsson, Gudmar; Yang, Jian; Albrecht, Eva; Amin, Najaf; Bragg-Gresham, Jennifer L.; Cadby, Gemma; den Heijer, Martin; Eklund, Niina; Fischer, Krista; Goel, Anuj; Hottenga, Jouke-Jan; Huffman, Jennifer E.; Jarick, Ivonne; Johansson, Asa; Johnson, Toby; Kanoni, Stavroula; Kleber, Marcus E.; Koenig, Inke R.; Kristiansson, Kati; Kutalik, Zoltn; Lamina, Claudia; Lecoeur, Cecile; Li, Guo; Mangino, Massimo; McArdle, Wendy L.; Medina-Gomez, Carolina; Mueller-Nurasyid, Martina; Ngwa, Julius S.; Nolte, Ilja M.; Paternoster, Lavinia; Pechlivanis, Sonali; Perola, Markus; Peters, Marjolein J.; Preuss, Michael; Rose, Lynda M.; Shi, Jianxin; Shungin, Dmitry; Smith, Albert Vernon; Strawbridge, Rona J.; Surakka, Ida; Teumer, Alexander; Trip, Mieke D.; Tyrer, Jonathan; Van Vliet-Ostaptchouk, Jana V.; Vandenput, Liesbeth; Waite, Lindsay L.; Zhao, Jing Hua; Absher, Devin; Asselbergs, Folkert W.; Atalay, Mustafa; Attwood, Antony P.; Balmforth, Anthony J.; Basart, Hanneke; Beilby, John; Bonnycastle, Lori L.; Brambilla, Paolo; Bruinenberg, Marcel; Campbell, Harry; Chasman, Daniel I.; Chines, Peter S.; Collins, Francis S.; Connell, John M.; Cookson, William O.; de Faire, Ulf; de Vegt, Femmie; Dei, Mariano; Dimitriou, Maria; Edkins, Sarah; Estrada, Karol; Evans, David M.; Farrall, Martin; Ferrario, Marco M.; Ferrieres, Jean; Franke, Lude; Frau, Francesca; Gejman, Pablo V.; Grallert, Harald; Groenberg, Henrik; Gudnason, Vilmundur; Hall, Alistair S.; Hall, Per; Hartikainen, Anna-Liisa; Hayward, Caroline; Heard-Costa, Nancy L.; Heath, Andrew C.; Hebebrand, Johannes; Homuth, Georg; Hu, Frank B.; Hunt, Sarah E.; Hyppoenen, Elina; Iribarren, Carlos; Jacobs, Kevin B.; Jansson, John-Olov; Jula, Antti; Kahonen, Mika; Kathiresan, Sekar; Kee, Frank; Khaw, Kay-Tee; Kivimaki, Mika; Koenig, Wolfgang; Kraja, Aldi T.; Kumari, Meena; Kuulasmaa, Kari; Kuusisto, Johanna; Laitinen, Jaana H.; Lakka, Timo A.; Langenberg, Claudia; Launer, Lenore J.; Lind, Lars; Lindstrom, Jaana; Liu, Jianjun; Liuzzi, Antonio; Lokki, Marja-Liisa; Lorentzon, Mattias; Madden, Pamela A.; Magnusson, Patrik K.; Manunta, Paolo; Marek, Diana; Maerz, Winfried; Leach, Irene Mateo; McKnight, Barbara; Medland, Sarah E.; Mihailov, Evelin; Milani, Lili; Montgomery, Grant W.; Mooser, Vincent; Muehleisen, Thomas W.; Munroe, Patricia B.; Musk, Arthur W.; Narisu, Narisu; Navis, Gerjan; Nicholson, George; Nohr, Ellen A.; Ong, Ken K.; Oostra, Ben A.; Palmer, Colin N. A.; Palotie, Aarno; Peden, John F.; Pedersen, Nancy; Peters, Annette; Polasek, Ozren; Pouta, Anneli; Pramstaller, Peter P.; Prokopenko, Inga; Puetter, Carolin; Radhakrishnan, Aparna; Raitakari, Olli; Rendon, Augusto; Rivadeneira, Fernando; Rudan, Igor; Saaristo, Timo E.; Sambrook, Jennifer G.; Sanders, Alan R.; Sanna, Serena; Saramies, Jouko; Schipf, Sabine; Schreiber, Stefan; Schunkert, Heribert; Shin, So-Youn; Signorini, Stefano; Sinisalo, Juha; Skrobek, Boris; Soranzo, Nicole; Stancakova, Alena; Stark, Klaus; Stephens, Jonathan C.; Stirrups, Kathleen; Stolk, Ronald P.; Stumvoll, Michael; Swift, Amy J.; Theodoraki, Eirini V.; Thorand, Barbara; Tregouet, David-Alexandre; Tremoli, Elena; Van der Klauw, Melanie M.; van Meurs, Joyce B. J.; Vermeulen, Sita H.; Viikari, Jorma; Virtamo, Jarmo; Vitart, Veronique; Waeber, Gerard; Wang, Zhaoming; Widen, Elisabeth; Wild, Sarah H.; Willemsen, Gonneke; Winkelmann, Bernhard R.; Witteman, Jacqueline C. M.; Wolffenbuttel, Bruce H. R.; Wong, Andrew; Wright, Alan F.; Zillikens, M. Carola; Amouyel, Philippe; Boehm, Bernhard O.; Boerwinkle, Eric; Boomsma, Dorret I.; Caulfield, Mark J.; Chanock, Stephen J.; Cupples, L. Adrienne; Cusi, Daniele; Dedoussis, George V.; Erdmann, Jeanette; Eriksson, Johan G.; Franks, Paul W.; Froguel, Philippe; Gieger, Christian; Gyllensten, Ulf; Hamsten, Anders; Harris, Tamara B.; Hengstenberg, Christian; Hicks, Andrew A.; Hingorani, Aroon; Hinney, Anke; Hofman, Albert; Hovingh, Kees G.; Hveem, Kristian; Illig, Thomas; Jarvelin, Marjo-Riitta; Joeckel, Karl-Heinz; Keinanen-Kiukaanniemi, Sirkka M.; Kiemeney, Lambertus A.; Kuh, Diana; Laakso, Markku; Lehtimaki, Terho; Levinson, Douglas F.; Martin, Nicholas G.; Metspalu, Andres; Morris, Andrew D.; Nieminen, Markku S.; Njolstad, Inger; Ohlsson, Claes; Oldehinkel, Albertine J.; Ouwehand, Willem H.; Palmer, Lyle J.; Penninx, Brenda; Power, Chris; Province, Michael A.; Psaty, Bruce M.; Qi, Lu; Rauramaa, Rainer; Ridker, Paul M.; Ripatti, Samuli; Salomaa, Veikko; Samani, Nilesh J.; Snieder, Harold; Sorensen, Thorkild I. A.; Spector, Timothy D.; Stefansson, Kari; Tonjes, Anke; Tuomilehto, Jaakko; Uitterlinden, Andre G.; Uusitupa, Matti; van der Harst, Pim; Vollenweider, Peter; Wallaschofski, Henri; Wareham, Nicholas J.; Watkins, Hugh; Wichmann, H-Erich; Wilson, James F.; Abecasis, Goncalo R.; Assimes, Themistocles L.; Barroso, Ines; Boehnke, Michael; Borecki, Ingrid B.; Deloukas, Panos; Fox, Caroline S.; Frayling, Timothy; Groop, Leif C.; Haritunian, Talin; Heid, Iris M.; Hunter, David; Kaplan, Robert C.; Karpe, Fredrik; Moffatt, Miriam F.; Mohlke, Karen L.; O'Connell, Jeffrey R.; Pawitan, Yudi; Schadt, Eric E.; Schlessinger, David; Steinthorsdottir, Valgerdur; Strachan, David P.; Thorsteinsdottir, Unnur; van Duijn, Cornelia M.; Visscher, Peter M.; Di Blasio, Anna Maria; Hirschhorn, Joel N.; Lindgren, Cecilia M.; Morris, Andrew P.; Meyre, David; Scherag, Andr; McCarthy, Mark I.; Speliotes, Elizabeth K.; North, Kari E.; Loos, Ruth J. F.; Ingelsson, Erik			Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture	NATURE GENETICS			English	Article							BODY-MASS INDEX; MISSING HERITABILITY; COMMON VARIANTS; EXTREME OBESITY; CONFER RISK; EARLY-ONSET; ASSOCIATION; POPULATION; EXPRESSION; SORTILIN	Approaches exploiting trait distribution extremes may be used to identify loci associated with common traits, but it is unknown whether these loci are generalizable to the broader population. In a genome-wide search for loci associated with the upper versus the lower 5th percentiles of body mass index, height and waist-to-hip ratio, as well as clinical classes of obesity, including up to 263,407 individuals of European ancestry, we identified 4 new loci (IGFBP4, H6PD, RSRC1 and PPP2R2A) influencing height detected in the distribution tails and 7 new loci (HNF4G, RPTOR, GNAT2, MRPS33P4, ADCY9, HS6ST3 and ZZZ3) for clinical classes of obesity. Further, we find a large overlap in genetic structure and the distribution of variants between traits based on extremes and the general population and little etiological heterogeneity between obesity subgroups.	[Berndt, Sonja I.; Shi, Jianxin; Jacobs, Kevin B.; Wang, Zhaoming; Chanock, Stephen J.] NCI, US Dept HHS, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Gustafsson, Stefan; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Gustafsson, Stefan; Ganna, Andrea; Fall, Tove; Groenberg, Henrik; Hall, Per; Magnusson, Patrik K.; Pedersen, Nancy; Pawitan, Yudi; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Maegi, Reedik; Ferreira, Teresa; Randall, Joshua C.; Min, Josine L.; Prokopenko, Inga; Lindgren, Cecilia M.; Morris, Andrew P.; McCarthy, Mark I.; Ingelsson, Erik] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Maegi, Reedik; Esko, Tonu; Fischer, Krista; Perola, Markus; Mihailov, Evelin; Milani, Lili; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Wheeler, Eleanor; Randall, Joshua C.; Kanoni, Stavroula; Edkins, Sarah; Hunt, Sarah E.; Palotie, Aarno; Radhakrishnan, Aparna; Shin, So-Youn; Soranzo, Nicole; Stirrups, Kathleen; Ouwehand, Willem H.; Ripatti, Samuli; Barroso, Ines; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Feitosa, Mary F.; Kraja, Aldi T.; Province, Michael A.; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Justice, Anne E.; Monda, Keri L.; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Monda, Keri L.] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA USA; [Croteau-Chonka, Damien C.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Day, Felix R.; Luan, Jian'an; Zhao, Jing Hua; Langenberg, Claudia; Ong, Ken K.; Wareham, Nicholas J.; Loos, Ruth J. F.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Esko, Tonu; Mihailov, Evelin; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Gentilini, Davide; Di Blasio, Anna Maria] Ist Auxol Italiano, Dept Mol Biol, Milan, Italy; [Jackson, Anne U.; Bragg-Gresham, Jennifer L.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Vedantam, Sailaja; Kathiresan, Sekar; Hirschhorn, Joel N.] Broad Inst, Metab Initiat, Cambridge, MA USA; [Vedantam, Sailaja; Kathiresan, Sekar; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Willer, Cristen J.] Univ Michigan, Dept Internal Med Cardiovasc, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Willer, Cristen J.; Speliotes, Elizabeth K.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Winkler, Thomas W.; Heid, Iris M.] Univ Regensburg, Med Ctr, Inst Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Wood, Andrew R.; Frayling, Timothy; Ingelsson, Erik] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Workalemahu, Tsegaselassie; Hu, Frank B.; Franks, Paul W.; Qi, Lu; Hunter, David] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Workalemahu, Tsegaselassie; Qi, Lu; Hunter, David] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Workalemahu, Tsegaselassie; Qi, Lu; Hunter, David] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Sang Hong; Visscher, Peter M.] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Thorleifsson, Gudmar; Stefansson, Kari; Steinthorsdottir, Valgerdur; Thorsteinsdottir, Unnur] deCODE Genet, Reykjavik, Iceland; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Yang, Jian; Medland, Sarah E.; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Albrecht, Eva; Amin, Najaf; Mueller-Nurasyid, Martina; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Medina-Gomez, Carolina; Peters, Marjolein J.; Estrada, Karol; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Witteman, Jacqueline C. M.; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Cadby, Gemma; Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Cadby, Gemma] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA, Australia; [den Heijer, Martin] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Eklund, Niina; Kristiansson, Kati; Perola, Markus; Surakka, Ida] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Unit Publ Hlth Gen, Helsinki, Finland; [Goel, Anuj; Farrall, Martin; Ripatti, Samuli; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hottenga, Jouke-Jan; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Huffman, Jennifer E.; Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Western Gen Hosp, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Johansson, Asa; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Johansson, Asa] Univ Uppsala Hosp, Uppsala Clin Res Ctr, Uppsala, Sweden; [Johnson, Toby; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Genome Ctr, London, England; [Johnson, Toby; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Kleber, Marcus E.] Ludwigshafen Risk & Cardiovasc Hlth LURIC Study, Freiburg, Germany; [Koenig, Inke R.; Preuss, Michael] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim, Germany; [Koenig, Inke R.; Preuss, Michael] Med Univ Lubeck, Inst Med Biometrie & Stat, Univ Klinikum Schleswig Holstein, D-23538 Lubeck, Germany; [Kutalik, Zoltn; Marek, Diana] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltn; Marek, Diana] Swiss Inst Bioinformat, Lausanne, Switzerland; [Lamina, Claudia] Med Univ Innsbruck, Div Genet Epidemiol Mol & Clin Pharmacol, Dept Med Genet, A-6020 Innsbruck, Austria; [Lecoeur, Cecile; Skrobek, Boris; Froguel, Philippe; Meyre, David] Univ Lille Nord France, Lille, France; [Lecoeur, Cecile; Skrobek, Boris; Froguel, Philippe; Meyre, David] Inst Pasteur, CNRS, UMR 8199, Inst Biol Lille, F-59019 Lille, France; [Li, Guo; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Mangino, Massimo; Soranzo, Nicole; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Medina-Gomez, Carolina; Peters, Marjolein J.; Estrada, Karol; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Zillikens, M. Carola; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina; Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Ngwa, Julius S.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Nolte, Ilja M.; Stolk, Ronald P.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Paternoster, Lavinia; Evans, David M.] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Pechlivanis, Sonali; Puetter, Carolin; Joeckel, Karl-Heinz; Scherag, Andr] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol IMIBE, Essen, Germany; [Perola, Markus; Surakka, Ida; Palotie, Aarno; Widen, Elisabeth; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Preuss, Michael; Erdmann, Jeanette] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Rose, Lynda M.; Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Shungin, Dmitry; Franks, Paul W.] Lund Univ, Genet & Mol Epidemiol Unit, Dept Clin Sci, Skane Univ Hosp Malmo, Malmo, Sweden; [Shungin, Dmitry; Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Shungin, Dmitry] Umea Univ, Dept Odontol, Umea, Sweden; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur; Stefansson, Kari; Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Strawbridge, Rona J.; Hamsten, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Teumer, Alexander; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Trip, Mieke D.; Basart, Hanneke; Hovingh, Kees G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Trip, Mieke D.] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Tyrer, Jonathan] Univ Cambridge, Dept Oncol, Cambridge, England; [Van Vliet-Ostaptchouk, Jana V.; Van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Van Vliet-Ostaptchouk, Jana V.; Bruinenberg, Marcel; Franke, Lude; Stolk, Ronald P.; Van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, Groningen, Netherlands; [Vandenput, Liesbeth; Lorentzon, Mattias] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med, Gothenburg, Sweden; [Waite, Lindsay L.; Absher, Devin; Ohlsson, Claes] Hudson Alpha Inst Biotechnol, Huntsville, TN USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Atalay, Mustafa; Lakka, Timo A.] Univ Eastern Finland, Inst Biomed Physiol, Kuopio, Finland; [Attwood, Antony P.; Rendon, Augusto; Ouwehand, Willem H.] Biomed Res Ctr, Natl Inst Hlth Res NIHR, Cambridge, England; [Balmforth, Anthony J.] Univ Leeds, Div Epidemiol, Multidisciplinary Cardiovasc Res Ctr MCRC, Leeds Inst Genet Hlth & Therapeut LIGHT, Leeds, W Yorkshire, England; [Beilby, John] Queen Elizabeth II Med Ctr, PathW Lab Western Australia, Dept Mol Genet, Nedlands, WA, Australia; [Beilby, John] Univ Western Australia, Dept Surg & Pathol, Nedlands, WA 6009, Australia; [Bonnycastle, Lori L.; Chines, Peter S.; Collins, Francis S.; Narisu, Narisu; Swift, Amy J.] NHGRI, Genome Technol Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Brambilla, Paolo] Univ Milano Bicocca, Dipartimento Med Sperimentale, Monza, Italy; [Campbell, Harry; Rudan, Igor; Wild, Sarah H.; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Connell, John M.] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Cookson, William O.; Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [de Vegt, Femmie; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Dei, Mariano; Sanna, Serena] CNR, Ist Ric Genet & Biomed, Monserrato, Italy; [Dimitriou, Maria; Theodoraki, Eirini V.; Dedoussis, George V.] Harokopio Univ, Dept Dietet Nutr, Athens, Greece; [Ferrario, Marco M.] Univ Insubria, Epidemiol & Prevent Med Res Ctr, Dept Clin & Expt Med, Varese, Italy; [Ferrieres, Jean] Toulouse Univ, Sch Med, Rangueil Hosp, Dept Cardiol, Toulouse, France; [Franke, Lude; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Frau, Francesca; Cusi, Daniele] Univ Milan, Dept Hlth Sci, Osped San Paolo, Milan, Italy; [Gejman, Pablo V.; Sanders, Alan R.] Univ Chicago, Chicago, IL 60637 USA; [Gejman, Pablo V.; Sanders, Alan R.] Northshore Univ Hlth Syst, Evanston, IL USA; [Grallert, Harald; Peters, Annette; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Hall, Alistair S.] Univ Leeds, LIGHT, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Neuronal Remodelling, Leeds, W Yorkshire, England; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Heard-Costa, Nancy L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Heath, Andrew C.; Madden, Pamela A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Hyppoenen, Elina; Power, Chris] UCL, Inst Child Hlth, MRC, Ctr Paediat Epidemiol & Biostat,Ctr Epidemiol Chi, London, England; [Iribarren, Carlos] Kaiser Permanente, Northern Calif, Div Res, Oakland, CA USA; [Jacobs, Kevin B.; Wang, Zhaoming] NCI, SAIC Frederick, Core Genotyping Facil, Frederick, MD 21701 USA; [Jansson, John-Olov] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden; [Jula, Antti] Natl Inst Hlth & Welf, Populat Studies Unit, Dept Chron Dis Prevent, Turku, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kee, Frank] Queens Univ Belfast, UK Clin Res Collaborat UKCRC, Ctr Excellence Publ Hlth Northern Ireland, Belfast, Antrim, North Ireland; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Kivimaki, Mika; Kumari, Meena; Langenberg, Claudia; Hingorani, Aroon] UCL, Dept Epidemiol & Publ Hlth, London, England; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Kuulasmaa, Kari; Virtamo, Jarmo; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Laitinen, Jaana H.] Finnish Inst Occupat Hlth, Oulu, Finland; [Lakka, Timo A.; Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Lind, Lars] Uppsala Univ, Dept Med Sci, Akademiska Sjukhuset, Uppsala, Sweden; [Lindstrom, Jaana; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Liuzzi, Antonio] Ist Auxol Italiano, Dept Internal Med, Verbania, Italy; [Lokki, Marja-Liisa] Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; [Manunta, Paolo] Univ Vita Salute San Raffaele, Chair Nephrol San Raffaele Sci Inst, Unite Osped Nephrol & Dialysis, Milan, Italy; [Maerz, Winfried] Synlab Acad, Mannheim, Germany; [Leach, Irene Mateo; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Mooser, Vincent] GlaxoSmithKline, Genet Div, King Of Prussia, PA USA; [Muehleisen, Thomas W.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Muehleisen, Thomas W.] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Musk, Arthur W.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Nedlands, WA 6009, Australia; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Nicholson, George] MRC, Harwell, Berks, England; [Nicholson, George] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Nohr, Ellen A.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Ong, Ken K.; Wong, Andrew; Kuh, Diana] MRC, Unit Lifelong Hlth & Ageing, London, England; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Oostra, Ben A.; van Duijn, Cornelia M.] Leiden Univ, Med Ctr, Ctr Med Syst Biol, Leiden, Netherlands; [Palmer, Colin N. A.; Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Peden, John F.] Illumina Inc, Cambridge, England; [Peters, Annette; Thorand, Barbara] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Peters, Annette] Munich Heart Alliance, Munich, Germany; [Polasek, Ozren] Univ Split, Fac Med, Split, Croatia; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Pramstaller, Peter P.; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Prokopenko, Inga; Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Prokopenko, Inga; Karpe, Fredrik; McCarthy, Mark I.] Univ Cambridge, Dept Haematol, Cambridge, England; [Radhakrishnan, Aparna; Rendon, Augusto; Sambrook, Jennifer G.; Stephens, Jonathan C.; Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv NHS Blood & Transplant, Cambridge, England; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Rendon, Augusto] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; [Saaristo, Timo E.] Finnish Diabet Assoc, Tampere, Finland; [Saaristo, Timo E.] Pirkanmaa Hosp Dist, Tampere, Finland; [Saramies, Jouko] South Karelia Cent Hosp, Lappeenranta, Finland; [Schipf, Sabine] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schunkert, Heribert; Erdmann, Jeanette] Deutsch Herzzentrum Munich, Munich, Germany; [Schunkert, Heribert; Erdmann, Jeanette] DZHK German Ctr Cardiovasc Res, Munich, Germany; [Signorini, Stefano] Azienda Osped Desio & Vimercate, Milan, Italy; [Sinisalo, Juha; Nieminen, Markku S.] Univ Helsinki, Cent Hosp, Div Cardiol, Cardiovasc Lab, Helsinki, Finland; [Stancakova, Alena] Univ Eastern Finland, Kuopio, Finland; [Stancakova, Alena] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Stark, Klaus; Hengstenberg, Christian] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Stumvoll, Michael; Tonjes, Anke] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Stumvoll, Michael; Tonjes, Anke] Univ Leipzig, Integrierte Forsch & Behandlungszentren IFB Adipo, D-04109 Leipzig, Germany; [Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMRS 937, Inst Cardiometab & Nutr ICAN, Paris, France; [Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Ctr Cardiol Monzino, Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma] Turku Univ Hosp, FIN-20520 Turku, Finland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, Univ Hosp, CH-1011 Lausanne, Switzerland; [Winkelmann, Bernhard R.] Cardiol Grp, Frankfurt, Germany; [Amouyel, Philippe] Univ Lille Nord France, INSERM, Inst Pasteur Lille, U744, F-59019 Lille, France; [Boehm, Bernhard O.] Univ Hosp, Dept Med, Div Endocrinol & Diabet, Ulm, Germany; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Cusi, Daniele] Fdn Filarete, Milan, Italy; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Hveem, Kristian] Norwegian Univ Sci & Technol, Helseundersokelsen Nord Trondelag HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Levanger, Norway; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta; Keinanen-Kiukaanniemi, Sirkka M.] Univ Oulu, Bioctr, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka M.] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Comprehens Canc Ctr East, Nijmegen, Netherlands; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Fimlab Labs, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Levinson, Douglas F.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Njolstad, Inger] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Njolstad, Inger] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Penninx, Brenda] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth, Seattle, WA USA; [Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England; [Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Uusitupa, Matti; McCarthy, Mark I.] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Wichmann, H-Erich; Heid, Iris M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Fox, Caroline S.] NHLBI, Div Intramural Res, Framingham Heart Study, Framingham, MA USA; [Groop, Leif C.] Lund Univ, Dept Clin Sci, Ctr Diabet, Malmo, Sweden; [Haritunian, Talin] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Karpe, Fredrik] Churchill Hosp, Oxford NIHR Biomed Res, Oxford OX3 7LJ, England; [O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Schadt, Eric E.] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY USA; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostatist, Hamilton, ON, Canada; [Speliotes, Elizabeth K.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uppsala University; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; University of Tartu; Wellcome Trust Sanger Institute; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; Amgen; University of North Carolina; University of North Carolina Chapel Hill; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Tartu; IRCCS Istituto Auxologico Italiano; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Regensburg; University of Exeter; University of Plymouth; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Emory University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; Vrije Universiteit Amsterdam; Finland National Institute for Health & Welfare; University of Oxford; Wellcome Centre for Human Genetics; Vrije Universiteit Amsterdam; University of Edinburgh; Philipps University Marburg; Uppsala University; Uppsala University; Uppsala University Hospital; University of London; Queen Mary University London; University of London; Queen Mary University London; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Lausanne; Swiss Institute of Bioinformatics; Medical University of Innsbruck; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Washington; University of Washington Seattle; University of London; King's College London; University of Bristol; Erasmus University Rotterdam; Erasmus MC; University of Munich; University of Munich; University of Munich; Boston University; University of Groningen; University of Bristol; University of Duisburg Essen; University of Helsinki; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Harvard University; Brigham & Women's Hospital; Lund University; Skane University Hospital; Umea University; Umea University; Icelandic Heart Association; University of Iceland; Karolinska Institutet; Karolinska University Hospital; Ernst Moritz Arndt Universitat Greifswald; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; University of Groningen; University of Groningen; University of Gothenburg; Utrecht University; Utrecht University Medical Center; University of Eastern Finland; University of Cambridge; University of Leeds; University of Western Australia; University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Milano-Bicocca; University of Edinburgh; Harvard University; Harvard Medical School; University of Glasgow; University of Dundee; Imperial College London; Karolinska Institutet; Radboud University Nijmegen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Harokopio University Athens; University of Insubria; CHU de Toulouse; Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Groningen; San Paolo-Polo Universitaria Hospital; University of Milan; University of Chicago; NorthShore University Health System; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Leeds; University of Oulu; Boston University; Washington University (WUSTL); University of Duisburg Essen; University of London; University College London; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Gothenburg; Finland National Institute for Health & Welfare; Tampere University; Tampere University; Tampere University Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Queens University Belfast; University of Cambridge; University of London; University College London; Ulm University; Finland National Institute for Health & Welfare; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finnish Institute of Occupational Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uppsala University; Uppsala University Hospital; Finland National Institute for Health & Welfare; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); IRCCS Istituto Auxologico Italiano; University of Helsinki; Vita-Salute San Raffaele University; SYNLAB Group; University of Groningen; University of Washington; University of Washington Seattle; GlaxoSmithKline; University of Bonn; University of Bonn; University of Western Australia; University of Western Australia; University of Western Australia; University of Groningen; University of Oxford; Aarhus University; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Dundee; Illumina; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Munich Heart Alliance; University of Split; Finland National Institute for Health & Welfare; European Academy of Bozen-Bolzano; Krankenhaus Bozen; University of Lubeck; University of Oxford; University of Cambridge; University of Turku; University of Turku; MRC Biostatistics Unit; University of Cambridge; Pirkanmaa Hospital District; Greifswald Medical School; University of Kiel; German Heart Centre Munich; German Centre for Cardiovascular Research; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Regensburg; Leipzig University; Leipzig University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Centro Cardiologico Monzino; University of Milan; Radboud University Nijmegen; University of Turku; University of Turku; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Ulm University; University of Texas System; University of Texas Health Science Center Houston; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Imperial College London; Norwegian University of Science & Technology (NTNU); Hannover Medical School; Imperial College London; University of Oulu; University of Oulu; University of Oulu; Radboud University Nijmegen; Tampere University; Tampere University; Tampere University Hospital; Stanford University; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Groningen; University of Groningen; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kuopio University Hospital; University of Eastern Finland; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; Danube University Krems; King Abdulaziz University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Lund University; Cedars Sinai Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Oxford; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; McMaster University; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ingelsson, E (corresponding author), Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden.	erik.ingelsson@medsci.uu.se	Lehtimäki, Terho/AAD-1094-2022; Feitosa, Mary F/K-8044-2012; Hall, Alistair/K-1953-2019; Penninx, Brenda WJH/S-7627-2017; Strawbridge, Rona/H-5422-2012; Hengstenberg, Christian/U-5485-2019; Erdmann, Jeanette/P-7513-2014; Polasek, Ozren/B-6002-2011; Lorentzon, Mattias/W-7878-2019; Lee, Sang Hong/A-2569-2011; Erdmann, Jeanette/A-4417-2009; Langenberg, Claudia/ABG-9067-2021; Lamina, Claudia/F-7608-2010; Smith, Albert Vernon/K-5150-2015; Campbell, Harry/E-2959-2010; sanna, serena/H-3009-2019; FROGUEL, Philippe/O-6799-2017; Medland, Sarah/AAT-7595-2020; Grallert, Harald/B-3424-2013; Vermeulen, Sita H./L-4716-2015; Hveem, Kristian/AFV-4683-2022; Colaus, PsyColaus/K-6607-2013; Study, GoDARTS/K-9448-2016; Dedoussis, George/AAN-7252-2021; Johansson, Åsa/G-5270-2011; Teumer, Alexander/S-7438-2019; Palmer, Lyle John/K-3196-2014; Magnusson, Patrik KE/C-4458-2017; Milani, Lili/N-1097-2019; Palmer, Colin NA/C-7053-2008; Manunta, Paolo/ABH-5476-2020; Loos, Ruth J F/Q-2862-2016; Mägi, Reedik/AAJ-9679-2021; Narisu, Narisu/T-6908-2019; Prokopenko, Inga/H-3241-2014; Vandenput, Liesbeth/AAI-4100-2021; Evans, David M/H-6325-2013; Kivimaki, Mika/B-3607-2012; de Vegt, F./L-4704-2015; Cadby, Gemma/AAE-3849-2022; Mangino, Massimo/F-5134-2011; Wang, Zhaoming/R-5527-2018; Berndt, Sonja I/J-8423-2016; Hypponen, Elina/B-2596-2014; Visscher, Peter/ABB-6151-2020; Cookson, William/HHC-1790-2022; Hayward, Caroline/M-8818-2016; Montgomery, Grant W/B-7148-2008; Müller-Nurasyid, Martina/I-8735-2018; Wichmann, Heinz Erich/AAA-5695-2022; Prokopenko, Inga/AAU-9895-2020; Fall, Tove/O-7226-2014; Loos, Ruth/GON-5877-2022; Stancakova, Alena/AAN-6723-2020; Stumvoll, Michael/ABE-1121-2021; Yang, Jian/A-5852-2010; Ripatti, Samuli/H-9446-2014; Milani, Lili/C-8759-2011; Gentilini, Davide/AAB-2567-2019; Kanoni, Stavroula/AAN-7161-2021; Wood, Andrew R/AAB-3807-2019; Kiemeney, Lambertus A./D-3357-2009; Peters, Annette/A-6117-2011; Deloukas, Panos/B-2922-2013; Gudnason, Vilmundur/K-6885-2015; Tregouet, David-Alexandre/E-3961-2016; Boehm, Bernhard Otto/F-8750-2015; Rudan, Igor/I-1467-2012; Raitakari, Olli/AAQ-7389-2021; Scherag, Andre/B-3805-2014; Franks, Paul/AAA-3300-2020; Gudnason, Vilmundur/AAE-7126-2019; Medina-Gomez, Carolina/I-1725-2019; Wilson, James F/A-5704-2009; Hinney, Anke/D-6953-2011; Wong, Andrew/AAE-6995-2019; König, Inke R/A-4544-2009; Kuh, Diana/L-6019-2014; Liu, Jianjun/AAK-4989-2020; Stefansson, Kari/AAE-7187-2019; Wong, Andrew/M-8899-2016; Stark, Klaus/L-7367-2013; Franke, Lude/P-7036-2016; Johansson, Åsa/AAG-6799-2021; Martin, Nicholas/R-9235-2019; van der Klauw, M. M./A-2138-2014; Palmer, Lyle John/N-1948-2019; Assimes, Themistocles Leonard/D-9696-2015; Njolstad, Inger/X-3784-2019; Dei, Mariano/AAY-3870-2020; Boomsma, Dorret I/AAX-4470-2020; Medland, Sarah E/C-7630-2013; Asselbergs, Folkert W./ABD-6752-2021; Hicks, Andrew Anthony/E-9518-2017; Trégouët, David-Alexandre/P-9210-2019; Thorand, Barbara/B-5349-2014; Meyre, David/D-7315-2011; Ferrario, Marco M./ABH-2115-2021; Vandenput, Liesbeth/AAP-3655-2020; Ohlsson, Claes/AGP-3544-2022; Khaw, Kay-Tee/AAZ-3209-2021; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Pramstaller, Peter P/C-2357-2008; Rivadeneira, Fernando/O-5385-2015; TREMOLI, ELENA/I-8126-2018; den Heijer, Martin/J-8036-2015; Ferrieres, Jean/S-7993-2016; Paternoster, Lavinia/C-1292-2015; McCarthy, Mark/M-3763-2015	Lehtimäki, Terho/0000-0002-2555-4427; Feitosa, Mary F/0000-0002-0933-2410; Penninx, Brenda WJH/0000-0001-7779-9672; Strawbridge, Rona/0000-0001-8506-3585; Erdmann, Jeanette/0000-0002-4486-6231; Polasek, Ozren/0000-0002-5765-1862; Lorentzon, Mattias/0000-0003-0749-1431; Lee, Sang Hong/0000-0001-9701-2718; Langenberg, Claudia/0000-0002-5017-7344; Lamina, Claudia/0000-0002-5398-5806; Smith, Albert Vernon/0000-0003-1942-5845; Campbell, Harry/0000-0002-6169-6262; sanna, serena/0000-0002-3768-1749; FROGUEL, Philippe/0000-0003-2972-0784; Medland, Sarah/0000-0003-1382-380X; Vermeulen, Sita H./0000-0003-4913-8601; Dedoussis, George/0000-0002-7798-6221; Johansson, Åsa/0000-0002-2915-4498; Teumer, Alexander/0000-0002-8309-094X; Palmer, Lyle John/0000-0002-1628-3055; Magnusson, Patrik KE/0000-0002-7315-7899; Milani, Lili/0000-0002-5323-3102; Palmer, Colin NA/0000-0002-6415-6560; Manunta, Paolo/0000-0003-3976-9696; Loos, Ruth J F/0000-0002-8532-5087; Prokopenko, Inga/0000-0003-1624-7457; Vandenput, Liesbeth/0000-0002-1712-6131; Evans, David M/0000-0003-0663-4621; Kivimaki, Mika/0000-0002-4699-5627; de Vegt, F./0000-0001-8728-3397; Mangino, Massimo/0000-0002-2167-7470; Wang, Zhaoming/0000-0001-7556-3869; Hypponen, Elina/0000-0003-3670-9399; Visscher, Peter/0000-0002-2143-8760; Hayward, Caroline/0000-0002-9405-9550; Montgomery, Grant W/0000-0002-4140-8139; Müller-Nurasyid, Martina/0000-0003-3793-5910; Stancakova, Alena/0000-0002-1375-0252; Stumvoll, Michael/0000-0001-6225-8240; Yang, Jian/0000-0003-2001-2474; Ripatti, Samuli/0000-0002-0504-1202; Milani, Lili/0000-0002-5323-3102; Kanoni, Stavroula/0000-0002-1691-9615; Wood, Andrew R/0000-0003-1726-948X; Kiemeney, Lambertus A./0000-0002-2368-1326; Peters, Annette/0000-0001-6645-0985; Deloukas, Panos/0000-0001-9251-070X; Gudnason, Vilmundur/0000-0001-5696-0084; Rudan, Igor/0000-0001-6993-6884; Gudnason, Vilmundur/0000-0001-5696-0084; Medina-Gomez, Carolina/0000-0001-7999-5538; Wilson, James F/0000-0001-5751-9178; Hinney, Anke/0000-0001-5659-0706; Wong, Andrew/0000-0003-2079-4779; König, Inke R/0000-0003-0504-6465; Kuh, Diana/0000-0001-7386-2857; Liu, Jianjun/0000-0002-3255-3019; Wong, Andrew/0000-0003-2079-4779; Stark, Klaus/0000-0002-7832-1942; Franke, Lude/0000-0002-5159-8802; Johansson, Åsa/0000-0002-2915-4498; Martin, Nicholas/0000-0003-4069-8020; van der Klauw, M. M./0000-0001-7178-009X; Palmer, Lyle John/0000-0002-1628-3055; Assimes, Themistocles Leonard/0000-0003-2349-0009; Medland, Sarah E/0000-0003-1382-380X; Asselbergs, Folkert W./0000-0002-1692-8669; Hicks, Andrew Anthony/0000-0001-6320-0411; Trégouët, David-Alexandre/0000-0001-9084-7800; Thorand, Barbara/0000-0002-8416-6440; Meyre, David/0000-0003-4850-7444; Vandenput, Liesbeth/0000-0002-1712-6131; Ohlsson, Claes/0000-0002-9633-2805; Rivadeneira, Fernando/0000-0001-9435-9441; Kristiansson, Kati/0000-0003-4688-107X; Beilby, John/0000-0002-4915-2254; Preuss, Michael/0000-0001-5266-8465; Randall, Joshua/0000-0003-1540-203X; Soranzo, Nicole/0000-0003-1095-3852; Lindstrom, Jaana/0000-0001-9255-020X; Ferrario, Marco M/0000-0003-2741-7124; Dei, Mariano/0000-0002-7404-508X; Magi, Reedik/0000-0002-2964-6011; Kahonen, Mika/0000-0002-4510-7341; Gentilini, Davide/0000-0002-8391-0725; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Esko, Tonu/0000-0003-1982-6569; Munroe, Patricia/0000-0002-4176-2947; Lindgren, Cecilia/0000-0002-4903-9374; Sinisalo, Juha/0000-0002-0169-5137; van Meurs, Joyce/0000-0001-6245-2123; Rendon, Augusto/0000-0001-8994-0039; Stolk, Ronald/0000-0002-0518-1205; Day, Felix/0000-0003-3789-7651; Cupples, L. Adrienne/0000-0003-0273-7965; Amin, Najaf/0000-0002-8944-1771; Caulfield, Mark/0000-0001-9295-3594; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; Kleber, Marcus/0000-0003-0663-7275; Van Duijn, Cornelia/0000-0002-2374-9204; Lakka, Timo/0000-0002-9199-2871; Gieger, Christian/0000-0001-6986-9554; Shungin, Dmitry/0000-0001-7900-5856; TREMOLI, ELENA/0000-0002-0929-6106; Jones, Lindsay/0000-0002-4219-8356; Hingorani, Aroon/0000-0001-8365-0081; Willer, Cristen/0000-0001-5645-4966; den Heijer, Martin/0000-0003-3620-5617; Hunt, Sarah/0000-0002-8350-1235; Ouwehand, Willem/0000-0002-7744-1790; North, Kari/0000-0002-8903-0366; Holland, Sherri/0000-0003-2860-0668; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Karpe, Fredrik/0000-0002-2751-1770; Goel, Anuj/0000-0003-2307-4021; Stephens, Jonathan/0000-0003-2020-9330; Barroso, Ines/0000-0001-5800-4520; Peters, Marjolein/0000-0003-3167-9063; Ganna, Andrea/0000-0002-8147-240X; Ferrieres, Jean/0000-0001-6144-1297; Nicholson, George/0000-0001-9588-6075; Waeber, Gerard/0000-0003-4193-788X; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Kuulasmaa, Kari/0000-0003-2165-1411; Eriksson, Johan/0000-0002-2516-2060; Palotie, Aarno/0000-0002-2527-5874; Paternoster, Lavinia/0000-0003-2514-0889; Justice, Anne/0000-0002-8903-8712; Willemsen, Gonneke/0000-0003-3755-0236; Johnson, Toby/0000-0002-5998-3270; Hall, Alistair/0000-0003-0306-7887; Franks, Paul/0000-0002-0520-7604; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; McCarthy, Mark/0000-0002-4393-0510; Radhakrishnan, Aparna/0000-0002-8153-9037; Abecasis, Goncalo/0000-0003-1509-1825; Kumari, Meena/0000-0001-9716-1035; Koenig, Wolfgang/0000-0002-2064-9603; Amouyel, Philippe/0000-0001-9088-234X; Scherag, Andre/0000-0002-9406-4704; Heard-Costa, Nancy/0000-0001-9730-0306; Surakka, Ida/0000-0002-6669-5541; Watkins, Hugh/0000-0002-5287-9016; s, hema/0000-0002-3440-9475; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Wheeler, Eleanor/0000-0002-8616-6444; Pramstaller, Peter P/0000-0002-9831-8302	Aarno Koskelo Foundation; Agency for Science, Technology and Research of Singapore; Australian National Health and Medical Research Council; Australian Research Council; BDA Research; BioSHaRE Consortium; British Heart Foundation; Cedars-Sinai Board of Governors' Chair in Medical Genetics; Centre for Clinical Research at the University of Leipzig; Centre of Excellence in Genomics; University of Tartu; Chief Scientist Office of the Scottish government; City of Kuopio; Social Insurance Institution of Finland; Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; Donald W. Reynolds Foundation; Dutch Ministry for Health, Welfare and Sports; Dutch Ministry of Education, Culture and Science; Dutch BBRMI-NL; Dutch Brain Foundation; Dutch Centre for Medical Systems Biology; Dutch Diabetes Research Foundation; Dutch Government Economic Structure-Enhancing Fund; Dutch Inter-University Cardiology Institute; Dutch Kidney Foundation; Dutch Ministry of Economic Affairs; Dutch Ministry of Justice; Dutch Research Institute for Diseases in the Elderly; Eleanor Nichols endowments; Emil Aaltonen Foundation; Erasmus Medical Center; Erasmus University; Estonian government; European Commission; European Regional Development Fund; European Research Council; European Science Foundation; Faculty of Biology and Medicine of Lausanne; Finland's Slot Machine Association; Finnish Cultural Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Funding Agency for Technology and Innovation; Finnish Heart Association; Finnish Medical Society; Finnish Ministry of Education and Culture; Finnish Ministry of Health and Social Affairs; Finnish National Institute for Health and Welfare; Finnish Social Insurance Institution; Finska Lakaresallskapet; Folkhalsan Research Foundation; Foundation for Life and Health in Finland; French Ministry of Research; French National Research Agency; Genetic Association Information Network; German Diabetes Association; German Federal Ministry of Education and Research; German Ministry of Cultural Affairs; German National Genome Research Network; German Research Foundation; GlaxoSmithKline; Goteborg Medical Society; Greek General Secretary of Research and Technology; Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; Heinz Nixdorf Foundation; Helmholtz Zentrum Munchen-German Research Center for Environmental Health; Icelandic Heart Association; Icelandic Parliament; Intramural Research Program of the Division of Cancer Epidemiology and Genetics, the National Cancer Institute, NIH; Italian Ministry of Education, Universities and Research; Italian Ministry of Health; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International; Knut and Alice Wallenberg Foundation; Kuopio, Tampere and Turku University Hospital Medical Funds; Leducq Foundation; Lundberg Foundation; March of Dimes; Munich Center of Health Sciences as part of LMUinnovativ; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Awards; Netherlands Genomics Initiative; Netherlands Organization for Health Research and Development; UK NHSBT; US National Institutes of Health; Nordic Center of Cardiovascular Research; Nordic Center of Excellence in Disease Genetics; Nordic Centre of Excellence on Systems Biology in Controlled Dietary Interventions and Cohort Studies; Northern Netherlands Collaboration of Provinces; Novo Nordisk Foundation; Ollqvist Foundation; Orion-Farmos Research Foundation; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Province of Groningen; Republic of Croatia Ministry of Science, Education and Sport; Reynold's Foundation; Royal Society; Samfundet Folkhalsan; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Sophia Foundation for Medical Research; South Tyrolean Sparkasse Foundation; Southern California Diabetes Endocrinology Research Center; Stockholm County Council; Strategic Cardiovascular Program of Karolinska Institutet; Strategic Support for Epidemiological Research at Karolinska Institutet; Susan G. Komen Breast Cancer Foundation; Swedish Ministry for Higher Education; Swedish Cancer Society; Swedish Cultural Foundation in Finland; Swedish Diabetes Association; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Swedish Medical Research Council; Swedish Ministry of Education; Swedish Research Council; Swedish Royal Academy of Science; Swedish Society for Medical Research; Swedish Society of Medicine; Swiss National Science Foundation; Tampere Tuberculosis Foundation; Great Wine Estates of the Margaret River Region of Western Australia; Paul Michael Donovan Charitable Foundation; Torsten and Ragnar Soderberg Foundation; Cancer Research UK; UK Diabetes Association; UK Heart Foundation; UK MRCUK NIHR, Biomedical Research Centre; UK West Anglia Primary and Community Care; University Medical Center Groningen; University of Groningen; Vastra Gotaland Foundation; VU University: the Institute for Health and Care Research and the Neuroscience Campus Amsterdam; Wellcome Trust; Yrjo Jahnsson Foundation; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, R01HL105756, R01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007416, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093757, R01DK072193, P30DK020572, R01DK075787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER; Cancer Research UK [14136] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1, ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_U106188470, MC_U105260558, G0600237, MC_U106179471, G1000143, G0401527, MC_PC_U127561128, MC_UU_12015/1, MC_UU_12015/2, MR/K006584/1, MC_U106179472, G0601261, G1002084, G9521010, MR/K013351/1, G0801056B, MC_U123092720] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10113, RP-PG-0310-1002, NF-SI-0611-10099] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005785] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; ESRC [ES/J023299/1, ES/G007438/1] Funding Source: UKRI; MRC [G0600237, G1002084, MC_UU_12015/1, MC_U105260558, G9521010, MC_U106188470, MC_U123092720, MR/K013351/1, MC_UU_12015/2, MC_U106179472, G0601261, MC_PC_U127561128] Funding Source: UKRI	Aarno Koskelo Foundation; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); BDA Research; BioSHaRE Consortium; British Heart Foundation(British Heart Foundation); Cedars-Sinai Board of Governors' Chair in Medical Genetics; Centre for Clinical Research at the University of Leipzig; Centre of Excellence in Genomics; University of Tartu; Chief Scientist Office of the Scottish government; City of Kuopio; Social Insurance Institution of Finland; Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; Donald W. Reynolds Foundation; Dutch Ministry for Health, Welfare and Sports; Dutch Ministry of Education, Culture and Science; Dutch BBRMI-NL; Dutch Brain Foundation; Dutch Centre for Medical Systems Biology; Dutch Diabetes Research Foundation; Dutch Government Economic Structure-Enhancing Fund; Dutch Inter-University Cardiology Institute; Dutch Kidney Foundation; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Dutch Ministry of Justice; Dutch Research Institute for Diseases in the Elderly; Eleanor Nichols endowments; Emil Aaltonen Foundation; Erasmus Medical Center; Erasmus University; Estonian government; European Commission(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fund(European Commission); European Research Council(European Research Council (ERC)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Faculty of Biology and Medicine of Lausanne; Finland's Slot Machine Association; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Heart Association; Finnish Medical Society; Finnish Ministry of Education and Culture; Finnish Ministry of Health and Social Affairs; Finnish National Institute for Health and Welfare; Finnish Social Insurance Institution; Finska Lakaresallskapet; Folkhalsan Research Foundation; Foundation for Life and Health in Finland; French Ministry of Research(Ministry of Research, FranceEuropean Commission); French National Research Agency(French National Research Agency (ANR)); Genetic Association Information Network; German Diabetes Association; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Cultural Affairs; German National Genome Research Network; German Research Foundation(German Research Foundation (DFG)); GlaxoSmithKline(GlaxoSmithKline); Goteborg Medical Society; Greek General Secretary of Research and Technology; Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; Heinz Nixdorf Foundation; Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); Icelandic Heart Association; Icelandic Parliament; Intramural Research Program of the Division of Cancer Epidemiology and Genetics, the National Cancer Institute, NIH; Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Juho Vainio Foundation; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kuopio, Tampere and Turku University Hospital Medical Funds; Leducq Foundation(Leducq Foundation); Lundberg Foundation(European Commission); March of Dimes(March of Dimes); Munich Center of Health Sciences as part of LMUinnovativ; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Awards(NARSAD); Netherlands Genomics Initiative; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); UK NHSBT; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nordic Center of Cardiovascular Research; Nordic Center of Excellence in Disease Genetics; Nordic Centre of Excellence on Systems Biology in Controlled Dietary Interventions and Cohort Studies; Northern Netherlands Collaboration of Provinces; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ollqvist Foundation; Orion-Farmos Research Foundation; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Province of Groningen; Republic of Croatia Ministry of Science, Education and Sport; Reynold's Foundation; Royal Society(Royal Society of London); Samfundet Folkhalsan; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Social Ministry of the Federal State of Mecklenburg-West Pomerania; Sophia Foundation for Medical Research; South Tyrolean Sparkasse Foundation; Southern California Diabetes Endocrinology Research Center; Stockholm County Council(Stockholm County Council); Strategic Cardiovascular Program of Karolinska Institutet; Strategic Support for Epidemiological Research at Karolinska Institutet; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Swedish Ministry for Higher Education; Swedish Cancer Society(Swedish Cancer Society); Swedish Cultural Foundation in Finland; Swedish Diabetes Association; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Ministry of Education; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Royal Academy of Science; Swedish Society for Medical Research; Swedish Society of Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Tampere Tuberculosis Foundation; Great Wine Estates of the Margaret River Region of Western Australia; Paul Michael Donovan Charitable Foundation; Torsten and Ragnar Soderberg Foundation; Cancer Research UK(Cancer Research UK); UK Diabetes Association; UK Heart Foundation; UK MRCUK NIHR, Biomedical Research Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK West Anglia Primary and Community Care; University Medical Center Groningen; University of Groningen; Vastra Gotaland Foundation; VU University: the Institute for Health and Care Research and the Neuroscience Campus Amsterdam; Wellcome Trust(Wellcome Trust); Yrjo Jahnsson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A full list of acknowledgments appears in the Supplementary Note. Funding was provided by the Aarno Koskelo Foundation; the Academy of Finland; the Agency for Science, Technology and Research of Singapore; the Australian National Health and Medical Research Council; the Australian Research Council; BDA Research; the BioSHaRE Consortium; the British Heart Foundation; the Cedars-Sinai Board of Governors' Chair in Medical Genetics; the Centre for Clinical Research at the University of Leipzig; the Centre of Excellence in Genomics and the University of Tartu; the Chief Scientist Office of the Scottish government; the City of Kuopio and the Social Insurance Institution of Finland; the Department of Educational Assistance, the University and Research of the Autonomous Province of Bolzano; the Donald W.; Reynolds Foundation; the Dutch Ministry for Health, Welfare and Sports; the Dutch Ministry of Education, Culture and Science; Dutch BBRMI-NL; the Dutch Brain Foundation; the Dutch Centre for Medical Systems Biology; the Dutch Diabetes Research Foundation; the Dutch Government Economic Structure-Enhancing Fund; the Dutch Inter-University Cardiology Institute; the Dutch Kidney Foundation; the Dutch Ministry of Economic Affairs; the Dutch Ministry of Justice; the Dutch Research Institute for Diseases in the Elderly; Eleanor Nichols endowments; the Emil Aaltonen Foundation; Erasmus Medical Center and Erasmus University; the Estonian government; the European Commission; the European Regional Development Fund; the European Research Council; the European Science Foundation; the Faculty of Biology and Medicine of Lausanne; Finland's Slot Machine Association; the Finnish Cultural Foundation; the Finnish Diabetes Research Foundation; the Finnish Foundation for Cardiovascular Research; the Finnish Funding Agency for Technology and Innovation; the Finnish Heart Association; the Finnish Medical Society; the Finnish Ministry of Education and Culture; the Finnish Ministry of Health and Social Affairs; the Finnish National Institute for Health and Welfare; the Finnish Social Insurance Institution; Finska Lakaresallskapet; the Folkhalsan Research Foundation; the Foundation for Life and Health in Finland; the French Ministry of Research; the French National Research Agency; the Genetic Association Information Network; the German Diabetes Association; the German Federal Ministry of Education and Research; the German Ministry of Cultural Affairs; the German National Genome Research Network; the German Research Foundation; GlaxoSmithKline; the Goteborg Medical Society; the Greek General Secretary of Research and Technology; the Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; the Heinz Nixdorf Foundation; Helmholtz Zentrum Munchen-German Research Center for Environmental Health; the Icelandic Heart Association; the Icelandic Parliament; the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, the National Cancer Institute, NIH; Italian Ministry of Education, Universities and Research; Italian Ministry of Health; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International; the Knut and Alice Wallenberg Foundation; Kuopio, Tampere and Turku University Hospital Medical Funds; the Leducq Foundation; the Lundberg Foundation; the March of Dimes; the Munich Center of Health Sciences as part of LMUinnovativ; the Municipal Health Care Center and Hospital in Jakobstad; the Municipality of Rotterdam; the Narpes Health Care Foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Awards; the Netherlands Genomics Initiative; the Netherlands Organization for Health Research and Development; UK NHSBT; US National Institutes of Health; the Nordic Center of Cardiovascular Research; the Nordic Center of Excellence in Disease Genetics; the Nordic Centre of Excellence on Systems Biology in Controlled Dietary Interventions and Cohort Studies; the Northern Netherlands Collaboration of Provinces; the Novo Nordisk Foundation; the Ollqvist Foundation; the Orion-Farmos Research Foundation; the Paavo Nurmi Foundation; the Paivikki and Sakari Sohlberg Foundation; the Perklen Foundation; the Petrus and Augusta Hedlunds Foundation; the Province of Groningen; the Republic of Croatia Ministry of Science, Education and Sport; the Reynold's Foundation; the Royal Society; Samfundet Folk; halsan; the Signe and Ane Gyllenberg Foundation; the Sigrid Juselius Foundation; the Social Ministry of the Federal State of Mecklenburg-West Pomerania; the Sophia Foundation for Medical Research; the South Tyrolean Sparkasse Foundation; the Southern California Diabetes Endocrinology Research Center; the Stockholm County Council; the Strategic Cardiovascular Program of Karolinska Institutet; Strategic Support for Epidemiological Research at Karolinska Institutet; the Susan G. Komen Breast Cancer Foundation; the Swedish Ministry for Higher Education; the Swedish Cancer Society; the Swedish Cultural Foundation in Finland; the Swedish Diabetes Association; the Swedish Foundation for Strategic Research; the Swedish Heart-Lung Foundation; the Swedish Medical Research Council; the Swedish Ministry of Education; the Swedish Research Council; the Swedish Royal Academy of Science; the Swedish Society for Medical Research; the Swedish Society of Medicine; the Swiss National Science Foundation; the Tampere Tuberculosis Foundation; The Great Wine Estates of the Margaret River Region of Western Australia; The Paul Michael Donovan Charitable Foundation; the Torsten and Ragnar Soderberg Foundation; Cancer Research UK; the UK Diabetes Association; the UK Heart Foundation; the UK MRC; the UK NIHR, Biomedical Research Centre; UK West Anglia Primary and Community Care; the University Medical Center Groningen and the University of Groningen; the Vastra Gotaland Foundation; VU University: the Institute for Health and Care Research and the Neuroscience Campus Amsterdam; the Wellcome Trust; and the Yrjo Jahnsson Foundation.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Chan YL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002439; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; den Hoed M, 2013, INT J OBESITY, V37, P191, DOI 10.1038/ijo.2012.34; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Harismendy O, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r118; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Jiao H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-51; Kaddai V, 2009, DIABETOLOGIA, V52, P932, DOI 10.1007/s00125-009-1273-3; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Min JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002505; Morris AP, 2005, GENET EPIDEMIOL, V29, P91, DOI 10.1002/gepi.20080; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nakajima H, 1996, RES COMMUN MOL PATH, V94, P327; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; Putter C, 2011, HUM HERED, V72, P173, DOI 10.1159/000332824; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028764; World Health Organization, 2000, WHO TECHN REP SER, V8949; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang M, 2003, J BONE MINER RES, V18, P836, DOI 10.1359/jbmr.2003.18.5.836; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	54	419	435	2	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2013	45	5					501	U69		10.1038/ng.2606	http://dx.doi.org/10.1038/ng.2606			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133RU	23563607	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000318158200011
J	Haffner, MC; Aryee, MJ; Toubaji, A; Esopi, DM; Albadine, R; Gurel, B; Isaacs, WB; Bova, GS; Liu, WN; Xu, JF; Meeker, AK; Netto, G; De Marzo, AM; Nelson, WG; Yegnasubramanian, S				Haffner, Michael C.; Aryee, Martin J.; Toubaji, Antoun; Esopi, David M.; Albadine, Roula; Gurel, Bora; Isaacs, William B.; Bova, G. Steven; Liu, Wennuan; Xu, Jianfeng; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.; Yegnasubramanian, Srinivasan			Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements	NATURE GENETICS			English	Article							DNA-TOPOISOMERASE-II; CHROMOSOMAL TRANSLOCATIONS; RECEPTOR; FUSION; PROGRESSION; ERG; CHEMOTHERAPY; TMPRSS2-ERG; ABERRATIONS; ACTIVATION	DNA double-strand breaks (DSBs) can lead to the development of genomic rearrangements, which are hallmarks of cancer. Fusions between TMPRSS2, encoding the transmembrane serine protease isoform 2, and ERG, encoding the v-ets erythroblastosis virus E26 oncogene homolog, are among the most common oncogenic rearrangements observed in human cancer. We show that androgen signaling promotes co-recruitment of androgen receptor and topoisomerase II beta (TOP2B) to sites of TMPRSS2-ERG genomic breakpoints, triggering recombinogenic TOP2B-mediated DSBs. Furthermore, androgen stimulation resulted in de novo production of TMPRSS2-ERG fusion transcripts in a process that required TOP2B and components of the DSB repair machinery. Finally, unlike normal prostate epithelium, prostatic intraepithelial neoplasia cells showed strong coexpression of androgen receptor and TOP2B. These findings implicate androgen-induced TOP2B-mediated DSBs in generating TMPRSS2-ERG rearrangements.	[Haffner, Michael C.; Aryee, Martin J.; Esopi, David M.; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.; Yegnasubramanian, Srinivasan] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Aryee, Martin J.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Toubaji, Antoun; Albadine, Roula; Gurel, Bora; Bova, G. Steven; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; [Isaacs, William B.; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Liu, Wennuan; Xu, Jianfeng] Wake Forest Univ Hlth Sci, Ctr Canc Genom, Winston Salem, NC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Wake Forest University; Wake Forest University School of Medicine	Yegnasubramanian, S (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	bnelson@jhmi.edu; syegnasu@jhmi.edu	Gurel, Bora/A-5458-2016; Aryee, Martin/AAC-8113-2020	Gurel, Bora/0000-0002-5018-8078; Netto, George/0000-0003-3915-9134; Bova, George/0000-0003-1639-3104	NIH/NCI; Department of Defense PCRP; Prostate Cancer Foundation; Maryland Cigarette Restitution Fund; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA070196, P30CA006973, P50CA058236] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense PCRP(United States Department of Defense); Prostate Cancer Foundation; Maryland Cigarette Restitution Fund; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Coffey for helpful comments and C. Heaphy, H. Zhang and L. Dasko-Vincent from the SKCCC Cell Imaging Core Facility for technical support. We also thank the Brady Urological Research Institute Prostate Specimen Repository for providing TMA sections. This work was supported by funding from the NIH/NCI, Department of Defense PCRP, Prostate Cancer Foundation, Maryland Cigarette Restitution Fund and the Patrick C. Walsh Prostate Cancer Research Fund/Dr. and Mrs. Peter S. Bing Scholarship.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Denmeade SR, 1996, PROSTATE, V28, P251; DeWeese TL, 1997, INT J RADIAT ONCOL, V37, P145, DOI 10.1016/S0360-3016(96)00448-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Haffner MC, 2008, J BIOL CHEM, V283, P22089, DOI 10.1074/jbc.M801041200; Hallstrom TMKA, 2008, PROSTATE, V68, P902, DOI 10.1002/pros.20746; Hermans KG, 2008, CANCER RES, V68, P3094, DOI 10.1158/0008-5472.CAN-08-0198; IRIZARRY RA, 2009, GENE SET ENRICHMENT; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu WN, 2007, GENE CHROMOSOME CANC, V46, P972, DOI 10.1002/gcc.20482; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Marker PC, 2008, DIFFERENTIATION, V76, P736, DOI 10.1111/j.1432-0436.2008.00297.x; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Morgan WF, 1998, MUTAT RES-FUND MOL M, V404, P125, DOI 10.1016/S0027-5107(98)00104-3; NELSON WG, 1986, NATURE, V322, P187, DOI 10.1038/322187a0; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Padilla PI, 2008, P NATL ACAD SCI USA, V105, P3357, DOI 10.1073/pnas.0712387105; Pedersen-Bjergaard J, 1998, J CLIN ONCOL, V16, P1897, DOI 10.1200/JCO.1998.16.5.1897; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Smith MA, 1996, JNCI-J NATL CANCER I, V88, P407, DOI 10.1093/jnci/88.7.407; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	52	419	429	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					668	U45		10.1038/ng.613	http://dx.doi.org/10.1038/ng.613			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20601956	Green Accepted			2022-12-17	WOS:000280524000010
J	Palstra, RJ; Tolhuis, B; Splinter, E; Nijmeijer, R; Grosveld, F; de Laat, W				Palstra, RJ; Tolhuis, B; Splinter, E; Nijmeijer, R; Grosveld, F; de Laat, W			The beta-globin nuclear compartment in development and erythroid differentiation	NATURE GENETICS			English	Article							LOCUS-CONTROL REGION; HYPERSENSITIVE SITE; TARGETED DELETION; GENE CLUSTERS; IN-VIVO; TRANSCRIPTION; VISUALIZATION; ORGANIZATION; EXPRESSION; DYNAMICS	Efficient transcription of genes requires a high local concentration of the relevant trans - acting factors. Nuclear compartmentalization can provide an effective means to locally increase the concentration of rapidly moving trans - acting factors; this may be achieved by spatial clustering of chromatin-associated binding sites for such factors(1-5). Here we analyze the structure of an erythroid-specific spatial cluster of cis regulatory elements and active beta-globin genes, the active chromatin hub (ACH; ref. 6), at different stages of development and in erythroid progenitors. We show, in mice and humans, that a core ACH is developmentally conserved and consists of the hypersensitive sites (HS1-HS6) of the locus control region (LCR), the upstream 5' HS 60/-62 and downstream 3' HS1. Globin genes switch their interaction with this cluster during development, correlating with the switch in their transcriptional activity(7). In mouse erythroid progenitors that are committed to but do not yet express beta-globin, only the interactions between 5' HS 60/-62, 3' HS1 and hypersensitive sites at the 5 side of the LCR are stably present. After induction of differentiation, these sites cluster with the rest of the LCR and the gene that is activated. We conclude that during erythroid differentiation, cis - regulatory DNA elements create a developmentally conserved nuclear compartment dedicated to RNA polymerase II transcription of beta-globin genes.	ErasmusMC, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Laat, W (corresponding author), ErasmusMC, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.			Palstra, Robert-Jan/0000-0003-4600-2303; de Laat, Wouter/0000-0002-6393-595X				Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Bulger M, 2000, P NATL ACAD SCI USA, V97, P14560, DOI 10.1073/pnas.97.26.14560; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; Droge P, 2001, BIOESSAYS, V23, P179, DOI 10.1002/1521-1878(200102)23:2<179::AID-BIES1025>3.0.CO;2-6; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; Farrell CM, 2000, P NATL ACAD SCI USA, V97, P14554, DOI 10.1073/pnas.97.26.14554; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; HARDISON R, 1993, MOL BIOL EVOL, V10, P73; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Imam AMA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e65; Isogai Y, 2003, CURR OPIN CELL BIOL, V15, P296, DOI 10.1016/S0955-0674(03)00052-8; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Stamatoyannopoulos G., 2001, MOL BASIS BLOOD DIS, Vthird, P135; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wai AWK, 2003, EMBO J, V22, P4489, DOI 10.1093/emboj/cdg437; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	28	419	443	0	28	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					190	194		10.1038/ng1244	http://dx.doi.org/10.1038/ng1244			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	14517543				2022-12-17	WOS:000185625300018
J	Yasutomo, K; Horiuchi, T; Kagami, S; Tsukamoto, H; Hashimura, C; Urushihara, M; Kuroda, Y				Yasutomo, K; Horiuchi, T; Kagami, S; Tsukamoto, H; Hashimura, C; Urushihara, M; Kuroda, Y			Mutation of DNASE1 in people with systemic lupus erythematosus	NATURE GENETICS			English	Article								Systemic lupus erythematosus (SLE) is a highly prevalent human autoimmune diseases that causes progressive glomerulonephritis, arthritis and an erythematoid rash(1,2). Mice deficient in deoxyribonuclease I (Dnase1) develop an SLE-like syndrome(3). Here we describe two patients with a heterozygous nonsense mutation in exon 2 of DNASE1, decreased DNASE1 activity and an extremely high immunoglobulin G titer against nucleosomal antigens. These data are consistent with the hypothesis that a direct connection exists between low activity of DNASE1 and progression of human SLE.	Univ Tokushima, Sch Med, Dept Pediat, Tokushima 7708503, Japan; Kyushu Univ, Fac Med, Dept Internal Med 1, Fukuoka 8128582, Japan	Tokushima University; Kyushu University	Kuroda, Y (corresponding author), Univ Tokushima, Sch Med, Dept Pediat, Tokushima 7708503, Japan.			Yasutomo, Koji/0000-0003-0411-2037				Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Arnett F C, 2000, Int Rev Immunol, V19, P297, DOI 10.3109/08830180009055501; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Eilat D, 1999, IMMUNOL TODAY, V20, P339, DOI 10.1016/S0167-5699(99)01457-7; Herrmann M, 2000, IMMUNOL TODAY, V21, P424, DOI 10.1016/S0167-5699(00)01675-3; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Tsao B P, 2000, Int Rev Immunol, V19, P319, DOI 10.3109/08830180009055502; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; Wagrowska-Danilewicz M, 1998, J NEPHROL, V11, P44; Wu JM, 1999, ARTHRITIS RHEUM, V42, P2601, DOI 10.1002/1529-0131(199912)42:12<2601::AID-ANR13>3.0.CO;2-4	10	419	440	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					313	314		10.1038/91070	http://dx.doi.org/10.1038/91070			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479590				2022-12-17	WOS:000170174800009
J	Bourdon, A; Minai, L; Serre, V; Jais, JP; Sarzi, E; Aubert, S; Chretien, D; de Lonlay, P; Paquis-Flucklinger, V; Arakawa, H; Nakamura, Y; Munnich, A; Rotig, A				Bourdon, Alice; Minai, Limor; Serre, Valerie; Jais, Jean-Philippe; Sarzi, Emmanuelle; Aubert, Sophie; Chretien, Dominique; de Lonlay, Pascale; Paquis-Flucklinger, Veronique; Arakawa, Hirofumi; Nakamura, Yusuke; Munnich, Arnold; Rotig, Agnes			Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion	NATURE GENETICS			English	Article							SWISS-MODEL; R2 PROTEIN; DNTP POOLS; GENE; ENCEPHALOMYOPATHY; CLUSPRO; DOCKING; KINASE; DAMAGE; CELLS	Mitochondrial DNA (mtDNA) depletion syndrome (MDS; MIM 251880) is a prevalent cause of oxidative phosphorylation disorders characterized by a reduction in mtDNA copy number. The hitherto recognized disease mechanisms alter either mtDNA replication (POLG (ref. 1)) or the salvage pathway of mitochondrial deoxyribonucleosides 5'- triphosphates (dNTPs) for mtDNA synthesis (DGUOK (ref. 2), TK2 (ref. 3) and SUCLA2 (ref. 4)). A last gene, MPV17 ( ref. 5), has no known function. Yet the majority of cases remain unexplained. Studying seven cases of profound mtDNA depletion (1-2% residual mtDNA in muscle) in four unrelated families, we have found nonsense, missense and splice-site mutations and in-frame deletions of the RRM2B gene, encoding the cytosolic p53-inducible ribonucleotide reductase small subunit. Accordingly, severe mtDNA depletion was found in various tissues of the Rrm2b(-/-) mouse. The mtDNA depletion triggered by p53R2 alterations in both human and mouse implies that p53R2 has a crucial role in dNTP supply for mtDNA synthesis.	Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Genet, F-75015 Paris, France; Univ Paris 07, F-75005 Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Serv Biostat & Informat, F-75015 Paris, France; Archet 2 Hosp, Dept Med Genet, F-06107 Nice, France; Univ Tokyo, Inst Med Sci, Human Genome Ctr, Minato Ku, Tokyo 1088639, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; University of Tokyo	Rotig, A (corresponding author), Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.	roetig@necker.fr	Rötig, Agnès/G-9592-2017; Arakawa, Hirofumi/L-3459-2013; JAIS, Jean-Philippe/B-2993-2009	Rötig, Agnès/0000-0003-0589-0703; Arakawa, Hirofumi/0000-0001-6077-0638; JAIS, Jean-Philippe/0000-0002-0708-8776; Sarzi, Emmanuelle/0000-0002-7623-6699				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PAQUISFLUCKLINGER V, 1995, EUR J PEDIATR, V154, P557, DOI 10.1007/BF02074834; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SARZI E, IN PRESS J PEDIATR; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Zhou BS, 2003, CANCER RES, V63, P6583	26	418	433	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					776	780		10.1038/ng2040	http://dx.doi.org/10.1038/ng2040			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17486094				2022-12-17	WOS:000246859100022
J	Lercher, MJ; Urrutia, AO; Hurst, LD				Lercher, MJ; Urrutia, AO; Hurst, LD			Clustering of housekeeping genes provides a unified model of gene order in the human genome	NATURE GENETICS			English	Article							MAP; CHROMOSOME; EXPRESSION; COMPLEX	It is often supposed that, except for tandem duplicates, genes are randomly distributed throughout the human genome. However, recent analyses suggest that when all the genes expressed in a given tissue (notably placenta(1) and skeletal muscle(2)) are examined, these genes do not map to random locations but instead resolve to clusters. We have asked three questions: (i) is this clustering true for most tissues, or are these the exceptions; (ii) is any clustering simply the result of the expression of tandem duplicates and (iii) how, if at all, does this relate to the observed clustering of genes with high expression rates(3) ? We provide a unified model of gene clustering that explains the previous observations. We examined Serial Analysis of Gene Expression (SAGE)(4) data for 14 tissues and found significant clustering, in each tissue, that persists even after the removal of tandem duplicates. We confirmed clustering by analysis of independent expressed-sequence tag (EST) data. We then tested the possibility that the human genome is organized into subregions, each specializing in genes needed in a given tissue. By comparing genes expressed in different tissues, we show that this is not the case: those genes that seem to be tissue-specific in their expression do not, as a rule, cluster. We report that genes that are expressed in most tissues (housekeeping genes) show strong clustering. In addition, we show that the apparent clustering of genes with high expression rates(3) is a consequence of the clustering of housekeeping genes.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Lercher, Martin/K-7939-2013; Martinez, Octavio/B-7375-2009; Hurst, Laurence/F-9215-2010	Lercher, Martin/0000-0003-3940-1621; Urrutia, Araxi/0000-0001-9011-8675; Hurst, Laurence/0000-0002-1002-1054				Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Bortoluzzi S, 1998, GENOME RES, V8, P817, DOI 10.1101/gr.8.8.817; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DURET L, 1994, NUCLEIC ACIDS RES, V22, P2360, DOI 10.1093/nar/22.12.2360; Fisher R., 1930, GENETICAL THEORY NAT; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; Ko MSH, 1998, HUM MOL GENET, V7, P1967, DOI 10.1093/hmg/7.12.1967; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Paul AL, 1999, PLANT MOL BIOL, V41, P713, DOI 10.1023/A:1006323222693; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	15	418	431	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					180	183		10.1038/ng887	http://dx.doi.org/10.1038/ng887			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	11992122				2022-12-17	WOS:000175903500015
J	Giaever, G; Shoemaker, DD; Jones, TW; Liang, H; Winzeler, EA; Astromoff, A; Davis, RW				Giaever, G; Shoemaker, DD; Jones, TW; Liang, H; Winzeler, EA; Astromoff, A; Davis, RW			Genomic profiling of drug sensitivities via induced haploinsufficiency	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENES; EXPRESSION	Lowering the dosage of a single gene from two copies to one copy in diploid yeast results in a heterozygote that is sensitized to any drug that acts on the product of this gene. This haploinsufficient phenotype thereby identifies the gene product of the heterozygous locus as the likely drug target. We exploited this finding in a genomic approach to drug-target identification. Genome sequence information was used to generate molecularly tagged heterozygous yeast strains that were pooled, grown competitively in drug and analysed for drug sensitivity using high-density oligonucleotide arrays. Individual heterozygous strain analysis verified six known drug targets. Parallel analysis identified the known target and two hypersensitive loci in a mixed culture of 233 strains in the presence of the drug tunicamycin, Our discovery that both drug target and hypersensitive loci exhibit drug-induced haploinsufficiency may have important consequences in pharmacogenomics and variable drug toxicity observed in human populations.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Rosetta Inpharmat, Kirkland, WA 98034 USA; Stanford DNA Sequencing & Technol Ctr, Palo Alto, CA 94394 USA	Stanford University; Merck & Company; Stanford University	Giaever, G (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	ggiaever@cmgm.stanford.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113	PHS HHS [H600198] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; BARNES G, 1984, MOL CELL BIOL, V4, P2381, DOI 10.1128/MCB.4.11.2381; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; Karim FD, 1996, GENETICS, V143, P315; KUO SC, 1974, BIOCHEM BIOPH RES CO, V58, P287, DOI 10.1016/0006-291X(74)90925-5; Launhardt H, 1998, YEAST, V14, P935, DOI 10.1002/(SICI)1097-0061(199807)14:10<935::AID-YEA289>3.0.CO;2-9; LINDSLEY DL, 1972, GENETICS, V71, P157; Nelissen B, 1997, FEMS MICROBIOL REV, V21, P113, DOI 10.1016/S0168-6445(97)00053-3; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; RINE J, 1991, METHOD ENZYMOL, V194, P239; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; RITTBERG DAH, 1989, BIOCHEM CELL BIOL, V67, P352, DOI 10.1139/o89-055; ROSE MD, 1990, METHODS YEAST GENETI; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; STEARNS T, 1990, GENETICS, V124, P251; TURI TG, 1992, J BIOL CHEM, V267, P2046; VOGEL F, 1997, HUM GENET, P267; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Zinn AR, 1998, CURR OPIN GENET DEV, V8, P322, DOI 10.1016/S0959-437X(98)80089-0	24	418	450	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1999	21	3					278	283		10.1038/6791	http://dx.doi.org/10.1038/6791			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	10080179				2022-12-17	WOS:000078977900020
J	Melov, S; Schneider, JA; Day, BJ; Hinerfeld, D; Coskun, P; Mirra, SS; Crapo, JD; Wallace, DC				Melov, S; Schneider, JA; Day, BJ; Hinerfeld, D; Coskun, P; Mirra, SS; Crapo, JD; Wallace, DC			A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase	NATURE GENETICS			English	Article							CENTRAL-NERVOUS-SYSTEM; HEART-MITOCHONDRIA; ALZHEIMERS-DISEASE; MIMETIC PROTECTS; NITRIC-OXIDE; INJURY; MUTANT; ENERGY	Reactive oxygen species (ROS) have been implicated in a wide range of degenerative processes including amyotrophic lateral sclerosis, ischemic heart disease, Alzheimer disease, Parkinson disease and aging(1-5). ROS are generated by mitochondria as the toxic by-products of oxidative phosphorylation, their energy generating pathway(6,7). Genetic inactivation of the mitochondrial form of superoxide dismutase in mice results in dilated cardiomyopathy, hepatic lipid accumulation and early neonatal deaths. We report that treatment with the superoxide dismutase (SOD) mimetic Manganese 5, 10, 15, 20-tetrakis (4-benzoic acid) porphyrin (MnTBAP) rescues these Sod2(tm1Cje)(-/-) mutant mice from this systemic pathology and dramatically prolongs their survival. The animals instead develop a pronounced movement disorder progressing to total debilitation by three weeks of age. Neuropathologic evaluation reveals a striking spongiform degeneration of the cortex and specific brain stem nuclei associated with gliosis and intramyelinic vacuolization similar to that observed in cytotoxic edema and disorders associated with mitochondrial abnormalities such as Leighs disease and Canavans disease. We believe that due to the failure of MnTBAP to cross the blood brain barrier progressive neuropathology is caused by excessive mitochondrial production of ROS. Consequently, MnTBAP-treated Sod2(tm1Cje)(-/-) mice may provide an excellent model for examining the relationship between free radicals and neurodegenerative diseases and for screening new drugs to treat these disorders.	Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Rush Presbyterian St Lukes Med Ctr, Rush Inst Aging, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; Emory Univ, Sch Med, Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30033 USA	Emory University; Rush University; Rush University; Duke University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University	Wallace, DC (corresponding author), Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA.		Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45572] Funding Source: Medline; NIA NIH HHS [AG13154] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADACHI M, 1967, J NEUROPATH EXP NEUR, V26, P164; Banchroft J.D., 1996, THEORY PRACTICE HIST, V4 th; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Day BJ, 1996, TOXICOL APPL PHARM, V140, P94, DOI 10.1006/taap.1996.0201; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HENSLEY K, 1995, P W PHARMACOL SOC, V38, P113; HIRANO A, 1968, J NEUROPATH EXP NEUR, V27, P571; KIMURA S, 1991, PEDIATR NEUROL, V7, P56, DOI 10.1016/0887-8994(91)90108-W; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; Schulz JB, 1995, ANN NY ACAD SCI, V765, P100, DOI 10.1111/j.1749-6632.1995.tb16565.x; SIMONIAN NA, 1996, ANN REV PHARM TOXICO, V36, P83106; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Wallace D., 1996, MOL GENETIC BASIS NE, P237; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	23	418	429	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					159	163		10.1038/ng0298-159	http://dx.doi.org/10.1038/ng0298-159			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462746				2022-12-17	WOS:000071779500025
J	Bamshad, M; Lin, RC; Law, DJ; Watkins, WS; Krakowiak, PA; Moore, ME; Franceschini, P; Lala, R; Holmes, LB; Gebuhr, TC; Bruneau, BG; Schinzel, A; Seidman, JG; Seidman, CE; Jorde, LB				Bamshad, M; Lin, RC; Law, DJ; Watkins, WS; Krakowiak, PA; Moore, ME; Franceschini, P; Lala, R; Holmes, LB; Gebuhr, TC; Bruneau, BG; Schinzel, A; Seidman, JG; Seidman, CE; Jorde, LB			Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome	NATURE GENETICS			English	Article							CONSERVED PROTEIN MOTIF; MOUSE BRACHYURY; EEC-SYNDROME; GENE FAMILY; HOMOLOG; DROSOPHILA; EXPRESSION; CLONING; HAND		HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV TURIN,IST DISCIPLINE PEDIAT,SERV GENET CLIN,TURIN,ITALY; OSPED INFANTILE R MARGHERETA,DIV ENDOCRINOL PEDIAT,TURIN,ITALY; MASSACHUSETTS GEN HOSP,GENET & TERATOL UNIT,BOSTON,MA 02114; UNIV ZURICH,INST MED GENET,CH-8001 ZURICH,SWITZERLAND; BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,BOSTON,MA 02115	Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Harvard University; Massachusetts General Hospital; University of Zurich; Harvard University; Brigham & Women's Hospital	Bamshad, M (corresponding author), UNIV UTAH,HLTH SCI CTR,DEPT PEDIAT,SALT LAKE CITY,UT 84112, USA.			Bruneau, Benoit/0000-0002-0804-7597	NHGRI NIH HHS [HG00209, 5-P30-HG00199] Funding Source: Medline; PHS HHS [M01-00064] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000199] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AGUINIK SI, 1996, GENETICS, V144, P249; AGULNIK SI, 1995, GENOMICS, V25, P214, DOI 10.1016/0888-7543(95)80128-9; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Bamshad M, 1996, AM J MED GENET, V65, P325, DOI 10.1002/(SICI)1096-8628(19961111)65:4<325::AID-AJMG15>3.0.CO;2-W; BAMSHAD M, 1995, HUM MOL GENET, V4, P1973, DOI 10.1093/hmg/4.10.1973; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; BUSS PW, 1995, J MED GENET, V32, P716, DOI 10.1136/jmg.32.9.716; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; FRANCESCHINI P, 1992, AM J MED GENET, V44, P807, DOI 10.1002/ajmg.1320440618; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; GONZALEZ CH, 1976, EUR J PEDIATR, V123, P225, DOI 10.1007/BF00444644; Hamel Ben, 1996, European Journal of Human Genetics, V4, P148; HECHT JT, 1984, CLIN GENET, V25, P63; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HOLT M, 1960, BRIT HEART J, V22, P236; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1994, GENE DEV, V8, P2137, DOI 10.1101/gad.8.18.2137; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; LECK I, 1993, HUMAN MALFORMATIONS, V1, P65; Li QY, 1997, NAT GENET, V15, P21; Morrison K, 1996, HUM MOL GENET, V5, P669, DOI 10.1093/hmg/5.5.669; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nakatani Y, 1996, DEVELOPMENT, V122, P2023; Pallister P D, 1976, Birth Defects Orig Artic Ser, V12, P247; PFLUGFELDER GO, 1992, BIOCHEM BIOPH RES CO, V186, P918, DOI 10.1016/0006-291X(92)90833-7; RUDIGER RA, 1970, AM J DIS CHILD, V120, P160; SCHINZEL A, 1987, CLIN GENET, V32, P160; SCHINZEL A, 1987, J MED GENET, V24, P778, DOI 10.1136/jmg.24.12.778; SCHINZEL A, 1987, CLIN GENET, V32, P425; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315	40	418	433	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					311	315		10.1038/ng0797-311	http://dx.doi.org/10.1038/ng0797-311			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207801				2022-12-17	WOS:A1997XG60900031
J	VANDUIJN, CM; DEKNIJFF, P; CRUTS, M; WEHNERT, A; HAVEKES, LM; HOFMAN, A; VAN BROECKHOVEN, C				VANDUIJN, CM; DEKNIJFF, P; CRUTS, M; WEHNERT, A; HAVEKES, LM; HOFMAN, A; VAN BROECKHOVEN, C			APOLIPOPROTEIN E4 ALLELE IN A POPULATION-BASED STUDY OF EARLY-ONSET ALZHEIMERS-DISEASE	NATURE GENETICS			English	Article							PRECURSOR PROTEIN GENE; HEREDITARY CEREBRAL-HEMORRHAGE; DUTCH TYPE; MUTATION; LOCUS; CHROMOSOME-19; DIAGNOSIS; DEMENTIA; LINKAGE; EXON-17	Several studies have reported an association of the apolipoprotein E allele epsilon 4 (APOE*4) to familial and sporadic late-onset Alzheimer's disease (LOAD). Here we report on the relationship between APOE*4 and early-onset Alzheimer's disease (EOAD) in a Dutch population-based study. The frequency of the APOE*4 allele was 2.3 times higher among EOAD cases compared to controls. Among patients, the allele frequency was 1.6 times higher in those with a positive family history than in those without. A significant increase in risk of EOAD was found for subjects homozygous for APOE*4 regardless of family history of dementia, but an increase in EOAD risk for APOE*4 heterozygotes could only be shown in subjects with a positive family history. Our study demonstrates a significant association between APOE*4 and EOAD which is modified by family history of dementia.	UNIV ANTWERP, DEPT BIOCHEM, BORN BUNGE FDN, NEUROGENET LAB, B-2610 ANTWERP, BELGIUM; ERASMUS UNIV ROTTERDAM, SCH MED, DEPT EPIDEMIOL & BIOSTAT, 3000 DR ROTTERDAM, NETHERLANDS; TNO, INST AGEING & VASC RES, GAUBIUS LAB, 2300 AK LEIDEN, NETHERLANDS; INNOGENET, B-9052 GHENT, BELGIUM	University of Antwerp; Erasmus University Rotterdam; Netherlands Organization Applied Science Research; Innogenetics NV			Van Broeckhoven, Christine/G-8362-2017; de Knijff, Peter/Y-2519-2018	Van Broeckhoven, Christine/0000-0003-0183-7665; de Knijff, Peter/0000-0002-0899-771X				ADROER R, 1992, NEUROSCI LETT, V141, P69, DOI 10.1016/0304-3940(92)90336-6; BAKKER E, 1991, AM J HUM GENET, V49, P518; BORGAONKAR DS, 1993, LANCET, V342, P625, DOI 10.1016/0140-6736(93)91458-X; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAS HK, 1985, J BIOL CHEM, V260, P6240; Elston RC, 1987, ESSENTIALS BIOSTATIS; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAVEKES LM, 1987, J LIPID RES, V28, P445; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MAHLEY RW, 1989, METABOLIC BASIS INHE, V1, P1195; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAYAMI H, 1993, LANCET, V342, P738; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Schlesselman James J., 1982, CASE CONTROL STUDIES; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VANBROECKHOVEN C, IN PRESS NEUROSCI LE; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; 1993, LANCET, V342, P737	38	418	424	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1994	7	1					74	78		10.1038/ng0594-74	http://dx.doi.org/10.1038/ng0594-74			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075646	Green Published			2022-12-17	WOS:A1994NJ84200017
J	CHU, CS; TRAPNELL, BC; CURRISTIN, S; CUTTING, GR; CRYSTAL, RG				CHU, CS; TRAPNELL, BC; CURRISTIN, S; CUTTING, GR; CRYSTAL, RG			GENETIC-BASIS OF VARIABLE EXON-9 SKIPPING IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MESSENGER-RNA	NATURE GENETICS			English	Article							3' SPLICE-SITE; MAMMALIAN INTRONS; XENOPUS OOCYTES; CL CHANNEL; CFTR GENE; IDENTIFICATION; SEQUENCES; CELLS; DNA; MUTATIONS	Variable in-frame skipping of exon 9 in cystic fibrosis transmembrane conductance regulator (CFTR) mRNA transcripts (exon 9-) occurs in the respiratory epithelium. To explore the genetic basis of this event, we evaluated respiratory epithelial cells and blood leukocytes from 124 individuals (38 with cystic fibrosis (CF), 86 without CF). We found an inverse relationship between the length of the polythymidine tract at the exon 9 splice branch/acceptor site and the proportion of exon 9- CFTR mRNA transcripts. These results strongly indicate a genetic basis in vivo modulating post-transcriptional processing of CFTR mRNA transcripts.	JOHNS HOPKINS UNIV HOSP, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV HOSP, CTR MED GENET, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	CHU, CS (corresponding author), NHLBI, PULM BRANCH, BETHESDA, MD 20892 USA.							ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BARGON J, 1992, MOL CELL BIOL, V12, P1872, DOI 10.1128/MCB.12.4.1872; BARGON J, 1992, J BIOL CHEM, V267, P16056; BARINAGA M, 1992, SCIENCE, V256, P444, DOI 10.1126/science.1373905; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1991, J BIOL CHEM, V266, P19142; BINDEREIF A, 1986, MOL CELL BIOL, V6, P2582, DOI 10.1128/MCB.6.7.2582; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; CUPPENS H, 1990, J MED GENET, V27, P717, DOI 10.1136/jmg.27.11.717; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTVILL X, NATURE, V326, P840; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; JIN W, 1990, NUCLEIC ACIDS RES, V18, P5995, DOI 10.1093/nar/18.20.5995; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PATTERSON B, 1991, CELL, V64, P181, DOI 10.1016/0092-8674(91)90219-O; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUBY SW, 1991, TRENDS GENET, V7, P79; RUSKIN B, 1985, NATURE, V317, P732, DOI 10.1038/317732a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; TRAPNELL BC, 1991, J BIOL CHEM, V266, P10319; WELSH MJ, 1987, J CLIN INVEST, V80, P1523, DOI 10.1172/JCI113237; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; YOSHIMURA K, 1991, J BIOL CHEM, V266, P9140; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	51	418	429	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1993	3	2					151	156		10.1038/ng0293-151	http://dx.doi.org/10.1038/ng0293-151			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	7684646				2022-12-17	WOS:A1993KL01000013
J	Niihori, T; Aoki, Y; Narumi, Y; Neri, G; Cave, H; Verloes, A; Okamoto, N; Hennekam, RCM; Gillessen-Kaesbach, G; Wieczorek, D; Kavamura, MI; Kurosawa, K; Ohashi, H; Wilson, L; Heron, D; Bonneau, D; Corona, G; Kaname, T; Naritomi, K; Baumann, C; Matsumoto, N; Kato, K; Kure, S; Matsubara, Y				Niihori, T; Aoki, Y; Narumi, Y; Neri, G; Cave, H; Verloes, A; Okamoto, N; Hennekam, RCM; Gillessen-Kaesbach, G; Wieczorek, D; Kavamura, MI; Kurosawa, K; Ohashi, H; Wilson, L; Heron, D; Bonneau, D; Corona, G; Kaname, T; Naritomi, K; Baumann, C; Matsumoto, N; Kato, K; Kure, S; Matsubara, Y			Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome	NATURE GENETICS			English	Article							CARDIOFACIOCUTANEOUS CFC SYNDROME; PTPN11 MUTATIONS; B-RAF; COSTELLO-SYNDROME; CANCER	Cardio-facio-cutaneous (CFC) syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. It phenotypically overlaps with Noonan and Costello syndrome, which are caused by mutations in PTPN11 and HRAS, respectively. In 43 individuals with CFC, we identified two heterozygous KRAS mutations in three individuals and eight BRAF mutations in 16 individuals, suggesting that dysregulation of the RAS-RAF-ERK pathway is a common molecular basis for the three related disorders.	Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi, Japan; Catholic Univ, Ist Genet Med, Rome, Italy; Hop Robert Debre, APHP, Dept Genet, Paris, France; Osaka Med Ctr, Dept Planning & Res, Osaka, Japan; Res Inst Maternal & Child Hlth, Osaka, Japan; Inst Child Hlth, Clin & Mol Genet Unit, London, England; Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands; Univ Essen Gesamthsch, Inst Human Genet, Essen, Germany; UNIFESP, Ctr Med Genet, Sao Paulo, Brazil; Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; Great Ormond St Hosp Sick Children, London, England; Pitie Salpetriere Univ Hosp, Dept Genet, Paris, France; Univ Hosp, Dept Genet, Angers, France; Azienda Osped Univ G Martino, Dipartimento Sci Pediat Med & Chirurg, Unita Operat Complessa Patol Neonatale & Terapia, Messina, Italy; Univ Ryukyus, Sch Med, Dept Med Genet, Okinawa, Japan; Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa, Japan; Tohoku Univ, Comprehens Res & Educ Ctr Planning Drug Dev & Cli, Cent COE Program 21, Sendai, Miyagi, Japan	Tohoku University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Duisburg Essen; Universidade Federal de Sao Paulo (UNIFESP); Saitama Children's Medical Center; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; AOU Policlinico Gaetano Martino; University of the Ryukyus; Yokohama City University; Tohoku University	Aoki, Y (corresponding author), Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi, Japan.	aokiy@mail.tains.tohoku.ac.jp	Bonneau, Dominique/K-6110-2015; /AAK-8500-2021; Kurosawa, Kenji/B-6561-2016; Niihori, Tetsuya/ABE-2350-2021; VERLOES, Alain/E-7287-2014	Kurosawa, Kenji/0000-0002-6817-7748; Niihori, Tetsuya/0000-0002-2118-9776; Cave, Helene/0000-0003-2840-1511; VERLOES, Alain/0000-0003-4819-0264				Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Ion A, 2002, HUM GENET, V111, P421, DOI 10.1007/s00439-002-0803-6; Kavamura MI, 2003, EUR J HUM GENET, V11, P64, DOI 10.1038/sj.ejhg.5200911; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Musante L, 2003, EUR J HUM GENET, V11, P201, DOI 10.1038/sj.ejhg.5200935; NERI G, 1991, AM J MED GENET, V39, P367, DOI 10.1002/ajmg.1320390323; REYNOLDS JF, 1986, AM J MED GENET, V25, P413, DOI 10.1002/ajmg.1320250303; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Van den Berg H, 1999, J MED GENET, V36, P799, DOI 10.1136/jmg.36.10.799; van Eeghen AM, 1999, AM J MED GENET, V82, P187, DOI 10.1002/(SICI)1096-8628(19990115)82:2<187::AID-AJMG17>3.0.CO;2-2; Wieczorek D, 1997, CLIN GENET, V52, P37; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578	15	417	460	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					294	296		10.1038/ng1749	http://dx.doi.org/10.1038/ng1749			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16474404				2022-12-17	WOS:000235589600008
J	Dickins, RA; Hemann, MT; Zilfou, JT; Simpson, DR; Ibarra, I; Hannon, GJ; Lowe, SW				Dickins, RA; Hemann, MT; Zilfou, JT; Simpson, DR; Ibarra, I; Hannon, GJ; Lowe, SW			Probing tumor phenotypes using stable and regulated synthetic microRNA precursors	NATURE GENETICS			English	Article							SHORT HAIRPIN RNAS; MAMMALIAN-CELLS; GENE-EXPRESSION; POLYMERASE-II; IN-VITRO; SYSTEM; INTERFERENCE; SENESCENCE; P53; CHEMORESISTANCE	RNA interference is a powerful method for suppressing gene expression in mammalian cells. Stable knock-down can be achieved by continuous expression of synthetic short hairpin RNAs, typically from RNA polymerase III promoters. But primary microRNA transcripts, which are endogenous triggers of RNA interference, are normally synthesized by RNA polymerase II. Here we show that RNA polymerase II promoters expressing rationally designed primary microRNA based short hairpin RNAs produce potent, stable and regulatable gene knock-down in cultured cells and in animals, even when present at a single copy in the genome. Most notably, by tightly regulating Trp53 knock-down using tetracycline-based systems, we show that cultured mouse fibroblasts can be switched between proliferative and senescent states and that tumors induced by Trp53 suppression and cooperating oncogenes regress upon re-expression of Trp53. In practice, this primary microRNA-based short hairpin RNA vector system is markedly similar to cDNA overexpression systems and is a powerful tool for studying gene function in cells and animals.	Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Lowe, SW (corresponding author), Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Dickins, Ross A/K-2852-2012	Dickins, Ross A/0000-0003-4112-5304	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen YC, 2003, CANCER RES, V63, P4801; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng127; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; HARVEY M, 1993, ONCOGENE, V8, P2457; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hosono T, 2004, HUM GENE THER, V15, P813, DOI 10.1089/1043034041648462; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Ling X, 2004, BIOTECHNIQUES, V36, P450, DOI 10.2144/04363RR01; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Song J, 2004, CANCER RES, V64, P7661, DOI 10.1158/0008-5472.CAN-04-1751; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	417	442	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1289	1295		10.1038/ng1651	http://dx.doi.org/10.1038/ng1651			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16200064				2022-12-17	WOS:000233045200032
J	Kashima, T; Manley, JL				Kashima, T; Manley, JL			A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy	NATURE GENETICS			English	Article							HNRNP A/B PROTEINS; MOTOR-NEURON SMN; IN-VIVO; SILENCER ELEMENT/; SINGLE NUCLEOTIDE; DETERMINING GENE; BINDING-SITES; SR PROTEINS; A1; ASF/SF2	Spinal muscular atrophy (SMA) is a relatively common neurodegenerative disease caused by homozygous loss of the survival motor neuron 1 (SMN1) gene(1). Humans possess a linked, nearly identical gene, SMN2, which produces a functional SMN protein but at levels insufficient to compensate for loss of SMN1 (refs. 1,2). A C/T transition at position +6 in exon 7 is all that differentiates the two genes, but this is sufficient to prevent efficient exon 7 splicing in SMN2 ( refs. 2,3). Here we show that the C/T transition functions not to disrupt an exonic splicing enhancer (ESE) in SMN1 (ref. 4), as previously suggested, but rather to create an exonic splicing silencer (ESS) in SMN2. We show that this ESS functions as a binding site for a known repressor protein, hnRNP A1, which binds to SMN2 but not SMN1 exon 7 RNA. We establish the physiological importance of these results by using small interfering RNAs to reduce hnRNP A protein levels in living cells and show that this results in efficient SMN2 exon 7 splicing. Our findings not only define a new mechanism underlying the inefficient splicing of SMN2 exon 7 but also illustrate more generally the remarkable sensitivity and precision that characterizes control of mRNA splicing.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.			Manley, James/0000-0002-8341-1459				Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hou VC, 2002, EMBO J, V21, P6195, DOI 10.1093/emboj/cdf625; Hutchison S, 2002, J BIOL CHEM, V277, P29745, DOI 10.1074/jbc.M203633200; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Tange TO, 2001, EMBO J, V20, P5748; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; WANG J, 1995, RNA, V1, P335; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577	30	417	432	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					460	463		10.1038/ng1207	http://dx.doi.org/10.1038/ng1207			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12833158				2022-12-17	WOS:000184470500027
J	Modrek, B; Lee, CJ				Modrek, B; Lee, CJ			Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss	NATURE GENETICS			English	Article							HUMAN GENES; WIDE DETECTION; SEQUENCE; INFORMATION; PREDICTION	One of the most interesting opportunities in comparative genomics is to compare not only genome sequences but additional phenomena, such as alternative splicing, using orthologous genes in different genomes to find similarities and differences between organisms(1,2). Recently, genomics studies have suggested that 40-60% of human genes are alternatively spliced(3-8) and have catalogued up to 30,000 alternative splice relationships in human genes(9). Here we report an analysis of 9,434 orthologous genes in human and mouse, which indicates that alternative splicing is associated with a large increase in frequency of recent exon creation and/or loss. Whereas most exons in the mouse and human genomes are strongly conserved in both genomes, exons that are only included in alternative splice forms (as opposed to the constitutive or major transcript form) are mostly not conserved and thus are the product of recent exon creation or loss events. A similar comparison of orthologous exons in rat and human validates this pattern. Although this says nothing about the complex question of adaptive benefit, it does indicate that alternative splicing in these genomes has been associated with increased evolutionary change.	Univ Calif Los Angeles, Ctr Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, CJ (corresponding author), Univ Calif Los Angeles, Ctr Genom & Proteom, Los Angeles, CA 90095 USA.	leec@mbi.ucla.edu						Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Cui Y, 2002, P NATL ACAD SCI USA, V99, P809, DOI 10.1073/pnas.022240299; GREEN P, 1993, SCIENCE, V259, P1711, DOI 10.1126/science.8456298; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492	18	417	428	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					177	180		10.1038/ng1159	http://dx.doi.org/10.1038/ng1159			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730695				2022-12-17	WOS:000183200500023
J	Lee, B; Thirunavukkarasu, K; Zhou, L; Pastore, L; Baldini, A; Hecht, J; Geoffroy, V; Ducy, P; Karsenty, G				Lee, B; Thirunavukkarasu, K; Zhou, L; Pastore, L; Baldini, A; Hecht, J; Geoffroy, V; Ducy, P; Karsenty, G			Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia	NATURE GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; TGF-BETA-SUPERFAMILY; SRY-RELATED GENE; DROSOPHILA SEGMENTATION; CAMPOMELIC DYSPLASIA; RUNT; FAMILY; MICRODELETION; EXPRESSION; MEMBER		UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT MOL GENET,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DIV MED GENET,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas System	Lee, B (corresponding author), BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030, USA.		Geoffroy, Valerie/P-1521-2014; genes, anthony/F-2541-2012; Pastore, Lucio/AAF-3487-2019; Pastore, Lucio/F-4668-2010; K, Thirunavukkarasu/AAA-7615-2019; Baldini, Antonio/M-2355-2015	Geoffroy, Valerie/0000-0003-3920-7482; Pastore, Lucio/0000-0001-6894-9317; Baldini, Antonio/0000-0002-5330-0256				Ahn MY, 1996, GENE, V168, P279, DOI 10.1016/0378-1119(95)00751-2; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baldini A, 1994, Methods Mol Biol, V33, P75; DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Francomano CA, 1996, CURR OPIN GENET DEV, V6, P301, DOI 10.1016/S0959-437X(96)80006-2; GELB BD, 1995, AM J MED GENET, V58, P200, DOI 10.1002/ajmg.1320580222; GERGEN JP, 1985, DEV BIOL, V109, P321, DOI 10.1016/0012-1606(85)90459-2; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jones K. L., 1997, SMITHS RECOGNIZABLE; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; MUNDLOS S, 1995, HUM MOL GENET, V4, P71, DOI 10.1093/hmg/4.1.71; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rousseau F, 1996, HORM RES, V45, P108, DOI 10.1159/000184768; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; TSAI CC, 1994, DEVELOPMENT, V120, P1671; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/0307-4412(91), DOI 10.1016/0307-4412(91)]; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0	30	417	438	4	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					307	310		10.1038/ng0797-307	http://dx.doi.org/10.1038/ng0797-307			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207800				2022-12-17	WOS:A1997XG60900030
J	Kato, N; Takeuchi, F; Tabara, Y; Kelly, TN; Go, MJ; Sim, XL; Tay, WT; Chen, CH; Zhang, Y; Yamamoto, K; Katsuya, T; Yokota, M; Kim, YJ; Ong, RTH; Nabika, T; Gu, DF; Chang, LC; Kokubo, Y; Huang, W; Ohnaka, K; Yamori, Y; Nakashima, E; Jaquish, CE; Lee, JY; Seielstad, M; Isono, M; Hixson, JE; Chen, YT; Miki, T; Zhou, XY; Sugiyama, T; Jeon, JP; Liu, JJ; Takayanagi, R; Kim, SS; Aung, T; Sung, YJ; Zhang, XG; Wong, TY; Han, BG; Kobayashi, S; Ogihara, T; Zhu, DL; Iwai, N; Wu, JY; Teo, YY; Tai, ES; Cho, YS; He, J				Kato, Norihiro; Takeuchi, Fumihiko; Tabara, Yasuharu; Kelly, Tanika N.; Go, Min Jin; Sim, Xueling; Tay, Wan Ting; Chen, Chien-Hsiun; Zhang, Yi; Yamamoto, Ken; Katsuya, Tomohiro; Yokota, Mitsuhiro; Kim, Young Jin; Ong, Rick Twee Hee; Nabika, Toru; Gu, Dongfeng; Chang, Li-Ching; Kokubo, Yoshihiro; Huang, Wei; Ohnaka, Keizo; Yamori, Yukio; Nakashima, Eitaro; Jaquish, Cashell E.; Lee, Jong-Young; Seielstad, Mark; Isono, Masato; Hixson, James E.; Chen, Yuan-Tsong; Miki, Tetsuro; Zhou, Xueya; Sugiyama, Takao; Jeon, Jae-Pil; Liu, Jian Jun; Takayanagi, Ryoichi; Kim, Sung Soo; Aung, Tin; Sung, Yun Ju; Zhang, Xuegong; Wong, Tien Yin; Han, Bok-Ghee; Kobayashi, Shotai; Ogihara, Toshio; Zhu, Dingliang; Iwai, Naoharu; Wu, Jer-Yuarn; Teo, Yik Ying; Tai, E. Shyong; Cho, Yoon Shin; He, Jiang			Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians	NATURE GENETICS			English	Article							GENETIC-BASIS; POSITIVE SELECTION; REGIONAL BURDEN; GLOBAL BURDEN; RISK-FACTORS; WILL UNLOCK; HYPERTENSION; LOCI; ANNOTATION; PARAMETERS	We conducted a meta-analysis of genome-wide association studies of systolic (SBP) and diastolic (DBP) blood pressure in 19,608 subjects of east Asian ancestry from the AGEN-BP consortium followed up with de novo genotyping (n = 10,518) and further replication (n = 20,247) in east Asian samples. We identified genome-wide significant (P < 5 x 10(-8)) associations with SBP or DBP, which included variants at four new loci (ST7L-CAPZA1, FIGN-GRB14, ENPEP and NPR3) and a newly discovered variant near TBX3. Among the five newly discovered variants, we obtained significant replication in the independent samples for all of these loci except NPR3. We also confirmed seven loci previously identified in populations of European descent. Moreover, at 12q24.13 near ALDH2, we observed strong association signals (P = 7.9 x 10(-31) and P = 1.3 x 10(-35) for SBP and DBP, respectively) with ethnic specificity. These findings provide new insights into blood pressure regulation and potential targets for intervention.	[Tabara, Yasuharu] Ehime Univ, Grad Sch Med, Dept Basic Med Res & Educ, Toon, Japan; [Kelly, Tanika N.; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Go, Min Jin; Kim, Young Jin; Lee, Jong-Young; Jeon, Jae-Pil; Kim, Sung Soo; Han, Bok-Ghee; Cho, Yoon Shin] Natl Inst Hlth, Ctr Genome Sci, Chungcheongbuk Do, South Korea; [Sim, Xueling; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Tay, Wan Ting; Aung, Tin; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Chen, Chien-Hsiun; Chang, Li-Ching; Chen, Yuan-Tsong; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun; Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Zhang, Yi; Zhu, Dingliang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, State Key Lab Med Genet, Shanghai 200030, Peoples R China; [Zhang, Yi; Zhu, Dingliang] Shanghai Res Inst Hypertens, Shanghai, Peoples R China; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Div Genome Anal, Fukuoka 812, Japan; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Ong, Rick Twee Hee; Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gu, Dongfeng] Chinese Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Huang, Wei] Chinese Natl Human Genom Ctr, Dept Genet, Shanghai, Peoples R China; [Ohnaka, Keizo] Kyushu Univ, Grad Sch Med Sci, Dept Geriatr Med, Fukuoka 812, Japan; [Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan; [Nakashima, Eitaro] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Nakashima, Eitaro] Chubu Rosai Hosp, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Jaquish, Cashell E.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Hixson, James E.] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol, Houston, TX USA; [Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon, Japan; [Zhou, Xueya; Zhang, Xuegong] Tsinghua Univ, Dept Automat, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Sugiyama, Takao; Teo, Yik Ying] Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan; [Liu, Jian Jun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Sung, Yun Ju] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Kobayashi, Shotai] Shimane Univ Hosp, Izumo, Shimane, Japan; [Ogihara, Toshio] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Iwai, Naoharu] Natl Cerebral & Cardiovasc Ctr, Dept Genom Med, Suita, Osaka, Japan; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Kato, Norihiro; Takeuchi, Fumihiko; Isono, Masato] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan	Ehime University; Tulane University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; National University of Singapore; National University of Singapore; Singapore National Eye Center; Academia Sinica - Taiwan; China Medical University Taiwan; Shanghai Jiao Tong University; Kyushu University; Osaka University; Aichi Gakuin University; National University of Singapore; Shimane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Cerebral & Cardiovascular Center - Japan; Kyushu University; Mukogawa Women's University; Nagoya University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Ehime University; Tsinghua University; Asahi Life Foundation; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Kyushu University; National University of Singapore; Washington University (WUSTL); Centre for Eye Research Australia; University of Melbourne; Shimane University; Osaka University; National Cerebral & Cardiovascular Center - Japan; National University of Singapore; National University of Singapore; National University of Singapore; Tulane University; National Center for Global Health & Medicine - Japan	Kato, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan.	nokato@ri.ncgm.go.jp	Liu, Jianjun/AAK-4989-2020; Tai, E Shyong/J-9831-2013; Wu, Jer-Yuarn/S-7010-2018; Lee, Jong-Young/M-6319-2013; Sim, Xueling/AAZ-6652-2020; Wong, Tien Yin/AAC-9724-2020; Kim, Young-jin/GSD-3168-2022; Chen, Chien Hsiun/Q-3826-2018; Seielstad, Mark/T-7841-2019; He, Jiang/AAF-5303-2020	Liu, Jianjun/0000-0002-3255-3019; Lee, Jong-Young/0000-0002-0092-9958; Sim, Xueling/0000-0002-1233-7642; Wong, Tien Yin/0000-0002-8448-1264; He, Jiang/0000-0002-8286-9652; Tai, E Shyong/0000-0003-2929-8966; Seielstad, Mark/0000-0001-5783-1401; Zhou, Xueya/0000-0003-2350-081X; Hixson, James/0000-0002-0849-9315	Japan Science Technology Agency; National Institute of Biomedical Innovation Organization (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan; National Center for Global Health and Medicine (NCGM); National Heart, Lung, and Blood Institute, National Institutes of Health (Bethesda, Maryland, USA) [U01HL072507, R01HL087263, R01HL090682]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (Bethesda, Maryland, USA) [K12HD043451]; Korea Centers for Disease Control & Prevention, Republic of Korea [4845-301, 4851-302, 4851-307]; Chinese National Key Program for Basic Research [2004CB518603, 2006CB503804, 2009CB521905]; Chinese National High Tech Program [2009AA022703, 2006AA02Z179]; Ministry of Science and Technology, National Natural Science Foundation [30871361]; National Medical Research Council [NMRC 0796/2003, NMRC/STaR/0003/2008, NMRC/CSA/008/2009]; Biomedical Research Council (BMRC) [09/1/35/19/616]; Biomedical Research Council of Singapore [BMRC 05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore [NMRC/1174/2008]; Singapore National Research Foundation [NRF-RF-2010-05]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan [H15-longevity-005, H17-longevity-003, H16-kenko-001, H18-longevity (kokusai)]; Japan Atherosclerosis Prevention Fund; Academia Sinica Genomic Medicine Multicenter Study; National Science Council, Taiwan (National Clinical Core) [NSC97-3112-B-001-014]; National Science Council, Taiwan (National Genotyping Center) [NSC97-3112-B-001-015]; Grants-in-Aid for Scientific Research [23710228, 21390209, 22133003] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090682, U01HL072507, R01HL087263] Funding Source: NIH RePORTER	Japan Science Technology Agency(Japan Science & Technology Agency (JST)); National Institute of Biomedical Innovation Organization (NIBIO)(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine (NCGM); National Heart, Lung, and Blood Institute, National Institutes of Health (Bethesda, Maryland, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (Bethesda, Maryland, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Korea Centers for Disease Control & Prevention, Republic of Korea; Chinese National Key Program for Basic Research; Chinese National High Tech Program(National High Technology Research and Development Program of China); Ministry of Science and Technology, National Natural Science Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Atherosclerosis Prevention Fund(Japan Atherosclerosis Prevention Fund); Academia Sinica Genomic Medicine Multicenter Study(Academia Sinica - Taiwan); National Science Council, Taiwan (National Clinical Core)(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan (National Genotyping Center)(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CAGE: The CAGE Network Studies were supported by grants for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency; the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation Organization (NIBIO); KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas 'Applied Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Grant of National Center for Global Health and Medicine (NCGM).; GenSalt: The Genetic Epidemiology Network of Salt Sensitivity is supported by research grants (U01HL072507, R01HL087263 and R01HL090682) from the National Heart, Lung, and Blood Institute, National Institutes of Health (Bethesda, Maryland, USA). T.N.K. is supported partially by Award Number K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (Bethesda, Maryland, USA).; KARE: KARE and HEXA-shared control studies were supported by grants from Korea Centers for Disease Control & Prevention, Republic of Korea (4845-301, 4851-302, 4851-307).; Shanghai: This work was supported by the Chinese National Key Program for Basic Research (grants 973: 2004CB518603, 2006CB503804 and 2009CB521905) and Chinese National High Tech Program (grants 863: 2009AA022703 and 2006AA02Z179) and the Ministry of Science and Technology, National Natural Science Foundation (30871361).; SiMES: The Singapore Malay Eye Study (SiMES) was funded by the National Medical Research Council (NMRC 0796/2003 and NMRC/STaR/0003/2008) and the Biomedical Research Council (BMRC, 09/1/35/19/616).; SP2: The Singapore Prospective Study Program (SP2) was funded through grants from the Biomedical Research Council of Singapore (BMRC 05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC/1174/2008). Y.Y.T. acknowledges support from the Singapore National Research Foundation (NRF-RF-2010-05). E. S. T. also receives additional support from the National Medical Research Council through a clinician scientist award (NMRC/CSA/008/2009).; Suita/Ehime Study: The Ehime Study was supported by Grants for Scientific Research (Priority Areas 'Medical Genome Science (Millennium Genome Project)' and 'Applied Genomics') from the Ministry of Education, Culture, Sports, Science and Technology, Japan; a Grants-in-Aid (H15-longevity-005, H17-longevity-003, H16-kenko-001, H18-longevity (kokusai)) from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan; a Science and Technology Incubation Program in Advanced Regions, Japan Science and Technology Agency; and the Japan Atherosclerosis Prevention Fund.; Taiwan Super Control Study: This study was supported by Academia Sinica Genomic Medicine Multicenter Study; National Research Program for Genomic Medicine, National Science Council, Taiwan (National Clinical Core, NSC97-3112-B-001-014; and National Genotyping Center, NSC97-3112-B-001-015).	Anand-Srivastava MB, 2005, PEPTIDES, V26, P1044, DOI 10.1016/j.peptides.2004.09.023; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dominiczak AF, 2010, HYPERTENSION, V56, P1017, DOI 10.1161/HYPERTENSIONAHA.110.156208; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Goenaga D, 2009, MOL ENDOCRINOL, V23, P1043, DOI 10.1210/me.2008-0360; HARADA S, 1980, AM J HUM GENET, V32, P8; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong KW, 2010, J HUM GENET, V55, P336, DOI 10.1038/jhg.2010.31; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Katoh M, 2002, INT J ONCOL, V20, P1247; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kurtz TW, 2010, HYPERTENSION, V56, P1021, DOI 10.1161/HYPERTENSIONAHA.110.156190; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li H, 2009, ANN HUM GENET, V73, P335, DOI 10.1111/j.1469-1809.2009.00517.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mizutani S, 2008, HEART FAIL REV, V13, P273, DOI 10.1007/s10741-007-9065-7; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Rodgers A, 1998, LANCET, V352, P1801; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429; Takeuchi F, 2011, CIRC J, V75, P911, DOI 10.1253/circj.CJ-10-0774; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	43	416	435	1	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					530	U57		10.1038/ng.834	http://dx.doi.org/10.1038/ng.834			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21572416	Green Accepted			2022-12-17	WOS:000291017000009
J	Broderick, P; Carvajal-Carmona, L; Pittman, AM; Webb, E; Howarth, K; Rowan, A; Lubbe, S; Spain, S; Sullivan, K; Fielding, S; Jaeger, E; Vijayakrishnan, J; Kemp, Z; Gorman, M; Chandler, I; Papaemmanuil, E; Penegar, S; Wood, W; Sellick, G; Qureshi, M; Teixeira, A; Domingo, E; Barclay, E; Martin, L; Sieber, O; Kerr, D; Gray, R; Peto, J; Cazier, JB; Tomlinson, I; Houlston, RS				Broderick, Peter; Carvajal-Carmona, Luis; Pittman, Alan M.; Webb, Emily; Howarth, Kimberley; Rowan, Andrew; Lubbe, Steven; Spain, Sarah; Sullivan, Kate; Fielding, Sarah; Jaeger, Emma; Vijayakrishnan, Jayaram; Kemp, Zoe; Gorman, Maggie; Chandler, Ian; Papaemmanuil, Elli; Penegar, Steven; Wood, Wendy; Sellick, Gabrielle; Qureshi, Mobshra; Teixeira, Ana; Domingo, Enric; Barclay, Ella; Martin, Lynn; Sieber, Oliver; Kerr, David; Gray, Richard; Peto, Julian; Cazier, Jean-Baptiste; Tomlinson, Ian; Houlston, Richard S.			A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk	NATURE GENETICS			English	Article								To identify risk variants for colorectal cancer (CRC), we conducted a genome-wide association study, genotyping 550,163 tag SNPs in 940 individuals with familial colorectal tumor ( 627 CRC, 313 advanced adenomas) and 965 controls. We evaluated selected SNPs in three replication sample sets ( 7,473 cases, 5,984 controls) and identified three SNPs in SMAD7 ( involved in TGF-beta and Wnt signaling) associated with CRC. Across the four sample sets, the association between rs4939827 and CRC was highly statistically significant ( P-trend 1.0 x 10(-12)).	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Canc Res UK, London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; Univ London, Queen Mary Coll, Inst Canc, Barts & London Med Sch, London EC1M 6BQ, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Birmingham Womens Hosp, Dept Med Genet, Birmingham B15 2TG, W Midlands, England; Univ Oxford, Weatherall Inst Mol Med, Canc & Immunogenet Lab, Oxford OX3 9DS, England; Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England	University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Queen Mary University London; University of Manchester; Birmingham Women's Hospital; University of Oxford; Radcliffe Infirmary; University of Oxford; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	ian.tomlinson@cancer.org.uk; richard.houlston@icr.ac.uk	Evans, D Gareth/AAB-4308-2022; Cazier, Jean-Baptiste/F-2369-2010; Sieber, Oliver/M-9473-2015; Lubbe, Steven/L-8261-2013; Carvajal-Carmona, Luis G/B-3882-2010; Cazier, Jean-Baptiste/GLR-2949-2022; Pittman, Alan/AAP-2534-2020; Sieber, Oliver/ABA-9211-2021; Domingo, Enric/A-9099-2018; Pittman, Alan M/D-6231-2012; Spain, Sarah/G-1968-2010	Evans, D Gareth/0000-0002-8482-5784; Cazier, Jean-Baptiste/0000-0001-7581-9051; Sieber, Oliver/0000-0001-9480-0786; Lubbe, Steven/0000-0002-7103-6671; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Cazier, Jean-Baptiste/0000-0001-7581-9051; Pittman, Alan/0000-0002-8112-2987; Sieber, Oliver/0000-0001-9480-0786; Domingo, Enric/0000-0003-4390-8767; Pittman, Alan M/0000-0002-8112-2987; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Broderick, Peter/0000-0002-8348-5829; Penegar, Steven/0000-0002-3768-0236; Gray, Richard/0000-0003-4440-574X; Webb, Emily/0000-0002-4019-7456; Spain, Sarah/0000-0002-7591-8364; Houlston, Richard/0000-0002-5268-0242	MRC [G0301100] Funding Source: UKRI; Medical Research Council [G0301100] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	12	416	432	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1315	1317		10.1038/ng.2007.18	http://dx.doi.org/10.1038/ng.2007.18			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17934461				2022-12-17	WOS:000250575900014
J	Hubner, N; Wallace, CA; Zimdahl, H; Petretto, E; Schulz, H; Maciver, F; Mueller, M; Hummel, O; Monti, J; Zidek, V; Musilova, A; Kren, V; Causton, H; Game, L; Born, G; Schmidt, S; Muller, A; Cook, SA; Kurtz, TW; Whittaker, J; Pravenec, M; Aitman, TJ				Hubner, N; Wallace, CA; Zimdahl, H; Petretto, E; Schulz, H; Maciver, F; Mueller, M; Hummel, O; Monti, J; Zidek, V; Musilova, A; Kren, V; Causton, H; Game, L; Born, G; Schmidt, S; Muller, A; Cook, SA; Kurtz, TW; Whittaker, J; Pravenec, M; Aitman, TJ			Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; RECOMBINANT INBRED STRAINS; SPONTANEOUSLY HYPERTENSIVE RATS; ANGIOTENSIN-CONVERTING-ENZYME; FATTY-ACID-METABOLISM; BLOOD-PRESSURE; INSULIN-RESISTANCE; CHROMOSOME 1; CONGENIC STRAINS; COMPLEX TRAITS	Integration of genome-wide expression profiling with linkage analysis is a new approach to identifying genes underlying complex traits. We applied this approach to the regulation of gene expression in the BXH/HXB panel of rat recombinant inbred strains, one of the largest available rodent recombinant inbred panels and a leading resource for genetic analysis of the highly prevalent metabolic syndrome. In two tissues important to the pathogenesis of the metabolic syndrome, we mapped cis- and transregulatory control elements for expression of thousands of genes across the genome. Many of the most highly linked expression quantitative trait loci are regulated in cis, are inherited essentially as monogenic traits and are good candidate genes for previously mapped physiological quantitative trait loci in the rat. By comparative mapping we generated a data set of 73 candidate genes for hypertension that merit testing in human populations. Mining of this publicly available data set is expected to lead to new insights into the genes and regulatory pathways underlying the extensive range of metabolic and cardiovascular disease phenotypes that segregate in these recombinant inbred strains.	Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague 4, Czech Republic; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Univ London Imperial Coll Sci & Technol, Fac Med, Ctr Clin Sci, MRC, London W12 0NN, England; Ctr Appl Gen, Prague 14220 4, Czech Republic; Charles Univ Prague, Inst Biol & Med Genet, Prague 12000 2, Czech Republic; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ London Imperial Coll Sci & Technol, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Imperial College London; Charles University Prague; University of California System; University of California San Francisco; Imperial College London	Pravenec, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	pravenec@biomed.cas.cz; t.aitman@csc.mrc.ac.uk	Zidek, Vaclav/C-6685-2012; Cook, Stuart/G-9567-2011; Whittaker, John C/B-8609-2012; Pravenec, Michal/B-1666-2012	Whittaker, John C/0000-0002-3529-2379; Pravenec, Michal/0000-0001-9197-5871; Causton, Helen/0000-0003-4630-6569; Cook, Stuart/0000-0001-6628-194X; Aitman, Timothy/0000-0002-7875-4502	Medical Research Council [MC_U120097112, MC_U120061454] Funding Source: Medline; MRC [MC_U120061454] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Belknap JK, 1996, BEHAV GENET, V26, P149, DOI 10.1007/BF02359892; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bottger A, 1996, J CLIN INVEST, V98, P856, DOI 10.1172/JCI118858; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; CHURCHILL GA, 1994, GENETICS, V138, P963; Cowley AW, 2004, J PHYSIOL-LONDON, V554, P46, DOI 10.1113/jphysiol.2003.052613; Frantz S, 2001, HYPERTENSION, V38, P216, DOI 10.1161/01.HYP.38.2.216; Frantz SA, 1998, HYPERTENSION, V32, P639, DOI 10.1161/01.HYP.32.4.639; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Glazier AN, 2002, MAMM GENOME, V13, P108, DOI 10.1007/s00335-001-2132-9; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hubner N, 1999, HYPERTENSION, V34, P643, DOI 10.1161/01.HYP.34.4.643; HULMAN S, 1993, METABOLISM, V42, P14, DOI 10.1016/0026-0495(93)90165-K; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jirout M, 2003, MAMM GENOME, V14, P537, DOI 10.1007/s00335-003-2266-z; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kato N, 1999, MAMM GENOME, V10, P259, DOI 10.1007/s003359900983; Kovacs P, 1997, BIOCHEM BIOPH RES CO, V235, P343, DOI 10.1006/bbrc.1997.6782; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; McBride MW, 2003, HYPERTENSION, V41, P847, DOI 10.1161/01.HYP.0000047103.07205.03; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; OKAMOTO K, 1972, SPONTANEOUS HYPERTEN; Pravenec M., 2001, American Journal of Hypertension, V14, p82A, DOI 10.1016/S0895-7061(01)01767-8; Pravenec M, 2004, PHYSIOL RES, V53, pS15; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Pravenec M, 1999, FOLIA BIOL-PRAGUE, V45, P203; Pravenec M, 1996, MAMM GENOME, V7, P117, DOI 10.1007/s003359900031; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Printz MP, 2003, J APPL PHYSIOL, V94, P2510, DOI 10.1152/japplphysiol.00064.2003; RAO RH, 1993, DIABETES, V42, P1364, DOI 10.2337/diabetes.42.9.1364; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Silver L.M., 1995, MOUSE GENETICS CONCE; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Wallace CA, 2004, NAT GENET, V36, P441, DOI 10.1038/ng1349; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	50	416	433	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					243	253		10.1038/ng1522	http://dx.doi.org/10.1038/ng1522			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15711544				2022-12-17	WOS:000227297800015
J	ZUCMAN, J; DELATTRE, O; DESMAZE, C; EPSTEIN, AL; STENMAN, G; SPELEMAN, F; FLETCHERS, CDM; AURIAS, A; THOMAS, G				ZUCMAN, J; DELATTRE, O; DESMAZE, C; EPSTEIN, AL; STENMAN, G; SPELEMAN, F; FLETCHERS, CDM; AURIAS, A; THOMAS, G			EWS AND ATF-1 GENE FUSION INDUCED BY T(12-22) TRANSLOCATION IN MALIGNANT-MELANOMA OF SOFT PARTS	NATURE GENETICS			English	Article							CLEAR-CELL-SARCOMA; EWINGS-SARCOMA; PERIPHERAL NEUROEPITHELIOMA; CHROMOSOME-TRANSLOCATION; CDNA CLONES; PROTEINS; LEUKEMIA; APONEUROSES; TENDONS; DOMAIN	The genes involved in the t(12;22)(q13;q12) translocation found recurrently in malignant melanoma of soft parts have been characterized and shown to form, in four cases studied, hybrid transcripts. The deduced chimaeric protein encoded by the der(22) chromosome consists of the N-terminal domain of EWS linked to the bZIP domain of ATF-1, a transcription factor which may normally be regulated by cAMP. ATF-1 has not previously been implicated in oncogenesis. EWS was first identified as forming a hybrid transcript in Ewing's sarcoma, which links its N-terminal domain to the DNA binding domain of the FLI-1 gene. Thus the oncogenic conversion of EWS follows a common scheme of activation, exchanging its putative RNA binding domain with different DNA binding domains that appear to be tumour-specific.	INST CURIE, INSERM, TUMOUR GENET LAB, CJF 9201, 26 RUE ULM, F-75231 PARIS 05, FRANCE; UNIV SO CALIF, MED CTR, DEPT PATHOL, LOS ANGELES, CA 90033 USA; GOTHENBURG UNIV, DEPT ODONTOL, S-400330 GOTEBOTG, SWEDEN; STATE UNIV GHENT HOSP, DEPT MED GENET, B-9000 GHENT, BELGIUM; ST THOMAS HOSP, DEPT HISTOPATHOL, LONDON SE1 7EH, ENGLAND	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; University of Gothenburg; Ghent University; Ghent University Hospital; Guy's & St Thomas' NHS Foundation Trust			zucman-rossi, Jessica/B-5098-2009; j, zucman-rossi/AAV-3594-2021; speleman, frank/AAR-5184-2020	zucman-rossi, Jessica/0000-0002-5687-0334; j, zucman-rossi/0000-0002-5687-0334; speleman, frank/0000-0002-6628-8559; Desmaze, Chantal/0000-0003-0777-8854; delattre, olivier/0000-0002-8730-2276				BRIDGE JA, 1991, CANCER GENET CYTOGEN, V52, P101, DOI 10.1016/0165-4608(91)90059-4; BRIDGE JA, 1990, AM J CLIN PATHOL, V93, P26, DOI 10.1093/ajcp/93.1.26; CHUNG EB, 1983, AM J SURG PATHOL, V7, P405, DOI 10.1097/00000478-198307000-00003; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DESMAZE C, 1992, GENE CHROMOSOME CANC, V5, P30, DOI 10.1002/gcc.2870050105; DOUGLASS EC, 1986, J NATL CANCER I, V77, P1211; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; EPSTEIN AL, 1984, CANCER RES, V44, P1265; FLETCHER JA, 1992, GENE CHROMOSOME CANC, V5, P184, DOI 10.1002/gcc.2870050214; FLINT KJ, 1991, ONCOGENE, V6, P2019; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Maniatis T, 1989, MOL CLONING; Mitelman F., 1988, CATALOG CHROMOSOME A; PEULVE P, 1991, GENE CHROMOSOME CANC, V3, P400, DOI 10.1002/gcc.2870030512; SPELEMAN F, 1992, CANCER GENET CYTOGEN, V60, P176, DOI 10.1016/0165-4608(92)90012-W; STENMAN G, 1992, GENE CHROMOSOME CANC, V4, P122, DOI 10.1002/gcc.2870040204; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x; ZUCMAN J, 1992, GENE CHROMOSOME CANC, V5, P271, DOI 10.1002/gcc.2870050402	25	416	425	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					341	345		10.1038/ng0893-341	http://dx.doi.org/10.1038/ng0893-341			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401579				2022-12-17	WOS:A1993LQ17800009
J	Chia, JM; Song, C; Bradbury, PJ; Costich, D; de Leon, N; Doebley, J; Elshire, RJ; Gaut, B; Geller, L; Glaubitz, JC; Gore, M; Guill, KE; Holland, J; Hufford, MB; Lai, JS; Li, M; Liu, X; Lu, YL; McCombie, R; Nelson, R; Poland, J; Prasanna, BM; Pyhajarvi, T; Rong, TZ; Sekhon, RS; Sun, Q; Tenaillon, MI; Tian, F; Wang, J; Xu, X; Zhang, ZW; Kaeppler, SM; Ross-Ibarra, J; McMullen, MD; Buckler, ES; Zhang, GY; Xu, YB; Ware, D				Chia, Jer-Ming; Song, Chi; Bradbury, Peter J.; Costich, Denise; de Leon, Natalia; Doebley, John; Elshire, Robert J.; Gaut, Brandon; Geller, Laura; Glaubitz, Jeffrey C.; Gore, Michael; Guill, Kate E.; Holland, Jim; Hufford, Matthew B.; Lai, Jinsheng; Li, Meng; Liu, Xin; Lu, Yanli; McCombie, Richard; Nelson, Rebecca; Poland, Jesse; Prasanna, Boddupalli M.; Pyhaejaervi, Tanja; Rong, Tingzhao; Sekhon, Rajandeep S.; Sun, Qi; Tenaillon, Maud I.; Tian, Feng; Wang, Jun; Xu, Xun; Zhang, Zhiwu; Kaeppler, Shawn M.; Ross-Ibarra, Jeffrey; McMullen, Michael D.; Buckler, Edward S.; Zhang, Gengyun; Xu, Yunbi; Ware, Doreen			Maize HapMap2 identifies extant variation from a genome in flux	NATURE GENETICS			English	Article							QUANTITATIVE RESISTANCE; WIDE ASSOCIATION; LEAF-BLIGHT; DIVERSITY; EVOLUTION; ALIGNMENT; ZEA; BIOCONDUCTOR; ULTRAFAST; PATTERNS	Whereas breeders have exploited diversity in maize for yield improvements, there has been limited progress in using beneficial alleles in undomesticated varieties. Characterizing standing variation in this complex genome has been challenging, with only a small fraction of it described to date. Using a population genetics scoring model, we identified 55 million SNPs in 103 lines across pre-domestication and domesticated Zea mays varieties, including a representative from the sister genus Tripsacum. We find that structural variations are pervasive in the Z. mays genome and are enriched at loci associated with important traits. By investigating the drivers of genome size variation, we find that the larger Tripsacum genome can be explained by transposable element abundance rather than an allopolyploid origin. In contrast, intraspecies genome size variation seems to be controlled by chromosomal knob content. There is tremendous overlap in key gene content in maize and Tripsacum, suggesting that adaptations from Tripsacum (for example, perennialism and frost and drought tolerance) can likely be integrated into maize.	[Bradbury, Peter J.; Costich, Denise; Elshire, Robert J.; Glaubitz, Jeffrey C.; Li, Meng; Sun, Qi; Tian, Feng; Zhang, Zhiwu; Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Chia, Jer-Ming; Geller, Laura; McCombie, Richard; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Song, Chi; Liu, Xin; Wang, Jun; Xu, Xun; Zhang, Gengyun] BGI Shenzhen, Shenzhen, Peoples R China; [de Leon, Natalia; Sekhon, Rajandeep S.; Kaeppler, Shawn M.] Univ Wisconsin, US Dept Energy DOE, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [de Leon, Natalia; Sekhon, Rajandeep S.; Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Gaut, Brandon; Tenaillon, Maud I.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Gore, Michael] US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Guill, Kate E.; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Holland, Jim] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Hufford, Matthew B.; Pyhaejaervi, Tanja; Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Lai, Jinsheng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Lai, Jinsheng] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China; [Lai, Jinsheng] China Agr Univ, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [Lu, Yanli; Rong, Tingzhao] Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China; [Nelson, Rebecca] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Prasanna, Boddupalli M.] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya; [Poland, Jesse] Kansas State Univ, Manhattan, KS 66506 USA; [Tenaillon, Maud I.] Univ Paris 11, CNRS, INRA, Unite Mixte Rech UMR Genet Vegetale,AgroParisTech, Gif Sur Yvette, France; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Xu, Yunbi] Chinese Acad Agr Sci, Natl Key Facil Crop Genet Resources & Improvement, Inst Crop Sci, Beijing 100193, Peoples R China; [Xu, Yunbi] CIMMYT, Texcoco, Mexico	Cornell University; Cold Spring Harbor Laboratory; Beijing Genomics Institute (BGI); United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University; University of California System; University of California Davis; China Agricultural University; China Agricultural University; China Agricultural University; Sichuan Agricultural University; Cornell University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Kansas State University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Buckler, ES (corresponding author), Cornell Univ, Inst Genom Div, Ithaca, NY USA.	mcmullenm@missouri.edu; esb33@cornell.edu; zhanggengyun@genomics.org.cn; y.xu@cgiar.org; ware@cshl.edu	Ross-Ibarra, Jeffrey/D-7782-2011; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Hufford, Matthew/E-7810-2012; Zhang, zs/GXN-3521-2022; Xu, Xun/AAI-6763-2020; Pyhäjärvi, Tanja/ABD-4161-2021; Wang, Jun/A-7261-2013; Zhang, Zhiwu/P-6156-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Buckler, Edward/0000-0002-3100-371X; Hufford, Matthew/0000-0003-3945-1143; Xu, Xun/0000-0002-5338-5173; Zhang, Zhiwu/0000-0002-5784-9684; Boddupalli, Prasanna/0000-0002-5761-2273; Liu, Xin/0000-0003-3256-2940; Elshire, Robert/0000-0003-1753-6920; Gore, Michael/0000-0001-6896-8024; Tenaillon, Maud/0000-0002-0867-3678; Wang, Jun/0000-0002-2113-5874; Holland, James/0000-0002-4341-9675; Wang, Jun/0000-0002-8540-8931; McCombie, W. Richard/0000-0003-1899-0682; Poland, Jesse/0000-0002-7856-1399; Pyhajarvi, Tanja/0000-0001-6958-5172; Kaeppler, Shawn/0000-0002-5964-1668	US National Science Foundation [DBI-0820619, 0321467, 0703908, 0638566, IOS-092270]; USDA-ARS; USDA-National Institute of Food and Agriculture (NIFA) [2009-01864]; US DOE (BER) [DE-FC02-07ER44494, DE-AC02-03CH11211]; Rockefeller Foundation; Bill and Melinda Gates Foundation; Generation Challenge Program; Chinese 971 program [2007CB813701, 2007CB813703]; National Natural Science Foundation of China (NSFC) [10723008]; Chinese Ministry of Agriculture [2010-Z11]; National High Technology Research and Development Program of China [2009AA10AA03-2]; National Basic Research Program of China [2007CB108900]; Direct For Biological Sciences [0922703] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Institute of Food and Agriculture (NIFA); US DOE (BER)(United States Department of Energy (DOE)); Rockefeller Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Generation Challenge Program; Chinese 971 program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the US National Science Foundation (DBI-0820619, 0321467, 0703908, 0638566 and IOS-092270), the USDA-ARS, the USDA-National Institute of Food and Agriculture (NIFA) (2009-01864), the US DOE (BER DE-FC02-07ER44494 and DE-AC02-03CH11211), The Rockefeller Foundation, the Bill and Melinda Gates Foundation, the Generation Challenge Program, the Chinese 971 program (2007CB813701, 2007CB813701 and 2007CB813703), the National Natural Science Foundation of China (NSFC) to Young Scientists (10723008), Guangdong Innovation Team Funding, the Chinese Ministry of Agriculture 984 program (2010-Z11), the National High Technology Research and Development Program of China (2009AA10AA03-2) and the National Basic Research Program of China (2007CB108900).	Albert PS, 2010, CYTOGENET GENOME RES, V129, P6, DOI 10.1159/000314342; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson Edgar, 1944, ANN MISSOURI BOT GARD, V31, P317, DOI 10.2307/2394366; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P229, DOI [DOI 10.1007/BF02672073, 10.1007/BF02672073]; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gaut BS, 2000, P NATL ACAD SCI USA, V97, P7008, DOI 10.1073/pnas.97.13.7008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAURIE DA, 1985, HEREDITY, V55, P307, DOI 10.1038/hdy.1985.112; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Poggio L, 1998, ANN BOT-LONDON, V82, P107, DOI 10.1006/anbo.1998.0757; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	40	415	436	3	197	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					803	U238		10.1038/ng.2313	http://dx.doi.org/10.1038/ng.2313			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22660545				2022-12-17	WOS:000305886900016
J	Kettunen, J; Tukiainen, T; Sarin, AP; Ortega-Alonso, A; Tikkanen, E; Lyytikainen, LP; Kangas, AJ; Soininen, P; Wurtz, P; Silander, K; Dick, DM; Rose, RJ; Savolainen, MJ; Viikari, J; Kahonen, M; Lehtimaki, T; Pietilainen, KH; Inouye, M; McCarthy, MI; Jula, A; Eriksson, J; Raitakari, OT; Salomaa, V; Kaprio, J; Jarvelin, MR; Peltonen, L; Perola, M; Freimer, NB; Ala-Korpela, M; Palotie, A; Ripatti, S				Kettunen, Johannes; Tukiainen, Taru; Sarin, Antti-Pekka; Ortega-Alonso, Alfredo; Tikkanen, Emmi; Lyytikainen, Leo-Pekka; Kangas, Antti J.; Soininen, Pasi; Wuertz, Peter; Silander, Kaisa; Dick, Danielle M.; Rose, Richard J.; Savolainen, Markku J.; Viikari, Jorma; Kahonen, Mika; Lehtimaki, Terho; Pietilainen, Kirsi H.; Inouye, Michael; McCarthy, Mark I.; Jula, Antti; Eriksson, Johan; Raitakari, Olli T.; Salomaa, Veikko; Kaprio, Jaakko; Jarvelin, Marjo-Riitta; Peltonen, Leena; Perola, Markus; Freimer, Nelson B.; Ala-Korpela, Mika; Palotie, Aarno; Ripatti, Samuli			Genome-wide association study identifies multiple loci influencing human serum metabolite levels	NATURE GENETICS			English	Article							APOLIPOPROTEIN-E; MAST-CELLS; POPULATION; RECEPTOR; RISK; GENE; ATHEROSCLEROSIS; IMPUTATION; DISEASE	Nuclear magnetic resonance assays allow for measurement of a wide range of metabolic phenotypes. We report here the results of a GWAS on 8,330 Finnish individuals genotyped and imputed at 7.7 million SNPs for a range of 216 serum metabolic phenotypes assessed by NMR of serum samples. We identified significant associations (P < 2.31 x 10(-10)) at 31 loci, including 11 for which there have not been previous reports of associations to a metabolic trait or disorder. Analyses of Finnish twin pairs suggested that the metabolic measures reported here show higher heritability than comparable conventional metabolic phenotypes. In accordance with our expectations, SNPs at the 31 loci associated with individual metabolites account for a greater proportion of the genetic component of trait variance (up to 40%) than is typically observed for conventional serum metabolic phenotypes. The identification of such associations may provide substantial insight into cardiometabolic disorders.	[Kettunen, Johannes; Tukiainen, Taru; Sarin, Antti-Pekka; Ortega-Alonso, Alfredo; Tikkanen, Emmi; Wuertz, Peter; Silander, Kaisa; Pietilainen, Kirsi H.; Kaprio, Jaakko; Perola, Markus; Palotie, Aarno; Ripatti, Samuli] Univ Helsinki, FIMM, Helsinki, Finland; [Kettunen, Johannes; Sarin, Antti-Pekka; Tikkanen, Emmi; Silander, Kaisa; Jula, Antti; Salomaa, Veikko; Perola, Markus; Ripatti, Samuli] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Tukiainen, Taru; Wuertz, Peter; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Tukiainen, Taru] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Wuertz, Peter; Ala-Korpela, Mika] Univ Oulu, Computat Med Res Grp, Inst Clin Med, Oulu, Finland; [Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Wuertz, Peter; Savolainen, Markku J.; Jarvelin, Marjo-Riitta; Ala-Korpela, Mika] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lyytikainen, Leo-Pekka; Kahonen, Mika; Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Nucl Magnet Resonance NMR Metabon Lab, Dept Biosci, Kuopio, Finland; [Dick, Danielle M.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Rose, Richard J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Savolainen, Markku J.; Ala-Korpela, Mika] Univ Oulu, Dept Internal Med, Clin Res Ctr, SF-90220 Oulu, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma] Turku Univ Hosp, FIN-20520 Turku, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med,Obes Res Unit, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Inouye, Michael] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Inouye, Michael] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Headington, England; [Eriksson, Johan] Natl Inst Hlth & Welf, Unit Chron Dis Epidemiol & Prevent, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Alcohol Abuse Serv, Helsinki, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC, HPA, Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Palotie, Aarno; Ripatti, Samuli] Wellcome Trust Sanger Inst, Hinxton, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Palotie, Aarno] Helsinki Univ Hosp, Helsinki, Finland	University of Helsinki; Finland National Institute for Health & Welfare; Imperial College London; Aalto University; University of Oulu; University of Oulu; Tampere University; Tampere University; Tampere University Hospital; University of Eastern Finland; Virginia Commonwealth University; Indiana University System; Indiana University Bloomington; University of Oulu; University of Turku; University of Turku; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Turku; University of Turku; Finland National Institute for Health & Welfare; Health Protection Agency; Imperial College London; University of Oulu; Finland National Institute for Health & Welfare; University of Tartu; University of California System; University of California Los Angeles; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Helsinki University Central Hospital	Ripatti, S (corresponding author), Univ Helsinki, FIMM, Helsinki, Finland.	samuli.ripatti@fimm.fi	Lehtimäki, Terho/AAD-1094-2022; Lyytikäinen, Leo-Pekka/C-8544-2016; Soininen, Pasi/B-9716-2008; Ripatti, Samuli/H-9446-2014; Raitakari, Olli/AAQ-7389-2021; Kaprio, Jaakko/A-1820-2008; McCarthy, Mark/M-3763-2015	Lehtimäki, Terho/0000-0002-2555-4427; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Ripatti, Samuli/0000-0002-0504-1202; Kaprio, Jaakko/0000-0002-3716-2455; Wurtz, Peter/0000-0002-5832-0221; Inouye, Michael/0000-0001-9413-6520; Eriksson, Johan/0000-0002-2516-2060; Tukiainen, Taru/0000-0002-5404-8398; Pietilainen, Kirsi/0000-0002-8522-1288; McCarthy, Mark/0000-0002-4393-0510; Kangas, Antti/0000-0001-7492-1732; Kahonen, Mika/0000-0002-4510-7341; Ala-Korpela, Mika/0000-0001-5905-1206; Palotie, Aarno/0000-0002-2527-5874	European Community; BioSHaRE Consortium [261433]; Sigrid Juselius Foundation [251217]; Academy of Finland [137870, 135973, 129269, 129429, 126925, 121584, 124282, 129378, 117787, 41071, 120386, 125876, 126775, 118081, 100499, 205585, 118555, 141054, 104781, 120315, 1114194, 139900]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Finnish Foundation for Cardiovascular Research; Instrumentarium Science Foundation; Finnish Cultural Foundation; Aalto University School of Science and Technology; Wellcome Trust [098051, 89061/Z/09/Z, 089062/Z/09/Z, GR069224]; Social Insurance Institution of Finland; Turku University Foundation; Yrjo Jahnsson Foundation; Emil Aaltonen Foundation; Tampere University Hospital; Turku University Hospital; Juho Vainio Foundation; Tampere Tuberculosis Foundation; Finnish Diabetes Research Society; Novo Nordisk Foundation; European Science Foundation (EuroSTRESS); Samfundet Folkhalsan; Finska Lakaresallskapet; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [AA-12502, AA-09203, AA-08315, AA-15416]; Diabetes Research Foundation; Biomedicum Helsinki and Helsinki University Central Hospital; SALVE; Center of Excellence in Complex Disease Genetics; University Hospital Oulu, Biocenter, University of Oulu [75617]; European Commission EURO-BLCS [QLG1-CT-2000-01643]; US National Heart, Lung, and Blood Institute (NHLBI) [5R01HL087679]; US National Institute of Mental Health (NIMH) [1RL1MH083268]; European Network for Genetic and Genomic Epidemiology (ENGAGE) [HEALTH-F4-2007-201413]; MRC UK [G0500539, G0600705]; PrevMetSyn/Salve; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0801056B, G0600705] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K02AA018755, R01AA012502, R01AA015416, R37AA012502, R01AA008315, R01AA009203] Funding Source: NIH RePORTER	European Community(European Commission); BioSHaRE Consortium; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Finnish Foundation for Cardiovascular Research; Instrumentarium Science Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Aalto University School of Science and Technology; Wellcome Trust(Wellcome TrustEuropean Commission); Social Insurance Institution of Finland; Turku University Foundation; Yrjo Jahnsson Foundation; Emil Aaltonen Foundation; Tampere University Hospital; Turku University Hospital; Juho Vainio Foundation; Tampere Tuberculosis Foundation; Finnish Diabetes Research Society; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Science Foundation (EuroSTRESS)(European Science Foundation (ESF)); Samfundet Folkhalsan; Finska Lakaresallskapet; National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Diabetes Research Foundation; Biomedicum Helsinki and Helsinki University Central Hospital; SALVE; Center of Excellence in Complex Disease Genetics(Academy of Finland); University Hospital Oulu, Biocenter, University of Oulu; European Commission EURO-BLCS(European CommissionEuropean Commission Joint Research Centre); US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); European Network for Genetic and Genomic Epidemiology (ENGAGE); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PrevMetSyn/Salve; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank all the Finnish volunteers who participated in the studies. We thank the IT Center for Science and the technology center of the Institute for Molecular Medicine Finland for providing the computational facilities required in this study. The expert technical assistance for statistical analyses provided by A. Vikman, I. Lisinen, V. Aalto and the Genotyping Facilities at the Wellcome Trust Sanger Institute are gratefully acknowledged. The study was supported through funds from The European Community's Seventh Framework Programme (FP7/2007-2013), the BioSHaRE Consortium (261433), the Sigrid Juselius Foundation (251217 to S. R.), the Academy of Finland (137870 to P. S. and 135973 to P. W.), the Responding to Public Health Challenges Research Programme of the Academy of Finland (129269 to M. J. S., 129429 to M. A.-K., 129322 to M. P. and 139635 to V. S.), the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680 to A. P., J. Kaprio, L. P., K. S. and S. R.), the Finnish Foundation for Cardiovascular Research (to M. J. S., M. A.-K., M. P., S. R. and K. H. P), the Jenny and Antti Wihuri Foundation (to A. J. K.), the Instrumentarium Science Foundation (to T. T. and P. W.), the Finnish Cultural Foundation (to T. T. and T. L.), an Aalto University School of Science and Technology researcher training scholarship (to T. T.) and the Wellcome Trust (098051 to A. P.). The Young Finns Study has been financially supported by the Academy of Finland (126925, 121584, 124282, 129378 (Salve), 117787 (Gendi) and 41071 (Skidi)), the Social Insurance Institution of Finland, the Turku University Foundation, the Yrjo Jahnsson Foundation, the Emil Aaltonen Foundation (to T. L.), the Medical Research Fund of Tampere University Hospital, the Turku University Hospital Medical Fund, the Juho Vainio Foundation, the Finnish Foundation for Cardiovascular Research (to T. L.) and the Tampere Tuberculosis Foundation (to T. L. and M. K.). The Helsinki Birth Cohort Study has been supported by grants from the Academy of Finland (120386, 125876 and 126775 to J. E.), the Finnish Diabetes Research Society, the Novo Nordisk Foundation, the European Science Foundation (EuroSTRESS), the Wellcome Trust (89061/Z/09/Z and 089062/Z/09/Z), the Samfundet Folkhalsan and the Finska Lakaresallskapet. The FINRISK/DILGOM study was supported by the Academy of Finland (118081). Data collection for FinnTwin12 and FinnTwin16 were supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (AA-12502, AA-09203 and AA-08315 to R. J. R. and AA-15416 to D. M. D.) and the Academy of Finland (100499, 205585, 118555 and 141054 (Skidi-Kids) to J. Kaprio). The Finnish Twin cohorts are also supported by the Novo Nordisk Foundation, the Diabetes Research Foundation, Biomedicum Helsinki and Helsinki University Central Hospital grants (all to K. H. P.). NFBC1966 received financial support from the Academy of Finland (104781, 120315, 129269, 1114194, 139900 and SALVE to M.-R. J. and Center of Excellence in Complex Disease Genetics to L. P.), University Hospital Oulu, Biocenter, University of Oulu (75617 to M.-R. J. and M. J. S.), the European Commission EURO-BLCS Framework 5 award (QLG1-CT-2000-01643 to M.-R. J.), the US National Heart, Lung, and Blood Institute (NHLBI) (5R01HL087679), the US National Institute of Mental Health (NIMH) (1RL1MH083268), European Network for Genetic and Genomic Epidemiology (ENGAGE) (HEALTH-F4-2007-201413 to L. P. and M.-R. J.), the MRC UK (G0500539, G0600705 and PrevMetSyn/Salve to M.-R. J.) and the Wellcome Trust (GR069224).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BERGSTROM JD, 1980, ARCH BIOCHEM BIOPHYS, V204, P71, DOI 10.1016/0003-9861(80)90008-9; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cohen PTW, 2002, J CELL SCI, V115, P241; Cross LJM, 1997, INFLAMM RES, V46, P306, DOI 10.1007/s000110050192; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hernandez-Vargas P, 2006, CIRC RES, V99, P1188, DOI 10.1161/01.RES.0000250556.07796.6c; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Isaacs A, 2007, EUR J EPIDEMIOL, V22, P99, DOI 10.1007/s10654-006-9103-0; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Koot BGP, 2004, EUR J PEDIATR, V163, P664, DOI 10.1007/s00431-004-1492-z; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marone Gianni, 2002, Trends in Immunology, V23, P425, DOI 10.1016/S1471-4906(02)02274-3; NATT E, 1992, P NATL ACAD SCI USA, V89, P9297, DOI 10.1073/pnas.89.19.9297; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; R Development Core Team, 2007, R LANG ENV STAT COMP; Rosipal S, 2006, AM J MED, V119, P181, DOI 10.1016/j.amjmed.2005.10.038; SCHLESSINGER BS, 1959, CIRCULATION, V19, P265, DOI 10.1161/01.CIR.19.2.265; Shin YS, 2005, AM J PHYSIOL-ENDOC M, V289, pE993, DOI 10.1152/ajpendo.00037.2005; SOETERS PB, 1976, LANCET, V2, P880; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125; Zhao M, 2010, J IMMUNOL, V184, P2253, DOI 10.4049/jimmunol.0902654	44	415	420	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					269	U65		10.1038/ng.1073	http://dx.doi.org/10.1038/ng.1073			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286219	Green Accepted			2022-12-17	WOS:000300843600011
J	Svistoonoff, S; Creff, A; Reymond, M; Sigoillot-Claude, C; Ricaud, L; Blanchet, A; Nussaume, L; Desnos, T				Svistoonoff, Sergio; Creff, Audrey; Reymond, Matthieu; Sigoillot-Claude, Cecile; Ricaud, Lilian; Blanchet, Aline; Nussaume, Laurent; Desnos, Thierry			Root tip contact with low-phosphate media reprograms plant root architecture	NATURE GENETICS			English	Article							SYSTEM ARCHITECTURE; ARABIDOPSIS; AVAILABILITY; STARVATION; ADAPTATION; COMPONENT; OXIDASES; LACCASE	Plant roots are able to sense soil nutrient availability. In order to acquire heterogeneously distributed water and minerals(1-3), they optimize their root architecture. One poorly understood plant response to soil phosphate ( Pi) deficiency is a reduction in primary root growth with an increase in the number and length of lateral roots(4-12). Here we show that physical contact of the Arabidopsis thaliana primary root tip with low-P-i medium is necessary and sufficient to arrest root growth. We further show that loss-of-function mutations in Low Phosphate Root1 (LPR1) and its close paralog LPR2 strongly reduce this inhibition. LPR1 was previously mapped as a major quantitative trait locus (QTL)(12); the molecular origin of this QTL is explained by the differential allelic expression of LPR1 in the root cap. These results provide strong evidence for the involvement of the root cap in sensing nutrient deficiency, responding to it, or both. LPR1 and LPR2 encode multicopper oxidases (MCOs), highlighting the essential role of MCOs for plant development.	Univ Aix Marseille 2, CNRS, CEA, UMR 6191,Lab Biol Dev Plantes,Dept Ecophysiol Veg, F-13108 St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Desnos, T (corresponding author), Univ Aix Marseille 2, CNRS, CEA, UMR 6191,Lab Biol Dev Plantes,Dept Ecophysiol Veg, F-13108 St Paul Les Durance, France.	thierry.desnos@cea.fr	NUSSAUME, Laurent/AAA-5980-2022; SVISTOONOFF, Sergio/X-9659-2019; NUSSAUME, Laurent/AAB-8312-2020	NUSSAUME, Laurent/0000-0002-9445-2563; SVISTOONOFF, Sergio/0000-0001-8554-2922; DESNOS, Thierry/0000-0002-6585-1362				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chevalier F, 2003, PLANT CELL ENVIRON, V26, P1839, DOI 10.1046/j.1365-3040.2003.01100.x; CHIDAMBARAM MV, 1984, J INORG BIOCHEM, V22, P231, DOI 10.1016/0162-0134(84)85008-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CURZON G, 1960, BIOCHEM J, V77, P66, DOI 10.1042/bj0770066; DECAMPILLO E, 2004, PLANT MOL BIOL, V56, P309; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Forde B, 2001, PLANT SOIL, V232, P51, DOI 10.1023/A:1010329902165; Franco-Zorrilla JM, 2005, PLANT PHYSIOL, V138, P847, DOI 10.1104/pp.105.060517; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Naito K, 2005, GENETICS, V169, P881, DOI 10.1534/genetics.104.033654; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Sanchez-Calderon L, 2006, PLANT PHYSIOL, V140, P879, DOI 10.1104/pp.105.073825; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y	30	415	447	3	150	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					792	796		10.1038/ng2041	http://dx.doi.org/10.1038/ng2041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17496893	Green Published			2022-12-17	WOS:000246859100025
J	Roberts, AE; Araki, T; Swanson, KD; Montgomery, KT; Schiripo, TA; Joshi, VA; Li, L; Yassin, Y; Tamburino, AM; Neel, BG; Kucherlapati, RS				Roberts, Amy E.; Araki, Toshiyuki; Swanson, Kenneth D.; Montgomery, Kate T.; Schiripo, Taryn A.; Joshi, Victoria A.; Li, Li; Yassin, Yosuf; Tamburino, Alex M.; Neel, Benjamin G.; Kucherlapati, Raju S.			Germline gain-of-function mutations in SOS1 cause Noonan syndrome	NATURE GENETICS			English	Article							RAS ACTIVATOR SON; FACIO-CUTANEOUS SYNDROME; SEVENLESS; MUTANTS; PATHWAY; DOMAIN; KRAS	Noonan syndrome, the most common single-gene cause of congenital heart disease, is characterized by short stature, characteristic facies, learning problems and leukemia predisposition(1). Gain-of-function mutations in PTPN11, encoding the tyrosine phosphatase SHP2, cause similar to 50% of Noonan syndrome cases. SHP2 is required for RAS-ERK MAP kinase (MAPK) cascade activation(2), and Noonan syndrome mutants enhance ERK activation ex vivo(3,4) and in mice(5). KRAS mutations account for < 5% of cases of Noonan syndrome(6), but the gene(s) responsible for the remainder are unknown. We identified missense mutations in SOS1, which encodes an essential RAS guanine nucleotide-exchange factor (RAS-GEF), in similar to 20% of cases of Noonan syndrome without PTPN11 mutation. The prevalence of specific cardiac defects differs in SOS1 mutation-associated Noonan syndrome. Noonan syndrome-associated SOS1 mutations are hypermorphs encoding products that enhance RAS and ERK activation. Our results identify SOS1 mutants as a major cause of Noonan syndrome, representing the first example of activating GEF mutations associated with human disease ;and providing new insights into RAS-GEF regulation.	Beth Israel Deaconess Med Ctr, Canc Biol Program, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA; Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	Neel, BG (corresponding author), Beth Israel Deaconess Med Ctr, Canc Biol Program, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA.	bneel@bidmc.harvard.edu	Kucherlapati, Raju/ABC-8807-2021	Araki, Toshiyuki/0000-0002-1179-4534	NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016140] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA49152] Funding Source: Medline; NCRR NIH HHS [M01-RR02172] Funding Source: Medline; NIDCR NIH HHS [DE16140] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; BOS JL, 1989, CANCER RES, V49, P4682; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; Goi T, 1999, MOL CELL BIOL, V19, P1731; Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lauchle JO, 2006, PEDIATR BLOOD CANCER, V46, P579, DOI 10.1002/pbc.20644; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102; Sondermann H, 2003, STRUCTURE, V11, P1583, DOI 10.1016/j.str.2003.10.015; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213	23	415	438	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					70	74		10.1038/ng1926	http://dx.doi.org/10.1038/ng1926			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143285				2022-12-17	WOS:000243136500019
J	Tartaglia, M; Pennacchio, LA; Zhao, C; Yadav, KK; Fodale, V; Sarkozy, A; Pandit, B; Oishi, K; Martinelli, S; Schackwitz, W; Ustaszewska, A; Martin, J; Bristow, J; Carta, C; Lepri, F; Neri, C; Vasta, I; Gibson, K; Curry, CJ; Siguero, JPL; Digilio, MC; Zampino, G; Dallapiccola, B; Bar-Sagi, D; Gelb, BD				Tartaglia, Marco; Pennacchio, Len A.; Zhao, Chen; Yadav, Kamlesh K.; Fodale, Valentina; Sarkozy, Anna; Pandit, Bhaswati; Oishi, Kimihiko; Martinelli, Simone; Schackwitz, Wendy; Ustaszewska, Anna; Martin, Joel; Bristow, James; Carta, Claudio; Lepri, Francesca; Neri, Cinzia; Vasta, Isabella; Gibson, Kate; Curry, Cynthia J.; Lopez Siguero, Juan Pedro; Digilio, Maria Cristina; Zampino, Giuseppe; Dallapiccola, Bruno; Bar-Sagi, Dafna; Gelb, Bruce D.			Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome	NATURE GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; RAS ACTIVATOR SON; PTPN11 MUTATIONS; GERMLINE MUTATIONS; PHENOTYPE; SEVENLESS; GENE; KRAS; MUTANTS; PATHWAY	Noonan syndrome is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart defects and skeletal anomalies(1). Increased RAS-mitogen-activated protein kinase (MAPK) signaling due to PTPN11 and KRAS mutations causes 50% of cases of Noonan syndrome(2-6). Here, we report that 22 of 129 individuals with Noonan syndrome without PTPN11 or KRAS mutation have missense mutations in SOS1, which encodes a RAS-specific guanine nucleotide exchange factor. SOS1 mutations cluster at codons encoding residues implicated in the maintenance of SOS1 in its autoinhibited form. In addition, ectopic expression of two Noonan syndrome-associated mutants induces enhanced RAS and ERK activation. The phenotype associated with SOS1 defects lies within the Noonan syndrome spectrum but is distinctive, with a high prevalence of ectodermal abnormalities but generally normal development and linear growth. Our findings implicate gain-of-function mutations in a RAS guanine nucleotide exchange factor in disease for the first time and define a new mechanism by which upregulation of the RAS pathway can profoundly change human development.	Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Lawrence Berkeley Lab, Div Genom, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Ist Ricovero & Cura Carattere Sci, San Giovanni Rotondo & CSS Mendel Inst, I-00198 Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00198 Rome, Italy; Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-00168 Rome, Italy; Royal Childrens Hosp, Herston, Qld 4029, Australia; Genet Med Cent Florida, Fresno, CA 93710 USA; Hosp Materno Infantil, Malaga 29011, Spain; Osped Bambino Gesu, I-00165 Rome, Italy	Istituto Superiore di Sanita (ISS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; New York University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Royal Children's Hospital Brisbane; IRCCS Bambino Gesu	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it; bruce.gelb@mssm.edu	Digilio, Maria Cristina/AAI-2434-2019; Zampino, Giuseppe/AAC-2152-2019; Carta, Claudio/A-7305-2013; Tartaglia, Marco/K-2955-2018; zhao, chen/C-7358-2011; Lepri, Francesca Romana/AAA-6115-2020; Martinelli, Simone/J-9432-2018; Schackwitz, Wendy/GXH-9536-2022; Dallapiccola, Bruno/K-8692-2016	Carta, Claudio/0000-0003-3545-198X; Tartaglia, Marco/0000-0001-7736-9672; Martinelli, Simone/0000-0002-5843-419X; Oishi, Kimihiko/0000-0001-9446-8912; Martin, Joel/0000-0001-9511-6441; Bar-Sagi, Dafna/0000-0003-2597-8948; Lepri, Francesca Romana/0000-0001-5331-0473; Schackwitz, Wendy/0000-0002-3013-9180; Pennacchio, Len/0000-0002-8748-3732; Dallapiccola, Bruno/0000-0002-5031-1013	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA028146, R01CA055360, R56CA055360, R37CA055360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207, P50HL074728] Funding Source: NIH RePORTER; NCI NIH HHS [CA28146, CA55360] Funding Source: Medline; NHLBI NIH HHS [HL074728, HL71207] Funding Source: Medline; NICHD NIH HHS [HD01294] Funding Source: Medline; Telethon [GGP04172] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Qian XL, 2000, EMBO J, V19, P642, DOI 10.1093/emboj/19.4.642; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; SHARLAND M, 1992, ARCH DIS CHILD, V67, P178, DOI 10.1136/adc.67.2.178; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang DZM, 1997, GENE DEV, V11, P309, DOI 10.1101/gad.11.3.309; YANG SS, 1995, J BIOL CHEM, V270, P18212, DOI 10.1074/jbc.270.31.18212	28	415	439	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					75	79		10.1038/ng1939	http://dx.doi.org/10.1038/ng1939			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143282	Green Submitted			2022-12-17	WOS:000243136500020
J	Souza, RF; Appel, R; Yin, J; Wang, SN; Smolinski, KN; Abraham, JM; Zou, TT; Shi, YQ; Lei, JY; Cottrell, J; Cymes, K; Biden, K; Simms, L; Leggett, B; Lynch, PM; Frazier, M; Powell, SM; Harpaz, N; Sugimura, H; Young, J; Meltzer, SJ				Souza, RF; Appel, R; Yin, J; Wang, SN; Smolinski, KN; Abraham, JM; Zou, TT; Shi, YQ; Lei, JY; Cottrell, J; Cymes, K; Biden, K; Simms, L; Leggett, B; Lynch, PM; Frazier, M; Powell, SM; Harpaz, N; Sugimura, H; Young, J; Meltzer, SJ			Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours	NATURE GENETICS			English	Letter							MANNOSE 6-PHOSPHATE RECEPTOR; FACTOR-BETA; HETEROZYGOSITY; CANCER; COLON; CELLS		UNIV MARYLAND, SCH MED, DEPT MED, GASTROINTESTINAL DIV, BALTIMORE, MD 21201 USA; UNIV MARYLAND, SCH MED, DEPT PATHOL, BALTIMORE, MD 21201 USA; VET ADM MED CTR, BALTIMORE, MD 21201 USA; ROYAL BRISBANE HOSP, GLAXO CONJOINT GASTROENTEROL LAB, BRISBANE, QLD 4029, AUSTRALIA; UNIV TEXAS, MD ANDERSON CANC CTR, DEPT GASTROENTEROL MED ONCOL & DIGEST DIS, HOUSTON, TX 77030 USA; INDIANA UNIV, SCH MED, DEPT MED, INDIANAPOLIS, IN 46202 USA; MT SINAI MED CTR, NEW YORK, NY 10029 USA; HAMAMATSU UNIV SCH MED, DEPT PATHOL 1, HAMAMATSU, SHIZUOKA 43131, JAPAN	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Royal Brisbane & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis; Icahn School of Medicine at Mount Sinai; Hamamatsu University School of Medicine			Young, Joanne P/B-9981-2011; Harpaz, Noam/L-3411-2017; Young, Joanne P/H-7774-2014; Leggett, Barbara A/D-3579-2011	Harpaz, Noam/0000-0003-4923-2200; Leggett, Barbara/0000-0003-2062-7380; Simms, Lisa/0000-0002-5387-7397	NCI NIH HHS [CA67497] Funding Source: Medline; NIDDK NIH HHS [DK47717] Funding Source: Medline; NIEHS NIH HHS [ES07120] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007120] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BASERGA R, 1995, CANCER RES, V55, P249; BASERGA R, 1994, CELL, V79, P927, DOI 10.1016/0092-8674(94)90023-X; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; DESOUZA AT, 1995, ONCOGENE, V10, P1725; Ellis MJC, 1996, MOL ENDOCRINOL, V10, P286, DOI 10.1210/me.10.3.286; Hankins GR, 1996, ONCOGENE, V12, P2003; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; KOJIMA S, 1993, J CELL BIOL, V121, P439, DOI 10.1083/jcb.121.2.439; KOMFELD S, 1992, ANNU REV BIOCHEM, V61, P307; KOVACINA KS, 1989, BIOCHEM BIOPH RES CO, V160, P393, DOI 10.1016/0006-291X(89)91669-0; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MYEROFF LL, 1995, CANCER RES, V55, P5545; OKA Y, 1985, J BIOL CHEM, V260, P9435; PARSONS R, 1995, CANCER RES, V55, P5548; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; SOUA RF, IN PRESS GASTROENTER	18	415	426	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					255	257		10.1038/ng1196-255	http://dx.doi.org/10.1038/ng1196-255			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896552				2022-12-17	WOS:A1996VQ14600017
J	Nakamura, T; Largaespada, DA; Lee, MP; Johnson, LA; Ohyashiki, K; Toyama, K; Chen, SJ; Willman, CL; Chen, IM; Feinberg, AP; Jenkins, NA; Copeland, NG; Shaughnessy, JD				Nakamura, T; Largaespada, DA; Lee, MP; Johnson, LA; Ohyashiki, K; Toyama, K; Chen, SJ; Willman, CL; Chen, IM; Feinberg, AP; Jenkins, NA; Copeland, NG; Shaughnessy, JD			Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia	NATURE GENETICS			English	Article							LEUKEMIA; IDENTIFICATION; EXPRESSION; CLONING; FAMILY; SET	Expression of Hoxa7 and Hoxa9 is activated by proviral integration in BXH2 murine myeloid leukaemias. This result, combined with the mapping of the HOXA, locus to human chromosome 7p15, suggested that one of the HOXA genes might be involved in the t(7;11)(p15;p15) translocation found in some human myeloid leukaemia patients. Here we show that in three patients with t(7;11), the chromosome rearrangement creates a genomic fusion between the HOXA9 gene and the nucleoporin gene NUP98 on chromosome 11p15. The translocation produces an invariant chimaeric NUP98/HOXA9 transcript containing the amino terminal half of NUP98 fused in frame to HOXA9. These studies identify HOXA9 as an important human myeloid leukaemia gene and suggest an important role for nucleoporins in human myeloid leukaemia given that a second nucleoporin, NUP214, has also been implicated in human myeloid leukaemia.	NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MAMMALIAN GENET LAB, FREDERICK, MD 21702 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT ONCOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MOLEC BIOL, BALTIMORE, MD 21205 USA; TOKYO MED COLL, DEPT INTERNAL MED 1, TOKYO 160, JAPAN; SHANGHAI MED UNIV 2, RUI JIN HOSP, INST HEMATOL, SHANGHAI, PEOPLES R CHINA; UNIV NEW MEXICO, CTR CANC, DEPT CELL BIOL, ALBUQUERQUE, NM 87131 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Tokyo Medical University; Shanghai Jiao Tong University; University of New Mexico			Feinberg, Andrew/AAY-7666-2020; Largaespada, David/C-9832-2014	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [CA54358, R01 CA054358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ADACHI Y, 1994, J BIOL CHEM, V269, P2258; BARKER D, 1984, AM J HUM GENET, V36, P1159; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; BURD CG, 1994, SCIENCE, V154, P1662; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FABRE E, 1994, CELL, V78, P275, DOI 10.1016/0092-8674(94)90297-6; FORNEROD M, 1995, ONCOGENE, V10, P1739; FUJIMURA T, 1993, CANCER GENET CYTOGEN, V68, P143, DOI 10.1016/0165-4608(93)90012-B; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HOOVERS JMN, IN PRESS P NATL ACAD; IRIS FJM, 1993, NAT GENET, V3, P137, DOI 10.1038/ng0293-137; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; KWONG YL, 1994, AM J HEMATOL, V47, P62, DOI 10.1002/ajh.2830470117; MORRIS CM, 1989, BRIT J HAEMATOL, V71, P481, DOI 10.1111/j.1365-2141.1989.tb06306.x; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; REDEKER E, 1994, GENOMICS, V21, P538, DOI 10.1006/geno.1994.1312; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; Sambrook J., 1989, MOL CLONING LAB MANU; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; SHIMAMOTO T, 1995, LEUKEMIA, V9, P640; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; WINQVIST R, 1995, CANCER RES, V55, P2660	35	415	425	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					154	158		10.1038/ng0296-154	http://dx.doi.org/10.1038/ng0296-154			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563753				2022-12-17	WOS:A1996TU07900015
J	VALENTIJN, LJ; BAAS, F; WOLTERMAN, RA; HOOGENDIJK, JE; VANDENBOSCH, NHA; ZORN, I; GABREELSFESTEN, AWM; DEVISSER, M; BOLHUIS, PA				VALENTIJN, LJ; BAAS, F; WOLTERMAN, RA; HOOGENDIJK, JE; VANDENBOSCH, NHA; ZORN, I; GABREELSFESTEN, AWM; DEVISSER, M; BOLHUIS, PA			IDENTICAL POINT MUTATIONS OF PMP-22 IN TREMBLER-J MOUSE AND CHARCOT-MARIE-TOOTH DISEASE TYPE-1A	NATURE GENETICS			English	Article							ARREST-SPECIFIC GENE; GROWTH ARREST; PROTEOLIPID PROTEIN; CHROMOSOME 17P11.2; X-CHROMOSOME; DUPLICATION; NEUROPATHY; DISORDER; LINKAGE; REGION	We have investigated the peripheral myelin protein gene, PMP-22, in a family with Charcot-Marie-Tooth disease type 1A (CMT1A). The DNA duplication commonly found in CMT1A was absent in this family, but strong linkage existed between the disease and the CMT1A marker VAW409R3 on chromosome 17p11.2. We found a point mutation in PMP-22 which was completely linked with the disease. The mutation, a proline for leucine substitution in the first putative transmembrane domain, is identical to that recently found in the Trembler-J mouse. The presence of this PMP-22 defect in this CMT1A family and the location of PMP-22 within the DNA duplication associated with CMT1A suggest that both structural alteration and overexpression of PMP-22 may lead to the disease.	UNIV HOSP NIJMEGEN,INST NEUROL,NIJMEGEN,NETHERLANDS	Radboud University Nijmegen	VALENTIJN, LJ (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS.		Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428				BIRD TD, 1982, AM J HUM GENET, V34, P388; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CREMERS FPM, 1987, HUM GENET, V77, P23, DOI 10.1007/BF00284707; GABREELSFESTEN AAWM, 1992, J NEUROL SCI, V107, P145, DOI 10.1016/0022-510X(92)90282-P; GENCIC S, 1989, AM J HUM GENET, V45, P435; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; HOOGENDIJK JE, 1991, HDB CLIN NEUROLOGY H, V60; HOOGENDIJK JE, IN PRESS NEUROLOGY; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; PATEL IP, 1992, NATURE GENET, V1, P159; RAEYMAEKER SP, 1991, NEUROMUSC DIS, V1, P93; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Sambrook J., 1989, MOL CLONING LAB MANU; SCHNEIDER A, 1992, NATURE, V358, P158; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	31	415	419	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					288	291		10.1038/ng1292-288	http://dx.doi.org/10.1038/ng1292-288			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303281				2022-12-17	WOS:A1992KB49500012
J	Armenia, J; Wankowicz, SAM; Liu, D; Gao, JJ; Kundra, R; Reznik, E; Chatila, WK; Chakravarty, D; Han, GC; Coleman, I; Montgomery, B; Pritchard, C; Morrissey, C; Barbieri, CE; Beltran, H; Sboner, A; Zafeiriou, Z; Miranda, S; Bielski, CM; Penson, AV; Tolonen, C; Huang, FW; Robinson, D; Wu, YM; Lonigro, R; Garraway, LA; Demichelis, F; Kantoff, PW; Taplin, ME; Abida, W; Taylor, BS; Scher, HI; Nelson, PS; de Bono, JS; Rubin, MA; Sawyers, CL; Chinnaiyan, AM; Schultz, N; Van Allen, EM				Armenia, Joshua; Wankowicz, Stephanie A. M.; Liu, David; Gao, Jianjiong; Kundra, Ritika; Reznik, Ed; Chatila, Walid K.; Chakravarty, Debyani; Han, G. Celine; Coleman, Ilsa; Montgomery, Bruce; Pritchard, Colin; Morrissey, Colm; Barbieri, Christopher E.; Beltran, Himisha; Sboner, Andrea; Zafeiriou, Zafeiris; Miranda, Susana; Bielski, Craig M.; Penson, Alexander V.; Tolonen, Charlotte; Huang, Franklin W.; Robinson, Dan; Wu, Yi Mi; Lonigro, Robert; Garraway, Levi A.; Demichelis, Francesca; Kantoff, Philip W.; Taplin, Mary-Ellen; Abida, Wassim; Taylor, Barry S.; Scher, Howard I.; Nelson, Peter S.; de Bono, Johann S.; Rubin, Mark A.; Sawyers, Charles L.; Chinnaiyan, Arul M.; Schultz, Nikolaus; Van Allen, Eliezer M.		PCF SU2C Int Prostate Canc Dre	The long tail of oncogenic drivers in prostate cancer	NATURE GENETICS			English	Article							MUTATIONS; GENES; SPOP; TRANSCRIPTION; EVOLUTION; COFACTOR; GENOMICS; SAMPLES; SHARP	Comprehensive genomic characterization of prostate cancer has identified recurrent alterations in genes involved in androgen signaling, DNA repair, and PI3K signaling, among others. However, larger and uniform genomic analysis may identify additional recurrently mutated genes at lower frequencies. Here we aggregate and uniformly analyze exome sequencing data from 1,013 prostate cancers. We identify and validate a new class of E26 transformation-specific (ETS)-fusion-negative tumors defined by mutations in epigenetic regulators, as well as alterations in pathways not previously implicated in prostate cancer, such as the spliceosome pathway. We find that the incidence of significantly mutated genes (SMGs) follows a long-tail distribution, with many genes mutated in less than 3% of cases. We identify a total of 97 SMGs, including 70 not previously implicated in prostate cancer, such as the ubiquitin ligase CUL3 and the transcription factor SPEN. Finally, comparing primary and metastatic prostate cancer identifies a set of genomic markers that may inform risk stratification.	[Armenia, Joshua; Gao, Jianjiong; Kundra, Ritika; Reznik, Ed; Chatila, Walid K.; Chakravarty, Debyani; Bielski, Craig M.; Penson, Alexander V.; Taylor, Barry S.; Sawyers, Charles L.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Armenia, Joshua; Gao, Jianjiong; Kundra, Ritika; Reznik, Ed; Chatila, Walid K.; Chakravarty, Debyani; Bielski, Craig M.; Penson, Alexander V.; Taylor, Barry S.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Wankowicz, Stephanie A. M.; Liu, David; Han, G. Celine; Huang, Franklin W.; Garraway, Levi A.; Taplin, Mary-Ellen; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wankowicz, Stephanie A. M.; Liu, David; Han, G. Celine; Tolonen, Charlotte; Huang, Franklin W.; Garraway, Levi A.; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Coleman, Ilsa; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Coleman, Ilsa; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Montgomery, Bruce; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA USA; [Pritchard, Colin] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Morrissey, Colm] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Barbieri, Christopher E.; Sboner, Andrea] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Beltran, Himisha] Weill Cornell Med, Dept Med, Div Med Oncol, New York, NY USA; [Beltran, Himisha; Rubin, Mark A.] New York Presbyterian Hosp, Weill Cornell Med Coll, Englander Inst Precis Med, New York, NY USA; [Beltran, Himisha; Rubin, Mark A.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Zafeiriou, Zafeiris; Miranda, Susana; de Bono, Johann S.] Inst Canc Res, Div Clin Studies, Biomarkers Team, London, England; [Zafeiriou, Zafeiris; Miranda, Susana; de Bono, Johann S.] Royal Marsden Hosp, London, England; [Robinson, Dan; Wu, Yi Mi; Lonigro, Robert; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Demichelis, Francesca] Univ Trento, Ctr Integrated Biol, Trento, Italy; [Kantoff, Philip W.; Abida, Wassim; Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Taylor, Barry S.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Michigan System; University of Michigan; University of Trento; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Schultz, N (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.; Schultz, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.	schultzn@mskcc.org; eliezerm_vanallen@dfci.harvard.edu	Kundra, Ritika/ABC-9927-2020; Schultz, Nikolaus/ABE-6347-2020; Liu, David/ABF-1275-2020; Demichelis, Francesca/J-9829-2016; Gao, JianJiong/B-5673-2016	Liu, David/0000-0003-0346-5033; Demichelis, Francesca/0000-0002-8266-8631; Gao, JianJiong/0000-0002-5739-1781; de Bono, Johann S/0000-0002-2034-595X; Rubin, Mark/0000-0002-8321-9950; Han, Celine/0000-0003-2004-8186; Reznik, Ed/0000-0002-6511-5947	SU2C-PCF Prostate Cancer International Dream Team; Prostate Cancer Foundation Young Investigator Awards; Prostate Cancer Foundation-V Foundation Challenge Award; NIH [K08CA188615]; NCI [P50-CA097186, P50-CA92629]; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; National Cancer Institute Cancer Center Core Grant [P30-CA008748]; Robertson Foundation; NATIONAL CANCER INSTITUTE [U54CA224079, P30CA008748, P50CA097186, P50CA092629, K08CA188615, R01CA193837, R01CA155169] Funding Source: NIH RePORTER	SU2C-PCF Prostate Cancer International Dream Team; Prostate Cancer Foundation Young Investigator Awards; Prostate Cancer Foundation-V Foundation Challenge Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marie-Josee and Henry R. Kravis Center for Molecular Oncology; National Cancer Institute Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robertson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the patients for participating in this study. We also thank the Broad Cancer Genome Analysis and Data Sciences groups for analysis methodology and computational support. This work was supported by the SU2C-PCF Prostate Cancer International Dream Team, Prostate Cancer Foundation Young Investigator Awards (B.S.T., C.P., N.S., and E.M.V.A.), Prostate Cancer Foundation-V Foundation Challenge Award (E.M.V.A., P.S.N., and J.S.d.B.), NIH K08CA188615 (E.M.V.A.), NCI P50-CA097186 and NCI P50-CA92629 SPOREs in Prostate Cancer, the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, a National Cancer Institute Cancer Center Core Grant (P30-CA008748), and the Robertson Foundation (B.S.T. and N.S.).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Abida W, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00029; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Boysen G, 2015, ELIFE, V4, DOI 10.7554/eLife.09207; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI [10.1038/leu.2014.331, 10.1038/leu.2015.178]; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Groner AC, 2016, CANCER CELL, V29, P846, DOI 10.1016/j.ccell.2016.04.012; Hartmaier RJ, 2017, CANCER RES, V77, P2464, DOI 10.1158/0008-5472.CAN-16-2479; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Legare S, 2015, CANCER RES, V75, P4351, DOI 10.1158/0008-5472.CAN-14-3475; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Theurillat JPP, 2014, SCIENCE, V346, P85, DOI 10.1126/science.1250255; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	41	414	421	5	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2018	50	5					645	+		10.1038/s41588-018-0078-z	http://dx.doi.org/10.1038/s41588-018-0078-z			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE7EA	29610475	Green Accepted			2022-12-17	WOS:000431394900006
J	Xu, P; Zhang, XF; Wang, XM; Li, JT; Liu, GM; Kuang, YY; Xu, J; Zheng, XH; Ren, LF; Wang, GL; Zhang, Y; Huo, LH; Zhao, ZX; Cao, DC; Lu, CY; Li, C; Zhou, Y; Liu, ZJ; Fan, ZH; Shan, GL; Li, XG; Wu, SX; Song, LP; Hou, GY; Jiang, YL; Jeney, Z; Yu, D; Wang, L; Shao, CJ; Song, L; Sun, J; Ji, PF; Wang, J; Li, Q; Xu, LM; Sun, FY; Feng, JX; Wang, CH; Wang, SL; Wang, BS; Li, Y; Zhu, YP; Xue, W; Zhao, L; Wang, JT; Gu, Y; Lv, WH; Wu, KJ; Xiao, JF; Wu, JY; Zhang, Z; Yu, J; Sun, XW				Xu, Peng; Zhang, Xiaofeng; Wang, Xumin; Li, Jiongtang; Liu, Guiming; Kuang, Youyi; Xu, Jian; Zheng, Xianhu; Ren, Lufeng; Wang, Guoliang; Zhang, Yan; Huo, Linhe; Zhao, Zixia; Cao, Dingchen; Lu, Cuiyun; Li, Chao; Zhou, Yi; Liu, Zhanjiang; Fan, Zhonghua; Shan, Guangle; Li, Xingang; Wu, Shuangxiu; Song, Lipu; Hou, Guangyuan; Jiang, Yanliang; Jeney, Zsigmond; Yu, Dan; Wang, Li; Shao, Changjun; Song, Lai; Sun, Jing; Ji, Peifeng; Wang, Jian; Li, Qiang; Xu, Liming; Sun, Fanyue; Feng, Jianxin; Wang, Chenghui; Wang, Shaolin; Wang, Baosen; Li, Yan; Zhu, Yaping; Xue, Wei; Zhao, Lan; Wang, Jintu; Gu, Ying; Lv, Weihua; Wu, Kejing; Xiao, Jingfa; Wu, Jiayan; Zhang, Zhang; Yu, Jun; Sun, Xiaowen			Genome sequence and genetic diversity of the common carp, Cyprinus carpio	NATURE GENETICS			English	Article							LINKAGE MAP; MICROSATELLITE LOCI; TELEOST FISH; HOX CLUSTERS; EVOLUTION; DUPLICATION; L.; DIVERSIFICATION; PIGMENTATION; ANNOTATION	The common carp, Cyprinus carpio, is one of the most important cyprinid species and globally accounts for 10% of freshwater aquaculture production. Here we present a draft genome of domesticated C. carpio (strain Songpu), whose current assembly contains 52,610 protein-coding genes and approximately 92.3% coverage of its paleotetraploidized genome (2n = 100). The latest round of whole-genome duplication has been estimated to have occurred approximately 8.2 million years ago. Genome resequencing of 33 representative individuals from worldwide populations demonstrates a single origin for C. carpio in 2 subspecies (C. carpio Haematopterus and C. carpio carpio). Integrative genomic and transcriptomic analyses were used to identify loci potentially associated with traits including scaling patterns and skin color. In combination with the high-resolution genetic map, the draft genome paves the way for better molecular studies and improved genome-assisted breeding of C. carpio and other closely related species.	[Xu, Peng; Li, Jiongtang; Xu, Jian; Zhang, Yan; Zhao, Zixia; Liu, Zhanjiang; Hou, Guangyuan; Jiang, Yanliang; Ji, Peifeng; Wang, Jian; Li, Qiang; Xu, Liming; Wang, Baosen; Li, Yan; Zhu, Yaping; Xue, Wei; Zhao, Lan; Wang, Jintu; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Zhang, Xiaofeng; Kuang, Youyi; Zheng, Xianhu; Cao, Dingchen; Lu, Cuiyun; Li, Chao; Gu, Ying; Lv, Weihua; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Peoples R China; [Wang, Xumin; Liu, Guiming; Ren, Lufeng; Wang, Guoliang; Huo, Linhe; Fan, Zhonghua; Shan, Guangle; Li, Xingang; Wu, Shuangxiu; Song, Lipu; Yu, Dan; Wang, Li; Shao, Changjun; Song, Lai; Sun, Jing; Wu, Kejing; Xiao, Jingfa; Wu, Jiayan; Zhang, Zhang; Yu, Jun] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhou, Yi] Harvard Univ, Sch Med, Stem Cell Program, Div Hematol & Oncol,Boston Childrens Hosp, Boston, MA USA; [Zhou, Yi] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Liu, Zhanjiang; Sun, Fanyue] Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Jeney, Zsigmond] Res Inst Fisheries Aquaculture & Irrigat, Szarvas, Hungary; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Peoples R China; [Wang, Chenghui] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Wang, Shaolin] Univ Virginia, Dept Psychiat & Neurobiol Sci, Charlottesville, VA USA	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Auburn University System; Auburn University; Shanghai Ocean University; University of Virginia	Sun, XW (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	junyu@big.ac.cn; sunxw@cafs.ac.cn	Zhao, Zi-Xia/AAM-8065-2021; Wang, Shaolin/FDL-8163-2022; Liu, Zhanjiang/R-9633-2019; Xu, Jian/H-5349-2019; Wang, Jian/M-4594-2018; Xu, Peng/J-4018-2012; Kuang, Youyi/AFO-8327-2022; Wang, Shaolin/M-2282-2013; Wu, Ke/HCQ-3503-2022	Zhao, Zi-Xia/0000-0003-1099-3387; Wang, Shaolin/0000-0003-0866-4584; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078; Kuang, Youyi/0000-0003-4053-9353; Wang, Shaolin/0000-0003-0866-4584; Zhao, Lan/0000-0003-2681-7695; Li, Xingang/0000-0003-0252-154X; wu, jia yan/0000-0001-6048-405X	National High-Technology Research and Development Program of China (863 program) [2011AA100401, 2011AA100402, 2009AA10Z105]; National Department Public Benefit Research Foundation of China [200903045]; National Basic Research Program of China (973 Program) [2010CB126305]; National Natural Science Foundation of China [31302174, 31101893]; Special Scientific Research Funds for Central Non-Profit Institutes of the Chinese Academy of Fishery Sciences [2009B002, 2011C016]	National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Department Public Benefit Research Foundation of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Scientific Research Funds for Central Non-Profit Institutes of the Chinese Academy of Fishery Sciences	We acknowledge Z. Zhu, N. Li, J. Gui, Z. Bao, G. Zhang, X.L. Zhang, J. Li, Y. Liu, Q. Liu and S. Chen for their support on the common carp genome project. We thank H. Hu, G.Z. Liu, J.H. Yu and C.J. Li for their assistance in sample collection and Y. Wan, T. Sun, W. Liu, L. Jiang, Shu Wang, Y. Zhu, X. Xing, P. Zhou and R. Cut for genotyping and sequencing. We thank J. Postlethwait, G. Hulata, L. David, L. Orban and F. Zhao for their helpful discussions. We acknowledge grant support from the National High-Technology Research and Development Program of China (863 program; 2011AA100401,2011AA100402 and 2009AA10Z105), the National Department Public Benefit Research Foundation of China (200903045), the National Basic Research Program of China (973 Program; 2010CB126305), the National Natural Science Foundation of China (31302174 and 31101893) and Special Scientific Research Funds for Central Non-Profit Institutes of the Chinese Academy of Fishery Sciences (2009B002 and 2011C016).	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; *FAO FISH AQ DEP, 2007, STAT WORLD FISH AQ 2; Fu SM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029552, 10.1371/journal.pone.0048140]; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Henkel CV, 2012, ZEBRAFISH, V9, P59, DOI 10.1089/zeb.2012.0773; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ito S, 2011, PIGM CELL MELANOMA R, V24, P63, DOI 10.1111/j.1755-148X.2010.00755.x; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; LARHAMMAR D, 1994, MOL PHYLOGENET EVOL, V3, P59, DOI 10.1006/mpev.1994.1007; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mungpakdee S, 2008, MOL BIOL EVOL, V25, P1333, DOI 10.1093/molbev/msn097; OHNO S, 1967, CHROMOSOMA, V23, P1, DOI 10.1007/BF00293307; Ojima Y., 1990, Kromosomo (Tokyo), V57, P1871; Pritchard JK, 2000, GENETICS, V155, P945; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Sun XW, 2004, AQUACULTURE, V238, P165, DOI 10.1016/S0044-8486(03)00445-9; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhang Y, 2011, MAR BIOTECHNOL, V13, P376, DOI 10.1007/s10126-010-9307-x; Zhang YJ, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-169; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x	43	414	473	17	213	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1212	1219		10.1038/ng.3098	http://dx.doi.org/10.1038/ng.3098			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25240282	hybrid			2022-12-17	WOS:000344131900012
J	Bond, J; Roberts, E; Mochida, GH; Hampshire, DJ; Scott, S; Askham, JM; Springell, K; Mahadevan, M; Crow, YJ; Markham, AF; Walsh, CA; Woods, CG				Bond, J; Roberts, E; Mochida, GH; Hampshire, DJ; Scott, S; Askham, JM; Springell, K; Mahadevan, M; Crow, YJ; Markham, AF; Walsh, CA; Woods, CG			ASPM is a major determinant of cerebral cortical size	NATURE GENETICS			English	Article							RECESSIVE MICROCEPHALY MAPS; NEURONAL MIGRATION; MOLECULAR-GENETICS; ABNORMAL SPINDLE; DROSOPHILA; LOCUS; ADULT; NEUROGENESIS; CENTROSOMES; MUTATIONS	One of the most notable trends in mammalian evolution is the massive increase in size of the cerebral cortex, especially in primates. Humans with autosomal recessive primary microcephaly (MCPH) show a small but otherwise grossly normal cerebral cortex associated with mild to moderate mental retardation(1-4). Genes linked to this condition offer potential insights into the development and evolution of the cerebral cortex. Here we show that the most common cause of MCPH is homozygous mutation of ASPM, the human ortholog of the Drosophila melanogaster abnormal spindle gene (asp)(5), which is essential for normal mitotic spindle function in embryonic neuroblasts(6). The mouse gene Aspm is expressed specifically in the primary sites of prenatal cerebral cortical neurogenesis. Notably, the predicted ASPM proteins encode systematically larger numbers of repeated 'IQ' domains between flies, mice and humans, with the predominant difference between Aspm and ASPM being a single large insertion coding for IQ domains. Our results and evolutionary considerations suggest that brain size is controlled in part through modulation of mitotic spindle activity in neuronal progenitor cells.	Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, St Jamess Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol,Div Neurogenet,Harvard Inst Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Woods, CG (corresponding author), Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Beckett St, Leeds LS9 7TF, W Yorkshire, England.		Crow, Yanick J/N-6120-2014; Hampshire, Daniel/Q-3540-2019; woods, christopher g/A-1361-2010	Crow, Yanick J/0000-0001-7211-7564; Walsh, Christopher/0000-0002-0156-2238; Mochida, Ganeshwaran/0000-0001-7912-4097				AICARDI J, 1998, DIS NERVOUS SYSTEM C, V2, P90; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; BUNDEY S, 1997, EMERY RIMOINS PRINCI, P730; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Craig R, 1998, J CELL SCI, V111, P3609; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; GONZALEZ C, 1990, J CELL SCI, V96, P605; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; ROBERTS E, 2002, IN PRESS J MED GENET; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131	30	414	437	1	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					316	320		10.1038/ng995	http://dx.doi.org/10.1038/ng995			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355089				2022-12-17	WOS:000178311100024
J	Liu, WG; Dong, XY; Mai, M; Seelan, RS; Taniguchi, K; Krishnadath, KK; Halling, KC; Cunningham, JM; Qian, CP; Christensen, E; Roche, PC; Smith, DI; Thibodeau, SN				Liu, WG; Dong, XY; Mai, M; Seelan, RS; Taniguchi, K; Krishnadath, KK; Halling, KC; Cunningham, JM; Qian, CP; Christensen, E; Roche, PC; Smith, DI; Thibodeau, SN			Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling	NATURE GENETICS			English	Article							BAX GENE; CONDUCTIN; HOMOLOG; TUMOR		Mayo Clin & Mayo Med Sch, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55905 USA	Mayo Clinic	Liu, WG (corresponding author), Mayo Clin & Mayo Med Sch, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55905 USA.			Seelan, Ratnam/0000-0002-8925-1070	NCI NIH HHS [CA 48031, CA 60117] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA048031, U01CA060117, R01CA060117] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Boland CR, 1998, CANCER RES, V58, P5248; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; Mai M, 1999, GENOMICS, V55, P341, DOI 10.1006/geno.1998.5650; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; MIYASHITA T, 1995, CELL, V80, P293; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448	14	414	434	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					146	147		10.1038/79859	http://dx.doi.org/10.1038/79859			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017067				2022-12-17	WOS:000089638800009
J	Furukawa, T; Morrow, EM; Li, TS; Davis, FC; Cepko, CL				Furukawa, T; Morrow, EM; Li, TS; Davis, FC; Cepko, CL			Retinopathy and attenuated circadian entrainment in Crx-deficient mice	NATURE GENETICS			English	Article							CONE-ROD DYSTROPHY; RDS MUTANT MICE; HOMEOBOX GENE; RETINITIS-PIGMENTOSA; TRANSGENIC MICE; OUTER SEGMENTS; MUTATIONS; PHOTORECEPTOR; EXPRESSION; DIFFERENTIATION	Crx, an Otx-like homeobox gene, is expressed specifically in the photoreceptors of the retina and the pinealocytes of the pineal gland(1,2). Crx has been proposed to have a role in the regulation of photoreceptor-specific genes in the eye and of pineal-specific genes in the pineal gland. Mutations in human CRX are associated with the retinal diseases, cone-rod dystrophy-2 (adCRD2; refs 3-5), retinitis pigmentosa(5) (RP) and Leber congenital amaurosis(5,6) (LCA), which all lead to loss of vision. We generated mice carrying a targeted disruption of Crx. Crx(-/-) mice do not elaborate photoreceptor outer segments and lacked rod and cone activity as assayed by electroretinogram (ERG). Expression of several photoreceptor- and pineal-specific genes was reduced in Crx mutants. Circadian entrainment was also affected in Crx(-/-) mice.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Northeastern University; Harvard University; Harvard Medical School	Furukawa, T (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, 5323 Harry Hines Blvd, Dallas, TX USA.	furukawa@utsw.swmed.edu; cepko@rascal.med.harvard.edu	Morrow, Eric/J-2767-2013	Morrow, Eric/0000-0003-3430-3520				Blackshaw S, 1997, J NEUROSCI, V17, P8074; Boatright J H, 1997, Mol Vis, V3, P15; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; Grosse D, 1998, J NEUROSCI, V18, P8032; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; LIOU GI, 1991, BIOCHEM BIOPH RES CO, V181, P159, DOI 10.1016/S0006-291X(05)81395-6; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Morrow EM, 1999, DEVELOPMENT, V126, P23; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Soni BG, 1998, NATURE, V394, P27, DOI 10.1038/27794; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7	27	414	422	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1999	23	4					466	470		10.1038/70591	http://dx.doi.org/10.1038/70591			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581037				2022-12-17	WOS:000084023900026
J	Irby, RB; Mao, WG; Coppola, D; Kang, J; Loubeau, JM; Trudeau, W; Karl, R; Fujita, DJ; Jove, R; Yeatman, TJ				Irby, RB; Mao, WG; Coppola, D; Kang, J; Loubeau, JM; Trudeau, W; Karl, R; Fujita, DJ; Jove, R; Yeatman, TJ			Activating SRC mutation in a subset of advanced human colon cancers	NATURE GENETICS			English	Article							PROTEIN-KINASE ACTIVITY; C-SRC; TYROSINE PHOSPHORYLATION; CELL-TRANSFORMATION; SARCOMA VIRUS; PP60C-SRC; CARCINOMA; ONCOGENES; MUTANTS; REGION	The discovery of Rous sarcoma virus (RSV) led to the identification of cellular Src (c-Src), a non-receptor tyrosine kinase, which has since been implicated in the development of numerous human cancers(1-4). c-Src has been found to be highly activated in colon cancers, particularly in those metastatic to the liver(5-11) Studies of the mechanism of c-Src regulation have suggested that c-Src kinase activity is downregulated by phosphorylation of a critical carboxy-terminal tyrosine (Tyr 530 in human c-Src, equivalent to Tyr 527 in chicken Src) and have implied the existence of activating mutations in this C-terminal regulatory region(12-18). We report here the identification of a truncating mutation in SRC at codon 531 in 12% of cases of advanced human colon cancer tested and demonstrate that the mutation is activating, transforming, tumorigenic and promotes metastasis. These results provide, for the first time, genetic evidence that activating SRC mutations may have a role in the malignant progression of human colon cancer.	Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Surg, Tampa, FL 33612 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biochem & Mol Biol, Tampa, FL 33612 USA; Univ Calgary, Med Ctr, Dept Med Biochem, Calgary, AB T2N 4N1, Canada	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Calgary	Yeatman, TJ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Surg, Tampa, FL 33612 USA.				NATIONAL CANCER INSTITUTE [R01CA055652, K11CA065512] Funding Source: NIH RePORTER; NCI NIH HHS [CA65512, CA55652] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; EGAN SE, 1987, SCIENCE, V238, P202, DOI 10.1126/science.3659911; Guo Z, 1997, NAT BIOTECHNOL, V15, P331, DOI 10.1038/nbt0497-331; HAMAGUCHI M, 1995, ONCOGENE, V10, P1037; JOVE R, 1989, ONCOGENE RES, V5, P49; JOVE R, 1987, CELL, V50, P937, DOI 10.1016/0092-8674(87)90520-4; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; ROSEN N, 1986, J BIOL CHEM, V261, P3754; SNYDER MA, 1983, CELL, V32, P891, DOI 10.1016/0092-8674(83)90074-0; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; TALAMONTI MA, 1991, J CLIN INVEST, V91, P53; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978; TANAKA A, 1986, MOL CELL BIOL, V6, P3900, DOI 10.1128/MCB.6.11.3900; Tatsuka M, 1996, MOL CARCINOGEN, V15, P300, DOI 10.1002/(SICI)1098-2744(199604)15:4<300::AID-MC7>3.0.CO;2-J; TERMUHLEN PM, 1993, J SURG RES, V54, P293, DOI 10.1006/jsre.1993.1046; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	28	414	431	3	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					187	190		10.1038/5971	http://dx.doi.org/10.1038/5971			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988270				2022-12-17	WOS:000078399500020
J	EICHLER, EE; HOLDEN, JJA; POPOVICH, BW; REISS, AL; SNOW, K; THIBODEAU, SN; RICHARDS, CS; WARD, PA; NELSON, DL				EICHLER, EE; HOLDEN, JJA; POPOVICH, BW; REISS, AL; SNOW, K; THIBODEAU, SN; RICHARDS, CS; WARD, PA; NELSON, DL			LENGTH OF UNINTERRUPTED CGG REPEATS DETERMINES INSTABILITY IN THE FMR1 GENE	NATURE GENETICS			English	Article							FRAGILE-X-SYNDROME; FOUNDER CHROMOSOMES; MISMATCH REPAIR; FULL MUTATION; DNA; REPLICATION; POPULATION; SEQUENCE; SITE	Analysis of 84 human X chromosomes for the presence of interrupting AGG trinucleotides within the CGG repeat tract of the FMR1 gene revealed that most alleles possess two interspersed AGGs and that the longest tract of uninterrupted CGG repeats is usually found at the 3' end. Variation in the length of the repeat appears polar. Alleles containing between 34 and 55 repeats, with documented unstable transmissions, were shown to have lost one or both AGG interruptions. These comparisons define an instability threshold of 34-38 uninterrupted CGG repeats. Analysis of premutation alleles in Fragile X syndrome carriers reveals that 70% of these alleles contain a single AGG interruption. These data suggest that the loss of an AGG is an important mutational event in the generation of unstable alleles predisposed to the Fragile X syndrome.	BAYLOR COLL MED,CTR HUMAN GENOME,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; QUEENS UNIV,DEPT PSYCHIAT,KINGSTON K7L 3N6,ON,CANADA; ONGWANADA RESOURCE CTR,CYTOGENET & DNA RES LAB,KINGSTON K7L 3N6,ON,CANADA; OREGON HLTH SCI UNIV,DEPT MED & MOLEC GENET,PORTLAND,OR 97201; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; MAYO CLIN & MAYO FDN,GENET LAB,ROCHESTER,MN 55905; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205	Baylor College of Medicine; Queens University - Canada; Oregon Health & Science University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; Johns Hopkins University; Kennedy Krieger Institute					NICHD NIH HHS [HD29256] Funding Source: Medline; NIMH NIH HHS [MH01142, MH50047] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050047, K02MH001142] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXIOU M, 1992, DEVELOPMENT, V114, P185; ARMOUR JAL, 1993, HUM MOL GENET, V2, P1137, DOI 10.1093/hmg/2.8.1137; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BUYLE S, 1993, HUM GENET, V92, P269, DOI 10.1007/BF00244471; CHONG SS, 1994, AM J MED GENET, V51, P522, DOI 10.1002/ajmg.1320510447; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1993, J MED GENET, V30, P647, DOI 10.1136/jmg.30.8.647; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; KREMER EJ, 1991, AM J HUM GENET, V49, P656; LEVINSON G, 1986, A REV BIOCH, P203; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; NELSON DL, 1993, NAT GENET, V4, P107, DOI 10.1038/ng0693-107; NELSON DL, 1992, AM J HUM GENET, V51, pA186; NETHANEL T, 1992, J VIROL, V66, P6634, DOI 10.1128/JVI.66.11.6634-6640.1992; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OUDET C, 1993, AM J HUM GENET, V52, P297; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PERGOLIZZI RG, 1992, LANCET, V339, P271, DOI 10.1016/0140-6736(92)91334-5; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SNOW K, 1993, AM J HUM GENET, V53, P1217; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMMES P, 1990, EUR J BIOCHEM, V194, P699, DOI 10.1111/j.1432-1033.1990.tb19460.x; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WELLS RD, 1993, GENOME ANAL GENOME R, P107; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	41	414	444	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					88	94		10.1038/ng0994-88	http://dx.doi.org/10.1038/ng0994-88			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987398				2022-12-17	WOS:A1994PE15700021
J	Mullighan, CG; Collins-Underwood, JR; Phillips, LAA; Loudin, MG; Liu, W; Zhang, JH; Ma, J; Coustan-Smith, E; Harvey, RC; Willman, CL; Mikhail, FM; Meyer, J; Carroll, AJ; Williams, RT; Cheng, JJ; Heerema, NA; Basso, G; Pession, A; Pui, CH; Raimondi, SC; Hunger, SP; Downing, JR; Carroll, WL; Rabin, KR				Mullighan, Charles G.; Collins-Underwood, J. Racquel; Phillips, Letha A. A.; Loudin, Michael G.; Liu, Wei; Zhang, Jinghui; Ma, Jing; Coustan-Smith, Elaine; Harvey, Richard C.; Willman, Cheryl L.; Mikhail, Fady M.; Meyer, Julia; Carroll, Andrew J.; Williams, Richard T.; Cheng, Jinjun; Heerema, Nyla A.; Basso, Giuseppe; Pession, Andrea; Pui, Ching-Hon; Raimondi, Susana C.; Hunger, Stephen P.; Downing, James R.; Carroll, William L.; Rabin, Karen R.			Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia	NATURE GENETICS			English	Article							THYMIC STROMAL LYMPHOPOIETIN; DOWN-SYNDROME; CELL DEVELOPMENT; COMPETING RISK; MUTATIONS; RECEPTOR; GENE; JAK2; EXPRESSION; CYTOKINE	Aneuploidy and translocations are hallmarks of B-progenitor acute lymphoblastic leukemia (ALL), but many individuals with this cancer lack recurring chromosomal alterations. Here we report a recurring interstitial deletion of the pseudoautosomal region 1 of chromosomes X and Y in B-progenitor ALL that juxtaposes the first, noncoding exon of P2RY8 with the coding region of CRLF2. We identified the P2RY8-CRLF2 fusion in 7% of individuals with B-progenitor ALL and 53% of individuals with ALL associated with Down syndrome. CRLF2 alteration was associated with activating JAK mutations, and expression of human P2RY8-CRLF2 together with mutated mouse Jak2 resulted in constitutive Jak-Stat activation and cytokine-independent growth of Ba/F3 cells overexpressing interleukin-7 receptor alpha. Our findings indicate that these two genetic lesions together contribute to leukemogenesis in B-progenitor ALL.	[Mullighan, Charles G.; Collins-Underwood, J. Racquel; Phillips, Letha A. A.; Cheng, Jinjun; Raimondi, Susana C.; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Loudin, Michael G.; Rabin, Karen R.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Liu, Wei] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Zhang, Jinghui] NCI, Ctr Biomed Informat & Informat Technol, NIH, Rockville, MD USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Coustan-Smith, Elaine; Williams, Richard T.; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Harvey, Richard C.; Willman, Cheryl L.] Univ New Mexico, Canc Res Facil, Univ New Mexico Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Mikhail, Fady M.; Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Meyer, Julia; Carroll, William L.] NYU, New York Univ Canc Inst, Langone Med Ctr, New York, NY USA; [Heerema, Nyla A.] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Dept Pathol, Columbus, OH 43210 USA; [Basso, Giuseppe] Univ Padua, Dept Pediat, Padua, Italy; [Pession, Andrea] Univ Bologna, Dept Pediat, Hematol & Oncol Unit Lalla Seragnoli, Bologna, Italy; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp, Sect Pediat Hematol Oncol & Bone Marrow Transplan, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp, Ctr Canc & Blood Disorders, Aurora, CO USA	St Jude Children's Research Hospital; Baylor College of Medicine; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of New Mexico; University of Alabama System; University of Alabama Birmingham; New York University; NYU Langone Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Padua; University of Bologna; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Downing, James R./N-8102-2018; Meyer, Julia/ABD-4452-2021; Zhang, Jing/GWZ-7332-2022; Pession, Andrea/O-3200-2013; Raimondi, Susana C/N-8166-2018; Mullighan, Charles/H-3253-2011; Pui, Ching-Hon/N-8076-2018	Pession, Andrea/0000-0002-0379-9562; Mullighan, Charles/0000-0002-1871-1850; Pui, Ching-Hon/0000-0003-0303-5658; Harvey, Richard/0000-0002-4904-9767; BASSO, GIUSEPPE/0000-0002-2634-9302	National Cancer Institute Cancer Center [P30 CA021765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; a Bear Necessities Pediatric Research Foundation; Children's Cancer Research Foundation; National Institutes of Health [CA90433-06]; NATIONAL CANCER INSTITUTE [U10CA098543, U01CA157937, U10CA098413, K12CA090433, P30CA021765] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); a Bear Necessities Pediatric Research Foundation; Children's Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Wang and D. Naeve (Functional Genomics Laboratory, Hartwell Center, St. Jude Children's Research Hospital) for conducting array-CGH analysis; E. Walker and J. Morris (CACT Laboratory, Hartwell Center) for conducting SNP microarrays; S. Tate, J. Armstrong and K. Rakestraw (St. Jude Hartwell Center Sequencing Core) for conducting sequencing; the St. Jude Flow Cytometry Core; John Gray and the St. Jude Vector Core for lentiviral reagents and methods; the St. Jude Tissue Resources Laboratory for providing primary patient samples; S. Nutt for providing the MSCV-mIL7R-IRES-hCD4 retroviral vector; G. P. Nolan, Stanford University, for the Eco Phoenix packaging cells (http://www.stanford.edu/group/nolan); and M. Smith and K. Dobbin for gene expression studies of CRLF2. This work was supported by National Cancer Institute Cancer Center Support Grant P30 CA021765, the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, a Bear Necessities Pediatric Research Foundation grant (to K. R. R.), a Children's Cancer Research Foundation grant (to K. R. R.) and National Institutes of Health Pediatric Oncology Clinical Research Training Grant CA90433-06 (to K. R. R.).	Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Forestier E, 2008, BLOOD, V111, P1575, DOI 10.1182/blood-2007-09-114231; Fujiwara SI, 2007, LEUKEMIA LYMPHOMA, V48, P978, DOI 10.1080/10428190701225882; Gaikwad A, 2009, BRIT J HAEMATOL, V144, P930, DOI 10.1111/j.1365-2141.2008.07552.x; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Parrish YK, 2009, J IMMUNOL, V182, P4255, DOI 10.4049/jimmunol.0800489; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pounds S, 2009, BIOINFORMATICS, V25, P315, DOI 10.1093/bioinformatics/btn624; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rochman Y, 2008, CURR OPIN PHARMACOL, V8, P249, DOI 10.1016/j.coph.2008.03.002; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Storlazzi CT, 2007, LEUKEMIA, V21, P2221, DOI 10.1038/sj.leu.2404784; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Whitlock JA, 2006, BRIT J HAEMATOL, V135, P595, DOI 10.1111/j.1365-2141.2006.06337.x; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	33	413	421	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1243	U111		10.1038/ng.469	http://dx.doi.org/10.1038/ng.469			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19838194	Green Accepted			2022-12-17	WOS:000271247600019
J	Raychaudhuri, S; Remmers, EF; Lee, AT; Hackett, R; Guiducci, C; Burtt, NP; Gianniny, L; Korman, BD; Padyukov, L; Kurreeman, FAS; Chang, M; Catanese, JJ; Ding, B; Wong, S; Mil, AHMV; Neale, BM; Coblyn, J; Cui, J; Tak, PP; Wolbink, GJ; Crusius, JBA; van der Horst-Bruinsma, IE; Criswell, LA; Amos, CI; Seldin, MF; Kastner, DL; Ardlie, KG; Alfredsson, L; Costenbader, KH; Altshuler, D; Huizinga, TWJ; Shadick, NA; Weinblatt, ME; de Vries, N; Worthington, J; Seielstad, M; Toes, REM; Karlson, EW; Begovich, AB; Klareskog, L; Gregersen, PK; Daly, MJ; Plenge, RM				Raychaudhuri, Soumya; Remmers, Elaine F.; Lee, Annette T.; Hackett, Rachel; Guiducci, Candace; Burtt, Noel P.; Gianniny, Lauren; Korman, Benjamin D.; Padyukov, Leonid; Kurreeman, Fina A. S.; Chang, Monica; Catanese, Joseph J.; Ding, Bo; Wong, Sandra; Mil, Annette H. M. van der Helm-van; Neale, Benjamin M.; Coblyn, Jonathan; Cui, Jing; Tak, Paul P.; Wolbink, Gert Jan; Crusius, J. Bart A.; van der Horst-Bruinsma, Irene E.; Criswell, Lindsey A.; Amos, Christopher I.; Seldin, Michael F.; Kastner, Daniel L.; Ardlie, Kristin G.; Alfredsson, Lars; Costenbader, Karen H.; Altshuler, David; Huizinga, Tom W. J.; Shadick, Nancy A.; Weinblatt, Michael E.; de Vries, Niek; Worthington, Jane; Seielstad, Mark; Toes, Rene E. M.; Karlson, Elizabeth W.; Begovich, Ann B.; Klareskog, Lars; Gregersen, Peter K.; Daly, Mark J.; Plenge, Robert M.			Common variants at CD40 and other loci confer risk of rheumatoid arthritis	NATURE GENETICS			English	Article							NF-KAPPA-B; SINGLE-NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; GRAVES-DISEASE; SUSCEPTIBILITY; GENE; COOPERATION; EXPRESSION; INTERACTS; ANTIBODY	To identify rheumatoid arthritis risk loci in European populations, we conducted a meta-analysis of two published genome-wide association (GWA) studies totaling 3,393 cases and 12,462 controls(1,2). We genotyped 31 top-ranked SNPs not previously associated with rheumatoid arthritis in an independent replication of 3,929 autoantibody-positive rheumatoid arthritis cases and 5,807 matched controls from eight separate collections. We identified a common variant at the CD40 gene locus (rs4810485, P = 0.0032 replication, P = 8.2 x 10(-9) overall, OR = 0.87). Along with other associations near TRAF1 (refs. 2,3) and TNFAIP3 (refs. 4,5), this implies a central role for the CD40 signaling pathway in rheumatoid arthritis pathogenesis. We also identified association at the CCL21 gene locus (rs2812378, P = 0.00097 replication, P = 2.8 x 10(-7) overall), a gene involved in lymphocyte trafficking. Finally, we identified evidence of association at four additional gene loci: MMEL1-TNFRSF14 (rs3890745, P = 0.0035 replication, P = 1.1 x 10(-7) overall), CDK6 (rs42041, P = 0.010 replication, P = 4.0 x 10(-6) overall), PRKCQ (rs4750316, P = 0.0078 replication, P = 4.4 x 10(-6) overall), and KIF5A-PIP4K2C (rs1678542, P = 0.0026 replication, P = 8.8 x 10(-8) overall).	[Raychaudhuri, Soumya; Hackett, Rachel; Guiducci, Candace; Burtt, Noel P.; Gianniny, Lauren; Wong, Sandra; Neale, Benjamin M.; Ardlie, Kristin G.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Hackett, Rachel; Guiducci, Candace; Burtt, Noel P.; Gianniny, Lauren; Wong, Sandra; Neale, Benjamin M.; Ardlie, Kristin G.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] MIT, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Coblyn, Jonathan; Cui, Jing; Costenbader, Karen H.; Shadick, Nancy A.; Weinblatt, Michael E.; Karlson, Elizabeth W.; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Neale, Benjamin M.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Remmers, Elaine F.; Korman, Benjamin D.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Kurreeman, Fina A. S.; Mil, Annette H. M. van der Helm-van; Huizinga, Tom W. J.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands; [Chang, Monica; Catanese, Joseph J.; Begovich, Ann B.] Celera, Alameda, CA 94502 USA; [Ding, Bo; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Neale, Benjamin M.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, NL-326 Amsterdam, Netherlands; [Wolbink, Gert Jan] Jan van Breemen Inst, NL-1056 AB Amsterdam, Netherlands; [Wolbink, Gert Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res Landsteiner Lab, NL-1006 AD Amsterdam, Netherlands; [van der Horst-Bruinsma, Irene E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands; [Crusius, J. Bart A.] Vrije Univ Amsterdam, Med Ctr, Immunogenet Lab, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Ardlie, Kristin G.] SeraCare Life Sci, Cambridge, MA 02139 USA; [Worthington, Jane] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Seielstad, Mark] Genome Inst Singapore, Singapore 138672, Singapore	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwell Health; Karolinska Institutet; Karolinska University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; University of London; King's College London; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Plenge, RM (corresponding author), Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	rplenge@partners.org	Altshuler, David M/A-4476-2009; Seielstad, Mark/T-7841-2019; Padyukov, Leonid/A-4890-2009; Alfredsson, Lars/AAC-9007-2019; Worthington, Jane/M-9770-2014; Crusius, Jakob Bart/AAE-9051-2019; van der Horst-Bruinsma, Irene/AAC-7744-2022; de Vries, Niek/J-9348-2013; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; Padyukov, Leonid/0000-0003-2950-5670; Alfredsson, Lars/0000-0003-1688-6697; Worthington, Jane/0000-0003-0544-042X; Crusius, Jakob Bart/0000-0001-9046-0155; van der Horst-Bruinsma, Irene/0000-0002-8086-9915; de Vries, Niek/0000-0002-6257-8604; Daly, Mark J/0000-0002-0949-8752; Toes, Rene/0000-0002-9618-6414; Raychaudhuri, Soumya/0000-0002-1901-8265; Hearn, Sandra/0000-0002-9748-697X; van der Helm - van Mil, Annette/0000-0001-8572-1437; Wolbink, Gerrit Jan/0000-0003-1924-7460; Remmers, Elaine F/0000-0002-9522-1249; Seielstad, Mark/0000-0001-5783-1401; Klareskog, Lars/0000-0001-9601-6186; Korman, Benjamin/0000-0002-4873-2628	T32 NIH training grant [AR007530-23]; NIH [KAR055688A, AI55314-3, RO1-AR44422, NO1-AR-2-2263, R01 AR49880, CA87969, P60 AR047782, K24 AR0524-01, BIRCWH K12 HD051959]; Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund; UO1 NIH [UO1 HG004171]; Millennium Pharmaceuticals and Biogen-Idec; National Center for Research Resources [U54 RR020278]; National Institutes of Health; Swedish Medical Research Council; Swedish Council for Working Life and Social Research; King Gustaf V's 80-year Foundation; Swedish Rheumatic Foundation; Stockholm County Council; Arbetsmarknadens Forrsarkringsaktiebolag; lCounty of Sormland Research and Development Center; Agency for Science Technology and Research (Singapore); Doris Duke Charitable Foundation; US National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; American College of Rheumatology Arthritis Investigator Award; Katherine Swan Ginsburg Memorial Award; Kirkland Scholar Awardee [K24 AR02175, R01 AI065841, 5 M01 RR-00079]; European Community's FP6 funding; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051959] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, U54RR020278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065841, K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782, K24AR002175, R01AR049880, K08AR055688, N01AR022263, Z01AR041180, ZIAAR041139, T32AR007530, R01AR044422] Funding Source: NIH RePORTER	T32 NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); UO1 NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium Pharmaceuticals and Biogen-Idec; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); King Gustaf V's 80-year Foundation; Swedish Rheumatic Foundation; Stockholm County Council(Stockholm County Council); Arbetsmarknadens Forrsarkringsaktiebolag; lCounty of Sormland Research and Development Center; Agency for Science Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American College of Rheumatology Arthritis Investigator Award; Katherine Swan Ginsburg Memorial Award; Kirkland Scholar Awardee; European Community's FP6 funding(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the WTCCC for making access to genotype data available online, and for providing autoantibody status of the WTCCC rheumatoid arthritis cases. We thank S. Myers and J. Marchini for help with IMPUTE. S. R. is supported by a T32 NIH training grant (AR007530-23), a K08 grant from the NIH (KAR055688A), and through the BWH Rheumatology Fellowship program, directed by S. Helfgott. R. M. P. is supported by a K08 grant from the NIH (AI55314-3), a private donation from the Fox Trot Fund, the William Randolph Hearst Fund of Harvard University, and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. M. J. D. is supported by a UO1 NIH grant (UO1 HG004171). The BRASS Registry is supported by a grant from Millennium Pharmaceuticals and Biogen-Idec. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The NARAC is supported by NIH grants RO1-AR44422 and NO1-AR-2-2263 (P. K. G.). This work was also supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. The EIRA study is supported by grants from the Swedish Medical Research Council, the Swedish Council for Working Life and Social Research, King Gustaf V's 80-year Foundation, the Swedish Rheumatic Foundation, the Stockholm County Council, the insurance company Arbetsmarknadens Forrsarkringsaktiebolag, and the County of Sormland Research and Development Center. Genotyping of the EIRA cohort was supported by the Agency for Science Technology and Research (Singapore). Genotyping of the GCI and LUMC samples was funded by Celera. D. A. is a Burroughs Wellcome Fund Clinical Scholar in Translational Research, and a Distinguished Clinical Scholar of the Doris Duke Charitable Foundation. B. D. K. was supported by the NIH Clinical Research Training Program, a public-private partnership between the Foundation for the National Institutes of Health and Pfizer Inc. E. W. K. is supported by NIH grants R01 AR49880, CA87969, P60 AR047782, K24 AR0524-01 and BIRCWH K12 HD051959 (supported by US National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development and the Office of the Director). K. H. C. is the recipient of an Arthritis Foundation/American College of Rheumatology Arthritis Investigator Award and a Katherine Swan Ginsburg Memorial Award. L. A. C. is a Kirkland Scholar Awardee and her work on this project was supported by K24 AR02175, R01 AI065841 and 5 M01 RR-00079. P. P. T. and N. d. V. were supported by European Community's FP6 funding (Autocure). We acknowledge the help of C. Ellen van der Schoot for healthy control samples for GENRA and the help of B. A. C. Dijkmans, D. van Schaardenburg, A. S. Pena, P.L. Klarenbeek, Z. Zhang, M. T. Nurmohammed, W. F. Lems, R. R. J. van de Stadt, W. H. Bos, J. Ursum, M. G. M. Bartelds, D. M. Gerlag, M. G. H. van der Sande, C. A. Wijbrandts and M. M. J. Herenius in gathering GENRA subject samples and data. We thank Y. Li, S. Schrodi, and J. Sninsky (Celera); and B. Voight and C. Cotsapas (Broad Institute) for comments on the manuscript.	Balasa B, 1997, J IMMUNOL, V159, P4620; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carpenter CL, 2004, BIOCHEM SOC T, V32, P326, DOI 10.1042/BST0320326; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Gruber T, 2008, MOL IMMUNOL, V45, P117, DOI 10.1016/j.molimm.2007.05.003; HARNETT MM, 2004, SCI STKE, pPE25; Heward JM, 2004, CLIN ENDOCRINOL, V61, P269, DOI 10.1111/j.1365-2265.2004.02099.x; Houston FA, 2004, THYROID, V14, P506, DOI 10.1089/1050725041517039; ISHIDA T, 1995, J IMMUNOL, V155, P5527; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	30	413	426	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1216	1223		10.1038/ng.233	http://dx.doi.org/10.1038/ng.233			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794853	Green Accepted			2022-12-17	WOS:000259651000022
J	Murrell, A; Heeson, S; Reik, W				Murrell, A; Heeson, S; Reik, W			Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops	NATURE GENETICS			English	Article							CTCF; MECHANISMS; INSULATOR; UPSTREAM; DELETION; SITES; EXPRESSION; ELEMENT	Imprinted genes are expressed from only one of the parental alleles and are marked epigenetically by DNA methylation and histone modifications(1-5). The paternally expressed gene insulin-like growth-factor 2 (Igf2) is separated by similar to100 kb from the maternally expressed noncoding gene H19 on mouse distal chromosome 7. Differentially methylated regions in Igf2 and H19 contain chromatin boundaries(6-9), silencers(10,11) and activators(12) and regulate the reciprocal expression of the two genes in a methylation-sensitive manner by allowing them exclusive access to a shared set of enhancers(13-15). Various chromatin models have been proposed that separate Igf2 and H19 into active and silent domains(16-19). Here we used a GAL4 knock-in approach as well as the chromosome conformation capture technique to show that the differentially methylated regions in the imprinted genes Igf2 and H19 interact in mice. These interactions are epigenetically regulated and partition maternal and paternal chromatin into distinct loops. This generates a simple epigenetic switch for Igf2 through which it moves between an active and a silent chromatin domain.	Babraham Inst, Dev Genet Programme, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Murrell, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	amm@sanger.ac.uk; wolf.reik@bbsrc.ac.uk	Reik, Wolf/I-6794-2012	Murrell, adele/0000-0003-2647-3511; Reik, Wolf/0000-0003-0216-9881				Banerjee Subhasis, 2001, TheScientificWorld, V1, P218; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Davies K, 2002, DEVELOPMENT, V129, P1657; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEIL R, 1994, DEVELOPMENT, V120, P2933; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kaffer CR, 2001, MOL CELL BIOL, V21, P8189, DOI 10.1128/MCB.21.23.8189-8196.2001; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Sleutels F, 2002, ADV GENET, V46, P119; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Weber M, 2003, MOL CELL BIOL, V23, P8953, DOI 10.1128/MCB.23.24.8953-8959.2003; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	30	413	431	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					889	893		10.1038/ng1402	http://dx.doi.org/10.1038/ng1402			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273689				2022-12-17	WOS:000222974000024
J	LINDBLOM, A; TANNERGARD, P; WERELIUS, B; NORDENSKJOLD, M				LINDBLOM, A; TANNERGARD, P; WERELIUS, B; NORDENSKJOLD, M			GENETIC-MAPPING OF A 2ND LOCUS PREDISPOSING TO HEREDITARY NONPOLYPOSIS COLON-CANCER	NATURE GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; IDENTIFICATION; POLYMORPHISMS; CHROMOSOME-5	Hereditary colon cancer is caused by mutations in several different loci. The APC gene on chromosome 5 causing adenomatous polyposis coli represents a minority of the inherited colon cancer cases, while hereditary-non polyposis colon cancer (HNPCC) may cause five percent of all human colon cancer. One gene causing HNPCC was recently mapped to chromosome 2 but the same study also showed that at least one additional locus may cause HNPCC. We now present tight linkage between a polymorphic marker on the short arm of chromosome 3 and the disease locus, and find that these families also manifest signs of a general DNA replication disorder.			LINDBLOM, A (corresponding author), KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM 60,SWEDEN.			Nordenskjold, Magnus/0000-0002-4974-425X				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; ERLANDSSON R, 1990, ONCOGENE, V5, P1207; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HERRERA L, 1986, AM J MED GENET, V25, P473, DOI 10.1002/ajmg.1320250309; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; LYNCH HT, 1985, CA-CANCER J CLIN, V35, P95, DOI 10.3322/canjclin.35.2.95; MECKLIN JP, 1986, GASTROENTEROLOGY, V90, P328, DOI 10.1016/0016-5085(86)90928-5; OTT J, 1976, AM J HUM GENET, V28, P528; PALTOMAKI P, 1993, SCIENCE, V260, P810; SPIRIO L, 1993, AM J HUM GENET, V52, P286; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VASEN HFA, 1990, ANTICANCER RES, V10, P555; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Warthin AS, 1913, ARCH INTERN MED, V12, P546; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	22	413	416	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					279	282		10.1038/ng1193-279	http://dx.doi.org/10.1038/ng1193-279			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	7903889				2022-12-17	WOS:A1993MF12200020
J	Alimonti, A; Carracedo, A; Clohessy, JG; Trotman, LC; Nardella, C; Egia, A; Salmena, L; Sampieri, K; Haveman, WJ; Brogi, E; Richardson, AL; Zhang, JW; Pandolfi, PP				Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Trotman, Lloyd C.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Sampieri, Katia; Haveman, William J.; Brogi, Edi; Richardson, Andrea L.; Zhang, Jiangwen; Pandolfi, Pier Paolo			Subtle variations in Pten dose determine cancer susceptibility	NATURE GENETICS			English	Article							EXPRESSION; MUTATION; REVEALS; GENE; MICE	Cancer susceptibility has been attributed to at least one heterozygous genetic alteration in a tumor suppressor gene (TSG)(1). It has been hypothesized that subtle variations in TSG expression can promote cancer development(2,3). However, this hypothesis has not yet been definitively supported in vivo. PTEN is a TSG frequently lost in human cancer and mutated in inherited cancer-predisposition syndromes(4). Here we analyze Pten hypermorphic mice (Pten(hy/+)), expressing 80% normal levels of Pten. Ptenhy/+ mice develop a spectrum of tumors, with breast tumors occurring at the highest penetrance. All breast tumors analyzed here retained two intact copies of Pten and maintained Pten levels above heterozygosity. Notably, subtle downregulation of Pten altered the steady-state biology of the mammary tissues and the expression profiles of genes involved in cancer cell proliferation. We present an alterative working model for cancer development in which subtle reductions in the dose of TSGs predispose to tumorigenesis in a tissue-specific manner.	[Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Sampieri, Katia; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Med, Canc Genet Program, Boston, MA 02115 USA; [Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Sampieri, Katia; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Med Sch, Dept Pathol, Boston, MA 02215 USA; [Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Trotman, Lloyd C.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Haveman, William J.; Brogi, Edi; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, Sloan Kettering Inst, New York, NY 10021 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhang, Jiangwen] Harvard Univ, FAS, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Dept Med, Canc Genet Program, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Alimonti, Andrea/J-4150-2012; Zhang, Jiangwen/A-7654-2013; Carracedo, Arkaitz/F-7029-2011	Zhang, Jiangwen/0000-0002-2911-8446; Carracedo, Arkaitz/0000-0001-5957-1260; Alimonti, Andrea/0000-0002-9362-2313; Salmena, Leonardo/0000-0003-4023-658X; Nardella, Caterina/0000-0002-1901-7916; Clohessy, John/0000-0001-5186-9775	US National Cancer Institute [SPORE 92629, MMHCC CA-84292, RO1 CA-82328]; European Molecular Biology Organization; NATIONAL CANCER INSTITUTE [U01CA141457, P50CA092629, U01CA084292, RC2CA147940, R01CA137050, R01CA082328] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Z. Chen for help with genotyping and characterization of the Pten hypomorphic mutant mice. This study was supported, in part, by US National Cancer Institute grants (SPORE 92629 in Prostate Cancer, MMHCC CA-84292 and RO1 CA-82328). A. C. was supported by a long-term European Molecular Biology Organization fellowship.	Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Friend SH, 2003, GENE CHROMOSOME CANC, V38, P326, DOI 10.1002/gcc.10257; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799	21	412	426	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					454	U136		10.1038/ng.556	http://dx.doi.org/10.1038/ng.556			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20400965	Green Accepted			2022-12-17	WOS:000277179500019
J	Orso, E; Broccardo, C; Kaminski, WE; Bottcher, A; Liebisch, G; Drobnik, W; Gotz, A; Chambenoit, O; Diederich, W; Langmann, T; Spruss, T; Luciani, MF; Rothe, G; Lackner, KJ; Chimini, G; Schmitz, G				Orso, E; Broccardo, C; Kaminski, WE; Bottcher, A; Liebisch, G; Drobnik, W; Gotz, A; Chambenoit, O; Diederich, W; Langmann, T; Spruss, T; Luciani, MF; Rothe, G; Lackner, KJ; Chimini, G; Schmitz, G			Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice	NATURE GENETICS			English	Article							FREE-CHOLESTEROL; A-I; LIPOPROTEINS; MACROPHAGES; METABOLISM; CAVEOLAE; EFFLUX; CELLS	Mutations in the gene encoding ATP-binding cassette transporter 1 (ABC1) have been reported in Tangier disease(1-3) (TD), an autosomal recessive disorder that is characterized by almost complete absence of plasma high-density lipoprotein (HDL), deposition of cholesteryl esters in the reticulo-endothelial system(4) (RES) and aberrant cellular lipid trafficking(5-12). We demonstrate here that mice with a targeted inactivation of Abc1 display morphologic abnormalities and perturbations in their lipoprotein metabolism concordant with TD. ABC1 is expressed on the plasma membrane and the Golgi complex, mediates apo-Al associated export of cholesterol and phospholipids from the cell, and is regulated by cholesterol flux. Structural and functional abnormalities in caveolar processing and the trans-Golgi secretory pathway of cells lacking functional ABC1 indicate that lipid export processes involving vesicular budding between the Golgi and the plasma membrane are severely disturbed.	Univ Regensburg, Inst Clin Chem & Lab Med, D-93042 Regensburg, Germany; CNRS Marseille Luminy, INSERM, Ctr Immunol, Marseille 9, France; Univ Regensburg, Lab Anim Facil, D-8400 Regensburg, Germany	University of Regensburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Regensburg	Schmitz, G (corresponding author), Univ Regensburg, Inst Clin Chem & Lab Med, Franz Josef Str Allee 11, D-93042 Regensburg, Germany.		Broccardo, Cyril/G-2796-2017; Liebisch, Gerhard/G-6130-2010	Broccardo, Cyril/0000-0003-3016-6549; Liebisch, Gerhard/0000-0003-4886-0811; Schmitz, Gerd/0000-0002-1325-1007				ASSMANN G, 1989, METABOLIC BASIS INHE, P1267; BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOJANOVSKI D, 1987, J CLIN INVEST, V80, P1742, DOI 10.1172/JCI113266; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Drobnik W, 1999, ARTERIOSCL THROM VAS, V19, P28, DOI 10.1161/01.ATV.19.1.28; Fielding CJ, 1997, P NATL ACAD SCI USA, V94, P3753, DOI 10.1073/pnas.94.8.3753; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; GINGRAS D, 1993, AM J PHYSIOL, V265, pF316, DOI 10.1152/ajprenal.1993.265.2.F316; Glauert AM., 1975, PRACTICAL METHODS EL; Huber AM, 1999, BBA-GEN SUBJECTS, V1426, P43, DOI 10.1016/S0304-4165(98)00121-4; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Li N, 1997, BRIT J HAEMATOL, V99, P808, DOI 10.1046/j.1365-2141.1997.4993305.x; Liu PS, 1999, NAT CELL BIOL, V1, P369, DOI 10.1038/14067; MARTIN OC, 1993, P NATL ACAD SCI USA, V90, P2661, DOI 10.1073/pnas.90.7.2661; ROBENEK H, 1991, ARTERIOSCLER THROMB, V11, P1007, DOI 10.1161/01.ATV.11.4.1007; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SCHMITZ G, 1985, P NATL ACAD SCI USA, V82, P6305, DOI 10.1073/pnas.82.18.6305; Schmitz G, 1997, ELECTROPHORESIS, V18, P1807, DOI 10.1002/elps.1150181015; SCHMITZ G, 1985, EMBO J, V4, P613, DOI 10.1002/j.1460-2075.1985.tb03674.x; SCHMITZ G, 1990, ARTERIOSCLEROSIS, V10, P1010, DOI 10.1161/01.ATV.10.6.1010; SCHMITZ G, 1984, J CHROMATOGR, V307, P65, DOI 10.1016/S0378-4347(00)84073-6; Schmitz G, 1998, P SOC PHOTO-OPT INS, V3260, P127, DOI 10.1117/12.307088; Stohr J, 1998, ARTERIOSCL THROM VAS, V18, P1424, DOI 10.1161/01.ATV.18.9.1424; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; WILLIAMS MA, 1977, PRACTICLA METHODS EL	30	412	434	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2000	24	2					192	196		10.1038/72869	http://dx.doi.org/10.1038/72869			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	10655069				2022-12-17	WOS:000085104600024
J	Drazen, JM; Yandava, CN; Dube, L; Szczerback, N; Hippensteel, R; Pillari, A; Israel, E; Schork, N; Silverman, ES; Katz, DA; Drajesk, J				Drazen, JM; Yandava, CN; Dube, L; Szczerback, N; Hippensteel, R; Pillari, A; Israel, E; Schork, N; Silverman, ES; Katz, DA; Drajesk, J			Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment	NATURE GENETICS			English	Article							GENE-TRANSCRIPTION; 5-LIPOXYGENASE; ZILEUTON; THERAPY	Clinically similar asthma patients may develop airway obstruction by different mechanisms(1,2). Asthma treatments that specifically interfere with the 5-lipoxygenase (ALOX5) pathway(3-5) provide a method to identify those patients in whom the products of the ALOX5 pathway (that is, the leukotrienes) contribute to the expression of the asthma phenotype. Failure of an asthma,patient to respond to treatment with ALOX5-pathway modifiers indicates that leukotrienes are not critical to the expression of the asthmatic phenotype in that patient. We previously defined a family of DNA sequence variants in the core promoter of the gene ALOX5 (on chromosome 10q11.2) associated with diminished promoter-reporter activity in tissue culture(6,7) 7. Because expression of ALOX5 is in part transcriptionally regulated(8), we reasoned that patients with these sequence variants may have diminished gene transcription, and therefore decreased ALOX5 product production and a diminished clinical response to treatment with a drug targeting this pathway. Such an effect indicates an interaction between gene promoter sequence variants and. drug-treatment responses, that is, a pharmacogenetic effect of a promoter sequence on treatment responses.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Abbott Labs, Abbott Pk, IL 60064 USA; Genset Corp, La Jolla, CA 92037 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Abbott Laboratories	Drazen, JM (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jdrazen@rics.bwh.harvard.edu	Drazen, Jeffrey M/E-5841-2012	Schork, Nicholas/0000-0003-0920-5013; Katz, David/0000-0002-4400-5669	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056383] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50-HL-56383] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; ARRANZ M, 1995, LANCET, V346, P281, DOI 10.1016/S0140-6736(95)92168-0; BARNES PJ, 1987, AM REV RESPIR DIS, V136, pS77, DOI 10.1164/ajrccm/136.6_Pt_2.S77; BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307; Busse WW, 1998, AM J RESP CRIT CARE, V157, pS210, DOI 10.1164/ajrccm.157.6.mar-1; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Hancox RJ, 1998, EUR RESPIR J, V11, P589; In KH, 1997, J CLIN INVEST, V99, P1130, DOI 10.1172/JCI119241; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Lemanske RF, 1997, JAMA-J AM MED ASSOC, V278, P1855, DOI 10.1001/jama.278.22.1855; McGill KA, 1996, LANCET, V348, P519, DOI 10.1016/S0140-6736(95)12297-4; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; NADEL JA, 1989, CHEST, V95, P1328, DOI 10.1378/chest.95.6.1328; NEBERT DW, 1990, PRINCIPLES DRUG ACTI; OByrne PM, 1997, ANN INTERN MED, V127, P472, DOI 10.7326/0003-4819-127-6-199709150-00009; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Schwartz HJ, 1998, ARCH INTERN MED, V158, P141, DOI 10.1001/archinte.158.2.141; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; SMITH LJ, 1991, AM REV RESPIR DIS, V143, pS100, DOI 10.1164/ajrccm/143.5_Pt_2.S100; STANKOVA J, 1995, BLOOD, V85, P3719, DOI 10.1182/blood.V85.12.3719.bloodjournal85123719; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; Wong SL, 1998, CLIN PHARMACOL THER, V63, P324, DOI 10.1016/S0009-9236(98)90164-3; Wong SL, 1998, EUR J CLIN PHARMACOL, V54, P715, DOI 10.1007/s002280050540	25	412	442	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1999	22	2					168	170		10.1038/9680	http://dx.doi.org/10.1038/9680			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369259				2022-12-17	WOS:000080680900022
J	Drenth, JPH; Cuisset, L; Grateau, G; Vasseur, C; van de Velde-Visser, SD; de Jong, JGN; Beckmann, JS; van der Meer, JWM; Delpech, M				Drenth, JPH; Cuisset, L; Grateau, G; Vasseur, C; van de Velde-Visser, SD; de Jong, JGN; Beckmann, JS; van der Meer, JWM; Delpech, M		Int Hyper-IgD Study Grp	Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome	NATURE GENETICS			English	Article							FAMILIAL HIBERNIAN FEVER; HYPERIMMUNOGLOBULINEMIA-D; CLINICAL SPECTRUM; IDENTIFICATION; ACIDURIA; LINKAGE; ATTACKS; 12P13	Hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS; MIM 260920) is a rare, apparently monogenic, autosomal recessive disorder characterized by recurrent episodes of fever accompanied with lymphadenopathy, abdominal distress,joint involvement and skin lesions'.;All patients have high serum IgD values (>100 U/ml) and HIDS 'attacks' are associated with an intense acute phase reaction whose exact pathophysiology remains obscure(2-4). Two other hereditary febrile disorders have been described. Familial Mediterranean fever (MIM 249100) is an autosomal recessive disorder affecting mostly populations from the Mediterranean basin and is caused by mutations in the gene MEFV(refs 5,6). Familial Hibernian fever (MIM 142680), also known as autosomal: dominant familial recurrent-fever, is caused by missense mutations in the gene encoding type 1 tumour necrosis factor receptor(7-10). Here we perform a genome-wide search to map the HIDS; gene. Haplotype analysis:placed the gene at 12q24 between D12S330 and D12S79. We identified the gene MVK,: encoding mevalonate kinase (MK, ATP:mevalonate 5-phosphotransferase; EC 2.7.1.36), as a candidate gene. We characterized 3 missense mutations, a 92-bp loss stemming from a deletion or from exon skipping, and the absence of expression of one allele Functional analysis demonstrated diminished MK activity in: fibroblasts from HIDS-patients. Our data establish MVK as the: gene responsible for HIDS.	Inst Cochin Genet Mol, Lab Genet Mol Humaine, Paris, France; Hop Cochin, Assistance Publ Hopitaux Paris, F-75674 Paris, France; Univ Nijmegen St Radboud Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen St Radboud Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Hotel Dieu, Serv Med Interne, AP HP, Paris, France; Univ Nijmegen St Radboud Hosp, Lab Pediat & Neurol, NL-6500 HB Nijmegen, Netherlands; URA CNRS 1922, Evry, France; Ctr Natl Genotypage, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay	Delpech, M (corresponding author), Inst Cochin Genet Mol, Lab Genet Mol Humaine, Paris, France.		Drenth, J.P.H./H-8025-2014; Drenth, Joost/V-7436-2019; Beckmann, Jacques S/A-9772-2008; van der Meer, Jos W.M./C-8521-2013	Beckmann, Jacques S/0000-0002-9741-1900; van der Meer, Jos W.M./0000-0001-5120-3690				Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586; Drenth JPH, 1996, J IMMUNOL, V157, P400; DRENTH JPH, 1995, EUR J CLIN INVEST, V25, P683, DOI 10.1111/j.1365-2362.1995.tb01986.x; DRENTH JPH, 1994, HUM GENET, V94, P616, DOI 10.1007/BF00206953; GIBSON KM, 1989, ENZYME, V41, P47, DOI 10.1159/000469050; HOFFMAN G, 1986, NEW ENGL J MED, V314, P1610, DOI 10.1056/NEJM198606193142504; HOFFMANN GF, 1993, PEDIATRICS, V91, P915; McDermott EM, 1997, MAYO CLIN PROC, V72, P806, DOI 10.4065/72.9.806; McDermott MF, 1998, AM J HUM GENET, V62, P1446, DOI 10.1086/301886; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Mulley J, 1998, AM J HUM GENET, V62, P884, DOI 10.1086/301793; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Yamagishi A, 1996, HUM MUTAT, V7, P23, DOI 10.1002/(SICI)1098-1004(1996)7:1<23::AID-HUMU3>3.3.CO;2-K	21	412	425	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					178	181		10.1038/9696	http://dx.doi.org/10.1038/9696			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369262				2022-12-17	WOS:000080680900025
J	Neubauer, G; King, A; Rappsilber, J; Calvio, C; Watson, M; Ajuh, P; Sleeman, J; Lamond, A; Mann, M				Neubauer, G; King, A; Rappsilber, J; Calvio, C; Watson, M; Ajuh, P; Sleeman, J; Lamond, A; Mann, M			Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex	NATURE GENETICS			English	Article							POLYACRYLAMIDE GELS; IDENTIFICATION; GENOME; NANOELECTROSPRAY; HELICASE; U4/U6; BOX; U1	Many important cell mechanisms are carried our and regulated by multi-protein complexes, for example, transcription and RNA processing machinery, receptor complexes end cytoskeletal structures. Most of these complexes remain only partially characterized due to the difficulty of conventional protein analysis methods. The rapid expansion of DNA sequence databases now provides whole or partial gene sequences of model organisms, and recent advances in protein microcharacterization via mass spectrometry allow the possibility of linking these DNA sequences to the proteins in functional complexes(1). This approach has been demonstrated in organisms whose genomes have been sequenced(2), such as budding yeast. Here we report the first characterization of an entire mammalian multi-protein complex using these methods. The machinery that removes introns from mRNA percursors-the spliceosome-is a large multi-protein complex(3,4). Approximately half of the components excised from a two-dimensional gel separation of the spliceosome were found in protein sequence databases. Using nanoelectrospray mass spectrometry, the remainder were identified and cloned using public expressed sequence tag (EST) databases. Existing EST databases are thus already sufficiently complete to allow rapid characterization of large mammalian protein complexes via mass spectrometry.	European Mol Biol Lab, Prot & Peptide Grp, D-69115 Heidelberg, Germany; Univ Dundee, Dept Biochem, Dundee DD1 4HN, Scotland	European Molecular Biology Laboratory (EMBL); University of Dundee	Mann, M (corresponding author), Odense Univ, Dept Mol Biol, Campusvej 55, DK-5230 Odense, Denmark.	mann@cebi.ou.dk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Cinzia, Calvio/E-1353-2011; Mann, Matthias/A-3454-2013	Rappsilber, Juri/0000-0001-5999-1310; Cinzia, Calvio/0000-0003-1631-0452; Mann, Matthias/0000-0003-1292-4799; Watson, Mark/0000-0002-3557-101X; Sleeman, Judith/0000-0003-0345-6508; Lamond, Angus/0000-0001-6204-6045	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEGGS JD, 1995, PREMRNA PROCESSING, P79; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; CALVIO C, 1995, RNA, V1, P724; CARMOFONSECA M, 1992, J CELL BIOL, V117, P1, DOI 10.1083/jcb.117.1.1; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Lamond AI, 1997, TRENDS CELL BIOL, V7, P139, DOI 10.1016/S0962-8924(97)01031-3; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; Lauber J, 1997, RNA, V3, P926; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Molnar GM, 1997, P NATL ACAD SCI USA, V94, P7831, DOI 10.1073/pnas.94.15.7831; Moore M., 1993, RNA WORLD, P303; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; ONO W, 1994, MOL CELL BIOL, V14, P7611, DOI 10.1128/MCB.14.11.7611; REED R, 1988, CELL, V53, P949, DOI 10.1016/S0092-8674(88)90489-8; REED R, 1990, P NATL ACAD SCI USA, V87, P8031, DOI 10.1073/pnas.87.20.8031; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SUKEGAWA J, 1995, J BIOL CHEM, V270, P15702, DOI 10.1074/jbc.270.26.15702; WILL CL, 1995, NUCL ACIDS MOL BIOL, P342; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519	27	412	446	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					46	50		10.1038/1700	http://dx.doi.org/10.1038/1700			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731529				2022-12-17	WOS:000075671400017
J	Soranzo, N; Spector, TD; Mangino, M; Kuhnel, B; Rendon, A; Teumer, A; Willenborg, C; Wright, B; Chen, L; Li, MY; Salo, P; Voight, BF; Burns, P; Laskowski, RA; Xue, YL; Menzel, S; Altshuler, D; Bradley, JR; Bumpstead, S; Burnett, MS; Devaney, J; Doring, A; Elosua, R; Epstein, SE; Erber, W; Falchi, M; Garner, SF; Ghori, MJR; Goodall, AH; Gwilliam, R; Hakonarson, HH; Hall, AS; Hammond, N; Hengstenberg, C; Illig, T; Konig, IR; Knouff, CW; McPherson, R; Melander, O; Mooser, V; Nauck, M; Nieminen, MS; O'Donnell, CJ; Peltonen, L; Potter, SC; Prokisch, H; Rader, DJ; Rice, CM; Roberts, R; Salomaa, V; Sambrook, J; Schreiber, S; Schunkert, H; Schwartz, SM; Serbanovic-Canic, J; Sinisalo, J; Siscovick, DS; Stark, K; Surakka, I; Stephens, J; Thompson, JR; Volker, U; Volzke, H; Watkins, NA; Wells, GA; Wichmann, HE; Van Heel, DA; Tyler-Smith, C; Thein, SL; Kathiresan, S; Perola, M; Reilly, MP; Stewart, AFR; Erdmann, J; Samani, NJ; Meisinger, C; Greinacher, A; Deloukas, P; Ouwehand, WH; Gieger, C				Soranzo, Nicole; Spector, Tim D.; Mangino, Massimo; Kuehnel, Brigitte; Rendon, Augusto; Teumer, Alexander; Willenborg, Christina; Wright, Benjamin; Chen, Li; Li, Mingyao; Salo, Perttu; Voight, Benjamin F.; Burns, Philippa; Laskowski, Roman A.; Xue, Yali; Menzel, Stephan; Altshuler, David; Bradley, John R.; Bumpstead, Suzannah; Burnett, Mary-Susan; Devaney, Joseph; Doering, Angela; Elosua, Roberto; Epstein, Stephen E.; Erber, Wendy; Falchi, Mario; Garner, Stephen F.; Ghori, Mohammed J. R.; Goodall, Alison H.; Gwilliam, Rhian; Hakonarson, Hakon H.; Hall, Alistair S.; Hammond, Naomi; Hengstenberg, Christian; Illig, Thomas; Koenig, Inke R.; Knouff, Christopher W.; McPherson, Ruth; Melander, Olle; Mooser, Vincent; Nauck, Matthias; Nieminen, Markku S.; O'Donnell, Christopher J.; Peltonen, Leena; Potter, Simon C.; Prokisch, Holger; Rader, Daniel J.; Rice, Catherine M.; Roberts, Robert; Salomaa, Veikko; Sambrook, Jennifer; Schreiber, Stefan; Schunkert, Heribert; Schwartz, Stephen M.; Serbanovic-Canic, Jovana; Sinisalo, Juha; Siscovick, David S.; Stark, Klaus; Surakka, Ida; Stephens, Jonathan; Thompson, John R.; Voelker, Uwe; Voelzke, Henry; Watkins, Nicholas A.; Wells, George A.; Wichmann, H-Erich; Van Heel, David A.; Tyler-Smith, Chris; Thein, Swee Lay; Kathiresan, Sekar; Perola, Markus; Reilly, Muredach P.; Stewart, Alexandre F. R.; Erdmann, Jeanette; Samani, Nilesh J.; Meisinger, Christa; Greinacher, Andreas; Deloukas, Panos; Ouwehand, Willem H.; Gieger, Christian			A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium	NATURE GENETICS			English	Article							MEAN PLATELET VOLUME; MYOCARDIAL-INFARCTION; RISK; VARIANTS; DISEASE; GENE; EXPRESSION; MUTATIONS; PROTEIN; DIFFERENTIATION	The number and volume of cells in the blood affect a wide range of disorders including cancer and cardiovascular, metabolic, infectious and immune conditions. We consider here the genetic variation in eight clinically relevant hematological parameters, including hemoglobin levels, red and white blood cell counts and platelet counts and volume. We describe common variants within 22 genetic loci reproducibly associated with these hematological parameters in 13,943 samples from six European population-based studies, including 6 associated with red blood cell parameters, 15 associated with platelet parameters and 1 associated with total white blood cell count. We further identified a long-range haplotype at 12q24 associated with coronary artery disease and myocardial infarction in 9,479 cases and 10,527 controls. We show that this haplotype demonstrates extensive disease pleiotropy, as it contains known risk loci for type 1 diabetes, hypertension and celiac disease and has been spread by a selective sweep specific to European and geographically nearby populations.	[Soranzo, Nicole; Xue, Yali; Bumpstead, Suzannah; Ghori, Mohammed J. R.; Gwilliam, Rhian; Hammond, Naomi; Potter, Simon C.; Rice, Catherine M.; Tyler-Smith, Chris; Deloukas, Panos; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Hinxton, England; [Soranzo, Nicole; Spector, Tim D.; Mangino, Massimo; Falchi, Mario] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Kuehnel, Brigitte; Doering, Angela; Illig, Thomas; Wichmann, H-Erich; Meisinger, Christa; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Rendon, Augusto; Burns, Philippa; Garner, Stephen F.; Sambrook, Jennifer; Serbanovic-Canic, Jovana; Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Rendon, Augusto; Burns, Philippa; Garner, Stephen F.; Sambrook, Jennifer; Serbanovic-Canic, Jovana; Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Teumer, Alexander; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Willenborg, Christina; Koenig, Inke R.] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Willenborg, Christina; Schunkert, Heribert; Erdmann, Jeanette] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Wright, Benjamin; Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Chen, Li; McPherson, Ruth; Roberts, Robert; Wells, George A.; Stewart, Alexandre F. R.] Univ Ottawa, Inst Heart, John & Jennifer Ruddy Canadian Cardiovasc Genet C, Ottawa, ON, Canada; [Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Salo, Perttu; Peltonen, Leena; Salomaa, Veikko; Perola, Markus] Natl Inst Hlth & Welf, Helsinki, Finland; [Salo, Perttu; Peltonen, Leena; Salomaa, Veikko; Surakka, Ida; Perola, Markus] Univ Helsinki, Inst Mol Med, FIN-00014 Helsinki, Finland; [Voight, Benjamin F.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Voight, Benjamin F.; Altshuler, David] MIT & Harvard, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Laskowski, Roman A.] European Bioinformat Inst, Hinxton, England; [Menzel, Stephan; Thein, Swee Lay] Kings Coll London, Dept Haematol, London WC2R 2LS, England; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Altshuler, David; O'Donnell, Christopher J.; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Bradley, John R.] Univ Cambridge, Sch Clin Med, Dept Med, Addenbrookes Hosp, Cambridge, England; [Burnett, Mary-Susan; Devaney, Joseph; Epstein, Stephen E.] Washington Hosp Ctr, MedStar Res Inst, Cardiovasc Res Inst, Washington, DC 20010 USA; [Elosua, Roberto] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Elosua, Roberto] CIBER Epidemiol & Salud Publ, E-08003 Barcelona, Spain; [Erber, Wendy] Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge, England; [Falchi, Mario] Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London, England; [Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Leicester, Leics, England; [Hakonarson, Hakon H.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hall, Alistair S.] Leeds Gen Infirm, BHF Heart Res Ctr, Leeds, W Yorkshire, England; [Hengstenberg, Christian; Stark, Klaus] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Knouff, Christopher W.; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA USA; [Melander, Olle] Lund Univ, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo Univ Hosp, Malmo, Sweden; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem & Lab Med, Greifswald, Germany; [Nieminen, Markku S.; Sinisalo, Juha] Univ Helsinki, Cent Hosp, Dept Med, Div Cardiol, Helsinki, Finland; [O'Donnell, Christopher J.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [O'Donnell, Christopher J.; Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Prokisch, Holger] Tech Univ Munich, Klinikum Rechts Isar, Dept Human Genet, D-8000 Munich, Germany; [Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Schreiber, Stefan] Univ Kiel, Inst Klin Mol Biol, Kiel, Germany; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Van Heel, David A.] Queen Mary Univ London, Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England; [Greinacher, Andreas] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany	Wellcome Trust Sanger Institute; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cambridge; NHS Blood & Transplant (NHSBT); Ernst Moritz Arndt Universitat Greifswald; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Leicester; University of Ottawa; University of Ottawa Heart Institute; University of Pennsylvania; Finland National Institute for Health & Welfare; University of Helsinki; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; European Molecular Biology Laboratory (EMBL); University of London; King's College London; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MedStar Washington Hospital Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Cambridge; Imperial College London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Leeds General Infirmary; University of Leeds; University of Regensburg; GlaxoSmithKline; Lund University; Skane University Hospital; Ernst Moritz Arndt Universitat Greifswald; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Kiel; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Ernst Moritz Arndt Universitat Greifswald; University of Munich; University of Munich; University of London; Queen Mary University London; Ernst Moritz Arndt Universitat Greifswald	Soranzo, N (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton, England.	ns6@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Wells, George A/M-4549-2017; König, Inke R/A-4544-2009; Stewart, Alexandre F.R./A-5677-2011; Prokisch, Holger/N-8964-2013; Stark, Klaus/L-7367-2013; Altshuler, David M/A-4476-2009; Voight, Benjamin/F-1775-2011; Willenborg, Christina/D-2668-2012; Menzel, Stephan/U-6906-2019; Hengstenberg, Christian/U-5485-2019; Wichmann, Heinz Erich/AAA-5695-2022; Erdmann, Jeanette/A-4417-2009; Spector, Tim D/F-6533-2012; Falchi, Mario/F-5956-2013; Erdmann, Jeanette/P-7513-2014; Erber, Wendy/A-1955-2012; Mangino, Massimo/F-5134-2011; Teumer, Alexander/S-7438-2019; Hall, Alistair/K-1953-2019; Stark, Klaus/D-3813-2009; Meisinger, Christine/B-5358-2014	Deloukas, Panos/0000-0001-9251-070X; Wells, George A/0000-0002-2289-9139; König, Inke R/0000-0003-0504-6465; Stark, Klaus/0000-0002-7832-1942; Altshuler, David M/0000-0002-7250-4107; Willenborg, Christina/0000-0001-5217-6882; Erdmann, Jeanette/0000-0002-4486-6231; Mangino, Massimo/0000-0002-2167-7470; Teumer, Alexander/0000-0002-8309-094X; Stark, Klaus/0000-0002-7832-1942; Surakka, Ida/0000-0002-6669-5541; Perola, Markus/0000-0003-4842-1667; Serbanovic-Canic, Jovana/0000-0002-8835-1491; van Heel, David/0000-0002-0637-2265; Laskowski, Roman/0000-0001-5528-0087; Soranzo, Nicole/0000-0003-1095-3852; Melander, Olle/0000-0002-2581-484X; Rendon, Augusto/0000-0001-8994-0039; Stewart, Alexandre/0000-0003-2673-9164; Falchi, Mario/0000-0002-5646-1004; Menzel, Stephan/0000-0002-1590-9108; Hall, Alistair/0000-0003-0306-7887; Bradley, John/0000-0002-7774-8805; Erber, Wendy/0000-0002-1028-9376; Voight, Benjamin/0000-0002-6205-9994; Meisinger, Christa/0000-0002-9026-6544; Volker, Uwe/0000-0002-5689-3448; Sinisalo, Juha/0000-0002-0169-5137; Reilly, Muredach/0000-0002-3035-9386; Goodall, Alison/0000-0002-7883-9645; Prokisch, Holger/0000-0003-2379-6286; Gieger, Christian/0000-0001-6986-9554	Wellcome Trust [UKBS-CC1]; EU [HEALTH-F2-2008-ENGAGE, QLG2-CT-2002-01254, LSHM-CT-2006-037593]; National Institute for Health Research of England (NIHR) (TwinsUK); Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFN); Munich Center of Health Sciences (MC Health) (KORA); Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Ministry of Cultural Affairs, Social Ministry of the Federal State of Mecklenburg-West Pomerania; Deutsche Forschungsgemeinschaft [SFB TR 19]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania (SHIP); NIHR, CBMRC, NHSBT, (CBR); Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research (BMBF) [NGFN-2]; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; EU-FP6 [LSHM-CT-2004-503485]; Cardiovascular Institute (University of Pennsylvania); GlaxoSmithKline; MedSTAR Research Institute (PennCATH/MedSTAR); US National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (STAMPEED); National Center for Research Resource [U54 RR020278]; Canadian Institutes of Health Research [MOP82810, NA6650, MOP77682]; Canada Foundation for Innovation and Ontario Research Foundation [11966]; Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation (COROGENE); Juvenile Diabetes Research Foundation/Wellcome Trust [T1D]; Medical Research Council [G0000111] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056931] Funding Source: NIH RePORTER; MRC [G0000111] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); National Institute for Health Research of England (NIHR) (TwinsUK)(National Institute for Health Research (NIHR)); Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFN); Munich Center of Health Sciences (MC Health) (KORA); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs, Social Ministry of the Federal State of Mecklenburg-West Pomerania; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania (SHIP); NIHR, CBMRC, NHSBT, (CBR)(National Institute for Health Research (NIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; EU-FP6(European Commission); Cardiovascular Institute (University of Pennsylvania); GlaxoSmithKline(GlaxoSmithKline); MedSTAR Research Institute (PennCATH/MedSTAR); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (STAMPEED)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation and Ontario Research Foundation; Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation (COROGENE)(Sigrid Juselius Foundation); Juvenile Diabetes Research Foundation/Wellcome Trust(Juvenile Diabetes Research FoundationWellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust, EU (HEALTH-F2-2008-ENGAGE, QLG2-CT-2002-01254), National Institute for Health Research of England (NIHR) (TwinsUK); The Wellcome Trust (UKBS-CC1); Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany, the German Federal Ministry of Education and Research (BMBF), the German National Genome Research Network (NGFN), Munich Center of Health Sciences (MC Health) (KORA); Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103 and 01ZZ0403), Ministry of Cultural Affairs, Social Ministry of the Federal State of Mecklenburg-West Pomerania, Deutsche Forschungsgemeinschaft (grant SFB TR 19), the Federal Ministry of Education and Research (grant no. 03ZIK012); a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania (SHIP); NIHR, CBMRC, NHSBT, (CBR); Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research (BMBF) (NGFN-2 and NGFN-plus), EU (LSHM-CT-2006-037593) (GerMIFS I and II); BHF and the UK MRC, the Wellcome Trust, Leicester NIHR Biomedical Research Unit in Cardiovascular Disease and EU-FP6 (LSHM-CT-2004-503485) (WTCCC-CAD); Cardiovascular Institute (University of Pennsylvania), GlaxoSmithKline, MedSTAR Research Institute (PennCATH/MedSTAR); US National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute (STAMPEED), National Center for Research Resource (U54 RR020278) (MIGen); Canadian Institutes of Health Research (MOP82810, NA6650 and MOP77682), Canada Foundation for Innovation and Ontario Research Foundation (# 11966) (OHGS); Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation (COROGENE); Juvenile Diabetes Research Foundation/Wellcome Trust (T1D).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Boos CJ, 2007, THROMB RES, V120, P11, DOI 10.1016/j.thromres.2006.09.002; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; ENSRUD K, 1992, AM HEART J, V124, P207, DOI 10.1016/0002-8703(92)90942-O; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Fay JC, 2000, GENETICS, V155, P1405; Fukuda MN, 2008, CELL MOL LIFE SCI, V65, P92, DOI 10.1007/s00018-007-7302-9; Garner C, 2000, BLOOD, V95, P342; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hoffman M, 2004, ATHEROSCLEROSIS, V172, P1, DOI 10.1016/S0021-9150(03)00164-3; HOLLARD D, 1975, SEM HOP PARIS, V51, P643; Huczek Z, 2005, J AM COLL CARDIOL, V46, P284, DOI 10.1016/j.jacc.2005.03.065; HUGUES L, 2005, HAEMATOLOGICA, V90, P853; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Kitajima K, 2001, EXP HEMATOL, V29, P507, DOI 10.1016/S0301-472X(00)00686-X; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Merched AJ, 2004, CIRCULATION, V110, P3830, DOI 10.1161/01.CIR.0000148681.01282.89; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Sun L, 2007, J THROMB HAEMOST, V5, P146, DOI 10.1111/j.1538-7836.2006.02271.x; Takizawa H, 2008, EXP HEMATOL, V36, P897, DOI 10.1016/j.exphem.2008.02.004; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wallace DF, 2007, WORLD J GASTROENTERO, V13, P4690, DOI 10.3748/wjg.v13.i35.4690; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wickrema A, 2007, ONCOGENE, V26, P6803, DOI 10.1038/sj.onc.1210763; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004; Yang A, 2006, THROMB RES, V117, P371, DOI 10.1016/j.thromres.2005.04.004	52	411	425	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1182	U38		10.1038/ng.467	http://dx.doi.org/10.1038/ng.467			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19820697	Green Accepted			2022-12-17	WOS:000271247600010
J	Sahoo, T; del Gaudio, D; German, JR; Shinawi, M; Peters, SU; Person, RE; Garnica, A; Cheung, SW; Beaudet, AL				Sahoo, Trilochan; del Gaudio, Daniela; German, Jennifer R.; Shinawi, Marwan; Peters, Sarika U.; Person, Richard E.; Garnica, Adolfo; Cheung, Sau Wai; Beaudet, Arthur L.			Prader-Willi phenotype caused by paternal deficiency for the HBII-85C/D box small nucleolar RNA cluster	NATURE GENETICS			English	Article							TRANSLOCATION BREAKPOINT; SNRPN; GENE; EXCLUSION; DELETION; HBII-52; REGION; UBE3A	Prader-Willi syndrome (PWS) is caused by deficiency for one or more paternally expressed imprinted transcripts within chromosome 15q11-q13, including SNURF-SNRPN and multiple small nucleolar RNAs (snoRNAs). Balanced chromosomal translocations that preserve expression of SNURF-SNRPN and centromeric genes but separate the snoRNA HBII-85 cluster from its promoter cause PWS. A microdeletion of the HBII-85 snoRNAs in a child with PWS provides, in combination with previous data, effectively conclusive evidence that deficiency of HBII-85 snoRNAs causes the key characteristics of the PWS phenotype, although some atypical features suggest that other genes in the region may make more subtle phenotypic contributions.	[Sahoo, Trilochan; del Gaudio, Daniela; German, Jennifer R.; Shinawi, Marwan; Peters, Sarika U.; Person, Richard E.; Cheung, Sau Wai; Beaudet, Arthur L.] Baylor Coll Med, Houston, TX 77030 USA; [Garnica, Adolfo] St Francis Hosp, Tulsa, OK 74136 USA	Baylor College of Medicine; St. Francis Hospital - Oklahoma	Beaudet, AL (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	abeaudet@bcm.edu		shinawi, Marwan/0000-0003-1329-4100	NCRR NIH HHS [M01 RR000188, M01 RR000188-447797, M01-RR00188, U54 RR019478, U54 RR019478-05S16956, RR-019478] Funding Source: Medline; NICHD NIH HHS [R01 HD037283-10, HD-024064, R01 HD037283, HD-037283, P30 HD024064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283, P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019478, M01RR000188] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Burger J, 2002, AM J MED GENET, V111, P233, DOI 10.1002/ajmg.10498; Conroy JM, 1997, AM J HUM GENET, V61, P388, DOI 10.1086/514852; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kuslich CD, 1999, AM J HUM GENET, V64, P70, DOI 10.1086/302177; Runte M, 2005, HUM GENET, V116, P228, DOI 10.1007/s00439-004-1219-2; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Schule B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-18; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; Wirth J, 2001, HUM MOL GENET, V10, P201, DOI 10.1093/hmg/10.3.201	15	411	428	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					719	721		10.1038/ng.158	http://dx.doi.org/10.1038/ng.158			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18500341	Green Accepted			2022-12-17	WOS:000256212000013
J	Romeo, S; Pennacchio, LA; Fu, YX; Boerwinkle, E; Tybjaerg-Hansen, A; Hobbs, HH; Cohen, JC				Romeo, Stefano; Pennacchio, Len A.; Fu, Yunxin; Boerwinkle, Eric; Tybjaerg-Hansen, Anne; Hobbs, Helen H.; Cohen, Jonathan C.			Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL	NATURE GENETICS			English	Article							ANGIOPOIETIN-LIKE PROTEIN-4; HEPATIC STEATOSIS; LIPOPROTEIN; OVEREXPRESSION; HYPERLIPIDEMIA; GENETICS	Resequencing genes provides the opportunity to assess the full spectrum of variants that influence complex traits. Here we report the first application of resequencing to a large population (n = 3,551) to examine the role of the adipokine ANGPTL4 in lipid metabolism. Nonsynonymous variants in ANGPTL4 were more prevalent in individuals with triglyceride levels in the lowest quartile than in individuals with levels in the highest quartile (P = 0.016). One variant (E40K), present in similar to 3% of European Americans, was associated with significantly lower plasma levels of triglyceride and higher levels of highdensity lipoprotein cholesterol in European Americans from the Atherosclerosis Risk in Communities Study and in Danes from the Copenhagen City Heart Study. The ratio of nonsynonymous to synonymous variants was higher in European Americans than in African Americans (4:1 versus 1.3:1), suggesting population- specific relaxation of purifying selection. Thus, resequencing of ANGPTL4 in a multiethnic population allowed analysis of the phenotypic effects of both rare and common variants while taking advantage of genetic variation arising from ethnic differences in population history.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; Univ Texas, SW Med Ctr, Howard Hughes Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Rigshospitalet; University of Copenhagen; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu; jonathan.cohen@utsouthwestern.edu	Romeo, Stefano/L-6861-2015	Romeo, Stefano/0000-0001-9168-4898; Pennacchio, Len/0000-0002-8748-3732	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681, RL1HL092550] Funding Source: NIH RePORTER; NHLBI NIH HHS [RL1 HL092550-02, RL1 HL092550, HL066681, U01 HL066681] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; FU YX, 1993, GENETICS, V133, P693; Gibbs R, 2005, NATURE, V437, P1233, DOI 10.1038/4371233a; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Rondinone CM, 2006, ENDOCRINE, V29, P81, DOI 10.1385/ENDO:29:1:81; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; TAJIMA F, 1989, GENETICS, V123, P585; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102	21	411	421	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					513	516		10.1038/ng1984	http://dx.doi.org/10.1038/ng1984			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322881	Green Accepted			2022-12-17	WOS:000245271200021
J	Pinkel, D; Albertson, DG				Pinkel, D; Albertson, DG			Array comparative genomic hybridization and its applications in cancer	NATURE GENETICS			English	Article							DNA COPY-NUMBER; MICROARRAY ANALYSIS; IN-SITU; BREAST-CANCER; SEGMENTAL DUPLICATIONS; PCR AMPLIFICATION; CGH; RESOLUTION; GENE; TUMOR	Alteration in DNA copy number is one of the many ways in which gene expression and function may be modified. Some variations are found among normal individuals, others occur in the course of normal processes in some species and still others participate in causing various disease states. For example, many defects in human development are due to gains and losses of chromosomes and chromosomal segments that occur before or shortly after fertilization, and DNA dosage-alteration changes occurring in somatic cells are frequent contributors to cancer. Detecting these aberrations and interpreting them in the context of broader knowledge facilitates the identification of crucial genes and pathways involved in biological processes and disease. Over the past several years, array comparative genomic hybridization has proven its value for analyzing DNA copy-number variations. Here, we discuss the state of the art of array comparative genomic hybridization and its applications in cancer, emphasizing general concepts rather than specific results.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Pinkel, D (corresponding author), Univ Calif San Francisco, Dept Lab Med, Box 0808, San Francisco, CA 94143 USA.	pinkel@cc.ucsf.edu; albertson@cc.ucsf.edu						Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Albertson DG, 2003, BREAST CANCER RES TR, V78, P289, DOI 10.1023/A:1023025506386; Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; BOCKER T, 1999, BIOCHIM BIOPHYS ACTA, V1423, P1; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Callagy G, 2005, J PATHOL, V205, P388, DOI 10.1002/path.1694; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; Daigo Y, 2001, AM J PATHOL, V158, P1623, DOI 10.1016/S0002-9440(10)64118-1; Daruwala RS, 2004, P NATL ACAD SCI USA, V101, P16292, DOI 10.1073/pnas.0407247101; DeVries S, 2005, J MOL DIAGN, V7, P65, DOI 10.1016/S1525-1578(10)60010-4; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; DUMANOIR S, 1993, HUM GENET, V90, P590, DOI 10.1007/BF00202476; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Esteller M, 2000, EUR J CANCER, V36, P2294, DOI 10.1016/S0959-8049(00)00303-8; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Fukiya S, 2004, J BACTERIOL, V186, P3911, DOI 10.1128/JB.186.12.3911-3921.2004; Guillaud-Bataille M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh108; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Hyman E, 2002, CANCER RES, V62, P6240; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Karhu R, 1999, GENE CHROMOSOME CANC, V24, P112, DOI 10.1002/(SICI)1098-2264(199902)24:2<112::AID-GCC3>3.0.CO;2-U; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Liu DX, 2004, DIAGN MOL PATHOL, V13, P105, DOI 10.1097/00019606-200406000-00007; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Lucito R, 2000, GENOME RES, V10, P1726, DOI 10.1101/gr.138300; Lupski JR, 1996, AM J HUM GENET, V58, P21; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mantripragada KK, 2004, INT J MOL MED, V13, P273; Martinez-Climent JA, 2003, BLOOD, V101, P3109, DOI 10.1182/blood-2002-07-2119; Mohapatra G, 1997, GENE CHROMOSOME CANC, V20, P311, DOI 10.1002/(SICI)1098-2264(199712)20:4<311::AID-GCC1>3.0.CO;2-4; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; PINKEL D, IN PRESS ANN REV GEN; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; RUBIOMOSCARDO F, 2005, BLOOD           0217, DOI DOI 10.1182/BLOOD-2004-10-3907; Schwaenen C, 2004, P NATL ACAD SCI USA, V101, P1039, DOI 10.1073/pnas.0304717101; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Smirnov DA, 2004, GENE CHROMOSOME CANC, V40, P72, DOI 10.1002/gcc.20015; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SNIJDERS AM, 2005, ONCOGENE        0411, DOI DOI 10.1038/SJ.ONC.1208601; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Tanabe C, 2003, GENE CHROMOSOME CANC, V38, P168, DOI 10.1002/gcc.10269; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; Waldman FM, 2000, JNCI-J NATL CANCER I, V92, P313, DOI 10.1093/jnci/92.4.313; Wang G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh070; Wang G, 2004, GENOME RES, V14, P2357, DOI 10.1101/gr.2813404; Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668; Wang P, 2005, BIOSTATISTICS, V6, P45, DOI 10.1093/biostatistics/kxh017; Watanabe T, 2004, YEAST, V21, P351, DOI 10.1002/yea.1103; Weiss MM, 2004, CELL ONCOL, V26, P307; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhou XF, 2004, HUM GENET, V115, P327, DOI 10.1007/s00439-004-1163-1	75	411	447	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S11	S17		10.1038/ng1569	http://dx.doi.org/10.1038/ng1569			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920524	Bronze			2022-12-17	WOS:000229590000004
J	Bond, J; Roberts, E; Springell, K; Lizarraga, S; Scott, S; Higgins, J; Hampshire, DJ; Morrison, EE; Leal, GF; Silva, EO; Costa, SMR; Baralle, D; Raponi, M; Karbani, G; Rashid, Y; Jafri, H; Bennett, C; Corry, P; Walsh, CA; Woods, CG				Bond, J; Roberts, E; Springell, K; Lizarraga, S; Scott, S; Higgins, J; Hampshire, DJ; Morrison, EE; Leal, GF; Silva, EO; Costa, SMR; Baralle, D; Raponi, M; Karbani, G; Rashid, Y; Jafri, H; Bennett, C; Corry, P; Walsh, CA; Woods, CG			A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size	NATURE GENETICS			English	Article							MICROCEPHALIN; MUTATIONS; LOCUS; ASPM; IDENTIFICATION; MAPS	Autosomal recessive primary microcephaly is a potential model in which to research genes involved in human brain growth. We show that two forms of the disorder result from homozygous mutations in the genes CDK5RAP2 and CENPJ. We found neuroepithelial expression of the genes during prenatal neurogenesis and protein localization to the spindle poles of mitotic cells, suggesting that a centrosomal mechanism controls neuron number in the developing mammalian brain.	Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, CIMR, Cambridge CB2 2BP, England; Univ Leeds, St James Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr,Harvard Inst Med, Boston, MA 02115 USA; St James Univ Hosp, Canc Res UK Ctr Leeds, Div Canc Med Res, Leeds LS9 7TF, W Yorkshire, England; Inst Maternoinfantil Pernambuco, Recife, PE, Brazil; Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Lady Wellington Hosp, Dept Obstet & Gynaecol, Lahore, Pakistan; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Saint James's University Hospital; University of Leeds; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cancer Research UK; Saint James's University Hospital; Universidade Federal de Pernambuco; Saint James's University Hospital	Woods, CG (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, CIMR, Cambridge CB2 2BP, England.	cw347@cam.ac.uk	woods, christopher g/A-1361-2010; Hampshire, Daniel/Q-3540-2019; raponi, michela/E-3500-2014	raponi, michela/0000-0001-7570-828X; Baralle, Diana/0000-0003-3217-4833				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kumar A, 2004, CLIN GENET, V66, P341, DOI 10.1111/j.1399-0004.2004.00304.x; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200	15	411	419	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					353	355		10.1038/ng1539	http://dx.doi.org/10.1038/ng1539			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15793586				2022-12-17	WOS:000228040000017
J	Nagaki, K; Cheng, ZK; Ouyang, S; Talbert, PB; Kim, M; Jones, KM; Henikoff, S; Buell, CR; Jiang, JM				Nagaki, K; Cheng, ZK; Ouyang, S; Talbert, PB; Kim, M; Jones, KM; Henikoff, S; Buell, CR; Jiang, JM			Sequencing of a rice centromere uncovers active genes	NATURE GENETICS			English	Article							CENP-A; CHROMATIN IMMUNOPRECIPITATION; TRANSPOSABLE ELEMENT; SATELLITE REPEAT; DNA ELEMENT; ORGANIZATION; NEOCENTROMERE; KINETOCHORE; REGIONS; COMPLEX	Centromeres are the last frontiers of complex eukaryotic genomes, consisting of highly repetitive sequences that resist mapping, cloning and sequencing. The centromere of rice Chromosome 8 (Cen8) has an unusually low abundance of highly repetitive satellite DNA, which allowed us to determine its sequence. A region of similar to750 kb in Cen8 binds rice CENH3, the centromere-specific H3 histone. CENH3 binding is contained within a larger region that has abundant dimethylation of histone H3 at Lys9 (H3-Lys9), consistent with Cen8 being embedded in heterochromatin. Fourteen predicted and at least four active genes are interspersed in Cen8, along with CENH3 binding sites. The retrotransposons located in and outside of the CENH3 binding domain have similar ages and structural dynamics. These results suggest that Cen8 may represent an intermediate stage in the evolution of centromeres from genic regions, as in human neocentromeres, to fully mature centromeres that accumulate megabases of homogeneous satellite arrays.	Inst Genom Res, Rockville, MD 20850 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	J. Craig Venter Institute; University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Buell, CR (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	rbuell@tigr.org; jjiang1@wisc.edu	Nagaki, Kiyotaka/B-2519-2011; Jiang, Jiming/V-6060-2019; Jiang, Jiming/A-9614-2009	Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Buell, C Robin/0000-0002-6727-4677; Henikoff, Steven/0000-0002-7621-8685				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Cheng ZK, 2001, CHROMOSOMA, V110, P24, DOI 10.1007/s004120000126; CHLEBOWICZSLEDZIEWSKA E, 1985, GENE, V39, P25, DOI 10.1016/0378-1119(85)90103-9; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; DEVLIN RH, 1990, GENETICS, V125, P129; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Hosouchi T, 2002, DNA RES, V9, P117, DOI 10.1093/dnares/9.4.117; Hudakova S, 2001, NUCLEIC ACIDS RES, V29, P5029, DOI 10.1093/nar/29.24.5029; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Kaszas E, 1998, GENETICS, V150, P1683; Kniola B, 2001, MOL BIOL CELL, V12, P2767, DOI 10.1091/mbc.12.9.2767; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; LOHE AR, 1995, CURR OPIN GENET DEV, V5, P746, DOI 10.1016/0959-437X(95)80007-R; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Motohashi R, 1996, MOL GEN GENET, V250, P148, DOI 10.1007/BF02174173; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2003, GENETICS, V163, P759; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Saffery R, 2003, MOL CELL, V12, P509, DOI 10.1016/S1097-2765(03)00279-X; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Satinover DL, 2001, CHROMOSOMA, V110, P275, DOI 10.1007/s004120100143; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Sutton G.G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; TALBERT PB, 2000, ANN DROS RES C, V41, pC247; Tolchkov EV, 2000, GENETICS, V154, P1611; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Vafa O, 1999, CHROMOSOMA, V108, P367, DOI 10.1007/s004120050388; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Wong LH, 2001, GENOME RES, V11, P513, DOI 10.1101/gr.183901; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yu HG, 1997, J CELL BIOL, V139, P831, DOI 10.1083/jcb.139.4.831; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	50	411	455	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					138	145		10.1038/ng1289	http://dx.doi.org/10.1038/ng1289			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14716315	Bronze			2022-12-17	WOS:000188542700014
J	Nezu, JI; Tamai, I; Oku, A; Ohashi, R; Yabuuchi, H; Hashimoto, N; Nikaido, H; Sai, A; Koizumi, K; Shoji, Y; Takada, G; Matsuishi, T; Yoshino, M; Kato, H; Ohura, T; Tsujimoto, G; Hayakawa, J; Shimane, M; Tsuji, A				Nezu, JI; Tamai, I; Oku, A; Ohashi, R; Yabuuchi, H; Hashimoto, N; Nikaido, H; Sai, A; Koizumi, K; Shoji, Y; Takada, G; Matsuishi, T; Yoshino, M; Kato, H; Ohura, T; Tsujimoto, G; Hayakawa, J; Shimane, M; Tsuji, A			Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter	NATURE GENETICS			English	Article							CARDIOMYOPATHY; CHROMOSOME-11	Primary systemic carnitine deficiency (SCD; OMIM 212140) is an autosomal recessive disorder characterized by progressive cardiomyopathy, skeletal myopathy, hypoglycaemia and hyperammonaemia(1-3), SCD has also been linked to sudden infant death syndrome(4). Membrane-physiological studies have suggested a defect of the carnitine transport system in the plasma membrane in SCD patients(5) and in the mouse model, juvenile visceral steatosis (jvs; ref, 6), Although the responsible loci have been mapped in both human(7) and mouse(8), the underlying gene has not yet been identified. Recently, we cloned and analysed the function of a novel transporter protein termed OCTN2 (ref, 9). Our observation that OCTN2 has the ability to transport carnitine in a sodium-dependent manner prompted us to search for mutations in the gene encoding OCTN2. SLC22A5. initially we analysed the mouse gene and found a missense mutation in Slc22a5 in jvs mice. Biochemical analysis revealed that this mutation abrogates carnitine transport, Subsequent analysis of the human gene identified four mutations in three SCD pedigrees. Affected individuals in one family were homozygous for the deletion of a 113-bp region containing the start codon. In the second pedigree, the affected individual was shown to be a compound heterozygote for two mutations that cause a frameshift and a premature stop codon, respectively. In an affected individual belonging to a third family, we found a homozygous splice-site mutation also resulting in a premature stop codon, These mutations provide the first evidence that loss of OCTN2 function causes SCD.	Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan; Kanazawa Univ, Fac Med, Inst Expt Anim, Kanazawa, Ishikawa 9208640, Japan; Akita Univ, Sch Med, Dept Hyg, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Pediat, Akita 0108543, Japan; Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan; Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9808575, Japan; Natl Childrens Med Res Ctr, Dept Mol Cell Pharmacol, Setagaya Ku, Tokyo 1548509, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Chugai Res Inst Mol Med, Ibaraki, Osaka 3004101, Japan	Kanazawa University; Kanazawa University; Akita University; Akita University; Kurume University; Tohoku University; National Center for Child Health & Development - Japan; Japan Science & Technology Agency (JST)	Tsuji, A (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.	tsuji@kenroku.ipc.kanazawa-u.ac.jp	TAMAI, Ikumi/D-8412-2015	Yoshino, Makoto/0000-0001-9048-1490				BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; CHAPOY PR, 1980, NEW ENGL J MED, V303, P1389, DOI 10.1056/NEJM198012113032403; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Hashimoto N, 1998, BIOCHEM PHARMACOL, V55, P1729, DOI 10.1016/S0006-2952(97)00670-9; HORIUCHI M, 1994, BBA-MOL BASIS DIS, V1226, P25, DOI 10.1016/0925-4439(94)90054-X; KARPATI G, 1975, NEUROLOGY, V25, P16, DOI 10.1212/WNL.25.1.16; KOIZUMI T, 1988, LAB ANIM, V22, P83, DOI 10.1258/002367788780746511; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; MATSUISHI T, 1985, NEUROPEDIATRICS, V16, P6, DOI 10.1055/s-2008-1052536; NIKAIDO H, 1995, MAMM GENOME, V6, P369, DOI 10.1007/BF00364804; Okita K, 1996, GENOMICS, V33, P289, DOI 10.1006/geno.1996.0194; Rinaldo P, 1997, J PEDIATR-US, V131, P304, DOI 10.1016/S0022-3476(97)70171-9; Roe CR, 1995, METABOLIC MOL BASES, P1508; Shoji Y, 1998, AM J HUM GENET, V63, P101, DOI 10.1086/301911; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020; TREEM WR, 1988, NEW ENGL J MED, V319, P1331, DOI 10.1056/NEJM198811173192006; TRIPP ME, 1981, NEW ENGL J MED, V305, P385, DOI 10.1056/NEJM198108133050707; WABER LJ, 1982, J PEDIATR-US, V101, P700, DOI 10.1016/S0022-3476(82)80294-1; Walter JH, 1996, ARCH DIS CHILD, V74, P475, DOI 10.1136/adc.74.6.475	21	411	432	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					91	94		10.1038/5030	http://dx.doi.org/10.1038/5030			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	9916797				2022-12-17	WOS:000077960700015
J	Motoyama, J; Liu, J; Mo, R; Ding, Q; Post, M; Hui, CC				Motoyama, J; Liu, J; Mo, R; Ding, Q; Post, M; Hui, CC			Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus	NATURE GENETICS			English	Article							PALLISTER-HALL SYNDROME; SONIC-HEDGEHOG; PATCHED GENE; MOUSE; MORPHOGENESIS; INVOLVEMENT; EXPRESSION; INDUCTION; POLARITY; MESODERM	Foregut malformations (oesophageal atresia. tracheo-oesophageal fistula, lung anomalies and congenital stenosis of the oesophagus and trachea) are relatively common anomalies occurring in 1 in 2,000-5,000 live births, although their aetiology is poorly understood(1). The secreted glycoprotein Sonic hedgehog (Shh) has been suggested to act as an endodermal signal that controls hindgut patterning(2) and lung growth(3). In mice, three zinc-finger transcription factors, Gli1, Gli2 and Gli3, have been implicated in the transduction of Shh signal(4-10). We report here that mutant mice lacking Gli2 function exhibit Foregut defects, including stenosis of the oesophagus and trachea, as well as hypoplasia and lobulation defects of the lung. A reduction of 50% in the gene dosage of Gli3 in a Gli2(-/-) background resulted in oesophageal atresia with tracheo-oesophageal fistula and a severe lung phenotype. Mutant mice lacking both Gli2 and Gli3 function did not form oesophagus, trachea and lung. These results indicate that Gli2 and Gli3 possess specific and overlapping functions in Shh signalling during foregut development, and suggest that mutations in GLI genes may be involved in human foregut malformations.	Hosp Sick Children, Res Inst, Programs Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Program Lung Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Program Canc & Blood, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Physiol, Toronto, ON, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Hui, CC (corresponding author), Hosp Sick Children, Res Inst, Programs Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cchui@sickkids.on.ca						Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Ding Q, 1998, DEVELOPMENT, V125, P2533; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; Mo R, 1997, DEVELOPMENT, V124, P113; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Skandalakis JE., 1994, EMBRYOLOGY SURG; SPOONER BS, 1970, J EXP ZOOL, V175, P445, DOI 10.1002/jez.1401750404; Takabatake T, 1997, FEBS LETT, V410, P485, DOI 10.1016/S0014-5793(97)00645-5; VERLOES A, 1995, J MED GENET, V32, P605, DOI 10.1136/jmg.32.8.605; WESSELLS NK, 1970, J EXP ZOOL, V175, P455, DOI 10.1002/jez.1401750405	27	411	430	2	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					54	57		10.1038/1711	http://dx.doi.org/10.1038/1711			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731531				2022-12-17	WOS:000075671400019
J	Pendas, AM; Zhou, ZJ; Cadinanos, J; Freije, JMP; Wang, JM; Hultenby, K; Astudillo, A; Wernerson, A; Rodriguez, F; Tryggvason, K; Lopez-Otin, C				Pendas, AM; Zhou, ZJ; Cadinanos, J; Freije, JMP; Wang, JM; Hultenby, K; Astudillo, A; Wernerson, A; Rodriguez, F; Tryggvason, K; Lopez-Otin, C			Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice	NATURE GENETICS			English	Article							ENCODING LAMIN A/C; NUCLEAR LAMINA; DYSTROPHY; MATURATION; PROTEINS; DISEASE; PROTEOLYSIS; MUTATIONS; HEART; GENE	The mouse ortholog of human FACE-1, Zmpste24, is a multi-spanning membrane protein widely distributed in mammalian tissues(1,2) and structurally related to Afc1p/ste24p, a yeast metalloproteinase involved in the maturation of fungal pheromones(3). Disruption of the gene Zmpste24 caused severe growth retardation and premature death in homozygous-null mice. Histopathological analysis of the mutant mice revealed several abnormalities, including dilated cardiomyopathy, muscular dystrophy and lipodystrophy. These alterations are similar to those developed by mice deficient in A-type lamin(4), a major component of the nuclear lamina(5), and phenocopy most defects observed in humans with diverse congenital laminopathies(6-8). In agreement with this finding, Zmpste24-null mice are defective in the proteolytic processing of prelamin A. This deficiency in prelamin A maturation leads to the generation of abnormalities in nuclear architecture that probably underlie the many phenotypes observed in both mice and humans with mutations in the lamin A gene. These results indicate that prelamin A is a specific substrate for Zmpste24 and demonstrate the usefulness of genetic approaches for identifying the in vivo substrates of proteolytic enzymes.	Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Pathol, S-14186 Huddinge, Sweden; Univ Oviedo, Hosp Cent Asturias, Serv Anat Patol, E-33080 Oviedo, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Karolinska Institutet; Karolinska Institutet; Central University Hospital Asturias; University of Oviedo	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.		López-Otín, Carlos/AAB-2106-2020; zhou, zhongjun/D-4818-2012; Freije, José M.P./A-6535-2008; Pendas, Alberto M/L-1017-2014; Zhou, Zhongjun/C-4476-2009	López-Otín, Carlos/0000-0001-6964-1904; Freije, José M.P./0000-0002-4688-8266; Wernerson, Annika/0000-0003-2792-0010; Pendas, Alberto M/0000-0001-9264-3721; Cadinanos, Juan/0000-0001-7561-7759; Zhou, Zhongjun/0000-0001-7092-8128; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809				Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Freije JMP, 1999, GENOMICS, V58, P270, DOI 10.1006/geno.1999.5834; HOGAN B, 1994, MANIPULATING MOUSE E; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; Manilal S, 1999, HUM MOL GENET, V8, P353, DOI 10.1093/hmg/8.2.353; Morris GE, 1999, HUM MOL GENET, V8, P1847, DOI 10.1093/hmg/8.10.1847; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; SINENSKY M, 1994, J CELL SCI, V107, P61; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	18	410	435	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					94	99		10.1038/ng871	http://dx.doi.org/10.1038/ng871			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11923874	Bronze			2022-12-17	WOS:000175362500022
J	Kurotaki, N; Imaizumi, K; Harada, N; Masuno, M; Kondoh, T; Nagai, T; Ohashi, H; Naritomi, K; Tsukahara, M; Makita, Y; Sugimoto, T; Sonoda, T; Hasegawa, T; Chinen, Y; Tomita, H; Kinoshita, A; Mizuguchi, T; Yoshiura, K; Ohta, T; Kishino, T; Fukushima, Y; Niikawa, N; Matsumoto, N				Kurotaki, N; Imaizumi, K; Harada, N; Masuno, M; Kondoh, T; Nagai, T; Ohashi, H; Naritomi, K; Tsukahara, M; Makita, Y; Sugimoto, T; Sonoda, T; Hasegawa, T; Chinen, Y; Tomita, H; Kinoshita, A; Mizuguchi, T; Yoshiura, K; Ohta, T; Kishino, T; Fukushima, Y; Niikawa, N; Matsumoto, N			Haploinsufficiency of NSD1 causes Sotos syndrome	NATURE GENETICS			English	Article							CEREBRAL GIGANTISM; CHROMATIN; DOMAINS; PROTEIN	We isolated NSD1 from the 5q35 breakpoint in an individual with Sotos syndrome harboring a chromosomal translocation. We identified 1 nonsense, 3 frameshift and 20 submicroscopic deletion mutations of NSD1 among 42 individuals with sporadic cases of Sotos syndrome. The results indicate that haploinsufficiency of NSD1 is the major cause of Sotos syndrome.	Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; Kyushu Med Sci Nagasaki Lab, Nagasaki, Japan; Nagasaki Univ, Sch Med, Dept Pediat, Nagasaki 852, Japan; Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Pediat, Koshigaya, Japan; Saitama Childrens Med Ctr, Div Med Genet, Kawagoe, Saitama, Japan; Univ Ryukyus, Sch Med, Dept Med Genet, Okinawa, Japan; Yamaguchi Univ, Sch Med, Fac Hlth Sci, Ube, Yamaguchi 755, Japan; Asahikawa Med Coll, Dept Publ Hlth, Asahikawa, Hokkaido 078, Japan; Kansai Med Univ, Otokoyama Hosp, Dept Pediat, Yawata, Japan; Miyazaki Med Coll, Dept Pediat, Miyazaki 88916, Japan; Shizuoka Childrens Med Ctr, Div Clin Genet & Cytogenet, Shizuoka, Japan; Univ Ryukyus, Sch Med, Dept Pediat, Okinawa, Japan; Nagasaki Univ, Ctr Gene Res, Nagasaki 852, Japan; Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Matsumoto, Nagano 390, Japan	Nagasaki University; Japan Science & Technology Agency (JST); Nagasaki University; Dokkyo Medical University; Saitama Children's Medical Center; University of the Ryukyus; Yamaguchi University; Asahikawa Medical College; Kansai Medical University; University of Miyazaki; University of the Ryukyus; Nagasaki University; Shinshu University	Matsumoto, N (corresponding author), Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan.			Tomita, Hiroaki/0000-0003-2628-880X				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; BALE AE, 1985, AM J MED GENET, V20, P613, DOI 10.1002/ajmg.1320200407; BOMAN H, 1980, CLIN GENET, V18, P421; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Imaizumi K, 2002, AM J MED GENET, V107, P58, DOI 10.1002/ajmg.10080; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kurotaki N, 2001, GENE, V279, P197, DOI 10.1016/S0378-1119(01)00750-8; Opitz JM, 1998, AM J MED GENET, V79, P294, DOI 10.1002/(SICI)1096-8628(19981002)79:4<294::AID-AJMG12>3.0.CO;2-M; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; TOWNES PL, 1976, J MED GENET, V13, P80, DOI 10.1136/jmg.13.1.80	10	410	425	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					365	366		10.1038/ng863	http://dx.doi.org/10.1038/ng863			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11896389				2022-12-17	WOS:000174682000012
J	Cohen, BA; Mitra, RD; Hughes, JD; Church, GM				Cohen, BA; Mitra, RD; Hughes, JD; Church, GM			A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; PROMOTER REGION; YEAST; TRANSCRIPTION; SEQUENCES; LOCATION; START	Chromosome correlation maps display correlations between the expression patterns of genes on the same chromosome. Using these maps, we show here that adjacent pairs of genes, as well as nearby non-adjacent pairs of genes, show correlated expression independent of their orientation. We present specific examples of adjacent pairs with highly correlated expression patterns, in which the promoter of only one of the two genes contains an upstream activating sequence (UAS) known to be associated with that expression pattern. Finally, we show that genes with similar functions tend to occur in adjacent positions along the chromosomes. Our results suggest that, in certain chromosomal expression domains, an UAS can affect the transcription of genes that are not immediately downstream from it.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			Mitra, Robi/0000-0002-2680-4264; church, george/0000-0001-6232-9969				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; KRAAKMAN LS, 1989, NUCLEIC ACIDS RES, V17, P9693, DOI 10.1093/nar/17.23.9693; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Moore D., 1998, INTRO PRACTICE STAT; NAKAO J, 1986, MOL CELL BIOL, V6, P2613, DOI 10.1128/MCB.6.7.2613; NASMYTH K, 1985, CELL, V42, P225, DOI 10.1016/S0092-8674(85)80118-5; OSLEY MA, 1986, CELL, V45, P537, DOI 10.1016/0092-8674(86)90285-0; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	17	410	426	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					183	186		10.1038/79896	http://dx.doi.org/10.1038/79896			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017073				2022-12-17	WOS:000089638800014
J	Sanna, S; van Zuydam, NR; Mahajan, A; Kurilshikov, A; Vila, AV; Vosa, U; Mujagic, Z; Masclee, AAM; Jonkers, DMAE; Oosting, M; Joosten, LAB; Netea, MG; Franke, L; Zhernakova, A; Fu, JY; Wijmenga, C; McCarthy, MI				Sanna, Serena; van Zuydam, Natalie R.; Mahajan, Anubha; Kurilshikov, Alexander; Vila, Arnau Vich; Vosa, Urmo; Mujagic, Zlatan; Masclee, Ad A. M.; Jonkers, Daisy M. A. E.; Oosting, Marge; Joosten, Leo A. B.; Netea, Mihai G.; Franke, Lude; Zhernakova, Alexandra; Fu, Jingyuan; Wijmenga, Cisca; McCarthy, Mark, I			Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; GENETIC-VARIANTS; CYTOKINE PRODUCTION; COMMON VARIANTS; HOST GENETICS; BUTYRATE; GLUCOSE; MODEL; PROPIONATE	Microbiome-wide association studies on large population cohorts have highlighted associations between the gut microbiome and complex traits, including type 2 diabetes (T2D) and obesity(1). However, the causal relationships remain largely unresolved. We leveraged information from 952 normoglycemic individuals for whom genome-wide genotyping, gut metagenomic sequence and fecal short-chain fatty acid (SCFA) levels were available(2), then combined this information with genome-wide-association summary statistics for 17 metabolic and anthropometric traits. Using bidirectional Mendelian randomization (MR) analyses to assess causality(3), we found that the host-genetic-driven increase in gut production of the SCFA butyrate was associated with improved insulin response after an oral glucose-tolerance test (P = 9.8 x 10(-5)), whereas abnormalities in the production or absorption of another SCFA, propionate, were causally related to an increased risk of T2D (P = 0.004). These data provide evidence of a causal effect of the gut microbiome on metabolic traits and support the use of MR as a means to elucidate causal relationships from microbiome-wide association findings.	[Sanna, Serena; Kurilshikov, Alexander; Vila, Arnau Vich; Vosa, Urmo; Franke, Lude; Zhernakova, Alexandra; Fu, Jingyuan; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van Zuydam, Natalie R.; Mahajan, Anubha; McCarthy, Mark, I] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [van Zuydam, Natalie R.; Mahajan, Anubha; McCarthy, Mark, I] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Vila, Arnau Vich] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Mujagic, Zlatan; Masclee, Ad A. M.; Jonkers, Daisy M. A. E.] Maastricht Univ, Med Ctr, Div Gastroenterol Hepatol, NUTR Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Oosting, Marge; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, RIMLS, Dept Internal Med, Nijmegen, Netherlands; [Oosting, Marge; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Wijmenga, Cisca] Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Dept Immunol, Oslo, Norway; [McCarthy, Mark, I] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England	University of Groningen; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Groningen; Maastricht University; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; University of Oslo; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Sanna, S; Wijmenga, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; McCarthy, MI (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Oxford, England.; McCarthy, MI (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.; Wijmenga, C (corresponding author), Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Dept Immunol, Oslo, Norway.; McCarthy, MI (corresponding author), Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England.	s.sanna@umcg.nl; c.wijmenga@umcg.nl; mark.mccarthy@drl.ox.ac.uk	sanna, serena/H-3009-2019; Joosten, Leo AB/H-3138-2015; Fu, JY/GRR-6179-2022; Kurilshikov, Alexander/GWC-1519-2022; Fu, Jingyuan/ABE-6868-2020; Wijmenga, Cisca/AAE-7719-2019; Netea, Mihai/N-5155-2014; Fu, Jingyuan/E-8980-2012; Võsa, Urmo/AAJ-5928-2020; Zhernakova, Alexandra/ABA-9372-2020; McCarthy, Mark/M-3763-2015	sanna, serena/0000-0002-3768-1749; Joosten, Leo AB/0000-0001-6166-9830; Kurilshikov, Alexander/0000-0003-2541-5627; Fu, Jingyuan/0000-0001-5578-1236; Wijmenga, Cisca/0000-0002-5635-1614; Võsa, Urmo/0000-0003-3476-1652; Vich Vila, Arnau/0000-0003-4691-5583; McCarthy, Mark/0000-0002-4393-0510; Mahajan, Anubha/0000-0001-5585-3420	BBMRI-NL; IN-CONTROL CVON grant [CVON2012-03]; Top Institute Food and Nutrition (TiFN, Wageningen, the Netherlands) grant [TiFN GH001]; Netherlands Organization for Scientific Research (NWO) [NWO-VENI 016.176.006, NWO-VIDI 864.13.013, NWO-VIDI 016.Vidi.178.056]; NWO Spinoza Prizes [SPI 92-266, SPI 94-212]; European Research Council (ERC) [715772]; FP7/2007-2013/ERC Advanced Grant [2012-322698]; ERC [310372]; Tripartite Immunometabolism consortium (TrIC)-Novo Nordisk Foundation grant [NNF15CC0018486]; Wellcome grants [090532, 098381, 106130, 203141]; Rosalind Franklin Fellowship from the University of Groningen; TarGet; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK105535] Funding Source: NIH RePORTER	BBMRI-NL; IN-CONTROL CVON grant; Top Institute Food and Nutrition (TiFN, Wageningen, the Netherlands) grant; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Spinoza Prizes; European Research Council (ERC)(European Research Council (ERC)European Commission); FP7/2007-2013/ERC Advanced Grant; ERC(European Research Council (ERC)European Commission); Tripartite Immunometabolism consortium (TrIC)-Novo Nordisk Foundation grant; Wellcome grants; Rosalind Franklin Fellowship from the University of Groningen; TarGet; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the participants and staff of the LL-DEEP cohort for their collaboration, the UMCG Genomics Coordination center, the UG Center for Information Technology and their sponsors BBMRI-NL and TarGet for storage and compute infrastructure. We are also grateful to M.J. Bonder for help in formatting summary statistics; to R. K. Weersma and Y. Li for discussions; and to K. Mc Intyre for editing the manuscript. Part of this work was conducted by using the UK Biobank resource under application no. 9161. This project was funded by IN-CONTROL CVON grant CVON2012-03 to M.G.N., A.Z., L.A.B.J. and J.F.; Top Institute Food and Nutrition (TiFN, Wageningen, the Netherlands) grant TiFN GH001 to C.W.; the Netherlands Organization for Scientific Research (NWO) grants NWO-VENI 016.176.006 to M.O., NWO-VIDI 864.13.013 to J.F. and NWO-VIDI 016.Vidi.178.056 to A.Z.; NWO Spinoza Prizes SPI 92-266 to C.W. and SPI 94-212 to M.G.N.; European Research Council (ERC) starting grant ERC no. 715772 to A.Z.; FP7/2007-2013/ERC Advanced Grant (agreement 2012-322698) to C.W.; ERC Consolidator Grant ERC no. 310372 to M.G.N.; Tripartite Immunometabolism consortium (TrIC)-Novo Nordisk Foundation grant NNF15CC0018486 to M.I.M.; and Wellcome grants 090532, 098381, 106130 and 203141 to M.I.M. A.Z. is also supported by a Rosalind Franklin Fellowship from the University of Groningen. M.I.M. is supported as a Wellcome Senior Investigator and a National Institute of Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Bowden J., 2018, PREPRINT; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brunkwall L, 2017, DIABETOLOGIA, V60, P943, DOI 10.1007/s00125-017-4278-3; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI 10.1099/00207713-52-6-2141; Eastwood SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162388; Evans DM, 2015, ANNU REV GENOM HUM G, V16, P327, DOI 10.1146/annurev-genom-090314-050016; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Garcia-Villalba R, 2012, J SEP SCI, V35, P1906, DOI 10.1002/jssc.201101121; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Jakobsdottir G, 2013, SCAND J GASTROENTERO, V48, P696, DOI 10.3109/00365521.2013.786128; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kootte RS, 2017, CELL METAB, V26, P611, DOI 10.1016/j.cmet.2017.09.008; Kreznar JH, 2017, CELL REP, V18, P1739, DOI 10.1016/j.celrep.2017.01.062; Kurilshikov A, 2017, TRENDS IMMUNOL, V38, P633, DOI 10.1016/j.it.2017.06.003; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li NS, 2014, DIABETES, V63, P3149, DOI 10.2337/db13-1800; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Liu FT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10722-2; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pingitore A, 2017, DIABETES OBES METAB, V19, P257, DOI 10.1111/dom.12811; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Taylor AE, 2014, ECON HUM BIOL, V13, P99, DOI 10.1016/j.ehb.2013.12.002; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Wang J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0479-3; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	55	409	436	28	355	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2019	51	4					600	+		10.1038/s41588-019-0350-x	http://dx.doi.org/10.1038/s41588-019-0350-x			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HQ9SJ	30778224	Green Submitted, Green Accepted			2022-12-17	WOS:000462767500006
J	Kulis, M; Heath, S; Bibikova, M; Queiros, AC; Navarro, A; Clot, G; Martinez-Trillos, A; Castellano, G; Brun-Heath, I; Pinyol, M; Barberan-Soler, S; Papasaikas, P; Jares, P; Bea, S; Rico, D; Ecker, S; Rubio, M; Royo, R; Ho, V; Klotzle, B; Hernandez, L; Conde, L; Lopez-Guerra, M; Colomer, D; Villamor, N; Aymerich, M; Rozman, M; Bayes, M; Gut, M; Gelpi, JL; Orozco, M; Fan, JB; Quesada, V; Puente, XS; Pisano, DG; Valencia, A; Lopez-Guillermo, A; Gut, I; Lopez-Otin, C; Campo, E; Martin-Subero, JI				Kulis, Marta; Heath, Simon; Bibikova, Marina; Queiros, Ana C.; Navarro, Alba; Clot, Guillem; Martinez-Trillos, Alejandra; Castellano, Giancarlo; Brun-Heath, Isabelle; Pinyol, Magda; Barberan-Soler, Sergio; Papasaikas, Panagiotis; Jares, Pedro; Bea, Silvia; Rico, Daniel; Ecker, Simone; Rubio, Miriam; Royo, Romina; Ho, Vincent; Klotzle, Brandy; Hernandez, Lluis; Conde, Laura; Lopez-Guerra, Monica; Colomer, Dolors; Villamor, Neus; Aymerich, Marta; Rozman, Maria; Bayes, Monica; Gut, Marta; Gelpi, Josep L.; Orozco, Modesto; Fan, Jian-Bing; Quesada, Victor; Puente, Xose S.; Pisano, David G.; Valencia, Alfonso; Lopez-Guillermo, Armando; Gut, Ivo; Lopez-Otin, Carlos; Campo, Elias; Martin-Subero, Jose I.			Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia	NATURE GENETICS			English	Article							METHYLATION; MUTATIONS; PHENOTYPE; SIGNATURE; SF3B1; ARRAY	We have extensively characterized the DNA methylomes of 139 patients with chronic lymphocytic leukemia (CLL) with mutated or unmutated IGHV and of several mature B-cell subpopulations through the use of whole-genome bisulfite sequencing and high-density microarrays. The two molecular subtypes of CLL have differing DNA methylomes that seem to represent epigenetic imprints from distinct normal B-cell subpopulations. DNA hypomethylation in the gene body, targeting mostly enhancer sites, was the most frequent difference between naive and memory B cells and between the two molecular subtypes of CLL and normal B cells. Although DNA methylation and gene expression were poorly correlated, we identified gene-body CpG dinucleotides whose methylation was positively or negatively associated with expression. We have also recognized a DNA methylation signature that distinguishes new clinicobiological subtypes of CLL. We propose an epigenomic scenario in which differential methylation in the gene body may have functional and clinical implications in leukemogenesis.	[Queiros, Ana C.; Martin-Subero, Jose I.] Univ Barcelona, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain; [Kulis, Marta; Navarro, Alba; Clot, Guillem; Castellano, Giancarlo; Jares, Pedro; Bea, Silvia; Hernandez, Lluis; Conde, Laura; Lopez-Guerra, Monica; Colomer, Dolors; Villamor, Neus; Aymerich, Marta; Rozman, Maria; Campo, Elias] Univ Barcelona, Hosp Clin, Serv Anat Patol, Unidad Hematopatol,IDIBAPS, Barcelona, Spain; [Heath, Simon; Brun-Heath, Isabelle; Bayes, Monica; Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona, Spain; [Bibikova, Marina; Ho, Vincent; Klotzle, Brandy; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA; [Martinez-Trillos, Alejandra; Lopez-Guillermo, Armando] Univ Barcelona, Hosp Clin, Serv Hematol, Barcelona, Spain; [Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona, Spain; [Barberan-Soler, Sergio; Papasaikas, Panagiotis] Univ Pompeu Fabra, Ctr Regulacio Genom, Barcelona, Spain; [Rico, Daniel; Ecker, Simone; Rubio, Miriam; Pisano, David G.; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Program, Madrid, Spain; [Royo, Romina; Gelpi, Josep L.; Orozco, Modesto] BSC, Joint Program Computat Biol, Barcelona, Spain; [Royo, Romina; Gelpi, Josep L.; Orozco, Modesto] IRB, Barcelona, Spain; [Quesada, Victor; Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Illumina; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Martin-Subero, JI (corresponding author), Univ Barcelona, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain.	imartins@clinic.ub.es	Valencia, Alfonso/I-3127-2015; Campo, Elias/AAC-5593-2019; López-Otín, Carlos/AAB-2106-2020; Brun-Heath, Isabelle/G-9844-2013; Jares, Pedro/T-3778-2019; Lopez-Guillermo, Armando/Z-5684-2019; Puente, Xosé S./ADB-0672-2022; Papasaikas, Panagiotis/J-8581-2015; bea, silvia/K-7699-2014; Navarro, Alba/H-2611-2015; Quesada, Víctor/B-6557-2014; Hernandez, Luis/D-4684-2018; Gut, Ivo/ABF-3188-2020; Heath, Simon C/J-4138-2012; COLOMER, DOLORS/ABG-6894-2020; Gelpí, Josep Ll./M-6401-2013; Pisano, David/N-5817-2014; Clot, Guillem/AAD-9087-2020; Ecker, Simone/W-8200-2019; Rico, Daniel/I-2049-2013	Valencia, Alfonso/0000-0002-8937-6789; Campo, Elias/0000-0001-9850-9793; López-Otín, Carlos/0000-0001-6964-1904; Brun-Heath, Isabelle/0000-0002-5828-0020; Puente, Xosé S./0000-0001-9525-1483; Papasaikas, Panagiotis/0000-0002-1640-7636; bea, silvia/0000-0001-7192-2385; Navarro, Alba/0000-0002-4041-0974; Quesada, Víctor/0000-0002-8398-3457; Hernandez, Luis/0000-0002-4854-3069; Gut, Ivo/0000-0001-7219-632X; Heath, Simon C/0000-0002-9550-0897; Gelpí, Josep Ll./0000-0002-0566-7723; Pisano, David/0000-0002-4895-4124; Clot, Guillem/0000-0003-2588-7413; Ecker, Simone/0000-0001-5648-1710; COLOMER, DOLORS/0000-0001-7486-8484; JARES, PEDRO/0000-0002-8401-579X; Royo, Romina/0000-0003-3493-0874; Queiros, Ana/0000-0001-8585-4803; Rico, Daniel/0000-0002-6561-2310; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Castellano, Giancarlo/0000-0002-5715-7733; Rozman, Maria/0000-0002-2641-1110; Barberan-Soler, Sergio/0000-0002-5243-6813; Kulis, Marta/0000-0001-8104-9620; Orozco Lopez, Modesto/0000-0002-8608-3278	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII; European Union's Seventh Framework Programme through the Blueprint Consortium [282510]; Botin Foundation; MINECO; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya); Portuguese Fundacao para a Ciencia e a Tecnologia; EMBO Long-Term Fellowship; La Caixa;  [SAF2009-08663];  [MCyT-BIO2007-666855]	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII; European Union's Seventh Framework Programme through the Blueprint Consortium; Botin Foundation; MINECO(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); La Caixa(La Caixa Foundation); ; 	We thank M. Seifert for advice about isolating normal mature B-cell subpopulations and C. Rozman, J. Valcarcel, R. Kuppers and R. Siebert for their comments on the manuscript. We are grateful to S. Guijarro, S. Martin, C. Capdevila, M. Sanchez and L. Pla for excellent technical assistance; to M. Lozano for helping us obtain normal peripheral blood samples; and to N. Villahoz and C. Muro for excellent work in the coordination of the CLL Spanish Consortium. We are indebted to the Hospital Clinic de Barcelona-IDIBAPS Biobank-Tumor Bank and Hematopathology Collection for the sample procurement. We are also very grateful to the patients with CLL who have participated in this study. This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII) (to E.C. and C.L.-O.) and the Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII (to E.C.), project SAF2009-08663 (to J.I.M.-S.) and project MCyT-BIO2007-666855 (to A.V.), as well as the European Union's Seventh Framework Programme through the Blueprint Consortium (grant agreement 282510) (to E.C. and I.G.) and the Botin Foundation (to C.L.-O.). J.I.M.-S. is supported by a Ramon y Cajal contract of the MINECO, M.K. by the Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya), A.C.Q. by the Portuguese Fundacao para a Ciencia e a Tecnologia, S.B.-S. by an EMBO Long-Term Fellowship and S.E. by La Caixa.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rahmatpanah FB, 2009, EPIGENOMICS-UK, V1, P39, DOI [10.2217/epi.09.10, 10.2217/EPI.09.10]; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	34	409	419	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1236	1242		10.1038/ng.2443	http://dx.doi.org/10.1038/ng.2443			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23064414				2022-12-17	WOS:000310495800016
J	Karlsson, EK; Baranowska, I; Wade, CM; Salmon Hillbertz, NHC; Zody, MC; Anderson, N; Biagi, TM; Patterson, N; Pielberg, GR; Kulbokas, EJ; Comstock, KE; Keller, ET; Mesirov, JP; von Euler, H; Kampe, O; Hedhammar, A; Lander, ES; Andersson, R; Andersson, L; Lindblad-Toh, K				Karlsson, Elinor K.; Baranowska, Izabella; Wade, Claire M.; Salmon Hillbertz, Nicolette H. C.; Zody, Michael C.; Anderson, Nathan; Biagi, Tara M.; Patterson, Nick; Pielberg, Gerli Rosengren; Kulbokas, Edward J., III; Comstock, Kenine E.; Keller, Evan T.; Mesirov, Jill P.; von Euler, Henrik; Kampe, Olle; Hedhammar, Ake; Lander, Eric S.; Andersson, Ran; Andersson, Leif; Lindblad-Toh, Kerstin			Efficient mapping of mendelian traits in dogs through genome-wide association	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GENE; WAARDENBURG-SYNDROME; DOMESTIC DOG; MITF; DIFFERENTIATION; PIGMENTATION; INHERITANCE; NEURULATION; MELANOCYTES; REGULATOR	With several hundred genetic diseases and an advantageous genome structure, dogs are ideal for mapping genes that cause disease. Here we report the development of a genotyping array with similar to 27,000 SNPs and show that genome-wide association mapping of mendelian traits in dog breeds can be achieved with only similar to 20 dogs. Specifically, we map two traits with mendelian inheritance: the major white spotting ( S) locus and the hair ridge in Rhodesian ridgebacks. For both traits, we map the loci to discrete regions of <1 Mb. Fine-mapping of the S locus in two breeds refines the localization to a region of similar to 100 kb contained within the pigmentation-related gene MITF. Complete sequencing of the white and solid haplotypes identifies candidate regulatory mutations in the melanocyte-specific promoter of MITF. Our results show that genome-wide association mapping within dog breeds, followed by fine-mapping across multiple breeds, will be highly efficient and generally applicable to trait mapping, providing insights into canine and human health.	MIT, Broad Inst Harvard, Cambridge, MA 02142 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, SE-75124 Uppsala, Sweden; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Uppsala Univ, Dept Med Biochem, SE-75124 Uppsala, Sweden; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Swedish Univ Agr Sci, Dept Clin Sci, SE-75007 Uppsala, Sweden; Uppsala Univ, Univ Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts General Hospital; Uppsala University; University of Michigan System; University of Michigan; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Karlsson, EK (corresponding author), MIT, Broad Inst Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	elinor@broad.mit.edu; leif.andersson@imbim.uu.se; kersli@broad.mit.edu	Fiumefreddo, Andrea/T-2977-2019; Keller, Evan T/M-1446-2016; Mesirov, Jill/AGF-7626-2022; Andersson, Goran/AAK-6564-2020; Ronnberg, HENRIK Paul Olof/AAP-9678-2021	Keller, Evan T/0000-0002-7592-7535; Andersson, Goran/0000-0001-5131-3144; Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Karlsson, Elinor/0000-0002-4343-3776; Hedhammar, Ake/0000-0001-7048-3851; Wade, Claire/0000-0003-3413-4771; Kampe, Olle/0000-0001-6091-9914				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; BURNS M, 1966, GENETICWS DOG BASIS; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Dourmishev AL, 1999, INT J DERMATOL, V38, P656, DOI 10.1046/j.1365-4362.1999.00750.x; Goudet J., 2001, CLADISTICS; Hart D. L., 2007, PRINCIPLES POPULATIO; Hillbertz NHCS, 2006, J SMALL ANIM PRACT, V47, P184, DOI 10.1111/j.1748-5827.2006.00016.x; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Jacquemin P, 2001, BIOCHEM BIOPH RES CO, V285, P1200, DOI 10.1006/bbrc.2001.5294; Jordan SF, 2000, MECH DEVELOP, V92, P135, DOI 10.1016/S0925-4773(99)00332-9; Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Little C., 1957, INHERITANCE COAT COL; METALLINOS D, 2000, GENOME BIOL, V1; MOTOHASHI H, 1994, HEARING RES, V80, P10, DOI 10.1016/0378-5955(94)90003-5; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TIETZ W, 1963, AM J HUM GENET, V15, P259; Udono T, 2000, BBA-GENE STRUCT EXPR, V1491, P205, DOI 10.1016/S0167-4781(00)00051-8; van Hagen MAE, 2004, J HERED, V95, P526, DOI 10.1093/jhered/esh083; Wade CM, 2006, COLD SPRING HARB MON, V44, P179; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yoshida H, 1996, DEVELOPMENT, V122, P1207	36	409	422	1	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1321	1328		10.1038/ng.2007.10	http://dx.doi.org/10.1038/ng.2007.10			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906626				2022-12-17	WOS:000250575900016
J	Sayer, JA; Otto, EA; O'Toole, JF; Nurnberg, G; Kennedy, MA; Becker, C; Hennies, HC; Helou, J; Attanasio, M; Fausett, BV; Utsch, B; Khanna, H; Liu, Y; Drummond, I; Kawakami, I; Kusakabe, T; Tsuda, M; Ma, L; Lee, H; Larson, RG; Allen, SJ; Wilkinson, CJ; Nigg, EA; Shou, CC; Lillo, C; Williams, DS; Hoppe, B; Kemper, MJ; Neuhaus, T; Parisi, MA; Glass, IA; Petry, M; Kispert, A; Gloy, J; Ganner, A; Walz, G; Zhu, XL; Goldman, D; Nurnberg, P; Swaroop, A; Leroux, MR; Hildebrandt, F				Sayer, John A.; Otto, Edgar A.; O'Toole, John F.; Nurnberg, Gudrun; Kennedy, Michael A.; Becker, Christian; Hennies, Hans Christian; Helou, Juliana; Attanasio, Massimo; Fausett, Blake V.; Utsch, Boris; Khanna, Hemant; Liu, Yan; Drummond, Iain; Kawakami, Isao; Kusakabe, Takehiro; Tsuda, Motoyuki; Ma, Li; Lee, Hwankyu; Larson, Ronald G.; Allen, Susan J.; Wilkinson, Christopher J.; Nigg, Erich A.; Shou, Chengchao; Lillo, Concepcion; Williams, David S.; Hoppe, Bernd; Kemper, Markus J.; Neuhaus, Thomas; Parisi, Melissa A.; Glass, Ian A.; Petry, Marianne; Kispert, Andreas; Gloy, Joachim; Ganner, Athina; Walz, Gerd; Zhu, Xueliang; Goldman, Daniel; Nurnberg, Peter; Swaroop, Anand; Leroux, Michel R.; Hildebrandt, Friedhelm			The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4	NATURE GENETICS			English	Article							PRIMARY CILIA; RETINITIS-PIGMENTOSA; DOMAIN PROTEIN; NEPHRONOPHTHISIS; GENE; INVERSIN; MUTATIONS; INTERACTS; ENCODES; DISEASE	The molecular basis of nephronophthisis(1), the most frequent genetic cause of renal failure in children and young adults, and its association with retinal degeneration and cerebellar vermis aplasia in Joubert syndrome(2) are poorly understood. Using positional cloning, we here identify mutations in the gene CEP290 as causing nephronophthisis. It encodes a protein with several domains also present in CENPF, a protein involved in chromosome segregation. CEP290 ( also known as NPHP6) interacts with and modulates the activity of ATF4, a transcription factor implicated in cAMP-dependent renal cyst formation. NPHP6 is found at centrosomes and in the nucleus of renal epithelial cells in a cell cycle-dependent manner and in connecting cilia of photoreceptors. Abrogation of its function in zebrafish recapitulates the renal, retinal and cerebellar phenotypes of Joubert syndrome. Our findings help establish the link between centrosome function, tissue architecture and transcriptional control in the pathogenesis of cystic kidney disease, retinal degeneration, and central nervous system development.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Newcastle Univ, Sch Clin Med Sci, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Cologne, Cologne Ctr Genom, D-5000 Cologne 41, Germany; RZPD Deutsch Ressourcectr Genomforsch, Berlin, Germany; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Univ Michigan, Inst Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Ophthalmol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Renal Unit, Charlestown, MA 02129 USA; Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Peking Univ, Sch Oncol, Beijing Inst Canc Res, Dept Biochem & Mol Biol, Beijing 100036, Peoples R China; Univ Calif San Diego, Sch Med, Dept Pharmacol & Neurosci, La Jolla, CA 92093 USA; Univ Cologne, Dept Pediat, D-5000 Cologne 41, Germany; Univ Zurich, Dept Pediat, CH-8006 Zurich, Switzerland; Univ Washington, Dept Pediat, Seattle, WA 98105 USA; Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; Univ Cologne, Inst Genet, D-5000 Cologne 41, Germany; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Newcastle University - UK; University of Cologne; Simon Fraser University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard University; Massachusetts General Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Max Planck Society; Peking University; University of California System; University of California San Diego; University of Cologne; University of Zurich; University of Washington; University of Washington Seattle; Hannover Medical School; University of Cologne; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Sayer, John A./AAN-2729-2020; Hennies, Hans C/G-9424-2014; Lillo, Concepcion/A-6321-2009; Kusakabe, Takehiro/H-7178-2012	Sayer, John A./0000-0003-1881-3782; Hennies, Hans C/0000-0001-7210-2389; Lillo, Concepcion/0000-0001-5814-9826; Kusakabe, Takehiro/0000-0002-8325-3665; Otto, Edgar/0000-0002-2387-9973; Utsch, Boris/0000-0003-4623-581X; nigg, erich/0000-0003-4835-5719; Swaroop, Anand/0000-0002-1975-1141; Wilkinson, Christopher/0000-0002-7448-0938; Attanasio, Massimo/0000-0002-1278-3650; Lee, Hwankyu/0000-0002-2036-1490	NATIONAL EYE INSTITUTE [R01EY007961, R01EY013408, R01EY007042, R29EY007961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053093, R01DK064614] Funding Source: NIH RePORTER; NEI NIH HHS [EY07003, EY07961, R01 EY007042, EY13408, R01 EY007042-20] Funding Source: Medline; NIDDK NIH HHS [DK53093, DK1068306, DK1069274, DK064614] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Barthel LK, 2000, METHOD ENZYMOL, V316, P579; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; HILDEBRANDT F, 2001, DIS KIDNEY URINARY T; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; KHANNA H, IN PRESS HUM MOL GEN; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Nakashima Y, 2003, J COMP NEUROL, V460, P180, DOI 10.1002/cne.10645; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Westerfield M, 1995, ZEBRAFISH BOOK; Zhou XB, 2005, J BIOL CHEM, V280, P13973, DOI 10.1074/jbc.M414310200	30	409	422	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					674	681		10.1038/ng1786	http://dx.doi.org/10.1038/ng1786			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682973				2022-12-17	WOS:000237954800022
J	McLysaght, A; Hokamp, K; Wolfe, KH				McLysaght, A; Hokamp, K; Wolfe, KH			Extensive genomic duplication during early chordate evolution	NATURE GENETICS			English	Article							VERTEBRATE EVOLUTION; LARGE-SCALE; GENE FAMILIES; ANCIENT; HYPOTHESIS; SEQUENCE; CHROMOSOMES; POLYPLOIDS; RECEPTOR; HISTORY	Opinions on the hypothesis(1) that ancient genome duplications contributed to the vertebrate genome range from strong skepticism(2-4) to strong credence(5-7). Previous studies concentrated on small numbers of gene families or chromosomal regions that might not have been representative of the whole genome(4,5), or used subjective methods to identify paralogous genes and regions(5,8). Here we report a systematic and objective analysis of the draft human genome sequence to identify paralogous chromosomal regions (paralogons) formed during chordate evolution and to estimate the ages of duplicate genes. We found that the human genome contains many more paralogons than would be expected by chance. Molecular clock analysis of all protein families in humans that have orthologs in the fly and nematode indicated that a burst of gene duplication activity took place in the period 350-650 Myr ago and that many of the duplicate genes formed at this time are located within paralogons. Our results support the contention that many of the gene families in vertebrates were formed or expanded by large- scale DNA duplications in an early chordate. Considering the incompleteness of the sequence data and the antiquity of the event, the results are compatible with at least one round of polyploidy.	Univ Dublin, Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland	Trinity College Dublin	Wolfe, KH (corresponding author), Univ Dublin, Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland.	khwolfe@tcd.ie	Hokamp, Karsten/C-5534-2009; Wolfe, Kenneth H/B-4653-2009	Hokamp, Karsten/0000-0001-7464-2370; Wolfe, Kenneth/0000-0003-4992-4979; McLysaght, Aoife/0000-0003-2552-6220				Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Friedman R, 2001, GENOME RES, V11, P1842, DOI 10.1101/gr.200601; Gu X, 2002, GENOME RES, V12, P1, DOI 10.1101/gr.214402; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hughes AL, 1998, MOL BIOL EVOL, V15, P854, DOI 10.1093/oxfordjournals.molbev.a025990; Hughes AL, 2001, GENOME RES, V11, P771, DOI 10.1101/gr.GR-1600R; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koh YS, 1999, GENOMICS, V57, P289, DOI 10.1006/geno.1998.5683; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Makalowski W, 2001, GENOME RES, V11, P667, DOI 10.1101/gr.188801; Martin A, 2001, MOL BIOL EVOL, V18, P89, DOI 10.1093/oxfordjournals.molbev.a003723; Miyata T, 2001, BIOESSAYS, V23, P1018, DOI 10.1002/bies.1147; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohno S., 1970, EVOLUTION GENE DUPLI; Pebusque MJ, 1998, MOL BIOL EVOL, V15, P1145, DOI 10.1093/oxfordjournals.molbev.a026022; Popovici C, 2001, BIOCHEM BIOPH RES CO, V288, P362, DOI 10.1006/bbrc.2001.5794; RUDDLE FH, 1994, DEVELOPMENT, P155; Smith NGC, 1999, BIOESSAYS, V21, P697, DOI 10.1002/(SICI)1521-1878(199908)21:8<697::AID-BIES9>3.0.CO;2-X; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Tomsig JL, 2000, BIOCHEMISTRY-US, V39, P16163, DOI 10.1021/bi0019949; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009	31	409	420	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					200	204		10.1038/ng884	http://dx.doi.org/10.1038/ng884			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12032567				2022-12-17	WOS:000175903500019
J	Jazwinska, EC; Cullen, LM; Busfield, F; Pyper, WR; Webb, SI; Powell, LW; Morris, CP; Walsh, TP				Jazwinska, EC; Cullen, LM; Busfield, F; Pyper, WR; Webb, SI; Powell, LW; Morris, CP; Walsh, TP			Haemochromatosis and HLA-H	NATURE GENETICS			English	Letter							AUSTRALIAN HEMOCHROMATOSIS PATIENTS; HEREDITARY HEMOCHROMATOSIS; ANCESTRAL HAPLOTYPE; EXPRESSION; GENE		QUEENSLAND UNIV TECHNOL, COOPERAT RES CTR DIAGNOST TECHNOL, BRISBANE, QLD 4001, AUSTRALIA	Queensland University of Technology (QUT)	Jazwinska, EC (corresponding author), QUEENSLAND INST MED RES, BRISBANE, QLD 4029, AUSTRALIA.			Morris, Phillip/0000-0001-8976-619X				Burt MJ, 1996, GENOMICS, V33, P153, DOI 10.1006/geno.1996.0178; Camaschella C, 1996, HUM GENET, V97, P476; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; Cox T, 1996, NAT GENET, V13, P386, DOI 10.1038/ng0896-386; CRAWFORD DHG, 1995, AM J HUM GENET, V57, P362; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gandon G, 1996, HUM GENET, V97, P103, DOI 10.1007/BF00218843; JAZWINSKA EC, 1995, AM J HUM GENET, V56, P428; Little P, 1996, NATURE, V382, P494, DOI 10.1038/382494a0; POWELL LW, 1988, ANN NY ACAD SCI, V526, P23, DOI 10.1111/j.1749-6632.1988.tb55489.x; Seese NK, 1996, BLOOD CELL MOL DIS, V22, P36, DOI 10.1006/bcmd.1996.0006; SIMON M, 1980, GASTROENTEROLOGY, V78, P703; WORWOOD M, 1994, BRIT J HAEMATOL, V86, P863, DOI 10.1111/j.1365-2141.1994.tb04843.x; 1996, NAT GENET, V13, P375	14	409	411	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1996	14	3					249	251		10.1038/ng1196-249	http://dx.doi.org/10.1038/ng1196-249			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896549				2022-12-17	WOS:A1996VQ14600013
J	FLINT, J; WILKIE, AOM; BUCKLE, VJ; WINTER, RM; HOLLAND, AJ; MCDERMID, HE				FLINT, J; WILKIE, AOM; BUCKLE, VJ; WINTER, RM; HOLLAND, AJ; MCDERMID, HE			THE DETECTION OF SUBTELOMERIC CHROMOSOMAL REARRANGEMENTS IN IDIOPATHIC MENTAL-RETARDATION	NATURE GENETICS			English	Article							WOLF-HIRSCHHORN SYNDROME; INSITU HYBRIDIZATION; PATHOGENETIC ASPECTS; HUMAN MINISATELLITES; MOLECULAR ANALYSIS; DISEASE GENE; DNA MARKERS; ALLELE LOSS; SHORT ARM; TRANSLOCATION	A major challenge for human genetics is to identify new causes of mental retardation, which, although present in about 3% of individuals, is unexplained in more than half of all cases. We have developed a strategy to screen for the abnormal inheritance of subtelomeric DNA polymorphisms in individuals with mental-retardation and have detected three abnormalities in 99 patients with normal routine karyotypes. Pulsed-field gel electrophoresis and reverse chromosome painting showed that one case arose from an interstitial or terminal deletion and two from the de novo inheritance of derivative translocation chromosomes. At least 6% of unexplained mental retardation is accounted for by these relatively small chromosomal abnormalities, which will be an important resource in the characterization of the genetic basis of neurodevelopment.	INST CHILD HLTH,MOTHERCARE UNIT PAEDIAT & FETAL MED,LONDON WC1N 1EH,ENGLAND; UNIV CAMBRIDGE,DEPT PSYCHIAT,DEV PSYCHIAT SECT,CAMBRIDGE CB2 2AH,ENGLAND; UNIV ALBERTA,DEPT GENET,EDMONTON,AB T6G 2E9,CANADA	University of London; University College London; University of Cambridge; University of Alberta	FLINT, J (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND.		Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTHERR MR, 1991, AM J HUM GENET, V49, P1235; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; ARMOUR JAL, 1990, GENOMICS, V8, P501, DOI 10.1016/0888-7543(90)90037-U; ARMOUR JAL, 1992, GENOMICS, V12, P116, DOI 10.1016/0888-7543(92)90413-M; ARMOUR JAL, 1991, NUCLEIC ACIDS RES, V19, P5447; BATES GP, 1991, AM J HUM GENET, V49, P7; Birch HG, 1970, MENTAL SUBNORMALITY; Broman S., 1987, RETARDATION YOUNG CH; BUCAN M, 1990, GENOMICS, V6, P1; Buckle VJ, 1993, HUMAN GENETIC DISEAS, P59; BUNDEY S, 1989, J MED GENET, V26, P260, DOI 10.1136/jmg.26.4.260; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; CROSIER M, 1991, NUCLEIC ACIDS RES, V19, P5446, DOI 10.1093/nar/19.19.5446; DRILLIEN CM, 1966, ARCH DIS CHILD, V41, P528, DOI 10.1136/adc.41.219.528; EINFELD SL, 1984, J MENT DEFIC RES, V28, P129; ELWOOD JH, 1981, J MENT DEFIC RES, V25, P147; GOODSHIP J, 1992, J MED GENET, V29, P451; GOSTASON R, 1991, J MENT DEFIC RES, V35, P240; GUSTAVSON KH, 1977, NEUROPADIATRIE, V8, P293, DOI 10.1055/s-0028-1091525; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HAGBERG B, 1981, ACTA PAEDIATR SCAND, V70, P441, DOI 10.1111/j.1651-2227.1981.tb05720.x; HAGBERG B, 1981, ACTA PAEDIATR SCAND, V70, P445, DOI 10.1111/j.1651-2227.1981.tb05721.x; HENKE A, 1993, GENOMICS, V18, P478, DOI 10.1016/S0888-7543(11)80003-0; Henry I., 1993, European Journal of Human Genetics, V1, P19; HING AV, 1993, AM J HUM GENET, V53, P509; James R. S., 1994, European Journal of Human Genetics, V2, P83; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; KUWANO A, 1991, AM J HUM GENET, V49, P707; LAMB J, 1989, LANCET, V2, P819; LAMB J, 1993, AM J HUM GENET, V52, P668; LAMONT MA, 1988, ARCH DIS CHILD, V63, P1032, DOI 10.1136/adc.63.9.1032; LAXOVA R, 1977, AM J MED GENET, V1, P75, DOI 10.1002/ajmg.1320010109; LEDBETTER DH, 1992, AM J HUM GENET, V52, P451; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MCDONALD AD, 1973, AM J MENT DEF, V78, P205; MCQUEEN PC, 1986, DEV MED CHILD NEUROL, V28, P697; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; NESSLINGER NJ, 1994, AM J HUM GENET, V54, P464; NICHOLLS RD, 1993, AM J MED GENET, V46, P16, DOI 10.1002/ajmg.1320460106; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; RACK KA, 1993, AM J HUM GENET, V52, P987; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; ROYLE NJ, 1993, GENOMICS, V15, P119, DOI 10.1006/geno.1993.1019; RUTTER M, 1970, ED HLTH BEHAVIOR; Sambrook J., 1989, MOL CLONING LAB MANU; TAKAHASHI E, 1992, GENOMICS, V13, P1047, DOI 10.1016/0888-7543(92)90018-N; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; WILKIE AOM, 1993, AM J HUM GENET, V63, P688; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	52	409	422	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					132	140		10.1038/ng0295-132	http://dx.doi.org/10.1038/ng0295-132			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719339	Bronze			2022-12-17	WOS:A1995QE67200013
J	Hu, M; Yao, J; Cai, L; Bachman, KE; van den Brule, F; Velculescu, V; Polyak, K				Hu, M; Yao, J; Cai, L; Bachman, KE; van den Brule, F; Velculescu, V; Polyak, K			Distinct epigenetic changes in the stromal cells of breast cancers	NATURE GENETICS			English	Article							HUMAN COLON-CARCINOMA; CPG ISLANDS; ALTERED METHYLATION; PROTEOGLYCAN GENE; DNA METHYLATION; HYPOMETHYLATION; EXPRESSION; HIN-1; TRANSCRIPTOME; EPIGENOMICS	Increasing evidence suggests that changes in the cellular microenvironment contribute to tumorigenesis, but the molecular basis of these alterations is not well understood. Although epigenetic modifications of the neoplastic cells in tumors have been firmly implicated in tumorigenesis(1), it is not known whether epigenetic modifications occur in the non-neoplastic stromal cells. To address this question in an unbiased and genome-wide manner, we developed a new method, methylation-specific digital karyotyping, and applied it to epithelial and myoepithelial cells, stromal fibroblasts from normal breast tissue, and in situ and invasive breast carcinomas. Our analyses showed that distinct epigenetic alterations occur in all three cell types during breast tumorigenesis in a tumor stage- and cell type-specific manner, suggesting that epigenetic changes have a role in the maintenance of the abnormal cellular microenvironment in breast cancer.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; Univ Liege, Lab Biol & Dev Biol, B-4000 Liege, Belgium; Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21231 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University of Liege; Johns Hopkins University	Polyak, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	Kornelia_Polyak@dfci.harvard.edu	Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Cai, Li/0000-0003-3344-337X				ADANY R, 1991, BIOCHEM J, V276, P301, DOI 10.1042/bj2760301; ADANY R, 1990, BIOCHEM BIOPH RES CO, V171, P1402, DOI 10.1016/0006-291X(90)90841-A; ADANY R, 1990, J BIOL CHEM, V265, P11389; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Cai L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r51; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Dai ZY, 2002, GENOME RES, V12, P1591, DOI 10.1101/gr.197402; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kremenskoy M, 2003, BIOCHEM BIOPH RES CO, V311, P884, DOI 10.1016/j.bbrc.2003.10.078; Krop I, 2004, MOL CANCER RES, V2, P489; Krop IE, 2001, P NATL ACAD SCI USA, V98, P9796, DOI 10.1073/pnas.171138398; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Plass C, 2002, HUM MOL GENET, V11, P2479, DOI 10.1093/hmg/11.20.2479; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shi HD, 2002, CANCER RES, V62, P3214; Shigematsu H, 2005, INT J CANCER, V113, P600, DOI 10.1002/ijc.20622; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899	29	408	432	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					899	905		10.1038/ng1596	http://dx.doi.org/10.1038/ng1596			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16007089				2022-12-17	WOS:000230880400023
J	Tong, ZB; Gold, L; Pfeifer, KE; Dorward, H; Lee, E; Bondy, CA; Dean, J; Nelson, LM				Tong, ZB; Gold, L; Pfeifer, KE; Dorward, H; Lee, E; Bondy, CA; Dean, J; Nelson, LM			Mater, a maternal effect gene required for early embryonic development in mice	NATURE GENETICS			English	Article							MOUSE EMBRYO; TRANSCRIPTION; ACTIVATION; PROTEINS; EXPRESSION; TRANSITION; DIVERSITY; FAMILY; STAGE		NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD USA; NICHD, Dev Endocrinol Branch, NIH, Bethesda, MD USA; NICHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD USA; Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Dean, J (corresponding author), NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD USA.	jurrien@helix.nih.gov; nelsonl@cc1.nichd.nih.gov		Pfeifer, Karl/0000-0002-0254-682X				Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; CONOVER JC, 1991, DEV BIOL, V144, P392, DOI 10.1016/0012-1606(91)90431-2; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gardner RL, 1996, HUM REPROD UPDATE, V2, P3, DOI 10.1093/humupd/2.1.3; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; LATHAM KE, 1993, MOL REPROD DEV, V35, P140, DOI 10.1002/mrd.1080350207; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nothias JY, 1996, EMBO J, V15, P5715, DOI 10.1002/j.1460-2075.1996.tb00955.x; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Tong ZB, 2000, MAMM GENOME, V11, P281, DOI 10.1007/s003350010053	15	408	443	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					267	268		10.1038/81547	http://dx.doi.org/10.1038/81547			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062459				2022-12-17	WOS:000165176500008
J	Sosnay, PR; Siklosi, KR; Van Goor, F; Kaniecki, K; Yu, HH; Sharma, N; Ramalho, AS; Amaral, MD; Dorfman, R; Zielenski, J; Masica, DL; Karchin, R; Millen, L; Thomas, PJ; Patrinos, GP; Corey, M; Lewis, MH; Rommens, JM; Castellani, C; Penland, CM; Cutting, GR				Sosnay, Patrick R.; Siklosi, Karen R.; Van Goor, Fredrick; Kaniecki, Kyle; Yu, Haihui; Sharma, Neeraj; Ramalho, Anabela S.; Amaral, Margarida D.; Dorfman, Ruslan; Zielenski, Julian; Masica, David L.; Karchin, Rachel; Millen, Linda; Thomas, Philip J.; Patrinos, George P.; Corey, Mary; Lewis, Michelle H.; Rommens, Johanna M.; Castellani, Carlo; Penland, Christopher M.; Cutting, Garry R.			Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene	NATURE GENETICS			English	Article							UNKNOWN CLINICAL-SIGNIFICANCE; LOCUS-SPECIFIC DATABASES; MESSENGER-RNA; CFTR GENE; PULMONARY-DISEASE; SEQUENCE VARIANTS; SPLICE-SITE; MUTATION; GUIDELINES; PHENOTYPE	Allelic heterogeneity in disease-causing genes presents a substantial challenge to the translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the cystic fibrosis transmembrane conductance regulator gene CFTR have empirical evidence that they cause cystic fibrosis. To address this gap, we collected both genotype and phenotype data for 39,696 individuals with cystic fibrosis in registries and clinics in North America and Europe. In these individuals, 159 CFTR variants had an allele frequency of >= 0.01%. These variants were evaluated for both clinical severity and functional consequence, with 127 (80%) meeting both clinical and functional criteria consistent with disease. Assessment of disease penetrance in 2,188 fathers of individuals with cystic fibrosis enabled assignment of 12 of the remaining 32 variants as neutral, whereas the other 20 variants remained of indeterminate effect. This study illustrates that sourcing data directly from well-phenotyped subjects can address the gap in our ability to interpret clinically relevant genomic variation.	[Sosnay, Patrick R.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Sosnay, Patrick R.] Perdana Univ, Grad Sch Med, Serdang, Malaysia; [Sosnay, Patrick R.; Siklosi, Karen R.; Kaniecki, Kyle; Sharma, Neeraj; Cutting, Garry R.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Van Goor, Fredrick; Yu, Haihui] Vertex Pharmaceut Inc, San Diego, CA USA; [Kaniecki, Kyle] Columbia Univ, Coll Physicians & Surg, Dept Genet & Dev, New York, NY USA; [Ramalho, Anabela S.; Amaral, Margarida D.] Univ Lisbon, Fac Sci, Cetr Biodivers Funct & Integrat Genom BioFIG, Lisbon, Portugal; [Ramalho, Anabela S.; Amaral, Margarida D.] Natl Inst Hlth, Dept Genet, Lisbon, Portugal; [Dorfman, Ruslan; Zielenski, Julian; Rommens, Johanna M.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Dorfman, Ruslan] Geneyouin Inc, Maple, ON, Canada; [Masica, David L.; Karchin, Rachel] Johns Hopkins Univ, Inst Computat Med, Dept Biomed Engn, Baltimore, MD USA; [Millen, Linda; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX USA; [Patrinos, George P.] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece; [Corey, Mary] Hosp Sick Children, Program Child Evaluat Hlth Sci, Toronto, ON M5G 1X8, Canada; [Corey, Mary] Univ Toronto, Dalla Lana Sch Publ Hlth Sci, Toronto, ON, Canada; [Lewis, Michelle H.] Johns Hopkins Univ, Genet & Publ Policy Ctr, Berman Inst Bioeth, Baltimore, MD USA; [Rommens, Johanna M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Castellani, Carlo] Azienda Osped Univ Integrata, Cyst Fibrosis Ctr, Verona, Italy; [Penland, Christopher M.] Cyst Fibrosis Fdn, Bethesda, MD USA; [Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Perdana University; Johns Hopkins University; Vertex Pharmaceuticals; Columbia University; Universidade de Lisboa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Patras; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Johns Hopkins University; University of Toronto; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Cystic Fibrosis Foundation; Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	gcutting@jhmi.edu	Ramalho, Anabela/AAY-4037-2020; Castellani, Carlo/AAB-3847-2019; Karchin, Rachel/A-3385-2010; Raraigh, Karen/B-3734-2012; Amaral, Margarida D/E-5748-2012; Rommens, Johanna/AAT-7465-2021	Raraigh, Karen/0000-0001-6730-6854; Amaral, Margarida D/0000-0002-0828-8630; Dorfman, Ruslan/0000-0002-3421-5582; Karchin, Rachel/0000-0002-5069-1239; Ramalho, Anabela/0000-0002-6480-8725	NIDDK [5R37DK044003]; US NIH [DK49835]; Cystic Fibrosis Foundation Therapeutics, Inc.; US Cystic Fibrosis Foundation [CUTTING08A, CUTTING09A, CUTTING10A, SOSNAY10Q]; FCT Portugal [PIC/IC/83103/2007, PEstOE/BIA/UI4046/2011, BioFIG]; Genome Canada through the Ontario Genomics Institute [2004-OGI-3-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044003, R37DK049835, R01DK049835, R37DK044003] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics, Inc.; US Cystic Fibrosis Foundation; FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Genome Canada through the Ontario Genomics Institute(Genome Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank the subjects who participated in their national/clinic registries. The authors thank D. Gruenert (University of California, San Francisco) for CFBE 41o-cells and M. Welsh (University of Iowa) for FRT cells. This work was supported by grants from the NIDDK (5R37DK044003 to G. R. C.) and the US NIH (DK49835 to P.J.T.) and by funding from Cystic Fibrosis Foundation Therapeutics, Inc. (to P.J.T.), the US Cystic Fibrosis Foundation (CUTTING08A, CUTTING09A and CUTTING10A to G. R. C. and SOSNAY10Q to P. R. S.) and FCT Portugal (PIC/IC/83103/2007 and PEstOE/BIA/UI4046/2011 to M. D. A. and BioFIG). Assistance with statistical analysis was provided by E. Johnson, M. B. Drummond, D. Cutler and D. Arking. The authors received considerable guidance from the CFTR2 clinical expert panel: C. De Boeck, P. Durie, S. Elborn, P. Farrell, M. Knowles and I. Sermet; from the CFTR2 functional studies expert panel: R. Bridges, G. Lukacs and D. Sheppard; and from M. Sheridan who provided critical review.; DNA samples from fathers of individuals with cystic fibrosis were contributed by T. Casals (Bellvitge Biomedical Research Institute, Spain), G. Cutting (Johns Hopkins University, USA), C. Dechecchi (University Hospital of Verona, Italy), R. Dorfman (The Hospital for Sick Children, Canada), C. Ferec (Centre Hospitalier Universitaire, France), E. Girodon (GH Henri Mondor, France), M. Macek Jr. (Charles University, Czech Republic), D. Radojkovic (Institute of Molecular Genetics and Genetic Engineering, Serbia), M. Schwarz (St. Mary's Hospital, UK), M. Seia (Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Italy), M. Stuhrmann (Medical School Hannover, Germany), M. Tzetis (National Kapodistrian University of Athens, Greece) and J. Zielenski (The Hospital for Sick Children, Canada, with partial support from Genome Canada, through the Ontario Genomics Institute per research agreement 2004-OGI-3-05).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amos JA, 2006, EXPERT REV MOL DIAGN, V6, P15, DOI 10.1586/14737159.6.1.15; ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beck S, 1999, HUM MUTAT, V14, P133, DOI 10.1002/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-T; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bombieri C, 2000, HUM GENET, V106, P172, DOI 10.1007/s004390051025; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Castellani C, 2009, J CYST FIBROS, V8, P153, DOI 10.1016/j.jcf.2009.01.004; Celli J, 2012, HUM MUTAT, V33, P291, DOI 10.1002/humu.21626; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHILLON M, 1995, AM J HUM GENET, V56, P623; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; CLACKSON T, 1989, NUCLEIC ACIDS RES, V17, P10163, DOI 10.1093/nar/17.24.10163; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; CUPPENS H, 1993, GENOMICS, V18, P693, DOI 10.1016/S0888-7543(05)80376-3; DISANTAGNESE PA, 1953, AM J MED, V15, P777, DOI 10.1016/0002-9343(53)90169-7; Dorfman R, 2010, CLIN GENET, V77, P464, DOI 10.1111/j.1399-0004.2009.01351.x; Dujardin G, 2011, J CYST FIBROS, V10, P212, DOI 10.1016/j.jcf.2010.12.008; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Estivill X, 1996, NAT GENET, V12, P348, DOI 10.1038/ng0496-348; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; GIBSON LE, 1959, PEDIATRICS, V23, P545; Grody WW, 2007, GENET MED, V9, P739, DOI 10.1097/GIM.0b013e318159a331; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Highsmith WE, 1997, HUM MUTAT, V9, P332, DOI 10.1002/(SICI)1098-1004(1997)9:4<332::AID-HUMU5>3.0.CO;2-7; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Krasnov KV, 2008, HUM MUTAT, V29, P1364, DOI 10.1002/humu.20866; Kricka Larry J, 2013, Nat Genet, V45, P4, DOI 10.1038/ng.2510; Krulisova V, 2012, EUR J PEDIATR, V171, P1223, DOI 10.1007/s00431-012-1747-z; LeGrys VA, 2007, J PEDIATR-US, V151, P85, DOI 10.1016/j.jpeds.2007.03.002; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Masica DL, 2012, HUM MUTAT, V33, P1267, DOI 10.1002/humu.22110; Massie RJH, 2012, MED J AUSTRALIA, V196, P67, DOI 10.5694/mja11.10686; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mitchell AA, 2005, GENOME RES, V15, P960, DOI 10.1101/gr.3761405; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; Neuberger T, 2011, METHODS MOL BIOL, V741, P39, DOI 10.1007/978-1-61779-117-8_4; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Ramalho AS, 2011, METHODS MOL BIOL, V741, P115, DOI 10.1007/978-1-61779-117-8_9; Ramalho AS, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e88; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Raynal C, 2013, HUM MUTAT, V34, P774, DOI 10.1002/humu.22291; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Rishishwar L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042336; Rohlfs EM, 2002, GENET MED, V4, P319, DOI 10.1097/00125817-200209000-00001; Samuels ME, 2011, NAT REV GENET, V12, P378, DOI 10.1038/nrg3011; Scott A, 2012, J CYST FIBROS, V11, P511, DOI 10.1016/j.jcf.2012.04.009; Sheridan MB, 2011, J MED GENET, V48, P235, DOI 10.1136/jmg.2010.083287; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; Strom CM, 2011, GENET MED, V13, P166, DOI 10.1097/GIM.0b013e3181fa24c4; TAUSSIG LM, 1972, NEW ENGL J MED, V287, P586, DOI 10.1056/NEJM197209212871204; Thongnoppakhun W, 2009, J MOL DIAGN, V11, P334, DOI 10.2353/jmoldx.2009.080151; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vernooij-van Langen AMM, 2012, THORAX, V67, P289, DOI 10.1136/thoraxjnl-2011-200730; Vihinen M, 2012, HUM MUTAT, V33, P298, DOI 10.1002/humu.21646; Wagener JS, 2012, CURR OPIN PEDIATR, V24, P329, DOI 10.1097/MOP.0b013e328353489a; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wilschanski M, 2006, AM J RESP CRIT CARE, V174, P787, DOI 10.1164/rccm.200509-1377OC; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	77	407	413	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1160	U292		10.1038/ng.2745	http://dx.doi.org/10.1038/ng.2745			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	23974870	Green Accepted			2022-12-17	WOS:000324989600011
J	Bojesen, SE; Pooley, KA; Johnatty, SE; Beesley, J; Michailidou, K; Tyrer, JP; Edwards, SL; Pickett, HA; Shen, HC; Smart, CE; Hillman, KM; Mai, PL; Lawrenson, K; Stutz, MD; Lu, Y; Karevan, R; Woods, N; Johnston, RL; French, JD; Chen, XQ; Weischer, M; Nielsen, SF; Maranian, MJ; Ghoussaini, M; Ahmed, S; Baynes, C; Bolla, MK; Wang, Q; Dennis, J; McGuffog, L; Barrowdale, D; Lee, A; Healey, S; Lush, M; Tessier, DC; Vincent, D; Bacot, F; Vergote, I; Lambrechts, S; Despierre, E; Risch, HA; Gonzaalez-Neira, A; Rossing, MA; Pita, G; Doherty, JA; Alvarez, N; Larson, MC; Fridley, BL; Schoof, N; Chang-Claude, J; Cicek, MS; Peto, J; Kalli, KR; Broeks, A; Armasu, SM; Schmidt, MK; Braaf, LM; Winterhoff, B; Nevanlinna, H; Konecny, GE; Lambrechts, D; Rogmann, L; Guenel, P; Teoman, A; Milne, RL; Garcia, JJ; Cox, A; Shridhar, V; Burwinkel, B; Marme, F; Hein, R; Sawyer, EJ; Haiman, CA; Wang-Gohrke, S; Andrulis, IL; Moysich, KB; Hopper, JL; Odunsi, K; Lindblom, A; Giles, GG; Brenner, H; Simard, J; Lurie, G; Fasching, PA; Carney, ME; Radice, P; Wilkens, LR; Swerdlow, A; Goodman, MT; Brauch, H; Garcia-Closas, M; Hillemanns, P; Winqvist, R; Durst, M; Devilee, P; Runnebaum, I; Jakubowska, A; Lubinski, J; Mannermaa, A; Butzow, R; Bogdanova, NV; Dork, T; Pelttari, LM; Zheng, W; Leminen, A; Anton-Culver, H; Bunker, CH; Kristensen, V; Ness, RB; Muir, K; Edwards, R; Meind, A; Heitz, F; Matsuo, K; du Bois, A; Wu, AH; Harter, P; Teo, SH; Schwaab, I; Shu, XO; Blot, W; Hosono, S; Kang, D; Nakanishi, T; Hartman, M; Yatabe, Y; Hamann, U; Karlan, BY; Sangrajrang, S; Kjaer, SK; Gaborieau, V; Jensen, A; Eccles, D; Hogdall, E; Shen, CY; Brown, J; Woo, YL; Shah, M; Azmi, MAN; Luben, R; Omar, SZ; Czene, K; Vierkant, RA; Nordestgaard, BG; Flyger, H; Vachon, C; Olson, JE; Wang, XS; Levine, DA; Rudolph, A; Weber, RP; Flesch-Janys, D; Iversen, E; Nickels, S; Schildkraut, JM; Silva, ID; Cramer, DW; Gibson, L; Terry, KL; Fletcher, O; Vitonis, AF; van der Schoot, CE; Poole, EM; Hogervorst, FBL; Tworoger, SS; Liu, JJ; Bandera, EV; Li, JM; Olson, SH; Humphreys, K; Row, I; Blomqvist, C; Rodriguez-Rodriguez, L; Aittomaki, K; Salvesen, HB; Muranen, TA; Wik, E; Brouwers, B; Krakstad, C; Wauters, E; Halle, MK; Wildiers, H; Kiemeney, LA; Mulot, C; Aben, KK; Laurent-Puig, P; Altena, AM; Truong, T; Massuger, LFAG; Benitez, J; Pejovic, T; Perez, JIA; Hoatlin, M; Zamora, MP; Cook, LS; Balasubramanian, SP; Kelemen, LE; Schneeweiss, A; Le, ND; Sohn, C; Brooks-Wilson, A; Tomlinson, I; Kerin, MJ; Miller, N; Cybulski, C; Henderson, BE; Menkiszak, J; Schumacher, F; Wentzensen, N; Le Marchand, L; Yang, HP; Mulligan, AM; Glendon, G; Engelholm, SA; Knight, JA; Hogdall, CK; Apicella, C; Gore, M; Tsimiklis, H; Song, HL; Southey, MC; Jager, A; den Ouweland, AMW; Brown, R; Martens, JWM; Flanagan, JM; Kriege, M; Paul, J; Margolin, S; Siddiqui, N; Severi, G; Whittemore, AS; Baglietto, L; McGuire, V; Stegmaier, C; Sieh, W; Muller, H; Arndt, V; Labreche, F; Gao, YT; Goldberg, MS; Yang, G; Dumont, M; McLaughlin, JR; Hartmann, A; Ekici, AB; Beckmann, MW; Phelan, CM; Lux, MP; Permuth-Wey, J; Peissel, B; Sellers, TA; Ficarazzi, F; Barile, M; Ziogas, A; Ashworth, A; Gentry-Maharaj, A; Jones, M; Ramus, SJ; Orr, N; Menon, U; Pearce, CL; Bruning, T; Pike, MC; Ko, YD; Lissowska, J; Figueroa, J; Kupryjanczyk, J; Chanock, SJ; Dansonka-Mieszkowska, A; Jukkola-Vuorinen, A; Rzepecka, IK; Pylkas, K; Bidzinski, M; Kauppila, S; Hollestelle, A; Seynaeve, C; Tollenaar, RAEM; Durda, K; Jaworska, K; Hartikainen, JM; Kosma, VM; Kataja, V; Antonenkova, NN; Long, JR; Shrubsole, M; Deming-Halverson, S; Lophatananon, A; Siriwanarangsan, P; Stewart-Brown, S; Ditsch, N; Lichtner, P; Schmutzler, RK; Ito, H; Iwata, H; Tajima, K; Tseng, CC; Stram, DO; van den Berg, D; Yip, CH; Ikrarn, MK; Teh, YC; Cai, H; Lu, W; Signorello, LB; Cai, QY; Noh, DY; Yoo, KY; Miao, H; Iau, PTC; Teo, YY; McKay, J; Shapiro, C; Ademuyiwa, F; Fountzilas, G; Hsiung, CN; Yu, JC; Hou, MF; Healey, CS; Luccarini, C; Peock, S; Stoppa-Lyonnet, D; Peterlongo, P; Rebbeck, TR; Piedmonte, M; Singer, CF; Friedman, E; Thomassen, M; Offit, K; Hansen, TVO; Neuhausen, SL; Szabo, CI; Blanco, I; Garber, J; Narod, SA; Weitzel, JN; Montagna, M; Olah, E; Godwin, AK; Yannoukakos, D; Goldgar, DE; Caldes, T; Imyanitov, EN; Tihomirova, L; Arun, BK; Campbell, I; Mensenkamp, AR; van Asperen, CJ; van Roozendaa, KEP; Meijers-Heijboer, H; Collee, JM; Oosterwijk, JC; Hooning, MJ; Rookus, MA; van der Luijt, RB; Os, TAM; Evans, DG; Frost, D; Fineberg, E; Barwell, J; Walker, L; Kennedy, MJ; Platte, R; Davidson, R; Ellis, SD; Cole, T; Bressac-de Paillerets, B; Buecher, B; Damiola, F; Faivre, L; Frenay, M; Sinilnikova, OM; Caron, O; Giraud, S; Mazoyer, S; Bonadona, V; Caux-Moncoutier, V; Toloczko-Grabarek, A; Gronwald, J; Byrski, T; Spurdle, AB; Bonanni, B; Zaffaroni, D; Giannini, G; Bernard, L; Dolcetti, R; Manoukian, S; Arnold, N; Engel, C; Deissler, H; Rhiem, K; Niederacher, D; Pendl, H; Sutter, C; Wappenschmidt, B; Borg, A; Mein, B; Rantala, J; Soller, M; Nathanson, KL; Domchek, SM; Rodriguez, GC; Salani, R; Kaulich, DG; Tea, MK; Paluch, SS; Laitman, Y; Skytte, AB; Kruse, TA; Jensen, UB; Robson, M; Gerdes, AM; Ejlertsen, B; Foretova, L; Savage, SA; Lesterm, J; Soucy, P; Kuchenbaecker, KB; Olswold, C; Cunningham, JM; Slager, S; Pankratz, VS; Dicks, E; Lakhani, SR; Couch, FJ; Hall, P; Monteiro, ANA; Gayther, SA; Pharoah, PDP; Reddel, RR; Goode, EL; Greene, MH; Easton, DF; Berchuck, A; Antoniou, AC; Chenevix-Trench, G; Dunning, AM				Bojesen, Stig E.; Pooley, Karen A.; Johnatty, Sharon E.; Beesley, Jonathan; Michailidou, Kyriaki; Tyrer, Jonathan P.; Edwards, Stacey L.; Pickett, Hilda A.; Shen, Howard C.; Smart, Chanel E.; Hillman, Kristine M.; Mai, Phuong L.; Lawrenson, Kate; Stutz, Michael D.; Lu, Yi; Karevan, Rod; Woods, Nicholas; Johnston, Rebecca L.; French, Juliet D.; Chen, Xiaoqing; Weischer, Maren; Nielsen, Sune F.; Maranian, Melanie J.; Ghoussaini, Maya; Ahmed, Shahana; Baynes, Caroline; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; McGuffog, Lesley; Barrowdale, Daniel; Lee, Andrew; Healey, Sue; Lush, Michael; Tessier, Daniel C.; Vincent, Daniel; Bacot, Francis; Vergote, Ignace; Lambrechts, Sandrina; Despierre, Evelyn; Risch, Harvey A.; Gonzalez-Neira, Anna; Rossing, Mary Anne; Pita, Guillermo; Doherty, Jennifer A.; Alvarez, Nuria; Larson, Melissa C.; Fridley, Brooke L.; Schoof, Nils; Chang-Claude, Jenny; Cicek, Mine S.; Peto, Julian; Kalli, Kimberly R.; Broeks, Annegien; Armasu, Sebastian M.; Schmidt, Marjanka K.; Braaf, Linde M.; Winterhoff, Boris; Nevanlinna, Heli; Konecny, Gottfried E.; Lambrechts, Diether; Rogmann, Lisa; Guenel, Pascal; Teoman, Attila; Milne, Roger L.; Garcia, Joaquin J.; Cox, Angela; Shridhar, Vijayalakshmi; Burwinkel, Barbara; Marme, Frederik; Hein, Rebecca; Sawyer, Elinor J.; Haiman, Christopher A.; Wang-Gohrke, Shan; Andrulis, Irene L.; Moysich, Kirsten B.; Hopper, John L.; Odunsi, Kunle; Lindblom, Annika; Giles, Graham G.; Brenner, Hermann; Simard, Jacques; Lurie, Galina; Fasching, Peter A.; Carney, Michael E.; Radice, Paolo; Wilkens, Lynne R.; Swerdlow, Anthony; Goodman, Marc T.; Brauch, Hiltrud; Garcia-Closas, Montserrat; Hillemanns, Peter; Winqvist, Robert; Durst, Matthias; Devilee, Peter; Runnebaum, Ingo; Jakubowska, Anna; Lubinski, Jan; Mannermaa, Arto; Butzow, Ralf; Bogdanova, Natalia V.; Doerk, Thilo; Pelttari, Liisa M.; Zheng, Wei; Leminen, Arto; Anton-Culver, Hoda; Bunker, Clareann H.; Kristensen, Vessela; Ness, Roberta B.; Muir, Kenneth; Edwards, Robert; Meindl, Alfons; Heitz, Florian; Matsuo, Keitaro; du Bois, Andreas; Wu, Anna H.; Harter, Philipp; Teo, Soo-Hwang; Schwaab, Ira; Shu, Xiao-Ou; Blot, William; Hosono, Satoyo; Kang, Daehee; Nakanishi, Toru; Hartman, Mikael; Yatabe, Yasushi; Hamann, Ute; Karlan, Beth Y.; Sangrajrang, Suleeporn; Kjaer, Susanne Kruger; Gaborieau, Valerie; Jensen, Allan; Eccles, Diana; Hogdall, Estrid; Shen, Chen-Yang; Brown, Judith; Woo, Yin Ling; Shah, Mitul; Azmi, Mat Adenan Noor; Luben, Robert; Omar, Siti Zawiah; Czene, Kamila; Vierkant, Robert A.; Nordestgaard, Borge G.; Flyger, Henrik; Vachon, Celine; Olson, Janet E.; Wang, Xianshu; Levine, Douglas A.; Rudolph, Anja; Weber, Rachel Palmieri; Flesch-Janys, Dieter; Iversen, Edwin; Nickels, Stefan; Schildkraut, Joellen M.; Silva, Isabel Dos Santos; Cramer, Daniel W.; Gibson, Lorna; Terry, Kathryn L.; Fletcher, Olivia; Vitonis, Allison F.; van der Schoot, C. Ellen; Poole, Elizabeth M.; Hogervorst, Frans B. L.; Tworoger, Shelley S.; Liu, Jianjun; Bandera, Elisa V.; Li, Jingmei; Olson, Sara H.; Humphreys, Keith; Row, Irene; Blomqvist, Carl; Rodriguez-Rodriguez, Lorna; Aittomaki, Kristiina; Salvesen, Helga B.; Muranen, Taru A.; Wik, Elisabeth; Brouwers, Barbara; Krakstad, Camilla; Wauters, Els; Halle, Mari K.; Wildiers, Hans; Kiemeney, Lambertus A.; Mulot, Claire; Aben, Katja K.; Laurent-Puig, Pierre; Altena, Anne Mvan; Therese Truong; Massuger, Leon F. A. G.; Benitez, Javier; Pejovic, Tanja; Arias Perez, Jose Ignacio; Hoatlin, Maureen; Zamora, M. Pilar; Cook, Linda S.; Balasubramanian, Sabapathy P.; Kelemen, Linda E.; Schneeweiss, Andreas; Le, Nhu D.; Sohn, Christof; Brooks-Wilson, Angela; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Cybulski, Cezary; Henderson, Brian E.; Menkiszak, Janusz; Schumacher, Fredrick; Wentzensen, Nicolas; Marchand, Loic Le; Yang, Hannah P.; Mulligan, Anna Marie; Glendon, Gord; Engelholm, Svend Aage; Knight, Julia A.; Hogdall, Claus K.; Apicella, Carmel; Gore, Martin; Tsimiklis, Helen; Song, Honglin; Southey, Melissa C.; Jager, Agnes; den Ouweland, Ans M. Wvan; Brown, Robert; Martens, John W. M.; Flanagan, James M.; Kriege, Mieke; Paul, James; Margolin, Sara; Siddiqui, Nadeem; Severi, Gianluca; Whittemore, Alice S.; Baglietto, Laura; McGuire, Valerie; Stegmaier, Christa; Sieh, Weiva; Mueller, Heiko; Arndt, Volker; Labreche, France; Gao, Yu-Tang; Goldberg, Mark S.; Yang, Gong; Dumont, Martine; McLaughlin, John R.; Hartmann, Arndt; Ekici, Arif B.; Beckmann, Matthias W.; Phelan, Catherine M.; Lux, Michael P.; Permuth-Wey, Jenny; Peissel, Bernard; Sellers, Thomas A.; Ficarazzi, Filomena; Barile, Monica; Ziogas, Argyrios; Ashworth, Alan; Gentry-Maharaj, Aleksandra; Jones, Michael; Ramus, Susan J.; Orr, Nick; Menon, Usha; Pearce, Celeste L.; Bruening, Thomas; Pike, Malcolm C.; Ko, Yon-Dschun; Lissowska, Jolanta; Figueroa, Jonine; Kupryjanczyk, Jolanta; Chanock, Stephen J.; Dansonka-Mieszkowska, Agnieszka; Jukkola-Vuorinen, Arja; Rzepecka, Iwona K.; Pylkas, Katri; Bidzinski, Mariusz; Kauppila, Saila; Hollestelle, Antoinette; Seynaeve, Caroline; Tollenaar, Rob A. E. M.; Durda, Katarzyna; Jaworska, Katarzyna; Hartikainen, Jaana M.; Kosma, Veli-Matti; Kataja, Vesa; Antonenkova, Natalia N.; Long, Jirong; Shrubsole, Martha; Deming-Halverson, Sandra; Lophatananon, Artitaya; Siriwanarangsan, Pornthep; Stewart-Brown, Sarah; Ditsch, Nina; Lichtner, Peter; Schmutzler, Rita K.; Ito, Hidemi; Iwata, Hiroji; Tajima, Kazuo; Tseng, Chiu-Chen; Stram, Daniel O.; van den Berg, David; Yip, Cheng Har; Ikrarn, M. Kamran; Teh, Yew-Ching; Cai, Hui; Lu, Wei; Signorello, Lisa B.; Cai, Qiuyin; Noh, Dong-Young; Yoo, Keun-Young; Miao, Hui; Iau, Philip Tsau-Choong; Teo, Yik Ying; McKay, James; Shapiro, Charles; Ademuyiwa, Foluso; Fountzilas, George; Hsiung, Chia-Ni; Yu, Jyh-Cherng; Hou, Ming-Feng; Healey, Catherine S.; Luccarini, Craig; Peock, Susan; Stoppa-Lyonnet, Dominique; Peterlongo, Paolo; Rebbeck, Timothy R.; Piedmonte, Marion; Singer, Christian F.; Friedman, Eitan; Thomassen, Mads; Offit, Kenneth; Hansen, Thomas V. O.; Neuhausen, Susan L.; Szabo, Csilla I.; Blanco, Ignacio; Garber, Judy; Narod, Steven A.; Weitzel, Jeffrey N.; Montagna, Marco; Olah, Edith; Godwin, Andrew K.; Yannoukakos, Drakoulis; Goldgar, David E.; Caldes, Trinidad; Imyanitov, Evgeny N.; Tihomirova, Laima; Arun, Banu K.; Campbell, Ian; Mensenkamp, Arjen R.; van Asperen, Christi J.; van Roozendaa, Kees E. P.; Meijers-Heijboer, Hanne; Collee, J. Margriet; Oosterwijk, Jan C.; Hooning, Maartje J.; Rookus, Matti A.; van der Luijt, Rob B.; Os, Theo A. Mvan; Evans, D. Gareth; Frost, Debra; Fineberg, Elena; Barwell, Julian; Walker, Lisa; Kennedy, M. John; Platte, Radka; Davidson, Rosemarie; Ellis, Steve D.; Cole, Trevor; Bressac-de Paillerets, Brigitte; Buecher, Bruno; Damiola, Francesca; Faivre, Laurence; Frenay, Marc; Sinilnikova, Olga M.; Caron, Olivier; Giraud, Sophie; Mazoyer, Sylvie; Bonadona, Valerie; Caux-Moncoutier, Virginie; Toloczko-Grabarek, Aleksandra; Gronwald, Jacek; Byrski, Tomasz; Spurdle, Amanda B.; Bonanni, Bernardo; Zaffaroni, Daniela; Giannini, Giuseppe; Bernard, Loris; Dolcetti, Riccardo; Manoukian, Siranoush; Arnold, Norbert; Engel, Christoph; Deissler, Helmut; Rhiem, Kerstin; Niederacher, Dieter; Pendl, Hansjoerg; Sutter, Christian; Wappenschmidt, Barbara; Borg, Ake; Mein, Beatrice; Rantala, Johanna; Soller, Maria; Nathanson, Katherine L.; Domchek, Susan M.; Rodriguez, Gustavo C.; Salani, Ritu; Kaulich, Daphne Gschwantler; Tea, Muy-Kheng; Paluch, Shani Shimon; Laitman, Yael; Skytte, Anne-Bine; Kruse, Torben A.; Jensen, Uffe Birk; Robson, Mark; Gerdes, Anne-Marie; Ejlertsen, Bent; Foretova, Lenka; Savage, Sharon A.; Lesterm, Jenny; Soucy, Penny; Kuchenbaecker, Karoline B.; Olswold, Curtis; Cunningham, Julie M.; Slager, Susan; Pankratz, Vernon S.; Dicks, Ed; Lakhani, Sunil R.; Couch, Fergus J.; Hall, Per; Monteiro, Alvaro N. A.; Gayther, Simon A.; Pharoah, Paul D. P.; Reddel, Roger R.; Goode, Ellen L.; Greene, Mark H.; Easton, Douglas F.; Berchuck, Andrew; Antoniou, Antonis C.; Chenevix-Trench, Georgia; Dunning, Alison M.		Australian Canc Study; Australian Ovarian Canc Study; Kathleen Cuningham Fdn Consortium; Gene Environm Interactimi Breast; Swedish Breast Canc Study SWE-BRCA; Hereditary Breast Ovarian Canc Res; Epidemiological Study BRCA1; Genetic Modifiers Canc Risk BRCA1	Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; REVERSE-TRANSCRIPTASE; SUSCEPTIBILITY LOCI; TERT-CLPTM1L LOCUS; GENETIC-VARIATION; COMMON VARIANTS; BUCCAL CELLS; FIBROBLASTS; SEQUENCE; POLYMORPHISM	TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOG, we analyzed similar to 480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 x 10(-7)), lower risks for estrogen receptor (ER)-negative (P = 1.0 x 10(-8)) and BRCA1 mutation carrier (P = 1.1 x 10(-5)) breast cancers and altered promoter assay signal. The minor allele at the peak 2 SNP rs7705526 associates with longer telomeres (P = 2.3 x 10(-14)), higher risk of low-malignant-potential ovarian cancer (P = 1.3 x 10(-15)) and greater promoter activity. The minor alleles at the peak 3 SNPs rs10069690 and rs2242652 increase ER-negative (P = 1.2 x 10(-12)) and BRCA1 mutation carrier (P = 1.6 x 10-14) breast and invasive ovarian (P = 1.3 x 10(-11)) cancer risks but not via altered telomere length. The cancer risk alleles of rs2242652 and rs10069690, respectively, increase silencing and generate a truncated TERT splice variant.	[Bojesen, Stig E.; Weischer, Maren; Nielsen, Sune F.; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Bojesen, Stig E.; Weischer, Maren; Nielsen, Sune F.; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Pooley, Karen A.; Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; McGuffog, Lesley; Barrowdale, Daniel; Lee, Andrew; Lush, Michael; Brown, Judith; Luben, Robert; Peock, Susan; Frost, Debra; Fineberg, Elena; Ellis, Steve D.; Kuchenbaecker, Karoline B.; Dicks, Ed; Easton, Douglas F.; Antoniou, Antonis C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Johnatty, Sharon E.; Beesley, Jonathan; Lu, Yi; Chen, Xiaoqing; Healey, Sue; Spurdle, Amanda B.; Chenevix-Trench, Georgia] Queensland Inst Med Res, Dept Genet, Brisbane, Qld 4006, Australia; [Tyrer, Jonathan P.; Maranian, Melanie J.; Ghoussaini, Maya; Ahmed, Shahana; Baynes, Caroline; Shah, Mitul; Song, Honglin; Healey, Catherine S.; Luccarini, Craig; Pharoah, Paul D. P.; Easton, Douglas F.; Dunning, Alison M.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Edwards, Stacey L.; Hillman, Kristine M.; French, Juliet D.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Pickett, Hilda A.; Stutz, Michael D.; Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia; [Pickett, Hilda A.; Stutz, Michael D.; Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Shen, Howard C.; Lawrenson, Kate; Karevan, Rod; Haiman, Christopher A.; Wu, Anna H.; Henderson, Brian E.; Schumacher, Fredrick; Ramus, Susan J.; Pearce, Celeste L.; Pike, Malcolm C.; Tseng, Chiu-Chen; Stram, Daniel O.; van den Berg, David; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Smart, Chanel E.; Johnston, Rebecca L.; Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res UQCCR, Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Mai, Phuong L.; Savage, Sharon A.; Greene, Mark H.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Rockville, MD USA; [Woods, Nicholas; Phelan, Catherine M.; Permuth-Wey, Jenny; Sellers, Thomas A.; Monteiro, Alvaro N. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francis] McGill Univ, Montreal, PQ, Canada; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francis] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Vergote, Ignace; Lambrechts, Sandrina; Despierre, Evelyn] Katholieke Univ Leuven Hosp, Dept Obstet & Gynaecol, Div Gynecol Oncol, Louvain, Belgium; [Vergote, Ignace; Lambrechts, Sandrina; Despierre, Evelyn] Katholieke Univ Leuven Hosp, Leuven Canc Inst, Louvain, Belgium; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Risch, Harvey A.] Yale Univ, Sch Med, New Haven, CT USA; [Gonzalez-Neira, Anna; Pita, Guillermo; Alvarez, Nuria; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Ctr Nacl Genotipac, Madrid, Spain; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rossing, Mary Anne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Doherty, Jennifer A.] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Lebanon, NH USA; [Larson, Melissa C.; Armasu, Sebastian M.; Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Fridley, Brooke L.] Univ Kansas, Ctr Canc, Kansas IDeA Network Biomed Res Excellence Bioinfo, Kansas City, KS USA; [Schoof, Nils; Hartman, Mikael; Czene, Kamila; Humphreys, Keith; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chang-Claude, Jenny; Hein, Rebecca; Rudolph, Anja; Nickels, Stefan] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Cicek, Mine S.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Peto, Julian; Silva, Isabel Dos Santos; Gibson, Lorna] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Kalli, Kimberly R.] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Broeks, Annegien; Schmidt, Marjanka K.; Braaf, Linde M.; Rookus, Matti A.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Winterhoff, Boris; Rogmann, Lisa; Teoman, Attila] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Nevanlinna, Heli; Butzow, Ralf; Pelttari, Liisa M.; Leminen, Arto; Muranen, Taru A.] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Konecny, Gottfried E.; Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Lambrechts, Diether; Wauters, Els] Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, Louvain, Belgium; [Lambrechts, Diether; Wauters, Els] VIB, VRC, Louvain, Belgium; [Guenel, Pascal; Therese Truong] CESP Ctr Res Epidemiol & Populat Hlth, U1018, INSERM, Villejuif, France; [Guenel, Pascal; Therese Truong] Univ Paris Sud, UMRS, Villejuif, France; [Milne, Roger L.] CNIO, Human Canc Genet Program, Genet & Mol Epidemiol Grp, Madrid, Spain; [Garcia, Joaquin J.; Shridhar, Vijayalakshmi; Wang, Xianshu; Cunningham, Julie M.; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN USA; [Cox, Angela; Balasubramanian, Sabapathy P.] Univ Sheffield, Dept Oncol, Canc Res UK Norkshire Canc Res Sheffield Canc Red, Sheffield, S Yorkshire, England; [Burwinkel, Barbara; Marme, Frederik; Schneeweiss, Andreas; Sohn, Christof] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Burwinkel, Barbara] DKFZ, Mol Epidemiol Grp, Heidelberg, Germany; [Marme, Frederik; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Hein, Rebecca] Univ Cologne, Primarmed Versorgung PMV Res Grp, Dept Child & Adolescent Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Sawyer, Elinor J.] Kings Coll London, Div Canc Studies, Natl Inst Hlth Res NIHR, Comprehens Biomed Res Ctr,Guys & St Thomas Natl H, London WC2R 2LS, England; [Wang-Gohrke, Shan; Deissler, Helmut] Univ Ulm, Dept Obstet & Gynaecol, Ulm, Germany; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Andrulis, Irene L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ontario Canc Genet Network, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Moysich, Kirsten B.; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Hopper, John L.; Giles, Graham G.; Apicella, Carmel; Severi, Gianluca; Baglietto, Laura] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Giles, Graham G.; Severi, Gianluca; Baglietto, Laura] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Giles, Graham G.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Brenner, Hermann; Mueller, Heiko; Arndt, Volker] DKFZ, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Simard, Jacques; Dumont, Martine; Soucy, Penny] CHU Quebec, Canc Genom Lab, Quebec City, PQ, Canada; [Simard, Jacques; Dumont, Martine; Soucy, Penny] Univ Laval, Quebec City, PQ, Canada; [Lurie, Galina; Carney, Michael E.; Wilkens, Lynne R.; Marchand, Loic Le] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Fasching, Peter A.; Beckmann, Matthias W.; Lux, Michael P.] Univ Breast Ctr Franconia Erlangen Univ Hosp, Dept Gynecol & Obstet, Erlangen, Germany; [Radice, Paolo; Peterlongo, Paolo] Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, I-20133 Milan, Italy; [Radice, Paolo; Ficarazzi, Filomena; Peterlongo, Paolo] Ist Fdn Italiana Ric Cancro Oncol Mol, Milan, Italy; [Swerdlow, Anthony; Jones, Michael] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, Sutton, Surrey, England; [Goodman, Marc T.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Fac Med, Tubingen, Germany; [Garcia-Closas, Montserrat; Fletcher, Olivia; Ashworth, Alan; Orr, Nick] Inst Canc Res, Div Breast Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Hillemanns, Peter] Hannover Med Sch, Clin Obstet, Hannover, Germany; [Hillemanns, Peter] Hannover Med Sch, Clin Gynaecol, Hannover, Germany; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Genet, Oulu Univ Hosp, Oulu, Finland; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Durst, Matthias; Runnebaum, Ingo] Jena Univ Hosp, Dept Gynecol, Jena, Germany; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Jakubowska, Anna; Lubinski, Jan; Durda, Katarzyna; Jaworska, Katarzyna; Toloczko-Grabarek, Aleksandra; Gronwald, Jacek; Byrski, Tomasz] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Mannermaa, Arto; Hartikainen, Jaana M.; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Mannermaa, Arto; Hartikainen, Jaana M.; Kosma, Veli-Matti; Kataja, Vesa] Univ Eastern Finland, Canc Ctr Eastern Finland, Bioctr Kuopio, Sch Med,Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Cent Hosp, Helsinki, Finland; [Bogdanova, Natalia V.; Doerk, Thilo] Hannover Med Sch, Dept Obstet & Gynaecol, Hannover, Germany; [Bogdanova, Natalia V.; Cai, Qiuyin] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Zheng, Wei; Shu, Xiao-Ou; Blot, William; Yang, Gong; Long, Jirong; Shrubsole, Martha; Deming-Halverson, Sandra; Cai, Hui; Signorello, Lisa B.] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr,Vanderbilt Ingr, Nashville, TN 37212 USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Bunker, Clareann H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Kristensen, Vessela] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Kristensen, Vessela] Univ Oslo, Fac Med, Fac Div Ahus, Oslo, Norway; [Ness, Roberta B.] Univ Texas Sch Publ Hlth, Houston, TX USA; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth; Lophatananon, Artitaya] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Edwards, Robert] Magee Womens Hosp, Pittsburgh, PA USA; [Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Div Tumor Genet, Dept Gynecol & Obstet, D-80290 Munich, Germany; [Heitz, Florian; du Bois, Andreas; Harter, Philipp] Dr Horst Schmidt Klin Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [Heitz, Florian; du Bois, Andreas; Harter, Philipp] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Matsuo, Keitaro; Hosono, Satoyo; Ito, Hidemi; Tajima, Kazuo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Teo, Soo-Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo-Hwang; Yip, Cheng Har; Teh, Yew-Ching] Univ Malaya, Med Ctr, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur, Malaysia; [Schwaab, Ira] Inst Humangenet Wiesbaden, Wiesbaden, Germany; [Blot, William; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD USA; [Kang, Daehee; Noh, Dong-Young; Yoo, Keun-Young] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Nakanishi, Toru] Aichi Canc Ctr Cent Hosp, Dept Gynecol Oncol, Nagoya, Aichi, Japan; [Hartman, Mikael; Iau, Philip Tsau-Choong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael; Miao, Hui; Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yatabe, Yasushi] Aichi Canc Ctr Cent Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan; [Hamann, Ute] DKFZ, Heidelberg, Germany; [Karlan, Beth Y.; Lesterm, Jenny] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Sangrajrang, Suleeporn] Natl Canc Inst, Div Res, Bangkok, Thailand; [Kjaer, Susanne Kruger; Jensen, Allan; Hogdall, Estrid] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Kjaer, Susanne Kruger; Hogdall, Claus K.] Rigshosp, Dept Obstet & Gynecol, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; [Gaborieau, Valerie; McKay, James] Int Agcy Res Canc, F-69372 Lyon, France; [Eccles, Diana] Univ Southampton, Fac Med, Southampton Univ Hosp, Southampton SO9 5NH, Hants, England; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Taichong, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Woo, Yin Ling; Azmi, Mat Adenan Noor; Omar, Siti Zawiah] Univ Malaya, Fac Med, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Copenhagen, Denmark; [Vachon, Celine; Olson, Janet E.; Olswold, Curtis; Slager, Susan; Pankratz, Vernon S.; Couch, Fergus J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Weber, Rachel Palmieri; Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Clin Canc Registry, Dept Canc Epidemiol, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Iversen, Edwin] Duke Univ, Dept Stat Sci, Durham, NC USA; [Iversen, Edwin; Schildkraut, Joellen M.] Duke Canc Inst, Canc Prevent Detect & Control Res Program, Durham, NC USA; [Cramer, Daniel W.; Terry, Kathryn L.; Vitonis, Allison F.] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Vitonis, Allison F.] Harvard Univ, Sch Med, Boston, MA USA; [Cramer, Daniel W.; Terry, Kathryn L.; Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [van der Schoot, C. Ellen] Sanquin Res, Amsterdam, Netherlands; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Med, Channing Div Network Med, Boston, MA USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Hogervorst, Frans B. L.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Liu, Jianjun; Li, Jingmei] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Bandera, Elisa V.; Rodriguez-Rodriguez, Lorna] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Olson, Sara H.; Row, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Salvesen, Helga B.; Wik, Elisabeth; Krakstad, Camilla; Halle, Mari K.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Salvesen, Helga B.; Wik, Elisabeth; Krakstad, Camilla; Halle, Mari K.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Brouwers, Barbara] Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Louvain, Belgium; [Brouwers, Barbara; Wildiers, Hans] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium; [Kiemeney, Lambertus A.; Aben, Katja K.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Mulot, Claire; Laurent-Puig, Pierre] Univ Paris Sorbonne Cite, UMR S775, INSERM, Paris, France; [Altena, Anne Mvan; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynecol, NL-6525 ED Nijmegen, Netherlands; [Benitez, Javier] CNIO, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Biomed Network Rare Dis CIBERER, Madrid, Spain; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Hoatlin, Maureen] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Zamora, M. Pilar] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain; [Cook, Linda S.] Univ New Mexico, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Kelemen, Linda E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Kelemen, Linda E.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Le, Nhu D.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Tomlinson, Ian] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland Univ Coll Galway, Sch Med, Galway, Ireland; [Cybulski, Cezary] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Menkiszak, Janusz] Pomeranian Med Univ, Dept Surg Gynecol & Gynecol Oncol Adults & Adolsc, Szczecin, Poland; [Wentzensen, Nicolas; Yang, Hannah P.; Figueroa, Jonine; Chanock, Stephen J.] NCI, Div Canc Epidemiol, Bethesda, MD 20892 USA; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Glendon, Gord; McLaughlin, John R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Engelholm, Svend Aage] Univ Copenhagen, Rigshosp, Dept Radiat Oncol, DK-2100 Copenhagen, Denmark; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Gore, Martin] Royal Marsden Hosp, Gynecol Oncol Unit, London SW3 6JJ, England; [Tsimiklis, Helen; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Jager, Agnes; Martens, John W. M.; Kriege, Mieke; Hollestelle, Antoinette; Seynaeve, Caroline; Hooning, Maartje J.] Erasmus Univ, Med Ctr, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [den Ouweland, Ans M. Wvan; Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Family Canc Clin, Rotterdam, Netherlands; [Brown, Robert; Flanagan, James M.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Paul, James] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Margolin, Sara] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden; [Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Whittemore, Alice S.; McGuire, Valerie; Sieh, Weiva] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Labreche, France] Univ Montreal, Fac Med, Dept Environm & Occupat Hlth, Montreal, PQ H3C 3J7, Canada; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [McLaughlin, John R.] Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hartmann, Arndt] Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, Erlangen, Germany; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Peissel, Bernard; Zaffaroni, Daniela; Manoukian, Siranoush] Fdn IRCCS INT, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Ficarazzi, Filomena; Bernard, Loris] Cogentech Canc Genet Test Lab, Milan, Italy; [Barile, Monica; Bonanni, Bernardo] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, Ctr Canc Genet Res & Prevent, Irvine, CA 92717 USA; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Gynaecol Canc Res Ctr, Elizabeth Garrett Anderson Inst Womens Hlth, London, England; [Bruening, Thomas] Ruhr Univ Bochum, Inst Prevent & Occupat Med, German Social Accid Insurance, Bochum, Germany; [Ko, Yon-Dschun] Johanniter Krankenhaus, Evangel Kliniken Bonn, Dept Internal Med, Bonn, Germany; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Kupryjanczyk, Jolanta; Dansonka-Mieszkowska, Agnieszka; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol Pathol, Warsaw, Poland; [Kupryjanczyk, Jolanta; Dansonka-Mieszkowska, Agnieszka; Rzepecka, Iwona K.; Bidzinski, Mariusz] Inst Oncol, Warsaw, Poland; [Jukkola-Vuorinen, Arja] Univ Oulu, Oulu Univ Hosp, Dept Oncol, Oulu, Finland; [Bidzinski, Mariusz] Maria Sklodowska Curie Mem Canc Ctr, Dept Gynecol Oncol, Warsaw, Poland; [Kauppila, Saila] Univ Oulu, Dept Pathol, Oulu Univ Hosp, Oulu, Finland; [Tollenaar, Rob A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Jaworska, Katarzyna] Warsaw Med Univ, Postgrad Sch Mol Med, Warsaw, Poland; [Antonenkova, Natalia N.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Bangkok, Thailand; [Ditsch, Nina] Univ Munich, Dept Gynecol & Obstet, Munich, Germany; [Lichtner, Peter] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Schmutzler, Rita K.; Rhiem, Kerstin; Wappenschmidt, Barbara] Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Dept Gynaecol & Obstet, Cologne, Germany; [Schmutzler, Rita K.; Rhiem, Kerstin; Wappenschmidt, Barbara] Univ Hosp Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi, Japan; [Ikrarn, M. Kamran] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Shapiro, Charles] Ohio State Univ, Div Oncol, Wexner Med Ctr, Columbus, OH 43210 USA; [Ademuyiwa, Foluso] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Yu, Jyh-Cherng] Triserv Gen Hosp, Dept Surg, Taipei, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Stoppa-Lyonnet, Dominique; Buecher, Bruno; Caux-Moncoutier, Virginie] Inst Curie, Dept Tumor Biol, Paris, France; [Stoppa-Lyonnet, Dominique] INSERM, Inst Curie, U830, Paris, France; [Stoppa-Lyonnet, Dominique] Univ Paris 05, Paris, France; [Rebbeck, Timothy R.; Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Basser Res Ctr, Philadelphia, PA USA; [Rebbeck, Timothy R.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Piedmonte, Marion] Roswell Pk Canc Inst, Gynecol Oncol Grp Stat, Buffalo, NY 14263 USA; [Piedmonte, Marion] Roswell Pk Canc Inst, Ctr Data, Buffalo, NY 14263 USA; [Singer, Christian F.; Kaulich, Daphne Gschwantler; Tea, Muy-Kheng] Med Univ Vienna, Ctr Comprehens Canc, Dept Obstet & Gynecol, Vienna, Austria; [Friedman, Eitan; Paluch, Shani Shimon; Laitman, Yael] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, IL-52621 Tel Hashomer, Israel; [Friedman, Eitan; Paluch, Shani Shimon; Laitman, Yael] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Tel Hashomer, Israel; [Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Offit, Kenneth; Robson, Mark] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, New York, NY 10021 USA; [Hansen, Thomas V. O.] Rigshosp, Copenhagen Univ Hosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Szabo, Csilla I.] Univ Delaware, Dept Biol Sci, Ctr Translat Canc Res, Newark, DE USA; [Blanco, Ignacio] Inst Invest Biomed Bellvitge Catalan Inst Oncol, Hereditary Canc Program, Genet Counseling Unit, Barcelona, Spain; [Garber, Judy] Dana Farber Canc Inst, Ctr Canc Genet & Prevent, Boston, MA 02115 USA; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Clin Canc Genet, Duarte, CA USA; [Montagna, Marco] IRCCS, Ist Oncol Veneto IOV, Immunol & Mol Oncol Unit, Padua, Italy; [Olah, Edith] Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Yannoukakos, Drakoulis] Aghia Paraskevi Attikis, Mol Diagnost Lab, Inst Radioisotopes & Radiodiagnost Prod, Natl Ctr Sci Res Demokritos, Athens, Greece; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Goldgar, David E.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Caldes, Trinidad] Hosp Clin San Carlos, Mol Oncol Lab, Madrid, Spain; [Imyanitov, Evgeny N.] NN Petrov Inst Oncol, St Petersburg, Russia; [Tihomirova, Laima] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Arun, Banu K.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Arun, Banu K.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Campbell, Ian] Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium Canc Genet L, Melbourne, Vic, Australia; [Mensenkamp, Arjen R.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [van Roozendaa, Kees E. P.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Meijers-Heijboer, Hanne] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Oosterwijk, Jan C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Os, Theo A. Mvan] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Evans, D. Gareth] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Barwell, Julian] Univ Hosp Leicester NHS Trust, Leicestershire Clin Genet Serv, Leicester, Leics, England; [Walker, Lisa] Churchill Hosp, Oxford Reg Genet Serv, Oxford OX3 7LJ, England; [Kennedy, M. John] Trinity Coll Dublin, Acad Unit Clin & Mol Oncol, Dublin, Ireland; [Kennedy, M. John] St James Hosp, Dublin 8, Ireland; [Davidson, Rosemarie] So Gen Hosp, Lab Med, Glasgow G51 4TF, Lanark, Scotland; [Cole, Trevor] Birmingham Womens Hosp Healthcare NHS Trust, West Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Bressac-de Paillerets, Brigitte] Fdn Jean Dausset, INSERM, U946, Paris, France; [Bressac-de Paillerets, Brigitte] Inst Cancerol Gustave Roussy, Serv Genet, Villejuif, France; [Damiola, Francesca; Sinilnikova, Olga M.; Mazoyer, Sylvie] Univ Lyon 1, INSERM, U1052, CNRS,UMR 5286,Ctr Rech Cancerol Lyon, F-69365 Lyon, France; [Faivre, Laurence] Univ Bourgogne, CHU Dijon, Ctr Genet, Dijon, France; [Faivre, Laurence] Ctr Georges Francois Leclerc, Dijon, France; [Frenay, Marc] Ctr Antoine Lacassagne, Nice, France; [Sinilnikova, Olga M.; Giraud, Sophie] Hosp Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitut Canc Frequents, Lyon, France; [Caron, Olivier] Inst Cancerol Gustave Roussy, Dept Med, Villejuif, France; [Bonadona, Valerie] Ctr Leon Berard, Unite Prevent & Epiderniol Genet, F-69373 Lyon, France; [Bonadona, Valerie] Univ Lyon 1, CNRS, UMR 5558, F-69365 Lyon, France; [Giannini, Giuseppe] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Dolcetti, Riccardo] IRCCS, Ctr Riferimento Oncol, Canc Bioimmunotherapy Unit, Aviano, Italy; [Arnold, Norbert] Univ Hosp Schleswig Holstein, Dept Gynecol & Obstet, Kiel, Germany; [Arnold, Norbert] Univ Kiel, Kiel, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Niederacher, Dieter] Univ Dusseldorf, Univ Med Ctr, Dept Obstet & Gynecol, D-40225 Dusseldorf, Germany; [Pendl, Hansjoerg] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Human Genet, Kiel, Germany; [Sutter, Christian] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Borg, Ake] Lund Univ, Dept Oncol, Lund, Sweden; [Mein, Beatrice] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Rantala, Johanna] Karolinska Hosp, Dept Clin Genet, S-10401 Stockholm, Sweden; [Soller, Maria] Univ Lund Hosp, Univ & Reg Labs, Dept Clin Genet, S-22185 Lund, Sweden; [Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rodriguez, Gustavo C.] Univ Chicago, North Shore Univ Hlth Syst, Div Gynecol Oncol, Evanston, IL USA; [Salani, Ritu] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Skytte, Anne-Bine] Vejle Hosp, Dept Clin Genet, Vejle, Denmark; [Jensen, Uffe Birk] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Gerdes, Anne-Marie] Rigshosp, Copenhagen Univ Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Ejlertsen, Bent] Rigshosp, Copenhagen Univ Hosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Herston, Qld, Australia; [Berchuck, Andrew] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Cambridge; QIMR Berghofer Medical Research Institute; University of Cambridge; University of Queensland; Children's Medical Research Institute - Australia; University of Sydney; University of Southern California; Royal Brisbane & Women's Hospital; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; McGill University; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Yale University; Yale University; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Dartmouth College; Mayo Clinic; University of Kansas; Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); Mayo Clinic; University of London; London School of Hygiene & Tropical Medicine; Mayo Clinic; Netherlands Cancer Institute; Netherlands Cancer Institute; Mayo Clinic; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; KU Leuven; Flanders Institute for Biotechnology (VIB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centro Nacional de Investigaciones Oncologicas (CNIO); Mayo Clinic; University of Sheffield; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Cologne; University of London; King's College London; Ulm University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; Roswell Park Cancer Institute; University of Melbourne; Karolinska Institutet; Cancer Council Victoria; Monash University; Helmholtz Association; German Cancer Research Center (DKFZ); Laval University; Laval University; Cancer Research Center of Hawaii; University of Hawaii System; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Cedars Sinai Medical Center; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Hannover Medical School; Hannover Medical School; University of Oulu; University of Oulu; Friedrich Schiller University of Jena; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pomeranian Medical University; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; Hannover Medical School; Hannover Medical School; Vanderbilt University; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oslo; University of Oslo; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Warwick; University of Manchester; Technical University of Munich; Kliniken Essen-Mitte; Aichi Cancer Center; Universiti Malaya; Seoul National University (SNU); Aichi Cancer Center; National University of Singapore; National University of Singapore; Aichi Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Cedars Sinai Medical Center; National Cancer Institute - Thailand; Danish Cancer Society; Rigshospitalet; University of Copenhagen; World Health Organization; International Agency for Research on Cancer (IARC); University of Southampton; University of Copenhagen; Herlev & Gentofte Hospital; China Medical University Taiwan; Academia Sinica - Taiwan; Universiti Malaya; University of Copenhagen; Herlev & Gentofte Hospital; Mayo Clinic; Memorial Sloan Kettering Cancer Center; Duke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Duke University; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Netherlands Cancer Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Memorial Sloan Kettering Cancer Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Radboud University Nijmegen; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); Radboud University Nijmegen; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Hospital Universitario La Paz; University of New Mexico; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; British Columbia Cancer Agency; British Columbia Cancer Agency; Simon Fraser University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Pomeranian Medical University; Pomeranian Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Rigshospitalet; University of Copenhagen; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Royal Marsden NHS Foundation Trust; University of Melbourne; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Beatson Oncology Centre; Karolinska Institutet; University of Glasgow; Stanford University; Universite de Montreal; Shanghai Jiao Tong University; McGill University; McGill University; Royal Victoria Hospital; University of Toronto; University of Erlangen Nuremberg; University of Erlangen Nuremberg; IRCCS European Institute of Oncology (IEO); University of California System; University of California Irvine; University of London; University College London; Ruhr University Bochum; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Oulu; Maria Sklodowska-Curie National Research Institute of Oncology; University of Oulu; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Medical University of Warsaw; Ministry of Public Health - Thailand; University of Munich; Technical University of Munich; University of Cologne; University of Cologne; Aichi Cancer Center; National University of Singapore; Singapore National Eye Center; Shanghai Center for Disease Control & Prevention; University System of Ohio; Ohio State University; Roswell Park Cancer Institute; Aristotle University of Thessaloniki; Papageorgiou Hospital; Tri-Service General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Medical University of Vienna; Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Southern Denmark; Odense University Hospital; Memorial Sloan Kettering Cancer Center; Rigshospitalet; University of Copenhagen; City of Hope; Beckman Research Institute of City of Hope; University of Delaware; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; Womens College Hospital; City of Hope; IRCCS Istituto Oncologico Veneto (IOV); National Institute of Oncology Hungary; University of Kansas; University of Kansas Medical Center; National Centre of Scientific Research "Demokritos"; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Hospital Clinico San Carlos; N.N. Petrov Research Institute of Oncology; Latvian Biomedical Research & Study Centre; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Peter Maccallum Cancer Center; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Vrije Universiteit Amsterdam; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Manchester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Oxford; Trinity College Dublin; Trinity College Dublin; University of Glasgow; Birmingham Women's Hospital; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Dijon Bourgogne; Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; UNICANCER; Centre Antoine Lacassagne; CHU Lyon; UNICANCER; Centre Leon Berard; UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Sapienza University Rome; IRCCS European Institute of Oncology (IEO); IRCCS Aviano (CRO); University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Leipzig University; Heinrich Heine University Dusseldorf; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; Lund University; Umea University; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Chicago; University System of Ohio; Ohio State University; University of Southern Denmark; Lillebaelt Hospital; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Masaryk Memorial Cancer Institute; Royal Brisbane & Women's Hospital; Duke University	Bojesen, SE (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark.	stig.egil.bojesen@regionh.dk; Georgia.Trench@qimr.edu.au; amd24@medschl.cam.ac.uk	Arndt, Volker/AAI-7282-2020; Pharoah, Paul/V-6658-2019; YATABE, Yasushi/J-6461-2014; Wik, E./AAA-9105-2020; campbell, Ian G/F-6006-2011; Brüning, Thomas/G-8120-2015; Andrulis, Irene L./E-7267-2013; Brenner, Hermann/B-4627-2017; Ramus, Susan/AAG-8352-2019; French, Juliet D/A-4982-2011; Radice, Paolo/O-3119-2013; Salani, Ritu/E-4008-2011; /AAM-5330-2020; Rebbeck, Timothy/GLU-8348-2022; McLaughlin, John R/E-4577-2013; montagna, marco/E-2225-2012; Edwards, Stacey/A-4980-2011; Liu, Jianjun/AAK-4989-2020; Krakstad, Camilla/AAB-5138-2020; Lu, Yi/G-9292-2018; Devilee, Peter/GXV-8005-2022; Michailidou, Kyriaki/ABD-5122-2020; Knight, Julia/A-6843-2012; Schmidt, Marjanka K/G-9058-2011; Van Den Berg, David J/G-8598-2017; Garcia-Closas, Montserrat/F-3871-2015; Gao, Y./GWZ-3665-2022; laurent-puig, pierre/B-2226-2013; OMAR, SITI ZAWIAH BINTI/B-9817-2010; gao, yi/HCI-8298-2022; Miller, Nicola/F-4009-2018; Arnold, Norbert/E-3012-2010; Rzepecka, Iwona K/AFO-1670-2022; Baglietto, Laura/AAB-9051-2019; Noh, Dong-Young/G-5531-2011; Matsuo, Keitaro/H-6758-2019; Mensenkamp, Arjen/L-4520-2015; Reddel, Roger R/A-6635-2014; Gao, Yu/HGE-1937-2022; Laurent-Puig, Pierre/K-3641-2019; manoukian, siranoush/E-7132-2017; Woo, Yin Ling/B-5198-2010; Ditsch, Nina/F-6267-2014; Zheng, Wei/O-3351-2013; truong, therese/A-2837-2013; Fridley, Brooke L/D-8315-2015; Massuger, Leon F.A.G./H-8072-2014; Garcia-Closas, Montserrat/AAZ-6930-2021; Menkiszak, Janusz JM/I-4036-2014; Blanco, Ignacio/AAN-5426-2021; Wentzensen, Nicolas/AAG-8522-2019; Halle, Mari K/AAT-4856-2020; Luben, Robert N/H-5519-2015; DEVILEE, PETER/ABR-2140-2022; Jakubowska, Anna/O-8050-2014; Mazoyer, Sylvie/N-7559-2017; Margolin, Sara/AAX-9034-2020; Smart, Chanel E/C-9583-2011; Gronwald, Jacek/A-4576-2017; BYRSKI, Tomasz/I-2844-2014; Woo, Yin Ling/GPX-0086-2022; Knight, Julia/R-5617-2019; Narod, Steven A/AAA-6112-2022; Hartikainen, Jaana M/E-6256-2015; Eccles, Diana/K-6327-2019; Jensen, Uffe Birk/ABA-8306-2021; Menon, Usha/C-4716-2008; Paillerets, Brigitte Bressac-de/D-8954-2018; Bernard, Loris/K-5953-2014; Peterlongo, Paolo/Q-4717-2018; Vierkant, Robert/AAP-4927-2020; Bandera, Elisa V/M-4169-2014; Yip, Cheng-Har/B-1909-2010; Hansen, Thomas v. O./J-9361-2014; Lu, Wei/AAE-2921-2022; wildiers, hans/AAV-8158-2021; jager, agnes/V-6381-2017; Iau, Philip/B-4641-2011; Oosterwijk, Jan C./G-5770-2011; Johnatty, Sharon E/R-8890-2016; Severi, Gianluca/H-3774-2018; Giannini, Giuseppe/B-5672-2013; Jensen, Uffe Birk/E-6066-2017; Lissowska, Jolanta/AAH-3252-2020; Verdrengh, Evelien/H-4571-2012; Whittemore, Alice S/F-9925-2014; Fountzilas, George/ABF-2139-2020; Severi, Gianluca/Q-1824-2019; Kerin, Michael J/D-6748-2013; Guenel, Pascal/AAS-7688-2021; Bogdanova, Natalia V./Y-2205-2019; Savage, Sharon/AAB-5160-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Bonanni, Bernardo/AAM-7928-2020; Muranen, Taru/AAC-8418-2019; Savage, Sharon A/B-9747-2015; Li, Jingmei/I-2904-2012; Chenevix-Trench, Georgia/AAV-2014-2020; Figueroa, Jonine/AFK-2752-2022; Ekici, Arif B/C-3971-2013; Lambrechts, Diether/AAJ-3167-2020; Kiemeney, Lambertus A./D-3357-2009; Johnston, Rebecca L./C-7683-2011; Arndt, Volker/B-4999-2014; Hansen, Thomas/GWZ-2858-2022; balasubramanian, saba prakash/H-2830-2019; Figueroa, Jonine/GWD-1322-2022; Figueroa, Jonine/AAG-1065-2022; Peissel, Bernard/E-8187-2017; jones, Rob j/N-9379-2017; Evans, D Gareth/AAB-4308-2022; Imyanitov, Evgeny/ABG-8619-2021; Flyger, Henrik/AAM-6494-2021; Dörk, Thilo/J-8620-2012; Teo, Soo-hwang/H-2353-2014; Dolcetti, Riccardo/O-3832-2015; Johnston, Rebecca L./AAX-7868-2021; Fasching, Peter A/ABH-9912-2020; Guenel, Pascal/H-3728-2018; Schumacher, Fredrick/R-6043-2019; Bidzinski, Mariusz/AAH-5019-2019; zhang, weihua/GXV-1334-2022; Monteiro, Alvaro N. A./A-7566-2009; Brenner, Hermann/ABE-6383-2020; French, Juliet/AAV-4435-2020; Blanco, Ignacio/D-2565-2013; Lakhani, Sunil R/I-1970-2018; Bowtell, David/H-1007-2016; Zaffaroni, Daniela/I-8731-2017; Shrubsole, Martha J/K-5052-2015; van Asperen, Christi J/D-3970-2012; salvesen, Helga B/C-1187-2017; Gonzalez-Neira, Anna/C-5791-2015; Aben, Katja KH/G-9686-2016; Spurdle, Amanda B/A-4978-2011; Brooks-Wilson, Angela/E-9399-2012; Hartman, Mikael/B-4324-2011	Arndt, Volker/0000-0001-9320-8684; Pharoah, Paul/0000-0001-8494-732X; YATABE, Yasushi/0000-0003-1788-559X; Brüning, Thomas/0000-0001-9560-5464; Brenner, Hermann/0000-0002-6129-1572; Ramus, Susan/0000-0003-0005-7798; Radice, Paolo/0000-0001-6298-4111; Rebbeck, Timothy/0000-0002-4799-1900; montagna, marco/0000-0002-4929-2150; Liu, Jianjun/0000-0002-3255-3019; Krakstad, Camilla/0000-0002-0174-8139; Lu, Yi/0000-0001-9933-3654; Michailidou, Kyriaki/0000-0001-7065-1237; Schmidt, Marjanka K/0000-0002-2228-429X; Van Den Berg, David J/0000-0002-5404-5218; Garcia-Closas, Montserrat/0000-0003-1033-2650; laurent-puig, pierre/0000-0001-8475-5459; Miller, Nicola/0000-0002-5416-7047; Arnold, Norbert/0000-0003-4523-8808; Matsuo, Keitaro/0000-0003-1761-6314; Mensenkamp, Arjen/0000-0003-3805-877X; Reddel, Roger R/0000-0002-6302-6107; Laurent-Puig, Pierre/0000-0001-8475-5459; manoukian, siranoush/0000-0002-6034-7562; Woo, Yin Ling/0000-0003-1742-1066; Zheng, Wei/0000-0003-1226-070X; truong, therese/0000-0002-2943-6786; Fridley, Brooke L/0000-0001-7739-7956; Garcia-Closas, Montserrat/0000-0003-1033-2650; Menkiszak, Janusz JM/0000-0001-8279-7196; Blanco, Ignacio/0000-0002-7414-7481; Luben, Robert N/0000-0002-5088-6343; Jakubowska, Anna/0000-0002-5650-0501; Gronwald, Jacek/0000-0002-3643-2871; BYRSKI, Tomasz/0000-0001-9181-5026; Woo, Yin Ling/0000-0003-1742-1066; Knight, Julia/0000-0002-7610-7635; Hartikainen, Jaana M/0000-0001-8267-1905; Eccles, Diana/0000-0002-9935-3169; Jensen, Uffe Birk/0000-0002-6205-6355; Menon, Usha/0000-0003-3708-1732; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Peterlongo, Paolo/0000-0001-6951-6855; Vierkant, Robert/0000-0001-6242-5221; Bandera, Elisa V/0000-0002-8789-2755; Hansen, Thomas v. O./0000-0003-4635-2653; Lu, Wei/0000-0002-4150-8674; jager, agnes/0000-0002-7713-1450; Johnatty, Sharon E/0000-0002-7888-1966; Severi, Gianluca/0000-0001-7157-419X; Giannini, Giuseppe/0000-0003-0299-4056; Jensen, Uffe Birk/0000-0002-6205-6355; Lissowska, Jolanta/0000-0003-2695-5799; Severi, Gianluca/0000-0001-7157-419X; Guenel, Pascal/0000-0002-8359-518X; Savage, Sharon/0000-0001-6006-0740; Muranen, Taru/0000-0002-5895-1808; Savage, Sharon A/0000-0001-6006-0740; Li, Jingmei/0000-0001-8587-7511; Chenevix-Trench, Georgia/0000-0002-1878-2587; Figueroa, Jonine/0000-0002-5100-623X; Ekici, Arif B/0000-0001-6099-7066; Lambrechts, Diether/0000-0002-3429-302X; Kiemeney, Lambertus A./0000-0002-2368-1326; Johnston, Rebecca L./0000-0001-7503-9514; Arndt, Volker/0000-0001-9320-8684; balasubramanian, saba prakash/0000-0001-5953-2843; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Peissel, Bernard/0000-0001-9233-3571; Evans, D Gareth/0000-0002-8482-5784; Dörk, Thilo/0000-0002-9458-0282; Dolcetti, Riccardo/0000-0003-1625-9853; Fasching, Peter A/0000-0003-4885-8471; Guenel, Pascal/0000-0002-8359-518X; Schumacher, Fredrick/0000-0002-3073-7463; Monteiro, Alvaro N. A./0000-0002-8448-4801; Brenner, Hermann/0000-0002-6129-1572; French, Juliet/0000-0002-9770-0198; Blanco, Ignacio/0000-0002-7414-7481; Lakhani, Sunil R/0000-0003-4067-2760; Bowtell, David/0000-0001-9089-7525; Zaffaroni, Daniela/0000-0002-6995-2216; Shrubsole, Martha J/0000-0002-5591-7575; van Asperen, Christi J/0000-0002-1436-7650; salvesen, Helga B/0000-0002-4438-8831; Gonzalez-Neira, Anna/0000-0002-5421-2020; Aben, Katja KH/0000-0002-0214-2147; Spurdle, Amanda B/0000-0003-1337-7897; Brooks-Wilson, Angela/0000-0003-1009-6408; Brauch, Hiltrud/0000-0001-7531-2736; Winqvist, Robert/0000-0003-0932-9104; Dunning, Alison Margaret/0000-0001-6651-7166; Wauters, Els/0000-0002-0115-0030; Lux, Michael Patrick/0000-0002-2781-2178; Jensen, Allan/0000-0001-8124-4880; Thorne, Heather/0000-0003-3610-2511; Nevanlinna, Heli/0000-0002-0916-2976; Czene, Kamila/0000-0002-3233-5695; Goodman, Marc/0000-0002-4839-3021; van der Luijt, Rob/0000-0002-0018-1089; ADEMUYIWA, FOLUSO/0000-0002-6766-2258; Kerin, Michael/0000-0003-4164-5561; Pita, Guillermo/0000-0003-2393-0510; Blomqvist, Carl/0000-0003-3041-1938; Beesley, Jonathan/0000-0003-1942-325X; Orlow, Irene/0000-0001-6234-6961; Ito, Hidemi/0000-0002-8023-4581; Robson, Mark/0000-0002-3109-1692; Tworoger, Shelley/0000-0002-6986-7046; Heitz, Florian/0000-0002-2412-0352; Barrowdale, Daniel/0000-0003-1661-3939; Arias Perez, Jose Ignacio/0000-0003-4500-397X; Devilee, Peter/0000-0002-8023-2009; Nathanson, Katherine/0000-0002-6740-0901; Stutz, Michael/0000-0002-9298-1728; Mulligan, Anna Marie/0000-0002-7239-5297; Ikram, Mohammad Kamran/0000-0003-0173-9571; Damiola, Francesca/0000-0002-0238-1252; Schoof, Nils/0000-0003-0509-9217; Levine, Douglas/0000-0003-1038-8232; Brown, Robert/0000-0001-7960-5755; Yannoukakos, Drakoulis/0000-0001-7509-3510; Lubinski, Jan/0000-0003-2931-3003; Gerdes, Anne-Marie/0000-0002-0328-3320; Kupryjanczyk, Jolanta/0000-0001-5820-0214; Hou, Ming-Feng/0000-0001-6030-9702; Kang, Daehee/0000-0003-4031-5878; Lawrenson, Kate/0000-0002-6469-2515; Flanagan, James/0000-0003-4955-1383; Rudolph, Anja/0000-0001-7520-2035; Paul, James/0000-0001-7367-5816; Hogdall, Estrid/0000-0003-4689-5658; Roth, Rebecca/0000-0002-2841-4921; Hollestelle, Antoinette/0000-0003-1166-1966; Nordestgaard, Borge/0000-0002-1954-7220; Skytte, Anne-Bine/0000-0002-0067-9557; Hartman, Mikael/0000-0001-5726-9965; Fletcher, Olivia/0000-0001-9387-7116; Kataja, Vesa/0000-0003-4846-4843; Mariusz, Bidzinski/0000-0003-4767-6369; Cox, Angela/0000-0002-5138-1099; Baglietto, Laura/0000-0002-8193-7529; Southey, Melissa/0000-0002-6313-9005; Woods, Nicholas/0000-0002-4962-9083; Engel, Christoph/0000-0002-7247-282X; Foretova, Lenka/0000-0003-0494-2620; Dennis, Joe/0000-0003-4591-1214; Jones, Michael/0000-0001-7479-3451; Simard, Jacques/0000-0001-6906-3390; Weber, Rachel/0000-0001-7119-7734; Swerdlow, Anthony/0000-0001-5550-4159; Pelttari, Liisa/0000-0001-8091-9751; Faivre, Laurence/0000-0001-9770-444X; Giles, Graham/0000-0003-4946-9099; Pylkas, Katri/0000-0002-2449-0521; Campbell, Ian/0000-0002-7773-4155; Kjaer, Susanne/0000-0002-8347-1398; Durocher, Francine/0000-0001-8012-4641; Fountzilas, George/0000-0001-8045-2186; Hogdall, Claus/0000-0002-5959-8874; Halle, Mari K/0000-0002-2660-8271; Labreche, France/0000-0001-8722-0433; Long, Jirong/0000-0002-7433-9766; Margolin, Sara/0000-0002-5526-5570; Rzepecka, Iwona Krystyna/0000-0001-7305-6687; Bojesen, Stig/0000-0002-4061-4133; Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Olson, Sara/0000-0003-0182-2754; Mazoyer, Sylvie/0000-0002-2135-0160	European Commission's Seventh Framework Programme [223175, HEALTH-F2-2009-223175]; Cancer Research UK [C1287/A10118, C1287/Al2014]; European Union Cooperation in Science and Technology (COST) [BM0606]; Cancer Research UK; Canadian Institutes of Health Research (CIHR); Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; Genetic Associations and Mechanisms in Oncology [U19-CA148112]; US National Institutes of Health [CAl28978]; National Cancer Institute (NCI) [CA116201]; US Department of Defense Ovarian Cancer Idea [W81XWH-10-1-0341]; Breast Cancer Research Foundation; Komen Foundation for the Cure; Wellcome Trust Case Control Consortium; Wellcome Trust [076113]; NATIONAL CANCER INSTITUTE [U19CA148112, P30CA071789, P30CA008748, P30CA016520, R01CA092447, P50CA116201, R01CA112523, RC4CA153828, ZIACP010201, P50CA136393, ZIACP010126, R01CA087538, ZIACP010144, R01CA149429, R01CA122443, R01CA128978, P30CA072720, R37CA070867, R01CA083918, P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; Cancer Research UK [11174, 11022, 16565, 10118, 13086, 15960, 16561] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; National Breast Cancer Foundation [ECF-12-04, IF-12-06] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish	European Commission's Seventh Framework Programme(European Commission); Cancer Research UK(Cancer Research UK); European Union Cooperation in Science and Technology (COST); Cancer Research UK(Cancer Research UK); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade of Quebec; Genetic Associations and Mechanisms in Oncology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense Ovarian Cancer Idea(United States Department of Defense); Breast Cancer Research Foundation; Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Wellcome Trust Case Control Consortium(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; National Breast Cancer Foundation; Cancer Foundation Finland sr	We thank all the individuals who took part in these studies and all the researchers, clinicians, technicians and administrative staff who have enabled this work to be carried out. COGS is funded through a grant from the European Commission's Seventh Framework Programme (agreement 223175 HEALTH-F2-2009-223175). BCAC is funded by Cancer Research UK (C1287/A10118 and C1287/Al2014). BCAC meetings have been funded by the European Union Cooperation in Science and Technology (COST) programme (BM0606). Telomere length measurement and analysis were funded by Cancer Research UK project grant C1287/A9540 and Chief Physician Johan Boserup and Lise Boserup's Fund. CIMBA data management and analysis were supported by Cancer Research UK grants C12292/A11174 and C1287/A10118. OCAC is supported by a grant from the Ovarian Cancer Research Fund thanks to the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). Genotyping of the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program (J.S. and D.E.) and the Ministry of Economic Development, Innovation and Export Trade of Quebec (grant PSR-SIIRI-701; J.S., D.E. and P. Hall). Scientific development and funding of the OCAC portion of this project were supported by Genetic Associations and Mechanisms in Oncology (GAME-ON; U19-CA148112). CIMBA genotyping was supported by US National Institutes of Health (NIH) grant CAl28978, a National Cancer Institute (NCI) Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a US Department of Defense Ovarian Cancer Idea award (W81XWH-10-1-0341) and grants from the Breast Cancer Research Foundation and the Komen Foundation for the Cure. This study made use of data generated by The Wellcome Trust Case Control Consortium (funding was provided by Wellcome Trust award 076113) and the TCGA Pilot Project established by NCI and the National Human Genome Research Institute.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baird DM, 2006, EXP GERONTOL, V41, P1223, DOI 10.1016/j.exger.2006.09.009; Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Beesley J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024987; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chen YJ, 2008, CANCER RES, V68, P5724, DOI 10.1158/0008-5472.CAN-08-0058; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Colgin LM, 2000, NEOPLASIA, V2, P426, DOI 10.1038/sj.neo.7900112; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hiyama E, 1996, J NATL CANCER I, V88, P116, DOI 10.1093/jnci/88.2.116; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mirabello L, 2010, HUM MUTAT, V31, P1050, DOI 10.1002/humu.21314; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, pE1363, DOI 10.1073/pnas.1112414108; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Saeboe-Larssen S, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-26; Shen J, 2010, CANCER EPIDEM BIOMAR, V19, P219, DOI 10.1158/1055-9965.EPI-09-0771; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stampfer MR, 2003, CANCER LETT, V194, P199, DOI 10.1016/S0304-3835(02)00707-3; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Thomas P, 2008, MECH AGEING DEV, V129, P183, DOI 10.1016/j.mad.2007.12.004; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360; Zhao YM, 2011, INT J CANCER, V129, P2463, DOI 10.1002/ijc.25918; Zou P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-7	70	407	423	2	266	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					371	384		10.1038/ng.2566	http://dx.doi.org/10.1038/ng.2566			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23535731	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000316840600007
J	Mito, Y; Henikoff, JG; Henikoff, S				Mito, Y; Henikoff, JG; Henikoff, S			Genome-scale profiling of histone H3.3 replacement patterns	NATURE GENETICS			English	Article							INTERGENIC TRANSCRIPTION; DNA-REPLICATION; ACTIVE GENES; CHROMATIN; METHYLATION; POLYCOMB; ACETYLATION; DEPOSITION; VARIANTS; ELONGATION	Histones of multicellular organisms are assembled into chromatin primarily during DNA replication. When chromatin assembly occurs at other times, the histone H3.3 variant replaces canonical H3. Here we introduce a new strategy for profiling epigenetic patterns on the basis of H3.3 replacement, using microarrays covering roughly one-third of the Drosophila melanogaster genome at 100-bp resolution. We identified patterns of H3.3 replacement over active genes and transposons. H3.3 replacement occurred prominently at sites of abundant RNA polymerase II and methylated H3 Lys4 throughout the genome and was enhanced on the dosage-compensated male X chromosome. Active genes were depleted of histones at promoters and were enriched in H3.3 from upstream to downstream of transcription units. We propose that deposition and inheritance of actively modified H3.3 in regulatory regions maintains transcriptionally active chromatin.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Echalier G., 1997, DROSOPHILA CELLS CUL; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; HENIKOFF S, 1993, CELL, V72, P1, DOI 10.1016/0092-8674(93)90040-W; Hogga I, 2002, DEVELOPMENT, V129, P4915; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Straub T, 2005, FEBS LETT, V579, P3258, DOI 10.1016/j.febslet.2005.03.050; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; WATERBORG JH, 1990, J BIOL CHEM, V265, P17157; WOLFFE A, 1992, CHROMATIN STRUCTURE; Workman JL, 2004, P NATL ACAD SCI USA, V101, P1429, DOI 10.1073/pnas.0308506101; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	50	407	424	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1090	1097		10.1038/ng1637	http://dx.doi.org/10.1038/ng1637			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16155569				2022-12-17	WOS:000232185600020
J	Kim, SH; Kaminker, P; Campisi, J				Kim, SH; Kaminker, P; Campisi, J			TIN2, a new regulator of telomere length in human cells	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; REPLICATIVE SENESCENCE; CHROMOSOME STABILITY; RETROVIRAL VECTORS; HUMAN FIBROBLASTS; GENE-TRANSFER; RAP1 PROTEIN; LIFE-SPAN; IN-VITRO; YEAST	Telomeres are DNA-protein structures that cap linear chromosomes and are essential for maintaining genomic stability and cell phenotype. We identified a novel human telomere-associated protein, TIN2, by interaction cloning using the telomeric DNA-binding-protein TRF1 as a bait. TIN2 interacted with TRF1 in vitro and in cells, and colocalized with TRF1 in nuclei and metaphase chromosomes. A mutant TIN2 that lacks amino-terminal sequences effects elongated human telomeres in a telomerase-dependent manner. Our findings suggest that TRF1 is insufficient for control of telomere length in human cells, and that TIN2 is an essential mediator of TRF1 function.	Lawrence Berkeley Natl Lab, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Campisi, J (corresponding author), Lawrence Berkeley Natl Lab, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.	jcampisi@lbl.gov			NATIONAL INSTITUTE ON AGING [R01AG009909, T32AG000266, R37AG009909] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG009909, T32 AG000266, AG00266, AG09909] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BRIAND P, 1987, IN VITRO CELL DEV B, V23, P181, DOI 10.1007/BF02623578; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi Judith, 1996, P121; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; COMPTON DA, 1991, J CELL BIOL, V112, P1083, DOI 10.1083/jcb.112.6.1083; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Dimri GP, 1996, BIOL SIGNAL, V5, P154; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; FINER MH, 1994, BLOOD, V83, P43; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; James P, 1996, GENETICS, V144, P1425; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lingner J, 1998, CURR OPIN GENET DEV, V8, P226, DOI 10.1016/S0959-437X(98)80145-7; Marcand S, 1996, GENE DEV, V10, P1297, DOI 10.1101/gad.10.11.1297; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Sambrook J., 1989, MOL CLONING; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Shore D, 1997, TRENDS BIOCHEM SCI, V22, P233, DOI 10.1016/S0968-0004(97)01082-7; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	47	407	432	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1999	23	4					405	412		10.1038/70508	http://dx.doi.org/10.1038/70508			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581025	Green Published, Green Accepted			2022-12-17	WOS:000084023900014
J	SHIANG, R; RYAN, SG; ZHU, YZ; HAHN, AF; OCONNELL, P; WASMUTH, JJ				SHIANG, R; RYAN, SG; ZHU, YZ; HAHN, AF; OCONNELL, P; WASMUTH, JJ			MUTATIONS IN THE ALPHA-1 SUBUNIT OF THE INHIBITORY GLYCINE RECEPTOR CAUSE THE DOMINANT NEUROLOGIC DISORDER, HYPEREKPLEXIA	NATURE GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; CHROMOSOMAL LOCALIZATION; STARTLE DISEASE; FUNCTIONAL EXPRESSION; GENES; MOUSE; HYPEREXPLEXIA; ASSIGNMENT; FRAGMENTS	Hereditary hyperekplexia, or familiar startle disease (STHE), is an autosomal dominant neurologic disorder characterized by marked muscle rigidity of central nervous system origin and an exaggerated startle response to unexpected acoustic or tactile stimuli. Linkage analyses in several large families provided evidence for locus homogeneity and showed the disease gene was linked to DNA markers on the long arm of chromosome 5. Here we describe the identification of point mutations in the gene encoding the alpha(1) subunit of the glycine receptor (GLRA1) in STHE patients from four different families. All mutations occur in the same base pair of exon 6 and result in the substitution of an uncharged amino acid (leucine or glutamine) for Arg271 in the mature protein.	UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717; UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,SAN ANTONIO,TX 78284; UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284; UNIV WESTERN ONTARIO,DEPT CLIN NEUROL STUDIES,LONDON,ON,CANADA	University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Western University (University of Western Ontario)								ANDERMANN F, 1980, BRAIN, V103, P985, DOI 10.1093/brain/103.4.985; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BROWN P, 1991, BRAIN, V114, P1903, DOI 10.1093/brain/114.4.1903; BUCKLE VJ, 1989, NEURON, V3, P647, DOI 10.1016/0896-6273(89)90275-4; BUCKWALTER MS, 1993, GENOMICS, V17, P279, DOI 10.1006/geno.1993.1322; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; DAVIS M, 1982, J NEUROSCI, V2, P791; DAVIS M, 1976, PSYCHOPHARMACOLOGY, V47, P217, DOI 10.1007/BF00427605; EICHER EM, 1980, J HERED, V71, P315, DOI 10.1093/oxfordjournals.jhered.a109378; GIACOLA GP, IN PRESS AM J DIS CH; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HELLER AH, 1982, BRAIN RES, V234, P299, DOI 10.1016/0006-8993(82)90870-8; KIRSTEIN L, 1958, ACTA PSYCH NEUROL, V33, P471, DOI 10.1111/j.1600-0447.1958.tb03533.x; KRNJEVIC K, 1981, HDB PHYSL, P107; LANE PW, 1987, J HERED, V78, P353, DOI 10.1093/oxfordjournals.jhered.a110414; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; MARKAND ON, 1984, ARCH NEUROL-CHICAGO, V41, P71, DOI 10.1001/archneur.1984.04050130077028; MATSUMOTO J, 1992, ANN NEUROL, V32, P41, DOI 10.1002/ana.410320108; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NIGRO MA, 1992, PEDIATR NEUROL, V8, P221, DOI 10.1016/0887-8994(92)90073-8; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; PUCKETT C, 1991, P NATL ACAD SCI USA, V88, P7557, DOI 10.1073/pnas.88.17.7557; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; RYAN SG, 1992, AM J HUM GENET, V51, P1334; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SUHREN O, 1966, J NEUROL SCI, V3, P577, DOI 10.1016/0022-510X(66)90047-5; TEBECIS AK, 1972, BRAIN RES, V40, P373, DOI 10.1016/0006-8993(72)90140-0; Warrington J. A., 1992, American Journal of Human Genetics, V51, pA248; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WASMUTH JJ, 1991, CYTOGENET CELL GENET, V58, P261, DOI 10.1159/000133165	36	407	420	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					351	358		10.1038/ng1293-351	http://dx.doi.org/10.1038/ng1293-351			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298642				2022-12-17	WOS:A1993ML14500010
J	Bonder, MJ; Kurilshikov, A; Tigchelaar, EF; Mujagic, Z; Imhann, F; Vila, AV; Deelen, P; Vatanen, T; Schirmer, M; Smeekens, SP; Zhernakova, DV; Jankipersadsing, SA; Jaeger, M; Oosting, M; Cenit, MC; Masclee, AAM; Swertz, MA; Li, Y; Kumar, V; Joosten, L; Harmsen, H; Weersma, RK; Franke, L; Hofker, MH; Xavier, RJ; Jonkers, D; Netea, MG; Wijmenga, C; Fu, JY; Zhernakova, A				Bonder, Marc Jan; Kurilshikov, Alexander; Tigchelaar, Ettje F.; Mujagic, Zlatan; Imhann, Floris; Vila, Arnau Vich; Deelen, Patrick; Vatanen, Tommi; Schirmer, Melanie; Smeekens, Sanne P.; Zhernakova, Dania V.; Jankipersadsing, Soesma A.; Jaeger, Martin; Oosting, Marije; Cenit, Maria Carmen; Masclee, Ad A. M.; Swertz, Morris A.; Li, Yang; Kumar, Vinod; Joosten, Leo; Harmsen, Hermie; Weersma, Rinse K.; Franke, Lude; Hofker, Marten H.; Xavier, Ramnik J.; Jonkers, Daisy; Netea, Mihai G.; Wijmenga, Cisca; Fu, Jingyuan; Zhernakova, Alexandra			The effect of host genetics on the gut microbiome	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; LACTASE PERSISTENCE; COLORECTAL-CANCER; RECEPTOR; EXPRESSION; DIVERSITY; VARIANTS; OBESITY	The gut microbiome is affected by multiple factors, including genetics. In this study, we assessed the influence of host genetics on microbial species, pathways and gene ontology categories, on the basis of metagenomic sequencing in 1,514 subjects. In a genome-wide analysis, we identified associations of 9 loci with microbial taxonomies and 33 loci with microbial pathways and gene ontology terms at P < 5 x 10(-8). Additionally, in a targeted analysis of regions involved in complex diseases, innate and adaptive immunity, or food preferences, 32 loci were identified at the suggestive level of P < 5 x 10(-6). Most of our reported associations are new, including genome-wide significance for the C-type lectin molecules CLEC4F-CD207 at 2p13.3 and CLEC4A-FAM90A1 at 12p13. We also identified association of a functional LCT SNP with the Bifidobacterium genus (P = 3.45 x 10(-8)) and provide evidence of a gene-diet interaction in the regulation of Bifidobacterium abundance. Our, results demonstrate the importance of understanding host-microbe interactions to gain better insight into human health.	[Bonder, Marc Jan; Kurilshikov, Alexander; Tigchelaar, Ettje F.; Deelen, Patrick; Zhernakova, Dania V.; Jankipersadsing, Soesma A.; Cenit, Maria Carmen; Swertz, Morris A.; Li, Yang; Kumar, Vinod; Franke, Lude; Wijmenga, Cisca; Fu, Jingyuan; Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Kurilshikov, Alexander] RAS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia; [Kurilshikov, Alexander] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Tigchelaar, Ettje F.; Mujagic, Zlatan; Zhernakova, Alexandra] Top Inst Food & Nutr, Wageningen, Netherlands; [Mujagic, Zlatan; Masclee, Ad A. M.; Jonkers, Daisy] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Div Gastroenterol Hepatol, Dept Internal Med Med Ctr, Maastricht, Netherlands; [Imhann, Floris; Vila, Arnau Vich; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Deelen, Patrick; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Vatanen, Tommi; Schirmer, Melanie; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Vatanen, Tommi] Aalto Univ, Dept Comp Sci, Sch Sci, Espoo, Finland; [Schirmer, Melanie] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Smeekens, Sanne P.; Jaeger, Martin; Oosting, Marije; Joosten, Leo; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Smeekens, Sanne P.; Jaeger, Martin; Oosting, Marije; Joosten, Leo; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Jankipersadsing, Soesma A.; Hofker, Marten H.; Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Harmsen, Hermie] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Cenit, Maria Carmen] Dr Peset Univ Hosp, Dept Pediat, Valencia, Spain	University of Groningen; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Top Institute Food & Nutrition; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; University of Groningen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Aalto University; Harvard University; Harvard T.H. Chan School of Public Health; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; University of Groningen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wijmenga, C; Fu, JY; Zhernakova, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; Zhernakova, A (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Fu, JY (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.	c.wijmenga@umcg.nl; j.fu@umcg.nl; a.zhernakova@umcg.nl	Kurilshikov, Alexander/GWC-1519-2022; Kumar, Vinod/ABC-4866-2020; Netea, Mihai/N-5155-2014; Li, Yang/HGT-8446-2022; Joosten, Leo AB/H-3138-2015; Fu, Jingyuan/ABE-6868-2020; Smeekens, Sanne/G-8307-2011; Deelen, Patrick/B-3566-2013; Wijmenga, Cisca/AAE-7719-2019; Zhernakova, Alexandra/ABA-9372-2020; Oosting, Marije/H-7437-2015; Fu, Jingyuan/E-8980-2012; Jaeger, Martin/H-3359-2015; Weersma, Rinse/ABE-3807-2021; Fu, JY/GRR-6179-2022; Vatanen, Tommi/J-5458-2018; Schirmer, Melanie/HDN-5528-2022; Smeekens, Sanne/AAZ-2061-2021; Zhernakova, Daria/M-5619-2016; Cenit, Maria Carmen MC/E-9538-2017; Franke, Lude/P-7036-2016	Kurilshikov, Alexander/0000-0003-2541-5627; Kumar, Vinod/0000-0002-2775-6049; Li, Yang/0000-0003-4022-7341; Joosten, Leo AB/0000-0001-6166-9830; Fu, Jingyuan/0000-0001-5578-1236; Smeekens, Sanne/0000-0002-7835-914X; Deelen, Patrick/0000-0002-5654-3966; Wijmenga, Cisca/0000-0002-5635-1614; Jaeger, Martin/0000-0001-6994-493X; Vatanen, Tommi/0000-0003-0949-1291; Smeekens, Sanne/0000-0002-7835-914X; Zhernakova, Daria/0000-0001-6531-3890; Cenit, Maria Carmen MC/0000-0001-8667-5313; Jankipersadsing, Soesma/0000-0001-9225-9236; Vich Vila, Arnau/0000-0003-4691-5583; Franke, Lude/0000-0002-5159-8802; Schirmer, Melanie/0000-0001-6456-3679; Bonder, Marc Jan/0000-0002-8431-3180	Top Institute Food and Nutrition, Wageningen [TiFN GH001]; Netherlands Organization for Scientific Research [NWO-VIDI 864.13.013]; ZonMW-VIDI [917.14.374, 016.136.308]; CardioVasculair Onderzoek Nederland [CVON 2012-03]; University of Groningen; European Research Council under the European Union; ERC [2012-322698]; Spinoza Prize from the Netherlands Organization for Scientific Research; ERC Consolidator Grant [310372, 259867]; ERC Starting Grant [637640]; Netherlands Organization for Scientific Research VENI grant [863.13.011]	Top Institute Food and Nutrition, Wageningen; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ZonMW-VIDI(Netherlands Organization for Health Research and Development); CardioVasculair Onderzoek Nederland; University of Groningen; European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Spinoza Prize from the Netherlands Organization for Scientific Research; ERC Consolidator Grant(European Research Council (ERC)); ERC Starting Grant(European Research Council (ERC)); Netherlands Organization for Scientific Research VENI grant	This project was funded by grants from Top Institute Food and Nutrition, Wageningen, to C.W. (TiFN GH001), the Netherlands Organization for Scientific Research to J.F. (NWO-VIDI 864.13.013), L.F. (ZonMW-VIDI 917.14.374) and R.K.W. (ZonMW-VIDI 016.136.308), and CardioVasculair Onderzoek Nederland to M.H.H., M.G.N., A.Z. and J.F. (CVON 2012-03). A.Z. holds a Rosalind Franklin Fellowship (University of Groningen). This research received funding from the European Research Council under the European Union's Seventh Framework Programme: C.W. is supported by FP7/2007-2013/ERC Advanced Grant (agreement 2012-322698) and a Spinoza Prize from the Netherlands Organization for Scientific Research. M.G.N. holds an ERC Consolidator Grant (310372). L.P. has an FP7/2007-2013 grant (agreement 259867) and an ERC Starting Grant (637640, ImmRisk). Y.L. holds a Netherlands Organization for Scientific Research VENI grant (863.13.011).	Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bunge J, 2014, ANNU REV STAT APPL, V1, P427, DOI 10.1146/annurev-statistics-022513-115654; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Casals F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-202; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davenport ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140301; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Doney ASF, 2004, DIABETOLOGIA, V47, P555, DOI 10.1007/s00125-003-1323-1; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Galeone Massimiliano, 2012, Patholog Res Int, V2012, P595380, DOI 10.1155/2012/595380; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hromatka BS, 2015, HUM MOL GENET, V24, P2700, DOI 10.1093/hmg/ddv028; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juste C, 2014, GUT, V63, P1566, DOI 10.1136/gutjnl-2012-303786; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Khan MT, 2012, ANTIOXID REDOX SIGN, V17, P1433, DOI 10.1089/ars.2012.4701; Klingberg S, 2008, AM J CLIN NUTR, V87, P993, DOI 10.1093/ajcn/87.4.993; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Koren I, 2010, CURR BIOL, V20, P1093, DOI 10.1016/j.cub.2010.04.041; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Landy J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12955; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; Lee S, 2011, PATHOL INT, V61, P210, DOI 10.1111/j.1440-1827.2011.02646.x; Liu TC, 2016, INFLAMM BOWEL DIS, V22, pS4, DOI 10.1097/01.MIB.0000480097.23732.5e; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mujagic Z, 2014, ALIMENT PHARM THER, V40, P288, DOI 10.1111/apt.12829; Netea MG, 2016, NAT MED, V22, P831, DOI 10.1038/nm.4140; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Singh V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8113; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Tigchelaar EF, 2016, GUT, V65, P540, DOI 10.1136/gutjnl-2015-310328; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Torres J, 2016, ALIMENT PHARM THER, V43, P790, DOI 10.1111/apt.13552; Troelsen JT, 2005, BBA-GEN SUBJECTS, V1723, P19, DOI 10.1016/j.bbagen.2005.02.003; Tyler AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066934; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Yahiro K, 2014, INFECT IMMUN, V82, P4899, DOI 10.1128/IAI.02213-14; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhou YH, 2013, J MOL HISTOL, V44, P555, DOI 10.1007/s10735-013-9504-9	66	406	416	12	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1407	1412		10.1038/ng.3663	http://dx.doi.org/10.1038/ng.3663			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27694959				2022-12-17	WOS:000386543400017
J	Barreiro, LB; Laval, G; Quach, H; Patin, E; Quintana-Murci, L				Barreiro, Luis B.; Laval, Guillaume; Quach, Helene; Patin, Etienne; Quintana-Murci, Lluis			Natural selection has driven population differentiation in modern humans	NATURE GENETICS			English	Article							HUMAN GENOME; POSITIVE SELECTION; HAPLOTYPE MAP; SIGNATURES; REGIONS; POLYMORPHISM; PATTERNS; SNPS	The considerable range of observed phenotypic variation in human populations may reflect, in part, distinctive processes of natural selection and adaptation to variable environmental conditions. Although recent genome-wide studies have identified candidate regions under selection(1-5), it is not yet clear how natural selection has shaped population differentiation. Here, we have analyzed the degree of population differentiation at 2.8 million Phase II HapMap single-nucleotide polymorphisms(6). We find that negative selection has globally reduced population differentiation at amino acid-altering mutations, particularly in disease-related genes. Conversely, positive selection has ensured the regional adaptation of human populations by increasing population differentiation in gene regions, primarily at nonsynonymous and 5'-UTR variants. Our analyses identify a fraction of loci that have contributed, and probably still contribute, to the morphological and disease-related phenotypic diversity of current human populations.	[Barreiro, Luis B.; Laval, Guillaume; Quach, Helene; Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, CNRS URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Quintana-Murci, L (corresponding author), Inst Pasteur, CNRS URA3012, Human Evolutionary Genet Unit, 25 Rue Dr Roux, F-75015 Paris, France.	quintana@pasteur.fr	Barreiro, Luis/I-7772-2015; Patin, Etienne/G-6768-2012; Quintana-Murci, Lluis/AAB-7468-2022	Patin, Etienne/0000-0002-9911-4459; Quach, Helene/0000-0002-3493-0973; Quintana-Murci, Lluis/0000-0003-2429-6320; Barreiro, Luis/0000-0001-9456-367X				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; EXCOFFIER L, 1992, GENETICS, V131, P491; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; McVean G, 2006, CURR OPIN GENET DEV, V16, P624, DOI 10.1016/j.gde.2006.09.004; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	30	406	416	0	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					340	345		10.1038/ng.78	http://dx.doi.org/10.1038/ng.78			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246066				2022-12-17	WOS:000253548400026
J	Valdar, W; Solberg, LC; Gauguier, D; Burnett, S; Klenerman, P; O Cookson, W; Taylor, MS; Rawlins, JNP; Mott, R; Flint, J				Valdar, William; Solberg, Leah C.; Gauguier, Dominique; Burnett, Stephanie; Klenerman, Paul; O Cookson, William; Taylor, Martin S.; Rawlins, J. Nicholas P.; Mott, Richard; Flint, Jonathan			Genome-wide genetic association of complex traits in heterogeneous stock mice	NATURE GENETICS			English	Article							AIRWAY HYPERRESPONSIVENESS; MODEL SELECTION; LOCUS ANALYSIS; QTL; RESOLUTION; C57BL/6J; DISSECTION; IDENTIFY; STRAINS; ANXIETY	Difficulties in fine-mapping quantitative trait loci (QTLs) are a major impediment to progress in the molecular dissection of complex traits in mice. Here we show that genome-wide high-resolution mapping of multiple phenotypes can be achieved using a stock of genetically heterogeneous mice. We developed a conservative and robust bootstrap analysis to map 843 QTLs with an average 95% confidence interval of 2.8 Mb. The QTLs contribute to variation in 97 traits, including models of human disease (asthma, type 2 diabetes mellitus, obesity and anxiety) as well as immunological, biochemical and hematological phenotypes. The genetic architecture of almost all phenotypes was complex, with many loci each contributing a small proportion to the total variance. Our data set, freely available at http://gscan.well.ox.ac.uk, provides an entry point to the functional characterization of genes involved in many complex traits.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford	Flint, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	rmott@well.ox.ac.uk; jf@well.ox.ac.uk	Valdar, William/AAE-4354-2019; Taylor, Martin S/C-3825-2009; Gauguier, Dominique/G-2190-2016	Taylor, Martin S/0000-0001-7656-330X; Gauguier, Dominique/0000-0001-6156-9530; klenerman, paul/0000-0003-4307-9161; Flint, Jonathan/0000-0002-9427-4429; Mott, Richard/0000-0002-1022-9330				Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Balding DJ, 2002, J R STAT SOC B, V64, P737; Ball RD, 2001, GENETICS, V159, P1351; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cohen RM, 2001, MAMM GENOME, V12, P501, DOI 10.1007/s00335-001-2047-5; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Demarest K, 2001, BEHAV GENET, V31, P79, DOI 10.1023/A:1010261909853; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; DiPetrillo K, 2005, TRENDS GENET, V21, P683, DOI 10.1016/j.tig.2005.09.008; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Foreman JE, 2005, PHYSIOL GENOMICS, V23, P295, DOI 10.1152/physiolgenomics.00062.2005; Gershenfeld HK, 1997, BEHAV GENET, V27, P201, DOI 10.1023/A:1025653812535; Hackett CA, 2001, GENET RES, V77, P95, DOI 10.1017/S0016672300004869; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Morris KH, 1999, MAMM GENOME, V10, P225, DOI 10.1007/s003359900977; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mott R, 2002, GENETICS, V160, P1609; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Sillanpaa MJ, 2002, TRENDS GENET, V18, P301, DOI 10.1016/S0168-9525(02)02688-4; Singer JB, 2005, GENETICS, V169, P855, DOI 10.1534/genetics.104.031492; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Steinberger D, 2003, J NEUROSCI, V23, P2426; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Valdar W, 2006, GENETICS, V172, P1783, DOI 10.1534/genetics.104.039313; VALDAR W, IN PRESS GENETICS; Visscher PM, 1996, THEOR APPL GENET, V93, P691, DOI 10.1007/BF00224064; Visscher PM, 1996, GENETICS, V143, P1013; Wang XS, 2005, CIRC RES, V96, P27, DOI 10.1161/01.RES.0000151332.39871.13; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Wehner JM, 1997, NAT GENET, V17, P331, DOI 10.1038/ng1197-331; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2005, GENETICS, V171, P673, DOI 10.1534/genetics.104.028902; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450	48	406	410	2	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					879	887		10.1038/ng1840	http://dx.doi.org/10.1038/ng1840			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16832355				2022-12-17	WOS:000239325700016
J	Zhu, LM; Vranckx, R; Van Kien, PK; Lalande, A; Boisset, N; Mathieu, F; Wegman, M; Glancy, L; Gasc, JM; Brunotte, FO; Bruneval, P; Wolf, JE; Michel, JB; Jeunemaitre, X				Zhu, LM; Vranckx, R; Van Kien, PK; Lalande, A; Boisset, N; Mathieu, F; Wegman, M; Glancy, L; Gasc, JM; Brunotte, FO; Bruneval, P; Wolf, JE; Michel, JB; Jeunemaitre, X			Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus	NATURE GENETICS			English	Article							HEAVY-CHAIN ISOFORMS; COILED-COILS; LOCUS; ANEURYSM/DISSECTION; DISEASE	We have recently described two kindreds presenting thoracic aortic aneurysm and/or aortic dissection ( TAAD) and patent ductus arteriosus (PDA)(1,2) and mapped the disease locus to 16p12.2-p13.13 (ref. 3). We now demonstrate that the disease is caused by mutations in the MYH11 gene affecting the C-terminal coiled-coil region of the smooth muscle myosin heavy chain, a specific contractile protein of smooth muscle cells (SMC). All individuals bearing the heterozygous mutations, even if asymptomatic, showed marked aortic stiffness. Examination of pathological aortas showed large areas of medial degeneration with very low SMC content. Abnormal immunological recognition of SM-MHC and the colocalization of wild-type and mutant rod proteins in SMC, in conjunction with differences in their coimmunoprecipitation capacities, strongly suggest a dominant-negative effect. Human MYH11 gene mutations provide the first example of a direct change in a specific SMC protein leading to an inherited arterial disease.	Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Genet, F-75015 Paris, France; INSERM, U36, F-75005 Paris, France; INSERM, U772, F-75005 Paris, France; Coll France, F-75005 Paris, France; Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, French Chinese Genom Pole, Shanghai, Peoples R China; INSERM, U698, Paris, France; Univ Paris 07, Fac Med Xavier Bichat, F-75018 Paris, France; Univ Bourgogne, Lab Physiopathol & Pharmacol Cardiovasc Expt, F-21000 Dijon, France; CHU Dijon, Serv Cardiol 2, F-21000 Dijon, France; CHU Dijon, Ctr Imagerie Resonance Magnet, F-21000 Dijon, France; CNRS, UMR 158, Lab Elect & Informat Image, F-21000 Dijon, France; CNRS, UMR 7590, Dept Biol Struct, IMPMC, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Louisiana State Univ, Hlth Sci Ctr, Dept Med, Cardiol Sect, New Orleans, LA 70112 USA; Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Anatomopathol, F-75015 Paris, France; Univ Paris 05, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Shanghai Jiao Tong University; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Jeunemaitre, X (corresponding author), Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Genet, F-75015 Paris, France.	xavier.jeunemaitre@epg.aphp.fr	ZHU, Limin/AAZ-9201-2020; JEUNEMAITRE, Xavier/AAQ-4853-2021; Mathieu, Flavie/M-9855-2017; Michel, Jean-Baptiste/AAH-9336-2020; Lalande, Alain/T-1050-2017	JEUNEMAITRE, Xavier/0000-0001-5925-381X; Lalande, Alain/0000-0002-7970-366X; KHAU VAN KIEN, Philippe/0000-0001-7754-969X; Mathieu, Flavie/0000-0002-3386-0299				AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Boileau C, 2005, CURR OPIN CARDIOL, V20, P194, DOI 10.1097/01.hco.0000162398.21972.cd; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Coady MA, 1999, ARCH SURG-CHICAGO, V134, P361, DOI 10.1001/archsurg.134.4.361; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Glancy DL, 2001, AM J CARDIOL, V87, P813, DOI 10.1016/S0002-9149(00)01515-0; Guo DC, 2001, CIRCULATION, V103, P2461; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HORNBLAD PY, 1967, CARDIOLOGIA, V51, P262, DOI 10.1159/000165823; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalande A, 2002, INVEST RADIOL, V37, P685, DOI 10.1097/00004424-200212000-00008; Laurent S, 2005, HYPERTENSION, V45, P1050, DOI 10.1161/01.HYP.0000164580.39991.3d; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mani A, 2002, P NATL ACAD SCI USA, V99, P15054, DOI 10.1073/pnas.192582999; Meloni I, 2001, Hum Mutat, V18, P85, DOI 10.1002/humu.1157; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; NACHTIGAL M, 1989, IN VITRO CELL DEV B, V25, P892; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Quevillon-Cheruel S, 1999, FEBS LETT, V454, P303, DOI 10.1016/S0014-5793(99)00827-3; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003, DOI 10.1161/01.ATV.17.5.1003; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; Van Kien PK, 2005, CIRCULATION, V112, P200, DOI 10.1161/CIRCULATIONAHA.104.506345; Van Kien PK, 2004, EUR J HUM GENET, V12, P173, DOI 10.1038/sj.ejhg.5201119; Vaughan CJ, 2001, CIRCULATION, V103, P2469	30	406	420	2	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					343	349		10.1038/ng1721	http://dx.doi.org/10.1038/ng1721			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16444274				2022-12-17	WOS:000235589600017
J	Du, W; Bautista, JF; Yang, HH; Diez-Sampedro, A; You, SA; Wang, LJ; Kotagal, P; Luders, HO; Shi, JY; Cui, JM; Richerson, GB; Wang, QK				Du, W; Bautista, JF; Yang, HH; Diez-Sampedro, A; You, SA; Wang, LJ; Kotagal, P; Luders, HO; Shi, JY; Cui, JM; Richerson, GB; Wang, QK			Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder	NATURE GENETICS			English	Article							BETA-SUBUNIT; ATAXIA; GENE; OSCILLATION; MUTATIONS; MYOKYMIA; FEATURES	The large conductance calcium- sensitive potassium ( BK) channel is widely expressed in many organs and tissues, but its in vivo physiological functions have not been fully defined. Here we report a genetic locus associated with a human syndrome of coexistent generalized epilepsy and paroxysmal dyskinesia on chromosome 10q22 and show that a mutation of the a subunit of the BK channel causes this syndrome. The mutant BK channel had a markedly greater macroscopic current. Single- channel recordings showed an increase in open-channel probability due to a three- to fivefold increase in Ca2+ sensitivity. We propose that enhancement of BK channels in vivo leads to increased excitability by inducing rapid repolarization of action potentials, resulting in generalized epilepsy and paroxysmal dyskinesia by allowing neurons to fire at a faster rate. These results identify a gene that is mutated in generalized epilepsy and paroxysmal dyskinesia and have implications for the pathogenesis of human epilepsy, the neurophysiology of paroxysmal movement disorders and the role of BK channels in neurological disease.	Cleveland Clin Fdn, Ctr Mol Sci, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; Cleveland Clin Fdn, Dept Neurol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Vet Adm Med Ctr, West Haven, CT 06516 USA; Huazhong Univ Sci & Technol, Human Genome Res Ctr, Wuhan, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Case Western Reserve University; Washington University (WUSTL); Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Huazhong University of Science & Technology	Wang, QK (corresponding author), Cleveland Clin Fdn, Ctr Mol Sci, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org	Bautista, Jocelyn F./AAP-6901-2021	Yang, Huanghe/0000-0001-9521-9328; Richerson, George/0000-0001-5696-1554	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070393] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; DEMIRKIRAN M, 1995, ANN NEUROL, V38, P571, DOI 10.1002/ana.410380405; Eunson LH, 2000, ANN NEUROL, V48, P647; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Guerrini R, 2002, EPILEPSIA, V43, P1224, DOI 10.1046/j.1528-1157.2002.13802.x; Guerrini R, 2001, EPILEPSIA, V42, P36, DOI 10.1046/j.1528-1157.2001.042suppl.3036.x; Guerrini R, 1999, ANN NEUROL, V45, P344, DOI 10.1002/1531-8249(199903)45:3<344::AID-ANA10>3.0.CO;2-9; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lee HY, 2004, HUM MOL GENET, V13, P3161, DOI 10.1093/hmg/ddh330; LUBBERS WJ, 1995, J NEUROL NEUROSUR PS, V59, P400, DOI 10.1136/jnnp.59.4.400; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Rutten F, 2001, J TURBUL, V2, P1, DOI 10.1088/1468-5248/2/1/003; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; World Health Organisation, 2002, WORLD HLTH REPORT 20; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956	29	406	422	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					733	738		10.1038/ng1585	http://dx.doi.org/10.1038/ng1585			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15937479				2022-12-17	WOS:000230196400020
J	Darvasi, A				Darvasi, A			Experimental strategies for the genetic dissection of complex traits in animal models	NATURE GENETICS			English	Article							GENOME-WIDE SEARCH; COLON-TUMOR SUSCEPTIBILITY; CONTROLLING BRISTLE SCORE; MARKER LOCI; QUANTITATIVE TRAITS; DROSOPHILA-MELANOGASTER; CONFIDENCE-INTERVALS; CHROMOSOME SECTIONS; DETERMINING LINKAGE; MULTIPLE-SCLEROSIS	Current success in detecting complex trait loci in general, and quantitative trait loci (QTLs) using model organisms in particular, has attracted major biological and biomedical interest. The potential ability to identify genes and their function provides opportunities for new diagnostics and treatments of complex genetic diseases. Despite the success in gene mapping, however, cloning of complex trait loci or QTLs is not straightforward. A major obstacle lies in achieving fine mapping resolution for the detected loci. Compared to the rapid development of sophisticated statistical and molecular tools, development and analysis of experimental designs for various stages in QTL mapping experiments have barely been considered. In this study, novel and existing experimental strategies for QTL analysis are presented and evaluated.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Darvasi, A (corresponding author), SmithKline Beecham Pharmaceut, NSFP 3rd Ave, Harlow CM19 5AW, Essex, England.							Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BERRETTINI WH, 1994, NAT GENET, V7, P54, DOI 10.1038/ng0594-54; BREESE E. L., 1957, HEREDITY, V11, P373, DOI 10.1038/hdy.1957.30; CHANGJIAN J, 1995, GENETICS, V140, P1111; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; DARVASI A, 1993, GENETICS, V134, P943; DARVASI A, 1994, THEOR APPL GENET, V89, P351, DOI 10.1007/BF00225166; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; DARVASI A, 1995, GENETICS, V141, P1199; DARVASI A, 1994, GENETICS, V138, P1365; DAVIES RW, 1971, GENETICS, V69, P363; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; ESHED Y, 1995, GENETICS, V141, P1147; Falconer DS, 1996, INTRO QUANTITATIVE G; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; FRANKEL WN, 1995, MAMM GENOME, V6, P839, DOI 10.1007/BF00292432; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALEY CS, 1995, TRENDS GENET, V11, P488, DOI 10.1016/S0168-9525(00)89158-1; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; Kemp SJ, 1997, NAT GENET, V16, P194, DOI 10.1038/ng0697-194; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; KOROL AB, 1995, GENETICS, V140, P1137; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEBOWITZ RJ, 1987, THEOR APPL GENET, V73, P556, DOI 10.1007/BF00289194; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; MANGIN B, 1994, GENETICS, V138, P1301; MCCOUCH SR, 1995, TRENDS GENET, V11, P482, DOI 10.1016/S0168-9525(00)89157-X; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; MOTRO U, 1993, THEOR APPL GENET, V85, P658, DOI 10.1007/BF00225002; PATERSON AH, 1990, GENETICS, V124, P735; RAPP JP, 1995, HYPERTENSION, V25, P1121, DOI 10.1161/01.HYP.25.6.1121; Rothschild M, 1996, P NATL ACAD SCI USA, V93, P201, DOI 10.1073/pnas.93.1.201; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SHRIMPTON AE, 1988, GENETICS, V118, P437; SHRIMPTON AE, 1988, GENETICS, V118, P445; SILVER LM, 1995, MOUSE GNEETICS CONCE; SOLLER M, 1976, THEOR APPL GENET, V47, P35, DOI 10.1007/BF00277402; STUBER CW, 1995, TRENDS GENET, V11, P477, DOI 10.1016/S0168-9525(00)89156-8; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Visscher PM, 1996, GENETICS, V143, P1013; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	63	406	412	1	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					19	24		10.1038/ng0198-19	http://dx.doi.org/10.1038/ng0198-19			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425894				2022-12-17	WOS:000071259600015
J	Graham, BH; Waymire, KG; Cottrell, B; Trounce, IA; MacGregor, GR; Wallace, DC				Graham, BH; Waymire, KG; Cottrell, B; Trounce, IA; MacGregor, GR; Wallace, DC			A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator	NATURE GENETICS			English	Article							MUSCLE ADP/ATP TRANSLOCATOR; EMBRYONIC STEM-CELLS; ADP ATP TRANSLOCASE; MUSCULAR-DYSTROPHY LOCUS; SYNTHASE BETA-SUBUNIT; SKELETAL-MUSCLE; MOLECULAR-CLONING; NUCLEAR GENES; DNA DISEASE; CARRIER	In an attempt to create an animal model of tissue-specific mitochondrial disease, we generated 'knockout' mice deficient in the heart/muscle isoform of the adenine nucleotide translocator (Ant1). Histological and ultrastructural examination of skeletal muscle from Anti null mutants revealed ragged-red muscle fibers and a dramatic proliferation of mitochondria, while examination of the heart revealed cardiac hypertrophy with mitochondrial proliferation. Mitochondria isolated from mutant skeletal muscle exhibited a severe defect in coupled respiration. Ant1 mutant adults also had a resting serum lactate level fourfold higher than that of controls, indicative of metabolic acidosis. Significantly, mutant adults manifested severe exercise intolerance. Therefore, Anti mutant mice have the biochemical, histological, metabolic and physiological characteristics of mitochondrial myopathy and cardiomyopathy.	EMORY UNIV, SCH MED, CTR MOL MED, ATLANTA, GA 30322 USA	Emory University			Trounce, Ian A/F-8338-2010; Graham, Brett/R-8685-2018	Trounce, Ian A/0000-0002-1070-8892; Graham, Brett/0000-0001-8451-8154	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKKER HD, 1993, J INHERIT METAB DIS, V16, P548, DOI 10.1007/BF00711678; BAKKER HD, 1993, PEDIATR RES, V33, P412; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; BATTINI R, 1987, J BIOL CHEM, V262, P4355; BLAU DM, 1995, VIROLOGY, V210, P91, DOI 10.1006/viro.1995.1320; BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099; CHEN ST, 1990, SOMAT CELL MOLEC GEN, V16, P143, DOI 10.1007/BF01233044; CHUNG AB, 1992, J BIOL CHEM, V267, P21154; COZENS AL, 1989, J MOL BIOL, V206, P261, DOI 10.1016/0022-2836(89)90477-4; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; DUBOWITZ V, 1985, MUSCLE BIOPSY MODERN; Ellison JW, 1996, MAMM GENOME, V7, P25, DOI 10.1007/s003359900007; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; HARAGUCHI Y, 1994, J BIOL CHEM, V269, P9330; HARAGUCHI Y, 1993, GENOMICS, V16, P479, DOI 10.1006/geno.1993.1214; HATCHELL PL, 1973, GENETICS, V75, P191; KLINGENBERG M, 1992, BIOCHEM SOC T, V20, P547, DOI 10.1042/bst0200547; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; KU DH, 1990, J BIOL CHEM, V265, P16060; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; LI K, 1989, J BIOL CHEM, V264, P13998; LI K, 1990, J BIOL CHEM, V265, P20585; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Mills KA, 1996, MAMM GENOME, V7, P707, DOI 10.1007/s003359900296; Munnich A, 1996, EUR J PEDIATR, V155, P262; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; OMALLEY K, 1982, J BIOL CHEM, V257, P2097; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; PFANNER N, 1987, J BIOL CHEM, V262, P7528; POWELL SJ, 1989, BIOCHEMISTRY-US, V28, P866, DOI 10.1021/bi00428a069; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RASMUSSEN UB, 1986, BIOCHEM BIOPH RES CO, V138, P850, DOI 10.1016/S0006-291X(86)80574-5; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; SALMONS S, 1981, MUSCLE NERVE, V4, P94, DOI 10.1002/mus.880040204; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHAMBRA UB, 1992, ATLAS PRENATAL MOUSE, V1; Servidei S, 1994, Adv Pediatr, V41, P1; SHANSKE S, 1994, CURR TOP BIOENERG, V17, P21; Sheehan D.C., 1980, THEORY PRACTICE HIST, VSecond; SHINOHARA Y, 1993, BIOCHIM BIOPHYS ACTA, V1152, P192, DOI 10.1016/0005-2736(93)90248-X; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEELE BF, 1950, ARCH BIOCHEM, V25, P124; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WASSERMAN K, 1987, PRINCIPLES EXERCISE, P1; WIJMENGA C, 1993, HUM GENET, V92, P198; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376	53	405	419	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1997	16	3					226	234		10.1038/ng0797-226	http://dx.doi.org/10.1038/ng0797-226			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207786				2022-12-17	WOS:A1997XG60900016
J	HANSON, IM; FLETCHER, JM; JORDAN, T; BROWN, A; TAYLOR, D; ADAMS, RJ; PUNNETT, HH; VANHEYNINGEN, V				HANSON, IM; FLETCHER, JM; JORDAN, T; BROWN, A; TAYLOR, D; ADAMS, RJ; PUNNETT, HH; VANHEYNINGEN, V			MUTATIONS AT THE PAX6 LOCUS ARE FOUND IN HETEROGENEOUS ANTERIOR SEGMENT MALFORMATIONS INCLUDING PETERS ANOMALY	NATURE GENETICS			English	Article							HOMEOBOX-CONTAINING GENE; WILMS-TUMOR; VARIABLE EXPRESSIVITY; INSITU HYBRIDIZATION; ANIRIDIA; MOUSE; CONSERVATION; DOMAIN; DELETION; PROTEIN	Mutation or deletion of the PAX6 gene underlies many cases of aniridia. Three lines of evidence now converge to implicate PAX6 more widely in anterior segment malformations including Peters' anomaly. First, a child with Peters' anomaly is deleted for one copy of PAX6. Second, affected members of a family with dominantly inherited anterior segment malformations, including Peters' anomaly are heterozygous for an R26G mutation in the PAX6 paired box. Third, a proportion of Sey/+ Smalleye mice, heterozygous for a nonsense mutation in murine Pax-6, have an ocular phenotype resembling Peters' anomaly. We therefore propose that a variety of anterior segment anomalies may be associated with PAX6 mutations.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; HOSP SICK CHILDREN,DEPT OPHTHALMOL,LONDON WC1N 3JH,ENGLAND; ST CHRISTOPHERS HOSP CHILDREN,PHILADELPHIA,PA 19134	University of Edinburgh; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust			Fletcher, Jack/AAX-2931-2020; van Heyningen, Veronica/B-8039-2008; fletcher, jack/Q-5975-2019; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; Hanson, Isabel/0000-0002-1878-0530	Medical Research Council [MC_U127527199] Funding Source: Medline; NCI NIH HHS [CA8659] Funding Source: Medline; MRC [MC_U127527199] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [F33CA008659] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASHER JH, 1991, AM J HUM GENET, V48, P43; BEATTIE PH, 1947, BRIT J OPHTHALMOL, V31, P649, DOI 10.1136/bjo.31.11.649; BEAUCHAMP GR, 1978, J PEDIATR OPHTHALMOL, V17, P55; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CHALEPAKIS G, 1992, J CELL SCI S, V16, P61; CLAYTON R, 1985, OCULAR LENS, P61; EIFERMAN RA, 1984, ANN OPHTHALMOL, V16, P933; FANTES JA, 1992, AM J HUM GENET, V51, P1286; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Green MC., 1989, GENETIC VARIANTS STR, P12; HANSON IM, 1993, HUM MOL GENET, V2, P915; HEON E, 1992, OPHTHALMIC PAED GEN, V13, P137, DOI 10.3109/13816819209087614; HILL R, 1992, TRENDS GENET, V8, P119, DOI 10.1016/0168-9525(92)90359-C; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HITTNER HM, 1980, AM J OPHTHALMOL, V89, P531, DOI 10.1016/0002-9394(80)90062-8; HITTNER HM, 1982, AM J OPHTHALMOL, V93, P57, DOI 10.1016/0002-9394(82)90700-0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; HOLMSTROM GE, 1991, BRIT J OPHTHALMOL, V75, P591, DOI 10.1136/bjo.75.10.591; HOTH CF, 1993, AM J HUM GENET, V52, P455; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; JOTTERAND V, 1990, BRIT J OPHTHALMOL, V74, P568, DOI 10.1136/bjo.74.9.568; KENYON KR, 1975, EXP EYE RES, V21, P125, DOI 10.1016/0014-4835(75)90077-9; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MARTIN P, 1992, ONCOGENE, V7, P1721; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; Peters A., 1906, KLIN MONATSBL AUGENH, V44; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; STONE DL, 1976, AM J OPHTHALMOL, V81, P173, DOI 10.1016/0002-9394(76)90729-7; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; VANHEYNINGEN V, 1990, P NATL ACAD SCI USA, V87, P5383, DOI 10.1073/pnas.87.14.5383; WALTER MA, 1992, NATURE, V355, P590, DOI 10.1038/355590a0; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Waring G O 3rd, 1975, Surv Ophthalmol, V20, P3, DOI 10.1016/0039-6257(75)90034-X	40	405	415	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					168	173		10.1038/ng0294-168	http://dx.doi.org/10.1038/ng0294-168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162071				2022-12-17	WOS:A1994MU76300012
J	Si, LZ; Chen, JY; Huang, XH; Gong, H; Luo, JH; Hou, QQ; Zhou, TY; Lu, TT; Zhu, JJ; Shangguan, YY; Chen, EW; Gong, CX; Zhao, Q; Jing, YF; Zhao, Y; Li, Y; Cui, LL; Fan, DL; Lu, YQ; Weng, QJ; Wang, YC; Zhan, QL; Liu, KY; Wei, XH; An, K; An, G; Han, B				Si, Lizhen; Chen, Jiaying; Huang, Xuehui; Gong, Hao; Luo, Jianghong; Hou, Qingqing; Zhou, Taoying; Lu, Tingting; Zhu, Jingjie; Shangguan, Yingying; Chen, Erwang; Gong, Chengxiang; Zhao, Qiang; Jing, Yufeng; Zhao, Yan; Li, Yan; Cui, Lingling; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Wang, Yongchun; Zhan, Qilin; Liu, Kunyan; Wei, Xinghua; An, Kyungsook; An, Gynheung; Han, Bin			OsSPL13 controls grain size in cultivated rice	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; NATURAL VARIATION; DNA-BINDING; PLANT ARCHITECTURE; VARIATION REVEALS; CELL ELONGATION; GENETIC-CONTROL; TRANSITION; EXPRESSION	Although genetic diversity has a cardinal role in domestication, abundant natural allelic variations across the rice genome that cause agronomically important differences between diverse varieties have not been fully explored. Here we implement an approach integrating genome-wide association testing with functional analysis on grain size in a diverse rice population. We report that a major quantitative trait locus, GLW7, encoding the plant-specific transcription factor OsSPL13, positively regulates cell size in the grain hull, resulting in enhanced rice grain length and yield. We determine that a tandem-repeat sequence in the 5'UTR of OsSPL13 alters its expression by affecting transcription and translation and that high expression of OsSPL13 is associated with large grains in tropical japonica rice. Further analysis indicates that the large-grain allele of GLW7 in tropical japonica rice was introgressed from indica varieties under artificial selection. Our study demonstrates that new genes can be effectively identified on the basis of genome-wide association data.	[Si, Lizhen; Chen, Jiaying; Huang, Xuehui; Gong, Hao; Luo, Jianghong; Hou, Qingqing; Zhou, Taoying; Lu, Tingting; Zhu, Jingjie; Shangguan, Yingying; Chen, Erwang; Gong, Chengxiang; Zhao, Qiang; Jing, Yufeng; Zhao, Yan; Li, Yan; Cui, Lingling; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Wang, Yongchun; Zhan, Qilin; Liu, Kunyan; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China; [Wei, Xinghua] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [An, Kyungsook; An, Gynheung] Kyung Hee Univ, Crop Biotech Inst, Yongin, South Korea	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Kyung Hee University	Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China.	bhan@ncgr.ac.cn		Han, Bin/0000-0001-8695-0274; gong, hao/0000-0002-0327-6673	Chinese Academy of Sciences [XDA08020101]; National Natural Science Foundation of China [91535202, 31421093]; Ministry of Science and Technology of China [2013CBA01404]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank J. Wang and W. Cai for help in the construction of the MIM156 vector, K. Chong (Institute of Botany, Chinese Academy of Sciences) for providing the pTCK303 vector, P. Hu and G. Jiao for the measurements of grain quality, and J. Li, Xiaoyan Gao and Xiaoshu Gao for microscopy experiments. This work was supported by the Chinese Academy of Sciences (XDA08020101), the National Natural Science Foundation of China (91535202 and 31421093) and the Ministry of Science and Technology of China (2013CBA01404).	Ali ML, 2011, CROP SCI, V51, P2021, DOI 10.2135/cropsci2010.11.0641; BENHAJSALAH H, 1995, PLANT PHYSIOL, V109, P861, DOI 10.1104/pp.109.3.861; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Catterou M, 2001, PLANTA, V212, P673, DOI 10.1007/s004250000467; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/s004380050046; Lee Y, 2001, PLANT PHYSIOL, V127, P645, DOI 10.1104/pp.010345; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Park CH, 2010, PHYTOCHEMISTRY, V71, P380, DOI 10.1016/j.phytochem.2009.11.003; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yamasaki K, 2004, J MOL BIOL, V337, P49, DOI 10.1016/j.jmb.2004.01.015; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	49	404	463	31	349	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					447	+		10.1038/ng.3518	http://dx.doi.org/10.1038/ng.3518			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26950093				2022-12-17	WOS:000372908800016
J	Bentham, J; Morris, DL; Graham, DSC; Pinder, CL; Tombleson, P; Behrens, TW; Martin, J; Fairfax, BP; Knight, JC; Chen, LY; Replogle, J; Syvanen, AC; Ronnblom, L; Graham, RR; Wither, JE; Rioux, JD; Alarcon-Riquelme, ME; Vyse, TJ				Bentham, James; Morris, David L.; Graham, Deborah S. Cunninghame; Pinder, Christopher L.; Tombleson, Philip; Behrens, Timothy W.; Martin, Javier; Fairfax, Benjamin P.; Knight, Julian C.; Chen, Lingyan; Replogle, Joseph; Syvanen, Ann-Christine; Ronnblom, Lars; Graham, Robert R.; Wither, Joan E.; Rioux, John D.; Alarcon-Riquelme, Marta E.; Vyse, Timothy J.			Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION STRATIFICATION; SUSCEPTIBILITY VARIANTS; HLA ALLELES; T-CELLS; POLYMORPHISM; AUTOIMMUNE; EXPRESSION; RISK; IMPUTATION	Systemic lupus erythematosus (SLE) is a genetically complex autoimmune disease characterized by loss of immune tolerance to nuclear and cell surface antigens. Previous genome-wide association studies (GWAS) had modest sample sizes, reducing their scope and reliability. Our study comprised 7,219 cases and 15,991 controls of European ancestry, constituting a new GWAS, a meta-analysis with a published GWAS and a replication study. We have mapped 43 susceptibility loci, including ten new associations. Assisted by dense genome coverage, imputation provided evidence for missense variants underpinning associations in eight genes. Other likely causal genes were established by examining associated alleles for cis-acting eQTL effects in a range of ex vivo immune cells. We found an over-representation (n = 16) of transcription factors among SLE susceptibility genes. This finding supports the view that aberrantly regulated gene expression networks in multiple cell types in both the innate and adaptive immune response contribute to the risk of developing SLE.	[Bentham, James; Morris, David L.; Graham, Deborah S. Cunninghame; Pinder, Christopher L.; Tombleson, Philip; Chen, Lingyan; Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Behrens, Timothy W.; Graham, Robert R.] Genentech Inc, San Francisco, CA 94080 USA; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Fairfax, Benjamin P.; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Replogle, Joseph] Harvard Univ, Sch Med, Boston, MA USA; [Syvanen, Ann-Christine; Ronnblom, Lars] Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden; [Wither, Joan E.] Univ Hlth Network, TWRI, Toronto, ON, Canada; [Rioux, John D.] Univ Montreal, Genet & Genom Med Inflammat, Montreal, PQ, Canada; [Rioux, John D.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Alarcon-Riquelme, Marta E.] Pfizer Univ Granada Junta Andalucia, Ctr Genom & Invest Oncol GENYO, Granada, Spain; [Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England	University of London; King's College London; Roche Holding; Genentech; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; Uppsala University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite de Montreal; Universite de Montreal; Pfizer; University of Granada; University of London; King's College London	Vyse, TJ (corresponding author), Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England.	timothy.vyse@kcl.ac.uk	Alarcón-Riquelme, Marta E./ABF-8163-2020; Martín, María/HDL-9512-2022; Bentham, James/ABF-5746-2020; Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; Knight, Julian Charles/W-2399-2019; Rioux, John D/A-9599-2015	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Martin, Javier/0000-0002-2202-0622; Knight, Julian Charles/0000-0002-0377-5536; Rioux, John D/0000-0001-7560-8326; Replogle, Joseph/0000-0003-1832-919X; Morris, David/0000-0002-1754-8932; Bentham, James/0000-0001-5733-9417; Chen, Lingyan/0000-0003-3750-6761; Fairfax, Benjamin/0000-0001-7413-5002; Pinder, Christopher/0000-0003-4149-226X; Wither, Joan/0000-0001-5961-9228	George Koukis Foundation; Arthritis Research UK Special Strategic Award [19289]; Instituto de Salud Carlos III [PS09/00129]; FEDER funds of the European Union; Consejeria de Salud de Andalucia [PI0012]; Swedish Research Council of Medicine; European Science Foundation; Arthritis Research UK Special Strategic Award; Canadian Institutes of Health Research [94825]; Wellcome Trust grant [085492]; China Scholarship Council [201406380127]; National Institute for Health Research (NIHR) Biomedical Research Centre; King's College London; National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029]; US National Institutes of Health (NIH) [3P50CA093459, 5P50CA097007, 5R01ES011740, 5R01CA133996]; Genes and Blood Clotting Study was provided through the US NIH/National Heart, Lung, and Blood Institute (NHLBI) [R37HL039693]; US NIH/NHLBI [R37HL039693]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P50CA097007, P50CA093459, R01CA133996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039693] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036495, RC4AG039029, U01AG009740] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-SGCL13-Fairfax] Funding Source: researchfish; National Institute for Health Research [CL-2012-13-004] Funding Source: researchfish; Versus Arthritis [19289] Funding Source: researchfish	George Koukis Foundation; Arthritis Research UK Special Strategic Award(Versus Arthritis); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER funds of the European Union(European Commission); Consejeria de Salud de Andalucia; Swedish Research Council of Medicine; European Science Foundation(European Science Foundation (ESF)European Commission); Arthritis Research UK Special Strategic Award(Versus Arthritis); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust grant(Wellcome Trust); China Scholarship Council(China Scholarship Council); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genes and Blood Clotting Study was provided through the US NIH/National Heart, Lung, and Blood Institute (NHLBI); US NIH/NHLBI; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	T.J.V., J.D.R. and M.E.A.-R. were awarded funding to carry out genotyping and analysis from the George Koukis Foundation and an Arthritis Research UK Special Strategic Award (19289). M.E.A.-R. received grants from the Instituto de Salud Carlos III (PS09/00129), co-financed by the FEDER funds of the European Union, the Consejeria de Salud de Andalucia (PI0012) and the Swedish Research Council of Medicine, and from the European Science Foundation to the BIOLUPUS network. J.B. was funded by the George Koukis Foundation and the Arthritis Research UK Special Strategic Award. J.E.W. was funded by the Canadian Institutes of Health Research (94825). C.L.P. was funded by a Wellcome Trust grant (085492). P.T. is employed by the Biomedical Research Centre. L.C. was funded by the China Scholarship Council (201406380127). The research was funded and supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health.; HRS genetic data were obtained from the database of Genotypes and Phenotypes (dbGaP) under accession phs000187.v1.p1; the study is sponsored by the National Institute on Aging (grants U01AG009740, RC2AG036495 and RC4AG039029) and was conducted by the University of Michigan. The melanoma study data were obtained from dbGaP under accession phs000187.v1.p1. Research support to collect data and develop an application to support this project was provided by US National Institutes of Health (NIH) grants 3P50CA093459, 5P50CA097007, 5R01ES011740 and 5R01CA133996. Funding support for the Genes and Blood Clotting Study was provided through the US NIH/National Heart, Lung, and Blood Institute (NHLBI) (R37HL039693). The Genes and Blood Clotting Study is one of the Phase 3 studies that are part of the Gene-Environment Association Studies (GENEVA) under the Genes, Environment and Health Initiative (GEI). Assistance with genotype cleaning was provided by the GENEVA Coordinating Center (U01HG004446, US NIH). Funding support for DNA extraction and genotyping, which were performed at the Broad Institute, was provided by the US NIH/NHLBI (R37HL039693). Additional support was provided by the Howard Hughes Medical Institute. The data sets used for the analyses described in this manuscript were obtained from dbGaP under accession phs000304.v2.p1. CGEMS prostate cancer study data were obtained from dbGaP under accession phs000207.v1.p1. We thank Genentech, Inc., for providing the genotype data from their GWAS. We thank V. Anand and S. Ragan for their help in coordinating data collection. We thank T. Axelsson, B. Furnrohr, S. Ragan and J. Kelly for their help with the replication study.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Alexander T, 2013, ANN RHEUM DIS, V72, P1549, DOI 10.1136/annrheumdis-2012-202216; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Bronson PG, 2011, GENES IMMUN, V12, P667, DOI 10.1038/gene.2011.36; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caster DJ, 2013, J AM SOC NEPHROL, V24, P1743, DOI 10.1681/ASN.2013020148; Castillejo-Lopez C, 2012, ANN RHEUM DIS, V71, P136, DOI 10.1136/annrheumdis-2011-200085; Chrabot BS, 2013, GENES IMMUN, V14, P471, DOI 10.1038/gene.2013.42; Crispin JC, 2010, ARTHRITIS RHEUM-US, V62, P1431, DOI 10.1002/art.27385; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fujimoto M, 2004, INT IMMUNOL, V16, P303, DOI 10.1093/intimm/dxh030; Gagliano SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098122; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Jeffreys H., 1961, THEORY PROBABILITY, V3; Karassa FB, 2002, ARTHRITIS RHEUM-US, V46, P1563, DOI 10.1002/art.10306; Kaufman KM, 2013, ANN RHEUM DIS, V72, P437, DOI 10.1136/annrheumdis-2012-201851; Kim SJ, 2013, J CLIN INVEST, V123, P823, DOI 10.1172/JCI64712; Knight J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014808; Kottyan LC, 2015, HUM MOL GENET, V24, P582, DOI 10.1093/hmg/ddu455; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; LAWRENCE JS, 1987, J RHEUMATOL, V14, P913; Lewis MJ, 2015, AM J HUM GENET, V96, P221, DOI 10.1016/j.ajhg.2014.12.024; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manjarrez-Orduno N, 2012, NAT GENET, V44, P1227, DOI 10.1038/ng.2439; Manku H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003554; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Mori T, 2014, J IMMUNOL, V193, P1728, DOI 10.4049/jimmunol.1303243; Morris DL, 2012, AM J HUM GENET, V91, P778, DOI 10.1016/j.ajhg.2012.08.026; Morris EE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3189; Namjou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069404; Namjou B, 2009, ARTHRITIS RHEUM-US, V60, P1085, DOI 10.1002/art.24387; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Noble JA, 2003, DIABETES, V52, P1579, DOI 10.2337/diabetes.52.6.1579; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Oparina NY, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204909; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Rhodes B, 2012, ANN RHEUM DIS, V71, P2028, DOI 10.1136/annrheumdis-2012-201390; Sakurai D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003870; Scofield RH, 2008, ARTHRITIS RHEUM-US, V58, P2511, DOI 10.1002/art.23701; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Tchernev VT, 2002, MOL MED, V8, P56, DOI 10.1007/BF03402003; Vaughn SE, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00450; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhang J, 2013, ANN HUM GENET, V77, P344, DOI 10.1111/ahg.12018; Zhang Y, 2011, GENES IMMUN, V12, P231, DOI 10.1038/gene.2010.66; Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148; Zhao H, 2012, GENES IMMUN, V13, P536, DOI 10.1038/gene.2012.33; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	79	404	412	8	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1457	+		10.1038/ng.3434	http://dx.doi.org/10.1038/ng.3434			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26502338	Green Submitted, Green Accepted			2022-12-17	WOS:000365813200018
J	Parker, JA; Arango, M; Abderrahmane, S; Lambert, E; Tourette, C; Catoire, H; Neri, C				Parker, JA; Arango, M; Abderrahmane, S; Lambert, E; Tourette, C; Catoire, H; Neri, C			Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons	NATURE GENETICS			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; SIRT1 DEACETYLASE; C-ELEGANS; DAF-16; RESTRICTION; ACTIVATORS; MODELS; GENES	We report that Sir2 activation through increased sir-2.1 dosage or treatment with the sirtuin activator resveratrol specifically rescued early neuronal dysfunction phenotypes induced by mutant polyglutamines in transgenic Caenorhabditis elegans. These effects are dependent on daf-16 ( Forkhead). Additionally, resveratrol rescued mutant polyglutamine - specific cell death in neuronal cells derived from HdhQ111 knock-in mice. We conclude that Sir2 activation may protect against mutant polyglutamines.	INSERM, Avenir Grp, Lab Genom Biol, Ctr Paul Broca, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Neri, C (corresponding author), INSERM, Avenir Grp, Lab Genom Biol, Ctr Paul Broca, F-75014 Paris, France.	christian.neri@broca.inserm.fr	Tourette, Cendrine/U-2540-2017; Parker, Alex/F-4953-2014; Neri, Christian/F-6729-2013	Parker, Alex/0000-0002-3333-2445; Neri, Christian/0000-0002-3790-2978				Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	15	404	426	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2005	37	4					349	350		10.1038/ng1534	http://dx.doi.org/10.1038/ng1534			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15793589				2022-12-17	WOS:000228040000015
J	Rosenbauer, F; Wagner, K; Kutok, JL; Iwasaki, H; Le Beau, MM; Okuno, Y; Akashi, K; Fiering, S; Tenen, DG				Rosenbauer, F; Wagner, K; Kutok, JL; Iwasaki, H; Le Beau, MM; Okuno, Y; Akashi, K; Fiering, S; Tenen, DG			Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1	NATURE GENETICS			English	Article							COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; C/EBP-ALPHA; TRANSGENIC MICE; DIFFERENTIATION; MUTATIONS; GENE; PROGENITORS; MYC; ABNORMALITIES	Transcription factors are believed to have a dominant role in acute myeloid leukemia (AML). This idea is supported by analysis of gene-knockout mice, which uncovered crucial roles of several transcription factors in normal hematopoiesis(1), and of individuals with leukemia, in whom transcription factors are frequently downregulated or mutated(2). However, analysis of knockout animals has not shown a direct link between abrogated transcription factors and the pathogenesis of AML. Sfpi1, encoding the lineage-specific transcription factor PU.1, is indispensable for normal myeloid and lymphoid development(3,4). We found that mice carrying hypomorphic Sfpi1 alleles that reduce PU.1 expression to 20% of normal levels, unlike mice carrying homo- or heterozygous deletions of Sfpi1, developed AML. Unlike complete or 50% loss, 80% loss of PU.1 induced a precancerous state characterized by accumulation of an abnormal precursor pool retaining responsiveness to G-CSF with disruption of M- and GM-CSF pathways. Malignant transformation was associated with a high frequency of clonal chromosomal changes. Retroviral restoration of PU.1 expression rescued myeloid differentiation of mutant progenitors and AML blasts. These results suggest that tightly graded reduction, rather than complete loss, of a lineage-indispensable transcription factor can induce AML.	Harvard Univ, Inst Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Canc Immunol & AIDS, Boston, MA 02115 USA; Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03756 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Chicago; Dartmouth College	Tenen, DG (corresponding author), Harvard Univ, Inst Med, Room 954,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu		Rosenbauer, Frank/0000-0001-7977-9421; Tenen, Daniel/0000-0002-6423-3888; Fiering, Steven/0000-0003-0624-974X	NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA023108] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Duprez EA, 2002, BLOOD, V100, p61A; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Iwasaki-Arai J, 2002, BLOOD, V100, p61A; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	30	404	411	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					624	630		10.1038/ng1361	http://dx.doi.org/10.1038/ng1361			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15146183	Bronze			2022-12-17	WOS:000221763700021
J	Dragatsis, I; Levine, MS; Zeitlin, S				Dragatsis, I; Levine, MS; Zeitlin, S			Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice	NATURE GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; CAG REPEAT; NEURONAL DEGENERATION; WIDESPREAD EXPRESSION; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BASAL GANGLIA; WILD-TYPE; PROTEIN; CELL	Inactivation of the mouse homologue of the Huntington disease gene (Hdh) results in early embryonic lethality. To investigate the normal function of Hdh in the adult and to evaluate current models for Huntington disease (HD), we have used the Cre/IoxP site-specific recombination strategy to inactivate Hdh expression in the forebrain and testis, resulting in a progressive degenerative neuronal phenotype and sterility. On the basis of these results, we propose that huntingtin is required for neuronal function and survival in the brain and that a loss-of-function mechanism may contribute to HD pathogenesis.	Columbia Univ, Dept Pathol, New York, NY USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; Columbia Univ, Dept Genet & Dev, New York, NY USA	Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University	Zeitlin, S (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22903 USA.		Zeitlin, Scott/P-5787-2019					BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Bordelon YM, 1999, NEUROSCIENCE, V93, P843, DOI 10.1016/S0306-4522(99)00239-0; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NEUROSCI LETT, V282, P37, DOI 10.1016/S0304-3940(00)00872-7; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Ferrante RJ, 1997, J NEUROSCI, V17, P3052; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LALONDE R, 1987, EXP BRAIN RES, V65, P479; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.3.CO;2-6; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matsuoka Y, 1997, EXP NEUROL, V146, P57, DOI 10.1006/exnr.1997.6488; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Metzler M, 1999, J NEUROCHEM, V72, P1009, DOI 10.1046/j.1471-4159.1999.0721009.x; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; Reddy PH, 1999, TRENDS NEUROSCI, V22, P248, DOI 10.1016/S0166-2236(99)01415-0; Rich T, 1999, HUM MOL GENET, V8, P2451, DOI 10.1093/hmg/8.13.2451; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; SANTAROSA R, 1994, LAB INVEST, V70, P503; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	46	404	422	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					300	306		10.1038/81593	http://dx.doi.org/10.1038/81593			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062468				2022-12-17	WOS:000165176500017
J	Nishida, T; Hirota, S; Taniguchi, M; Hashimoto, K; Isozaki, K; Nakamura, H; Kanakura, Y; Tanaka, T; Takabayashi, A; Matsuda, H; Kitamura, Y				Nishida, T; Hirota, S; Taniguchi, M; Hashimoto, K; Isozaki, K; Nakamura, H; Kanakura, Y; Tanaka, T; Takabayashi, A; Matsuda, H; Kitamura, Y			Familial gastrointestinal stromal tumours with germline mutation of the KIT gene	NATURE GENETICS			English	Letter							LIGAND-INDEPENDENT ACTIVATION; PROTOONCOGENE C-KIT; POINT MUTATION; MAST-CELLS; LEIOMYOMATOSIS; IDENTIFICATION; DISORDER; DOMAIN; MICE		Osaka Univ, Sch Med, Dept Surg 1, Suita, Osaka 565, Japan; Osaka Univ, Sch Med, Dept Pathol, Suita, Osaka 565, Japan; Osaka Univ, Sch Med, Dept Internal Med 2, Suita, Osaka 565, Japan; Osaka Univ, Sch Med, Dept Hematol Oncol, Suita, Osaka 565, Japan; Kinan Gen Hosp, Div Pathol, Tanabe, Japan; Kitano Hosp, Dept Surg, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Kitano Hospital	Nishida, T (corresponding author), Osaka Univ, Sch Med, Dept Surg 1, Yamada Oka 2-2, Suita, Osaka 565, Japan.	toshin@surg1.med.osaka-u.ac.jp						ELOMAR M, 1994, POSTGRAD MED J, V70, P661, DOI 10.1136/pgmj.70.827.661; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; HONGYO T, 1993, NUCLEIC ACIDS RES, V21, P3637, DOI 10.1093/nar/21.16.3637; Kapur R, 1997, BLOOD, V90, P3018, DOI 10.1182/blood.V90.8.3018; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, BLOOD, V53, P492; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; MARSHALL JB, 1990, GASTROENTEROLOGY, V98, P1358, DOI 10.1016/0016-5085(90)90357-7; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; STEIN A, 1992, NUCLEIC ACIDS RES, V20, P5237, DOI 10.1093/nar/20.19.5237; TSUJIMURA T, 1994, BLOOD, V83, P2619; Tsujimura T, 1996, BLOOD, V87, P273	15	404	417	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1998	19	4					323	324		10.1038/1209	http://dx.doi.org/10.1038/1209			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697690				2022-12-17	WOS:000075107600011
J	Nickerson, DA; Taylor, SL; Weiss, KM; Clark, AG; Hutchinson, RG; Stengard, J; Salomaa, V; Vartiainen, E; Boerwinkle, E; Sing, CF				Nickerson, DA; Taylor, SL; Weiss, KM; Clark, AG; Hutchinson, RG; Stengard, J; Salomaa, V; Vartiainen, E; Boerwinkle, E; Sing, CF			DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene	NATURE GENETICS			English	Article							HUMAN GENOME; LPL GENE; POLYMORPHISMS; ATHEROSCLEROSIS; MUTATION; FAMILY	Lipoprotein lipase plays a central role in lipid metabolism and the gene that encodes this enzyme (LPL) is a candidate susceptibility gene for cardiovascular disease. Here we report the complete sequence of a fraction of the LPL gene for 71 individuals (142 chromosomes) from three populations that may have different histories affecting the organization of the sequence variation. Eighty-eight sites in this 9.7 kb vary among individuals from these three populations. Of these, 79 were single nucleotide substitutions and 9 sites involved insertion-deletion variations. The average nucleotide diversity across the region was 0.2% (or on average 1 variable site every 500 bp). At 34 of these sites, the variation was found in only one of the populations, reflecting the differing population and mutational histories. If LPL is a typical human gene, the pattern of sequence variation that exists in introns as well as exons, even for the small number of samples considered here, will present challenges for the identification of sites, or combinations of sites, that influence Variation in risk of disease in the population at large.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98125 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77225 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Mississippi; University of Mississippi Medical Center; Finland National Institute for Health & Welfare; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Nickerson, DA (corresponding author), Univ Washington, Dept Mol Biotechnol, Box 357730, Seattle, WA 98125 USA.	debnick@u.washington.edu		Clark, Andrew/0000-0001-7159-8511; Sing, Charles/0000-0001-5872-7956	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058238, R01HL058239, R01HL058240] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58238, HL58239, HL58240] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1990, AM J HUM GENET, V46, P649; CLARK AG, UNPUB AM J HUM GENET; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Crandall Keith A., 1996, P137; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Eng C, 1997, NAT BIOTECHNOL, V15, P422, DOI 10.1038/nbt0597-422; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FISHER KL, 1987, NUCLEIC ACIDS RES, V15, P7657, DOI 10.1093/nar/15.18.7657; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harding RM, 1997, AM J HUM GENET, V60, P772; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; HEINZMANN C, 1987, NUCLEIC ACIDS RES, V15, P6763, DOI 10.1093/nar/15.16.6763; KIRCHGESSNER TG, 1989, P NATL ACAD SCI USA, V86, P9647, DOI 10.1073/pnas.86.24.9647; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; KRYGLYAK L, 1997, NAT GENET, V17, P21; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LI WH, 1991, GENETICS, V129, P513; LI WH, 1997, MOL EVOLUTION, P178; Murthy V, 1996, PHARMACOL THERAPEUT, V70, P101, DOI 10.1016/0163-7258(96)00005-8; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roberts RJ, 1997, NUCLEIC ACIDS RES, V25, P248, DOI 10.1093/nar/25.1.248; Rowen L, 1997, SCIENCE, V278, P605, DOI 10.1126/science.278.5338.605; SING CF, 1996, VARIATION HUMAN GENO, P211; TEMPLETON AR, 1996, VARIATION HUMAN GENO, P259; VOGEL F, 1977, J MOL EVOL, V9, P159, DOI 10.1007/BF01732746; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISS KM, 1997, GENETIC VARIATION HU; WIEBUSCH H, 1992, CIRCULATION, V86, P1; Zhang HF, 1996, BBA-LIPID LIPID MET, V1302, P159, DOI 10.1016/0005-2760(96)00059-8	41	404	429	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					233	240		10.1038/907	http://dx.doi.org/10.1038/907			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662394				2022-12-17	WOS:000074565900017
J	Isella, C; Terrasi, A; Bellomo, SE; Petti, C; Galatola, G; Muratore, A; Mellano, A; Senetta, R; Cassenti, A; Sonetto, C; Inghirami, G; Trusolino, L; Fekete, Z; De Ridder, M; Cassoni, P; Storme, G; Bertotti, A; Medico, E				Isella, Claudio; Terrasi, Andrea; Bellomo, Sara Erika; Petti, Consalvo; Galatola, Giovanni; Muratore, Andrea; Mellano, Alfredo; Senetta, Rebecca; Cassenti, Adele; Sonetto, Cristina; Inghirami, Giorgio; Trusolino, Livio; Fekete, Zsolt; De Ridder, Mark; Cassoni, Paola; Storme, Guy; Bertotti, Andrea; Medico, Enzo			Stromal contribution to the colorectal cancer transcriptome	NATURE GENETICS			English	Article							FIBROBLAST ACTIVATION PROTEIN; GENE-EXPRESSION; TUMOR XENOGRAFTS; POOR-PROGNOSIS; RECTAL-CANCER; HUMAN COLON; STEM-CELLS; RESISTANCE; HETEROGENEITY; RECURRENCE	Recent studies identified a poor-prognosis stem/serrated/mesenchymal (SSM) transcriptional subtype of colorectal cancer (CRC). We noted that genes upregulated in this subtype are also prominently expressed by stromal cells, suggesting that SSM transcripts could derive from stromal rather than epithelial cancer cells. To test this hypothesis, we analyzed CRC expression data from patient-derived xenografts, where mouse stroma supports human cancer cells. Species-specific expression analysis showed that the mRNA levels of SSM genes were mostly due to stromal expression. Transcriptional signatures built to specifically report the abundance of cancer-associated fibroblasts (CAFs), leukocytes or endothelial cells all had significantly higher expression in human CRC samples of the SSM subtype. High expression of the CAF signature was associated with poor prognosis in untreated CRC, and joint high expression of the stromal signatures predicted resistance to radiotherapy in rectal cancer. These data show that the distinctive transcriptional and clinical features of the SSM subtype can be ascribed to its particularly abundant stromal component.	[Isella, Claudio; Bellomo, Sara Erika; Petti, Consalvo; Galatola, Giovanni; Muratore, Andrea; Mellano, Alfredo; Trusolino, Livio; Bertotti, Andrea; Medico, Enzo] Fdn Piemontese Oncol, Ist Ricovero & Cura Carattere Sci FRO IRCCS, Candiolo Canc Inst, Candiolo, Italy; [Isella, Claudio; Terrasi, Andrea; Bellomo, Sara Erika; Trusolino, Livio; Bertotti, Andrea; Medico, Enzo] Univ Turin, Dept Oncol, Candiolo, Italy; [Senetta, Rebecca; Cassenti, Adele] Univ Turin, Dept Med Sci, Turin, Italy; [Sonetto, Cristina] Univ Turin, Dept Oncol, Orbassano, Italy; [Inghirami, Giorgio] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Expt Res & Med Studies, Turin, Italy; [Fekete, Zsolt] Inst Oncol Prof Dr Ion Chiricuta, Cluj Napoca, Romania; [De Ridder, Mark; Storme, Guy] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Radiotherapy, Brussels, Belgium	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; University of Turin; University of Turin; Oncology Institute Prof. Dr. Ion Chiricuta; University Hospital Brussels; Vrije Universiteit Brussel	Medico, E (corresponding author), Fdn Piemontese Oncol, Ist Ricovero & Cura Carattere Sci FRO IRCCS, Candiolo Canc Inst, Candiolo, Italy.	claudio.isella@ircc.it; enzo.medico@ircc.it	Fekete, Zsolt/F-2489-2015; Cassoni, Paola/I-8544-2018; bellomo, sara erika/AAC-1862-2022; Petti, Consalvo/K-9367-2016; Medico, Enzo/AAC-3185-2021; De Ridder, Mark/F-4794-2013; Terrasi, Andrea/J-1102-2018; Isella, Claudio/F-7327-2012	Fekete, Zsolt/0000-0003-3386-8263; bellomo, sara erika/0000-0001-5738-2351; Petti, Consalvo/0000-0002-3509-3142; Medico, Enzo/0000-0002-3917-2438; De Ridder, Mark/0000-0003-4433-8807; Terrasi, Andrea/0000-0003-4955-3346; Isella, Claudio/0000-0003-0679-4756; Trusolino, Livio/0000-0002-6379-3365; Mellano, Alfredo/0000-0002-9090-5123	Associazione Italiana per la Ricerca sul Cancro (Special Program Molecular Clinical Oncology 5x1000) [IG12944, IG14205, 9970-2010]; Fondazione Piemontese per la Ricerca sul Cancro (5x1000 Ministero della Salute); Compagnia di San Paolo/Ateneo (project 'Rethe')	Associazione Italiana per la Ricerca sul Cancro (Special Program Molecular Clinical Oncology 5x1000)(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro (5x1000 Ministero della Salute); Compagnia di San Paolo/Ateneo (project 'Rethe')(Compagnia di San Paolo)	We thank E. Trisolini, R. Porporato, D. Cantarella, B. Martinoglio, F. Sassi and S. Destefanis for technical assistance. E.M., A.B. and L.T. are members of the EurOPDX Consortium. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (IG12944 and IG14205; 9970-2010 Special Program Molecular Clinical Oncology 5x1000), Fondazione Piemontese per la Ricerca sul Cancro (5x1000 Ministero della Salute 2010 and 2011) and Compagnia di San Paolo/Ateneo (project 'Rethe').	Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chargari C, 2013, DRUG RESIST UPDATE, V16, P10, DOI 10.1016/j.drup.2013.01.001; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079874; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fearon DT, 2014, CANCER IMMUNOL RES, V2, P187, DOI 10.1158/2326-6066.CIR-14-0002; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gutman DA, 2013, J AM MED INFORM ASSN, V20, P1091, DOI 10.1136/amiajnl-2012-001469; Hollingshead MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-393; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isella C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-382; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Laize V, 2005, J BIOL CHEM, V280, P26659, DOI 10.1074/jbc.M500257200; Lex A, 2012, COMPUT GRAPH FORUM, V31, P1175, DOI 10.1111/j.1467-8659.2012.03110.x; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Martelli ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-254; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Oh SC, 2012, GUT, V61, P1291, DOI 10.1136/gutjnl-2011-300812; Pai RK, 2011, AM J SURG PATHOL, V35, P1373, DOI 10.1097/PAS.0b013e318224d9df; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Saigusa S, 2011, INT J ONCOL, V38, P655, DOI 10.3892/ijo.2011.906; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Sautes-Fridman C, 2011, CANCER METAST REV, V30, P13, DOI 10.1007/s10555-011-9279-y; Schneider S, 2006, PHARMACOGENET GENOM, V16, P555, DOI 10.1097/01.fpc.0000220563.44724.6d; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Suarez J, 2008, COLORECTAL DIS, V10, P563, DOI 10.1111/j.1463-1318.2007.01424.x; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	57	403	420	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					312	U49		10.1038/ng.3224	http://dx.doi.org/10.1038/ng.3224			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25706627	Green Submitted			2022-12-17	WOS:000351922900005
J	Lin, DC; Hao, JJ; Nagata, Y; Xu, L; Shang, L; Meng, X; Sato, Y; Okuno, Y; Varela, AM; Ding, LW; Garg, M; Liu, LZ; Yang, H; Yin, D; Shi, ZZ; Jiang, YY; Gu, WY; Gong, T; Zhang, Y; Xu, X; Kalid, O; Shacham, S; Ogawa, S; Wang, MR; Koeffler, HP				Lin, De-Chen; Hao, Jia-Jie; Nagata, Yasunobu; Xu, Liang; Shang, Li; Meng, Xuan; Sato, Yusuke; Okuno, Yusuke; Varela, Ana Maria; Ding, Ling-Wen; Garg, Manoj; Liu, Li-Zhen; Yang, Henry; Yin, Dong; Shi, Zhi-Zhou; Jiang, Yan-Yi; Gu, Wen-Yue; Gong, Ting; Zhang, Yu; Xu, Xin; Kalid, Ori; Shacham, Sharon; Ogawa, Seishi; Wang, Ming-Rong; Koeffler, H. Phillip			Genomic and molecular characterization of esophageal squamous cell carcinoma	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; MULTIPLE HUMAN CANCERS; LYMPH-NODE METASTASIS; NUCLEAR EXPORT; PROGNOSTIC-FACTOR; EXPRESSION; CRM1; INHIBITOR	Esophageal squamous cell carcinoma (ESCC) is prevalent worldwide and particularly common in certain regions of Asia. Here we report the whole-exome or targeted deep sequencing of 139 paired ESCC cases, and analysis of somatic copy number variations (SCNV) of over 180 ESCCs. We identified previously uncharacterized mutated genes such as FAT1, FAT2, ZNF750 and KMT2D, in addition to those already known (TP53, PIK3CA and NOTCH 1). Further SCNV evaluation, immunohistochemistry and biological analysis suggested their functional relevance in ESCC. Notably, RTK-MAPK-PI3K pathways, cell cycle and epigenetic regulation are frequently dysregulated by multiple molecular mechanisms in this cancer. Our approaches also uncovered many druggable candidates, and XPO1 was further explored as a therapeutic target because it showed both gene mutation and protein overexpression. Our integrated study unmasks a number of novel genetic lesions in ESCC and provides an important molecular foundation for understanding esophageal tumors and developing therapeutic targets.	[Lin, De-Chen; Koeffler, H. Phillip] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA USA; [Lin, De-Chen; Xu, Liang; Meng, Xuan; Varela, Ana Maria; Ding, Ling-Wen; Garg, Manoj; Liu, Li-Zhen; Yang, Henry; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Hao, Jia-Jie; Shang, Li; Shi, Zhi-Zhou; Jiang, Yan-Yi; Gu, Wen-Yue; Gong, Ting; Zhang, Yu; Xu, Xin; Wang, Ming-Rong] Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Hao, Jia-Jie; Shang, Li; Shi, Zhi-Zhou; Jiang, Yan-Yi; Gu, Wen-Yue; Gong, Ting; Zhang, Yu; Xu, Xin; Wang, Ming-Rong] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Nagata, Yasunobu; Sato, Yusuke; Okuno, Yusuke; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan; [Yin, Dong] Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Kalid, Ori; Shacham, Sharon] Karyopharm Therapeut, Natick, MA USA; [Koeffler, H. Phillip] Natl Univ Singapore Hosp, Nat Univ Canc Inst, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; University of Tokyo; Sun Yat Sen University; National University of Singapore	Wang, MR (corresponding author), Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	dchlin11@gmail.com; wangmr2015@126.com	Xu, Liang/I-9877-2014; Garg, Manoj/C-4076-2019; Ding, Ling-Wen/H-6916-2019; Okuno, Yusuke/C-9082-2009; LIN, DECHEN/K-9457-2014; Ogawa, Seishi/AAE-7088-2019	Xu, Liang/0000-0002-2700-4840; Garg, Manoj/0000-0002-3492-2957; Ding, Ling-Wen/0000-0003-0022-1551; Okuno, Yusuke/0000-0003-3139-9272; WANG, Ming-Rong/0000-0002-8767-9356; Yin, Dong/0000-0002-1878-4849	National High-Tech R&D Program of China [2012AA02A503, 2012AA02A209]; National Natural Science Foundation of China [81330052]; US National Institutes of Health [R01CA026038-35]; National Research Foundation Singapore; Singapore Ministry of Education under Research Centers of Excellence; Singapore Ministry of Health's National Medical Research Council under Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under Research Centers of Excellence(Ministry of Education, Singapore); Singapore Ministry of Health's National Medical Research Council under Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P.Tan and Z.Zang for generously sharing related facilities.We also thank B. Koegler and S. Koegler for their generous support. This work is supported by National High-Tech R&D Program of China 2012AA02A503 and 2012AA02A209 (M.-R.W.), National Natural Science Foundation of China 81330052 (M.-R.W.), US National Institutes of Health grant R01CA026038-35 (H.P.K.), National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centers of Excellence initiative (H.P.K.), and Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award to H.P.K.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Akagi I, 2009, INT J ONCOL, V34, P767, DOI 10.3892/ijo_00000202; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boone J, 2008, J CLIN PATHOL, V61, P909, DOI 10.1136/jcp.2008.055772; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chen HY, 2013, MOL CANCER RES, V11, P1542, DOI 10.1158/1541-7786.MCR-13-0317; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cohen I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042628; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; Dikshit B, 2013, ONCOGENE, V32, P3798, DOI 10.1038/onc.2012.393; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Hirasaki S, 2007, ONCOLOGIST, V12, P406, DOI 10.1634/theoncologist.12-4-406; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kim JY, 2010, CELL CYCLE, V9, P3680, DOI 10.4161/cc.9.18.12716; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lapalombella R, 2012, BLOOD, V120, P4621, DOI 10.1182/blood-2012-05-429506; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sato-Kuwabara Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-6; Schmidt J, 2013, LEUKEMIA, V27, P2357, DOI 10.1038/leu.2013.172; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Shigaki H, 2013, CLIN CANCER RES, V19, P2451, DOI 10.1158/1078-0432.CCR-12-3559; Somaiah N, 2011, J THORAC ONCOL, V6, pS1758, DOI 10.1097/01.JTO.0000407557.30793.a6; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Walker CJ, 2013, BLOOD, V122, P3034, DOI 10.1182/blood-2013-04-495374; Wei QC, 2007, INT J ONCOL, V31, P493; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang Y, 2012, GASTROENTEROLOGY, V142, P521, DOI 10.1053/j.gastro.2011.11.023; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	54	403	423	3	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					467	473		10.1038/ng.2935	http://dx.doi.org/10.1038/ng.2935			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24686850	Green Accepted, Green Submitted			2022-12-17	WOS:000335422900013
J	Arking, DE; Pfeufer, A; Post, W; Kao, WHL; Newton-Cheh, C; Ikeda, M; West, K; Kashuk, C; Akyol, M; Perz, S; Jalilzadeh, S; Illig, T; Gieger, C; Guo, CY; Larson, MG; Wichmann, HE; Marban, E; O'Donnell, CJ; Hirschhorn, JN; Kaab, S; Spooner, PM; Meitinger, T; Chakravarti, A				Arking, Dan E.; Pfeufer, Arne; Post, Wendy; Kao, W. H. Linda; Newton-Cheh, Christopher; Ikeda, Morna; West, Kristen; Kashuk, Carl; Akyol, Mahmut; Perz, Siegfried; Jalilzadeh, Shapour; Illig, Thomas; Gieger, Christian; Guo, Chao-Yu; Larson, Martin G.; Wichmann, H. Erich; Marban, Eduardo; O'Donnell, Christopher J.; Hirschhorn, Joel N.; Kaeaeb, Stefan; Spooner, Peter M.; Meitinger, Thomas; Chakravarti, Aravinda			A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization	NATURE GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-HEART-DISEASE; FACTOR-H POLYMORPHISM; ALL-CAUSE MORTALITY; QT-INTERVAL; MACULAR DEGENERATION; CARDIOVASCULAR MORTALITY; QUANTITATIVE TRAIT; ELDERLY-MEN; K+ CHANNEL	Extremes of the electrocardiographic QT interval, a measure of cardiac repolarization, are associated with increased cardiovascular mortality. We identified a common genetic variant influencing this quantitative trait through a genome-wide association study on 200 subjects at the extremes of a population-based QT interval distribution of 3,966 subjects from the KORA cohort in Germany, with follow-up screening of selected markers in the remainder of the cohort. We validated statistically significant findings in two independent samples of 2,646 subjects from Germany and 1,805 subjects from the US Framingham Heart Study. This genome-wide study identified NOS1AP ( CAPON), a regulator of neuronal nitric oxide synthase, as a new target that modulates cardiac repolarization. Approximately 60% of subjects of European ancestry carry at least one minor allele of the NOS1AP genetic variant, which explains up to 1.5% of QT interval variation.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Univ Munich, Inst Informat Management Biometry & Epidemiol, D-81377 Munich, Germany; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Program Genom, Boston, MA 02115 USA; Univ Munich, Dept Med 1, D-81377 Munich, Germany; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Boston University; University of Munich; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Munich; Harvard University; Harvard Medical School	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu	Marban, Eduardo/GWC-8514-2022; Wichmann, Heinz Erich/AAA-5695-2022; Meitinger, Thomas/O-1318-2015; Pfeufer, Arne/B-6634-2013; Kaab, Stefan/H-3915-2012; AKYOL, Mahmut/C-2490-2016	AKYOL, Mahmut/0000-0003-1156-5384; Guo, Chao-Yu/0000-0002-9066-9933; Meitinger, Thomas/0000-0002-8838-8403; Larson, Martin/0000-0002-9631-1254; Gieger, Christian/0000-0001-6986-9554	NHLBI NIH HHS [5U01HL066582, K23HL080025, N01-HC-25195] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066582, K23HL080025] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAILEY JJ, 1990, CIRCULATION, V81, P730, DOI 10.1161/01.CIR.81.2.730; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Busjahn A, 1999, CIRCULATION, V99, P3161, DOI 10.1161/01.CIR.99.24.3161; Carter N, 2000, J HUM HYPERTENS, V14, P389, DOI 10.1038/sj.jhh.1001026; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Leonoudakis D, 2001, J CELL SCI, V114, P987; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Massion PB, 2005, COMP BIOCHEM PHYS A, V142, P144, DOI 10.1016/j.cbpb.2005.05.048; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Mortara D W, 1992, J Electrocardiol, V25 Suppl, P200, DOI 10.1016/0022-0736(92)90102-6; Murata M, 2001, AM J PHYSIOL-HEART C, V281, pH2575, DOI 10.1152/ajpheart.2001.281.6.H2575; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Page GP, 1999, AM J HUM GENET, V64, P1194, DOI 10.1086/302331; PERZ S, 2004, ANAL BIOMEDICAL SIGN, V17, P47; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Priori SG, 2004, ANN NY ACAD SCI, V1015, P96, DOI 10.1196/annals.1302.008; Risch NJ, 1996, AM J HUM GENET, V58, P836; Robertson A., 1967, Heritage from Mendel., P265; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Sharp DS, 1998, ANN EPIDEMIOL, V8, P99, DOI 10.1016/S1047-2797(97)00121-X; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Weir B., 1996, GENETIC DATA ANAL; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C	45	403	416	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					644	651		10.1038/ng1790	http://dx.doi.org/10.1038/ng1790			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16648850				2022-12-17	WOS:000237954800017
J	Parant, J; Chavez-Reyes, A; Little, NA; Yan, W; Reinke, V; Jochemsen, AG; Lozano, G				Parant, J; Chavez-Reyes, A; Little, NA; Yan, W; Reinke, V; Jochemsen, AG; Lozano, G			Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53	NATURE GENETICS			English	Article							MDM2-DEFICIENT MICE; ONCOPROTEIN MDM2; DEGRADATION; APOPTOSIS; REGION	The p53 protein can inhibit cell cycling or induce apoptosis, and is thus a critical regulator of tumorigenesis'. This protein is negatively regulated by a physical interaction with MDM2, an E3 ubiquitin ligase(2-4). This interaction is critical for cell viability; loss of Mdm2 causes cell death in vitro and in vivo in a p53-dependent manner(5-7). The recently discovered(8) MDM2-related protein MDM4 (also known as MDMX) has some of the same properties as MDM2. MDM4 binds and inhibits p53 transcriptional activity in vitro. Unlike MDM2, however, MDM4 does not cause nuclear export or degradation of p53 (refs. 9,10). To study MDM4 function in vivo, we deleted Mdm4 in mice. Mdm4-null mice died at 7.5-8.5 dpc, owing to loss of cell proliferation and not induction of apoptosis. To assess the importance of p53 in the death of Mdm4(-/-) embryos, we crossed in the Trp53-null allele. The loss of Trp53 completely rescued the Mdm4(-/-) embryonic lethality. Thus, MDM2 and MDM4 are nonoverlapping critical regulators of p53 in vivo. These data define a new pathway of p53 regulation and raise the possibility that increased MDM4 levels and the resulting inactivation of p53 contribute to the development of human tumors.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; Univ Autonoma Nuevo Leon, Sch Biol Sci, Dept Microbiol & Immunol, Monterrey, NL, Mexico; Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RA Leiden, Netherlands	University of Texas System; UTMD Anderson Cancer Center; Universidad Autonoma de Nuevo Leon; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lozano, G (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Box 11,1515 Holcombe Blvd, Houston, TX 77030 USA.		Chavez-Reyes, Arturo/ABG-1231-2020	Chavez-Reyes, Arturo/0000-0002-6655-815X				de Rozieres S, 2000, ONCOGENE, V19, P1691, DOI 10.1038/sj.onc.1203468; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LUNA RMD, 1995, NATURE, V378, P203; Manova K, 1998, DEV DYNAM, V213, P293, DOI 10.1002/(SICI)1097-0177(199811)213:3<293::AID-AJA6>3.0.CO;2-D; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Parant JM, 2001, GENE, V270, P277, DOI 10.1016/S0378-1119(01)00432-2; Ramos YFM, 2001, CANCER RES, V61, P1839; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stad R, 2000, J BIOL CHEM, V275, P28039; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WILKINSON DG, 1998, IN SITU HYBRIDIZATIO	18	403	408	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					92	95		10.1038/ng714	http://dx.doi.org/10.1038/ng714			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528400				2022-12-17	WOS:000170781300025
J	Yant, SR; Meuse, L; Chiu, W; Ivics, Z; Izsvak, Z; Kay, MA				Yant, SR; Meuse, L; Chiu, W; Ivics, Z; Izsvak, Z; Kay, MA			Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system	NATURE GENETICS			English	Article							MEDIATED GENE-TRANSFER; ADENOASSOCIATED VIRUS; MARINER TRANSPOSASE; FACTOR-IX; IN-VITRO; HEMOPHILIA-B; HUMAN ALPHA-1-ANTITRYPSIN; RECOMBINANT ADENOVIRUSES; IMMUNE-RESPONSES; MOUSE-LIVER	The development of non-viral gene-transfer technologies that can support stable chromosomal integration and persistent gene expression in vivo is desirable. Here we describe the successful use of transposon technology for the nonhomologous insertion of foreign genes into the genomes of adult mammals using naked DNA. We show that the Sleeping Beauty transposase can efficiently insert transposon DNA into the mouse genome in approximately 5-6% of transfected mouse liver cells. Chromosomal transposition resulted in long-term expression (>5 months) of human blood coagulation factor IX at levels that were therapeutic in a mouse model of haemophilia B. Our results establish DNA-mediated transposition as a new genetic tool for mammals, and provide new strategies to improve existing non-viral and viral vectors for human gene therapy applications.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Max Delbruck Ctr Mol Med, Berlin, Germany	Stanford University; Stanford University; University of Washington; University of Washington Seattle; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kay, MA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	markay@stanford.edu	Wilson, Matthew H/K-3193-2013	Kay, Mark/0000-0002-2799-2615; Yant, Stephen R,/0000-0002-4444-7483	NIDDK NIH HHS [DK49022] Funding Source: Medline; NIGMS NIH HHS [T32 GM07270] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALINO SF, 1994, BIOCHEM BIOPH RES CO, V204, P1023, DOI 10.1006/bbrc.1994.2565; CAPLEN NJ, 1995, NAT MED, V1, P39, DOI 10.1038/nm0195-39; Choate KA, 1997, HUM GENE THER, V8, P1659, DOI 10.1089/hum.1997.8.14-1659; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Gordon Erlinda M., 1994, Current Opinion in Biotechnology, V5, P611, DOI 10.1016/0958-1669(94)90083-3; Hartl DL, 1997, TRENDS GENET, V13, P197, DOI 10.1016/S0168-9525(97)01087-1; Hernandez YJ, 1999, J VIROL, V73, P8549, DOI 10.1128/JVI.73.10.8549-8558.1999; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; KAY MA, 1995, HEPATOLOGY, V21, P815, DOI 10.1002/hep.1840210331; Kay MA, 1997, P NATL ACAD SCI USA, V94, P4686, DOI 10.1073/pnas.94.9.4686; KAY MA, 1993, SCIENCE, V262, P117, DOI 10.1126/science.8211118; Kay MA, 1997, MOL MED TODAY, V3, P108, DOI 10.1016/S1357-4310(96)10062-9; Koeberl DD, 1997, P NATL ACAD SCI USA, V94, P1426, DOI 10.1073/pnas.94.4.1426; Kovesdi I, 1997, CURR OPIN BIOTECH, V8, P583, DOI 10.1016/S0958-1669(97)80033-X; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lampe DJ, 1998, GENETICS, V149, P179; Latchman David S., 1994, Molecular Biotechnology, V2, P179, DOI 10.1007/BF02824809; Li K, 1997, J MOL CELL CARDIOL, V29, P1499, DOI 10.1006/jmcc.1997.0389; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; Lohe AR, 1996, GENETICS, V144, P1087; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Miao CH, 1998, NAT GENET, V19, P13, DOI 10.1038/ng0598-13; Miao CH, 2000, J VIROL, V74, P3793, DOI 10.1128/JVI.74.8.3793-3803.2000; Mumper RJ, 1996, PHARMACEUT RES, V13, P701, DOI 10.1023/A:1016039330870; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Park F, 2000, NAT GENET, V24, P49, DOI 10.1038/71673; PERALES JC, 1994, EUR J BIOCHEM, V226, P255, DOI 10.1111/j.1432-1033.1994.tb20049.x; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; Rabinowitz JE, 1998, CURR OPIN BIOTECH, V9, P470, DOI 10.1016/S0958-1669(98)80031-1; Raz E, 1998, CURR BIOL, V8, P82, DOI 10.1016/S0960-9822(98)70038-7; REINER AP, 1995, METABOLIC MOL BASIS; Rutledge EA, 1997, J VIROL, V71, P8429, DOI 10.1128/JVI.71.11.8429-8436.1997; Schouten GJ, 1998, NUCLEIC ACIDS RES, V26, P3013, DOI 10.1093/nar/26.12.3013; Sherman A, 1998, NAT BIOTECHNOL, V16, P1050, DOI 10.1038/3497; Snyder RO, 1999, NAT MED, V5, P64, DOI 10.1038/4751; Vos JC, 1996, GENE DEV, V10, P755, DOI 10.1101/gad.10.6.755; Walter J, 1996, P NATL ACAD SCI USA, V93, P3056, DOI 10.1073/pnas.93.7.3056; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Xiao WD, 1998, J VIROL, V72, P10222, DOI 10.1128/JVI.72.12.10222-10226.1998; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Yew NS, 1997, HUM GENE THER, V8, P575, DOI 10.1089/hum.1997.8.5-575; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang LN, 1998, NUCLEIC ACIDS RES, V26, P3687, DOI 10.1093/nar/26.16.3687; Zhu JD, 1999, HUM GENE THER, V10, P113, DOI 10.1089/10430349950019246	50	403	444	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2000	25	1					35	41		10.1038/75568	http://dx.doi.org/10.1038/75568			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802653				2022-12-17	WOS:000086884000013
J	Engelender, S; Kaminsky, Z; Guo, X; Sharp, AH; Amaravi, RK; Kleiderlein, JJ; Margolis, RL; Troncoso, JC; Lanahan, AA; Worley, PF; Dawson, VL; Dawson, TM; Ross, CA				Engelender, S; Kaminsky, Z; Guo, X; Sharp, AH; Amaravi, RK; Kleiderlein, JJ; Margolis, RL; Troncoso, JC; Lanahan, AA; Worley, PF; Dawson, VL; Dawson, TM; Ross, CA			Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions	NATURE GENETICS			English	Article							PARKINSONS-DISEASE; LEWY BODIES; ALZHEIMERS-DISEASE; PROTEIN; BRAIN; IDENTIFICATION; COMPONENT; PATHOLOGY; DEMENTIA; MUTATION	Parkinson disease (PD) is a neurodegenerative disease characterized by tremor, bradykinesia, rigidity and postural instability. Post-mortem examination shows loss of neurons and Lewy bodies, which are cytoplasmic eosinophilic inclusions, in the substantia nigra and other brain regions(1,2). A few families have PD caused by mutations (A53T or A30P) in the gene SNCA (encoding alpha-synuclein; refs 3-5). alpha-synuclein is present in Lewy bodies of patients with sporadic PD (refs 6,7), suggesting that alpha-synuclein may be involved in the pathogenesis of PD. It is unknown how alpha-synuclein contributes to the cellular and biochemical mechanisms of PD, and its normal functions and biochemical properties are poorly understood(8-10). To determine the protein-interaction partners of alpha-synuclein, we performed a yeast two-hybrid screen. We identified a novel interacting protein, which we term synphilin-1 (encoded by the gene SNCAIP). We found that alpha-synuclein interacts in vivo with synphilin-1 in neurons. Co-transfection of both proteins (but not control proteins) in HEK 293 cells yields cytoplasmic eosinophilic inclusions.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Div Neuropathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Program Cellular & Mol Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ross, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.		Dawson, Valina/Y-9757-2019; Ross, Christopher A/H-8395-2013	Engelender, Simone/0000-0001-7401-6855; Dawson, Valina/0000-0002-2915-3970	NINDS NIH HHS [NS16375, NS38377] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375, P50NS016375, P50NS038377] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baba M, 1998, AM J PATHOL, V152, P879; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; DAWSON VL, 1993, J NEUROSCI, V13, P2651; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Heintz N, 1997, NAT GENET, V16, P325, DOI 10.1038/ng0897-325; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lupas A, 1996, METHOD ENZYMOL, V266, P513; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; NAKAJO S, 1990, J NEUROCHEM, V55, P2031, DOI 10.1111/j.1471-4159.1990.tb05792.x; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6	30	403	425	2	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					110	114		10.1038/8820	http://dx.doi.org/10.1038/8820			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319874				2022-12-17	WOS:000080096300035
J	Mollenhauer, J; Wiemann, S; Scheurlen, W; Korn, B; Hayashi, Y; Wilgenbus, KK; vonDeimling, A; Poustka, A				Mollenhauer, J; Wiemann, S; Scheurlen, W; Korn, B; Hayashi, Y; Wilgenbus, KK; vonDeimling, A; Poustka, A			DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours	NATURE GENETICS			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; LONG ARM; RECEPTOR; HETEROZYGOSITY; SEQUENCES; DOMAIN; HYBRIDIZATION; PROGRESSION; MELANOMA	Loss of sequences from human chromosome 10q has been associated with the progression of human cancer. Medulloblastoma and glioblastoma multiforme ave the most common malignant brain tumours in children and adults, respectively. In glioblastoma multiforme, the most aggressive form, 80% of the tumours show loss of 10q. We have used representational difference analysis to identify a homozygous deletion at 10q25.3-26.1 in a medulloblastoma cell line and have cloned a novel gene, DMBT1, spanning this deletion. DMBT1 shows homology to the scavenger receptor cysteine-rich (SRCR) superfamily. Intragenic homozygous deletions have been detected in 2/20 medulloblastomas and in 9/39 glioblastomas mutliformes. Lack of DMBT1 expression has been demonstrated in 4/5 brain-tumour cell lines. We suggest that DMBT1 is a putative tumour-suppressor gene implicated in the carcinogenesis of medulloblastoma and glioblastoma multiforme.	DEUTSCH KREBSFORSCHUNGSZENTRUM, DIV MOL GENOME ANAL, D-69120 HEIDELBERG, GERMANY; CHILDRENS HOSP, D-68167 MANNHEIM, GERMANY; UNIV BONN, MED CTR, DEPT NEUROPATHOL, D-53105 BONN, GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Bonn			Abrams, William R/A-5782-2008; Mollenhauer, Jan/G-4452-2012; von Deimling, Andreas/F-7774-2013; Wiemann, Stefan/E-4424-2013	von Deimling, Andreas/0000-0002-5863-540X; Wiemann, Stefan/0000-0003-4683-3174				AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571, DOI 10.1152/ajpcell.1996.270.6.C1571; Albarosa R, 1996, AM J HUM GENET, V58, P1260; ALBRECHT S, 1994, NEUROPATH APPL NEURO, V20, P74, DOI 10.1111/j.1365-2990.1994.tb00959.x; AZIZI E, 1995, CANCER, V76, P1571, DOI 10.1002/1097-0142(19951101)76:9<1571::AID-CNCR2820760912>3.0.CO;2-6; BIEGEL JA, 1995, GENE CHROMOSOME CANC, V14, P85, DOI 10.1002/gcc.2870140202; BIEGEL JA, 1989, GENE CHROMOSOME CANC, V1, P139, DOI 10.1002/gcc.2870010206; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Cheng H, 1996, ANAT REC, V244, P327; CHUMAKOV IM, 1995, NATURE, V377, P175; COGEN PH, 1990, GENOMICS, V8, P279, DOI 10.1016/0888-7543(90)90283-Z; FUJII YJ, 1994, GENE CHROMOSOME CANC, V11, P205, DOI 10.1002/gcc.2870110402; GRAY IC, 1995, CANCER RES, V55, P4800; HAHN SA, 1995, CANCER RES, V55, P4670; HERBST RA, 1994, CANCER RES, V54, P3111; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KELSELL DP, 1995, ANN HUM GENET, V59, P233, DOI 10.1111/j.1469-1809.1995.tb00743.x; Kleihues P, 1993, HISTOLOGICAL TYPING; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUHL J, 1993, AM J PEDIAT HEMAT SA, V15, P567; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEUMANN E, 1993, CANCER GENET CYTOGEN, V71, P40, DOI 10.1016/0165-4608(93)90200-6; NUNES DP, 1995, BIOCHEM J, V310, P41, DOI 10.1042/bj3100041; PEIFFER SL, 1995, CANCER RES, V55, P1922; Petersen I, 1997, BRIT J CANCER, V75, P79, DOI 10.1038/bjc.1997.13; POUSTKA A, 1990, Methods (Orlando), V1, P204, DOI 10.1016/S1046-2023(05)80136-7; RASHEED BKA, 1995, ONCOGENE, V10, P2243; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Scheurlen WG, 1997, GENE CHROMOSOME CANC, V18, P50, DOI 10.1002/(SICI)1098-2264(199701)18:1<50::AID-GCC6>3.0.CO;2-0; Schutz BR, 1996, GENE CHROMOSOME CANC, V16, P196; Starling GC, 1996, EUR J IMMUNOL, V26, P738, DOI 10.1002/eji.1830260403; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; THOMAS GA, 1991, CANCER RES, V51, P639; ULLRICH A, 1994, J BIOL CHEM, V269, P18401; WHITNEY GS, 1995, J BIOL CHEM, V270, P18187, DOI 10.1074/jbc.270.31.18187; Zedenius J, 1996, HUM GENET, V97, P299, DOI 10.1007/BF02185758	41	403	416	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					32	39		10.1038/ng0997-32	http://dx.doi.org/10.1038/ng0997-32			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288095				2022-12-17	WOS:A1997XU72400015
J	Naski, MC; Wang, Q; Xu, JS; Ornitz, DM				Naski, MC; Wang, Q; Xu, JS; Ornitz, DM			Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia	NATURE GENETICS			English	Letter							FEATURES; HEPARIN; PROTEIN; DOMAIN		WASHINGTON UNIV, SCH MED, DEPT MOLEC BIOL & PHARMACOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL)				Ornitz, David/0000-0003-1592-7629	NATIONAL CANCER INSTITUTE [R01CA060673] Funding Source: NIH RePORTER; NCI NIH HHS [CA-60673] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; BRINER J, 1991, PATHOL RES PRACT, V187, P271; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FORMISANO P, 1993, J BIOL CHEM, V268, P5241; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNEKEN A, 1994, P NATL ACAD SCI USA, V91, P9170, DOI 10.1073/pnas.91.19.9170; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; KEEGAN K, 1991, ONCOGENE, V6, P2229; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; OLWIN BB, 1990, J CELL BIOL, V110, P503, DOI 10.1083/jcb.110.2.503; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; RIMOIN DL, 1993, MCKUSICKS HERITABLE, P557; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SHAH K, 1973, J MED GENET, V10, P243, DOI 10.1136/jmg.10.3.243; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WILKIE AOM, 1995, CURR BIOL, V5, P500	30	403	422	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					233	237		10.1038/ng0696-233	http://dx.doi.org/10.1038/ng0696-233			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640234				2022-12-17	WOS:A1996UN39500027
J	BONNEMANN, CG; MODI, R; NOGUCHI, S; MIZUNO, Y; YOSHIDA, M; GUSSONI, E; MCNALLY, EM; DUGGAN, DJ; ANGELINI, C; HOFFMAN, EP; OZAWA, E; KUNKEL, LM				BONNEMANN, CG; MODI, R; NOGUCHI, S; MIZUNO, Y; YOSHIDA, M; GUSSONI, E; MCNALLY, EM; DUGGAN, DJ; ANGELINI, C; HOFFMAN, EP; OZAWA, E; KUNKEL, LM			BETA-SARCOGLYCAN (A3B) MUTATIONS CAUSE AUTOSOMAL RECESSIVE MUSCULAR-DYSTROPHY WITH LOSS OF THE SARCOGLYCAN COMPLEX	NATURE GENETICS			English	Article							GLYCOPROTEIN COMPLEX; DEFICIENCY; PROTEINS; MUSCLE; HETEROGENEITY; SARCOLEMMA; LINKAGE; ADHALIN	The dystrophin associated proteins (DAPs) are good candidates for harboring primary mutations in the genetically heterogeneous autosomal recessive muscular dystrophies (ARMD). The transmembrane components of the DAPs cab be separated into the dystroglycan and the sarcoglycan complexes. Here we report the isolation of cDNAs encoding the 43 kD sarcoglycan protein beta-sarcoglycan (A3b) and the localization of the human gene to chromosome 4q12. We describe a young girl with ARMD with truncating mutations on both alleles. Immunostaining of her muscle biopsy shows specific loss of the components of the sarcoglycan complex (beta-sarcoglycan, alpha-sarcoglycan (adhalin), and 35 kD sarcoglycan). Thus secondary destabilization of the sarcoglycan complex may be an important pathophysiological event in ARMD.	CHILDRENS HOSP, HOWARD HUGHES MED INST, DIV GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; UNIV PITTSBURGH, SCH MED, DEPT MOLEC GENET & BIOCHEM, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT PEDIAT, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT HUMAN GENET, PITTSBURGH, PA 15261 USA; NATL CTR NEUROL & PSYCHIAT, NATL INST NEUROSCI, DEPT CELL BIOL, KODAIRA, TOKYO 187, JAPAN; UNIV PADUA, NEUROL CLIN 1, I-35128 PADUA, ITALY; MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02114 USA; UNIV PITTSBURGH, MED CTR, DEPT CARDIOL, PITTSBURGH, PA 15261 USA; GUNMA UNIV, DEPT NEUROL, MAEBASHI, GUMMA 371, JAPAN	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Center for Neurology & Psychiatry - Japan; University of Padua; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Gunma University			Gussoni, Emanuela/AAL-6150-2021; McNally, Elizabeth/W-4909-2019; Angelini, Corrado I/J-3655-2019	Gussoni, Emanuela/0000-0002-9915-3677; Angelini, Corrado I/0000-0002-9554-8794; McNally, Elizabeth/0000-0002-1221-719X; Hoffman, Eric/0000-0001-6470-5139	NINDS NIH HHS [5 RO1 NS 23740-09] Funding Source: Medline; Telethon [552] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023740] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BECK JS, 1993, HUM GENET, V53, pA974; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; DUBOIS BL, 1993, GENOMICS, V16, P315, DOI 10.1006/geno.1993.1191; ELKERCH F, 1994, J MED GENET, V31, P342, DOI 10.1136/jmg.31.4.342; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FARDEAU M, 1993, CR ACAD SCI III-VIE, V316, P799; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAMIDA MB, 1983, MUSCLE NERVE, V6, P469, DOI 10.1002/mus.880060702; HAYASHI YK, 1995, NEUROLOGY, V45, P551, DOI 10.1212/WNL.45.3.551; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1992, NEUROLOGY, V42, P967, DOI 10.1212/WNL.42.5.967; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KAWASAKI H, 1990, ANAL BIOCHEM, V191, P332, DOI 10.1016/0003-2697(90)90227-Z; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; LJUNGGREN A, IN PRESS ANN NEUROL; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MCNALLY EM, 1994, P NATL ACAD SCI USA, V91, P9690, DOI 10.1073/pnas.91.21.9690; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MIZUNO Y, 1995, AM J PATHOL, V146, P530; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; MIZUNO Y, 1994, BIOCHEM BIOPH RES CO, V203, P979, DOI 10.1006/bbrc.1994.2278; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OZAWA E, IN PRESS HUM MOL GEN; PASSOSBUENO MR, 1993, HUM MOL GENET, V2, P1945, DOI 10.1093/hmg/2.11.1945; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; Sambrook J., 1989, MOL CLONING LAB MANU; SPECHT LA, 1993, MOL GENETIC BASIS NE, P613; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TINSLEY JM, 1994, P NATL ACAD SCI USA, V91, P8307, DOI 10.1073/pnas.91.18.8307; von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S; YAMAMOTO H, 1993, J BIOCHEM-TOKYO, V114, P132, DOI 10.1093/oxfordjournals.jbchem.a124128; YAMAMOTO H, 1994, J BIOCHEM-TOKYO, V115, P162, DOI 10.1093/oxfordjournals.jbchem.a124294; YOSHIDA M, 1993, J BIOCHEM-TOKYO, V114, P634, DOI 10.1093/oxfordjournals.jbchem.a124229; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; YOSHIDA M, 1992, J BIOCHEM-TOKYO, V112, P433, DOI 10.1093/oxfordjournals.jbchem.a123918; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401; ZATZ M, 1994, J NEUROL SCI, V123, P122, DOI 10.1016/0022-510X(94)90213-5	51	403	415	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1995	11	3					266	273		10.1038/ng1195-266	http://dx.doi.org/10.1038/ng1195-266			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581449				2022-12-17	WOS:A1995TC63900014
J	STGEORGEHYSLOP, P; HAINES, J; ROGAEV, E; MORTILLA, M; VAULA, G; PERICAKVANCE, M; FONCIN, JF; MONTESI, M; BRUNI, A; SORBI, S; RAINERO, I; PINESSI, L; POLLEN, D; POLINSKY, R; NEE, L; KENNEDY, J; MACCIARDI, F; ROGAEVA, E; LIANG, Y; ALEXANDROVA, N; LUKIW, W; SCHLUMPF, K; TANZI, R; TSUDA, T; FARRER, L; CANTU, JM; DUARA, R; AMADUCCI, L; BERGAMINI, L; GUSELLA, J; ROSES, A; MCLACHLAN, DC				STGEORGEHYSLOP, P; HAINES, J; ROGAEV, E; MORTILLA, M; VAULA, G; PERICAKVANCE, M; FONCIN, JF; MONTESI, M; BRUNI, A; SORBI, S; RAINERO, I; PINESSI, L; POLLEN, D; POLINSKY, R; NEE, L; KENNEDY, J; MACCIARDI, F; ROGAEVA, E; LIANG, Y; ALEXANDROVA, N; LUKIW, W; SCHLUMPF, K; TANZI, R; TSUDA, T; FARRER, L; CANTU, JM; DUARA, R; AMADUCCI, L; BERGAMINI, L; GUSELLA, J; ROSES, A; MCLACHLAN, DC			GENETIC-EVIDENCE FOR A NOVEL FAMILIAL ALZHEIMERS-DISEASE LOCUS ON CHROMOSOME-14	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; MARKERS; RECOMBINATION; MUTATION; REGION	Familial Alzheimer's disease (FAD) has been shown to be genetically heterogeneous, with a very small proportion of early onset pedigrees being associated with mutations in the amyloid precursor protein (APP) gene on chromosome 21, and some late onset pedigrees showing associations with markers on chromosome 19. We now provide evidence for a major early onset FAD locus on the long arm of chromosome 14 near the markers D14S43 and D14S53 (multipoint lod score z = 23.4) and suggest that the inheritance of FAD may be more complex than had initially been suspected.	UNIV TORONTO, CTR RES NEURODEGENERAT DIS, DEPT PHYSIOL, TORONTO M5S 1A8, ONTARIO, CANADA; MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET LAB, BOSTON, MA 02129 USA; ACAD MED SCI, NATL RES CTR MENT HLTH, MOLEC BRAIN GENET LAB, MOSCOW 113152, USSR; UNIV FLORENCE, DEPT NEUROL, I-50121 FLORENCE, ITALY; UNIV TURIN, DEPT NEUROL, I-10126 TURIN, ITALY; DUKE UNIV, MED CTR, BRYAN ALZHEIMERS DIS RES CTR, DURHAM, NC 27710 USA; UNIV MILANO, SCH MED, DEPT NEUROSCI, I-20127 MILAN, ITALY; TOHOKU UNIV, SCH MED, DEPT NEUROL, SENDAI, MIYAGI 980, JAPAN; BOSTON UNIV, SCH MED, NEUROGENET LAB, BOSTON, MA 02118 USA; IST MEXICANO SEGURO SOCIAL, DEPT GENET, GUADALAJARA, MEXICO; ECOLE PRAT HAUTES ETUD, NEUROHISTOL LAB, F-75651 PARIS 13, FRANCE; CNR, SERV NEUROL, USSL 17, I-88046 LAMEZIA TERME, ITALY; UNIV MASSACHUSETTS, MED CTR, DEPT NEUROL, WORCESTER, MA 01655 USA; SANDOZ PHARMACEUT CORP, SANDOZ RES INST, E HANOVER, NJ 07936 USA; NINCDS, CLIN NEUROPHARMACOL SECT, BETHESDA, MD 20892 USA; UNIV TORONTO, CLARKE INST PSYCHIAT, DEPT PSYCHIAT, NEUROGENET SECT, TORONTO M5T 1R8, ONTARIO, CANADA; MT SINAI MED CTR, WEIN CTR, MIAMI BEACH, FL 33140 USA	University of Toronto; Harvard University; Massachusetts General Hospital; Russian Academy of Medical Sciences; University of Florence; University of Turin; Duke University; University of Milan; Tohoku University; Boston University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Consiglio Nazionale delle Ricerche (CNR); University of Massachusetts System; University of Massachusetts Worcester; Novartis; Sandoz; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Mount Sinai Medical Center	STGEORGEHYSLOP, P (corresponding author), UNIV TORONTO, CTR RES NEURODEGENERAT DIS, DEPT MED, DIV NEUROL, TORONTO M5S 1A8, ONTARIO, CANADA.		Rogaev, Evgeny/AAN-7662-2020; Mortilla, Marzia/AAV-5525-2020; Farrer, Lindsay/AAS-1035-2020; Tanzi, Rudolph/AAE-9622-2019; Macciardi, Fabio/N-3768-2014; Haines, Jonathan/C-3374-2012; Bruni, Amalia/K-5038-2016	Tanzi, Rudolph/0000-0002-7032-1454; Macciardi, Fabio/0000-0003-0537-4266; Haines, Jonathan/0000-0002-4351-4728; Farrer, Lindsay/0000-0001-5533-4225; St George-Hyslop, Peter/0000-0003-0796-7209; Bruni, Amalia/0000-0003-3471-3343; sorbi, sandro/0000-0002-0380-6670				BEYREUTHER K, 1991, ANN NY ACAD SCI, V640, P129; CARTER DA, 1992, NATURE GNET, V2; COX DW, 1990, CYTOGENET CELL GENET, V55, P183, DOI 10.1159/000133010; GADJUSEK DC, 1991, BRAIN RES BRAIN RES, V16, P83; Glenner G G, 1989, Prog Clin Biol Res, V317, P857; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; HAINES JL, 1991, AM J HUM GENET, V48, P1021; HARDY J, 1992, AM J HUM GENET, V50, P648; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HESTON LL, 1991, AM J MED GENET, V40, P449, DOI 10.1002/ajmg.1320400415; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; HOFKER MH, 1990, GENOMICS, V6, P33, DOI 10.1016/0888-7543(90)90445-Z; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; KARLINSKY H, 1992, NEUROLOGY, V42, P1445, DOI 10.1212/WNL.42.8.1445; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; LAFAUCI G, 1989, BIOCHEM BIOPH RES CO, V159, P297, DOI 10.1016/0006-291X(89)92437-6; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; POLLWEIN P, 1992, NUCLEIC ACIDS RES, V20, P63, DOI 10.1093/nar/20.1.63; ROSES AD, IN PRESS HETEROGENEI; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SEFTON L, 1990, GENOMICS, V7, P382, DOI 10.1016/0888-7543(90)90172-Q; STGEORGEHYSLOP PH, 1989, NEUROBIOL AGING, V10, P417, DOI 10.1016/0197-4580(89)90082-1; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P85; TANZI RE, 1992, AM J HUM GENET, V51, P273; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WISNIEWSKI HM, 1988, IMMUNOLOGY ALZHEIMER, P1	33	403	418	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					330	334		10.1038/ng1292-330	http://dx.doi.org/10.1038/ng1292-330			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303289	Green Published			2022-12-17	WOS:A1992KB49500020
J	TIMMERMAN, V; NELIS, E; VANHUL, W; NIEUWENHUIJSEN, BW; CHEN, KL; WANG, S; OTHMAN, KB; CULLEN, B; LEACH, RJ; HANEMANN, CO; DE JONGHE, P; RAEYMAEKERS, P; VANOMMEN, GJB; MARTIN, JJ; MULLER, HW; VANCE, JM; FISCHBECK, KH; VAN BROECKHOVEN, C				TIMMERMAN, V; NELIS, E; VANHUL, W; NIEUWENHUIJSEN, BW; CHEN, KL; WANG, S; OTHMAN, KB; CULLEN, B; LEACH, RJ; HANEMANN, CO; DE JONGHE, P; RAEYMAEKERS, P; VANOMMEN, GJB; MARTIN, JJ; MULLER, HW; VANCE, JM; FISCHBECK, KH; VAN BROECKHOVEN, C			THE PERIPHERAL MYELIN PROTEIN GENE PMP-22 IS CONTAINED WITHIN THE CHARCOT-MARIE-TOOTH DISEASE TYPE-1A DUPLICATION	NATURE GENETICS			English	Article							NEUROPATHY TYPE-I; MOUSE; MAP	Charcot-Marie-Tooth disease (CMT1) is the most common form of inherited peripheral neuropathy. Although the disease is genetically heterogeneous, it has been demonstrated that the gene defect in the most frequent type (CMT1A) is the result of a partial duplication of band 17p11.2. Recent studies suggested that the peripheral hypomyelination syndrome in the trembler (Tr) mouse, a possible animal model for CMT1 disease, is associated with a point mutation in the peripheral myelin protein-22 gene (pmp-22). Expression of pmp-22 is particularly high in Schwann cells, and the protein is found in peripheral myelin. We now report that the human PMP-22 gene is contained within the CMT1A duplication. We therefore, suggest that increased dosage of the PMP-22 gene may be the cause of CMT1A neuropathy.	UNIV INSTELLING ANTWERP, DEPT BIOCHEM,BORN BUNGE FDN,NEUROGENET LAB, UNIV PLEIN 1, B-2610 WILRIJK, BELGIUM; UNIV PENN, SCH MED, DEPT NEUROL, PHILADELPHIA, PA 19104 USA; DUKE UNIV, MED CTR, DIV NEUROL, DURHAM, NC 27710 USA; UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA; UNIV DUSSELDORF, DEPT NEUROL, MOLEC NEUROBIOL LAB, W-4000 DUSSELDORF 1, GERMANY; UNIV INSTELLING ANTWERP, DEPT MED, BORN BUNGE FDN, NEUROPATHOL LAB, B-2610 WILRIJK, BELGIUM; ACAD HOSP ANTWERP, DIV NEUROL, B-2610 ANTWERP, BELGIUM; LEIDEN UNIV, DEPT HUMAN GENET, 2300 RA LEIDEN, NETHERLANDS	University of Antwerp; University of Pennsylvania; Duke University; University of Texas System; University of Texas Health San Antonio; Heinrich Heine University Dusseldorf; University of Antwerp; University of Antwerp; Leiden University; Leiden University - Excl LUMC			Timmerman, Vincent/O-7283-2019; Van Broeckhoven, Christine/M-7853-2019; Hanemann, C Oliver/AAV-6257-2020	Timmerman, Vincent/0000-0002-2162-0933; Van Broeckhoven, Christine/0000-0003-0183-7665; Hanemann, C Oliver/0000-0002-1951-1025; Vance, Jeffery/0000-0003-3815-8199; Leach, Robin/0000-0002-3201-5579; Van Hul, Wim/0000-0002-5065-7858				AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; BUCHBERG AM, 1989, GENETICS, V122, P153; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLOMBO MP, 1992, MAMM GENOME, V2, P130, DOI 10.1007/BF00353861; DOCHERTY Z, 1983, J MED GENET, V20, P138, DOI 10.1136/jmg.20.2.138; DRIESEN MS, 1991, GENOMICS, V11, P1079, DOI 10.1016/0888-7543(91)90035-D; Dyck P.J., 1984, PERIPHERAL NEUROPATH, P1600; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; OCONNELL P, 1989, SCIENCE, V244, P1087, DOI 10.1126/science.2543077; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMMERMAN V, 1990, AM J HUM GENET, V47, P680; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; VANOMMEN GJB, 1986, ANAL HUMAN GENETIC D, P113; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	29	403	403	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1992	1	3					171	175		10.1038/ng0692-171	http://dx.doi.org/10.1038/ng0692-171			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303230				2022-12-17	WOS:A1992JC98200007
J	Odom, DT; Dowell, RD; Jacobsen, ES; Gordon, W; Danford, TW; MacIsaac, KD; Rolfe, PA; Conboy, CM; Gifford, DK; Fraenkel, E				Odom, Duncan T.; Dowell, Robin D.; Jacobsen, Elizabeth S.; Gordon, William; Danford, Timothy W.; MacIsaac, Kenzie D.; Rolfe, P. Alexander; Conboy, Caitlin M.; Gifford, David K.; Fraenkel, Ernest			Tissue-specific transcriptional regulation has diverged significantly between human and mouse	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; EVOLUTION; GENOME; LIVER	We demonstrate that the binding sites for highly conserved transcription factors vary extensively between human and mouse. We mapped the binding of four tissue-specific transcription factors (FOXA2, HNF1A, HNF4A and HNF6) to 4,000 orthologous gene pairs in hepatocytes purified from human and mouse livers. Despite the conserved function of these factors, from 41% to 89% of their binding events seem to be species specific. When the same protein binds the promoters of orthologous genes, approximately two-thirds of the binding sites do not align.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Fraenkel, E (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	fraenkel-admin@mit.edu	Pillay, Nischalan/F-9536-2012; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Fraenkel, Ernest/0000-0001-9249-8181; Odom, Duncan/0000-0001-6201-5599; Conboy, Caitlin/0000-0001-8280-056X; DOWELL, ROBIN/0000-0001-7665-9985	Cancer Research UK [15603, A15603] Funding Source: Medline; NIDDK NIH HHS [F32 DK076284, DK68655, R01 DK068655, DK92310, DK70813, K25 DK070813, DK076284] Funding Source: Medline; NLM NIH HHS [N01DK92310] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068655, N01DK092310, K25DK070813, F32DK076284] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bird CP, 2006, CURR OPIN GENET DEV, V16, P559, DOI 10.1016/j.gde.2006.10.003; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Kim SH, 2004, DIABETES, V53, P1375, DOI 10.2337/diabetes.53.5.1375; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; NATARAJAN AT, 1991, MUTAGENESIS, V6, P399, DOI 10.1093/mutage/6.5.399; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; Richert L, 2006, DRUG METAB DISPOS, V34, P870, DOI 10.1124/dmd.105.007708; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	14	402	415	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					730	732		10.1038/ng2047	http://dx.doi.org/10.1038/ng2047			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529977	Green Accepted			2022-12-17	WOS:000246859100016
J	Mandel, H; Szargel, R; Labay, V; Elpeleg, O; Saada, A; Shalata, A; Anbinder, Y; Berkowitz, D; Hartman, C; Barak, M; Eriksson, S; Cohen, N				Mandel, H; Szargel, R; Labay, V; Elpeleg, O; Saada, A; Shalata, A; Anbinder, Y; Berkowitz, D; Hartman, C; Barak, M; Eriksson, S; Cohen, N			The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA	NATURE GENETICS			English	Article							MTDNA DEPLETION; LIVER; EXPRESSION; CLONING; LOCALIZATION; DEFECTS; CDNA	Mitochondrial DNA (mtDNA)-depletion syndromes (MDS; OMIM 251880) are phenotypically heterogeneous, autosomal-recessive disorders characterized by tissue-specific reduction in mtDNA copy number(1-8). Affected individuals with the hepatocerebral form of MDS have early progressive liver failure and neurological abnormalities, hypoglycemia and increased lactate in body fluids. Affected tissues show both decreased activity of the mtDNA-encoded respiratory chain complexes (I, III, IV, V) and mtDNA depletion(1-4,8-13). We used homozygosity mapping in three kindreds of Druze origin to map the gene causing hepatocerebral MDS to a region of 6.1 cM on chromosome 2p13, between markers D2S291 and D2S2116. This interval encompasses the gene (DGUOK) encoding the mitochondrial deoxyguanosine kinase (dGK)(14-16). We identified a single-nucleotide deletion (204delA) within the coding region of DGUOK that segregates with the disease in the three kindreds studied. Western-blot analysis did not detect dGK protein in the liver of affected individuals. The main supply of deoxyribonucleotides (dNTPs) for mtDNA synthesis comes from the salvage pathway initiated by dGK and thymidine kinase-2 (TK2)(17-19). The association of mtDNA depletion with mutated DGUOK suggests that the salvage-pathway enzymes are involved in the maintenance of balanced mitochondrial dNTP pools.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Pediat,Metab Dis Unit, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Tamkin Human Mol Genet Res Facil, Dept Genet, IL-31096 Haifa, Israel; Shaare Zedek Med Ctr, Metab Dis Unit, Jerusalem, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Pediat Gastroenterol & Nutr Unit, IL-31096 Haifa, Israel; Western Galilee Med Ctr, Neonatal Intens Care Unit, Nahariyya, Israel; Swedish Univ Agr Sci, Dept Vet Med Chem, Uppsala, Sweden	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Western Galilee Hospital; Swedish University of Agricultural Sciences	Cohen, N (corresponding author), RW Johnson Pharmaceut Res Inst, 1000 Rd 202, Raritan, NJ 08869 USA.		Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656				ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bakker HD, 1996, J PEDIATR-US, V128, P683, DOI 10.1016/S0022-3476(96)80135-1; BODNAR AG, 1993, AM J HUM GENET, V53, P663; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1; GIBLETT ER, 1976, NEW ENGL J MED, V295, P1375, DOI 10.1056/NEJM197612092952409; Gyapay Gabor, 1996, Methods (Orlando), V9, P91, DOI 10.1006/meth.1996.0012; Hirano M, 2000, BRAIN PATHOL, V10, P451; Jenuth JP, 1996, BIOCHEM CELL BIOL, V74, P219, DOI 10.1139/o96-022; Johansson M, 1996, GENOMICS, V38, P450, DOI 10.1006/geno.1996.0654; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; Jullig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; MAASWINKELMOOIJ PD, 1996, J PEDIATR, V128, P979; Marin-Garcia J, 2000, PEDIATR NEUROL, V22, P122, DOI 10.1016/S0887-8994(99)00117-4; MARRIOTI C, 1995, J NEUROL, V242, P547; MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X; MORAES CT, 1991, AM J HUM GENET, V48, P492; Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Shaag A, 1999, AM J MED GENET, V82, P177, DOI 10.1002/(SICI)1096-8628(19990115)82:2<177::AID-AJMG15>3.3.CO;2-0; Spelbrink JN, 1998, HUM GENET, V102, P327, DOI 10.1007/s004390050700; Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935; Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783; Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0	31	402	413	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					337	341		10.1038/ng746	http://dx.doi.org/10.1038/ng746			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687800				2022-12-17	WOS:000171911000023
J	Riley, P; Anson-Cartwright, L; Cross, JC				Riley, P; Anson-Cartwright, L; Cross, JC			The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis	NATURE GENETICS			English	Article							MOUSE; GENE; EXPRESSION; HEART; CLONING; CELLS; IMPLANTATION; PROTEINS; ENCODES; SYSTEM	The placenta and cardiovascular system are the first organ systems to form during mammalian embryogenesis. We show here that a single gene is critical for development of both. The Hand1 gene, previously called Hxt, eHAND and Thing1, encodes a basic helix-loop-helix (bHLH) transcription factor that starts to be expressed during pre-implantation development. After implantation, Hand1 expression is restricted to placental trophoblast cells and later to embryonic cardiac and neural crest cells(1-3). We generated Hand1-null mutant mice by gene targetting. Homozygous mutant embryos arrested by embryonic day (E) 7.5 of gestation with defects in trophoblast giant cell differentiation. This early mortality could be rescued by aggregation of mutant embryos with wild-type tetraploid embryos, which contribute wild-type cells to the trophoblast, but not the embryo. By E10.5, however, the Hand1-null fetuses derived from tetraploid chimaeras died due to cardiac failure. Their heart tubes showed abnormal looping and ventricular myocardial differentiation. Therefore, Hand1 is essential for differentiation of both trophoblast and cardiomyocytes, which are embryologically distinct cell lineages.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Dev & Fetal Hlth, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Cross, JC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Dev & Fetal Hlth, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Cross, James/F-4814-2011; Cross, James/AAU-2973-2020	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				Alexander CM, 1996, DEVELOPMENT, V122, P1723; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; CHENG AK, 1995, MECH DEVELOP, V52, P187, DOI 10.1016/0925-4773(95)00400-U; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; CROSS JC, 1995, DEVELOPMENT, V121, P2513; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hogan B., 1986, MANIPULATING MOUSE E; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; ILGREN EB, 1983, PLACENTA, V4, P307, DOI 10.1016/S0143-4004(83)80010-1; JACKSON LL, 1986, P NATL ACAD SCI USA, V83, P8496, DOI 10.1073/pnas.83.22.8496; KNUDSEN TB, 1991, BIOL REPROD, V44, P171, DOI 10.1095/biolreprod44.1.171; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Millen Kathleen J., 1996, P339; Nagy A., 1993, Gene targeting: a practical approach., P147; NIETO MA, 1992, DEVELOPMENT, V116, P227; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SMITH DE, 1992, DEVELOPMENT, V116, P1033; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Wurst W., 1993, Gene targeting: a practical approach., P33	31	402	414	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					271	275		10.1038/ng0398-271	http://dx.doi.org/10.1038/ng0398-271			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500551				2022-12-17	WOS:000072325000027
J	YOSHIDA, K; FURIHATA, K; TAKEDA, S; NAKAMURA, A; YAMAMOTO, K; MORITA, H; HIYAMUTA, S; IKEDA, S; SHIMIZU, N; YANAGISAWA, N				YOSHIDA, K; FURIHATA, K; TAKEDA, S; NAKAMURA, A; YAMAMOTO, K; MORITA, H; HIYAMUTA, S; IKEDA, S; SHIMIZU, N; YANAGISAWA, N			A MUTATION IN THE CERULOPLASMIN GENE IS ASSOCIATED WITH SYSTEMIC HEMOSIDEROSIS IN HUMANS	NATURE GENETICS			English	Article							WILSON DISEASE GENE; COPPER-TRANSPORTING ATPASE; AMINO-ACID-SEQUENCE; CANDIDATE GENE; MENKES DISEASE; NONSENSE MUTATIONS; INTERNAL TRIPLICATION; IRON METABOLISM; DEFICIENCY; CDNA	We identified a mutation in the ceruloplasmin (Cp) gene in a Japanese family with aceruloplasminemia, some of whose members showed extrapyramidal disorders, cerebellar ataxia, and diabetes mellitus. A post-mortem study of the proband revealed excessive iron deposition mainly in the brain, liver and pancreas. The G to A transition at the splice acceptor site introduces a premature termination codon at the amino acid position 991 by defective splicing, thereby truncating the carboxyl terminus of Cp in affected individuals. We conclude that the mutation in the Cp gene is associated with systemic hemosiderosis in humans.	SHINSHU UNIV,SCH MED,DEPT LAB MED,MATSUMOTO,NAGANO 390,JAPAN; SHINSHU UNIV,SCH MED,DEPT MED NEUROL,MATSUMOTO,NAGANO 390,JAPAN; NATL CTR NEUROL & PSYCHIAT,NATL INST NEUROSCI,KODAIRA,TOKYO 187,JAPAN; IDEMITSU KOSAN CO LTD,CENT RES LABS,SODEGAURA,CHIBA 29902,JAPAN; TOHO UNIV,SCH MED,DEPT PEDIAT,MEGURO KU,TOKYO 153,JAPAN	Shinshu University; Shinshu University; National Center for Neurology & Psychiatry - Japan; Idemitsu Kosan; Toho University	YOSHIDA, K (corresponding author), NINCDS,DEV & METAB NEUROL BRANCH,BLDG 10,ROOM 3D-04,BETHESDA,MD 20892, USA.							ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DWULET FE, 1981, P NATL ACAD SCI-BIOL, V78, P2805, DOI 10.1073/pnas.78.5.2805; FOJO SS, 1989, J CLIN INVEST, V84, P1215, DOI 10.1172/JCI114287; FRIEDEN E, 1981, MET IONS BIOL SYST, V13, P117; GAREY CE, 1994, NAT GENET, V6, P426, DOI 10.1038/ng0494-426; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HIYAMUTA S, 1994, HYBRIDOMA, V13, P139, DOI 10.1089/hyb.1994.13.139; HIYAMUTA S, 1993, BIOCHEM BIOPH RES CO, V197, P1140, DOI 10.1006/bbrc.1993.2596; KINGSTON IB, 1977, P NATL ACAD SCI USA, V74, P5377, DOI 10.1073/pnas.74.12.5377; KINGSTON IB, 1979, P NATL ACAD SCI USA, V76, P1668, DOI 10.1073/pnas.76.4.1668; KINGSTON IB, 1980, J BIOL CHEM, V255, P2886; KINGSTON IB, 1980, J BIOL CHEM, V255, P2878; KOSCHINSKY ML, 1986, P NATL ACAD SCI USA, V83, P5086, DOI 10.1073/pnas.83.14.5086; KOSCHINSKY ML, 1987, BIOCHEMISTRY-US, V26, P7760, DOI 10.1021/bi00398a034; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; LOGAN JI, 1994, Q J MED, V87, P663; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; MERCER JFB, 1986, FEBS LETT, V203, P185, DOI 10.1016/0014-5793(86)80739-6; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; MORITA H, IN PRESS ANN NEUROL; MORITA H, 1992, CLIN NEUROL TOKYO, V32, P483; NOYER M, 1981, BIOCHEMISTRY-US, V20, P3536, DOI 10.1021/bi00515a036; ORTEL TL, 1984, P NATL ACAD SCI-BIOL, V81, P4761, DOI 10.1073/pnas.81.15.4761; OSAKI S, 1971, J BIOL CHEM, V246, P3018; OSAKI S, 1966, J BIOL CHEM, V241, P2746; OWEN CA, 1973, AM J PHYSIOL, V224, P514; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Poulik M. D., 1975, PLASMA PROTEINS, V2, P51; RAGAN HA, 1969, AM J PHYSIOL, V217, P1320, DOI 10.1152/ajplegacy.1969.217.5.1320; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; RYDEN L, 1982, P NATL ACAD SCI-BIOL, V79, P6767, DOI 10.1073/pnas.79.22.6767; SATO M, 1991, J BIOL CHEM, V266, P5128; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P390, DOI 10.1073/pnas.81.2.390; TAKAHASHI N, 1983, P NATL ACAD SCI-BIOL, V80, P115, DOI 10.1073/pnas.80.1.115; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; YANG F, 1986, P NATL ACAD SCI USA, V83, P3257, DOI 10.1073/pnas.83.10.3257	47	402	410	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					267	272		10.1038/ng0395-267	http://dx.doi.org/10.1038/ng0395-267			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7539672				2022-12-17	WOS:A1995QL23200016
J	Graubert, TA; Shen, D; Ding, L; Okeyo-Owuor, T; Lunn, CL; Shao, J; Krysiak, K; Harris, CC; Koboldt, DC; Larson, DE; McLellan, MD; Dooling, DJ; Abbott, RM; Fulton, RS; Schmidt, H; Kalicki-Veizer, J; O'Laughlin, M; Grillot, M; Baty, J; Heath, S; Frater, JL; Nasim, T; Link, DC; Tomasson, MH; Westervelt, P; DiPersio, JF; Mardis, ER; Ley, TJ; Wilson, RK; Walter, MJ				Graubert, Timothy A.; Shen, Dong; Ding, Li; Okeyo-Owuor, Theresa; Lunn, Cara L.; Shao, Jin; Krysiak, Kilannin; Harris, Christopher C.; Koboldt, Daniel C.; Larson, David E.; McLellan, Michael D.; Dooling, David J.; Abbott, Rachel M.; Fulton, Robert S.; Schmidt, Heather; Kalicki-Veizer, Joelle; O'Laughlin, Michelle; Grillot, Marcus; Baty, Jack; Heath, Sharon; Frater, John L.; Nasim, Talat; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; DiPersio, John F.; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Walter, Matthew J.			Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; METHYLTRANSFERASE GENE EZH2; AU-RICH ELEMENT; MESSENGER-RNA; SMALL-SUBUNIT; DNMT3A MUTATIONS; RECOGNITION; IDENTIFICATION; TET2; SITE	Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders that often progress to chemotherapy-resistant secondary acute myeloid leukemia (sAML). We used whole-genome sequencing to perform an unbiased comprehensive screen to discover the somatic mutations in a sample from an individual with sAML and genotyped the loci containing these mutations in the matched MDS sample. Here we show that a missense mutation affecting the serine at codon 34 (Ser34) in U2AF1 was recurrently present in 13 out of 150 (8.7%) subjects with de novo MDS, and we found suggestive evidence of an increased risk of progression to sAML associated with this mutation. U2AF1 is a U2 auxiliary factor protein that recognizes the AG splice acceptor dinucleotide at the 3' end of introns, and the alterations in U2AF1 are located in highly conserved zinc fingers of this protein(1,2). Mutant U2AF1 promotes enhanced splicing and exon skipping in reporter assays in vitro. This previously unidentified, recurrent mutation in U2AF1 implicates altered pre-mRNA splicing as a potential mechanism for MDS pathogenesis.	[Graubert, Timothy A.; Okeyo-Owuor, Theresa; Lunn, Cara L.; Shao, Jin; Krysiak, Kilannin; Grillot, Marcus; Heath, Sharon; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; DiPersio, John F.; Walter, Matthew J.] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63130 USA; [Graubert, Timothy A.; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; DiPersio, John F.; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Walter, Matthew J.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Graubert, Timothy A.; Frater, John L.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Shen, Dong; Ding, Li; Harris, Christopher C.; Koboldt, Daniel C.; Larson, David E.; McLellan, Michael D.; Dooling, David J.; Abbott, Rachel M.; Fulton, Robert S.; Schmidt, Heather; Kalicki-Veizer, Joelle; O'Laughlin, Michelle; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Ding, Li; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Walter, Matthew J.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Baty, Jack] Washington Univ, Div Biostat, St Louis, MO USA; [Nasim, Talat] Guys Hosp, Kings Coll, Dept Med & Mol Genet, London SE1 9RT, England; [Nasim, Talat] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, NIHR, Biomed Res Ctr, London, England; [Nasim, Talat] Kings Coll London, London WC2R 2LS, England	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London	Walter, MJ (corresponding author), Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63130 USA.	mjwalter@dom.wustl.edu	Wilson, Richard K./AAF-4139-2019; Walter, Matthew J/S-7758-2018; Mardis, Elaine/W-2202-2019	Wilson, Richard K./0000-0002-1992-1358; Larson, David/0000-0001-7934-5906; Graubert, Timothy/0000-0002-7710-1171; Tomasson, Michael/0000-0003-4518-7123; MCLELLAN, MICHAEL/0000-0002-2703-8784; Krysiak, Kilannin/0000-0002-6299-9230; Nasim, Talat/0000-0003-1968-5663	US National Institutes of Health [R01HL082973, RC2HL102927, U54HG003079, P01CA101937]; Howard Hughes Medical Institute; National Cancer Institute Cancer Center [P30CA91842]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes of Health grants R01HL082973 (T.A.G.), RC2HL102927 (T.A.G.), U54HG003079 (R.K.W.) and P01CA101937 (T.J.L.) and a Howard Hughes Medical Institute Physician-Scientist Early Career Award (M.J.W.). Technical assistance was provided by the Alvin J. Siteman Cancer Center High Speed Cell Sorting Core, the Molecular and Genomic Analysis Core, the Biomedical Informatics Core and the Tissue Procurement Core, which are all supported by the National Cancer Institute Cancer Center Support Grant P30CA91842. Additional technical assistance was provided by M. Izumi. We thank K. Ohno (Nagoya University Graduate School of Medicine, Japan) for minigene constructs. We thank K. Hall (Washington University School of Medicine) for helpful scientific discussions.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BAUM LE, 1967, B AM MATH SOC, V73, P360, DOI 10.1090/S0002-9904-1967-11751-8; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fortier JM, 2010, LEUKEMIA, V24, P950, DOI 10.1038/leu.2010.61; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kralovicova J, 2010, HUM GENET, V128, P383, DOI 10.1007/s00439-010-0860-1; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Rudner DZ, 1996, P NATL ACAD SCI USA, V93, P10333, DOI 10.1073/pnas.93.19.10333; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visconte V, 2012, LEUKEMIA, V26, P542, DOI 10.1038/leu.2011.232; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Webb CJ, 2004, MOL CELL BIOL, V24, P4229, DOI 10.1128/MCB.24.10.4229-4240.2004; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zorio DAR, 1999, RNA, V5, P487, DOI 10.1017/S1355838299982225	46	401	424	4	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					53	U77		10.1038/ng.1031	http://dx.doi.org/10.1038/ng.1031			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158538	Green Accepted, Green Published			2022-12-17	WOS:000298664000013
J	Bergen, AAB; Plomp, AS; Schuurman, EJ; Terry, S; Breuning, M; Dauwerse, H; Swart, J; Kool, M; van Soest, S; Baas, F; ten Brink, JB; de Jong, PTVM				Bergen, AAB; Plomp, AS; Schuurman, EJ; Terry, S; Breuning, M; Dauwerse, H; Swart, J; Kool, M; van Soest, S; Baas, F; ten Brink, JB; de Jong, PTVM			Mutations in ABCC6 cause pseudoxanthoma elasticum	NATURE GENETICS			English	Article							CHROMOSOME 16P13.1; REGION; GENE; EXPRESSION; CLONING; CANCER; TISSUE; MAPS	Pseudoxanthoma elasticum (PXE) is a heritable disorder of the connective tissue. PXE patients frequently experience visual field loss and skin lesions, and occasionally cardiovascular complication(1-4). Histopathological findings reveal calcification of the elastic fibres and abnormalities of the collagen fibrils(5). Most PXE patients are sporadic, but autosomal recessive and dominant inheritance are also observed(6,7). We previously localized the PXE gene to chromosome 16p13.1 (refs 8,9) and constructed a physical map(10). Here we describe homozygosity mapping in five PXE families and the detection of deletions or mutations in ABCC6 (formerly MRP6) associated with all genetic forms of PXE in seven patients or families.	Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; AMC, Dept Clin Genet, Amsterdam, Netherlands; AMC, Dept Neurol, Amsterdam, Netherlands; AMC, Dept Ophthalmol, Amsterdam, Netherlands; PXE Int Inc, Sharon, MA USA; Leiden Univ, Ctr Med Genet, Dept Human Genet, Leiden, Netherlands; EUR, Dept Epidemiol & Stat, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam	Bergen, AAB (corresponding author), Netherlands Ophthalm Res Inst, POB 12141, NL-1100 AC Amsterdam, Netherlands.		Breuning, Martijn H/E-3429-2010; Bergen, Arthur/J-3637-2013; Kool, Marcel/H-2541-2013; Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Bergen, Arthur/0000-0002-6333-9576; /0000-0002-4903-8232				Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; BERGEN AAB, 1993, CYTOGENET CELL GENET, V62, P231, DOI 10.1159/000133484; Christiano AM, 1996, AM J HUM GENET, V58, P671; CHRISTIANO AM, 1992, J INVEST DERMATOL, V99, P660, DOI 10.1111/1523-1747.ep12668156; CHRISTIANO AM, 1994, J INVEST DERMATOL, V103, P535; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DAUWERSE JG, 1993, HUM MOL GENET, V2, P1527, DOI 10.1093/hmg/2.10.1527; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; HAUSSER I, 1991, HUM GENET, V87, P693; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Kool M, 1999, CANCER RES, V59, P175; Le Saux O, 1999, GENOMICS, V62, P1, DOI 10.1006/geno.1999.5925; LEBWOHL M, 1993, ARCH DERMATOL RES, V285, P121, DOI 10.1007/BF01112912; LEBWOHL M, 1994, J AM ACAD DERMATOL, V30, P103, DOI 10.1016/S0190-9622(08)81894-4; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; MENDELSOHN G, 1978, ARCH PATHOL LAB MED, V102, P298; Struk B, 1997, HUM MOL GENET, V6, P1823, DOI 10.1093/hmg/6.11.1823; Van Soest S, 1999, SURV OPHTHALMOL, V43, P321, DOI 10.1016/S0039-6257(98)00046-0; VANOMMEN GB, 1987, AM J HUM GENET, V41, P689; vanSoest S, 1997, GENOME RES, V7, P830, DOI 10.1101/gr.7.8.830; YAP EY, 1992, RETINA-J RET VIT DIS, V12, P315, DOI 10.1097/00006982-199212040-00004	23	401	417	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					228	231		10.1038/76109	http://dx.doi.org/10.1038/76109			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835643				2022-12-17	WOS:000087459200027
J	AVRAHAM, KB; HASSON, T; STEEL, KP; KINGSLEY, DM; RUSSELL, LB; MOOSEKER, MS; COPELAND, NG; JENKINS, NA				AVRAHAM, KB; HASSON, T; STEEL, KP; KINGSLEY, DM; RUSSELL, LB; MOOSEKER, MS; COPELAND, NG; JENKINS, NA			THE MOUSE SNELLS WALTZER DEAFNESS GENE ENCODES AN UNCONVENTIONAL MYOSIN REQUIRED FOR STRUCTURAL INTEGRITY OF INNER-EAR HAIR-CELLS	NATURE GENETICS			English	Article							SUPERFAMILY; SEQUENCES; HEARING; CLONES; LOCUS	The mouse represents an excellent model system for the study of genetic deafness in humans. Many mouse deafness mutants have been identified and the anatomy of the mouse and human ear is similar. Here we report the use of a positional cloning approach to identify the gene encoded by the mouse recessive deafness mutation, Snell's waltzer (sv). We show that sv encodes an unconventional myosin heavy chain, myosin VI, which is expressed within the sensory hair cells of the inner ear, and appears to be required for maintaining their structural integrity. The requirement for myosin VI in hearing makes this gene an excellent candidate for a human deafness disorder.	YALE UNIV,DEPT CELL BIOL,NEW HAVEN,CT 06511; YALE UNIV,DEPT PATHOL,NEW HAVEN,CT 06511; MRC,INST HEARING RES,NOTTINGHAM NG7 2RD,ENGLAND; STANFORD UNIV,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305; OAK RIDGE NATL LAB,DIV BIOL,OAK RIDGE,TN 37831; YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06511	Yale University; Yale University; Stanford University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Yale University	AVRAHAM, KB (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,ABL,BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702, USA.			HASSON, TAMA/0000-0002-5405-662X; Avraham, Karen B/0000-0002-4913-251X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038979, R37DK025387, R01DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015909] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-38979, DK-25387] Funding Source: Medline; NIGMS NIH HHS [5F32GM15909-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; BURKE DT, 1991, MAMM GENOME, V1, P65, DOI 10.1007/BF00350849; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Deol M S, 1968, J Med Genet, V5, P137, DOI 10.1136/jmg.5.2.137; DEOL MS, 1966, GENET RES, V8, P339, DOI 10.1017/S0016672300010193; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HARVEY D, 1992, HEARING RES, V61, P137, DOI 10.1016/0378-5955(92)90044-N; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; LEHRACH H., 1990, GENOME ANAL, P39; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; NADOL JB, 1993, NEW ENGL J MED, V329, P1092, DOI 10.1056/NEJM199310073291507; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; RUSSELL LB, 1971, MUTAT RES, V11, P107, DOI 10.1016/0027-5107(71)90036-4; SPOENDLIN H, 1976, EFFECTS NOISE HEARIN; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; STEEL KP, 1994, TRENDS GENET, V10, P428, DOI 10.1016/0168-9525(94)90113-9; Titus MA, 1993, CURR OPIN CELL BIOL, V5, P77, DOI 10.1016/S0955-0674(05)80011-0	28	401	406	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					369	375		10.1038/ng1295-369	http://dx.doi.org/10.1038/ng1295-369			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493015				2022-12-17	WOS:A1995TH62900012
J	Gaulton, KJ; Nammo, T; Pasquali, L; Simon, JM; Giresi, PG; Fogarty, MP; Panhuis, TM; Mieczkowski, P; Secchi, A; Bosco, D; Berney, T; Montanya, E; Mohlke, KL; Lieb, JD; Ferrer, J				Gaulton, Kyle J.; Nammo, Takao; Pasquali, Lorenzo; Simon, Jeremy M.; Giresi, Paul G.; Fogarty, Marie P.; Panhuis, Tami M.; Mieczkowski, Piotr; Secchi, Antonio; Bosco, Domenico; Berney, Thierry; Montanya, Eduard; Mohlke, Karen L.; Lieb, Jason D.; Ferrer, Jorge			A map of open chromatin in human pancreatic islets	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BETA-CELLS; VARIANTS; RISK; SUSCEPTIBILITY; REVEALS; ORGANIZATION; INSIGHTS	Tissue-specific transcriptional regulation is central to human disease(1). To identify regulatory DNA active in human pancreatic islets, we profiled chromatin by formaldehyde-assisted isolation of regulatory elements(2-4) coupled with high-throughput sequencing (FAIRE-seq). We identified similar to 80,000 open chromatin sites. Comparison of FAIRE-seq data from islets to that from five non-islet cell lines revealed similar to 3,300 physically linked clusters of islet-selective open chromatin sites, which typically encompassed single genes that have islet-specific expression. We mapped sequence variants to open chromatin sites and found that rs7903146, a TCF7L2 intronic variant strongly associated with type 2 diabetes(5), is located in islet-selective open chromatin. We found that human islet samples heterozygous for rs7903146 showed allelic imbalance in islet FAIRE signals and that the variant alters enhancer activity, indicating that genetic variation at this locus acts in cis with local chromatin and regulatory changes. These findings illuminate the tissue-specific organization of cis-regulatory elements and show that FAIRE-seq can guide the identification of regulatory variants underlying disease susceptibility.	[Nammo, Takao; Pasquali, Lorenzo; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Gaulton, Kyle J.; Simon, Jeremy M.; Fogarty, Marie P.; Panhuis, Tami M.; Mieczkowski, Piotr; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Nammo, Takao; Pasquali, Lorenzo; Montanya, Eduard; Ferrer, Jorge] CIBER Diabet Enfermedades Metab Asociadas CIBERDE, Barcelona, Spain; [Simon, Jeremy M.; Giresi, Paul G.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Secchi, Antonio] Ist Sci San Raffaele, Clin Transplant Unit, I-20132 Milan, Italy; [Bosco, Domenico; Berney, Thierry] Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Montanya, Eduard] Univ Barcelona, Lab Diabet & Expt Endocrinol, Inst Invest Biomed Bellvitge IDIBELL, Hosp Univ Bellvitge,Endocrine Unit, E-08007 Barcelona, Spain; [Mohlke, Karen L.; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Mohlke, Karen L.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ferrer, Jorge] Hosp Clin Barcelona, Dept Endocrinol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of North Carolina; University of North Carolina Chapel Hill; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of North Carolina; University of North Carolina Chapel Hill; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Barcelona; Hospital Clinic de Barcelona	Ferrer, J (corresponding author), Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	mohlke@med.unc.edu; jlieb@bio.unc.edu; jferrer@clinic.ub.es	Ferrer, Jorge/A-3176-2012; Berney, Thierry/ABE-9450-2021; Pasquali, Lorenzo/B-6239-2008	Ferrer, Jorge/0000-0002-5959-5729; Berney, Thierry/0000-0002-4230-9378; Pasquali, Lorenzo/0000-0003-2423-1826; Gaulton, Kyle/0000-0003-1318-7161; Montanya, Eduard/0000-0003-2518-9076; Lieb, Jason/0000-0001-7601-8061; Bosco, Domenico/0000-0003-3453-9613; Mieczkowski, Piotr/0000-0003-2418-0096	European Union [SAF2008-03116]; Juvenile Diabetes Research Foundation [26-2008-633, 31-2008-416, 6-2005-1178]; US National Human Genome Research Institute Encyclopedia Of DNA Elements (NHGRI ENCODE) [U54 HG004563]; US National Institutes of Health [R01 DK072193]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193] Funding Source: NIH RePORTER	European Union(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); US National Human Genome Research Institute Encyclopedia Of DNA Elements (NHGRI ENCODE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank X. Garcia for experimental support in rs7903146 functional studies, I. Moran for insights and help in the analysis of COREs, P. Maechler (Univ. Geneva Medical Center) for generously providing insulin release data, L. Piemonti and R. Nano (San Raffaele Scientific Institute), and M. Nacher (IDIBELL) for human islets. This work was supported by the European Union VI Framework Programme project Eurodia to J. F., Ministerio de Ciencia e Innovacion (SAF2008-03116) to J. F., Juvenile Diabetes Research Foundation (26-2008-633 to J. F., 31-2008-416 to T. B., 6-2005-1178 and 31-2008-416 to A. S.), the US National Human Genome Research Institute Encyclopedia Of DNA Elements (NHGRI ENCODE) project (U54 HG004563 subcontract to J. D. L.) and R01 DK072193 (US National Institutes of Health) to K. L. M. K. L. M. is a Pew Scholar in the Biomedical Sciences.	Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Luco RF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000079; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; McCarthy MI, 2007, TRENDS PHARMACOL SCI, V28, P598, DOI 10.1016/j.tips.2007.10.008; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Mohlke KL, 2008, HUM MOL GENET, V17, pR102, DOI 10.1093/hmg/ddn275; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sander M, 2000, DEVELOPMENT, V127, P5533; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; WALLRATH LL, 1994, BIOESSAYS, V16, P165, DOI 10.1002/bies.950160306; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	57	400	405	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					255	U41		10.1038/ng.530	http://dx.doi.org/10.1038/ng.530			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20118932	Green Accepted, Green Submitted			2022-12-17	WOS:000274912400016
J	Fantes, J; Ragge, NK; Lynch, SA; McGill, NI; Collin, JRO; Howard-Peebles, PN; Hayward, C; Vivian, AJ; Williamson, K; van Heyningen, V; FitzPatrick, DR				Fantes, J; Ragge, NK; Lynch, SA; McGill, NI; Collin, JRO; Howard-Peebles, PN; Hayward, C; Vivian, AJ; Williamson, K; van Heyningen, V; FitzPatrick, DR			Mutations in SOX2 cause anophthalmia	NATURE GENETICS			English	Article							EXPRESSION; GENE; ARM	A submicroscopic deletion containing SOX2 was identified at the 3q breakpoint in a child with t(3;11)(q26.3;p11.2) associated with bilateral anophthalmia. Subsequent SOX2 mutation analysis identified de novo truncating mutations of SOX2 in 4 of 35 (11%) individuals with anophthalmia. Both eyes were affected in all cases with an identified mutation.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; St Thomas Hosp, Dept Ophthalmol, London, England; Moorfields Eye Hosp, Adnexal Serv, London, ON, Canada; Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Genet & IVF Inst, Fairfax, VA 22039 USA; W Suffolk Hosp, Dept Ophthalmol, Bury St Edmunds, Suffolk, England; Addenbrookes Hosp, Cambridge, England	University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Newcastle University - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	FitzPatrick, DR (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@hgu.mrc.ac.uk	FitzPatrick, David R/B-8311-2008; van Heyningen, Veronica/B-8039-2008; Hayward, Caroline/M-8818-2016; VAN HEYNINGEN, Veronica/GYE-0531-2022; FitzPatrick, David R/C-7301-2013	van Heyningen, Veronica/0000-0003-0359-0141; Hayward, Caroline/0000-0002-9405-9550; Lynch, Sally Ann/0000-0003-3540-1333; FitzPatrick, David R./0000-0003-4861-969X	Medical Research Council [MC_U127527199] Funding Source: Medline; MRC [MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Chitayat D, 1996, AM J MED GENET, V61, P45, DOI 10.1002/(SICI)1096-8628(19960102)61:1<45::AID-AJMG9>3.0.CO;2-W; Driggers RW, 1999, AM J MED GENET, V87, P201, DOI 10.1002/(SICI)1096-8628(19991126)87:3<201::AID-AJMG1>3.0.CO;2-H; Guan XY, 1996, NAT GENET, V12, P10, DOI 10.1038/ng0196-10; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kurbasic M, 2000, Ophthalmic Genet, V21, P239, DOI 10.1076/1381-6810(200012)21:4;1-H;FT239; Le Rouedec D, 2002, J ANAT, V200, P51, DOI 10.1046/j.0021-8782.2001.00007.x; Male A, 2002, EUR J HUM GENET, V10, P807, DOI 10.1038/sj.ejhg.5200890; STEVANOVIC M, 1994, MAMM GENOME, V5, P640, DOI 10.1007/BF00411460; Szymanski M, 2002, GENOME BIOL, V3; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Zappone MV, 2000, DEVELOPMENT, V127, P2367	13	400	415	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2003	33	4					461	463		10.1038/ng1120	http://dx.doi.org/10.1038/ng1120			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12612584	Bronze			2022-12-17	WOS:000181928600014
J	Kishimoto, T; Radulovic, J; Radulovic, M; Lin, CR; Schrick, C; Hooshmand, F; Hermanson, O; Rosenfeld, MG; Spiess, J				Kishimoto, T; Radulovic, J; Radulovic, M; Lin, CR; Schrick, C; Hooshmand, F; Hermanson, O; Rosenfeld, MG; Spiess, J			Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2	NATURE GENETICS			English	Article							IMPAIRED STRESS-RESPONSE; RAT-BRAIN; MICE; IDENTIFICATION; ANXIETY; MOUSE; HEART; NEUROENDOCRINE; EXPRESSION; SAUVAGINE	Corticotropin-releasing hormone(1,2) (Crh), a 41-residue polypeptide, activates two G-protein-coupled receptors, Crhr1 (refs 3-5) and Crhr2 (refs 6-9), causing (among other transductional events) phosphorylation of the transcription factor Creb (ref. 10). The physiologic;role of these receptors is only partially understood. Here we report that male, but not female, Crhr2-deficient mice exhibit enhanced anxious behaviour in several tests of anxiety in contrast to mice lacking Crhr1 (refs 11,12). The enhanced anxiety of Crhr2-deficient mice is not due to changes in hypothalamic-pituitary-adrenal (HPA) axis activity, but rather reflects impaired responses in specific brain regions involved in emotional and autonomic function, as monitored by a reduction of Creb phosphorylation in male, but not female, Crhr2(-/-) mice. We propose that Crhr2 predominantly mediates a central anxiolytic response, opposing the general anxiogenic effect of Crh mediated by Crhr1. Neither male nor female Crhr2-deficient mice show alterations of baseline feeding behaviour. Both respond with increased edema formation in response to thermal exposure, however, indicating that in contrast to its central role in anxiety, the peripheral role of Crhr2 in vascular permeability is independent of gender.	Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany; Univ Calif San Diego, Howard Hughes Med Inst, Dept & Sch Med, La Jolla, CA 92093 USA	Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Diego	Radulovic, J (corresponding author), Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	radulovic@mail.mpiem.gwdg.de; mrosenfeld@ucsd.edu; spiess@mail.mpiem.gwdg.de	, Ola/AAF-5126-2021	Radulovic, Jelena/0000-0002-0268-2426; Hermanson, Ola/0000-0001-9320-7921; Radulovic, Marko/0000-0002-2314-7457				Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; BALDWIN HA, 1991, PSYCHOPHARMACOLOGY, V103, P227, DOI 10.1007/BF02244208; CAREY MP, 1992, PHARMACOL BIOCHEM BE, V41, P719, DOI 10.1016/0091-3057(92)90218-5; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; CHEN Y, 1993, MOL PHARMACOL, V44, P8; FISHER LA, 1989, TRENDS PHARMACOL SCI, V10, P189, DOI 10.1016/0165-6147(89)90236-8; FOX MW, 1965, ANIM BEHAV, V13, P232, DOI 10.1016/0003-3472(65)90040-0; Hinks GL, 1996, EUR J PHARMACOL, V312, P153, DOI 10.1016/0014-2999(96)00471-2; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; LEE EHY, 1989, BEHAV NEURAL BIOL, V51, P412, DOI 10.1016/S0163-1047(89)91052-2; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Radulovic J, 1998, J NEUROSCI, V18, P7452; Radulovic J, 1999, J NEUROSCI, V19, P5016; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Rossant CJ, 1999, ENDOCRINOLOGY, V140, P1525, DOI 10.1210/en.140.4.1525; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SPIESS J, 1981, P NATL ACAD SCI-BIOL, V78, P6517, DOI 10.1073/pnas.78.10.6517; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; TAKAHASHI LK, BEHAV NEUROSCI, V103, P645; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Turnbull AV, 1996, EUR J PHARMACOL, V303, P213, DOI 10.1016/0014-2999(96)00141-0; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; WEI ET, 1994, EUR J PHARMACOL, V263, P319, DOI 10.1016/0014-2999(94)90729-3	29	400	412	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2000	24	4					415	419		10.1038/74271	http://dx.doi.org/10.1038/74271			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742109				2022-12-17	WOS:000086192800024
J	STRAUB, RE; MACLEAN, CJ; ONEILL, FA; BURKE, J; MURPHY, B; DUKE, F; SHINKWIN, R; WEBB, BT; ZHANG, J; WALSH, D; KENDLER, KS				STRAUB, RE; MACLEAN, CJ; ONEILL, FA; BURKE, J; MURPHY, B; DUKE, F; SHINKWIN, R; WEBB, BT; ZHANG, J; WALSH, D; KENDLER, KS			A POTENTIAL VULNERABILITY LOCUS FOR SCHIZOPHRENIA ON CHROMOSOME 6P24-22 - EVIDENCE FOR GENETIC-HETEROGENEITY	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; ROSCOMMON FAMILY; COMPLEX DISEASES; NUCLEAR FAMILIES; MENTAL-ILLNESS; LOD SCORE; DISORDERS; RELATIVES; TRAITS; MODEL	In 265 Irish pedigrees, with linkage analysis we find evidence for a vulnerability locus for schizophrenia in region 6p24-22. The greatest lod score, assuming locus heterogeneity, is 3.51 (P = 0.0002) with D6S296. Another test, the C test, also supported linkage, the strongest results being obtained with D6S296 (P = 0.00001), D6S274 (P = 0.004) and D6S285 (P = 0.006). Non-parametric analysis yielded suggestive, but substantially weaker, findings. This locus appears to influence the vulnerability to schizophrenia in roughly 15 to 30% of our pedigrees. Evidence for linkage was maximal using an intermediate phenotypic definition and declined when this definition was narrowed or was broadened to include other psychiatric disorders.	VIRGINIA COMMONWEALTH UNIV, DEPT PSYCHIAT, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, HUMAN GENET MED COLL VIRGINIA, RICHMOND, VA 23298 USA; QUEENS UNIV BELFAST, DEPT PSYCHIAT, BELFAST, ANTRIM, NORTH IRELAND; HLTH RES BOARD, DUBLIN, IRELAND	Virginia Commonwealth University; Virginia Commonwealth University; Queens University Belfast; Health Research Board - Ireland			Webb, Bradley T/B-1459-2009; O'Neill, Francis A/C-5582-2008; Kendler, Kenneth/AAF-2876-2019	Webb, Bradley T/0000-0002-0576-5366; O'Neill, Francis A/0000-0002-7531-7657; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041953, R01MH045390] Funding Source: NIH RePORTER; NIMH NIH HHS [MH41953, MH45390] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1990, NATURE, V346, P618, DOI 10.1038/346618a0; CHEN WJ, 1992, GENET EPIDEMIOL, V9, P123, DOI 10.1002/gepi.1370090205; CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CLONINGER CR, 1994, AM J MED GENET, V54, P83, DOI 10.1002/ajmg.1320540202; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EASTON DF, 1993, AM J HUM GENET, V52, P678; ELSTON RC, 1994, GENETIC APPROACHES M, P3; GOLDIN LR, 1987, PSYCHIAT RES, V20, P69, DOI 10.1016/0165-1781(87)90124-7; GURLING H, 1995, NAT GENET, V11, P234, DOI 10.1038/ng1195-234; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HODGE SE, 1992, AM J HUM GENET, V50, P1053; KENDLER KK, IN PRESS AM J MED GE; KENDLER KS, 1995, BRIT J PSYCHIAT, V167, P184, DOI 10.1192/bjp.167.2.184; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; KENDLER KS, 1995, AM J PSYCHIAT, V152, P755; KENDLER KS, 1989, SCHIZOPHRENIA BULL, V15, P559, DOI 10.1093/schbul/15.4.559; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; KENDLER KS, 1988, HDB SCHIZOPHRENIA, V3, P437; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MACLEAN CJ, 1992, AM J HUM GENET, V50, P1259; MACLEAN CJ, 1994, AM J HUM GENET, V54, P564; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; MARTINEZ MM, 1989, AM J HUM GENET, V44, P552; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; MOWRY BJ, 1995, NAT GENET, V11, P233, DOI 10.1038/ng1195-233; ODONOVAN MC, 1992, ANN MED, V24, P171, DOI 10.3109/07853899209147816; OROURKE DH, 1982, AM J HUM GENET, V34, P630; OTT J, 1990, AM J HUM GENET, V46, P219; PRESCOTT CA, 1993, PSYCHIAT CLIN N AM, V16, P245; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1991, AM J HUM GENET, V48, P1058; Risch N.J., 1994, GENETIC APPROACHES M, P47; SANDKUYL LA, 1989, PROG CLIN BIOL RES, V329, P117; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Shields J, 1982, SCHIZOPHRENIA EPIGEN; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TANZI R, 1993, GENETICA, V91, P255, DOI 10.1007/BF01436002; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WRIGHT P, 1993, AM J MED GENET, V48, P40, DOI 10.1002/ajmg.1320480110; 1987, DIAGNOSTIC STATISTIC	58	400	415	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1995	11	3					287	293		10.1038/ng1195-287	http://dx.doi.org/10.1038/ng1195-287			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581452				2022-12-17	WOS:A1995TC63900017
J	Hahn, CN; Chong, CE; Carmichael, CL; Wilkins, EJ; Brautigan, PJ; Li, XC; Babic, M; Lin, M; Carmagnac, A; Lee, YK; Kok, CH; Gagliardi, L; Friend, KL; Ekert, PG; Butcher, CM; Brown, AL; Lewis, ID; To, LB; Timms, AE; Storek, J; Moore, S; Altree, M; Escher, R; Bardy, PG; Suthers, GK; D'Andrea, RJ; Horwitz, MS; Scott, HS				Hahn, Christopher N.; Chong, Chan-Eng; Carmichael, Catherine L.; Wilkins, Ella J.; Brautigan, Peter J.; Li, Xiao-Chun; Babic, Milena; Lin, Ming; Carmagnac, Amandine; Lee, Young K.; Kok, Chung H.; Gagliardi, Lucia; Friend, Kathryn L.; Ekert, Paul G.; Butcher, Carolyn M.; Brown, Anna L.; Lewis, Ian D.; To, L. Bik; Timms, Andrew E.; Storek, Jan; Moore, Sarah; Altree, Meryl; Escher, Robert; Bardy, Peter G.; Suthers, Graeme K.; D'Andrea, Richard J.; Horwitz, Marshall S.; Scott, Hamish S.			Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; RUNX1; APOPTOSIS; HEALTH	We report the discovery of GATA2 as a new myelodysplastic syndrome (MDS)-acute myeloid leukemia (AML) predisposition gene. We found the same, previously unidentified heterozygous c. 1061C>T (p.Thr354Met) missense mutation in the GATA2 transcription factor gene segregating with the multigenerational transmission of MDS-AML in three families and a GATA2 c. 1063_1065delACA (p.Thr355del) mutation at an adjacent codon in a fourth MDS family. The resulting alterations reside within the second zinc finger of GATA2, which mediates DNA-binding and protein-protein interactions. We show differential effects of the mutations on the transactivation of target genes, cellular differentiation, apoptosis and global gene expression. Identification of such predisposing genes to familial forms of MDS and AML is critical for more effective diagnosis and prognosis, counseling, selection of related bone marrow transplant donors and development of therapies.	[Hahn, Christopher N.; Chong, Chan-Eng; Brautigan, Peter J.; Li, Xiao-Chun; Babic, Milena; Lin, Ming; Lee, Young K.; Gagliardi, Lucia; Moore, Sarah; Scott, Hamish S.] SA Pathol, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA, Australia; [Hahn, Christopher N.; Chong, Chan-Eng; Lewis, Ian D.; To, L. Bik; D'Andrea, Richard J.; Scott, Hamish S.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [Carmichael, Catherine L.; Wilkins, Ella J.; Carmagnac, Amandine; Escher, Robert; Scott, Hamish S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Med Div, Parkville, Vic 3050, Australia; [Kok, Chung H.; Butcher, Carolyn M.; D'Andrea, Richard J.] Queen Elizabeth Hosp, Dept Haematol & Oncol, Woodville, SA 5011, Australia; [Kok, Chung H.; Butcher, Carolyn M.; Brown, Anna L.; Lewis, Ian D.; To, L. Bik; Bardy, Peter G.; D'Andrea, Richard J.] SA Pathol, Ctr Canc Biol, Dept Haematol, Adelaide, SA, Australia; [Friend, Kathryn L.] SA Pathol, Dept Paediat & Reprod Genet, Adelaide, SA, Australia; [Ekert, Paul G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Cell Signalling & Cell Death Div, Parkville, Vic 3050, Australia; [Timms, Andrew E.; Horwitz, Marshall S.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Storek, Jan] Univ Calgary, Dept Med, Calgary, AB, Canada; [Altree, Meryl; Suthers, Graeme K.] SA Pathol, SA Clin Genet Serv, Adelaide, SA, Australia; [Suthers, Graeme K.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Scott, Hamish S.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Centre for Cancer Biology; SA Pathology; SA Pathology; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Washington; University of Washington Seattle; University of Calgary; SA Pathology; University of Adelaide; University of Adelaide	Scott, HS (corresponding author), SA Pathol, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA, Australia.	hamish.scott@health.sa.gov.au	Ekert, Paul G/C-7247-2013; Hahn, Christopher/C-1369-2009; HAHN, CHRISTOPHER/D-8427-2018; wittert, gary/AAE-2398-2019; Scott, Hamish/B-2122-2009; Ekert, Paul/Q-1842-2015; CHONG, CHAN ENG/M-5109-2017	Ekert, Paul G/0000-0002-2976-8617; Hahn, Christopher/0000-0001-5105-2554; Scott, Hamish/0000-0002-5813-631X; Ekert, Paul/0000-0002-2976-8617; CHONG, CHAN ENG/0000-0001-8922-2416; D'Andrea, Richard/0000-0002-4915-4612; Horwitz, Marshall/0000-0002-1683-1680; Brown, Anna/0000-0002-9023-0138; Brautigan, Peter/0000-0001-9570-5879; Carmichael, Catherine/0000-0002-6751-153X	Major National Research Facilities program; National Health and Medical Research Council of Australia [257501, 219176, 1002317, 171601, 461204]; Dora Lush Postgraduate Award; Leukaemia Foundation of Australia; Cancer Council of South Australia; MedVet Pty Ltd; Adelaide Scholarships International; US National Institutes of Health [R01DK058161]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058161] Funding Source: NIH RePORTER	Major National Research Facilities program; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush Postgraduate Award; Leukaemia Foundation of Australia; Cancer Council of South Australia(Cancer Council South Australia); MedVet Pty Ltd; Adelaide Scholarships International; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank the families for their participation in our studies. Thanks also to J. Melo for provision of CML cell lines and R. Sharma for help with EMSA. Large-scale Sanger sequencing was performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities program. This work was supported by grants from the National Health and Medical Research Council of Australia (program grants 257501 (H. S. S.) and 219176 (H. S. S.), project grant 1002317 (C.N.H., R.J.D. and H. S. S.), fellowships 171601 (H. S. S.) and 461204 (H. S. S.), and a Dora Lush Postgraduate Award (C. L. C.)), Leukaemia Foundation of Australia (grant in aid to H. S. S. and a postdoctoral fellowship to C. L. C.), the Cancer Council of South Australia (H. S. S.) and MedVet Pty Ltd (H. S. S. and R.J.D.), Adelaide Scholarships International (scholarship to C.-E. C.) and US National Institutes of Health grant R01DK058161 (M.S.H.).	Barzi A, 2010, CLEV CLIN J MED, V77, P37, DOI 10.3949/ccjm.77a.09069; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Carmichael CL, 2010, BRIT J HAEMATOL, V150, P382, DOI 10.1111/j.1365-2141.2010.08204.x; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; DICKINSON RE, 2011, BLOOD           0715, DOI DOI 10.1182/BLOOD-2011-06-360313; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Ernst T, 2010, HAEMATOL-HEMATOL J, V95, P1473, DOI 10.3324/haematol.2010.021808; Fadilah SAW, 2002, LEUKEMIA, V16, P1563, DOI 10.1038/sj.leu.2402517; Horwitz M, 1996, AM J HEMATOL, V52, P295, DOI 10.1002/(SICI)1096-8652(199608)52:4<295::AID-AJH9>3.0.CO;2-N; HSU AP, 2011, BLOOD           0613, DOI DOI 10.1182/BLOOD-2011-05-356352; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Koldej R, 2005, J GENE MED, V7, P1390, DOI 10.1002/jgm.803; Kumar R, 2008, J BIOL CHEM, V283, P19026, DOI 10.1074/jbc.M709136200; Lahortiga I, 2004, GENE CHROMOSOME CANC, V40, P179, DOI 10.1002/gcc.20033; Mansour S, 2010, AM J MED GENET A, V152A, P2287, DOI 10.1002/ajmg.a.33445; Matheny CJ, 2007, EMBO J, V26, P1163, DOI 10.1038/sj.emboj.7601568; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; Minelli A, 2001, CANCER GENET CYTOGEN, V124, P147, DOI 10.1016/S0165-4608(00)00344-7; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Owen CJ, 2008, BLOOD, V112, P4639, DOI 10.1182/blood-2008-05-156745; ROBINSON CW, 1983, AUST NZ J MED, V13, P141, DOI 10.1111/j.1445-5994.1983.tb02669.x; Slape C, 2007, CANCER RES, V67, P5148, DOI 10.1158/0008-5472.CAN-07-0075; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsuzuki S, 2000, MOL CELL BIOL, V20, P6276, DOI 10.1128/MCB.20.17.6276-6286.2000; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Veitia RA, 2009, J PATHOL, V218, P409, DOI 10.1002/path.2583; Wieser R, 2000, BIOCHEM BIOPH RES CO, V273, P239, DOI 10.1006/bbrc.2000.2947; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105; Zhang SJ, 2009, LEUKEMIA RES, V33, P1141, DOI 10.1016/j.leukres.2009.02.025; Zhang SJ, 2008, BLOOD, V112, P536	36	399	408	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					1012	U130		10.1038/ng.913	http://dx.doi.org/10.1038/ng.913			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892162	Green Accepted			2022-12-17	WOS:000295316200018
J	Mizuki, N; Meguro, A; Ota, M; Ohno, S; Shiota, T; Kawagoe, T; Ito, N; Kera, J; Okada, E; Yatsu, K; Song, YW; Lee, EB; Kitaichi, N; Namba, K; Horie, Y; Takeno, M; Sugita, S; Mochizuki, M; Bahram, S; Ishigatsubo, Y; Inoko, H				Mizuki, Nobuhisa; Meguro, Akira; Ota, Masao; Ohno, Shigeaki; Shiota, Tomoko; Kawagoe, Tatsukata; Ito, Norihiko; Kera, Jiro; Okada, Eiichi; Yatsu, Keisuke; Song, Yeong-Wook; Lee, Eun-Bong; Kitaichi, Nobuyoshi; Namba, Kenichi; Horie, Yukihiro; Takeno, Mitsuhiro; Sugita, Sunao; Mochizuki, Manabu; Bahram, Seiamak; Ishigatsubo, Yoshiaki; Inoko, Hidetoshi			Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci	NATURE GENETICS			English	Article							IL23R; IDENTIFICATION; POLYMORPHISM; IL12RB2; GENES	Behcet's disease is a chronic systemic inflammatory disorder characterized by four major manifestations: recurrent ocular symptoms, oral and genital ulcers and skin lesions(1). We conducted a genome-wide association study in a Japanese cohort including 612 individuals with Behcet's disease and 740 unaffected individuals (controls). We identified two suggestive associations on chromosomes 1p31.3 (IL23R-IL12RB2, rs12119179, P = 2.7 x 10(-8)) and 1q32.1 (IL10, rs1554286, P = 8.0 x 10(-8)). A meta-analysis of these two loci with results from additional Turkish and Korean cohorts showed genome-wide significant associations (rs1495965 in IL23R-IL12RB2, P = 1.9 x 10(-11), odds ratio = 1.35; rs1800871 in IL10, P = 1.0 x 10(-14), odds ratio = 1.45).	[Mizuki, Nobuhisa; Meguro, Akira; Shiota, Tomoko; Kawagoe, Tatsukata; Ito, Norihiko; Kera, Jiro] Yokohama City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kanazawa Ku, Kanagawa, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Nagano, Japan; [Ohno, Shigeaki] Hokkaido Univ, Dept Ocular Inflammat & Immunol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Okada, Eiichi] Okada Eye Clin, Konan Ku, Kanagawa, Japan; [Yatsu, Keisuke; Inoko, Hidetoshi] Tokai Univ, Dept Mol Life Sci, Div Mol Med Sci & Mol Med, Sch Med, Kanagawa 2591100, Japan; [Song, Yeong-Wook; Lee, Eun-Bong] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kitaichi, Nobuyoshi] Hlth Sci Univ Hokkaido, Dept Ophthalmol, Kita Ku, Sapporo, Hokkaido, Japan; [Namba, Kenichi; Horie, Yukihiro] Hokkaido Univ, Dept Ophthalmol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Takeno, Mitsuhiro; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, Kanagawa, Japan; [Sugita, Sunao; Mochizuki, Manabu] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Bahram, Seiamak] Univ Strasbourg, Lab Immunogenet Mol Humaine, Ctr Rech Immunol & Hematol, Fac Med, Strasbourg, France; [Bahram, Seiamak] Hop Univ Strasbourg, Lab Cent Immunol, Nouvel Hop Civil, Strasbourg, France	Yokohama City University; Shinshu University; Hokkaido University; Tokai University; Seoul National University (SNU); Health Sciences University of Hokkaido; Hokkaido University; Yokohama City University; Tokyo Medical & Dental University (TMDU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mizuki, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kanazawa Ku, Kanagawa, Japan.	mizunobu@med.yokohama-cu.ac.jp; hinoko@is.icc.u-tokai.ac.jp	Ito, Norihiko/ABD-3147-2021; Bahram, Seiamak/GZA-7150-2022; Song, Yeong-Wook/J-2765-2012; Lee, Eun Bong/J-2780-2012	Lee, Eun Bong/0000-0003-0703-1208; Ota, Masao/0000-0002-6400-5658; Bahram, Seiamak/0000-0002-6928-9952	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare, Japan; Menicon Co., Ltd.; Johnson & Johnson KK Vision Care Company; Agence Nationale pour la Recherche (ANR); Federation des Maladies Orphelines; Association francaise de la maladie de Behcet	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Menicon Co., Ltd.; Johnson & Johnson KK Vision Care Company(Johnson & JohnsonJohnson & Johnson USA); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Federation des Maladies Orphelines; Association francaise de la maladie de Behcet	We sincerely thank the individuals with Behcet's disease who participated in this study. This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Ministry of Health, Labour and Welfare, Japan; a grant from Menicon Co., Ltd.; and a grant from the Johnson & Johnson KK Vision Care Company. The laboratory of S. B. was supported by the Agence Nationale pour la Recherche (ANR), the Federation des Maladies Orphelines and the Association francaise de la maladie de Behcet.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fei YP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2695; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; International Study Group for Behcet's Disease, 1990, LANCET, V335, P1078; Isomura M, 2008, CLIN CANCER RES, V14, P6683, DOI 10.1158/1078-0432.CCR-07-4389; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kaklamani VG, 1998, SEMIN ARTHRITIS RHEU, V27, P197, DOI 10.1016/S0049-0172(98)80001-2; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; MIZUSHIMA Y, 1988, INT J TISSUE REACT, V10, P59; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Wallace GR, 2007, HUM IMMUNOL, V68, P122, DOI 10.1016/j.humimm.2006.11.010	20	399	406	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2010	42	8					703	U83		10.1038/ng.624	http://dx.doi.org/10.1038/ng.624			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20622879				2022-12-17	WOS:000280524000016
J	Balmain, A; Gray, J; Ponder, B				Balmain, A; Gray, J; Ponder, B			The genetics and genomics of cancer	NATURE GENETICS			English	Review							FLUORESCENCE INSITU HYBRIDIZATION; FAMILIAL BREAST-CANCER; TUMOR MODIFIER LOCI; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CENTROSOME AMPLIFICATION; SV40-TRANSFORMED CELLS; HAPLO-INSUFFICIENT; SOMATIC MUTATIONS; P53 MUTATIONS	The past decade has seen great strides in our understanding of the genetic basis of human disease. Arguably, the most profound impact has been in the area of cancer genetics, where the explosion of genomic sequence and molecular profiling data has illustrated the complexity of human malignancies. In a tumor cell, dozens of different genes may be aberrant in structure or copy number, and hundreds or thousands of genes may be differentially expressed. A number of familial cancer genes with high-penetrance mutations have been identified, but the contribution of low-penetrance genetic variants or polymorphisms to the risk of sporadic cancer development remains unclear. Studies of the complex somatic genetic events that take place in the emerging cancer cell may aid the search for the more elusive germline variants that confer increased susceptibility. Insights into the molecular pathogenesis of cancer have provided new strategies for treatment, but a deeper understanding of this disease will require new statistical and computational approaches for analysis of the genetic and signaling networks that orchestrate individual cancer susceptibility and tumor behavior.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Canc Res UK, Dept Oncol, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Balmain, A (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu; jgray@cc.ucsf.edu; bajp@mole.bio.cam.ac.uk						Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; BAKER RC, 1989, ACTA ARITH, V53, P217, DOI 10.4064/aa-53-3-217-250; Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Bernard PS, 2002, CLIN CHEM, V48, P1178; Bernardi R, 2002, ONCOGENE, V21, P3445, DOI 10.1038/sj.onc.1205313; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; BUELL P, 1965, CANCER, V18, P656, DOI 10.1002/1097-0142(196505)18:5<656::AID-CNCR2820180515>3.0.CO;2-3; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Conrads TP, 2000, ANAL CHEM, V72, P3349, DOI 10.1021/ac0002386; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; ENG C, 2002, GENETIC BASIS HUMAN, P527; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Frame S, 2000, CURR OPIN GENET DEV, V10, P106, DOI 10.1016/S0959-437X(99)00052-0; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ginzinger DG, 2000, CANCER RES, V60, P5405; Gong G, 2001, CLIN CANCER RES, V7, P2410; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYASHIZAKI Y, 1993, ELECTROPHORESIS, V14, P251, DOI 10.1002/elps.1150140145; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Ji L, 2002, CANCER RES, V62, P2715; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kinzler K.W., 2002, GENETIC BASIS HUMAN, V2, P583; Knezevic V, 2001, PROTEOMICS, V1, P1271, DOI 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Linardopoulos S, 2000, INT J CANCER, V88, P920, DOI 10.1002/1097-0215(20001215)88:6<920::AID-IJC13>3.0.CO;2-#; LINEHAN WM, 2002, GENETIC BASIS HUMAN, P449; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Lynch HT, 1999, J MED GENET, V36, P801; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Nagase H, 2001, CANCER RES, V61, P1305; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olumi AF, 1999, CANCER RES, V59, P5002; PARSONS R, 1995, CANCER RES, V55, P5548; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Peto J, 2002, CANCER CELL, V1, P411, DOI 10.1016/S1535-6108(02)00079-X; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; PETO J, 1980, BANBURY REPORT, P203; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; REHMAN I, 1994, LANCET, V344, P788, DOI 10.1016/S0140-6736(94)92343-4; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Saran A, 2000, INT J CANCER, V88, P424, DOI 10.1002/1097-0215(20001101)88:3<424::AID-IJC15>3.0.CO;2-D; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHOR SL, 1985, J CELL SCI, V73, P235; Shaaban AM, 2002, AM J SURG PATHOL, V26, P421, DOI 10.1097/00000478-200204000-00003; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vogel CL, 2001, ONCOLOGY-BASEL, V61, P37, DOI 10.1159/000055400; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wright AF, 2001, GENOME BIOL, V2; YOU M, 1992, P NATL ACAD SCI USA, V89, P5804, DOI 10.1073/pnas.89.13.5804; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	108	399	423	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			238	244		10.1038/ng1107	http://dx.doi.org/10.1038/ng1107			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610533				2022-12-17	WOS:000181390900004
J	Hovanes, K; Li, TWH; Munguia, JE; Truong, T; Milovanovic, T; Marsh, JL; Holcombe, RF; Waterman, ML				Hovanes, K; Li, TWH; Munguia, JE; Truong, T; Milovanovic, T; Marsh, JL; Holcombe, RF; Waterman, ML			beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer	NATURE GENETICS			English	Article							COLORECTAL-CANCER; ALPHA-ENHANCER; TRANSCRIPTIONAL ACTIVATION; PROTEIN; GENE; TARGET; APC; LOCALIZATION; CARCINOMA; CONTAINS	Constitutive activation of the Wnt signaling pathway is a root cause of many colon cancers(1-3). Activation of this pathway is caused by genetic mutations that stabilize the beta -catenin protein, allowing it to accumulate in the nucleus and form complexes with any member of the lymphoid enhancer factor (LEF1) and T-cell factor (TCF1, TCF3, TCF4) family of transcription factors (referred to collectively as LEF/TCFs) to activate transcription of target genes(3,4). Target genes such as MYC. CCND1. MMP7 and TCF7 (refs, 5-9) are normally expressed in colon tissue, so it has been proposed that abnormal expression levels or patterns imposed by beta -catenin/TCF complexes have a role in tumor progression. We report here that LEF1 is a new type of target gene ectopically activated in colon cancer. The pattern of this ectopic expression is unusual because it derives from selective activation of a promoter for a full-length LEF1 isoform that binds beta -catenin, but not a second, intronic promoter that drives expression of a dominant-negative isoform. beta -catenin/TCF complexes can activate the promoter for full-length LEF1, indicating that in cancer high levels of these complexes misregulate transcription to favor a positive feedback loop for Wnt signaling by inducing selective expression of full-length, beta -catenin-sensitive forms of LEF/TCFs.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA USA; Univ Calif Irvine, Irvine Med Ctr, Div Hematol Oncol, Orange, CA 92668 USA; Univ Calif Irvine, Irvine Med Ctr, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Waterman, ML (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.		truong, therese/A-2837-2013	truong, therese/0000-0002-2943-6786	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036049, R01HD036081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA083982] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-83982] Funding Source: Medline; NICHD NIH HHS [R01 HD36081, R01 HD36049] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 1999, ADV EXP MED BIOL, V470, P23; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; SPOLSKI R, 1988, EUR J IMMUNOL, V18, P295; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1992, J BIOL CHEM, V267, P8530; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656	22	399	419	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					53	57		10.1038/ng0501-53	http://dx.doi.org/10.1038/ng0501-53			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326276				2022-12-17	WOS:000168413300016
J	Ng, L; Hurley, LB; Dierks, B; Srinivas, M; Salto, C; Vennstrom, B; Reh, TA; Forrest, D				Ng, L; Hurley, LB; Dierks, B; Srinivas, M; Salto, C; Vennstrom, B; Reh, TA; Forrest, D			A thyroid hormone receptor that is required for the development of green cone photoreceptors	NATURE GENETICS			English	Article							MICE LACKING; BETA; EXPRESSION; ALPHA; RESISTANCE; MOUSE; ISOFORM; GENE; PIGMENTS; CELLS	Color vision is facilitated by distinct populations of cone photoreceptors in the retina. In rodents, cones expressing different opsin photopigments are sensitive to middle (M, 'green') and short (S, 'blue') wavelengths, and are differentially distributed across the retina(1,2). The mechanisms that control which opsin is expressed in a particular cone are poorly understood(2,3), but previous in vitro studies implicated thyroid hormone in cone differentiation(4,5). Thyroid hormone receptor beta2 (TR beta2) is a ligand-activated transcription factor that is expressed in the outer nuclear layer of the embryonic retina(6,7). Here we delete Thrb (encoding Tr beta2) in mice, causing the selective loss of M-cones and a concomitant increase in S-opsin immunoreactive cones. Moreover, the gradient of cone distribution is disturbed, with S-cones becoming widespread across the retina. The results indicate that cone photoreceptors throughout the retina have the potential to follow a default S-cone pathway and reveal an essential role for Tr beta2 in the commitment to an M-cone identity. Our findings raise the possibility that Thrb mutations may be associated with human cone disorders(8).	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Washington, Hlth Sci Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Hlth Sci Ctr, Dept Biol Struct, Seattle, WA 98195 USA; Karolinska Inst, Dev Biol Lab, CMB, Stockholm, Sweden	Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Karolinska Institutet	Forrest, D (corresponding author), Mt Sinai Sch Med, Dept Human Genet, Box 1498, New York, NY 10029 USA.	tomreh@u.washington.edu; douglas.forrest@mssm.edu		Forrest, Douglas/0000-0002-3463-4162				Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Bayer AU, 1999, DOC OPHTHALMOL, V98, P233, DOI 10.1023/A:1002416918247; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHIU MI, 1994, VISUAL NEUROSCI, V11, P773, DOI 10.1017/S0952523800003072; Chomez P, 2000, DEVELOPMENT, V127, P1489; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; KELLEY MW, 1995, INVEST OPHTH VIS SCI, V36, P1280; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; NEWELL FW, 1977, KLIN MONATSBL AUGENH, V171, P731; NG L, 1995, MOL ENDOCRINOL, V9, P1202, DOI 10.1210/me.9.9.1202; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Rusch A, 1998, P NATL ACAD SCI USA, V95, P15758, DOI 10.1073/pnas.95.26.15758; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; SJOBERG M, 1992, DEVELOPMENT, V114, P39; SJOBERG M, 1994, EXPRESSION FUNCTION; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; Szel A, 2000, J OPT SOC AM A, V17, P568, DOI 10.1364/JOSAA.17.000568; SZEL A, 1994, NATURE, V370, P336, DOI 10.1038/370336a0; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WOOD WM, 1991, MOL ENDOCRINOL, V5, P1049, DOI 10.1210/mend-5-8-1049	31	399	403	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					94	98		10.1038/83829	http://dx.doi.org/10.1038/83829			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138006				2022-12-17	WOS:000166187900023
J	Le Saux, O; Urban, Z; Tschuch, C; Csiszar, K; Bacchelli, B; Quaglino, D; Pasquali-Ronchetti, I; Pope, FM; Richards, A; Terry, S; Bercovitch, L; de Paepe, A; Boyd, CD				Le Saux, O; Urban, Z; Tschuch, C; Csiszar, K; Bacchelli, B; Quaglino, D; Pasquali-Ronchetti, I; Pope, FM; Richards, A; Terry, S; Bercovitch, L; de Paepe, A; Boyd, CD			Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum	NATURE GENETICS			English	Article							CHROMOSOME 16P13.1; BETA-THALASSEMIA; EXPRESSION; DISEASE; MAPS	Pseudoxanthoma elasticum (PXE) is a heritable disorder characterized by calcification of elastic fibres in skin, arteries and retina that results in dermal lesions with associated laxity and loss of elasticity, arterial insufficiency and retinal haemorrhages leading to macular degefieration(1-5). PXE is usually found as a sporadic disorder, but examples of both autosomal recessive and autosomal dominant forms of PXE have been observed(6). Partial manifestations of the PXE phenotype have also been described in presumed carriers in PXE families(7,8). Linkage of both dominant and recessive forms of PXE to a 5-cM domain on chromosome 16013.1 has been reported (refs 8,9). We have refined this locus to an 820-kb region containing 6 candidate genes(10). Here we report the exclusion of five of these genes and the identification of the first mutations responsible for the development of PXE in a gene encoding a protein associated with multidrug resistance (ABCC6).	Univ Hawaii, Pacific Biomed Res Ctr, Lab Matrix Pathobiol, Honolulu, HI 96822 USA; Univ Modena, Dept Biomed Sci, Modena, Italy; Univ Wales Hosp, Inst Med Genet, MRC, Connect Tissue Genet Grp, Cardiff CF4 4XN, S Glam, Wales; Univ Cambridge, Dept Pathol, MRC, Connect Tissue Genet Grp, Cambridge CB2 1QP, England; PXE Int Inc, Sharon, MA USA; Brown Univ, Dept Dermatol, Providence, RI 02912 USA; Univ Hosp, Univ Ziekenhuis, Ctr Med Genet, Ghent, Belgium	University of Hawaii System; Universita di Modena e Reggio Emilia; Cardiff University; University of Cambridge; Brown University; Ghent University; Ghent University Hospital	Boyd, CD (corresponding author), Univ Hawaii, Pacific Biomed Res Ctr, Lab Matrix Pathobiol, Honolulu, HI 96822 USA.		Le Saux, Olivier/P-4668-2017; Urban, Zsolt/B-1977-2008; Urban, Zsolt/A-2018-2013; Quaglino, Daniela/A-9381-2010	Le Saux, Olivier/0000-0002-5605-3617; Urban, Zsolt/0000-0003-3890-1843; Quaglino, Daniela/0000-0002-4302-5078	NATIONAL EYE INSTITUTE [R01EY013019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050665] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03061] Funding Source: Medline; NEI NIH HHS [EY13019] Funding Source: Medline; NHLBI NIH HHS [HL50665] Funding Source: Medline; Telethon [E.0696] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Aessopos A, 1998, ANGIOLOGY, V49, P137, DOI 10.1177/000331979804900206; Bacchelli B, 1999, MODERN PATHOL, V12, P1112; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Belinsky MG, 1999, BRIT J CANCER, V80, P1342, DOI 10.1038/sj.bjc.6690527; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jones PM, 1998, J MEMBRANE BIOL, V166, P133, DOI 10.1007/s002329900455; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Kool M, 1999, CANCER RES, V59, P175; Le Saux O, 1999, GENOMICS, V62, P1, DOI 10.1006/geno.1999.5925; LEBWOHL M, 1993, NEW ENGL J MED, V329, P1237, DOI 10.1056/NEJM199310213291705; MENDELSOHN G, 1978, ARCH PATHOL LAB MED, V102, P298; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; Neldner K H, 1988, Clin Dermatol, V6, P1; Nikko AP, 1996, AM J DERMATOPATH, V18, P396, DOI 10.1097/00000372-199608000-00011; Ong-ajyooth L, 1998, NEPHRON, V78, P156, DOI 10.1159/000044904; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; POPE FM, 1975, BRIT J DERMATOL, V92, P493; Sapadin AN, 1998, J AM ACAD DERMATOL, V39, P338, DOI 10.1016/S0190-9622(98)70385-8; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Struk B, 1997, HUM MOL GENET, V6, P1823, DOI 10.1093/hmg/6.11.1823; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Urban Z, 1999, HUM GENET, V104, P135, DOI 10.1007/s004390050926; vanSoest S, 1997, GENOME RES, V7, P830, DOI 10.1101/gr.7.8.830; Weenink AC, 1996, NETH J MED, V49, P24, DOI 10.1016/0300-2977(95)00079-8; Wilton SD, 1998, HUM MUTAT, V11, P252, DOI 10.1002/(SICI)1098-1004(1998)11:3<252::AID-HUMU11>3.3.CO;2-Z; YAP EY, 1992, RETINA-J RET VIT DIS, V12, P315, DOI 10.1097/00006982-199212040-00004	26	399	415	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					223	227		10.1038/76102	http://dx.doi.org/10.1038/76102			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835642				2022-12-17	WOS:000087459200026
J	MATISE, TC; PERLIN, M; CHAKRAVARTI, A				MATISE, TC; PERLIN, M; CHAKRAVARTI, A			AUTOMATED CONSTRUCTION OF GENETIC-LINKAGE MAPS USING AN EXPERT-SYSTEM (MULTIMAP) - A HUMAN GENOME LINKAGE MAP	NATURE GENETICS			English	Article								High-resolution genetic linkage maps are indispensable for positional cloning of disease genes. Current procedures for map construction, although aided considerably by many existing computer programs, require extensive user-intervention at each of many repetitive steps. This is time consuming, labour intensive and increases the chance of error. We have developed an expert system computer program, MultiMap, which automates this step-by- step procedure. MultiMap is based on a novel map construction algorithm and allows investigator control of marker locus characteristics, such as informativeness, scorability or distance to nearest neighbours. We used MultiMap to construct a human genetic map at an average resolution of 6 cM, using published genotypes at 1266 microsatellite markers, and further extended this map by adding 397 VNTR and polymorphic gene markers.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT PSYCHIAT,PITTSBURGH,PA 15261; CARNEGIE MELLON UNIV,SCH COMP SCI,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University					NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000344] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00344] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BUCHANAN BG, 1988, ANNU REV COMPUT SCI, V3, P23, DOI 10.1146/annurev.cs.03.060188.000323; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CHAKRAVARTI A, 1991, BANBURY REPORT, V33, P307; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; Cox Tara K., 1992, American Journal of Human Genetics, V51, pA33; COX TK, THESIS; DAUSSET J, 1986, PRESSE MED, V15, P1801; DIETRICH W, 1992, GENETICS, V131, P423; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1989, AM J HUM GENET, V44, P397; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OTT J, 1974, AM J HUM GENET, V26, P588; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS D E, 1991, P297; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	24	399	405	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					384	390		10.1038/ng0494-384	http://dx.doi.org/10.1038/ng0494-384			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054979				2022-12-17	WOS:A1994ND87000018
J	GILL, P; IVANOV, PL; KIMPTON, C; PIERCY, R; BENSON, N; TULLY, G; EVETT, I; HAGELBERG, E; SULLIVAN, K				GILL, P; IVANOV, PL; KIMPTON, C; PIERCY, R; BENSON, N; TULLY, G; EVETT, I; HAGELBERG, E; SULLIVAN, K			IDENTIFICATION OF THE REMAINS OF THE ROMANOV FAMILY BY DNA ANALYSIS	NATURE GENETICS			English	Article							TETRANUCLEOTIDE REPEAT POLYMORPHISM; MITOCHONDRIAL-DNA; SKELETAL REMAINS; SEQUENCE; BONE; GENE	Nine skeletons found in a shallow grave in Ekaterinburg, Russia, in July 1991, were tentatively identified by Russian forensic authorities as the remains of the last Tsar, Tsarina, three of their five children, the Royal Physician and three servants. We have performed DNA based sex testing and short tandem repeat (STR) analysis and confirm that a family group was present in the grave. Analysis of mitochondrial (mt) DNA reveals an exact sequence match between the putative Tsarina and the three children with a living maternal relative. Amplified mtDNA extracted from the remains of the putative Tsar has been cloned to demonstrate heteroplasmy at a single base within the mtDNA control region. One of these sequences matches two living maternal relatives of the Tsar. We conclude that the DNA evidence supports the hypothesis that the remains are those of the Romanov family.	CENT RES & SUPPORT ESTAB,FORENS SCI SERV,READING RG7 4PN,BERKS,ENGLAND; ENGELHARDT MOLEC BIOL INST,MOSCOW 117984,RUSSIA; UNIV CAMBRIDGE,DEPT BIOL ANTHROPOL,CAMBRIDGE CB2 3DZ,ENGLAND	Forensic Science Service UK; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Cambridge			ivanov, pavel/I-3280-2016; Gill, Peter/C-3056-2009; Schneider, Peter M./A-6661-2011					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; EDWARDS A, 1991, AM J HUM GENET, V49, P746; FREGEAU CJ, 1993, BIOTECHNIQUES, V15, P100; HAGELBERG E, 1989, NATURE, V342, P485, DOI 10.1038/342485a0; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; HAGELBERG E, 1991, NATURE, V352, P427, DOI 10.1038/352427a0; HOWELL N, 1992, HUM GENET, V90, P117; JEFFREYS AJ, 1992, FORENSIC SCI INT, V56, P65, DOI 10.1016/0379-0738(92)90148-P; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; KIMPTON CP, 1993, PCR METH APPL, V3, P13; KOEHLER CM, 1991, GENETICS, V129, P247; Maniatis T., 1982, MOL CLONING; MANNUCCI A, 1993, INT J LEGAL MED, V15, P636; Orrrego C., 1990, PCR PROTOCOLS, P416; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4036; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4791; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; SULLIVAN KM, 1991, ELECTROPHORESIS, V12, P17, DOI 10.1002/elps.1150120105; SULLIVAN KM, IN PRESS BIOTECHNIQU; WARNE D, 1991, NUCLEIC ACIDS RES, V19, P6980	23	399	424	2	74	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					130	135		10.1038/ng0294-130	http://dx.doi.org/10.1038/ng0294-130			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162066				2022-12-17	WOS:A1994MU76300006
J	Chen, W; Gao, YQ; Xie, WB; Gong, L; Lu, K; Wang, WS; Li, Y; Liu, XQ; Zhang, HY; Dong, HX; Zhang, W; Zhang, LJ; Yu, SB; Wang, GW; Lian, XM; Luo, J				Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Liu, Xianqing; Zhang, Hongyan; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie			Genome-wide association analyses provide genetic and biochemical insights into natural variation in rice metabolism	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; COMPLEX TRAITS; CULTIVATED RICE; EXPRESSION; IDENTIFICATION; SEQUENCE; PLANTS; HEALTH; BIOSYNTHESIS; ACCUMULATION	Plant metabolites are important to world food security in terms of maintaining sustainable yield and providing food with enriched phytonutrients. Here we report comprehensive profiling of 840 metabolites and a further metabolic genome-wide association study based on similar to 6.4 million SNPs obtained from 529 diverse accessions of Oryza sativa. We identified hundreds of common variants influencing numerous secondary metabolites with large effects at high resolution. We observed substantial heterogeneity in the natural variation of metabolites and their underlying genetic architectures among different subspecies of rice. Data mining identified 36 candidate genes modulating levels of metabolites that are of potential physiological and nutritional importance. As a proof of concept, we functionally identified or annotated five candidate genes influencing metabolic traits. Our study provides insights into the genetic and biochemical bases of rice metabolome variation and can be used as a powerful complementary tool to classical phenotypic trait mapping for rice improvement.	[Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China; [Liu, Xianqing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Zhang, Hongyan] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Luo, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	xmlian@mail.hzau.edu.cn; jie.luo@mail.hzau.edu.cn	Xie, Weibo/AAI-2412-2021; Gong, Liang/CAG-5950-2022; Xie, Weibo/B-3771-2008	Xie, Weibo/0000-0002-2768-3572; Xie, Weibo/0000-0002-2768-3572; , sibin/0000-0003-0458-7526; Lian, Xingming/0000-0002-5307-2839	Major State Basic Research Development Program of China (973 Program) [2013CB127001]; National High Technology R&D Program of China (863 Program) [2012AA10A303, 2012AA10A304]; National Natural Science Foundation of China [31070267, 31100962]; Program for New Century Excellent Talents in University of Ministry of Education in China [NCET-09-0401]; Ministry of Science and Technology [2010CB125901, 2011CB100304]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education in China(Program for New Century Excellent Talents in University (NCET)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We appreciate the critical reading and helpful comments on the manuscript made by C. Martin from John Innes Centre, UK and Q. Zhang from Huazhong Agricultural University, China. We thank W Yan for kindly providing 148 varieties from a mini-core subset of the US Department of Agriculture rice gene bank. This work was supported by the Major State Basic Research Development Program of China (973 Program) (number 2013CB127001), the National High Technology R&D Program of China (863 Program) (numbers 2012AA10A303 and 2012AA10A304), the National Natural Science Foundation of China (numbers 31070267 and 31100962) and the Program for New Century Excellent Talents in University of Ministry of Education in China (NCET-09-0401). We are also thankful for support from the Ministry of Science and Technology (numbers 2010CB125901 and 2011CB100304).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Cheng AX, 2007, PHYTOCHEMISTRY, V68, P1632, DOI 10.1016/j.phytochem.2007.04.008; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Han B, 2003, CURR OPIN PLANT BIOL, V6, P134, DOI 10.1016/S1369-5266(03)00004-9; Hellmann H, 2010, MOLECULES, V15, P442, DOI 10.3390/molecules15010442; Herrero S, 2011, PLANT MOL BIOL, V76, P157, DOI 10.1007/s11103-011-9777-x; Heuberger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012915; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Johns MA, 2007, FUNCT INTEGR GENOMIC, V7, P135, DOI 10.1007/s10142-006-0036-1; Joseph B, 2013, ELIFE, V2, DOI 10.7554/eLife.00776; Jung KH, 2013, RICE, V6, DOI 10.1186/1939-8433-6-19; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kawaura K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-271; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Keurentjes JJB, 2009, CURR OPIN PLANT BIOL, V12, P223, DOI 10.1016/j.pbi.2008.12.003; Kliebenstein DJ, 2001, GENETICS, V159, P359; Ko JH, 2008, J PLANT PHYSIOL, V165, P435, DOI 10.1016/j.jplph.2007.01.006; Kusano M, 2012, MOL PLANT, V5, P442, DOI 10.1093/mp/ssr101; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Luo J, 2009, PLANT CELL, V21, P318, DOI 10.1105/tpc.108.063511; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Minorsky PV, 2002, PLANT PHYSIOL, V128, P1167, DOI 10.1104/pp.900030; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Redestig H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-176; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; Shimizu T, 2012, J BIOL CHEM, V287, P19315, DOI 10.1074/jbc.M112.351270; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Traka MH, 2011, PLANT CELL, V23, P2483, DOI 10.1105/tpc.111.087916; Weng JK, 2012, SCIENCE, V337, P960, DOI 10.1126/science.1221614; Yamamoto T, 2009, DNA RES, V16, P141, DOI 10.1093/dnares/dsp006; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	53	398	449	24	418	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					714	721		10.1038/ng.3007	http://dx.doi.org/10.1038/ng.3007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24908251				2022-12-17	WOS:000338093800012
J	Kamatani, Y; Wattanapokayakit, S; Ochi, H; Kawaguchi, T; Takahashi, A; Hosono, N; Kubo, M; Tsunoda, T; Kamatani, N; Kumada, H; Puseenam, A; Sura, T; Daigo, Y; Chayama, K; Chantratita, W; Nakamura, Y; Matsuda, K				Kamatani, Yoichiro; Wattanapokayakit, Sukanya; Ochi, Hidenori; Kawaguchi, Takahisa; Takahashi, Atsushi; Hosono, Naoya; Kubo, Michiaki; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Kumada, Hiromitsu; Puseenam, Aekkachai; Sura, Thanyachai; Daigo, Yataro; Chayama, Kazuaki; Chantratita, Wasun; Nakamura, Yusuke; Matsuda, Koichi			A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians	NATURE GENETICS			English	Article							VIRUS-INFECTION; SURFACE-ANTIGEN; RECEPTOR GENE; SUSCEPTIBILITY; POLYMORPHISMS; POPULATION; ALLELES; MARKERS	Chronic hepatitis B is a serious infectious liver disease that often progresses to liver cirrhosis and hepatocellular carcinoma; however, clinical outcomes after viral exposure vary enormously among individuals(1). Through a two-stage genome-wide association study using 786 Japanese chronic hepatitis B cases and 2,201 controls, we identified a significant association of chronic hepatitis B with 11 SNPs in a region including HLA-DPA1 and HLA-DPB1. We validated these associations by genotyping two SNPs from the region in three additional Japanese and Thai cohorts consisting of 1,300 cases and 2,100 controls (combined P = 6.34 x 10(-39) and 2.31 x 10(-38), OR = 0.57 and 0.56, respectively). Subsequent analyses revealed risk haplotypes (HLA-DPA1*0202-DPB1*0501 and HLA-DPA1*0202-DPB1*0301, OR = 1.45 and 2.31, respectively) and protective haplotypes (HLA-DPA1*0103-DPB1*0402 and HLA-DPA1*0103-DPB1*0401, OR = 0.52 and 0.57, respectively). Our findings show that genetic variants in the HLA-DP locus are strongly associated with risk of persistent infection with hepatitis B virus.	[Kamatani, Yoichiro; Daigo, Yataro; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Kamatani, Yoichiro; Daigo, Yataro] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo, Japan; [Wattanapokayakit, Sukanya] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Med Genet Sect, Nonthaburi, Thailand; [Ochi, Hidenori; Kawaguchi, Takahisa; Takahashi, Atsushi; Hosono, Naoya; Kubo, Michiaki; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Chayama, Kazuaki; Nakamura, Yusuke] RIKEN, Ctr Genom Med, Kanagawa, Japan; [Ochi, Hidenori; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Programs Biomed Res, Dept Med & Mol Sci,Div Frontier Med Sci, Hiroshima, Japan; [Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Puseenam, Aekkachai; Sura, Thanyachai] Mahidol Univ, Ramathidi Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand; [Chantratita, Wasun] Mahidol Univ, Ramathidi Hosp, Fac Med, Virol & Mol Microbiol Unit,Dept Pathol, Bangkok 10700, Thailand	University of Tokyo; University of Tokyo; Ministry of Public Health - Thailand; RIKEN; Hiroshima University; Toranomon Hospital; Mahidol University; Mahidol University	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; Kubo, Michiaki/N-7947-2015; Kamatani, Yoichiro/N-5513-2015; Matsuda, Koichi/D-4597-2011	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Matsuda, Koichi/0000-0001-7292-2686; Daigo, Yataro/0000-0002-0915-3025; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Tokunaga for useful advice of on HLA-DP genotyping and interpretation, and technical staff of Laboratory for Genotyping Development at RIKEN for SNP genotyping at the first and second stages of the GWAS. We are also grateful to members of Hiroshima Liver Study Group and The Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Ahn SH, 2000, HEPATOLOGY, V31, P1371, DOI 10.1053/jhep.2000.7988; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Fontenot AP, 2000, P NATL ACAD SCI USA, V97, P12717, DOI 10.1073/pnas.220430797; Frodsham AJ, 2005, TRANSPL IMMUNOL, V14, P183, DOI 10.1016/j.trim.2005.03.006; Frodsham AJ, 2006, P NATL ACAD SCI USA, V103, P9148, DOI 10.1073/pnas.0602800103; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; JUNG MC, 1995, J VIROL, V69, P3358, DOI 10.1128/JVI.69.6.3358-3368.1995; Kobayashi M, 2002, J MED VIROL, V68, P522, DOI 10.1002/jmv.10239; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; LASKUS T, 1992, J HEPATOL, V15, P174, DOI 10.1016/0168-8278(92)90032-K; LIN TM, 1989, ANTICANCER RES, V9, P737; Mineta M, 1996, INT IMMUNOL, V8, P525, DOI 10.1093/intimm/8.4.525; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saito A, 2002, J HUM GENET, V47, P360, DOI 10.1007/s100380200050; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SHEEN IS, 1994, J INFECT DIS, V170, P358, DOI 10.1093/infdis/170.2.358; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; VANDERZWAN A, 2002, TECHNICAL MANUAL GEN	25	398	429	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					591	595		10.1038/ng.348	http://dx.doi.org/10.1038/ng.348			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19349983				2022-12-17	WOS:000265575600021
J	Fanciulli, M; Norsworthy, PJ; Petretto, E; Dong, R; Harper, L; Kamesh, L; Heward, JM; Gough, SCL; de Smith, A; Blakemore, AIF; Owen, CJ; Pearce, SHS; Teixeira, L; Guillevin, L; Graham, DSC; Pusey, CD; Cook, HT; Vyse, TJ; Aitman, TJ				Fanciulli, Manuela; Norsworthy, Penny J.; Petretto, Enrico; Dong, Rong; Harper, Lorraine; Kamesh, Lavanya; Heward, Joanne M.; Gough, Stephen C. L.; de Smith, Adam; Blakemore, Alexandra I. F.; Owen, Catherine J.; Pearce, Simon H. S.; Teixeira, Luis; Guillevin, Loic; Graham, Deborah S. Cunninghame; Pusey, Charles D.; Cook, H. Terence; Vyse, Timothy J.; Aitman, Timothy J.			FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity	NATURE GENETICS			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; RECEPTORS; PATHOGENESIS; POLYMORPHISM; DISEASE; GENE	Naturally occurring variation in gene copy number is increasingly recognized as a heritable source of susceptibility to genetically complex diseases. Here we report strong association between FCGR3B copy number and risk of systemic lupus erythematosus (P = 2.7 x 10(-8)), microscopic polyangiitis (P = 2.9 x 10(-4)) and Wegener's granulomatosis in two independent cohorts from the UK ( P = 3 x 10(-3)) and France ( P = 1.1 x 10(-4)). We did not observe this association in the organ- specific Graves' disease or Addison's disease. Our findings suggest that low FCGR3B copy number, and in particular complete FCGR3B deficiency, has a key role in the development of systemic autoimmunity.	Univ London Imperial Coll Sci Technol & Med, Physiol Genom & Med Grp, UK Med Res Council, Clin Sci Ctr, London W12 0NN, England; Univ Birmingham, Sch Med, Div Med Sci, Birmingham B15 277, W Midlands, England; Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham B15 277, W Midlands, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, Div Med, London W12 0NN, England; Inst Pasteur, Inst Biol, CNRS, UMR 8090, F-59800 Lille, France; Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 EBZ, Tyne & Wear, England; Paris Descartes Univ, AP HP, Cochin Hosp, Dept Internal Med,Reference Ctr Vascul & System S, F-75679 Paris 14, France; Univ London Imperial Coll Sci Technol & Med, Sect Mol Genet & Rheumatol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Sect Renal Med, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London W12 0NN, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Birmingham; University of Birmingham; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Physiol Genom & Med Grp, UK Med Res Council, Clin Sci Ctr, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk	Blakemore, Alexandra I F/D-2253-2009; Pearce, Simon/AAB-3692-2019; Teixeira, Luis/C-3694-2013; FROGUEL, Philippe/O-6799-2017	Blakemore, Alexandra I F/0000-0003-0661-564X; Pearce, Simon/0000-0001-8384-8063; FROGUEL, Philippe/0000-0003-2972-0784; Norsworthy, Penny/0000-0002-5572-8491; de Smith, Adam/0000-0003-4880-7543; Teixeira, Luis/0000-0003-1049-9661; Aitman, Timothy/0000-0002-7875-4502	Medical Research Council [G0000934, G84/5959, MC_U120097112, MC_U120061454, G0400116] Funding Source: Medline; Medical Research Council [MC_U120061454, MC_U120097112] Funding Source: Medline; Wellcome Trust [068545/Z/02, 066780] Funding Source: Medline; MRC [G84/5959, G0400116, G0000934, MC_U120061454] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; CLARK MR, 1990, J CLIN INVEST, V86, P341, DOI 10.1172/JCI114706; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; DEHAAS M, 1995, BLOOD, V86, P2403, DOI 10.1182/blood.V86.6.2403.bloodjournal8662403; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Harper L, 2000, J PATHOL, V190, P349, DOI 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	15	398	418	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					721	723		10.1038/ng2046	http://dx.doi.org/10.1038/ng2046			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529978	Green Accepted			2022-12-17	WOS:000246859100013
J	Pickersgill, H; Kalverda, B; de Wit, E; Talhout, W; Fornerod, M; van Steensel, B				Pickersgill, Helen; Kalverda, Bernike; de Wit, Elzo; Talhout, Wendy; Fornerod, Maarten; van Steensel, Bas			Characterization of the Drosophila melanogaster genome at the nuclear lamina	NATURE GENETICS			English	Article							3-DIMENSIONAL ORGANIZATION; SPATIAL-ORGANIZATION; COEXPRESSED GENES; BUDDING YEAST; CHROMATIN; LOCALIZATION; CHROMOSOME; HETEROCHROMATIN; TRANSCRIPTION; REPLICATION	The nuclear lamina binds chromatin in vitro and is thought to function in its organization, but genes that interact with it are unknown. Using an in vivo approach, we identified similar to 500 Drosophila melanogaster genes that interact with B-type lamin ( Lam). These genes are transcriptionally silent and late replicating, lack active histone marks and are widely spaced. These factors collectively predict lamin binding behavior, indicating that the nuclear lamina integrates variant and invariant chromatin features. Consistently, proximity of genomic regions to the nuclear lamina is partly conserved between cell types, and induction of gene expression or active histone marks reduces Lam binding. Lam target genes cluster in the genome, and these clusters are coordinately expressed during development. This genome-wide analysis gives clear insight into the nature and dynamic behavior of the genome at the nuclear lamina, and implies that intergenic DNA functions in the global organization of chromatin in the nucleus.	Netherlands Canc Inst, Dept Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Mol Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Fornerod, M (corresponding author), Netherlands Canc Inst, Dept Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.fornerod@nki.nl; b.v.steensel@nki.nl	Kalverda, Bernike/A-7691-2010; Fornerod, Maarten/A-7503-2010	de Wit, Elzo/0000-0003-2883-1415; Fornerod, Maarten/0000-0002-6166-3030				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; BELMONT AS, 1993, J CELL BIOL, V123, P1671, DOI 10.1083/jcb.123.6.1671; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P393; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; Kosak ST, 2004, SCIENCE, V306, P644, DOI 10.1126/science.1103864; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Marshall WF, 1997, CURR OPIN GENET DEV, V7, P259, DOI 10.1016/S0959-437X(97)80136-0; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; MATHOG D, 1989, GENETICS, V121, P293; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; PADDY MR, 1990, CELL, V62, P89, DOI 10.1016/0092-8674(90)90243-8; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; STUURMAN N, 1995, J CELL SCI, V108, P3137; Sun LV, 2003, P NATL ACAD SCI USA, V100, P9428, DOI 10.1073/pnas.1533393100; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	50	398	411	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1005	1014		10.1038/ng1852	http://dx.doi.org/10.1038/ng1852			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16878134				2022-12-17	WOS:000240112100017
J	Fischer, E; Legue, E; Doyen, A; Nato, F; Nicolas, JF; Torres, V; Yaniv, M; Pontoglio, M				Fischer, E; Legue, E; Doyen, A; Nato, F; Nicolas, JF; Torres, V; Yaniv, M; Pontoglio, M			Defective planar cell polarity in polycystic kidney disease	NATURE GENETICS			English	Article							CILIA; MODEL	Morphogenesis involves coordinated proliferation, differentiation and spatial distribution of cells. We show that lengthening of renal tubules is associated with mitotic orientation of cells along the tubule axis, demonstrating intrinsic planar cell polarization, and we demonstrate that mitotic orientations are significantly distorted in rodent polycystic kidney models. These results suggest that oriented cell division dictates the maintenance of constant tubule diameter during tubular lengthening and that defects in this process trigger renal tubular enlargement and cyst formation.	CNRS, Gene Express & Dis Unit, FRE 2850, F-75700 Paris, France; CNRS, URA 2578, Dev Mol Biol Unit, Dept Dev Biol, F-75700 Paris, France; Inst Pasteur, Struct Biol & Chem Dept, Recombinant Prot & Antibody Unit, F-75724 Paris, France; Mayo Clin, Coll Med, Div Nephrol, Rochester, MN 55905 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mayo Clinic	Fischer, E (corresponding author), CNRS, Gene Express & Dis Unit, FRE 2850, F-75700 Paris, France.		Nicolas, Jean-François/AAW-9289-2020; fischer, evelyne/GLT-9457-2022	fischer, evelyne/0000-0001-5054-1444				Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; GATTONE VH, 1988, LAB INVEST, V59, P231; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Lager DJ, 2001, KIDNEY INT, V59, P126, DOI 10.1046/j.1523-1755.2001.00473.x; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	15	398	407	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2006	38	1					21	23		10.1038/ng1701	http://dx.doi.org/10.1038/ng1701			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341222				2022-12-17	WOS:000234227200012
J	Jaye, M; Lynch, KJ; Krawiec, T; Marchadier, D; Maugeais, C; Doan, K; South, V; Amin, D; Perrone, M; Rader, DJ				Jaye, M; Lynch, KJ; Krawiec, T; Marchadier, D; Maugeais, C; Doan, K; South, V; Amin, D; Perrone, M; Rader, DJ			A novel endothelial-derived lipase that modulates HDL metabolism	NATURE GENETICS			English	Article							HIGH-DENSITY-LIPOPROTEIN; HEPATIC TRIGLYCERIDE LIPASE; CHOLESTEROL LEVELS; PANCREATIC LIPASE; TRANSGENIC MICE; DEFICIENT MICE; GENE-TRANSFER; PLASMA HDL; ATHEROSCLEROSIS; OVEREXPRESSION	High-density lipoprotein (HDL) cholesterol levels are inversely associated with risk of atherosclerotic cardiovascular disease(1). At least 50% of the variation in HDL cholesterol levels is genetically determined(2,3), but the genes responsible for variation in HDL levels have not been fully elucidated. Lipoprotein lipase (LPL) and hepatic lipase (HL), two members of the triacylglyerol (TC) lipase family, both influence HDL metabolism(2,4-6) and the HL (LIPC) locus has been associated with variation in HDL cholesterol levels in humans(7,8). We describe here the cloning and in vivo functional analysis of a new member of the TG lipase family. In contrast to other family members, this new lipase is synthesized by endothelial cells in vitro and thus has been termed endothelial lipase (encoded by the LIPG gene). EL is expressed in vivo in organs including liver, lung, kidney and placenta, but not in skeletal muscle. In contrast to LPL and HL, EL has a lid of only 19 residues. EL has substantial phospholipase activity, but less triglyceride lipase activity. Overexpression of EL in mice reduced plasma concentrations of HDL cholesterol and its major protein apolipoprotein A-I. The endothelial expression, enzymatic profile and in vivo effects of EL suggest that it may have a role in lipoprotein metabolism and vascular biology.	Univ Penn, Hlth Syst, Dept Med, Philadelphia, PA 19104 USA; Rhone Poulenc Rorer, Res & Dev, Dept Cardiovasc Biol, Collegeville, PA 19426 USA	University of Pennsylvania	Rader, DJ (corresponding author), Univ Penn, Hlth Syst, Dept Med, Philadelphia, PA 19104 USA.							Bensadoun A, 1996, CURR OPIN LIPIDOL, V7, P77, DOI 10.1097/00041433-199604000-00005; BLADES B, 1993, ARTERIOSCLER THROMB, V13, P1227, DOI 10.1161/01.ATV.13.8.1227; BRESLOW JL, 1995, METABOLIC MOL BASES, P2031; BUSCH SJ, 1994, J BIOL CHEM, V269, P16376; COHEN JC, 1994, J CLIN INVEST, V94, P2377, DOI 10.1172/JCI117603; DUGI KA, 1995, J BIOL CHEM, V270, P25396, DOI 10.1074/jbc.270.43.25396; FAN JL, 1994, P NATL ACAD SCI USA, V91, P8724, DOI 10.1073/pnas.91.18.8724; Farese RV, 1998, TRENDS GENET, V14, P115, DOI 10.1016/S0168-9525(97)01377-2; Goldberg IJ, 1996, J LIPID RES, V37, P693; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Guerra R, 1997, P NATL ACAD SCI USA, V94, P4532, DOI 10.1073/pnas.94.9.4532; HEGELE RA, 1993, ARTERIOSCLER THROMB, V13, P720, DOI 10.1161/01.ATV.13.5.720; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Hokanson JE, 1997, INT J CLIN LAB RES, V27, P24, DOI 10.1007/BF02827239; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; MAHANEY MC, 1995, ARTERIOSCL THROM VAS, V15, P1730, DOI 10.1161/01.ATV.15.10.1730; Mahley RW, 1999, J LIPID RES, V40, P1; Mezdour H, 1997, J BIOL CHEM, V272, P13570, DOI 10.1074/jbc.272.21.13570; Murthy V, 1996, PHARMACOL THERAPEUT, V70, P101, DOI 10.1016/0163-7258(96)00005-8; PIMSTONE SN, 1995, ARTERIOSCL THROM VAS, V15, P1704, DOI 10.1161/01.ATV.15.10.1704; Shimada M, 1996, P NATL ACAD SCI USA, V93, P7242, DOI 10.1073/pnas.93.14.7242; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; Tsukamoto K, 1997, J LIPID RES, V38, P1869; Tsukamoto K, 1997, J CLIN INVEST, V100, P107, DOI 10.1172/JCI119501; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0	27	398	439	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					424	428		10.1038/7766	http://dx.doi.org/10.1038/7766			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192396				2022-12-17	WOS:000079439700027
J	Yaffe, E; Tanay, A				Yaffe, Eitan; Tanay, Amos			Probabilistic modeling of Hi-C contact maps eliminates systematic biases to characterize global chromosomal architecture	NATURE GENETICS			English	Article							CONFORMATION CAPTURE; NUCLEAR-ORGANIZATION; CHROMATIN STATE; GENOME; TRANSCRIPTION; PLURIPOTENT; FACTORIES; DYNAMICS	Hi-C experiments measure the probability of physical proximity between pairs of chromosomal loci on a genomic scale. We report on several systematic biases that substantially affect the Hi-C experimental procedure, including the distance between restriction sites, the GC content of trimmed ligation junctions and sequence uniqueness. To address these biases, we introduce an integrated probabilistic background model and develop algorithms to estimate its parameters and renormalize Hi-C data. Analysis of corrected human lymphoblast contact maps provides genome-wide evidence for interchromosomal aggregation of active chromatin marks, including DNase-hypersensitive sites and transcriptionally active foci. We observe extensive long-range (up to 400 kb) cis interactions at active promoters and derive asymmetric contact profiles next to transcription start sites and CTCF binding sites. Clusters of interacting chromosomal domains suggest physical separation of centromere-proximal and centromere-distal regions. These results provide a computational basis for the inference of chromosomal architectures from Hi-C experiments.	[Yaffe, Eitan; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	tanay@weizmann.ac.il		Yaffe, Eitan/0000-0002-2896-3349	Israeli Science Foundation; European Commission	Israeli Science Foundation(Israel Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank W. de Laat for discussions and members of the Tanay group for critical reading of the manuscript. Research at A.T.s laboratory was supported by the Israeli Science Foundation and by the EPIGENESYS FP7 program of the European Commission.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Miele Adriana, 2008, V464, P105; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]	26	397	412	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1059	U40		10.1038/ng.947	http://dx.doi.org/10.1038/ng.947			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	22001755				2022-12-17	WOS:000296584000008
J	Mortlock, DP; Innis, JW				Mortlock, DP; Innis, JW			Mutation of HOXA13 in hand-foot-genital syndrome	NATURE GENETICS			English	Article							URINARY-TRACT ABNORMALITIES; HOMEO DOMAIN; ANOMALIES; PROTEIN; FAMILY; UPDATE; DNA	There are several human syndromes which involve defects of the limbs and the Mullerian ducts or its derivatives. The hand-foot-genital (HFG) syndrome is an autosomal dominant, fully penetrant disorder that was originally described by Stern et al. Additional reports describing other affected families have also been published. Limb anomalies include short first metacarpals of normal thickness, small distal phalanges of the thumbs, short middle phalanges of the fifth fingers, and fusion or delayed ossification of wrist bones. In the feet, the great toe is shorter due to a short first metatarsal and a small, pointed distal phalanx. Uterine anomalies are common in females with HFG, and typically involve a partially divided (bicornuate) or completely divided (didelphic) uterus, representing defects of Mullerian duct fusion. Urinary tract malformations in affected HFG females include a displaced urethral opening and malposition of ureteral orifices in the bladder wall; affected males may have hypospadias (ventrally misplaced urethral opening) of variable severity. We report the identification of a HOXA13 nonsense mutation in a family with hand-foot-genital syndrome. The mutation converts a highly conserved tryptophan residue in the homeodomain to a stop codon, which truncates 20 amino acids from the protein and likely eliminates or greatly reduces the ability of the protein to bind to DNA.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Mortlock, Douglas P/C-9981-2010; Morlock, Doug/C-3482-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557] Funding Source: NIH RePORTER; NIAMS NIH HHS [5 P60 AR20557] Funding Source: Medline; NICHD NIH HHS [HD34059] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACIEN P, 1992, HUM REPROD, V7, P437, DOI 10.1093/oxfordjournals.humrep.a137666; Blum V, 1986, VERTEBRATE REPRODUCT; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; CLEVELAND RH, 1990, PEDIATR RADIOL, V20, P339, DOI 10.1007/BF02013170; Copeland JWR, 1996, NATURE, V379, P162, DOI 10.1038/379162a0; DONNENFELD AE, 1992, AM J MED GENET, V44, P482, DOI 10.1002/ajmg.1320440419; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; FRYNS JP, 1993, CLIN GENET, V43, P232; Giedion A, 1976, Pediatr Radiol, V4, P96, DOI 10.1007/BF00973951; Gruenwald P, 1941, ANAT REC, V81, P1, DOI 10.1002/ar.1090810102; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALAL F, 1988, AM J MED GENET, V30, P793, DOI 10.1002/ajmg.1320300312; HALAL F, 1986, AM J MED GENET, V24, P119, DOI 10.1002/ajmg.1320240114; HUMMEL KP, 1970, J HERED, V61, P219, DOI 10.1093/oxfordjournals.jhered.a108088; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; PINSKY L, 1973, TERATOLOGY, V9, P65; POZNANSKI AK, 1970, RADIOLOGY, V95, P129, DOI 10.1148/95.1.129; Schnabel CA, 1996, MOL CELL BIOL, V16, P2678; SHARMAN G B, 1970, Science (Washington D C), V167, P1221, DOI 10.1126/science.167.3922.1221; STERN AM, 1970, J PEDIATR-US, V77, P109, DOI 10.1016/S0022-3476(70)80052-X; VERP MS, 1983, FERTIL STERIL, V40, P80; VERP MS, 1989, AM J MED GENET, V32, P555, DOI 10.1002/ajmg.1320320429; VERSHON AK, 1995, GENE DEV, V9, P182, DOI 10.1101/gad.9.2.182; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732	25	397	420	1	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					179	180		10.1038/ng0297-179	http://dx.doi.org/10.1038/ng0297-179			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020844				2022-12-17	WOS:A1997WF08700018
J	JABS, EW; LI, X; SCOTT, AF; MEYERS, G; CHEN, W; ECCLES, M; MAO, JI; CHARNAS, LR; JACKSON, CE; JAYE, M				JABS, EW; LI, X; SCOTT, AF; MEYERS, G; CHEN, W; ECCLES, M; MAO, JI; CHARNAS, LR; JACKSON, CE; JAYE, M			JACKSON-WEISS-SYNDROME AND CROUZON-SYNDROME ARE ALLELIC WITH MUTATIONS IN FIBROBLAST GROWTH-FACTOR RECEPTOR-2	NATURE GENETICS			English	Article							SIGNAL TRANSDUCTION; FACTOR FAMILY; SPECIFICITY; DIVERSITY	Jackson-Weiss syndrome is an autosomal dominant condition characterized by craniosynostosis, foot anomalies and great phenotypic variability. Recently mutations in fibroblast growth factor receptor 2 (FGFR2) have been found in patients with another craniosynostotic syndrome, Crouzon syndrome. FGFR2 is a member of the tyrosine kinase receptor superfamily, having a high affinity for peptides that signal the transduction pathways for mitogenesis, cellular differentiation and embryogenesis. We now report an FGFR2 mutation in the conserved region of the immunoglobulin IIIc domain in the Jackson-Weiss syndrome family in which the syndrome was originally described. In addition, in four of 12 Crouzon syndrome cases, we identified two new mutations and found two previously described mutations in the same region.	JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT MED, BALTIMORE, MD 21287 USA; JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT SURG, BALTIMORE, MD 21287 USA; UNIV OTAGO, CTR GENE RES, DEPT BIOCHEM, MOLEC CARCINOGENESIS LAB, DUNEDIN, NEW ZEALAND; GENOME THERAPEUT CORP, DEPT HUMAN & MOLEC GENET, COLLABORAT RES, WALTHAM, MA 02154 USA; NEUROL ASSOCIATES WESTERN COLORADO, GRAND JCT, CO 81501 USA; HENRY FORD HOSP, DEPT MED, DETROIT, MI 48202 USA; RHONE POULENC RORER RES, COLLEGEVILLE, PA 19426 USA	Johns Hopkins University; Johns Hopkins University; University of Otago; Henry Ford Health System; Henry Ford Hospital	JABS, EW (corresponding author), JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT PEDIAT, 600 N WOLFE ST, BALTIMORE, MD 21287 USA.			Jabs, Ethylin/0000-0001-8983-5466	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011131, R01DE010180] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE10180, DE11131] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AVIVI A, 1993, FEBS LETT, V330, P249, DOI 10.1016/0014-5793(93)80882-U; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; BURGESS WH, 1994, REGULATION PROLIFERA; DIONNE CA, 1992, CYTOGENET CELL GENET, V60, P34, DOI 10.1159/000133290; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; JACKSON CE, 1976, J PEDIATR-US, V88, P963, DOI 10.1016/S0022-3476(76)81050-5; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; LI XA, 1994, GENOMICS, V22, P418, DOI 10.1006/geno.1994.1403; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIYAMOTO M, 1993, MOL CELL BIOL, V13, P4251, DOI 10.1128/MCB.13.7.4251; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PRESTON RA, 1994, NAT GENET, V7, P149, DOI 10.1038/ng0694-149; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROUSSEL MF, 1990, ONCOGENE, V5, P25; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669	21	397	410	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1994	8	3					275	279		10.1038/ng1194-275	http://dx.doi.org/10.1038/ng1194-275			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874170				2022-12-17	WOS:A1994PP76500018
J	KERCKAERT, JP; DEWEINDT, C; TILLY, H; QUIEF, S; LECOCQ, G; BASTARD, C				KERCKAERT, JP; DEWEINDT, C; TILLY, H; QUIEF, S; LECOCQ, G; BASTARD, C			LAZ3, A NOVEL ZINC-FINGER ENCODING GENE, IS DISRUPTED BY RECURRING CHROMOSOME-3Q27 TRANSLOCATIONS IN HUMAN LYMPHOMAS	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; ACUTE LEUKEMIAS; ONCOGENIC CONVERSION; DROSOPHILA-TRITHORAX; BURKITTS-LYMPHOMA; RAR-ALPHA; PROTEIN; EXPRESSION; FAMILY; T(15-17)	We have shown previously that chromosomal translocations involving chromosome 3q27 and immunoglobulin gene regions are the third most common specific translocations in non-Hodgkin's lymphoma (NHL). We now report the isolation of a gene that is disrupted in two cases by t(3;14) and t(3;4) translocations. The gene (LAZ3) encodes a 79 kDa protein containing six zinc-finger motifs and sharing amino-terminal homology with several transcription factors including the Drosophila tramtrack and Broad-complex genes, both of which are developmental transcription regulators. LAZ3 is transcribed as a 3.8 kb message predominantly in normal adult skeletal muscle and in several NHL carrying 3q27 chromosomal defects. We suggest that it may act as a transcription regulator and play an important role in lymphomagenesis.	CTR HENRI BECQUEREL,F-76038 ROUEN,FRANCE; CTR REG TRANSFUS SANGUINE,DEPT CYTOGENET,F-76232 BOISE GUILLAUME,FRANCE	UNICANCER; Centre Henri Becquerel	KERCKAERT, JP (corresponding author), INST RECH CANC LILLE,INSERM,U124,PL VERDUN,F-59045 LILLE,FRANCE.							ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; BASTARD C, 1992, BLOOD, V79, P2527; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DEWEINDT C, IN PRESS CANCER; DIBELLO PR, 1991, GENETICS, V129, P385; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FICHELSON S, 1992, LEUKEMIA, V6, P93; FUKUHARA S, 1979, CANCER RES, V39, P3119; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LENOIR GM, 1982, NATURE, V298, P474, DOI 10.1038/298474a0; LEWIN B, 1991, CELL, V64, P303, DOI 10.1016/0092-8674(91)90640-K; LICHTER P, 1992, GENOMICS, V13, P999, DOI 10.1016/0888-7543(92)90013-I; MANOLOVA Y, 1979, HEREDITAS, V90, P5; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; NICHOLS J, 1992, BLOOD, V80, P2953; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; YE BHH, 1993, CANCER RES, V53, P2732	30	397	402	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					66	70		10.1038/ng0993-66	http://dx.doi.org/10.1038/ng0993-66			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220427				2022-12-17	WOS:A1993LV56500018
J	Ellinghaus, D; Jostins, L; Spain, SL; Cortes, A; Bethune, J; Han, B; Park, YR; Raychaudhuri, S; Pouget, JG; Hubenthal, M; Folseraas, T; Wang, YP; Esko, T; Metspalu, A; Westra, HJ; Franke, L; Pers, TH; Weersma, RK; Collij, V; D'Amato, M; Halfvarson, J; Jensen, AB; Lieb, W; Degenhardt, F; Forstner, AJ; Hofmann, A; Schreiber, S; Mrowietz, U; Juran, BD; Lazaridis, KN; Brunak, S; Dale, AM; Trembath, RC; Weidinger, S; Weichenthal, M; Ellinghaus, E; Elder, JT; Barker, JNWN; Andreassen, OA; McGovern, DP; Karlsen, TH; Barrett, JC; Parkes, M; Brown, MA; Franke, A				Ellinghaus, David; Jostins, Luke; Spain, Sarah L.; Cortes, Adrian; Bethune, Joern; Han, Buhm; Park, Yu Rang; Raychaudhuri, Soumya; Pouget, Jennie G.; Huebenthal, Matthias; Folseraas, Trine; Wang, Yunpeng; Esko, Tonu; Metspalu, Andres; Westra, Harm-Jan; Franke, Lude; Pers, Tune H.; Weersma, Rinse K.; Collij, Valerie; D'Amato, Mauro; Halfvarson, Jonas; Jensen, Anders Boeck; Lieb, Wolfgang; Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea; Schreiber, Stefan; Mrowietz, Ulrich; Juran, Brian D.; Lazaridis, Konstantinos N.; Brunak, Soren; Dale, Anders M.; Trembath, Richard C.; Weidinger, Stephan; Weichenthal, Michael; Ellinghaus, Eva; Elder, James T.; Barker, Jonathan N. W. N.; Andreassen, Ole A.; McGovern, Dermot P.; Karlsen, Tom H.; Barrett, Jeffrey C.; Parkes, Miles; Brown, Matthew A.; Franke, Andre		IIBDGC; IGAS; IPSCSG; GAPC; PAGE	Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; KINASE C-THETA; BOWEL-DISEASE; RISK LOCI; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; METAANALYSIS; PSORIASIS; VARIANTS; COMMON	We simultaneously investigated the genetic landscape of ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis and ulcerative colitis to investigate pleiotropy and the relationship between these clinically related diseases. Using high-density genotype data from more than 86,000 individuals of European ancestry, we identified 244 independent multidisease signals, including 27 new genome-wide significant susceptibility loci and 3 unreported shared risk loci. Complex pleiotropy was supported when contrasting multidisease signals with expression data sets from human, rat and mouse together with epigenetic and expressed enhancer profiles. The comorbidities among the five immune diseases were best explained by biological pleiotropy rather than heterogeneity (a subgroup of cases genetically identical to those with another disease, possibly owing to diagnostic misclassification, molecular subtypes or excessive comorbidity). In particular, the strong comorbidity between primary sclerosing cholangitis and inflammatory bowel disease is likely the result of a unique disease, which is genetically distinct from classical inflammatory bowel disease phenotypes.	[Ellinghaus, David; Bethune, Joern; Huebenthal, Matthias; Schreiber, Stefan; Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Jostins, Luke; Spain, Sarah L.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Cortes, Adrian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Div Clin Neurol, Oxford OX3 9DU, England; [Cortes, Adrian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Han, Buhm] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Han, Buhm] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Park, Yu Rang] Univ Ulsan, Asan Inst Life Sci, Asan Med Ctr, Coll Med, Seoul, South Korea; [Raychaudhuri, Soumya; Westra, Harm-Jan; Pers, Tune H.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Brigham & Womens Hosp, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Harvard Sch Med, Dept Med, Boston, MA USA; [Pouget, Jennie G.] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Pouget, Jennie G.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Norwegian PSC Res Ctr, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Rikshosp, N-0450 Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Univ Oslo, KG Jebsen Inflammat Res Ctr, Inst Clin Med, Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Res Inst Internal Med, Div Canc Med Surg & Transplantat, Rikshosp, Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Dept Transplantat Med, Gastroenterol Sect, N-0450 Oslo, Norway; [Wang, Yunpeng; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Ulikooli 18, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA USA; [Esko, Tonu; Pers, Tune H.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Cambridge, MA USA; [Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Pers, Tune H.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Weersma, Rinse K.; Collij, Valerie] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [D'Amato, Mauro] BioCruces Hlth Res Inst, Bilbao, Spain; [D'Amato, Mauro] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain; [Halfvarson, Jonas] Univ Orebro, Dept Gastroenterol, Fac Med & Hlth, SE-70182 Orebro, Sweden; [Jensen, Anders Boeck; Brunak, Soren] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, Inst Epidemiol, Kiel, Germany; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany; [Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea] Univ Bonn, Inst Human Genet, Bonn, Germany; [Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea] Univ Bonn, Dept Genom Life & Brain Ctr, Bonn, Germany; [Schreiber, Stefan] Univ Klinikum Schleswig Holstein, Dept Gen Internal Med, Campus Kiel, Kiel, Germany; [Mrowietz, Ulrich; Weidinger, Stephan; Weichenthal, Michael] Univ Kiel, Dept Dermatol, Univ Hosp, Schleswig Holstein, Schittenhelmstr 7, Kiel, Germany; [Juran, Brian D.; Lazaridis, Konstantinos N.] Mayo Clin, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London, England; [Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Barker, Jonathan N. W. N.] Kings Coll London, St Johns Inst Dermatol, Div Genet & Mol Med, London, England; [Andreassen, Ole A.] Univ Oslo, NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, Oslo, Norway; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [McGovern, Dermot P.] F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA USA; [McGovern, Dermot P.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Brown, Matthew A.] Queensland Univ Technol, IHBI, Translat Res Inst, Brisbane, Qld 4001, Australia; [Ellinghaus, David] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of Kiel; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of California System; University of California San Diego; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Groningen; Novo Nordisk Foundation; University of Copenhagen; Statens Serum Institut; University of Groningen; Karolinska Institutet; Basque Foundation for Science; Orebro University; University of Copenhagen; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Bonn; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Mayo Clinic; University of California System; University of California San Diego; University of London; King's College London; University of Michigan System; University of Michigan; University of London; King's College London; University of Oslo; University of Oslo; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Queensland; Queensland University of Technology (QUT); University of Kiel	Ellinghaus, D (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	d.ellinghaus@ikmb.uni-kiel.de	Franke, Andre/B-2151-2010; Ellinghaus, David/G-4467-2012; Weidinger, Stephan/C-8461-2011; Andreassen, Ole A./AAY-7531-2020; Hübenthal, Matthias/M-8149-2015; Han, Buhm/AAQ-9672-2020; Weersma, Rinse/ABE-3807-2021; Brown, Matthew A/E-5749-2010; Franke, Lude/P-7036-2016; D'Amato, Mauro/B-5050-2019; Ellinghaus, David/ABC-3610-2020; Wang, Yunpeng/W-8871-2018; D'Amato, Mauro/F-2450-2010; Ellinghaus, Eva/E-6490-2012; Lieb, Wolfgang/AAC-7650-2022; Degenhardt, Franziska/H-4169-2017; Halfvarson, Jonas/AAU-4687-2020; Bethune, Jorn/A-9502-2016; Spain, Sarah/G-1968-2010; Brunak, Soren/O-6621-2016	Franke, Andre/0000-0003-1530-5811; Weidinger, Stephan/0000-0003-3944-252X; Hübenthal, Matthias/0000-0002-5956-3006; Brown, Matthew A/0000-0003-0538-8211; Franke, Lude/0000-0002-5159-8802; D'Amato, Mauro/0000-0003-2743-5197; Ellinghaus, David/0000-0002-4332-6110; Wang, Yunpeng/0000-0001-9831-1090; D'Amato, Mauro/0000-0003-2743-5197; Ellinghaus, Eva/0000-0003-2914-3382; Bethune, Jorn/0000-0002-6919-2595; Trembath, Richard/0000-0003-0550-3400; Barrett, Jeffrey/0000-0002-1152-370X; Collij, Valerie/0000-0003-3743-1544; Jensen, Anders Boeck/0000-0002-5784-308X; Spain, Sarah/0000-0002-7591-8364; Li, Zhixiu/0000-0002-2924-9120; Raychaudhuri, Soumya/0000-0002-1901-8265; Harrison, Pille/0000-0003-4117-6910; Parkes, Miles/0000-0002-6467-0631; Barker, Jonathan/0000-0002-9030-183X; Brunak, Soren/0000-0003-0316-5866; Pers, Tune/0000-0003-0207-4831	German Federal Ministry of Education and Research (BMBF) [01ZX1306A]; Estonian Research Council [IUT20-60]; Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; University of Cambridge; German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network [2 (NGFN-2)]; National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; Netherlands Organization for Scientific Research (NWO) [016.136.308]; Swedish Research Council [521-2011-2764]; US NIH [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]; Doris Duke Charitable Foundation [2013097]; Novo Nordisk Foundation [NNF14CC0001]; H2020 project MedBioinformatics [634143]; Norwegian PSC Research Center; German Federal Ministry of Education and Research (BMBF) [01ZX1306A]; Estonian Research Council [IUT20-60]; Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; University of Cambridge; German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network [2 (NGFN-2)]; National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; Netherlands Organization for Scientific Research (NWO) [016.136.308]; Swedish Research Council [521-2011-2764]; US NIH [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]; Doris Duke Charitable Foundation [2013097]; Novo Nordisk Foundation [NNF14CC0001]; H2020 project MedBioinformatics [634143]; Norwegian PSC Research Center; MRC [G0800675] Funding Source: UKRI; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [G0800675] Funding Source: researchfish; Medical Research Foundation [C0482] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065183, R01AR050511, R01AR063611, R01AR042742, R01AR063759, UH2AR067677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Estonian Research Council(Estonian Research Council); Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); University of Cambridge(University of Cambridge); German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); H2020 project MedBioinformatics; Norwegian PSC Research Center; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Estonian Research Council(Estonian Research Council); Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); University of Cambridge(University of Cambridge); German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); H2020 project MedBioinformatics; Norwegian PSC Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Crohn&quot;s and Colitis UK; Novo Nordisk Foundation Center for Protein Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all patients with ankylosing spondylitis, Crohn's disease, PSC, psoriasis and ulcerative colitis, their families, healthy control individuals and clinicians for their participation in this study. We thank T. Wesse, T. Henke, S. Sedghpour Sabet, R. Vogler, G. Jacobs, I. Urbach, W. Albrecht, V. Pelkonen, K. Holm, H. Dahlen Sollid, B. Woldseth, J.A. Anmarkrud and L. Wenche Torbjornsen for expert help. F. Braun, W. Kreisel, T. Berg and R. Gunther are acknowledged for contributing German patients with PSC. B. A. Lie and the Norwegian Bone Marrow Donor Registry at Oslo University Hospital, Rikshospitalet, in Oslo and the Nord-Trondelag Health Study (HUNT) are acknowledged for sharing the healthy Norwegian controls. This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (SysInflame grant 01ZX1306A). This project received infrastructure support from Deutsche Forschungsgemeinschaft (DFG) Excellence Cluster 306 'Inflammation at Interfaces' and the PopGen Biobank. A. F. receives an endowment professorship by the Foundation for Experimental Medicine (Zurich, Switzerland). The Estonian Genome Center at the University of Tartu (EGCUT) received targeted financing from Estonian Research Council grant IUT20-60, the Center of Excellence in Genomics (EXCEGEN) and the University of Tartu (SP1GVARENG). We acknowledge EGCUT technical personnel, especially V. Soo and S. Smit. Data analyses were carried out in part at the High-Performance Computing Center of the University of Tartu. We acknowledge support from the UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and to Addenbrooke's Hospital in partnership with the University of Cambridge. The study was supported by the German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network 2 (NGFN-2), National Genome Research Network plus (NGFNplus) and the Integrated Genome Research Network (IG) MooDS (grants 01GS08144 and 01GS08147). R. K. W. is supported by a VIDI grant (016.136.308) from the Netherlands Organization for Scientific Research (NWO). J.H. was supported by the Swedish Research Council (521-2011-2764). This work is supported in part by funding from the US NIH (1R01AR063759 (S. R.), 5U01GM092691-05 (S. R.), 1UH2AR067677-01 (S. R.), U19AI111224-01 (S. R.) and 1R01DK084960-05 (K.N.L.)) and Doris Duke Charitable Foundation grant 2013097. A.B.J. and S. B. acknowledge funding from the Novo Nordisk Foundation (grant NNF14CC0001) and the H2020 project MedBioinformatics (grant 634143). The study was supported by the Norwegian PSC Research Center. We thank G. Trynka for assistance in setting up GoShifter.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; de Vries AB, 2015, WORLD J GASTROENTERO, V21, P1956, DOI 10.3748/wjg.v21.i6.1956; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Han B., 2015, BIORXIV, DOI [10.1101/030783, DOI 10.1101/030783]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Jensen AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5022; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Karlsen TH, 2013, J HEPATOL, V59, P571, DOI 10.1016/j.jhep.2013.03.015; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Taylor JE, 2007, BIOMETRIKA, V94, P1, DOI 10.1093/biomet/asm004; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wachowicz K, 2014, BIOCHEM SOC T, V42, P1512, DOI 10.1042/BST20140179; Wang ZM, 2014, HUM MOL GENET, V23, P6616, DOI 10.1093/hmg/ddu363; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	55	396	402	6	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					510	+		10.1038/ng.3528	http://dx.doi.org/10.1038/ng.3528			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	26974007	Green Accepted, Green Submitted			2022-12-17	WOS:000374834100010
J	Laurie, CC; Laurie, CA; Rice, K; Doheny, KF; Zelnick, LR; McHugh, CP; Ling, H; Hetrick, KN; Pugh, EW; Amos, C; Wei, QY; Wang, LE; Lee, JE; Barnes, KC; Hansel, NN; Mathias, R; Daley, D; Beaty, TH; Scott, AF; Ruczinski, I; Scharpf, RB; Bierut, LJ; Hartz, SM; Landi, MT; Freedman, ND; Goldin, LR; Ginsburg, D; Li, J; Desch, KC; Strom, SS; Blot, WJ; Signorello, LB; Ingles, SA; Chanock, SJ; Berndt, SI; Le Marchand, L; Henderson, BE; Monroe, KR; Heit, JA; de Andrade, M; Armasu, SM; Regnier, C; Lowe, WL; Hayes, MG; Marazita, ML; Feingold, E; Murray, JC; Melbye, M; Feenstra, B; Kang, JH; Wiggs, JL; Jarvik, GP; McDavid, AN; Seshan, VE; Mirel, DB; Crenshaw, A; Sharopova, N; Wise, A; Shen, J; Crosslin, DR; Levine, DM; Zheng, XW; Udren, JI; Bennett, S; Nelson, SC; Gogarten, SM; Conomos, MP; Heagerty, P; Manolio, T; Pasquale, LR; Haiman, CA; Caporaso, N; Weir, BS				Laurie, Cathy C.; Laurie, Cecelia A.; Rice, Kenneth; Doheny, Kimberly F.; Zelnick, Leila R.; McHugh, Caitlin P.; Ling, Hua; Hetrick, Kurt N.; Pugh, Elizabeth W.; Amos, Chris; Wei, Qingyi; Wang, Li-E; Lee, Jeffrey E.; Barnes, Kathleen C.; Hansel, Nadia N.; Mathias, Rasika; Daley, Denise; Beaty, Terri H.; Scott, Alan F.; Ruczinski, Ingo; Scharpf, Rob B.; Bierut, Laura J.; Hartz, Sarah M.; Landi, Maria Teresa; Freedman, Neal D.; Goldin, Lynn R.; Ginsburg, David; Li, Jun; Desch, Karl C.; Strom, Sara S.; Blot, William J.; Signorello, Lisa B.; Ingles, Sue A.; Chanock, Stephen J.; Berndt, Sonja I.; Le Marchand, Loic; Henderson, Brian E.; Monroe, Kristine R.; Heit, John A.; de Andrade, Mariza; Armasu, Sebastian M.; Regnier, Cynthia; Lowe, William L.; Hayes, M. Geoffrey; Marazita, Mary L.; Feingold, Eleanor; Murray, Jeffrey C.; Melbye, Mads; Feenstra, Bjarke; Kang, Jae H.; Wiggs, Janey L.; Jarvik, Gail P.; McDavid, Andrew N.; Seshan, Venkatraman E.; Mirel, Daniel B.; Crenshaw, Andrew; Sharopova, Nataliya; Wise, Anastasia; Shen, Jess; Crosslin, David R.; Levine, David M.; Zheng, Xiuwen; Udren, Jenna I.; Bennett, Siiri; Nelson, Sarah C.; Gogarten, Stephanie M.; Conomos, Matthew P.; Heagerty, Patrick; Manolio, Teri; Pasquale, Louis R.; Haiman, Christopher A.; Caporaso, Neil; Weir, Bruce S.			Detectable clonal mosaicism from birth to old age and its relationship to cancer	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; COPY-NUMBER VARIATION; POLYMORPHISM ARRAY ANALYSIS; B-CELL LYMPHOCYTOSIS; STEM-CELLS; GENOME; MALIGNANCIES; ASSOCIATION; GENE; POPULATIONS	We detected clonal mosaicism for large chromosomal anomalies (duplications, deletions and uniparental disomy) using SNP microarray data from over 50,000 subjects recruited for genome-wide association studies. This detection method requires a relatively high frequency of cells with the same abnormal karyotype (>5-10%; presumably of clonal origin) in the presence of normal cells. The frequency of detectable clonal mosaicism in peripheral blood is low (<0.5%) from birth until 50 years of age, after which it rapidly rises to 2-3% in the elderly. Many of the mosaic anomalies are characteristic of those found in hematological cancers and identify common deleted regions with genes previously associated with these cancers. Although only 3% of subjects with detectable clonal mosaicism had any record of hematological cancer before DNA sampling, those without a previous diagnosis have an estimated tenfold higher risk of a subsequent hematological cancer (95% confidence interval = 6-18).	[Laurie, Cathy C.; Laurie, Cecelia A.; Rice, Kenneth; Zelnick, Leila R.; McHugh, Caitlin P.; Shen, Jess; Crosslin, David R.; Levine, David M.; Zheng, Xiuwen; Udren, Jenna I.; Bennett, Siiri; Nelson, Sarah C.; Gogarten, Stephanie M.; Conomos, Matthew P.; Heagerty, Patrick; Weir, Bruce S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Doheny, Kimberly F.; Ling, Hua; Hetrick, Kurt N.; Pugh, Elizabeth W.] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; [Amos, Chris; Wei, Qingyi; Wang, Li-E] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Div Surg, Houston, TX 77030 USA; [Barnes, Kathleen C.; Hansel, Nadia N.; Mathias, Rasika] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Daley, Denise] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Beaty, Terri H.] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Ruczinski, Ingo] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Scharpf, Rob B.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Bierut, Laura J.; Hartz, Sarah M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Landi, Maria Teresa; Freedman, Neal D.; Goldin, Lynn R.; Chanock, Stephen J.; Berndt, Sonja I.; Caporaso, Neil] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Li, Jun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Desch, Karl C.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Blot, William J.; Signorello, Lisa B.] Vanderbilt Univ, Dept Med, Vanderbilt Epidemiol Ctr, Div Epidemiol, Nashville, TN USA; [Ingles, Sue A.; Henderson, Brian E.; Monroe, Kristine R.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Heit, John A.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [de Andrade, Mariza; Armasu, Sebastian M.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Regnier, Cynthia] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Regnier, Cynthia] Mayo Clin, Mayo Hyperoxaluria Ctr, Rochester, MN USA; [Lowe, William L.; Hayes, M. Geoffrey] Northwestern Univ, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Feingold, Eleanor] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Melbye, Mads; Feenstra, Bjarke] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Kang, Jae H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wiggs, Janey L.; Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Jarvik, Gail P.] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [McDavid, Andrew N.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Mirel, Daniel B.; Crenshaw, Andrew] Broad Inst Harvard & MIT, Cambridge, MA USA; [Sharopova, Nataliya] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Wise, Anastasia; Manolio, Teri] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; University of British Columbia; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; Statens Serum Institut; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Laurie, CC (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	cclaurie@u.washington.edu	Hartz, Sarah M/AAD-7662-2020; Zheng, Xiuwen/J-4047-2019; Hartz, Sarah/AAD-4073-2019; Bierut, Laura Jean/W-6806-2019; Berndt, Sonja I/J-8423-2016; Freedman, Neal David/B-9741-2015; Nelson, Sarah Catherine/AAN-9814-2020; Rice, Kenneth M/A-4150-2013; Weir, Bruce S/A-2894-2013; Jarvik, Gail P/N-6476-2014; Conomos, Matthew P./A-8136-2019	Zheng, Xiuwen/0000-0002-1390-0708; Hartz, Sarah/0000-0002-5429-3799; Bierut, Laura Jean/0000-0002-9952-4810; Freedman, Neal David/0000-0003-0074-1098; Nelson, Sarah Catherine/0000-0002-2109-6465; Rice, Kenneth M/0000-0001-5779-4495; Jarvik, Gail P/0000-0002-6710-8708; Conomos, Matthew P./0000-0001-9744-0851; Feingold, Eleanor/0000-0003-2898-6484; melbye, mads/0000-0001-8264-6785; Li, Jun/0000-0001-6727-0812; Gogarten, Stephanie/0000-0002-7231-9745; Feenstra, Bjarke/0000-0003-1478-649X; Hayes, M Geoffrey/0000-0002-4617-3981; McDavid, Andrew/0000-0002-6581-1213; Ginsburg, David/0000-0002-6436-8942; Zelnick, Leila/0000-0002-8461-5111	US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI); NIH (NCI) [R29CA70334, R01CA100264, P50CA093459, U10AA008401, CA63464, CA54281, CA1326792, RC2 CA148085]; NIH [U01HG004738, HHSN268200782096C, U01HG004726, U01HG004735, U01HG004415, U01HG004423]; NIH (National Institute Dental and Craniofacial Research (NIDCR) [U01DE018993]; NIH, National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U01HG004422]; NIH, National Institute on Drug Abuse (NIDA) [P01CA089392, R01DA013423, R01DA019963]; NIH (NIDCR) [U01DE018903, R01DE014899]; NIH, NIH Center for Inherited Disease Research (CIDR) [HHSN268200-782096C]; NIH, National Eye Institute (NEI) [U01HG004728, R01EY015473, R01EY015872]; NIH, GENEVA Coordinating Center [U01 HG004446]; NIG, CIDR [HHSN268200782096C, U01HG004438]; NIH, Broad Center for Genotyping and Analysis [U01HG04424]; NIH, the National Library of Medicine; Division of Cancer Epidemiology and Genetics, NCI, NIH; Research to Prevent Blindness in NYC; Harvard Medical School; Harvard Glaucoma Center of Excellence; NCI [T32 CA09168]; NATIONAL CANCER INSTITUTE [R37CA054281, P50CA093459, R01CA063464, R01CA092447, Z01CP010200, U01CA063464, P01CA089392, T32CA009168, R01CA100264, RC2CA148085, R29CA070334, R01CA054281] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY014104, R01EY015872, R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039693, R01HL039693] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004728, U01HG004415, U01HG004423, U01HG004735, U01HG004422, U01HG004438, U01HG004738, U01HG004424, U01HG004446, U01HG004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148, R01DE014899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018993, U01DE018903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019963, R01DA013423, K08DA032680] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Institute Dental and Craniofacial Research (NIDCR); NIH, National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH, National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH, NIH Center for Inherited Disease Research (CIDR); NIH, National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, GENEVA Coordinating Center; NIG, CIDR; NIH, Broad Center for Genotyping and Analysis; NIH, the National Library of Medicine; Division of Cancer Epidemiology and Genetics, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Research to Prevent Blindness in NYC; Harvard Medical School; Harvard Glaucoma Center of Excellence; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The GENEVA Consortium thanks the subjects and the staff of all GENEVA studies for their important contributions. We thank the following state cancer registries for their help: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Nebraska, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington and Wyoming. We thank C. Laird and G. Marti for helpful comments on the manuscript and B. Wakimoto and D. Gottschling for enlightening discussions. We also thank K. Jacobs for exchanging ideas and for working with us to estimate cross-method concordance of mosaic detection using the PLCO/GENEVA Lung Cancer study. Support for the GENEVA genome-wide association studies was provided through the US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI). Some studies also received support from individual NIH Institutes. The grant numbers are: Melanoma (NCI R29CA70334, R01CA100264 and P50CA093459); Lung Health (U01HG004738); Cleft Lip/Palate (National Institute Dental and Craniofacial Research (NIDCR): U01DE018993 and NIH contract: HHSN268200782096C); Addiction (U01HG004422, National Institute on Alcohol Abuse and Alcoholism (NIAAA): U10AA008401, National Cancer Institute (NCI): P01CA089392, National Institute on Drug Abuse (NIDA): R01DA013423 and R01DA019963); Lung Cancer (Z01CP010200); Blood Clotting (R37 HL 039693); Prostate Cancer (U01HG004726, NCI: CA63464, CA54281, CA1326792 and RC2 CA148085); Venous Thromboembolism (U01HG004735); Birth Weight (U01HG004415); Dental Caries (NIDCR: U01DE018903 and R01DE014899, NIH Center for Inherited Disease Research (CIDR) contract: HHSN268200-782096C); Prematurity (U01HG004423); Glaucoma (U01HG004728, National Eye Institute (NEI): R01EY015473 and R01EY015872); GENEVA Coordinating Center (U01 HG004446); CIDR (U01HG004438 and HHSN268200782096C); Broad Center for Genotyping and Analysis (U01HG04424); the Intramural Research Program of the NIH, the National Library of Medicine; and the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, NCI, NIH. L. R. P. was also supported by a Physician Scientist award from Research to Prevent Blindness in NYC and an Ophthalmology Scholar Award from Harvard Medical School and from the Harvard Glaucoma Center of Excellence. L.R.Z. was supported by the NCI (T32 CA09168).	Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Cogle CR, 2011, BLOOD, V117, P7121, DOI 10.1182/blood-2011-02-337964; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delhanty JDA, 2005, CYTOGENET GENOME RES, V111, P237, DOI 10.1159/000086894; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dougherty MJ, 2011, CANCER GENET-NY, V204, P26, DOI 10.1016/j.cancergencyto.2010.10.007; Fischbach F, 1992, MANUAL LAB DIAGNOSTI; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Gardner RJ, 2004, CHROMOSOME ABNORMALI; Gunn SR, 2009, LEUKEMIA RES, V33, P1276, DOI 10.1016/j.leukres.2008.10.010; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; HASSOLD T, 1982, HUM GENET, V61, P31, DOI 10.1007/BF00291327; Heim S., 2009, CANC CYTOGENETICS, P25; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Lin P, 2011, HUM HERED, V71, P141, DOI 10.1159/000324683; Lindstrom DL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002015; Ma XM, 2008, AM J HEMATOL, V83, P359, DOI 10.1002/ajh.21129; Maciejewski JP, 2009, BRIT J HAEMATOL, V146, P479, DOI 10.1111/j.1365-2141.2009.07757.x; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Miller O.J., 2001, HUMAN CHROMOSOMES; Mukherjee AB, 1997, EXP CELL RES, V235, P161, DOI 10.1006/excr.1997.3673; Neukirchen J, 2011, LEUKEMIA RES, V35, P1591, DOI 10.1016/j.leukres.2011.06.001; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pekarsky Y, 2010, SEMIN CANCER BIOL, V20, P370, DOI 10.1016/j.semcancer.2010.09.003; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Prchal JT, 1996, J EXP MED, V183, P561, DOI 10.1084/jem.183.2.561; Raghavan M, 2010, ADV ENZYME REGUL, V50, P96, DOI 10.1016/j.advenzreg.2009.10.030; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shanafelt TD, 2010, LEUKEMIA, V24, P512, DOI 10.1038/leu.2009.287; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Strachan T., 2004, HUM MOL GENET, V3; Swierczek SI, 2008, BLOOD, V112, P3186, DOI 10.1182/blood-2008-03-143925; TRACY ND, 1992, J QUAL TECHNOL, V24, P88, DOI 10.1080/00224065.1992.12015232; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Vandewoestyne ML, 2011, LEUKEMIA, V25, P883, DOI 10.1038/leu.2011.14; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vorobtsova I, 2001, MECH AGEING DEV, V122, P1373, DOI 10.1016/S0047-6374(01)00275-5; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	53	396	402	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					642	U58		10.1038/ng.2271	http://dx.doi.org/10.1038/ng.2271			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561516	Green Accepted, Green Submitted			2022-12-17	WOS:000304551100010
J	Ayroles, JF; Carbone, MA; Stone, EA; Jordan, KW; Lyman, RF; Magwire, MM; Rollmann, SM; Duncan, LH; Lawrence, F; Anholt, RRH; Mackay, TFC				Ayroles, Julien F.; Carbone, Mary Anna; Stone, Eric A.; Jordan, Katherine W.; Lyman, Richard F.; Magwire, Michael M.; Rollmann, Stephanie M.; Duncan, Laura H.; Lawrence, Faye; Anholt, Robert R. H.; Mackay, Trudy F. C.			Systems genetics of complex traits in Drosophila melanogaster	NATURE GENETICS			English	Article							EXPRESSION; SEX; EVOLUTION; NETWORKS; FITNESS; SELECTION; PROTEINS; GENOMICS; BEHAVIOR; GENES	Determining the genetic architecture of complex traits is challenging because phenotypic variation arises from interactions between multiple, environmentally sensitive alleles. We quantified genome-wide transcript abundance and phenotypes for six ecologically relevant traits in D. melanogaster wild-derived inbred lines. We observed 10,096 genetically variable transcripts and high heritabilities for all organismal phenotypes. The transcriptome is highly genetically intercorrelated, forming 241 transcriptional modules. Modules are enriched for transcripts in common pathways, gene ontology categories, tissue-specific expression and transcription factor binding sites. The high degree of transcriptional connectivity allows us to infer genetic networks and the function of predicted genes from annotations of other genes in the network. Regressions of organismal phenotypes on transcript abundance implicate several hundred candidate genes that form modules of biologically meaningful correlated transcripts affecting each phenotype. Overlapping transcripts in modules associated with different traits provide insight into the molecular basis of pleiotropy between complex traits.	[Ayroles, Julien F.; Carbone, Mary Anna; Jordan, Katherine W.; Lyman, Richard F.; Magwire, Michael M.; Rollmann, Stephanie M.; Duncan, Laura H.; Lawrence, Faye; Anholt, Robert R. H.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Ayroles, Julien F.; Carbone, Mary Anna; Jordan, Katherine W.; Lyman, Richard F.; Magwire, Michael M.; Rollmann, Stephanie M.; Duncan, Laura H.; Lawrence, Faye; Anholt, Robert R. H.; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Stone, Eric A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu	Anholt, Robert/S-5977-2019; Stone, Eric/Q-7840-2016	Stone, Eric/0000-0002-2725-4209	NIAAA NIH HHS [R01 AA016560] Funding Source: Medline; NIGMS NIH HHS [R01 GM 076083, R01 GM 45146, R01 GM059469, R01 GM 59469, R01 GM076083, R01 GM059469-12A1, R01 GM045146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076083, R01GM059469, R01GM045146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016560] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Date-Ito A, 2002, J MOL EVOL, V54, P665, DOI 10.1007/s00239-001-0062-5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeZazzo J, 2000, NEURON, V27, P145, DOI 10.1016/S0896-6273(00)00016-7; *DROS 12 GEN CONS, 2007, NATURE, V45, P203; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Falconer DS, 1996, INTRO QUANTITATIVE G; Foronda D, 2006, DEVELOPMENT, V133, P117, DOI 10.1242/dev.02173; HARTL DL, 1979, EVOLUTION, V33, P371, DOI 10.1111/j.1558-5646.1979.tb04690.x; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KNIGHT GR, 1957, GENETICS, V42, P524; Lemos B, 2008, P NATL ACAD SCI USA, V105, P14471, DOI 10.1073/pnas.0805160105; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Lynch M, 1998, GENETICS ANAL QUANTI; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morozova TV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r231; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Robertson A., 1967, Heritage from Mendel., P265; Robertson LK, 2004, DEVELOPMENT, V131, P2781, DOI 10.1242/dev.01159; Rollmann SM, 2006, NAT GENET, V38, P824, DOI 10.1038/ng1823; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; *WELLC TRUST CAS C, 2007, NATURE, V44, P66; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wolfner M.F., 2007, P183; Wong A, 2008, MOL BIOL EVOL, V25, P497, DOI 10.1093/molbev/msm270; Yamamoto A, 2008, P NATL ACAD SCI USA, V105, P12393, DOI 10.1073/pnas.0804889105; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	48	396	401	1	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					299	307		10.1038/ng.332	http://dx.doi.org/10.1038/ng.332			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19234471	Green Accepted			2022-12-17	WOS:000263640200010
J	Yamaji, M; Seki, Y; Kurimoto, K; Yabuta, Y; Yuasa, M; Shigeta, M; Yamanaka, K; Ohinata, Y; Saitou, M				Yamaji, Masashi; Seki, Yoshiyuki; Kurimoto, Kazuki; Yabuta, Yukihiro; Yuasa, Mihoko; Shigeta, Mayo; Yamanaka, Kaori; Ohinata, Yasuhide; Saitou, Mitinori			Critical function of Prdm14 for the establishment of the germ cell lineage in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; OLIGONUCLEOTIDE MICROARRAY ANALYSIS; CDNA AMPLIFICATION; BREAST CANCERS; MOUSE EMBRYO; SPECIFICATION; EXPRESSION; DYNAMICS; BLIMP1; SOX2	Specification of germ cell fate is fundamental in development and heredity. Recent evidence indicates that in mice, specification of primordial germ cells (PGCs), the common source of both oocytes and spermatozoa, occurs through the integration of three key events: repression of the somatic program(1), reacquisition of potential pluripotency(2,3) and ensuing genome-wide epigenetic reprogramming(4,5). Here we provide genetic evidence that Prdm14, a PR domain-containing transcriptional regulator with exclusive expression in the germ cell lineage and pluripotent cell lines, is critical in two of these events, the reacquisition of potential pluripotency and successful epigenetic reprogramming. In Prdm14 mutants, the failure of these two events manifests even in the presence of Prdm1 (also known as Blimp1), a key transcriptional regulator for PGC specification(6,7). Our combined evidence demonstrates that Prdm14 defines a previously unknown genetic pathway, initiating independently from Prdm1, for ensuring the launching of the mammalian germ cell lineage.	[Yamaji, Masashi; Seki, Yoshiyuki; Kurimoto, Kazuki; Yabuta, Yukihiro; Yuasa, Mihoko; Shigeta, Mayo; Yamanaka, Kaori; Ohinata, Yasuhide; Saitou, Mitinori] RIKEN, Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol,Chuo Ku, Kobe, Hyogo 6500047, Japan; [Saitou, Mitinori] Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Kyoto University	Saitou, M (corresponding author), RIKEN, Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol,Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	saitou@cdb.riken.jp	Yamaji, Masashi/ABA-5267-2020	Yamaji, Masashi/0000-0002-8215-2184				Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Bernstein A, 1990, CIBA F SYMP, V148, P166; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2005, CELL CYCLE, V4, P1736, DOI 10.4161/cc.4.12.2209; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	31	396	420	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1016	1022		10.1038/ng.186	http://dx.doi.org/10.1038/ng.186			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622394				2022-12-17	WOS:000258026900020
J	Lorson, CL; Strasswimmer, J; Yao, JM; Baleja, JD; Hahnen, E; Wirth, B; Le, T; Burghes, AHM; Androphy, EJ				Lorson, CL; Strasswimmer, J; Yao, JM; Baleja, JD; Hahnen, E; Wirth, B; Le, T; Burghes, AHM; Androphy, EJ			SMN oligomerization defect correlates with spinal muscular atrophy severity	NATURE GENETICS			English	Article							MOTOR-NEURON GENE; MOLECULAR ANALYSIS; DELETIONS; PHENOTYPE; 5Q13	Spinal muscular atrophy (SMA) is a motor-neuron disorder resulting from anterior-horn-cell death. The autosomal recessive form has a carrier frequency of 1 in 50 and is the most common genetic cause of infant death. SMA is categorized as types I-III, ranging from severe to mild, based upon age of onset and clinical course. Two closely flanking copies of the survival motor neuron (SMN) gene are on chromosome 5913 (ref. 1). The telomeric SMN (SMN1) copy is homozygously deleted or converted in >95% of SMA patients, while a small number of SMA disease alleles contain missense mutations within the carboxy terminus. We have identified a modular oligomerization domain within exon 6 of SMN1. All previously identified missense mutations map within or immediately adjacent to this domain. Comparison of wild-type to mutant SMN proteins of type I, II and III SMA patients showed a direct correlation between oligomerization and clinical type. Moreover, the most abundant centromeric SMN product, which encodes exons 1-6 but not 7, demonstrated reduced self-association. These findings identify decreased SMN self-association as a biochemical defect in SMA, and imply that disease severity is proportional to the intracellular concentration of oligomerization-competent SMN proteins.	New England Med Ctr, Dept Dermatol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem Med, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; University of Bonn; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Androphy, EJ (corresponding author), New England Med Ctr, Dept Dermatol, 750 Washington St, Boston, MA 02111 USA.		Wirth, Brunhilde/H-3192-2019	Burghes, Arthur/0000-0001-9031-1555; Androphy, Elliot/0000-0002-8104-0703; Wirth, Brunhilde/0000-0003-4051-5191; strasswimmer, john/0000-0002-5790-2633				Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; Breiding DE, 1996, VIROLOGY, V221, P34, DOI 10.1006/viro.1996.0350; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; BUSSAGLIA E, 1995, NAT GENET, V11, P355; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; vanderSteege G, 1996, AM J HUM GENET, V59, P834; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257	25	396	407	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					63	66		10.1038/ng0598-63	http://dx.doi.org/10.1038/ng0598-63			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590291				2022-12-17	WOS:000073346700019
J	Ben-David, U; Ha, G; Tseng, YY; Greenwald, NF; Oh, C; Shih, J; McFarland, JM; Wong, B; Boehm, JS; Beroukhim, R; Golub, TR				Ben-David, Uri; Ha, Gavin; Tseng, Yuen-Yi; Greenwald, Noah F.; Oh, Coyin; Shih, Juliann; McFarland, James M.; Wong, Bang; Boehm, Jesse S.; Beroukhim, Rameen; Golub, Todd R.			Patient-derived xenografts undergo mouse-specific tumor evolution	NATURE GENETICS			English	Article							GENE-EXPRESSION; BREAST-CANCER; GENOMIC CHARACTERIZATION; COPY NUMBER; CHROMOSOMAL INSTABILITY; STEM-CELLS; MODELS; HETEROGENEITY; SIGNATURE; CHEMOTHERAPY	Patient-derived xenografts (PDXs) have become a prominent cancer model system, as they are presumed to faithfully represent the genomic features of primary tumors. Here we monitored the dynamics of copy number alterations (CNAs) in 1,110 PDX samples across 24 cancer types. We observed rapid accumulation of CNAs during PDX passaging, often due to selection of preexisting minor clones. CNA acquisition in PDXs was correlated with the tissue-specific levels of aneuploidy and genetic heterogeneity observed in primary tumors. However, the particular CNAs acquired during PDX passaging differed from those acquired during tumor evolution in patients. Several CNAs recurrently observed in primary tumors gradually disappeared in PDXs, indicating that events undergoing positive selection in humans can become dispensable during propagation in mice. Notably, the genomic stability of PDXs was associated with their response to chemotherapy and targeted drugs. These findings have major implications for PDX-based modeling of human cancer.	[Ben-David, Uri; Ha, Gavin; Tseng, Yuen-Yi; Greenwald, Noah F.; Oh, Coyin; Shih, Juliann; McFarland, James M.; Wong, Bang; Boehm, Jesse S.; Beroukhim, Rameen; Golub, Todd R.] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA; [Ha, Gavin; Shih, Juliann; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Greenwald, Noah F.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Greenwald, Noah F.] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Beroukhim, Rameen] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Beroukhim, R; Golub, TR (corresponding author), Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Golub, TR (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Golub, TR (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Golub, TR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	rameen_beroukhim@dfci.harvard.edu; golub@broadinstitute.org	Greenwald, Noah/GNH-3982-2022; Ben-David, Uri/H-4119-2019; Ha, Gavin/N-1984-2019; Oh, Coyin/CAF-2704-2022	Ben-David, Uri/0000-0001-7098-2378; Ha, Gavin/0000-0001-7578-7272; Oh, Coyin/0000-0002-5732-3471; Greenwald, Noah/0000-0002-7836-4379; Golub, Todd/0000-0003-0113-2403	Human Frontiers Science Program postdoctoral fellowship; US National Institutes of Health [R01 CA188228]; Gray Matters Brain Cancer Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA188228] Funding Source: NIH RePORTER	Human Frontiers Science Program postdoctoral fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gray Matters Brain Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Franke for assistance with functional genomic mRNA profiling; A. Bass, K. Ligon, A.J. Aguirre and J. Lorch for providing the clinical samples for cell line derivation; A. Tubelli for assistance with figure preparation; M. Meyerson, A. J. Cherniack, A. Taylor, A. Pearson and Z. Tothova for helpful discussions; and W.J. Gibson for copy number data. U.B.-D. is supported by a Human Frontiers Science Program postdoctoral fellowship, R.B. received support from the US National Institutes of Health (R01 CA188228) and the Gray Matters Brain Cancer Foundation, and T.R.G. received support from the Howard Hughes Medical Institute.	Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Bakker B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0971-7; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-David U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12160; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Ben-David U, 2013, NAT PROTOC, V8, P989, DOI 10.1038/nprot.2013.051; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bi WYLD, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0014-7; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Burrell RA, 2010, J CELL BIOCHEM, V111, P782, DOI 10.1002/jcb.22781; Cai YY, 2016, CANCER CELL, V29, P751, DOI 10.1016/j.ccell.2016.04.003; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen GB, 2015, CELL, V160, P771, DOI 10.1016/j.cell.2015.01.026; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079874; Cifola I, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-244; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Gu QY, 2015, ONCOTARGET, V6, P20160, DOI 10.18632/oncotarget.3969; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hedberg ML, 2016, J CLIN INVEST, V126, P169, DOI 10.1172/JCI82066; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Hollingshead MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-393; Huynh H, 2008, J HEPATOL, V49, P52, DOI 10.1016/j.jhep.2008.02.022; Jager W, 2015, ONCOTARGET, V6, P21522; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Khan F, 2010, TOXIN REV, V29, P130, DOI 10.3109/15569543.2010.516463; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Kresse SH, 2012, CANCER-AM CANCER SOC, V118, P558, DOI 10.1002/cncr.26276; Larson JL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0571-7; Lee SML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107567; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lim B, 2015, ONCOTARGET, V6, P22179, DOI 10.18632/oncotarget.4246; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Ma CX, 2012, J CLIN INVEST, V122, P1541, DOI 10.1172/JCI58765; Monsma DJ, 2014, PEDIATR BLOOD CANCER, V61, P1570, DOI 10.1002/pbc.25039; Morisot S, 2010, LEUKEMIA, V24, P1859, DOI 10.1038/leu.2010.184; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Peng SH, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-198; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/NCHEMBIO.1986, 10.1038/nchembio.1986]; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roschke AV, 2003, CANCER RES, V63, P8634; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Silk AD, 2013, P NATL ACAD SCI USA, V110, pE4134, DOI 10.1073/pnas.1317042110; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Smith KB, 2013, AM J PATHOL, V182, P1400, DOI 10.1016/j.ajpath.2013.01.002; Sveen A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006225; Tempest HG, 2008, HUM REPROD, V23, P251, DOI 10.1093/humrep/dem389; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Um SW, 2016, CANCER RES, V76, P6568, DOI 10.1158/0008-5472.CAN-16-0873; Wong NC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-416; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhang XT, 2015, CLIN CANCER RES, V21, P4698, DOI 10.1158/1078-0432.CCR-15-0157	69	395	404	3	61	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2017	49	11					1567	+		10.1038/ng.3967	http://dx.doi.org/10.1038/ng.3967			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL0OD	28991255	Green Accepted, Green Submitted			2022-12-17	WOS:000413909800005
J	Abnet, CC; Freedman, ND; Hu, N; Wang, ZM; Yu, K; Shu, XO; Yuan, JM; Zheng, W; Dawsey, SM; Dong, LM; Lee, MP; Ding, T; Qiao, YL; Gao, YT; Koh, WP; Xiang, YB; Tang, ZZ; Fan, JH; Wang, CY; Wheeler, W; Gail, MH; Yeager, M; Yuenger, J; Hutchinson, A; Jacobs, KB; Giffen, CA; Burdett, L; Fraumeni, JF; Tucker, MA; Chow, WH; Goldstein, AM; Chanock, SJ; Taylor, PR				Abnet, Christian C.; Freedman, Neal D.; Hu, Nan; Wang, Zhaoming; Yu, Kai; Shu, Xiao-Ou; Yuan, Jian-Min; Zheng, Wei; Dawsey, Sanford M.; Dong, Linda M.; Lee, Maxwell P.; Ding, Ti; Qiao, You-Lin; Gao, Yu-Tang; Koh, Woon-Puay; Xiang, Yong-Bing; Tang, Ze-Zhong; Fan, Jin-Hu; Wang, Chaoyu; Wheeler, William; Gail, Mitchell H.; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin B.; Giffen, Carol A.; Burdett, Laurie; Fraumeni, Joseph F., Jr.; Tucker, Margaret A.; Chow, Wong-Ho; Goldstein, Alisa M.; Chanock, Stephen J.; Taylor, Philip R.			A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CANCER; CHINA; RISK; MUTATIONS; VARIANT; TRACT; CHEK2	We conducted a genome-wide association study of gastric cancer and esophageal squamous cell carcinoma (ESCC) in ethnic Chinese subjects in which we genotyped 551,152 SNPs. We report a combined analysis of 2,240 gastric cancer cases, 2,115 ESCC cases and 3,302 controls drawn from five studies. In logistic regression models adjusted for age, sex and study, multiple variants at 10q23 had genome-wide significance for gastric cancer and ESCC independently. A notable signal was rs2274223, a nonsynonymous SNP located in PLCE1, for gastric cancer (P = 8.40 x 10(-9); per-allele odds ratio (OR) = 1.31) and ESCC (P = 3.85 x 10(-9); OR = 1.34). The association with gastric cancer differed by anatomic subsite. For tumors in the cardia the association was stronger (P = 4.19 x 10(-15); OR = 1.57), and for those in the noncardia stomach it was absent (P = 0.44; OR = 1.05). Our findings at 10q23 could provide insight into the high incidence of both cancers in China.	[Abnet, Christian C.; Freedman, Neal D.; Hu, Nan; Wang, Zhaoming; Yu, Kai; Dawsey, Sanford M.; Dong, Linda M.; Wang, Chaoyu; Gail, Mitchell H.; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin B.; Burdett, Laurie; Fraumeni, Joseph F., Jr.; Tucker, Margaret A.; Chow, Wong-Ho; Goldstein, Alisa M.; Chanock, Stephen J.; Taylor, Philip R.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Wang, Zhaoming; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin B.; Burdett, Laurie] SAIC Frederick Inc, NCI Frederick, Core Genotyping Facil, Frederick, MD USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Yuan, Jian-Min] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Lee, Maxwell P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ding, Ti; Tang, Ze-Zhong] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China; [Qiao, You-Lin; Fan, Jin-Hu] Chinese Acad Med Sci, Dept Epidemiol, Canc Inst Hosp, Beijing 100037, Peoples R China; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Shanghai, Peoples R China; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Wheeler, William; Giffen, Carol A.] Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Vanderbilt University; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Shanghai Jiao Tong University; National University of Singapore; Information Management Services, Inc.	Abnet, CC (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	abnetc@mail.nih.gov	Wang, Zhaoming/R-5527-2018; Gao, Y./GWZ-3665-2022; Gao, Yu/HGE-1937-2022; Tucker, Margaret A/B-4297-2015; Yeager, Meredith/AAA-5322-2020; Liao, Linda M/B-3960-2011; Freedman, Neal David/B-9741-2015; zhang, weihua/GXV-1334-2022; Qiao, You-Lin/B-4139-2012; Zheng, Wei/O-3351-2013; Abnet, Christian C/C-4111-2015; gao, yi/HCI-8298-2022	Wang, Zhaoming/0000-0001-7556-3869; Liao, Linda M/0000-0002-1923-5294; Freedman, Neal David/0000-0003-0074-1098; Qiao, You-Lin/0000-0001-6380-0871; Zheng, Wei/0000-0003-1226-070X; Abnet, Christian C/0000-0002-3008-7843; fan, jinhu/0000-0003-3159-7893; Jacobs, Kevin/0000-0002-4657-6473; Yuan, Jian-Min/0000-0002-4620-3108	National Cancer Institute [SMHS: R01 CA82729, SWHS: R37 CA70837, NO2-CP-11010, SCHS: R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034, NO2-SC-66211, NO1-SC-91030, HHSN261200477001C]; Shanxi Cancer Hospital and Institute; Cancer Institute of the Chinese Academy of Medical Sciences; NIH, National Cancer Institute; Division of Cancer Epidemiology and Genetics; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011253] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Shanxi Cancer Hospital and Institute; Cancer Institute of the Chinese Academy of Medical Sciences; NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the study participants and staff of the Shanghai Men's Health Study (SMHS), Shanghai Women's Health Study (SWHS) and Singapore Chinese Health Study (SCHS). Supported by the National Cancer Institute (SMHS: R01 CA82729; SWHS: R37 CA70837 and contract NO2-CP-11010 with Vanderbilt University; SCHS: R01 CA55069, R35 CA53890, R01 CA80205 and R01 CA144034). We thank M. C. Yu and H.-P. Lee for establishing this cohort. Cancer cases were identified through database linkage by the Ministry of Health in Singapore. The Shanxi Upper Gastrointestinal Cancer Genetics Project was supported by the National Cancer Institute contract NO2-SC-66211 with the Shanxi Cancer Hospital and Institute. The Nutrition Intervention Trials (NIT) were supported by National Cancer Institute contracts NO1-SC-91030 and HHSN261200477001C with the Cancer Institute of the Chinese Academy of Medical Sciences. The current analysis was supported by the Intramural Research Program of the NIH, National Cancer Institute, the Division of Cancer Epidemiology and Genetics, and the Center for Cancer Research.	Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Falush D, 2003, GENETICS, V164, P1567; Gao Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-269; Hall J, 2007, CARCINOGENESIS, V28, P665, DOI 10.1093/carcin/bgl160; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Johmura Y, 2008, BIOL PHARM BULL, V31, P1092, DOI 10.1248/bpb.31.1092; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Tran G.D., 2004, INT J CANCER, V113, P176; YANG CS, 1980, CANCER RES, V40, P2633; Yokoyama A, 2003, JPN J CLIN ONCOL, V33, P111, DOI 10.1093/jjco/hyg026; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; ZHENG W, 1993, BRIT J CANCER, V68, P978, DOI 10.1038/bjc.1993.465	28	395	424	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					764	U51		10.1038/ng.649	http://dx.doi.org/10.1038/ng.649			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20729852	Green Accepted			2022-12-17	WOS:000281388400011
J	LaVaute, T; Smith, S; Cooperman, S; Iwai, K; Land, W; Meyron-Holtz, E; Drake, SK; Miller, G; Abu-Asab, M; Tsokos, M; Switzer, R; Grinberg, A; Love, P; Tresser, N; Rouault, TA				LaVaute, T; Smith, S; Cooperman, S; Iwai, K; Land, W; Meyron-Holtz, E; Drake, SK; Miller, G; Abu-Asab, M; Tsokos, M; Switzer, R; Grinberg, A; Love, P; Tresser, N; Rouault, TA			Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice	NATURE GENETICS			English	Article							RESPONSIVE ELEMENT; CEREBRAL-CORTEX; RNA-BINDING; SYSTEM; DEGRADATION; EXPRESSION; MEMBRANES; ACONITASE; FEATURES; FERRITIN	In mammalian cells, regulation of the expression of proteins involved in iron metabolism is achieved through interactions of iron-sensing proteins known as iron regulatory proteins (IRPs), with transcripts that contain RNA stem-loop structures referred to as iron responsive elements (IREs). Two distinct but highly homologous proteins, IRP1 and IRP2, bind IREs with high affinity when cells are depleted of iron, inhibiting translation of some transcripts, such as ferritin, or turnover of others, such as the transferrin receptor (TFRC). IRPs sense cytosolic iron levels and modify expression of proteins involved in iron uptake, export and sequestration according to the needs of individual cells(1,2). Here we generate mice with a targeted disruption of the gene encoding Irp2 (Ireb2). These mutant mice misregulate iron metabolism in the intestinal mucosa and the central nervous system. In adulthood, Ireb2(-/-) mice develop a movement disorder characterized by ataxia, bradykinesia and tremor. Significant accumulations of iron in white matter tracts and nuclei throughout the brain precede the onset of neurodegeneration and movement disorder symptoms by many months. Ferric iron accumulates in the cytosol of neurons and oligodendrocytes in distinctive regions of the brain. Abnormal accumulations of ferritin colocalize with iron accumulations in populations of neurons that degenerate, and iron-laden oligodendrocytes accumulate ubiquitin-positive inclusions. Thus, misregulation of iron metabolism leads to neurodegenerative disease in Ire62(-/-) mice and may contribute to the pathogenesis of comparable human neurodegenerative diseases.	NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA; NIH, Vet Resources Program, Off Director, Bethesda, MD USA; NCI, Div Clin Sci, Bethesda, MD 20892 USA; NeuroSci Associates, Knoxville, TN USA; NICHHD, Lab Mammalian Genet & Dev, Bethesda, MD 20892 USA; NINDS, Neuroimmunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Rouault, TA (corresponding author), NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA.		IWAI, KAZUHIRO/GSN-7385-2022; Meyron-Holtz, Esther/B-5991-2013	Iwai, Kazuhiro/0000-0001-5620-5951; Lipko, Nancy/0000-0001-9267-4587; Abu-Asab, Mones/0000-0002-4047-1232	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803, ZIAHD001602] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001803, Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439; Andrews NC, 1999, NUTR REV, V57, P114, DOI 10.1111/j.1753-4887.1999.tb06934.x; ARAI N, 1994, NEUROSCI LETT, V182, P197, DOI 10.1016/0304-3940(94)90796-X; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DERUSSO PA, 1995, J BIOL CHEM, V270, P15451, DOI 10.1074/jbc.270.26.15451; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Fix AS, 2000, TOXICOL PATHOL, V28, P122, DOI 10.1177/019262330002800115; Fix AS, 1996, TOXICOL PATHOL, V24, P291, DOI 10.1177/019262339602400305; FRANCOIS C, 1981, BRAIN RES, V215, P317, DOI 10.1016/0006-8993(81)90510-2; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Ishino K, 2000, J CELL BIOCHEM, V76, P411, DOI 10.1002/(SICI)1097-4644(20000301)76:3<411::AID-JCB9>3.0.CO;2-J; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; Katz RL, 1997, HUM PATHOL, V28, P502, DOI 10.1016/S0046-8177(97)90042-3; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; KONIJN AM, 1982, J IMMUNOL METHODS, V54, P297, DOI 10.1016/0022-1759(82)90314-3; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Yin X, 1997, J NEUROSCI RES, V50, P238, DOI 10.1002/(SICI)1097-4547(19971015)50:2<238::AID-JNR12>3.0.CO;2-4	30	395	406	2	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					209	214		10.1038/84859	http://dx.doi.org/10.1038/84859			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175792				2022-12-17	WOS:000166839200025
J	Arikawa-Hirasawa, E; Watanabe, H; Takami, H; Hassell, JR; Yamada, Y				Arikawa-Hirasawa, E; Watanabe, H; Takami, H; Hassell, JR; Yamada, Y			Perlecan is essential for cartilage and cephalic development	NATURE GENETICS			English	Article							FIBROBLAST GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCAN; FACTOR RECEPTOR 3; DYSPLASIA TYPE-I; THANATOPHORIC DYSPLASIA; EXPRESSION; ACTIVATION; MUTATIONS; SKELETAL; MEMBRANE		Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; Shriners Hosp Crippled Children, Tampa, FL 33612 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yamada, Y (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov						ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; Aszodi A, 1998, J MOL MED-JMM, V76, P238, DOI 10.1007/s001090050214; Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Delezoide AL, 1997, HUM MOL GENET, V6, P1899, DOI 10.1093/hmg/6.11.1899; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Harris MJ, 1997, TERATOLOGY, V56, P177, DOI 10.1002/(SICI)1096-9926(199709)56:3<177::AID-TERA1>3.0.CO;2-Z; HORTON WA, 1988, BONE, V9, P53, DOI 10.1016/8756-3282(88)90027-0; Horton William A., 1997, Current Opinion in Pediatrics, V9, P437, DOI 10.1097/00008480-199708000-00021; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; MORRISSKAY G, 1991, J CRAN GENET DEV BIO, V11, P181; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Naski MC, 1998, DEVELOPMENT, V125, P4977; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; ORNOY A, 1985, AM J MED GENET, V21, P613, DOI 10.1002/ajmg.1320210402; Peters PWJ, 1977, METHODS PRENATAL TOX, P153; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Weber M, 1998, J PEDIATR ORTHOP B, V7, P1, DOI 10.1097/01202412-199801000-00001; Wilcox WR, 1998, AM J MED GENET, V78, P274, DOI 10.1002/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C	30	395	409	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1999	23	3					354	358		10.1038/15537	http://dx.doi.org/10.1038/15537			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	257QC	10545953				2022-12-17	WOS:000083792200028
J	BRIGGS, MD; HOFFMAN, SMG; KING, LM; OLSEN, AS; MOHRENWEISER, H; LEROY, JG; MORTIER, GR; RIMOIN, DL; LACHMAN, RS; GAINES, ES; CEKLENIAK, JA; KNOWLTON, RG; COHN, DH				BRIGGS, MD; HOFFMAN, SMG; KING, LM; OLSEN, AS; MOHRENWEISER, H; LEROY, JG; MORTIER, GR; RIMOIN, DL; LACHMAN, RS; GAINES, ES; CEKLENIAK, JA; KNOWLTON, RG; COHN, DH			PSEUDOACHONDROPLASIA AND MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO MUTATIONS IN THE CARTILAGE OLIGOMERIC MATRIX PROTEIN GENE	NATURE GENETICS			English	Article							V COLLAGEN; THROMBOSPONDIN; BINDING; HEPARIN; SITES	Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED) are dominantly inherited chondrodysplasias characterized by short stature and early-onset osteoarthrosis. The disease genes in families with PSACH and MED have been localized to an 800 kilobase interval on the short arm of chromosome 19. Recently the gene for cartilage oligomeric matrix protein (COMP) was localized to chromosome 19p13.1. In three patients with these diseases, we identified COMP mutations in a region of the gene that encodes a CA(++) binding motif. Our data demonstrate that PSACH and some forms of MED are allelic and suggest an essential role for Ca++ binding in COMP structure and function.	CEDARS SINAI RES INST,STEVEN SPIELBERG PEDIAT RES CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90024; LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,BIOL & BIOTECHNOL RES PROGRAM,LIVERMORE,CA 94550; STATE UNIV GHENT,SCH MED,DEPT PEDIAT,B-9000 GHENT,BELGIUM; STATE UNIV GHENT,SCH MED,DEPT MED GENET,B-9000 GHENT,BELGIUM; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Ghent University; Ghent University; Jefferson University			Mortier, Geert/D-2542-2012; Hoffman, Susan/K-1995-2019	Mortier, Geert/0000-0001-9871-4578; 	NIAMS NIH HHS [AR43139, AR39740] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043139, P01AR039740] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BORNSTEIN P, 1993, GENOMICS, V15, P607, DOI 10.1006/geno.1993.1114; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; BRANDRIFF BF, 1994, GENOMICS, V23, P582, DOI 10.1006/geno.1994.1546; BRIGGS MD, 1993, GENOMICS, V18, P656, DOI 10.1016/S0888-7543(05)80369-6; BRIGGS MD, 1994, AM J HUM GENET, V55, P678; DEERE M, 1995, AM J HUM GENET, V56, P698; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; DIXIT VM, 1984, J BIOL CHEM, V259, P100; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HELLSTEN E, 1995, GENOMICS, V25, P404, DOI 10.1016/0888-7543(95)80040-S; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; KNOWLTON RG, IN PRESS GENOMICS; LAHAV J, 1982, CELL, V31, P253, DOI 10.1016/0092-8674(82)90425-1; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; MAROTEAUX P, 1959, PRESSE MED, V67, P383; MAROTEAUX P, 1980, EUR J PEDIATR, V133, P227, DOI 10.1007/BF00496081; MAYNARD JA, 1972, LAB INVEST, V26, P40; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; MUMBY SM, 1984, J CELL BIOL, V98, P646, DOI 10.1083/jcb.98.2.646; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Ribbing S, 1937, ACTA RADIOL S, V34, P1; RIMOIN DL, 1994, HUM GENET, V93, P236, DOI 10.1007/BF00212015; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1982, EUR J PEDIATR, V138, P221, DOI 10.1007/BF00441206; STANESCU V, 1977, ARCH FR PEDIATR   S3, V34, P1; TAKAGI J, 1993, J BIOL CHEM, V268, P15544; TYNAN K, 1993, GENOMICS, V17, P316, DOI 10.1006/geno.1993.1327; WARMAN ML, 1994, GENOMICS, V23, P158, DOI 10.1006/geno.1994.1472; 1992, AM J MED GENET, V44, P223	37	395	416	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					330	336		10.1038/ng0795-330	http://dx.doi.org/10.1038/ng0795-330			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670472				2022-12-17	WOS:A1995RG38600018
J	Pott, S; Lieb, JD				Pott, Sebastian; Lieb, Jason D.			What are super-enhancers?	NATURE GENETICS			English	Editorial Material							BROMODOMAIN PROTEIN BRD4; HEAVY-CHAIN LOCUS; BETA-GLOBIN GENE; C-MYC GENE; TRANSCRIPTION FACTORS; HUMAN GENOME; REGULATORY ELEMENTS; OPEN CHROMATIN; CELL IDENTITY; IN-VIVO	The term 'super-enhancer' has been used to describe groups of putative enhancers in close genomic proximity with unusually high levels of Mediator binding, as measured by chromatin immunoprecipitation and sequencing (ChIP-seq). Here we review the identification and composition of super-enhancers, describe links between super-enhancers, gene regulation and disease, and discuss the functional significance of enhancer clustering. We also provide our perspective regarding the proposition that super-enhancers are a regulatory entity conceptually distinct from what was known before the introduction of the term. Our opinion is that there is not yet strong evidence that super-enhancers are a novel paradigm in gene regulation and that use of the term in this context is not currently justified. However, the term likely identifies strong enhancers that exhibit behaviors consistent with previous models and concepts of transcriptional regulation. In this respect, the super-enhancer definition is useful in identifying regulatory elements likely to control genes important for cell type specification.	[Pott, Sebastian; Lieb, Jason D.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Lieb, JD (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	jdlieb@uchicago.edu		Lieb, Jason/0000-0001-7601-8061				Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fan XC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005029; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Park D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083506; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Walker BA, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.13; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	69	394	410	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					8	12		10.1038/ng.3167	http://dx.doi.org/10.1038/ng.3167			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25547603				2022-12-17	WOS:000346990400005
J	Love, C; Sun, Z; Jima, D; Li, GJ; Zhang, J; Miles, R; Richards, KL; Dunphy, CH; Choi, WWL; Srivastava, G; Lugar, PL; Rizzieri, DA; Lagoo, AS; Bernal-Mizrachi, L; Mann, KP; Flowers, CR; Naresh, KN; Evens, AM; Chadburn, A; Gordon, LI; Czader, MB; Gill, JI; Hsi, ED; Greenough, A; Moffitt, AB; McKinney, M; Banerjee, A; Grubor, V; Levy, S; Dunson, DB; Dave, SS				Love, Cassandra; Sun, Zhen; Jima, Dereje; Li, Guojie; Zhang, Jenny; Miles, Rodney; Richards, Kristy L.; Dunphy, Cherie H.; Choi, William W. L.; Srivastava, Gopesh; Lugar, Patricia L.; Rizzieri, David A.; Lagoo, Anand S.; Bernal-Mizrachi, Leon; Mann, Karen P.; Flowers, Christopher R.; Naresh, Kikkeri N.; Evens, Andrew M.; Chadburn, Amy; Gordon, Leo I.; Czader, Magdalena B.; Gill, Javed I.; Hsi, Eric D.; Greenough, Adrienne; Moffitt, Andrea B.; McKinney, Matthew; Banerjee, Anjishnu; Grubor, Vladimir; Levy, Shawn; Dunson, David B.; Dave, Sandeep S.			The genetic landscape of mutations in Burkitt lymphoma	NATURE GENETICS			English	Article							C-MYC ONCOGENE; SOMATIC MUTATIONS; GENOME; CANCER; EXPRESSION; AMPLIFICATION; FREQUENT; REVEALS	Burkitt lymphoma is characterized by deregulation of MYC, but the contribution of other genetic mutations to the disease is largely unknown. Here, we describe the first completely sequenced genome from a Burkitt lymphoma tumor and germline DNA from the same affected individual. We further sequenced the exomes of 59 Burkitt lymphoma tumors and compared them to sequenced exomes from 94 diffuse large B-cell lymphoma (DLBCL) tumors. We identified 70 genes that were recurrently mutated in Burkitt lymphomas, including ID3, GNA13, RET, PIK3R1 and the SWI/SNF genes ARID1A and SMARCA4. Our data implicate a number of genes in cancer for the first time, including CCT6B, SALL3, FTCD and PC. ID3 mutations occurred in 34% of Burkitt lymphomas and not in DLBCLs. We show experimentally that ID3 mutations promote cell cycle progression and proliferation. Our work thus elucidates commonly occurring gene-coding mutations in Burkitt lymphoma and implicates ID3 as a new tumor suppressor gene.	[Love, Cassandra; Sun, Zhen; Jima, Dereje; Li, Guojie; Zhang, Jenny; Greenough, Adrienne; Moffitt, Andrea B.; McKinney, Matthew; Grubor, Vladimir; Dave, Sandeep S.] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA; [Miles, Rodney] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Richards, Kristy L.; Dunphy, Cherie H.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Choi, William W. L.; Srivastava, Gopesh] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lugar, Patricia L.; Rizzieri, David A.; Lagoo, Anand S.; McKinney, Matthew; Dave, Sandeep S.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Lugar, Patricia L.; Rizzieri, David A.; Lagoo, Anand S.; McKinney, Matthew; Dave, Sandeep S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Bernal-Mizrachi, Leon; Mann, Karen P.; Flowers, Christopher R.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Naresh, Kikkeri N.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Evens, Andrew M.] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; [Chadburn, Amy; Gordon, Leo I.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Czader, Magdalena B.] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA; [Gill, Javed I.] Baylor Univ, Med Ctr, Dept Hematol, Dallas, TX USA; [Hsi, Eric D.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Banerjee, Anjishnu; Dunson, David B.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Levy, Shawn] Hudson Alpha Inst Biotechnol, Huntsville, AL USA	Duke University; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; University of Hong Kong; Duke University; Duke University; Emory University; Imperial College London; University of Massachusetts System; University of Massachusetts Worcester; Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Baylor University; Baylor University Medical Center; Cleveland Clinic Foundation; Duke University	Dave, SS (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA.	sandeep.dave@duke.edu	Zhang, Jenny/GXV-4980-2022; Flowers, Christopher R/F-1953-2010	Flowers, Christopher R/0000-0002-9524-3990; Nugent, Adrienne/0000-0002-1818-2098; Gordon, Leo/0000-0003-1666-7064; Levy, Shawn/0000-0002-1369-5740; Jima, Dereje/0000-0002-7784-1612; Moffitt, Andrea/0000-0001-5964-7851; Naresh, Kikkeri N/0000-0003-3807-3638; Evens, Andrew/0000-0002-6900-1824	Hertz Foundation; National Cancer Institute [R21CA1561686, R01CA136895]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA136895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	Hertz Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Sunay and the Georgia Cancer Coalition for support in sample collection. A.B.M. was supported by the Hertz Foundation. This work was supported through grants R21CA1561686 and R01CA136895 from the National Cancer Institute (S.S.D.). S.S.D. was also supported by the American Cancer Society. We gratefully acknowledge the generous support of C. Stiefel and D. Stiefel.	Augenlicht LH, 1997, CANCER RES, V57, P1769; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; MUNZEL P, 1991, J CANCER RES CLIN, V117, P603, DOI 10.1007/BF01613296; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Schiffman JD, 2011, BRIT J HAEMATOL, V155, P477, DOI 10.1111/j.1365-2141.2011.08883.x; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow SH., 2017, WHO CLASSIFICATION T; Wang ZR, 1999, EXP MOL PATHOL, V66, P140, DOI 10.1006/exmp.1999.2259; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	26	394	405	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1321	1325		10.1038/ng.2468	http://dx.doi.org/10.1038/ng.2468			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143597	Green Accepted, Green Submitted			2022-12-17	WOS:000311713200009
J	Chambers, JC; Zhang, WH; Sehmi, J; Li, XZ; Wass, MN; Van der Harst, P; Holm, H; Sanna, S; Kavousi, M; Baumeister, SE; Coin, LJ; Deng, GH; Gieger, C; Heard-Costa, NL; Hottenga, JJ; Kuhnel, B; Kumar, V; Lagou, V; Liang, LM; Luan, JA; Vidal, PM; Leach, IM; O'Reilly, PF; Peden, JF; Rahmioglu, N; Soininen, P; Speliotes, EK; Yuan, X; Thorleifsson, G; Alizadeh, BZ; Atwood, LD; Borecki, IB; Brown, MJ; Charoen, P; Cucca, F; Das, D; de Geus, EJC; Dixon, AL; Doering, A; Ehret, G; Eyjolfsson, GI; Farrall, M; Forouhi, NG; Friedrich, N; Goessling, W; Gudbjartsson, DF; Harris, TB; Hartikainen, AL; Heath, S; Hirschfield, GM; Hofman, A; Homuth, G; Hypponen, E; Janssen, HLA; Johnson, T; Kangas, AJ; Kema, IP; Kuhn, JP; Lai, S; Lathrop, M; Lerch, MM; Li, Y; Liang, TJ; Lin, JP; Loos, RJF; Martin, NG; Moffatt, MF; Montgomery, GW; Munroe, PB; Musunuru, K; Nakamura, Y; O'Donnell, CJ; Olafsson, I; Penninx, BW; Pouta, A; Prins, BP; Prokopenko, I; Puls, R; Ruokonen, A; Savolainen, MJ; Schlessinger, D; Schouten, JNL; Seedorf, U; Sen-Chowdhry, S; Siminovitch, KA; Smit, JH; Spector, TD; Tan, WT; Teslovich, TM; Tukiainen, T; Uitterlinden, AG; Van der Klauw, MM; Vasan, RS; Wallace, C; Wallaschofski, H; Wichmann, HE; Willemsen, G; Wurtz, P; Xu, C; Yerges-Armstrong, LM; Abecasis, GR; Ahmadi, KR; Boomsma, DI; Caulfield, M; Cookson, WO; van Duijn, CM; Froguel, P; Matsuda, K; McCarthy, MI; Meisinger, C; Mooser, V; Pietilainen, KH; Schumann, G; Snieder, H; Sternberg, MJE; Stolk, RP; Thomas, HC; Thorsteinsdottir, U; Uda, M; Waeber, G; Wareham, NJ; Waterworth, DM; Watkins, H; Whitfield, JB; Witteman, JCM; Wolffenbuttel, BHR; Fox, CS; Ala-Korpela, M; Stefansson, K; Vollenweider, P; Volzke, H; Schadt, EE; Scott, J; Jarvelin, MR; Elliott, P; Kooner, JS				Chambers, John C.; Zhang, Weihua; Sehmi, Joban; Li, Xinzhong; Wass, Mark N.; Van der Harst, Pim; Holm, Hilma; Sanna, Serena; Kavousi, Maryam; Baumeister, Sebastian E.; Coin, Lachlan J.; Deng, Guohong; Gieger, Christian; Heard-Costa, Nancy L.; Hottenga, Jouke-Jan; Kuehnel, Brigitte; Kumar, Vinod; Lagou, Vasiliki; Liang, Liming; Luan, Jian'an; Vidal, Pedro Marques; Leach, Irene Mateo; O'Reilly, Paul F.; Peden, John F.; Rahmioglu, Nilufer; Soininen, Pasi; Speliotes, Elizabeth K.; Yuan, Xin; Thorleifsson, Gudmar; Alizadeh, Behrooz Z.; Atwood, Larry D.; Borecki, Ingrid B.; Brown, Morris J.; Charoen, Pimphen; Cucca, Francesco; Das, Debashish; de Geus, Eco J. C.; Dixon, Anna L.; Doering, Angela; Ehret, Georg; Eyjolfsson, Gudmundur I.; Farrall, Martin; Forouhi, Nita G.; Friedrich, Nele; Goessling, Wolfram; Gudbjartsson, Daniel F.; Harris, Tamara B.; Hartikainen, Anna-Liisa; Heath, Simon; Hirschfield, Gideon M.; Hofman, Albert; Homuth, Georg; Hyppoenen, Elina; Janssen, Harry L. A.; Johnson, Toby; Kangas, Antti J.; Kema, Ido P.; Kuehn, Jens P.; Lai, Sandra; Lathrop, Mark; Lerch, Markus M.; Li, Yun; Liang, T. Jake; Lin, Jing-Ping; Loos, Ruth J. F.; Martin, Nicholas G.; Moffatt, Miriam F.; Montgomery, Grant W.; Munroe, Patricia B.; Musunuru, Kiran; Nakamura, Yusuke; O'Donnell, Christopher J.; Olafsson, Isleifur; Penninx, Brenda W.; Pouta, Anneli; Prins, Bram P.; Prokopenko, Inga; Puls, Ralf; Ruokonen, Aimo; Savolainen, Markku J.; Schlessinger, David; Schouten, Jeoffrey N. L.; Seedorf, Udo; Sen-Chowdhry, Srijita; Siminovitch, Katherine A.; Smit, Johannes H.; Spector, Timothy D.; Tan, Wenting; Teslovich, Tanya M.; Tukiainen, Taru; Uitterlinden, Andre G.; Van der Klauw, Melanie M.; Vasan, Ramachandran S.; Wallace, Chris; Wallaschofski, Henri; Wichmann, H-Erich; Willemsen, Gonneke; Wuertz, Peter; Xu, Chun; Yerges-Armstrong, Laura M.; Abecasis, Goncalo R.; Ahmadi, Kourosh R.; Boomsma, Dorret I.; Caulfield, Mark; Cookson, William O.; van Duijn, Cornelia M.; Froguel, Philippe; Matsuda, Koichi; McCarthy, Mark I.; Meisinger, Christa; Mooser, Vincent; Pietilainen, Kirsi H.; Schumann, Gunter; Snieder, Harold; Sternberg, Michael J. E.; Stolk, Ronald P.; Thomas, Howard C.; Thorsteinsdottir, Unnur; Uda, Manuela; Waeber, Gerard; Wareham, Nicholas J.; Waterworth, Dawn M.; Watkins, Hugh; Whitfield, John B.; Witteman, Jacqueline C. M.; Wolffenbuttel, Bruce H. R.; Fox, Caroline S.; Ala-Korpela, Mika; Stefansson, Kari; Vollenweider, Peter; Voelzke, Henry; Schadt, Eric E.; Scott, James; Jarvelin, Marjo-Riitta; Elliott, Paul; Kooner, Jaspal S.		Alcohol Genome-wide Assoc AlcGen; Diabet Genetics Replication; Genetic Invest Anthropometric; Global Lipids Genetics Consortium; Genetics Liver Dis GOLD Consortium; Int Consortium Blood Pressure ICBP; Meta-Anal Glucose Insulin-Related	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma	NATURE GENETICS			English	Article							C-REACTIVE PROTEIN; SALT EXPORT PUMP; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; SUSCEPTIBILITY LOCI; METABOLIC SYNDROME; GENETIC-VARIANTS; TYPE-2; TWIN; DISEASE	Concentrations of liver enzymes in plasma are widely used as indicators of liver disease. We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci associated with concentrations of liver enzymes in plasma, of which 32 are new associations (P = 10(-8) to P = 10(-190)). We used functional genomic approaches including metabonomic profiling and gene expression analyses to identify probable candidate genes at these regions. We identified 69 candidate genes, including genes involved in biliary transport (ATP8B1 and ABCB11), glucose, carbohydrate and lipid metabolism (FADS1, FADS2, GCKR, JMJD1C, HNF1A, MLXIPL, PNPLA3, PPP1R3B, SLC2A2 and TRIB1), glycoprotein biosynthesis and cell surface glycobiology (ABO, ASGR1, FUT2, GPLD1 and ST3GAL4), inflammation and immunity (CD276, CDH6, GCKR, HNF1A, HPR, ITGA1, RORA and STAT4) and glutathione metabolism (GSTT1, GSTT2 and GGT), as well as several genes of uncertain or unknown function (including ABHD12, EFHD1, EFNA1, EPHA2, MICAL3 and ZNF827). Our results provide new insight into genetic mechanisms and pathways influencing markers of liver function.	[Chambers, John C.; Zhang, Weihua; Coin, Lachlan J.; O'Reilly, Paul F.; Charoen, Pimphen; Sen-Chowdhry, Srijita; Tukiainen, Taru; Wuertz, Peter; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, London, England; [Chambers, John C.; Thomas, Howard C.; Kooner, Jaspal S.] Imperial Coll Healthcare Natl Hlth Serv NHS Trust, London, England; [Chambers, John C.; Zhang, Weihua; Sehmi, Joban; Das, Debashish; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Middlesex, England; [Sehmi, Joban; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Li, Xinzhong] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Inst Clin Sci, London, England; [Wass, Mark N.; Sternberg, Michael J. E.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Struct Bioinformat Grp, London, England; [Van der Harst, Pim; Leach, Irene Mateo] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 AB Groningen, Netherlands; [Holm, Hilma; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Sanna, Serena; Cucca, Francesco; Lai, Sandra; Uda, Manuela] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Kavousi, Maryam; Hofman, Albert; Janssen, Harry L. A.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Kavousi, Maryam; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Netherlands Genom Initiat, Rotterdam, Netherlands; [Baumeister, Sebastian E.; Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Deng, Guohong; Tan, Wenting] Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing, Peoples R China; [Gieger, Christian; Kuehnel, Brigitte] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Heard-Costa, Nancy L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hottenga, Jouke-Jan; de Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] VU Univ Amsterdam VUA, Dept Biol Psychol, Amsterdam, Netherlands; [Kumar, Vinod; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan; [Lagou, Vasiliki; Alizadeh, Behrooz Z.; Prins, Bram P.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Lagou, Vasiliki; Rahmioglu, Nilufer; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lagou, Vasiliki; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Luan, Jian'an; Forouhi, Nita G.; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Vidal, Pedro Marques] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Vidal, Pedro Marques; Ehret, Georg] Univ Lausanne, Lausanne, Switzerland; [Peden, John F.; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; [Soininen, Pasi; Kangas, Antti J.; Savolainen, Markku J.; Tukiainen, Taru; Wuertz, Peter; Ala-Korpela, Mika] Univ Oulu, Inst Clin Med, Computat Med Res Grp, Oulu, Finland; [Soininen, Pasi; Kangas, Antti J.; Savolainen, Markku J.; Tukiainen, Taru; Wuertz, Peter; Ala-Korpela, Mika] Univ Oulu, Bioctr, Oulu, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Dept Biosci, Nucl Magnet Resonance NMR Metabon Lab, Kuopio, Finland; [Speliotes, Elizabeth K.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Speliotes, Elizabeth K.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Yuan, Xin; Mooser, Vincent; Waterworth, Dawn M.] GlaxoSmithKline, Genet, King Of Prussia, PA USA; [Atwood, Larry D.; Musunuru, Kiran] Boston Univ, Sch Med, Boston, MA 02118 USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Brown, Morris J.; Wallace, Chris] Univ Cambridge, Cambridge Inst Med Res, Diabet Inflammat Lab, Cambridge, England; [Charoen, Pimphen] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [de Geus, Eco J. C.] VUA, Amsterdam, Netherlands; [de Geus, Eco J. C.] VUA Med Ctr, Amsterdam, Netherlands; [Dixon, Anna L.; Moffatt, Miriam F.; Cookson, William O.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Doering, Angela; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Ehret, Georg] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Ehret, Georg] CHU Vaudois, IUMSP, CH-1011 Lausanne, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Dept Med, Geneva, Switzerland; [Eyjolfsson, Gudmundur I.] Lab Mjodd, Reykjavik, Iceland; [Farrall, Martin; Watkins, Hugh] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Friedrich, Nele; Wallaschofski, Henri] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, D-17487 Greifswald, Germany; [Goessling, Wolfram] Brigham & Womens Hosp, Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Div Genet, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Div Gastroenterol, Gastrointestinal Canc Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Inst Clin Med, Oulu, Finland; [Heath, Simon; Lathrop, Mark] CEA IG Ctr Natl Genotypage, Evry, France; [Hirschfield, Gideon M.; Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hirschfield, Gideon M.] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Hirschfield, Gideon M.] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Hyppoenen, Elina] Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Janssen, Harry L. A.; Schouten, Jeoffrey N. L.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Johnson, Toby; Munroe, Patricia B.; Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Genome Ctr, London, England; [Kema, Ido P.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Kuehn, Jens P.; Puls, Ralf] Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Lathrop, Mark] Fdn Jean Dausset Ceph, Paris, France; [Lerch, Markus M.] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Li, Yun] Univ N Carolina, Dept Biostat, Dept Genet, Chapel Hill, NC USA; [Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD USA; [Lin, Jing-Ping] NHLBI, Off Biostat Res, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John B.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Musunuru, Kiran] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Musunuru, Kiran] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Musunuru, Kiran] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [O'Donnell, Christopher J.; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, Reykjavik, Iceland; [Penninx, Brenda W.; Smit, Johannes H.] VUA Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W.; Smit, Johannes H.] VUA Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, Oulu, Finland; [Savolainen, Markku J.; Ala-Korpela, Mika] Univ Oulu, Clin Res Ctr, Dept Internal Med, Oulu, Finland; [Savolainen, Markku J.; Ala-Korpela, Mika] Univ Oulu, Clin Res Ctr, Bioctr Oulu, Oulu, Finland; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Siminovitch, Katherine A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Siminovitch, Katherine A.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Siminovitch, Katherine A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada; [Spector, Timothy D.; Ahmadi, Kourosh R.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Teslovich, Tanya M.; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Van der Klauw, Melanie M.; Sternberg, Michael J. E.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, Groningen, Netherlands; [Van der Klauw, Melanie M.; Sternberg, Michael J. E.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Biobank, Groningen, Netherlands; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Willemsen, Gonneke; Boomsma, Dorret I.] VUA Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Xu, Chun] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Xu, Chun] Toronto Gen Res Inst, Toronto, ON, Canada; [Yerges-Armstrong, Laura M.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [van Duijn, Cornelia M.] Ctr Med Syst Biol, Rotterdam, Netherlands; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, London, England; [McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res, Oxford OX3 7LJ, England; [Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Pietilainen, Kirsi H.] Helsinki Univ Hosp, Div Internal Med, Dept Med, Obes Res Unit, Helsinki, Finland; [Pietilainen, Kirsi H.] Inst Mol Med FIMM, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Schumann, Gunter] Kings Coll London, Inst Psychiat, MRC Social Genet Dev Psychiat SGDP Ctr, London WC2R 2LS, England; [Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Thomas, Howard C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol Hypertens & Metab, Boston, MA 02115 USA; [Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC, HPA, Ctr Environm Hlth, London, England	Imperial College London; Imperial College London; Imperial College London; Royal Brompton Hospital; Imperial College London; University of Groningen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Erasmus University Rotterdam; Erasmus MC; Ernst Moritz Arndt Universitat Greifswald; Army Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Boston University; University of Tokyo; University of Groningen; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Oxford; Wellcome Centre for Human Genetics; University of Oulu; University of Oulu; University of Eastern Finland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; GlaxoSmithKline; Boston University; Washington University (WUSTL); University of Cambridge; Mahidol University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Oxford; Ernst Moritz Arndt Universitat Greifswald; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oulu; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Birmingham; Ernst Moritz Arndt Universitat Greifswald; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; University of London; Queen Mary University London; University of Groningen; Ernst Moritz Arndt Universitat Greifswald; Foundation Jean Dausset-CEPH; Greifswald Medical School; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Landspitali National University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Munster; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of London; King's College London; University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; University of Groningen; Boston University; Boston University; University of Munich; University of Munich; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University System of Maryland; University of Maryland Baltimore; Imperial College London; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of London; King's College London; University of Groningen; Imperial College London; University of Iceland; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai; University of Oulu; Health Protection Agency; Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Norfolk Pl, London, England.	john.chambers@ic.ac.uk; p.elliott@ic.ac.uk; j.kooner@ic.ac.uk	Charchar, Fadi/I-6656-2017; Lerch, Markus M./E-2206-2016; Langenberg, Claudia/ABG-9067-2021; Laan, Maris/A-4100-2011; Wolffenbuttel, Bruce/A-8419-2011; Zgaga, Lina/Q-9415-2018; Hide, Winston/R-3815-2019; Prabhakaran, Dorairaj/B-4147-2011; Meisinger, Christine/B-5358-2014; Lucas, Gavin/D-4346-2012; Singleton, Andrew B/C-3010-2009; van Dijk, Ko Willems/A-1798-2008; Erdmann, Jeanette/P-7513-2014; Prokopenko, Inga/AAU-9895-2020; Kaprio, Jaakko/A-1820-2008; Zhu, Xiaofeng/O-6874-2019; Penninx, Brenda WJH/S-7627-2017; Elliott, Amanda/G-5120-2012; Tzoulaki, Ioanna/ABE-6269-2020; Beckmann, Jacques S/A-9772-2008; Lai, Sandra/AAY-4176-2020; Naitza, Silvia/D-5620-2017; Polasek, Ozren/B-6002-2011; Alizadeh, Behrooz Z Ziad/J-2921-2017; Siminovitch, Katherine/K-1475-2013; Visvikis-Siest, Sophie/H-2324-2014; Baumeister, Sebastian-Edgar/P-7894-2019; Boomsma, Dorret I/AAX-4470-2020; Mukherjee, Sutapa/U-7262-2017; Schumann, Gunter/H-1013-2013; Coin, Lachlan/O-4976-2019; Palmer, Lyle John/K-3196-2014; Wass, Mark/H-3398-2019; Staessen, Jan A/A-1065-2011; Hernaez, Ruben/C-4039-2014; Martin, Nicholas/R-9235-2019; Hirschfield, Gideon M/M-2143-2015; Gudnason, Vilmundur/K-6885-2015; Stolk, Ronald P/B-2341-2013; Knowles, Josh w/C-9241-2013; zhang, weihua/GXV-1334-2022; Marmot, M G/Y-3920-2019; Liu, Jianjun/AAK-4989-2020; Kiemeney, Lambertus A./D-3357-2009; Kumar, Vinod/ABC-4866-2020; Coin, Lachlan JM/A-9001-2014; Lagou, Vasiliki/N-8451-2013; Loos, Ruth J F/Q-2862-2016; Ripatti, Samuli/H-9446-2014; Cookson, William/HHC-1790-2022; Stefansson, Kari/AAE-7187-2019; Meitinger, Thomas/O-1318-2015; Boehringer, Stefan/Y-2442-2018; Marroni, Fabio/R-1819-2017; Ramachandran, Vasan/Y-2527-2019; Bochud, Murielle/A-3981-2010; Brunner, Eric/H-2114-2011; Kuznetsova, Tatiana/I-6882-2013; Pattou, Francois/O-6151-2017; Kanoni, Stavroula/AAN-7161-2021; Lee, Jong-Young/M-6319-2013; Crisponi, Laura/AAC-2642-2019; Kronenberg, Florian/B-1736-2008; Clark, Jeanne/AGG-8199-2022; Visscher, Peter/ABB-6151-2020; Kyvik, Kirsten O/K-5680-2016; Ahmadi, Kourosh R/B-6379-2012; Prokopenko, Inga/H-3241-2014; Heath, Simon C/J-4138-2012; Erdmann, Jeanette/A-4417-2009; MASSON, David/R-4557-2017; Wichmann, Heinz Erich/AAA-5695-2022; Ejebe, Kenechi/I-9238-2016; rahmioglu, nilufer/AAO-5653-2020; MASSON, David/AAC-8896-2022; Li, Man/AAX-3400-2020; Montgomery, Grant W/B-7148-2008; van der Klauw, M. M./A-2138-2014; Kavousi, Maryam/F-1174-2018; Gaunt, Tom R/O-3918-2014; Dominiczak, Anna F/P-9390-2017; EHRET, Georg B/A-9532-2009; Onland-Moret, N. Charlotte/G-9185-2011; de Geus, Eco J.C./M-9318-2015; Ridderstråle, Martin/F-7678-2012; Uda, Manuela/AAC-2645-2019; Matullo, Giuseppe/K-6383-2016; Feitosa, Mary F/K-8044-2012; FROGUEL, Philippe/O-6799-2017; Rudan, Igor/I-1467-2012; Bonnefond, Amélie/O-2784-2017; Hide, Winston A/V-2727-2017; Hide, Winston Hide/C-7217-2009; Benediktsson, Rafn/R-2457-2018; Loos, Ruth/GON-5877-2022; Aben, Katja KH/G-9686-2016; Palmer, Lyle John/N-1948-2019; Grobbee, Diederick/C-7651-2014; Hypponen, Elina/B-2596-2014; Raso, Francesco Mattace-/L-2541-2015; Walters, G. Bragi/L-4215-2013; Arora, Pankaj/F-3437-2011; Colaus, PsyColaus/K-6607-2013; sanna, serena/H-3009-2019; Soininen, Pasi/B-9716-2008; BOUATIA-NAJI, NABILA/D-5863-2013; Boehm, Bernhard Otto/F-8750-2015; Aspelund, Thor/C-5983-2008; Nyholt, Dale/J-3174-2017; Luben, Robert/H-5519-2015; Carr, John/A-1938-2012; FAVA, Cristiano/K-9590-2015; Marques-Vidal, Pedro/C-9449-2009; Smith, Albert Vernon/K-5150-2015; Grarup, Niels/K-2807-2015; Aulchenko, Yurii/M-8270-2013; Doney, Alexander/P-7437-2017; Matsuda, Koichi/D-4597-2011; Soler Artigas, Maria/L-6529-2013; McCarthy, Mark/M-3763-2015; Okamura, Tomonori/L-1693-2013	Charchar, Fadi/0000-0002-6164-9941; Lerch, Markus M./0000-0002-9643-8263; Langenberg, Claudia/0000-0002-5017-7344; Laan, Maris/0000-0002-8519-243X; Wolffenbuttel, Bruce/0000-0001-9262-6921; Zgaga, Lina/0000-0003-4089-9703; Hide, Winston/0000-0002-8621-3271; Prabhakaran, Dorairaj/0000-0002-3172-834X; van Dijk, Ko Willems/0000-0002-2172-7394; Erdmann, Jeanette/0000-0002-4486-6231; Kaprio, Jaakko/0000-0002-3716-2455; Penninx, Brenda WJH/0000-0001-7779-9672; Tzoulaki, Ioanna/0000-0002-4275-9328; Beckmann, Jacques S/0000-0002-9741-1900; Polasek, Ozren/0000-0002-5765-1862; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Visvikis-Siest, Sophie/0000-0001-8104-8425; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Mukherjee, Sutapa/0000-0001-5021-1648; Coin, Lachlan/0000-0002-4300-455X; Palmer, Lyle John/0000-0002-1628-3055; Wass, Mark/0000-0001-5428-6479; Staessen, Jan A/0000-0002-3026-1637; Hernaez, Ruben/0000-0002-1518-4020; Martin, Nicholas/0000-0003-4069-8020; Hirschfield, Gideon M/0000-0002-6736-2255; Gudnason, Vilmundur/0000-0001-5696-0084; Stolk, Ronald P/0000-0002-0518-1205; Marmot, M G/0000-0002-2431-6419; Liu, Jianjun/0000-0002-3255-3019; Kiemeney, Lambertus A./0000-0002-2368-1326; Kumar, Vinod/0000-0002-2775-6049; Coin, Lachlan JM/0000-0002-4300-455X; Loos, Ruth J F/0000-0002-8532-5087; Ripatti, Samuli/0000-0002-0504-1202; Boehringer, Stefan/0000-0001-9108-9212; Marroni, Fabio/0000-0002-1556-5907; Ramachandran, Vasan/0000-0001-7357-5970; Bochud, Murielle/0000-0002-5727-0218; Brunner, Eric/0000-0002-0595-4474; Kuznetsova, Tatiana/0000-0003-3564-7405; Pattou, Francois/0000-0001-8388-3766; Kanoni, Stavroula/0000-0002-1691-9615; Lee, Jong-Young/0000-0002-0092-9958; Crisponi, Laura/0000-0001-9128-8537; Kronenberg, Florian/0000-0003-2229-1120; Clark, Jeanne/0000-0003-1194-0092; Visscher, Peter/0000-0002-2143-8760; Kyvik, Kirsten O/0000-0003-2981-0245; Prokopenko, Inga/0000-0003-1624-7457; Heath, Simon C/0000-0002-9550-0897; MASSON, David/0000-0003-1692-0699; Ejebe, Kenechi/0000-0002-6090-8657; MASSON, David/0000-0003-1692-0699; Li, Man/0000-0002-3839-0281; Montgomery, Grant W/0000-0002-4140-8139; van der Klauw, M. M./0000-0001-7178-009X; Kavousi, Maryam/0000-0001-5976-6519; Gaunt, Tom R/0000-0003-0924-3247; Dominiczak, Anna F/0000-0003-4913-3608; EHRET, Georg B/0000-0002-5730-0675; Onland-Moret, N. Charlotte/0000-0002-2360-913X; de Geus, Eco J.C./0000-0001-6022-2666; Uda, Manuela/0000-0002-4890-6456; Matullo, Giuseppe/0000-0003-0674-7757; Feitosa, Mary F/0000-0002-0933-2410; FROGUEL, Philippe/0000-0003-2972-0784; Rudan, Igor/0000-0001-6993-6884; Bonnefond, Amélie/0000-0001-9976-3005; Hide, Winston A/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Benediktsson, Rafn/0000-0002-2954-9801; Aben, Katja KH/0000-0002-0214-2147; Palmer, Lyle John/0000-0002-1628-3055; Grobbee, Diederick/0000-0003-4472-4468; Hypponen, Elina/0000-0003-3670-9399; Walters, G. Bragi/0000-0002-5415-6487; Arora, Pankaj/0000-0003-2420-3550; sanna, serena/0000-0002-3768-1749; Eyheramendy, Susana/0000-0003-4723-9660; Kangas, Antti/0000-0001-7492-1732; Chandak, Giriraj Ratan/0000-0002-3095-9453; Hattersley, Andrew/0000-0001-5620-473X; Dina, Christian/0000-0002-7722-7348; Weedon, Michael/0000-0002-6174-6135; Dorr, Marcus/0000-0001-7471-475X; Ikram, Mohammad Arfan/0000-0003-0372-8585; Schmidt, Carsten Oliver/0000-0001-5266-9396; Aspelund, Thor/0000-0002-7998-5433; Kumari, Meena/0000-0001-9716-1035; SCUTERI, ANGELO/0000-0003-4784-5441; Aihie Sayer, Avan/0000-0003-1283-6457; Elliott, Paul/0000-0002-7511-5684; Demirkan, Ayse/0000-0002-7546-0867; Tai, E Shyong/0000-0003-2929-8966; Nyholt, Dale/0000-0001-7159-3040; Forouhi, Nita/0000-0002-5041-248X; Luben, Robert/0000-0002-5088-6343; Carr, John/0000-0002-4398-8237; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Pramstaller, Peter P/0000-0002-9831-8302; Frayling, Timothy/0000-0001-8362-2603; Emilsson, Valur/0000-0001-9982-0524; Lakatta, Edward/0000-0002-4772-0035; Ohlsson, Claes/0000-0002-9633-2805; Seedorf, Udo/0000-0003-4652-5358; Magi, Reedik/0000-0002-2964-6011; Lindgren, Cecilia/0000-0002-4903-9374; Meisinger, Christa/0000-0002-9026-6544; Terzic, Janos/0000-0003-3228-2076; Preuss, Michael/0000-0001-5266-8465; Tomaszewski, Maciej/0000-0001-8215-6567; Org, Elin/0000-0001-8688-9717; Sternberg, Michael/0000-0002-1884-5445; Prins, Bram/0000-0001-5774-034X; Whincup, Peter/0000-0002-5589-4107; FAVA, Cristiano/0000-0002-8910-7378; Boekholdt, Matthijs/0000-0002-0861-0765; Adeyemo, Adebowale/0000-0002-3105-3231; Thelle, Dag Steinar/0000-0002-4417-5967; Melander, Olle/0000-0002-2581-484X; Shriner, Daniel/0000-0003-1928-5520; Kivimaki, Mika/0000-0002-4699-5627; Wain, Louise/0000-0003-4951-1867; Voight, Benjamin/0000-0002-6205-9994; Pirruccello, James/0000-0001-6088-4037; Willemsen, Gonneke/0000-0003-3755-0236; Citterio, Lorena/0000-0001-6455-2291; Jorgensen, Torben/0000-0001-9453-2830; Ala-Korpela, Mika/0000-0001-5905-1206; Goessling, Wolfram/0000-0001-9972-1569; Raychaudhuri, Soumya/0000-0002-1901-8265; Lawlor, Debbie A/0000-0002-6793-2262; Gudbjartsson, Daniel/0000-0002-5222-9857; Kovacs, Peter/0000-0002-0290-5423; Ongen, Halit/0000-0002-4197-5790; Wurtz, Peter/0000-0002-5832-0221; Wallace, Chris/0000-0001-9755-1703; Hui, Jennie/0000-0002-1653-2496; O'Reilly, Paul/0000-0001-7515-0845; Marques-Vidal, Pedro/0000-0002-4548-8500; CUCCA, Francesco/0000-0002-7414-1995; Volker, Uwe/0000-0002-5689-3448; Viigimaa, Margus/0000-0001-5575-5978; Humphries, Stephen E/0000-0002-8221-6547; RAHMIOGLU, NILUFER/0000-0002-5169-8571; Org, Elin/0000-0003-1451-9375; Abecasis, Goncalo/0000-0003-1509-1825; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Meitinger, Thomas/0000-0002-8838-8403; Caulfield, Mark/0000-0001-9295-3594; Smith, Albert Vernon/0000-0003-1942-5845; Ouwehand, Willem/0000-0002-7744-1790; Gieger, Christian/0000-0001-6986-9554; Bergman, Richard/0000-0003-1539-4471; Zhu, Xiaofeng/0000-0003-0037-411X; Grarup, Niels/0000-0001-5526-1070; Aulchenko, Yurii/0000-0002-7899-1575; Lagou, Vasiliki/0000-0003-3165-8940; Watkins, Hugh/0000-0002-5287-9016; Gloyn, Anna/0000-0003-1205-1844; Munroe, Patricia/0000-0002-4176-2947; Taylor, Andrew/0000-0003-4194-7113; Kraft, Peter/0000-0002-4472-8103; Lucas, Gavin/0000-0003-4166-9416; Stumvoll, Michael/0000-0001-6225-8240; ELOSUA, ROBERTO/0000-0001-8235-0095; Wang, Thomas/0000-0003-4063-6508; Glazer, Nicole/0000-0002-6397-609X; Sim, Xueling/0000-0002-1233-7642; Van Duijn, Cornelia/0000-0002-2374-9204; Pietilainen, Kirsi/0000-0002-8522-1288; Hillman, David/0000-0001-9987-539X; Zeggini, Eleftheria/0000-0003-4238-659X; Heard-Costa, Nancy/0000-0001-9730-0306; Yaluri, Alena/0000-0002-1375-0252; Weyant, Robert/0000-0002-5252-9120; Chen, Ming-Huei/0000-0003-3551-8726; Rivolta, Carlo/0000-0002-0733-9950; Waeber, Gerard/0000-0003-4193-788X; Beilby, John/0000-0002-4915-2254; Doney, Alexander/0000-0002-6210-5620; Soranzo, Nicole/0000-0003-1095-3852; Whitfield, John/0000-0002-1103-0876; Matsuda, Koichi/0000-0001-7292-2686; Soler Artigas, Maria/0000-0002-3213-1107; Zagato, Laura/0000-0002-0441-2120; Tukiainen, Taru/0000-0002-5404-8398; Seshadri, Sudha/0000-0001-6135-2622; Mattace-Raso, Francesco/0000-0002-1688-6497; McCarthy, Mark/0000-0002-4393-0510; Johnson, Toby/0000-0002-5998-3270; Ricketts, Sally/0000-0002-5644-7958; maschio, andrea/0000-0002-4238-9144; Hopewell, Jemma/0000-0002-3870-8018; Tobin, Martin/0000-0002-3596-7874; Okamura, Tomonori/0000-0003-0488-0351; Ballantyne, Christie/0000-0002-6432-1730	European Commission; European Science Foundation; European Science Council; US NIH; US National Institute of Mental Health; US NIDDK; Genetic Association Information Network; US National Institute on Aging; US National Human Genome Research Institute; US NHLBI; UK NIHR; NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' NHS Trust; UK Biotechnology and Biological Sciences Research Council; UK MRC; British Heart Foundation; Wellcome Trust; Swiss National Science Foundation; Academy of Finland; Finnish Cardiovascular Research Foundation; Swedish Research Council; Swedish Heart-Lung Foundation; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education and Research; German National Genome Research Network; Netherlands Organization for Scientific Research; Dutch Ministries of Economic Affairs, of Education, Culture and Science, for Health, Welfare and Sports; Netherlands Organization for Health Research and Development; Dutch government; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Dutch Brain Foundation; Dutch Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative; Canadian Institutes for Health Research; Ontario Research Fund; Barts and the London Charity; University Medical Center Groningen; University of Groningen; University of Oulu, Biocenter Oulu; University Hospital Oulu; Biocentrum Helsinki; Erasmus Medical Center and Erasmus University, Rotterdam; Karolinska Institutet; Stockholm County Council; Municipality of Rotterdam; Federal State of Mecklenburg-West Pomerania; AstraZeneca; GlaxoSmithKline; Siemens Healthcare; Novo Nordisk Foundation; Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Gyllenberg Foundation; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg Foundation; Boston University School of Medicine; Instrumentarium Science Foundation; Jenny and Antti Wihuri Foundation; Canadian Primary Biliary Cirrhosis Society; MRC [G0902037, MC_UP_A620_1015, G0700342, G0700931, MC_PC_U127561128, G0601966, G9521010, MC_UP_A100_1003, MC_U127561128, G0601653, G0701863, MC_U106188470] Funding Source: UKRI; British Heart Foundation [PG/09/002/26056, FS/10/011/27881, PG/09/023/26806, RG/07/008/23674] Funding Source: researchfish; Medical Research Council [U1475000002, G0401527, MC_UP_A100_1003, G0601966, MC_UP_A620_1015, G9521010, G0100222, G0801056B, G0700342, MC_U106188470, MC_U106179471, G0701863, G8802774, G0700931, G0902037, MC_U127561128, G1000143, G19/35, G0601653, G9817803B, MC_PC_U127561128] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014660] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087647, ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG001050, ZIAAG007380, ZIAAG000675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); European Science Council; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US NIDDK; Genetic Association Information Network; US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UK NIHR(National Institute for Health Research (NIHR)); NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' NHS Trust; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland(Academy of Finland); Finnish Cardiovascular Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Ministries of Economic Affairs, of Education, Culture and Science, for Health, Welfare and Sports; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch government; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Dutch Brain Foundation; Dutch Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Barts and the London Charity; University Medical Center Groningen; University of Groningen; University of Oulu, Biocenter Oulu; University Hospital Oulu; Biocentrum Helsinki; Erasmus Medical Center and Erasmus University, Rotterdam; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Municipality of Rotterdam; Federal State of Mecklenburg-West Pomerania; AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Siemens Healthcare(Siemens AG); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Gyllenberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderberg Foundation; Boston University School of Medicine; Instrumentarium Science Foundation; Jenny and Antti Wihuri Foundation; Canadian Primary Biliary Cirrhosis Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank the many colleagues who contributed to collection and phenotypic characterization of the clinical samples, as well as genotyping and analysis of data. We also thank the research participants who took part in these studies. Major support for the work came from European Commission (FP5, FP6 and FP7); European Science Foundation; European Science Council; US NIH; US National Institute of Mental Health; US NIDDK; Genetic Association Information Network; US National Institute on Aging; US National Human Genome Research Institute; US NHLBI; UK NIHR; NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' NHS Trust; UK Biotechnology and Biological Sciences Research Council; UK MRC; British Heart Foundation; Wellcome Trust; Swiss National Science Foundation; Academy of Finland; Finnish Cardiovascular Research Foundation; Swedish Research Council; Swedish Heart-Lung Foundation; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education and Research; German National Genome Research Network; Netherlands Organization for Scientific Research; Dutch Ministries of Economic Affairs, of Education, Culture and Science, for Health, Welfare and Sports; Netherlands Organization for Health Research and Development; Economic Structure Enhancing Fund of the Dutch government; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Dutch Brain Foundation; Dutch Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative; Canadian Institutes for Health Research; Ontario Research Fund; The Barts and the London Charity; University Medical Center Groningen; University of Groningen; University of Oulu, Biocenter Oulu; University Hospital Oulu; Biocentrum Helsinki; Erasmus Medical Center and Erasmus University, Rotterdam; Karolinska Institutet; Stockholm County Council; Municipality of Rotterdam; Federal State of Mecklenburg-West Pomerania; AstraZeneca; GlaxoSmithKline; Siemens Healthcare; Novo Nordisk Foundation; Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Gyllenberg Foundation; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg Foundation; Robert Dawson Evans Endowment, Boston University School of Medicine; Instrumentarium Science Foundation; Jenny and Antti Wihuri Foundation and the Canadian Primary Biliary Cirrhosis Society. A full list of acknowledgments is provided in the Supplementary Note.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/twin.9.6.849; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dunn JS, 2006, ANN HUM GENET, V70, P587, DOI 10.1111/j.1469-1809.2005.00248.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171; Iwamori M, 2004, BIOCHEM J, V380, P75, DOI 10.1042/BJ20031668; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kaprio J, 2006, TWIN RES HUM GENET, V9, P772, DOI 10.1375/183242706779462778; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; LeBoeuf RC, 1998, MAMM GENOME, V9, P710, DOI 10.1007/s003359900851; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Nugent C, 2007, NAT CLIN PRACT GASTR, V4, P432, DOI 10.1038/ncpgasthep0879; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Petit JM, 2010, J CLIN ENDOCR METAB, V95, pE430, DOI 10.1210/jc.2010-0814; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rahmioglu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004435; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Van Mil SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/j.gastro.2004.04.065; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Watkins PB, 2005, TOXICOL PATHOL, V33, P1, DOI 10.1080/01926230590888306; Watkinson C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-144; Wolpin BM, 2010, CANCER EPIDEM BIOMAR, V19, P3140, DOI 10.1158/1055-9965.EPI-10-0751; Wurtz P, 2011, MOL BIOSYST, V7, P385, DOI 10.1039/c0mb00066c; XU KC, 1992, AM J GASTROENTEROL, V87, P991; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	72	394	401	0	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1131	1138		10.1038/ng.970	http://dx.doi.org/10.1038/ng.970			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	22001757	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000296584000019
J	Tuupanen, S; Turunen, M; Lehtonen, R; Hallikas, O; Vanharanta, S; Kivioja, T; Bjorklund, M; Wei, GH; Yan, J; Niittymaki, I; Mecklin, JP; Jarvinen, H; Ristimaki, A; Di-Bernardo, M; East, P; Carvajal-Carmona, L; Houlston, RS; Tomlinson, I; Palin, K; Ukkonen, E; Karhu, A; Taipale, J; Aaltonen, LA				Tuupanen, Sari; Turunen, Mikko; Lehtonen, Rainer; Hallikas, Outi; Vanharanta, Sakari; Kivioja, Teemu; Bjorklund, Mikael; Wei, Gonghong; Yan, Jian; Niittymaki, Iina; Mecklin, Jukka-Pekka; Jarvinen, Heikki; Ristimaki, Ari; Di-Bernardo, Mariachiara; East, Phil; Carvajal-Carmona, Luis; Houlston, Richard S.; Tomlinson, Ian; Palin, Kimmo; Ukkonen, Esko; Karhu, Auli; Taipale, Jussi; Aaltonen, Lauri A.			The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BETA-CATENIN; PROSTATE-CANCER; SUSCEPTIBILITY LOCUS; GENETIC-VARIATION; COLON-CANCER; RISK; ELEMENTS; VARIANTS; SCAN	Homozygosity for the G allele of rs6983267 at 8q24 increases colorectal cancer (CRC) risk B1.5 fold. We report here that the risk allele G shows copy number increase during CRC development. Our computer algorithm, Enhancer Element Locator (EEL), identified an enhancer element that contains rs6983267. The element drove expression of a reporter gene in a pattern that is consistent with regulation by the key CRC pathway Wnt. rs6983267 affects a binding site for the Wnt-regulated transcription factor TCF4, with the risk allele G showing stronger binding in vitro and in vivo. Genome-wide ChIP assay revealed the element as the strongest TCF4 binding site within 1 Mb of MYC. An unambiguous correlation between rs6983267 genotype and MYC expression was not detected, and additional work is required to scrutinize all possible targets of the enhancer. Our work provides evidence that the common CRC predisposition associated with 8q24 arises from enhanced responsiveness to Wnt signaling.	[Tuupanen, Sari; Lehtonen, Rainer; Vanharanta, Sakari; Niittymaki, Iina; Karhu, Auli; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Turunen, Mikko; Hallikas, Outi; Kivioja, Teemu; Bjorklund, Mikael; Wei, Gonghong; Yan, Jian; Taipale, Jussi] Univ Helsinki, Inst Biomed, Genome Scale Biol Res Program, Helsinki, Finland; [Kivioja, Teemu; Palin, Kimmo; Ukkonen, Esko] Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland; [Mecklin, Jukka-Pekka] Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; [Jarvinen, Heikki] Univ Helsinki Hosp, Dept Surg 2, Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Ristimaki, Ari] Helsinki Univ Cent Hosp, HUSLAB, Dept Pathol, Helsinki, Finland; [Ristimaki, Ari] Helsinki Univ Cent Hosp, Haartman Inst, Helsinki, Finland; [Ristimaki, Ari] Univ Oulu, Dept Pathol, Oulu, Finland; [Ristimaki, Ari] Oulu Univ Hosp, Oulu, Finland; [Di-Bernardo, Mariachiara; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [East, Phil; Carvajal-Carmona, Luis; Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford, England	University of Helsinki; University of Helsinki; University of Helsinki; Central Finland Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics	Aaltonen, LA (corresponding author), Univ Helsinki, Dept Med Genet, Haartmaninkatu 3, Helsinki, Finland.	jussi.taipale@helsinki.fi; lauri.aaltonen@helsinki.fi	Aaltonen, Lauri/A-5375-2010; Palin, Kimmo/ABG-5710-2020; Yan, Jian/B-2631-2018; Wei, Gonghong/C-6263-2014; Carvajal-Carmona, Luis G/B-3882-2010; Bjorklund, Mikael/AAA-2894-2020; Mecklin, Jukka-Pekka/AAB-5378-2020; Björklund, Mikael/D-3362-2009; Bjørklund, Geir/B-7319-2014; Mecklin, Jukka-Pekka/AAC-9650-2019	Aaltonen, Lauri/0000-0001-6839-4286; Palin, Kimmo/0000-0002-4621-6128; Yan, Jian/0000-0002-1267-2870; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Björklund, Mikael/0000-0002-2176-681X; Bjørklund, Geir/0000-0003-2632-3935; Houlston, Richard/0000-0002-5268-0242; Karhu, Auli/0000-0002-7927-0796; Wei, Gong-Hong/0000-0001-6546-9334; Turunen, Mikko/0000-0001-5134-1559; East, Philip/0000-0001-5801-5713; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Ukkonen, Esko/0000-0002-5978-1505				Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BADIS G, 2009, SCIENCE         0514, DOI DOI 10.1126/SCIENCE.1162327; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gruber SB, 2007, CANCER BIOL THER, V6, P1143, DOI 10.4161/cbt.6.7.4704; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hallikas O, 2006, NAT PROTOC, V1, P215, DOI 10.1038/nprot.2006.33; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Li L, 2008, CANCER EPIDEM BIOMAR, V17, P339, DOI 10.1158/1055-9965.EPI-07-0713; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Miller C, 1998, DEVELOPMENT, V125, P3201; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; SMYTH GK, 2005, BIOINFORMATICS COMPU; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	54	394	407	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					885	U37		10.1038/ng.406	http://dx.doi.org/10.1038/ng.406			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19561604				2022-12-17	WOS:000268432900011
J	Bahlo, M; Booth, DR; Broadley, SA; Brown, MA; Foote, SJ; Griffiths, LR; Kilpatrick, TJ; Lechner-Scott, J; Moscato, P; Perreau, VM; Rubio, JP; Scott, RJ; Stankovich, J; Stewart, GJ; Taylor, BV; Wiley, J; Clarke, G; Cox, MB; Csurhes, PA; Danoy, P; Drysdale, K; Field, J; Foote, SJ; Greer, JM; Griffiths, LR; Hadler, J; McMorran, BJ; Jensen, CJ; Johnson, LJ; McCallum, R; Merriman, M; Merriman, T; Pryce, K; Tajouri, L; Wilkins, EJ; Browning, BL; Browning, SR; Perera, D; Butzkueven, H; Carroll, WM; Chapman, C; Kermode, AG; Marriott, M; Mason, D; Heard, RN; Pender, MP; Slee, M; Tubridy, N; Willoughby, E				Bahlo, Melanie; Booth, David R.; Broadley, Simon A.; Brown, Matthew A.; Foote, Simon J.; Griffiths, Lyn R.; Kilpatrick, Trevor J.; Lechner-Scott, Jeanette; Moscato, Pablo; Perreau, Victoria M.; Rubio, Justin P.; Scott, Rodney J.; Stankovich, Jim; Stewart, Graeme J.; Taylor, Bruce V.; Wiley, James; Clarke, Glynnis; Cox, Mathew B.; Csurhes, Peter A.; Danoy, Patrick; Drysdale, Karen; Field, Judith; Foote, Simon J.; Greer, Judith M.; Guru, Preethi; Hadler, Johanna; McMorran, Brendan J.; Jensen, Cathy J.; Johnson, Laura J.; McCallum, Ruth; Merriman, Marilyn; Merriman, Tony; Pryce, Karen; Tajouri, Lotfi; Wilkins, Ella J.; Browning, Brian L.; Browning, Sharon R.; Perera, Devindri; Butzkueven, Helmut; Carroll, William M.; Chapman, Caron; Kermode, Allan G.; Marriott, Mark; Mason, Deborah; Heard, Robert N.; Pender, Michael P.; Slee, Mark; Tubridy, Niall; Willoughby, Ernest		Australia & New Zealand Multiple S	Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20	NATURE GENETICS			English	Article							RHEUMATOID-ARTHRITIS; DIAGNOSTIC-CRITERIA; CD40; POLYMORPHISM; GUIDELINES; INDUCTION; INFERENCE; ANTIBODY; MODELS; LIGAND	To identify multiple sclerosis (MS) susceptibility loci, we conducted a genome-wide association study (GWAS) in 1,618 cases and used shared data for 3,413 controls. We performed replication in an independent set of 2,256 cases and 2,310 controls, for a total of 3,874 cases and 5,723 controls. We identified risk-associated SNPs on chromosome 12q13-14 (rs703842, P = 5.4 x 10(-11); rs10876994, P = 2.7 x 10(-10); rs12368653, P = 1.0 x 10(-7)) and upstream of CD40 on chromosome 20q13 (rs6074022, P = 1.3 x 10(-7); rs1569723, P = 2.9 x 10(-7)). Both loci are also associated with other autoimmune diseases(1-5). We also replicated several known MS associations (HLA-DR15, P = 7.0 x 10(-184); CD58, P = 9.6 x 10(-8); EVI5-RPL5, P = 2.5 x 10(-6); IL2RA, P = 7.4 x 10(-6); CLEC16A, P = 1.1 x 10(-4); IL7R, P = 1.3 x 10(-3); TYK2, P = 3.5 x 10(-3)) and observed a statistical interaction between SNPs in EVI5-RPL5 and HLA-DR15 (P = 0.001).	[Rubio, Justin P.; Field, Judith; Jensen, Cathy J.; Johnson, Laura J.; Wilkins, Ella J.; Butzkueven, Helmut] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia; [Bahlo, Melanie] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Booth, David R.; Stewart, Graeme J.] Westmead Millenium Inst, Westmead, NSW, Australia; [Broadley, Simon A.] Griffith Univ, Sch Med, Nathan, Qld 4111, Australia; [Brown, Matthew A.; Hadler, Johanna; Pryce, Karen] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Brown, Matthew A.] Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Oxford, England; [Stankovich, Jim; Taylor, Bruce V.; Drysdale, Karen; Foote, Simon J.; Guru, Preethi; McMorran, Brendan J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Griffiths, Lyn R.; Tajouri, Lotfi] Griffith Univ, Genom Res Ctr, Nathan, Qld 4111, Australia; [Kilpatrick, Trevor J.; Perreau, Victoria M.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Kilpatrick, Trevor J.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Lechner-Scott, Jeanette; Scott, Rodney J.] John Hunter Hosp, Hunter New England Hlth Serv, Newcastle, NSW, Australia; [Lechner-Scott, Jeanette; Moscato, Pablo; Cox, Mathew B.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Moscato, Pablo; Scott, Rodney J.; Cox, Mathew B.] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Wiley, James] Nepean Hosp, Dept Med, Penrith, NSW, Australia; [Clarke, Glynnis] Univ Otago, Christchurch Sch Med & Hlth Sci, Christchurch, New Zealand; [Csurhes, Peter A.; Greer, Judith M.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld 4072, Australia; [McCallum, Ruth; Merriman, Marilyn; Merriman, Tony] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Browning, Brian L.; Browning, Sharon R.] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Carroll, William M.; Kermode, Allan G.] Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [Carroll, William M.; Kermode, Allan G.] Australian Neuromuscular Res Inst, Nedlands, WA, Australia; [Chapman, Caron] Barwon Hlth, Geelong, Vic, Australia; [Mason, Deborah] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Pender, Michael P.] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Pender, Michael P.] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Slee, Mark] Flinders Univ S Australia, Dept Neurol, Sch Med, Adelaide, SA 5001, Australia; [Tubridy, Niall] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland; [Willoughby, Ernest] Auckland Dist Hlth Board, Auckland, New Zealand	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Sydney; Westmead Institute for Medical Research; Griffith University; University of Queensland; University of Oxford; University of Tasmania; Menzies Institute for Medical Research; Griffith University; University of Melbourne; Royal Melbourne Hospital; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Nepean Hospital; University of Sydney; University of Otago; University of Queensland; University of Otago; University of Auckland; University of Western Australia; University of Western Australia; University of Queensland; Royal Brisbane & Women's Hospital; Flinders University South Australia; University College Dublin; Saint Vincent's University Hospital; Auckland District Health Board	Rubio, JP (corresponding author), Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia.	justin.rubio@florey.edu.au	Browning, Brian L/A-1178-2010; Perera, Devindri/V-8796-2019; Csurhes, Peter A/F-1510-2010; MOSCATO, PABLO ALBERTO/G-7668-2013; Slee, Mark/J-4731-2015; Browning, Sharon/B-1530-2008; Scott, Rodney J/B-2827-2013; Foote, Simon J/F-2802-2013; Kermode, Allan/G-3568-2019; Pender, Michael P/F-4110-2010; Greer, Judith/C-4945-2009; Brown, Matthew A/E-5749-2010	Browning, Brian L/0000-0001-6454-6633; Csurhes, Peter A/0000-0002-6626-301X; Slee, Mark/0000-0003-4323-2453; Browning, Sharon/0000-0001-7251-9715; Scott, Rodney J/0000-0001-7724-3404; Kermode, Allan/0000-0002-4476-4016; Greer, Judith/0000-0003-4440-4309; Brown, Matthew A/0000-0003-0538-8211; Wiley, James/0000-0001-9421-4154; Stankovich, Jim/0000-0001-9344-7749; Moscato, Pablo/0000-0003-2570-5966; Bahlo, Melanie/0000-0001-5132-0774; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727; Pender, Michael/0000-0003-3792-3768; Foote, Simon/0000-0002-9142-2107; Field, Judith/0000-0002-7089-0999; Merriman, Tony/0000-0003-0844-8726; RUBIO, JUSTIN/0000-0003-3750-917X; Topless, Ruth/0000-0002-9343-8911; Griffiths, Lyn/0000-0002-6774-5475	The National Health and Medical Research Council of Australia (NHMRC); NHMRC Principal Research Fellow; John Hunter Hospital Charitable Trust Fund; Macquarie Bank	The National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Principal Research Fellow(National Health and Medical Research Council (NHMRC) of Australia); John Hunter Hospital Charitable Trust Fund; Macquarie Bank	We thank individuals with MS in Australia and New Zealand for supporting this research. We are grateful to M. Tanner for database management and J. Wright and C. Remediakis from Multiple Sclerosis Research Australia (MSRA) for expediting this research. J. P. R. and M. B. are supported by Career Development Awards from The National Health and Medical Research Council of Australia (NHMRC). M. A. B. is an NHMRC Principal Research Fellow. H. B. is an NHMRC Peter Doherty Postdoctoral Fellow. J. F. is an MSRA Post-doctoral Fellow. M. B. C. is supported by a grant from the John Hunter Hospital Charitable Trust Fund and a special grant from Macquarie Bank. Replication genotyping was conducted at the Murdoch	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; ISHIDA T, 1995, J IMMUNOL, V155, P5527; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Marzo N, 2008, J IMMUNOL, V180, P1189, DOI 10.4049/jimmunol.180.2.1189; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; Sekine C, 2008, J IMMUNOL, V180, P1954, DOI 10.4049/jimmunol.180.3.1954; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8	35	394	403	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					824	U84		10.1038/ng.396	http://dx.doi.org/10.1038/ng.396			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19525955				2022-12-17	WOS:000267786200014
J	Villani, AC; Lemire, M; Fortin, G; Louis, E; Silverberg, MS; Collette, C; Baba, N; Libioulle, C; Belaiche, J; Bitton, A; Gaudet, D; Cohen, A; Langelier, D; Fortin, PR; Wither, JE; Sarfati, M; Rutgeerts, P; Rioux, JD; Vermeire, S; Hudson, TJ; Franchimont, D				Villani, Alexandra-Chloe; Lemire, Mathieu; Fortin, Genevieve; Louis, Edouard; Silverberg, Mark S.; Collette, Catherine; Baba, Nobuyasu; Libioulle, Cecile; Belaiche, Jacques; Bitton, Alain; Gaudet, Daniel; Cohen, Albert; Langelier, Diane; Fortin, Paul R.; Wither, Joan E.; Sarfati, Marika; Rutgeerts, Paul; Rioux, John D.; Vermeire, Severine; Hudson, Thomas J.; Franchimont, Denis			Common variants in the NLRP3 region contribute to Crohn's disease susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; GENE; EXPRESSION; LOCI; ANTAGONIST; DIPEPTIDE; AUTOPHAGY; DISTINCT; MAPS	We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease. The associations were consistently replicated in four sample sets from individuals of European descent. In the combined analysis of all samples (710 father-mother-child trios, 239 cases and 107 controls), these SNPs were strongly associated with risk of Crohn's disease (P-combined = 3.49 x 10(-9), odds ratio 1.78, confidence interval = 1.47-2.16 for rs10733113), reaching a level consistent with the stringent significance thresholds imposed by whole-genome association studies. In addition, we observed significant associations between SNPs in the associated regions and NLRP3 expression and IL-1b production. Mutations in NLRP3 are known to be responsible for three rare autoinflammatory disorders(1,2). These results suggest that the NLRP3 region is also implicated in the susceptibility of more common inflammatory diseases such as Crohn's disease.	[Villani, Alexandra-Chloe] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Villani, Alexandra-Chloe] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Lemire, Mathieu; Hudson, Thomas J.] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Louis, Edouard; Libioulle, Cecile; Belaiche, Jacques] Univ Liege, CHU, Div Gastroenterol, B-4000 Liege, Belgium; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; [Baba, Nobuyasu; Sarfati, Marika] Univ Montreal, CHUM Res Ctr, Immunoregulat Lab, Montreal, PQ H2L 4M1, Canada; [Bitton, Alain] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3A 1A1, Canada; [Gaudet, Daniel] Univ Montreal, Hop Univ Chicoutimi, Ctr Med Genique Communautaire, Chicoutimi, PQ G7H 2B1, Canada; [Cohen, Albert] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Langelier, Diane] CHU Sherbrooke, Hotel Dieu, Sherbrooke, PQ J1G 2E8, Canada; [Fortin, Paul R.; Wither, Joan E.] Toronto Western Hosp, Res Inst, Arthritis Ctr Excellence, Toronto, ON M5T 2S8, Canada; [Fortin, Paul R.; Vermeire, Severine] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Franchimont, Denis] ULB, Erasme Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium	McGill University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Liege; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Universite de Montreal; McGill University; Royal Victoria Hospital; Universite de Montreal; McGill University; Laval University; University of Sherbrooke; University of Toronto; University Toronto Affiliates; University Health Network Toronto; KU Leuven; University Hospital Leuven; Universite de Montreal; Universite de Montreal; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Villani, AC (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Gastroenterol, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	alexandra-chloe.villani@mail.mcgill.ca; Denis.Franchimont@erasme.ulb.ac.be	Silverberg, Mark/B-4183-2008; Baba, Nobuyasu/AAF-8593-2019; Rioux, John D/A-9599-2015	Baba, Nobuyasu/0000-0001-9945-080X; Rioux, John D/0000-0001-7560-8326; Fortin, Paul R./0000-0002-7278-2596; Wither, Joan/0000-0001-5961-9228; Vermeire, Severine/0000-0001-9942-3019	Canada Foundation for Innovation; Canada Research Chair program; McGill University Health Centre; Crohn's & Colitis Foundation of Canada (CCFC); National Institute of Diabetes and Digestive and Kidney Diseases [DK624230]; National Institutes of Allergy and Infectious Diseases [AI065687, AI067152, DK064869, DK062432]; Crohn's and Colitis Foundation of America [SRA512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065687, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869, U01DK062423, U01DK062432] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs); McGill University Health Centre; Crohn's & Colitis Foundation of Canada (CCFC); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the study participants and their families for their collaboration; A. Montpetit and the genotyping and sequencing platforms of the McGill University and Genome Quebec Innovation Centre for their technical assistance; T. McKenzie, G. Bonventi and C. Landolt-Maticorena for their help with acquisition and preparation of the PBCs; F. Martinon and J. Tschopp for their technical assistance in designing the functional studies; and T. Kwan for helpful discussion. This research was supported by grants to D. F. from the Canada Foundation for Innovation, the Canada Research Chair program, the Research Institute of the McGill University Health Centre and the Crohn's & Colitis Foundation of Canada (CCFC). A.- C. V. is supported by a PhD training award from the Fonds de la recherche en sante du Quebec. M. S. S. is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (DK624230), the CCFC and the Mount Sinai Hospital Gale and Graham Wright Research Chair in Digestive Diseases. J. D. R. is funded by grants from the National Institutes of Allergy and Infectious Diseases (AI065687 and AI067152), the National Institute of Diabetes and Digestive and Kidney Diseases (DK064869 and DK062432) and the Crohn's and Colitis Foundation of America (SRA512). E. L. is a senior research associate at the Belgium Foundation for Scientific Research (FNRS). S. V. is a clinical investigator for the Funds for Scientific Research of Flanders. T. J. H. is the recipient of an Investigator Award from the Ontario Institute for Cancer Research through funding from the Government of Ontario's Ministry of Research and Innovation. D. F. is a senior clinical scientist at the Belgium FNRS. None of the funding agencies had any role in the design and conduct of the study; in the collection, analysis and interpretation of the data; or in the preparation, review or approval of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bell PA, 2002, BIOTECHNIQUES, P70; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van den Boom Dirk, 2007, Methods Mol Biol, V366, P287; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8	30	394	400	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					71	76		10.1038/ng.285	http://dx.doi.org/10.1038/ng.285			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19098911	Green Accepted, Green Submitted			2022-12-17	WOS:000262085300018
J	Curtis, ARJ; Fey, C; Morris, CM; Bindoff, LA; Ince, PG; Chinnery, PF; Coulthard, A; Jackson, MJ; Jackson, AP; McHale, DP; Hay, D; Barker, WA; Markham, AF; Bates, D; Curtis, A; Burn, J				Curtis, ARJ; Fey, C; Morris, CM; Bindoff, LA; Ince, PG; Chinnery, PF; Coulthard, A; Jackson, MJ; Jackson, AP; McHale, DP; Hay, D; Barker, WA; Markham, AF; Bates, D; Curtis, A; Burn, J			Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease	NATURE GENETICS			English	Article							NEURODEGENERATIVE DISEASES; HUMAN-H; IRON; MAP; CERULOPLASMIN; METABOLISM; METALS; BRAIN	We describe here a previously unknown, dominantly inherited, late-onset basal ganglia disease, variably presenting with extrapyramidal features similar to those of Huntington's disease (HD) or parkinsonism. We mapped the disorder, by linkage analysis, to 19q13.3, which contains the gene for ferritin light polypeptide (FTL). We found an adenine insertion at position 460-461 that is predicted to alter carboxy-terminal residues of the gene product. Brain histochemistry disclosed abnormal aggregates of ferritin and iron. Low serum ferritin levels also characterized patients. Ferritin, the main iron storage protein, is composed of 24 subunits of two types (heavy, H and light, L) which form a soluble, hollow sphere(1). Brain iron deposition increases normally with age, especially in the basal ganglia, and is a suspected causative factor in several neurodegenerative diseases(2) in which it correlates with visible pathology(3), possibly by its involvement in toxic free-radical reactions(4). We found the same mutation in five apparently unrelated subjects with similar extrapyramidal symptoms. An abnormality in ferritin strongly indicates a primary function for iron in the pathogenesis of this new disease, for which we propose the name 'neuroferritinopathy'.	Inst Human Genet, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Ctr Dev Clin Brain Ageing, Joint MRC, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Hosp NHS Trust, Dept Neurol, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Hosp NHS Trust, Dept Neuropathol, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Hosp NHS Trust, Dept Radiol, Newcastle Upon Tyne, Tyne & Wear, England; St Jamess Univ Hosp, Mol Med Unit, Leeds, W Yorkshire, England	Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Saint James's University Hospital; University of Leeds	Burn, J (corresponding author), Inst Human Genet, 19-20 Claremont Pl, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.		Coulthard, Alan/C-3649-2011; Jackson, Andrew P/D-3442-2009; Ince, Paul G/A-5064-2009	Coulthard, Alan/0000-0003-1110-9207; Jackson, Andrew P/0000-0002-8739-2646; Ince, Paul G/0000-0001-6677-8753; Chinnery, Patrick/0000-0002-7065-6617; Morris, Christopher/0000-0002-3749-0993; Burn, John/0000-0002-9823-2322; Bindoff, Laurence/0000-0003-0988-276X				ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GATTI RA, 1987, AM J HUM GENET, V41, P654; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Jappelli R, 1998, BIOCHEM BIOPH RES CO, V250, P342, DOI 10.1006/bbrc.1998.9317; Juan SH, 1999, ARCH BIOCHEM BIOPHYS, V361, P295, DOI 10.1006/abbi.1998.0998; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; MCGILL JR, 1987, HUM GENET, V76, P66; MORRIS CM, 1992, ACTA ANAT, V144, P235; Nappi AJ, 2000, CELL MOL BIOL, V46, P637; OLANOW CW, 1994, CURR OPIN NEUROL, V7, P548, DOI 10.1097/00019052-199412000-00013; REGUIGNEARNOULD I, 1995, CYTOGENET CELL GENET, V71, P158, DOI 10.1159/000134098; SANTORO C, 1986, NUCLEIC ACIDS RES, V14, P2863, DOI 10.1093/nar/14.7.2863; Sheth S, 2000, ANNU REV MED, V51, P443, DOI 10.1146/annurev.med.51.1.443; Takahashi Y, 1996, HUM MOL GENET, V5, P81, DOI 10.1093/hmg/5.1.81; Taylor TD, 1996, NAT GENET, V14, P479, DOI 10.1038/ng1296-479; WORWOOD M, 1987, HAEMATOLOGIA, V20, P229	23	394	401	1	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					350	354		10.1038/ng571	http://dx.doi.org/10.1038/ng571			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11438811				2022-12-17	WOS:000170174800015
J	Waterman, MJF; Stavridi, ES; Waterman, JLF; Halazonetis, TD				Waterman, MJF; Stavridi, ES; Waterman, JLF; Halazonetis, TD			ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins	NATURE GENETICS			English	Article							WILD-TYPE P53; ATAXIA-TELANGIECTASIA; TETRAMERIZATION DOMAIN; CANCER-THERAPY; DNA-BINDING; CHECKPOINT; APOPTOSIS; PATHWAYS; IRRADIATION; FIBROBLASTS	The p53 tumour-suppressor protein is a sequence-specific DNA-binding transcription factor that induces cell cycle arrest or apoptosis in response to genotoxic stress(1-6). Activation of p53 by DNA-damaging agents is critical for eliminating cells with damaged genomic DNA and underlies the apoptotic response of human cancers treated with ionizing radiation (IR) and radiomimetic drugs(7-8). The molecular mechanisms by which DNA damage activates p53 have not been elucidated. Both the levels of p53 protein and its affinity for specific DNA sequences increase in response to genotoxic stress(6,9-10). In vitro, the affinity of p53 for DNA is regulated by its carboxy-terminus(11-13). We therefore examined whether this region of p53 is targeted by DNA-damage signalling pathways in vivo. In nonirradiated cells, serines 376 and 378 of p53 were phosphorylated. IR led to dephosphorylation of Ser376, creating a consensus binding site for 14-3-3 proteins and leading to association of p53 with 14-3-3. In turn, this increased the affinity of p53 for sequence-specific DNA. Consistent with the lack of p53 activation by IR in ataxia telangiectasia (AT; refs 14, 15), neither Ser376 dephosphorylation, nor the interaction of p53 with 14-3-3 proteins occurred in AT cells.	Wistar Inst, Dept Mol Genet, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Program Mol Biol & Genet, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Halazonetis, TD (corresponding author), Wistar Inst, Dept Mol Genet, 3601 Spruce St, Philadelphia, PA 19104 USA.		Halazonetis, Thanos/D-7923-2011					Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Chernov MV, 1997, ONCOGENE, V14, P2503, DOI 10.1038/sj.onc.1201104; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DELPHIN C, 1994, J BIOL CHEM, V269, P29579; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Haapajarvi T, 1997, MOL CELL BIOL, V17, P3074, DOI 10.1128/MCB.17.6.3074; HALAZONETIS TD, 1993, EMBO J, V12, P1021, DOI 10.1002/j.1460-2075.1993.tb05743.x; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KHANNA KK, 1993, ONCOGENE, V8, P3307; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Soussi T, 1996, J MOL BIOL, V260, P623, DOI 10.1006/jmbi.1996.0425; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; Waterman MJF, 1996, CANCER RES, V56, P158; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	30	394	403	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					175	178		10.1038/542	http://dx.doi.org/10.1038/542			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620776				2022-12-17	WOS:000073865100027
J	MOCHIZUKI, T; LEMMINK, HH; MARIYAMA, M; ANTIGNAC, C; GUBLER, MC; PIRSON, Y; VERELLENDUMOULIN, C; CHAN, B; SCHRODER, CH; SMEETS, HJ; REEDERS, ST				MOCHIZUKI, T; LEMMINK, HH; MARIYAMA, M; ANTIGNAC, C; GUBLER, MC; PIRSON, Y; VERELLENDUMOULIN, C; CHAN, B; SCHRODER, CH; SMEETS, HJ; REEDERS, ST			IDENTIFICATION OF MUTATIONS IN THE ALPHA-3(IV) AND ALPHA-4(IV) COLLAGEN GENES IN AUTOSOMAL RECESSIVE ALPORT SYNDROME	NATURE GENETICS			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; IV COLLAGEN; GOODPASTURE ANTIGEN; HEREDITARY NEPHRITIS; MOLECULAR-GENETICS; CHAIN; LOCALIZATION; HETEROGENEITY; ORGANIZATION; CHROMOSOME-2	Alport syndrome (AS) is an hereditary disease of basement membranes characterized by progressive renal failure and deafness. Changes in the glomerular basement membrane (GBM) in AS suggest that the type IV collagen matrix, the major structural component of GBM, is disrupted. We recently isolated the genes for two type IV collagens, alpha 3(IV) and alpha 4(IV), that are encoded head-to-head on human chromosome 2. These chains are abundant in normal GBM but are sometimes absent in AS. We screened for mutations in families in which consanguinity suggested autosomal recessive inheritance. Homozygous mutations were found in alpha 3(IV) in two families and in alpha 4(IV) in two others, demonstrating that these chains are important in the structural integrity of the GBM and that there is an autosomal form of AS in addition to the previously-defined X-linked form.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06536; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT PEDIAT,6500 HB NIJMEGEN,NETHERLANDS; HOP NECKER ENFANTS MALAD,INSERM,U192,F-75743 PARIS 15,FRANCE; UNIV CATHOLIQUE LOUVAIN,SCH MED,NEPHROL UNIT,B-1200 BRUSSELS,BELGIUM; UNIV CATHOLIQUE LOUVAIN,SCH MED,CTR HUMAN GENET,B-1200 BRUSSELS,BELGIUM	Howard Hughes Medical Institute; Yale University; Yale University; Radboud University Nijmegen; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel			ANTIGNAC, Corinne/H-8945-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Gubler, Marie-Claire/0000-0002-3526-5661				ATKIN CL, 1988, DISEASES KIDNEY, V1, P617; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; BUTKOWSKI RJ, 1989, KIDNEY INT, V35, P1195, DOI 10.1038/ki.1989.110; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FEINGOLD J, 1985, KIDNEY INT, V27, P672, DOI 10.1038/ki.1985.63; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; Habib R, 1982, Kidney Int Suppl, V11, pS20; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1993, KIDNEY INT, V43, P135, DOI 10.1038/ki.1993.22; HUDSON BG, 1989, LAB INVEST, V61, P256; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; JOHANSSON C, 1992, J BIOL CHEM, V267, P24533; KAMAGATA Y, 1992, J BIOL CHEM, V267, P23753; KLEPPEL MM, 1989, AM J PATHOL, V134, P813; KLEPPEL MM, 1987, J CLIN INVEST, V80, P263, DOI 10.1172/JCI113057; KLEPPEL MM, 1992, KIDNEY INT, V41, P1629, DOI 10.1038/ki.1992.235; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; MARINI JC, 1993, J BIOL CHEM, V268, P2667; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; MARIYAMA M, 1992, J BIOL CHEM, V267, P1253; McKusick V.A., 1992, MENDELIAN INHERITANC; MORRISON KE, 1991, J BIOL CHEM, V266, P34; MORRISON KE, 1991, AM J HUM GENET, V49, P545; OLSON DL, 1980, J PEDIATR-US, V96, P697, DOI 10.1016/S0022-3476(80)80746-3; PASSWELL JH, 1981, J PEDIATR-US, V98, P85, DOI 10.1016/S0022-3476(81)80545-8; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P13758; QUINONES S, 1992, J BIOL CHEM, V267, P19780; REEDERS ST, 1992, KIDNEY INT, V42, P783, DOI 10.1038/ki.1992.348; RENLERI A, 1993, AM J HUM GENET S, V53, pA1219; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SAUS J, 1988, J BIOL CHEM, V263, P13374; SUGIMOTO M, 1993, FEBS LETT, V330, P122, DOI 10.1016/0014-5793(93)80256-T; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; VANDERHEUVEL LPWJ, 1989, PEDIATR NEPHROL, V3, P406; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	39	394	410	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					77	82		10.1038/ng0994-77	http://dx.doi.org/10.1038/ng0994-77			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987396				2022-12-17	WOS:A1994PE15700019
J	Gerull, B; Gramlich, M; Atherton, J; McNabb, M; Trombitas, K; Sasse-Klaassen, S; Seidman, JG; Seidman, C; Granzier, H; Labeit, S; Frenneaux, M; Thierfelder, L				Gerull, B; Gramlich, M; Atherton, J; McNabb, M; Trombitas, K; Sasse-Klaassen, S; Seidman, JG; Seidman, C; Granzier, H; Labeit, S; Frenneaux, M; Thierfelder, L			Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy	NATURE GENETICS			English	Article							IDENTIFICATION; PROTEINS; ELASTICITY; EXPRESSION; CONNECTIN; SEQUENCE; DISEASE; GENE; EXON	Congestive heart failure (CHF) can result from various disease states with inadequate cardiac output. CHF due to dilated cardiomyopathy (DCM) is a familial disease in 20-30% of cases and is associated with mutations in genes encoding cytoskeletal, contractile or inner-nuclear membrane proteins(1). We show that mutations in the gene encoding giant-muscle filament titin (TTN) cause autosomal dominant DCM linked to chromosome 2q31 (CMD1G; MIM 604145). Titin molecules extend from sarcomeric Z-discs to M-lines, provide an extensible scaffold for the contractile machinery and are crucial for myofibrillar elasticity and integrity(2). in a large DCM kindred, a segregating 2-bp insertion mutation in TTN exon 326 causes a frameshift, truncating A-band titin. The truncated protein of approximately 2 mD is expressed in skeletal muscle, but western blot studies with epitope-specific anti-titin antibodies suggest that the mutant protein is truncated to a 1.14-mD subfragment by site-specific cleavage. In another large family with DCM linked to CMD1G, a TTN missense mutation (Trp930Arg) is predicted to disrupt a highly conserved hydrophobic core sequence of an immunoglobulin fold located in the Z-disc-1-band transition zone. The identification of TTN mutations in individuals with CMD1G should provide further insights into the pathogenesis of familial forms of CHF and myofibrillar titin turnover.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Humboldt Univ, HELIOS Kliniken GmbH, Franz Volhard Klin, Charite, Berlin, Germany; Royal Brisbane Hosp, Dept Cardiol, Brisbane, Qld 4029, Australia; Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Hosp Mannheim, D-68135 Mannheim, Germany; Cardiff Univ, Dept Cardiol, Cardiff CF4 4XN, S Glam, Wales	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Royal Brisbane & Women's Hospital; Washington State University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Ruprecht Karls University Heidelberg; Cardiff University	Thierfelder, L (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	lthier@mdc-berlin.de	Atherton, John J/B-9994-2011	Atherton, John J/0000-0003-2271-578X				Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Freiburg A, 2000, CIRC RES, V86, P1114; Granzier H, 1996, BIOPHYS J, V70, P430, DOI 10.1016/S0006-3495(96)79586-3; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hutchison CJ, 2001, J CELL SCI, V114, P9; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Macrae CA, 2000, EUR HEART J, V21, P1817, DOI 10.1053/euhj.2000.2374; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; TAKAHASHI K, 1992, J BIOCHEM-TOKYO, V111, P778, DOI 10.1093/oxfordjournals.jbchem.a123835; Trinick J, 1999, TRENDS CELL BIOL, V9, P377, DOI 10.1016/S0962-8924(99)01641-4; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816	19	393	413	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					201	204		10.1038/ng815	http://dx.doi.org/10.1038/ng815			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788824				2022-12-17	WOS:000173708700022
J	Hu, ZL; Bonifas, JM; Beech, J; Bench, G; Shigihara, T; Ogawa, H; Ikeda, S; Mauro, T; Epstein, EH				Hu, ZL; Bonifas, JM; Beech, J; Bench, G; Shigihara, T; Ogawa, H; Ikeda, S; Mauro, T; Epstein, EH			Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease	NATURE GENETICS			English	Article							YEAST SECRETORY PATHWAY; IDENTIFICATION; GENE; CHROMOSOME; RETICULUM; GOLGI; PMR1; DIFFERENTIATION; TRANSPORT; PEMPHIGUS	Hailey-Hailey disease (HHD, MIM 16960) is inherited in an autosomal dominant manner and characterized by persistent blisters and erosions of the skin(1). Impaired intercellular adhesion and epidermal blistering also occur in individuals with pemphigus (which is due to autoantibodies directed against desmosomal proteins) and in patients with Darier disease (DD, MIM 124200), which is caused by mutations in a gene encoding a sarco/endoplasmic reticulum (ER)-Golgi calcium pump(2). We report here the identification of mutations in ATP2C1, encoding the human homologue of an ATP-powered pump that sequesters calcium into the Golgi in yeast, in 21 HHD kindreds. Regulation of cytoplasmic calcium is impaired in cultured keratinocytes from HHD patients, and the normal epidermal calcium gradient is attenuated in vivo in HHD patients. Our findings not only provide an understanding of the molecular basis of HHD, but also underscore the importance of calcium control to the functioning of stratified squamous epithelia.	San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Dermatol, VA Med Ctr, San Francisco, CA 94143 USA; Univ Calif Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; Juntendo Univ, Sch Med, Dept Dermatol, Tokyo 113, Japan	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; Juntendo University	Epstein, EH (corresponding author), San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94110 USA.			Bench, Graham/0000-0002-1969-6867; hu, zhilan/0000-0003-2925-5595	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043119, R29AR044341] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR43119, AR44341] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amagai M, 1996, J INVEST DERMATOL, V107, P539, DOI 10.1111/1523-1747.ep12582796; Amar LS, 1999, CELL ADHES COMMUN, V7, P125, DOI 10.3109/15419069909034396; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; BERTELLI A, 1994, DRUG EXP CLIN RES, V20, P7; BUNSE T, 1991, ACTA DERM-VENEREOL, V71, P287; BURGE SM, 1992, BRIT J DERMATOL, V126, P275, DOI 10.1111/j.1365-2133.1992.tb00658.x; CHAKRAVARTHY BR, 1995, J BIOL CHEM, V270, P1362, DOI 10.1074/jbc.270.3.1362; Christiano AM, 1997, HUM MUTAT, V10, P408, DOI 10.1002/(SICI)1098-1004(1997)10:5<408::AID-HUMU12>3.3.CO;2-B; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; GUNTESKIHAMBLIN AM, 1992, BIOCHEMISTRY-US, V31, P7600, DOI 10.1021/bi00148a023; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; IKEDA S, 1994, HUM MOL GENET, V3, P1147, DOI 10.1093/hmg/3.7.1147; IKEDA S, 1991, J INVEST DERMATOL, V97, P644, DOI 10.1111/1523-1747.ep12483596; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; Mauro T, 1997, J INVEST DERMATOL, V108, P864, DOI 10.1111/1523-1747.ep12292585; ODA K, 1992, J BIOL CHEM, V267, P17465; PELUSO AM, 1995, GENOMICS, V30, P77; RESING KA, 1993, J BIOL CHEM, V268, P25139; Richards L, 1995, STUDIES QUALITATIVE, V5, P105; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Sorin A, 1997, J BIOL CHEM, V272, P9895; VULPE CD, 1995, ANNU REV NUTR, V15, P293, DOI 10.1146/annurev.nu.15.070195.001453	27	393	427	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2000	24	1					61	65		10.1038/71701	http://dx.doi.org/10.1038/71701			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	10615129				2022-12-17	WOS:000084609200017
J	Martindale, D; Hackam, A; Wieczorek, A; Ellerby, L; Wellington, C; McCutcheon, K; Singaraja, R; Kazemi-Esfarjani, P; Devon, R; Kim, SU; Bredesen, DE; Tufaro, F; Hayden, MR				Martindale, D; Hackam, A; Wieczorek, A; Ellerby, L; Wellington, C; McCutcheon, K; Singaraja, R; Kazemi-Esfarjani, P; Devon, R; Kim, SU; Bredesen, DE; Tufaro, F; Hayden, MR			Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates	NATURE GENETICS			English	Article							SIMPLEX VIRUS TYPE-1; COLORIMETRIC ASSAY; TRANSGENIC MICE; CAG REPEAT; PROTEIN; PHENOTYPE; CELLS	It is unclear how polyglutamine expansion is associated with the pathogenesis of Huntington disease (HD). Here. we provide evidence that polyglutamine expansion leads to the formation of large intracellular aggregates in vitro and in vivo. In vitro these huntingtin-containing aggregates disrupt normal cellular architecture and increase in frequency with polyglutamine length. Huntingtin truncated at nucleotide 1955, close to the caspase-3 cleavage site, forms perinuclear aggregates more readily than full-length huntingtin and increases the susceptibility of cells to death following apoptotic stimuli. Further truncation of huntingtin to nucleotide 436 results in both intranuclear and perinuclear aggregates. For a given protein size, increasing polyglutamine length is associated with increased cellular toxicity. Asymptomatic transgenic mice expressing full-length huntingtin with 138 polyglutamines form exclusively perinuclear aggregates in neurons. These data support the hypothesis that proteolytic cleavage of mutant huntingtin leads to the development of aggregates which compromise cell viability, and that their localization is influenced by protein length.	Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z4, Canada; NeuroVir Inc, Vancouver, BC V6T 1Z3, Canada; Burnham Inst, Program Aging, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; Univ Saskatchewan, Coll Dent, Saskatoon, SK S7N 5E4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of Saskatchewan	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z4, Canada.	mrh@ulam.generes.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012282] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NIA NIH HHS [AG12282] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CARMICHAEL J, 1987, CANCER RES, V47, P936; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; CUNNINGHAM C, 1993, VIROLOGY, V197, P116, DOI 10.1006/viro.1993.1572; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DIFIGLIA M, 1997, SCIENCE, V277, P199; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Johnson PR, 1997, TRENDS CELL BIOL, V7, P408, DOI 10.1016/S0962-8924(97)01132-X; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Perutz MF, 1996, CURR OPIN STRUC BIOL, V6, P848, DOI 10.1016/S0959-440X(96)80016-9; SAPP E, 1997, ANN NEUROL, V23, P2247; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; TELLEZNAGEL I, 1973, ADV NEUROL, V1, P387; VISTICA DT, 1991, CANCER RES, V51, P2515; Wellington CL, 1997, CURR OPIN NEUROL, V10, P291, DOI 10.1097/00019052-199708000-00003	27	393	406	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					150	154		10.1038/ng0298-150	http://dx.doi.org/10.1038/ng0298-150			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462744				2022-12-17	WOS:000071779500023
J	Buczkowicz, P; Hoeman, C; Rakopoulos, P; Pajovic, S; Letourneau, L; Dzamba, M; Morrison, A; Lewis, P; Bouffet, E; Bartels, U; Zuccaro, J; Agnihotri, S; Rya, S; Barszczyk, M; Chornenkyy, Y; Bourgey, M; Bourque, G; Montpetit, A; Cordero, F; Castelo-Branco, P; Mangere, J; Tabori, U; Ching, K; Huang, A; Taylor, KR; Mackay, A; Bendell, AE; Nazarian, J; Fangusaro, JR; Karajannis, MA; Zagzag, D; Foreman, NK; Donson, A; Hegert, JV; Smith, A; Chan, J; Lafay-Cousin, L; Dunn, S; Hukin, J; Dunham, C; Scheinemann, K; Michaud, J; Zelcer, S; Ramsay, D; Cain, J; Brennan, C; Souweidane, MM; Jones, C; Allis, CD; Brudno, M; Becher, O; Hawkins, C				Buczkowicz, Pawel; Hoeman, Christine; Rakopoulos, Patricia; Pajovic, Sanja; Letourneau, Louis; Dzamba, Misko; Morrison, Andrew; Lewis, Peter; Bouffet, Eric; Bartels, Ute; Zuccaro, Jennifer; Agnihotri, Sameer; Rya, Scott; Barszczyk, Mark; Chornenkyy, Yevgen; Bourgey, Mathieu; Bourque, Guillaume; Montpetit, Alexandre; Cordero, Francisco; Castelo-Branco, Pedro; Mangere, Joshua; Tabori, Uri; Ching, King; Huang, Annie; Taylor, Kathryn R.; Mackay, Alan; Bendell, Anne E.; Nazarian, Javad; Fangusaro, Jason R.; Karajannis, Matthias A.; Zagzag, David; Foreman, Nicholas K.; Donson, Andrew; Hegert, Julia V.; Smith, Amy; Chan, Jennifer; Lafay-Cousin, Lucy; Dunn, Sandra; Hukin, Juliette; Dunham, Chris; Scheinemann, Katrin; Michaud, Jean; Zelcer, Shayna; Ramsay, David; Cain, Jason; Brennan, Cameron; Souweidane, Mark M.; Jones, Chris; Allis, C. David; Brudno, Michael; Becher, Oren; Hawkins, Cynthia			Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; BONE MORPHOGENETIC PROTEIN; BRAIN-STEM GLIOMAS; CELL-PROLIFERATION; ID2 EXPRESSION; HISTONE H3.3; CANCER; GENES; DIFFERENTIATION; FEATURES	Diffuse intrinsic pontine glioma (DIPG) is a fatal brain cancer that arises in the brainstem of children, with no effective treatment and near 100% fatality. The failure of most therapies can be attributed to the delicate location of these tumors and to the selection of therapies on the basis of assumptions that DIPGs are molecularly similar to adult disease. Recent studies have unraveled the unique genetic makeup of this brain cancer, with nearly 80% found to harbor a p.Lys27Met histone H3.3 or p.Lys27Met histone H3.1 alteration. However, DIPGs are still thought of as one disease, with limited understanding of the genetic drivers of these tumors. To understand what drives DIPGs, we integrated whole-genome sequencing with methylation, expression and copy number profiling, discovering that DIPGs comprise three molecularly distinct subgroups (H3-K27M, silent and MYCN) and uncovering a new recurrent activating mutation affecting the activin receptor gene ACVR1 in 20% of DIPGs. Mutations in ACVR1 were constitutively activating, leading to SMAD phosphorylation and increased expression of the downstream activin signaling targets ID1 and ID2. Our results highlight distinct molecular subgroups and novel therapeutic targets for this incurable pediatric cancer.	[Buczkowicz, Pawel; Hawkins, Cynthia] Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; [Buczkowicz, Pawel; Rakopoulos, Patricia; Pajovic, Sanja; Morrison, Andrew; Zuccaro, Jennifer; Agnihotri, Sameer; Barszczyk, Mark; Chornenkyy, Yevgen; Castelo-Branco, Pedro; Mangere, Joshua; Tabori, Uri; Ching, King; Huang, Annie; Hawkins, Cynthia] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Buczkowicz, Pawel; Rakopoulos, Patricia; Barszczyk, Mark; Chornenkyy, Yevgen; Hawkins, Cynthia] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hoeman, Christine; Cordero, Francisco] Duke Univ, Med Ctr, Div Pediat Hematol Oncol, Durham, NC USA; [Letourneau, Louis; Bourgey, Mathieu; Bourque, Guillaume; Montpetit, Alexandre] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Dzamba, Misko; Brudno, Michael] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Lewis, Peter; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Bouffet, Eric; Bartels, Ute; Tabori, Uri; Huang, Annie] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Taylor, Kathryn R.; Mackay, Alan; Jones, Chris] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Bendell, Anne E.] Childrens Hosp & Clin Minnesota, Dept Pediat Hematol Oncol, Minneapolis, MN USA; [Nazarian, Javad] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA; [Fangusaro, Jason R.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat Hematol, Chicago, IL USA; [Karajannis, Matthias A.] NYU, Langone Med Ctr, Inst Canc, Div Pediat Hematol Oncol & Neuropathol, New York, NY USA; [Foreman, Nicholas K.; Donson, Andrew] Childrens Hosp Colorado, Dept Pediat, Denver, CO USA; [Hegert, Julia V.; Smith, Amy] Arnold Palmer Hosp Children, Dept Pathol, Orlando, FL USA; [Chan, Jennifer; Lafay-Cousin, Lucy] Univ Calgary, Fac Med, Clark H Smith Brain Tumour Ctr, Calgary, AB, Canada; [Dunn, Sandra; Hukin, Juliette; Dunham, Chris] BC Childrens Hosp, Dept Pediat Neurol & Neurooncol, Vancouver, BC, Canada; [Scheinemann, Katrin] McMaster Childrens Hosp, Div Hematol Oncol, Hamilton, ON, Canada; [Michaud, Jean] Childrens Hosp Eastern Ontario, Dept Pathol & Lab Med, Ottawa, ON K1H 8L1, Canada; [Zelcer, Shayna; Ramsay, David] Childrens Hosp London, Hlth Sci Ctr, Dept Hematol Oncol, London, ON, Canada; [Cain, Jason] Monash Inst Med Res, Monash Med Ctr, Clayton, Vic, Australia; [Brennan, Cameron; Souweidane, Mark M.] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Brennan, Cameron; Souweidane, Mark M.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Brudno, Michael] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Duke University; McGill University; University of Toronto; Rockefeller University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Children's Hospitals & Clinics of Minnesota; Children's National Health System; Ann & Robert H. Lurie Children's Hospital of Chicago; New York University; NYU Langone Medical Center; Children's Hospital Colorado; University of Calgary; BC Childrens Hospital; University of British Columbia; McMaster University; University of Ottawa; Children's Hospital of Eastern Ontario; London Health Sciences Centre; University of Manitoba; Children's Hospital Research Institute of Manitoba; Western University (University of Western Ontario); Monash University; Cornell University; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Hawkins, C (corresponding author), Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada.	oren.becher@duke.edu; cynthia.hawkins@sickkids.ca	Becher, Oren/AAI-7495-2020; Karajannis, Matthias A/H-8845-2019; Brennan, Cameron/R-7082-2019; Bourque, Guillaume/AFR-2927-2022; Jones, Chris/ABE-6059-2021; Bouffet, Eric/AAB-8999-2020	Karajannis, Matthias A/0000-0002-7151-6528; Brennan, Cameron/0000-0003-4064-8891; Bourque, Guillaume/0000-0002-3933-9656; Jones, Chris/0000-0001-8118-2296; Nazarian, Javad/0000-0002-1951-9828; Hukin, Juliette/0000-0002-8727-8456; Lewis, Peter/0000-0002-9816-7823; Dunham, Christopher/0000-0002-6244-0584; Becher, Oren/0000-0003-4016-8492; Foreman, Nicholas/0000-0003-4848-4801; Bourgey, Mathieu/0000-0002-8432-834X; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Tabori, Uri/0000-0002-5019-2683	Canadian Institutes of Health Research (CIHR) [MOP 115004]; Genome Canada/CIHR; Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research); US Department of Defense; Pediatric Brain Tumor Foundation; National Health Service (NHS); Stavros Niarchos Foundation; National Center for Research Resources [UL1TR000038]; US National Institutes of Health; National Cancer Institute [5P30CA016087-32]; Genome Canada/CIHR joint ATID Competition; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014236, P30CA008748, P30CA016087, P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada/CIHR; Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research)(Canadian Institutes of Health Research (CIHR)); US Department of Defense(United States Department of Defense); Pediatric Brain Tumor Foundation; National Health Service (NHS); Stavros Niarchos Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genome Canada/CIHR joint ATID Competition; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank all of the patients and families for donating tissue for this research. This work was supported by the Canadian Institutes of Health Research (CIHR, MOP 115004) and was funded in part by a Genome Canada/CIHR grant (cofunding from Genome BC, Genome Quebec, CIHR-ICR (Institute for Cancer Research) and C17, through the Genome Canada/CIHR joint ATID Competition (project title: The Canadian Paediatric Cancer Genome Consortium (CPCGC): Translating Next-Generation Sequencing Technologies into Improved Therapies for High-Risk Childhood Cancer)). P.B. is a recipient of a CIHR Doctoral Frederick Banting and Charles Best Canada Graduate Scholarships award. O.B. is a Damon Runyon Clinical Investigator and is supported by the US Department of Defense and the Pediatric Brain Tumor Foundation. C.J., A. Mackay and K.R.T. acknowledge National Health Service (NHS) funding to the Biomedical Research Centre and support from the Stavros Niarchos Foundation. Sample collection for M.A.K. and D.Z. was supported in part by grant UL1TR000038 from the National Center for Research Resources, US National Institutes of Health and by grant 5P30CA016087-32 from the National Cancer Institute.	Buczkowicz P, 2013, BRAIN PATHOL, V23, P244, DOI 10.1111/j.1750-3639.2012.00633.x; Chen XS, 2012, J NEUROSCI RES, V90, P925, DOI 10.1002/jnr.22826; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Freeman CR, 1999, CHILD NERV SYST, V15, P545, DOI 10.1007/s003810050542; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herbert Brittney-Shea, 2003, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1806s20; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kurooka H, 2012, BIOCHEM BIOPH RES CO, V420, P281, DOI 10.1016/j.bbrc.2012.02.150; Liu Z, 2012, ACTA BIOCH BIOPH SIN, V44, P503, DOI 10.1093/abbs/gms030; MARIA BL, 1993, J CHILD NEUROL, V8, P112, DOI 10.1177/088307389300800203; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Petrie KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005005; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shin M, 2013, J BONE MINER METAB, V31, P34, DOI 10.1007/s00774-012-0381-1; Song GA, 2010, J BIOL CHEM, V285, P22542, DOI 10.1074/jbc.M109.094557; STILLER CA, 1994, BRIT MED J, V309, P1612, DOI 10.1136/bmj.309.6969.1612; Wazir U, 2013, ANTICANCER RES, V33, P2179; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	24	392	404	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					451	456		10.1038/ng.2936	http://dx.doi.org/10.1038/ng.2936			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705254	Green Submitted, Green Accepted			2022-12-17	WOS:000335422900010
J	Wrensch, M; Jenkins, RB; Chang, JS; Yeh, RF; Xiao, YY; Decker, PA; Ballman, KV; Berger, M; Buckner, JC; Chang, S; Giannini, C; Halder, C; Kollmeyer, TM; Kosel, ML; LaChance, DH; McCoy, L; O'Neill, BP; Patoka, J; Pico, AR; Prados, M; Quesenberry, C; Rice, T; Rynearson, AL; Smirnov, I; Tihan, T; Wiemels, J; Yang, P; Wiencke, JK				Wrensch, Margaret; Jenkins, Robert B.; Chang, Jeffrey S.; Yeh, Ru-Fang; Xiao, Yuanyuan; Decker, Paul A.; Ballman, Karla V.; Berger, Mitchel; Buckner, Jan C.; Chang, Susan; Giannini, Caterina; Halder, Chandralekha; Kollmeyer, Thomas M.; Kosel, Matthew L.; LaChance, Daniel H.; McCoy, Lucie; O'Neill, Brian P.; Patoka, Joe; Pico, Alexander R.; Prados, Michael; Quesenberry, Charles; Rice, Terri; Rynearson, Amanda L.; Smirnov, Ivan; Tihan, Tarik; Wiemels, Joe; Yang, Ping; Wiencke, John K.			Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility	NATURE GENETICS			English	Article							TELOMERASE ACTIVITY; GENOME; LOCUS; TUMOR; EPIDEMIOLOGY; P15(INK4B); TRAITS; GROWTH; LENGTH; MYC	The causes of glioblastoma and other gliomas remain obscure(1,2). To discover new candidate genes influencing glioma susceptibility, we conducted a principal component adjusted(3) genome-wide association study (GWAS) of 275,895 autosomal variants among 692 adult high-grade glioma cases (622 from the San Francisco Adult Glioma Study (AGS) and 70 from the Cancer Genome Atlas (TCGA))(4) and 3,992 controls (602 from AGS and 3,390 from Illumina iControlDB (iControls)). For replication, we analyzed the 13 SNPs with P < 10(-6) using independent data from 176 high-grade glioma cases and 174 controls from the Mayo Clinic. On 9p21, rs1412829 near CDKN2B had discovery P = 3.4 x 10(-8), replication P = 0.0038 and combined P = 1.85 x 10(-10). On 20q13.3, rs6010620 intronic to RTEL1 had discovery P = 1.5 x 10(-7), replication P = 0.00035 and combined P = 3.40 x 10(-9) . For both SNPs, the direction of association was the same in discovery and replication phases.	[Wrensch, Margaret; Berger, Mitchel; Chang, Susan; McCoy, Lucie; Patoka, Joe; Prados, Michael; Rice, Terri; Smirnov, Ivan; Wiencke, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Wrensch, Margaret; Wiemels, Joe; Wiencke, John K.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Jenkins, Robert B.; Giannini, Caterina; Halder, Chandralekha; Kollmeyer, Thomas M.; Rynearson, Amanda L.] Mayo Clin, Dept Expt Pathol, Rochester, MN USA; [Chang, Jeffrey S.; Yeh, Ru-Fang; Xiao, Yuanyuan; Wiemels, Joe] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Decker, Paul A.; Ballman, Karla V.; Kosel, Matthew L.] Mayo Clin, Div Biostat, Rochester, MN USA; [Buckner, Jan C.] Mayo Clin, Dept Oncol, Rochester, MN USA; [LaChance, Daniel H.; O'Neill, Brian P.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Pico, Alexander R.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Quesenberry, Charles] Kaiser Permanente, Div Res, Oakland, CA USA; [Tihan, Tarik] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Yang, Ping] Mayo Clin, Div Epidemiol, Rochester, MN USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; The J David Gladstone Institutes; Kaiser Permanente; University of California System; University of California San Francisco; Mayo Clinic	Wrensch, M (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	margaret.wrensch@ucsf.edu	Rice, Terri/J-6071-2014; Chang, Jeffrey Shu-Ming/AAR-4161-2020; Tihan, Tarik/AAU-6371-2021; Giannini, Caterina/AAB-7551-2022; Prados, Michael/N-5220-2019; Buckner, Jan/AAE-6388-2019; Pico, Alexander/HCH-4305-2022; Chang, Jeffrey Shu-Ming/B-1092-2010	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205; Tihan, Tarik/0000-0003-4551-2555; Pico, Alexander/0000-0001-5706-2163; Ballman, Karla/0000-0002-4492-0357	NCI NIH HHS [R01 CA052689, P30 CA15083, R01CA52689, P50CA097257, P30 CA015083, P50 CA097257, R25 CA 112355, R25 CA112355, R01 CA052689-19, P50 CA108961] Funding Source: Medline; NINDS NIH HHS [RC1 NS068222-01, RC1 NS068222] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052689, P50CA108961, P50CA097257, P30CA015083, R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068222] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahuau M, 1998, CANCER RES, V58, P2298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; *CBTRUS, 2008, PRIM BRAIN TUM US ST; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Davis FG, 2008, CANCER EPIDEM BIOMAR, V17, P484, DOI 10.1158/1055-9965.EPI-07-0725; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Falchetti ML, 2006, NEUROL RES, V28, P532, DOI 10.1179/016164106X116818; Felini MJ, 2009, CANCER CAUSE CONTROL, V20, P87, DOI 10.1007/s10552-008-9220-z; Fuxe J, 2000, CELL GROWTH DIFFER, V11, P373; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Lemmens R, 2009, EUR J HUM GENET, V17, P1287, DOI 10.1038/ejhg.2009.42; Maes L, 2007, ONCOL REP, V18, P1571; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mohlke KL, 2008, HUM MOL GENET, V17, pR102, DOI 10.1093/hmg/ddn275; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pico AR, 2009, NUCLEIC ACIDS RES, V37, pD803, DOI 10.1093/nar/gkn756; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schaefer AS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000378; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shervington A, 2006, MOL CELL BIOCHEM, V283, P1, DOI 10.1007/s11010-006-2495-z; Wrensch M, 2007, CLIN CANCER RES, V13, P197, DOI 10.1158/1078-0432.CCR-06-1199	28	392	397	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					905	U61		10.1038/ng.408	http://dx.doi.org/10.1038/ng.408			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19578366	Green Accepted			2022-12-17	WOS:000268432900015
J	Verjovski-Almeida, S; DeMarco, R; Martins, EAL; Guimaraes, PEM; Ojopi, EPB; Paquola, ACM; Piazza, JP; Nishiyama, MY; Kitajima, JP; Adamson, RE; Ashton, PD; Bonaldo, MF; Coulson, PS; Dillon, GP; Farias, LP; Gregorio, SP; Ho, PL; Leite, RA; Malaquias, LCC; Marques, RCP; Miyasato, PA; Nascimento, ALTO; Ohlweiler, FP; Reis, EM; Ribeiro, MA; Sa, RG; Stukart, GC; Soares, MB; Gargioni, C; Kawano, T; Rodrigues, V; Madeira, AMBN; Wilson, RA; Menck, CFM; Setubal, JC; Leite, LCC; Dias-Neto, E				Verjovski-Almeida, S; DeMarco, R; Martins, EAL; Guimaraes, PEM; Ojopi, EPB; Paquola, ACM; Piazza, JP; Nishiyama, MY; Kitajima, JP; Adamson, RE; Ashton, PD; Bonaldo, MF; Coulson, PS; Dillon, GP; Farias, LP; Gregorio, SP; Ho, PL; Leite, RA; Malaquias, LCC; Marques, RCP; Miyasato, PA; Nascimento, ALTO; Ohlweiler, FP; Reis, EM; Ribeiro, MA; Sa, RG; Stukart, GC; Soares, MB; Gargioni, C; Kawano, T; Rodrigues, V; Madeira, AMBN; Wilson, RA; Menck, CFM; Setubal, JC; Leite, LCC; Dias-Neto, E			Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni	NATURE GENETICS			English	Article							GENE-EXPRESSION; RNA INTERFERENCE; CDNA LIBRARIES; LIFE-SPAN; GENOME; SEQUENCE; PROTEINS; MEMBRANE; INVERTEBRATES; CONSTRUCTION	Schistosoma mansoni is the primary causative agent of schistosomiasis, which affects 200 million individuals in 74 countries. We generated 163,000 expressed-sequence tags ( ESTs) from normalized cDNA libraries from six selected developmental stages of the parasite, resulting in 31,000 assembled sequences and 92% sampling of an estimated 14,000 gene complement. By analyzing automated Gene Ontology assignments, we provide a detailed view of important S. mansoni biological systems, including characterization of metazoa-specific and eukarya-conserved genes. Phylogenetic analysis suggests an early divergence from other metazoa. The data set provides insights into the molecular mechanisms of tissue organization, development, signaling, sexual dimorphism, host interactions and immune evasion and identifies novel proteins to be investigated as vaccine candidates and potential drug targets.	Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil; Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil; Univ Sao Paulo, HCFM, Inst Psiquiatria, Lab Neurosci LIM27, BR-05403010 Sao Paulo, Brazil; Univ Sao Paulo, Inst Quim, Dept Bioquim, Lab Bioinformat, BR-05508900 Sao Paulo, Brazil; Univ Estadual Campinas, Inst Computacao, BR-13084971 Campinas, SP, Brazil; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508900 Sao Paulo, Brazil; Univ Vale Rio Doce, BR-35030390 Governador Valadares, MG, Brazil; Inst Butantan, Parasitol Lab, BR-05503900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Vet & Zootecnia, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, SP, Brazil; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Univ Iowa, Dept Orthopaed, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol, Iowa City, IA 52242 USA; Univ Iowa, Dept Biophys, Iowa City, IA 52242 USA; Inst Adolfo Lutz Registro, Dept Parasitol, BR-01246902 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of York - UK; University of Iowa; Universidade de Sao Paulo; University Vale Rio Doce; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Instituto Adolfo Lutz	Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.	verjo@iq.usp.br	Dias-Neto, Emmanuel/A-5869-2008; Leite, Luciana/D-1353-2012; Miyasato, Patricia A/P-8045-2018; Farias, Leonardo Paiva/GLV-4591-2022; Malaquias, Luiz Cosme/K-7210-2013; Nishiyama, Milton/AAE-5736-2021; Martins, Elizabeth AL/B-7135-2015; Setubal, Joao Carlos/C-7305-2012; Farias, Leonardo P/C-4072-2012; Reis, Eduardo M/H-2008-2011; Wilson, Alan/AAD-5050-2020; Reis, Eduardo Moraes Rego/AAF-3553-2020; Nishiyama, Milton Y/H-4002-2013; Menck, Carlos FM/G-6321-2011; Ho, Paulo/P-8267-2015; Madeira, AMBN/E-7971-2012; DeMarco, Ricardo/A-7773-2008; Rodrigues, Vanderlei/I-4528-2012; GARGIONI, CYBELE/B-5213-2016; Dias-Neto, Emmanuel/AAA-6701-2019; Ojopi, Elida Benquique/A-6773-2012; Verjovski-Almeida, Sergio/E-4082-2012; Nascimento, Ana L. T. O./E-8488-2012; Guimaraes, Pedro/A-9715-2008	Dias-Neto, Emmanuel/0000-0001-5670-8559; Leite, Luciana/0000-0003-0156-1312; Miyasato, Patricia A/0000-0003-4871-5972; Farias, Leonardo Paiva/0000-0002-4909-5333; Malaquias, Luiz Cosme/0000-0002-4920-072X; Nishiyama, Milton/0000-0002-2410-0562; Martins, Elizabeth AL/0000-0002-2333-9379; Setubal, Joao Carlos/0000-0001-9174-2816; Farias, Leonardo P/0000-0002-4909-5333; Reis, Eduardo M/0000-0002-9556-3070; Nishiyama, Milton Y/0000-0002-2410-0562; Menck, Carlos FM/0000-0003-1941-0694; Ho, Paulo/0000-0003-3652-241X; Madeira, AMBN/0000-0002-3917-1849; DeMarco, Ricardo/0000-0001-8944-1301; GARGIONI, CYBELE/0000-0002-9154-6839; Ojopi, Elida Benquique/0000-0001-5824-5199; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Nascimento, Ana L. T. O./0000-0003-4851-0870; Guimaraes, Pedro/0000-0002-7530-600X; Wilson, Alan/0000-0002-7210-0321; Ashton, Peter/0000-0002-7446-5009; Dillon, Gary/0000-0002-7743-5040				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BASCH PF, 1988, COMP BIOCHEM PHYS B, V90, P389, DOI 10.1016/0305-0491(88)90093-4; Boyle JP, 2003, MOL BIOCHEM PARASIT, V128, P205, DOI 10.1016/S0166-6851(03)00078-1; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Coulson PS, 1997, ADV PARASIT, V39, P271, DOI 10.1016/S0065-308X(08)60048-2; Cutts L, 1997, PARASITE IMMUNOL, V19, P91, DOI 10.1046/j.1365-3024.1997.d01-184.x; DAMONNEVILLE M, 1984, INT ARCH ALLER A IMM, V73, P248, DOI 10.1159/000233477; de Mendonca RL, 2000, PARASITOL TODAY, V16, P233, DOI 10.1016/S0169-4758(00)01641-0; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DeMarco R, 2003, BIOCHEM BIOPH RES CO, V307, P831, DOI 10.1016/S0006-291X(03)01268-3; DISSOUS C, 1995, PARASITOL TODAY, V11, P45, DOI 10.1016/0169-4758(95)80111-1; Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0; Dorsey CH, 2002, MICRON, V33, P279, DOI 10.1016/S0968-4328(01)00019-1; Dunne D, 2001, SCHISTOSOMIASIS, P133, DOI DOI 10.1142/9781848161511_0005; Fietto JLR, 2002, BIOTECHNIQUES, V32, P1404, DOI 10.2144/02326rr01; FULFORD AJC, 1995, PARASITOLOGY, V110, P307, DOI 10.1017/S0031182000080896; Halton DW, 1996, PARASITOLOGY, V113, pS47, DOI 10.1017/S0031182000077891; Hausdorf B, 2000, SYST BIOL, V49, P130, DOI 10.1080/10635150050207438; Hoffmann KF, 2001, MOL BIOCHEM PARASIT, V112, P113, DOI 10.1016/S0166-6851(00)00352-2; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; King CL, 2001, SCHISTOSOMIASIS, P218; Mair GR, 2000, PARASITOLOGY, V121, P163, DOI 10.1017/S0031182099006174; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mansour TE., 2002, CHEMOTHERAPEUTIC TAR, DOI 10.1017/CBO9780511546440; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Neto ED, 1997, GENE, V186, P135, DOI 10.1016/S0378-1119(96)00699-3; Osman A, 2001, J BIOL CHEM, V276, P10072, DOI 10.1074/jbc.M005933200; PAPPAS PW, 1975, EXP PARASITOL, V37, P469, DOI 10.1016/0014-4894(75)90016-8; Paquola ACM, 2003, BIOINFORMATICS, V19, P1587, DOI 10.1093/bioinformatics/btg196; PAX RA, 1991, PARASITOLOGY, V102, pS31, DOI 10.1017/S0031182000073273; Pryon SC, 2000, ACTA BIOL HUNG, V51, P331; Racoosin EL, 1999, MOL BIOCHEM PARASIT, V104, P285, DOI 10.1016/S0166-6851(99)00156-5; Ramos CRR, 2003, J BIOL CHEM, V278, P12745, DOI 10.1074/jbc.M211268200; Salter JP, 2002, J BIOL CHEM, V277, P24618, DOI 10.1074/jbc.M202364200; Santos TM, 1999, MOL BIOCHEM PARASIT, V103, P79, DOI 10.1016/S0166-6851(99)00100-0; Saule P, 2002, J PARASITOL, V88, P849, DOI 10.1645/0022-3395(2002)088[0849:EVOHTA]2.0.CO;2; SIMPSON AJG, 1982, MOL BIOCHEM PARASIT, V6, P125, DOI 10.1016/0166-6851(82)90070-6; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; SMART D, 1994, J COMP NEUROL, V347, P426, DOI 10.1002/cne.903470308; SNYDER SD, 2000, INTERRELATIONSHIPS P, P194; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Williams SA, 1999, PARASITOLOGY, V118, pS19, DOI 10.1017/S0031182099004473; WILSON RA, 1977, PARASITOLOGY, V74, P61, DOI 10.1017/S0031182000047533; World Health Organization (WHO), 2002, TDR STRAT DIR RES SC; XU XF, 1992, EUR J CELL BIOL, V57, P229	50	392	414	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					148	157		10.1038/ng1237	http://dx.doi.org/10.1038/ng1237			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973350				2022-12-17	WOS:000185625300011
J	HORINOUCHI, K; ERLICH, S; PERL, DP; FERLINZ, K; BISGAIER, CL; SANDHOFF, K; DESNICK, RJ; STEWART, CL; SCHUCHMAN, EH				HORINOUCHI, K; ERLICH, S; PERL, DP; FERLINZ, K; BISGAIER, CL; SANDHOFF, K; DESNICK, RJ; STEWART, CL; SCHUCHMAN, EH			ACID SPHINGOMYELINASE DEFICIENT MICE - A MODEL OF TYPE-A AND TYPE-B NIEMANN-PICK DISEASE	NATURE GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; STEM-CELLS; RAT-BRAIN; GENE; MOUSE; ORGANIZATION; EXPRESSION; SMPD1	Types A and B Niemann-Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM). An animal model of NPD has been created by gene targeting. In affected animals, the disease followed a severe, neurodegenerative course and death occurred by eight months of age. Analysis of these animals showed their tissues had no detectable ASM activity, the blood cholesterol levels and sphingomyelin in the liver and brain were elevated, and atrophy of the cerebellum and marked deficiency of Purkinje cells was evident. Microscopic analysis revealed 'NPD cells' in reticuloendothelial organs and characteristic NPD lesions in the brain. Thus, the ASM deficient mice should be of great value for studying the pathogenesis and treatment of NPD, and for investigations into the role of ASM in signal transduction and apoptosis.	MT SINAI SCH MED, DEPT HUMAN GENET, NEW YORK, NY 10029 USA; MT SINAI SCH MED, DEPT PATHOL, NEW YORK, NY 10029 USA; UNIV BONN, INST ORGAN CHEM & BIOCHEM, W-5300 BONN, GERMANY; PARKE DAVIS PHARMACEUT RES, DEPT ATHEROSCLEROSIS THERAPEUT, ANN ARBOR, MI 48105 USA; ROCHE INST MOLEC BIOL, ROCHE RES CTR, DEPT CELL BIOL & DEV BIOL, NUTLEY, NJ 07110 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Bonn; Pfizer; Roche Holding			Perl, Daniel/GPS-9879-2022		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028607] Funding Source: NIH RePORTER; NICHD NIH HHS [1 R01 HD28607] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AALTOSETALA K, 1994, J CLIN INVEST, V93, P1776, DOI 10.1172/JCI117163; ALTAIN CC, 1974, CLIN CHEM, V20, P470; BISHOP DF, 1981, J BIOL CHEM, V256, P1307; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; DINUR T, 1992, HUM GENE THER, V3, P633, DOI 10.1089/hum.1992.3.6-633; GATT S, 1978, J NEUROCHEM, V31, P547, DOI 10.1111/j.1471-4159.1978.tb02671.x; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HORINOUCHI K, 1993, GENOMICS, V18, P450, DOI 10.1006/geno.1993.1497; KANFER JN, 1966, J BIOL CHEM, V241, P1081; KIEFT KA, 1991, J LIPID RES, V32, P859; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARUYAMA EN, 1989, J NEUROCHEM, V52, P611, DOI 10.1111/j.1471-4159.1989.tb09163.x; NEWRZELLA D, 1992, BIOL CHEM H-S, V373, P1233, DOI 10.1515/bchm3.1992.373.2.1233; PEREIRA LD, 1991, GENOMICS, V9, P229, DOI 10.1016/0888-7543(91)90246-B; QUINTERN LE, 1991, METHOD ENZYMOL, V197, P536; RAO BG, 1976, J LIPID RES, V17, P506; SALKI RK, 1988, SCIENCE, V239, P487; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; SCHUCHMAN EH, 1992, GENOMICS, V12, P197, DOI 10.1016/0888-7543(92)90366-Z; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; SCHUCHMAN EH, 1994, METABOLIC MOL BASES, P2601; STEWART CL, 1987, EMBO J, V6, P383, DOI 10.1002/j.1460-2075.1987.tb04766.x; STEWART CL, 1993, METHOD ENZYMOL, V225, P825; SUCHI M, 1992, P NATL ACAD SCI USA, V89, P3227, DOI 10.1073/pnas.89.8.3227; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; YEDGAR S, 1976, BIOCHEMISTRY-US, V15, P2570, DOI 10.1021/bi00657a013	31	392	414	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1995	10	3					288	293		10.1038/ng0795-288	http://dx.doi.org/10.1038/ng0795-288			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670466				2022-12-17	WOS:A1995RG38600011
J	SMITH, SA; EASTON, DF; EVANS, DGR; PONDER, BAJ				SMITH, SA; EASTON, DF; EVANS, DGR; PONDER, BAJ			ALLELE LOSSES IN THE REGION 17Q12-21 IN FAMILIAL BREAST AND OVARIAN-CANCER INVOLVE THE WILD-TYPE CHROMOSOME	NATURE GENETICS			English	Article							GENE; LOCUS	A predisposing gene for breast and ovarian cancer has recently been mapped to chromosome 17q12-21. If this gene is a tumour suppressor gene, allele losses would be expected in the tumours of affected family members and the losses should affect the wild-type chromosome, reflecting the need for inactivation of the wild-type allele at the predisposing locus. In four multiple case breast-ovarian cancer families, we have found that in each of nine tumours which showed allele losses, the losses were from the wild-type chromosome. This suggests that the putative 'breast-ovarian' cancer gene is indeed a tumour suppressor gene.	INST CANC RES,EPIDEMIOL SECT,SUTTON SM2 5NG,SURREY,ENGLAND; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,ENGLAND	University of London; Institute of Cancer Research - UK; University of Manchester	SMITH, SA (corresponding author), UNIV CAMBRIDGE,DEPT PATHOL,CANC RES CAMPAIGN,HUMAN CANC GENET RES GRP,COURT RD,CAMBRIDGE CB2 1QP,ENGLAND.		Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784				ECCLES DM, 1990, ONCOGENE, V5, P1599; FUTREAL PA, 1992, CANCER RES, V52, P2624; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HALL JM, IN PRESS AM J HUM GE; NAROD SA, 1991, LANCET, V338, P82; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; SATO T, 1992, CANCER RES, V52, P1643; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	12	392	402	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					128	131		10.1038/ng1092-128	http://dx.doi.org/10.1038/ng1092-128			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303261				2022-12-17	WOS:A1992JR08400011
J	Wang, JG; Cazzato, E; Ladewig, E; Frattini, V; Rosenbloom, DIS; Zairis, S; Abate, F; Liu, ZQ; Elliott, O; Shin, YJ; Lee, JK; Lee, IH; Park, WY; Eoli, M; Blumberg, AJ; Lasorella, A; Nam, DH; Finocchiaro, G; Iavarone, A; Rabadan, R				Wang, Jiguang; Cazzato, Emanuela; Ladewig, Erik; Frattini, Veronique; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Shin, Yong-Jae; Lee, Jin-Ku; Lee, In-Hee; Park, Woong-Yang; Eoli, Marica; Blumberg, Andrew J.; Lasorella, Anna; Nam, Do-Hyun; Finocchiaro, Gaetano; Iavarone, Antonio; Rabadan, Raul			Clonal evolution of glioblastoma under therapy	NATURE GENETICS			English	Article							TGF-BETA; GENOMIC ALTERATIONS; SEQUENCING DATA; BRAIN-TUMORS; CANCER GENOMICS; MSH6 MUTATIONS; GENE FUSIONS; GLIOMA; TEMOZOLOMIDE; LANDSCAPE	Glioblastoma (GBM) is the most common and aggressive primary brain tumor. To better understand how GBM evolves, we analyzed longitudinal genomic and transcriptomic data from 114 patients. The analysis shows a highly branched evolutionary pattern in which 63% of patients experience expression-based subtype changes. The branching pattern, together with estimates of evolutionary rate, suggests that relapse-associated clones typically existed years before diagnosis. Fifteen percent of tumors present hypermutation at relapse in highly expressed genes, with a clear mutational signature. We find that 11% of recurrence tumors harbor mutations in LTBP4, which encodes a protein binding to TGF-beta. Silencing LTBP4 in GBM cells leads to suppression of TGF-beta activity and decreased cell proliferation. In recurrent GBM with wild-type IDH1, high LTBP4 expression is associated with worse prognosis, highlighting the TGF-b pathway as a potential therapeutic target in GBM.	[Wang, Jiguang; Ladewig, Erik; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Dept Syst Biol, New York, NY USA; [Wang, Jiguang; Ladewig, Erik; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Cazzato, Emanuela; Eoli, Marica; Finocchiaro, Gaetano] Fdn IRCCS Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy; [Frattini, Veronique; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Inst Canc Genet, New York, NY USA; [Shin, Yong-Jae; Lee, Jin-Ku; Lee, In-Hee; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Blumberg, Andrew J.] Univ Texas Austin, Dept Math, Austin, TX 78712 USA; [Lasorella, Anna] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Dept Pathol, New York, NY USA; [Nam, Do-Hyun] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Iavarone, Antonio] Columbia Univ, Dept Neurol, New York, NY USA	Columbia University; Columbia University; IRCCS Istituto Neurologico Besta; Columbia University; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Texas System; University of Texas Austin; Columbia University; Columbia University; Sungkyunkwan University (SKKU); Columbia University	Rabadan, R (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY USA.; Rabadan, R (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY USA.; Finocchiaro, G (corresponding author), Fdn IRCCS Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy.; Iavarone, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY USA.; Nam, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea.; Iavarone, A (corresponding author), Columbia Univ, Dept Pathol, New York, NY USA.; Nam, DH (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Iavarone, A (corresponding author), Columbia Univ, Dept Neurol, New York, NY USA.	nsnam@skku.edu; gaetano.finocchiaro@gmail.com; ai2102@columbia.edu; rr2579@cumc.columbia.edu	Rabadan, Raul/AAZ-7367-2020; Finocchiaro, Gaetano/AAG-6791-2020; Eoli, Marica/K-7748-2016; Wang, Jiguang/B-2717-2012	Eoli, Marica/0000-0003-4744-9377; Lee, In-Hee/0000-0002-8857-1355; Lee, Jin-Ku/0000-0003-0263-3234; Iavarone, Antonio/0000-0002-0683-4634; Rabadan, Raul/0000-0001-7946-9255; Park, Woong-Yang/0000-0003-4234-0380; Wang, Jiguang/0000-0002-6923-4097; Finocchiaro, Gaetano/0000-0003-3583-4040	NIH [U54 CA193313, R01 CA185486, R01 CA179044, R01 CA101644, R01 CA131126, R01 CA178546, R01 NS061776]; Precision Medicine Fellowship [UL1 TR000040]; Cancer Biology Training Program [T32 CA09503]; US National Library of Medicine [T15 LM007079]; Personalized Medicine Fellowship [TL1 TR000082]; NIH (Chemotherapy Foundation); American Brain Tumor Association (ABTA); Italian Ministry of Health; Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health and Welfare, Republic of Korea [HI14C3418]; NATIONAL CANCER INSTITUTE [R01CA185486, T32CA009503, R01CA131126, R01CA101644, R01CA178546, R01CA179044, U54CA193313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000082, UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007079] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Precision Medicine Fellowship; Cancer Biology Training Program; US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Personalized Medicine Fellowship; NIH (Chemotherapy Foundation)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association (ABTA); Italian Ministry of Health(Ministry of Health, Italy); Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	R.R. acknowledges funding from the NIH (U54 CA193313, R01 CA185486, and R01 CA179044). J.W. is supported by a Precision Medicine Fellowship (UL1 TR000040). E.L. is supported by the Cancer Biology Training Program (T32 CA09503). D.I.S.R. is supported by the US National Library of Medicine (T15 LM007079). S.Z. is supported by a Personalized Medicine Fellowship (TL1 TR000082). This work is also supported by NIH grants to A.L. (R01 CA101644 and R01 CA131126) and A.I. (R01 CA178546 and R01 NS061776 and a grant from the Chemotherapy Foundation). V.F. is supported by a fellowship from the American Brain Tumor Association (ABTA). G.F. is partly funded by the Italian Ministry of Health. D.-H.N. is supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI14C3418).	Abate F, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0097-z; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Han JF, 2015, AM J CANCER RES, V5, P945; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Kaminska B, 2013, ADV EXP MED BIOL, V986, P171, DOI 10.1007/978-94-007-4719-7_9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khalili JS, 2012, ONCOIMMUNOLOGY, V1, P1281, DOI 10.4161/onci.21511; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Melamed RD, 2015, J MOL CELL BIOL, V7, P203, DOI 10.1093/jmcb/mjv026; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S2; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-25; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zairis Sakellarios, 2014, Brain Informatics and Health. International Conference, BIH 2014. Proceedings: LNCS 8609, P528, DOI 10.1007/978-3-319-09891-3_48; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	61	391	397	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					768	+		10.1038/ng.3590	http://dx.doi.org/10.1038/ng.3590			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27270107	Bronze, Green Accepted			2022-12-17	WOS:000378840100014
J	Jacobs, KB; Yeager, M; Zhou, WY; Wacholder, S; Wang, ZM; Rodriguez-Santiago, B; Hutchinson, A; Deng, X; Liu, CW; Horner, MJ; Cullen, M; Epstein, CG; Burdett, L; Dean, MC; Chatterjee, N; Sampson, J; Chung, CC; Kovaks, J; Gapstur, SM; Stevens, VL; Teras, LT; Gaudet, MM; Albanes, D; Weinstein, SJ; Virtamo, J; Taylor, PR; Freedman, ND; Abnet, CC; Goldstein, AM; Hu, N; Yu, K; Yuan, JM; Liao, LD; Ding, T; Qiao, YL; Gao, YT; Koh, WP; Xiang, YB; Tang, ZZ; Fan, JH; Aldrich, MC; Amos, C; Blot, WJ; Bock, CH; Gillanders, EM; Harris, CC; Haiman, CA; Henderson, BE; Kolonel, LN; Le Marchand, L; McNeill, LH; Rybicki, BA; Schwartz, AG; Signorello, LB; Spitz, MR; Wiencke, JK; Wrensch, M; Wu, XF; Zanetti, KA; Ziegler, RG; Figueroa, JD; Garcia-Closas, M; Malats, N; Marenne, G; Prokunina-Olsson, L; Baris, D; Schwenn, M; Johnson, A; Landi, MT; Goldin, L; Consonni, D; Bertazzi, PA; Rotunno, M; Rajaraman, P; Andersson, U; Freeman, LEB; Berg, CD; Buring, JE; Butler, MA; Carreon, T; Feychting, M; Ahlbom, A; Gaziano, JM; Giles, GG; Hallmans, G; Hankinson, SE; Hartge, P; Henriksson, R; Inskip, PD; Johansen, C; Landgren, A; McKean-Cowdin, R; Michaud, DS; Melin, BS; Peters, U; Ruder, AM; Sesso, HD; Severi, G; Shu, XO; Visvanathan, K; White, E; Wolk, A; Zeleniuch-Jacquotte, A; Zheng, W; Silverman, DT; Kogevinas, M; Gonzalez, JR; Villa, O; Li, DH; Duell, EJ; Risch, HA; Olson, SH; Kooperberg, C; Wolpin, BM; Jiao, L; Hassan, M; Wheeler, W; Arslan, AA; Bueno-de-Mesquita, HB; Fuchs, CS; Gallinger, S; Gross, MD; Holly, EA; Klein, AP; LaCroix, A; Mandelson, MT; Petersen, G; Boutron-Ruault, MC; Bracci, PM; Canzian, F; Chang, K; Cotterchio, M; Giovannucci, EL; Goggins, M; Bolton, JAH; Jenab, M; Khaw, KT; Krogh, V; Kurtz, RC; McWilliams, RR; Mendelsohn, JB; Rabe, KG; Riboli, E; Tjonneland, A; Tobias, GS; Trichopoulos, D; Elena, JW; Yu, H; Amundadottir, L; Stolzenberg-Solomon, RZ; Kraft, P; Schumacher, F; Stram, D; Savage, SA; Mirabello, L; Andrulis, IL; Wunder, JS; Garcia, AP; Sierrasesumaga, L; Barkauskas, DA; Gorlick, RG; Purdue, M; Chow, WH; Moore, LE; Schwartz, KL; Davis, FG; Hsing, AW; Berndt, SI; Black, A; Wentzensen, N; Brinton, LA; Lissowska, J; Peplonska, B; McGlynn, KA; Cook, MB; Graubard, BI; Kratz, CP; Greene, MH; Erickson, RL; Hunter, DJ; Thomas, G; Hoover, RN; Real, FX; Fraumeni, JF; Caporaso, NE; Tucker, M; Rothman, N; Perez-Jurado, LA; Chanock, SJ				Jacobs, Kevin B.; Yeager, Meredith; Zhou, Weiyin; Wacholder, Sholom; Wang, Zhaoming; Rodriguez-Santiago, Benjamin; Hutchinson, Amy; Deng, Xiang; Liu, Chenwei; Horner, Marie-Josephe; Cullen, Michael; Epstein, Caroline G.; Burdett, Laurie; Dean, Michael C.; Chatterjee, Nilanjan; Sampson, Joshua; Chung, Charles C.; Kovaks, Joseph; Gapstur, Susan M.; Stevens, Victoria L.; Teras, Lauren T.; Gaudet, Mia M.; Albanes, Demetrius; Weinstein, Stephanie J.; Virtamo, Jarmo; Taylor, Philip R.; Freedman, Neal D.; Abnet, Christian C.; Goldstein, Alisa M.; Hu, Nan; Yu, Kai; Yuan, Jian-Min; Liao, Linda; Ding, Ti; Qiao, You-Lin; Gao, Yu-Tang; Koh, Woon-Puay; Xiang, Yong-Bing; Tang, Ze-Zhong; Fan, Jin-Hu; Aldrich, Melinda C.; Amos, Christopher; Blot, William J.; Bock, Cathryn H.; Gillanders, Elizabeth M.; Harris, Curtis C.; Haiman, Christopher A.; Henderson, Brian E.; Kolonel, Laurence N.; Le Marchand, Loic; McNeill, Lorna H.; Rybicki, Benjamin A.; Schwartz, Ann G.; Signorello, Lisa B.; Spitz, Margaret R.; Wiencke, John K.; Wrensch, Margaret; Wu, Xifeng; Zanetti, Krista A.; Ziegler, Regina G.; Figueroa, Jonine D.; Garcia-Closas, Montserrat; Malats, Nuria; Marenne, Gaelle; Prokunina-Olsson, Ludmila; Baris, Dalsu; Schwenn, Molly; Johnson, Alison; Landi, Maria Teresa; Goldin, Lynn; Consonni, Dario; Bertazzi, Pier Alberto; Rotunno, Melissa; Rajaraman, Preetha; Andersson, Ulrika; Freeman, Laura E. Beane; Berg, Christine D.; Buring, Julie E.; Butler, Mary A.; Carreon, Tania; Feychting, Maria; Ahlbom, Anders; Gaziano, J. Michael; Giles, Graham G.; Hallmans, Goran; Hankinson, Susan E.; Hartge, Patricia; Henriksson, Roger; Inskip, Peter D.; Johansen, Christoffer; Landgren, Annelie; McKean-Cowdin, Roberta; Michaud, Dominique S.; Melin, Beatrice S.; Peters, Ulrike; Ruder, Avima M.; Sesso, Howard D.; Severi, Gianluca; Shu, Xiao-Ou; Visvanathan, Kala; White, Emily; Wolk, Alicja; Zeleniuch-Jacquotte, Anne; Zheng, Wei; Silverman, Debra T.; Kogevinas, Manolis; Gonzalez, Juan R.; Villa, Olaya; Li, Donghui; Duell, Eric J.; Risch, Harvey A.; Olson, Sara H.; Kooperberg, Charles; Wolpin, Brian M.; Jiao, Li; Hassan, Manal; Wheeler, William; Arslan, Alan A.; Bueno-de-Mesquita, H. Bas; Fuchs, Charles S.; Gallinger, Steven; Gross, Myron D.; Holly, Elizabeth A.; Klein, Alison P.; LaCroix, Andrea; Mandelson, Margaret T.; Petersen, Gloria; Boutron-Ruault, Marie-Christine; Bracci, Paige M.; Canzian, Federico; Chang, Kenneth; Cotterchio, Michelle; Giovannucci, Edward L.; Goggins, Michael; Bolton, Judith A. Hoffman; Jenab, Mazda; Khaw, Kay-Tee; Krogh, Vittorio; Kurtz, Robert C.; McWilliams, Robert R.; Mendelsohn, Julie B.; Rabe, Kari G.; Riboli, Elio; Tjonneland, Anne; Tobias, Geoffrey S.; Trichopoulos, Dimitrios; Elena, Joanne W.; Yu, Herbert; Amundadottir, Laufey; Stolzenberg-Solomon, Rachael Z.; Kraft, Peter; Schumacher, Fredrick; Stram, Daniel; Savage, Sharon A.; Mirabello, Lisa; Andrulis, Irene L.; Wunder, Jay S.; Patino Garcia, Ana; Sierrasesumaga, Luis; Barkauskas, Donald A.; Gorlick, Richard G.; Purdue, Mark; Chow, Wong-Ho; Moore, Lee E.; Schwartz, Kendra L.; Davis, Faith G.; Hsing, Ann W.; Berndt, Sonja I.; Black, Amanda; Wentzensen, Nicolas; Brinton, Louise A.; Lissowska, Jolanta; Peplonska, Beata; McGlynn, Katherine A.; Cook, Michael B.; Graubard, Barry I.; Kratz, Christian P.; Greene, Mark H.; Erickson, Ralph L.; Hunter, David J.; Thomas, Gilles; Hoover, Robert N.; Real, Francisco X.; Fraumeni, Joseph F., Jr.; Caporaso, Neil E.; Tucker, Margaret; Rothman, Nathaniel; Perez-Jurado, Luis A.; Chanock, Stephen J.			Detectable clonal mosaicism and its relationship to aging and cancer	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOMIC IMBALANCES; MAFFUCCI SYNDROME; OLLIER DISEASE; MUTATIONS; SUSCEPTIBILITY; ASSOCIATION; ABERRATIONS; MECHANISMS; ANEUPLOIDY	In an analysis of 31,717 cancer cases and 26,136 cancer-free controls from 13 genome-wide association studies, we observed large chromosomal abnormalities in a subset of clones in DNA obtained from blood or buccal samples. We observed mosaic abnormalities, either aneuploidy or copy-neutral loss of heterozygosity, of > 2 Mb in size in autosomes of 517 individuals (0.89%), with abnormal cell proportions of between 7% and 95%. In cancer-free individuals, frequency increased with age, from 0.23% under 50 years to 1.91% between 75 and 79 years (P = 4.8 x 10(-8)). Mosaic abnormalities were more frequent in individuals with solid tumors (0.97% versus 0.74% in cancer-free individuals; odds ratio (OR) = 1.25; P = 0.016), with stronger association with cases who had DNA collected before diagnosis or treatment (OR = 1.45; P = 0.0005). Detectable mosaicism was also more common in individuals for whom DNA was collected at least 1 year before diagnosis with leukemia compared to cancer-free individuals (OR = 35.4; P = 3.8 x 10(-11)). These findings underscore the time-dependent nature of somatic events in the etiology of cancer and potentially other late-onset diseases.	[Jacobs, Kevin B.; Yeager, Meredith; Zhou, Weiyin; Wacholder, Sholom; Wang, Zhaoming; Hutchinson, Amy; Deng, Xiang; Liu, Chenwei; Horner, Marie-Josephe; Cullen, Michael; Epstein, Caroline G.; Burdett, Laurie; Chatterjee, Nilanjan; Sampson, Joshua; Chung, Charles C.; Kovaks, Joseph; Albanes, Demetrius; Weinstein, Stephanie J.; Taylor, Philip R.; Freedman, Neal D.; Abnet, Christian C.; Goldstein, Alisa M.; Hu, Nan; Yu, Kai; Liao, Linda; Ziegler, Regina G.; Figueroa, Jonine D.; Garcia-Closas, Montserrat; Prokunina-Olsson, Ludmila; Baris, Dalsu; Landi, Maria Teresa; Goldin, Lynn; Rotunno, Melissa; Rajaraman, Preetha; Freeman, Laura E. Beane; Hartge, Patricia; Inskip, Peter D.; Landgren, Annelie; Silverman, Debra T.; Mendelsohn, Julie B.; Tobias, Geoffrey S.; Amundadottir, Laufey; Stolzenberg-Solomon, Rachael Z.; Savage, Sharon A.; Mirabello, Lisa; Purdue, Mark; Chow, Wong-Ho; Moore, Lee E.; Hsing, Ann W.; Berndt, Sonja I.; Black, Amanda; Wentzensen, Nicolas; Brinton, Louise A.; McGlynn, Katherine A.; Cook, Michael B.; Graubard, Barry I.; Kratz, Christian P.; Greene, Mark H.; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Caporaso, Neil E.; Tucker, Margaret; Rothman, Nathaniel; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Jacobs, Kevin B.; Yeager, Meredith; Zhou, Weiyin; Wang, Zhaoming; Hutchinson, Amy; Deng, Xiang; Liu, Chenwei; Cullen, Michael; Burdett, Laurie] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Rodriguez-Santiago, Benjamin; Villa, Olaya; Real, Francisco X.; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Rodriguez-Santiago, Benjamin; Villa, Olaya; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Rodriguez-Santiago, Benjamin; Villa, Olaya] qGenomics, Quantitat Genom Med Lab, Barcelona, Spain; [Dean, Michael C.] NCI, Expt Immunol Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Gapstur, Susan M.; Stevens, Victoria L.; Teras, Lauren T.; Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Yuan, Jian-Min] Univ Minnesota, Sch Publ Hlth, Dept Epidemiol & Community Hlth, Minneapolis, MN USA; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Ding, Ti; Tang, Ze-Zhong] Shanxi Canc Hosp, Taiyuan, Peoples R China; [Qiao, You-Lin; Fan, Jin-Hu] Chinese Acad Med Sci, Dept Epidemiol, Canc Inst Hosp, Beijing 100730, Peoples R China; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Shanghai, Peoples R China; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Aldrich, Melinda C.] Vanderbilt Univ, Sch Med, Dept Thorac Surg, Nashville, TN 37212 USA; [Aldrich, Melinda C.; Blot, William J.; Signorello, Lisa B.; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN USA; [Amos, Christopher; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Gillanders, Elizabeth M.; Zanetti, Krista A.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Harris, Curtis C.; Zanetti, Krista A.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Haiman, Christopher A.; Henderson, Brian E.; McKean-Cowdin, Roberta; Schumacher, Fredrick; Stram, Daniel; Barkauskas, Donald A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Div Off Vice President Canc Prevent & Populat Sci, Houston, TX 77030 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Ctr Community Engaged & Translat Res, Duncan Family Inst, Houston, TX 77030 USA; [Rybicki, Benjamin A.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Signorello, Lisa B.; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Spitz, Margaret R.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Wiencke, John K.; Wrensch, Margaret] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Malats, Nuria; Marenne, Gaelle] CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Consonni, Dario; Bertazzi, Pier Alberto] Univ Milan, Dept Occupat & Environm Hlth, Milan, Italy; [Consonni, Dario; Bertazzi, Pier Alberto] Osped Maggiore Policlin Mangiagalli & Regina Elen, Unit Epidemiol, Fdn Ist Ricevero & Cura Carattere Sci IRCCS, Milan, Italy; [Andersson, Ulrika; Henriksson, Roger; Melin, Beatrice S.] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Berg, Christine D.; Elena, Joanne W.] NCI, Clin & Translat Epidemiol Branch, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Buring, Julie E.; Gaziano, J. Michael; Sesso, Howard D.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA; [Butler, Mary A.; Carreon, Tania; Ruder, Avima M.] NIOSH, Ctr Dis Control & Prevent, Cincinnati, OH 45226 USA; [Feychting, Maria; Ahlbom, Anders] Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden; [Gaziano, J. Michael] Harvard Univ, Sch Med, Div Aging, Brigham & Womens Hosp, Boston, MA 02115 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hankinson, Susan E.; Wolpin, Brian M.; Fuchs, Charles S.; Giovannucci, Edward L.; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Med, Channing Lab, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Henriksson, Roger] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Johansen, Christoffer; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Michaud, Dominique S.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Div Epidemiol & Biostat, London, England; [Michaud, Dominique S.] Brown Univ, Div Biol & Med, Dept Epidemiol, Providence, RI 02912 USA; [Peters, Ulrike; White, Emily; Kooperberg, Charles; LaCroix, Andrea; Mandelson, Margaret T.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Peters, Ulrike; White, Emily] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Visvanathan, Kala; Bolton, Judith A. Hoffman] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden; [Zeleniuch-Jacquotte, Anne] NYU, Dept Environm Med, Sch Med, Div Epidemiol, New York, NY 10016 USA; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Kogevinas, Manolis; Gonzalez, Juan R.] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Gonzalez, Juan R.] IMIM, Barcelona, Spain; [Kogevinas, Manolis; Gonzalez, Juan R.] CIBERESP, Barcelona, Spain; [Li, Donghui; Hassan, Manal] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Duell, Eric J.] Inst Invest Biomed Bellvitge IDIBELL, Catalan Inst Oncol ICO, Barcelona, Spain; [Risch, Harvey A.; Yu, Herbert] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Olson, Sara H.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Wolpin, Brian M.; Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jiao, Li] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Wheeler, William] Informat Management Serv Inc, Silver Spring, MD USA; [Arslan, Alan A.] NYU, Dept Obstet & Gynecol, Sch Med, New York, NY 10016 USA; [Arslan, Alan A.] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Arslan, Alan A.] NYU, Inst Canc, New York, NY USA; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Gallinger, Steven; Andrulis, Irene L.; Wunder, Jay S.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Gross, Myron D.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Holly, Elizabeth A.; Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Klein, Alison P.; Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Mandelson, Margaret T.] Grp Hlth Ctr Hlth Studies, Seattle, WA USA; [Petersen, Gloria; Rabe, Kari G.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Boutron-Ruault, Marie-Christine] Univ Paris Sud, INSERM, Inst Gustave Roussy, Villejuif, France; [Canzian, Federico] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chang, Kenneth] Univ Calif Irvine, Med Ctr, Comprehens Digest Dis Ctr, Orange, CA USA; [Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Giovannucci, Edward L.; Trichopoulos, Dimitrios; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Jenab, Mazda] Int Agcy Res Canc, World Hlth Org, F-69372 Lyon, France; [Khaw, Kay-Tee] Univ Cambridge, Addenbrookes Hosp, Dept Publ Hlth & Primary Care, Cambridge CB2 2QQ, England; [Krogh, Vittorio] Ist Nazl Tumori, IRCCS, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Kurtz, Robert C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [McWilliams, Robert R.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Andrulis, Irene L.; Wunder, Jay S.] Mt Sinai Hosp, Christopher Sharp Ctr Surg & Oncol, Toronto, ON M5G 1X5, Canada; [Patino Garcia, Ana; Sierrasesumaga, Luis] Univ Navarra Clin, Dept Pediat, Pamplona, Spain; [Gorlick, Richard G.] Yeshiva Univ, Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY USA; [Gorlick, Richard G.] Yeshiva Univ, Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Schwartz, Kendra L.] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Davis, Faith G.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Peplonska, Beata] Nofer Inst Occupat Med, Lodz, Poland; [Kratz, Christian P.] Hannover Med Sch, Klin Padiatr Hematol & Onkol, Zentrum Kinderheilkunde & Jugendmed, D-30623 Hannover, Germany; [Erickson, Ralph L.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Thomas, Gilles] Univ Lyon 1, Ctr Leon Berard, F-69365 Lyon, France; [Real, Francisco X.] CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; Finland National Institute for Health & Welfare; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Shanghai Jiao Tong University; National University of Singapore; Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Henry Ford Health System; Henry Ford Hospital; Vanderbilt University; Baylor College of Medicine; University of California System; University of California San Francisco; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Umea University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Karolinska Institutet; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Cancer Council Victoria; University of Melbourne; Umea University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Karolinska Institutet; Karolinska University Hospital; Danish Cancer Society; Imperial College London; Brown University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Karolinska Institutet; New York University; National & Kapodistrian University of Athens; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Texas System; UTMD Anderson Cancer Center; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Yale University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Baylor College of Medicine; Information Management Services, Inc.; New York University; New York University; New York University; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Johns Hopkins University; Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California Irvine; University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; World Health Organization; International Agency for Research on Cancer (IARC); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Fondazione IRCCS Istituto Nazionale Tumori Milan; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Academy of Athens; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Navarra; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; Hannover Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centro Nacional de Investigaciones Oncologicas (CNIO)	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	chanocks@mail.nih.gov	Brinton, Louise A/G-7486-2015; Aldrich, Melinda/C-7783-2013; Dean, Michael C/G-8172-2012; Gao, Y./GWZ-3665-2022; Wang, Zhaoming/R-5527-2018; Kogevinas, Manolis/C-3918-2017; Figueroa, Jonine/AFK-2752-2022; Purdue, Mark P/C-9228-2016; Gao, Yu/HGE-1937-2022; Tobias, Geoffrey S/M-4135-2016; Pérez Jurado, Luis Alberto/M-7706-2015; Figueroa, Jonine/AAG-1065-2022; Tucker, Margaret A/B-4297-2015; Garcia-Closas, Montserrat/AAZ-6930-2021; Amundadottir, Laufey T/L-7656-2016; Gallinger, Steven/E-4575-2013; Prokunina-Olsson, Ludmila/V-7960-2019; Mirabello, Lisa/H-5594-2018; Abnet, Christian C/C-4111-2015; Malats, Nuria/H-7041-2015; Berndt, Sonja I/J-8423-2016; Canzian, Federico/I-2804-2014; Visvanathan, Kumar/AAC-4349-2020; Prokunina-Olsson, Ludmila/A-8240-2019; bertazzi, pietro alberto/D-5039-2017; Cook, Michael B/A-5641-2009; Garcia-Closas, Montserrat/F-3871-2015; Krogh, Vittorio/K-2628-2016; Rybicki, Benjamin/L-4614-2019; Patiño-Garcia, Ana/I-4299-2012; Lissowska, Jolanta/AAH-3252-2020; Figueroa, Jonine/GWD-1322-2022; Krogh, Vittorio/AAA-9171-2019; Yeager, Meredith/AAA-5322-2020; Albanes, Demetrius/B-9749-2015; Wentzensen, Nicolas/AAG-8522-2019; Consonni, Dario/K-7943-2016; Arribas, Francisco X Real/H-5275-2015; Kratz, Christian/AAC-9726-2021; Savage, Sharon A/B-9747-2015; Qiao, You-Lin/B-4139-2012; gao, yi/HCI-8298-2022; Berg, Christine/K-1047-2014; Boutron-Ruault, Marie-Christine/H-3936-2014; zhang, weihua/GXV-1334-2022; Marenne, Gaelle/AAU-8338-2020; Freeman, Laura E. Beane/C-4468-2015; Stolzenberg-Solomon, Rachael/Y-9280-2018; Freedman, Neal David/B-9741-2015; Zheng, Wei/O-3351-2013; Dean, Michael/R-7501-2019; Weinstein, Stephanie J/P-1627-2017; Peplonska, Beata/F-6004-2010; Severi, Gianluca/H-3774-2018; Severi, Gianluca/Q-1824-2019; Peplonska, Beata/AAO-1265-2020; Savage, Sharon/AAB-5160-2019; Andrulis, Irene L./E-7267-2013; Khaw, Kay-Tee/AAZ-3209-2021; Gonzalez, Juan R/B-7860-2018; Schumacher, Fredrick/R-6043-2019; Michaud, Dominique S/I-5231-2014; Henriksson, Roger/AAI-8608-2020; Ruder, Avima/I-4155-2012; Consonni, Dario/AAM-2947-2020; Liao, Linda M/B-3960-2011; Johansen, Christoffer/AAG-7916-2020	Brinton, Louise A/0000-0003-3853-8562; Dean, Michael C/0000-0003-2234-0631; Wang, Zhaoming/0000-0001-7556-3869; Kogevinas, Manolis/0000-0002-9605-0461; Figueroa, Jonine/0000-0002-5100-623X; Purdue, Mark P/0000-0003-1177-3108; Tobias, Geoffrey S/0000-0002-2878-8253; Figueroa, Jonine/0000-0002-5100-623X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Amundadottir, Laufey T/0000-0003-1859-8971; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Abnet, Christian C/0000-0002-3008-7843; Malats, Nuria/0000-0003-2538-3784; Visvanathan, Kumar/0000-0002-1176-5442; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; bertazzi, pietro alberto/0000-0003-3475-2449; Cook, Michael B/0000-0002-0533-7302; Garcia-Closas, Montserrat/0000-0003-1033-2650; Krogh, Vittorio/0000-0003-0122-8624; Rybicki, Benjamin/0000-0003-3190-3467; Patiño-Garcia, Ana/0000-0002-4066-8203; Lissowska, Jolanta/0000-0003-2695-5799; Figueroa, Jonine/0000-0002-5100-623X; Krogh, Vittorio/0000-0003-0122-8624; Consonni, Dario/0000-0002-8935-3843; Arribas, Francisco X Real/0000-0001-9501-498X; Savage, Sharon A/0000-0001-6006-0740; Qiao, You-Lin/0000-0001-6380-0871; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Marenne, Gaelle/0000-0002-4363-7170; Freeman, Laura E. Beane/0000-0003-1294-4124; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Freedman, Neal David/0000-0003-0074-1098; Zheng, Wei/0000-0003-1226-070X; Weinstein, Stephanie J/0000-0002-3834-1535; Severi, Gianluca/0000-0001-7157-419X; Severi, Gianluca/0000-0001-7157-419X; Peplonska, Beata/0000-0003-3915-2872; Savage, Sharon/0000-0001-6006-0740; Gonzalez, Juan R/0000-0003-3267-2146; Schumacher, Fredrick/0000-0002-3073-7463; Ruder, Avima/0000-0003-0419-6664; Consonni, Dario/0000-0002-8935-3843; Liao, Linda M/0000-0002-1923-5294; Johansen, Christoffer/0000-0002-4384-206X; Jenab, Mazda/0000-0002-0573-1852; Arslan, Alan/0000-0002-7775-8085; Yuan, Jian-Min/0000-0002-4620-3108; Riboli, Elio/0000-0001-6795-6080; fan, jinhu/0000-0003-3159-7893; Duell, Eric J/0000-0001-5256-0163; Canzian, Federico/0000-0002-4261-4583; GORLICK, RICHARD/0000-0001-8995-2929; Giles, Graham/0000-0003-4946-9099; Jacobs, Kevin/0000-0002-4657-6473; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Olson, Sara/0000-0003-0182-2754; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852; Tjonneland, Anne/0000-0003-4385-2097; Carreon, Tania/0000-0003-1745-0852	Intramural Research Program; US National Institutes of Health (NIH), NCI [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA098661, P50CA102701, ZICCP010178, R01CA092447, R01CA127219, ZIABC011300, R01CA097193] Funding Source: NIH RePORTER; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish	Intramural Research Program; US National Institutes of Health (NIH), NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program and by contract number HHSN261200800001E of the US National Institutes of Health (NIH), NCI. Support for each contributing study is listed in the Supplementary Note. We thank C. Laurie and B. Weir for constructive discussion and a comparison of methodology and results for the GENEVA study. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Cancer Institute, the National Institute for Occupational Safety and Health or the Maryland Cancer Registry.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Benetatos L, 2011, INT J CANCER, V129, P773, DOI 10.1002/ijc.26052; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frio TR, 2010, NEW ENGL J MED, V363, P2628, DOI 10.1056/NEJMoa1006565; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; Hafner C, 2011, NEW ENGL J MED, V365, P1940, DOI 10.1056/NEJMc1109381; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; HSU LYF, 1992, PRENATAL DIAG, V12, P555, DOI 10.1002/pd.1970120702; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lanasa MC, 2011, LEUKEMIA, V25, P1459, DOI 10.1038/leu.2011.117; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Mitelman F, 2009, CANC CYTOGENETICS; Notini AJ, 2008, CYTOGENET GENOME RES, V123, P270, DOI 10.1159/000184717; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pekarsky Y, 2010, SEMIN CANCER BIOL, V20, P370, DOI 10.1016/j.semcancer.2010.09.003; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pique-Regi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-380; Rodiguez-Santiago B., 2010, AM J HUM GENET, V87, P129; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	43	391	401	0	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					651	U68		10.1038/ng.2270	http://dx.doi.org/10.1038/ng.2270			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561519	Green Accepted, Green Submitted			2022-12-17	WOS:000304551100011
J	Harvey, NL; Srinivasan, RS; Dillard, ME; Johnson, NC; Witte, MH; Boyd, K; Sleeman, MW; Oliver, G				Harvey, NL; Srinivasan, RS; Dillard, ME; Johnson, NC; Witte, MH; Boyd, K; Sleeman, MW; Oliver, G			Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity	NATURE GENETICS			English	Article							ENDOTHELIAL-CELL-LINEAGE; ADIPOSE-TISSUE; LYMPHOID-CELLS; LIVER; RECEPTOR; NODES; GENE; DIFFERENTIATION; LYMPHEDEMA; EXPRESSION	Multiple organs cooperate to regulate appetite, metabolism, and glucose and fatty acid homeostasis. Here, we identified and characterized lymphatic vasculature dysfunction as a cause of adult-onset obesity. We found that functional inactivation of a single allele of the homeobox gene Prox1 led to adult-onset obesity due to abnormal lymph leakage from mispatterned and ruptured lymphatic vessels. Prox1 heterozygous mice are a new model for adult-onset obesity and lymphatic vascular disease.	St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85724 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Arizona; Regeneron	Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	guillermo.oliver@stjude.org		Harvey, Natasha/0000-0001-9839-8966				Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Brorson H, 2003, Scand J Surg, V92, P287; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; DIGIROLAMO M, 1971, AM J PHYSIOL, V221, P850, DOI 10.1152/ajplegacy.1971.221.3.850; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Esther CR, 2004, PEDIATR PULM, V38, P308, DOI 10.1002/ppul.20100; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; HO MK, 1982, J IMMUNOL, V128, P1221; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mattacks CA, 2003, J ANAT, V202, P551, DOI 10.1046/j.1469-7580.2003.00188.x; NOUGUES J, 1988, INT J OBESITY, V12, P321; POND CM, 1995, J LIPID RES, V36, P2219; Pond CM, 2003, BRIT J NUTR, V89, P375, DOI 10.1079/BJN2002784; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan L, 2002, DEVELOPMENT, V129, P4797; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	33	391	411	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2005	37	10					1072	1081		10.1038/ng1642	http://dx.doi.org/10.1038/ng1642			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16170315				2022-12-17	WOS:000232185600018
J	Gibbons, RJ; McDowell, TL; Raman, S; O'Rourke, DM; Garrick, D; Ayyub, H; Higgs, DR				Gibbons, RJ; McDowell, TL; Raman, S; O'Rourke, DM; Garrick, D; Ayyub, H; Higgs, DR			Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation	NATURE GENETICS			English	Article							SEQUENCES; REGION	A goal of molecular genetics is to understand the relationship between basic nuclear processes, epigenetic changes and the numerous proteins that orchestrate these effects. One such protein, ATRX, contains a highly conserved plant homeodomain (PHD)-like domain, present in many chromatin-associated proteins, and a carboxy-terminal domain which identifies it as a member of the SNF2 family of helicase/ATPases(1,2). Mutations in ATRX give rise to characteristic developmental abnormalities including severe mental retardation, facial dysmorphism, urogenital abnormalities and alpha-thalassaemia(1). This circumstantial evidence suggests that ATRX may act as a transcriptional regulator through an effect on chromatin. We have recently shown that ATRX is localized to pericentromeric heterochromatin during interphase and mitosis, suggesting that ATRX might exert other chromatin-mediated effects in the nucleus. Moreover, at metaphase, some ATRX is localized at or close to the ribosomal DNA (rDNA) arrays on the short arms of human acrocentric chromosomes(3). Here we show that mutations in ATRX give rise to changes in the pattern of methylation of several highly repeated sequences including the rDNA arrays, a Y-specific satellite and subtelomeric repeats. Our findings provide a potential link between the processes of chromatin remodelling, DNA methylation and gene expression in mammalian development.	John Radcliffe Hosp, Inst Mol Med, MRC Mol Haematol, Oxford OX3 9DU, England; Univ Oxford, Nuffield Dept Clin Lab, Oxford, England	University of Oxford; University of Oxford	Higgs, DR (corresponding author), John Radcliffe Hosp, Inst Mol Med, MRC Mol Haematol, Oxford OX3 9DU, England.		Garrick, David/F-1728-2017; GARRICK, David/O-5734-2019	Garrick, David/0000-0001-7422-7986; GARRICK, David/0000-0001-7422-7986				BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; FROMMER M, 1984, NUCLEIC ACIDS RES, V12, P2887, DOI 10.1093/nar/12.6.2887; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Goenechea L. G., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P841; Jacobsen SE, 1999, CURR BIOL, V9, pR617, DOI 10.1016/S0960-9822(99)80388-1; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; KAKUTANI T, 1995, NUCLEIC ACIDS RES, V23, P130, DOI 10.1093/nar/23.1.130; Kakutani T, 1999, GENETICS, V151, P831; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; TASSERONDEJONG JG, 1988, GENE, V74, P147, DOI 10.1016/0378-1119(88)90272-7; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	20	391	407	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					368	371		10.1038/74191	http://dx.doi.org/10.1038/74191			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742099				2022-12-17	WOS:000086192800014
J	Bilaud, T; Brun, C; Ancelin, K; Koering, CE; Laroche, T; Gilson, E				Bilaud, T; Brun, C; Ancelin, K; Koering, CE; Laroche, T; Gilson, E			Telomeric localization of TRF2, a novel human telobox protein	NATURE GENETICS			English	Article							CHROMOSOMES; CHROMATIN; MYB	Natural chromosomal ends are stabilized by proteins that bind duplex telomeric DNA repeats. In human cells, the TTAGGG Repeat factor 1 (TRF1) was identified by two independent studies, one screening for factors that bind duplex telomeric DNA(1,2) and the other screening for proteins containing a particular Myb motif called the telobox, which is required for telomeric repeat recognition (Fig. 1a; refs 3-5). A second human open reading frame, orf2, contains a telobox sequence and encodes a polypeptide that specifically recognizes mammalian telomeric repeat DNA in vitro(3). We show that two proteins of 65 and 69 kD, expressed in HeLa cells, contain the orf2 telobox sequence. These proteins are collectively termed TRF2. Affinity-purified antibodies specific for anti-TRF2 label the telomeres of intact human chromosomes, strengthening the correlation between occurrence of telobox and telomere-repeat recognition in vivo.	ECOLE NORMALE SUPER LYON,BIOL CELLULAIRE & MOL LAB,CNRS,UMR 49,F-69364 LYON 07,FRANCE; SWISS INST EXPT CANC RES,CH-1066 EPALINGES,SWITZERLAND	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Swiss Institute Experimental Cancer Research			Ancelin, Katia/R-1719-2019; Brun, Christine/B-4922-2008	Brun, Christine/0000-0002-5563-6765; Ancelin, Katia/0000-0002-2117-9754				ALFONSO PJ, 1994, J MOL BIOL, V236, P189, DOI 10.1006/jmbi.1994.1128; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Broccoli D, 1997, HUM MOL GENET, V6, P69, DOI 10.1093/hmg/6.1.69; Brun C, 1997, TRENDS CELL BIOL, V7, P317, DOI 10.1016/S0962-8924(97)01092-1; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; GASSER SM, 1987, EXP CELL RES, V173, P85, DOI 10.1016/0014-4827(87)90334-X; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Lipsick JS, 1996, ONCOGENE, V13, P223; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; MUYLDERMANS S, 1994, NUCLEIC ACIDS RES, V22, P5635, DOI 10.1093/nar/22.25.5635; Nickerson JA, 1997, P NATL ACAD SCI USA, V94, P4446, DOI 10.1073/pnas.94.9.4446; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	19	391	404	0	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					236	239		10.1038/ng1097-236	http://dx.doi.org/10.1038/ng1097-236			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326951				2022-12-17	WOS:A1997XZ55500037
J	Comuzzie, AG; Hixson, JE; Almasy, L; Mitchell, BD; Mahaney, MC; Dyer, TD; Stern, MP; MacCluer, JW; Blangero, J				Comuzzie, AG; Hixson, JE; Almasy, L; Mitchell, BD; Mahaney, MC; Dyer, TD; Stern, MP; MacCluer, JW; Blangero, J			A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2	NATURE GENETICS			English	Article							APOLIPOPROTEIN-B GENE; OBESE GENE; PEDIGREE ANALYSIS; ADIPOSE-TISSUE; OB GENE; WEIGHT; EXPRESSION; PROTEIN; POLYMORPHISM; INHERITANCE	Obesity is a major predisposing factor for the development of several chronic diseases including non-insulin dependent diabetes mellitus (NIDDM) and coronary heart disease (CHD). Leptin is a serum protein which is secreted by adipocytes(1-4) and thought to play a role in the regulation of body fat(5-8). Leptin levels in humans have been found to be highly correlated with an individual's total adiposity(8,9). We performed a genome-wide scan and conducted multipoint linkage analysis using a general pedigree-based variance component approach to identify genes with measurable effects on quantitative variation in leptin levels in Mexican Americans. A microsatellite polymorphism, D2S1788, mapped to chromosome 2p21 (approximately 74 cM from the tip of the short arm) and showed strong evidence of linkage with serum leptin levels with a lod score of 4.95 (P = 9 x 10(-7)). This locus accounted for 47% of the variation in serum leptin levels, with a residual additive genetic component contributing an additional 24%. This region contains several potential candidate genes for obesity, including glucokinase regulatory protein (GCKR) and pro-opiomelanocortin (POMC). Our results show strong evidence of linkage of this region of chromosome 2 with serum leptin levels and indicate that this region could contain an important human obesity gene.	UNIV TEXAS, HLTH SCI CTR, DEPT MED, DIV CLIN EPIDEMIOL, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio	Comuzzie, AG (corresponding author), SW FDN BIOMED RES, DEPT GENET, POB 760549, SAN ANTONIO, TX 78245 USA.		Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021; Mitchell, Braxton/CAF-0876-2022	Hixson, James/0000-0002-0849-9315; Mitchell, Braxton/0000-0003-4920-4744	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522, P01HL028972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015803] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45522, HL28972] Funding Source: Medline; NIGMS NIH HHS [GM15803] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOS CI, 1994, AM J HUM GENET, V54, P535; Blangero J, 1996, 6 SW FDN BIOM RES PO; BOTTINI E, 1990, HUM BIOL, V62, P403; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Davis S, 1996, AM J HUM GENET, V58, P867; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Duggirala R, 1996, AM J HUM GENET, V59, P694; Frisancho AR, 1990, ANTHROPOMETRIC STAND; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Green P, 1990, DOCUMENTATION CRI MA; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; HASSTEDT SJ, 1989, AM J HUM GENET, V45, P917; HAUTANEN A, 1993, J INTERN MED, V234, P461, DOI 10.1111/j.1365-2796.1993.tb00779.x; HAZUDA HP, 1991, AM J CLIN NUTR, V53, pS1529, DOI 10.1093/ajcn/53.6.1529S; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Klein S, 1996, DIABETES, V45, P984, DOI 10.2337/diabetes.45.7.984; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; Ma ZM, 1996, CLIN CHEM, V42, P942; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MAHANEY MC, 1995, CIRCULATION, V92, P3240, DOI 10.1161/01.CIR.92.11.3240; MASUZAKI H, 1995, DIABETES, V44, P855, DOI 10.2337/diabetes.44.7.855; Mitchell BD, 1996, ARTERIOSCL THROM VAS, V16, P281, DOI 10.1161/01.ATV.16.2.281; Mitchell Braxton D., 1993, Ethnicity and Disease, V3, P22; MURAKAMI T, 1995, BIOCHEM BIOPH RES CO, V214, P1260, DOI 10.1006/bbrc.1995.2422; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; POULIOT MC, 1994, ARTERIOSCLER THROMB, V14, P527, DOI 10.1161/01.ATV.14.4.527; PRICE RA, 1990, HUM BIOL, V62, P747; RAJPUTWILLIAMS J, 1988, LANCET, V2, P1442; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; RICE T, 1993, AM J HUM GENET, V52, P967; SAHA N, 1993, CLIN GENET, V44, P113; WARNER JP, 1995, MAMM GENOME, V6, P532, DOI 10.1007/BF00356171; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	41	391	405	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					273	276		10.1038/ng0397-273	http://dx.doi.org/10.1038/ng0397-273			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054940				2022-12-17	WOS:A1997WK38600017
J	Saitsu, H; Kato, M; Mizuguchi, T; Hamada, K; Osaka, H; Tohyama, J; Uruno, K; Kumada, S; Nishiyama, K; Nishimura, A; Okada, I; Yoshimura, Y; Hirai, S; Kumada, T; Hayasaka, K; Fukuda, A; Ogata, K; Matsumoto, N				Saitsu, Hirotomo; Kato, Mitsuhiro; Mizuguchi, Takeshi; Hamada, Keisuke; Osaka, Hitoshi; Tohyama, Jun; Uruno, Katsuhisa; Kumada, Satoko; Nishiyama, Kiyomi; Nishimura, Akira; Okada, Ippei; Yoshimura, Yukiko; Hirai, Syu-ichi; Kumada, Tatsuro; Hayasaka, Kiyoshi; Fukuda, Atsuo; Ogata, Kazuhiro; Matsumoto, Naomichi			De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy	NATURE GENETICS			English	Article							EARLY MYOCLONIC ENCEPHALOPATHY; IDIOPATHIC MENTAL-RETARDATION; SYNAPTIC VESICLE DOCKING; OHTAHARA-SYNDROME; POLYALANINE EXPANSION; WEST-SYNDROME; SECRETION; SYNTAXIN; COMPLEX; PROTEIN	Early infantile epileptic encephalopathy with suppression-burst (EIEE), also known as Ohtahara syndrome, is one of the most severe and earliest forms of epilepsy(1). Using array-based comparative genomic hybridization, we found a de novo 2.0-Mb microdeletion at 9q33.3-q34.11 in a girl with EIEE. Mutation analysis of candidate genes mapped to the deletion revealed that four unrelated individuals with EIEE had heterozygous missense mutations in the gene encoding syntaxin binding protein 1 (STXBP1). STXBP1 (also known as MUNC18-1) is an evolutionally conserved neuronal Sec1/Munc-18 (SM) protein that is essential in synaptic vesicle release in several species(2-4). Circular dichroism melting experiments revealed that a mutant form of the protein was significantly thermolabile compared to wild type. Furthermore, binding of the mutant protein to syntaxin was impaired. These findings suggest that haploinsufficiency of STXBP1 causes EIEE.	[Saitsu, Hirotomo; Mizuguchi, Takeshi; Nishiyama, Kiyomi; Nishimura, Akira; Okada, Ippei; Yoshimura, Yukiko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Kato, Mitsuhiro; Hayasaka, Kiyoshi] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 9909585, Japan; [Hamada, Keisuke; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Pediat, Epilepsy Ctr, Nishi Ku, Niigata 9502085, Japan; [Uruno, Katsuhisa] Yamagata Natl Hosp, Epilepsy Ctr, Yamagata 9900876, Japan; [Kumada, Satoko] Tokyo Metropolitan Neurol Hosp, Dept Neuropediat, Fuchu, Tokyo 1830042, Japan; [Hirai, Syu-ichi] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Kumada, Tatsuro; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan	Yokohama City University; Yamagata University; Yokohama City University; Tokyo Metropolitan Institute for Neuroscience; Yokohama City University; Hamamatsu University School of Medicine	Saitsu, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Hayasaka, Kiyoshi/H-5340-2012; Saitsu, Hirotomo/AAM-7131-2021; Kumada, Tatsuro/AAY-9117-2020; Fukuda, Atsuo/ABA-6843-2020	Fukuda, Atsuo/0000-0001-7112-4834; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553				Djukic A, 2006, EPILEPSY RES, V70, pS68, DOI 10.1016/j.eplepsyres.2005.11.022; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Gurnett CA, 2007, ARCH NEUROL-CHICAGO, V64, P324, DOI 10.1001/archneur.64.3.324; Harada N, 2004, J MED GENET, V41, P130, DOI 10.1136/jmg.2003.014639; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Kalidas S, 2000, ACTA NEUROPATHOL, V99, P191, DOI 10.1007/PL00007424; Kato M, 2003, NEUROLOGY, V61, P267, DOI 10.1212/01.WNL.0000068012.69928.92; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Miyake N, 2006, AM J MED GENET A, V140A, P205, DOI 10.1002/ajmg.a.31098; Ohtahara S., 1976, NO TO HATTATSU TOKYO, V8, P270, DOI DOI 10.11251/OJJSCN1969.8.270; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SPREAFICO R, 1993, EPILEPSIA, V34, P800, DOI 10.1111/j.1528-1157.1993.tb02093.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tohyama J, 2008, BRAIN DEV-JPN, V30, P349, DOI 10.1016/j.braindev.2007.10.006; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; Weimer RM, 2005, CURR TOP DEV BIOL, V65, P83; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; YANG JT, 1986, METHOD ENZYMOL, V130, P208	30	390	408	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					782	788		10.1038/ng.150	http://dx.doi.org/10.1038/ng.150			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469812				2022-12-17	WOS:000256212000021
J	Rustici, G; Mata, J; Kivinen, K; Lio, P; Penkett, CJ; Burns, G; Hayles, J; Brazma, A; Nurse, P; Bahler, J				Rustici, G; Mata, J; Kivinen, K; Lio, P; Penkett, CJ; Burns, G; Hayles, J; Brazma, A; Nurse, P; Bahler, J			Periodic gene expression program of the fission yeast cell cycle	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REGULATORY NETWORKS; DNA-SYNTHESIS GENES; CENP-A; MEIOSIS; PROTEIN; IDENTIFICATION; MICROARRAYS; TRANSITION; MCM1; SWI5	Cell-cycle control of transcription seems to be universal, but little is known about its global conservation and biological significance. We report on the genome-wide transcriptional program of the Schizosaccharomyces pombe cell cycle, identifying 407 periodically expressed genes of which 136 show high-amplitude changes. These genes cluster in four major waves of expression. The forkhead protein Sep1p regulates mitotic genes in the first cluster, including Ace2p, which activates transcription in the second cluster during the M-G1 transition and cytokinesis. Other genes in the second cluster, which are required for G1-S progression, are regulated by the MBF complex independently of Sep1p and Ace2p. The third cluster coincides with S phase and a fourth cluster contains genes weakly regulated during G2 phase. Despite conserved cell-cycle transcription factors, differences in regulatory circuits between fission and budding yeasts are evident, revealing evolutionary plasticity of transcriptional control. Periodic transcription of most genes is not conserved between the two yeasts, except for a core set of similar to40 genes that seem to be universally regulated during the eukaryotic cell cycle and may have key roles in cell-cycle progression.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; European Bioinformat Inst, EMBL Outstn Hinxton, Cambridge CB10 1SD, England; Canc Res UK London Res Inst, London WC2A 3PX, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Cancer Research UK	Bahler, J (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	jurg@sanger.ac.uk	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Mata, Juan/0000-0002-5514-3653; Kivinen, Katja/0000-0002-1135-7625; Rustici, Gabriella/0000-0003-3085-1271; Brazma, Alvis/0000-0001-5988-7409	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Cooper Stephen, 2003, Cell Chromosome, V2, P1, DOI 10.1186/1475-9268-2-1; Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LOWNDES NF, 1992, NATURE, V357, P505, DOI 10.1038/357505a0; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; LYDALL D, 1991, GENE DEV, V5, P2405, DOI 10.1101/gad.5.12b.2405; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; MacKay VL, 2001, MOL CELL BIOL, V21, P4140, DOI 10.1128/MCB.21.13.4140-4148.2001; MACNEILL SA, 1997, MOL CELLULAR BIOL YE, P697; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MATSUMOTO S, 1985, EMBO J, V4, P3531, DOI 10.1002/j.1460-2075.1985.tb04113.x; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; McInerny CJ, 1995, NUCLEIC ACIDS RES, V23, P4761; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VILO J, 2000, ISMB, V8, P384; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Woollard A, 1996, EMBO J, V15, P4603, DOI 10.1002/j.1460-2075.1996.tb00838.x; WYNNE J, 1992, NUCLEIC ACIDS RES, V20, P3297, DOI 10.1093/nar/20.13.3297; Wyrick JJ, 2002, CURR OPIN GENET DEV, V12, P130, DOI 10.1016/S0959-437X(02)00277-0; Yang IV, 2002, GENOME BIOL, V3; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zilahi E, 2000, FEBS LETT, V481, P105, DOI 10.1016/S0014-5793(00)01990-6	50	390	396	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					809	817		10.1038/ng1377	http://dx.doi.org/10.1038/ng1377			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15195092				2022-12-17	WOS:000222974000012
J	Hyde, CL; Nagle, MW; Tian, C; Chen, X; Paciga, SA; Wendland, JR; Tung, JY; Hinds, DA; Perlis, RH; Winslow, AR				Hyde, Craig L.; Nagle, Michael W.; Tian, Chao; Chen, Xing; Paciga, Sara A.; Wendland, Jens R.; Tung, Joyce Y.; Hinds, David A.; Perlis, Roy H.; Winslow, Ashley R.			Identification of 15 genetic loci associated with risk of major depression in individuals of European descent	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MOOD DISORDERS; SCHIZOPHRENIA; MEF2C; EPILEPSY; BURDEN; DORSAL; BRAIN; TRIAL; MEIS2	Despite strong evidence supporting the heritability of major depressive disorder (MDD), previous genome-wide studies were unable to identify risk loci among individuals of European descent. We used self-report data from 75,607 individuals reporting clinical diagnosis of depression and 231,747 individuals reporting no history of depression through 23andMe and carried out meta-analysis of these results with published MDD genome-wide association study results. We identified five independent variants from four regions associated with self-report of clinical diagnosis or treatment for depression. Loci with a P value <1.0 x 10(-5) in the meta-analysis were further analyzed in a replication data set (45,773 cases and 106,354 controls) from 23andMe. A total of 17 independent SNPs from 15 regions reached genome-wide significance after joint analysis over all three data sets. Some of these loci were also implicated in genome-wide association studies of related psychiatric traits. These studies provide evidence for large-scale consumer genomic data as a powerful and efficient complement to data collected from traditional means of ascertainment for neuropsychiatric disease genomics.	[Hyde, Craig L.; Chen, Xing] Pfizer Inc, Pfizer Global Res & Dev, Stat, Cambridge, MA USA; [Nagle, Michael W.; Paciga, Sara A.; Wendland, Jens R.; Winslow, Ashley R.] Pfizer Inc, Pfizer Global Res & Dev, Human Genet & Computat Biomed, Cambridge, MA USA; [Tian, Chao; Tung, Joyce Y.; Hinds, David A.] 23andMe Inc, Mountain View, CA 94041 USA; [Perlis, Roy H.] Massachusetts Gen Hosp, Ctr Human Genet Res, Ct Expt Drugs & Diagnost, Boston, MA 02114 USA; [Perlis, Roy H.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Winslow, Ashley R.] Univ Penn, Perelman Sch Med, Orphan Dis Ctr, Philadelphia, PA 19104 USA	Pfizer; Pfizer; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine	Hinds, DA (corresponding author), 23andMe Inc, Mountain View, CA 94041 USA.; Perlis, RH (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Ct Expt Drugs & Diagnost, Boston, MA 02114 USA.; Perlis, RH (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	dhinds@23andme.com; rperlis@mgh.harvard.edu	tian, chao/GYD-3462-2022	Hinds, David/0000-0002-4911-803X; Winslow, Ashley/0000-0003-1265-5023; Nagle, Michael/0000-0002-4677-7582	Pfizer, Inc.; National Institute of Mental Health; National Human Genome Research Institute [P50 MH106933]; Pfizer, Inc.; National Institute of Mental Health; National Human Genome Research Institute [P50 MH106933]; National Center for Complementary & Integrative Health [R01AT009144] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106933, R01MH100286] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Pfizer, Inc.(Pfizer); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by Pfizer, Inc. R.H.P. is supported in part by the National Institute of Mental Health and the National Human Genome Research Institute (P50 MH106933). We also thank the Social Science Genetics Association Consortium (SSGAC) for sharing results for subjective well-being, depressive symptoms, and neuroticism.	Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Agoston Z, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-10; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Castro VM, 2015, AM J PSYCHIAT, V172, P363, DOI 10.1176/appi.ajp.2014.14030423; Durand E. Y., 2014, ANCESTRY COMPOSITION; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; KELLER MB, 1995, AM J PSYCHIAT, V152, P843; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lehoucq R. B., 1998, ARPACK USERS GUIDE S; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Paciorkowski AR, 2013, NEUROGENETICS, V14, P99, DOI 10.1007/s10048-013-0356-y; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tucker G, 2014, GENETICS, V197, P1045, DOI 10.1534/genetics.114.164285; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473; Whitehead A., 2002, METAANALYSIS CONTROL; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Wisniewski SR, 2009, AM J PSYCHIAT, V166, P599, DOI 10.1176/appi.ajp.2008.08071027; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	36	389	397	4	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1031	+		10.1038/ng.3623	http://dx.doi.org/10.1038/ng.3623			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27479909	Green Accepted			2022-12-17	WOS:000382398800013
J	Palomero, T; Couronne, L; Khiabanian, H; Kim, MY; Ambesi-Impiombato, A; Perez-Garcia, A; Carpenter, Z; Abate, F; Allegretta, M; Haydu, JE; Jiang, XY; Lossos, IS; Nicolas, C; Balbin, M; Bastard, C; Bhagat, G; Piris, MA; Campo, E; Bernard, OA; Rabadan, R; Ferrando, AA				Palomero, Teresa; Couronne, Lucile; Khiabanian, Hossein; Kim, Mi-Yeon; Ambesi-Impiombato, Alberto; Perez-Garcia, Arianne; Carpenter, Zachary; Abate, Francesco; Allegretta, Maddalena; Haydu, J. Erika; Jiang, Xiaoyu; Lossos, Izidore S.; Nicolas, Concha; Balbin, Milagros; Bastard, Christian; Bhagat, Govind; Piris, Miguel A.; Campo, Elias; Bernard, Olivier A.; Rabadan, Raul; Ferrando, Adolfo A.			Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas	NATURE GENETICS			English	Article							READ ALIGNMENT; FAMILY GTPASES; PROTEIN; ACTIVATION; APOPTOSIS; SENSITIVITY; INHIBITION; LEUKEMIA; TET2; GEFS	Peripheral T cell lymphomas (PTCLs) are a heterogeneous and poorly understood group of non-Hodgkin lymphomas1,2. Here we combined whole-exome sequencing of 12 tumor-normal DNA pairs, RNA sequencing analysis and targeted deep sequencing to identify new genetic alterations in PTCL transformation. These analyses identified highly recurrent epigenetic factor mutations in TET2, DNMT3A and IDH2 as well as a new highly prevalent RHOA mutation encoding a p. Gly17Val alteration present in 22 of 35 (67%) angioimmunoblastic T cell lymphoma (AITL) samples and in 8 of 44 (18%) PTCL, not otherwise specified (PTCL-NOS) samples. Mechanistically, the RHOA Gly17Val protein interferes with RHOA signaling in biochemical and cellular assays, an effect potentially mediated by the sequestration of activated guanine-exchange factor (GEF) proteins. In addition, we describe new and recurrent, albeit less frequent, genetic defects including mutations in FYN, ATM, B2M and CD58 implicating SRC signaling, impaired DNA damage response and escape from immune surveillance mechanisms in the pathogenesis of PTCL.	[Palomero, Teresa; Couronne, Lucile; Kim, Mi-Yeon; Ambesi-Impiombato, Alberto; Perez-Garcia, Arianne; Allegretta, Maddalena; Haydu, J. Erika; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Couronne, Lucile; Bhagat, Govind; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Khiabanian, Hossein; Carpenter, Zachary; Abate, Francesco] Columbia Univ, Dept Syst Biol, New York, NY USA; [Abate, Francesco] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Jiang, Xiaoyu; Lossos, Izidore S.] Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL USA; [Lossos, Izidore S.] Univ Miami, Dept Mol & Cellular Pharmacol, Miami, FL USA; [Nicolas, Concha] Univ Oviedo, Hosp Cent Asturias, Hematol Serv, E-33080 Oviedo, Spain; [Balbin, Milagros] Hosp Univ Cent Asturias, Inst Univ Oncol Principado Asturias, Mol Oncol Lab, Oviedo, Spain; [Bastard, Christian] Univ Rouen, Ctr Henri Becquerel, INSERM U918, Rouen, France; [Piris, Miguel A.] Hosp Univ Marques Valdecilla, Dept Pathol, Santander, Spain; [Piris, Miguel A.] Inst Formac & Invest Marques Valdecilla IFIMAV, Santander, Spain; [Campo, Elias] Hosp Clin Barcelona, Dept Pathol, Hematopathol Sect, Barcelona, Spain; [Campo, Elias] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain; [Bernard, Olivier A.] INSERM U985, Villejuif, France; [Bernard, Olivier A.] Univ Paris 11, Orsay, France; [Bernard, Olivier A.] Inst Gustave Roussy, Villejuif, France; [Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Polytechnic University of Turin; University of Miami; Central University Hospital Asturias; University of Oviedo; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel; Universite de Rouen Normandie; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Columbia University; Columbia University	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	tp2151@columbia.edu; rabadan@dbmi.columbia.edu; af2196@columbia.edu	Piris, Miguel A/AAP-1445-2020; Campo, elias/O-7192-2016; Rabadan, Raul/AAZ-7367-2020; Khiabanian, Hossein/N-7207-2019; Campo, Elias/AAC-5593-2019; Balbín, Milagros/I-4206-2015; Bhagat, Govind/AAE-9493-2021; Bernard, Olivier A./E-5721-2016; Piris, Miguel A/B-7067-2008	Piris, Miguel A/0000-0001-5839-3634; Campo, elias/0000-0001-9850-9793; Khiabanian, Hossein/0000-0003-1446-4394; Campo, Elias/0000-0001-9850-9793; Balbín, Milagros/0000-0001-5325-0407; Bhagat, Govind/0000-0001-6250-048X; Piris, Miguel A/0000-0001-5839-3634; Bernard, Olivier/0000-0002-0463-9747; Couronne, Lucile/0000-0002-1357-5482; Rabadan, Raul/0000-0001-7946-9255	Leukemia and Lymphoma Society Translational Research Grant; Herbert Irving Comprehensive Cancer Center interprogrammatic pilot project grant; US National Institutes of Health Ruth L. Kirschstein National Research Service Award [1F30CA174099]; Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa)-Direction de l'Hospitalisation et de l'Organisation des soins (DHOS) translational research grant; ITMO (Institut Multi-Organismes Cancer); INCa; Leukemia and Lymphoma Society; Spanish Ministry of Science and Innovation [SAF2012-38432]; Institucio Catalana de Recerca i Estudis Avancats; NATIONAL CANCER INSTITUTE [K12CA090354, P30CA013696] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Translational Research Grant(Leukemia and Lymphoma Society); Herbert Irving Comprehensive Cancer Center interprogrammatic pilot project grant; US National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)-Direction de l'Hospitalisation et de l'Organisation des soins (DHOS) translational research grant; ITMO (Institut Multi-Organismes Cancer); INCa(Institut National du Cancer (INCA) France); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institucio Catalana de Recerca i Estudis Avancats(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank V. Ribrag (Institut Gustave Roussy) for providing a PTCL sample and R. Parsons (Mount Sinai School of Medicine) for assistance in the setup of RHOA GTP-loading assays. This work was supported by a Leukemia and Lymphoma Society Translational Research Grant (A. A. F.), a Herbert Irving Comprehensive Cancer Center interprogrammatic pilot project grant (A. A. F. and R. R.), a US National Institutes of Health Ruth L. Kirschstein National Research Service Award (1F30CA174099 to J. E. H.), a grant from the Ligue Nationale Contre le Cancer (O. A. B.) and an Institut National du Cancer (INCa)-Direction de l'Hospitalisation et de l'Organisation des soins (DHOS) translational research grant (O. A. B.). L. C. is funded by ITMO (Institut Multi-Organismes Cancer) and INCa. M.-Y. K. is funded by the Leukemia and Lymphoma Society. E. C. is supported by the Spanish Ministry of Science and Innovation (SAF2012-38432) and Institucio Catalana de Recerca i Estudis Avancats.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armitage JO, 2012, AM J HEMATOL, V87, P512, DOI 10.1002/ajh.23144; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Ghosh PM, 1999, ONCOGENE, V18, P4120, DOI 10.1038/sj.onc.1202792; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Harr MW, 2010, CELL DEATH DIFFER, V17, P1381, DOI 10.1038/cdd.2010.25; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Longenecker K, 2003, ACTA CRYSTALLOGR D, V59, P876, DOI 10.1107/S0907444903005390; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mayer T, 1999, ONCOGENE, V18, P2117, DOI 10.1038/sj.onc.1202537; McCormack PL, 2011, DRUGS, V71, P1771, DOI 10.2165/11207580-000000000-00000; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pan ZXK, 1998, J IMMUNOL, V160, P3038; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	36	389	398	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					166	+		10.1038/ng.2873	http://dx.doi.org/10.1038/ng.2873			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413734	Green Accepted			2022-12-17	WOS:000331208300013
J	Helgason, A; Palsson, S; Thorleifsson, G; Grant, SFA; Emilsson, V; Gunnarsdottir, S; Adeyemo, A; Chen, YX; Chen, GJ; Reynisdottir, I; Benediktsson, R; Hinney, A; Hansen, T; Andersen, G; Borch-Johnsen, K; Jorgensen, T; Schafer, H; Faruque, M; Doumatey, A; Zhou, J; Wilensky, RL; Reilly, MP; Rader, DJ; Bagger, Y; Christiansen, C; Sigurdsson, G; Hebebrand, J; Pedersen, O; Thorsteinsdottir, U; Gulcher, JR; Kong, A; Rotimi, C; Stefansson, K				Helgason, Agnar; Palsson, Snaebjorn; Thorleifsson, Gudmar; Grant, Struan F. A.; Emilsson, Valur; Gunnarsdottir, Steinunn; Adeyemo, Adebowale; Chen, Yuanxiu; Chen, Guanjie; Reynisdottir, Inga; Benediktsson, Rafn; Hinney, Anke; Hansen, Torben; Andersen, Gitte; Borch-Johnsen, Knut; Jorgensen, Torben; Schaefer, Helmut; Faruque, Mezbah; Doumatey, Ayo; Zhou, Jie; Wilensky, Robert L.; Reilly, Muredach P.; Rader, Daniel J.; Bagger, Yu; Christiansen, Claus; Sigurdsson, Gunnar; Hebebrand, Johannes; Pedersen, Oluf; Thorsteinsdottir, Unnur; Gulcher, Jeffrey R.; Kong, Augustine; Rotimi, Charles; Stefansson, Kari			Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution	NATURE GENETICS			English	Article							HUMAN GENOME; CONFERS RISK; POPULATION; ASSOCIATION; RECOMBINATION; PROGRAM; OBESITY; MAP	We recently described an association between risk of type 2 diabetes and variants in the transcription factor 7- like 2 gene ( TCF7L2; formerly TCF4), with a population attributable risk ( PAR) of 17% - 28% in three populations of European ancestry(1). Here, we refine the definition of the TCF7L2 type 2 diabetes risk variant, HapB(T2D), to the ancestral T allele of a SNP, rs7903146, through replication in West African and Danish type 2 diabetes case-control studies and an expanded Icelandic study. We also identify another variant of the same gene, HapA, that shows evidence of positive selection in East Asian, European and West African populations. Notably, HapA shows a suggestive association with body mass index and altered concentrations of the hunger-satiety hormones ghrelin and leptin in males, indicating that the selective advantage of HapA may have been mediated through effects on energy metabolism.	DeCODE Genet, IS-101 Reykjavik, Iceland; Univ Iceland, IS-101 Reykjavik, Iceland; Howard Univ, Natl Human Gen Ctr, Dept Community & Family Med, Washington, DC 20060 USA; Iceland Heart Assoc, IS-201 Kopavogur, Iceland; Natl Univ Hosp Reykjavik, IS-101 Reykjavik, Iceland; Univ Duisburg Essen, Rhein Klin Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Univ Aarhus, DK-8000 Aarhus, Denmark; Univ Hosp Glostrup, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; Univ Marburg, Inst Med Biometry & Epidemiol, D-35037 Marburg, Germany; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark	University of Iceland; Howard University; Icelandic Heart Association; Landspitali National University Hospital; University of Duisburg Essen; Steno Diabetes Center; Aarhus University; University of Copenhagen; Philipps University Marburg; University of Pennsylvania; Center Clinical & Basic Research	Helgason, A (corresponding author), DeCODE Genet, IS-101 Reykjavik, Iceland.	agnar@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Pedersen, Oluf/Z-1731-2019; Jørgensen, Torben/Z-1335-2018; Hinney, Anke/D-6953-2011; Stefansson, Kari/AAE-7187-2019; Palsson, Snaebjorn/J-9113-2012; Pedersen, Oluf/AAG-8015-2020; Benediktsson, Rafn/R-2457-2018	Pedersen, Oluf/0000-0002-3321-3972; Hinney, Anke/0000-0001-5659-0706; Benediktsson, Rafn/0000-0002-2954-9801; Adeyemo, Adebowale/0000-0002-3105-3231; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Reilly, Muredach/0000-0002-3035-9386; Emilsson, Valur/0000-0001-9982-0524; Reynisdottir, Inga/0000-0002-9730-7476; Grant, Struan/0000-0003-2025-5302; Kong, Augustine/0000-0001-8193-5438; Palsson, Snaebjorn/0000-0002-4297-3500; Helgason, Agnar/0000-0002-8545-3767	FIC NIH HHS [3T37TW00041-03S2] Funding Source: Medline; NIDDK NIH HHS [DK-54001] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [T37TW000041] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Adeyemo AA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-38; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Andersen G, 2006, DIABETOLOGIA, V49, P75, DOI 10.1007/s00125-005-0049-7; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Erdmann J, 2005, DIABETES, V54, P1371, DOI 10.2337/diabetes.54.5.1371; EXCOFFIER L, 1992, GENETICS, V131, P491; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; MANTEL N, 1959, J NATL CANCER I, V22, P719; McVean G, 2002, GENETICS, V160, P1231; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Slatkin M, 2001, GENETICS, V158, P865; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	30	389	406	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					218	225		10.1038/ng1960	http://dx.doi.org/10.1038/ng1960			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206141				2022-12-17	WOS:000244063900020
J	Topaz, O; Shurman, DI; Bergman, R; Indelman, M; Ratajczak, P; Mizrachi, M; Khamaysi, Z; Behar, D; Petronius, D; Friedman, V; Zelikovic, I; Raimer, S; Metzker, A; Richard, G; Sprecher, E				Topaz, O; Shurman, DI; Bergman, R; Indelman, M; Ratajczak, P; Mizrachi, M; Khamaysi, Z; Behar, D; Petronius, D; Friedman, V; Zelikovic, I; Raimer, S; Metzker, A; Richard, G; Sprecher, E			Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; PHOSPHATE; CLONING; FGF23	Familial tumoral calcinosis (FTC; OMIM 211900) is a severe autosomal recessive metabolic disorder that manifests with hyperphosphatemia and massive calcium deposits in the skin and subcutaneous tissues. Using linkage analysis, we mapped the gene underlying FTC to 2q24-q31. This region includes the gene GALNT3, which encodes a glycosyltransferase responsible for initiating mucin-type O-glycosylation. Sequence analysis of GALNT3 identified biallelic deleterious mutations in all individuals with FTC, suggesting that defective post-translational modification underlies the disease.	Technion Israel Inst Technol, Rambam Med Ctr, Dept Dermatol, Haifa, Israel; Technion Israel Inst Technol, Rambam Med Ctr, Lab Mol Dermatol, Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel; Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Rambam Med Ctr, Pediat Nephrol Unit, Haifa, Israel; Rambam Med Ctr, Lab Dev Nephrol, Haifa, Israel; Univ Texas, Med Branch, Dept Dermatol, Galveston, TX USA	Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Jefferson University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Texas System; University of Texas Medical Branch Galveston	Sprecher, E (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Dept Dermatol, Haifa, Israel.	e-sprecher@rambam.health.gov.il						Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Berndt T, 2003, J CLIN INVEST, V112, P785, DOI 10.1172/JC1200318563; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; de Beur SMJ, 2002, J CLIN ENDOCR METAB, V87, P2467, DOI 10.1210/jc.87.6.2467; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; PRINCE MJ, 1982, ANN INTERN MED, V96, P586, DOI 10.7326/0003-4819-96-5-586; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; Schiavi SC, 2004, KIDNEY INT, V65, P1, DOI 10.1111/j.1523-1755.2004.00355.x; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; SLAVIN RE, 1993, AM J SURG PATHOL, V17, P788, DOI 10.1097/00000478-199308000-00004; STEINHERZ R, 1985, AM J DIS CHILD, V139, P816, DOI 10.1001/archpedi.1985.02140100078036; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007	15	389	404	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					579	581		10.1038/ng1358	http://dx.doi.org/10.1038/ng1358			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15133511	Bronze			2022-12-17	WOS:000221763700013
J	White, JK; Auerbach, W; Duyao, MP; Vonsattel, JP; Gusella, JF; Joyner, AL; MacDonald, ME				White, JK; Auerbach, W; Duyao, MP; Vonsattel, JP; Gusella, JF; Joyner, AL; MacDonald, ME			Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion	NATURE GENETICS			English	Article							ABNORMAL BRAIN-DEVELOPMENT; GENE HOMOLOG HDH; TRANSGENIC MICE; TRINUCLEOTIDE REPEAT; EMBRYONIC LETHALITY; PROTEIN; MOUSE; POLYGLUTAMINE; PHENOTYPE; LOCALIZATION	Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder caused by a CAG repeat expansion that lengthens a glutamine segment in the novel huntingtin protein. To elucidate the molecular basis of HD, we extended the polyglutamine tract of the mouse homologue, Hdh, by targetted introduction of an expanded human HD CAG repeat, creating mutant Hdh(neoQ50) and Hdh(Q50) alleles that express reduced and wildtype levels of altered huntingtin, respectively. Mice homozygous for reduced levels displayed characteristic aberrant brain development and perinatal lethality, indicating a critical function for Hdh in neurogenesis. However, mice with normal levels of mutant huntingtin did not display these abnormalities, indicating that the expanded CAG repeat does not eliminate or detectably impair huntingtin's neurogenic function. Thus, the HD defect in man does not mimic complete or partial Hdh inactivation and appears to cause neurodegenerative disease by a gain-of-function mechanism.	MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,CHARLESTOWN,MA 02129; NYU,MED CTR,DEPT CELL BIOL,NEW YORK,NY 10016; NYU,MED CTR,SKIRBALL INST BIOMOL MED,DEV GENET PROGRAM,NEW YORK,NY 10016; MASSACHUSETTS GEN HOSP,MOL NEUROPATHOL LAB,CHARLESTOWN,MA 02129	Harvard University; Massachusetts General Hospital; New York University; New York University; Harvard University; Massachusetts General Hospital					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS016367, R01NS032765] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16367, NS32765] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Gusella JF, 1997, MOL MED, V3, P238, DOI 10.1007/BF03401677; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; *HUNT DIS COLL RES, 1993, CELL, V72, P971; IDE K, 1995, BIOCHEM BIOPH RES CO, V209, P1119, DOI 10.1006/bbrc.1995.1613; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIN BY, 1995, GENOMICS, V25, P707, DOI 10.1016/0888-7543(95)80014-D; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; MACDONALD ME, 1996, HDB COLD SPRING HARB, V61, P627; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; McNeil SM, 1997, HUM MOL GENET, V6, P775, DOI 10.1093/hmg/6.5.775; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MYERS RH, 1989, AM J HUM GENET, V45, P615; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 1993, Gene targeting: a practical approach., P147; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; PERSICHETTI F, 1995, NEUROBIOL DIS, V1, P159; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SHAH V, 1995, NAT GENET, V10, P175; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; Wu M, 1996, P NATL ACAD SCI USA, V93, P2110, DOI 10.1073/pnas.93.5.2110; Wurst W., 1993, Gene targeting: a practical approach., P33; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	47	389	403	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					404	410		10.1038/ng1297-404	http://dx.doi.org/10.1038/ng1297-404			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398841				2022-12-17	WOS:A1997YJ92400020
J	Koutnikova, H; Campuzano, V; Foury, F; Dolle, P; Cazzalini, O; Koenig, M				Koutnikova, H; Campuzano, V; Foury, F; Dolle, P; Cazzalini, O; Koenig, M			Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin	NATURE GENETICS			English	Article							FRIEDREICHS ATAXIA; GENE; MUTATIONS; PROTEIN; DISEASE; CELLS	Friedreich's ataxia is due to loss of function mutations in the gene encoding frataxin (FRDA). Frataxin is a protein of unknown function. In situ hybridization analyses revealed that mouse frataxin expression correlates well with the main site of neurodegeneration, but the expression pattern is broader than expected from the pathology of the disease. Frataxin mRNA is predominantly expressed in tissues with a high metabolic rate, including liver, kidney, brown fat and heart. We found that mouse and yeast frataxin homologues contain a potential mitochondrial targeting sequence in their N-terminal domains and that disruption of the yeast gene results in mitochondrial dysfunction. Finally, tagging experiments demonstrate that human frataxin co-localizes with a mitochondrial protein. Friedreich's ataxia is therefore a mitochondrial disease caused by a mutation in the nuclear genome.	UNIV STRASBOURG 1, INST GENET & BIOL MOL & CELLULAIRE, INSERM, CNRS, F-67404 ILLKIRCH STRASBOU, FRANCE; UNIV CATHOLIQUE LOUVAIN, UNITE BIOCHIM PHYSIOL, B-1348 LOUVAIN, BELGIUM	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Catholique Louvain			Dolle, Pascal/A-8037-2010; CAMPUZANO, VICTORIA/K-7883-2019; Campuzano, V/G-1826-2014; Koutnikova, Hana/I-7758-2017; Campuzano, Victoria/ABG-7429-2020	Dolle, Pascal/0000-0002-9294-9090; Campuzano, V/0000-0001-8128-2641; Campuzano, Victoria/0000-0001-8128-2641				Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; CARVAJAL JJ, 1995, HUM MOL GENET, V4, P1411, DOI 10.1093/hmg/4.8.1411; Cossee M, 1997, NAT GENET, V15, P337, DOI 10.1038/ng0497-337; DECIMO D, 1995, GENE PROBES PRACTICA, V2, P183; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GORMAN CM, 1984, PHILOS T ROY SOC B, V307, P343, DOI 10.1098/rstb.1984.0137; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; KROWCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408, DOI 10.1093/nar/17.15.6408; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OPPENHEIMER DR, 1992, GREENFIELDS NEUROPAT, P1015; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; ROMEO G, 1983, AM J HUM GENET, V35, P523; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J, 1989, MOL CLONNING LAB MAN; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHREIBER V, 1994, GENE, V150, P411, DOI 10.1016/0378-1119(94)90466-9; SKRE H, 1975, CLIN GENET, V7, P287; Stryer L., 1988, BIOCHEMISTRY-US; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	27	389	401	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1997	16	4					345	351		10.1038/ng0897-345	http://dx.doi.org/10.1038/ng0897-345			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241270				2022-12-17	WOS:A1997XM90900015
J	GIANNOUKAKIS, N; DEAL, C; PAQUETTE, J; GOODYER, CG; POLYCHRONAKOS, C				GIANNOUKAKIS, N; DEAL, C; PAQUETTE, J; GOODYER, CG; POLYCHRONAKOS, C			PARENTAL GENOMIC IMPRINTING OF THE HUMAN IGF2 GENE	NATURE GENETICS			English	Article							GROWTH FACTOR-II; DETERMINES METHYLATION; MICE; EXPRESSION; RECEPTOR; ALLELES	The mouse igf2 gene, coding for the insulin-like growth factor II (IGF-II) is parentally imprinted, only the gene copy derived from the father is expressed. To know whether IGF2, the human homologue, is also imprinted, we used an ApaI polymorphism at the 3' untranslated region in order to distinguish between mRNA derived from each copy of the gene in placentae from heterozygote human fetuses, studied after careful removal of the decidua. Six term and two pre-term placentae of heterozygotes were studied, and in each case the cDNA contained only one of the two alleles present in the genomic DNA. In three cases the mother was homozygous for the non-expressed allele, allowing assignment of paternal origin to the transcribed gene copy. We conclude that, as in the mouse, human IGF2 is parentally imprinted.	MCGILL UNIV,DEPT PEDIAT,DIV ENDOCRINOL,MONTREAL H3H 1P3,QUEBEC,CANADA; UNIV MONTREAL,DEPT PEDIAT,DIV ENDOCRINOL,MONTREAL H3W 2C2,PQ,CANADA	McGill University; Universite de Montreal			Polychronakos, Constantin/B-8151-2008	Polychronakos, Constantin/0000-0002-7624-6635				BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; HAIG D, 1991, CELL, V64, P1045; HALL JG, 1990, AM J HUM GENET, V46, P857; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HERGERSBERG M, 1991, EXPERIENTIA, V47, P1171, DOI 10.1007/BF01918381; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; MANN JR, 1984, NATURE, V310, P66, DOI 10.1038/310066a0; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; POLYCHRONAKOS C, 1989, MOLECULAR AND CELLULAR BIOLOGY OF INSULIN-LIKE GROWTH FACTORS AND THEIR RECEPTORS, P369; POURCEL C, 1987, NATURE, V329, P454; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SAPIENZA C, 1991, BIOCHIM BIOPHYS ACTA, V1072, P51, DOI 10.1016/0304-419X(91)90006-7; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SUSSENBACH JS, 1992, MODERN CONCEPTS INSU, P639; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	34	389	396	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					98	101		10.1038/ng0593-98	http://dx.doi.org/10.1038/ng0593-98			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8099843				2022-12-17	WOS:A1993LA33700022
J	Holt, KE; Parkhill, J; Mazzoni, CJ; Roumagnac, P; Weill, FX; Goodhead, I; Rance, R; Baker, S; Maskell, DJ; Wain, J; Dolecek, C; Achtman, M; Dougan, G				Holt, Kathryn E.; Parkhill, Julian; Mazzoni, Camila J.; Roumagnac, Philippe; Weill, Francois-Xavier; Goodhead, Ian; Rance, Richard; Baker, Stephen; Maskell, Duncan J.; Wain, John; Dolecek, Christiane; Achtman, Mark; Dougan, Gordon			High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi	NATURE GENETICS			English	Article							ENTERICA SEROVAR TYPHI; PATHOGENICITY ISLAND; VI EXOPOLYSACCHARIDE; STRAINS; RECOMBINATION; ACQUISITION; RESISTANCE; DIVERSITY; SANTIAGO; CARRIERS	Isolates of Salmonella enterica serovar Typhi (Typhi), a human-restricted bacterial pathogen that causes typhoid, show limited genetic variation. We generated whole-genome sequences for 19 Typhi isolates using 454 (Roche) and Solexa (Illumina) technologies. Isolates, including the previously sequenced CT18 and Ty2 isolates, were selected to represent major nodes in the phylogenetic tree. Comparative analysis showed little evidence of purifying selection, antigenic variation or recombination between isolates. Rather, evolution in the Typhi population seems to be characterized by ongoing loss of gene function, consistent with a small effective population size. The lack of evidence for antigenic variation driven by immune selection is in contrast to strong adaptive selection for mutations conferring antibiotic resistance in Typhi. The observed patterns of genetic isolation and drift are consistent with the proposed key role of asymptomatic carriers of Typhi as the main reservoir of this pathogen, highlighting the need for identification and treatment of carriers.	[Holt, Kathryn E.; Parkhill, Julian; Goodhead, Ian; Rance, Richard; Baker, Stephen; Wain, John; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Mazzoni, Camila J.; Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Mazzoni, Camila J.; Roumagnac, Philippe; Achtman, Mark] Max Planck Inst Infektionsbiol, Dept Mol Biol, D-10117 Berlin, Germany; [Roumagnac, Philippe] Aix Marseille Univ, Univ Mixte Rech Ctr Natl Rech Sci 6191, Commissariat Energie Atom, F-13108 St Paul Les Durance, France; [Weill, Francois-Xavier] Inst Pasteur, Lab Bacteries Pathogenes Enter, F-75724 Paris 15, France; [Baker, Stephen; Dolecek, Christiane] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Maskell, Duncan J.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Wellcome Trust Sanger Institute; University College Cork; Max Planck Society; CEA; UDICE-French Research Universities; Aix-Marseille Universite; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford; University of Cambridge	Holt, KE (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	kh2@sanger.ac.uk	Parkhill, Julian/G-4703-2011; Mazzoni, Camila/AAJ-9702-2020; Goodhead, Ian/ABC-9200-2020; Mazzoni, Camila J/L-3441-2014; Holt, Kathryn E/A-8108-2012; Wain, John/B-3446-2013	Parkhill, Julian/0000-0002-7069-5958; Mazzoni, Camila/0000-0001-6758-5427; Holt, Kathryn E/0000-0003-3949-2471; Wain, John/0000-0002-1257-1148; Goodhead, Ian/0000-0002-3110-9442; Baker, Stephen/0000-0003-1308-5755; Roumagnac, Philippe/0000-0001-5002-6039; Achtman, Mark/0000-0001-6815-0070; Weill, Francois-Xavier/0000-0001-9941-5799	Wellcome Trust [067321] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; Boyd EF, 2003, J CLIN MICROBIOL, V41, P3823, DOI 10.1128/JCM.41.8.3823-3828.2003; Bueno SM, 2004, J BACTERIOL, V186, P3202, DOI 10.1128/JB.186.10.3202-3213.2004; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Cho JC, 1999, FEMS MICROBIOL LETT, V170, P257, DOI 10.1111/j.1574-6968.1999.tb13382.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Falush D, 2006, TRENDS MICROBIOL, V14, P353, DOI 10.1016/j.tim.2006.06.003; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Lewis MD, 2005, CLIN INFECT DIS, V40, P554, DOI 10.1086/427503; Nair S, 2004, J BACTERIOL, V186, P3214, DOI 10.1128/JB.186.10.3214-3223.2004; Octavia S, 2007, J CLIN MICROBIOL, V45, P3795, DOI 10.1128/JCM.00720-07; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; SEARS SD, 1984, J INFECT DIS, V149, P640, DOI 10.1093/infdis/149.4.640; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050	41	388	404	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					987	993		10.1038/ng.195	http://dx.doi.org/10.1038/ng.195			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18660809	Green Accepted			2022-12-17	WOS:000258026900015
J	Kim, S; Plagnol, V; Hu, TT; Toomajian, C; Clark, RM; Ossowski, S; Ecker, JR; Weigel, D; Nordborg, M				Kim, Sung; Plagnol, Vincent; Hu, Tina T.; Toomajian, Christopher; Clark, Richard M.; Ossowski, Stephan; Ecker, Joseph R.; Weigel, Detlef; Nordborg, Magnus			Recombination and linkage disequilibrium in Arabidopsis thaliana	NATURE GENETICS			English	Article							GENE CONVERSION; HUMAN GENOME; HISTORY; DNA; POLYMORPHISM; POPULATIONS; ASSOCIATION; DROSOPHILA; PATTERNS; RATES	Linkage disequilibrium ( LD) is a major aspect of the organization of genetic variation in natural populations. Here we describe the genome- wide pattern of LD in a sample of 19 Arabidopsis thaliana accessions using 341,602 non- singleton SNPs. LD decays within 10 kb on average, considerably faster than previously estimated. Tag SNP selection algorithms and ' hide- the- SNP' simulations suggest that genome- wide association mapping will require only 40% - 50% of the observed SNPs, a reduction similar to estimates in a sample of African Americans. An Affymetrix genotyping array containing 250,000 SNPs has been designed based on these results; we demonstrate that it should have more than adequate coverage for genome- wide association mapping. The extent of LD is highly variable, and we find clear evidence of recombination hotspots, which seem to occur preferentially in intergenic regions. LD also reflects the action of selection, and it is more extensive between nonsynonymous polymorphisms than between synonymous polymorphisms.	Univ So Calif, Los Angeles, CA 90089 USA; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Salk Inst Genome Anal Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of Southern California; University of Cambridge; Max Planck Society; Salk Institute; Salk Institute	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu	Ecker, Joseph R/B-9144-2008; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Ossowski, Stephan/E-2139-2011; Toomajian, Christopher/ABA-2615-2021; Plagnol, Vincent/A-5667-2011; Weigel, Detlef/C-1418-2008	Ecker, Joseph R/0000-0001-5799-5895; Weigel, Detlef/0000-0002-2114-7963; Ossowski, Stephan/0000-0002-7416-9568; Toomajian, Christopher/0000-0002-6763-0678; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748; Plagnol, Vincent/0000-0002-5597-9215	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG002790] Funding Source: Medline; NIGMS NIH HHS [GM62932, R01 GM062932] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 1998, GENETICS, V148, P1397; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hagenblad J, 2002, GENETICS, V161, P289; Haubold B, 2002, GENETICS, V161, P1269; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Li N, 2003, GENETICS, V165, P2213; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2000, GENETICS, V154, P923; Padhukasahasram B, 2006, GENETICS, V174, P1517, DOI 10.1534/genetics.106.060723; Pagnol V, 2006, GENETICS, V172, P2441, DOI 10.1534/genetics.104.040311; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Schmuths H, 2004, ANN BOT-LONDON, V93, P317, DOI 10.1093/aob/mch037; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	27	388	397	3	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1151	1155		10.1038/ng2115	http://dx.doi.org/10.1038/ng2115			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676040				2022-12-17	WOS:000249122400027
J	Lorenz-Depiereux, B; Bastepe, M; Benet-Pages, A; Amyere, M; Wagenstaller, J; Muller-Barth, U; Badenhoop, K; Kaiser, SM; Rittmaster, RS; Shlossberg, AH; Olivares, JL; Loris, C; Ramos, FJ; Glorieux, F; Vikkula, M; Juppner, H; Strom, TM				Lorenz-Depiereux, Bettina; Bastepe, Murat; Benet-Pages, Anna; Amyere, Mustapha; Wagenstaller, Janine; Mueller-Barth, Ursula; Badenhoop, Klaus; Kaiser, Stephanie M.; Rittmaster, Roger S.; Shlossberg, Alan H.; Olivares, Jose L.; Loris, Cesar; Ramos, Feliciano J.; Glorieux, Francis; Vikkula, Miikka; Juppner, Harald; Strom, Tim M.			DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis	NATURE GENETICS			English	Article							PHEX; MINERALIZATION; IDENTIFICATION; ROLES; GENE	Hypophosphatemia is a genetically heterogeneous disease. Here, we mapped an autosomal recessive form (designated ARHP) to chromosome 4q21 and identified homozygous mutations in DMP1 (dentin matrix protein 1), which encodes a non-collagenous bone matrix protein expressed in osteoblasts and osteocytes. Intact plasma levels of the phosphaturic protein FGF23 were clearly elevated in two of four affected individuals, providing a possible explanation for the phosphaturia and inappropriately normal 1,25(OH) 2D levels and suggesting that DMP1 may regulate FGF23 expression.	GSF, Inst Human Genet, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany; Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Catholic Univ Louvain, B-1200 Brussels, Belgium; Christian Duve Inst, B-1200 Brussels, Belgium; Med Genet, D-63450 Hanau, Germany; Univ Hosp, Div Endocrinol Diabet & Metab, D-60590 Frankfurt, Germany; Queen Elizabeth 2 Hlth Sci Ctr, Div Endocrinol & Metab, Halifax, NS, Canada; Univ Zaragoza, Fac Med, Univ Hosp Lozano Blesa, Dept Pediat, E-50009 Zaragoza, Spain; Univ Zaragoza, Childrens Hosp Miguel Servet, Serv Nephrol, E-50009 Zaragoza, Spain; Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada; Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Universite Catholique Louvain; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Queen Elizabeth II Health Sciences Centre; Lozano Blesa University Clinical Hospital; University of Zaragoza; Miguel Servet University Hospital; University of Zaragoza; McGill University; Harvard University; Massachusetts General Hospital; Technical University of Munich	Juppner, H (corresponding author), GSF, Inst Human Genet, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany.	jueppner@helix.mgh.harvard.edu; TimStrom@gsf.de	Bastepe, Murat/GQQ-3389-2022; Ramos, Feliciano J./ABH-8920-2020; Vikkula, Miikka/Q-1038-2018	Ramos, Feliciano J./0000-0002-5732-2209; Vikkula, Miikka/0000-0002-6236-338X; Bastepe, Murat/0000-0002-2643-3504	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075856, R37DK046718, P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK075856, R21 DK075856-01, R37 DK046718, P30 DK040561, P30 DK040561-11, R01 DK046718] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boileau G, 2001, BIOCHEM J, V355, P707, DOI 10.1042/bj3550707; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200	15	388	402	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1248	1250		10.1038/ng1868	http://dx.doi.org/10.1038/ng1868			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17033625	Green Accepted			2022-12-17	WOS:000241592700012
J	Yarden, RI; Pardo-Reoyo, S; Sgagias, M; Cowan, KH; Brody, LC				Yarden, RI; Pardo-Reoyo, S; Sgagias, M; Cowan, KH; Brody, LC			BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage	NATURE GENETICS			English	Article							CELL-CYCLE; PHOSPHORYLATION; PROTEIN; CDC25; SERINE-216; LINKAGE; COMPLEX; LINE; ATM	The breast cancer tumor-suppressor gene, BRCA1, encodes a protein with a BRCT domain-a motif that is found in many proteins that are implicated in DNA damage response and in genome stability(1). Phosphorylation of BRCA1 by the DNA damage-response proteins ATM, ATR and hCds1/Chk2 changes in response to DNA damage and at replication-block checkpoints(2-5). Although cells that lack BRCA1 have an abnormal response to DNA damage, the exact role of BRCA1 in this process has remained unclear. Here we show that BRCA1 is essential for activating the Chk1 kinase that regulates DNA damage-induced G2/M arrest. Thus, BRCA1 controls the expression, phosphorylation and cellular localization of Cdc25C and Cdc2/cyclin B kinase-proteins that are crucial for the G2/M transition. We show that BRCA1 regulates the expression of both Wee1 kinase, an inhibitor of Cdc2/cyclin B kinase, and the 14-3-3 family of proteins that sequesters phosphorylated Cdc25C and Cdc2/cyclin B kinase in the cytoplasm(6). We conclude that BRCA1 regulates key effectors that control the G2/M checkpoint and is therefore involved in regulating the onset of mitosis.	NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Nebraska System; University of Nebraska Medical Center	Brody, LC (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.							Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Chen JJ, 2000, CANCER RES, V60, P5037; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Foray N, 1999, ONCOGENE, V18, P7334, DOI 10.1038/sj.onc.1203165; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; OCONNOR PM, 1993, J BIOL CHEM, V268, P8298; OGG S, 1994, J BIOL CHEM, V269, P30461; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Tomlinson GE, 1998, CANCER RES, V58, P3237; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	25	388	416	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					285	289		10.1038/ng837	http://dx.doi.org/10.1038/ng837			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836499				2022-12-17	WOS:000174157600012
J	Kibar, Z; Vogan, KJ; Groulx, N; Justice, MJ; Underhill, DA; Gros, P				Kibar, Z; Vogan, KJ; Groulx, N; Justice, MJ; Underhill, DA; Gros, P			Ltap, a mammalian homolog of Drosophila Strabismus/Van Gogh, is altered in the mouse neural tube mutant Loop-tail	NATURE GENETICS			English	Letter							CONVERGENT EXTENSION MOVEMENTS; TISSUE POLARITY; MESSENGER-RNA; PDZ DOMAINS; DEFECTS; GASTRULATION; RECOGNITION; EXPRESSION; VICINITY; MUTATION	Neural tube defects (NTDs) such as spina bifida and anencephaly are common congenital malformations in humans (1/1,000 births) that result from failure of the neural tube to close during embryogenesis(1,2). The etiology of NTDs is complex, with both genetic and environmental contributions; the genetic component has been extensively studied with mouse models(3). Loop-tail (Lp) is a semidominant mutation on mouse chromosome 1 (ref. 4). In the two known Lp alleles (Lp. Lp(m1Jus)), heterozygous mice exhibit a characteristic looped tail, and homozygous embryos show a completely open neural tube in the hindbrain and spinal region, a condition similar to the severe craniorachischisis defect in humans(4-6). Morphological and neural patterning studies indicate a role for the Lp gene product in controlling early morphogenesis and patterning of both axial midline structures and the developing neural plate(7). The 0.6-cM/0.7-megabase (Mb) Lp interval is delineated proximally by D1Mit113/Apoa2/Fcer1g and distally by Fcer1a/D1Mit149/Spna1 and contains a minimum of 17 transcription units(8-11). One of these genes, Ltap, encodes a homolog of Drosophila Strabismus/Van Gogh (Stbm/Vang), a component of the frizzled/dishevelled tissue polarity pathway(12-14). Ltap is expressed broadly in the neuroectoderm throughout early neurogenesis and is altered in two independent Lp alleles, identifying this gene as a strong candidate for Lp.	McGill Univ, Dept Biochem, Montreal, PQ, Canada; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	McGill University; Harvard University; Harvard Medical School; Baylor College of Medicine; University of Alberta	Gros, P (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.			Vogan, Kyle/0000-0001-9565-9665; Underhill, Darrell/0000-0003-0957-7407	NCI NIH HHS [P01 CA75719] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA075719] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; Djiane A, 2000, DEVELOPMENT, V127, P3091; Doudney K, 2001, GENOMICS, V72, P180, DOI 10.1006/geno.2000.6463; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Gerrelli D, 1997, DEV BRAIN RES, V102, P217, DOI 10.1016/S0165-3806(97)00099-0; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; MULLICK A, 1995, GENOMICS, V26, P479, DOI 10.1016/0888-7543(95)80166-J; SMITH LJ, 1962, J EMBRYOL EXP MORPH, V10, P73; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STEIN KF, 1953, J HERED, V44, P59, DOI 10.1093/oxfordjournals.jhered.a106356; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Taylor MF, 1998, ANTISENSE NUCLEIC A, V8, P199, DOI 10.1089/oli.1.1998.8.199; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Underhill DA, 1999, GENOMICS, V55, P185, DOI 10.1006/geno.1998.5643; Underhill DA, 2000, MAMM GENOME, V11, P633, DOI 10.1007/s003350010118; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WILSON DB, 1992, ACTA ANAT, V143, P89; Wolff T, 1998, DEVELOPMENT, V125, P1149	30	388	395	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					251	255		10.1038/90081	http://dx.doi.org/10.1038/90081			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431695				2022-12-17	WOS:000169656400017
J	Cho, C; Willis, WD; Goulding, EH; Haesook, JH; Choi, YC; Hecht, NB; Eddy, EM				Cho, C; Willis, WD; Goulding, EH; Haesook, JH; Choi, YC; Hecht, NB; Eddy, EM			Haploinsufficiency of protamine-1 or-2 causes infertility in mice	NATURE GENETICS			English	Article							MAMMALIAN SPERM NUCLEI; MALE GERM-CELLS; MOUSE PROTAMINE-1; PROTEINS; SEQUENCE; FERTILITY; DEFICIENT; GENES; CDNA	Protamines are the major DNA-binding proteins in the nucleus of sperm in most vertebrates(1-5) and package the DNA in a volume less than 5% of a somatic cell nucleus(6). Many mammals have one protamine, but a few species, including humans and mice, have two(7-13). Here we use gene targeting to determine if the second protamine provides redundancy to an essential process, or if both protamines are necessary. We disrupted the coding sequence of one allele of either Prm1 or Prm2 in embryonic stem (ES) cells derived from 129-strain mice, and injected them into blastocysts from C57BL/6-strain mice. Male chimeras produced 129-genotype sperm with disrupted Prm1 or Prm2 alleles, but failed to sire offspring carrying the 129 genome. We also found that a decrease in the amount of either protamine disrupts nuclear formation, processing of protamine-2 and normal sperm function. Our studies show that both protamines are essential and that haploinsufficiency caused by a mutation in one allele of Prm1or Prm2 prevents genetic transmission of both mutant and wild-type alleles.	NIEHS, Gamet Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; Univ Penn, Med Ctr, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Eddy, EM (corresponding author), NIEHS, Gamet Biol Sect, Reprod & Dev Toxicol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	eddy@niehs.nih.gov			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070076, Z01ES070076] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BALHORN R, 1977, BIOCHEMISTRY-US, V16, P4074, DOI 10.1021/bi00637a021; BALHORN R, 1984, EXP CELL RES, V150, P298, DOI 10.1016/0014-4827(84)90572-X; BALHORN R, 1988, EXPERIENTIA, V44, P52, DOI 10.1007/BF01960243; Balhorn R., 1989, P366; Balhorn R, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P55; BELLVE AR, 1975, DEV BIOL, V47, P349, DOI 10.1016/0012-1606(75)90289-4; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; CALDWELL KA, 1991, P NATL ACAD SCI USA, V88, P2407, DOI 10.1073/pnas.88.6.2407; CHO C, 1997, PCR METHOD DISTINGUI; DEBARLE M, 1995, MOL REPROD DEV, V40, P84, DOI 10.1002/mrd.1080400111; DEYEBRA L, 1993, J BIOL CHEM, V268, P10553; DOMENJOUD L, 1988, NUCLEIC ACIDS RES, V16, P7733, DOI 10.1093/nar/16.15.7733; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; HECHT NB, 1990, J REPROD FERTIL, V88, P679, DOI 10.1530/jrf.0.0880679; Hecht NB, 1989, HISTONES OTHER BASIC, P347; KLEENE KC, 1985, BIOCHEMISTRY-US, V24, P719, DOI 10.1021/bi00324a027; KOSOWER NS, 1992, J ANDROL, V13, P342; Kuratani S, 1997, DEV DYNAM, V209, P139, DOI 10.1002/(SICI)1097-0177(199706)209:2<139::AID-AJA1>3.0.CO;2-J; Lee K, 1995, P NATL ACAD SCI USA, V92, P12451, DOI 10.1073/pnas.92.26.12451; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; MCKAY DJ, 1985, BIOSCIENCE REP, V5, P383, DOI 10.1007/BF01116555; Meistrich M., 1989, HISTONES OTHER BASIC, P165; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; STANKER LH, 1993, MOL IMMUNOL, V30, P1633, DOI 10.1016/0161-5890(93)90436-F; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; WYROBEK AJ, 1976, BIOPHYS J, V16, P811, DOI 10.1016/S0006-3495(76)85730-X; YELICK PC, 1987, MOL CELL BIOL, V7, P2173, DOI 10.1128/MCB.7.6.2173; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683	28	388	405	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					82	86		10.1038/ng0501-82	http://dx.doi.org/10.1038/ng0501-82			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326282				2022-12-17	WOS:000168413300022
J	Gatei, M; Young, D; Cerosaletti, KM; Desai-Mehta, A; Spring, K; Kozlov, S; Lavin, MF; Gatti, RA; Concannon, P; Khanna, K				Gatei, M; Young, D; Cerosaletti, KM; Desai-Mehta, A; Spring, K; Kozlov, S; Lavin, MF; Gatti, RA; Concannon, P; Khanna, K			ATM-dependent phosphorylation of nibrin in response to radiation exposure	NATURE GENETICS			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; IONIZING-RADIATION; C-ABL; PROTEIN; KINASE; GENE; P53; PHENOTYPE; PRODUCT	Mutations in the gene ATM are responsible for the genetic disorder ataxia-telangiectasia (A-T), which is characterized by cerebellar dysfunction, radiosensitivity, chromosomal instability and cancer predisposition. Both the A-T phenotype and the similarity of the ATM protein to other DNA-damage sensors suggests a role for ATM in biochemical pathways involved in the recognition, signalling and repair of DNA double-strand breaks (DSBs). Them are strong parallels between the pattern of radiosensitivity, chromosomal instability and cancer predisposition in A-T patients and that in patients with Nijmegen breakage syndrome (NBS). The protein defective in NBS, nibrin (encoded by NBS1), forms a complex with MRE11 and RAD50 (refs 1,2). This complex localizes to DSBs within 30 minutes after cellular exposure to ionizing radiation (1R) and is observed in brightly staining nuclear foci after a longer period of time(3). The overlap between clinical and cellular phenotypes in A-T and NBS suggests that ATM and nibrin may function in the same biochemical pathway. Here we demonstrate that nibrin is phosphorylated within one hour of treatment of cells with IR. This response is abrogated in A-T cells that either do not express ATM protein or express near full-length mutant protein. We also show that ATM physically interacts with and phosphorylates nibrin on serine 343 both in vivo and in vitro. Phosphorylation of this site appears to be functionally important because mutated nibrin (S343A) does not completely complement radiosensitivity in NBS cells. ATM phosphorylation of nibrin does not affect nibrin-MRE11-RAD50 association as revealed by radiation-induced foci formation. Our data provide a biochemical explanation for the similarity in phenotype between A-T and NBS.	PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia; Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; Univ Washington, Virginia Mason Res Ctr, Mol Genet Program, Seattle, WA USA; Univ Queensland, Dept Pathol, Joint Oncol Programme, Brisbane, Qld, Australia; Univ Queensland, Dept Surg, Brisbane, Qld, Australia; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; University of Queensland; University of Queensland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khanna, K (corresponding author), PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia.		Khanna, Kum Kum/I-1747-2013; Kozlov, Sergei/M-2067-2014; Lavin, Martin F/F-5961-2014; Kozlov, Sergei/T-9779-2019	Kozlov, Sergei/0000-0001-6183-7339; Lavin, Martin F/0000-0002-5940-4769; Concannon, Patrick/0000-0002-5801-1859; Khanna, Kum Kum/0000-0001-8650-5381; Spring, Kevin/0000-0003-0601-924X	NATIONAL CANCER INSTITUTE [R01CA057569] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057569, CA57569] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; FRANK JR, 1993, BIOMASS BIOENERG, V5, P1, DOI 10.1016/0961-9534(93)90002-L; GATEI M, IN PRESS CANCER; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; PEAR WS, 1996, GENE THERAPY PROTOCO, P41; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	19	388	398	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					115	119		10.1038/75508	http://dx.doi.org/10.1038/75508			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802669				2022-12-17	WOS:000086884000029
J	Dahme, M; Bartsch, U; Martini, R; Anliker, B; Schachner, M; Mantei, N				Dahme, M; Bartsch, U; Martini, R; Anliker, B; Schachner, M; Mantei, N			Disruption of the mouse L1 gene leads to malformations of the nervous system	NATURE GENETICS			English	Article							CELL-ADHESION MOLECULE; NEURITE OUTGROWTH; CEREBELLAR NEURONS; PERIPHERAL-NERVES; CLINICAL SPECTRUM; N-CAM; EXPRESSION; ANTIBODIES; SHOW; HYDROCEPHALUS	The adhesion molecule L1 is a member of the immunoglobulin superfamily(1). L1 is involved in various recognition processes in the CNS and PNS2,3, and binding to LI can activate signal transduction pathways(4,5). Mutations in the human LI gene are associated with a variable phenotype, including mental retardation and anomalous development of the nervous system, referred to as 'CRASH' (corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraplegia, and hydrocephalus)(6). We generated an animal model of these conditions by gene targetting, Mutant mice were smaller than wild-type and were less sensitive to touch and pain, and their hind-legs appeared weak and uncoordinated, The size of the corticospinal tract was reduced and, depending on genetic background, the lateral ventricles were often enlarged, Non-myelinating Schwann cells formed processes not associated with axons and showed reduced association with axons, In vitro, neurite outgrowth on an L1 substrate and fasciculation were impaired, The mutant mouse described here will help to elucidate the functions of L1 in the nervous system and how these depend on genetic influences.	ETH HONGGERBERG, SWISS FED INST TECHNOL, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND; UNIV WURZBURG, DEPT NEUROL, DEV NEUROBIOL SECT, D-97080 WURZBURG, GERMANY; UNIV HAMBURG, ZENTRUM MOL NEUROBIOL, D-20246 HAMBURG, GERMANY	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf				Martini, Rudolf/0000-0002-5463-5592				APPEL F, 1993, J NEUROSCI, V13, P4764; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; BIXBY JL, 1990, J CELL BIOL, V111, P2725, DOI 10.1083/jcb.111.6.2725; CONSTAM DB, 1994, EUR J NEUROSCI, V6, P766, DOI 10.1111/j.1460-9568.1994.tb00988.x; Doherty P, 1996, PERSPECT DEV NEUROBI, V4, P157; FISCHER G, 1986, J NEUROSCI, V6, P605; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Holm J, 1996, EUR J NEUROSCI, V8, P1613, DOI 10.1111/j.1460-9568.1996.tb01306.x; Kadmon G, 1997, DIFFERENTIATION, V61, P143, DOI 10.1046/j.1432-0436.1997.6130143.x; KLINZ SG, 1995, J NEUROCHEM, V65, P84; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; MAH C, 1980, J COMP PHYSIOL PSYCH, V94, P1160, DOI 10.1037/h0077742; Maness PF, 1996, PERSPECT DEV NEUROBI, V4, P169; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MARTINI R, 1995, J NEUROSCI, V15, P4488; MIURA M, 1992, J BIOL CHEM, V267, P10752; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SCHRANDERSTUMPEL C, 1995, AM J MED GENET, V57, P107, DOI 10.1002/ajmg.1320570122; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2	28	388	391	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1997	17	3					346	349		10.1038/ng1197-346	http://dx.doi.org/10.1038/ng1197-346			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354804				2022-12-17	WOS:A1997YD66700034
J	Scholl, UI; Goh, G; Stolting, G; de Oliveira, RC; Choi, M; Overton, JD; Fonseca, AL; Korah, R; Starker, LF; Kunstman, JW; Prasad, ML; Hartung, EA; Mauras, N; Benson, MR; Brady, T; Shapiro, JR; Loring, E; Nelson-Williams, C; Libutti, SK; Mane, S; Hellman, P; Westin, G; Aring;kerstrom, G; Bjorklund, P; Carling, T; Fahlke, C; Hidalgo, P; Lifton, RP				Scholl, Ute I.; Goh, Gerald; Stoelting, Gabriel; de Oliveira, Regina Campos; Choi, Murim; Overton, John D.; Fonseca, Annabelle L.; Korah, Reju; Starker, Lee F.; Kunstman, John W.; Prasad, Manju L.; Hartung, Erum A.; Mauras, Nelly; Benson, Matthew R.; Brady, Tammy; Shapiro, Jay R.; Loring, Erin; Nelson-Williams, Carol; Libutti, Steven K.; Mane, Shrikant; Hellman, Per; Westin, Gunnar; Akerstrom, Goran; Bjorklund, Peyman; Carling, Tobias; Fahlke, Christoph; Hidalgo, Patricia; Lifton, Richard P.			Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism	NATURE GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; SUBUNIT; REVEALS; LACKING; GENE	Adrenal aldosterone-producing adenomas (APAs) constitutively produce the salt-retaining hormone aldosterone and are a common cause of severe hypertension. Recurrent mutations in the potassium channel gene KCNJ5 that result in cell depolarization and Ca2+ influx cause similar to 40% of these tumors(1). We identified 5 somatic mutations (4 altering Gly403 and 1 altering Ile770) in CACNA1D, encoding a voltage-gated calcium channel, among 43 APAs without mutated KCNJ5. The altered residues lie in the S6 segments that line the channel pore. Both alterations result in channel activation at less depolarized potentials; Gly403 alterations also impair channel inactivation. These effects are inferred to cause increased Ca2+ influx, which is a sufficient stimulus for aldosterone production and cell proliferation in adrenal glomerulosa(2). We also identified de novo germline mutations at identical positions in two children with a previously undescribed syndrome featuring primary aldosteronism and neuromuscular abnormalities. These findings implicate gain-of-function Ca2+ channel mutations in APAs and primary aldosteronism.	[Scholl, Ute I.; Goh, Gerald; Choi, Murim; Overton, John D.; Loring, Erin; Nelson-Williams, Carol; Mane, Shrikant; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; [Scholl, Ute I.; Goh, Gerald; Choi, Murim; Loring, Erin; Nelson-Williams, Carol; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT USA; [Stoelting, Gabriel; Fahlke, Christoph; Hidalgo, Patricia] Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophysik ICS 4, D-52425 Julich, Germany; [de Oliveira, Regina Campos] Medizin Hsch Hannover, Inst Neurophysiol, Hannover, Germany; [Choi, Murim; Overton, John D.; Loring, Erin; Lifton, Richard P.] Yale Ctr Mendelian Gen, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Helmholtz Association; Research Center Julich; Hannover Medical School	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT USA.	richard.lifton@yale.edu	Goh, Gerald/N-1684-2015; Björklund, Peyman/A-1509-2014; Hidalgo, Patricia/I-7506-2013; Wang, Guilin/G-8794-2018; Goh, Gerald/E-9158-2014; Hartung, Erum A/M-3143-2015; Hellman, Per/AAL-9817-2021; Choi, Murim/AAP-9120-2021; Stolting, Gabriel/G-3704-2014; Fahlke, Christoph/G-3635-2013	Goh, Gerald/0000-0002-3832-6466; Björklund, Peyman/0000-0002-9398-4496; Hidalgo, Patricia/0000-0002-4162-6590; Goh, Gerald/0000-0002-3832-6466; Hartung, Erum A/0000-0001-5617-6505; Hellman, Per/0000-0002-5322-5073; Benson, Matthew/0000-0001-8458-2973; Fonseca, Annabelle/0000-0002-4972-5139; Scholl, Ute/0000-0002-0309-8045; Kunstman, John/0000-0002-2618-4173; Stolting, Gabriel/0000-0002-2339-0545; Fahlke, Christoph/0000-0001-8602-9952	US National Institutes of Health (NIH) Centers for Mendelian Genomics [5U54HG006504]; Fondation Leducq Transatlantic Network in Hypertension; Deutsche Forschungsgemeinschaft; Swedish Cancer Society; Swedish Research Council; Lions Cancer Fund, Uppsala; Agency for Science, Technology and Research, Singapore; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Transatlantic Network in Hypertension(Leducq Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Fund, Uppsala; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the subjects and families whose participation made this study possible. We thank the staff of the Yale West Campus Genomics Center, the Yale Cellular and Molecular Physiology Microscopy and Imaging Core, the Endocrine Surgical Laboratory, Clinical Research Centre, Uppsala University Hospital and the Department of Surgery, Montefiore Medical Center and Albert Einstein College of Medicine for their invaluable contributions to this research. J. Matthes (Universitat Koln) and F. Lehmann-Horn (Universitat Ulm) kindly provided us with clones for the alpha<INF>2</INF>delta subunits. This work was supported by the US National Institutes of Health (NIH) Centers for Mendelian Genomics (5U54HG006504), the Fondation Leducq Transatlantic Network in Hypertension and the Deutsche Forschungsgemeinschaft and by the Swedish Cancer Society, the Swedish Research Council and the Lions Cancer Fund, Uppsala. G. G. is supported by the Agency for Science, Technology and Research, Singapore. T. C. is a Doris Duke-Damon Runyon Clinical Investigator. R. P. L. is an Investigator of the Howard Hughes Medical Institute.	Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Battistini S, 1999, NEUROLOGY, V53, P38, DOI 10.1212/WNL.53.1.38; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; BRENNER CH, 1993, TRANSFUSION, V33, P51, DOI 10.1046/j.1537-2995.1993.33193142310.x; Butler JM, 2003, J FORENSIC SCI, V48, P908; Catterall WA, 2010, NEUROSCI LETT, V486, P107, DOI 10.1016/j.neulet.2010.08.085; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; CONN JW, 1955, J LAB CLIN MED, V45, P3; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Hans M, 1999, J NEUROSCI, V19, P1610; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Hering S, 2008, CHANNELS, V2, P61, DOI 10.4161/chan.2.2.5999; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Hu CL, 2012, J CLIN INVEST, V122, P2046, DOI 10.1172/JCI61996; Kang S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2149; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; Peloquin JB, 2007, NEUROSCIENCE, V150, P335, DOI 10.1016/j.neuroscience.2007.09.021; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Scholl UI, 2013, CURR OPIN NEPHROL HY, V22, P141, DOI 10.1097/MNH.0b013e32835cecf8; Scholl UI, 2012, P NATL ACAD SCI USA, V109, P2533, DOI 10.1073/pnas.1121407109; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Tadjine M, 2008, CLIN ENDOCRINOL, V68, P264, DOI 10.1111/j.1365-2265.2007.03033.x; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308	28	387	402	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1050	U126		10.1038/ng.2695	http://dx.doi.org/10.1038/ng.2695			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23913001	Green Accepted			2022-12-17	WOS:000323748200015
J	Myers, AJ; Gibbs, JR; AWebster, J; Rohrer, K; Zhao, A; Marlowe, L; Kaleem, M; Leung, D; Bryden, L; Nath, P; Zismann, VL; Joshipura, K; Huentelman, MJ; Hu-Lince, D; Coon, KD; Craig, DW; Pearson, JV; Holmans, P; Heward, CB; Reiman, EM; Stephan, D; Hardy, J				Myers, Amanda J.; Gibbs, J. Raphael; AWebster, Jennifer; Rohrer, Kristen; Zhao, Alice; Marlowe, Lauren; Kaleem, Mona; Leung, Doris; Bryden, Leslie; Nath, Priti; Zismann, Victoria L.; Joshipura, Keta; Huentelman, Matthew J.; Hu-Lince, Diane; Coon, Keith D.; Craig, David W.; Pearson, John V.; Holmans, Peter; Heward, Christopher B.; Reiman, Eric M.; Stephan, Dietrich; Hardy, John			A survey of genetic human cortical gene expression	NATURE GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; ALZHEIMERS-DISEASE; ALLELIC EXPRESSION; BRAIN; HAPLOTYPE; INFERENCE; MICE; APOE	It is widely assumed that genetic differences in gene expression underpin much of the difference among individuals and many of the quantitative traits of interest to geneticists. Despite this, there has been little work on genetic variability in human gene expression and almost none in the human brain, because tools for assessing this genetic variability have not been available. Now, with whole-genome SNP genotyping arrays and whole-transcriptome expression arrays, such experiments have become feasible. We have carried out whole-genome genotyping and expression analysis on a series of 193 neuropathologically normal human brain samples using the Affymetrix GeneChip Human Mapping 500K Array Set and Illumina HumanRefseq-8 Expression BeadChip platforms. Here we present data showing that 58% of the transcriptome is cortically expressed in at least 5% of our samples and that of these cortically expressed transcripts, 21% have expression profiles that correlate with their genotype. These genetic-expression effects should be useful in determining the underlying biology of associations with common diseases of the human brain and in guiding the analysis of the genomic regions involved in the control of normal gene expression.	NIH, NIA, Neurogenet Lab, Bethesda, MD 20892 USA; Univ Miami, Miller Sch Med, Dept Psychiat & Biobehav Sci, Div Neurosci, Miami, FL 33136 USA; Reta Lila Weston Inst, Neurol Inst, Dept Mol Neurosci & Neurodegenerat Dis, London WC1N 3BG, England; Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; Arizona Alzheimers Consortium, Phoenix, AZ 85006 USA; St Josephs Hosp, Med Ctr, Div Thorac Oncol Res, Phoenix, AZ 85013 USA; Cardiff Univ, Dept Psychol Med, Bioinformat Unit, Cardiff CF14 4XN, Wales; Kronos Sci Lab, Phoenix, AZ 85016 USA; Banner Alzheimers Inst, Phoenix, AZ 85006 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Miami; University of London; University College London; Translational Genomics Research Institute; St. Joseph's Hospital and Medical Center; Cardiff University; Banner Research; Banner Health; Banner Alzheimer's Institute	Myers, AJ (corresponding author), NIH, NIA, Neurogenet Lab, Bldg 10,Main Campus,Porter Neurosci Bldg, Bethesda, MD 20892 USA.	amyers@med.miami.edu	Holmans, Peter/F-4518-2015; Pearson, John V/F-2249-2011; Hardy, John/C-2451-2009; Leung, Doris G/R-5447-2016; Gibbs, J. Raphael/A-3984-2010; Myers, Amanda J/B-1796-2010; Pearson, John/AAT-4211-2020; Craig, David Wesley/K-6961-2019	Holmans, Peter/0000-0003-0870-9412; Pearson, John V/0000-0003-0904-4598; Hardy, John/0000-0002-3122-0423; Leung, Doris G/0000-0002-2558-7798; Gibbs, J. Raphael/0000-0002-6985-0658; Myers, Amanda J/0000-0002-3100-9396; Craig, David Wesley/0000-0003-2040-1955	MRC [G0701075, G9810900] Funding Source: UKRI; Medical Research Council [G0701075, G9810900] Funding Source: Medline; NHLBI NIH HHS [UO1HL084744] Funding Source: Medline; NIA NIH HHS [P30-AG13846, P50AG05681, P50-AG08671, P30 AG19610, AG10161, P50 AG16570, U01 AG016976, AG05128, AG05146, AG05144, P50 AG05136] Funding Source: Medline; NIMH NIH HHS [MH60451] Funding Source: Medline; NINDS NIH HHS [U24NS051872, NS39764] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764, U24NS051872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, P50AG016570, P50AG005136, P50AG005146, U01AG016976, P30AG010161, P30AG019610, P50AG005144, P30AG013846, P50AG008671] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Falush D, 2003, GENETICS, V164, P1567; GILBERT JM, 1981, J NEUROCHEM, V36, P976, DOI 10.1111/j.1471-4159.1981.tb01689.x; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tukey JW, 1977, EXPLORATORY DATA ANA, Vxvi; WORKMAN C, 2002, GENOME BIOL, V0003	20	387	394	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1494	1499		10.1038/ng.2007.16	http://dx.doi.org/10.1038/ng.2007.16			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982457				2022-12-17	WOS:000251267400018
J	Goring, HHH; Curran, JE; Johnson, MP; Dyer, TD; Charlesworth, J; Cole, SA; Jowett, JBM; Abraham, LJ; Rainwater, DL; Comuzzie, AG; Mahaney, MC; Almasy, L; MacCluer, JW; Kissebah, AH; Collier, GR; Moses, EK; Blangero, J				Goering, Harald H. H.; Curran, Joanne E.; Johnson, Matthew P.; Dyer, Thomas D.; Charlesworth, Jac; Cole, Shelley A.; Jowett, Jeremy B. M.; Abraham, Lawrence J.; Rainwater, David L.; Comuzzie, Anthony G.; Mahaney, Michael C.; Almasy, Laura; MacCluer, Jean W.; Kissebah, Ahmed H.; Collier, Gregory R.; Moses, Eric K.; Blangero, John			Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes	NATURE GENETICS			English	Article							HUMAN GENE-EXPRESSION; LINKAGE ANALYSIS; HUMAN GENOME; YEAST; IDENTIFICATION; ASSOCIATION; SEGREGATION; POPULATIONS; NUCLEOTIDE; PHENOTYPES	Quantitative differences in gene expression are thought to contribute to phenotypic differences between individuals. We generated genome-wide transcriptional profiles of lymphocyte samples from 1,240 participants in the San Antonio Family Heart Study. The expression levels of 85% of the 19,648 detected autosomal transcripts were significantly heritable. Linkage analysis uncovered > 1,000 cis-regulated transcripts at a false discovery rate of 5% and showed that the expression quantitative trait loci with the most significant linkage evidence are often located at the structural locus of a given transcript. To highlight the usefulness of this much- enlarged map of cis-regulated transcripts for the discovery of genes that influence complex traits in humans, as an example we selected high-density lipoprotein cholesterol concentration as a phenotype of clinical importance, and identified the cis-regulated vanin 1 (VNN1) gene as harboring sequence variants that influence high-density lipoprotein cholesterol concentrations.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; Int Diab Inst, Caulfield, Vic 3162, Australia; ChemGenex Pharmaceut, Geelong, Vic 3216, Australia; Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia; Med Coll Wisconsin, TOPS Ctr Obes & Metab Res, Milwaukee, WI 53226 USA; Deakin Univ, Sch Hlth Sci, Metab Res Unit, Waurn Ponds, Vic 3216, Australia	Texas Biomedical Research Institute; University of Western Australia; Medical College of Wisconsin; Deakin University	Goring, HHH (corresponding author), SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA.	hgoring@sfbrgenetics.org	Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019; Jowett, Jeremy/A-3809-2009; Charlesworth, Jac/J-7661-2014; Moses, Eric/A-3101-2010	Charlesworth, Jac/0000-0001-6201-3518; Moses, Eric/0000-0001-7781-4465; Curran, Joanne/0000-0002-6898-155X	NCRR NIH HHS [RR013556] Funding Source: Medline; NHLBI NIH HHS [HL045222] Funding Source: Medline; NIMH NIH HHS [MH059490] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero J, 2005, HUM BIOL, V77, P541, DOI 10.1353/hub.2006.0003; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kent JW, 2007, GENET EPIDEMIOL, V31, P173, DOI 10.1002/gepi.20200; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Perez-Enciso M, 2004, GENETICS, V166, P547, DOI 10.1534/genetics.166.1.547; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yamazaki K, 2002, BIOCHEM BIOPH RES CO, V290, P1114, DOI 10.1006/bbrc.2001.6319; Young Christine E, 2004, Cardiol Rev, V12, P107, DOI 10.1097/01.crd.0000097140.29929.8a; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	50	387	404	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1208	1216		10.1038/ng2119	http://dx.doi.org/10.1038/ng2119			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873875				2022-12-17	WOS:000249737400016
J	Cavalli-Sforza, LL; Feldman, MW				Cavalli-Sforza, LL; Feldman, MW			The application of molecular genetic approaches to the study of human evolution	NATURE GENETICS			English	Review							MITOCHONDRIAL-DNA SEQUENCES; Y-CHROMOSOME HAPLOTYPES; LINKAGE DISEQUILIBRIUM; HIGH-RESOLUTION; HUMAN GENOME; POPULATION-STRUCTURE; BALANCING SELECTION; NATURAL-SELECTION; HUMAN MIGRATIONS; NEANDERTHAL DNA	The past decade of advances in molecular genetic technology has heralded a new era for all evolutionary studies, but especially the science of human evolution. Data on various kinds of DNA variation in human populations have rapidly accumulated. There is increasing recognition of the importance of this variation for medicine and developmental biology and for understanding the history of our species. Haploid markers from mitochondrial DNA and the Y chromosome have proven invaluable for generating a standard model for evolution of modern humans. Conclusions from earlier research on protein polymorphisms have been generally supported by more sophisticated DNA analysis. Co-evolution of genes with language and some slowly evolving cultural traits, together with the genetic evolution of commensals and parasites that have accompanied modern humans in their expansion from Africa to the other continents, supports and supplements the standard model of genetic evolution. The advances in our understanding of the evolutionary history of humans attests to the advantages of multidisciplinary research.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Stanford Med Sch, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Feldman, MW (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	marc@charles.stanford.edu						ABETI PC, 2002, NATURE, V419, P832; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Ammerman A.J., 1984, NEOLITHIC TRANSITION; ANATI E, 1983, VALC S 79 CTR CAM ST; ARENSBURG B, 1990, AM J PHYS ANTHROPOL, V83, P137, DOI 10.1002/ajpa.1330830202; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza L. L., 2000, GENES PEOPLES LANGUA; Cavalli-Sforza L. L., 1981, CULTURAL TRANSMISSIO; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1975, THEOR POPUL BIOL, V8, P127, DOI 10.1016/0040-5809(75)90029-5; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1973, AM J HUM GENET, V25, P82; CEPPELLINI R, 1967, HISTOCOMPATIBILITY T; CHEN YS, 1995, AM J HUM GENET, V57, P133; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; CONKEY MW, 1997, MEMOIRS CALIFORNIA A, V23; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DONNELLY P, 1996, CIBA FDN S, V197; Edwards A.W.F., 1964, P 11 INT C GEN, V2, P923; Edwards AWF, 1964, PHENETIC PHYLOGENETI, P67; Ellis N, 2002, GENOME RES, V12, P339; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; EWENS WJ, 1979, MATH POPULATION GENE, P98; Fagan Brian M, 1987, GREAT JOURNEY PEOPLI; FELDMAN MW, 1974, GENET RES, V24, P151, DOI 10.1017/S0016672300015184; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Greenberg J. H, 1987, LANGUAGE AM; Greenberg JH, 1971, CURR TRENDS LINGUIST, V8, P809; GREENBERG JH, 1963, LANGUAGES AFRICA; Greenberg Joseph H., 2000, INDOEUROPEAN ITS CLO; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; Hewlett BS, 2002, CURR ANTHROPOL, V43, P313, DOI 10.1086/339379; Hirschfeld L, 1918, ANTHROPOLOGIE, V29, P505; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1990, OXF SURV EVOL BIOL, V7, P203; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; KIVISILD T, IN PRESS AM J HUM GE; Klein R.G., 1999, HUMAN CAREER; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LEWONTIN RC, 1966, GENETICS, V54, P595; LEWONTIN RC, 1973, GENETICS, V74, P175; Lieberman Philip, 1971, LINGUIST INQ, V2, P203; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Mountain JL, 2002, GENOME RES, V12, P1766, DOI 10.1101/gr.238602; MOUNTAIN JL, 1992, PHILOS T ROY SOC B, V337, P159, DOI 10.1098/rstb.1992.0093; Mourant A., 1954, DISTRIBUTION HUMAN B; Mourant A. E., 1978, BLOOD GROUPS DIS; Mourant AE, 1976, DISTRIBUTION HUMAN B; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; NEI M, 1974, AM J HUM GENET, V26, P421; Nei M., 1988, HUMAN POLYMORPHIC GE; OBERACHER H, NUCL ACIDS RES, V30, pE67; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paracchini S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e27; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PAYNE R, 1977, TISSUE ANTIGENS, V9, P135; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Race RR., 1975, BLOOD GROUPS MAN; Rana BK, 1999, GENETICS, V151, P1547; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg N.A., 2002, MODERN DEV THEORETIC, P130; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ruhlen Merritt, 1994, ORIGIN LANGUAGES STU; RYMAN N, 1983, HUM HERED, V33, P93, DOI 10.1159/000153357; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salem AH, 1996, AM J HUM GENET, V59, P741; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shen PD, 2002, HUM MUTAT, V20, P209, DOI 10.1002/humu.10117; SLATKIN M, 1991, GENETICS, V129, P555; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Sugimoto C, 1997, P NATL ACAD SCI USA, V94, P9191, DOI 10.1073/pnas.94.17.9191; TAJIMA F, 1989, GENETICS, V123, P585; Tang H, 2002, GENETICS, V161, P447; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; THANGARAJ K, IN PRESS CURR BIOL; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Toomajian C, 2002, GENETICS, V161, P1609; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Weidenreich Franz, 1946, APES GIANTS MAN; Weir B., 1996, GENETIC DATA ANAL; WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; XIAO W, HUM MUTAT, V17, P439; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Zerjal T, 1997, AM J HUM GENET, V60, P1174	146	387	411	2	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			266	275		10.1038/ng1113	http://dx.doi.org/10.1038/ng1113			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	652QY	12610536				2022-12-17	WOS:000181390900007
J	Dyrskjot, L; Thykjaer, T; Kruhoffer, M; Jensen, JL; Marcussen, N; Hamilton-Dutoit, S; Wolf, H; Orntoft, TF				Dyrskjot, L; Thykjaer, T; Kruhoffer, M; Jensen, JL; Marcussen, N; Hamilton-Dutoit, S; Wolf, H; Orntoft, TF			Identifying distinct classes of bladder carcinoma using microarrays	NATURE GENETICS			English	Article							GENE-EXPRESSION PATTERNS; GENOME-WIDE; PREDICTION; CANCER; TUMOR; IDENTIFICATION; CLASSIFICATION	Bladder cancer is a common malignant disease characterized by frequent recurrences(1,2). The stage of disease at diagnosis and the presence of surrounding carcinoma in situ are important in determining the disease course of an affected individual(3). Despite considerable effort, no accepted immunohistological or molecular markers have been identified to define clinically relevant subsets of bladder cancer. Here we report the identification of clinically relevant subclasses of bladder carcinoma using expression microarray analysis of 40 well characterized bladder tumors. Hierarchical cluster analysis identified three major stages, Ta, T1 and T2-4, with the Ta tumors further classified into subgroups. We built a 32-gene molecular classifier using a cross-validation approach that was able to classify benign and muscle-invasive tumors with close correlation to pathological staging in an independent test set of 68 tumors. The classifier provided new predictive information on disease progression in Ta tumors compared with conventional staging (P < 0.005). To delineate non-recurring Ta tumors from frequently recurring Ta tumors, we analyzed expression patterns in 31 tumors by applying a supervised learning classification methodology, which classified 75% of the samples correctly (P < 0.006). Furthermore, gene expression profiles characterizing each stage and subtype identified their biological properties, producing new potential targets for therapy.	Aarhus Univ Hosp, Dept Clin Biochem, Mol Diagnost Lab, DK-8200 Aarhus N, Denmark; Aros Appl Biotechnol, Aarhus, Denmark; Aarhus Univ Hosp, Dept Urol, DK-8000 Aarhus N, Denmark; Dept Theoret Stat, Aarhus, Denmark; Dept Math Sci, Aarhus, Denmark; Aarhus Univ Hosp, Univ Inst Pathol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Orntoft, TF (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Mol Diagnost Lab, DK-8200 Aarhus N, Denmark.	orntoft@kba.sks.au.dk	Jensen, Jens Ledet/B-7172-2008; Dyrskjot, Lars/H-4922-2012	Dyrskjot, Lars/0000-0001-7061-9851; Hamilton-Dutoit, Stephen/0000-0003-2158-3885; Jensen, Jens Ledet/0000-0002-8776-5764				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bergkvist A, 1965, Acta Chir Scand, V130, P371; Cheng L, 1999, CANCER-AM CANCER SOC, V85, P2469, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.3.CO;2-L; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox SB, 2001, LANCET ONCOL, V2, P278, DOI 10.1016/S1470-2045(00)00323-5; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kerr JS, 2000, EXPERT OPIN INV DRUG, V9, P1271, DOI 10.1517/13543784.9.6.1271; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Luo J, 2001, CANCER RES, V61, P4683; Notterman DA, 2001, CANCER RES, V61, P3124; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Seymour L, 1999, CANCER TREAT REV, V25, P301, DOI 10.1053/ctrv.1999.0134; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thykjaer T, 2001, CANCER RES, V61, P2492; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wolf H, 1986, Prog Clin Biol Res, V221, P223	26	387	398	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2003	33	1					90	96		10.1038/ng1061	http://dx.doi.org/10.1038/ng1061			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12469123				2022-12-17	WOS:000180136100024
J	Peters, AHFM; Mermoud, JE; O'Carroll, D; Pagani, M; Schweizer, D; Brockdorff, N; Jenuwein, T				Peters, AHFM; Mermoud, JE; O'Carroll, D; Pagani, M; Schweizer, D; Brockdorff, N; Jenuwein, T			Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin	NATURE GENETICS			English	Article							INACTIVE X-CHROMOSOME; ACETYLATION; LOCALIZATION; FEMALE; RNA; PROTEINS; MACROH2A; GENE; SITE	Post-translational modifications of histone amino termini are an important regulatory mechanism that induce transitions in chromatin structure, thereby contributing to epigenetic gene control and the assembly of specialized chromosomal subdomains(1,2). Methylation of histone H3 at lysine 9 (H3-Lys9) by site-specific histone methyltransferases (Suv39h HMTaseS)(3) marks constitutive heterochromatin(4-6). Here, we show that H3-Lys9 methylation also occurs in facultative heterochromatin of the inactive X chromosome (X-i) in female mammals. H3-Lys9 methylation is retained through mitosis, indicating that it might provide an epigenetic imprint for the maintenance of the inactive state. Disruption of the two mouse Suv39h HMTases abolishes H3-Lys9 methylation of constitutive heterochromatin but not that of the X-i. In addition, HP1 proteins, which normally associate with heterochromatin, do not accumulate with the X-i. These observations suggest the existence of an Suv39h-HP1-independent pathway regulating H3-Lys9 methylation of facultative heterochromatin.	Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria; Hammersmith Hosp, ISCM, MRC, Ctr Clin Sci, London W12 0NN, England; Univ Vienna, Inst Bot, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Imperial College London; University of Vienna	Jenuwein, T (corresponding author), Res Inst Mol Pathol, Vienna Bioctr, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	jenuwein@nt.imp.univie.ac.at		Brockdorff, Neil/0000-0003-4838-2653; Mermoud, Jacqueline/0000-0002-7718-646X; Peters, Antoine/0000-0002-0311-1887; O'Carroll, Donal/0000-0002-8626-2217				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	30	387	403	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					77	80		10.1038/ng789	http://dx.doi.org/10.1038/ng789			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11740497				2022-12-17	WOS:000173105600017
J	Kazazian, HH; Moran, JV				Kazazian, HH; Moran, JV			The impact of L1 retrotransposons on the human genome	NATURE GENETICS			English	Article							HUMAN TRANSPOSABLE ELEMENT; RNA-BINDING PROTEIN; REVERSE TRANSCRIPTION; RIBONUCLEOPROTEIN-PARTICLES; LINE-1 ELEMENT; SPASTIC MOUSE; GENE FAMILY; FACTOR YY1; ALU RNA; INSERTION	The 'master' human mobile element, the L1 retrotransposon, has come of age as a biological entity. Knowledge of how it retrotransposes in vivo, how its proteins act to retrotranspose other poly A elements and the extent of its role in shaping the human genome should emerge rapidly over the next few years. We review the impact of retrotransposons and how new insight is likely to lead to important practical applications for these intriguing mobile elements.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazazian, HH (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.							ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Argeson AC, 1996, GENETICS, V142, P557; BECKER KG, 1993, HUM MOL GENET, V2, P1697, DOI 10.1093/hmg/2.10.1697; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; BRATTHAUER GL, 1992, ONCOGENE, V7, P507; CHANG DY, 1995, MOL CELL BIOL, V15, P2109; CHANG DY, 1993, J BIOL CHEM, V268, P6423; CHANG DY, 1994, MOL CELL BIOL, V14, P3949, DOI 10.1128/MCB.14.6.3949; Dhellin O, 1997, EMBO J, V16, P6590, DOI 10.1093/emboj/16.21.6590; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Eickbush TH, 1997, SCIENCE, V277, P911, DOI 10.1126/science.277.5328.911; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; GPORMAN MA, 1997, EMBO J, V16, P6548; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUROSE K, 1995, NUCLEIC ACIDS RES, V23, P3704, DOI 10.1093/nar/23.18.3704; Kuster JE, 1997, MAMM GENOME, V8, P673, DOI 10.1007/s003359900535; LEIBOLD DM, 1990, P NATL ACAD SCI USA, V87, P6990, DOI 10.1073/pnas.87.18.6990; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; MARTIN SL, 1995, GENE, V153, P261, DOI 10.1016/0378-1119(94)00785-Q; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; MCMILLAN JP, 1993, P NATL ACAD SCI USA, V90, P11533, DOI 10.1073/pnas.90.24.11533; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; MIKI Y, 1992, CANCER RES, V52, P643; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Perou CM, 1997, GENOMICS, V42, P366, DOI 10.1006/geno.1997.4740; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; TEMIN HM, 1985, MOL BIOL EVOL, V2, P455; Vidaud Dominique, 1993, European Journal of Human Genetics, V1, P30; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WOODSAMUELS P, 1989, GENOMICS, V4, P290, DOI 10.1016/0888-7543(89)90332-7; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	68	387	400	5	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					19	24		10.1038/ng0598-19	http://dx.doi.org/10.1038/ng0598-19			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590283				2022-12-17	WOS:000073346700011
J	Decottignies, A; Goffeau, A				Decottignies, A; Goffeau, A			Complete inventory of the yeast ABC proteins	NATURE GENETICS			English	Article							BINDING CASSETTE TRANSPORTER; ATP-DEPENDENT PERMEASES; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; ADRENOLEUKODYSTROPHY GENE; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; MEMBRANE-PROTEINS; CANDIDA-ALBICANS	The complete sequence of the yeast genome predicts the existence of 29 proteins belonging to the ubiquitous ATP-binding cassette (ABC) superfamily. Using binary comparison, phylogenetic classification and detection of conserved amino acid residues, the yeast ABC proteins have been classified in a total of six clusters, including ten subclusters of distinct predicted topology and presumed distinct function. Study of the yeast ABC proteins provides insight into the physiological function and biochemical mechanisms of their human homologues, such as those involved in cystic fibrosis, adrenoleukodystrophy, Zellweger syndrome, multidrug resistance and the antiviral activity of interferons.	UNIV CATHOLIQUE LOUVAIN,UNITE BIOCHIM PHYSIOL,B-1348 LOUVAIN,BELGIUM	Universite Catholique Louvain								ALLIGNET J, 1992, GENE, V117, P45, DOI 10.1016/0378-1119(92)90488-B; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; BOSSIER P, 1994, YEAST, V10, P1; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; CUCCA F, 1994, TISSUE ANTIGENS, V44, P234, DOI 10.1111/j.1399-0039.1994.tb02388.x; CUI Z, IN PRESS J BIOL CHEM; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; DREESEN TD, 1988, MOL CELL BIOL, V8, P5206, DOI 10.1128/MCB.8.12.5206; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; DUJON B, 1994, NATURE, V369, P371, DOI 10.1038/369371a0; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GOFFEAU A, 1994, NATURE, V369, P101, DOI 10.1038/369101a0; GOFFEAU A, 1993, FEBS LETT, V325, P112, DOI 10.1016/0014-5793(93)81425-Y; GOFFEAU A, 1993, YEAST, V9, P691, DOI 10.1002/yea.320090703; GONZALEZESCRIBANO MF, 1995, ANN RHEUM DIS, V54, P386, DOI 10.1136/ard.54.5.386; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; HAASE E, 1992, CURR GENET, V21, P319, DOI 10.1007/BF00351689; HETTEMA EH, IN PRESS EMBO J; Hieter P, 1996, NAT GENET, V13, P253, DOI 10.1038/ng0796-253; HIRATA D, 1994, CURR GENET, V26, P285, DOI 10.1007/BF00310491; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; JOHNSTON M, 1994, SCIENCE, V265, P2077, DOI 10.1126/science.8091229; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KERPPOLA RE, 1992, J BIOL CHEM, V267, P2329; KOLACZKOWSKI M, 1996, IN PRESS J BIOL CHEM; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; LEPPERT G, 1990, GENETICS, V125, P13; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; Michaelis S, 1995, COLD SPRING HARB SYM, V60, P291, DOI 10.1101/SQB.1995.060.01.034; MIDDLETON D, 1994, HUM IMMUNOL, V40, P131, DOI 10.1016/0198-8859(94)90057-4; MIOSGA T, IN PRESS YEAST; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MURAKAMI Y, 1995, NAT GENET, V10, P261, DOI 10.1038/ng0795-261; NAGAO K, 1995, J BACTERIOL, V177, P1536, DOI 10.1128/jb.177.6.1536-1543.1995; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OHARE K, 1984, J MOL BIOL, V180, P437, DOI 10.1016/0022-2836(84)90021-4; OROZCO E, 1995, PARASITOL TODAY, V11, P473, DOI 10.1016/0169-4758(95)80067-0; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; PARLE AG, IN PRESS YEAST; PARRALOPEZ C, 1993, EMBO J, V12, P4053, DOI 10.1002/j.1460-2075.1993.tb06089.x; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; PURNELLE B, 1991, YEAST, V7, P867, DOI 10.1002/yea.320070813; QIN SL, 1990, J BIOL CHEM, V265, P1903; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; SANDBAKEN MG, 1990, J BIOL CHEM, V265, P15838; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; SAPTARSHI P, 1996, P NATL ACAD SCI USA, V93, P6929; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; SAVARY S, IN PRESS MAMMAL GENO; SERVOS J, 1993, MOL GEN GENET, V236, P214, DOI 10.1007/BF00277115; Shan N, 1996, J BIOL CHEM, V271, P8725, DOI 10.1074/jbc.271.15.8725; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; Smart CC, 1996, J BIOL CHEM, V271, P19351, DOI 10.1074/jbc.271.32.19351; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; TABAK HF, 1995, TRANSPORT PROTEINS M, P649; TAULER A, 1990, J BIOL CHEM, V265, P15617; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; WEMMIE JA, 1994, J BIOL CHEM, V269, P35592; XIE JX, 1995, J BIOL CHEM, V270, P28084; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	78	387	405	1	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					137	145		10.1038/ng0297-137	http://dx.doi.org/10.1038/ng0297-137			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020838				2022-12-17	WOS:A1997WF08700012
J	ALTON, EWFW; MIDDLETON, PG; CAPLEN, NJ; SMITH, SN; STEEL, DM; MUNKONGE, FM; JEFFERY, PK; GEDDES, DM; HART, SL; WILLIAMSON, R; FASOLD, KI; MILLER, AD; DICKINSON, P; STEVENSON, BJ; MCLACHLAN, G; DORIN, JR; PORTEOUS, DJ				ALTON, EWFW; MIDDLETON, PG; CAPLEN, NJ; SMITH, SN; STEEL, DM; MUNKONGE, FM; JEFFERY, PK; GEDDES, DM; HART, SL; WILLIAMSON, R; FASOLD, KI; MILLER, AD; DICKINSON, P; STEVENSON, BJ; MCLACHLAN, G; DORIN, JR; PORTEOUS, DJ			NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE	NATURE GENETICS			English	Article							CONDUCTANCE REGULATOR GENE; POTENTIAL DIFFERENCE; EPITHELIAL-CELLS; MAMMALIAN-CELLS; MOUSE; INVIVO; EXPRESSION; CLONING; LUNG	We report gene transfer to the Edinburgh insertional mutant mouse (cf/cf), delivering CFTR cDNA-liposome complexes into the airways by nebulization. We show full restoration of cAMP related chloride responses in some animals and demonstrate, in the same tissues, human CFTR cDNA expression. Overall, a range of correction was seen with restoration of about 50% of the deficit between wild type mice and untreated cf/cf controls. We report modest correction in the intestinal tract following direct instillation and provide initial encouraging safety data for both the respiratory and intestinal tract following the liposome mediated gene delivery. The non-viral nature and potentially lower immunogenicity of DNA-liposomes suggest that this may offer a therapeutic alternative to adenoviral therapies.	NATL HEART & LUNG INST,DEPT LUNG PATHOL,LONDON SW3 6LR,ENGLAND; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND; UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT CHEM,LONDON SW7 1NA,ENGLAND; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	Imperial College London; Imperial College London; Imperial College London; University of Edinburgh	ALTON, EWFW (corresponding author), NATL HEART & LUNG INST,ION TRANSPORT LAB,LONDON SW3 6LR,ENGLAND.		Dickinson, Paul/B-7598-2014; Caplen, Natasha J/H-2768-2016; Porteous, David/AAA-3446-2021; Middleton, Peter G/ABC-5138-2020; Miller, Andrew/G-8291-2019; Hart, Stephen L/C-1615-2008; Porteous, David J/C-7289-2013	Caplen, Natasha J/0000-0002-0001-9460; Porteous, David/0000-0003-1249-6106; Middleton, Peter G/0000-0003-3361-4941; Miller, Andrew/0000-0003-0661-249X; Hart, Stephen L/0000-0001-8254-376X; Porteous, David J/0000-0003-1249-6106				ALTON EWFW, 1990, EUR RESPIR J, V3, P922; ALTON EWFW, 1992, THORAX, V47, P1010, DOI 10.1136/thx.47.12.1010; BOUCHER RC, 1982, FLUID ELECTROLYTE AB, P271; DORIN JR, 1989, SCIENCE, V243, P1357; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; Dorin Julia R., 1992, Transgenic Research, V1, P101, DOI 10.1007/BF02513027; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; FELDMAN C, 1991, AM J RESP CELL MOL, V5, P416, DOI 10.1165/ajrcmb/5.5.416; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; GAO X, 1991, BIOCHEM BIOPH RES CO, V179, P280, DOI 10.1016/0006-291X(91)91366-K; GEDDES DM, 1991, RECENT ADV RESPIRATO, P203; HAZINSKI TA, 1992, SEMIN PERINATOL, V15, P200; HYDE SC, 1993, NATURE, V362, P250, DOI 10.1038/362250a0; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MENTZ WM, 1986, AM REV RESPIR DIS, V134, P938, DOI 10.1164/arrd.1986.134.5.938; Nabel G. J., 1992, HUM GENE THER, V3, P399; PORTEOUS DJ, 1993, HUM MOL GENET, V2, P211, DOI 10.1093/hmg/2.3.211; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SAMBROOK J, 1988, MOL CLONING LABORATO; SMITH SN, 1992, CLIN SCI, V82, P667, DOI 10.1042/cs0820667; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; STRIBLING R, 1992, P NATL ACAD SCI USA, V89, P11277, DOI 10.1073/pnas.89.23.11277; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WHITSETT JA, 1992, NAT GENET, V2, P13, DOI 10.1038/ng0992-13; WIDDICOMBE JH, 1985, P NATL ACAD SCI USA, V82, P6167, DOI 10.1073/pnas.82.18.6167; YAMAGUCHI M, 1991, NUCLEIC ACIDS RES, V19, P2403, DOI 10.1093/nar/19.9.2403; YOSHIMURA K, 1992, NUCLEIC ACIDS RES, V20, P3233, DOI 10.1093/nar/20.12.3233	33	387	416	0	29	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					135	142		10.1038/ng1093-135	http://dx.doi.org/10.1038/ng1093-135			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	7504552				2022-12-17	WOS:A1993MA05600010
J	Barrett, JC; Lee, JC; Lees, CW; Prescott, NJ; Anderson, CA; Phillips, A; Wesley, E; Parnell, K; Zhang, H; Drummond, H; Nimmo, ER; Massey, D; Blaszczyk, K; Elliott, T; Cotterill, L; Dallal, H; Lobo, AJ; Mowat, C; Sanderson, JD; Jewell, DP; Newman, WG; Edwards, C; Ahmad, T; Mansfield, JC; Satsangi, J; Parkes, M; Mathew, CG; Donnelly, P; Peltonen, L; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Craddock, N; Deloukas, P; Duncanson, A; Jankowski, J; Markus, HS; McCarthy, MI; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Samani, N; Trembath, RC; Viswanathan, AC; Wood, N; Spencer, CCA; Bellenguez, C; Davison, D; Freeman, C; Strange, A; Langford, C; Hunt, SE; Edkins, S; Gwilliam, R; Blackburn, H; Bumpstead, SJ; Dronov, S; Gillman, M; Gray, E; Hammond, N; Jayakumar, A; McCann, OT; Liddle, J; Perez, ML; Potter, SC; Ravindrarajah, R; Ricketts, M; Waller, M; Weston, P; Widaa, S; Whittaker, P; Attwood, AP; Stephens, J; Sambrook, J; Ouwehand, WH; McArdle, WL; Ring, SM; Strachan, DP				Barrett, Jeffrey C.; Lee, James C.; Lees, Charles W.; Prescott, Natalie J.; Anderson, Carl A.; Phillips, Anne; Wesley, Emma; Parnell, Kirstie; Zhang, Hu; Drummond, Hazel; Nimmo, Elaine R.; Massey, Dunecan; Blaszczyk, Kasia; Elliott, Timothy; Cotterill, Lynn; Dallal, Helen; Lobo, Alan J.; Mowat, Craig; Sanderson, Jeremy D.; Jewell, Derek P.; Newman, William G.; Edwards, Cathryn; Ahmad, Tariq; Mansfield, John C.; Satsangi, Jack; Parkes, Miles; Mathew, Christopher G.; Donnelly, Peter; Peltonen, Leena; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas; Deloukas, Panos; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S.; McCarthy, Mark I.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Samani, Nilesh; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas; Spencer, Chris C. A.; Bellenguez, Celine; Davison, Daniel; Freeman, Colin; Strange, Amy; Langford, Cordelia; Hunt, Sarah E.; Edkins, Sarah; Gwilliam, Rhian; Blackburn, Hannah; Bumpstead, Suzannah J.; Dronov, Serge; Gillman, Matthew; Gray, Emma; Hammond, Naomi; Jayakumar, Alagurevathi; McCann, Owen T.; Liddle, Jennifer; Perez, Marc L.; Potter, Simon C.; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Widaa, Sara; Whittaker, Pamela; Attwood, Antony P.; Stephens, Jonathan; Sambrook, Jennifer; Ouwehand, Willem H.; McArdle, Wendy L.; Ring, Susan M.; Strachan, David P.		UK IBD Genetics Consortium; Wellcome Trust Case Control Consor; Management Comm; Data Anal Grp; DNA Genotyping Data QC Informatics; Publications Comm; UK Blood Serv Controls; 1958 Birth Cohort Controls	Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; E-CADHERIN; COLORECTAL-CANCER; SEQUENCE VARIANTS; NUCLEAR FACTOR-4; RISK LOCI; GENE; EXPRESSION	Ulcerative colitis is a common form of inflammatory bowel disease with a complex etiology. As part of the Wellcome Trust Case Control Consortium 2, we performed a genome-wide association scan for ulcerative colitis in 2,361 cases and 5,417 controls. Loci showing evidence of association at P < 1 x 10(-5) were followed up by genotyping in an independent set of 2,321 cases and 4,818 controls. We find genome-wide significant evidence of association at three new loci, each containing at least one biologically relevant candidate gene, on chromosomes 20q13 (HNF4A; P = 3.2 x 10(-17)), 16q22 (CDH1 and CDH3; P = 2.8 x 10(-8)) and 7q31 (LAMB1; P = 3.0 x 10(-8)). Of note, CDH1 has recently been associated with susceptibility to colorectal cancer, an established complication of longstanding ulcerative colitis. The new associations suggest that changes in the integrity of the intestinal epithelial barrier may contribute to the pathogenesis of ulcerative colitis.	[Barrett, Jeffrey C.; Anderson, Carl A.; Peltonen, Leena; Deloukas, Panos; Langford, Cordelia; Hunt, Sarah E.; Edkins, Sarah; Gwilliam, Rhian; Blackburn, Hannah; Bumpstead, Suzannah J.; Dronov, Serge; Gillman, Matthew; Gray, Emma; Hammond, Naomi; Jayakumar, Alagurevathi; McCann, Owen T.; Liddle, Jennifer; Perez, Marc L.; Potter, Simon C.; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Widaa, Sara; Whittaker, Pamela; Attwood, Antony P.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Lee, James C.; Zhang, Hu; Massey, Dunecan; Parkes, Miles] Addenbrookes Hosp, Gastroenterol Res Unit, Cambridge, England; [Lees, Charles W.; Phillips, Anne; Drummond, Hazel; Nimmo, Elaine R.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Prescott, Natalie J.; Blaszczyk, Kasia; Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Anderson, Carl A.; Donnelly, Peter; Rautanen, Anna; Spencer, Chris C. A.; Bellenguez, Celine; Freeman, Colin; Strange, Amy] Wellcome Trust Ctr Human Genet, Oxford, England; [Wesley, Emma; Parnell, Kirstie; Ahmad, Tariq] Peninsula Coll Med & Dent, Exeter, Devon, England; [Elliott, Timothy; Sanderson, Jeremy D.] St Thomas Hosp, Dept Gastroenterol, Guys & St Thomas NHS Fdn Trust, London, England; [Cotterill, Lynn] Univ Manchester, Dept Med Genet, MAHSC, Manchester, Lancs, England; [Cotterill, Lynn; Newman, William G.] Cent Manchester NHS Fdn Trust, NIHR Biomed Res Ctr, Manchester, Lancs, England; [Dallal, Helen] S Tees Hosp NHS Trust, James Cook Univ Hosp, Dept Gastroenterol, Middlesbrough, Cleveland, England; [Lobo, Alan J.] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Div Mol & Genet Med, Sheffield S10 2JF, S Yorkshire, England; [Jewell, Derek P.] Radcliffe Infirm, Gastroenterol Unit, Gibson Labs, Oxford OX2 6HE, England; [Edwards, Cathryn] Torbay Hosp, Endoscopy Reg Training Unit, Torquay, England; [Mansfield, John C.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Donnelly, Peter; Davison, Daniel] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Blackwell, Jenefer M.] Addenbrookes Hosp, Cambridge Inst Med Res, Genet & Infect Lab, Cambridge, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Biomed Res Ctr Mental Hlth, Div Psychol Med & Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Craddock, Nicholas] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Duncanson, Audrey] Wellcome Trust Res Labs, Mol & Physiol Sci, London, England; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Markus, Hugh S.] St Georges Univ London, London, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab ICDEM, Oxford OX3 7LJ, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Samani, Nilesh] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp, NHS Fdn Trust, Glaucoma Res Unit, London, England; [Viswanathan, Ananth C.] UCL, Dept Genet, Inst Ophthalmol, London, England; [Wood, Nicholas] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Attwood, Antony P.; Stephens, Jonathan; Sambrook, Jennifer; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Attwood, Antony P.; Stephens, Jonathan; Sambrook, Jennifer; Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children DNA Ba, Bristol, Avon, England; [Ring, Susan M.] Dept Social Med, ALSPAC Lab, Cambridge, England; [Strachan, David P.] St George Hosp, Div Community Hlth Sci, London, England	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Plymouth; Guy's & St Thomas' NHS Foundation Trust; University of Manchester; James Cook University Hospital; University of Sheffield; Radcliffe Infirmary; University of Oxford; Newcastle University - UK; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; Trinity College Dublin; Cardiff University; University of London; Queen Mary University London; St Georges University London; University of Oxford; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Cambridge; University of Bristol; St Georges University London	Barrett, JC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	barrett@sanger.ac.uk; chris.spencer@well.ox.ac.uk	Blackwell, Jenefer M/H-3015-2015; Palmer, Colin NA/C-7053-2008; Bellenguez, Céline/X-4004-2019; Prescott, Natalie J/F-6490-2011; Mowat, Craig/AAD-1851-2019; Lee, James/ABD-5920-2020; Mathew, Christopher G/G-3434-2015; Anderson, Carl A/B-8327-2013; Belllenguez, Céline/Y-3183-2018; Plomin, Robert/B-8911-2008; Wood, Nicholas W/C-2505-2009; Jankowski, Janusz/H-2706-2012; Brown, Matthew A/E-5749-2010; Deloukas, Panos/B-2922-2013; Bramon, Elvira/HHC-3809-2022; Bramon, Elvira/A-9463-2011; McCarthy, Mark/M-3763-2015	Palmer, Colin NA/0000-0002-6415-6560; Bellenguez, Céline/0000-0002-1240-7874; Prescott, Natalie J/0000-0002-5901-7371; Mowat, Craig/0000-0002-5021-415X; Lee, James/0000-0001-5711-9385; Mathew, Christopher G/0000-0003-4178-1838; Anderson, Carl A/0000-0003-1719-7009; Belllenguez, Céline/0000-0002-1240-7874; Wood, Nicholas W/0000-0002-9500-3348; Jankowski, Janusz/0000-0003-2130-9181; Brown, Matthew A/0000-0003-0538-8211; Deloukas, Panos/0000-0001-9251-070X; Bramon, Elvira/0000-0003-1369-5983; Lees, Charlie/0000-0002-0732-8215; Plomin, Robert/0000-0002-0756-3629; Massey, Dunecan/0000-0002-7144-4579; ZHANG, HU/0000-0002-3281-4661; Newman, William/0000-0002-6382-4678; Potter, Simon/0000-0003-4208-4102; Trembath, Richard/0000-0003-0550-3400; Walters, James/0000-0002-6980-4053; Parkes, Miles/0000-0002-6467-0631; Donnelly, Peter/0000-0001-9495-3408; Corvin, Aiden/0000-0001-6717-4089; McCarthy, Mark/0000-0002-4393-0510; Gillman, Matthew S./0000-0002-2340-6930; Hunt, Sarah/0000-0002-8350-1235	Wellcome Trust [083948/Z/07/Z, 068545/Z/02]; National Association for Colitis and Crohn's Disease (NACC); Medical Research Council UK; Guy's and St. Thomas' Charity; Clinical Research Facility at the Peninsular College of Medicine and Dentistry, Exeter; Torbay Hospital Medical Fund; Evelyn Trust; Wolfson-Royal Society Merit Award; UK Medical Research Council [G0601387]; Special Trustees of Moorfields National Health Service (NHS) Foundation Trust; Department of Health via the National Institute for Health Research (NIHR); Cambridge University Hospitals NHS Foundation; Central Manchester NHS Foundation Trust in partnership with the University of Manchester; Moorfields Eye Hospital in partnership with University College London Institute of Ophthalmology; Medical Research Council [G0000934]; MRC [G0800759, G0601387, G19/2, G0600329, G0800675, G0800509, MC_qA137934, G0000934, G0800383] Funding Source: UKRI; Medical Research Council [G0800509, G19/2, G0800759, MC_qA137934, G9817803B, G0800675, G0600329, G0800383, G0601387] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016, NF-SI-0507-10379] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Association for Colitis and Crohn's Disease (NACC); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Guy's and St. Thomas' Charity; Clinical Research Facility at the Peninsular College of Medicine and Dentistry, Exeter; Torbay Hospital Medical Fund; Evelyn Trust; Wolfson-Royal Society Merit Award(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Special Trustees of Moorfields National Health Service (NHS) Foundation Trust; Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cambridge University Hospitals NHS Foundation; Central Manchester NHS Foundation Trust in partnership with the University of Manchester; Moorfields Eye Hospital in partnership with University College London Institute of Ophthalmology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The principal funding for this study was provided by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project (083948/Z/07/Z). We thank all subjects who contributed samples and consultants and nursing staff across the UK who helped with recruitment of study subjects. We also thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, A. Wilk, C. R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. Case collections were supported by the National Association for Colitis and Crohn's Disease (NACC), the Wellcome Trust, the Medical Research Council UK, the Guy's and St. Thomas' Charity, the Clinical Research Facility at the Peninsular College of Medicine and Dentistry, Exeter, the Torbay Hospital Medical Fund and the Evelyn Trust. P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. We also acknowledge support from the UK Medical Research Council (R. C. T., grant G0601387), the Special Trustees of Moorfields National Health Service (NHS) Foundation Trust, and the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, the Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge School of Clinical Medicine, the Central Manchester NHS Foundation Trust in partnership with the University of Manchester, and Moorfields Eye Hospital in partnership with University College London Institute of Ophthalmology. We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Festen EAM, 2009, GUT, V58, P799, DOI 10.1136/gut.2008.166918; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peignon G, 2006, J BIOL CHEM, V281, P3560, DOI 10.1074/jbc.M506360200; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Schmehl K, 2000, INT J COLORECTAL DIS, V15, P39, DOI 10.1007/s003840050006; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	34	386	392	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2009	41	12					1330	U99		10.1038/ng.483	http://dx.doi.org/10.1038/ng.483			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19915572	Green Accepted, Green Submitted			2022-12-17	WOS:000272144900016
J	Ang, SO; Chen, H; Hirota, K; Gordeuk, VR; Jelinek, J; Guan, YL; Liu, EL; Sergueeva, AI; Miasnikova, GY; Mole, D; Maxwell, PH; Stockton, DW; Semenza, GL; Prchal, JT				Ang, SO; Chen, H; Hirota, K; Gordeuk, VR; Jelinek, J; Guan, YL; Liu, EL; Sergueeva, AI; Miasnikova, GY; Mole, D; Maxwell, PH; Stockton, DW; Semenza, GL; Prchal, JT			Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; HIPPEL-LINDAU-DISEASE; TRANSCRIPTIONAL ACTIVITY; PROLYL HYDROXYLATION/; HIF-ALPHA; VHL GENE; HYPOXIA; ERYTHROPOIESIS; ERYTHROCYTOSIS	Chuvash polycythemia is an autosomal recessive disorder that is endemic to the mid-Volga River region. We previously mapped the locus associated with Chuvash polycythemia to chromosome 3p25. The gene associated with von Hippel-Lindau syndrome, VHL, maps to this region, and homozygosity with respect to a C-->T missense mutation in VHL, causing an arginine-to-tryptophan change at amino-acid residue 200 (Arg200Trp), was identified in all individuals affected with Chuvash polycythemia. The protein VHL modulates the ubiquitination and subsequent destruction of hypoxia-inducible factor 1, subunit alpha(HIF1alpha). Our data indicate that the Arg200Trp substitution impairs the interaction of VHL with HIF1alpha reducing the rate of degradation of HIF1alpha and resulting in increased expression of downstream target genes including EPO (encoding erythropoietin), SLC2A1 (also known as GLUT1, encoding solute carrier family 2 (facilitated glucose transporter), member 1), TF (encoding transferrin), TFRC (encoding transferrin receptor (p90, CD71)) and VEGF (encoding vascular endothelial growth factor).	Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; Howard Univ, Dept Med, Washington, DC 20059 USA; Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; Chuvash State Univ, Cheboksary, Chuvashia, Russia; Univ Oxford, Oxford, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Howard University; Howard University; University of Oxford; Baylor College of Medicine	Prchal, JT (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	jprchal@bcm.tmc.edu	Jelinek, Jaroslav/A-8476-2008; Maxwell, Patrick H/C-5557-2008; Jelinek, Jaroslav/D-2282-2012; Gordeuk, Victor/AAG-6577-2019; Jelinek, Jaroslav/O-6876-2019; Hirota, Kiichi/E-9181-2010	Maxwell, Patrick H/0000-0002-0338-2679; Jelinek, Jaroslav/0000-0002-2533-0220; Hirota, Kiichi/0000-0003-1110-0827; Mole, David/0000-0002-0984-300X				Ang SO, 2002, BLOOD CELL MOL DIS, V28, P57, DOI 10.1006/bcmd.2002.0488; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Beutler E., 1971, RED CELL METABOLISM; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gordeuk VR, 2001, BLOOD, V98, p224A; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; HAGESAWA K, 1990, BIOCHIM BIOPHYS ACTA, V1051, P221; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jacobson LO, 2000, J AM SOC NEPHROL, V11, P589; Jenkins MM, 1996, BLOOD, V87, P2993, DOI 10.1182/blood.V87.7.2993.bloodjournal8772993; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Karasawa Y, 2001, INTERNAL MED, V40, P38, DOI 10.2169/internalmedicine.40.38; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; Kralovics R, 2000, CURR OPIN PEDIATR, V12, P29, DOI 10.1097/00008480-200002000-00006; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; POLYAKOVA LA, 1977, FAMILIAL HEREDITARY; Prchal J F, 1999, Curr Opin Hematol, V6, P100, DOI 10.1097/00062752-199903000-00008; Prchal JT, 2001, SEMIN HEMATOL, V38, P10, DOI 10.1053/shem.2001.23040; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sergeyeva A, 1997, BLOOD, V89, P2148, DOI 10.1182/blood.V89.6.2148; Shih LY, 1999, J AM SOC NEPHROL, V10, P315; Stopka T, 1998, BLOOD, V91, P3766; Vasserman NN, 1999, HUM HERED, V49, P129, DOI 10.1159/000022859; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhong H, 1999, CANCER RES, V59, P5830	34	386	400	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					614	621		10.1038/ng1019	http://dx.doi.org/10.1038/ng1019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12415268				2022-12-17	WOS:000179593000013
J	Castillo-Davis, CI; Mekhedov, SL; Hartl, DL; Koonin, EV; Kondrashov, FA				Castillo-Davis, CI; Mekhedov, SL; Hartl, DL; Koonin, EV; Kondrashov, FA			Selection for short introns in highly expressed genes	NATURE GENETICS			English	Article							GENOME EVOLUTION; CODON BIAS; C-ELEGANS; DROSOPHILA; LENGTH; TRANSCRIPTION; RATES; SIZE; DNA; CAENORHABDITIS	Transcription is a slow and expensive process: in eukaryotes, approximately 20 nucleotides can be transcribed per second(1,2) at the expense of at least two ATP molecules per nucleotide(3). Thus, at least for highly expressed genes, transcription of long introns, which are particularly common in mammals, is costly. Using data on the expression of genes that encode proteins in Caenorhabditis elegans and Homo sapiens, we show that introns in highly expressed genes are substantially shorter than those in genes that are expressed at low levels. This difference is greater in humans, such that introns are, on average, 14 times shorter in highly expressed genes than in genes with low expression, whereas in C. elegans the difference in intron length is only twofold. In contrast, the density of introns in a gene does not strongly depend on the level of gene expression. Thus, natural selection appears to favor short introns in highly expressed genes to minimize the cost of transcription and other molecular processes, such as splicing.	Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; Harvard University	Kondrashov, FA (corresponding author), Natl Ctr Biotechnol Informat, NIH, 8600 Rockville Pike, Bethesda, MD 20894 USA.	fkondras@ncbi.nlm.nih.gov	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694	NATIONAL LIBRARY OF MEDICINE [Z01LM000073, ZIALM000073] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bortoluzzi S, 1999, TRENDS GENET, V15, P118, DOI 10.1016/S0168-9525(98)01682-5; BOULIKAS T, 1992, J MOL EVOL, V35, P156, DOI 10.1007/BF00183227; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carels N, 2000, GENETICS, V154, P1819; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Comeron JM, 2000, GENETICS, V156, P1175; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; EyreWalker A, 1996, MOL BIOL EVOL, V13, P864, DOI 10.1093/oxfordjournals.molbev.a025646; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hurst LD, 1999, TRENDS GENET, V15, P437, DOI 10.1016/S0168-9525(99)01832-6; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; LEHNINGER AL, 1982, PRINCIPLES BIOCH, P615; Moriyama EN, 1998, MOL BIOL EVOL, V15, P770, DOI 10.1093/oxfordjournals.molbev.a025980; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Ogata H, 1996, FEBS LETT, V390, P99, DOI 10.1016/0014-5793(96)00636-9; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; SULLIVAN DT, 1995, CURR OPIN GENET DEV, V5, P786, DOI 10.1016/0959-437X(95)80012-T; UCKER DS, 1984, J BIOL CHEM, V259, P7416; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	30	386	404	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					415	418		10.1038/ng940	http://dx.doi.org/10.1038/ng940			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134150	Green Published			2022-12-17	WOS:000177147100019
J	Di Cristofano, A; De Acetis, M; Koff, A; Cordon-Cardo, C; Pandolfi, PP				Di Cristofano, A; De Acetis, M; Koff, A; Cordon-Cardo, C; Pandolfi, PP			Pten and p27(KIP1) cooperate in prostate cancer tumor suppression in the mouse	NATURE GENETICS			English	Article							MICE LACKING; HYPERPLASIA; PTEN/MMAC1	The genetic bases underlying prostate tumorigenesis are poorly understood. Inactivation of the tumor-suppressor gene PTEN and lack of p27(KIP1) expression have been detected in most advanced prostate cancers(1,2). But mice deficient for Cdkn1b (encoding p27(KIp1)) do not develop prostate cancer(3-5). PTEN activity leads to the induction of p27(KIP1) expression, which in turn can negatively regulate the transition through the cell cycle(6). Thus, the inactivation of p27(KIP1)may epistatic to PTEN in the control of the cell cycle. Here we show that the concomitant inactivation of one Pten allele and one or both Cdkn1b alleles accelerates spontaneous neoplastic transformation and incidence of tumors of various histological origins. Cell proliferation, but not cell survival, is increased in Pten(+/-)/Cdkn1b(-/-)mice. Moreover, Pten(+/-)/Cdkn1b(-/-) mice develop prostate carcinoma at complete penetrance within three months from birth. These cancers recapitulate the natural history and pathological features of human prostate cancer. Our findings reveal the crucial relevance of the combined tumor-suppressive activity of Pten and p27(Kip1) through the control of cell-cycle progression.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Human Genet, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.		di cristofano, antonio/AAJ-3796-2020; Di Cristofano, Antonio/B-4148-2016	di cristofano, antonio/0000-0003-2537-3228; Koff, Andrew/0000-0003-3271-3067				Cairns P, 1997, CANCER RES, V57, P4997; Cordon-Cardo C, 1998, JNCI-J NATL CANCER I, V90, P1284, DOI 10.1093/jnci/90.17.1284; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Green JE, 1998, PROSTATE, V36, P59, DOI 10.1002/(SICI)1097-0045(19980615)36:1<59::AID-PROS11>3.0.CO;2-H; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Macri E, 1998, CANCER METAST REV, V17, P337, DOI 10.1023/A:1006133620914; MCNEAL JE, 1969, CANCER, V23, P24, DOI 10.1002/1097-0142(196901)23:1<24::AID-CNCR2820230103>3.0.CO;2-1; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Osman I, 1997, CLIN CANCER RES, V3, P531; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; PRICE D, 1963, BIOL PROSTATE RELATE, P1; Verma RS, 1999, CANCER INVEST, V17, P441, DOI 10.3109/07357909909021436	18	386	400	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					222	224		10.1038/84879	http://dx.doi.org/10.1038/84879			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175795				2022-12-17	WOS:000166839200028
J	Li, YP; Chen, W; Liang, YQ; Li, E; Stashenko, P				Li, YP; Chen, W; Liang, YQ; Li, E; Stashenko, P			Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification	NATURE GENETICS			English	Article							PROTON PUMP; RESORPTION; CELLS; PH	Solubilization of bone mineral by osteoclasts depends on the formation of an acidic extracellular compartment through the action of a V-proton pump that has not yet been characterized at the molecular level(1-3). We previously cloned a gene (Atp6i, for V-proton pump, H+ transporting (vacuolar proton pump) member I) encoding a putative osteoclast-specific proton pump subunit, termed OC-116kD (ref, 4), Here we show that targeted disruption of Atp6i in mice results in severe osteopetrosis. Atp6i(-/-) osteoclast-like cells (OCLs) lose the function of extracellular acidification, but retain intracellular lysosomal proton pump activity. The pH in Atp6i(-/-) liver lysosomes and proton transport in microsomes of Atp6i(-/-) kidney are identical to that in wild-type mice. Atp6i(-/-) mice exhibit a normal acid-base balance in blood and urine. Our results demonstrate that Atp6i is unique and necessary for osteoclast-mediated extracellular acidification.	Forsyth Inst, Dept Cytokine Biol, Boston, MA USA; Harvard Univ, Forsyth Inst, Forsyth Dept Oral Biol, Boston, MA 02115 USA; Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr,Dept Med, Charlestown, MA USA	Harvard University; Forsyth Institute; Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts General Hospital	Li, YP (corresponding author), Forsyth Inst, Dept Cytokine Biol, Boston, MA USA.	ypli@forsyth.org			NIAMS NIH HHS [AR44741] Funding Source: Medline; NIDCR NIH HHS [DE-07378] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE007378] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; Blair Harry C., 1992, P259; Chen W, 1998, J BONE MINER RES, V13, P1112, DOI 10.1359/jbmr.1998.13.7.1112; DAVID P, 1994, J BIOL CHEM, V269, P30158; GERRITSEN EJA, 1994, PEDIATRICS, V93, P247; Horton W. A., 1990, GROWTH GENET HORM, V6, P1; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, J BONE MINER RES, V14, P487, DOI 10.1359/jbmr.1999.14.4.487; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; SHIBUTANI T, 1993, J BONE MINER RES, V8, P331; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; TAMURA T, 1993, J BONE MINER RES, V8, P953; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; VAES G, 1968, J CELL BIOL, V39, P676, DOI 10.1083/jcb.39.3.676; WANG SJ, 1992, J OPT SOC AM B, V9, P360, DOI 10.1364/JOSAB.9.000360; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49	20	386	402	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1999	23	4					447	451		10.1038/70563	http://dx.doi.org/10.1038/70563			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581033				2022-12-17	WOS:000084023900022
J	Conrad, DF; Keebler, JEM; DePristo, MA; Lindsay, SJ; Zhang, YJ; Casals, F; Idaghdour, Y; Hartl, CL; Torroja, C; Garimella, KV; Zilversmit, M; Cartwright, R; Rouleau, GA; Daly, M; Stone, EA; Hurles, ME; Awadalla, P				Conrad, Donald F.; Keebler, Jonathan E. M.; DePristo, Mark A.; Lindsay, Sarah J.; Zhang, Yujun; Casals, Ferran; Idaghdour, Youssef; Hartl, Chris L.; Torroja, Carlos; Garimella, Kiran V.; Zilversmit, Martine; Cartwright, Reed; Rouleau, Guy A.; Daly, Mark; Stone, Eric A.; Hurles, Matthew E.; Awadalla, Philip		1000 Genomes Project	Variation in genome-wide mutation rates within and between human families	NATURE GENETICS			English	Article							NUCLEOTIDE	J.B.S. Haldane proposed in 1947 that the male germline may be more mutagenic than the female germline(1). Diverse studies have supported Haldane's contention of a higher average mutation rate in the male germline in a variety of mammals, including humans(2,3). Here we present, to our knowledge, the first direct comparative analysis of male and female germline mutation rates from the complete genome sequences of two parent-offspring trios. Through extensive validation, we identified 49 and 35 germline de novo mutations (DNMs) in two trio offspring, as well as 1,586 non-germline DNMs arising either somatically or in the cell lines from which the DNA was derived. Most strikingly, in one family, we observed that 92% of germline DNMs were from the paternal germline, whereas, in contrast, in the other family, 64% of DNMs were from the maternal germline. These observations suggest considerable variation in mutation rates within and between families.	[Keebler, Jonathan E. M.; Casals, Ferran; Idaghdour, Youssef; Zilversmit, Martine; Awadalla, Philip] Univ Montreal, Fac Med, Dept Pediat, Ste Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Conrad, Donald F.; Lindsay, Sarah J.; Zhang, Yujun; Torroja, Carlos; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge, England; [Conrad, Donald F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Keebler, Jonathan E. M.; Stone, Eric A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [DePristo, Mark A.; Hartl, Chris L.; Garimella, Kiran V.; Daly, Mark] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Cartwright, Reed; Stone, Eric A.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Rouleau, Guy A.] Univ Montreal, Fac Med, Dept Med, Ste Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Wellcome Trust Sanger Institute; Washington University (WUSTL); University of North Carolina; North Carolina State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; North Carolina State University; Universite de Montreal	Awadalla, P (corresponding author), Univ Montreal, Fac Med, Dept Pediat, Ste Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada.	meh@sanger.ac.uk; philip.awadalla@umontreal.ca	Herrero, Javier/H-6971-2019; Casals, Ferran/H-4347-2015; Myers, Simon R/A-6792-2015; Li, Yingrui/K-1064-2015; Mills, Ryan/F-4225-2010; Wilson, Richard K./AAF-4139-2019; Cooper, David N/H-4384-2011; Awadalla, Philip/AAC-4896-2021; Cartwright, Reed/A-9707-2009; Rosenstiel, Philip/A-5137-2009; Torroja, Carlos/N-6022-2014; Sahinalp, Suleyman Cenk/X-7843-2018; Lindsay, Sarah/CAF-4613-2022; Daly, Mark J/B-2453-2017; Khurana, Ekta/C-4933-2013; Dahl, Andreas/E-3783-2017; Browning, Brian L/A-1178-2010; Chen, Wei/AAX-5994-2020; Stone, Eric/Q-7840-2016; Ye, Kai/B-3640-2012	Herrero, Javier/0000-0001-7313-717X; Casals, Ferran/0000-0002-8941-0369; Myers, Simon R/0000-0002-2585-9626; Mills, Ryan/0000-0003-3425-6998; Wilson, Richard K./0000-0002-1992-1358; Cooper, David N/0000-0002-8943-8484; Rosenstiel, Philip/0000-0002-9692-8828; Torroja, Carlos/0000-0001-8914-3400; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Daly, Mark J/0000-0002-0949-8752; Dahl, Andreas/0000-0002-2668-8371; Browning, Brian L/0000-0001-6454-6633; Chen, Wei/0000-0001-7196-8703; Clark, Andrew/0000-0001-7159-8511; Stone, Eric/0000-0002-2725-4209; Leinonen, Rasko/0000-0002-2639-7187; MacArthur, Daniel/0000-0002-5771-2290; Lindsay, Sarah/0000-0002-0965-3070; Walter, Klaudia/0000-0003-4448-0301; Sebat, Jonathan/0000-0002-9087-526X; Clarke, Laura/0000-0002-5989-6898; Kulesha, Eugene/0000-0002-4285-6232; Haraksingh, Rajini/0000-0002-6644-8874; McLaren, William/0000-0001-6218-1116; Keane, Thomas/0000-0001-7532-6898; Borodina, Tatiana/0000-0002-6978-016X; Radhakrishnan, Rajesh/0000-0001-7170-699X; Garimella, Kiran/0000-0002-6212-5736; Keenan, Stephen/0000-0002-9141-7690; Chinwalla, Asif/0000-0001-7831-3996; Zalunin, Vadim/0000-0002-7722-1958; Swerdlow, Harold/0000-0002-9510-160X; Hartl, Christopher/0000-0003-3352-4356; Bustamante, Carlos D./0000-0002-4187-7920	Wellcome Trust [077014/Z/05/Z]; Ministry of Development, Exploration and Innovation in Quebec [PSR-SIIRI-195]; Genome Quebec Award for Population and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070806] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Ministry of Development, Exploration and Innovation in Quebec; Genome Quebec Award for Population and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Kernytsky, G. McVean, T. Massingham, J. Thorne, J. Hussin, A. Motsinger, Coriell Cell Repositories and members of the 1000 Genomes analysis group for their help and support. D.F.C., S.J.L., Y.Z., C.T. and M.E.H. were funded by the Wellcome Trust (grant number 077014/Z/05/Z). J.E.M.K., F.C., Y.I., M.Z., G.A.R. and P.A. were funded by the Ministry of Development, Exploration and Innovation (grant number PSR-SIIRI-195) in Quebec and a Genome Quebec Award for Population and Medical Genomics to P.A.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Nachman MW, 2000, GENETICS, V156, P297; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	18	385	393	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					712	U137		10.1038/ng.862	http://dx.doi.org/10.1038/ng.862			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21666693	Green Accepted			2022-12-17	WOS:000292184600019
J	Walder, RY; Landau, D; Meyer, P; Shalev, H; Tsolia, M; Borochowitz, Z; Boettger, MB; Beck, GE; Englehardt, RK; Carmi, R; Sheffield, VC				Walder, RY; Landau, D; Meyer, P; Shalev, H; Tsolia, M; Borochowitz, Z; Boettger, MB; Beck, GE; Englehardt, RK; Carmi, R; Sheffield, VC			Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia	NATURE GENETICS			English	Article							PROTEIN-KINASES; MAGNESIUM; PARACELLIN-1; TRANSPORT	Familial hypomagnesemia with secondary hypocalcemia (OMIM 602014) is an autosomal recessive disease that results in electrolyte abnormalities shortly after birth(1-6). Affected individuals show severe hypomagnesemia and hypocalcemia. which lead to seizures and tetany. The disorder has been thought to be caused by a defect in the intestinal absorption of magnesium, rather than by abnormal renal loss of magnesium. Restoring the concentrations of serum magnesium to normal values by high-dose magnesium supplementation can overcome the apparent defect in magnesium absorption and in serum concentrations of calcium. Life-long magnesium supplementation is required to overcome the defect in magnesium handling by these individuals(1,3,4). We previously mapped the gene locus to chromosome 9q in three large inbred kindreds from israel(2). Here we report that mutation of TRPM6 causes hypomagnesemia with secondary hypocalcemia and show that individuals carrying mutations in this gene have abnormal renal magnesium excretion.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Ben Gurion Univ Negev, Dept Pediat, Beer Sheva, Israel; Univ Heidelberg, INF 328, Inst Human Genet, D-69120 Heidelberg, Germany; Univ Athens, Dept Pediat, P A Kyriakou Childrens Hosp, Athens, Greece; Bnai Zion Med Ctr, Simon Winter Inst Human Genet, Haifa, Israel	University of Iowa; Howard Hughes Medical Institute; University of Iowa; Ben Gurion University; Ruprecht Karls University Heidelberg; National & Kapodistrian University of Athens; Bnai Zion Medical Center	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.			Sheffield, Val/0000-0002-6282-0835				ABDULRAZZAQ YM, 1989, EUR J PEDIATR, V148, P459, DOI 10.1007/BF00595914; ALGHAMDI SMG, 1994, AM J KIDNEY DIS, V24, P737, DOI 10.1016/S0272-6386(12)80667-6; Blanchard A, 2001, KIDNEY INT, V59, P2206, DOI 10.1046/j.1523-1755.2001.00736.x; CHALLA A, 1995, ACTA PAEDIATR, V84, P1075, DOI 10.1111/j.1651-2227.1995.tb13830.x; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Meyer P, 2001, J INHERIT METAB DIS, V24, P875, DOI 10.1023/A:1013952510698; MILLA PJ, 1979, GUT, V20, P1028, DOI 10.1136/gut.20.11.1028; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; PRAGA M, 1995, KIDNEY INT, V47, P1419, DOI 10.1038/ki.1995.199; PRONICKA E, 1991, J INHERIT METAB DIS, V14, P397, DOI 10.1007/BF01811713; RODRIGUEZSORIANO J, 1987, PEDIATR NEPHROL, V1, P465, DOI 10.1007/BF00849255; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; RYZEN E, 1985, Magnesium, V4, P137; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Shalev H, 1998, ARCH DIS CHILD, V78, P127, DOI 10.1136/adc.78.2.127; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; STAPLETON FB, 1983, J PEDIATR-US, V102, P88, DOI 10.1016/S0022-3476(83)80297-2; Walder RY, 1997, HUM MOL GENET, V6, P1491, DOI 10.1093/hmg/6.9.1491; YAMAMOTO T, 1985, Magnesium, V4, P153	22	385	411	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					171	174		10.1038/ng901	http://dx.doi.org/10.1038/ng901			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12032570				2022-12-17	WOS:000175903500013
J	RUTLAND, P; PULLEYN, LJ; REARDON, W; BARAITSER, M; HAYWARD, R; JONES, B; MALCOLM, S; WINTER, RM; OLDRIDGE, M; SLANEY, SF; POOLE, MD; WILKIE, AOM				RUTLAND, P; PULLEYN, LJ; REARDON, W; BARAITSER, M; HAYWARD, R; JONES, B; MALCOLM, S; WINTER, RM; OLDRIDGE, M; SLANEY, SF; POOLE, MD; WILKIE, AOM			IDENTICAL MUTATIONS IN THE FGFR2 GENE CAUSE BOTH PFEIFFER AND CROUZON SYNDROME PHENOTYPES	NATURE GENETICS			English	Article								Mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been identified in Crouzon syndrome, an autosomal dominant condition causing premature fusion of the cranial sutures (craniosynostosis). A mutation in FGFR1 has been established in several families with Pfeiffer syndrome, where craniosynostosis is associated with specific digital abnormalities. We now report point mutations in FGFR2 in seven sporadic Pfeiffer syndrome patients. Six of the seven Pfeiffer syndrome patients share two missense mutations, which have also been reported in Crouzon syndrome. The Crouzon and Pfeiffer phenotypes usually breed true within families and the finding of identical mutations in unrelated individuals giving different phenotypes is a highly unexpected observation.	INST CHILD HLTH,GENET & FETAL MED CLIN,MOTHERCARE UNIT,LONDON WC1N 1EH,ENGLAND; INST CHILD HLTH,MOLEC GENET UNIT,LONDON WC1N 1EH,ENGLAND; GREAT ORMOND ST HOSP CHILDREN,DEPT NEUROSURG,LONDON,ENGLAND; GREAT ORMOND ST HOSP CHILDREN,CRANIOFACIAL UNIT,LONDON,ENGLAND; JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,DEPT MED GENET,OXFORD OX3 7LJ,ENGLAND; RADCLIFFE INFIRM,OXFORD CRANIOFACIAL UNIT,OXFORD OX2 6HE,ENGLAND	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oxford; University of Oxford; Radcliffe Infirmary			Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Reardon, Willie/0000-0001-7329-9179	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARAITSER M, 1980, J MED GENET, V17, P250, DOI 10.1136/jmg.17.4.250; Cohen, 1986, CRANIOSYNOSTOSIS DIA; COHEN MM, 1993, AM J MED GENET, V45, P300, DOI 10.1002/ajmg.1320450305; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; HODACH RJ, 1995, Z KINDERHEILKD, V119, P87; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JACKSON CE, 1976, J PEDIATR-US, V88, P963, DOI 10.1016/S0022-3476(76)81050-5; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; KROCZEK RA, 1986, EUR J PEDIATR, V145, P442, DOI 10.1007/BF00439257; McKusick V.A., 1992, MENDELIAN INHERITANC; MUENCKE M, NAT GENET, V8, P269; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROBIN NH, 1994, HUM MOL GENET, V3, P2153, DOI 10.1093/hmg/3.12.2153; Soekarman D, 1992, Genet Couns, V3, P217; WILKIE AOM, 1995, NATURE GENET, V9; WINTER RM, 1994, LONDON DYSMORPHOLOGY	18	385	395	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					173	176		10.1038/ng0295-173	http://dx.doi.org/10.1038/ng0295-173			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719345				2022-12-17	WOS:A1995QE67200019
J	COLLINS, FS				COLLINS, FS			POSITIONAL CLONING - LETS NOT CALL IT REVERSE ANYMORE	NATURE GENETICS			English	Editorial Material							CYSTIC-FIBROSIS GENE; DNA; IDENTIFICATION; CANDIDATE; MUTATIONS; DISEASE; SEGMENT; REGION				COLLINS, FS (corresponding author), UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,1150 W MED CTR DR,ANN ARBOR,MI 48109, USA.							ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BATES GP, 1991, AM J HUM GENET, V49, P7; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GIESTERFERLOWRA.AA, 1990, CELL, V62, P999; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; McKusick V. A. E., 1991, MENDELIAN INHERITANC; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; RUDDLE FH, 1984, AM J HUM GENET, V36, P944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TODD JA, 1988, NATURE, V334, P154; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11262; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; 1990, NEW ENGL J MED, V323, P70	52	385	395	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					3	6		10.1038/ng0492-3	http://dx.doi.org/10.1038/ng0492-3			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1301996				2022-12-17	WOS:A1992JC97800002
J	Onengut-Gumuscu, S; Chen, WM; Burren, O; Cooper, NJ; Quinlan, AR; Mychaleckyj, JC; Farber, E; Bonnie, JK; Szpak, M; Schofield, E; Achuthan, P; Guo, H; Fortune, MD; Stevens, H; Walker, NM; Ward, LD; Kundaje, A; Kellis, M; Daly, MJ; Barrett, JC; Cooper, JD; Deloukas, P; Todd, JA; Wallace, C; Concannon, P; Rich, SS				Onengut-Gumuscu, Suna; Chen, Wei-Min; Burren, Oliver; Cooper, Nick J.; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Farber, Emily; Bonnie, Jessica K.; Szpak, Michal; Schofield, Ellen; Achuthan, Premanand; Guo, Hui; Fortune, Mary D.; Stevens, Helen; Walker, Neil M.; Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis; Daly, Mark J.; Barrett, Jeffrey C.; Cooper, Jason D.; Deloukas, Panos; Todd, John A.; Wallace, Chris; Concannon, Patrick; Rich, Stephen S.		Type 1 Diabet Genetics Consortium	Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; EXPRESSION; RISK; RESOURCE; LINKAGE	Genetic studies of type 1 diabetes (T1D) have identified 50 susceptibility regions(1,2), finding major pathways contributing to risk(3), with some loci shared across immune disorders(4-6). To make genetic comparisons across autoimmune disorders as informative as possible, a dense genotyping array, the Immunochip, was developed, from which we identified four new T1D-associated regions (P < 5 x 10(-8)). A comparative analysis with 15 immune diseases showed that T1D is more similar genetically to other autoantibody-positive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least similar to ulcerative colitis, and provided support for three additional new T1D risk loci. Using a Bayesian approach, we defined credible sets for the T1D-associated SNPs. The associated SNPs localized to enhancer sequences active in thymus, T and B cells, and CD34(+) stem cells. Enhancer-promoter interactions can now be analyzed in these cell types to identify which particular genes and regulatory sequences are causal.	[Onengut-Gumuscu, Suna; Chen, Wei-Min; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Farber, Emily; Bonnie, Jessica K.; Szpak, Michal; Concannon, Patrick; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Onengut-Gumuscu, Suna] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA USA; [Chen, Wei-Min; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Burren, Oliver; Cooper, Nick J.; Schofield, Ellen; Achuthan, Premanand; Guo, Hui; Fortune, Mary D.; Stevens, Helen; Walker, Neil M.; Cooper, Jason D.; Todd, John A.; Wallace, Chris] Univ Cambridge, Natl Inst Hlth Res,Dept Med Genet, Biomed Res Ctr,Wellcome Trust Diabet & Inflammat, Cambridge Inst Med Res,Juvenile Diabet Res Fdn, Cambridge, England; [Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Kundaje, Anshul] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kundaje, Anshul; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Barrett, Jeffrey C.; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Wallace, Chris] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Virginia; University of Virginia; University of Virginia; University of Cambridge; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute; MRC Biostatistics Unit; University of Cambridge	Rich, SS (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	ssr4n@virginia.edu	Vázquez, Federico/AAF-9825-2021; Deloukas, Panos/B-2922-2013; Todd, John A/A-3542-2010; Paterson, Andrew D/A-4088-2011; Roep, Bart/AAD-7609-2021; Kundaje, Anshul/Y-2739-2019; Kundaje, Anshul/Y-2598-2019; Boehm, Bernhard Otto/F-8750-2015; Briggs, Farren/Q-2164-2019; Tillmann, Vallo/G-8118-2012; Skrha, Jan/C-3095-2017; Kellis, Manolis/ABE-7385-2020; Paterson, Andrew/AAQ-7511-2020; Ludvigsson, Johnny/AAI-2051-2020; Cameron, Fergus J/N-9535-2015; de Bakker, Paul IW/B-8730-2009; Daly, Mark J/B-2453-2017; Urbanavicius, Vaidotas/D-4907-2016; Doria, Alessandro/H-9157-2018; Kretowski, Adam/U-6299-2018; Argente, Jesus/L-2928-2013	Vázquez, Federico/0000-0001-6493-2374; Deloukas, Panos/0000-0001-9251-070X; Todd, John A/0000-0003-2740-8148; Paterson, Andrew D/0000-0002-9169-118X; Kundaje, Anshul/0000-0003-3084-2287; Kundaje, Anshul/0000-0003-3084-2287; Briggs, Farren/0000-0003-0903-1359; Tillmann, Vallo/0000-0002-5279-4493; Skrha, Jan/0000-0001-8012-8802; Kellis, Manolis/0000-0001-7113-9630; Paterson, Andrew/0000-0002-9169-118X; Ludvigsson, Johnny/0000-0003-1695-5234; de Bakker, Paul IW/0000-0001-7735-7858; Daly, Mark J/0000-0002-0949-8752; Ampudia Blasco, Francisco Javier/0000-0003-0221-0901; Couper, Jennifer/0000-0003-4448-8629; Li, Xiaoying/0000-0002-9383-5757; Willi, Steven/0000-0002-4910-2425; Szpak, Michal/0000-0002-9096-852X; Dunger, Professor David/0000-0002-2566-9304; Quinlan, Aaron/0000-0003-1756-0859; Metzger, Daniel/0000-0002-1715-4319; McIndoe, Richard/0000-0002-3040-3631; Urbanavicius, Vaidotas/0000-0002-8601-4563; Doria, Alessandro/0000-0002-3830-4304; Achuthan, Premanand/0000-0002-1119-6892; Kretowski, Adam/0000-0002-4522-4978; Knip, Mikael/0000-0003-0474-0033; Colman, Peter/0000-0001-8718-6175; Concannon, Patrick/0000-0002-5801-1859; Pirags, Valdis/0000-0002-3650-7394; Wallace, Chris/0000-0001-9755-1703; Abdul Ghani, Rohana/0000-0002-3520-8472; Schofield, Ellen/0000-0003-0648-1418; Walker, Neil/0000-0001-9796-7688; Ward, Lucas/0000-0002-8017-809X; Burren, Oliver/0000-0002-3388-5760; Van der Auwera, Bart/0000-0003-4133-2565; Pociot, Flemming/0000-0003-3274-5448; Castano, Luis/0000-0003-0437-9401; Barrett, Jeffrey/0000-0002-1152-370X; Guo, Hui/0000-0003-0282-6933; Wagner, Ana M/0000-0002-7663-9308; Rich, Stephen/0000-0003-3872-7793; Plagnol, Vincent/0000-0002-5597-9215; McLaren, William/0000-0001-6218-1116; Johannesen, Jesper/0000-0003-2772-2567; Avbelj Stefanija, Magdalena/0000-0002-0836-5114; CUCCA, Francesco/0000-0002-7414-1995; Sumnik, Zdenek/0000-0002-6462-6462; vandiedonck, claire/0000-0002-6669-6923; Argente, Jesus/0000-0001-5826-0276	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); US National Institutes of Health [U01 DK062418]; NIDDK [DK046635, DK085678]; joint JDRF; Wellcome Trust [WT061858/09115, 089989]; NIHR Cambridge Biomedical Research Centre; Eli Lilly and Company; Wellcome Trust Strategic Award [100140]; UK Medical Research Council; Wellcome Trust award [076113]; Medical Research Council [1508956, MR/N01104X/1, MC_U105261167, G1001799] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10143, NF-SI-0513-10012, NF-SI-0508-10275, NF-SI-0508-10274] Funding Source: researchfish; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation; MRC [MC_U105261167, MR/N01104X/1, G1001799] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK085678, U01DK062418, R01DK046635, R01DK096926] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); joint JDRF; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Eli Lilly and Company(Eli Lilly); Wellcome Trust Strategic Award(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHD) and JDRF and supported by grant U01 DK062418 from the US National Institutes of Health. Further support was provided by grants from the NIDDK (DK046635 and DK085678) to P.C. and by a joint JDRF and Wellcome Trust grant (WT061858/09115) to the Diabetes and Inflammation Laboratory at Cambridge University, which also received support from the NIHR Cambridge Biomedical Research Centre. ImmunoBase receives support from Eli Lilly and Company. C.W. and H.G. are funded by the Wellcome Trust (089989). The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (100140).; We gratefully acknowledge the following groups and individuals who provided biological samples or data for this study. We obtained DNA samples from the British 1958 Birth Cohort collection, funded by the UK Medical Research Council and the Wellcome Trust. We acknowledge use of DNA samples from the NIHR Cambridge BioResource. We thank volunteers for their support and participation in the Cambridge BioResource and members of the Cambridge BioResource Scientific Advisory Board (SAB) and Management Committee for their support of our study. We acknowledge the NIHR Cambridge Biomedical Research Centre for funding. Access to Cambridge BioResource volunteers and to their data and samples are governed by the Cambridge BioResource SAB. Documents describing access arrangements and contact details are available at http://www.cambridgebioresource.org.uk/. We thank the Avon Longitudinal Study of Parents and Children laboratory in Bristol, UK, and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton, for preparing and providing the control DNA samples. This study makes use of data generated by the Wellcome Trust Case Control Consortium, funded by Wellcome Trust award 076113; a full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; [Anonymous], 2012, SNPSTATS SNPMATRIX X; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; Concannon P, 2009, DIABETES, V58, P1018, DOI 10.2337/db08-1551; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Genuth S, 2003, DIABETES CARE, V26, P3160; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hilner JE, 2010, CLIN TRIALS, V7, pS5, DOI 10.1177/1740774510373497; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wallace C., 2013, WGSEA WILCOXON BASED; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zaykin DV, 2010, GENET EPIDEMIOL, V34, P725, DOI 10.1002/gepi.20536; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	48	384	386	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					381	U199		10.1038/ng.3245	http://dx.doi.org/10.1038/ng.3245			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25751624	Green Submitted, Green Accepted			2022-12-17	WOS:000351922900014
J	Saburi, S; Hester, I; Fischer, E; Pontoglio, M; Eremina, V; Gessler, M; Quaggin, SE; Harrison, R; Mount, R; McNeill, H				Saburi, Sakura; Hester, Ian; Fischer, Evelyne; Pontoglio, Marco; Eremina, Vera; Gessler, Manfred; Quaggin, Sue E.; Harrison, Robert; Mount, Richard; McNeill, Helen			Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease	NATURE GENETICS			English	Article							PLANAR POLARITY; DROSOPHILA EYE; MICE LACKING; HAIR-CELLS; CILIA; ORIENTATION; EXPRESSION; CADHERINS; DEFECTS; GENES	Tissue organization in Drosophila is regulated by the core planar cell polarity (PCP) proteins Frizzled, Dishevelled, Prickle, Van Gogh and Flamingo. Core PCP proteins are conserved in mammals and function in mammalian tissue organization. Recent studies have identified another group of Drosophila PCP proteins, consisting of the protocadherins Fat and Dachsous (Ds) and the transmembrane protein Four-jointed (Fj). In Drosophila, Fat represses fj transcription, and Ds represses Fat activity in PCP. Here we show that Fat4 is an essential gene that has a key role in vertebrate PCP. Loss of Fat4 disrupts oriented cell divisions and tubule elongation during kidney development, leading to cystic kidney disease. Fat4 genetically interacts with the PCP genes Vangl2 and Fjx1 in cyst formation. In addition, Fat4 represses Fjx1 expression, indicating that Fat signaling is conserved. Together, these data suggest that Fat4 regulates vertebrate PCP and that loss of PCP signaling may underlie some cystic diseases in humans.	[Saburi, Sakura; Hester, Ian; Eremina, Vera; Quaggin, Sue E.; McNeill, Helen] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Fischer, Evelyne; Pontoglio, Marco] Ctr Natl Rech Sci URA 2578, Dept Dev Biol, Gene Express Dev & Dis Lab, Inst Pasteur, Paris, France; [Gessler, Manfred] Univ Wurzburg, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Quaggin, Sue E.] St Michaels Hosp, Toronto, ON M5G 1X5, Canada; [Harrison, Robert; Mount, Richard] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [McNeill, Helen] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Wurzburg; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	McNeill, H (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	mcneill@mshri.on.ca	McNeill, Helen/E-4579-2013; fischer, evelyne/GLT-9457-2022	McNeill, Helen/0000-0003-1126-5154; Gessler, Manfred/0000-0002-7915-6045; fischer, evelyne/0000-0001-5054-1444	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kume T, 2000, DEVELOPMENT, V127, P1387; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Probst B, 2007, DEV BIOL, V312, P461, DOI 10.1016/j.ydbio.2007.09.054; Rawls AS, 2002, CURR BIOL, V12, P1021, DOI 10.1016/S0960-9822(02)00893-X; Rock R, 2005, DEV DYNAM, V234, P747, DOI 10.1002/dvdy.20515; Saburi S, 2005, CURR OPIN CELL BIOL, V17, P482, DOI 10.1016/j.ceb.2005.08.011; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0	30	384	394	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1010	1015		10.1038/ng.179	http://dx.doi.org/10.1038/ng.179			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18604206				2022-12-17	WOS:000258026900019
J	Nichols, KE; Crispino, JD; Poncz, M; White, JG; Orkin, SH; Maris, JM; Weiss, MJ				Nichols, KE; Crispino, JD; Poncz, M; White, JG; Orkin, SH; Maris, JM; Weiss, MJ			Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GATA-1; FINGER PROTEIN; CELLS; FOG; DIFFERENTIATION; PRECURSORS; MATURATION; EXPRESSION; COFACTOR; LACKING	Haematopoietic development is regulated by nuclear protein complexes that coordinate lineage-specific patterns of gene expression. Targeted mutagenesis in embryonic stem cells and mice has revealed roles for the X-linked gene Gata1 in erythrocyte and megakaryocyte differentiation(1-4), GATA-1 is the founding member of a family of DNA-binding proteins that recognize the motif WGATAR through a conserved multifunctional domain consisting of two C4-type zinc fingers(5-8). Here we describe a family with X-linked dyserythropoietic anaemia and thrombocytopenia due to a substitution of methionine for valine at amino acid 205 of GATA-1. This highly conserved valine is necessary for interaction of the amino-terminal zinc finger of GATA-1 with its essential cofactor, FOG-1 (for friend of GATA-1; refs 9-12). We show that the V205M mutation abrogates the interaction between Gata-1 and Fog-1, inhibiting the ability of Gata-1 to rescue erythroid differentiation in an erythroid cell line deficient for Gata-1 (G1E). Our findings underscore the importance of FOG-1:Gata-1 associations in both megakaryocyte and erythroid development, and suggest that other X-linked anaemias or thrombocytopenias may be caused by defects in GATA1.	Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; Harvard Univ, Childrens Hosp, Sch Med, Div Hematol & Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.		Nichols, Kim/E-9353-2016; Nichols, Kim/AAP-8592-2020; Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013	Nichols, Kim/0000-0002-5581-6555; Nichols, Kim/0000-0002-5581-6555; Weiss, Mitchell J/0000-0003-2460-3036; Crispino, John/0000-0002-8182-8306	NCI NIH HHS [R01 CA78545] Funding Source: Medline; NHLBI NIH HHS [HL40387] Funding Source: Medline; NIAID NIH HHS [AI K11AI01331-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078545] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K11AI001331] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; HUTSON JM, 1994, REPROD FERT DEVELOP, V6, P151, DOI 10.1071/RD9940151; Kowalski K, 1999, J BIOMOL NMR, V13, P249, DOI 10.1023/A:1008309602929; MARTINEZCARRION M, 1986, COENZYMES COFACTOR B, V1, P1; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; ORKIN SH, 1992, BLOOD, V80, P575; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; THOMPSON AR, 1977, BLOOD, V50, P303; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Viger RS, 1998, DEVELOPMENT, V125, P2665; Vyas P, 1999, BLOOD, V93, P2867; WEISS MJ, 1995, EXP HEMATOL, V23, P99; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; WEISS TG, 1994, ETHICS INT AFF, V8, P1; Weissberg RP, 1997, ISS CHILDR FAM LIVES, V8, P1; White JG, 1998, SEMIN THROMB HEMOST, V24, P163, DOI 10.1055/s-2007-995836; YANG HY, 1992, MOL CELL BIOL, V12, P4562, DOI 10.1128/MCB.12.10.4562; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759	27	384	392	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					266	270		10.1038/73480	http://dx.doi.org/10.1038/73480			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700180				2022-12-17	WOS:000085590600017
J	Hacia, JG				Hacia, JG			Resequencing and mutational analysis using oligonucleotide microarrays	NATURE GENETICS			English	Review							DNA ANALYSIS; ARRAYS; HYBRIDIZATION; SEQUENCE; POLYMORPHISMS; DIAGNOSTICS; MICROCHIPS	Oligonucleotide microarray (DNA chip)-based hybridization analysis is a promising new technology which potentially allows rapid and cost-effective screens for all possible mutations and sequence variations in genomic DNA. Here, I review current strategies and uses for DNA chip-based resequencing and mutational analysis, the underlying principles of experimental designs, and future efforts to improve the sensitivity and specificity of chip-based assays.	NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Hacia, JG (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, Bldg 49-3A14, Bethesda, MD 20892 USA.	jhacia@nhgri.nih.gov						Arlinghaus HF, 1997, ANAL CHEM, V69, P3747, DOI 10.1021/ac970267p; BAINS W, 1988, J THEOR BIOL, V135, P303, DOI 10.1016/S0022-5193(88)80246-7; Blanchard AP, 1996, BIOSENS BIOELECTRON, V11, P687, DOI 10.1016/0956-5663(96)83302-1; BROUDE NE, 1994, P NATL ACAD SCI USA, V91, P3072, DOI 10.1073/pnas.91.8.3072; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.3.CO;2-D; DRMANAC R, 1989, GENOMICS, V4, P114; Drmanac S, 1998, NAT BIOTECHNOL, V16, P54, DOI 10.1038/nbt0198-54; Dubiley S, 1997, NUCLEIC ACIDS RES, V25, P2259, DOI 10.1093/nar/25.12.2259; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Edman CF, 1997, NUCLEIC ACIDS RES, V25, P4907, DOI 10.1093/nar/25.24.4907; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; HACIA J, IN PRESS GENOME RES; Hacia JG, 1998, NUCLEIC ACIDS RES, V26, P3865, DOI 10.1093/nar/26.16.3865; Hacia JG, 1998, NUCLEIC ACIDS RES, V26, P4975, DOI 10.1093/nar/26.21.4975; Hacia JG, 1998, NAT GENET, V18, P155, DOI 10.1038/ng0298-155; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Head SR, 1997, NUCLEIC ACIDS RES, V25, P5065, DOI 10.1093/nar/25.24.5065; HOFKER MH, 1986, AM J HUM GENET, V39, P438; Hoheisel JD, 1996, NUCLEIC ACIDS RES, V24, P430, DOI 10.1093/nar/24.3.430; KHRAPKO KR, 1989, FEBS LETT, V256, P118, DOI 10.1016/0014-5793(89)81730-2; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marshall A, 1998, NAT BIOTECHNOL, V16, P27, DOI 10.1038/nbt0198-27; McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555; Milner N, 1997, NAT BIOTECHNOL, V15, P537, DOI 10.1038/nbt0697-537; Moldin SO, 1997, SCHIZOPHRENIA BULL, V23, P547, DOI 10.1093/schbul/23.4.547; Nguyen HK, 1998, NUCLEIC ACIDS RES, V26, P4249, DOI 10.1093/nar/26.18.4249; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; NIKIFOROV TT, 1994, NUCLEIC ACIDS RES, V22, P4167, DOI 10.1093/nar/22.20.4167; Parinov S, 1996, NUCLEIC ACIDS RES, V24, P2998, DOI 10.1093/nar/24.15.2998; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Proudnikov D, 1998, ANAL BIOCHEM, V259, P34, DOI 10.1006/abio.1998.2620; Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; Sosnowski RG, 1997, P NATL ACAD SCI USA, V94, P1119, DOI 10.1073/pnas.94.4.1119; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J; Southern EM, 1996, TRENDS GENET, V12, P110, DOI 10.1016/0168-9525(96)81422-3; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weiler J, 1997, NUCLEIC ACIDS RES, V25, P2792, DOI 10.1093/nar/25.14.2792; WILSON RK, 1990, GENOMICS, V6, P626, DOI 10.1016/0888-7543(90)90497-I; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913; Zhang HP, 1997, ANN MED, V29, P493, DOI 10.3109/07853899709007473	55	384	491	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1999	21			S			42	47		10.1038/4469	http://dx.doi.org/10.1038/4469			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156NU	9915500				2022-12-17	WOS:000078008200011
J	Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Pearce, WG; Koop, B; Fishman, GA; Mets, M; Musarella, MA; Boycott, KM				Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Pearce, WG; Koop, B; Fishman, GA; Mets, M; Musarella, MA; Boycott, KM			Loss-of-function mutations in a calcium-channel alpha(1)-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness	NATURE GENETICS			English	Article							B-WAVE; ELECTRORETINOGRAM; EXPRESSION; SUBTYPE; DNA	X-linked congenital stationary night blindness (CSNB) is a recessive non-progressive retinal disorder characterized by night blindness, decreased visual acuity, myopia, nystagmus and strabismus(1-3). Two distinct clinical entities of X-linked CSNB have been proposed(4). Patients with complete CSNB show moderate to severe myopia, undetectable rod function and a normal cone response, whereas patients with incomplete CSNB show moderate myopia to hyperopia and subnormal but measurable rod and cone function. The electrophysiological and psychophysical features of these clinical entities suggest a defect in retinal neurotransmission. The apparent clinical heterogeneity in X-linked CSNB reflects the recently described genetic heterogeneity in which the locus for complete CSNB (CSNB1) was mapped to Xp11.4, and the locus for incomplete CSNB (CSNB2) was refined within Xp11.23 (ref. 5). A novel retina-specific gene mapping to the CSNB2 minimal region was characterized and found to have similarity to voltage-gated L-type calcium channel alpha(1)-subunit genes. Mutation analysis of this new alpha(1)-subunit gene, CACNA1F, in 20 families with incomplete CSNB revealed six different mutations that are all predicted to cause premature protein truncation. These findings establish that loss-of-function mutations in CACNA1F cause incomplete CSNB, making this disorder an example of a human channelopathy of the retina.	Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2G3, Canada; Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; Univ Illinois, Dept Ophthalmol, Chicago, IL 60612 USA; Childrens Mem Hosp, Dept Ophthalmol, Chicago, IL 60614 USA; Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; Long Isl Coll Hosp, Dept Ophthalmol, Brooklyn, NY 11201 USA	University of Calgary; University of Alberta; University of Victoria; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Toronto; Long Island College Hospital	Bech-Hansen, NT (corresponding author), Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada.		Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200				BECHHANSEN NT, 1993, AM J HUM GENET, V52, P71; BECHHANSEN NT, IN PRESS HUMAN GENET; Boycott KM, 1997, CYTOGENET CELL GENET, V76, P223, DOI 10.1159/000134555; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Boycott KM, 1996, GENOMICS, V33, P488, DOI 10.1006/geno.1996.0224; Boycott KM, 1998, GENOMICS, V48, P369, DOI 10.1006/geno.1997.5167; Carr R E, 1974, Trans Am Ophthalmol Soc, V72, P448; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Doyle JL, 1998, TRENDS GENET, V14, P92, DOI 10.1016/S0168-9525(97)01370-X; Epp FH, 1975, MENNONITES CANADA 17; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher SE, 1997, GENOMICS, V45, P340, DOI 10.1006/geno.1997.4941; FISHMAN GA, 1990, ELECTROPHYSIOLOGIC T; Heon E, 1994, MOL GENETICS INHERIT, P277; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; NATHANS J, 1984, P NATL ACAD SCI USA, V81, P193; PEARCE WG, 1990, CAN J OPHTHALMOL, V25, P3; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindelhauer D, 1996, GENOME RES, V6, P1056, DOI 10.1101/gr.6.11.1056; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; Smith LA, 1996, J NEUROSCI, V16, P7868; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; STEA A, 1995, LIGAND VOLTAGE GATED, P113; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656	34	384	399	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					264	267		10.1038/947	http://dx.doi.org/10.1038/947			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662400				2022-12-17	WOS:000074565900023
J	Gowen, LC; Johnson, BL; Latour, AM; Sulik, KK; Koller, BH				Gowen, LC; Johnson, BL; Latour, AM; Sulik, KK; Koller, BH			Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities	NATURE GENETICS			English	Letter							CELLS; GENE; BREAST; MOUSE		UNIV N CAROLINA, CURRICULUM GENET & MOLEC BIOL, CHAPEL HILL, NC 27515 USA; UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC USA; UNIV N CAROLINA, DEPT CELL BIOL & ANAT, CHAPEL HILL, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NIAAA NIH HHS [5R01AA08204-05] Funding Source: Medline; NIDDK NIH HHS [DK38103, R01 DK46003-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008204] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABEL KJ, 1995, HUM MOL GENET, V4, P2265, DOI 10.1093/hmg/4.12.2265; BOYD M, 1995, NATURE, V375, P541, DOI 10.1038/375541b0; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EASTON DF, 1993, AM J HUM GENET, V52, P678; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOHN AR, 1995, DNA CLONING MAMMALIA, P142; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SMITH HS, 1993, J CELL BIOCHEM, P144; SULIK KK, 1993, ANN NY ACAD SCI, V678, P8; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444	20	384	390	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					191	194		10.1038/ng0296-191	http://dx.doi.org/10.1038/ng0296-191			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563759				2022-12-17	WOS:A1996TU07900021
J	ZHANG, YH; TYCKO, B				ZHANG, YH; TYCKO, B			MONOALLELIC EXPRESSION OF THE HUMAN H19 GENE	NATURE GENETICS			English	Article							SPORADIC WILMS-TUMOR; LOCUS; MOUSE; MAP; CHROMOSOME-11; ANTICIPATION; METHYLATION; MECHANISM; MODEL	Monoallelic expression of several genes has been observed in mice in which transcripts from parental homologues are distinguishable, but this phenomenon has not been demonstrated in humans. One monoallelically expressed murine gene, H19, encodes an abundant fetal RNA. We have found restriction site polymorphisms in the human H19 gene, located on chromosome 11p15, and examined the representation of these polymorphisms in cDNAs from fetal organs. Expression of H19 is largely or exclusively from a single allele; a similar analysis of the WT1 gene, on 11p13, shows biallelic expression. In the context of previous studies of 11p15 allelic losses in human embryonal tumours, our findings support the possibility of single-step inactivation of monoallelically expressed growth-regulating genes in human oncogenesis.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, DIV NEUROPATHOL, NEW YORK, NY 10032 USA	Columbia University	ZHANG, YH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, DIV ONCOL, NEW YORK, NY 10032 USA.							BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Eldridge R, 1981, Adv Neurol, V29, P57; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HABER DA, 1991, CELL, V64, P5, DOI 10.1016/0092-8674(91)90200-I; HAIG D, 1991, CELL, V64, P1045; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOVAN PR, 1990, NUCLEIC ACIDS RES, V19, P1164; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KITTUR SD, 1985, P NATL ACAD SCI USA, V82, P5064, DOI 10.1073/pnas.82.15.5064; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LEIBOVITCH MP, 1991, BIOCHEM BIOPH RES CO, V180, P1241, DOI 10.1016/S0006-291X(05)81329-4; LITTLE M, 1991, NATURE, V351, P609, DOI 10.1038/351609a0; Maniatis T., 1982, MOL CLONING; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PACHNIS V, 1984, P NATL ACAD SCI-BIOL, V81, P5523, DOI 10.1073/pnas.81.17.5523; PAL N, 1990, ONCOGENE, V5, P1665; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; SAPIENZA C, 1989, PROG NUCLEIC ACID RE, V36, P145; SCHROEDER WT, 1987, AM J HUM GENET, V53, P89; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TYCKO B, 1989, SCIENCE, V245, P1242, DOI 10.1126/science.2551037; VANDERMEY AGL, 1989, LANCET, V2, P1291; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WILES MV, 1988, DEVELOPMENT, V104, P403	35	384	391	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1992	1	1					40	44		10.1038/ng0492-40	http://dx.doi.org/10.1038/ng0492-40			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1363808				2022-12-17	WOS:A1992JC97800010
J	Brastianos, PK; Horowitz, PM; Santagata, S; Jones, RT; McKenna, A; Getz, G; Ligon, KL; Palescandolo, E; Van Hummelen, P; Ducar, MD; Raza, A; Sunkavalli, A; MacConaill, LE; Stemmer-Rachamimov, AO; Louis, DN; Hahn, WC; Dunn, IF; Beroukhim, R				Brastianos, Priscilla K.; Horowitz, Peleg M.; Santagata, Sandro; Jones, Robert T.; McKenna, Aaron; Getz, Gad; Ligon, Keith L.; Palescandolo, Emanuele; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Stemmer-Rachamimov, Anat O.; Louis, David N.; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen			Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations	NATURE GENETICS			English	Article							BASAL-CELL CARCINOMAS; NF2; PATHWAY; CANCER; MEDULLOBLASTOMA; COMPLEXITY; LANDSCAPE; PATTERNS; TUMORS	Meningiomas are the most common primary nervous system tumor. The tumor suppressor NF2 is disrupted in approximately half of all meningiomas(1), but the complete spectrum of genetic changes remains undefined. We performed whole-genome or whole-exome sequencing on 17 meningiomas and focused sequencing on an additional 48 tumors to identify and validate somatic genetic alterations. Most meningiomas had simple genomes, with fewer mutations, rearrangements and copy-number alterations than reported in other tumors in adults. However, several meningiomas harbored more complex patterns of copy-number changes and rearrangements, including one tumor with chromothripsis. We confirmed focal NF2 inactivation in 43% of tumors and found alterations in epigenetic modifiers in an additional 8% of tumors. A subset of meningiomas lacking NF2 alterations harbored recurrent oncogenic mutations in AKT1 (p.Glu17Lys) and SMO (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways. These mutations were present in therapeutically challenging tumors of the skull base and higher grade. These results begin to define the spectrum of genetic alterations in meningiomas and identify potential therapeutic targets.	[Brastianos, Priscilla K.; Jones, Robert T.; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Hahn, William C.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Brastianos, Priscilla K.] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Brastianos, Priscilla K.; Horowitz, Peleg M.; Santagata, Sandro; Ligon, Keith L.; Stemmer-Rachamimov, Anat O.; Louis, David N.; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen] Harvard Univ, Sch Med, Boston, MA USA; [Brastianos, Priscilla K.; Horowitz, Peleg M.; McKenna, Aaron; Getz, Gad; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen] Broad Inst MIT & Harvard, Boston, MA USA; [Horowitz, Peleg M.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Horowitz, Peleg M.; Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Santagata, Sandro; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jones, Robert T.; Palescandolo, Emanuele; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Hahn, William C.; Beroukhim, Rameen] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Stemmer-Rachamimov, Anat O.; Louis, David N.] Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02114 USA; [Louis, David N.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu; idunn@partners.org; rameen@broadinstitute.org		Santagata, Sandro/0000-0002-7528-9668; van hummelen, paul/0000-0002-4801-8600; Sunkavalli, Ashwini/0000-0002-5561-3694; Horowitz, Peleg/0000-0002-5177-1783; Brastianos, Priscilla/0000-0003-4470-8425; Jones, Robert/0000-0001-8007-4023	Brain Science Foundation; Pediatric Low-Grade Astrocytoma Foundation; American Brain Tumor Association; Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (NIH) [K08 CA122833, K08 NS064168, K12 CA090354-11]; US Department of Defense grant [W81XWE-12-1-0136]; NATIONAL CANCER INSTITUTE [K12CA090354, K08CA122833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Brain Science Foundation; Pediatric Low-Grade Astrocytoma Foundation; American Brain Tumor Association; Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank M. Lawrence, N. Stransky, M. Imielinski, K. Cibulskis, S. Carter, C. Stewart, C.-Z. Zhang, Y. Drier, S. Schumacher and B. Tabak for their assistance with genomic analyses; P. Wen, O. Al-Mefty, T. Batchelor, B. Reisler, M. Johnson, W. Richards and J. Kim for their assistance with tissue acquisition; and A. Pisarek-Horowitz, S.A. Horowitz, G. Bergthold and C.H. Brastianos for critical review of the manuscript. This work was supported by the Brain Science Foundation (I.F.D., P.K.B., R.B. and S.S.), the Pediatric Low-Grade Astrocytoma Foundation (R.B. and W.C.H.), the American Brain Tumor Association (P.K.B.), a Conquer Cancer Foundation Young Investigator Award (P.K.B.), US National Institutes of Health (NIH) grants K08 CA122833 (R.B.), K08 NS064168 (S.S.) and K12 CA090354-11 (P.K.B.), and US Department of Defense grant W81XWE-12-1-0136 (P.M.H.).	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Choy W, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1116; Durand A, 2009, J NEURO-ONCOL, V95, P367, DOI 10.1007/s11060-009-9934-0; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Goutagny S, 2010, CLIN CANCER RES, V16, P4155, DOI 10.1158/1078-0432.CCR-10-0891; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Karst AM, 2011, GYNECOL ONCOL, V123, P5, DOI 10.1016/j.ygyno.2011.05.021; Ketter R, 2007, J NEURO-ONCOL, V83, P213, DOI 10.1007/s11060-006-9318-7; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Krayenbuhl N, 2007, NEUROSURGERY, V61, P495, DOI 10.1227/01.NEU.0000280009.79813.DE; Laurendeau I, 2010, MOL MED, V16, P262, DOI 10.2119/molmed.2010.00005; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mathiesen T, 1996, NEUROSURGERY, V39, P2, DOI 10.1097/00006123-199607000-00002; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Nunes F, 2005, CANCER GENET CYTOGEN, V162, P135, DOI 10.1016/j.cancergencyto.2005.04.003; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reifenberger J, 1998, CANCER RES, V58, P1798; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Santos DCC, 2011, INT J DERMATOL, V50, P838, DOI 10.1111/j.1365-4632.2010.04866.x; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van Alkemade H, 2012, NEURO-ONCOLOGY, V14, P658, DOI 10.1093/neuonc/nos013; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; WELLENREUTHER R, 1995, AM J PATHOL, V146, P827; Wen PY, 2010, J NEURO-ONCOL, V99, P365, DOI 10.1007/s11060-010-0349-8; Yang HW, 2012, NEOPLASIA, V14, P20, DOI 10.1593/neo.111574	40	383	389	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					285	289		10.1038/ng.2526	http://dx.doi.org/10.1038/ng.2526			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23334667	Green Accepted, Green Submitted			2022-12-17	WOS:000315664800012
J	Zhu, J; Zhang, B; Smith, EN; Drees, B; Brem, RB; Kruglyak, L; Bumgarner, RE; Schadt, EE				Zhu, Jun; Zhang, Bin; Smith, Erin N.; Drees, Becky; Brem, Rachel B.; Kruglyak, Leonid; Bumgarner, Roger E.; Schadt, Eric E.			Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks	NATURE GENETICS			English	Article							SEGREGATING MOUSE-POPULATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; PROTEIN; PHOSPHATE; PATHWAYS; DISEASE; OBESITY; TRAITS	A key goal of biology is to construct networks that predict complex system behavior. We combine multiple types of molecular data, including genotypic, expression, transcription factor binding site (TFBS), and protein-protein interaction (PPI) data previously generated from a number of yeast experiments, in order to reconstruct causal gene networks. Networks based on different types of data are compared using metrics devised to assess the predictive power of a network. We show that a network reconstructed by integrating genotypic, TFBS and PPI data is the most predictive. This network is used to predict causal regulators responsible for hot spots of gene expression activity in a segregating yeast population. We also show that the network can elucidate the mechanisms by which causal regulators give rise to larger-scale changes in gene expression activity. We then prospectively validate predictions, providing direct experimental evidence that predictive networks can be constructed by integrating multiple, appropriate data types.	[Zhu, Jun; Zhang, Bin; Schadt, Eric E.] LLC, Rosetta Inpharmat, Seattle, WA 98109 USA; [Smith, Erin N.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA; [Smith, Erin N.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA; [Smith, Erin N.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Bumgarner, Roger E.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brem, Rachel B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Merck & Company; Princeton University; Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley	Schadt, EE (corresponding author), LLC, Rosetta Inpharmat, Seattle, WA 98109 USA.	eric_schadt@merck.com	Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger E/K-3531-2015; Smith, Erin/E-5933-2011	Bumgarner, Roger E/0000-0002-8168-6985; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50GM071508, P50 GM071508] Funding Source: Medline; NIMH NIH HHS [R37 MH059520-11, R37 MH059520] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Deeds EJ, 2006, P NATL ACAD SCI USA, V103, P311, DOI 10.1073/pnas.0509715102; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kulp DC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-125; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Nielsen J, 2005, TRENDS BIOTECHNOL, V23, P544, DOI 10.1016/j.tibtech.2005.08.005; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Ong Irene M, 2002, Bioinformatics, V18 Suppl 1, pS241; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Rajagopalan D, 2005, BIOINFORMATICS, V21, P788, DOI 10.1093/bioinformatics/bti069; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Tan K, 2007, P NATL ACAD SCI USA, V104, P1283, DOI 10.1073/pnas.0606914104; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	36	383	387	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					854	861		10.1038/ng.167	http://dx.doi.org/10.1038/ng.167			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18552845	Green Accepted			2022-12-17	WOS:000257166500020
J	Menzel, S; Garner, C; Gut, I; Matsuda, F; Yamaguchi, M; Heath, S; Foglio, M; Zelenika, D; Boland, A; Rooks, H; Best, S; Spector, TD; Farrall, M; Lathrop, M; Thein, SL				Menzel, Stephan; Garner, Chad; Gut, Ivo; Matsuda, Fumihiko; Yamaguchi, Masao; Heath, Simon; Foglio, Mario; Zelenika, Diana; Boland, Anne; Rooks, Helen; Best, Steve; Spector, Tim D.; Farrall, Martin; Lathrop, Mark; Thein, Swee Lay			A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15	NATURE GENETICS			English	Article							FETAL-HEMOGLOBIN; ASSOCIATION; ADULTS	F cells measure the presence of fetal hemoglobin, a heritable quantitative trait in adults that accounts for substantial phenotypic diversity of sickle cell disease and beta thalassemia. We applied a genome-wide association mapping strategy to individuals with contrasting extreme trait values and mapped a new F cell quantitative trait locus to BCL11A, which encodes a zinc-finger protein, on chromosome 2p15. The 2p15 BCL11A quantitative trait locus accounts for 15.1% of the trait variance.	Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, London SE5 9PJ, England; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92697 USA; Ctr Natl Genotypage, Inst Genom, Commissariat Lenergie Atom, F-91006 Evry, France; St Thomas Hosp, Univ London Kings Coll, Sch Med, Div Genet & Mol Med, London SE1 7EH, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; Kings Coll Hosp London, Dept Haematol Med, London SE5 9RS, England	University of London; King's College London; University of California System; University of California Irvine; CEA; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; King's College Hospital NHS Foundation Trust; King's College Hospital	Thein, SL (corresponding author), Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, Kings Denmark Hill Campus, London SE5 9PJ, England.	sl.thein@kcl.ac.uk	Gut, Ivo/ABF-3188-2020; Best, Steve/A-7531-2012; Spector, Tim D/F-6533-2012; Menzel, Stephan/U-6906-2019; Foglio, mary A./B-9149-2012; Matsuda, Fumihiko/B-9893-2009; Heath, Simon C/J-4138-2012	Gut, Ivo/0000-0001-7219-632X; Foglio, mary A./0000-0001-7715-4452; Heath, Simon C/0000-0002-9550-0897; Menzel, Stephan/0000-0002-1590-9108	MRC [G0000111] Funding Source: UKRI; Medical Research Council [G0000111] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Garner C, 2000, BLOOD, V95, P342; Garner C, 2000, GENESCREEN, V1, P9, DOI DOI 10.1046/J.1466-9218.2000.00001.X; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Tenesa A, 2005, BEHAV GENET, V35, P219, DOI 10.1007/s10519-004-0811-5; Thein SL, 1998, HEMOGLOBIN, V22, P401, DOI 10.3109/03630269809071538; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104	15	383	407	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1197	1199		10.1038/ng2108	http://dx.doi.org/10.1038/ng2108			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767159				2022-12-17	WOS:000249737400013
J	Berezikov, E; Thuemmler, F; van Laake, LW; Kondova, I; Bontrop, R; Cuppen, E; Plasterk, RHA				Berezikov, Eugene; Thuemmler, Fritz; van Laake, Linda W.; Kondova, Ivanela; Bontrop, Ronald; Cuppen, Edwin; Plasterk, Ronald H. A.			Diversity of microRNAs in human and chimpanzee brain	NATURE GENETICS			English	Article							IDENTIFICATION; SEQUENCES; RNAS; PATHWAY; GENES	We used massively parallel sequencing to compare the microRNA (miRNA) content of human and chimpanzee brains, and we identified 447 new miRNA genes. Many of the new miRNAs are not conserved beyond primates, indicating their recent origin, and some miRNAs seem species specific, whereas others are expanded in one species through duplication events. These data suggest that evolution of miRNAs is an ongoing process and that along with ancient, highly conserved miRNAs, there are a number of emerging miRNAs.	KNAW, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Vertis Biotechnol AG, D-85354 Freising Weihenstephan, Germany; Univ Utrecht, Med Ctr, Dept Cardiol, NL-3508 GA Utrecht, Netherlands; Biomed Primate Res Ctr, Rijswijk, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Plasterk, RHA (corresponding author), KNAW, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Cuppen, Edwin/H-2389-2016; Bontrop, Ronald E./D-4844-2011; Cuppen, Edwin/F-5696-2011; Bontrop, Ronald E/J-3628-2012; Berezikov, Eugene/D-3363-2013	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Bontrop, Ronald E/0000-0003-0874-6467; Berezikov, Eugene/0000-0002-1145-2884				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	15	383	407	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1375	1377		10.1038/ng1914	http://dx.doi.org/10.1038/ng1914			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17072315				2022-12-17	WOS:000242404200013
J	Irwin, WA; Bergamin, N; Sabatelli, P; Reggiani, C; Megighian, A; Merlini, L; Braghetta, P; Columbaro, M; Volpin, D; Bressan, GM; Bernardi, P; Bonaldo, P				Irwin, WA; Bergamin, N; Sabatelli, P; Reggiani, C; Megighian, A; Merlini, L; Braghetta, P; Columbaro, M; Volpin, D; Bressan, GM; Bernardi, P; Bonaldo, P			Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency	NATURE GENETICS			English	Article							PERMEABILITY TRANSITION; MECHANISM; CHANNELS; RELEASE; FIBERS; ONSET; CA2+	Collagen VI is an extracellular matrix protein that forms a microfilamentous network in skeletal muscles and other organs(1-3). Inherited mutations in genes encoding collagen VI in humans cause two muscle diseases, Bethlem myopathy and Ullrich congenital muscular dystrophy(4,5). We previously generated collagen VI deficient (Col6a1(-/-)) mice and showed that they have a muscle phenotype that strongly resembles Bethlem myopathy(6). The pathophysiological defects and mechanisms leading to the myopathic disorder were not known. Here we show that Col6a1(-/-) muscles have a loss of contractile strength associated with ultrastructural alterations of sarcoplasmic reticulum (SR) and mitochondria and spontaneous apoptosis. We found a latent mitochondrial dysfunction in myofibers of Col6a1(-/-) mice on incubation with the selective F1FO-ATPase inhibitor oligomycin, which caused mitochondrial depolarization, Ca2+ deregulation and increased apoptosis. These defects were reversible, as they could be normalized by plating Col6a1(-/-) myofibers on collagen VI or by addition of cyclosporin A (CsA), the inhibitor of mitochondrial permeability transition pore (PTP). Treatment of Col6a1(-/-) mice with CsA rescued the muscle ultrastructural defects and markedly decreased the number of apoptotic nuclei in vivo. These findings indicate that collagen VI myopathies have an unexpected mitochondrial pathogenesis that could be exploited for therapeutic intervention.	Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; ITOI CNR IOR, I-40136 Bologna, Italy; Univ Padua, Dept Human Anat, I-35121 Padua, Italy; Univ Padua, Dept Physiol, I-35121 Padua, Italy; Orthoped Inst Rizzoli, I-40136 Bologna, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy.	bernardi@bio.unipd.it; bonaldo@bio.unipd.it	Bergamin, Natascha/A-9315-2010; Sabatelli, Patrizia/C-7479-2019; Bernardi, Paolo/C-3656-2008; Megighian, Aram/G-6478-2014; MEGIGHIAN, ARAM/I-8146-2019; Columbaro, Marta/C-6960-2019; Merlini, Luciano/N-6478-2019; Braghetta, Paola/K-5478-2016	Sabatelli, Patrizia/0000-0003-2345-5094; Bernardi, Paolo/0000-0001-9187-3736; Megighian, Aram/0000-0002-7971-5310; MEGIGHIAN, ARAM/0000-0002-7971-5310; Merlini, Luciano/0000-0002-1108-1198; Braghetta, Paola/0000-0003-2547-8679; Columbaro, Marta/0000-0002-4439-8976; Bonaldo, Paolo/0000-0002-9571-8140	Telethon [GGP02123, GP0229Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; Bowser DN, 2002, FASEB J, V16, P1105, DOI 10.1096/fj.01-0828fje; Bowser DN, 1998, BIOPHYS J, V75, P2004, DOI 10.1016/S0006-3495(98)77642-8; Camacho V.O., 2001, P NATL ACAD SCI USA, V98, P7516, DOI DOI 10.1073/PNAS.121027598; D'hahan N, 1999, P NATL ACAD SCI USA, V96, P12162, DOI 10.1073/pnas.96.21.12162; Germinario E, 2002, J APPL PHYSIOL, V92, P2045, DOI 10.1152/japplphysiol.00673.2001; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gugliucci A, 2002, J BIOL CHEM, V277, P31789, DOI 10.1074/jbc.M204450200; Howell SJ, 1998, EXP CELL RES, V241, P230, DOI 10.1006/excr.1998.4051; Irwin W, 2002, J BIOL CHEM, V277, P12221, DOI 10.1074/jbc.M108938200; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P10014, DOI 10.1073/pnas.1633614100; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Plant DR, 2002, J PHYSIOL-LONDON, V543, P169, DOI 10.1113/jphysiol.2002.022418; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Rossi R, 2001, AM J PHYSIOL-CELL PH, V281, pC585, DOI 10.1152/ajpcell.2001.281.2.C585; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5; TIMPL R, 1994, EXTRACELLULAR MATRIX, P208; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	26	383	392	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					367	371		10.1038/ng1270	http://dx.doi.org/10.1038/ng1270			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14625552				2022-12-17	WOS:000186791000019
J	Sakata-Yanagimoto, M; Enami, T; Yoshida, K; Shiraishi, Y; Ishii, R; Miyake, Y; Muto, H; Tsuyama, N; Sato-Otsubo, A; Okuno, Y; Sakata, S; Kamada, Y; Nakamoto-Matsubara, R; Tran, NB; Izutsu, K; Sato, Y; Ohta, Y; Furuta, J; Shimizu, S; Komeno, T; Sato, Y; Ito, T; Noguchi, M; Noguchi, E; Sanada, M; Chiba, K; Tanaka, H; Suzukawa, K; Nanmoku, T; Hasegawa, Y; Nureki, O; Miyano, S; Nakamura, N; Takeuchi, K; Ogawa, S; Chiba, S				Sakata-Yanagimoto, Mamiko; Enami, Terukazu; Yoshida, Kenichi; Shiraishi, Yuichi; Ishii, Ryohei; Miyake, Yasuyuki; Muto, Hideharu; Tsuyama, Naoko; Sato-Otsubo, Aiko; Okuno, Yusuke; Sakata, Seiji; Kamada, Yuhei; Nakamoto-Matsubara, Rie; Nguyen Bich Tran; Izutsu, Koji; Sato, Yusuke; Ohta, Yasunori; Furuta, Junichi; Shimizu, Seiichi; Komeno, Takuya; Sato, Yuji; Ito, Takayoshi; Noguchi, Masayuki; Noguchi, Emiko; Sanada, Masashi; Chiba, Kenichi; Tanaka, Hiroko; Suzukawa, Kazumi; Nanmoku, Toru; Hasegawa, Yuichi; Nureki, Osamu; Miyano, Satoru; Nakamura, Naoya; Takeuchi, Kengo; Ogawa, Seishi; Chiba, Shigeru			Somatic RHOA mutation in angioimmunoblastic T cell lymphoma	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; TET2; FREQUENT; PHOSPHORYLATION; ALIGNMENT; GTPASES; FAMILY; GENES; FORM	Angioimmunoblastic T cell lymphoma (AITL) is a distinct subtype of peripheral T cell lymphoma characterized by generalized lymphadenopathy and frequent autoimmune-like manifestations(1,2). Although frequent mutations in TET2, IDH2 and DNMT3A, which are common to various hematologic malignancies3,4, have been identified in AITL(5-8), the molecular pathogenesis specific to this lymphoma subtype is unknown. Here we report somatic RHOA mutations encoding a p. Gly17Val alteration in 68% of AITL samples. Remarkably, all cases with the mutation encoding p. Gly17Val also had TET2 mutations. The RHOA mutation encoding p. Gly17Val was specifically identified in tumor cells, whereas TET2 mutations were found in both tumor cells and non-tumor hematopoietic cells. RHOA encodes a small GTPase that regulates diverse biological processes. We demonstrated that the Gly17Val RHOA mutant did not bind GTP and also inhibited wild-type RHOA function. Our findings suggest that impaired RHOA function in cooperation with preceding loss of TET2 function contributes to AITL-specific pathogenesis.	[Sakata-Yanagimoto, Mamiko; Enami, Terukazu; Miyake, Yasuyuki; Muto, Hideharu; Kamada, Yuhei; Nakamoto-Matsubara, Rie; Nguyen Bich Tran; Suzukawa, Kazumi; Hasegawa, Yuichi; Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan; [Yoshida, Kenichi; Sato-Otsubo, Aiko; Okuno, Yusuke; Sato, Yusuke; Sanada, Masashi; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Cancer Genom Project, Tokyo, Japan; [Yoshida, Kenichi; Sato-Otsubo, Aiko; Sato, Yusuke; Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Ishii, Ryohei; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Tsuyama, Naoko; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Sakata, Seiji; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Izutsu, Koji] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Izutsu, Koji] Okinaka Mem Inst Med Res, Tokyo, Japan; [Ohta, Yasunori] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Furuta, Junichi] Univ Tsukuba, Dept Dermatol, Fac Med, Tsukuba, Ibaraki, Japan; [Shimizu, Seiichi] Tsuchiura Kyodo Gen Hosp, Dept Hematol, Tsuchiura, Ibaraki, Japan; [Komeno, Takuya] Natl Hosp Org, Mito Med Ctr, Dept Hematol, Mito, Ibaraki, Japan; [Sato, Yuji] Tsukuba Mem Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan; [Ito, Takayoshi] JA Toride Med Ctr, Dept Hematol, Toride, Japan; [Noguchi, Masayuki] Univ Tsukuba, Dept Pathol, Fac Med, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Fac Med, Tsukuba, Ibaraki, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Suzukawa, Kazumi; Nanmoku, Toru] Univ Tsukuba Hosp, Dept Clin Lab, Tsukuba, Ibaraki, Japan; [Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 25911, Japan; [Chiba, Shigeru] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tokyo; Kyoto University; University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Toranomon Hospital; Toranomon Hospital; University of Tsukuba; Tsuchiura Kyodo Hospital; University of Tsukuba; University of Tsukuba; University of Tokyo; University of Tsukuba; Tokai University; University of Tsukuba	Chiba, S (corresponding author), Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan.	sogawa-tky@umin.ac.jp; schiba-t@md.tsukuba.ac.jp	Nguyen, Tran/AAH-8493-2019; NUREKI, OSAMU/G-4960-2014; Mamiko, Sakata-yanagimoto/AAP-3298-2020; Izutsu, Koji/AAI-1125-2019; Ogawa, Seishi/AAE-7088-2019; Okuno, Yusuke/C-9082-2009; Takeuchi, Kengo/C-3614-2008	Okuno, Yusuke/0000-0003-3139-9272; Yoshida, Kenichi/0000-0003-4612-2778; Muto, Hideharu/0000-0002-9146-012X; Tsuyama, Naoko/0000-0002-8718-4599; Izutsu, Koji/0000-0001-9129-8057; Miyano, Satoru/0000-0002-1753-6616; Ishii, Ryohei/0000-0003-2486-1393; Takeuchi, Kengo/0000-0002-1599-5800; Suzukawa, Kazumi/0000-0001-9904-3905	Ministry of Education, Culture, Sports, Science and Technology of Japan [22134006, 22130002, 24390241, 25112703, 25670444, 25461407]; Sagawa Foundation for Promotion of Cancer Research; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [25670444, 24390241] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Foundation for Promotion of Cancer Research; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Okoshi, N. Obara, Y. Yokoyama, H. Nishikii, N. Kurita and M. Seki for contributing to sample collection and banking. We also thank Y. Sakashita and T. Takahashi for technical assistance, and S. Narumiya and I. Kitabayashi for efficient discussion. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22134006 to S. O.; 22130002, 24390241, 25112703 and 25670444 to S. C.; 25461407 to M. S.-Y.) and was supported by the Sagawa Foundation for Promotion of Cancer Research, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research (M. S.-Y.).	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Cleverley SC, 2000, ONCOGENE, V19, P13, DOI 10.1038/sj.onc.1203259; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleige A, 2007, J BIOL CHEM, V282, P24320, DOI 10.1074/jbc.M703119200; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Rodriguez-Pinilla SM, 2008, AM J SURG PATHOL, V32, P1787, DOI 10.1097/PAS.0b013e31817f123e; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mylona A, 2011, MOL CELL BIOL, V31, P267, DOI 10.1128/MCB.01058-10; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow S.H., 2008, WHO CLASSIFICATION T, P306; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041007; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	34	382	392	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					171	+		10.1038/ng.2872	http://dx.doi.org/10.1038/ng.2872			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413737				2022-12-17	WOS:000331208300014
J	Riedelsheimer, C; Czedik-Eysenberg, A; Grieder, C; Lisec, J; Technow, F; Sulpice, R; Altmann, T; Stitt, M; Willmitzer, L; Melchinger, AE				Riedelsheimer, Christian; Czedik-Eysenberg, Angelika; Grieder, Christoph; Lisec, Jan; Technow, Frank; Sulpice, Ronan; Altmann, Thomas; Stitt, Mark; Willmitzer, Lothar; Melchinger, Albrecht E.			Genomic and metabolic prediction of complex heterotic traits in hybrid maize	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; QUANTITATIVE RESISTANCE; GENETIC-VARIATION; WIDE ASSOCIATION; LEAF-BLIGHT; SELECTION; DIVERSITY; LINES	Maize is both an exciting model organism in plant genetics and also the most important crop worldwide for food, animal feed and bioenergy production. Recent genome-wide association and metabolic profiling studies aimed to resolve quantitative traits to their causal genetic loci and key metabolic regulators. Here we present a complementary approach that exploits large-scale genomic and metabolic information to predict complex, highly polygenic traits in hybrid testcrosses. We crossed 285 diverse Dent inbred lines from worldwide sources with two testers and predicted their combining abilities for seven biomass- and bioenergy-related traits using 56,110 SNPs and 130 metabolites. Whole-genome and metabolic prediction models were built by fitting effects for all SNPs or metabolites. Prediction accuracies ranged from 0.72 to 0.81 for SNPs and from 0.60 to 0.80 for metabolites, allowing a reliable screening of large collections of diverse inbred lines for their potential to create superior hybrids.	[Riedelsheimer, Christian; Grieder, Christoph; Technow, Frank; Melchinger, Albrecht E.] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-7000 Stuttgart, Germany; [Czedik-Eysenberg, Angelika; Lisec, Jan; Sulpice, Ronan; Stitt, Mark; Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Altmann, Thomas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany; [Willmitzer, Lothar] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	University Hohenheim; Max Planck Society; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; King Abdulaziz University	Melchinger, AE (corresponding author), Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-7000 Stuttgart, Germany.	melchinger@uni-hohenheim.de	Sulpice, Ronan/I-2738-2013; Willmitzer, Lothar/F-7377-2011; Technow, Frank/AAC-4994-2019; Stitt, Mark/GVT-1242-2022	Sulpice, Ronan/0000-0002-6113-9570; Technow, Frank/0000-0002-2497-3136; Altmann, Thomas/0000-0002-3759-360X; Lisec, Jan/0000-0003-1220-2286; Melchinger, Albrecht E./0000-0002-8346-7786; Stitt, Mark/0000-0002-4900-1763	Max-Planck Society; German Federal Ministry of Education and Research (BMBF) [FKZ: 0315045, FKZ: 0315528D]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank the staff of the experimental research stations of the University of Hohenheim for assistance in conducting the field experiments. This research was funded by the Max-Planck Society and the German Federal Ministry of Education and Research (BMBF) within the project GABI-Energy (FKZ: 0315045) and the AgroClustEr 'Synbreed-Synergistic plant and animal breeding' (FKZ: 0315528D).	Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Duvick D. N., 2004, Plant Breeding Reviews, V24, P109; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Fischer S, 2008, PLANT BREEDING, V127, P446, DOI 10.1111/j.1439-0523.2007.01475.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hallauer AR, 2010, HANDB PLANT BREED, V6, P33, DOI 10.1007/978-1-4419-0766-0_2; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Melchinger AE, 1998, THEOR APPL GENET, V96, P503, DOI 10.1007/s001220050767; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen Theo, 2010, Genetics, V185, P623, DOI 10.1534/genetics.110.116590; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Montes JM, 2011, FIELD CROP RES, V121, P268, DOI 10.1016/j.fcr.2010.12.017; Montes JM, 2007, TRENDS PLANT SCI, V12, P433, DOI 10.1016/j.tplants.2007.08.006; Nelson PT, 2008, CROP SCI, V48, P1673, DOI 10.2135/cropsci2008.02.0092; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smith JSC, 2008, MOL BREEDING, V22, P51, DOI 10.1007/s11032-007-9155-1; Steinfath M, 2010, PLANT BIOTECHNOL J, V8, P900, DOI 10.1111/j.1467-7652.2010.00516.x; Stitt M, 2010, PLANT PHYSIOL, V152, P428, DOI 10.1104/pp.109.150821; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	47	382	410	2	198	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					217	220		10.1038/ng.1033	http://dx.doi.org/10.1038/ng.1033			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246502				2022-12-17	WOS:000299664400023
J	Hinkes, B; Wiggins, RC; Gbadegesin, R; Vlangos, CN; Seelow, D; Nurnberg, G; Garg, P; Verma, R; Chaib, H; Hoskins, BE; Ashraf, S; Becker, C; Hennies, HC; Goyal, M; Wharram, BL; Schachter, AD; Mudumana, S; Drummond, I; Kerjaschki, D; Waldherr, R; Dietrich, A; Ozaltin, F; Bakkaloglu, A; Cleper, R; Basel-Vanagaite, L; Pohl, M; Griebel, M; Tsygin, AN; Soylu, A; Muller, D; Sorli, CS; Bunney, TD; Katan, M; Liu, JH; Attanasio, M; O'Toole, JF; Hasselbacher, K; Mucha, B; Otto, EA; Airik, R; Kispert, A; Kelley, GG; Smrcka, AV; Gudermann, T; Holzman, LB; Nurnberg, P; Hildebrandt, F				Hinkes, Bernward; Wiggins, Roger C.; Gbadegesin, Rasheed; Vlangos, Christopher N.; Seelow, Dominik; Nuernberg, Gudrun; Garg, Puneet; Verma, Rakesh; Chaib, Hassan; Hoskins, Bethan E.; Ashraf, Shazia; Becker, Christian; Hennies, Hans Christian; Goyal, Meera; Wharram, Bryan L.; Schachter, Asher D.; Mudumana, Sudha; Drummond, Iain; Kerjaschki, Dontscho; Waldherr, Ruediger; Dietrich, Alexander; Ozaltin, Fatih; Bakkaloglu, Aysin; Cleper, Roxana; Basel-Vanagaite, Lina; Pohl, Martin; Griebel, Martin; Tsygin, Alexey N.; Soylu, Alper; Mueller, Dominik; Sorli, Caroline S.; Bunney, Tom D.; Katan, Matilda; Liu, Jinhong; Attanasio, Massimo; O'Toole, John F.; Hasselbacher, Katrin; Mucha, Bettina; Otto, Edgar A.; Airik, Rannar; Kispert, Andreas; Kelley, Grant G.; Smrcka, Alan V.; Gudermann, Thomas; Holzman, Lawrence B.; Nuernberg, Peter; Hildebrandt, Friedhelm			Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible	NATURE GENETICS			English	Article							PHOSPHOLIPASE-C-EPSILON; PODOCYTE DEPLETION; GLOMERULAR PROTEIN; DRASH-SYNDROME; NEPHRIN; GLOMERULOSCLEROSIS; PODOCALYXIN; EXPRESSION; IQGAP1; GENE	Nephrotic syndrome, a malfunction of the kidney glomerular filter, leads to proteinuria, edema and, in steroid-resistant nephrotic syndrome, end-stage kidney disease. Using positional cloning, we identified mutations in the phospholipase C epsilon gene (PLCE1) as causing early-onset nephrotic syndrome with end-stage kidney disease. Kidney histology of affected individuals showed diffuse mesangial sclerosis (DMS). Using immunofluorescence, we found PLC epsilon 1 expression in developing and mature glomerular podocytes and showed that DMS represents an arrest of normal glomerular development. We identified IQ motif-containing GTPase-activating protein 1 as a new interaction partner of PLC epsilon 1. Two siblings with a missense mutation in an exon encoding the PLCe1 catalytic domain showed histology characteristic of focal segmental glomerulosclerosis. Notably, two other affected individuals responded to therapy, making this the first report of a molecular cause of nephrotic syndrome that may resolve after therapy. These findings, together with the zebrafish model of human nephrotic syndrome generated by plce1 knockdown, open new inroads into pathophysiology and treatment mechanisms of nephrotic syndrome.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; RZPD Deutsches Ressourcenzentrum Genomforsch GmbH, Berlin, Germany; Univ Cologne, Inst Genet, Cologne, Germany; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Childrens Hosp, Boston, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02129 USA; Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria; Gerneinschaftspraxis Pathol, D-69115 Heidelberg, Germany; Univ Marburg, Dept Pharmacol & Toxicol, Marburg, Germany; Hacettepe Univ, Fac Med, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; Schneider Childrens Med Ctr, Dept Med Genet, Petah Tiqwa, Israel; Rabin Med Ctr, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Univ Freiburg, Dept Pediat, D-79106 Freiburg, Germany; Tech Univ Munich, Childrens Hosp, Schwabing, Germany; Sci Ctr Childrens Hlth, Moscow, Russia; Dokuz Eylul Univ, Dept Pediat, Izmir, Turkey; Charite Childrens Hosp, Dept Pediat Nephrol, Berlin, Germany; Inst Canc Res, Chester Beatty Labs, Ctr Cell & Mol Biol, Canc Res UK, London SW3 6JB, England; Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; Univ Rochester, Sch Med, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Cologne; University of Cologne; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Vienna; Philipps University Marburg; Hacettepe University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Freiburg; Technical University of Munich; Dokuz Eylul University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Hannover Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Rochester; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Airik, Rannar/AAS-7810-2021; Hennies, Hans C/G-9424-2014; Dietrich, Alexander/G-8619-2013; Soylu, Alper/AAR-7694-2020; Seelow, Dominik/HGB-3124-2022	Airik, Rannar/0000-0002-7055-6325; Hennies, Hans C/0000-0001-7210-2389; Dietrich, Alexander/0000-0002-1168-8707; Soylu, Alper/0000-0002-5901-7398; Seelow, Dominik/0000-0002-9746-4412; Alexey, Tsygin/0000-0001-6301-9313; Bunney, Tom/0000-0002-0281-8813; Holzman, Lawrence/0000-0002-8961-234X; Wiggins, Roger/0000-0002-1166-2849; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Attanasio, Massimo/0000-0002-1278-3650; Mucha, Bettina/0000-0002-6410-7320; Garg, Puneet/0000-0001-7439-459X; Otto, Edgar/0000-0002-2387-9973	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255, R56DK046073, R01DK053093, R01DK056294, R01DK046073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK53093, DK46073, R01-DK56294, P50-DK039255] Funding Source: Medline; NIGMS NIH HHS [R01-GM053536] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1981, KIDNEY INT, V20, P765; Antignac C, 2005, NEFROLOGIA, V25, P25; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRODEHL J, 1988, LANCET, V1, P380; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Habib R, 1993, Adv Nephrol Necker Hosp, V22, P43; HABIB R, 1993, PEDIATR NEPHROL, V7, P347, DOI 10.1007/BF00857534; HABIB R, 1985, CLIN NEPHROL, V24, P269; Hasselbacher K, 2006, KIDNEY INT, V70, P1008, DOI 10.1038/sj.ki.5001679; HOLMBERG C, 2004, PEDIAT NEPHROLOGY; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; KERSHAW DB, 1995, J BIOL CHEM, V270, P29439, DOI 10.1074/jbc.270.49.29439; KESTILA M, 1994, GENOMICS, V19, P570, DOI 10.1006/geno.1994.1109; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Mucha B, 2006, PEDIATR RES, V59, P325, DOI 10.1203/01.pdr.0000196717.94518.f0; Ransom RF, 2004, CONTRIB NEPHROL, V141, P189; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; SCHNABEL E, 1989, EUR J CELL BIOL, V48, P313; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Strauch K, 2003, AM J HUM GENET, V73, P615; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Westerfield M, 1994, ZEBRAFISH BOOK; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yang YX, 1999, AM J PATHOL, V154, P181, DOI 10.1016/S0002-9440(10)65264-9; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284	41	382	425	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1397	1405		10.1038/ng1918	http://dx.doi.org/10.1038/ng1918			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17086182				2022-12-17	WOS:000242404200016
J	Cam, HP; Sugiyama, T; Chen, ES; Chen, X; FitzGerald, PC; Grewal, SIS				Cam, HP; Sugiyama, T; Chen, ES; Chen, X; FitzGerald, PC; Grewal, SIS			Comprehensive analysis of heterochromatin- and RNAi-mediated epigenetic control of the fission yeast genome	NATURE GENETICS			English	Article							HISTONE LYSINE METHYLATION; SCHIZOSACCHAROMYCES-POMBE; TRANSPOSABLE ELEMENTS; CHROMODOMAIN PROTEIN; DNA METHYLATION; H3 METHYLATION; INTERFERENCE; DISTINCT; DOMAIN; POLYMERASE	The organization of eukaryotic genomes into distinct structural and functional domains is important for the regulation and transduction of genetic information. Here, we investigated heterochromatin and euchromatin profiles of the entire fission yeast genome and explored the role of RNA interference (RNAi) in genome organization. Histone H3 methylated at Lys4, which defines euchromatin, was not only distributed across most of the chromosomal landscape but was also present at the centromere core, the site of kinetochore assembly. In contrast, histone H3 methylated at Lys9 and its interacting protein Swi6/HP1, which define heterochromatin, coated extended domains associated with a variety of repeat elements and small islands corresponding to meiotic genes. Notably, RNAi components were distributed throughout all these heterochromatin domains, and their localization depended on Clr4/Suv39h histone methyltransferase. Sequencing of small interfering RNAs (siRNAs) associated with the RITS RNAi effector complex identified hot spots of siRNAs, which mapped to a diverse array of elements in these RNAi-heterochromatin domains. We found that Clr4/Suv39h predominantly silenced repeat elements whose derived transcripts, transcribed mainly by RNA polymerase II, serve as a source for siRNAs. Our analyses also uncover an important role for the RNAi machinery in maintaining genomic integrity.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Sugiyama, Tomoyasu/0000-0001-5704-6606	NATIONAL CANCER INSTITUTE [ZIABC010523, Z01BC010523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; KANNO T, 2005, NAT GENET       0529; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mandell JG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r1; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Partridge JF, 2000, GENE DEV, V14, P783; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Thon G, 2000, GENETICS, V155, P551; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	49	382	395	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2005	37	8					809	819		10.1038/ng1602	http://dx.doi.org/10.1038/ng1602			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	15976807				2022-12-17	WOS:000230880400010
J	Baird, DM; Rowson, J; Wynford-Thomas, D; Kipling, D				Baird, DM; Rowson, J; Wynford-Thomas, D; Kipling, D			Extensive allelic variation and ultrashort telomeres in senescent human cells	NATURE GENETICS			English	Article							HUMAN FIBROBLASTS; LIFE-SPAN; STOCHASTIC MECHANISM; LENGTH; REPEAT; PROLIFERATION; MODEL	By imposing a limit on the proliferative lifespan of most somatic cells, telomere erosion represents an innate mechanism for tumor suppression(1) and may contribute to age-related disease(2). A detailed understanding of the pathways that link shortened telomeres to replicative senescence has been severely hindered by the inability of current methods to analyze telomere dynamics in detail. Here we describe single telomere length analysis (STELA), a PCR-based approach that accurately measures the full spectrum of telomere lengths from individual chromosomes. STELA analysis of human XpYp telomeres in fibroblasts identifies several features of telomere biology. We observe bimodal distributions of telomeres in normal fibroblasts; these distributions result from inter-allelic differences of up to 6.5 kb, indicating that unexpectedly large-scale differences in zygotic telomere length are maintained throughout development. Most telomeres shorten in a gradual fashion consistent with simple losses through end replication, and the rates of erosion are independent of allele size. Superimposed on this are occasional, more substantial changes in length, which may be the consequence of additional mutational mechanisms. Notably, some alleles show almost complete loss of TTAGGG repeats at senescence.	Univ Wales Coll Med, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Baird, DM (corresponding author), Univ Wales Coll Med, Dept Pathol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		Baird, Duncan M/C-9671-2011	Baird, Duncan M/0000-0001-8408-5467				ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Baird DM, 2000, AM J HUM GENET, V66, P235, DOI 10.1086/302721; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bond JA, 1999, MOL CELL BIOL, V19, P3103; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Jones CJ, 1998, EXP CELL RES, V240, P333, DOI 10.1006/excr.1998.3944; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kipling D, 2001, MATURITAS, V38, P25, DOI 10.1016/S0378-5122(00)00189-4; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Rubelj I, 1999, J THEOR BIOL, V197, P425, DOI 10.1006/jtbi.1998.0886; Sambrook J, 1989, MOL CLONING LAB MANU; SMITH JR, 1980, SCIENCE, V207, P82; Tan Z, 1999, EXP GERONTOL, V34, P831, DOI 10.1016/S0531-5565(99)00056-X; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Varley H, 2002, NAT GENET, V30, P301, DOI 10.1038/ng834; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	29	382	407	0	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					203	207		10.1038/ng1084	http://dx.doi.org/10.1038/ng1084			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539050				2022-12-17	WOS:000180773700021
J	Gasser, T; Muller-Myhsok, B; Wszolek, ZK; Oehlmann, R; Calne, DB; Bonifati, V; Bereznai, B; Fabrizio, E; Vieregge, P; Horstmann, RD				Gasser, T; Muller-Myhsok, B; Wszolek, ZK; Oehlmann, R; Calne, DB; Bonifati, V; Bereznai, B; Fabrizio, E; Vieregge, P; Horstmann, RD			A susceptibility locus for Parkinson's disease maps to chromosome 2p13	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; LINKAGE ANALYSIS; GENETIC-LINKAGE; HUMAN GENOME; LEWY BODY; INHERITANCE	Parkinson's disease (PD) is a common degenerative neurologic disorder, which is pathologically characterized by a selective degeneration of dopaminergic neurons of the substantia nigra pars compacta, and the presence of characteristic eosinophilic inclusions, known as Lewy-bodies in affected brain areas(1). The cause of PD is unknown but, in recent years, genetic factors have been implicated in the aetiology of the disease(2). Firstly, clinico-genetic, epidemiologic and twin studies revealed inheritable effects(3) and questioned earlier studies which had denied such influences(4). Secondly, several family studies suggested autosomal-dominant inheritance of syndromes which, to variable degrees, resembled sporadic PD clinically(5) and in some cases also neuropathologically(6,7). Recently, a disease locus has been mapped to chromosome 4q21-22 in a large Mediterranean pedigrees, in which disease expression is clinically and pathologically within the spectrum of sporadic PD; being atypical only for a relatively young mean age at onset of 46 years and rapid course of 10 years from onset to death(9). In affected individuals of this family and of three unrelated Greek kindreds, a putative disease-causing mutation has been identified in the gene encoding alpha-synuclein(10). With the first variant being defined, genetic heterogeneity has become apparent, as in other families parkinsonism was not linked to the 4q-locus(11) and was not associated with the alpha-synuclein mutation (unpublished data). We describe a different genetic locus that appears to be involved in the development of parkinsonism closely resembling sporadic PD including a similar mean age of onset (59 years in the families, 59.7 years in sporadic PD; ref. 12). This locus was detected in a group of families of European origin. In two of these families, there is genetic evidence for a common founder. The penetrance of the mutation appears to be low, most likely below 40%. This is compatible with a possible role of this locus not only in familial, but also in typical (sporadic) PD.	Univ Munich, Klinikum Grosshadern, Neurol Klin, D-8000 Munich, Germany; Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; Univ Nebraska, Med Ctr, Dept Internal Med, Neurol Sect, Omaha, NE USA; Univ British Columbia, Ctr Neurodegenerat Disorders, Vancouver, BC V5Z 1M9, Canada; Univ Roma La Sapienza, Dipartimento Sci Neurol, Rome, Italy; Univ Lubeck, Neurol Klin, D-2400 Lubeck, Germany	University of Munich; Bernhard Nocht Institut fur Tropenmedizin; University of Nebraska System; University of Nebraska Medical Center; University of British Columbia; Sapienza University Rome; University of Lubeck	Gasser, T (corresponding author), Univ Munich, Klinikum Grosshadern, Neurol Klin, D-8000 Munich, Germany.	tgasser@brain.nefo.med.uni-muenchen.de	Wszolek, Zbigniew K./AAB-1431-2019; Gasser, Thomas/GNH-5293-2022; Müller-Myhsok, Bertram/A-3289-2013	Gasser, Thomas/0000-0002-1069-1146; 				ALEXI T, 1993, NEUROSCIENCE, V55, P903, DOI 10.1016/0306-4522(93)90307-2; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Denson MA, 1997, ANN NEUROL, V42, P638, DOI 10.1002/ana.410420415; DENSON MA, 1995, PARKINSONISM RELAT D, V1, P1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DiRocco A, 1996, ADV NEUROL, V69, P3; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; DUVOISIN RC, 1969, PROGR NEUROGENETICS, P492; Gasser T, 1997, SCIENCE, V277, P388; GASSER T, 1994, ANN NEUROL, V36, P387, DOI 10.1002/ana.410360310; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; HOFMANN K, 1994, GENOMICS, V24, P20, DOI 10.1006/geno.1994.1577; JELLINGER K, 1990, ADV NEUROL, V53, P1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Mark MH, 1996, ADV NEUROL, V69, P315; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1986, GENET EPIDEMIOL, P251; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; VIEREGGE P, 1994, J NEURAL TRANSM-PARK, V8, P1, DOI 10.1007/BF02250916; WARD CD, 1990, ADV NEUROL, V53, P245; Wood N, 1997, J NEUROL NEUROSUR PS, V62, P305, DOI 10.1136/jnnp.62.4.305; Wszolek Z K, 1997, Parkinsonism Relat Disord, V3, P125, DOI 10.1016/S1353-8020(97)00013-8; WSZOLEK ZK, 1995, NEUROLOGY, V45, P502, DOI 10.1212/WNL.45.3.502; WSZOLEK ZK, 1993, NERVENARZT, V64, P331	29	382	394	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					262	265		10.1038/ng0398-262	http://dx.doi.org/10.1038/ng0398-262			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500549				2022-12-17	WOS:000072325000025
J	Wu, W; Cogan, JD; Pfaffle, RW; Dasen, JS; Frisch, H; O'Connell, SM; Flynn, SE; Brown, MR; Mullis, PE; Parks, JS; Phillips, JA; Rosenfeld, MG				Wu, W; Cogan, JD; Pfaffle, RW; Dasen, JS; Frisch, H; O'Connell, SM; Flynn, SE; Brown, MR; Mullis, PE; Parks, JS; Phillips, JA; Rosenfeld, MG			Mutations in PROP1 cause familial combined pituitary hormone deficiency	NATURE GENETICS			English	Article							AMES DWARF MICE; GENE; PIT-1; DF	Combined pituitary hormone deficiency (CPHD) in man denotes impaired production of growth hormone (CH) and one or more of the other five anterior pituitary hormones. Mutations of the pituitary transcription factor gene POU?FI (the human homologue of mouse Pit1) are responsible for deficiencies of GH, prolactin and thyroid stimulating hormone (TSH) in Snell and Jackson dwarf mice and in man, while the production of adrenocorticotrophic hormone (ACTH), luteinizing hormone (LH) and follicle stimulating hormone (FSH) is preserved, The Ames dwarf (df) mouse displays a similar phenotype, and appears to be epistatic to Snell and Jackson dwarfism. We have recently positionally cloned the putative Ames dwarf gene Prop? (ref. 1), which encodes a paired-like homeodomain protein that is expressed specifically in embryonic pituitary and is necessary for Pit? expression. In this report, we have identified four CPHD families with homozygosity or compound heterozygosity for inactivating mutations of PROP1. These mutations in the human PROP1 gene result in a gene product with reduced DNA-binding and transcriptional activation ability in comparison to the product of the murine df mutation. In contrast to individuals with POU1F1 mutations, those with PROP? mutations cannot produce LH and FSH at a sufficient level and do not enter puberty spontaneously. Our results identify a major cause of CPHD in humans and suggest a direct or indirect role for PROP? in the ontogenesis of pituitary gonadotropes, as well as somatotropes, lactotropes and caudomedial thyrotropes.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Rhein Westfal TH Aachen, Sch Med, Dept Pediat, D-52057 Aachen, Germany; Univ Vienna, Dept Pediat, Div Endocrinol, A-1090 Vienna, Austria; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Univ Bern, Dept Pediat, Div Endocrinol, Inselspital, CH-3010 Bern, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Diego; Vanderbilt University; RWTH Aachen University; University of Vienna; Emory University; University of Bern	Wu, W (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.		Parks, John/F-8570-2011		NIDDK NIH HHS [DK52312, DK46312] Funding Source: Medline; NIH HHS [GF 97-27] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052312, R01DK046312] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040; BARTKE A, 1965, GEN COMP ENDOCR, V5, P418, DOI 10.1016/0016-6480(65)90102-4; BARTKE A, 1979, GENETIC VARIATION HO, P111; BUCKWALTER MS, 1991, GENOMICS, V10, P515, DOI 10.1016/0888-7543(91)90430-M; COHEN LE, 1995, J CLIN ENDOCR METAB, V80, P679, DOI 10.1210/jc.80.2.679; Gage PJ, 1996, DEVELOPMENT, V122, P151; GAGE PJ, 1995, ENDOCRINOLOGY, V136, P1161, DOI 10.1210/en.136.3.1161; KAPPEN C, 1993, GENOMICS, V18, P54, DOI 10.1006/geno.1993.1426; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Raskin S, 1996, HUM GENET, V98, P703, DOI 10.1007/s004390050289; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; TANG KC, 1993, ENDOCRINOLOGY, V132, P2518, DOI 10.1210/en.132.6.2518; TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56	13	382	392	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					147	149		10.1038/ng0298-147	http://dx.doi.org/10.1038/ng0298-147			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462743				2022-12-17	WOS:000071779500022
J	Shi, YY; Zhao, H; Shi, YH; Cao, YX; Yang, DZ; Li, ZQ; Zhang, B; Liang, XY; Li, T; Chen, JH; Shen, JW; Zhao, JZ; You, L; Gao, X; Zhu, DY; Zhao, XM; Yan, Y; Qin, YY; Li, WJ; Junhao, YH; Wang, QZ; Zhao, JL; Geng, L; Ma, JL; Zhao, YR; He, G; Zhang, AP; Zou, SH; Yang, AJ; Liu, JY; Li, WD; Li, BJ; Wan, CL; Qin, Y; Shi, JZ; Yang, J; Jiang, H; Xu, JE; Qi, XJ; Sun, Y; Zhang, YJ; Hao, CF; Ju, XQ; Zhao, DN; Ren, CE; Li, XQ; Zhang, W; Zhang, YW; Zhang, JT; Wu, D; Zhang, CM; He, L; Chen, ZJ				Shi, Yongyong; Zhao, Han; Shi, Yuhua; Cao, Yunxia; Yang, Dongzi; Li, Zhiqiang; Zhang, Bo; Liang, Xiaoyan; Li, Tao; Chen, Jianhua; Shen, Jiawei; Zhao, Junzhao; You, Li; Gao, Xuan; Zhu, Dongyi; Zhao, Xiaoming; Yan, Ying; Qin, Yingying; Li, Wenjin; Yan, Junhao; Wang, Qingzhong; Zhao, Junli; Geng, Ling; Ma, Jinlong; Zhao, Yueran; He, Guang; Zhang, Aiping; Zou, Shuhua; Yang, Aijun; Liu, Jiayin; Li, Weidong; Li, Baojie; Wan, Chunling; Qin, Ying; Shi, Juanzi; Yang, Jing; Jiang, Hong; Xu, Jin-e; Qi, Xiujuan; Sun, Yun; Zhang, Yajie; Hao, Cuifang; Ju, Xiuqing; Zhao, Dongni; Ren, Chun-e; Li, Xiuqing; Zhang, Wei; Zhang, Yiwen; Zhang, Jiangtao; Wu, Di; Zhang, Changming; He, Lin; Chen, Zi-Jiang			Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome	NATURE GENETICS			English	Article							INSULIN-RECEPTOR GENE; SUSCEPTIBILITY LOCI; POLYMORPHISMS; METAANALYSIS; KNOWLEDGEBASE; SUBFAMILY; REACTOME; PANTHER; DEATH; PART	Following a previous genome-wide association study (GWAS 1) including 744 cases and 895 controls, we analyzed genome-wide association data from a new cohort of Han Chinese (GWAS 2) with 1,510 polycystic ovary syndrome (PCOS) cases and 2,016 controls. We followed up significantly associated signals identified in the combined results of GWAS 1 and 2 in a total of 8,226 cases and 7,578 controls. In addition to confirming the three loci we previously reported, we identify eight new PCOS association signals at P < 5 x 10(-8): 9q22.32, 11q22.1, 12q13.2, 12q14.3, 16q12.1, 19p13.3, 20q13.2 and a second independent signal at 2p16.3 (the FSHR gene). These PCOS association signals show evidence of enrichment for candidate genes related to insulin signaling, sexual hormone function and type 2 diabetes (T2D). Other candidate genes were related to calcium signaling and endocytosis. Our findings provide new insight and direction for discovering the biological mechanisms of PCOS.	[Shi, Yongyong; Li, Zhiqiang; Chen, Jianhua; Shen, Jiawei; Li, Wenjin; Wang, Qingzhong; He, Guang; Zhang, Aiping; Li, Weidong; Li, Baojie; Wan, Chunling; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Shi, Yongyong; Li, Zhiqiang; He, Lin] Shanghai GenomePilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [Shi, Yongyong; Li, Zhiqiang] Changning Mental Hlth Ctr, Shanghai, Peoples R China; [Shi, Yongyong] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Zhao, Han; Shi, Yuhua; You, Li; Gao, Xuan; Qin, Yingying; Yan, Junhao; Geng, Ling; Ma, Jinlong; Zhao, Yueran; Zhang, Jiangtao; Wu, Di; Zhang, Changming; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Zhao, Han; Shi, Yuhua; You, Li; Gao, Xuan; Qin, Yingying; Yan, Junhao; Geng, Ling; Ma, Jinlong; Zhao, Yueran; Chen, Zi-Jiang] Minist Educ Peoples Republ China, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Zhao, Han; Shi, Yuhua; You, Li; Gao, Xuan; Qin, Yingying; Yan, Junhao; Geng, Ling; Ma, Jinlong; Zhao, Yueran; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China; [Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Hefei, Peoples R China; [Yang, Dongzi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Bo] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Reprod Med Ctr, Nanning, Peoples R China; [Liang, Xiaoyan] Sun Yat Sen Univ, Affiliated Hosp 6, Reprod Med Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jianhua] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [Zhao, Junzhao] Wenzhou Med Coll, Affiliated Hosp 1, Reprod Med Unit, Wenzhou, Peoples R China; [Zhu, Dongyi] Linyi Peoples Hosp, Reprod Med Ctr, Linyi, Peoples R China; [Zhao, Xiaoming; Sun, Yun; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Ctr Reprod Med, Shanghai 200030, Peoples R China; [Yan, Ying] Minist Hlth Peoples Republ China, Natl Inst Hosp Adm, Beijing, Peoples R China; [Zhao, Junli] Ningxia Med Univ, Affiliated Hosp, Reprod Med Ctr, Yinchuan, Peoples R China; [Zou, Shuhua] Qingdao Women & Children Med Healthcare Ctr, Ctr Reprod Med, Qingdao, Peoples R China; [Yang, Aijun] Jining Med Coll, Affiliated Hosp, Reprod Med Ctr, Jining, Peoples R China; [Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Peoples R China; [Qin, Ying] GlaxoSmithKline R&D China, Oncol Translat Med, Shanghai, Peoples R China; [Shi, Juanzi] Maternal & Child Hlth Care Hosp Shaanxi Prov, Assisted Reprod Ctr, Xian, Peoples R China; [Yang, Jing] Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China; [Jiang, Hong] Peoples Liberat Army, Hosp 105, Dept Obstet & Gynecol, Hefei, Peoples R China; [Xu, Jin-e; Qi, Xiujuan] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Obstet & Gynecol, Qingdao 266071, Peoples R China; [Zhang, Yajie] Jinan Hlth Inst Matern & Infant, Dept Obstet & Gynecol, Jinan, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Reprod Med Ctr, Yantai, Peoples R China; [Ju, Xiuqing] Tengzhou Peoples Hosp, Dept Obstet & Gynecol, Tengzhou, Peoples R China; [Zhao, Dongni] China Med Univ, Shengjing Hosp, Reprod Med Ctr, Shenyang, Peoples R China; [Ren, Chun-e] Weifang Med Coll, Affiliated Hosp, Dept Obstet & Gynecol, Weifang, Peoples R China; [Li, Xiuqing] Anqiu Peoples Hosp, Dept Obstet & Gynecol, Anqiu, Peoples R China; [Zhang, Wei] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200433, Peoples R China; [Zhang, Yiwen] Weihai Women & Children Hosp, Reprod Med Unit, Weihai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Ministry of Education, China; Anhui Medical University; Sun Yat Sen University; Sun Yat Sen University; Wenzhou Medical University; Shanghai Jiao Tong University; Ningxia Medical University; Jining Medical University; Nanjing Medical University; GlaxoSmithKline; Wuhan University; Qingdao University; China Medical University; Weifang Medical University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China.	helinhelin@gmail.com; chenzijiang@hotmail.com	Shi, Yongyong/GSO-1627-2022; Chen, Jianhua/AAS-8417-2020; Yan, Junhao/AAH-8310-2019; Li, Zhiqiang/AAI-4003-2021; He, Guang/ABF-7381-2021; Chen, Zi-Jiang/GOE-6119-2022; liang, xiaoyan/GYJ-5006-2022	Shi, Yongyong/0000-0003-1710-1505; Li, Zhiqiang/0000-0002-0174-9254; He, Guang/0000-0002-4911-088X; Chen, Zi-Jiang/0000-0001-6637-6631; Li, Weidong/0000-0001-5384-4838	National Basic Research Program of China (973 Program) [2012CB944700, 2010CB529600, 2011CB944502, 2010CB945002]; 863 Program [2012AA02A515]; National Natural Science Foundation of China [81130022, 30973170, 81121001, 31000553, 81000238, 81070461, 81000236]; National Key Technology Research and Development Program [2011BAI17B00]; Science Research Foundation Item of No-earnings Health Vocation [201002013]; Program for Changjiang Scholars and the Innovative Research Team in University [IRT1025]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201026]; Program for New Century Excellent Talents in University [NCET-09-0550]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program(National Key Technology R&D Program); Science Research Foundation Item of No-earnings Health Vocation; Program for Changjiang Scholars and the Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	We thank all participants involved in this study. This study was supported by grants from the National Basic Research Program of China (973 Program: 2012CB944700, 2010CB529600, 2011CB944502 and 2010CB945002), the 863 Program (2012AA02A515), the National Natural Science Foundation of China (81130022, 30973170, 81121001, 31000553, 81000238, 81070461 and 81000236), the National Key Technology Research and Development Program (2011BAI17B00), the Science Research Foundation Item of No-earnings Health Vocation (201002013), the Program for Changjiang Scholars and the Innovative Research Team in University (IRT1025), the Foundation for the Author of National Excellent Doctoral Dissertation of China (201026) and the Program for New Century Excellent Talents in University (NCET-09-0550).	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; ASHAR HR, 1995, CELL, V82, P57; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Chen Zi-jiang, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P582; Cooper JD, 2009, GENES IMMUN, V10, pS95, DOI 10.1038/gene.2009.98; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Kazmierczak B, 1998, AM J PATHOL, V152, P431; Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036; Li T, 2012, J MED GENET, V49, P254, DOI 10.1136/jmedgenet-2011-100727; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; MOLLER DE, 1988, NEW ENGL J MED, V319, P1526, DOI 10.1056/NEJM198812083192306; MOLLER DE, 1990, J BIOL CHEM, V265, P14979; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Siegel S, 2002, FERTIL STERIL, V78, P1240, DOI 10.1016/S0015-0282(02)04241-3; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011789; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wild Sarah, 2000, Hum Fertil (Camb), V3, P101, DOI 10.1080/1464727002000198781; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	50	381	406	5	113	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1020	+		10.1038/ng.2384	http://dx.doi.org/10.1038/ng.2384			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22885925				2022-12-17	WOS:000308491200013
J	Kooner, JS; Saleheen, D; Sim, X; Sehmi, J; Zhang, WH; Frossard, P; Been, LF; Chia, KS; Dimas, AS; Hassanali, N; Jafar, T; Jowett, JBM; Li, XZ; Radha, V; Rees, SD; Takeuchi, F; Young, R; Aung, T; Basit, A; Chidambaram, M; Das, D; Grundberg, E; Hedman, AK; Hydrie, ZI; Islam, M; Khor, CC; Kowlessur, S; Kristensen, MM; Liju, S; Lim, WY; Matthews, DR; Liu, JJ; Morris, AP; Nica, AC; Pinidiyapathirage, JM; Prokopenko, I; Rasheed, A; Samuel, M; Shah, N; Shera, AS; Small, KS; Suo, C; Wickremasinghe, AR; Wong, TY; Yang, MY; Zhang, F; Abecasis, GR; Barnett, AH; Caulfield, M; Deloukas, P; Frayling, TM; Froguel, P; Kato, N; Katulanda, P; Kelly, MA; Liang, JB; Mohan, V; Sanghera, DK; Scott, J; Seielstad, M; Zimmet, PZ; Elliott, P; Teo, YY; McCarthy, MI; Danesh, J; Tai, ES; Chambers, JC				Kooner, Jaspal S.; Saleheen, Danish; Sim, Xueling; Sehmi, Joban; Zhang, Weihua; Frossard, Philippe; Been, Latonya F.; Chia, Kee-Seng; Dimas, Antigone S.; Hassanali, Neelam; Jafar, Tazeen; Jowett, Jeremy B. M.; Li, Xinzhong; Radha, Venkatesan; Rees, Simon D.; Takeuchi, Fumihiko; Young, Robin; Aung, Tin; Basit, Abdul; Chidambaram, Manickam; Das, Debashish; Grundberg, Elin; Hedman, Asa K.; Hydrie, Zafar I.; Islam, Muhammed; Khor, Chiea-Chuen; Kowlessur, Sudhir; Kristensen, Malene M.; Liju, Samuel; Lim, Wei-Yen; Matthews, David R.; Liu, Jianjun; Morris, Andrew P.; Nica, Alexandra C.; Pinidiyapathirage, Janani M.; Prokopenko, Inga; Rasheed, Asif; Samuel, Maria; Shah, Nabi; Shera, A. Samad; Small, Kerrin S.; Suo, Chen; Wickremasinghe, Ananda R.; Wong, Tien Yin; Yang, Mingyu; Zhang, Fan; Abecasis, Goncalo R.; Barnett, Anthony H.; Caulfield, Mark; Deloukas, Panos; Frayling, Timothy M.; Froguel, Philippe; Kato, Norihiro; Katulanda, Prasad; Kelly, M. Ann; Liang, Junbin; Mohan, Viswanathan; Sanghera, Dharambir K.; Scott, James; Seielstad, Mark; Zimmet, Paul Z.; Elliott, Paul; Teo, Yik Ying; McCarthy, Mark I.; Danesh, John; Tai, E. Shyong; Chambers, John C.		DIAGRAM; MuTHER	Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci	NATURE GENETICS			English	Article							GENETIC-VARIATION; INSULIN-RESISTANCE; EXPRESSION; METHODOLOGY; PROTEINS; PATTERNS; STORAGE; OBESITY; GRB10; RISK	We carried out a genome-wide association study of type-2 diabetes (T2D) in individuals of South Asian ancestry. Our discovery set included 5,561 individuals with T2D (cases) and 14,458 controls drawn from studies in London, Pakistan and Singapore. We identified 20 independent SNPs associated with T2D at P < 10(-4) for testing in a replication sample of 13,170 cases and 25,398 controls, also all of South Asian ancestry. In the combined analysis, we identified common genetic variants at six loci (GRB14, ST6GAL1, VPS26A, HMG20A, AP3S2 and HNF4A) newly associated with T2D (P = 4.1 x 10(-8) to P = 1.9 x 10(-11)). SNPs at GRB14 were also associated with insulin sensitivity (P = 5.0 x 10(-4)), and SNPs at ST6GAL1 and HNF4A were also associated with pancreatic beta-cell function (P = 0.02 and P = 0.001, respectively). Our findings provide additional insight into mechanisms underlying T2D and show the potential for new discovery from genetic association studies in South Asians, a population with increased susceptibility to T2D.	[Kooner, Jaspal S.; Sehmi, Joban; Das, Debashish; Chambers, John C.] Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England; [Kooner, Jaspal S.; Sehmi, Joban; Li, Xinzhong; Scott, James] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London, England; [Saleheen, Danish; Frossard, Philippe; Rasheed, Asif; Samuel, Maria; Shah, Nabi] Ctr Noncommunicable Dis Pakistan, Karachi, Pakistan; [Saleheen, Danish; Young, Robin; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Sim, Xueling; Chia, Kee-Seng; Khor, Chiea-Chuen; Lim, Wei-Yen; Suo, Chen; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Genet,Coll Med, Oklahoma City, OK 73190 USA; [Chia, Kee-Seng; Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Dimas, Antigone S.; Nica, Alexandra C.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dimas, Antigone S.; Hedman, Asa K.; Morris, Andrew P.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hassanali, Neelam; Matthews, David R.; Katulanda, Prasad; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford, England; [Jafar, Tazeen; Islam, Muhammed] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Jafar, Tazeen] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Jowett, Jeremy B. M.; Kristensen, Malene M.; Zimmet, Paul Z.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Radha, Venkatesan; Chidambaram, Manickam; Liju, Samuel; Mohan, Viswanathan] Madras Diabet Res Fdn, ICMR, Dept Mol Genet, Adv Ctr Genom Diabet, Madras, Tamil Nadu, India; [Rees, Simon D.; Barnett, Anthony H.; Kelly, M. Ann] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Rees, Simon D.; Barnett, Anthony H.; Kelly, M. Ann] Heart England NHS Fdn Trust, BioMed Res Ctr, Birmingham, W Midlands, England; [Takeuchi, Fumihiko; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Aung, Tin; Khor, Chiea-Chuen; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Basit, Abdul; Hydrie, Zafar I.] Baqai Inst Diabetol & Endocrinol, Karachi, Pakistan; [Grundberg, Elin; Small, Kerrin S.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Khor, Chiea-Chuen; Liu, Jianjun; Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Kowlessur, Sudhir] Minist Hlth, Port Louis, Mauritius; [Pinidiyapathirage, Janani M.; Wickremasinghe, Ananda R.] Univ Kelaniya, Fac Med, Dept Publ Hlth, Ragama, Sri Lanka; [Shera, A. Samad] Diabet Assoc Pakistan, Karachi, Pakistan; [Small, Kerrin S.; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Yang, Mingyu; Zhang, Fan; Liang, Junbin] Beijing Genom Inst, Shenzhen, Peoples R China; [Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Barts & London Genome Ctr, London, England; [Frayling, Timothy M.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, London, England; [Katulanda, Prasad] Univ Colombo, Diabet Res Unit, Dept Clin Med, Colombo, Sri Lanka; [Mohan, Viswanathan] Dr Mohans Diabet Specialties Ctr, Madras, Tamil Nadu, India; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, HPA, MRC, Ctr Environm & Hlth, London, England; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res NIHR, Biomed Res Ctr, Oxford OX3 7LJ, England; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	Imperial College London; Imperial College London; University of Cambridge; National University of Singapore; University of Oklahoma System; University of Oklahoma Health Sciences Center; National University of Singapore; University of Geneva; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Aga Khan University; Aga Khan University; Baker Heart and Diabetes Institute; Indian Council of Medical Research (ICMR); Madras Diabetes Research Foundation; University of Birmingham; Heart of England NHS Foundation Trust; National Center for Global Health & Medicine - Japan; National University of Singapore; National University of Singapore; Singapore National Eye Center; Baqai Medical University; University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University Kelaniya; Wellcome Trust Sanger Institute; Centre for Eye Research Australia; University of Melbourne; Beijing Genomics Institute (BGI); University of Michigan System; University of Michigan; University of London; Queen Mary University London; University of Exeter; Imperial College London; University of Colombo; University of California System; University of California San Francisco; Health Protection Agency; Imperial College London; National University of Singapore; National University of Singapore; University of Oxford; National University of Singapore; National University of Singapore	Chambers, JC (corresponding author), Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England.	j.kooner@imperial.ac.uk; john.chambers@ic.ac.uk	Zimmet, Paul/H-7635-2013; Prokopenko, Inga/AAU-9895-2020; Sim, Xueling/AAZ-6652-2020; Prokopenko, Inga/H-3241-2014; Liu, Jianjun/AAK-4989-2020; Pinidiyapathirage, Janani/AAR-8074-2021; Seielstad, Mark/T-7841-2019; Hydrie, Muhammad Zafar Iqbal/H-8490-2017; Tai, E Shyong/J-9831-2013; Shah, Nabi/Q-1008-2016; Wong, Tien Yin/AAC-9724-2020; zhang, weihua/GXV-1334-2022; Deloukas, Panos/B-2922-2013; Zimmet, Paul/O-8486-2019; Shah, Nabi/AAG-7378-2021; Abecasis, Goncalo R/B-7840-2010; FROGUEL, Philippe/O-6799-2017; McCarthy, Mark/M-3763-2015	Sim, Xueling/0000-0002-1233-7642; Prokopenko, Inga/0000-0003-1624-7457; Liu, Jianjun/0000-0002-3255-3019; Pinidiyapathirage, Janani/0000-0003-2947-3015; Hydrie, Muhammad Zafar Iqbal/0000-0002-1317-6975; Shah, Nabi/0000-0003-2764-3615; Wong, Tien Yin/0000-0002-8448-1264; Deloukas, Panos/0000-0001-9251-070X; Zimmet, Paul/0000-0003-0627-0776; Shah, Nabi/0000-0003-2764-3615; FROGUEL, Philippe/0000-0003-2972-0784; Sanghera, Dharambir/0000-0001-7203-8655; Hedman, Asa/0000-0001-5413-204X; Elliott, Paul/0000-0002-7511-5684; Small, Kerrin/0000-0003-4566-0005; Katulanda, Prasad/0000-0003-4313-7528; Abecasis, Goncalo/0000-0003-1509-1825; Tai, E Shyong/0000-0003-2929-8966; McCarthy, Mark/0000-0002-4393-0510; Manickam, Chidambaram/0000-0001-8750-8576; Caulfield, Mark/0000-0001-9295-3594; Seielstad, Mark/0000-0001-5783-1401; Khor, Chiea Chuen/0000-0002-1128-4729	Wellcome Trust [070854/Z/03/Z, 080747/Z/06/Z, 083270/Z/07/Z, 084723/Z/08/Z]; Chennai Wellingdon Corporate Foundation; Diabetes UK [07/0003512]; National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; British Heart Foundation [SP/04/002]; Medical Research Council [G0700931]; National Institute for Health Research [RP-PG-0407-10371]; US National Institutes of Health [DK-25446, KO1TW006087]; KAKENHI; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Center for Global Health and Medicine; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082766]; A*STAR Biomedical Research Council [05/1/21/19/425]; Biomedical Research Council Singapore [09/1/35/19/616, 08/1/35/19/550]; National Medical Research Council Singapore [NMRC/STaR/0003/2008, 1174/2008]; National Science Foundation of Sri Lanka; Oxford NIHR Biomedical Research Centre; MRC [G0801056, G0700931, G0601966] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0601966, G0801056, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10272] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [K01TW006087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025446, R01DK082766] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Chennai Wellingdon Corporate Foundation; Diabetes UK(Diabetes UK); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science Foundation of Sri Lanka; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the many colleagues who contributed to collection and phenotypic characterization of the clinical samples as well as genotyping and analysis of the GWAS data. We would also like to acknowledge those individuals who agreed to participate in these studies. Major funding for the work described in this paper comes from Wellcome Trust awards (070854/Z/03/Z, 080747/Z/06/Z, 083270/Z/07/Z, 084723/Z/08/Z); Chennai Wellingdon Corporate Foundation; Diabetes UK (07/0003512); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; British Heart Foundation (SP/04/002); Medical Research Council (G0700931); National Institute for Health Research (RP-PG-0407-10371); US National Institutes of Health (DK-25446); KAKENHI (Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Center for Global Health and Medicine; US National Institutes of Health (KO1TW006087); National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082766); A*STAR Biomedical Research Council (05/1/21/19/425); Biomedical Research Council Singapore (09/1/35/19/616, 08/1/35/19/550); National Medical Research Council Singapore (NMRC/STaR/0003/2008, 1174/2008); National Science Foundation of Sri Lanka; and Oxford NIHR Biomedical Research Centre. A full list of acknowledgments is provided in the Supplementary Note.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Artegiani B, 2010, J BIOL CHEM, V285, P24740, DOI 10.1074/jbc.M109.090654; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bellary S, 2008, LANCET, V371, P1769, DOI 10.1016/S0140-6736(08)60764-3; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Chambers JC, 2000, LANCET, V355, P523, DOI 10.1016/S0140-6736(99)93019-2; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chidambaram M, 2010, METABOLISM, V59, P1760, DOI 10.1016/j.metabol.2010.04.024; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Harries LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007855; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Holt LJ, 2009, MOL ENDOCRINOL, V23, P1406, DOI 10.1210/me.2008-0386; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jowett JB, 2009, TWIN RES HUM GENET, V12, P44, DOI 10.1375/twin.12.1.44; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Kim E, 2008, BIOCHEM BIOPH RES CO, V375, P16, DOI 10.1016/j.bbrc.2008.07.067; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2004, CLIN GENET, V66, P299, DOI 10.1111/j.1399-0004.2004.00309.x; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Rees SD, 2011, DIABETIC MED, V28, P673, DOI 10.1111/j.1464-5491.2011.03257.x; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Saleheen D, 2009, EUR J EPIDEMIOL, V24, P329, DOI 10.1007/s10654-009-9334-y; Sanghera DK, 2006, HUM BIOL, V78, P43, DOI 10.1353/hub.2006.0027; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Siitonen N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-5; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soderberg S, 2004, J INTERN MED, V256, P37, DOI 10.1111/j.1365-2796.2004.01336.x; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	57	381	388	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					984	U94		10.1038/ng.921	http://dx.doi.org/10.1038/ng.921			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21874001	Green Accepted			2022-12-17	WOS:000295316200013
J	Mencia, A; Modamio-Hoybjor, S; Redshaw, N; Morin, M; Mayo-Merino, F; Olavarrieta, L; Aguirre, LA; del Castillo, I; Steel, KP; Dalmay, T; Moreno, F; Moreno-Pelayo, MA				Mencia, Angeles; Modamio-Hoybjor, Silvia; Redshaw, Nick; Morin, Matias; Mayo-Merino, Fernando; Olavarrieta, Leticia; Aguirre, Luis A.; del Castillo, Ignacio; Steel, Karen P.; Dalmay, Tamas; Moreno, Felipe; Angel Moreno-Pelayo, Miguel			Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss	NATURE GENETICS			English	Article							GENE; EXPRESSION; MICRORNAS; TARGET; MIRNA; SITE; RNA	MicroRNAs (miRNAs) bind to complementary sites in their target mRNAs to mediate post-transcriptional repression(1,2), with the specificity of target recognition being crucially dependent on the miRNA seed region(3). Impaired miRNA target binding resulting from SNPs within mRNA target sites has been shown to lead to pathologies associated with dysregulated gene expression(4-7). However, no pathogenic mutations within the mature sequence of a miRNA have been reported so far. Here we show that point mutations in the seed region of miR-96, a miRNA expressed in hair cells of the inner ear(8), result in autosomal dominant, progressive hearing loss. This is the first study implicating a miRNA in a mendelian disorder. The identified mutations have a strong impact on miR-96 biogenesis and result in a significant reduction of mRNA targeting. We propose that these mutations alter the regulatory role of miR-96 in maintaining gene expression profiles in hair cells required for their normal function.	[Mencia, Angeles; Modamio-Hoybjor, Silvia; Morin, Matias; Mayo-Merino, Fernando; Olavarrieta, Leticia; Aguirre, Luis A.; del Castillo, Ignacio; Moreno, Felipe; Angel Moreno-Pelayo, Miguel] Hosp Ramon & Cajal, Unidad Genet Mol, E-28034 Madrid, Spain; [Mencia, Angeles; Modamio-Hoybjor, Silvia; Morin, Matias; Mayo-Merino, Fernando; Olavarrieta, Leticia; Aguirre, Luis A.; del Castillo, Ignacio; Moreno, Felipe; Angel Moreno-Pelayo, Miguel] ISCIII, CIBERER, Madrid, Spain; [Redshaw, Nick; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge, England	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of East Anglia; Wellcome Trust Sanger Institute	Moreno-Pelayo, MA (corresponding author), Hosp Ramon & Cajal, Unidad Genet Mol, E-28034 Madrid, Spain.	mmoreno.hrc@salud.madrid.org	Aguirre, Luis/ABD-8789-2021; Mencia, Angeles/H-8688-2017; Mencia, Angeles/AAE-4134-2021; Dalmay, Tamas/E-1377-2011; del Castillo, Ignacio/B-4314-2013; Olavarrieta, Leticia/GYQ-5751-2022; MORIN, MATIAS/H-5411-2011; Pérez, Luis Augusto Aguirre/J-2175-2015	Dalmay, Tamas/0000-0003-1492-5429; del Castillo, Ignacio/0000-0003-1188-3665; MORIN, MATIAS/0000-0002-7985-592X; Pérez, Luis Augusto Aguirre/0000-0003-0903-9385; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098; Mayo-Merino, Fernando/0000-0001-5714-4003	L'Oreal-UNESCO "for women in Science''; Spanish Ministerio de Ciencia y Tecnologia; Spanish Ministerio de Ciencia y Tecnologia [SAF2005-06355]; Spanish Fondo de Investigaciones anitarias [FIS CP03/00014, PI08/0045, PI-051942, G03/203]; European Commission [LSHG-CT-2006-037900, LSHG-CT-2004-512063]; Deafness Research UK; Wellcome Trust; MRC [G0300212, MC_qA137918] Funding Source: UKRI; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish; RNID [G41] Funding Source: researchfish	L'Oreal-UNESCO "for women in Science''(L'Oreal Group); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Fondo de Investigaciones anitarias(Instituto de Salud Carlos III); European Commission(European CommissionEuropean Commission Joint Research Centre); Deafness Research UK; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID	We thank members of the Spanish families whose participation made this study possible. We also express our gratitude to A. Fatica and I. Bozzoni (Universita di Roma "La Sapienza'') for the donation of the microRNA expression vector and to P. Morales (Hospital 12 de Octubre) for providing control DNAs. S. M.-H. is recipient of a fellowship from L'Oreal-UNESCO "for women in Science''. A. M. is recipient of a contract from the Centre for Biomedical Research on Rare Diseases (CIBERER) and M. M. is recipient of a contract from the EuroHear project. F. M.-M. is a fellow from the Spanish Ministerio de Ciencia y Tecnologia. This work was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (SAF2005-06355 to F. M.), Spanish Fondo de Investigaciones anitarias (FIS CP03/00014 and PI08/0045 to M. A. M.-P; PI-051942; G03/203), the European Commission (FP6 Integrated Projects: SIROCCO LSHG-CT-2006-037900 to T. D.; EUROHEAR, LSHG-CT-2004-512063), Deafness Research UK and the Wellcome Trust.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Denti MA, 2004, MOL THER, V10, P191, DOI 10.1016/j.ymthe.2004.04.008; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Enright AJ, 2004, GENOME BIOL, V5; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; JENSEN KP, MOL PSYCHIATR, DOI DOI 10.1038/MP.2008.15; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Modamio-Hoybjor S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012500; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	381	432	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					609	613		10.1038/ng.355	http://dx.doi.org/10.1038/ng.355			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19363479				2022-12-17	WOS:000265575600024
J	Teichmann, SA; Babu, MM				Teichmann, SA; Babu, MM			Gene regulatory network growth by duplication	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; COMPLEX NETWORKS; EVOLUTION; PROTEINS; MODEL; ORGANIZATION; ASSIGNMENTS; SEQUENCES; HOMOLOGY	We are beginning to elucidate transcriptional regulatory networks on a large scale(1) and to understand some of the structural principles of these networks(2,3), but the evolutionary mechanisms that form these networks are still mostly unknown. Here we investigate the role of gene duplication in network evolution. Gene duplication is the driving force for creating new genes in genomes: at least 50% of prokaryotic genes(4,5) and over 90% of eukaryotic genes(6) are products of gene duplication. The transcriptional interactions in regulatory networks consist of multiple components, and duplication processes that generate new interactions would need to be more complex. We define possible duplication scenarios and show that they formed the regulatory networks of the prokaryote Escherichia coli and the eukaryote Saccharomyces cerevisiae. Gene duplication has had a key role in network evolution: more than one-third of known regulatory interactions were inherited from the ancestral transcription factor or target gene after duplication, and roughly one-half of the interactions were gained during divergence after duplication. In addition, we conclude that evolution has been incremental, rather than making entire regulatory circuits or motifs by duplication with inheritance of interactions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Teichmann, SA (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sat@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019	Teichmann, Sarah/0000-0002-6294-6366				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; BRENNER SE, 1995, NATURE, V378, P140, DOI 10.1038/378140a0; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Papp B, 2003, TRENDS GENET, V19, P417, DOI 10.1016/S0168-9525(03)00174-4; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sole R., 2002, ADV COMPLEX SYST, V5, P43, DOI [10.1142/S021952590200047X, DOI 10.1142/S021952590200047X]; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; VAZQUEZ A, 2003, COMPLEXUS, V21, P38; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	30	381	395	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					492	496		10.1038/ng1340	http://dx.doi.org/10.1038/ng1340			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107850	Bronze			2022-12-17	WOS:000221183000022
J	Carpten, J; Nupponen, N; Isaacs, S; Sood, R; Robbins, C; Xu, J; Faruque, M; Moses, T; Ewing, C; Gillanders, E; Hu, P; Buinovszky, P; Makalowska, I; Baffoe-Bonnie, A; Faith, D; Smith, J; Stephan, D; Wiley, K; Brownstein, M; Gildea, D; Kelly, B; Jenkins, R; Hostetter, G; Matikainen, M; Schleutker, J; Klinger, K; Connors, T; Xiang, Y; Wang, Z; De Marzo, A; Papadopoulos, N; Kallioniemi, OP; Burk, R; Meyers, D; Gronberg, H; Meltzer, P; Silverman, R; Bailey-Wilson, J; Walsh, P; Isaacs, W; Trent, J				Carpten, J; Nupponen, N; Isaacs, S; Sood, R; Robbins, C; Xu, J; Faruque, M; Moses, T; Ewing, C; Gillanders, E; Hu, P; Buinovszky, P; Makalowska, I; Baffoe-Bonnie, A; Faith, D; Smith, J; Stephan, D; Wiley, K; Brownstein, M; Gildea, D; Kelly, B; Jenkins, R; Hostetter, G; Matikainen, M; Schleutker, J; Klinger, K; Connors, T; Xiang, Y; Wang, Z; De Marzo, A; Papadopoulos, N; Kallioniemi, OP; Burk, R; Meyers, D; Gronberg, H; Meltzer, P; Silverman, R; Bailey-Wilson, J; Walsh, P; Isaacs, W; Trent, J			Germline mutations in the ribonuclease L gene in families showing linkage with HPC1	NATURE GENETICS			English	Article							PROSTATE-CANCER INCIDENCE; 2-5A-DEPENDENT RNASE; INTERFERON ACTION; PROTEIN-SYNTHESIS; EXPRESSION; MORTALITY; CLEAVAGE; TRENDS; CELLS	Although prostate cancer is the most common non-cutaneous malignancy diagnosed in men in the United States(1,2), little is known about inherited factors that influence its genetic predisposition(3-5). Here we report that germline mutations in the gene encoding 2'-5'-oligoadenylate(2-5A)-dependent RNase L (RNASEL)(6-8) segregate in prostate cancer families that show linkage to the HPC1 (hereditary prostate cancer 1) region at 1q24-25 (ref. 9). We identified RNASEL by a positional cloning/candidate gene method, and show that a nonsense mutation and a mutation in an initiation codon of RNASEL segregate independently in two HPC1-linked families. inactive RNASEL alleles are present at a low frequency in the general population. RNASEL regulates cell proliferation and apoptosis through the interferon-regulated 2-5A pathway and has been suggested to be a candidate tumor suppressor gene(10-12). We found that microdissected tumors with a germline mutation showed loss of heterozygosity and loss of RNase L protein, and that RNASEL activity was reduced in lymphoblasts from heterozyogous individuals compared with family members who were homozygous with respect to the wildtype allele. Thus, germline mutations in RNASEL may be of diagnostic value, and the 2-5A pathway might provide opportunities for developing therapies for those with prostate cancer.	NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA; Vanderbilt Univ, Div Med Genet, Nashville, TN USA; Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; NIMH, Genet Lab, NIH, Bethesda, MD 20892 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Univ Tampere, Canc Genet Lab, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Canc Genet Lab, Inst Med Technol, Tampere, Finland; Genzyme Mol Oncol, Framingham, MA USA; Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Columbia Univ, Dept Pathol, Inst Canc Genet, New York, NY USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Albert Einstein Sch Med, Bronx, NY 10461 USA; Umea Univ, Dept Oncol, Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fox Chase Cancer Center; Vanderbilt University; Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Mayo Clinic; Tampere University; Tampere University; Tampere University Hospital; Sanofi-Aventis; Cleveland Clinic Foundation; Columbia University; Yeshiva University; Albert Einstein College of Medicine; Umea University	Trent, J (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.		Brownstein, Michael/B-8609-2009; Makalowska, Izabela/AAF-4967-2021; Makalowska, Izabela/AAU-2682-2021; Smith, Jeff/C-3484-2012; Kallioniemi, Olli P/H-5111-2011; Papadopoulos, Nickolas/K-7272-2012	Makalowska, Izabela/0000-0002-8144-5671; Kallioniemi, Olli P/0000-0002-3231-0332; Schleutker, Johanna/0000-0002-1863-0305; Smith, Jeffrey/0000-0001-8424-910X; Bailey-Wilson, Joan/0000-0002-9153-2920	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002771] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Carpten JD, 2000, GENOMICS, V64, P1, DOI 10.1006/geno.1999.6051; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Dennis LK, 2000, PROSTATE, V42, P247; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Hartge P, 1999, AM J HUM GENET, V64, P963, DOI 10.1086/302320; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; ISAACS JT, 1994, SEMIN CANCER BIOL, V5, P391; KAIGHN ME, 1979, INVEST UROL, V17, P16; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; LENGYEL P, 1993, P NATL ACAD SCI USA, V90, P5893, DOI 10.1073/pnas.90.13.5893; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; SHERMAN F, 1980, BIOCHIM BIOPHYS ACTA, V609, P343, DOI 10.1016/0005-2787(80)90246-4; SILVERMAN RH, 1983, J VIROL, V46, P1051, DOI 10.1128/JVI.46.3.1051-1055.1983; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Sood R, 2001, GENOMICS, V73, P211, DOI 10.1006/geno.2001.6500; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Tnani M, 1998, BBA-MOL CELL RES, V1402, P139, DOI 10.1016/S0167-4889(97)00158-4; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	23	381	398	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					181	184		10.1038/ng823	http://dx.doi.org/10.1038/ng823			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799394	Green Published			2022-12-17	WOS:000173708700018
J	Khanna, KK; Keating, KE; Kozlov, S; Scott, S; Gatei, M; Hobson, K; Taya, Y; Gabrielli, B; Chan, D; Lees-Miller, SP; Lavin, MF				Khanna, KK; Keating, KE; Kozlov, S; Scott, S; Gatei, M; Hobson, K; Taya, Y; Gabrielli, B; Chan, D; Lees-Miller, SP; Lavin, MF			ATM associates with and phosphorylates p53: mapping the region of interaction	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; PROTEIN; KINASE; PRODUCT; DOMAIN; GENE	The human genetic disorder ataxia-telangiectasia (AT) is characterized by immunodeficiency. progressive cerebellar ataxia. radiosensitivity, cell cycle checkpoint defects and cancer predisposition(1). The gene mutated in this syndrome, ATM (for AT mutated), encodes a protein containing a phosphatidyl-inositol 3-kinase (PI-3 kinase)-like domain(2,3). ATM also contains a proline-rich region(4) and a leucine zipper(2,5), both of which implicate this protein in signal transduction. The proline-rich region has been shown to bind to the SH3 domain of c-Abl, which facilitates its phosphorylation and activation by ATM (refs 4,6). Previous results have demonstrated that AT cells are defective in the G1/S checkpoint activated after radiation damage and that this defect is attributable to a defective p53 signal transduction pathway(7,8). We report here direct interaction between ATM and p53 involving two regions in ATM. one at the amino terminus and the other at the carboxy terminus, corresponding to the PI-3 kinase domain. Recombinant ATM protein phosphorylates p53 on serine 15 near the N terminus. Furthermore, ectopic expression of ATM in AT cells restores normal ionizing radiation (IR)-induced phosphorylation of p53, whereas expression of ATM antisense RNA in control cells abrogates the rapid IR-induced phosphorylation of p53 on serine 15. These results demonstrate that ATM can bind p53 directly and is responsible for its serine 15 phosphorylation. thereby contributing to the activation and stabilization of p53 during the IR-induced DNA damage response.	PO Royal Brisbane Hosp, Queensland Inst Med Res, Dept Pathol, Brisbane, Qld 4029, Australia; Natl Canc Ctr, Res Inst, Chuo Ku, Tokyo 104, Japan; Univ Calgary, Calgary, AB T2N 1N4, Canada; PO Royal Brisbane Hosp, Queensland Inst Med Res, Dept Surg, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; National Cancer Center - Japan; University of Calgary; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Khanna, KK (corresponding author), PO Royal Brisbane Hosp, Queensland Inst Med Res, Dept Pathol, Brisbane, Qld 4029, Australia.	kumkumK@qimr.edu.au	Kozlov, Sergei/T-9779-2019; Hobson, Keith/Q-9306-2019; Chan, Doris/O-1227-2014; Gabrielli, Brian G/B-3655-2011; Khanna, Kum Kum/I-1747-2013; Kozlov, Sergei/M-2067-2014; Lavin, Martin F/F-5961-2014	Chan, Doris/0000-0002-4990-986X; Gabrielli, Brian G/0000-0003-3933-1651; Kozlov, Sergei/0000-0001-6183-7339; Lavin, Martin F/0000-0002-5940-4769; Khanna, Kum Kum/0000-0001-8650-5381				Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1993, ONCOGENE, V8, P3307; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; RUPPERT JM, 1993, MOL CELL BIOL, V13, P3811, DOI 10.1128/MCB.13.6.3811; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scott SP, 1998, BIOCHEM BIOPH RES CO, V245, P144, DOI 10.1006/bbrc.1998.8137; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Zhang N, 1998, ONCOGENE, V17, P811, DOI 10.1038/sj.onc.1202007; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021	20	381	400	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					398	400		10.1038/3882	http://dx.doi.org/10.1038/3882			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843217				2022-12-17	WOS:000077199600032
J	Chen, ZF; Paquette, AJ; Anderson, DJ				Chen, ZF; Paquette, AJ; Anderson, DJ			NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis	NATURE GENETICS			English	Article							RESTRICTIVE SILENCER ELEMENT; CELL-ADHESION MOLECULE; SODIUM-CHANNEL GENE; CHICK-EMBRYO; SYNAPSIN-I; EXPRESSION; IDENTIFICATION; TRANSCRIPTION; PROTEIN; VECTORS	The neuron-restrictive silencer factor NRSF (also known as REST and XBR) can silence transcription from neuronal promoters in non-neuronal cell lines, but its function during normal development is unknown. In mice, a targeted mutation of Rest, the gene encoding NRSF, caused derepression of neuron-specific tubulin in a subset of non-neural tissues and embryonic lethality. Mosaic inhibition of NRSF in chicken embryos, using a dominant-negative form of NRSF, also caused derepression of neuronal tubulin, as well as of several other neuronal target genes, in both non-neural tissues and central nervous system neuronal progenitors. These results indicate that NRSF is required to repress neuronal gene expression in vivo, in both extra-neural and undifferentiated neural tissue.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.							Arnone MI, 1997, DEVELOPMENT, V124, P1851; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Homburger SA, 1996, DEV DYNAM, V206, P112, DOI 10.1002/(SICI)1097-0177(199605)206:1<112::AID-AJA10>3.0.CO;2-7; Hunter E, 1979, Methods Enzymol, V58, P379; KALLUNKI P, 1995, J BIOL CHEM, V270, P21291, DOI 10.1074/jbc.270.36.21291; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; KALLUNKI P, IN PRESS P NATL ACAD; Kaufman M. H, 1990, POSTIMPLANTATION MAM, P81; Kohler J, 1996, NUCLEIC ACIDS RES, V24, P2543, DOI 10.1093/nar/24.13.2543; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MANDEL G, 1993, ANNU REV NEUROSCI, V16, P323, DOI 10.1146/annurev.ne.16.030193.001543; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; MORGAN BA, 1996, METHODS AVIAN EMBRYO, P185; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Palm K, 1998, J NEUROSCI, V18, P1280; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Scholl T, 1996, J IMMUNOL, V156, P1448; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; VANDENBERGH DJ, 1989, NEURON, V3, P507, DOI 10.1016/0896-6273(89)90209-2; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X	36	381	387	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					136	142		10.1038/2431	http://dx.doi.org/10.1038/2431			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771705				2022-12-17	WOS:000076231300014
J	Tapanainen, JS; Aittomaki, K; Min, J; Vaskivuo, T; Huhtaniemi, IT				Tapanainen, JS; Aittomaki, K; Min, J; Vaskivuo, T; Huhtaniemi, IT			Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility	NATURE GENETICS			English	Article							SERTOLI; NUMBERS; CLONING; CELLS	Gonadal function is controlled by the two pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). While LH mainly regulates gonadal steroidogenesis, FSH is considered essential for folliculogenesis in the female and spermatogenesis in the male. We recently discovered that an inactivating point mutation in the FSH receptor (R) gene causes a recessively inherited form of hypergonadotropic ovarian failure in homozygous females(1). This 566C-->T mutation, predicting an alanine to valine substitution, is located in exon 7 of the FSHR gene, in the region encoding the extracellular domain of the receptor molecule. Functional testing showed a clear-cut reduction in ligand binding and signal transduction by the mutated receptor. Hence, lack of FSH function is incompatible with ovarian follicular maturation and female fertility. In the male, FSH is generally considered essential for the pubertal initiation of spermatogenesis and maintenance of quantitatively normal sperm production in adults(2-5). We report here the first characterization of males homozygous for an inactivating FSHR mutation. They have variable degrees of spermatogenic failure. but, surprisingly, do not show azoospermia or absolute infertility. These results question the essential role of FSH for the initiation of spermatogenesis, and demonstrate that FSH is more important for female than for male fertility.	UNIV HELSINKI,DEPT MED GENET,FIN-00290 HELSINKI,FINLAND; UNIV HELSINKI,CENT HOSP,DEPT CLIN GENET,FIN-00290 HELSINKI,FINLAND; UNIV TURKU,INST BIOMED,DEPT PHYSIOL,FIN-20520 TURKU,FINLAND	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku	Tapanainen, JS (corresponding author), OULU UNIV HOSP,DEPT OBSTET & GYNECOL,FIN-90220 OULU,FINLAND.							AITTOMAKI K, 1994, AM J HUM GENET, V54, P844; Aittomaki K, 1996, J CLIN ENDOCR METAB, V81, P3722, DOI 10.1210/jc.81.10.3722; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; BREMNER WJ, 1981, J CLIN INVEST, V68, P1044, DOI 10.1172/JCI110327; Gromoll J, 1996, J CLIN ENDOCR METAB, V81, P1367, DOI 10.1210/jc.81.4.1367; HESS RA, 1993, ENDOCRINOLOGY, V132, P2607, DOI 10.1210/en.132.6.2607; KELTON CA, 1992, MOL CELL ENDOCRINOL, V89, P141, DOI 10.1016/0303-7207(92)90220-Z; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; MATSUMOTO AM, 1986, J CLIN ENDOCR METAB, V62, P1184, DOI 10.1210/jcem-62-6-1184; MINEGISH T, 1991, BIOCHEM BIOPH RES CO, V175, P1125, DOI 10.1016/0006-291X(91)91682-3; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Sharpe Richard M., 1994, P1363; STEIN LJ, 1991, PHYSIOL BEHAV, V51, P1; WEINBAUER GF, 1991, ENDOCRINOLOGY, V129, P1831, DOI 10.1210/endo-129-4-1831; World Health Organization, 1992, LAB MAN EX HUM SEM S; ZELEZNIK AJ, 1993, OVARY, P41; ZIRKIN BR, 1994, J ANDROL, V15, P273	17	381	390	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					205	206		10.1038/ng0297-205	http://dx.doi.org/10.1038/ng0297-205			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020851				2022-12-17	WOS:A1997WF08700025
J	Rice, GI; Duany, YD; Jenkinson, EM; Forte, GMA; Anderson, BH; Ariaudo, G; Bader-Meunier, B; Baildam, EM; Battini, R; Beresford, MW; Casarano, M; Chouchane, M; Cimaz, R; Collins, AE; Cordeiro, NJV; Dale, RC; Davidson, JE; De Waele, L; Desguerre, I; Faivre, L; Fazzi, E; Isidor, B; Lagae, L; Latchman, AR; Lebon, P; Li, CM; Livingston, JH; Lourenco, CM; Mancardi, MM; Masurel-Paulet, A; McInnes, LB; Menezes, MP; Mignot, C; O'Sullivan, J; Orcesi, S; Picco, PP; Riva, E; Robinson, RA; Rodriguez, D; Salvatici, E; Scott, C; Szybowska, M; Tolmie, JL; Vanderver, A; Vanhulle, C; Vieira, JP; Webb, K; Whitney, RN; Williams, SG; Wolfe, LA; Zuberi, SM; Hur, S; Crow, YJ				Rice, Gillian I.; Duany, Yoandris del Toro; Jenkinson, Emma M.; Forte, Gabriella M. A.; Anderson, Beverley H.; Ariaudo, Giada; Bader-Meunier, Brigitte; Baildam, Eileen M.; Battini, Roberta; Beresford, Michael W.; Casarano, Manuela; Chouchane, Mondher; Cimaz, Rolando; Collins, Abigail E.; Cordeiro, Nuno J. V.; Dale, Russell C.; Davidson, Joyce E.; De Waele, Liesbeth; Desguerre, Isabelle; Faivre, Laurence; Fazzi, Elisa; Isidor, Bertrand; Lagae, Lieven; Latchman, Andrew R.; Lebon, Pierre; Li, Chumei; Livingston, John H.; Lourenco, Charles M.; Mancardi, Maria Margherita; Masurel-Paulet, Alice; McInnes, Lain B.; Menezes, Manoj P.; Mignot, Cyril; O'Sullivan, James; Orcesi, Simona; Picco, Paolo P.; Riva, Enrica; Robinson, Robert A.; Rodriguez, Diana; Salvatici, Elisabetta; Scott, Christiaan; Szybowska, Marta; Tolmie, John L.; Vanderver, Adeline; Vanhulle, Catherine; Vieira, Jose Pedro; Webb, Kate; Whitney, Robyn N.; Williams, Simon G.; Wolfe, Lynne A.; Zuberi, Sameer M.; Hur, Sun; Crow, Yanick J.			Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling	NATURE GENETICS			English	Article							AICARDI-GOUTIERES-SYNDROME; DYSCHROMATOSIS SYMMETRICA HEREDITARIA; EXPRESSION SIGNATURE; DSRNA RECOGNITION; MDA5 FILAMENTS; AUTOIMMUNITY; LUPUS; TREX1; MICE; DISORDERS	The type I interferon system is integral to human antiviral immunity. However, inappropriate stimulation or defective negative regulation of this system can lead to inflammatory disease. We sought to determine the molecular basis of genetically uncharacterized cases of the type I interferonopathy Aicardi-Goutieres syndrome and of other undefined neurological and immunological phenotypes also demonstrating an upregulated type I interferon response. We found that heterozygous mutations in the cytosolic double-stranded RNA receptor gene IFIH1 (also called MDA5) cause a spectrum of neuroimmunological features consistently associated with an enhanced interferon state. Cellular and biochemical assays indicate that these mutations confer gain of function such that mutant IFIH1 binds RNA more avidly, leading to increased baseline and ligand-induced interferon signaling. Our results demonstrate that aberrant sensing of nucleic acids can cause immune upregulation.	[Rice, Gillian I.; Jenkinson, Emma M.; Forte, Gabriella M. A.; Anderson, Beverley H.; O'Sullivan, James; Williams, Simon G.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Duany, Yoandris del Toro; Hur, Sun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Duany, Yoandris del Toro; Hur, Sun] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Ariaudo, Giada; Orcesi, Simona] C Mondino Natl Neurol Inst, Child Neurol & Psychiat Unit, Pavia, Italy; [Ariaudo, Giada] Univ Pavia, Dept Brain & Behav Sci, Unit Child Neurol & Psychiat, I-27100 Pavia, Italy; [Bader-Meunier, Brigitte] Hop Necker Enfants Malad, AP HP, Imagine Fdn, Dept Pediat Immunol & Rheumatol,INSERM U76, Paris, France; [Baildam, Eileen M.; Beresford, Michael W.] Alder Hey Childrens Natl Hlth Serv NHS Fdn Trus, Dept Paediat Rheumatol, Liverpool, Merseyside, England; [Battini, Roberta; Casarano, Manuela] IRCCS Stella Mans, Dept Dev Neurosci, Pisa, Italy; [Beresford, Michael W.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Chouchane, Mondher] CHU Dijon, Serv Pediat 1, Dijon, France; [Cimaz, Rolando] AOU Meyer, Dept Pediat, Florence, Italy; [Cimaz, Rolando] Univ Florence, Florence, Italy; [Collins, Abigail E.] Univ Colorado, Sch Med, Dept Pediat, Div Pediat Neurol, Denver, CO USA; [Cordeiro, Nuno J. V.] Rainbow House NHS Ayrshire & Arran, Dept Paediat, Irvine, CA USA; [Dale, Russell C.] Univ Sydney, Childrens Hosp Westmead, Neuroimmunol Grp, Sydney, NSW 2006, Australia; [Davidson, Joyce E.] Royal Hosp Sick Children, Dept Paediat Rheumatol, Glasgow G3 8SJ, Lanark, Scotland; [De Waele, Liesbeth; Lagae, Lieven] Katholieke Univ Leuven Hosp, Dept Paediat Neurol, Louvain, Belgium; [Desguerre, Isabelle] Hop Necker Enfants Malad, AP HP, INSERM U768, Dept Pediat Neurol, Paris, France; [Faivre, Laurence; Masurel-Paulet, Alice] CHU Dijon, Hop Enfants, Ctr Genet, Dijon, France; [Faivre, Laurence; Masurel-Paulet, Alice] Univ Bourgogne, Dijon, France; [Fazzi, Elisa] Univ Brescia, Dept Clin & Expt Sci, Civil Hosp, Child Neurol & Psychiat Unit, Brescia, Italy; [Isidor, Bertrand] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Isidor, Bertrand] INSERM, UMRS 957, Nantes, France; [Latchman, Andrew R.] McMaster Univ, Dept Pediat, Div Gen Pediat, McMaster Childrens Hosp, Hamilton, ON, Canada; [Lebon, Pierre] Univ & Fac Med Paris Descartes, Paris, France; [Li, Chumei; Szybowska, Marta] McMaster Univ, McMaster Childrens Hosp, Clin Genet Program, Dept Pediat, Hamilton, ON, Canada; [Livingston, John H.] Leeds Teaching Hosp NHS Trust, Dept Paediat Neurol, Leeds, W Yorkshire, England; [Lourenco, Charles M.] Univ Sao Paulo, Clin Hosp Ribeirao Preto, Sao Paulo, Brazil; [Mancardi, Maria Margherita] Giannina Gaslim Inst, Dept Neurosci, Operat Unit Child Neuropsychiat, Genoa, Italy; [McInnes, Lain B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Menezes, Manoj P.] Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2006, Australia; [Mignot, Cyril] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Picco, Paolo P.] Giannina Gaslini Inst, Genoa, Italy; [Salvatici, Elisabetta] Univ Milan, San Paolo Hosp, Clin Dept Pediat, Milan, Italy; [Robinson, Robert A.] Great Ormond St Hosp Sick Children, Dept Neurol, London WC1N 3JH, England; [Rodriguez, Diana] HUEP, AP HP, Hop A Trousseau, Serv Neuropediat,Ctr Reference Neurogenet, Paris, France; [Rodriguez, Diana] Univ Paris 06, Paris, France; [Rodriguez, Diana] INSERM U676, Paris, France; [Scott, Christiaan; Webb, Kate] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat Rheumatol, ZA-79250 Cape Town, South Africa; [Tolmie, John L.] So Gen Hosp, Dept Clin Genet, Glasgow G51 4TF, Lanark, Scotland; [Vanderver, Adeline] Childrens Natl Med Ctr, Dept Pediat Neurol, Washington, DC 20010 USA; [Vanhulle, Catherine] CHU Rouen, Hop Charles Nicolle, Serv Neonatal & Reanimat, Rouen, France; [Vieira, Jose Pedro] Hosp Dona Estefania, Ctr Hosp Lisboa Cent, Dept Neurol, Lisbon, Portugal; [Whitney, Robyn N.] McMaster Univ, McMaster Childrens Hosp, Dept Pediat, Div Pediat Neurol, Hamilton, ON, Canada; [Wolfe, Lynne A.] US Natl Inst Hlth Undiagnosed Dis Program, Bethesda, MD USA; [Zuberi, Sameer M.] Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Paediat Neurosci Res Grp, Glasgow G3 8SJ, Lanark, Scotland; [Zuberi, Sameer M.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland	University of Manchester; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; IRCCS Fondazione Casimiro Mondino; University of Pavia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Alder Hey Children's NHS Foundation Trust; IRCCS Fondazione Stella Maris; University of Liverpool; CHU Dijon Bourgogne; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Sydney; University of Glasgow; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Universite de Bourgogne; University of Brescia; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); McMaster University; UDICE-French Research Universities; Universite Paris Cite; McMaster University; University of Leeds; Universidade de Sao Paulo; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Glasgow; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; San Paolo-Polo Universitaria Hospital; University of Milan; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Cape Town; University of Glasgow; Children's National Health System; CHU de Rouen; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; McMaster University; National Institutes of Health (NIH) - USA; University of Glasgow; University of Glasgow	Crow, YJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	sun.hur@childrens.harvard.edu; yanickcrow@mac.com	Scott, Chris/I-4442-2019; Rodriguez, Diana/GVR-7668-2022; Isidor, Bertrand/L-2435-2015; CIMAZ, Rolando/AAA-9058-2019; Latchman, Andrew/AAW-2493-2021; Vanderver, Adeline/CAG-5072-2022; battini, roberta/P-9095-2017; Isidor, Bertrand/AAJ-3456-2021; Whitney, Robyn/AAS-2867-2021; Beresford, Michael William/AAB-5261-2021; orcesi, simona/J-6030-2016; Crow, Yanick J/N-6120-2014; vieira, jose pedro/AAT-4370-2020; Rice, Gillian I/G-3128-2015; Fazzi, Elisa/J-6076-2016	Scott, Chris/0000-0003-3874-1704; Isidor, Bertrand/0000-0001-6480-126X; CIMAZ, Rolando/0000-0002-3260-4226; Latchman, Andrew/0000-0001-6946-8611; battini, roberta/0000-0002-7889-1355; Isidor, Bertrand/0000-0001-6480-126X; Whitney, Robyn/0000-0001-6851-0646; Beresford, Michael William/0000-0002-5400-9911; orcesi, simona/0000-0001-8947-9342; Crow, Yanick J/0000-0001-7211-7564; vieira, jose pedro/0000-0002-2270-5314; Rice, Gillian I/0000-0002-4223-0571; Fazzi, Elisa/0000-0003-4805-7906; McInnes, Iain/0000-0002-6462-4280; Williams, Simon/0000-0001-7396-4108; Webb, Kate/0000-0003-1087-5946; Faivre, Laurence/0000-0001-9770-444X; Picco, Paolo/0000-0003-0686-0725; Menezes, Manoj/0000-0003-3160-6112; bader-meunier, brigitte/0000-0001-8476-8196; Vanderver, Adeline/0000-0002-6290-6751	Novartis Foundation; Boston Children's Hospital; Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre; Greater Manchester Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; European Union's Seventh Framework Programme [241779]; European Research Council [GA 309449]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Great Ormond Street Hospital Childrens Charity [V1212] Funding Source: researchfish	Novartis Foundation(Novartis); Boston Children's Hospital; Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre; Greater Manchester Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; European Union's Seventh Framework Programme(European Commission); European Research Council(European Research Council (ERC)European Commission); Lung GO Sequencing Project; Women's Health Initiative (WHI) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Great Ormond Street Hospital Childrens Charity	We sincerely thank the participating families for the use of genetic samples and clinical information and all clinicians who contributed samples and data not included in this manuscript. We thank D. Chase for proofreading the manuscript. We thank G. Notarangelo for helpful discussion. Y.d.T.D. holds a Novartis Foundation postdoctoral fellowship. S.H. holds a Pew scholarship and Career Development award from Boston Children's Hospital. Y.J.C. acknowledges the Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre, the Greater Manchester Comprehensive Local Research Network, the Great Ormond Street Hospital Children's Charity, the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 241779 and the European Research Council (GA 309449). The authors would like to thank the NHLBI GO ESP and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Cen H, 2013, AUTOIMMUNITY, V46, P455, DOI 10.3109/08916934.2013.796937; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Crow YJ, 2014, CLIN EXP IMMUNOL, V175, P1, DOI 10.1111/cei.12115; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gresser I, 1980, Ann N Y Acad Sci, V350, P12, DOI 10.1111/j.1749-6632.1980.tb20602.x; GRESSER I, 1975, NATURE, V258, P76, DOI 10.1038/258076a0; GRESSER I, 1976, NATURE, V263, P420, DOI 10.1038/263420a0; Herries D.G., 1985, ENZYME STRUCTURE MEC; Kondo T, 2008, J DERMATOL, V35, P662, DOI 10.1111/j.1346-8138.2008.00540.x; Livingston JH, 2014, J MED GENET, V51, P76, DOI 10.1136/jmedgenet-2013-102038; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Stetson DB, 2012, CURR OPIN IMMUNOL, V24, P692, DOI 10.1016/j.coi.2012.09.007; Tojo K, 2006, MOVEMENT DISORD, V21, P1510, DOI 10.1002/mds.21011; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048	29	380	393	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					503	509		10.1038/ng.2933	http://dx.doi.org/10.1038/ng.2933			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24686847	Green Accepted, Green Submitted			2022-12-17	WOS:000335422900020
J	Berkel, S; Marshall, CR; Weiss, B; Howe, J; Roeth, R; Moog, U; Endris, V; Roberts, W; Szatmari, P; Pinto, D; Bonin, M; Riess, A; Engels, H; Sprengel, R; Scherer, SW; Rappold, GA				Berkel, Simone; Marshall, Christian R.; Weiss, Birgit; Howe, Jennifer; Roeth, Ralph; Moog, Ute; Endris, Volker; Roberts, Wendy; Szatmari, Peter; Pinto, Dalila; Bonin, Michael; Riess, Angelika; Engels, Hartmut; Sprengel, Rolf; Scherer, Stephen W.; Rappold, Gudrun A.			Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation	NATURE GENETICS			English	Article							POSTSYNAPTIC DENSITY; PROTEINS	Using microarrays, we identified de novo copy number variations in the SHANK2 synaptic scaffolding gene in two unrelated individuals with autism-spectrum disorder (ASD) and mental retardation. DNA sequencing of SHANK2 in 396 individuals with ASD, 184 individuals with mental retardation and 659 unaffected individuals (controls) revealed additional variants that were specific to ASD and mental retardation cases, including a de novo nonsense mutation and seven rare inherited changes. Our findings further link common genes between ASD and intellectual disability.	[Berkel, Simone; Weiss, Birgit; Roeth, Ralph; Endris, Volker; Rappold, Gudrun A.] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany; [Marshall, Christian R.; Howe, Jennifer; Pinto, Dalila; Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5S 1A1, Canada; [Moog, Ute] Univ Heidelberg, Dept Human Genet, Heidelberg, Germany; [Roberts, Wendy] Univ Toronto, Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Offord Ctr Child Studies, Hamilton, ON, Canada; [Bonin, Michael; Riess, Angelika] Univ Tubingen, Inst Human Genet, Dept Med Genet, Tubingen, Germany; [Engels, Hartmut] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Sprengel, Rolf] Univ Heidelberg, Max Planck Inst Med Res MPI, Heidelberg, Germany; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Eberhard Karls University of Tubingen; University of Bonn; Max Planck Society; Ruprecht Karls University Heidelberg; University of Toronto	Rappold, GA (corresponding author), Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany.	gudrun_rappold@med.uni-heidelberg.de	Pinto, Dalila/C-4218-2016; Scherer, Stephen W./B-3785-2013	Pinto, Dalila/0000-0002-8769-0846; Scherer, Stephen W./0000-0002-8326-1999	international Autism Genome Project; Autism Speaks; German Mental Retardation Network (MRNET); Federal Ministry of Education and Research, Germany; Deutsche Forschungsgesellschaft (DFG) [SFB488]; Medical Faculty of Heidelberg; CellNetworks-Cluster of Excellence [EXC81]; Centre for Applied Genomics, Genome Canada; Ontario Genomics Institute; Canadian Institutes for Health Research (CIHR); Canadian Institute for Advanced Research (CIFAR); McLaughlin Centre; Canada Foundation for Innovation; Ontario Ministry of Research and Innovation; Hospital for Sick Children Foundation	international Autism Genome Project; Autism Speaks; German Mental Retardation Network (MRNET); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Medical Faculty of Heidelberg; CellNetworks-Cluster of Excellence; Centre for Applied Genomics, Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); McLaughlin Centre; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Hospital for Sick Children Foundation	We gratefully thank E. Fenner, M. Fritsche and S. Peykov for sequencing and technical support, and we thank all the affected individuals' families for their cooperation. We thank A. Fiebig, A. Franke and S. Schreiber at POPGEN (University of Kiel, Kiel, Germany) and A. Stewart, R. McPherson and R. Roberts of the University of Ottawa Heart Institute (University of Ottawa, Ottawa, Canada) for generously providing population control microarray data. The international Autism Genome Project and Autism Speaks is also gratefully acknowledged for support. Funding was provided by the German Mental Retardation Network (MRNET), supported by the Federal Ministry of Education and Research, Germany, by the Deutsche Forschungsgesellschaft (DFG; SFB488) and the Medical Faculty of Heidelberg. S. B. was funded by a fellowship of CellNetworks-Cluster of Excellence (EXC81) and is a member of Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS). S. W. S. is supported by The Centre for Applied Genomics, Genome Canada and Ontario Genomics Institute, the Canadian Institutes for Health Research (CIHR), the Canadian Institute for Advanced Research (CIFAR), the McLaughlin Centre, the Canada Foundation for Innovation, the Ontario Ministry of Research and Innovation and the Hospital for Sick Children Foundation. S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children. G.A.R. is a member of CellNetworks-Cluster of Excellence (EXC81). Dedicated to Mrs. Elisabeth Berkel.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Sheng M, 2000, J CELL SCI, V113, P1851; Szatmari P, 2008, AM J MED GENET B, V147B, P3, DOI 10.1002/ajmg.b.30561; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	15	380	402	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					489	491		10.1038/ng.589	http://dx.doi.org/10.1038/ng.589			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20473310				2022-12-17	WOS:000278081500011
J	Aragones, J; Schneider, M; Van Geyte, K; Fraisl, P; Dresselaers, T; Mazzone, M; Dirkx, R; Zacchigna, S; Lemieux, H; Jeoung, NH; Lambrechts, D; Bishop, T; Lafuste, P; Diez-Juan, A; Harten, SK; Van Noten, P; De Bock, K; Willam, C; Tjwa, M; Grosfeld, A; Navet, R; Moons, L; Vandendriessche, T; Deroose, C; Wijeyekoon, B; Nuyts, J; Jordan, B; Silasi-Mansat, R; Lupu, F; Dewerchin, M; Pugh, C; Salmon, P; Mortelmans, L; Gallez, B; Gorus, F; Buyse, J; Sluse, F; Harris, RA; Gnaiger, E; Hespel, P; Van Hecke, P; Schuit, F; Van Veldhoven, P; Ratcliffe, P; Baes, M; Maxwell, P; Carmeliet, P				Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Dresselaers, Tom; Mazzone, Massimiliano; Dirkx, Ruud; Zacchigna, Serena; Lemieux, Helene; Jeoung, Nam Ho; Lambrechts, Diether; Bishop, Tammie; Lafuste, Peggy; Diez-Juan, Antonio; Harten, Sarah K.; Van Noten, Pieter; De Bock, Katrien; Willam, Carsten; Tjwa, Marc; Grosfeld, Alexandra; Navet, Rachel; Moons, Lieve; Vandendriessche, Thierry; Deroose, Christophe; Wijeyekoon, Bhathiya; Nuyts, Johan; Jordan, Benedicte; Silasi-Mansat, Robert; Lupu, Florea; Dewerchin, Mieke; Pugh, Chris; Salmon, Phil; Mortelmans, Luc; Gallez, Bernard; Gorus, Frans; Buyse, Johan; Sluse, Francis; Harris, Robert A.; Gnaiger, Erich; Hespel, Peter; Van Hecke, Paul; Schuit, Frans; Van Veldhoven, Paul; Ratcliffe, Peter; Baes, Myriam; Maxwell, Patrick; Carmeliet, Peter			Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; EXPRESSION; ALPHA; HIF; INCREASES; MICE; RESPIRATION; HIF-1-ALPHA; HOMEOSTASIS; ADAPTATION	HIF prolyl hydroxylases (PHD1-3) are oxygen sensors that regulate the stability of the hypoxia-inducible factors (HIFs) in an oxygen-dependent manner. Here, we show that loss of Phd1 lowers oxygen consumption in skeletal muscle by reprogramming glucose metabolism from oxidative to more anaerobic ATP production through activation of a Ppar alpha pathway. This metabolic adaptation to oxygen conservation impairs oxidative muscle performance in healthy conditions, but it provides acute protection of myofibers against lethal ischemia. Hypoxia tolerance is not due to HIF-dependent angiogenesis, erythropoiesis or vasodilation, but rather to reduced generation of oxidative stress, which allows Phd1-deficient myofibers to preserve mitochondrial respiration. Hypoxia tolerance relies primarily on Hif-2 alpha and was not observed in heterozygous Phd2-deficient or homozygous Phd3-deficient mice. Of medical importance, conditional knockdown of Phd1 also rapidly induces hypoxia tolerance. These findings delineate a new role of Phd1 in hypoxia tolerance and offer new treatment perspectives for disorders characterized by oxidative stress.	[Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Mazzone, Massimiliano; Zacchigna, Serena; Lambrechts, Diether; Lafuste, Peggy; Diez-Juan, Antonio; Tjwa, Marc; Moons, Lieve; Vandendriessche, Thierry; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Mazzone, Massimiliano; Zacchigna, Serena; Lemieux, Helene; Lambrechts, Diether; Lafuste, Peggy; Diez-Juan, Antonio; Tjwa, Marc; Moons, Lieve; Vandendriessche, Thierry; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Dresselaers, Tom; Van Hecke, Paul] Katholieke Univ Leuven, Biomed MRI Unit, B-3000 Louvain, Belgium; [Dirkx, Ruud; Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, B-3000 Louvain, Belgium; [Lemieux, Helene; Gnaiger, Erich] Med Univ Innsbruck, Dept Transplant Surg, D Swarovski Res Lab, A-6020 Innsbruck, Austria; [Jeoung, Nam Ho; Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Bishop, Tammie; Willam, Carsten; Grosfeld, Alexandra; Wijeyekoon, Bhathiya; Pugh, Chris; Ratcliffe, Peter] Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England; [Harten, Sarah K.; Maxwell, Patrick] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England; [Van Noten, Pieter; De Bock, Katrien; Hespel, Peter] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Exercise & Hlth Lab, B-3001 Louvain, Belgium; [Navet, Rachel; Sluse, Francis] Univ Liege, Dept Life Sci, Lab Bioenerget & Mol Physiol, B-4000 Liege, Belgium; [Deroose, Christophe; Nuyts, Johan; Mortelmans, Luc] Katholieke Univ Leuven, Univ Hosp, Dept Nucl Med, B-3000 Louvain, Belgium; [Jordan, Benedicte; Gallez, Bernard] Catholic Univ Louvain, Biomed Magnet Resonance Unit, B-1200 Brussels, Belgium; [Silasi-Mansat, Robert; Lupu, Florea] Oklahoma Med Res Fdn, Cardiovasc Res Program, Oklahoma City, OK 73104 USA; [Salmon, Phil] Skyscan NV, B-2630 Aartselaar, Belgium; [Gorus, Frans] Free Univ Brussels, Diabet Res Ctr, B-1090 Brussels, Belgium; [Buyse, Johan] Katholieke Univ Leuven, Dept Biosyst, Lab Physiol Immunol & Genet Domest Anim, B-3001 Louvain, Belgium; [Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium; [Van Veldhoven, Paul] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, Dept Mol Cell Biol, B-3000 Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Medical University of Innsbruck; Indiana University System; Indiana University-Purdue University Indianapolis; University of Oxford; Imperial College London; KU Leuven; University of Liege; KU Leuven; Universite Catholique Louvain; Oklahoma Medical Research Foundation; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; KU Leuven; KU Leuven	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; De Bock, Katrien/B-7208-2012; Grosfeld, Alexandra/R-1404-2017; Maxwell, Patrick H/C-5557-2008; Schneider, Martin/H-3745-2011; Lupu, Florea/C-3162-2009; Verdrengh, Evelien/H-4571-2012; Lambrechts, Diether/AAJ-3167-2020; Grosfeld, Alexandra/AAH-3510-2020; Diez Juan, Antonio/D-3695-2018; Lupu, Florea/AAV-3257-2021; De Bock, Katrien/L-2273-2013; Deroose, Christophe/AAG-7385-2020; , Van Veldhoven Paul/U-6359-2019; Diez-Juan, Antonio/H-5464-2015; ZACCHIGNA, SERENA/E-9496-2017	Carmeliet, Peter/0000-0001-7961-1821; Grosfeld, Alexandra/0000-0002-9508-036X; Maxwell, Patrick H/0000-0002-0338-2679; Lupu, Florea/0000-0003-1249-9278; Lambrechts, Diether/0000-0002-3429-302X; Lupu, Florea/0000-0003-1249-9278; De Bock, Katrien/0000-0001-8232-4663; Deroose, Christophe/0000-0002-6080-1577; , Van Veldhoven Paul/0000-0002-4478-2564; Hespel, Peter/0000-0003-1283-2229; Gnaiger, Erich/0000-0003-3647-5895; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Aragones Lopez, Julian/0000-0002-0193-4679; Baes, Myriam/0000-0002-2525-2269; Gorus, Frans/0000-0002-9007-6177; Wijeyekoon, Jananath/0000-0003-3414-4304; Ratcliffe, Peter/0000-0002-2853-806X; Diez-Juan, Antonio/0000-0002-0166-1869; ZACCHIGNA, SERENA/0000-0001-6705-3076; Bishop, Tammie/0000-0003-3308-9139; Pugh, Chris/0000-0002-5170-1662; Silasi, Robert/0000-0001-9590-6160; Nuyts, Johan/0000-0003-1923-6198; Dresselaers, Tom/0000-0002-0884-5142; Wilkinson, Sarah/0000-0002-1912-8384; Lafuste, Peggy/0000-0001-8239-3482; Vandendriessche, Thierry/0000-0003-4230-745X; Jeoung, Nam Ho/0000-0002-7584-3761; Mazzone, Massimiliano/0000-0001-8824-4015	MRC [G84/6411] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037704] Funding Source: NIH RePORTER; Medical Research Council [G84/6411] Funding Source: Medline; NIDDK NIH HHS [12R01DK47844] Funding Source: Medline; NIGMS NIH HHS [5R01GM037704] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Buck MJ, 2002, PHYSIOL GENOMICS, V8, P5, DOI 10.1152/physiolgenomics.00076.2001; Buyse J, 1998, BRIT POULTRY SCI, V39, P264, DOI 10.1080/00071669889231; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hochachka PW, 1998, J EXP BIOL, V201, P1243; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jordan BF, 2002, CANCER RES, V62, P3555; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; RERNIREZ JM, 2007, ANNU REV PHYSIOL, V69, P113; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Willam C, 2002, P NATL ACAD SCI USA, V99, P10423, DOI 10.1073/pnas.162119399; Wouters BG, 2004, DRUG RESIST UPDATE, V7, P25, DOI 10.1016/j.drup.2003.12.004; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	49	380	393	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					170	180		10.1038/ng.2007.62	http://dx.doi.org/10.1038/ng.2007.62			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176562	Green Accepted, Green Published			2022-12-17	WOS:000252732900015
J	Mata, J; Lyne, R; Burns, G; Bahler, J				Mata, J; Lyne, R; Burns, G; Bahler, J			The transcriptional program of meiosis and sporulation in fission yeast	NATURE GENETICS			English	Article							SCHIZOSACCHAROMYCES-POMBE; MEIOTIC RECOMBINATION; SPORE FORMATION; DNA-SYNTHESIS; GENES; EXPRESSION; PROTEIN; ENCODES; CONJUGATION; REGULATOR	Sexual reproduction requires meiosis to produce haploid gametes, which in turn can fuse to regenerate a diploid organism. We have studied the transcriptional program that drives this developmental process in Schizosaccharomyces pombe using DNA microarrays. Here we show that hundreds of genes are regulated in successive waves of transcription that correlate with major biological events of meiosis and sporulation. Each wave is associated with specific promoter motifs. Clusters of neighboring genes (mostly close to telomeres) are co-expressed early in the process, which reflects a more global control of these genes. We find that two Atf-like transcription factors are essential for the expression of late genes and formation of spores, and identify dozens of potential Atf target genes. Comparison with the meiotic program of the distantly related Saccharomyces cerevisiae reveals an unexpectedly small shared meiotic transcriptome, suggesting that the transcriptional regulation of meiosis evolved independently in both species.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Bahler, J (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	jurg@sanger.ac.uk	Lyne, Rachel/AAE-2189-2020; Bahler, Jurg/B-4572-2009	Lyne, Rachel/0000-0001-8050-402X; Bahler, Jurg/0000-0003-4036-1532; Mata, Juan/0000-0002-5514-3653	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Abe H, 2000, GENETICS, V154, P1497; Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Blanco MA, 2001, J CELL SCI, V114, P2135; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Ding R, 1998, MOL GEN GENET, V258, P663, DOI 10.1007/s004380050780; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fares H, 1996, J CELL BIOL, V132, P399, DOI 10.1083/jcb.132.3.399; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; IINO Y, 1985, MOL GEN GENET, V198, P416, DOI 10.1007/BF00332932; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; NURSE P, 1985, MOL GEN GENET, V198, P497, DOI 10.1007/BF00332946; Ohmiya R, 1999, MOL GEN GENET, V261, P297, DOI 10.1007/s004380050970; PETERSEN J, 1995, MOL CELL BIOL, V15, P3697; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; SUGIYAMA A, 1994, EMBO J, V13, P1881, DOI 10.1002/j.1460-2075.1994.tb06457.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamamoto A, 2001, BIOESSAYS, V23, P526, DOI 10.1002/bies.1072; YAMAMOTO M, 1997, MOL CELLULAR BIOL YE, P1035; ZHU Y, 1994, GENE DEV, V8, P885, DOI 10.1101/gad.8.8.885	30	380	395	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					143	147		10.1038/ng951	http://dx.doi.org/10.1038/ng951			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12161753				2022-12-17	WOS:000177714900013
J	Shinkura, R; Kitada, K; Matsuda, F; Tashiro, K; Ikuta, K; Suzuki, M; Kogishi, K; Serikawa, T; Honjo, T				Shinkura, R; Kitada, K; Matsuda, F; Tashiro, K; Ikuta, K; Suzuki, M; Kogishi, K; Serikawa, T; Honjo, T			Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase	NATURE GENETICS			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; TUMOR-NECROSIS-FACTOR; PERIPHERAL LYMPHOID ORGANS; ALY MUTANT MICE; DEFICIENT MICE; CELL-DEATH; ALPHA; ORGANOGENESIS; ORGANIZATION; EXPRESSION	The alymphoplasia (aly) mutation of mouse is autosomal recessive and characterized by the systemic absence of lymph nodes (LN) and Peyer's patches (PP) and disorganized splenic and thymic structures with immunodeficiency(1-3). Although recent reports have shown that the interaction between lymphotoxin (LT) and the LT beta-receptor (Lt beta r, encoded by Ltbr) provides a critical signal for LN genesis in mice(4-10), the aly locus on chromosome 11 (ref, 11) is distinct from those for LT and its receptor. We found that the aly allele carries a point mutation causing an amino acid substitution in the carboxy-terminal interaction domain of Nf-kappa b-inducing kinase(12,13) (Nik, encoded by the gene Nik). Transgenic complementation with wild-type Nik restored the normal structures of LN, PP, spleen and thymus, and the normal immune response in aly/aly mice. In addition, the aly mutation in a kinase domain-truncated Nik abolished its dominant-negative effect on Nf-kappa b activation induced by an excess of Lt beta r. Our observations agree with previous reports that Lt beta r-deficient mice showed defects in LN genesis(4) and that Nik is a common mediator of Nf-kappa b activation by the tumour necrosis factor (TNF) receptor family(12,13). Nik is able to interact with members of the TRAF family (Traf1, 2, 3, 5 and 6; ref. 13), suggesting it acts downstream of TRAF-associating receptor signalling pathways, including Tnfr (ref. 12), Cd40 (refs 14,15), Cd30 (refs 16,17) and Lt beta r (refs 18-21). The phenotypes of aly/aly mice are more severe than those of Ltbr(-/-) mice, however, indicating involvement of Nik in signal transduction mediated by other receptors.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan	Kyoto University; Kyoto University; Kyoto University; Kumamoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.		Honjo, Tasuku/N-4470-2016; Matsuda, Fumihiko/B-9893-2009	Ikuta, Koichi/0000-0003-1319-1021				BANKS TA, 1995, J IMMUNOL, V155, P1685; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Koike R, 1996, EUR J IMMUNOL, V26, P669, DOI 10.1002/eji.1830260324; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KOSCO MH, 1992, J IMMUNOL, V148, P2331; Krajewska M, 1998, AM J PATHOL, V152, P1549; KURAMOTO T, 1994, INT IMMUNOL, V6, P991, DOI 10.1093/intimm/6.7.991; KVIST S, 1983, EMBO J, V2, P245, DOI 10.1002/j.1460-2075.1983.tb01413.x; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0; Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460	28	380	388	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					74	77		10.1038/8780	http://dx.doi.org/10.1038/8780			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319865				2022-12-17	WOS:000080096300026
J	Meindl, A; Dry, K; Herrmann, K; Manson, F; Ciccodicola, A; Edgar, A; Carvalho, MRS; Achatz, H; Hellebrand, H; Lennon, A; Migliaccio, C; Porter, K; Zrenner, E; Bird, A; Jay, M; Lorenz, B; Wittwer, B; DUrso, M; Meitinger, T; Wright, A				Meindl, A; Dry, K; Herrmann, K; Manson, F; Ciccodicola, A; Edgar, A; Carvalho, MRS; Achatz, H; Hellebrand, H; Lennon, A; Migliaccio, C; Porter, K; Zrenner, E; Bird, A; Jay, M; Lorenz, B; Wittwer, B; DUrso, M; Meitinger, T; Wright, A			A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3)	NATURE GENETICS			English	Article							CHROMOSOME CONDENSATION; CELL-CYCLE; DNA; SEQUENCE; LINKAGE; HETEROGENEITY; REPLICATION; EXPRESSION; REGULATOR; DISEASE	X-linked retinitis pigmentosa (xlRP) is a severe progressive retinal degeneration which affects about 1 in 25,000 of the population. The most common form of xlRP, RP3, has been localised to the interval between CYBB and OTC in Xp21.1 by linkage analysis and deletion mapping. Identification of microdeletions within this region has now led to the positional cloning of a gene, RPGR, thai spans 60 kb of genomic DNA and is ubiquitously expressed. The predicted 90 kD protein contains in its N-terminal half a tandem repeat structure highly similar to RCC1 (regulator of chromosome condensation), suggesting an interaction with a small GTPase. The C-terminal half contains a domain, rich in acidic residues, and ends in a potential isoprenylation anchorage site. The two intragenic deletions, two nonsense and three missense mutations within conserved domains provide evidence that RPGR (retinitis pigmentosa GTPase regulator) is the RP3 gene.	UNIV MUNICH, KINDERPOLIKLIN, ABT PADIAT GENET, D-80336 MUNICH, GERMANY; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; CNR, INT INST GENET & BIOPHYS, I-80125 NAPLES, ITALY; UNIV TUBINGEN, AUGENKLIN, D-72076 TUBINGEN, GERMANY; UCL, MOORFIELDS EYE HOSP, DEPT CLIN OPHTHALMOL, LONDON, ENGLAND; UNIV REGENSBURG, AUGENKLIN, D-93042 REGENSBURG, GERMANY; UNIV MUNSTER, INST HUMAN GENET, D-48149 MUNSTER, GERMANY	University of Munich; University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University of Munster			Carvalho, Maria Raquel Santos/HHN-1690-2022; Manson, Forbes/G-2222-2015; Carvalho, Maria Raquel/C-7310-2016; Meitinger, Thomas/O-1318-2015	Carvalho, Maria Raquel Santos/0000-0002-1744-448X; Manson, Forbes/0000-0002-8342-660X; Carvalho, Maria Raquel/0000-0002-1744-448X; Dry, Katherine/0000-0002-8008-6208; Meitinger, Thomas/0000-0002-8838-8403; Ciccodicola, Alfredo/0000-0002-9924-1482	Telethon [E.0344] Funding Source: Medline	Telethon(Fondazione Telethon)		Aldred MA, 1994, MOL GENETICS INHERIT, P259; BASSI MT, 1995, NAT GENET, V10, P13, DOI 10.1038/ng0595-13; BEDDOW AL, 1995, P NATL ACAD SCI USA, V92, P3328, DOI 10.1073/pnas.92.8.3328; BERGEN AAB, 1995, OPHTHALMIC GENET, V16, P63, DOI 10.3109/13816819509056914; BERMAN ER, 1991, BIOCH EYE; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BROWN MS, 1993, NATURE, V366, P14, DOI 10.1038/366014a0; CHEN JD, 1989, AM J HUM GENET, V45, P401; CHENG Y, 1995, SCIENCE, V267, P1807, DOI 10.1126/science.7534442; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CLARK KL, 1989, MOL CELL BIOL, V9, P2682, DOI 10.1128/MCB.9.6.2682; COUTAVAS EE, 1994, MAMM GENOME, V5, P623, DOI 10.1007/BF00411457; DASSO M, 1993, TRENDS BIOCHEM SCI, V18, P96, DOI 10.1016/0968-0004(93)90161-F; DESTBASILE G, 1988, HUM GENET, V80, P85, DOI 10.1007/BF00451463; DRY KL, 1995, HUM MOL GENET, V4, P2347, DOI 10.1093/hmg/4.12.2347; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; FISHMAN GA, 1978, ARCH OPHTHALMOL-CHIC, V96, P822, DOI 10.1001/archopht.1978.03910050428005; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FURUNO N, 1991, GENOMICS, V11, P459, DOI 10.1016/0888-7543(91)90156-9; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Heckenlively JR, 1988, RETINITIS PIGMENTOSA, P1; HOLT IJ, 1990, AM J HUM GENET, V46, P428; JAY M, 1982, BRIT J OPHTHALMOL, V66, P405, DOI 10.1136/bjo.66.7.405; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KETTERLING RP, 1995, AM J HUM GENET, V56, P343; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; KOZAK M, 1991, J BIOL CHEM, V266, P19867; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; MEINDL A, 1995, HUM MOL GENET, V4, P2339, DOI 10.1093/hmg/4.12.2339; Moore MS, 1996, CURR BIOL, V6, P137, DOI 10.1016/S0960-9822(02)00444-X; MURAKAWA K, 1994, GENOMICS, V23, P379, DOI 10.1006/geno.1994.1514; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; NARCISI TME, 1995, AM J HUM GENET, V57, P1298; NISHITANI H, J BIOCH, V107, P228; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; Nomura N, 1994, DNA Res, V1, P47, DOI 10.1093/dnares/1.1.47; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REN MD, 1995, MOL CELL BIOL, V15, P2117; ROUX AF, 1994, HUM MOL GENET, V3, P257, DOI 10.1093/hmg/3.2.257; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; SAITOH H, 1995, J BIOL CHEM, V270, P10658, DOI 10.1074/jbc.270.18.10658; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WENNBORG A, 1995, P NATL ACAD SCI USA, V92, P7322, DOI 10.1073/pnas.92.16.7322	53	380	393	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1996	13	1					35	42		10.1038/ng0596-35	http://dx.doi.org/10.1038/ng0596-35			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673101				2022-12-17	WOS:A1996UH43000013
J	Beuschlein, F; Boulkroun, S; Osswald, A; Wieland, T; Nielsen, HN; Lichtenauer, UD; Penton, D; Schack, VR; Amar, L; Fischer, E; Walther, A; Tauber, P; Schwarzmayr, T; Diener, S; Graf, E; Allolio, B; Samson-Couterie, B; Benecke, A; Quinkler, M; Fallo, F; Plouin, PF; Mantero, F; Meitinger, T; Mulatero, P; Jeunemaitre, X; Warth, R; Vilsen, B; Zennaro, MC; Strom, TM; Reincke, M				Beuschlein, Felix; Boulkroun, Sheerazed; Osswald, Andrea; Wieland, Thomas; Nielsen, Hang N.; Lichtenauer, Urs D.; Penton, David; Schack, Vivien R.; Amar, Laurence; Fischer, Evelyn; Walther, Anett; Tauber, Philipp; Schwarzmayr, Thomas; Diener, Susanne; Graf, Elisabeth; Allolio, Bruno; Samson-Couterie, Benoit; Benecke, Arndt; Quinkler, Marcus; Fallo, Francesco; Plouin, Pierre-Francois; Mantero, Franco; Meitinger, Thomas; Mulatero, Paolo; Jeunemaitre, Xavier; Warth, Richard; Vilsen, Bente; Zennaro, Maria-Christina; Strom, Tim M.; Reincke, Martin			Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension	NATURE GENETICS			English	Article							ZONA GLOMERULOSA; KCNJ5 MUTATIONS; ATPASE; PREVALENCE; PATHWAYS; CELLS; PUMP	Primary aldosteronism is the most prevalent form of secondary hypertension. To explore molecular mechanisms of autonomous aldosterone secretion, we performed exome sequencing of aldosterone-producing adenomas (APAs). We identified somatic hotspot mutations in the ATP1A1 (encoding an Na+/K+ ATPase (1 subunit) and ATP2B3 (encoding a Ca2+ ATPase) genes in three and two of the nine APAs, respectively. These ATPases are expressed in adrenal cells and control sodium, potassium and calcium ion homeostasis. Functional in vitro studies of ATP1A1 mutants showed loss of pump activity and strongly reduced affinity for potassium. Electrophysiological ex vivo studies on primary adrenal adenoma cells provided further evidence for inappropriate depolarization of cells with ATPase alterations. In a collection of 308 APAs, we found 16(5.2%) somatic mutations in ATP1A1 and 5 (1.6%) in ATP2B3. Mutation-positive cases showed male dominance, increased plasma aldosterone concentrations and lower potassium concentrations compared with mutationnegative cases. In summary, dominant somatic alterations in two members of the ATPase gene family result in autonomous aldosterone secretion.	[Beuschlein, Felix; Osswald, Andrea; Lichtenauer, Urs D.; Fischer, Evelyn; Reincke, Martin] Univ Munich, Med Klin & Poliklin 4, Munich, Germany; [Boulkroun, Sheerazed; Amar, Laurence; Samson-Couterie, Benoit; Plouin, Pierre-Francois; Jeunemaitre, Xavier; Zennaro, Maria-Christina] Paris Cardiovasc Res Ctr, INSERM, UMRS 970, Paris, France; [Boulkroun, Sheerazed; Amar, Laurence; Samson-Couterie, Benoit; Plouin, Pierre-Francois; Jeunemaitre, Xavier; Zennaro, Maria-Christina] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Wieland, Thomas; Walther, Anett; Schwarzmayr, Thomas; Diener, Susanne; Graf, Elisabeth; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Nielsen, Hang N.; Schack, Vivien R.; Vilsen, Bente] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Penton, David; Tauber, Philipp; Warth, Richard] Univ Regensburg, D-93053 Regensburg, Germany; [Amar, Laurence; Plouin, Pierre-Francois; Jeunemaitre, Xavier; Zennaro, Maria-Christina] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Allolio, Bruno] Univ Hosp Wurzburg, Dept Med 1, Endocrine & Diabet Unit, Wurzburg, Germany; [Benecke, Arndt] Inst Hautes Etud Sci, CNRS, F-91440 Bures Sur Yvette, France; [Quinkler, Marcus] Univ Hosp Charite, Berlin, Germany; [Fallo, Francesco] Univ Padua, Dept Med, Padua, Italy; [Mantero, Franco] Univ Padua, Dept Med, Endocrine Unit, Padua, Italy; [Meitinger, Thomas; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Mulatero, Paolo] Univ Turin, Dept Med Sci, Div Internal Med & Hypertens, Turin, Italy	University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Aarhus University; University of Regensburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Padua; University of Padua; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Turin	Reincke, M (corresponding author), Univ Munich, Med Klin & Poliklin 4, Munich, Germany.	felix.beuschlein@med.uni-muenchen.de; martin.reincke@med.uni-muenchen.de	Amar, Laurence/P-5278-2017; Benecke, Arndt G./T-1079-2019; Boulkroun, Sheerazed/AAX-8348-2021; Zennaro, Maria-Christina/G-2841-2013; Boulkroun, Sheerazed/M-4459-2017; Warth, Richard/N-7119-2014; Lichtenauer, Urs/AFU-2746-2022; Meitinger, Thomas/O-1318-2015; JEUNEMAITRE, Xavier/AAQ-4853-2021; Penton, David/L-2597-2016	Amar, Laurence/0000-0003-3942-4276; Boulkroun, Sheerazed/0000-0002-8796-7534; Zennaro, Maria-Christina/0000-0001-5449-9191; Boulkroun, Sheerazed/0000-0002-8796-7534; Warth, Richard/0000-0001-6084-0659; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Beuschlein, Felix/0000-0001-7826-3984; Vilsen, Bente/0000-0002-4727-9382; Meitinger, Thomas/0000-0002-8838-8403; FALLO, FRANCESCO/0000-0002-7511-0226; Schack, Vivien/0000-0002-1365-3938; Quinkler, Marcus/0000-0003-4028-1671	Else Kroner-Fresenius-Stiftung; German Conn's Registry-Else-Kroner Hyperaldosteronism Registry; Deutsche Forschungsgemeinschaft [Re 752/17-1, FOR1086]; German Ministry of Education and Research [01GR0802, 01GM0867]; European Commission's Seventh Framework Programme [261123]; GEUVADIS; DZHK Paris; INSERM [U982]; University Hospital of Rouen; INSERM; Agence Nationale pour la Recherche; ANR Physio [013-01]; Genopat [08-GEN0-021]; Fondation pour la Recherche sur l'Hypertension Arterielle [AO 2007]; Fondation pour la Recherche Medicate [ING20101221177]; Programme Hospitalier de Recherche Clinique; PHRC [AOM 06179]; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; Fondi Ricerca Ex-60% MIUR (Ministry of University, Scientific and Technological Research); Lundbeck Foundation [R118-2012-11726] Funding Source: researchfish	Else Kroner-Fresenius-Stiftung; German Conn's Registry-Else-Kroner Hyperaldosteronism Registry; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission's Seventh Framework Programme(European Commission); GEUVADIS; DZHK Paris; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Hospital of Rouen; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); ANR Physio(French National Research Agency (ANR)); Genopat; Fondation pour la Recherche sur l'Hypertension Arterielle; Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Programme Hospitalier de Recherche Clinique; PHRC; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Fondi Ricerca Ex-60% MIUR (Ministry of University, Scientific and Technological Research); Lundbeck Foundation(Lundbeckfonden)	Munich and Regensburg. This work has been made possible by a grant of the Else Kroner-Fresenius-Stiftung in support of the German Conn's Registry-Else-Kroner Hyperaldosteronism Registry (to M.R.). Additional funding was received from the Deutsche Forschungsgemeinschaft to F.B. and M.R. (Re 752/17-1) and R.W. (FOR1086). The work was also supported by the German Ministry of Education and Research (01GR0802 and 01GM0867), the European Commission's Seventh Framework Programme (261123, GEUVADIS) and the DZHK. Paris. We thank H. Lefebvre and E. Louiset (INSERM U982 and University Hospital of Rouen) and M. Sibony (Assistance Publique-Hopitaux de Paris, Hopital Cochin) for providing control adrenal samples. We thank the COMETE (COrtico et MEdullo-surrenale: les Tumeurs Endocrines) network for providing tissue samples from individuals with APA. This work was funded through institutional support from INSERM and by the Agence Nationale pour la Recherche (ANR Physio 2007, 013-01; Genopat 2008, 08-GEN0-021), the Fondation pour la Recherche sur l'Hypertension Arterielle (AO 2007), the Fondation pour la Recherche Medicate (ING20101221177), the Programme Hospitalier de Recherche Clinique (PHRC grant AOM 06179) and by grants from INSERM and the Ministere Delegue a. la Recherche et des Nouvelles Technologies. Aarhus. This work was supported in part by grants to B.V. from the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat) and the Lundbeck Foundation. Turin. This study was supported by grants from the Fondi Ricerca Ex-60% MIUR (Ministry of University, Scientific and Technological Research) 2012 and the Compagnia di San Paolo.	Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; BEUSCHLEIN F, 1994, CANCER RES, V54, P4927; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eide IK, 2004, J HYPERTENS, V22, P2217, DOI 10.1097/00004872-200411000-00026; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; GICQUEL C, 1994, CLIN ENDOCRINOL, V40, P465, DOI 10.1111/j.1365-2265.1994.tb02485.x; HAJNOCZKY G, 1992, ENDOCRINOLOGY, V130, P1637, DOI 10.1210/en.130.3.1637; Hannemann A, 2012, EUR J ENDOCRINOL, V167, P7, DOI 10.1530/EJE-11-1013; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moseley AE, 2005, CELL PHYSIOL BIOCHEM, V15, P145, DOI 10.1159/000083647; Mulatero P, 2012, HYPERTENSION, V59, P235, DOI 10.1161/HYPERTENSIONAHA.111.183996; Neri G, 2006, INT J MOL MED, V18, P315; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Yingst DR, 1999, METABOLISM, V48, P1167, DOI 10.1016/S0026-0495(99)90133-6	22	379	391	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					440	444		10.1038/ng.2550	http://dx.doi.org/10.1038/ng.2550			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23416519	Green Published			2022-12-17	WOS:000316840600016
J	Protas, ME; Hersey, C; Kochanek, D; Zhou, Y; Wilkens, H; Jeffery, WR; Zon, LI; Borowsky, R; Tabin, CJ				Protas, ME; Hersey, C; Kochanek, D; Zhou, Y; Wilkens, H; Jeffery, WR; Zon, LI; Borowsky, R; Tabin, CJ			Genetic analysis of cavefish reveals molecular convergence in the evolution of albinism	NATURE GENETICS			English	Article							PINK-EYED-DILUTION; OCULOCUTANEOUS ALBINISM; REGULATORY EVOLUTION; BLIND CAVEFISH; ASTYANAX; FISH; STICKLEBACKS; POPULATION; DIVERGENCE; UNDERLIES	The genetic basis of vertebrate morphological evolution has traditionally been very difficult to examine in naturally occurring populations. Here we describe the generation of a genome-wide linkage map to allow quantitative trait analysis of evolutionarily derived morphologies in the Mexican cave tetra, a species that has, in a series of independent caves, repeatedly evolved specialized characteristics adapted to a unique and well-studied ecological environment. We focused on the trait of albinism and discovered that it is linked to Oca2, a known pigmentation gene, in two cave populations. We found different deletions in Oca2 in each population and, using a cell-based assay, showed that both cause loss of function of the corresponding protein, OCA2. Thus, the two cave populations evolved albinism independently, through similar mutational events.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp Boston, Howard Hughes Med Inst, Dept Hematol Oncol, Childrens Hosp Stem Cell Program, Boston, MA 02115 USA; NYU, Dept Biol, Cave Biol Res Grp, New York, NY 10003 USA; Univ Hamburg, Inst Zool, D-20146 Hamburg, Germany; Univ Hamburg, Zool Museum, D-20146 Hamburg, Germany; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; New York University; University of Hamburg; University of Hamburg; University System of Maryland; University of Maryland College Park	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu			NEI NIH HHS [R01 EY014619] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Culver D. C., 1982, CAVE LIFE; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Espinasa L, 2001, ENVIRON BIOL FISH, V62, P339, DOI 10.1023/A:1011852603162; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Oetting WS, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9318; Page-McCaw PS, 2004, NAT NEUROSCI, V7, P1329, DOI 10.1038/nn1344; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Romero A, 2001, ENVIRON BIOL FISH, V62, P13, DOI 10.1023/A:1011844404235; SADOGLU P, 1969, J HERED, V60, P10, DOI 10.1093/oxfordjournals.jhered.a107917; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Strecker U, 2004, MOL PHYLOGENET EVOL, V33, P469, DOI 10.1016/j.ympev.2004.07.001; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sviderskaya EV, 1997, J INVEST DERMATOL, V108, P30, DOI 10.1111/1523-1747.ep12285621; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yi ZH, 2003, AM J HUM GENET, V72, P62, DOI 10.1086/345380	26	379	388	6	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					107	111		10.1038/ng1700	http://dx.doi.org/10.1038/ng1700			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341223				2022-12-17	WOS:000234227200025
J	Lin, SP; Youngson, N; Takada, S; Seitz, H; Reik, W; Paulsen, M; Cavaille, J; Ferguson-Smith, ACF				Lin, SP; Youngson, N; Takada, S; Seitz, H; Reik, W; Paulsen, M; Cavaille, J; Ferguson-Smith, ACF			Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12	NATURE GENETICS			English	Article							UNIPARENTAL DISOMY; GENES; DOMAIN; GTL2; DELETION; H19; IDENTIFICATION; EXPRESSION; DNMT3L; LOCUS	Genomic imprinting causes parental origin specific gene expression(1). Cis-acting regulatory elements that control imprinting are not fully understood but involve regions that become differentially methylated on the two parental chromosomes during male and female gametogenesis(2-4). Understanding properties of maternally and paternally inherited imprints provides insight into the mechanisms and evolution of genomic imprinting. Previously we identified an intergenic germline-derived differentially methylated region (IG-DMR) that is a candidate control element for an imprinted domain on distal mouse chromosome 12 (ref. 5). The 1-Mb cluster contains the paternally expressed protein-coding genes Dlk1 (refs. 6,7) and Dio3 (ref. 8,9) and several maternally expressed non-coding RNAs, including Gtl2 (refs. 6,7,10) and C/D snoRNAs(11). A retrotransposon-like gene (Rtl1) is expressed from the paternal chromosome and has an antisense transcript expressed from the maternal chromosome containing two microRNAs with full complementarity to Rtl1 (ref. 12). Here we show that deletion of the IG-DMR from the maternally inherited chromosome causes bidirectional loss of imprinting of all genes in the cluster. When the deletion is transmitted from the father, imprinting is unaltered. These results prove that the IG-DMR is a control element for all imprinted genes on the maternal chromosome only and indicate that the two parental chromosomes control allele-specific gene expression differently.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Toulouse 3, CNRS, UMR 5099, LBME, F-31062 Toulouse, France; Babraham Inst, Lab Dev Genet & Imprinting, Dev Genet Programme, Cambridge CB2 4AT, England	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Lin, SP (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.		cavaille, jerome/AAM-8047-2020; Ferguson-Smith, Anne C/G-7534-2011; Reik, Wolf/I-6794-2012; Youngson, Neil/AAB-7389-2019; Paulsen, Martina/G-2262-2010; Seitz, Hervé/AAE-6487-2019	Seitz, Hervé/0000-0001-8172-5393; CAVAILLE, Jerome/0000-0003-2833-6836; Takada, Shuji/0000-0002-9406-4683; Lin, Shau-Ping/0000-0003-3423-991X; Reik, Wolf/0000-0003-0216-9881; Ferguson-Smith, Anne/0000-0002-7608-5894; Youngson, Neil/0000-0003-0690-4580				Arney KL, 2003, TRENDS GENET, V19, P17, DOI 10.1016/S0168-9525(02)00004-5; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Buiting K, 2003, AM J HUM GENET, V72, P571, DOI 10.1086/367926; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Georgiades P, 2001, P NATL ACAD SCI USA, V98, P4522, DOI 10.1073/pnas.081540898; Hata K, 2002, DEVELOPMENT, V129, P1983; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435; Paulsen M, 2001, GENOME RES, V11, P2085, DOI 10.1101/gr.206901; Schmidt JV, 2000, GENE DEV, V14, P1997; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; WANG JCC, 1991, AM J HUM GENET, V48, P1069; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1	29	379	410	1	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					97	102		10.1038/ng1233	http://dx.doi.org/10.1038/ng1233			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12937418				2022-12-17	WOS:000185018500017
J	JEUNEMAITRE, X; LIFTON, RP; HUNT, SC; WILLIAMS, RR; LALOUEL, JM				JEUNEMAITRE, X; LIFTON, RP; HUNT, SC; WILLIAMS, RR; LALOUEL, JM			ABSENCE OF LINKAGE BETWEEN THE ANGIOTENSIN CONVERTING ENZYME LOCUS AND HUMAN ESSENTIAL-HYPERTENSION	NATURE GENETICS			English	Article							BLOOD-PRESSURE; GROWTH-HORMONE; INSULIN RESISTANCE; GENE; UTAH	The angiotensin converting enzyme (ACE) is a key component of the renin angiotensin system that contributes to the regulation of blood pressure (BP). Recent demonstration of linkage between the ACE locus and elevated BP in a rat model of hypertension has further emphasized ACE as a candidate gene in human hypertension1,2,3. We report the localization of the ACF gene on the genetic map of chromosome 17, and identify an extremely polymorphic marker at the human growth hormone (hGH) locus which shows no recombination with ACE. We have found no evidence to support linkage between the ACE locus and hypertension, which suggests that mutations at the ACE locus do not commonly contribute to the pathogenesis of hypertension in our test population.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; BRIGHAM & WOMENS HOSP,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV UTAH,CARDIOVASC GENET RES CLIN,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah	JEUNEMAITRE, X (corresponding author), UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112, USA.		JEUNEMAITRE, Xavier/AAQ-4853-2021	JEUNEMAITRE, Xavier/0000-0001-5925-381X				ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BRATUSCHMARRAIN PR, 1982, J CLIN ENDOCR METAB, V55, P973, DOI 10.1210/jcem-55-5-973; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; ERDOS EG, 1987, LAB INVEST, V56, P346; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; GOLDSTEIN JL, 1979, ANNU REV GENET, V13, P259, DOI 10.1146/annurev.ge.13.120179.001355; HARPER ME, 1982, AM J HUM GENET, V34, P227; HARRAP SB, 1990, HYPERTENSION, V16, P603, DOI 10.1161/01.HYP.16.6.603; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HYER RN, 1991, AM J HUM GENET, V48, P243; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JEUNEMAITRE X, 1992, HUM GENET, V88, P301; KURTZ T, 1991, NATURE, V353, P499, DOI 10.1038/353499a0; LANDER ES, 1989, GENETICS, V121, P185; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIFTON RP, 1991, HYPERTENSION, V17, P8, DOI 10.1161/01.HYP.17.1.8; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MATTEI MG, 1989, CYTOGENET CELL GENET, V51, P1041; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; POLLARE T, 1990, METABOLISM, V39, P167, DOI 10.1016/0026-0495(90)90071-J; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; REAVEN GM, 1991, AM J HYPERTENS, V4, P34, DOI 10.1093/ajh/4.1.34; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; RIGAT B, IN PRESS NUCL ACIDS; SASSANO P, 1987, AM J MED, V83, P227, DOI 10.1016/0002-9343(87)90690-5; SEGAL KR, 1985, J APPL PHYSIOL, V58, P1565, DOI 10.1152/jappl.1985.58.5.1565; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; WARD R, 1990, HYPERTENSION PATHOPH, P81; WEINBERGER MH, 1986, HYPERTENSION, V8, P127, DOI 10.1161/01.HYP.8.6_Pt_2.II127; WILLIAMS RR, 1988, JAMA-J AM MED ASSOC, V259, P3579, DOI 10.1001/jama.259.24.3579; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283	40	379	395	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					72	75		10.1038/ng0492-72	http://dx.doi.org/10.1038/ng0492-72			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1338766				2022-12-17	WOS:A1992JC97800017
J	Ule, J; Ule, A; Spencer, J; Williams, A; Hu, JS; Cline, M; Wang, H; Clark, T; Fraser, C; Ruggiu, M; Zeeberg, BR; Kane, D; Weinstein, JN; Blume, J; Darnell, RB				Ule, J; Ule, A; Spencer, J; Williams, A; Hu, JS; Cline, M; Wang, H; Clark, T; Fraser, C; Ruggiu, M; Zeeberg, BR; Kane, D; Weinstein, JN; Blume, J; Darnell, RB			Nova regulates brain-specific splicing to shape the synapse	NATURE GENETICS			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNAS; GENOME; CAMKII; DOMAIN; IDENTIFICATION; EXPRESSION; PLASTICITY; SEQUENCE; ISOFORMS	Alternative RNA splicing greatly increases proteome diversity and may thereby contribute to tissue-specific functions. We carried out genome-wide quantitative analysis of alternative splicing using a custom Affymetrix microarray to assess the role of the neuronal splicing factor Nova in the brain. We used a stringent algorithm to identify 591 exons that were differentially spliced in the brain relative to immune tissues, and 6.6% of these showed major splicing defects in the neocortex of Nova2(-/-) mice. We tested 49 exons with the largest predicted Nova-dependent splicing changes and validated all 49 by RT-PCR. We analyzed the encoded proteins and found that all those with defined brain functions acted in the synapse (34 of 40, including neurotransmitter receptors, cation channels, adhesion and scaffold proteins) or in axon guidance ( 8 of 40). Moreover, of the 35 proteins with known interaction partners, 74% (26) interact with each other. Validating a large set of Nova RNA targets has led us to identify a multi-tiered network in which Nova regulates the exon content of RNAs encoding proteins that interact in the synapse.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Univ Amsterdam, Fac Econ & Econometr, NL-1012 WX Amsterdam, Netherlands; Affymetrix Inc, Emeryville, CA USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; SRA Int Inc, Fairfax, VA 22033 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; University of Amsterdam; Affymetrix; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); SRA International	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Ule, Jernej/C-6315-2013; zeeberg, barry/AAO-1246-2020	Darnell, Robert B/0000-0002-5134-8088; Ule, Jernej/0000-0002-2452-4277; Weinstein, John/0000-0001-9401-6908; Ruggiu, Matteo/0000-0002-6404-1210; Spencer-Segal, Joanna/0000-0003-0467-2173; Clark, Tyson/0000-0002-7779-3227; Blume, John/0000-0003-3026-953X	NATIONAL CANCER INSTITUTE [Z01BC007349] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; ARGO F, 2004, CELL, V119, P257; Balla Z, 2002, J BIOL CHEM, V277, P21306, DOI 10.1074/jbc.M200553200; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; HUANG CS, IN PRESS CELL; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kim S, 2003, NUCLEIC ACIDS RES, V31, P1955, DOI 10.1093/nar/gkg286; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Le K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh173; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Parra M, 2004, GENOMICS, V84, P637, DOI 10.1016/j.ygeno.2004.06.004; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Wang H, 2003, BIOINFORMATICS, V19, pi315, DOI 10.1093/bioinformatics/btg1044; Wheeler R, 2002, LECT NOTES COMPUT SC, V2452, P201; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	50	378	391	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					844	852		10.1038/ng1610	http://dx.doi.org/10.1038/ng1610			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041372				2022-12-17	WOS:000230880400014
J	Takashima, H; Boerkoel, CF; John, J; Saifi, GM; Salih, MAM; Armstrong, D; Mao, YX; Quiocho, FA; Roa, BB; Nakagawa, M; Stockton, DW; Lupski, JR				Takashima, H; Boerkoel, CF; John, J; Saifi, GM; Salih, MAM; Armstrong, D; Mao, YX; Quiocho, FA; Roa, BB; Nakagawa, M; Stockton, DW; Lupski, JR			Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy	NATURE GENETICS			English	Article							PHOSPHOLIPASE-D SUPERFAMILY; COVALENT COMPLEXES; LINKAGE ANALYSIS; GENE; MEMBER; FAMILY; PHOSPHODIESTERASE; APOPTOSIS; MOTOR	Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs covalently bound topoisomerase I-DNA complexes(1-3) and is essential for preventing the formation of double-strand breaks that result when stalled topoisomerase I complexes interfere with DNA replication in yeast(4). Here we show that a deficiency of this DNA repair pathway in humans does not predispose to neoplasia or dysfunctions in rapidly replicating tissues, but instead causes spinocerebellar ataxia with axonal neuropathy (SCAN1) by affecting large, terminally differentiated, nondividing neuronal cells. Using genome-wide linkage mapping and a positional candidate approach in a Saudi Arabian family affected with autosomal recessive SCAN1, we identified a homozygous mutation in TDP1 (A1478G) that results in the substitution of histidine 493 with an arginine residue. The His493 residue is conserved in TDP1 across species and is located in the active site of the enzyme(3,5). Protein modeling predicts that mutation of this amino acid to arginine will disrupt the symmetric structure of the active site. We propose that loss-of-function mutations in TDP1 may cause SCAN1 either by interfering with DNA transcription or by inducing apoptosis in postmitotic neurons.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Kleberg Genotyping Ctr, Houston, TX 77030 USA; King Saud Univ, Coll Med, Dept Pediat, Div Pediat Neurol, Riyadh 11461, Saudi Arabia; Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Baylor DNA Diagnost Lab, Houston, TX 77030 USA; Kagoshima Univ, Sch Med, Dept Internal Med 3, Kagoshima 890, Japan; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; King Saud University; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Kagoshima University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.		Boerkoel, Cornelius Franciscus/AFW-4948-2022; Salih, Mustafa/C-1222-2014	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Mao, Yuxin/0000-0002-5064-1397; Salih, Mustafa/0000-0002-4379-2111				BENDIXEN C, 1990, BIOCHEMISTRY-US, V29, P5613, DOI 10.1021/bi00475a028; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Di Donato S, 2001, NEUROL SCI, V22, P219, DOI 10.1007/s100720100017; Gobbel GT, 1998, J NEUROSCI, V18, P147; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HARDING A, 1993, BRAINS DIS NERVOUS S, P432; Inamura N, 2000, J NEUROSCI RES, V60, P450, DOI 10.1002/(SICI)1097-4547(20000515)60:4<450::AID-JNR3>3.3.CO;2-G; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; KROEGER PE, 1989, NUCLEIC ACIDS RES, V17, P8495, DOI 10.1093/nar/17.21.8495; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Mao YX, 2001, CELL, V104, P433, DOI 10.1016/S0092-8674(01)00230-6; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; Ponting CP, 1996, PROTEIN SCI, V5, P914; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Rudolph AE, 1999, J BIOL CHEM, V274, P11824, DOI 10.1074/jbc.274.17.11824; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	30	378	383	1	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					267	272		10.1038/ng987	http://dx.doi.org/10.1038/ng987			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244316				2022-12-17	WOS:000178311100015
J	Kim, J; Piao, HL; Kim, BJ; Yao, F; Han, ZB; Wang, YM; Xiao, ZN; Siverly, AN; Lawhon, SE; Ton, BN; Lee, H; Zhou, ZC; Gan, BY; Nakagawa, S; Ellis, MJ; Liang, H; Hung, MC; You, MJ; Sun, YT; Ma, L				Kim, Jongchan; Piao, Hai-Long; Kim, Beom-Jun; Yao, Fan; Han, Zhenbo; Wang, Yumeng; Xiao, Zhenna; Siverly, Ashley N.; Lawhon, Sarah E.; Ton, Baochau N.; Lee, Hyemin; Zhou, Zhicheng; Gan, Boyi; Nakagawa, Shinichi; Ellis, Matthew J.; Liang, Han; Hung, Mien-Chie; You, M. James; Sun, Yutong; Ma, Li			Long noncoding RNA MALAT1 suppresses breast cancer metastasis	NATURE GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; MAMMARY-TUMORS; EMERGING ROLES; YAP; ACTIVATION; EXPRESSION; ONCOGENE; BINDING; GROWTH	MALAT1 has previously been described as a metastasis-promoting long noncoding RNA (lncRNA). We show here, however, that targeted inactivation of the Malat1 gene in a transgenic mouse model of breast cancer, without altering the expression of its adjacent genes, promotes lung metastasis, and that this phenotype can be reversed by genetic add-back of Malat1. Similarly, knockout of MALAT1 in human breast cancer cells induces their metastatic ability, which is reversed by re-expression of Malat1. Conversely, overexpression of Malat1 suppresses breast cancer metastasis in transgenic, xenograft, and syngeneic models. Mechanistically, the MALAT1 lncRNA binds and inactivates the prometastatic transcription factor TEAD, preventing TEAD from associating with its co-activator YAP and target gene promoters. Moreover, MALAT1 levels inversely correlate with breast cancer progression and metastatic ability. These findings demonstrate that MALAT1 is a metastasis-suppressing lncRNA rather than a metastasis promoter in breast cancer, calling for rectification of the model for this highly abundant and conserved lncRNA.	[Kim, Jongchan; Piao, Hai-Long; Yao, Fan; Xiao, Zhenna; Siverly, Ashley N.; Lawhon, Sarah E.; Ton, Baochau N.; Lee, Hyemin; Zhou, Zhicheng; Gan, Boyi; Ma, Li] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Piao, Hai-Long] Chinese Acad Sci, Dalian Inst Chem Phys, Sci Res Ctr Translat Med, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Kim, Beom-Jun; Ellis, Matthew J.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Han, Zhenbo; Hung, Mien-Chie; Sun, Yutong] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wang, Yumeng; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Xiao, Zhenna; Ma, Li] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Nakagawa, Shinichi] Hokkaido Univ, Fac Pharmaceut Sci, RNA Biol Lab, Sapporo, Hokkaido, Japan; [Hung, Mien-Chie] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [You, M. James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Hokkaido University; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Ma, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.; Ma, L (corresponding author), Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA.	lma4@mdanderson.org	Wang, Yumeng/W-4454-2018; Hung, Mien-Chie/ABD-5911-2021; Zhou, Zhicheng/AAM-8685-2020; Ma, Li/GQR-1313-2022; Gan, Boyi/HDM-4206-2022	Hung, Mien-Chie/0000-0003-4317-4740; Ma, Li/0000-0001-9965-989X; Xiao, Zhenna/0000-0002-7321-5593; Sun, Yutong/0000-0002-9368-2957; Kim, Jongchan/0000-0002-9733-9881	US National Institutes of Health (NIH) [R01CA166051, R01CA181029]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP150319]; Stand Up To Cancer Innovative Research Grant [403235]; NIH [R01CA164346, R01CA200703, R01CA175486, U24CA209851, R01CA181196, R01CA190370]; CPRIT [RP140402]; National Breast Cancer Foundation Inc.; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; CPRIT grant [RR140033]; NATIONAL CANCER INSTITUTE [R01CA166051, R01CA175486, R01CA164346, R01CA200703, R01CA181196, R01CA181029, R01CA190370, U24CA209851] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Stand Up To Cancer Innovative Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; National Breast Cancer Foundation Inc.; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; CPRIT grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Muller for providing MMTV-PyMT mice (C57BL/6 background), X. Zhang for providing luciferase-expressing LM2 cells, and J. Jacobson and L. Xin for providing ITGB4-luciferase and FU-luciferase-CRW/RFP constructs, respectively. We thank J. Zhang and MD Anderson's shRNA and ORFeome Core, Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core Facility, Sequencing and Microarray Facility, and Characterized Cell Line Core Facility for technical assistance. We thank all members of the Ma laboratory for discussions; J. Chen for critical reading of the manuscript; and J.-H. Yoon and M. Gorospe for advice on the CLIP assay. L.M. is supported by US National Institutes of Health (NIH) grants R01CA166051 and R01CA181029; a Cancer Prevention and Research Institute of Texas (CPRIT) grant (RP150319); and a Stand Up To Cancer Innovative Research Grant (403235). M.J.Y. was supported in part by NIH grants R01CA164346 and R01CA200703, and CPRIT RP140402. M.-C.H. is supported by National Breast Cancer Foundation Inc. and The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund. H. Liang is supported by NIH grants R01CA175486 and U24CA209851. M.J.E is supported by CPRIT grant RR140033. B.G. is supported by NIH grants R01CA181196 and R01CA190370.	Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bhattacharya R, 2017, BRIT J CANCER, V117, P848, DOI 10.1038/bjc.2017.238; Cao SZ, 2016, AM J CANCER RES, V6, P2561; Chao C, 1996, CANCER RES, V56, P4811; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Dai XF, 2017, J CANCER, V8, P3131, DOI 10.7150/jca.18457; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Evans JR, 2016, J CLIN INVEST, V126, P2775, DOI 10.1172/JCI84421; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Han Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.407; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang HT, 2017, ELIFE, V6, DOI 10.7554/eLife.26693; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jadaliha M, 2016, ONCOTARGET, V7, P40418, DOI 10.18632/oncotarget.9622; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Jiang GL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2911-z; Kim JC, 2016, CANCER RES, V76, P6424, DOI 10.1158/0008-5472.CAN-16-1571; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Latorre E, 2016, CANCER RES, V76, P2626, DOI 10.1158/0008-5472.CAN-15-2018; Leng C, 2016, CANCER LETT, V376, P188, DOI 10.1016/j.canlet.2016.03.023; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li L, 2009, P NATL ACAD SCI USA, V106, P12956, DOI 10.1073/pnas.0906005106; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Luo MN, 2016, CANCER LETT, V373, P1, DOI 10.1016/j.canlet.2016.01.010; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perrot-Applanat M, 2012, CELL ADHES MIGR, V6, P547, DOI 10.4161/cam.23332; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takaoka AS, 1998, J BIOL CHEM, V273, P33848, DOI 10.1074/jbc.273.50.33848; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Vogt M., 2013, BIO-PROTOCOL, V3, pe398, DOI DOI 10.21769/BioProtoc.398; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wood LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep19857; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Yoon JH, 2016, METHODS MOL BIOL, V1402, P11, DOI 10.1007/978-1-4939-3378-5_2; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	61	377	399	9	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1705	+		10.1038/s41588-018-0252-3	http://dx.doi.org/10.1038/s41588-018-0252-3			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30349115	Green Accepted			2022-12-17	WOS:000451434400018
J	Kamatani, Y; Matsuda, K; Okada, Y; Kubo, M; Hosono, N; Daigo, Y; Nakamura, Y; Kamatani, N				Kamatani, Yoichiro; Matsuda, Koichi; Okada, Yukinori; Kubo, Michiaki; Hosono, Naoya; Daigo, Yataro; Nakamura, Yusuke; Kamatani, Naoyuki			Genome-wide association study of hematological and biochemical traits in a Japanese population	NATURE GENETICS			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; PLATELET GLYCOPROTEIN-IB; HEMOGLOBIN LEVELS; LOCI; MUTATION; VARIANTS; GENE; ERYTHROCYTE; PROTEIN; HUMANS	We report genome-wide association studies for hematological and biochemical traits from similar to 14,700 Japanese individuals. We identified 60 associations for 8 hematological traits and 29 associations for 12 biochemical traits at genome-wide significance levels (P < 5 x 10(-8)). Of these, 46 associations were new to this study and 43 replicated previous reports. We compared these associated loci with those reported in similar GWAS in European populations. When the minor allele frequency was >10% in the Japanese population, 32 (94.1%) and 31 (91.2%) of the 34 hematological loci previously reported to be associated in a European population were replicated with P-values less than 0.05 and 0.01, respectively, and 31 (73.8%) and 27 (64.3%) of the 42 European biochemical loci were replicated.	[Kamatani, Yoichiro; Matsuda, Koichi; Daigo, Yataro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Kamatani, Yoichiro; Daigo, Yataro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Okada, Yukinori; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Kanagawa, Japan; [Kubo, Michiaki; Hosono, Naoya] RIKEN, Lab Genotyping Dev, Kanagawa, Japan; [Nakamura, Yusuke] RIKEN, Ctr Genom Med, Kanagawa, Japan	University of Tokyo; University of Tokyo; RIKEN; RIKEN; RIKEN	Kamatani, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	kamatani@msb.biglobe.ne.jp	Kamatani, Yoichiro/N-5513-2015; Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	Daigo, Yataro/0000-0002-0915-3025; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the technical staff of the Laboratory for Genotyping Development at RIKEN for SNP genotyping and K. Kamatani for useful advice about statistical analyses. We also thank all the participants and the staff of the BioBank Japan project. This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bagnasco SM, 2001, AM J PHYSIOL-RENAL, V281, pF400, DOI 10.1152/ajprenal.2001.281.3.F400; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Garner C, 2006, EUR J HUM GENET, V14, P101, DOI 10.1038/sj.ejhg.5201499; HARMON JT, 1986, J BIOL CHEM, V261, P3224; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ichida K, 2008, CLIN GENET, V74, P243, DOI 10.1111/j.1399-0004.2008.01021.x; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Maguire JM, 2008, STROKE, V39, P1710, DOI 10.1161/STROKEAHA.107.507228; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nose J, 2008, J HUM GENET, V53, P425, DOI 10.1007/s10038-008-0266-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; WARE J, 1990, P NATL ACAD SCI USA, V87, P2026, DOI 10.1073/pnas.87.5.2026; Whitehead A., 2002, METAANALYSIS CONTROL; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	40	377	388	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					210	U25		10.1038/ng.531	http://dx.doi.org/10.1038/ng.531			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20139978				2022-12-17	WOS:000274912400008
J	Chambers, JC; Elliott, P; Zabaneh, D; Zhang, WH; Li, Y; Froguel, P; Balding, D; Scott, J; Kooner, JS				Chambers, John C.; Elliott, Paul; Zabaneh, Delilah; Zhang, Weihua; Li, Yun; Froguel, Philippe; Balding, David; Scott, James; Kooner, Jaspal S.			Common genetic variation near MC4R is associated with waist circumference and insulin resistance	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; OBESITY; DISEASE; EXPRESSION; RISK	We carried out a genome-wide association study (318,237 SNPs) for insulin resistance and related phenotypes in 2,684 Indian Asians, with further testing in 11,955 individuals of Indian Asian or European ancestry. We found associations of rs12970134 near MC4R with waist circumference (P = 1.7 x 10(-9)) and, independently, with insulin resistance. Homozygotes for the risk allele of rs12970134 have similar to 2 cm increased waist circumference. Common genetic variation near MC4R is associated with risk of adiposity and insulin resistance.	[Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London W12 0NN, England; [Chambers, John C.; Elliott, Paul; Zabaneh, Delilah; Zhang, Weihua; Balding, David] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Li, Yun] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London W12 0NN, England; Inst Pasteur, Ctr Natl Rech Sci, Inst Biol 8090, F-59019 Lille, France	Imperial College London; Imperial College London; University of Michigan System; University of Michigan; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Kooner, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, Du Cane Rd, London W12 0NN, England.	j.kooner@imperial.ac.uk	zhang, weihua/GXV-1334-2022; FROGUEL, Philippe/O-6799-2017; Balding, David/G-9898-2011	FROGUEL, Philippe/0000-0003-2972-0784; Balding, David/0000-0002-1480-6115	British Heart Foundation [SP/04/002] Funding Source: Medline; Medical Research Council [G0601966, G0700931, G0600331] Funding Source: Medline; Wellcome Trust [066786] Funding Source: Medline; MRC [G0700931, G0600331, G0601966] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kooner JS, 1998, ARTERIOSCL THROM VAS, V18, P1021, DOI 10.1161/01.ATV.18.7.1021; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Trevaskis JL, 2007, OBESITY, V15, P2664, DOI 10.1038/oby.2007.318; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	15	377	390	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					716	718		10.1038/ng.156	http://dx.doi.org/10.1038/ng.156			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18454146	Green Submitted			2022-12-17	WOS:000256212000012
J	Fitzpatrick, GV; Soloway, PD; Higgins, MJ				Fitzpatrick, GV; Soloway, PD; Higgins, MJ			Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; GENE-CLUSTER; CONTROL ELEMENT; MOUSE MODEL; EXPRESSION; P57(KIP2); DISRUPTION; DOMAIN; IGF2; H19	Genomic imprinting is an epigenetic modification that results in expression from only one of the two parental copies of a gene. Differences in methylation between the two parental chromosomes are often observed at or near imprinted genes. Beckwith-Wiedemann syndrome (BWS), which predisposes to cancer and excessive growth, results from a disruption of imprinted gene expression in chromosome band 11p15.5. One third of individuals with BWS lose maternal-specific methylation at KvDMR1, a putative imprinting control region within intron 10 of the KCNQ1 gene(1-3), and it has been proposed that this epimutation results in aberrant imprinting and, consequently, BWS1,2. Here we show that paternal inheritance of a deletion of KvDMR1 results in the de-repression in cis of six genes, including Cdkn1c, which encodes cyclin-dependent kinase inhibitor 1C. Furthermore, fetuses and adult mice that inherited the deletion from their fathers were 20-25% smaller than their wildtype littermates. By contrast, maternal inheritance of this deletion had no effect on imprinted gene expression or growth. Thus, the unmethylated paternal KvDMR1 allele regulates imprinted expression by silencing genes on the paternal chromosome. These findings support the hypothesis that loss of methylation in BWS patients activates the repressive function of KvDMR1 on the maternal chromosome, resulting in abnormal silencing of CDKN1C and the development of BWS.	Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Higgins, MJ (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.		Soloway, Paul/T-8243-2019	Soloway, Paul/0000-0003-1967-0437				Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Cooper PR, 1998, GENOMICS, V49, P38, DOI 10.1006/geno.1998.5221; Engel JR, 2000, J MED GENET, V37, P921, DOI 10.1136/jmg.37.12.921; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Grandjean V, 2000, P NATL ACAD SCI USA, V97, P5279, DOI 10.1073/pnas.080409297; Hata K, 2002, DEVELOPMENT, V129, P1983; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Lee MP, 1999, HUM MOL GENET, V8, P683, DOI 10.1093/hmg/8.4.683; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; SINGERSAM J, 1994, PCR METH APPL, V3, pS48; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Srivastava M, 2000, GENE DEV, V14, P1186; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	29	377	385	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					426	431		10.1038/ng988	http://dx.doi.org/10.1038/ng988			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410230				2022-12-17	WOS:000179034800021
J	CLARK, RF; HUTTON, M; FULDNER, RA; FROELICH, S; KARRAN, E; TALBOT, C; CROOK, R; LENDON, C; PRIHAR, G; HE, C; KORENBLAT, K; MARTINEZ, A; WRAGG, M; BUSFIELD, F; BEHRENS, MI; MYERS, A; NORTON, J; MORRIS, J; MEHTA, N; PEARSON, C; LINCOLN, S; BAKER, M; DUFF, K; ZEHR, C; PEREZTUR, J; HOULDEN, H; RUIZ, A; OSSA, J; LOPERA, F; ARCOS, M; MADRIGAL, L; COLLINGE, J; HUMPHREYS, C; ASHWORTH, A; SARNER, S; FOX, N; HARVEY, R; KENNEDY, A; ROQUES, P; CLINE, RT; PHILLIPS, CA; VENTER, JC; FORSELL, L; AXELMAN, K; LILIUS, L; JOHNSTON, J; COWBURN, R; VIITANEN, M; WINBLAD, B; KOSIK, K; HALTIA, M; POYHONEN, M; DICKSON, D; MANN, D; NEARY, D; SNOWDEN, J; LANTOS, P; LANNFELT, L; ROSSOR, M; ROBERTS, GW; ADAMS, MD; HARDY, J; GOATE, A				CLARK, RF; HUTTON, M; FULDNER, RA; FROELICH, S; KARRAN, E; TALBOT, C; CROOK, R; LENDON, C; PRIHAR, G; HE, C; KORENBLAT, K; MARTINEZ, A; WRAGG, M; BUSFIELD, F; BEHRENS, MI; MYERS, A; NORTON, J; MORRIS, J; MEHTA, N; PEARSON, C; LINCOLN, S; BAKER, M; DUFF, K; ZEHR, C; PEREZTUR, J; HOULDEN, H; RUIZ, A; OSSA, J; LOPERA, F; ARCOS, M; MADRIGAL, L; COLLINGE, J; HUMPHREYS, C; ASHWORTH, A; SARNER, S; FOX, N; HARVEY, R; KENNEDY, A; ROQUES, P; CLINE, RT; PHILLIPS, CA; VENTER, JC; FORSELL, L; AXELMAN, K; LILIUS, L; JOHNSTON, J; COWBURN, R; VIITANEN, M; WINBLAD, B; KOSIK, K; HALTIA, M; POYHONEN, M; DICKSON, D; MANN, D; NEARY, D; SNOWDEN, J; LANTOS, P; LANNFELT, L; ROSSOR, M; ROBERTS, GW; ADAMS, MD; HARDY, J; GOATE, A			THE STRUCTURE OF THE PRESENILIN-1 (S182) GENE AND IDENTIFICATION OF 6 NOVEL MUTATIONS IN EARLY-ONSET AD FAMILIES	NATURE GENETICS			English	Letter							ALZHEIMERS-DISEASE LOCUS; HUMAN GENOME; CHROMOSOME-14; MAP		UNIV S FLORIDA,DEPT PSYCHIAT,SUNCOAST ALZHEIMERS DIS LAB,TAMPA,FL 33613; UNIV S FLORIDA,DEPT PHARMACOL,SUNCOAST ALZHEIMERS DIS LAB,TAMPA,FL 33613; UNIV S FLORIDA,DEPT BIOCHEM,SUNCOAST ALZHEIMERS DIS LAB,TAMPA,FL 33613; UNIV S FLORIDA,DEPT NEUROL,SUNCOAST ALZHEIMERS DIS LAB,TAMPA,FL 33613; WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; TIGR,GAITHERSBURG,MD 20878; KAROLINSKA INST,HUDDINGE,SWEDEN; SMITHKLINE BEECHAM,DEPT MOLEC NEUROPATHOL,HARLOW,ESSEX,ENGLAND; UNIV ANTIOQUIA,DEPT BIOCHEM,MEDELLIN,COLOMBIA; UNIV ANTIOQUIA,DEPT NEUROL,MEDELLIN,COLOMBIA; UNIV ANTIOQUIA,DEPT MED,MEDELLIN,COLOMBIA; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT BIOCHEM,LONDON W2 1PG,ENGLAND; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT NEUROL,LONDON W2 1PG,ENGLAND; NATL HOSP NEUROL & NEUROSURG,LONDON WC1,ENGLAND; BRIGHAM & WOMENS HOSP,DEPT NEUROL,BOSTON,MA 02113; UNIV HELSINKI,DEPT PATHOL,HELSINKI,FINLAND; OULU UNIV HOSP,DEPT CLIN GENET,OULU,FINLAND; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PATHOL,BRONX,NY 10461; UNIV MANCHESTER,DEPT PATHOL SCI,MANCHESTER,LANCS,ENGLAND; UNIV MANCHESTER,DEPT NEUROL,MANCHESTER,LANCS,ENGLAND; INST PSYCHIAT,DEPT NEUROPATHOL,LONDON SE5,ENGLAND	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); J. Craig Venter Institute; Karolinska Institutet; GlaxoSmithKline; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Imperial College London; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Harvard University; Brigham & Women's Hospital; University of Helsinki; University of Oulu; Yeshiva University; Albert Einstein College of Medicine; University of Manchester; University of Manchester			Fox, Nick C/B-1319-2009; Fox, Nick C/AAE-1849-2021; Rossor, Martin/C-1598-2008; Poyhonen, Minna/K-4866-2018; LOPERA, FRANCISCO/AAR-5968-2021; Myers, Amanda J/B-1796-2010; Houlden, Henry J/C-1532-2008; Johnston, Janet A/C-4890-2009; Perez-Tur, Jordi/A-2143-2010; Viitanen, Matti/AAY-5163-2020; Behrens, Maria I I/I-1083-2013; Duff, Karen EK/C-2510-2009; Hardy, John/C-2451-2009; Arcos-Burgos, Mauricio/H-1326-2017	Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Poyhonen, Minna/0000-0003-2037-2744; Myers, Amanda J/0000-0002-3100-9396; Houlden, Henry J/0000-0002-2866-7777; Perez-Tur, Jordi/0000-0002-9111-1712; Behrens, Maria I I/0000-0003-0964-426X; Hardy, John/0000-0002-3122-0423; Duff, Karen/0000-0002-6177-868X; Clark, Robert/0000-0001-5091-8280; Talbot, Christopher/0000-0001-7406-8962; Goate, Alison/0000-0002-0576-2472; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Rossor, Martin/0000-0001-8215-3120	NIA NIH HHS [AG12028, AG1187, AG00634] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012028] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMS MD, 1994, NATURE, V368, P474, DOI 10.1038/368474a0; AUFFRAY C, 1995, CR ACAD SCI III-VIE, V318, P263; BATESON AN, 1991, J NEUROCHEM, V56, P1437, DOI 10.1111/j.1471-4159.1991.tb11443.x; CLARK RF, IN PRESS HUM MOL GEN; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; GYNAPAY G, 1994, NAT GENET, V7, P246; HALTIA M, 1994, ANN NEUROL, V36, P362, DOI 10.1002/ana.410360307; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; HUTTON M, 1995, FOCUS, V17, P24; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; LEVYLAHAD E, 1995, SCIENCE, V268, P973; LEVYLAHAD E, 1995, SCIENCE, V268, P970; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SONG XH, IN PRESS SOC NEUR AB; SRIVASTAVA A, 1992, PCR METH APPL, V1, P25; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	22	377	395	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					219	222		10.1038/ng1095-219	http://dx.doi.org/10.1038/ng1095-219			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550356				2022-12-17	WOS:A1995RX80600030
J	Ahmed, S; Thomas, G; Ghoussaini, M; Healey, CS; Humphreys, MK; Platte, R; Morrison, J; Maranian, M; Pooley, KA; Luben, R; Eccles, D; Evans, DG; Fletcher, O; Johnson, N; Silva, ID; Peto, J; Stratton, MR; Rahman, N; Jacobs, K; Prentice, R; Anderson, GL; Rajkovic, A; Curb, JD; Ziegler, RG; Berg, CD; Buys, SS; McCarty, CA; Feigelson, HS; Calle, EE; Thun, MJ; Diver, WR; Bojesen, S; Nordestgaard, BG; Flyger, H; Dork, T; Schurmann, P; Hillemanns, P; Karstens, JH; Bogdanova, NV; Antonenkova, NN; Zalutsky, IV; Bermisheva, M; Fedorova, S; Khusnutdinova, E; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Devilee, P; van Asperen, CJ; Tollenaar, RAEM; Seynaeve, C; Garcia-Closas, M; Lissowska, J; Brinton, L; Peplonska, B; Nevanlinna, H; Heikkinen, T; Aittomaki, K; Blomqvist, C; Hopper, JL; Southey, MC; Smith, L; Spurdle, AB; Schmidt, MK; Broeks, A; van Hien, RR; Cornelissen, S; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Schmutzler, RK; Burwinkel, B; Bartram, CR; Meindl, A; Brauch, H; Justenhoven, C; Hamann, U; Chang-Claude, J; Hein, R; Wang-Gohrke, S; Lindblom, A; Margolin, S; Mannermaa, A; Kosma, VM; Kataja, V; Olson, JE; Wang, XS; Fredericksen, Z; Giles, GG; Severi, G; Baglietto, L; English, DR; Hankinson, SE; Cox, DG; Kraft, P; Vatten, LJ; Hveem, K; Kumle, M; Sigurdson, A; Doody, M; Bhatti, P; Alexander, BH; Hooning, MJ; van den Ouweland, AMW; Oldenburg, RA; Schutte, M; Hall, P; Czene, K; Liu, JJ; Li, YQ; Cox, A; Elliott, G; Brock, I; Reed, MWR; Shen, CY; Yu, JC; Hsu, GC; Chen, ST; Anton-Culver, H; Ziogas, A; Andrulis, IL; Knight, JA; Beesley, J; Goode, EL; Couch, F; Chenevix-Trench, G; Hoover, RN; Ponder, BAJ; Hunter, DJ; Pharoah, PDP; Dunning, AM; Chanock, SJ; Easton, DF				Ahmed, Shahana; Thomas, Gilles; Ghoussaini, Maya; Healey, Catherine S.; Humphreys, Manjeet K.; Platte, Radka; Morrison, Jonathan; Maranian, Melanie; Pooley, Karen A.; Luben, Robert; Eccles, Diana; Evans, D. Gareth; Fletcher, Olivia; Johnson, Nichola; Silva, Isabel dos Santos; Peto, Julian; Stratton, Michael R.; Rahman, Nazneen; Jacobs, Kevin; Prentice, Ross; Anderson, Garnet L.; Rajkovic, Aleksandar; Curb, J. David; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S.; McCarty, Catherine A.; Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, W. Ryan; Bojesen, Stig; Nordestgaard, Borge G.; Flyger, Henrik; Doerk, Thilo; Schuermann, Peter; Hillemanns, Peter; Karstens, Johann H.; Bogdanova, Natalia V.; Antonenkova, Natalia N.; Zalutsky, Iosif V.; Bermisheva, Marina; Fedorova, Sardana; Khusnutdinova, Elza; Kang, Daehee; Yoo, Keun-Young; Noh, Dong Young; Ahn, Sei-Hyun; Devilee, Peter; van Asperen, Christi J.; Tollenaar, R. A. E. M.; Seynaeve, Caroline; Garcia-Closas, Montserrat; Lissowska, Jolanta; Brinton, Louise; Peplonska, Beata; Nevanlinna, Heli; Heikkinen, Tuomas; Aittomaki, Kristiina; Blomqvist, Carl; Hopper, John L.; Southey, Melissa C.; Smith, Letitia; Spurdle, Amanda B.; Schmidt, Marjanka K.; Broeks, Annegien; van Hien, Richard R.; Cornelissen, Sten; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Schmutzler, Rita K.; Burwinkel, Barbara; Bartram, Claus R.; Meindl, Alfons; Brauch, Hiltrud; Justenhoven, Christina; Hamann, Ute; Chang-Claude, Jenny; Hein, Rebecca; Wang-Gohrke, Shan; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kosma, Veli-Matti; Kataja, Vesa; Olson, Janet E.; Wang, Xianshu; Fredericksen, Zachary; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; English, Dallas R.; Hankinson, Susan E.; Cox, David G.; Kraft, Peter; Vatten, Lars J.; Hveem, Kristian; Kumle, Merethe; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Alexander, Bruce H.; Hooning, Maartje J.; van den Ouweland, Ans M. W.; Oldenburg, Rogier A.; Schutte, Mieke; Hall, Per; Czene, Kamila; Liu, Jianjun; Li, Yuqing; Cox, Angela; Elliott, Graeme; Brock, Ian; Reed, Malcolm W. R.; Shen, Chen-Yang; Yu, Jyh-Cherng; Hsu, Giu-Cheng; Chen, Shou-Tung; Anton-Culver, Hoda; Ziogas, Argyrios; Andrulis, Irene L.; Knight, Julia A.; Beesley, Jonathan; Goode, Ellen L.; Couch, Fergus; Chenevix-Trench, Georgia; Hoover, Robert N.; Ponder, Bruce A. J.; Hunter, David J.; Pharoah, Paul D. P.; Dunning, Alison M.; Chanock, Stephen J.; Easton, Douglas F.		SEARCH; GENICA Consortium; KConFab; Australian Ovarian Cancer Study	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; COMMON VARIANTS	Genome-wide association studies (GWAS) have identified seven breast cancer susceptibility loci, but these explain only a small fraction of the familial risk of the disease. Five of these loci were identified through a two-stage GWAS involving 390 familial cases and 364 controls in the first stage, and 3,990 cases and 3,916 controls in the second stage(1). To identify additional loci, we tested over 800 promising associations from this GWAS in a further two stages involving 37,012 cases and 40,069 controls from 33 studies in the CGEMS collaboration and Breast Cancer Association Consortium. We found strong evidence for additional susceptibility loci on 3p (rs4973768: per-allele OR 1.11, 95% CI = 1.08-1.13, P = 4.1 x 10(-23)) and 17q (rs6504950: per-allele OR 0.95, 95% CI = 0.92-0.97, P = 1.4 x 10(-8)). Potential causative genes include SLC4A7 and NEK10 on 3p and COX11 on 17q.	[Humphreys, Manjeet K.; Morrison, Jonathan; Pooley, Karen A.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge, England; [Ahmed, Shahana; Ghoussaini, Maya; Healey, Catherine S.; Platte, Radka; Maranian, Melanie; Ponder, Bruce A. J.; Dunning, Alison M.; SEARCH] Univ Cambridge, Dept Oncol, Cambridge, England; [Thomas, Gilles; Jacobs, Kevin; Ziegler, Regina G.; Garcia-Closas, Montserrat; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Hoover, Robert N.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD USA; [Luben, Robert] Univ Cambridge, EPIC, Dept Publ Hlth & Primary Care, Cambridge, England; [Eccles, Diana] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Evans, D. Gareth] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; [Fletcher, Olivia; Johnson, Nichola] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Fletcher, Olivia; Silva, Isabel dos Santos; Peto, Julian] London Sch Hyg & Trop Med, London WC1, England; [Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Jacobs, Kevin] Bioinformed Consulting Serv, Gaithersburg, MD USA; [Jacobs, Kevin] NCI, Core Genotyping Facil, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Prentice, Ross; Anderson, Garnet L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Rajkovic, Aleksandar] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Curb, J. David] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Pacific Hlth Res Inst, Honolulu, HI 96822 USA; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Buys, Saundra S.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, W. Ryan] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Bojesen, Stig; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Dept Breast Surg, Herlev, Denmark; [Doerk, Thilo; Schuermann, Peter; Hillemanns, Peter; Bogdanova, Natalia V.; Bermisheva, Marina] Hannover Med Sch, Dept Obstet & Gynaecol, D-3000 Hannover, Germany; [Karstens, Johann H.] Hannover Med Sch, Dept Radiat Oncol, D-3000 Hannover, Germany; [Bogdanova, Natalia V.; Antonenkova, Natalia N.; Zalutsky, Iosif V.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Bermisheva, Marina; Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Fedorova, Sardana] Russian Acad Med Sci, Yakut Res Ctr, Dept Med Genet, Yakutsk, Russia; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong Young; Ahn, Sei-Hyun] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Tollenaar, R. A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Daniel Hoed Canc Ctr, Rotterdam Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Dept Epidemiol & Canc Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Brinton, Louise] NCI, Hormonal & Reprod Epidemiol Branch, Rockville, MD USA; [Peplonska, Beata] Nofer Inst Occupat Med, Dept Occupat & Environm Epidemiol, Lodz, Poland; [Nevanlinna, Heli; Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Hopper, John L.; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Smith, Letitia; Spurdle, Amanda B.; Beesley, Jonathan; Chenevix-Trench, Georgia] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Schmidt, Marjanka K.; Broeks, Annegien; Cornelissen, Sten] Netherlands Canc Inst, Amsterdam, Netherlands; [Milne, Roger L.] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Ribas, Gloria; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain; [Gonzalez-Neira, Anna; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Natl Genotyping Ctr CEGEN, Human Canc Genet Program, Madrid, Spain; [Schmutzler, Rita K.] Spanish Natl Canc Res Ctr CNIO, Natl Genotyping Ctr CEGEN, Human Canc Genet Program, Madrid, Spain; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, D-6900 Heidelberg, Germany; [Burwinkel, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Bartram, Claus R.] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Meindl, Alfons] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Brauch, Hiltrud; Justenhoven, Christina; GENICA Consortium] Univ Tubingen, Tubingen, Germany; [Hamann, Ute] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Chang-Claude, Jenny; Hein, Rebecca] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Wang-Gohrke, Shan] Womens Hosp Univ Ulm, Ulm, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Pathol & Oncol, S-17176 Stockholm, Sweden; [Mannermaa, Arto; Kosma, Veli-Matti] Univ Kuopio, Pathol & Forens Med & Bioctr Kuopio, Inst Clin Med, FIN-70211 Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Dept Oncol, SF-70210 Kuopio, Finland; [Kataja, Vesa] Vaasa Cent Hosp, Dept Oncol, Vaasa, Finland; [Olson, Janet E.; Wang, Xianshu; Fredericksen, Zachary; Couch, Fergus] Mayo Clin, Coll Med, Rochester, MN USA; [Giles, Graham G.; Severi, Gianluca; English, Dallas R.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Hankinson, Susan E.; Cox, David G.; Hunter, David J.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Hankinson, Susan E.; Cox, David G.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Vatten, Lars J.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Kumle, Merethe] Univ Tromso, Inst Community Med, Tromso, Norway; [Alexander, Bruce H.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Serv, Minneapolis, MN USA; [Hooning, Maartje J.; Schutte, Mieke] Erasmus Univ, Med Ctr, Rotterdam Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [van den Ouweland, Ans M. W.; Oldenburg, Rogier A.] Erasmus Univ, Med Ctr, Rotterdam Family Canc Clin, Dept Clin Genet, Rotterdam, Netherlands; [Hall, Per; Czene, Kamila] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Jianjun; Li, Yuqing] Genome Inst Singapore, Singapore, Singapore; [Elliott, Graeme] Univ Sheffield, Sch Med & Biomed Sci, Inst Canc Studies, Sheffield, S Yorkshire, England; [Reed, Malcolm W. R.] Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Surg Oncol, Sheffield, S Yorkshire, England; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Grad Inst Environm Sci, Taichong, Taiwan; [Yu, Jyh-Cherng; Hsu, Giu-Cheng] Tri Serv Gen Hosp, Taipei, Taiwan; [Chen, Shou-Tung] Changhua Christian Hosp, Changhua, Taiwan; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Andrulis, Irene L.; Knight, Julia A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Ontario Familial Breast Canc Registry, Toronto, ON, Canada; [KConFab; Australian Ovarian Cancer Study] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Ponder, Bruce A. J.] Canc Res UK Cambridge Canc Res Inst, Cambridge, England; [Chanock, Stephen J.] NCI, Adv Technol Ctr, Gaithersburg, MD USA; [Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Surrey, England	University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Fred Hutchinson Cancer Center; Baylor College of Medicine; Pacific Health Research & Education Institute; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; American Cancer Society; University of Copenhagen; University of Copenhagen; University of Copenhagen; Hannover Medical School; Hannover Medical School; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Russian Academy of Medical Sciences; Seoul National University (SNU); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nofer Institute of Occupational Medicine; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; Netherlands Cancer Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Vaasa Central Hospital; Mayo Clinic; Cancer Council Victoria; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University of Minnesota System; University of Minnesota Twin Cities; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Sheffield; University of Sheffield; Academia Sinica - Taiwan; China Medical University Taiwan; Tri-Service General Hospital; Changhua Christian Hospital; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Peter Maccallum Cancer Center; Cancer Research UK; CRUK Cambridge Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Institute of Cancer Research - UK	Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge, England.	douglas@srl.cam.ac.uk	Peplonska, Beata/F-6004-2010; Baglietto, Laura/AAB-9051-2019; Yoo, Keun-Young/J-5548-2012; Nordestgaard, Borge Gronne/ABF-1310-2020; Fedorova, Sardana/K-5445-2017; Noh, Dong-Young/G-5531-2011; Lissowska, Jolanta/AAH-3252-2020; Brinton, Louise A/G-7486-2015; Spurdle, Amanda B/A-4978-2011; Andrulis, Irene L./E-7267-2013; Eccles, Diana/K-6327-2019; DEVILEE, PETER/ABR-2140-2022; Severi, Gianluca/H-3774-2018; Margolin, Sara/AAX-9034-2020; Ribas-Despuig, Gloria/M-6190-2017; Rahman, Nazneen/B-8890-2012; Severi, Gianluca/Q-1824-2019; English, Dallas/AAH-5005-2019; van Asperen, Christi J/D-3970-2012; Chenevix-Trench, Georgia/AAV-2014-2020; Gonzalez-Neira, Anna/C-5791-2015; Knight, Julia/R-5617-2019; Luben, Robert N/H-5519-2015; Vatten, Lars/AAF-9380-2022; Garcia-Closas, Montserrat/F-3871-2015; Smith, Letitia/J-9035-2014; Vatten, Lars/AFK-2073-2022; Shen, CY/F-6271-2010; Bogdanova, Natalia V./Y-2205-2019; Cox, David G/A-2023-2009; Reed, Malcolm Walter/AAG-9219-2020; Evans, D Gareth/AAB-4308-2022; Schmidt, Marjanka K/G-9058-2011; Peplonska, Beata/AAO-1265-2020; Devilee, Peter/GXV-8005-2022; Khusnutdinova, Elza Kamilevna/A-4810-2013; Pharoah, Paul/V-6658-2019; Kang, Dae Hee/E-8631-2012; Bowtell, David/H-1007-2016; Dörk, Thilo/J-8620-2012; Cox, David/ABA-7454-2020; Diver, Ryan/AAG-3469-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Knight, Julia/A-6843-2012; Hveem, Kristian/AFV-4683-2022; Flyger, Henrik/AAM-6494-2021; Rahman, Nazneen/D-2802-2013; Ribas, Gloria/K-3379-2013	Lissowska, Jolanta/0000-0003-2695-5799; Brinton, Louise A/0000-0003-3853-8562; Spurdle, Amanda B/0000-0003-1337-7897; Eccles, Diana/0000-0002-9935-3169; Severi, Gianluca/0000-0001-7157-419X; Severi, Gianluca/0000-0001-7157-419X; English, Dallas/0000-0001-7828-8188; van Asperen, Christi J/0000-0002-1436-7650; Chenevix-Trench, Georgia/0000-0002-1878-2587; Gonzalez-Neira, Anna/0000-0002-5421-2020; Knight, Julia/0000-0002-7610-7635; Luben, Robert N/0000-0002-5088-6343; Garcia-Closas, Montserrat/0000-0003-1033-2650; Cox, David G/0000-0002-2152-9259; Reed, Malcolm Walter/0000-0001-7442-2132; Evans, D Gareth/0000-0002-8482-5784; Schmidt, Marjanka K/0000-0002-2228-429X; Peplonska, Beata/0000-0003-3915-2872; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Pharoah, Paul/0000-0001-8494-732X; Bowtell, David/0000-0001-9089-7525; Dörk, Thilo/0000-0002-9458-0282; Diver, Ryan/0000-0002-5418-9000; Garcia-Closas, Montserrat/0000-0003-1033-2650; Margolin, Sara/0000-0002-5526-5570; Nevanlinna, Heli/0000-0002-0916-2976; Rahman, Nazneen/0000-0003-4376-0440; Fedorova, Sardana/0000-0002-6952-3868; dos Santos Silva, Isabel/0000-0002-6596-8798; Thorne, Heather/0000-0003-3610-2511; Kataja, Vesa/0000-0003-4846-4843; Dunning, Alison Margaret/0000-0001-6651-7166; Beesley, Jonathan/0000-0003-1942-325X; Brauch, Hiltrud/0000-0001-7531-2736; Giles, Graham/0000-0003-4946-9099; McCarty, Catherine/0000-0003-1089-0142; Fletcher, Olivia/0000-0001-9387-7116; Bowcock, Anne/0000-0001-8691-9090; Liu, Jianjun/0000-0002-3255-3019; Southey, Melissa/0000-0002-6313-9005; Baglietto, Laura/0000-0002-8193-7529; Roth, Rebecca/0000-0002-2841-4921; Heikkinen, Tuomas/0000-0003-1154-6204; Kang, Daehee/0000-0003-4031-5878; Cox, David/0000-0003-2047-4687; Bhatti, Parveen/0000-0003-1709-1781; Czene, Kamila/0000-0002-3233-5695; Blomqvist, Carl/0000-0003-3041-1938; Ribas, Gloria/0000-0001-6883-4130; Cox, Angela/0000-0002-5138-1099	NATIONAL CANCER INSTITUTE [P30CA062203, U01CA067262, R01CA104021, U01CA069446, K07CA092044, R01CA122340, U01CA058860, U01CA098233, R01CA067262, U01CA069631, K22CA095011, R01CA065725, R01CA049449, P01CA087969, U01CA069638, P50CA116201, U01CA069467, U01CA049449, U01CA069417, R01CA050385, R01CA058860, U01CA069398, R01CA102740, U01CA098710] Funding Source: NIH RePORTER; Cancer Research UK [11021, C1287/A5260, C1287/A10118, 10118, A10123, C490/A11021, 10124, C1287/A7497, 11022] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [P50 CA116201, R01 CA065725, U01 CA049449, U01 CA069446, P01 CA087969, CA67262, R01 CA058860, CA65725, R01 CA104021-04, CA87969, U01 CA069398, U01 CA69638, U01 CA069638, U01 CA098233, U01 CA058860, CA-92044, CA-06-503, R01 CA050385, K07 CA092044, U01 CA069417, U01 CA067262, U01 CA69631, CA49449, UO1 CA69467, U01 CA069631, U01 CA69446, U01 CA69398, R01 CA102740, U01 CA69467, 5UO1CA098233, U01 CA069467, R01 CA102740-01A2, U01 CA69417, R01 CA067262, U01 CA098710, CA-95-011, R01 CA122340, R01 CA049449, UO1 CA098710, P30 CA062203, CA50385, CA-58860] Funding Source: Medline; Breast Cancer Now [2004NOV49] Funding Source: Medline; The Francis Crick Institute [10124] Funding Source: researchfish	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Now; The Francis Crick Institute		Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	11	376	386	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					585	590		10.1038/ng.354	http://dx.doi.org/10.1038/ng.354			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19330027	Green Accepted			2022-12-17	WOS:000265575600020
J	Rieder, MJ; Taylor, SL; Clark, AG; Nickerson, DA				Rieder, MJ; Taylor, SL; Clark, AG; Nickerson, DA			Sequence variation in the human angiotensin converting enzyme	NATURE GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; CARDIOVASCULAR-DISEASE; DNA-SEQUENCES; GENE; POLYMORPHISM; POPULATIONS; INFERENCE; GENOTYPE; AFRICAN; NUMBER	Angiotensin converting enzyme (encoded by the gene DCP1, also known as ACE) catalyses the conversion of angiotensin I to the physiologically active peptide angiotensin II, which controls fluid-electrolyte balance and systemic blood pressure. Because of its key function in the renin-angiotensin system, many association studies have been performed with DCP1. Nearly all studies have associated the presence (insertion, I) or absence (deletion, D) of a 287-bp Alu repeat element in intron 16 with the levels of circulating enzyme or cardiovascular pathophysiologies(1-3). Many epidemiological studies suggest that the DCP1*D allele confers increased susceptibility to cardiovascular disease; however, other reports have found no such association or even a beneficial effect (refs 4-7), We present here the complete genomic sequence of DCP1 from 11 individuals, representing the longest contiguous scan (24 kb) for sequence variation in human DNA, We identified 78 varying sites in 22 chromosomes that resolved into 13 distinct haplotypes. Of the variant sites, 17 were in absolute linkage disequilibrium with the commonly typed Alu insertion/deletion polymorphism, producing two distinct and distantly related clades. We also identified a major subdivision in the Alu deletion clade that enables further analysis of the traits associated with this gene. The diversity uncovered in DCP1 is comparable to that described for other regions in the human genomes-(8-11), The highly correlated structure in DCP1 raises important issues for the determination of functional DNA variants within genes and genetic studies in humans based on marker association.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rieder, MJ (corresponding author), Univ Washington, Dept Mol Biotechnol, Box 357730, Seattle, WA 98195 USA.		Rieder, Michael J/L-2397-2013	Clark, Andrew/0000-0001-7159-8511	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058238, R01HL058240] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001436] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01436] Funding Source: Medline; NHLBI NIH HHS [HL58238, HL58240] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; EVANS AE, 1994, Q J MED, V87, P211; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Harding RM, 1997, AM J HUM GENET, V60, P772; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; HUBERT C, 1991, J BIOL CHEM, V266, P15377; HUDSON RR, 1985, GENETICS, V111, P147; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Long AD, 1998, GENETICS, V149, P999; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Nachman MW, 1998, GENETICS, V150, P1133; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; O'Malley JP, 1998, CIRCULATION, V97, P1780, DOI 10.1161/01.CIR.97.18.1780; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schunkert H, 1997, J MOL MED-JMM, V75, P867, DOI 10.1007/s001090050178; SCRIVER CR, 1996, VARIATION HUMAN GENO, P73; SING CF, 1992, EUR J EPIDEMIOL, V8, P3, DOI 10.1007/BF00145343; SOUBRIER F, 1994, EUR HEART J, V15, P24, DOI 10.1093/eurheartj/15.suppl_D.24; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tavare S, 1997, GENETICS, V145, P505; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	30	376	390	2	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					59	62		10.1038/8760	http://dx.doi.org/10.1038/8760			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319862				2022-12-17	WOS:000080096300023
J	Stacey, SN; Manolescu, A; Sulem, P; Thorlacius, S; Gudjonsson, SA; Jonsson, GF; Jakobsdottir, M; Bergthorsson, JT; Gudmundsson, J; Aben, KK; Strobbe, LJ; Swinkels, DW; van Engelenburg, KCA; Henderson, BE; Kolonel, LN; Le Marchand, L; Millastre, E; Andres, R; Saez, B; Lambea, J; Godino, J; Polo, E; Tres, A; Picelli, S; Rantala, J; Margolin, S; Jonsson, T; Sigurdsson, H; Jonsdottir, T; Hrafnkelsson, J; Johannsson, J; Sveinsson, T; Myrdal, G; Grimsson, HN; Sveinsdottir, SG; Alexiusdottir, K; Saemundsdottir, J; Sigurdsson, A; Kostic, J; Gudmundsson, L; Kristjansson, K; Masson, G; Fackenthal, JD; Adebamowo, C; Ogundiran, T; Olopade, OI; Haiman, CA; Lindblom, A; Mayordomo, JI; Kiemeney, LA; Gulcher, JR; Rafnar, T; Thorsteinsdottir, U; Johannsson, OT; Kong, A; Stefansson, K				Stacey, Simon N.; Manolescu, Andrei; Sulem, Patrick; Thorlacius, Steinunn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjorn F.; Jakobsdottir, Margret; Bergthorsson, Jon T.; Gudmundsson, Julius; Aben, Katja K.; Strobbe, Luc J.; Swinkels, Dorine W.; van Engelenburg, K. C. Anton; Henderson, Brian E.; Kolonel, Laurence N.; Le Marchand, Loic; Millastre, Esther; Andres, Raquel; Saez, Berta; Lambea, Julio; Godino, Javier; Polo, Eduardo; Tres, Alejandro; Picelli, Simone; Rantala, Johanna; Margolin, Sara; Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Sveinsdottir, Steinunn G.; Alexiusdottir, Kristin; Saemundsdottir, Jona; Sigurdsson, Asgeir; Kostic, Jelena; Gudmundsson, Larus; Kristjansson, Kristleifur; Masson, Gisli; Fackenthal, James D.; Adebamowo, Clement; Ogundiran, Temidayo; Olopade, Olufunmilayo I.; Haiman, Christopher A.; Lindblom, Annika; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Johannsson, Oskar T.; Kong, Augustine; Stefansson, Kari			Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TUMORS; FGFR2; RISK	We carried out a genome-wide association study of breast cancer predisposition with replication and refinement studies involving 6,145 cases and 33,016 controls and identified two SNPs (rs4415084 and rs10941679) on 5p12 that confer risk, preferentially for estrogen receptor (ER)-positive tumors (OR = 1.27, P = 2.5 x 10(-12) for rs10941679). The nearest gene, MRPS30, was previously implicated in apoptosis, ER-positive tumors and favorable prognosis. A recently reported signal in FGFR2 was also found to associate specifically with ER-positive breast cancer.	[Stacey, Simon N.; Manolescu, Andrei; Sulem, Patrick; Thorlacius, Steinunn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjorn F.; Jakobsdottir, Margret; Bergthorsson, Jon T.; Gudmundsson, Julius; Saemundsdottir, Jona; Sigurdsson, Asgeir; Kostic, Jelena; Gudmundsson, Larus; Kristjansson, Kristleifur; Masson, Gisli; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr IKO, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.; Swinkels, Dorine W.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Aben, Katja K.; Swinkels, Dorine W.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem & Urol, NL-6500 HB Nijmegen, Netherlands; [Strobbe, Luc J.] Canisius Wilhelmina Hosp, Dept Surg, NL-6500 GS Nijmegen, Netherlands; [van Engelenburg, K. C. Anton] Slingeland Hosp, Dept Surg, NL-7009 BL Doetinchem, Netherlands; [Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; [Millastre, Esther; Andres, Raquel; Lambea, Julio; Tres, Alejandro; Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Saez, Berta; Godino, Javier] Nanotechnol Inst Aragon, Hlth Sci Inst, Zaragoza 50009, Spain; [Polo, Eduardo] Ernest Lluch Hosp, Div Med Oncol, Calatayud 50300, Spain; [Picelli, Simone; Rantala, Johanna; Lindblom, Annika] Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden; [Margolin, Sara] Karolinska Univ Hosp Sodersjukhuset, Dept Oncol, S-11883 Stockholm, Sweden; [Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Johannsson, Oskar T.] Landspitali Univ Hosp, Dept Oncol, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Johannsson, Oskar T.] Landspitali Univ Hosp, Dept Surg, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Johannsson, Oskar T.] Landspitali Univ Hosp, Dept Radiat Phys, IS-101 Reykjavik, Iceland; [Sveinsdottir, Steinunn G.; Alexiusdottir, Kristin] Clin Res Ctr, IS-110 Reykjavik, Iceland; [Fackenthal, James D.; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Chicago, IL 60615 USA; [Adebamowo, Clement; Ogundiran, Temidayo] Univ Ibadan, Univ Coll Ibadan Hosp, Coll Med, Div Oncol,Dept Surg, Ibadan, Oyo State, Nigeria	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Miguel Servet University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Chicago; University of Ibadan	Stacey, SN (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	simon.stacey@decode.is; kari.stefansson@decode.is	Mayordomo, Jose/K-3453-2013; Margolin, Sara/AAX-9034-2020; Adebamowo, Clement/C-8778-2011; Stefansson, Kari/AAE-7187-2019; Godino, Javier/M-3753-2018; Strobbe, Luc JA/N-8760-2018; Swinkels, Dorine W./H-8098-2014; Manolescu, Andrei/G-4565-2014; Kiemeney, Lambertus A./D-3357-2009; Aben, Katja KH/G-9686-2016	Adebamowo, Clement/0000-0002-6571-2880; Godino, Javier/0000-0002-5653-2722; Swinkels, Dorine W./0000-0002-1040-9446; Manolescu, Andrei/0000-0002-0713-4664; Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Margolin, Sara/0000-0002-5526-5570; Kong, Augustine/0000-0001-8193-5438; Bergthorsson, Jon Thor/0000-0002-0560-2639; Saez, Berta/0000-0003-0753-1165; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Millastre Bocos, Maria Esther/0000-0002-4781-068X	NATIONAL CANCER INSTITUTE [R01CA089085] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA89085-01A] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CAVDAR KE, 2001, FEBS LETT, V492, P166; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Huijts PEA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1793; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sun LJ, 1998, GENE, V208, P157, DOI 10.1016/S0378-1119(97)00626-4; Theodorou V, 2004, ONCOGENE, V23, P6047, DOI 10.1038/sj.onc.1207816; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yu K, 2006, CLIN CANCER RES, V12, P3288, DOI 10.1158/1078-0432.CCR-05-1530	14	375	388	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					703	706		10.1038/ng.131	http://dx.doi.org/10.1038/ng.131			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438407				2022-12-17	WOS:000256212000008
J	Pickering, MC; Cook, HT; Warren, J; Bygrave, AE; Moss, J; Walport, MJ; Botto, M				Pickering, MC; Cook, HT; Warren, J; Bygrave, AE; Moss, J; Walport, MJ; Botto, M			Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H	NATURE GENETICS			English	Article							HEMOLYTIC-UREMIC SYNDROME; HOMOZYGOUS FACTOR-H; ALTERNATIVE PATHWAY; GLOMERULAR DEPOSITS; PROTEIN BETA-1H; CONVERTASE; DISEASE; HYPOCOMPLEMENTEMIA; HEREDITARY; FAMILY	The alternative pathway of complement is activated continuously in vivo through the C3 'tick-over' pathway(1). This pathway is triggered by the hydrolysis of C3, resulting in the formation of C3 convertase. This, in turn, generates C3b, which mediates many of the biological functions of complement. Factor H, the main regulator of this activation, prevents formation and promotes dissociation of the C3 convertase enzyme(2,3), and, together with factor I, mediates the proteolytic inactivation of C3b(4). Factor H deficiency, described in 29 individuals from 12 families(5-14) and in pigs(15), allows unhindered activation of fluid-phase C3 and severe depletion of plasma C3 (ref. 11). Membranoproliferative glomerulonephritis (MPGN) occurs in factor H-deficient humans(6,12,13) and pigs(15). Although MPGN has been reported in other conditions in which uncontrolled activation of C3 occurs, the role of C3 dysregulation in the pathogenesis of MPGN is not understood. Here we show that mice deficient in factor H (Cfh(-/-) mice) develop MPGN spontaneously and are hypersensitive to developing renal injury caused by immune complexes. Introducing a second mutation in the gene encoding complement factor B, which prevents C3 turnover in vivo, obviates the phenotype of Cfh(-/-) mice. Thus, uncontrolled C3 activation in vivo is essential for the development of MPGN associated with deficiency of factor H.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Rheumatol Sect, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Histopathol, London W12 0NN, England; Charing Cross Hosp, Dept Histopathol, Electron Microscopy Unit, London W6 8RF, England	Imperial College London; Imperial College London; Imperial College London	Botto, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Rheumatol Sect, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.		Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768; Walport, Mark/0000-0001-7220-5273; Pickering, Matthew/0000-0002-1153-0192				Alexander JJ, 2001, J BIOL CHEM, V276, P32129, DOI 10.1074/jbc.M101299200; BERGER J, 1962, J Urol Nephrol (Paris), V68, P116; BRAI M, 1988, J CLIN IMMUNOL, V8, P50, DOI 10.1007/BF00915156; DAHA MR, 1976, J IMMUNOL, V116, P1; DROZ D, 1979, KIDNEY INT, V15, P386, DOI 10.1038/ki.1979.50; Fijen CAP, 1996, CLIN EXP IMMUNOL, V105, P511, DOI 10.1046/j.1365-2249.1996.d01-777.x; GALLE P, 1975, AM J MED, V58, P749, DOI 10.1016/0002-9343(75)90631-2; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; LEVY M, 1986, KIDNEY INT, V30, P949, DOI 10.1038/ki.1986.278; LOPEZLARREA C, 1987, BIOCHEM SOC T, V15, P648, DOI 10.1042/bst0150648; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; NIELSEN HE, 1989, SCAND J IMMUNOL, V30, P711, DOI 10.1111/j.1365-3083.1989.tb02480.x; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; PEPYS MB, 1977, IMMUNOLOGY, V33, P491; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; Robson MG, 2001, J IMMUNOL, V166, P6820, DOI 10.4049/jimmunol.166.11.6820; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; SIMPSON IJ, 1978, KIDNEY INT, V13, P467, DOI 10.1038/ki.1978.69; SPITZER RE, 1969, SCIENCE, V164, P436, DOI 10.1126/science.164.3878.436; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; VERROUST PJ, 1974, KIDNEY INT, V6, P157, DOI 10.1038/ki.1974.94; VIK DP, 1988, J BIOL CHEM, V263, P16720; VOGT BA, 1995, PEDIATR NEPHROL, V9, P11, DOI 10.1007/BF00858956; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; West CD, 2001, AM J KIDNEY DIS, V37, P1120, DOI 10.1053/ajkd.2001.24511; WEST CD, 1995, AM J KIDNEY DIS, V25, P853, DOI 10.1016/0272-6386(95)90567-7; WOODROW DF, 1989, J PATHOL, V157, P47, DOI 10.1002/path.1711570107	30	375	399	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					424	428		10.1038/ng912	http://dx.doi.org/10.1038/ng912			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12091909				2022-12-17	WOS:000177147100021
J	Olbrich, H; Haffner, K; Kispert, A; Volkel, A; Volz, A; Sasmaz, G; Reinhardt, R; Hennig, S; Lehrach, H; Konietzko, N; Zariwala, M; Noone, PG; Knowles, M; Mitchison, HM; Meeks, M; Chung, EMK; Hildebrandt, F; Sudbrak, R; Omran, H				Olbrich, H; Haffner, K; Kispert, A; Volkel, A; Volz, A; Sasmaz, G; Reinhardt, R; Hennig, S; Lehrach, H; Konietzko, N; Zariwala, M; Noone, PG; Knowles, M; Mitchison, HM; Meeks, M; Chung, EMK; Hildebrandt, F; Sudbrak, R; Omran, H			Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right and asymmetry	NATURE GENETICS			English	Article							INTERMEDIATE-CHAIN; HEAVY-CHAIN; DYNEIN; GENE; INVERSUS	Primary ciliary dyskinesia (PCD, MIM 242650) is characterized by recurrent infections of the respiratory tract due to reduced mucociliary clearance and by sperm immobility. Half of the affected offspring have situs inversus (reversed organs), which results from randomization of left-right (LR) asymmetry(1). We previously localized to chromosome 5p a PCD locus containing DNAH5, which encodes a protein highly similar to the Chlamydomonas gamma-dynein heavy chain(2). Here we characterize the full-length 14-kb transcript of DNAH5. Sequence analysis in individuals with PCD with randomization of LR asymmetry identified mutations resulting in non-functional DNAH5 proteins.	Univ Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; Med Hochschule Hannover, Hannover, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Ruhrland Klin, Essen, Germany; Univ N Carolina, Chapel Hill, NC USA; Royal Free & UCL, Dept Paediat & Child Hlth, London, England	University of Freiburg; Hannover Medical School; Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London	Omran, H (corresponding author), Univ Freiburg, Dept Pediat & Adolescent Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	omran@kikli.uk.uni-freiburg.de	Mitchison, Hannah M./C-1891-2008; Volz, Andreas/AAA-6290-2019	Omran, Heymut/0000-0003-0282-6765; Mitchison, Hannah/0000-0002-3163-6293; Meeks, Maggie/0000-0003-2593-235X; Reinhardt, Richard/0000-0001-9376-2132				Afzelius BA, 1995, METABOLIC MOL BASES, P3943; ASDAI J, 2001, TRENDS CELL BIOL, V11, P196; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Omran H, 2000, AM J RESP CELL MOL, V23, P696, DOI 10.1165/ajrcmb.23.5.4257; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; WILKERSON CG, 1994, J CELL SCI, V107, P497	15	375	397	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					143	144		10.1038/ng817	http://dx.doi.org/10.1038/ng817			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788826				2022-12-17	WOS:000173708700010
J	Hughes, TR; Roberts, CJ; Dai, HY; Jones, AR; Meyer, MR; Slade, D; Burchard, J; Dow, S; Ward, TR; Kidd, MJ; Friend, SH; Marton, MJ				Hughes, TR; Roberts, CJ; Dai, HY; Jones, AR; Meyer, MR; Slade, D; Burchard, J; Dow, S; Ward, TR; Kidd, MJ; Friend, SH; Marton, MJ			Widespread aneuploidy revealed by DNA microarray expression profiling	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; GENOME; IDENTIFICATION; BIOSYNTHESIS; EVOLUTION; SCALE	Expression profiling using DNA microarrays holds great promise for a variety of research applications, including the systematic characterization of genes discovered by sequencing projects(1,2) To demonstrate the general usefulness of this approach, we recently obtained expression profiles for nearly 300 Saccharomyces cerevisiae deletion mutants(3). Approximately 8% of the mutants profiled exhibited chromosome-wide expression biases, leading to spurious correlations among profiles. Competitive hybridization of genomic DNA from the mutant strains and their isogenic parental wild-type strains showed they were aneuploid for whole chromosomes or chromosomal segments. Expression profile data published by several other laboratories also suggest the use of aneuploid strains. In five separate cases. the extra chromosome harboured a close homologue of the deleted gene; in two cases, a clear growth advantage for cells acquiring the extra chromosome was demonstrated. Our results have implications for interpreting whole-genome expression data, particularly from cells known to suffer genomic instability, such as malignant or immortalized cells.	Rosetta Inpharmat Inc, Kirkland, WA USA		Marton, MJ (corresponding author), Rosetta Inpharmat Inc, Kirkland, WA USA.							Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; HARTWELL LH, 1985, GENETICS, V110, P381; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; HUGHES TR, IN PRESS CELL; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; LAI MH, 1994, GENE, V140, P41; Lussier M, 1997, GENETICS, V147, P435; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Pennisi E, 1998, SCIENCE, V282, P1972, DOI 10.1126/science.282.5396.1972; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Smith NGC, 1999, BIOESSAYS, V21, P697, DOI 10.1002/(SICI)1521-1878(199908)21:8<697::AID-BIES9>3.0.CO;2-X; Somerville C, 1999, SCIENCE, V285, P380, DOI 10.1126/science.285.5426.380; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	24	375	385	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					333	337		10.1038/77116	http://dx.doi.org/10.1038/77116			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888885				2022-12-17	WOS:000087920900025
J	Galvin, KM; Donovan, MJ; Lynch, CA; Meyer, RI; Paul, RJ; Lorenz, JN; Fairchild-Huntress, V; Dixon, KL; Dunmore, JH; Gimbrone, MA; Falb, D; Huszar, D				Galvin, KM; Donovan, MJ; Lynch, CA; Meyer, RI; Paul, RJ; Lorenz, JN; Fairchild-Huntress, V; Dixon, KL; Dunmore, JH; Gimbrone, MA; Falb, D; Huszar, D			A role for Smad6 in development and homeostasis of the cardiovascular system	NATURE GENETICS			English	Article							TGF-BETA; FAMILY MEMBERS; MESSENGER-RNA; GENE; EXPRESSION; BONE; ENDOTHELIUM; INDUCTION; LACZ	Smad proteins are intracellular mediators of signalling initiated by Tgf-beta superfamily ligands (Tgf-beta s, activins and bone morphogenetic proteins (Bmps)). Smads 1, 2, 3, 5 and 8 are activated upon phosphorylation by specific type I receptors, and associate with the common partner Smad4 to trigger transcriptional responses(1). The inhibitory Smads (6 and 7) are transcriptionally induced in cultured cells treated with Tgf-beta superfamily ligands, and downregulate signalling in in vitro assays(2-7). Gene disruption in mice has begun to reveal specific developmental and physiological functions of the signal-transducing Smads. Here we explore the role of an inhibitory Smad in vivo by targeted mutation of Madh6 (which encodes the Smad6 protein). Targeted insertion of a LacZ reporter demonstrated that Smad6 expression is largely restricted to the heart and blood vessels, and that Madh6 mutants have multiple cardiovascular abnormalities. Hyperplasia of the cardiac valves and outflow tract septation defects indicate a function for Smad6 in the regulation of endocardial cushion transformation. The role of Smad6 in the homeostasis of the adult cardiovascular system is indicated by the development of aortic ossification and elevated broad pressure in viable mutants. These defects highlight the importance of Smad6 in the tissue-specific modulation of Tgf-beta superfamily signalling pathways in vivo.	Millennium Pharmaceut, Cambridge, MA USA; Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH USA; Brigham & Womens Hosp, Div Vasc Res, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Galvin, KM (corresponding author), Millennium Pharmaceut, Cambridge, MA USA.							Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; BONNEROT C, 1993, METHOD ENZYMOL, V225, P451; BOSTROM K, 1995, AM J CARDIOL, V75, pB88, DOI 10.1016/0002-9149(95)80020-S; BRADLEY A, 1987, TERATOCARCINOMAS EMB; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; COHEN RA, 1988, J PHARMACOL EXP THER, V244, P550; Dudley AT, 1997, DEV DYNAM, V208, P349; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HUANG JX, 1995, ANN NY ACAD SCI, V752, P317, DOI 10.1111/j.1749-6632.1995.tb17441.x; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Lalli J, 1997, CIRC RES, V80, P506, DOI 10.1161/01.RES.80.4.506; Marchuk D A, 1998, Curr Opin Hematol, V5, P332, DOI 10.1097/00062752-199809000-00005; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Moore CS, 1998, DEV DYNAM, V212, P548, DOI 10.1002/(SICI)1097-0177(199808)212:4<548::AID-AJA8>3.0.CO;2-H; Perrella MA, 1998, MINER ELECTROL METAB, V24, P136, DOI 10.1159/000057361; REDDI AH, 1994, CURR OPIN GENET DEV, V4, P737, DOI 10.1016/0959-437X(94)90141-O; Takase M, 1998, BIOCHEM BIOPH RES CO, V244, P26, DOI 10.1006/bbrc.1998.8200; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314	22	375	394	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2000	24	2					171	174		10.1038/72835	http://dx.doi.org/10.1038/72835			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	10655064				2022-12-17	WOS:000085104600019
J	Goldfarb, LG; Park, KY; Cervenakova, L; Gorokhova, S; Lee, HS; Vasconcelos, O; Nagle, JW; Semino-Mora, C; Sivakumar, K; Dalakas, MC				Goldfarb, LG; Park, KY; Cervenakova, L; Gorokhova, S; Lee, HS; Vasconcelos, O; Nagle, JW; Semino-Mora, C; Sivakumar, K; Dalakas, MC			Missense mutations in desmin associated with familial cardiac and skeletal myopathy	NATURE GENETICS			English	Article							ELECTRON-MICROSCOPY; CELLS	Desmin-related myopathy (OMIM 601419) is a familial disorder characterized by skeletal muscle weakness associated with cardiac conduction blocks, arrhythmias and restrictive heart failure, and by intracytoplasmic accumulation of desmin-reactive deposits in cardiac and skeletal muscle cells(1-4). The underlying molecular mechanisms are unknown. Involvement of the desmin gene (DES) has been excluded in three families diagnosed with desmin-related myopathy(5), We report two new families with desmin-related cardioskeletal myopathy associated with mutations in the highly conserved carboxy-terminal end of the desmin rod domain. A heterozygous A337P mutation was identified in a family with an adult-onset skeletal myopathy and mild cardiac involvement. Compound heterozygosity for two other mutations, A360P and N393I, was detected in a second family characterized by childhood-onset aggressive course of cardiac and skeletal myopathy.	NINDS, Med Neurol Branch, NIH, Bethesda, MD 20892 USA; NINDS, Cent Nervous Syst Studies Lab, NIH, Bethesda, MD 20892 USA; Amer Red Cross, Jerome H Holland Lab, Rockville, MD 20855 USA; Barrow Neurol Inst, Phoenix, AZ 85013 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); American Red Cross; Barrow Neurological Institute	Goldfarb, LG (corresponding author), NINDS, Med Neurol Branch, NIH, Bethesda, MD 20892 USA.		Gorokhova, Svetlana/L-9380-2019	Gorokhova, Svetlana/0000-0001-6870-4061				FARDEAU M, 1978, REV NEUROL, V134, P411; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GOEBEL HH, 1978, MUSCLE NERVE, V1, P14, DOI 10.1002/mus.880010104; GOEBEL HH, 1995, MUSCLE NERVE, V18, P1306, DOI 10.1002/mus.880181114; HOROWITZ SH, 1994, MUSCLE NERVE, V17, P151, DOI 10.1002/mus.880170204; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008; RAATS JMH, 1991, EUR J CELL BIOL, V56, P84; Raats JMH, 1996, EUR J CELL BIOL, V71, P221; Vicart P, 1996, HUM GENET, V98, P422, DOI 10.1007/s004390050233; YU KR, 1994, P NATL ACAD SCI USA, V91, P2497, DOI 10.1073/pnas.91.7.2497	11	375	390	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					402	403		10.1038/1300	http://dx.doi.org/10.1038/1300			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697706				2022-12-17	WOS:000075107600028
J	Albrecht, U; Sutcliffe, JS; Cattanach, BM; Beechey, CV; Armstrong, D; Eichele, G; Beaudet, AL				Albrecht, U; Sutcliffe, JS; Cattanach, BM; Beechey, CV; Armstrong, D; Eichele, G; Beaudet, AL			Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons	NATURE GENETICS			English	Letter							PRADER-WILLI SYNDROMES; FACTOR-II GENE; PROTEIN; CLONING; ORIGIN	Angelman syndrome (AS) is a human genetic disorder characterized by mental retardation, seizures, inappropriate laughter, abnormal gait, tremor and ataxia(1-3). There is strong genetic evidence that the disorder is associated with a maternally expressed, imprinted gene mapping to chromosome 15q11-13. Affected patients demonstrate varied molecular abnormalities including large maternal deletions, uniparental paternal disomy (UPD), imprinting mutations(4) and loss of function mutations of E6-associated-protein (E6-AP) ubiquitin-protein ligase (UBE3A)(5,6). All of these abnormalities are associated with loss of maternal expression of UBE3A. Although mutations in UBE3A cause AS, indicating that maternal-specific expression of UBE3A is essential for a normal phenotype, evidence for maternal-specific expression of UBE3A has been lacking(7,8). Using mice with partial paternal UPD encompassing Ube3a to differentiate maternal and paternal expression, we found by in situ hybridization that expression of Ube3a in Purkinje cells, hippocampal neurons and mitral cells of the olfactory bulb in UPD mice was markedly reduced compared to non-UPD littermates. In contrast, expression of Ube3a in other regions of the brain was only moderately or not at all reduced in UPD mice. The major phenotypic features of AS correlate with the loss of maternal-specific expression of Ube3a in hippocampus and cerebellum as revealed in the mouse model.	BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT BIOCHEM, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA; MRC, MAMMALIAN GENET UNIT, DIDCOT OX11 0RD, OXON, ENGLAND	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; MRC Harwell			Sutcliffe, James S/C-1348-2012; Albrecht, Urs/A-9831-2011	Sutcliffe, James S/0000-0001-5200-6007; Albrecht, Urs/0000-0002-0663-8676				Albrecht U, 1997, MOL CELLULAR METHODS, P23; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KYRIAKIDES T, 1992, ACTA NEUROPATHOL, V83, P675, DOI 10.1007/BF00299421; LEDBETTER DH, 1995, METABOLIC MOL BASES, P811; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; REIS A, 1994, AM J HUM GENET, V54, P741; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; VANHILLE B, 1993, BIOCHEM BIOPH RES CO, V197, P15, DOI 10.1006/bbrc.1993.2434; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; ZACKOWSKI JL, 1993, AM J MED GENET, V46, P7, DOI 10.1002/ajmg.1320460104	23	375	383	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					75	78		10.1038/ng0997-75	http://dx.doi.org/10.1038/ng0997-75			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288101				2022-12-17	WOS:A1997XU72400021
J	CROSS, SH; CHARLTON, JA; NAN, XS; BIRD, AP				CROSS, SH; CHARLTON, JA; NAN, XS; BIRD, AP			PURIFICATION OF CPG ISLANDS USING A METHYLATED DNA-BINDING COLUMN	NATURE GENETICS			English	Article							VERTEBRATE DNA; GENE MARKERS; SEQUENCE; PROTEIN; LONG; EVOLUTION; FRAGMENTS; PATTERNS; GENOMES; CLUSTER	CpG islands are short stretches of DNA containing a high density of non-methylated CpG dinucleotides, predominantly associated with coding regions. We have constructed an affinity matrix that contains the methyl-CpG binding domain from the rat chromosomal protein MeCP2, attached to a solid support. A column containing the matrix fractionates DNA according to its degree of CpG methylation, strongly retaining those sequences that are highly methylated. Using this column, we have developed a procedure for bulk isolation of CpG islands from human genomic DNA. As CpG islands overlap with approximately 60% of human genes, the resulting CpG island library can be used to isolate full-length cDNAs and to place genes on genomic maps.			CROSS, SH (corresponding author), UNIV EDINBURGH,INST CELL & MOLEC BIOL,KINGS BLDG,EDINBURGH EH9 3JR,SCOTLAND.			Nan, Xinsheng/0000-0002-0865-7934; Cross, Sally/0000-0001-6518-6449; Bird, Adrian/0000-0002-8600-0372	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABBOTT C, 1991, GENOMICS, V9, P73, DOI 10.1016/0888-7543(91)90222-Z; ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; ANTEQUERA F, 1993, DNA METHYLATION MOL, P169; ANTEQUERA P, IN PRESS P NATN ACAD; BAENS M, 1993, GENOMICS, V16, P214, DOI 10.1006/geno.1993.1161; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; BROWN WRA, 1986, NATURE, V322, P477, DOI 10.1038/322477a0; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; COOPER DN, 1983, NUCLEIC ACIDS RES, V11, P647, DOI 10.1093/nar/11.3.647; CROSS S, 1991, NUCLEIC ACIDS RES, V19, P1469, DOI 10.1093/nar/19.7.1469; DAWID IB, 1974, SCIENCE, V184, P80, DOI 10.1126/science.184.4132.80; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FEARNLEY IM, 1991, BIOCHEM J, V278, P821, DOI 10.1042/bj2780821; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; HENDRIKS RW, 1992, GENET, V1, P187; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; KENWRICK S, 1992, HUM MOL GENET, V1, P179, DOI 10.1093/hmg/1.3.179; LARSEN F, 1993, HUM MOL GENET, V2, P1589, DOI 10.1093/hmg/2.10.1589; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LAVIA P, 1987, EMBO J, V6, P2773, DOI 10.1002/j.1460-2075.1987.tb02572.x; LAWN RM, 1981, SCIENCE, V212, P1159, DOI 10.1126/science.6165082; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; PONCE MR, 1992, NUCLEIC ACIDS RES, V20, P623, DOI 10.1093/nar/20.3.623; SHAFITZAGARDO B, 1982, GENE, V20, P397, DOI 10.1016/0378-1119(82)90208-6; SHEMER R, 1991, J BIOL CHEM, V266, P23676; STATES D J, 1991, Methods (Orlando), V3, P66, DOI 10.1016/S1046-2023(05)80165-3; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOLAN DR, 1986, MOL BIOL MED, V3, P245; VANSPRONSEN A, 1993, EUR J BIOCHEM, V213, P1117, DOI 10.1111/j.1432-1033.1993.tb17861.x	42	375	455	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					236	244		10.1038/ng0394-236	http://dx.doi.org/10.1038/ng0394-236			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012384				2022-12-17	WOS:A1994MZ56200009
J	de Cid, R; Riveira-Munoz, E; Zeeuwen, PLJM; Robarge, J; Liao, W; Dannhauser, EN; Giardina, E; Stuart, PE; Nair, R; Helms, C; Escaramis, G; Ballana, E; Martin-Ezquerra, G; den Heijer, M; Kamsteeg, M; Joosten, I; Eichler, EE; Lazaro, C; Pujol, RM; Armengol, L; Abecasis, G; Elder, JT; Novelli, G; Armour, JAL; Kwok, PY; Bowcock, A; Schalkwijk, J; Estivill, X				de Cid, Rafael; Riveira-Munoz, Eva; Zeeuwen, Patrick L. J. M.; Robarge, Jason; Liao, Wilson; Dannhauser, Emma N.; Giardina, Emiliano; Stuart, Philip E.; Nair, Rajan; Helms, Cynthia; Escaramis, Georgia; Ballana, Ester; Martin-Ezquerra, Gemma; den Heijer, Martin; Kamsteeg, Marijke; Joosten, Irma; Eichler, Evan E.; Lazaro, Conxi; Pujol, Ramon M.; Armengol, Lluis; Abecasis, Goncalo; Elder, James T.; Novelli, Giuseppe; Armour, John A. L.; Kwok, Pui-Yan; Bowcock, Anne; Schalkwijk, Joost; Estivill, Xavier			Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis	NATURE GENETICS			English	Article							COPY NUMBER; STRUCTURAL VARIATION; HUMAN GENOME; ASSOCIATION; PATHOGENESIS; GENETICS; PSORS1; LOCUS; IL12B; IL23R	Psoriasis is a common inflammatory skin disease with a prevalence of 2-3% in individuals of European ancestry(1). In a genome-wide search for copy number variants (CNV) using a sample pooling approach, we have identified a deletion comprising LCE3B and LCE3C, members of the late cornified envelope (LCE) gene cluster(2). The absence of LCE3B and LCE3C (LCE3C_LCE3B-del) is significantly associated (P = 1.38E-08) with risk of psoriasis in 2,831 samples from Spain, The Netherlands, Italy and the United States, and in a family-based study (P = 5.4E-04). LCE3C_LCE3B-del is tagged by rs4112788 (r(2) = 0.93), which is also strongly associated with psoriasis (P < 6.6E-09). LCE3C_LCE3B-del shows epistatic effects with the HLA-Cw6 allele on the development of psoriasis in Dutch samples and multiplicative effects in the other samples. LCE expression can be induced in normal epidermis by skin barrier disruption and is strongly expressed in psoriatic lesions, suggesting that compromised skin barrier function has a role in psoriasis susceptibility.	[de Cid, Rafael; Riveira-Munoz, Eva; Escaramis, Georgia; Ballana, Ester; Armengol, Lluis; Estivill, Xavier] Ctr Gene Regulat, Genes & Dis Programme, Barcelona 08003, Spain; [de Cid, Rafael; Riveira-Munoz, Eva; Escaramis, Georgia; Ballana, Ester; Armengol, Lluis; Estivill, Xavier] Publ Hlth & Epidemiol Network Biomed Res Ctr CIBE, Barcelona 08003, Spain; [Zeeuwen, Patrick L. J. M.; Kamsteeg, Marijke; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 Nijmegen, Netherlands; [Zeeuwen, Patrick L. J. M.; Kamsteeg, Marijke; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 Nijmegen, Netherlands; [Robarge, Jason; Helms, Cynthia; Bowcock, Anne] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Liao, Wilson; Kwok, Pui-Yan] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Dannhauser, Emma N.; Armour, John A. L.] Univ Nottingham, Inst Genet, Queens Med Ctr, Nottingham NG7 2RD, England; [Dannhauser, Emma N.; Armour, John A. L.] Univ Nottingham, Sch Biol, Queens Med Ctr, Nottingham NG7 2RD, England; [Giardina, Emiliano; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol, I-00133 Rome, Italy; [Stuart, Philip E.; Nair, Rajan; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Martin-Ezquerra, Gemma; Pujol, Ramon M.] Hosp del Mar, Dermatol Serv, IMAS, Barcelona 08003, Spain; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6525 Nijmegen, Netherlands; [Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 Nijmegen, Netherlands; [Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Lazaro, Conxi] Hosp Llobregat, Catalan Inst Canc, Barcelona 08907, Spain; [Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Estivill, Xavier] Pompeu Fabra Univ UPF, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Radboud University Nijmegen; Radboud University Nijmegen; Washington University (WUSTL); University of California System; University of California San Francisco; University of Nottingham; University of Nottingham; University of Rome Tor Vergata; University of Michigan System; University of Michigan; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Washington; University of Washington Seattle; University of Barcelona; University of Michigan System; University of Michigan; Pompeu Fabra University	Estivill, X (corresponding author), Ctr Gene Regulat, Genes & Dis Programme, Barcelona 08003, Spain.	xavier.estivill@crg.es	Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; de cid, rafael/Q-2952-2016; Kamsteeg, M./L-4422-2015; Escaramis, Georgia/AAR-5586-2020; Martin-Ezquerra, Gemma/AAF-2276-2021; Kwok, Pui-Yan/F-7725-2014; Estivill, Xavier/A-3125-2013; Novelli, Giuseppe/GQB-3329-2022; Schalkwijk, Joost/N-1774-2013; Guix, Ester Ballana/R-4117-2018; Estivill, Xavier/E-2957-2012; de Cid, Rafael/I-4220-2015; Schalkwijk, Joost/R-7509-2019; Joosten, Irma/N-4418-2013; Escaramis, Georgia/B-2997-2015; GARCIA, CONXI LAZARO/Q-2410-2016; Zeeuwen, Patrick/N-1779-2013; Giardina, Emiliano/J-1965-2012; Abecasis, Goncalo R/B-7840-2010; den Heijer, Martin/J-8036-2015	Novelli, Giuseppe/0000-0002-7781-602X; de cid, rafael/0000-0003-3579-6777; Martin-Ezquerra, Gemma/0000-0002-5106-7526; Kwok, Pui-Yan/0000-0002-5087-3059; Estivill, Xavier/0000-0002-0723-2256; Novelli, Giuseppe/0000-0002-7781-602X; Schalkwijk, Joost/0000-0002-1308-1319; Joosten, Irma/0000-0003-2950-4977; Escaramis, Georgia/0000-0002-5416-3177; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Zeeuwen, Patrick/0000-0002-6878-2438; den Heijer, Martin/0000-0003-3620-5617; Abecasis, Goncalo/0000-0003-1509-1825; Ballana, Ester/0000-0002-5215-7363; giardina, emiliano/0000-0002-2741-5009; Bowcock, Anne/0000-0001-8691-9090; PUJOL, RAMON M/0000-0002-5622-6055; Armour, John/0000-0002-8558-8506; Robarge, Jason/0000-0001-8941-1153; Riveira Munoz, Eva/0000-0002-6396-1162	Spanish Ministry of Science and Innovation; European Commission ENGAGE Project; ADIPSO; National Institutes for Arthritis; Musculoskeletal and Skin Diseases; CIBERESP (Carlos III Health Institute); Ann Arbor Veterans Affairs Hospital; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042742, R01AR050511, R01AR054966] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission ENGAGE Project(European CommissionEuropean Commission Joint Research Centre); ADIPSO; National Institutes for Arthritis; Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CIBERESP (Carlos III Health Institute)(Instituto de Salud Carlos III); Ann Arbor Veterans Affairs Hospital; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We gratefully acknowledge the participants in the genetic studies whose contributions made this work possible and personnel at the CeGen genotyping core facility (Barcelona node). We thank T. Henseler, S. Jenisch, M. Weichenthal and E. Christophers from the University of Kiel for making samples from Kiel, Germany available for analysis. We thank A. Poon for technical assistance, the University of California San Francisco Psoriasis Center Staff for help with subject recruitment and J. Gartlon for proofreading the manuscript. This work was supported in part by funds from the "Generalitat de Catalunya,'' the Spanish Ministry of Science and Innovation and the European Commission ENGAGE Project (X. E., R. d. C., L. A., E. R.-M., G. E. and E. B.), ADIPSO (G.N.) and National Institutes for Arthritis, Musculoskeletal and Skin Diseases (A. B., J.T.E., R.N. and P. E. S.). E. R.-M. is supported by CIBERESP (Carlos III Health Institute). J. T. E. is supported by the Ann Arbor Veterans Affairs Hospital. W. L. is supported by a grant from the Dermatology Foundation.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; ALKEMADE JAC, 1994, J CELL SCI, V107, P2335; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Capon F, 1999, J INVEST DERMATOL, V112, P32, DOI 10.1046/j.1523-1747.1999.00471.x; Capon F, 1999, AM J HUM GENET, V65, P1798, DOI 10.1086/302653; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen HJ, 2009, J INVEST DERMATOL, V129, P606, DOI 10.1038/jid.2008.273; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Elder JT, 2006, J INVEST DERMATOL, V126, P1205, DOI 10.1038/sj.jid.5700357; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Gonzalez JR, 2008, GENET EPIDEMIOL, V32, P246, DOI 10.1002/gepi.20299; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RUSSELL TJ, 1972, NEW ENGL J MED, V287, P738, DOI 10.1056/NEJM197210122871503; Zhao XP, 1997, GENOMICS, V45, P250, DOI 10.1006/geno.1997.4952	26	374	390	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					211	215		10.1038/ng.313	http://dx.doi.org/10.1038/ng.313			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19169253	Green Accepted			2022-12-17	WOS:000263091300022
J	Jin, YH; Clark, AB; Slebos, RJC; Al-Refai, H; Taylor, JA; Kunkel, TA; Resnick, MA; Gordenin, DA				Jin, YH; Clark, AB; Slebos, RJC; Al-Refai, H; Taylor, JA; Kunkel, TA; Resnick, MA; Gordenin, DA			Cadmium is a mutagen that acts by inhibiting mismatch repair	NATURE GENETICS			English	Article							DNA-POLYMERASES DELTA; REPLICATION; EXONUCLEASES; EPSILON; ERRORS; PCNA; RUNS	Most errors that arise during DNA replication can be corrected by DNA polymerase proofreading or by post-replication mismatch repair (MMR). Inactivation of both mutation-avoidance systems results in extremely high mutability that can lead to error catastrophe(1,2). High mutability and the likelihood of cancer can be caused by mutations and epigenetic changes that reduce MMR3,4. Hypermutability can also be caused by external factors that directly inhibit MMR. Identifying such factors has important implications for understanding the role of the environment in genome stability. We found that chronic exposure of yeast to environmentally relevant concentrations of cadmium, a known human carcinogen(5), can result in extreme hypermutability. The mutation specificity along with responses in proofreading-deficient and MMR-deficient mutants indicate that cadmium reduces the capacity for MMR of small misalignments and base-base mismatches. In extracts of human cells, cadmium inhibited at least one step leading to mismatch removal. Together, our data show that a high level of genetic instability can result from environmental impediment of a mutation-avoidance system.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Gordenin, DA (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.	gordenin@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; resnick, Michael/F-1668-2019; taylor, jack a/C-7154-2019; Dmitry, Gordenin/C-3907-2018	Kunkel, Thomas A./0000-0002-9900-1788; resnick, Michael/0000-0002-8473-7506; taylor, jack a/0000-0001-5303-6398; Dmitry, Gordenin/0000-0002-8399-1836	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065073] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 ES999999] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Coleman WB, 1999, ANTICANCER RES, V19, P4645; Drotschmann K, 1999, CURR BIOL, V9, P907, DOI 10.1016/S0960-9822(99)80396-0; Elinder C-G, 1985, CADMIUM HLTH TOXICOL, P81; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Gary R, 1999, MOL CELL BIOL, V19, P5373; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Harfe BD, 2000, GENETICS, V156, P571; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hartwig A, 2001, ANTIOXID REDOX SIGN, V3, P625, DOI 10.1089/15230860152542970; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; IARC, 1993, BER CADM MERC EXP GL, V58, P119; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; KHROMOVBORISOV NN, 2002, TECH TIPS ONLINE, V1; Kroutil LC, 1996, BIOCHEMISTRY-US, V35, P1046, DOI 10.1021/bi952178h; Leach Fredrick S, 2002, Curr Opin Urol, V12, P407, DOI 10.1097/00042307-200209000-00007; MAO L, 1994, P NATL ACAD SCI USA, V91, P9871, DOI 10.1073/pnas.91.21.9871; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Waalkes M.P., 1996, TOXICOLOGY METALS, P231	29	374	400	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					326	329		10.1038/ng1172	http://dx.doi.org/10.1038/ng1172			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796780	Green Accepted			2022-12-17	WOS:000183815300022
J	DODT, G; BRAVERMAN, N; WONG, C; MOSER, A; MOSER, HW; WATKINS, P; VALLE, D; GOULD, SJ				DODT, G; BRAVERMAN, N; WONG, C; MOSER, A; MOSER, HW; WATKINS, P; VALLE, D; GOULD, SJ			MUTATIONS IN THE PTS1 RECEPTOR GENE, PXR1, DEFINE COMPLEMENTATION GROUP-2 OF THE PEROXISOME BIOGENESIS DISORDERS	NATURE GENETICS			English	Article							TETRATRICOPEPTIDE-REPEAT PROTEIN; YEAST HANSENULA-POLYMORPHA; TARGETING SIGNAL; ZELLWEGER SYNDROME; SACCHAROMYCES-CEREVISIAE; PICHIA-PASTORIS; FIREFLY LUCIFERASE; DEFICIENT MUTANTS; 3-KETOACYL-COA THIOLASE; CARBOXY TERMINUS	The peroxisome biogenesis disorders (PBDs) are lethal recessive diseases caused by defects in peroxisome assembly. We have isolated PXR1, a human homologue of the yeast P. pastoris PAS8 (peroxisome assembly) gene. PXR1, like PAS8, encodes a receptor for proteins with the type-1 peroxisomal targeting signal (PTSI). Mutations in PXR1 define complementation group 2 of PBDs and expression of PXR1 rescues the PTS1 import defect of fibroblasts from these patients. Based on the observation that PXR1 exists both in the cytosol and in association with peroxisomes, we propose that PXR1 protein recognizes PTS1-containing proteins in the cytosol and directs them to the peroxisome.	JOHNS HOPKINS UNIV HOSP,SCH MED,KENNEDY KRIEGER RES INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University				Braverman, Nancy/0000-0003-1621-5164	NICHD NIH HHS [HD10981] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline; NIGMS NIH HHS [T32GM07471] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007471] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; AITCHISON JD, 1991, J BIOL CHEM, V266, P23197; BELLION E, 1987, CELL, V48, P165, DOI 10.1016/0092-8674(87)90367-9; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; CRANE DI, 1994, J BIOL CHEM, V269, P21835; CRANE DI, 1994, CURR GENET, V26, P443, DOI 10.1007/BF00309932; CREGG JM, 1990, YEAST, V6, P87, DOI 10.1002/yea.320060202; DIDION T, 1992, FEBS LETT, V303, P113, DOI 10.1016/0014-5793(92)80500-G; ELGERSMA Y, 1993, GENETICS, V135, P731; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GARTNER J, 1994, J INHERIT METAB DIS, V17, P327, DOI 10.1007/BF00711820; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; HANSEN H, 1992, MOL GEN GENET, V235, P269, DOI 10.1007/BF00279370; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; KOUTZ P, 1989, YEAST, V5, P167, DOI 10.1002/yea.320050306; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LIU H, 1992, J BACTERIOL, V174, P4943, DOI 10.1128/JB.174.15.4943-4951.1992; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MIURA S, 1992, J BIOL CHEM, V267, P14405; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; NUTTLEY WM, 1994, J BIOL CHEM, V269, P556; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; PETERS TJ, 1972, J EXP MED, V136, P1179; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SIKORSKI RS, 1993, MOL CELL BIOL, V13, P1212, DOI 10.1128/MCB.13.2.1212; SLAWECKI M, IN PRESS J CELL SCI; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; SOTO U, 1993, EXP CELL RES, V205, P66, DOI 10.1006/excr.1993.1059; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTON PA, 1994, J CELL BIOL, V125, P1037, DOI 10.1083/jcb.125.5.1037; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; WENDLAND M, 1993, J CELL BIOL, V120, P675, DOI 10.1083/jcb.120.3.675; Wolff J, 1986, Pediatr Neurol, V2, P141, DOI 10.1016/0887-8994(86)90004-4	62	374	376	2	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					115	125		10.1038/ng0295-115	http://dx.doi.org/10.1038/ng0295-115			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719337				2022-12-17	WOS:A1995QE67200011
J	Trynka, G; Sandor, C; Han, B; Xu, H; Stranger, BE; Liu, XS; Raychaudhuri, S				Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Xu, Han; Stranger, Barbara E.; Liu, X. Shirley; Raychaudhuri, Soumya			Chromatin marks identify critical cell types for fine mapping complex trait variants	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; T-CELLS; EXPRESSION; METHYLATIONS; METAANALYSIS; ENHANCERS; ARTHRITIS; DYNAMICS; PROVIDES	If trait-associated variants alter regulatory regions, then they should fall within chromatin marks in relevant cell types. However, it is unclear which of the many marks are most useful in defining cell types associated with disease and fine mapping variants. We hypothesized that informative marks are phenotypically cell type specific; that is, SNPs associated with the same trait likely overlap marks in the same cell type. We examined 15 chromatin marks and found that those highlighting active gene regulation were phenotypically cell type specific. Trimethylation of histone H3 at lysine 4 (H3K4me3) was the most phenotypically cell type specific (P < 1 x 10(-6)), driven by colocalization of variants and marks rather than gene proximity (P < 0.001). H3K4me3 peaks overlapped with 37 SNPs for plasma low-density lipoprotein concentration in the liver (P < 7 x 10(-5)), 31 SNPs for rheumatoid arthritis within CD4(+) regulatory T cells (P = 1 x 10(-4)), 67 SNPs for type 2 diabetes in pancreatic islet cells (P = 0.003) and the liver (P = 0.003), and 14 SNPs for neuropsychiatric disease in neuronal tissues (P = 0.007). We show how cell type-specific H3K4me3 peaks can inform the fine mapping of associated SNPs to identify causal variation.	[Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Stranger, Barbara E.; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol, Sch Med, Boston, MA 02115 USA; [Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Stranger, Barbara E.; Raychaudhuri, Soumya] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Xu, Han; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Xu, Han; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Manchester	Raychaudhuri, S (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.	soumya@broadinstitute.org	Han, Buhm/AAQ-9672-2020	Raychaudhuri, Soumya/0000-0002-1901-8265; Stranger, Barbara/0000-0001-9021-7331; Trynka, Gosia/0000-0002-6955-9529	Rubicon grant from The Netherlands Organization for Scientific Research (NWO); Harvard University Milton Fund; Brigham and Women's Hospital; US NIH [K08AR055688, U01HG0070033, R01 HG004069]; Arthritis Foundation; NHGRI; NIH Roadmap Epigenomics Mapping Consortium; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069, U01HG007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, K08AR055688] Funding Source: NIH RePORTER	Rubicon grant from The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Harvard University Milton Fund; Brigham and Women's Hospital; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Roadmap Epigenomics Mapping Consortium; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Daly, M. Kellis, D. Diogo, X. Hu, Y. Okada, R. Plenge, S. Ripke, G. Srivastava, E. Stahl and S. Sunyaev for critical feedback and discussion. G.T. is supported by the Rubicon grant from The Netherlands Organization for Scientific Research (NWO). B.E.S. and S.R. are supported by the Harvard University Milton Fund, and Brigham and Women's Hospital. S.R. is also supported by funds from the US NIH (K08AR055688 and U01HG0070033) and the Arthritis Foundation. X.S.L. is also supported by funds from the US NIH (R01 HG004069). We thank the ENCODE Project, supported by the NHGRI, and the NIH Roadmap Epigenomics Mapping Consortium for making data available.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ATCHISON ML, 1988, ANNU REV CELL BIOL, V4, P127, DOI 10.1146/annurev.cellbio.4.1.127; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; SMITH LC, 1978, ANNU REV BIOCHEM, V47, P751, DOI 10.1146/annurev.bi.47.070178.003535; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660	55	373	374	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					124	130		10.1038/ng.2504	http://dx.doi.org/10.1038/ng.2504			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23263488	Green Accepted			2022-12-17	WOS:000314333000005
J	Kump, KL; Bradbury, PJ; Wisser, RJ; Buckler, ES; Belcher, AR; Oropeza-Rosas, MA; Zwonitzer, JC; Kresovich, S; McMullen, MD; Ware, D; Balint-Kurti, PJ; Holland, JB				Kump, Kristen L.; Bradbury, Peter J.; Wisser, Randall J.; Buckler, Edward S.; Belcher, Araby R.; Oropeza-Rosas, Marco A.; Zwonitzer, John C.; Kresovich, Stephen; McMullen, Michael D.; Ware, Doreen; Balint-Kurti, Peter J.; Holland, James B.			Genome-wide association study of quantitative resistance to southern leaf blight in the maize nested association mapping population	NATURE GENETICS			English	Article							INBRED LINE POPULATION; DISEASE RESISTANCE; TRANSCRIPTION FACTORS; TRAIT LOCI; GENETIC ARCHITECTURE; NEGATIVE REGULATOR; DEFENSE-RESPONSE; ARABIDOPSIS NPR1; PROTEIN-KINASES; FLOWERING TIME	Nested association mapping (NAM) offers power to resolve complex, quantitative traits to their causal loci. The maize NAM population, consisting of 5,000 recombinant inbred lines (RILs) from 25 families representing the global diversity of maize, was evaluated for resistance to southern leaf blight (SLB) disease. Joint-linkage analysis identified 32 quantitative trait loci (QTLs) with predominantly small, additive effects on SLB resistance. Genome-wide association tests of maize HapMap SNPs were conducted by imputing founder SNP genotypes onto the NAM RILs. SNPs both within and outside of QTL intervals were associated with variation for SLB resistance. Many of these SNPs were within or near sequences homologous to genes previously shown to be involved in plant disease resistance. Limited linkage disequilibrium was observed around some SNPs associated with SLB resistance, indicating that the maize NAM population enables high-resolution mapping of some genome regions.	[Kump, Kristen L.; Oropeza-Rosas, Marco A.; Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Bradbury, Peter J.; Buckler, Edward S.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA; [Bradbury, Peter J.; Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Bradbury, Peter J.; Buckler, Edward S.; Kresovich, Stephen; Ware, Doreen] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Wisser, Randall J.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Belcher, Araby R.; Zwonitzer, John C.; Balint-Kurti, Peter J.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [McMullen, Michael D.] Univ Missouri, USDA ARS, Columbia, MO 65211 USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Balint-Kurti, Peter J.; Holland, James B.] USDA ARS, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Cornell University; United States Department of Agriculture (USDA); Cornell University; Cornell University; University of Delaware; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Holland, JB (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	jim.holland@ars.usda.gov	Balint-kurti, Peter/AES-0111-2022; Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Balint-Kurti, Peter/0000-0002-3916-194X; Holland, James/0000-0002-4341-9675	US National Science Foundation [DBI-0321467, IOS-0820619]; USDA-ARS; Pioneer Hi-Bred International; Direct For Biological Sciences [0820619] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Pioneer Hi-Bred International; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Eller, D. Rhyne, D. Stephens, G. Van Esbroek, C. Herring and the staffs of the North Carolina Central Crops Research Station and 27 Farms, Homestead, Florida, USA, for assistance in the field. We also thank J. Green and C.-R. Shyu for providing the photographs for Supplementary Figure 1. This research was supported by the US National Science Foundation (DBI-0321467 and IOS-0820619) and funds were provided by USDA-ARS. K.L.K. is supported by Pioneer Hi-Bred International.	[Anonymous], 2010, R LANG ENV STAT COMP; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Balint-Kurti PJ, 2008, PHYTOPATHOLOGY, V98, P315, DOI 10.1094/PHYTO-98-3-0315; Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; Balint-Kurti P J, 2006, Phytopathology, V96, P221, DOI 10.1094/PHYTO-96-0221; Balint-Kurti PJ, 2006, PHYTOPATHOLOGY, V96, P1067, DOI 10.1094/PHYTO-96-1067; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boyle P, 2009, PLANT CELL, V21, P3700, DOI 10.1105/tpc.109.069971; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Broglie K.E., 2009, U.S. Patent, Patent No. 7619133; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Haldane JBS, 1931, GENETICS, V16, P0357; HOLLEY RN, 1989, PLANT DIS, V73, P562, DOI 10.1094/PD-73-0562; HOOKER A L, 1972, Journal of Environmental Quality, V1, P244, DOI 10.2134/jeq1972.00472425000100030008x; Kou YJ, 2009, PLANT CELL REP, V28, P113, DOI 10.1007/s00299-008-0620-z; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Liu KJ, 2003, GENETICS, V165, P2117; LOH YT, 1995, PLANT PHYSIOL, V108, P1735, DOI 10.1104/pp.108.4.1735; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Poland JA, 2009, TRENDS PLANT SCI, V14, P21, DOI 10.1016/j.tplants.2008.10.006; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Takemoto D, 1999, PLANT CELL PHYSIOL, V40, P1232, DOI 10.1093/oxfordjournals.pcp.a029511; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; Wisser RJ, 2006, PHYTOPATHOLOGY, V96, P120, DOI 10.1094/PHYTO-96-0120; Wisser RJ, 2005, GENETICS, V169, P2277, DOI 10.1534/genetics.104.036327; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zwonitzer JC, 2010, PHYTOPATHOLOGY, V100, P72, DOI 10.1094/PHYTO-100-1-0072; Zwonitzer JC, 2009, THEOR APPL GENET, V118, P911, DOI 10.1007/s00122-008-0949-2; [No title captured]; [No title captured]	55	373	409	4	202	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2011	43	2					163	U120		10.1038/ng.747	http://dx.doi.org/10.1038/ng.747			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217757				2022-12-17	WOS:000286623800017
J	Cooper, JD; Smyth, DJ; Smiles, AM; Plagnol, V; Walker, NM; Allen, JE; Downes, K; Barrett, JC; Healy, BC; Mychaleckyj, JC; Warram, JH; Todd, JA				Cooper, Jason D.; Smyth, Deborah J.; Smiles, Adam M.; Plagnol, Vincent; Walker, Neil M.; Allen, James E.; Downes, Kate; Barrett, Jeffrey C.; Healy, Barry C.; Mychaleckyj, Josyf C.; Warram, James H.; Todd, John A.			Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci	NATURE GENETICS			English	Article							LARGE-SCALE; PKC-THETA; DISEASES; REGION; BACH2	We carried out a meta-analysis of data from three genome-wide association (GWA) studies of type 1 diabetes (T1D), testing 305,090 SNPs in 3,561 T1D cases and 4,646 controls of European ancestry. We obtained further support for 4q27 (IL2-IL21, P = 1.9 x 10(-8)) and, after genotyping an additional 6,225 cases, 6,946 controls and 2,828 families, convincing evidence for four previously unknown and distinct risk loci in chromosome regions 6q15 (BACH2, P = 4.7 x 10(-12)), 10p15 (PRKCQ, P = 3.7 x 10(-9)), 15q24 (CTSH, P = 3.2 x 10(-15)) and 22q13 (C1QTNF6, P = 2.0 x 10(-8)).	[Cooper, Jason D.; Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Allen, James E.; Downes, Kate; Barrett, Jeffrey C.; Healy, Barry C.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; [Smiles, Adam M.; Warram, James H.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Mychaleckyj, Josyf C.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Joslin Diabetes Center, Inc.; University of Virginia	Cooper, JD (corresponding author), Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England.	jason.cooper@cimr.cam.ac.uk	Plagnol, Vincent/A-5667-2011; Todd, John A/A-3542-2010; Allen, James/B-2457-2009	Todd, John A/0000-0003-2740-8148; smyth, deborah/0000-0002-6330-2669; Walker, Neil/0000-0001-9796-7688; Allen, James/0000-0002-3894-4854; Plagnol, Vincent/0000-0002-5597-9215	Juvenile Diabetes Research Foundation International; Wellcome Trust; National Institute for Health Research Cambridge Biomedical Centre; Wellcome Trust Strategic Award [079895]; Wellcome Trust [076113]; Medical Research Council [G0000934] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061675, R01MH059571, R01MH059587, R01MH059588, R01MH067257, R01MH060870, R01MH063420, R01MH059565, R01MH059566, R01MH059586, R01MH060879] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Centre(National Institute for Health Research (NIHR)); Wellcome Trust Strategic Award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Centre. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (079895). We thank all study participants and family members. We gratefully acknowledge D. Clayton for methodology advice and comments on the manuscript. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council and the Wellcome Trust. We thank The Avon Longitudinal Study of Parents and Children laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton, for preparing and providing the control DNA samples. We also thank H. Stevens, P. Clarke, G. Coleman, S. Duley, D. Harrison, S. Hawkins, M. Maisuria, T. Mistry and N. Taylor for preparation of DNA samples. We acknowledge use of DNA from the Human Biological Data Interchange and Diabetes UK for the USA and UK multiplex families, respectively; the Norwegian Study Group for Childhood Diabetes (D. Undlien and K. Ronningen) for the Norwegian families; D. Savage, C. Patterson, D. Carson and P. Maxwell for the Northern Irish families; the Genetics of Type 1 Diabetes in Finland (GET1FIN); J. Tuomilehto, L. Kinnunen, E. Tuomilehto-Wolf, V. Harjutsalo and T. Valle for the Finnish families; and C. Guja and C. Ionescu-Tirgoviste for the Romanian families. WTCCC: This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data are available from http://www.wtccc.org.uk/. Funding for the project was provided by the Wellcome Trust under award 076113 (see ref. 1). NIMH: We gratefully acknowledge the National Institute of Mental Health for generously allowing the use of their control CEL and genotype data. Control subjects from the National Institute of Mental Health Schizophrenia Genetics Initiative (NIMH-GI), data and biomaterials are being collected by the "Molecular Genetics of Schizophrenia II'' (MGS-2) collaboration. The investigators and co-investigators are as follows: P.V. Gejman (Collaboration coordinator) and A. R. Sanders (ENH/Northwestern University, MH059571); F. Amin (Emory University School of Medicine, MH59587); N. Buccola (Louisiana State University Health Sciences Center, MH067257); W. Byerley (University of California-Irvine, MH60870); C. R. Cloninger (Washington University, St. Louis, U01, MH060879); R. Crowe (PI) and D. Black (University of Iowa, MH59566); R. Freedman (University of Colorado, MH059565); D. Levinson (University of Pennsylvania, MH061675); B. Mowry (University of Queensland, MH059588); and J. Silverman (Mt. Sinai School of Medicine, MH59586). The samples were collected by V.L. Nimgaonkar's group at the University of Pittsburgh as part of a multi-institutional collaborative research project with J. Smoller and P. Sklar (Massachusetts General Hospital) (grant MH 63420). GoKinD: We acknowledge the National Institutes of Health for allowing the use of their control allele signal intensity and genotype data. The dataset(s) used for the analyses described in this manuscript were obtained from the GAIN Database, controlled through dbGaP accession number phs000018.v1.p1.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaudhary D, 2006, CURR OPIN INVEST DR, V7, P432; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Hong SW, 2008, BIOCHEM BIOPH RES CO, V365, P426, DOI 10.1016/j.bbrc.2007.10.183; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	15	373	383	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1399	1401		10.1038/ng.249	http://dx.doi.org/10.1038/ng.249			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978792	Green Accepted			2022-12-17	WOS:000261215900012
J	Mackay, DJG; Callaway, JLA; Marks, SM; White, HE; Acerini, CL; Boonen, SE; Dayanikli, P; Firth, HV; Goodship, JA; Haemers, AP; Hahnemann, JMD; Kordonouri, O; Masoud, AF; Oestergaard, E; Storr, J; Ellard, S; Hattersley, AT; Robinson, DO; Temple, IK				Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Marks, Sophie M.; White, Helen E.; Acerini, Carlo L.; Boonen, Susanne E.; Dayanikli, Pinar; Firth, Helen V.; Goodship, Judith A.; Haemers, Andreas P.; Hahnemann, Johanne M. D.; Kordonouri, Olga; Masoud, Ahmed F.; Oestergaard, Elsebet; Storr, John; Ellard, Sian; Hattersley, Andrew T.; Robinson, David O.; Temple, I. Karen			Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57	NATURE GENETICS			English	Article							STEM-CELLS; MELLITUS; IDENTIFICATION; REGION; ZFP-57	We have previously described individuals presenting with transient neonatal diabetes and showing a variable pattern of DNA hypomethylation at imprinted loci throughout the genome. We now report mutations in ZFP57, which encodes a zinc-finger transcription factor expressed in early development, in seven pedigrees with a shared pattern of mosaic hypomethylation and a conserved range of clinical features. This is the first description of a heritable global imprinting disorder that is compatible with life.	[Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Robinson, David O.; Temple, I. Karen] Univ Southampton, Div Human Genet, Southampton SO16 6YD, England; [Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Marks, Sophie M.; Robinson, David O.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, England; [White, Helen E.] Natl Genet Reference Lab Wessex, Salisbury SP2 8BJ, England; [Acerini, Carlo L.] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England; [Boonen, Susanne E.] Kennedy Ctr, Genet Counselling Clin, DK-2600 Glostrup, Denmark; [Dayanikli, Pinar] Amer Hosp, TR-80200 Istanbul, Turkey; [Firth, Helen V.] Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 0QQ, England; [Goodship, Judith A.] Univ Newcastle, Inst Human Genet, Newcastle upon Tyne NE1 3BZ, Tyne & Wear, England; [Hahnemann, Johanne M. D.] Kennedy Ctr, Med Genet Lab, DK-2600 Glostrup, Denmark; [Kordonouri, Olga] Kinderkrankenhaus Bult, D-30173 Hannover, Germany; [Masoud, Ahmed F.] Northwick Pk Hosp & Clin Res Ctr, Childrens Serv, Harrow HA1 3UJ, Middx, England; [Oestergaard, Elsebet] Natl Univ Hosp Rigshospitalet, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Storr, John] Cumberland Infirm, Dept Paediat, Carlisle CA2 7HY, Cumbria, England; [Ellard, Sian; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Temple, I. Karen] Southampton Univ Hosp, Acad Unit Genet Med, Wessex Clin Genet Serv, Southampton SO16 5YA, England	University of Southampton; Salisbury District Hospital; University of Cambridge; Amerikan Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK; Imperial College London; Rigshospitalet; University of Copenhagen; University of Exeter; University of Southampton	Mackay, DJG (corresponding author), Univ Southampton, Div Human Genet, Southampton SO16 6YD, England.	djgm@soton.ac.uk	temple, isabel K/K-2391-2015; Mackay, Deborah JG/B-2879-2015	Temple, Isabel Karen/0000-0002-6045-1781; Boonen, Susanne Eriksen/0000-0002-7824-2080; Ellard, Sian/0000-0002-7620-5526; Acerini, Carlo/0000-0003-2121-5871; Hattersley, Andrew/0000-0001-5620-473X; Mackay, Deborah JG/0000-0003-3088-4401				Akagi T, 2005, BIOCHEM BIOPH RES CO, V331, P23, DOI 10.1016/j.bbrc.2005.03.118; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Alonso MBD, 2004, J BIOL CHEM, V279, P25653, DOI 10.1074/jbc.M400415200; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Boonen SE, 2008, EUR J HUM GENET, V16, P453, DOI 10.1038/sj.ejhg.5201993; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Mackay DJG, 2005, HUM GENET, V116, P255, DOI 10.1007/s00439-004-1236-1; OKAZAKI S, 1994, J BIOL CHEM, V269, P6900; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rossignol S, 2006, J MED GENET, V43, P902, DOI 10.1136/jmg.2006.042135; Temple IK, 2002, J MED GENET, V39, P872, DOI 10.1136/jmg.39.12.872; Valerio G, 2001, J PEDIATR ENDOCR MET, V14, P897; Wood AJ, 2007, NUCLEIC ACIDS RES, V35, P7031, DOI 10.1093/nar/gkm742	15	373	385	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					949	951		10.1038/ng.187	http://dx.doi.org/10.1038/ng.187			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622393				2022-12-17	WOS:000258026900009
J	Gicquel, C; Rossignol, S; Cabrol, S; Houang, M; Steunou, V; Barbu, V; Danton, F; Thibaud, N; Le Merrer, M; Burglen, L; Bertrand, AM; Netchine, I; Le Bouc, Y				Gicquel, C; Rossignol, S; Cabrol, S; Houang, M; Steunou, V; Barbu, V; Danton, F; Thibaud, N; Le Merrer, M; Burglen, L; Bertrand, AM; Netchine, I; Le Bouc, Y			Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; ENHANCER-BLOCKING ACTIVITY; FACTOR-II GENE; H19 GENE; GROWTH-DEFICIENCY; GENOMIC VARIANTS; IGF2 GENE; METHYLATION; CTCF; PHENOTYPE	Silver- Russell syndrome ( SRS, OMIM 180860) is a congenital disorder characterized by severe intrauterine and postnatal growth retardation, dysmorphic facial features and body asymmetry. SRS is genetically heterogenous with maternal uniparental disomy with respect to chromosome 7 occurring in similar to 10% of affected individuals. Given the crucial role of the 11p15 imprinted region in the control of fetal growth, we hypothesized that dysregulation of genes at 11p15 might be involved in syndromic intrauterine growth retardation. We identified an epimutation ( demethylation) in the telomeric imprinting center region ICR1 of the 11p15 region in several individuals with clinically typical SRS. This epigenetic defect is associated with, and probably responsible for, relaxation of imprinting and biallelic expression of H19 and downregulation of IGF2. These findings provide new insight into the pathogenesis of SRS and strongly suggest that the 11p15 imprinted region, in addition to those of 7p11.2- p13 and 7q31- qter, is involved in SRS.	INSERM, U515, Lab Explorat Fonctionnelles Endocriniennes, F-75012 Paris, France; Univ Paris 06, Hop Armand Trousseau, APHP, F-75012 Paris, France; Fac St Antoine, INSERM, U680, F-75012 Paris, France; Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; Hop Armand Trousseau, Unite Genet, F-75012 Paris, France; Hop Besancon, Serv Endocrinol Pediat, F-25030 Besancon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Gicquel, C (corresponding author), INSERM, U515, Lab Explorat Fonctionnelles Endocriniennes, 26 Ave Arnold Netter, F-75012 Paris, France.	christine.gicquel@trs.aphp.fr	Rossignol, Sylvie/A-3439-2009; ROSSIGNOL, Sylvie/A-8506-2012	ROSSIGNOL, Sylvie/0000-0001-7559-5764; ROSSIGNOL, Sylvie/0000-0003-1268-0632				Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eggermann T, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028936; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Fisher AM, 2002, HUM GENET, V111, P290, DOI 10.1007/s00439-002-0787-2; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frevel MAE, 1999, J BIOL CHEM, V274, P29331, DOI 10.1074/jbc.274.41.29331; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hannula K, 2001, J MED GENET, V38, P273, DOI 10.1136/jmg.38.4.273; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hitchins MP, 2001, J MED GENET, V38, P810, DOI 10.1136/jmg.38.12.810; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Meyer E, 2005, MOL GENET METAB, V84, P376, DOI 10.1016/j.ymgme.2004.12.002; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Obermann C, 2004, MOL GENET METAB, V82, P246, DOI 10.1016/j.ymgme.2004.04.008; Price SM, 1999, J MED GENET, V36, P837; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; SCHNEID H, 1993, J MED GENET, V30, P353, DOI 10.1136/jmg.30.5.353; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Ulaner GA, 2003, ENDOCRINOLOGY, V144, P4420, DOI 10.1210/en.2003-0681; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317	30	373	384	0	26	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2005	37	9					1003	1007		10.1038/ng1629	http://dx.doi.org/10.1038/ng1629			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16086014				2022-12-17	WOS:000231591900028
J	Backman, SA; Stambolic, V; Suzuki, A; Haight, J; Elia, A; Pretorius, J; Tsao, MS; Shannon, P; Bolon, B; Ivy, GO; Mak, TW				Backman, SA; Stambolic, V; Suzuki, A; Haight, J; Elia, A; Pretorius, J; Tsao, MS; Shannon, P; Bolon, B; Ivy, GO; Mak, TW			Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR PTEN; SIGNALING PATHWAY; COWDEN-SYNDROME; CELL-SURVIVAL; GERMLINE MUTATIONS; PROTEUS SYNDROME; CANCER; GENE; CEREBELLUM; MICE	Initially identified in high-grade gliomas, mutations in the PTEN tumor-suppressor are also found in many sporadic cancers and a few related autosomal dominant hamartoma syndromes. PTEN is a 3'-specific phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P-3) phosphatase and functions as a negative regulator of PI3K signaling. We generated a tissue-specific deletion of the mouse homolog Pten to address its role in brain function. Mice homozygous for this deletion (Pten(loxP/loxP);Gfap-cre), developed seizures and ataxia by 9 wk and died by 29 wk. Histological analysis showed brain enlargement in Pten(loxP/loxP);Gfap-cre mice as a consequence of primary granule-cell dysplasia in the cerebellum and dentate gyrus. Pten mutant cells showed a cell-autonomous increase in soma size and elevated phosphorylation of Akt. These data represent the first evidence for the role of Pten and Akt in cell size regulation in mammals and provide an animal model for a human phakomatosis condition, Lhermitte-Duclos disease (LDD).	Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Amgen Res Inst, Toronto, ON M5G 2C1, Canada; Osaka Univ, Dept Mol Cell Biol, Microbial Dis Res Inst, Suita, Osaka 5650874, Japan; Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA; Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; Toronto Western Hosp, Div Neuropathol, Toronto, ON M5T 2S8, Canada; Univ Hlth Care Network, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Psychol, Scarborough, ON M1C 1A4, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Osaka University; Amgen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Mak, TW (corresponding author), Univ Toronto, Dept Med Biophys, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	tmak@oci.utoronto.ca	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; Suzuki, Akira/GYD-6697-2022	Tsao, Ming Sound/0000-0002-9160-5405; Suzuki, Akira/0000-0002-5950-8808; Stambolic, Vuk/0000-0001-8853-3239				Biesecker LG, 1999, AM J MED GENET, V84, P389, DOI 10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO;2-O; Brown W., 1987, SURGICAL TREATMENT E, P511; Bruni P, 2000, ONCOGENE, V19, P3146, DOI 10.1038/sj.onc.1203633; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ding H, 2001, CANCER RES, V61, P3826; Dorland W. A. N., 2000, DORLANDS ILLUSTRATED; Eng C, 1998, NAT GENET, V19, P223, DOI 10.1038/897; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; GRIFFITHS PD, 1994, NEUROPEDIATRICS, V25, P140, DOI 10.1055/s-2008-1073012; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hampe CS, 2001, J NEUROIMMUNOL, V113, P63, DOI 10.1016/S0165-5728(00)00423-9; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huang H, 1999, DEVELOPMENT, V126, P5365; Iida S, 1998, INT J MOL MED, V1, P925; Karle J, 2001, NEUROL RES, V23, P39, DOI 10.1179/016164101101198262; KHURGEL M, 1995, NEUROBIOL DIS, V2, P23, DOI 10.1006/nbdi.1995.0003; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1998, J MED GENET, V35, P881, DOI 10.1136/jmg.35.11.881; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Morrison ME, 1998, J NEUROSCI, V18, P3563; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nishio S, 2000, NEUROSURG REV, V23, P84; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; PRIVAT A, 1976, J COMP NEUROL, V166, P201, DOI 10.1002/cne.901660207; RAKIC P, 1975, ADV NEUROL, V12, P117; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; ROESSMANN U, 1984, J NEUROSURG, V60, P845, DOI 10.3171/jns.1984.60.4.0845; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; SOTELO C, 1976, BRAIN RES, V111, P389, DOI 10.1016/0006-8993(76)90782-4; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STEWARD O, 1992, EPILEPSY RES, P197; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; VINCHON M, 1994, J NEUROL NEUROSUR PS, V57, P699, DOI 10.1136/jnnp.57.6.699; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; WIESTLER OD, 2000, PATHOLOGY GENETICS T, P235; WUENSCHELL CW, 1986, P NATL ACAD SCI USA, V83, P6193, DOI 10.1073/pnas.83.16.6193; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	53	373	392	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					396	403		10.1038/ng782	http://dx.doi.org/10.1038/ng782			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726926				2022-12-17	WOS:000172507500014
J	Chen, H; Lun, Y; Ovchinnikov, D; Kokubo, H; Oberg, KC; Pepicelli, CV; Gan, L; Lee, B; Johnson, RL				Chen, H; Lun, Y; Ovchinnikov, D; Kokubo, H; Oberg, KC; Pepicelli, CV; Gan, L; Lee, B; Johnson, RL			Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome	NATURE GENETICS			English	Article							SONIC-HEDGEHOG; MOUSE; DOMAIN; GENES; EXPRESSION; POLARITY; REGION; CNS	Dorsal-ventral limb patterning in vertebrates is thought to be controlled by the LIM-homeodomain protein Lmx1b which is expressed in a spatially and temporally restricted manner along the dorsal-ventral limb axis(1,2). Here we describe the phenotype resulting from targeted disruption of Lmx1b. Our results demonstrate that Lmx1b is essential for the specification of dorsal limb fates at both the zeugopodal and autopodal level with prominent phenotypes including an absence of nails and patellae. These features are similar to those present in a dominantly inherited human condition called nail patella syndrome(3) (NPS), which also has renal involvement. Mouse Lmx1b maps to a region syntenic to that of the NPS gene(4), and kidneys of Lmx1b mutant mice exhibit pathological changes similar to that observed in NPS (refs 5,6), Our results demonstrate an essential function for Lmx1b in mouse limb and kidney development and suggest that NPS might result from mutations in the human LMX1B gene.	Univ Texas, MD Anderson Cancer Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Harvard Univ, Dept Cellular & Mol Biol, Biolabs, Cambridge, MA 02138 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Harvard University	Johnson, RL (corresponding author), Univ Texas, MD Anderson Cancer Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	rjohnson@odin.mdacc.tmc.edu	Ovchinnikov, Dmitry/J-7963-2014	Ovchinnikov, Dmitry/0000-0001-9603-8385; Oberg, Kerby/0000-0002-1241-4273				Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cygan JA, 1997, DEVELOPMENT, V124, P5021; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DELPOZO E, 1970, AM J CLIN PATHOL, V54, P845; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; HOGAN B, 1994, MANIPULATING MOUSE E; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Jones K. L., 1997, SMITHS RECOGNIZABLE; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; JOYNER AL, 1987, GENE DEV, V1, P521; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; McIntosh I, 1997, AM J HUM GENET, V60, P133; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MORITA T, 1973, ARCH INTERN MED, V131, P271, DOI 10.1001/archinte.131.2.271; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; PARR BA, 1993, DEVELOPMENT, V119, P247; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; PILZ A, 1994, GENOMICS, V21, P104, DOI 10.1006/geno.1994.1230; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIDDLE RD, 1995, CELL, V83, P61; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0	29	373	378	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					51	55		10.1038/ng0598-51	http://dx.doi.org/10.1038/ng0598-51			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590288				2022-12-17	WOS:000073346700016
J	Borrow, J; Shearman, AM; Stanton, VP; Becher, R; Collins, T; Williams, AJ; Dube, I; Katz, F; Kwong, YL; Morris, C; Ohyashiki, K; Toyama, K; Rowley, J; Housman, DE				Borrow, J; Shearman, AM; Stanton, VP; Becher, R; Collins, T; Williams, AJ; Dube, I; Katz, F; Kwong, YL; Morris, C; Ohyashiki, K; Toyama, K; Rowley, J; Housman, DE			The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9	NATURE GENETICS			English	Article							HUMAN HEMATOPOIETIC-CELLS; HOMEOBOX GENE; MESSENGER-RNA; LEUKEMIA; EXPRESSION; FUSION; ACID; DNA; TRANSCRIPTION; BREAKPOINT	The t(7;11)(p15;p15) translocation is a recurrent chromosomal abnormality associated primarily with acute myeloid leukaemia (FAB M2 and M4). We present here the molecular definition of this translocation. On chromosome 7 positional cloning revealed the consistent rearrangement of the HOXA9 gene, which encodes a class I homeodomain protein potentially involved in myeloid differentiation. On chromosome 11 the translocation targets the human homologue of NUP98, a member of the GLFG nucleoporin family. Chimaeric messages spliced over the breakpoint fuse the GLFG Massachusetts repeat domains of NUP98 in-frame to the HOXA9 homeobox. The predicted NUP98-HOXA9 fusion protein may promote leukaemogenesis through inhibition of HOXA9-mediated terminal differentiation and/or aberrant nucleocytoplasmic transport.	W GERMAN CANC CTR, D-45122 ESSEN 1, GERMANY; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA; UNIV TORONTO, TORONTO, ON M5G 1L5, CANADA; GREAT ORMOND ST HOSP SICK CHILDREN, LONDON WC1N 1EH, ENGLAND; UNIV HONG KONG, QUEEN MARY HOSP, DEPT MED, HONG KONG, HONG KONG; CHRISTCHURCH SCH MED, CHRISTCHURCH, NEW ZEALAND; TOKYO MED COLL, SHINJUKU KU, TOKYO 160, JAPAN; UNIV CHICAGO, MED CTR, CHICAGO, IL 60637 USA	Harvard University; Brigham & Women's Hospital; University of Toronto; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Hong Kong; University of Otago; Tokyo Medical University; University of Chicago; University of Chicago Medical Center	Borrow, J (corresponding author), MIT, CTR CANC RES, 77 MASSACHUSETTS AVE, CAMBRIDGE, MA 02139 USA.		Kwong, Yok Lam/C-4296-2009; Morris, Christine/G-1690-2011	Stanton, Vincent/0000-0002-2205-6000	NATIONAL CANCER INSTITUTE [R01CA017575, R37CA017575] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000299] Funding Source: NIH RePORTER; NCI NIH HHS [CA17575] Funding Source: Medline; NHGRI NIH HHS [HG00299] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; BILL J, 1986, SOMAT CELL MOLEC GEN, V12, P409, DOI 10.1007/BF01570736; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DUBE ID, 1991, BLOOD, V78, P2996; FABRE E, 1994, CELL, V78, P275, DOI 10.1016/0092-8674(94)90297-6; FORNEROD M, 1995, ONCOGENE, V10, P1739; FUJIMURA T, 1993, CANCER GENET CYTOGEN, V68, P143, DOI 10.1016/0165-4608(93)90012-B; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GLASER T, 1990, GENOMICS, V6, P48, DOI 10.1016/0888-7543(90)90447-3; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; KWONG YL, 1992, LEUKEMIA, V6, P232; KWONG YL, 1994, AM J HEMATOL, V47, P62, DOI 10.1002/ajh.2830470117; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; LIU J, 1995, GENOMICS, V26, P178, DOI 10.1016/0888-7543(95)80199-V; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; MORRIS CM, 1989, BRIT J HAEMATOL, V71, P481, DOI 10.1111/j.1365-2141.1989.tb06306.x; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rubin M R, 1990, DNA Seq, V1, P115, DOI 10.3109/10425179009016039; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; Sambrook J., 1989, MOL CLONING LAB MANU; SATO Y, 1987, BLOOD, V70, P1654; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SHEN WF, 1989, P NATL ACAD SCI USA, V86, P8536, DOI 10.1073/pnas.86.21.8536; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; TOMIYASU T, 1982, JPN J HUM GENET, V27, P243, DOI 10.1007/BF01901320; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VIEILLEGROSJEAN I, 1992, BIOCHEM BIOPH RES CO, V183, P1124, DOI 10.1016/S0006-291X(05)80307-9; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1990, MOL CELL BIOL, V10, P4016, DOI 10.1128/MCB.10.8.4016; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; WINQVIST R, 1993, CANCER RES, V53, P4486; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZAVORTINK M, 1989, GENE DEV, V3, P1969, DOI 10.1101/gad.3.12a.1969	59	373	384	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					159	167		10.1038/ng0296-159	http://dx.doi.org/10.1038/ng0296-159			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563754				2022-12-17	WOS:A1996TU07900016
J	MERAJVER, SD; PHAM, TM; CADUFF, RF; CHEN, M; POY, EL; COONEY, KA; WEBER, BL; COLLINS, FS; JOHNSTON, C; FRANK, TS				MERAJVER, SD; PHAM, TM; CADUFF, RF; CHEN, M; POY, EL; COONEY, KA; WEBER, BL; COLLINS, FS; JOHNSTON, C; FRANK, TS			SOMATIC MUTATIONS IN THE BRCA1 GENE IN SPORADIC OVARIAN-TUMORS	NATURE GENETICS			English	Article							FAMILIAL BREAST; ALLELE LOSSES; CANCER; CHROMOSOME-17; LINKAGE; REGION; TUMORS	The BRCA1 gene on chromosome 17q21 is responsible for an autosomal dominant syndrome of increased susceptibility to breast and ovarian cancer but no somatic mutations in tumours have yet been described. To study the potential role of BRCA1 in sporadic carcinogenesis, we analysed the genomic DNA of tumour and normal fractions of 47 ovarian cancers for mutations in BRCA1 using the single-strand conformation polymorphism technique. We now describe somatic mutations in the DNA of four tumours which also had loss of heterozygosity (LOH) at a BRCA1 intragenic marker. Our data support a tumour suppressor mechanism for BRCA1; somatic mutations and LOH may result in inactivation of BRCA1 in at least a small number of ovarian cancers.	UNIV MICHIGAN, SCH MED, DEPT PATHOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH MED, DEPT OBSTET & GYNECOL, ANN ARBOR, MI 48109 USA; UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT INTERNAL MED, PHILADELPHIA, PA 19104 USA; NIH, NATL CTR HUMAN GENOME RES, BETHESDA, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	MERAJVER, SD (corresponding author), UNIV MICHIGAN, SCH MED, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA.			Cooney, Kathleen/0000-0003-3831-6943	NCRR NIH HHS [3M01RR00042-34S1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CROPP CS, 1994, CANCER RES, V54, P2548; EASTON DF, 1993, AM J HUM GENET, V52, P678; ECCLES DM, 1990, ONCOGENE, V5, P1599; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRANK TS, 1994, MODERN PATHOL, V7, P3; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JACOBS IJ, 1993, CANCER RES, V53, P1218; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LEE JH, 1990, CANCER RES, V50, P2724; MERAJVER SD, IN PRESS CLIN CANCER; MILCI Y, 1994, SCIENCE, V266, P66; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SATO T, 1991, CANCER RES, V51, P5118; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; YOUNG RH, 1992, HEMATOL ONCOL CLIN N, V6, P739	22	373	387	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1995	9	4					439	443		10.1038/ng0495-439	http://dx.doi.org/10.1038/ng0495-439			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795652				2022-12-17	WOS:A1995QQ75300024
J	Scortegagna, M; Ding, K; Oktay, Y; Gaur, A; Thurmond, F; Yan, LJ; Marck, BT; Matsumoto, AM; Shelton, JM; Richardson, JA; Bennett, MJ; Garcia, JA				Scortegagna, M; Ding, K; Oktay, Y; Gaur, A; Thurmond, F; Yan, LJ; Marck, BT; Matsumoto, AM; Shelton, JM; Richardson, JA; Bennett, MJ; Garcia, JA			Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1(-/-) mice	NATURE GENETICS			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; HYPOXIA-INDUCIBLE FACTOR-1; SYSTEMIC CARNITINE DEFICIENCY; LUNG EPITHELIAL-CELLS; GENE-EXPRESSION; OXIDATIVE STRESS; MITOCHONDRIAL ABNORMALITIES; DILATED CARDIOMYOPATHY; ENDOTHELIAL-CELLS; KNOCKOUT MICE	Hypoxia-inducible factor (HIF) transcription factors respond to multiple environmental stressors, including hypoxia and hypoglycemia. We report that mice lacking the HIF family member HIF-2alpha (encoded by Epas1) have a syndrome of multiple-organ pathology, biochemical abnormalities and altered gene expression patterns. Histological and ultrastructural analyses showed retinopathy, hepatic steatosis, cardiac hypertrophy, skeletal myopathy, hypocellular bone marrow, azoospermia and mitochondrial abnormalities in these mice. Serum and urine metabolite studies showed hypoglycemia, lactic acidosis, altered Krebs cycle function and dysregulated fatty acid oxidation. Biochemical assays showed enhanced generation of reactive oxygen species (ROS), whereas molecular analyses indicated reduced expression of genes encoding the primary antioxidant enzymes (AOEs). Transfection analyses showed that HIF-2alpha could efficiently transactivate the promoters of the primary AOEs. Prenatal or postnatal treatment of Epas1(-/-) mice with a superoxide dismutase (SOD) mimetic reversed several aspects of the null phenotype. We propose a rheostat role for HIF-2alpha that allows for the maintenance of ROS as well as mitochondrial homeostasis.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Washington, Sch Med, Dept Med,VA Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA 98108 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Childrens Med Ctr, Dept Pathol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garcia, JA (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Matsumoto, Alvin/AAH-6096-2020; Oktay, Yavuz/G-4794-2015	Oktay, Yavuz/0000-0002-0158-2693; Garcia, Joseph/0000-0002-5621-7538; , Kan/0000-0003-3485-8200; Yan, Liang-Jun/0000-0002-5815-5430	NHLBI NIH HHS [K08 HL067154] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067154] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boveris A, 2002, METHOD ENZYMOL, V349, P280, DOI 10.1016/S0076-6879(02)49342-1; Brodsky SV, 2002, AM J PHYSIOL-HEART C, V283, pH2130, DOI 10.1152/ajpheart.00196.2002; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chang SH, 2003, BIOCHEM J, V371, P877, DOI 10.1042/BJ20021731; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Ghoshal K, 1999, BIOCHEM BIOPH RES CO, V264, P735, DOI 10.1006/bbrc.1999.1563; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Guyton KZ, 1996, FREE RADICAL BIO MED, V20, P735, DOI 10.1016/0891-5849(95)02151-5; HORIUCHI M, 1994, BBA-MOL BASIS DIS, V1226, P25, DOI 10.1016/0925-4439(94)90054-X; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; ISCHIROPOULOS H, 1995, J NEUROCHEM, V65, P2366; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jackson RM, 1998, FREE RADICAL BIO MED, V25, P463, DOI 10.1016/S0891-5849(98)00101-4; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kaido M, 1997, EUR NEUROL, V38, P302, DOI 10.1159/000113399; Kamiya H, 2001, BASIC RES CARDIOL, V96, P431, DOI 10.1007/s003950170024; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kuhn DM, 1999, J NEUROSCI, V19, P10289; Lai CT, 1997, BIOCHEM PHARMACOL, V53, P363, DOI 10.1016/S0006-2952(96)00731-9; Lando D, 2000, J BIOL CHEM, V275, P4618, DOI 10.1074/jbc.275.7.4618; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; MIYAGAWA J, 1995, VIRCHOWS ARCH, V426, P271; MohazzabH KM, 1997, CIRCULATION, V96, P614; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Phelan SA, 1998, GENOMICS, V54, P132, DOI 10.1006/geno.1998.5568; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; Rogers RJ, 2001, J BIOL CHEM, V276, P20419, DOI 10.1074/jbc.M008915200; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SCHISLER NJ, 1985, BIOCHEM GENET, V23, P291, DOI 10.1007/BF00504326; SCHISLER NJ, 1991, BIOCHEM GENET, V29, P65, DOI 10.1007/BF00578241; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; St Clair DK, 2002, METHOD ENZYMOL, V349, P306, DOI 10.1016/S0076-6879(02)49345-7; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WARNER BB, 1996, AM J PHYSIOL, V271, P150; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360	50	372	378	0	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					331	340		10.1038/ng1266	http://dx.doi.org/10.1038/ng1266			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14608355				2022-12-17	WOS:000186791000014
J	Tonon, G; Modi, S; Wu, LZ; Kubo, A; Coxon, AB; Komiya, T; O'Neil, K; Stover, K; El-Naggar, A; Griffin, JD; Kirsch, IR; Kaye, FJ				Tonon, G; Modi, S; Wu, LZ; Kubo, A; Coxon, AB; Komiya, T; O'Neil, K; Stover, K; El-Naggar, A; Griffin, JD; Kirsch, IR; Kaye, FJ			t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway	NATURE GENETICS			English	Article							MINOR SALIVARY-GLAND; NEOPLASTIC TRANSFORMATION; CHROMOSOMAL TRANSLOCATIONS; HUMAN HOMOLOG; GENE; TUMOR; ACTIVATION; EXPRESSION; MASTERMIND; RECEPTORS	Truncation of Notch1 has been shown to cause a subtype of acute leukemia(1), and activation of Notch4 has been associated with mammary and salivary gland carcinomas of mice(2). Here we identify a new mechanism for disrupting Notch signaling in human tumorigenesis, characterized by altered function of a new ortholog of the Drosophila melanogaster Notch co-activator molecule Mastermind. We cloned the t(11;19) translocation that underlies the most common type of human malignant salivary gland tumor. This rearrangement fuses exon 1 from a novel gene of unknown function at 19p13, termed mucoepidermoid carcinoma translocated 1 (MECT1), with exons 2-5 of a novel member of the Mastermind-like gene family (MAML2) at 11q21 (ref. 3). Similar to D. melanogaster Mastermind and MAML1 (refs. 4,5), full-length MAML2 functioned as a CSL (CBF-1, suppressor of hairless and Lag-1)-dependent transcriptional co-activator for ligand-stimulated Notch. In contrast, MECT1-MAML2 activated transcription of the Notch target gene HES1 independently of both Notch ligand and CSL binding sites. MECT1-MAML2 induced foci formation in RK3E epithelial cells, confirming a biological effect for the fusion product. These data suggest a new mechanism to disrupt the function of a Notch co-activator in a common type of malignant salivary gland tumor.	Natl Canc Inst, Genet Branch, Ctr Canc Res, Bethesda, MD 20889 USA; Natl Naval Med Ctr, Bethesda, MD 20889 USA; Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Natl Naval Med Ctr, Dept Med, Div Pulm, Bethesda, MD 20889 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Walter Reed National Military Medical Center; University of Texas System; UTMD Anderson Cancer Center	Kaye, FJ (corresponding author), Natl Canc Inst, Genet Branch, Ctr Canc Res, Bethesda, MD 20889 USA.	fkaye@helix.nih.gov	kaye, frederic/E-2437-2011; Tonon, Giovanni/J-9804-2018	Tonon, Giovanni/0000-0003-2973-5038	NATIONAL CANCER INSTITUTE [ZIASC007256, Z01SC007256] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; DAHLENFORS R, 1995, CANCER GENET CYTOGEN, V79, P188, DOI 10.1016/0165-4608(94)00121-Q; DAHLENFORS R, 1994, HEREDITAS, V120, P287, DOI 10.1111/j.1601-5223.1994.00287.x; Dumont E, 2000, ONCOGENE, V19, P556, DOI 10.1038/sj.onc.1203352; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; ElNaggar AK, 1996, CANCER GENET CYTOGEN, V87, P29, DOI 10.1016/0165-4608(95)00266-9; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; HORSMAN DE, 1995, CANCER GENET CYTOGEN, V80, P165, DOI 10.1016/0165-4608(94)00187-G; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; JOHANSSON M, 1995, CANCER GENET CYTOGEN, V80, P85, DOI 10.1016/0165-4608(94)00160-D; Kojika S, 2001, EXP HEMATOL, V29, P1041, DOI 10.1016/S0301-472X(01)00676-2; Kwon TK, 1996, GENE, V180, P113, DOI 10.1016/S0378-1119(96)00416-7; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Tang H, 1998, J BIOL CHEM, V273, P29156, DOI 10.1074/jbc.273.44.29156; Tonon G, 2000, GENE CHROMOSOME CANC, V27, P418, DOI 10.1002/(SICI)1098-2264(200004)27:4<418::AID-GCC12>3.0.CO;2-O; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; Wolfe MS, 2001, J MOL NEUROSCI, V17, P199, DOI 10.1385/JMN:17:2:199; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464	30	372	398	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					208	213		10.1038/ng1083	http://dx.doi.org/10.1038/ng1083			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539049	Green Published			2022-12-17	WOS:000180773700022
J	Knight, JC; Udalova, I; Hill, AVS; Greenwood, BM; Peshu, N; Marsh, K; Kwiatkowski, D				Knight, JC; Udalova, I; Hill, AVS; Greenwood, BM; Peshu, N; Marsh, K; Kwiatkowski, D			A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA GENE; NF-KAPPA-B; TRANSCRIPTIONAL ACTIVATION; CEREBRAL MALARIA; PLASMODIUM-FALCIPARUM; DISEASE; SUSCEPTIBILITY; MACROPHAGES; PROTECTION	Genetic Variation in cytokine promoter regions is postulated to influence susceptibility to infection, but the molecular mechanisms by which such polymorphisms might affect gene, regulation are unknown. Through systematic DNA footprinting of the TNF (encoding tumour necrosis factor, TNF) promoter region, we have identified a single nucleotide polymorphism (SNP) that causes the helix-turn-helix transcription factor OCT-1 to bind to a novel region of complex protein-DNA interactions and alters gene expression in human monocytes. The OCT-1-binding genotype, found in approximately 5% of Africans, is associated with fourfold increased susceptibility to cerebral malaria in large case-control studies of West African and East African populations, after correction for other known TNF polymorphisms and linked HLA alleles.	Inst Mol Med, Mol Infect Dis Grp, Oxford OX3 9DS, England; Inst Mol Med, Mol Immunol Grp, Oxford OX3 9DS, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Med Res Council Labs, Fajara, Senegal; Wellcome Clin Res Unit, Kilifi, Kenya	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Knight, JC (corresponding author), Inst Mol Med, Mol Infect Dis Grp, Oxford OX3 9DS, England.		Knight, Julian Charles/W-2399-2019; HILL, Adrian V>S>/C-1306-2008; Knight, Julian/C-7242-2009	Knight, Julian Charles/0000-0002-0377-5536; Knight, Julian/0000-0002-0377-5536; Udalova, Irina/0000-0002-6716-2528; Kwiatkowski, Dominic/0000-0002-5023-0176	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Brinkman BMN, 1996, J INFLAMM, V46, P32; Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516; Brinkman BMN, 1997, J INFECT DIS, V175, P188, DOI 10.1093/infdis/175.1.188; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CLARK IA, 1987, PARASITOL TODAY, V3, P300, DOI 10.1016/0169-4758(87)90187-6; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; DALFONSO S, 1994, IMMUNOGENETICS, V39, P150; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; FONG CLW, 1994, NUCLEIC ACIDS RES, V22, P1108, DOI 10.1093/nar/22.6.1108; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; HAMANN A, 1995, BIOCHEM BIOPH RES CO, V211, P833, DOI 10.1006/bbrc.1995.1887; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hohler T, 1997, J INVEST DERMATOL, V109, P562, DOI 10.1111/1523-1747.ep12337469; KAUSHANSKY K, 1994, J IMMUNOL, V152, P1812; KWIATKOWSKI D, 1995, PARASITOL TODAY, V11, P206, DOI 10.1016/0169-4758(95)80079-4; LEWONTIN RC, 1964, GENETICS, V49, P49; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Roy S, 1997, J INFECT DIS, V176, P530, DOI 10.1086/517282; SANDALTZOPOULOS R, 1994, NUCLEIC ACIDS RES, V22, P1511, DOI 10.1093/nar/22.8.1511; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Stuber F, 1996, J INFLAMM, V46, P42; UDALOVA IA, 1995, DOKL AKAD NAUK+, V342, P413; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; WILSON AG, 1993, J EXP MED, V177, P557, DOI 10.1084/jem.177.2.557; Wu GD, 1997, J BIOL CHEM, V272, P2396; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zuckerkandl E, 1997, J MOL EVOL, V44, pS2, DOI 10.1007/PL00000048	39	372	402	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					145	150		10.1038/9649	http://dx.doi.org/10.1038/9649			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369255				2022-12-17	WOS:000080680900018
J	Yasunaga, S; Grati, M; Cohen-Salmon, M; El-Amraoui, A; Mustapha, M; Salem, N; El-Zir, E; Loiselet, J; Petit, C				Yasunaga, S; Grati, M; Cohen-Salmon, M; El-Amraoui, A; Mustapha, M; Salem, N; El-Zir, E; Loiselet, J; Petit, C			A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness	NATURE GENETICS			English	Article							MYOSIN-VIIA GENE; RECESSIVE DEAFNESS; C-2-DOMAIN PROTEINS; VESICLE FUSION; HAIR-CELLS; C-2 DOMAIN; SYNAPTOTAGMIN; RABPHILIN-3A; JERVELL; BINDING	Using a candidate gene approach, we identified a novel human gene, OTOF, underlying an autosomal recessive, nonsyndromic prelingual deafness, DFNB9. The same nonsense mutation was detected in four unrelated affected families of Lebanese origin. OTOF is the second member of a mammalian gene family related to Caenorhabditis elegans fer-1. It encodes a predicted cytosolic protein (of 1,230 aa) with three C2 domains and a single carboxy-terminal transmembrane domain. The sequence homologies and predicted structure of otoferlin, the protein encoded by OTOF, suggest its involvement in vesicle membrane fusion. In the inner ear, the expression of the orthologous mouse gene, mainly in the sensory hair cells, indicates that such a role could apply to synaptic vesicles.	Inst Pasteur, CNRS, URA 1968, Unite Genet Deficits Sensoriels, F-75724 Paris 15, France; St Josephs Univ, Fac Med, Biochim Lab, Beyrouth, Lebanon; Hop Sacre Coeur, Clin Audiol, Baabda, Brazilia, Lebanon	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut	Petit, C (corresponding author), Inst Pasteur, CNRS, URA 1968, Unite Genet Deficits Sensoriels, 25 Rue Dr Roux, F-75724 Paris 15, France.		Grati, M'hamed/C-9563-2011	Grati, M'hamed/0000-0002-4490-1682; EL-AMRAOUI, Aziz/0000-0003-2692-4984; Petit, Christine/0000-0002-9069-002X; Grati, Mhamed/0000-0001-5149-3245; Cohen-Salmon, Martine/0000-0002-5312-8476				Achanzar WE, 1997, J CELL SCI, V110, P1073; Avraham KB, 1998, NAT MED, V4, P1238, DOI 10.1038/3215; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Chaib H, 1996, HUM MOL GENET, V5, P155, DOI 10.1093/hmg/5.1.155; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Kalatzis V, 1998, HUM MOL GENET, V7, P1589, DOI 10.1093/hmg/7.10.1589; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Leal SM, 1998, EUR J HUM GENET, V6, P341, DOI 10.1038/sj.ejhg.5200201; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Richardson GP, 1997, J NEUROSCI, V17, P9506; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; SAFIEDDINE S, IN PRESS EUR J NEURO; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; SCOTT DA, 1998, MOL BIOL HEARING DEA, P63; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	49	372	409	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					363	369		10.1038/7693	http://dx.doi.org/10.1038/7693			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192385				2022-12-17	WOS:000079439700016
J	Allen, KM; Gleeson, JG; Bagrodia, S; Partington, MW; MacMillan, JC; Cerione, RA; Mulley, JC; Walsh, CA				Allen, KM; Gleeson, JG; Bagrodia, S; Partington, MW; MacMillan, JC; Cerione, RA; Mulley, JC; Walsh, CA			PAK3 mutation in nonsyndromic X-linked mental retardation	NATURE GENETICS			English	Article							P21-ACTIVATED KINASE PAK1; ACTIVATED PROTEIN-KINASE; ADAPTER PROTEIN; FOCAL COMPLEXES; GTPASES; FAMILY; RHO; IDENTIFICATION; LOCALIZATION; CDC42	Nonsyndromic X-linked mental retardation (MRX) syndromes are clinically homogeneous but genetically heterogeneous disorders, whose genetic bases are largely unknown. Affected individuals in a multiplex pedigree with MRX (MRX30), previously mapped to Xq22, show a point mutation in the PAK3 (p21-activated kinase) gene, which encodes a serine-threonine kinase. PAK proteins are crucial effecters linking Rho GTPases to cytoskeletal reorganization and to nuclear signalling. The mutation produces premature termination, disrupting kinase function. MRI analysis showed no gross defects in brain development. Immunofluorescence analysis showed that PAK3 protein is highly expressed in postmitotic neurons of the developing and postnatal cerebral cortex and hippocampus. Signal transduction through Rho GTPases and PAK3 may be critical for human cognitive function.	Harvard Univ, Sch Med, Div Neurogenet, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol Biomed Sci, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Med Ctr, Boston, MA 02115 USA; Cornell Univ, Dept Mol Med, Ithaca, NY USA; Univ Newcastle, Newcastle, NSW 2308, Australia; Royal Brisbane Hosp, Queensland Clin Genet Serv, Brisbane, Qld 4029, Australia; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA, Australia	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Cornell University; University of Newcastle; Royal Brisbane & Women's Hospital; Womens & Childrens Hospital Australia	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Div Neurogenet, Beth Israel Deaconess Med Ctr, HIM 846,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	MacMillan, John C/C-9591-2011		NIMH NIH HHS [MH10691] Funding Source: Medline; NINDS NIH HHS [5K12NS01701, R01 NS 35129] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, K12NS001701] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN K, IN PRESS GENOMICS; Antonarakis SE, 1998, NAT GENET, V19, P106, DOI 10.1038/450; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Donnelly AJ, 1996, AM J MED GENET, V64, P113, DOI 10.1002/(SICI)1096-8628(19960712)64:1<113::AID-AJMG19>3.0.CO;2-Q; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.3.CO;2-V; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gregg RG, 1996, HUM MOL GENET, V5, P411, DOI 10.1093/hmg/5.3.411; Gu XX, 1996, J MED GENET, V33, P52, DOI 10.1136/jmg.33.1.52; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Illarioshkin SN, 1996, ANN NEUROL, V40, P75, DOI 10.1002/ana.410400113; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; LUO L, 1925, CURR OPIN NEUROBIOL, V7, P8197; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ogilvie D J, 1996, Methods Mol Biol, V54, P131; Osada S, 1997, FEBS LETT, V404, P227, DOI 10.1016/S0014-5793(97)00139-7; Ryan SG, 1997, NAT GENET, V17, P92, DOI 10.1038/ng0997-92; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	36	372	386	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					25	30		10.1038/1675	http://dx.doi.org/10.1038/1675			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731525				2022-12-17	WOS:000075671400013
J	Warner, LE; Mancias, P; Butler, IJ; McDonald, CM; Keppen, L; Koob, KG; Lupski, JR				Warner, LE; Mancias, P; Butler, IJ; McDonald, CM; Keppen, L; Koob, KG; Lupski, JR			Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; ZINC-FINGER PROTEIN; NGFI-A; TRANSCRIPTION FACTORS; BINDING DOMAINS; KROX-20; NEUROPATHY; HINDBRAIN; KROX20	The early growth response 2 gene (EGR2) is part of a multigene family encoding Cys(2)-His(2) type zinc-finger proteins and may play a role in the regulation of cellular proliferation(1,2). Egr2, (also known as Krox20) is the mouse orthologue of human EGR2 and was first identified as an immediate-early response gene, encoding a protein that binds DNA in a sequence-specific manner and acts as a transcription factor(3-6). Stable expression of Egr2 is specifically associated with the onset of myelination in the peripheral nervous system (PNS; ref.7). Egr2(-/-) mice display disrupted hindbrain segmentation and development(8,9). and a block of Schwann-cell differentiation at an early stage(10). We hypothesized that Egr2 may be a transcription factor affecting late myelin genes and that human myelinopathies of the PNS may result from mutations in EGR2. In support of this hypothesis, we have identified one recessive and two dominant missense mutations in EGR2 (within regions encoding conserved functional domains) in patients with congenital hypomyelinating neuropathy (CHN) and a family with Charcot-Marie-Tooth type 1 (CMT1).	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Neurol, Sch Med, Houston, TX 77030 USA; Univ Calif Davis, Med Ctr, Dept Phys Med & Rehabil, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; Univ S Dakota, Sch Med, Dept Pediat & Adolescent Med, Sioux Falls, SD 57117 USA; Neurol Associates PC, Sioux Falls, SD 57105 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Davis; University of California System; University of California Davis; University of South Dakota; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			McDonald, Craig/0000-0002-8779-3220	NICHD NIH HHS [HD94021] Funding Source: Medline; NIGMS NIH HHS [T32-GM08307] Funding Source: Medline; NINDS NIH HHS [R01 NS27042] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; BROWN RS, 1986, NATURE, V324, P215, DOI 10.1038/324215a0; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHAVRIER P, 1989, MOL CELL BIOL, V9, P787, DOI 10.1128/MCB.9.2.787; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; DEJONGHE P, 1997, J PERIPHER NERV SYST, V2, P370; Dyck P.J, 1993, PNP, P1094; GIBSON TJ, 1988, PROTEIN ENG, V2, P209, DOI 10.1093/protein/2.3.209; HARATI Y, 1985, J NEUROL NEUROSUR PS, V48, P1269, DOI 10.1136/jnnp.48.12.1269; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; Lupski JR, 1997, HOSP PRACT, V32, P83, DOI 10.1080/21548331.1997.11443485; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RANGNEKAR VM, 1990, NUCLEIC ACIDS RES, V18, P2749, DOI 10.1093/nar/18.9.2749; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Svaren J, 1996, MOL CELL BIOL, V16, P3545; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; VESQUE C, 1992, NUCLEIC ACIDS RES, V20, P2485, DOI 10.1093/nar/20.10.2485; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; WILSON TE, 1992, J BIOL CHEM, V267, P3718; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	30	372	384	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					382	384		10.1038/ng0498-382	http://dx.doi.org/10.1038/ng0498-382			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537424				2022-12-17	WOS:000072755500024
J	Core, LJ; Martins, AL; Danko, CG; Waters, CT; Siepel, A; Lis, JT				Core, Leighton J.; Martins, Andre L.; Danko, Charles G.; Waters, Colin T.; Siepel, Adam; Lis, John T.			Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers	NATURE GENETICS			English	Article							DIVERGENT TRANSCRIPTION; U1 SNRNP; ACTIVE ENHANCERS; MESSENGER-RNAS; GLOBIN GENE; POLYMERASE; CHROMATIN; RECRUITMENT; EXPRESSION; DISTINCT	Despite the conventional distinction between them, promoters and enhancers share many features in mammals, including divergent transcription and similar modes of transcription factor binding. Here we examine the architecture of transcription initiation through comprehensive mapping of transcription start sites (TSSs) in human lymphoblastoid B cell (GM12878) and chronic myelogenous leukemic (K562) ENCODE Tier 1 cell lines. Using a nuclear run-on protocol called GRO-cap, which captures TSSs for both stable and unstable transcripts, we conduct detailed comparisons of thousands of promoters and enhancers in human cells. These analyses identify a common architecture of initiation, including tightly spaced (110 bp apart) divergent initiation, similar frequencies of core promoter sequence elements, highly positioned flanking nucleosomes and two modes of transcription factor binding. Post-initiation transcript stability provides a more fundamental distinction between promoters and enhancers than patterns of histone modification and association of transcription factors or co-activators. These results support a unified model of transcription initiation at promoters and enhancers.	[Core, Leighton J.; Waters, Colin T.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Martins, Andre L.; Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Cornell University; Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	acs4@cornell.edu; jtl10@cornell.edu		Siepel, Adam/0000-0002-3557-7219; Waters, Colin/0000-0002-3096-0833	NIGMS (National Institute of General Medical Sciences); US National Institutes of Health [GM25232, HG0070707]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	NIGMS (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by NIGMS (National Institute of General Medical Sciences) and NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health under award numbers GM25232 to J.T.L. and HG0070707 to A.S. and J.T.L., respectively. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R., 2014, BIORXIV         0829, DOI [10.1101/005447, DOI 10.1101/005447]; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Foley JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-720; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kruesi WS, 2013, ELIFE, V2, DOI 10.7554/eLife.00808; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; MARUYAMA K, 1994, GENE, V138, P171; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Venters BJ, 2014, NATURE, V513, P444, DOI 10.1038/nature13588; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	55	371	376	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1311	1320		10.1038/ng.3142	http://dx.doi.org/10.1038/ng.3142			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25383968	Green Accepted			2022-12-17	WOS:000345547300012
J	Kirino, Y; Bertsias, G; Ishigatsubo, Y; Mizuki, N; Tugal-Tutkun, I; Seyahi, E; Ozyazgan, Y; Sacli, FS; Erer, B; Inoko, H; Emrence, Z; Cakar, A; Abaci, N; Ustek, D; Satorius, C; Ueda, A; Takeno, M; Kim, Y; Wood, GM; Ombrello, MJ; Meguro, A; Gul, A; Remmers, EF; Kastner, DL				Kirino, Yohei; Bertsias, George; Ishigatsubo, Yoshiaki; Mizuki, Nobuhisa; Tugal-Tutkun, Ilknur; Seyahi, Emire; Ozyazgan, Yilmaz; Sacli, F. Sevgi; Erer, Burak; Inoko, Hidetoshi; Emrence, Zeliha; Cakar, Atilla; Abaci, Neslihan; Ustek, Duran; Satorius, Colleen; Ueda, Atsuhisa; Takeno, Mitsuhiro; Kim, Yoonhee; Wood, Geryl M.; Ombrello, Michael J.; Meguro, Akira; Gul, Ahmet; Remmers, Elaine F.; Kastner, Daniel L.			Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1	NATURE GENETICS			English	Article							MHC CLASS-I; ANKYLOSING-SPONDYLITIS; METAANALYSIS; PSORIASIS; NKG2D; RISK; IL23R-IL12RB2; ARTHRITIS; NUMBER; IL10	Individuals with Behcet's disease suffer from episodic inflammation often affecting the orogenital mucosa, skin and eyes. To discover new susceptibility loci for Behcet's disease, we performed a genome-wide association study (GWAS) of 779,465 SNPs with imputed genotypes in 1,209 Turkish individuals with Behcet's disease and 1,278 controls. We identified new associations at CCR1, STAT4 and KLRC4. Additionally, two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln alterations, recessively conferred disease risk. These findings were replicated in 1,468 independent Turkish and/or 1,352 Japanese samples (combined meta-analysis P < 2 x 10(-9)). We also found evidence for interaction between HLA-B*51 and ERAP1 (P = 9 x 10(-4)). The CCR1 and STAT4 variants were associated with gene expression differences. Three risk loci shared with ankylosing spondylitis and psoriasis (the MHC class I region, ERAP1 and IL23R and the MHC class I-ERAP1 interaction), as well as two loci shared with inflammatory bowel disease (IL23R and IL10) implicate shared pathogenic pathways in the spondyloarthritides and Behcet's disease.	[Kirino, Yohei; Bertsias, George; Satorius, Colleen; Wood, Geryl M.; Ombrello, Michael J.; Remmers, Elaine F.; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, Med Genet Branch, US NIH, Bethesda, MD 20892 USA; [Kirino, Yohei; Ishigatsubo, Yoshiaki; Ueda, Atsuhisa; Takeno, Mitsuhiro] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Bertsias, George] Univ Crete, Fac Med, Iraklion, Greece; [Mizuki, Nobuhisa; Meguro, Akira] Yokohama City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Tugal-Tutkun, Ilknur] Istanbul Univ, Dept Ophthalmol, Istanbul Fac Med, Istanbul, Turkey; [Seyahi, Emire; Sacli, F. Sevgi] Istanbul Univ, Dept Internal Med, Cerrahpasa Fac Med, Div Rheumatol, Istanbul, Turkey; [Ozyazgan, Yilmaz] Istanbul Univ, Dept Ophthalmol, Cerrahpasa Fac Med, Istanbul, Turkey; [Erer, Burak; Gul, Ahmet] Istanbul Univ, Dept Internal Med, Div Rheumatol, Istanbul Fac Med, Istanbul, Turkey; [Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Mol Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan; [Emrence, Zeliha; Cakar, Atilla; Abaci, Neslihan; Ustek, Duran] Istanbul Univ, Dept Genet, Inst Expt Med, Istanbul, Turkey; [Kim, Yoonhee] NHGRI, Genometr Sect, Inherited Dis Res Branch, US NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yokohama City University; University of Crete; Yokohama City University; Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Tokai University; Istanbul University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kastner, DL (corresponding author), NHGRI, Inflammatory Dis Sect, Med Genet Branch, US NIH, Bethesda, MD 20892 USA.	dr.agul001@gmail.com; remmerse@mail.nih.gov; kastnerd@mail.nih.gov	SEYAHI, EMIRE/AAB-3576-2020; erer, burak/AAR-5866-2021; Gul, Ahmet/AAT-7787-2020; Seyahi, Emire/AAD-1769-2021; abacı, neslihan/AAD-5036-2020; Kirino, Yohei/B-3701-2009; Bertsias, George/AAA-8400-2020; Emrence, Zeliha/AAB-8563-2020; Ustek, Duran/C-3484-2009	Gul, Ahmet/0000-0001-8219-3720; Kirino, Yohei/0000-0002-9488-661X; Bertsias, George/0000-0001-5299-1406; Ustek, Duran/0000-0002-0060-2859; Remmers, Elaine F/0000-0002-9522-1249; Ombrello, Michael/0000-0003-3322-4089	National Human Genome Research Institute of the US National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health; Center for Human Immunology Autoimmunity and Inflammation of the US National Institutes of Health; Istanbul University Research Fund; Japanese Ministry of Health, Labor, and Welfare; Japan Rheumatism Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200374] Funding Source: NIH RePORTER	National Human Genome Research Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Human Immunology Autoimmunity and Inflammation of the US National Institutes of Health; Istanbul University Research Fund(Istanbul University); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Rheumatism Foundation(Japan Rheumatism Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and the Center for Human Immunology Autoimmunity and Inflammation of the US National Institutes of Health, and by the Istanbul University Research Fund, the Research on Specific Disease of the Health Science Research Grants from the Japanese Ministry of Health, Labor, and Welfare, and the Japan Rheumatism Foundation. We thank A. Wilson for helpful comments on this manuscript.	Abelson AK, 2009, ANN RHEUM DIS, V68, P1746, DOI 10.1136/ard.2008.097642; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Chang HK, 2002, J KOREAN MED SCI, V17, P524, DOI 10.3346/jkms.2002.17.4.524; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gebreselassie D, 2006, HUM IMMUNOL, V67, P894, DOI 10.1016/j.humimm.2006.08.294; Gul A, 2012, OCUL IMMUNOL INFLAMM, V20, P37, DOI 10.3109/09273948.2011.634978; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Hayashi T, 2006, CANCER RES, V66, P563, DOI 10.1158/0008-5472.CAN-05-2776; Karasneh J, 2005, ARTHRITIS RHEUM-US, V52, P1836, DOI 10.1002/art.21060; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; MOLL JMH, 1974, MEDICINE, V53, P343, DOI 10.1097/00005792-197409000-00002; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; OHNO S, 1973, LANCET, V2, P1383; Ohno S, 2004, J RHEUMATOL, V31, P1362; Olivieri I, 1997, J RHEUMATOL, V24, P1870; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; YAZICI H, 1981, ANN RHEUM DIS, V40, P558, DOI 10.1136/ard.40.6.558; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	34	371	382	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					202	207		10.1038/ng.2520	http://dx.doi.org/10.1038/ng.2520			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23291587	Green Accepted			2022-12-17	WOS:000314333000017
J	Lee, JS; Chu, IS; Mikaelyan, A; Calvisi, DF; Heo, J; Reddy, JK; Thorgeirsson, SS				Lee, JS; Chu, IS; Mikaelyan, A; Calvisi, DF; Heo, J; Reddy, JK; Thorgeirsson, SS			Application of comparative functional genomics to identify best-fit mouse models to study human cancer	NATURE GENETICS			English	Article							ACTIVATED RECEPTOR-ALPHA; GROWTH-FACTOR-ALPHA; ACYL-COA OXIDASE; PEROXISOME PROLIFERATOR; HEPATOCELLULAR-CARCINOMA; C-MYC; TRANSGENIC MICE; CELL LYMPHOMA; LIVER-TUMORS; HEPATOCARCINOGENESIS	Genetically modified mice have been extensively used for analyzing the molecular events that occur during tumor development. In many, if not all, cases, however, it is uncertain to what extent the mouse models reproduce features observed in the corresponding human conditions(1-3). This is due largely to lack of precise methods for direct and comprehensive comparison at the molecular level of the mouse and human tumors. Here we use global gene expression patterns of 68 hepatocellular carcinomas (HCCs) from seven different mouse models and 91 human HCCs from predefined subclasses(4) to obtain direct comparison of the molecular features of mouse and human HCCs. Gene expression patterns in HCCs from Myc, E2f1 and Myc E2f1 transgenic mice were most similar to those of the better survival group of human HCCs, whereas the expression patterns in HCCs from Myc Tgfa transgenic mice and in diethylnitrosamine-induced mouse HCCs were most similar to those of the poorer survival group of human HCCs. Gene expression patterns in HCCs from Acox1(-/-) mice and in ciprofibrate-induced HCCs were least similar to those observed in human HCCs. We conclude that our approach can effectively identify appropriate mouse models to study human cancers.	NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine	Thorgeirsson, SS (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	snorri_thorgeirsson@nih.gov						Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BENTLEY P, 1993, FOOD CHEM TOXICOL, V31, P857, DOI 10.1016/0278-6915(93)90225-N; Calvisi DF, 2004, GASTROENTEROLOGY, V126, P1374, DOI 10.1053/j.gastro.2004.02.014; Conner EA, 2000, ONCOGENE, V19, P5054, DOI 10.1038/sj.onc.1203885; Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; Hann B, 2001, CURR OPIN CELL BIOL, V13, P778, DOI 10.1016/S0955-0674(00)00283-0; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Klausner RD, 1999, ONCOGENE, V18, P5249, DOI 10.1038/sj.onc.1203089; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Meyer K, 2003, CARCINOGENESIS, V24, P975, DOI 10.1093/carcin/bgg040; MURAKAMI H, 1993, CANCER RES, V53, P1719; POIRIER LA, 1975, J NATL CANCER I, V54, P137, DOI 10.1093/jnci/54.1.137; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; RAO MS, 1984, CANCER RES, V44, P1072; REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Sambrook J., 1989, MOL CLONING LABORATO, V2, P916; Sargent LM, 1999, AM J PATHOL, V154, P1047, DOI 10.1016/S0002-9440(10)65357-6; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.E03-05-0279; Shirahashi H, 2002, LIVER, V22, P413, DOI 10.1034/j.1600-0676.2002.01541.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043	30	371	377	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1306	1311		10.1038/ng1481	http://dx.doi.org/10.1038/ng1481			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15565109				2022-12-17	WOS:000225354100019
J	Slonim, DK				Slonim, DK			From patterns to pathways: gene expression data analysis comes of age	NATURE GENETICS			English	Review							MOLECULAR CLASSIFICATION; CLUSTER-ANALYSIS; CLASS PREDICTION; TIME-SERIES; CANCER; IDENTIFICATION; CARCINOMAS; DISCOVERY; DIAGNOSIS; CIRCUITRY	Many different biological questions are routinely studied using transcriptional profiling on microarrays. A wide range of approaches are available for gleaning insights from the data obtained from such experiments. The appropriate choice of data-analysis technique depends both on the data and on the goals of the experiment. This review summarizes some of the common themes in microarray data analysis, including detection of differential expression, clustering, and predicting sample characteristics. Several approaches to each problem, and their relative merits, are discussed and key areas for additional research highlighted.	Wyeth Res, Dept Genom, Cambridge, MA 02140 USA	Pfizer	Slonim, DK (corresponding author), Wyeth Res, Dept Genom, 35 Cambridge Pk Dr, Cambridge, MA 02140 USA.	dslonim@wyeth.com		Slonim, Donna/0000-0003-3357-437X				Aach J, 2001, BIOINFORMATICS, V17, P495, DOI 10.1093/bioinformatics/17.6.495; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; [Anonymous], 2002, MANUAL SETTING USING; [Anonymous], 576 U CAL BERK DEP S; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Ben-Hur Asa, 2002, Pac Symp Biocomput, P6; BENDOR A, 2000, 200038 HEBR U I COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bo TH, 2002, GENOME BIOL, V3; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; CALIFANO A, 2000, ISMB, V8, P75; Chatfield C., 1996, ANAL TIME SERIES INT, P283; Chiang D Y, 2001, Bioinformatics, V17 Suppl 1, pS49; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; De Smet F, 2002, BIOINFORMATICS, V18, P735, DOI 10.1093/bioinformatics/18.5.735; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DUDOIT S, 2000, 578 U CAL BERK DEP S; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Filkov V, 2002, J COMPUT BIOL, V9, P317, DOI 10.1089/10665270252935485; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon AD, 1999, CLASSIFICATION; Hartemink A J, 2001, Pac Symp Biocomput, P422; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hastie T, 2001, GENOME BIOL, V2; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes I, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P202; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Ideker T E, 2000, Pac Symp Biocomput, P305; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jain A. K., 1988, ALGORITHMS CLUSTERIN, V6; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/ng0501-21; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Khan J, 1998, CANCER RES, V58, P5009; Kohane IS, 2000, J AM MED INFORM ASSN, V7, P512, DOI 10.1136/jamia.2000.0070512; Kohonen T., 1997, SELF ORG MAPS; Landgrebe J, 2002, GENOME BIOL, V3; Liang S, 1998, Pac Symp Biocomput, P18; Masys DR, 2001, BIOINFORMATICS, V17, P319, DOI 10.1093/bioinformatics/17.4.319; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Mitchell T.M., 1997, MACH LEARN, P414; Model F, 2001, Bioinformatics, V17 Suppl 1, pS157; Park P J, 2001, Pac Symp Biocomput, P52; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Potter JD, 2001, NAT REV GENET, V2, P142, DOI 10.1038/35052575; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1007/BF00116037; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Segal E, 2001, Bioinformatics, V17 Suppl 1, pS243; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Shatkay H, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P317; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHUMWAY RH, 2000, TIME SERIES ANAL ITS, P560; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Su AI, 2001, CANCER RES, V61, P7388; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Westfall P.H., 1993, RESAMPLING BASED MUL, P340; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; YONA G, 1999, THESIS HEBREW U JERU; Yoo C, 2002, Pac Symp Biocomput, P498; Zar J. H, 1996, BIOSTAT ANAL, VThird; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745	98	371	440	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			502	508		10.1038/ng1033	http://dx.doi.org/10.1038/ng1033			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454645				2022-12-17	WOS:000179742900010
J	Stockton, DW; Das, P; Goldenberg, M; D'Souza, RN; Patel, PI				Stockton, DW; Das, P; Goldenberg, M; D'Souza, RN; Patel, PI			Mutation of PAX9 is associated with oligodontia	NATURE GENETICS			English	Article							GENES; MSX1		Univ Texas, Hlth Sci Ctr, Dent Branch, Houston, TX 77225 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Patel, PI (corresponding author), Univ Texas, Hlth Sci Ctr, Dent Branch, Houston, TX 77225 USA.		Patel, Pragna/H-9129-2017	Patel, Pragna/0000-0003-3584-1072; D'Souza, Rena/0000-0002-1505-5173	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013368, R01DE011663] Funding Source: NIH RePORTER; NEI NIH HHS [EY00375] Funding Source: Medline; NIDCR NIH HHS [DE13368, DE11663] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Gorlin RJ, 1990, PLAST RECONSTR SURG; GRABER LW, 1978, J AM DENT ASSOC, V96, P266, DOI 10.14219/jada.archive.1978.0054; JORGENSON RJ, 1980, J AM DENT ASSOC, V101, P283, DOI 10.14219/jada.archive.1980.0186; NIEMINEN P, 1995, HUM GENET, V96, P305; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; SEMENZA GL, 1998, PAX PROTEINS, P169; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; VASTARDIS H, 1996, THESIS HARVARD U	9	371	393	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2000	24	1					18	19		10.1038/71634	http://dx.doi.org/10.1038/71634			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	10615120				2022-12-17	WOS:000084609200009
J	Quintana-Murci, L; Semino, O; Bandelt, HJ; Passarino, G; McElreavey, K; Santachiara-Benerecetti, AS				Quintana-Murci, L; Semino, O; Bandelt, HJ; Passarino, G; McElreavey, K; Santachiara-Benerecetti, AS			Genetic evidence of an early exit of Homo sapiens sapiens from Africa through eastern Africa	NATURE GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; MTDNA VARIATION; CONTROL REGION; NEW-WORLD; POPULATIONS; ORIGIN; POLYMORPHISMS; DIVERSITY; SEQUENCE; EVOLUTION	The out-of-Africa scenario(1) has hitherto provided little evidence for the precise route by which modern humans left Africa. Two major routes of dispersal have been hypothesized: one through North Africa into the Levant, documented by fossil remains(2), and one through Ethiopia along South Asia, for which little, if any, evidence exists(3). Mitochondrial DNA (mtDNA) can be used to trace maternal ancestry, The geographic distribution and variation of mtDNAs can be highly informative in defining potential range expansions and migration routes in the distant past. The mitochondrial haplogroup M, first regarded as an ancient marker of East-Asian origin(4,5), has been found at high frequency in India(6) and Ethiopia(7), raising the question of its origin. (A haplogroup is a group of haplotypes that share some sequence variations.) Its variation and geographical distribution suggest that Asian haplogroup M separated from eastern-African haplogroup M more than 50.000 years ago. Two other variants (489C and 10873C) also support a single origin of haplogroup M in Africa. These findings, together with the virtual absence of haplogroup M in the Levant and its high frequency in the South-Arabian peninsula, render Rn the first genetic indicator for the hypothesized exit route from Africa through eastern Africa/western India. This was possibly the only successful early dispersal event of modern humans out of Africa.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Hamburg, Math Seminar, D-2000 Hamburg, Germany; Univ Calabria, Dipartimento Biol Cellulare, Calabria, Italy; Inst Pasteur, Unite Immunogenet Humaine, Paris, France	University of Pavia; University of Hamburg; University of Calabria; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Santachiara-Benerecetti, AS (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.		Quintana-Murci, Lluis/AAB-7468-2022; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Quintana-Murci, Lluis/0000-0003-2429-6320; SEMINO, Ornella/0000-0002-9675-9403				BANDELT HJ, 1995, GENETICS, V141, P743; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHEN YS, 1995, AM J HUM GENET, V57, P133; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; Forster P, 1996, AM J HUM GENET, V59, P935; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Kolman CJ, 1996, GENETICS, V142, P1321; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; LEWIN R, 1987, SCIENCE, V237, P1292, DOI 10.1126/science.3114877; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Lutz S, 1999, INT J LEGAL MED, V112, P145; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B; Passarino G, 1996, AM J HUM GENET, V59, P927; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	31	371	383	0	90	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					437	441		10.1038/70550	http://dx.doi.org/10.1038/70550			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581031				2022-12-17	WOS:000084023900020
J	Jin, SC; Homsy, J; Zaidi, S; Lu, QS; Morton, S; DePalma, SR; Zeng, X; Qi, HJ; Chang, WI; Sierant, MC; Hung, WC; Haider, S; Zhang, JH; Knight, J; Bjornson, RD; Castaldi, C; Tikhonoa, IR; Bilguvar, K; Mane, SM; Sanders, SJ; Mital, S; Russell, MW; Gaynor, JW; Deanfield, J; Giardini, A; Porter, GA; Srivastava, D; Lo, CW; Shen, YF; Watkins, WS; Yandell, M; Yost, HJ; Tristani-Firouzi, M; Newburger, JW; Roberts, AE; Kim, R; Zhao, HY; Kaltman, JR; Goldmuntz, E; Chung, WK; Seidman, JG; Gelb, BD; Seidman, CE; Lifton, RP; Brueckner, M				Jin, Sheng Chih; Homsy, Jason; Zaidi, Samir; Lu, Qiongshi; Morton, Sarah; DePalma, Steven R.; Zeng, Xue; Qi, Hongjian; Chang, Weni; Sierant, Michael C.; Hung, Wei-Chien; Haider, Shozeb; Zhang, Junhui; Knight, James; Bjornson, Robert D.; Castaldi, Christopher; Tikhonoa, Irina R.; Bilguvar, Kaya; Mane, Shrikant M.; Sanders, Stephan J.; Mital, Seema; Russell, Mark W.; Gaynor, J. William; Deanfield, John; Giardini, Alessandro; Porter, George A., Jr.; Srivastava, Deepak; Lo, Cecelia W.; Shen, Yufeng; Watkins, W. Scott; Yandell, Mark; Yost, H. Joseph; Tristani-Firouzi, Martin; Newburger, Jane W.; Roberts, Amy E.; Kim, Richard; Zhao, Hongyu; Kaltman, Jonathan R.; Goldmuntz, Elizabeth; Chung, Wendy K.; Seidman, Jonathan G.; Gelb, Bruce D.; Seidman, Christine E.; Lifton, Richard P.; Brueckner, Martina			Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands	NATURE GENETICS			English	Article							SINGLE-VENTRICLE LESIONS; COPY-NUMBER VARIANTS; SEQUENCING DATA; FACTOR-I; MUTATIONS; GENE; ASSOCIATION; AUTISM; RISK; IDENTIFICATION	Congenital heart disease (CHD) is the leading cause of mortality from birth defects. Here, exome sequencing of a single cohort of 2,871 CHD probands, including 2,645 parent-offspring trios, implicated rare inherited mutations in 1.8%, including a recessive founder mutation in GDF1 accounting for similar to 5% of severe CHD in Ashkenazim, recessive genotypes in MYH6 accounting for similar to 11% of Shone complex, and dominant FLT4 mutations accounting for 2.3% of Tetralogy of Fallot. De novo mutations (DNMs) accounted for 8% of cases, including similar to 3% of isolated CHD patients and similar to 28% with both neurodevelopmental and extra-cardiac congenital anomalies. Seven genes surpassed thresholds for genome-wide significance, and 12 genes not previously implicated in CHD had > 70% probability of being disease related. DNMs in similar to 440 genes were inferred to contribute to CHD. Striking overlap between genes with damaging DNMs in probands with CHD and autism was also found.	[Jin, Sheng Chih; Zaidi, Samir; Zeng, Xue; Sierant, Michael C.; Hung, Wei-Chien; Zhang, Junhui; Brueckner, Martina] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Homsy, Jason; DePalma, Steven R.; Seidman, Jonathan G.; Seidman, Christine E.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Homsy, Jason; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Lu, Qiongshi; Zhao, Hongyu] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Morton, Sarah] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA USA; [Qi, Hongjian] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Chang, Weni] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA; [Haider, Shozeb] UCL, Sch Pharm, Dept Computat Chem, London, England; [Knight, James; Bjornson, Robert D.; Castaldi, Christopher; Tikhonoa, Irina R.; Bilguvar, Kaya; Mane, Shrikant M.] Yale Univ, Yale Ctr Genome Anal, New Haven, CT USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Mital, Seema] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Russell, Mark W.] Univ Michigan, Div Pediat Cardiol, Ann Arbor, MI 48109 USA; [Gaynor, J. William] Childrens Hosp Philadelphia, Dept Pediat Cardiac Surg, Philadelphia, PA 19104 USA; [Deanfield, John; Giardini, Alessandro] UCL, Dept Cardiol, London, England; [Deanfield, John; Giardini, Alessandro] Great Ormond St Hosp Sick Children, London, England; [Porter, George A., Jr.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Srivastava, Deepak] Roddenberry Stem Cell Ctr Gladstone, San Francisco, CA USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Lo, Cecelia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Shen, Yufeng] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Shen, Yufeng] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Watkins, W. Scott; Yandell, Mark; Yost, H. Joseph] Univ Utah, Dept Human Genet, Eccles Inst Human Genet, Salt Lake City, UT USA; [Yandell, Mark; Yost, H. Joseph] Sch Med, Salt Lake City, UT USA; [Yandell, Mark] Univ Utah, USTAR Ctr Genet Discovery, Salt Lake City, UT USA; [Tristani-Firouzi, Martin] Univ Utah, Div Pediat Cardiol, Salt Lake City, UT USA; [Newburger, Jane W.; Roberts, Amy E.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Kim, Richard] Childrens Hosp Los Angeles, Pediat Cardiac Surg, Los Angeles, CA 90027 USA; [Kaltman, Jonathan R.] NHLBI, Heart Dev & Struct Dis Branch, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Goldmuntz, Elizabeth] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Seidman, Christine E.] Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lifton, Richard P.] Rockefeller Univ, Lab Human Genet & Genome, 1230 York Ave, New York, NY 10021 USA; [Brueckner, Martina] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Yale University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Harvard University; Boston Children's Hospital; Columbia University; Columbia University; University of London; University College London; University of London School of Pharmacy; Yale University; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Rochester; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Columbia University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Children's Hospital Los Angeles; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Pennsylvania Medicine; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Howard Hughes Medical Institute; Rockefeller University; Yale University	Brueckner, M (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Seidman, JG; Seidman, CE (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Seidman, CE (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.; Gelb, BD (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.; Gelb, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.; Seidman, CE (corresponding author), Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA.; Lifton, RP (corresponding author), Rockefeller Univ, Lab Human Genet & Genome, 1230 York Ave, New York, NY 10021 USA.; Brueckner, M (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	cseidman@genetics.med.harvard.edu; richard.lifton@rockefeller.edu; martina.brueckner@yale.edu	Haider, Shozeb/Q-1599-2019; Lu, Qiongshi/AAF-5002-2021; Sanders, Stephan/S-8645-2019; Wang, Guilin/G-8794-2018; George A, Porter/E-7315-2013	Haider, Shozeb/0000-0003-2650-2925; Lu, Qiongshi/0000-0002-4514-0969; George A, Porter/0000-0003-0726-9988; Srivastava, Deepak/0000-0002-3480-5953; DePalma, Steven/0000-0002-0381-5016; Gelb, Bruce/0000-0001-8527-5027; Mital, Seema/0000-0002-7643-4484; Seidman, Christine/0000-0001-6380-1209; Jin, Sheng Chih/0000-0002-5777-7262; Knight, James/0000-0003-1166-0437; Morton, Sarah/0000-0002-7816-2646; Deanfield, John/0000-0001-8806-6052; Sanders, Stephan/0000-0001-9112-5148; Lo, Cecilia/0000-0003-4314-3434	National Center for Research Resources [U01 HL098153, UL1TR000003]; National Center for Advancing Translational Sciences, National Institutes of Health [UM1-HL098147, UM1-HL128761, UM1-HL098123, UM1-HL128711, UM1-HL098162, UO1-HL131003, UO1-HL098188, UO1-HL098153, UO1-HL098163]; NIH Centers for Mendelian Genomics [5U54HG006504]; Howard Hughes Medical Institute; Simons Foundation; Yale University School of Medicine; Harvard Medical School; Brigham and Women's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098160, U01HL131003, U01HL098163, U01HL098188, UM1HL098147, UM1HL098123, UM1HL128711, U01HL098147, U01HL098153, UM1HL098162, R01HL132024, UM1HL098160, U01HL098123, U01HL098180, U01HL098162] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM104390] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522, S10OD018521] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation; Yale University School of Medicine; Harvard Medical School; Brigham and Women's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the patients and families who participated in this research. We thank the following people for outstanding contributions to patient recruitment: A. Julian, M. Mac Neal, Y. Mendez, T. Mendiz-Ramdeen and C. Mintz (Icahn School of Medicine at Mount Sinai); N. Cross (Yale School of Medicine); J. Ellashek and N. Tran (Children's Hospital of Los Angeles); B. McDonough, J. Geva and M. Borensztein (Harvard Medical School), K. Flack, L. Panesar and N. Taylor (University College London); E. Taillie (University of Rochester School of Medicine and Dentistry); S. Edman, J. Garbarini, J. Tusi and S. Woyciechowski (Children's Hospital of Philadelphia); D. Awad, C. Breton, K. Celia, C. Duarte, D. Etwaru, N. Fishman, M. Kaspakoval, J. Kline, R. Korsin, A. Lanz, E. Marquez, D. Queen, A. Rodriguez, J. Rose, J. K. Sond, D. Warburton, A. Wilpers and R. Yee (Columbia Medical School). We are grateful to J. Ekstein and D. Yeshorim for provision of anonymized DNA samples. The authors thank S. Wang for critical discussion. This work was supported by U01 HL098153 and grant UL1TR000003 from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health; grants to the Pediatric Cardiac Genomics Consortium (UM1-HL098147, UM1-HL128761, UM1-HL098123, UM1-HL128711, UM1-HL098162, UO1-HL131003, UO1-HL098188, UO1-HL098153, UO1-HL098163); the NIH Centers for Mendelian Genomics (5U54HG006504); the Howard Hughes Medical Institute (R.P.L. and C.E.S.); and the Simons Foundation (W.K.C.). S.C.J. was supported by the James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship at the Yale University School of Medicine. J.H. was supported by the John S. LaDue Fellowship at Harvard Medical School and is a recipient of the Alan Lerner Research Award at the Brigham and Women's Hospital. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Center for Research Resources or the NIH.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ang SY, 2016, DEVELOPMENT, V143, P810, DOI 10.1242/dev.132688; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Egbe A, 2014, ANN PEDIAT CARDIOL, V7, P86, DOI 10.4103/0974-2069.132474; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fisher RA, 1925, STAT METHODS RES WOR; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Glessner JT, 2014, CIRC RES, V115, P884, DOI 10.1161/CIRCRESAHA.115.304458; Goldberg CS, 2014, J PEDIATR-US, V165, P490, DOI 10.1016/j.jpeds.2014.05.019; Harrison MJ, 2016, PAEDIATR RESPIR REV, V18, P25, DOI 10.1016/j.prrv.2015.09.003; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Hu H, 2013, GENET EPIDEMIOL, V37, P622, DOI 10.1002/gepi.21743; Ikemba CM, 2005, AM J CARDIOL, V95, P541, DOI 10.1016/j.amjcard.2004.10.030; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kaasinen E, 2010, HUM MOL GENET, V19, P2747, DOI 10.1093/hmg/ddq164; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morishima M, 1996, TERATOLOGY, V54, P183, DOI 10.1002/(SICI)1096-9926(199610)54:4<183::AID-TERA2>3.0.CO;2-2; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Ohye RG, 2010, NEW ENGL J MED, V362, P1980, DOI 10.1056/NEJMoa0912461; Oyen N, 2016, CIRCULATION, V133, P2243, DOI 10.1161/CIRCULATIONAHA.115.017465; Oyen N, 2009, CIRCULATION, V120, P295, DOI 10.1161/CIRCULATIONAHA.109.857987; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Prendiville T, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013946; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Razzaghi H, 2015, J PEDIATR-US, V166, P119, DOI 10.1016/j.jpeds.2014.09.006; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shieh JTC, 2012, AM J MED GENET A, V158A, P1236, DOI 10.1002/ajmg.a.35272; Sifrim A, 2016, NAT GENET, V48, P1060, DOI 10.1038/ng.3627; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tan HL, 2012, HUM MUTAT, V33, P720, DOI 10.1002/humu.22030; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Theis JL, 2015, CIRC-CARDIOVASC GENE, V8, P564, DOI 10.1161/CIRCGENETICS.115.001070; Timberlake AT, 2016, ELIFE, V5, DOI 10.7554/eLife.20125; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang CL, 2014, NAT GENET, V46, P409, DOI 10.1038/ng.2924; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ware James S, 2015, Curr Protoc Hum Genet, V87, DOI 10.1002/0471142905.hg0725s87; Wei Q, 2015, BIOINFORMATICS, V31, P1375, DOI 10.1093/bioinformatics/btu839; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Zaidi S, 2017, CIRC RES, V120, P923, DOI 10.1161/CIRCRESAHA.116.309140; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhu JY, 2017, ELIFE, V6, DOI 10.7554/eLife.22617	62	370	374	4	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2017	49	11					1593	+		10.1038/ng.3970	http://dx.doi.org/10.1038/ng.3970			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL0OD	28991257	Green Accepted, Green Submitted			2022-12-17	WOS:000413909800008
J	Coe, BP; Witherspoon, K; Rosenfeld, JA; van Bon, BWM; Vulto-van Silfhout, AT; Bosco, P; Friend, KL; Baker, C; Buono, S; Vissers, LELM; Schuurs-Hoeijmakers, JH; Hoischen, A; Pfundt, R; Krumm, N; Carvill, GL; Li, D; Amaral, D; Brown, N; Lockhart, PJ; Scheffer, IE; Alberti, A; Shaw, M; Pettinato, R; Tervo, R; de Leeuw, N; Reijnders, MRF; Torchia, BS; Peeters, H; O'Roak, BJ; Fichera, M; Hehir-Kwa, JY; Shendure, J; Mefford, HC; Haan, E; Gecz, J; de Vries, BBA; Romano, C; Eichler, EE				Coe, Bradley P.; Witherspoon, Kali; Rosenfeld, Jill A.; van Bon, Bregje W. M.; Vulto-van Silfhout, Anneke T.; Bosco, Paolo; Friend, Kathryn L.; Baker, Carl; Buono, Serafino; Vissers, Lisenka E. L. M.; Schuurs-Hoeijmakers, Janneke H.; Hoischen, Alex; Pfundt, Rolph; Krumm, Nik; Carvill, Gemma L.; Li, Deana; Amaral, David; Brown, Natasha; Lockhart, Paul J.; Scheffer, Ingrid E.; Alberti, Antonino; Shaw, Marie; Pettinato, Rosa; Tervo, Raymond; de Leeuw, Nicole; Reijnders, Margot R. F.; Torchia, Beth S.; Peeters, Hilde; O'Roak, Brian J.; Fichera, Marco; Hehir-Kwa, Jayne Y.; Shendure, Jay; Mefford, Heather C.; Haan, Eric; Gecz, Jozef; de Vries, Bert B. A.; Romano, Corrado; Eichler, Evan E.			Refining analyses of copy number variation identifies specific genes associated with developmental delay	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; AUTISM SPECTRUM DISORDER; SCHINZEL-GIEDION SYNDROME; INTELLECTUAL DISABILITY; MICRODELETION SYNDROME; MENTAL-RETARDATION; MOLECULAR CHARACTERIZATION; SEGMENTAL DUPLICATIONS; CLINICAL-SIGNIFICANCE; DELETIONS	Copy number variants (CNVs) are associated with many neurocognitive disorders; however, these events are typically large, and the underlying causative genes are unclear. We created an expanded CNV morbidity map from 29,085 children with developmental delay in comparison to 19,584 healthy controls, identifying 70 significant CNVs. We resequenced 26 candidate genes in 4,716 additional cases with developmental delay or autism and 2,193 controls. An integrated analysis of CNV and single-nucleotide variant (SNV) data pinpointed 10 genes enriched for putative loss of function. Follow-up of a subset of affected individuals identified new clinical subtypes of pediatric disease and the genes responsible for disease-associated CNVs. These genetic changes include haploinsufficiency of SETBP1 associated with intellectual disability and loss of expressive language and truncations of ZMYND11 in individuals with autism, aggression and complex neuropsychiatric features. This combined CNV and SNV approach facilitates the rapid discovery of new syndromes and genes involved in neuropsychiatric disease despite extensive genetic heterogeneity.	[Coe, Bradley P.; Witherspoon, Kali; Baker, Carl; Krumm, Nik; O'Roak, Brian J.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Torchia, Beth S.] PerkinElmer Inc, Signature Genom Labs LLC, Spokane, WA USA; [van Bon, Bregje W. M.; Vulto-van Silfhout, Anneke T.; Vissers, Lisenka E. L. M.; Schuurs-Hoeijmakers, Janneke H.; Hoischen, Alex; Pfundt, Rolph; de Leeuw, Nicole; Reijnders, Margot R. F.; Hehir-Kwa, Jayne Y.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van Bon, Bregje W. M.; Friend, Kathryn L.; Shaw, Marie; Haan, Eric; Gecz, Jozef] SA Pathol, Adelaide, SA, Australia; [Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Pettinato, Rosa; Fichera, Marco; Romano, Corrado] Associaz Oasi Maria Santissima, IRCCS, Troina, Italy; [Carvill, Gemma L.; Mefford, Heather C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Li, Deana; Amaral, David] Univ Calif Davis, MIND Inst, Autism Phenome Project, Sacramento, CA 95616 USA; [Brown, Natasha; Lockhart, Paul J.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Brown, Natasha] Barwon Hlth, Barwon Child Hlth Unit, Geelong, Vic, Australia; [Lockhart, Paul J.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Florey Inst, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Tervo, Raymond] Mayo Clin, Div Dev & Behav Pediat, Rochester, MN USA; [Peeters, Hilde] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Peeters, Hilde] Leuven Autism Res LAuRes, Leuven, Belgium; [Haan, Eric] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Gecz, Jozef] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Radboud University Nijmegen; SA Pathology; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; Mayo Clinic; KU Leuven; University Hospital Leuven; University of Adelaide; Robinson Research Institute; University of Adelaide; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Pfundt, Rolph/L-4576-2015; Shendure, Jay/AAU-3684-2021; AT, Vulto-van Silfhout/H-4199-2015; Hehir, g. J.Y./L-4358-2015; Scheffer, Ingrid E/G-1668-2013; Brown, Natasha Jane/AAP-6872-2020; Vissers, Lisenka ELM/A-2598-2015; Pettinato, Rosa/D-3358-2017; Peeters, Hilde/AAA-7338-2020; Fichera, Marco/K-9220-2016; Hoischen, Alexander/D-1282-2013; Lockhart, Paul J/E-7753-2011; van Bon, Bregje/Q-2445-2015; Buono, Serafino/D-8568-2017; Romano, Corrado/B-9695-2008; Coe, Bradley/A-2878-2009; de Leeuw, N./L-4480-2015; Gecz, Jozef/X-3469-2019; Alberti, Antonino/D-5653-2017; Hoischen, Alexander/AGF-7293-2022	Scheffer, Ingrid E/0000-0002-2311-2174; Brown, Natasha Jane/0000-0002-1822-9191; Vissers, Lisenka ELM/0000-0001-6470-5497; Pettinato, Rosa/0000-0002-2120-3152; Fichera, Marco/0000-0002-8225-6880; Hoischen, Alexander/0000-0002-8072-4476; Lockhart, Paul J/0000-0003-2531-8413; van Bon, Bregje/0000-0003-2234-0105; Buono, Serafino/0000-0002-3786-3323; Romano, Corrado/0000-0003-1049-0683; Gecz, Jozef/0000-0002-7884-6861; Alberti, Antonino/0000-0001-6742-7429; Hoischen, Alexander/0000-0002-8072-4476; Shendure, Jay/0000-0002-1516-1865; Coe, Bradley/0000-0001-8471-4016; Hehir-Kwa, Jayne/0000-0003-0837-304X; O'Roak, Brian/0000-0002-4141-0095; Rosenfeld, Jill/0000-0001-5664-7987; Peeters, Hilde/0000-0002-7295-3375	Canadian Institutes of Health Research; US National Institute of Mental Health [MH101221]; Paul G. Allen Family Foundation Award [11631]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS089858] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Paul G. Allen Family Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E Hormozdiari, M. Dennis and T. Brown for useful discussions and for editing the manuscript. B.P.C. is supported by a fellowship from the Canadian Institutes of Health Research. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/. JAR. and B.S.T. are employees of Signature Genomics Laboratories, LLC, a subsidiary of PerkinElmer, Inc. This work was supported by US National Institute of Mental Health grant MH101221 and Paul G. Allen Family Foundation Award 11631 to E.E.E. E.E.E. is an Allen Distinguished Investigator and an investigator of the Howard Hughes Medical Institute.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Alliman S, 2010, CLIN GENET, V78, P162, DOI 10.1111/j.1399-0004.2010.01373.x; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Burkardt DD, 2011, AM J MED GENET A, V155A, P1336, DOI 10.1002/ajmg.a.34049; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dabell MP, 2013, AM J MED GENET A, V161A, P717, DOI 10.1002/ajmg.a.35780; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeScipio C, 2012, AM J MED GENET A, V158A, P2152, DOI 10.1002/ajmg.a.35574; Docker D, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.280; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Filges I, 2011, J MED GENET, V48, P117, DOI 10.1136/jmg.2010.084582; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gimelli S, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-52; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kateb F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054715; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Madrigal I, 2012, AM J MED GENET A, V158A, P1071, DOI 10.1002/ajmg.a.35287; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Marseglia G, 2012, EUR J MED GENET, V55, P216, DOI 10.1016/j.ejmg.2012.01.005; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Paciorkowski AR, 2013, NEUROGENETICS, V14, P99, DOI 10.1007/s10048-013-0356-y; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shuvarikov A, 2013, HUM MUTAT, V34, P1415, DOI 10.1002/humu.22384; Stankiewicz P, 2012, HUM MUTAT, V33, P165, DOI 10.1002/humu.21614; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Thorsson T, 2015, CONGENIT HEART DIS, V10, P193, DOI 10.1111/chd.12179; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; van Bon BWM, 2011, EUR J HUM GENET, V19, P400, DOI 10.1038/ejhg.2010.211; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yu B, 2009, EXP CELL RES, V315, P3543, DOI 10.1016/j.yexcr.2009.09.011; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	56	370	385	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1063	1071		10.1038/ng.3092	http://dx.doi.org/10.1038/ng.3092			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25217958	Green Accepted			2022-12-17	WOS:000342554100008
J	Gronau, I; Hubisz, MJ; Gulko, B; Danko, CG; Siepel, A				Gronau, Ilan; Hubisz, Melissa J.; Gulko, Brad; Danko, Charles G.; Siepel, Adam			Bayesian inference of ancient human demography from individual genome sequences	NATURE GENETICS			English	Article							ANCESTRAL POPULATION SIZES; DIVERGENCE TIMES; HISTORY; DNA; MITOCHONDRIAL; MODELS; RATES	Whole-genome sequences provide a rich source of information about human evolution. Here we describe an effort to estimate key evolutionary parameters based on the whole-genome sequences of six individuals from diverse human populations. We used a Bayesian, coalescent-based approach to obtain information about ancestral population sizes, divergence times and migration rates from inferred genealogies at many neutrally evolving loci across the genome. We introduce new methods for accommodating gene flow between populations and integrating over possible phasings of diploid genotypes. We also describe a custom pipeline for genotype inference to mitigate biases from heterogeneous sequencing technologies and coverage levels. Our analysis indicates that the San population of southern Africa diverged from other human populations approximately 108-157 thousand years ago, that Eurasians diverged from an ancestral African population 38-64 thousand years ago, and that the effective population size of the ancestors of all modern humans was similar to 9,000.	[Gronau, Ilan; Hubisz, Melissa J.; Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA	Cornell University	Siepel, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	acs4@cornell.edu		Siepel, Adam/0000-0002-3557-7219; Danko, Charles/0000-0002-1999-7125; Hubisz, Melissa/0000-0002-9561-6830	Packard Fellowship; National Science Foundation [DBI-0644111]; National Institutes of Health [T32HD052471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER	Packard Fellowship(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a Packard Fellowship (to A. S.), National Science Foundation grant DBI-0644111 and National Institutes of Health training grant T32HD052471 (to C. G. D.). We thank S. Schuster, W. Miller, D. Reich, G. Coop, J. Hey, J. Wall, R. S. Wells, A. Keinan, A. G. Clark, S. C. Choi, C. D. Bustamante, B. Henn and others for helpful discussions and feedback.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beaumont MA, 2002, GENETICS, V162, P2025; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burgess R, 2008, MOL BIOL EVOL, V25, P1979, DOI 10.1093/molbev/msn148; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lewontin R., 1972, EVOLUTIONARY BIOL, V6; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nielsen R, 2001, GENETICS, V158, P885; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Paul JS, 2011, GENETICS, V187, P1115, DOI 10.1534/genetics.110.125534; Rannala B, 2003, GENETICS, V164, P1645; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	35	370	375	4	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					1031	U151		10.1038/ng.937	http://dx.doi.org/10.1038/ng.937			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21926973	Green Accepted			2022-12-17	WOS:000295316200022
J	Hoglinger, GU; Melhem, NM; Dickson, DW; Sleiman, PMA; Wang, LS; Klei, L; Rademakers, R; de Silva, R; Litvan, I; Riley, DE; van Swieten, JC; Heutink, P; Wszolek, ZK; Uitti, RJ; Vandrovcova, J; Hurtig, HI; Gross, RG; Maetzler, W; Goldwurm, S; Tolosa, E; Borroni, B; Pastor, P; Cantwell, LB; Han, MR; Dillman, A; van der Brug, MP; Gibbs, JR; Cookson, MR; Hernandez, DG; Singleton, AB; Farrer, MJ; Yu, CE; Golbe, LI; Revesz, T; Hardy, J; Lees, AJ; Devlin, B; Hakonarson, H; Muller, U; Schellenberg, GD				Hoeglinger, Guenter U.; Melhem, Nadine M.; Dickson, Dennis W.; Sleiman, Patrick M. A.; Wang, Li-San; Klei, Lambertus; Rademakers, Rosa; de Silva, Rohan; Litvan, Irene; Riley, David E.; van Swieten, John C.; Heutink, Peter; Wszolek, Zbigniew K.; Uitti, Ryan J.; Vandrovcova, Jana; Hurtig, Howard I.; Gross, Rachel G.; Maetzler, Walter; Goldwurm, Stefano; Tolosa, Eduardo; Borroni, Barbara; Pastor, Pau; Cantwell, Laura B.; Han, Mi Ryung; Dillman, Allissa; van der Brug, Marcel P.; Gibbs, J. Raphael; Cookson, Mark R.; Hernandez, Dena G.; Singleton, Andrew B.; Farrer, Matthew J.; Yu, Chang-En; Golbe, Lawrence I.; Revesz, Tamas; Hardy, John; Lees, Andrew J.; Devlin, Bernie; Hakonarson, Hakon; Mueller, Ulrich; Schellenberg, Gerard D.		PSP Genetics Study Grp	Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; UNFOLDED PROTEIN RESPONSE; ALZHEIMERS-DISEASE; CORTICOBASAL DEGENERATION; NEUROPATHOLOGIC CRITERIA; PARKINSONS-DISEASE; TAU-GENE; HAPLOTYPE; EXPRESSION; METAANALYSIS	Progressive supranuclear palsy (PSP) is a movement disorder with prominent tau neuropathology. Brain diseases with abnormal tau deposits are called tauopathies, the most common of which is Alzheimer's disease. Environmental causes of tauopathies include repetitive head trauma associated with some sports. To identify common genetic variation contributing to risk for tauopathies, we carried out a genome-wide association study of 1,114 individuals with PSP (cases) and 3,247 controls (stage 1) followed by a second stage in which we genotyped 1,051 cases and 3,560 controls for the stage 1 SNPs that yielded P <= 10(-3). We found significant previously unidentified signals (P < 5 x 10(-8)) associated with PSP risk at STX6, EIF2AK3 and MOBP. We confirmed two independent variants in MAPT affecting risk for PSP, one of which influences MAPT brain expression. The genes implicated encode proteins for vesicle-membrane fusion at the Golgi-endosomal interface, for the endoplasmic reticulum unfolded protein response and for a myelin structural component.	[Wang, Li-San; Cantwell, Laura B.; Han, Mi Ryung; Schellenberg, Gerard D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hoeglinger, Guenter U.] Univ Marburg, Dept Neurol, Marburg, Germany; [Melhem, Nadine M.; Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Dickson, Dennis W.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [de Silva, Rohan; Vandrovcova, Jana; Gibbs, J. Raphael; Hernandez, Dena G.; Hardy, John; Lees, Andrew J.] UCL, Inst Neurol, Reta Lila Weston Inst, London, England; [Litvan, Irene] Univ Louisville, Div Movement Disorders, Dept Neurol, Louisville, KY 40292 USA; [Riley, David E.] Case Western Reserve Univ, Dept Neurol, Univ Hosp, Cleveland, OH 44106 USA; [van Swieten, John C.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Heutink, Peter] Vrije Univ VU Med Ctr, Dept Clin Genet, Sect Med Genom, Amsterdam, Netherlands; [Wszolek, Zbigniew K.; Uitti, Ryan J.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Hurtig, Howard I.; Gross, Rachel G.] Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA; [Maetzler, Walter] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Ctr Neurol, Tubingen, Germany; [Maetzler, Walter] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Goldwurm, Stefano] Ist Clin Perfezionamento, Parkinson Inst, Milan, Italy; [Tolosa, Eduardo] Univ Barcelona, IDIBAPS, CIBERNED, Neurol Serv,Hosp Clin, Barcelona, Spain; [Borroni, Barbara] Univ Brescia, Inst Neurol, Dept Med & Surg Sci, Brescia, Italy; [Pastor, Pau] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Pastor, Pau] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neurogenet Lab, E-31080 Pamplona, Spain; [Pastor, Pau] Univ Navarra, Clin Univ Navarra, Dept Neurol, E-31080 Pamplona, Spain; [Dillman, Allissa; Gibbs, J. Raphael; Cookson, Mark R.; Hernandez, Dena G.; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [van der Brug, Marcel P.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Farrer, Matthew J.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Yu, Chang-En] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Yu, Chang-En] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA USA; [Golbe, Lawrence I.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA; [Revesz, Tamas; Lees, Andrew J.] UCL, UCL Inst Neurol, Dept Mol Neurosci, Queen Sq Brain Bank Neurol Disorders, London, England; [Mueller, Ulrich] Univ Giessen, Inst Humangenet, Giessen, Germany	University of Pennsylvania; Philipps University Marburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; University College London; University of Louisville; Case Western Reserve University; University Hospitals of Cleveland; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Mayo Clinic; University of Pennsylvania; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Brescia; CIBERNED; Instituto de Salud Carlos III; University of Navarra; University of Navarra; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Scripps Research Institute; University of British Columbia; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of London; University College London; Justus Liebig University Giessen	Schellenberg, GD (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ulrich.mueller@humangenetik.med.uni-giessen.de; gerardsc@mail.med.upenn.edu	Cookson, Mark/AAW-2516-2021; Cilia, Roberto/L-6679-2017; Goldwurm, Stefano/Q-8978-2016; O'Sullivan, Sean S/C-9333-2012; Avila, Jesus/I-2610-2015; Lees, Andrew J/A-6605-2009; Ross, Owen/D-7573-2013; Troakes, Claire/K-4346-2015; Hardy, John/C-2451-2009; Budka, Herbert/I-3486-2019; Maetzler, Walter/A-6796-2011; Höglinger, Günter U/F-2388-2015; Revesz, Tamas/A-8732-2010; Gibbs, J. Raphael/A-3984-2010; White, Charles L/AAJ-1858-2021; Berg, Daniela/A-8728-2019; Wszolek, Zbigniew K./AAB-1431-2019; Morris, Huw R/B-8527-2008; Antonini, Angelo/H-9726-2019; Pastor, Pau/C-9834-2009; Gasser, Thomas/GNH-5293-2022; Melhem, Nadine M/G-1510-2013; Borroni, Barbara/AAN-4105-2020; Singleton, Andrew B/C-3010-2009; Litvan, Irene/X-9319-2018; Maetzler, Walter/AAE-5831-2020; Silveira-Moriyama, Laura/G-4592-2014	Cookson, Mark/0000-0002-1058-3831; Cilia, Roberto/0000-0002-1990-1939; Goldwurm, Stefano/0000-0002-1651-567X; O'Sullivan, Sean S/0000-0002-0583-7956; Avila, Jesus/0000-0002-6288-0571; Lees, Andrew J/0000-0002-2476-4385; Hardy, John/0000-0002-3122-0423; Budka, Herbert/0000-0002-1933-1577; Maetzler, Walter/0000-0002-5945-4694; Höglinger, Günter U/0000-0001-7587-6187; Revesz, Tamas/0000-0003-2501-0259; Gibbs, J. Raphael/0000-0002-6985-0658; White, Charles L/0000-0002-3870-2804; Berg, Daniela/0000-0001-5796-5442; Morris, Huw R/0000-0002-5473-3774; Antonini, Angelo/0000-0003-1040-2807; Pastor, Pau/0000-0002-7493-8777; Gasser, Thomas/0000-0002-1069-1146; Litvan, Irene/0000-0002-3485-3445; Maetzler, Walter/0000-0002-5945-4694; Geller, Evan/0000-0002-8035-8736; Standaert, David/0000-0003-2921-8348; Heutink, Peter/0000-0001-5218-1737; Fabbrini, Giovanni/0000-0001-7614-8771; Zecchinelli, anna/0000-0002-7092-7034; Morris, Christopher/0000-0002-3749-0993; Farrer, Matthew/0000-0003-1159-5321; McLean, Catriona/0000-0002-0302-5727; van Swieten, John/0000-0001-6278-6844; Brice, Alexis/0000-0002-0941-3990; Dickson, Dennis W/0000-0001-7189-7917; Ross, Owen/0000-0003-4813-756X; Silveira-Moriyama, Laura/0000-0002-8267-0977; Wenning, Gregor/0000-0001-9077-1666; Rohrer, Jonathan/0000-0002-6155-8417; Rossor, Martin/0000-0001-8215-3120; Pezzoli, Gianni/0000-0003-4665-6710; Seppi, Klaus/0000-0001-6503-1455; Padovani, Alessandro/0000-0002-0119-3639; St George-Hyslop, Peter/0000-0003-0796-7209; Pickering-Brown, Stuart/0000-0003-1561-6054	CurePSP Foundation; Peebler PSP Research Foundation; US National Institutes of Health (NIH) (National Institute on Aging (NIA)/NIH) [R37 AG 11762, R01 PAS-03-092, P50 NS72187, P01 AG17216]; US National Institutes of Health (NIH) (National Institute of Mental Health (NIMH) [MH057881, MH077930]; NIA; German National Genome Research Network [01GS08136-4]; Deutsche Forschungsgemeinschaft [HO 2402/6-1]; Prinses Beatrix Fonds [01-0128]; Reta Lila Weston Trust; UK Medical Research Council [G0501560, G0400074]; Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age Related Diseases; Alzheimer's Society; Alzheimer's Research Trust; TELETHON Italy [GTB07001]; Fondazione Grigioni per il Morbo di Parkinson; Wellcome Trust; Howard Hughes Medical Institute; Canadian Institute of Health Research; Federal Ministry of Education and Research (BMBF) [01GI0505]; PSP (Europe) Association; Cure PSP+; NIH/NINDS [1RC2NS070276, NS057567, P50NS072187]; Mayo Clinic Florida (MCF) Research Committee [90052030]; Government of Navarra; Division of Neuroscience, NIA; Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, NIA; National Human Genome Research Institute (NHGRI) [U01HG004608]; National Institute for General Medical Sciences (NIGMS); Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy [D1A RH00025]; Wisconsin Department of Commerce [TDF FYO10718]; NIH [U01HG004438]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004603, U01HG004608, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH077930, R37MH057881, R01MH057881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, RC2NS070276, P50NS038377, R01NS057567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216, ZIAAG000951, R37AG011762, P01AG017586, ZIAAG000947] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PG2010-1, ART-PPG2011A-14, ART-PhD2007-2] Funding Source: researchfish; Medical Research Council [G0501560, G0701441, G0700943, G0502157, G0600676, MC_G1000734, G0900652, G0701075, G0400074] Funding Source: researchfish; MRC [G0701075, G0700943, G0701441, G0900652, G0400074, G0502157, G0600676, MC_G1000734, G0501560] Funding Source: UKRI	CurePSP Foundation; Peebler PSP Research Foundation; US National Institutes of Health (NIH) (National Institute on Aging (NIA)/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Institutes of Health (NIH) (National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Prinses Beatrix Fonds; Reta Lila Weston Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age Related Diseases(National Institute for Health Research (NIHR)); Alzheimer's Society; Alzheimer's Research Trust; TELETHON Italy(Fondazione Telethon); Fondazione Grigioni per il Morbo di Parkinson; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); PSP (Europe) Association; Cure PSP+; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Florida (MCF) Research Committee; Government of Navarra; Division of Neuroscience, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy; Wisconsin Department of Commerce; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the subjects and their families that participated in this study. This work was funded by grants from the CurePSP Foundation, the Peebler PSP Research Foundation and US National Institutes of Health (NIH) grants R37 AG 11762, R01 PAS-03-092, P50 NS72187, P01 AG17216 (National Institute on Aging (NIA)/NIH), MH057881 and MH077930 (National Institute of Mental Health (NIMH)). Work was also supported in part by the NIA Intramural Research Program, the German National Genome Research Network (01GS08136-4) and the Deutsche Forschungsgemeinschaft (HO 2402/6-1), Prinses Beatrix Fonds (JCvS, 01-0128), the Reta Lila Weston Trust and the UK Medical Research Council (RdS: G0501560). The Newcastle Brain Tissue Resource provided tissue and is funded in part by a grant from the UK Medical Research Council (G0400074), by the Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age Related Diseases to the Newcastle upon Tyne Hospitals National Health Service Foundation Trust and by a grant from the Alzheimer's Society and Alzheimer's Research Trust as part of the Brains for Dementia Research Project. We acknowledge the contribution of many tissue samples from the Harvard Brain Tissue Resource Center. We also acknowledge the 'Human Genetic Bank of Patients affected by Parkinson Disease and Parkinsonism' (http://www.parkinson.it/dnabank.html) of the Telethon Genetic Biobank Network, supported by TELETHON Italy (project no. GTB07001) and by Fondazione Grigioni per il Morbo di Parkinson. The University of Toronto sample collection was supported by grants from Wellcome Trust, Howard Hughes Medical Institute and the Canadian Institute of Health Research. Brain-Net-Germany is supported by the Federal Ministry of Education and Research (BMBF) (01GI0505). R.d.S., A.J.L. and J.A.H. are funded by the Reta Lila Weston Trust and the PSP (Europe) Association. R.d.S. is funded by the UK Medical Research Council (Grant G0501560) and Cure PSP+. Z.K.W. is partially supported by the NIH/NINDS 1RC2NS070276, NS057567, P50NS072187, Mayo Clinic Florida (MCF) Research Committee CR programs (MCF #90052030 and MCF #90052030) and the gift from C. E. Bolch Jr. and S. B. Bolch (MCF #90052031/PAU # 90052). The Mayo Clinic College of Medicine would like to acknowledge M. Baker, R. Crook, M. DeJesus-Hernandez and N. Rutherford for their preparation of samples. P. P. was supported by a grant from the Government of Navarra ('Ayudas para la Realizacion de Proyectos de Investigacion' 2006-2007) and acknowledges the 'Iberian Atypical Parkinsonism Study Group Researchers': M. A. Pastor, M. R. Luquin, M. Riverol, J.A. Obeso and M. C. Rodriguez-Oroz (Department of Neurology, Clinica Universitaria de Navarra, University of Navarra, Pamplona, Spain), M. Blazquez (Neurology Department, Hospital Universitario Central de Asturias, Oviedo, Spain), A. Lopez de Munain, B. Indakoetxea, J. Olaskoaga, J. Ruiz, J. Felix Marti Masso (Servicio de Neurologia, Hospital Donostia, San Sebastian, Spain), V. Alvarez (Genetics Department, Hospital Universitario Central de Asturias, Oviedo, Spain), T. Tu on (Banco de Tejidos Neurologicos, CIBERNED, Hospital de Navarra, Navarra, Spain), F. Moreno (Servicio de Neurologia, Hospital Ntra. Sra. de la Antigua, Zumarraga, Gipuzkoa, Spain), A. Alzualde (Neurogenetics Department, Hospital Donostia, San Sebastian, Spain). E. T. wishes to acknowledge the Banco de Tejidos Neurologicos de la Universidad de Barcelona-Hospital Clinic, which provided many tissue samples for the project. We also acknowledge E.; Loomis for providng technical support.; The datasets used for older controls were obtained from Database for Genotypes and Phenotypes (dbGap) at http://www.ncbi.nlm.nih.gov/gap/. Funding support for the 'Genetic Consortium for Late Onset Alzheimer's Disease' was provided through the Division of Neuroscience, NIA. The Genetic Consortium for Late Onset Alzheimer's Disease (study accession number: phs000168.v1.p1) includes a genome-wide association study funded as part of the Division of Neuroscience, NIA. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by Genetic Consortium for Late Onset Alzheimer's Disease. Funding support for the 'CIDR Visceral Adiposity Study' (study accession number: phs000169.v1.p1) was provided through the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, NIA. The CIDR Visceral Adiposity Study includes a genome-wide association study funded as part of the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, NIA. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by Heath ABC Study Investigators. Funding support for the Personalized Medicine Research Project (PMRP) was provided through a cooperative agreement (U01HG004608) with the National Human Genome Research Institute (NHGRI), with additional funding from the National Institute for General Medical Sciences (NIGMS). The samples used for PMRP analyses were obtained with funding from Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy grant number D1A RH00025 and Wisconsin Department of Commerce Technology Development Fund contract number TDF FYO10718. Funding support for genotyping, which was performed at Johns Hopkins University, was provided by the NIH (U01HG004438). Assistance with phenotype harmonization and genotype cleaning was provided by the eMERGE Administrative Coordinating Center (U01HG004603) and the National Center for Biotechnology Information (NCBI). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000170.v1.p1.	Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Crossett A, 2010, STAT MED, V29, P2932, DOI 10.1002/sim.4057; Cruchaga C, 2009, NEUROBIOL DIS, V33, P164, DOI 10.1016/j.nbd.2008.09.027; Dickson DW, 2007, BRAIN PATHOL, V17, P74, DOI 10.1111/j.1750-3639.2007.00054.x; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Golbe LI, 1996, NEUROLOGY, V47, P148, DOI 10.1212/WNL.47.1.148; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoppitt T, 2011, NEUROEPIDEMIOLOGY, V36, P19, DOI 10.1159/000321712; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Litvan Irene, 2004, Curr Neurol Neurosci Rep, V4, P296, DOI 10.1007/s11910-004-0055-z; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Osaki Y, 2004, MOVEMENT DISORD, V19, P181, DOI 10.1002/mds.10680; Paschen W, 2005, PHARMACOL THERAPEUT, V108, P362, DOI 10.1016/j.pharmthera.2005.05.008; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stamelou M, 2010, BRAIN, V133, P1578, DOI 10.1093/brain/awq115; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sundar PD, 2007, HUM MOL GENET, V16, P295, DOI 10.1093/hmg/ddl463; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	46	370	378	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2011	43	7					699	U125		10.1038/ng.859	http://dx.doi.org/10.1038/ng.859			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21685912	Green Submitted, Green Accepted			2022-12-17	WOS:000292184600017
J	Morelli, G; Song, YJ; Mazzoni, CJ; Eppinger, M; Roumagnac, P; Wagner, DM; Feldkamp, M; Kusecek, B; Vogler, AJ; Li, YJ; Cui, YJ; Thomson, NR; Jombart, T; Leblois, R; Lichtner, P; Rahalison, L; Petersen, JM; Balloux, F; Keim, P; Wirth, T; Ravel, J; Yang, RF; Carniel, E; Achtman, M				Morelli, Giovanna; Song, Yajun; Mazzoni, Camila J.; Eppinger, Mark; Roumagnac, Philippe; Wagner, David M.; Feldkamp, Mirjam; Kusecek, Barica; Vogler, Amy J.; Li, Yanjun; Cui, Yujun; Thomson, Nicholas R.; Jombart, Thibaut; Leblois, Raphael; Lichtner, Peter; Rahalison, Lila; Petersen, Jeannine M.; Balloux, Francois; Keim, Paul; Wirth, Thierry; Ravel, Jacques; Yang, Ruifu; Carniel, Elisabeth; Achtman, Mark			Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity	NATURE GENETICS			English	Article							EVOLUTION; INSIGHTS; STRAIN; PHYLOGEOGRAPHY; DYNAMICS; SPREAD; PLAGUE	Plague is a pandemic human invasive disease caused by the bacterial agent Yersinia pestis. We here report a comparison of 17 whole genomes of Y. pestis isolates from global sources. We also screened a global collection of 286 Y. pestis isolates for 933 SNPs using Sequenom MassArray SNP typing. We conducted phylogenetic analyses on this sequence variation dataset, assigned isolates to populations based on maximum parsimony and, from these results, made inferences regarding historical transmission routes. Our phylogenetic analysis suggests that Y. pestis evolved in or near China and spread through multiple radiations to Europe, South America, Africa and Southeast Asia, leading to country- specific lineages that can be traced by lineage-specific SNPs. All 626 current isolates from the United States reflect one radiation, and 82 isolates from Madagascar represent a second radiation. Subsequent local microevolution of Y. pestis is marked by sequential, geographically specific SNPs.	[Song, Yajun; Li, Yanjun; Cui, Yujun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Morelli, Giovanna; Mazzoni, Camila J.; Roumagnac, Philippe; Feldkamp, Mirjam; Kusecek, Barica; Achtman, Mark] Max Planck Inst Infekt Biol, Dept Mol Biol, Berlin, Germany; [Song, Yajun; Mazzoni, Camila J.; Achtman, Mark] Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Eppinger, Mark; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Roumagnac, Philippe] Ctr Cooprat Int Rech Agron Dev, Mixte Res Unit Biol & Genet Plant Pathogen Intera, Montpellier, France; [Wagner, David M.; Vogler, Amy J.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Cambridge, England; [Jombart, Thibaut; Balloux, Francois] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Outbreak Anal & Modeling, London, England; [Leblois, Raphael; Wirth, Thierry] Museum Natl Hist Nat, CNRS, Ecole Prat Hautes Etud, Dept Systemat & Evolut,UMR 7205, Paris, France; [Lichtner, Peter] German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Rahalison, Lila] Inst Pasteur Madagascar, Unite Peste, Antananarivo, Madagascar; [Petersen, Jeannine M.] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Carniel, Elisabeth] Inst Pasteur, Yersinia Res Unit, Paris, France; [Achtman, Mark] Univ Coll Cork, Dept Microbiol, Cork, Ireland	Beijing Institute of Microbiology & Epidemiology; Max Planck Society; University College Cork; University System of Maryland; University of Maryland Baltimore; CIRAD; Northern Arizona University; Wellcome Trust Sanger Institute; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Universite Paris Cite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Centers for Disease Control & Prevention - USA; Translational Genomics Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University College Cork	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; elisabeth.carniel@pasteur.fr; m.achtman@ucc.ie	Pacific-Southwest, RCE/B-6155-2009; Cui, Yujun/E-7015-2012; Balloux, Francois/D-4783-2009; Mazzoni, Camila J/L-3441-2014; Song, Yajun/GQQ-0476-2022; Wagner, David M/A-5125-2010; Leblois, Raphael/A-8815-2008; Song, Yajun/F-3714-2011; Wirth, Thierry/B-4915-2008; Balloux, Francois/X-7856-2019; Keim, Paul S/A-2269-2010; Ravel, Jacques/D-2530-2009; Mazzoni, Camila/AAJ-9702-2020; Yang, Ruifu/A-2273-2011; Thomson, Nicholas/P-5988-2014	Balloux, Francois/0000-0003-1978-7715; Song, Yajun/0000-0002-6628-2747; Leblois, Raphael/0000-0002-3051-4497; Song, Yajun/0000-0002-6628-2747; Wirth, Thierry/0000-0002-7371-0172; Balloux, Francois/0000-0003-1978-7715; Mazzoni, Camila/0000-0001-6758-5427; Yang, Ruifu/0000-0003-3219-7269; Thomson, Nicholas/0000-0002-4432-8505; Ravel, Jacques/0000-0002-0851-2233; Achtman, Mark/0000-0001-6815-0070; Roumagnac, Philippe/0000-0001-5002-6039; Wagner, David/0000-0003-2684-6007	NIAID NIH HHS [U54 AI065359, AI065359, N01 AI030071] Funding Source: Medline; Science Foundation Ireland [05/FE1/B882] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; Medical Research Council [G0600719B] Funding Source: researchfish	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Adjemian JZ, 2007, AM J TROP MED HYG, V76, P365, DOI 10.4269/ajtmh.2007.76.365; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Auerbach RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000770; Brygoo ER, 1966, ARCH I PASTEUR MADAG, V35, P7; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; DELRIO A, 1904, CHILENA HIJIENE, V9, P1; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DEVIGNAT R, 1951, Bull World Health Organ, V4, P247; DIAMOND J, 1997, GUNS GERMS STEEL FAT, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eppinger M, 2007, PLOS GENET, V3, P1508, DOI 10.1371/journal.pgen.0030142; Eppinger M, 2010, J BACTERIOL, V192, P1685, DOI 10.1128/JB.01518-09; Eppinger M, 2009, J BACTERIOL, V191, P7628, DOI 10.1128/JB.01227-09; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; GIRARD G., 1963, BIOL MED [PARIS], V52, P631; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Huson D H, 2001, Bioinformatics, V17 Suppl 1, pS132; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LAUZERAL P., 1932, Bulletin de la Societe de Pathologie Exotique, V25, P935; Levathes L., 1996, CHINA RULED SEAS TRE, P1; Li YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006701; LINK V B, 1955, Public Health Monogr, V26, P1; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NOCHT B, 1903, ARBEITEN KAISERLICHE, V20, P6; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; POLLITZER R, 1951, Bull World Health Organ, V4, P475; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; *SILKR FDN, 2009, BRIDG E W CULT; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Touchman JW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000220; Vogler AJ, 2008, BIOTECHNIQUES, V44, P201, DOI 10.2144/000112815; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wu L, 1936, PLAGUE MANUAL MED PU, P1; Yu Hwa-Lung, 2006, Int J Health Geogr, V5, P12, DOI 10.1186/1476-072X-5-12; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	47	370	409	4	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1140	+		10.1038/ng.705	http://dx.doi.org/10.1038/ng.705			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21037571	Bronze, Green Accepted, Green Submitted			2022-12-17	WOS:000284578800020
J	Marth, GT; Korf, I; Yandell, MD; Yeh, RT; Gu, ZJ; Zakeri, H; Stitziel, NO; Hillier, L; Kwok, PY; Gish, WR				Marth, GT; Korf, I; Yandell, MD; Yeh, RT; Gu, ZJ; Zakeri, H; Stitziel, NO; Hillier, L; Kwok, PY; Gish, WR			A general approach to single-nucleotide polymorphism discovery	NATURE GENETICS			English	Article							EXPRESSED SEQUENCE TAGS; HUMAN-GENOME	Single-nucleotide polymorphisms (SNPs) are the most abundant form of human genetic variation and a resource for mapping complex genetic traits'. The large volume of data produced by high-throughput sequencing projects is a rich and largely untapped source of SNPs (refs 2-5). We present here a unified approach to the discovery of variations in genetic sequence data of arbitrary DNA sources. We propose to use the rapidly emerging genomic: sequence(6,7) as a template on which to layer often unmapped, fragmentary sequence data(8-11) and to use base quality values(12) to discern true allelic variations from sequencing errors. By taking advantage of the genomic sequence we are able to use simpler yet more accurate methods for sequence organization: fragment clustering, paralogue identification and multiple alignment. We analyse these sequences with a novel, Bayesian inference engine, POLYBAYES, to calculate the probability that a given site is polymorphic. Rigorous treatment of base quality permits completely automated evaluation of the full length of all sequences, without limitations on alignment depth. We demonstrate this approach by accurate SNP predictions in human ESTs aligned to finished and working-draft quality genomic sequences, a data set representative of the typical challenges of sequence-based SNP discovery.	Washington Univ, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63110 USA; Washington Univ, Div Dermatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Marth, GT (corresponding author), Washington Univ, Dept Genet, St Louis, MO 63110 USA.		Kwok, Pui-Yan/F-7725-2014; Stitziel, Nathan/AAL-8413-2021; Gish, Warren/C-8123-2012	Kwok, Pui-Yan/0000-0002-5087-3059; Stitziel, Nathan/0000-0002-4963-8211; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001720, P50HG001458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007284] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50HG01458, R01HG1720] Funding Source: Medline; NIAMS NIH HHS [T32AR07284] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aaronson JS, 1996, GENOME RES, V6, P829, DOI 10.1101/gr.6.9.829; ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; Bayes T., 1763, PHILOS T ROY SOC LON, V53, P370, DOI [DOI 10.1098/RSTL.1763.0053, 10.1098/rstl.1763.0053]; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Durbin R, 1998, GENOME RES, V8, P161, DOI 10.1101/gr.8.3.161; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; Marra M, 1996, GENOME RES, V6, P1118, DOI 10.1101/gr.6.11.1118; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Picoult-Newberg L, 1999, GENOME RES, V9, P167; *SANG CTR WASH U G, 1998, GENOME RES, V8, P1097; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; TaillonMiller P, 1997, GENOMICS, V46, P307, DOI 10.1006/geno.1997.5042; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	23	370	436	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					452	456		10.1038/70570	http://dx.doi.org/10.1038/70570			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581034				2022-12-17	WOS:000084023900023
J	Bonnelykke, K; Sleiman, P; Nielsen, K; Kreiner-Moller, E; Mercader, JM; Belgrave, D; den Dekker, HT; Husby, A; Sevelsted, A; Faura-Tellez, G; Mortensen, LJ; Paternoster, L; Flaaten, R; Molgaard, A; Smart, DE; Thomsen, PF; Rasmussen, MA; Bonas-Guarch, S; Holst, C; Nohr, EA; Yadav, R; March, ME; Blicher, T; Lackie, PM; Jaddoe, VWV; Simpson, A; Holloway, JW; Duijts, L; Custovic, A; Davies, DE; Torrents, D; Gupta, R; Hollegaard, MV; Hougaard, DM; Hakonarson, H; Bisgaard, H				Bonnelykke, Klaus; Sleiman, Patrick; Nielsen, Kasper; Kreiner-Moller, Eskil; Mercader, Josep M.; Belgrave, Danielle; den Dekker, Herman T.; Husby, Anders; Sevelsted, Astrid; Faura-Tellez, Grissel; Mortensen, Li Juel; Paternoster, Lavinia; Flaaten, Richard; Molgaard, Anne; Smart, David E.; Thomsen, Philip F.; Rasmussen, Morten A.; Bonas-Guarch, Silvia; Holst, Claus; Nohr, Ellen A.; Yadav, Rachita; March, Michael E.; Blicher, Thomas; Lackie, Peter M.; Jaddoe, Vincent W. V.; Simpson, Angela; Holloway, John W.; Duijts, Liesbeth; Custovic, Adnan; Davies, Donna E.; Torrents, David; Gupta, Ramneek; Hollegaard, Mads V.; Hougaard, David M.; Hakonarson, Hakon; Bisgaard, Hans			A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations	NATURE GENETICS			English	Article							BLOOD SPOT SAMPLES; GENOTYPE IMPUTATION; SEQUENCE VARIANTS; BIRTH COHORT; CHILDREN; AIRWAY; EXPRESSION; RESOURCE; GENETICS; BIOBANK	Asthma exacerbations are among the most frequent causes of hospitalization during childhood, but the underlying mechanisms are poorly understood. We performed a genome-wide association study of a specific asthma phenotype characterized by recurrent, severe exacerbations occurring between 2 and 6 years of age in a total of 1,173 cases and 2,522 controls. Cases were identified from national health registries of hospitalization, and DNA was obtained from the Danish Neonatal Screening Biobank. We identified five loci with genome-wide significant association. Four of these, GSDMB, IL33, RAD50 and IL1RL1, were previously reported as asthma susceptibility loci, but the effect sizes for these loci in our cohort were considerably larger than in the previous genome-wide association studies of asthma. We also obtained strong evidence for a new susceptibility gene, CDHR3 (encoding cadherin-related family member 3), which is highly expressed in airway epithelium. These results demonstrate the strength of applying specific phenotyping in the search for asthma susceptibility genes.	[Bonnelykke, Klaus; Kreiner-Moller, Eskil; Husby, Anders; Sevelsted, Astrid; Mortensen, Li Juel; Flaaten, Richard; Molgaard, Anne] Univ Copenhagen, Gentofte, Denmark; [Bonnelykke, Klaus; Kreiner-Moller, Eskil; Husby, Anders; Sevelsted, Astrid; Mortensen, Li Juel; Flaaten, Richard; Molgaard, Anne] Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Gentofte, Denmark; [Sleiman, Patrick; March, Michael E.] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Nielsen, Kasper; Yadav, Rachita; Gupta, Ramneek] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Mercader, Josep M.; Bonas-Guarch, Silvia; Torrents, David] Joint Inst Res Biomed, Barcelona, Spain; [Mercader, Josep M.; Bonas-Guarch, Silvia; Torrents, David] IRB BSC, Barcelona Supercomputing Ctr, Program Computat Biol, Barcelona, Spain; [Belgrave, Danielle; Simpson, Angela; Custovic, Adnan] Univ Manchester, Ctr Resp Med & Allergy, Inst Inflammat & Repair, Manchester, Lancs, England; [Belgrave, Danielle; Simpson, Angela; Custovic, Adnan] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England; [Belgrave, Danielle] Univ Manchester, Ctr Hlth Informat, Inst Populat Hlth, Manchester, Lancs, England; [den Dekker, Herman T.; Jaddoe, Vincent W. V.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [den Dekker, Herman T.; Duijts, Liesbeth] Erasmus MC, Dept Pediat, Div Resp Med, Rotterdam, Netherlands; [den Dekker, Herman T.; Jaddoe, Vincent W. V.; Duijts, Liesbeth] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Husby, Anders; Davies, Donna E.] Univ Southampton, Southampton Univ Hosp, Fac Med, Brooke Lab Clin & Expt Sci, Southampton, Hants, England; [Faura-Tellez, Grissel; Holloway, John W.] Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton, Hants, England; [Faura-Tellez, Grissel] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen Res Inst Asthma & COPD, Groningen, Netherlands; [Paternoster, Lavinia] Univ Bristol, Sch Social & Community Med, Integrat Epidemiol Unit, Bristol, Avon, England; [Thomsen, Philip F.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Rasmussen, Morten A.] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark; [Holst, Claus] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Nohr, Ellen A.] Univ Southern Denmark, Inst Clin Res, Aarhus, Denmark; [Nohr, Ellen A.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Blicher, Thomas] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth Sci, Ctr Prot Res, Copenhagen, Denmark; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Duijts, Liesbeth] Erasmus MC, Dept Pediat, Div Neonatol, Rotterdam, Netherlands; [Torrents, David] ICREA, Barcelona, Spain; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Danish Ctr Neonatal Screening, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Technical University of Denmark; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southampton; University of Southampton; University of Groningen; University of Bristol; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark; Aarhus University; Novo Nordisk Foundation; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; ICREA; Statens Serum Institut	Bonnelykke, K (corresponding author), Univ Copenhagen, Gentofte, Denmark.	kb@copsac.com	Hougaard, David/AAD-6368-2019; Davies, Donna E/H-2993-2012; Bonàs-Guarch, Sílvia/K-2863-2017; Arendt, Morten/S-8843-2017; March, Michael/AAB-6502-2019; Holloway, John W/B-5424-2009; Bisgaard, Hans/N-4761-2016; Gupta, Ramneek/G-7278-2012; Rasmussen, Morten/AAE-9517-2020; Thomsen, Philip Francis/AAE-9354-2019; Custovic, Adnan/A-2435-2012; Torrents, David/G-5785-2015; Paternoster, Lavinia/C-1292-2015	Bonàs-Guarch, Sílvia/0000-0002-2085-7488; Arendt, Morten/0000-0001-7431-5206; March, Michael/0000-0001-9173-6862; Holloway, John W/0000-0001-9998-0464; Bisgaard, Hans/0000-0003-4131-7592; Gupta, Ramneek/0000-0001-6841-6676; Rasmussen, Morten/0000-0001-7431-5206; Thomsen, Philip Francis/0000-0002-9867-4366; Custovic, Adnan/0000-0001-5218-7071; Kreiner, Eskil/0000-0003-1204-2438; Bonnelykke, Klaus/0000-0003-2003-1018; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Davies, Donna/0000-0002-5117-2991; Nielsen, Kasper/0000-0002-5510-7767; Torrents, David/0000-0002-6086-9037; Mercader, Josep M/0000-0001-8494-3660; Paternoster, Lavinia/0000-0003-2514-0889; smart, David/0000-0002-1411-723X; Simpson, Angela/0000-0003-2733-6666; Husby, Anders/0000-0002-7634-8455	Medical Research Council [G0601361, MR/K002449/1, G0501506, G0900453] Funding Source: Medline; NHGRI NIH HHS [U01 HG006830] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830] Funding Source: NIH RePORTER; Lundbeck Foundation [R16-2007-1694] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Asthma UK [11/010] Funding Source: researchfish; MRC [G0900453, G0501506, MR/K002449/1, G0601361] Funding Source: UKRI; ICREA Funding Source: Custom	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Lundbeck Foundation(Lundbeckfonden); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ICREA(ICREA)		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hollegaard MV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-58; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Iskandar A, 2012, THORAX, V67, P252, DOI 10.1136/thoraxjnl-2011-200324; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kho AT, 2010, AM J RESP CRIT CARE, V181, P54, DOI 10.1164/rccm.200907-1063OC; Kocevar VS, 2004, CHEST, V125, P1680, DOI 10.1378/chest.125.5.1680; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Lowe L, 2002, LANCET, V359, P1904, DOI 10.1016/S0140-6736(02)08781-0; Lozano P, 1999, J ALLERGY CLIN IMMUN, V104, P957, DOI 10.1016/S0091-6749(99)70075-8; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matterne U, 2011, QUAL LIFE RES, V20, P1295, DOI 10.1007/s11136-011-9868-9; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Norgaard-Pedersen B, 2007, J INHERIT METAB DIS, V30, P530, DOI 10.1007/s10545-007-0631-x; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Thomsen SF, 2010, J ALLERGY CLIN IMMUN, V126, P626, DOI 10.1016/j.jaci.2010.06.017; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	54	369	382	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					51	+		10.1038/ng.2830	http://dx.doi.org/10.1038/ng.2830			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24241537				2022-12-17	WOS:000329113500012
J	Birkenhager, R; Otto, E; Schurmann, MJ; Vollmer, M; Ruf, EM; Maier-Lutz, I; Beekmann, F; Fekete, A; Omran, H; Feldmann, D; Milford, DV; Jeck, N; Konrad, M; Landau, D; Knoers, NVAM; Antignac, C; Sudbrak, R; Kispert, A; Hildebrandt, F				Birkenhager, R; Otto, E; Schurmann, MJ; Vollmer, M; Ruf, EM; Maier-Lutz, I; Beekmann, F; Fekete, A; Omran, H; Feldmann, D; Milford, DV; Jeck, N; Konrad, M; Landau, D; Knoers, NVAM; Antignac, C; Sudbrak, R; Kispert, A; Hildebrandt, F			Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure	NATURE GENETICS			English	Article							LANGE-NIELSEN-SYNDROME; CHLORIDE CHANNEL GENE; POTASSIUM CHANNEL; CAUSE JERVELL; HUMAN GENOME; COTRANSPORTER; LOCALIZATION; MAP; HETEROGENEITY; PROTEIN	Antenatal Bartter syndrome (aBS) comprises a heterogeneous group of autosomal recessive salt-losing nephropathies'. identification of three genes that code for renal transporters and channels as responsible for aBS(2-7) has resulted in new insights into renal salt handling, diuretic action and blood-pressure regulations. A gene locus of a fourth variant of aBS called BSND, which in contrast to the other forms is associated with sensorineural deafness (SND) and renal failure, has been mapped to chromosome 1p(9). We report here the identification by positional cloning, in a region not covered by the human genome sequencing projects, of a new gene, BSND, as the cause of BSND. We examined ten families with BSND and detected seven different mutations in BSND that probably result in loss of function. In accordance with the phenotype, BSND is expressed in the thin limb and the thick ascending limb of the loop of Henle in the kidney and in the dark cells of the inner ear. The gene encodes a hitherto unknown protein with two putative transmembrane a-helices and thus might function as a regulator for ion-transport proteins involved in aBS, or else as a new transporter or channel itself.	Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany; Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; Armand Trousseau Hosp, Dept Biochem, Paris, France; Birmingham Childrens Hosp, Birmingham, W Midlands, England; Univ Marburg, Childrens Hosp, Marburg, Germany; Soroka Med Ctr, Dept Pediat, IL-84101 Beer Sheva, Israel; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Hop Necker Enfants Malad, INSERM U423, Paris, France; Max Planck Inst Mol Genet, Berlin, Germany; Hannover Med Sch, Inst Mol Biol, Hannover, Germany	University of Freiburg; Semmelweis University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Birmingham; Philipps University Marburg; Ben Gurion University; Soroka Medical Center; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; Hannover Medical School	Hildebrandt, F (corresponding author), Univ Freiburg, Childrens Hosp, Hugstetter Str 55, D-79106 Freiburg, Germany.	hildebra@kikli.ukl.uni-freiburg.de	ANTIGNAC, Corinne/H-8945-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Otto, Edgar/0000-0002-2387-9973	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088767] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK088767] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brennan TMH, 1998, AM J HUM GENET, V62, P355, DOI 10.1086/301708; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Karolyi L, 1997, HUM MOL GENET, V6, P17; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; Kockerling A, 1996, J PEDIATR-US, V129, P519, DOI 10.1016/S0022-3476(96)70116-6; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Nicolas MT, 2001, HEARING RES, V153, P132, DOI 10.1016/S0378-5955(00)00268-9; Nothwang HG, 1998, GENOMICS, V47, P276, DOI 10.1006/geno.1997.5102; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Rodriguez-Soriano J, 1998, PEDIATR NEPHROL, V12, P315, DOI 10.1007/s004670050461; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; TYSON KP, 1997, HUM MOL GENET, V6, P2179; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vollmer M, 2000, NEPHROL DIAL TRANSPL, V15, P970, DOI 10.1093/ndt/15.7.970; Yoshikawa M, 1999, AM J PHYSIOL-RENAL, V276, pF552, DOI 10.1152/ajprenal.1999.276.4.F552	31	369	382	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					310	314		10.1038/ng752	http://dx.doi.org/10.1038/ng752			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687798				2022-12-17	WOS:000171911000018
